FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Gomes, ASL
   Falcao, EL
   de Araujo, CB
   Rativa, D
   de Araujo, RE
AF Gomes, A. S. L.
   Falcao Filho, E. L.
   de Araujo, Cid B.
   Rativa, Diego
   de Araujo, R. E.
TI Thermally managed eclipse Z-scan
SO OPTICS EXPRESS
LA English
DT Article
ID HIGH-REPETITION-RATE; RESOLVED Z-SCAN; SINGLE-BEAM; OPTICAL
   NONLINEARITIES; RATE LASERS; ABSORPTION; REFRACTION; PHASE
AB We report a new variation of the conventional Z-scan method to characterize the third-order optical nonlinearity of photonic materials. By exploiting the combination of the eclipse Z-scan with a thermal nonlinearity management technique, we demonstrate an improvement in sensitivity and flexibility of the method to simultaneously characterize the thermal and nonthermal nonlinearity of optical materials. The method is demonstrated by measuring the nonlinear refractive index in CS2, SiO2 and H2O, standard materials, and also in a biomaterial, the amino acid Tryptophan in water solution, using a femtosecond Ti-Sapphire laser operating at 76MHz repetition rate. (c) 2007 Optical Society of America.
C1 Univ Fed Pernambuco, Dept Fis, BR-50670901 Recife, PE, Brazil.
   Univ Fed Pernambuco, Dept Elect & Sist, BR-50740530 Recife, PE, Brazil.
RP Gomes, ASL (reprint author), Univ Fed Pernambuco, Dept Fis, BR-50670901 Recife, PE, Brazil.
EM anderson@df.ufpe.br
RI Falcao-Filho, Edilson/K-6851-2013; de Araujo, Renato/G-8540-2014; de
   Araujo, Cid/A-5565-2009; Rativa, Diego/Q-7011-2016
OI Falcao-Filho, Edilson/0000-0003-0600-4523; de Araujo,
   Renato/0000-0003-2026-070X; de Araujo, Cid/0000-0003-1205-9467; Rativa,
   Diego/0000-0002-5256-5279
CR Boyd R. W., 2002, NONLINEAR OPTICS
   CASTILLO J, 1994, OPT LETT, V19, P171, DOI 10.1364/OL.19.000171
   CHEN LXQ, 1988, J PHYS CHEM-US, V92, P4811, DOI 10.1021/j100327a049
   DESALVO R, 1993, OPT LETT, V18, P194, DOI 10.1364/OL.18.000194
   Falconieri M, 1999, APPL PHYS B-LASERS O, V69, P133, DOI 10.1007/s003400050785
   Falconieri M, 1999, J OPT A-PURE APPL OP, V1, P662, DOI 10.1088/1464-4258/1/6/302
   Gnoli A, 2005, OPT EXPRESS, V13, P7976, DOI 10.1364/OPEX.13.007976
   Levenson M., 1982, INTRO NONLINEAR LASE
   MA H, 1991, APPL PHYS LETT, V59, P2666, DOI 10.1063/1.105933
   OLIVEIRA LC, 1994, APPL PHYS LETT, V65, P2121, DOI 10.1063/1.112809
   PETROV DV, 1994, APPL PHYS LETT, V65, P1067, DOI 10.1063/1.112175
   PETROV DV, 1994, PHYS REV B, V50, P9092, DOI 10.1103/PhysRevB.50.9092
   Rodrigues JJ, 2002, OPT MATER, V20, P153, DOI 10.1016/S0925-3467(02)00062-9
   SHEIKBAHAE M, 1990, IEEE J QUANTUM ELECT, V26, P760, DOI 10.1109/3.53394
   SHEIKBAHAE M, 1992, OPT LETT, V17, P260
   Sutherland R. L., 1996, HDB NONLINEAR OPTICS
   Tai SP, 2006, OPT EXPRESS, V14, P6178, DOI 10.1364/OE.14.006178
   Taylor AJ, 1996, OPT LETT, V21, P1812, DOI 10.1364/OL.21.001812
   WANG J, 1994, J OPT SOC AM B, V11, P1009, DOI 10.1364/JOSAB.11.001009
   XIA T, 1994, OPT LETT, V19, P317, DOI 10.1364/OL.19.000317
NR 20
TC 30
Z9 30
U1 0
U2 12
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1094-4087
J9 OPT EXPRESS
JI Opt. Express
PD FEB 19
PY 2007
VL 15
IS 4
BP 1712
EP 1717
DI 10.1364/OE.15.001712
PG 6
WC Optics
SC Optics
GA 142WV
UT WOS:000244682500039
PM 19532408
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Wang, DG
   Chen, CZ
   Ma, J
   Lei, TQ
AF Wang, Diangang
   Chen, Chuanzhong
   Ma, Jie
   Lei, Tingquan
TI Microstructure of yttric calcium phosphate bioceramic coatings
   synthesized by laser cladding
SO APPLIED SURFACE SCIENCE
LA English
DT Article
DE biomaterial; yttria; microstructure; laser cladding
ID ND-YAG LASER; HYDROXYAPATITE COATINGS; THIN-FILMS; DEPOSITED
   HYDROXYAPATITE; STAINLESS-STEEL
AB The yttric calcium phosphate (CaP) coatings were in situ prepared on pure titanium substrate by laser cladding. The morphologies and phases constitution of CaP coatings were studied by electron probe microanalysis, X-ray diffraction and so on. The bonding state between the coating and the substrate is fine metallurgical combination, and the addition of yttria can fine the structure and increase the tensile strength of the coatings. The X-ray result shows that the coating is composed of the phases of HA, alpha-Ca2P2O7, beta-Ca2P2O7 and CaTiO3. (c) 2006 Elsevier B.V. All rights reserved.
C1 Shandong Univ, Sch Mat Sci & Engn, Jinan 250061, Peoples R China.
   Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Peoples R China.
RP Chen, CZ (reprint author), Shandong Univ, Sch Mat Sci & Engn, Jinan 250061, Peoples R China.
EM czchen@sdu.edu.cn
OI Chen, Chuanzhong/0000-0003-4044-6915; Wang, Diangang/0000-0003-4980-116X
CR Bezzi G, 2003, MATER CHEM PHYS, V78, P816, DOI 10.1016/S0254-0584(02)00392-9
   CHEN C, 2003, ORTHOP BIOMECH MAT C, V1, P51
   Ding SJ, 2003, SURF COAT TECH, V165, P248, DOI 10.1016/S0257-8972(02)00745-4
   Donazzon B, 1998, ANN CHIM-SCI MAT, V23, P53, DOI 10.1016/S0151-9107(98)80010-X
   Fernandez-Pradas JM, 2002, APPL SURF SCI, V195, P31, DOI 10.1016/S0169-4332(02)00002-8
   Ferro D, 2005, BIOMATERIALS, V26, P805, DOI 10.1016/j.biomaterials.2004.03.027
   Gan L, 2005, BIOMATERIALS, V26, P189, DOI 10.1016/j.biomaterials.2004.02.022
   Gao Jia-cheng, 2003, Chinese Journal of Nonferrous Metals, V13, P675
   Guo GS, 2005, CERAM INT, V31, P869, DOI 10.1016/j.ceramint.2004.10.003
   Hwang K, 2000, SURF COAT TECH, V123, P252, DOI 10.1016/S0257-8972(99)00512-5
   Khor KA, 2004, BIOMATERIALS, V25, P4009, DOI 10.1016/j.biomaterials.2003.10.089
   Liu DM, 2002, BIOMATERIALS, V23, P691, DOI 10.1016/S0142-9612(01)00157-0
   Lu X, 2004, BIOMATERIALS, V25, P1779, DOI 10.1016/j.biomaterials.2003.08.028
   Lusquinos F, 2005, APPL SURF SCI, V247, P486, DOI 10.1016/j.apsusc.2005.01.134
   Meng QW, 2005, MATER LETT, V59, P2774, DOI 10.1016/j.matlet.2005.03.056
   Nistor LC, 2004, MATER RES BULL, V39, P2089, DOI 10.1016/j.materresbull.2004.07.006
   Socol G, 2004, BIOMATERIALS, V25, P2539, DOI 10.1016/j.biomaterials.2003.09.044
   Sridhar TM, 2003, CORROS SCI, V45, P237, DOI 10.1016/S0010-938X(02)00091-4
   Sun LM, 2001, J BIOMED MATER RES, V58, P570, DOI 10.1002/jbm.1056.abs
   Tian YS, 2005, APPL SURF SCI, V242, P177, DOI 10.1016/j.apsusc.2004.08.011
   Wang C, 2002, MATER LETT, V57, P99, DOI 10.1016/S0167-577X(02)00706-1
NR 21
TC 28
Z9 29
U1 2
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-4332
J9 APPL SURF SCI
JI Appl. Surf. Sci.
PD FEB 15
PY 2007
VL 253
IS 8
BP 4016
EP 4020
DI 10.1016/j.apsusc.2006.08.036
PG 5
WC Chemistry, Physical; Materials Science, Coatings & Films; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 142NL
UT WOS:000244656600047
DA 2018-10-19
ER

PT J
AU Remant, BKC
   Aryal, S
   Bhattarai, SR
   Khil, MS
   Kim, HY
AF Remant, Bahadur K. C.
   Aryal, Santosh
   Bhattarai, Shanta Raj
   Khil, Myung Seob
   Kim, Hak Yong
TI Amphiphilic triblock copolymer based on poly(p-dioxanone) and
   poly(ethylene glycol): Synthesis, characterization, and aqueous
   dispersion
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE block copolymer; biomaterial; coprecipitation; nanoparticles;
   polymerization
ID DRUG-RELEASE BEHAVIORS; PLA-PEG NANOPARTICLES; BLOCK-COPOLYMERS;
   HYDROLYTIC DEGRADATION; EPSILON-CAPROLACTONE; MICELLE FORMATION;
   P-DIOXANONE; 1,4-DIOXAN-2-ONE; MICELLIZATION; DELIVERY
AB Amphiphilic triblock copolymers composed of poly(p-dioxanone) (PPDO) and poly(ethylene glycol) (PEG) were synthesized by ring opening polymerization of PDO initiated through dihydroxyl-terminated PEG in the presence of stannous 2-ethylhexanoate [Sn(oct)(2)] as a catalyst. Polymeric nanoparticles were prepared in an aqueous medium (triple distilled water and phosphate buffer pH 7.4) by cosolvent evaporation technique at room temperature (25 degrees C). Stability of nanoparticles was significantly enough in triple distilled water when compared with the phosphate buffer. Core-shell geometry of polymeric nanoparticles was characterized by H-1-NMR spectroscopy and further confirmed by spectrophotometric analysis using pyrene as a probe. Variation in physicochemical characteristics of polymeric nanoparticles with the fraction of PPDO was investigated through the analysis of microscopic, spectroscopic, and light scattering techniques. Critical micelle concentration of polymer in triple distilled water decreased from 2.3 x 10(-3) to 4.7 x 10(-3). Atomic force microscopic observation revealed that polymeric nanoparticles were spherical and uniform with smooth textured of around 50-68 nm diameter. Dynamic light scattering and electrophoretic light scattering measurements showed a mono-disperse size distribution of around 113-171 nm hydrodynamic diameters and negative zeta zeta-potential (-4.00 to -5.87 mV), respectively. The investigation showed a significant effect of polymeric composition on the physicochemical characteristic of polymeric nanoparticles. (c) 2006 Wiley Periodicals, Inc.
C1 Chonbuk Natl Univ, Dept Text Engn, Jeonju 561756, South Korea.
   Chonbuk Natl Univ, Dept Bionanosyst Engn, Jeonju 561756, South Korea.
   Chonbuk Natl Univ, Ctr Healthcare Technol Dev, Jeonju 561756, South Korea.
RP Kim, HY (reprint author), Chonbuk Natl Univ, Dept Text Engn, Jeonju 561756, South Korea.
EM khy@moak.chonbuk.ac.kr
RI Kim, Hak Yong/G-3826-2013
OI Kim, Hak Yong/0000-0002-4133-124X; KC, Remant/0000-0002-3554-7247
CR Allen C, 1999, COLLOID SURFACE B, V16, P3, DOI 10.1016/S0927-7765(99)00058-2
   Bhattarai N, 2003, EUR POLYM J, V39, P1603, DOI 10.1016/S0014-3057(03)00057-0
   Bhattarai N, 2003, EUR POLYM J, V39, P1365, DOI 10.1016/S0014-3057(02)00389-0
   Bhattarai N, 2004, J POLYM SCI POL PHYS, V42, P2558, DOI 10.1002/polb.20118
   Bhattarai N, 2002, POLYM DEGRAD STABIL, V78, P423, DOI 10.1016/S0141-3910(02)00178-7
   BHATTARAI N, 2003, J POLYM INT, V52, P6
   Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3
   CERRAI P, 1989, POLYMER, V30, P338, DOI 10.1016/0032-3861(89)90126-2
   GAO ZS, 1993, MACROMOLECULES, V26, P7353, DOI 10.1021/ma00078a035
   Ge HX, 2002, J PHARM SCI, V91, P1463, DOI 10.1002/jps.10143
   Govender T, 2000, INT J PHARMACEUT, V199, P95, DOI 10.1016/S0378-5173(00)00375-6
   GREF R, 1994, SCIENCE, V263, P1600, DOI 10.1126/science.8128245
   GRISLAIN L, 1983, INT J PHARM, V15, P335, DOI 10.1016/0378-5173(83)90166-7
   HEROLD DA, 1989, BIOCHEM PHARMACOL, V38, P73, DOI 10.1016/0006-2952(89)90151-2
   HUATAN H, 1995, J MICROENCAPSUL, V12, P557, DOI 10.3109/02652049509006786
   Jain NJ, 2000, COLLOID SURFACE A, V173, P85, DOI 10.1016/S0927-7757(99)00514-2
   Kabanov AV, 2002, ADV DRUG DELIVER REV, V54, P759, DOI 10.1016/S0169-409X(02)00047-9
   Kim SY, 1998, J CONTROL RELEASE, V51, P13, DOI 10.1016/S0168-3659(97)00124-7
   KOSSOVSKY N, 1993, BIO-TECHNOL, V11, P1534, DOI 10.1038/nbt1293-1534
   Kricheldorf HR, 1998, MACROMOL CHEM PHYSIC, V199, P1089, DOI 10.1002/macp.1998.021990624
   Luo LB, 2004, MACROMOLECULES, V37, P4008, DOI 10.1021/ma035910q
   Nishida H, 2000, MACROMOLECULES, V33, P6982, DOI 10.1021/ma000457t
   OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610
   PETRAK K, 1993, DRUGS PHARM SCI, V61, P275
   Rashkov I, 1996, MACROMOLECULES, V29, P50, DOI 10.1021/ma950530t
   RICHTER AW, 1987, ARCH ALLERGY APPL IM, V38, P73
   Riley T, 1999, COLLOID SURFACE B, V16, P147, DOI 10.1016/S0927-7765(99)00066-1
   Ruel-Gariepy E, 2002, J CONTROL RELEASE, V82, P373, DOI 10.1016/S0168-3659(02)00146-3
   SCHACT EH, 1997, ACS SYM SER, P297
   TUZAR Z, 1976, ADV COLLOID INTERFAC, V6, P201, DOI 10.1016/0001-8686(76)80009-7
   Wang H, 1998, J APPL POLYM SCI, V68, P2121, DOI 10.1002/(SICI)1097-4628(19980627)68:13<2121::AID-APP8>3.0.CO;2-E
   WILLELM M, 1991, MACROMOLECULES, V24, P1033
   ZHAO CL, 1990, LANGMUIR, V6, P514, DOI 10.1021/la00092a038
NR 33
TC 8
Z9 9
U1 1
U2 11
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD FEB 15
PY 2007
VL 103
IS 4
BP 2695
EP 2702
DI 10.1002/app.25429
PG 8
WC Polymer Science
SC Polymer Science
GA 119LN
UT WOS:000243013900082
DA 2018-10-19
ER

PT J
AU Vadiraj, A
   Kamaraj, M
   Gnanamoorthy, R
AF Vadiraj, Aravind
   Kamaraj, M.
   Gnanamoorthy, R.
TI Fretting wear studies on uncoated, plasma nitrided and laser nitrided
   biomedical titanium alloys
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE biomaterial; titanium alloys; plasma nitriding; laser nitriding;
   fretting wear
ID TI-6AL-4V ALLOY; SURFACE MODIFICATION; DISCHARGE; BEHAVIOR
AB Fretting wear resistance of uncoated and surface modified biomedical titanium alloys (Ti-6Al-7Nb) in air and Ringer fluid has been investigated in the present work. Laser nitrided specimen has shown superior performance with minimum surface damage and wear rate (< 0.1 X 10(-6) mm(3)/Nm) despite high friction coefficient in air (0.6) compared to uncoated and plasma nitrided (> 12 x 10(-6) mm(3)/Nm) specimens. This is due to presence of TiN dendrites (60-80%) in the laser nitrided layer. Plasma nitrided surface is relatively softer and hence wear rates and surface damage are comparable with uncoated alloys. Friction coefficient is high for uncoated (0.8) and plasma nitrided alloys (0.6) in air as well as Ringer fluid. Fretting induced electrochemical dissolution is responsible for higher wear rates in uncoated and plasma nitrided specimens. The fretting damage resistance is primarily governed by relative hardness and modified layer thickness of the mating components. (c) 2006 Elsevier B.V. All rights reserved.
C1 Indian Inst Technol, Dept Met & Mat Engn, Madras 600036, Tamil Nadu, India.
   Indian Inst Technol, Dept Mech Engn, Madras 600036, Tamil Nadu, India.
RP Vadiraj, A (reprint author), Indian Inst Technol, Dept Met & Mat Engn, Madras 600036, Tamil Nadu, India.
EM kamaraj@iitm.ac.in
RI R, Gnanamoorthy/M-6186-2017
OI R, Gnanamoorthy/0000-0001-6357-7219; M, Kamaraj/0000-0002-7170-3083
CR Alves C, 2005, SURF COAT TECH, V194, P196, DOI 10.1016/j.surfcoat.2004.10.009
   Carpene E, 2005, APPL SURF SCI, V247, P307, DOI 10.1016/j.apsusc.2005.01.059
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Ettaqi S, 1998, SURF COAT TECH, V100, P428, DOI 10.1016/S0257-8972(97)00664-6
   Galliano F, 2001, SURF COAT TECH, V145, P121, DOI 10.1016/S0257-8972(01)01309-3
   GOKUL LS, 2004, TRIBOL INT, V37, P627
   Hallab NJ, 2003, CORROS REV, V21, P183
   Hu C, 1999, MAT SCI ENG A-STRUCT, V265, P268, DOI 10.1016/S0921-5093(98)01135-6
   LEYENS C, 2004, TITANIUM TITANIUM AL, pCH5
   Liang H, 2004, VACUUM, V73, P317, DOI 10.1016/j.vacuum.2003.12.160
   Ma SL, 2004, SURF COAT TECH, V185, P205, DOI 10.1016/j.surfcoat.02003.11.028
   Man HC, 2005, SURF COAT TECH, V192, P341, DOI 10.1016/j.surfcoat.2004.07.076
   Mishra SC, 2003, J MATER PROCESS TECH, V132, P143, DOI 10.1016/S0924-0136(02)00840-3
   Ramesh R, 2006, MATER DESIGN, V27, P141, DOI 10.1016/j.matdes.2004.09.017
   Selamat MS, 2001, J MATER PROCESS TECH, V113, P509, DOI 10.1016/S0924-0136(01)00595-7
   Sobiecki JR, 2001, VACUUM, V64, P41, DOI 10.1016/S0042-207X(01)00373-6
   Sumita M., 2003, COMPREHENSIVE STRUCT, P131
   Tian YS, 2005, APPL SURF SCI, V242, P177, DOI 10.1016/j.apsusc.2004.08.011
   Wei RH, 2004, SURF COAT TECH, V186, P305, DOI 10.1016/j.surfcoat.2004.02.052
NR 19
TC 23
Z9 28
U1 0
U2 9
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD FEB 15
PY 2007
VL 445
BP 446
EP 453
DI 10.1016/j.msea.2006.09.086
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 137OI
UT WOS:000244301500057
DA 2018-10-19
ER

PT J
AU Lin, JJ
   Wei, JC
   Juang, TY
   Tsai, WC
AF Lin, Jiang-Jen
   Wei, Jiun-Chiou
   Juang, Tzong-Yuan
   Tsai, Wei-Cheng
TI Preparation of protein-silicate hybrids from polyamine intercalation of
   layered montmorillonite
SO LANGMUIR
LA English
DT Article
ID CONFORMATIONAL-CHANGE; ADSORPTION; NANOCOMPOSITES; IMMOBILIZATION;
   NANOPARTICLES; CONFINEMENT; COMPLEXES; MEMBRANES; POLYMERS; FILMS
AB Hybrids of the model BSA protein and layered silicate clay with d spacing of similar to 62 A were prepared from either direct or stepwise intercalation. The pristine montmorilloinite (Na+-MMT) was first modified by poly(oxyalkylene)-amine salts (POP- and POE-amine) of 2000 g/mol M-w to a gallery-expanded silicate (d spacing = 53 and 18 A, respectively), which became accessible for BSA protein embedding. Subsequent BSA substitution allowed the embedding of the protein into the layered clay galleries in an uncompressed conformation. The stepwise process of embedding large molecules into the silicate gallery provides a new method for synthesizing biomaterial/clay hybrids potentially useful in drug delivery or biomedical design.
C1 Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10617, Taiwan.
RP Lin, JJ (reprint author), Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10617, Taiwan.
EM jianglin@ntu.edu.tw
OI LIN, JIANG-JEN/0000-0002-8704-9653
CR Baron MH, 1999, J COLLOID INTERF SCI, V214, P319, DOI 10.1006/jcis.1999.6189
   Cao CX, 2005, ANAL CHEM, V77, P955, DOI 10.1021/ac049470s
   Causserand C, 2001, J MEMBRANE SCI, V186, P165, DOI 10.1016/S0376-7388(01)00332-5
   Chou CC, 2004, MACROMOLECULES, V37, P473, DOI 10.1021/ma0343941
   Chou CC, 2003, MACROMOLECULES, V36, P2187, DOI 10.1021/ma025773h
   Choy J. H., 2000, ANGEW CHEM INT EDIT, V22, P4041
   Choy JH, 1999, J AM CHEM SOC, V121, P1399, DOI 10.1021/ja981823f
   De Cristofaro A, 2001, APPL CLAY SCI, V19, P59, DOI 10.1016/S0169-1317(01)00047-3
   Dumat C, 2000, ENVIRON SCI TECHNOL, V34, P2985, DOI 10.1021/es990657o
   Fu X, 2001, POLYMER, V42, P807, DOI 10.1016/S0032-3861(00)00385-2
   Giannelis EP, 1996, ADV MATER, V8, P29, DOI 10.1002/adma.19960080104
   Gil ES, 2004, PROG POLYM SCI, V29, P1173, DOI 10.1016/j.progpolymsci.2004.08.003
   Kelleher BP, 2003, LANGMUIR, V19, P9411, DOI 10.1021/la034971e
   Lin JJ, 2003, MACROMOL RAPID COMM, V24, P492, DOI 10.1002/marc.200390073
   Lin JJ, 2001, MACROMOLECULES, V34, P8832, DOI 10.1021/ma011169f
   Liu YL, 2005, BIOMACROMOLECULES, V6, P368, DOI 10.1021/bm049531w
   LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026
   Mikhaylova M, 2004, CHEM MATER, V16, P2344, DOI 10.1021/cm0348904
   MOHAMMED J, 2003, J AM CHEM SOC, V125, P8015
   Musale DA, 1997, J MEMBRANE SCI, V136, P13, DOI 10.1016/S0376-7388(97)00179-8
   Naidja A, 1997, J MOL CATAL A-CHEM, V115, P305, DOI 10.1016/S1381-1169(96)00335-4
   Ray SS, 2003, PROG POLYM SCI, V28, P1539, DOI 10.1016/j.progpolymsci.2003.08.002
   Shchukin DG, 2005, SMALL, V1, P510, DOI 10.1002/smll.200400120
   Wang QG, 2004, J AM CHEM SOC, V126, P14346, DOI 10.1021/ja047224s
   Zhou YL, 2002, LANGMUIR, V18, P211, DOI 10.1021/la010834a
NR 25
TC 52
Z9 55
U1 0
U2 25
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD FEB 13
PY 2007
VL 23
IS 4
BP 1995
EP 1999
DI 10.1021/la062013h
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 133CW
UT WOS:000243990200057
PM 17279686
DA 2018-10-19
ER

PT J
AU Zhang, HZ
   Hayashi, T
   Tsuru, K
   Deguchi, K
   Nagdhara, M
   Hayakawa, S
   Nagai, M
   Kamiya, T
   Osaka, A
   Abe, K
AF Zhang, HanZhe
   Hayashi, Takeshi
   Tsuru, Kanji
   Deguchi, Kentaro
   Nagdhara, Mitsuyuki
   Hayakawa, Satoshi
   Nagai, Makiko
   Kamiya, Tatsushi
   Osaka, Akiyoshi
   Abe, Koji
TI Vascular endothelial growth factor promotes brain tissue regeneration
   with a novel biomaterial polydimethylsiloxane-tetraethoxysilane
SO BRAIN RESEARCH
LA English
DT Article
DE brain; scaffold; tissue regeneration; vascular endothelial growth factor
ID SPINAL-CORD; AXON REGENERATION; BIOMEDICAL APPLICATIONS; FUNCTIONAL
   RECOVERY; CELLS SECRETE; ADULT-RAT; IN-VIVO; ANGIOGENESIS; HYDROGELS;
   TRANSPLANTATION
AB In the brain after infarction or trauma, the tissue eventually becomes pannecrotic and forms a cavity. In such situations, a scaffold is necessary for the implanted or migrated cells to produce new tissue. In this present study, therefore, we attempted to restore brain tissue using a novel biomaterial, polydimethylsiloxane-tetraethoxysilane (PDMS-TEOS) hybrid with or without vascular endothelial growth factor (VEGF), which is crucial for new vessel formation. When PDMS-TEOS scaffold was implanted into the artificial brain defect, it remained at the implanted site and kept the integrity of the brain shape. At 30 days after the implantation, the marginal territory of PDMS-TEOS scaffold became occupied by newly formed tissue. Immunohistochemical analysis revealed that the new tissue was constituted by astrocytes and endothelial cells. Addition of VEGF increased the newly produced tissue volume, and the immunohistochemical analysis showed that the numbers of astrocytes and endothelial cells were increased. Double staining with proliferation maker Ki67 demonstrated that VEGF significantly increased newly formed astrocytes and endothelial cells, indicating that addition of VEGF accelerated tissue restoration and angiogenesis. These findings show that implantation of PDMS-TEOS scaffold with VEGF might be effective for treating old brain infarction or trauma. (c) 2006 Elsevier B.V. All rights reserved.
C1 Okayama Univ, Grad Sch Med, Dept Neurol, Okayama 7008558, Japan.
   Okayama Univ, Grad Sch Nat Sci & Technol, Biomat Lab, Okayama 7008558, Japan.
RP Abe, K (reprint author), Okayama Univ, Grad Sch Med, Dept Neurol, 2-5-1 Shikata Cho, Okayama 7008558, Japan.
EM neurotakeshi@hotmail.com
RI HAYAKAWA, Satoshi/B-2104-2011
OI HAYAKAWA, Satoshi/0000-0002-1097-8614
CR AUBERT I, 1995, CURR OPIN NEUROBIOL, V5, P625, DOI 10.1016/0959-4388(95)80068-9
   AUGUSTIN HG, 1995, AM J PATHOL, V147, P339
   Bani-Yaghoub M, 2005, BIOTECHNOL BIOENG, V92, P336, DOI 10.1002/bit.20618
   BELLAMKONDA R, 1995, J BIOMED MATER RES, V29, P663, DOI 10.1002/jbm.820290514
   Chang JC, 2003, BIOMATERIALS, V24, P2863, DOI 10.1016/S0142-9612(03)00116-9
   DEGUCHI K, 2006, J CEREB BLOOD FLOW M, V1, P1
   FERRARA N, 1989, BIOCHEM BIOPH RES CO, V161, P851, DOI 10.1016/0006-291X(89)92678-8
   FLAMME I, 1995, DEV BIOL, V171, P399, DOI 10.1006/dbio.1995.1291
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016
   Huang DW, 1999, NEURON, V24, P639, DOI 10.1016/S0896-6273(00)81118-6
   JAKEMAN LB, 1993, ENDOCRINOLOGY, V133, P848, DOI 10.1210/en.133.2.848
   Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9
   Kataoka K, 2005, BIOMATERIALS, V26, P2509, DOI 10.1016/j.biomaterials.2004.07.012
   Kataoka K, 2001, J BIOMED MATER RES, V54, P373, DOI 10.1002/1097-4636(20010305)54:3<373::AID-JBM90>3.0.CO;2-Q
   Krum JM, 2002, NEUROSCIENCE, V110, P589, DOI 10.1016/S0306-4522(01)00615-7
   KRUM JM, 2002, EXP NEUROL, V181, P241
   Lakatos A, 2003, EXP NEUROL, V184, P237, DOI 10.1016/S0014-4886(03)00270-X
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lesny P, 2002, J CHEM NEUROANAT, V23, P243, DOI 10.1016/S0891-0618(02)00011-X
   McKerracher L, 2001, NEUROBIOL DIS, V8, P11, DOI 10.1006/nbdi.2000.0359
   Papadopoulos CM, 2002, ANN NEUROL, V51, P433, DOI 10.1002/ana.10144
   PLATE KH, 1992, NATURE, V359, P845, DOI 10.1038/359845a0
   PORTER GA, 1990, EUR J CELL BIOL, V51, P85
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Ren L, 2001, J SOL-GEL SCI TECHN, V21, P115, DOI 10.1023/A:1011226104173
   Rosenstein JM, 1998, P NATL ACAD SCI USA, V95, P7086, DOI 10.1073/pnas.95.12.7086
   Scholl M, 2000, J NEUROSCI METH, V104, P65, DOI 10.1016/S0165-0270(00)00325-3
   SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562
   SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0
   SILVER J, 1988, CLIN RES, V36, P196
   Silverman WF, 1999, NEUROSCIENCE, V90, P1529, DOI 10.1016/S0306-4522(98)00540-5
   Sun YJ, 2003, J CLIN INVEST, V111, P1843, DOI 10.1172/JCI200317977
   Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513
   Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467
   WOERLY S, 1993, BIOMATERIALS, V14, P1056, DOI 10.1016/0142-9612(93)90205-G
   Woerly S, 2001, J NEUROSCI RES, V66, P1187
   Yabuta T, 2003, J SOL-GEL SCI TECHN, V26, P1219, DOI 10.1023/A:1020772521781
NR 38
TC 23
Z9 26
U1 1
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0006-8993
J9 BRAIN RES
JI Brain Res.
PD FEB 9
PY 2007
VL 1132
IS 1
BP 29
EP 35
DI 10.1016/j.brainres.2006.09.117
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA 135RJ
UT WOS:000244170400004
PM 17189618
DA 2018-10-19
ER

PT J
AU Chen, XY
   Wang, J
   Boughton, AP
   Kristalyn, CB
   Chen, Z
AF Chen, Xiaoyun
   Wang, Jie
   Boughton, Andrew P.
   Kristalyn, Cornelius B.
   Chen, Zhan
TI Multiple orientation of melittin inside a single lipid bilayer
   determined by combined vibrational spectroscopic studies
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID SUM-FREQUENCY GENERATION; BOVINE SERUM-ALBUMIN; INFRARED-SPECTROSCOPY;
   MEMBRANE-PROTEINS; SURFACE; INTERFACE; MONOLAYER; PEPTIDES; FILMS; SFG
AB Despite the availability of several mature structure determination techniques for bulk proteins, determination of structural and orientational information of interfacial proteins, e.g., in cell membranes or on biomaterial surfaces, remains a difficult problem. We combine sum frequency generation (SFG) vibrational spectroscopy with attenuated total reflection-Fourier transform infrared spectroscopy (ATR-FTIR) to investigate the orientation of alpha-helical peptides reconstituted in substrate supported lipid bilayers. Melittin was chosen as a model for alpha-helical peptides, and its orientation when interacting with a supported 1,2-dipalmitoyl-sn-glycero-3-phosphoglycerol (DPPG) bilayer has been examined. Through polarization analysis using amide I signals obtained from both SFG and ATR-FTIR measurements, the orientation distribution of melittin inside a DPPG bilayer was deduced using several trial distribution functions. Melittin was modeled as either an ideal helix or a helix with a bent structure. It was found that a simple distribution function such as a delta-distribution or a Gaussian distribution was not adequate to describe the melittin orientation distribution inside a DPPG bilayer. Instead, two populations of melittin, corresponding to two melittin-bilayer association states, could be used to interpret the experimentally observed result. The method employed in this study demonstrates the feasibility of acquiring a more accurate orientation distribution of peptides/proteins in situ using a combination of vibrational spectroscopic techniques without exogenous labeling.
C1 Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
RP Chen, Z (reprint author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.
EM zhanc@umich.edu
RI Chen, Zhan/G-8312-2016
OI Chen, Zhan/0000-0001-8687-8348; Boughton, Andrew/0000-0002-0318-4912
CR Allende D, 2005, BIOPHYS J, V88, P1828, DOI 10.1529/biophysj.104.049817
   Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815
   Beattie DA, 2006, J PHYS CHEM B, V110, P2278, DOI 10.1021/jp056204p
   CHEN X, UNPUB BIOPHYS J
   Chen XY, 2006, J AM CHEM SOC, V128, P2711, DOI 10.1021/ja057029t
   Chen XY, 2005, LANGMUIR, V21, P2662, DOI 10.1021/la050048w
   Constantinescu I, 2004, BBA-BIOMEMBRANES, V1667, P26, DOI 10.1016/j.bbamem.2004.08.012
   DEMPSEY CE, 1990, BIOCHIM BIOPHYS ACTA, V1031, P143, DOI 10.1016/0304-4157(90)90006-X
   Dreesen L, 2004, CHEMPHYSCHEM, V5, P1719, DOI 10.1002/cphc.200400213
   Dreesen L, 2004, LANGMUIR, V20, P7201, DOI 10.1021/la0488001
   Engel A, 2003, HISTOCHEM CELL BIOL, V120, P93, DOI 10.1007/s00418-003-0560-1
   FREY S, 1991, BIOPHYS J, V60, P922, DOI 10.1016/S0006-3495(91)82126-9
   Goormaghtigh E, 1999, BBA-REV BIOMEMBRANES, V1422, P105, DOI 10.1016/S0304-4157(99)00004-0
   HIROSE C, 1992, J CHEM PHYS, V96, P997, DOI 10.1063/1.462120
   Holman J, 2005, J PHYS CHEM B, V109, P18723, DOI 10.1021/jp051564y
   Hristova K, 2001, BIOPHYS J, V80, P801, DOI 10.1016/S0006-3495(01)76059-6
   Jung SY, 2003, J AM CHEM SOC, V125, P12782, DOI 10.1021/ja037263o
   Kataoka S, 2006, J AM CHEM SOC, V128, P5516, DOI 10.1021/ja060156k
   Kim J, 2003, J AM CHEM SOC, V125, P3150, DOI 10.1021/ja028987n
   Ladokhin AS, 2001, BBA-BIOMEMBRANES, V1514, P253, DOI 10.1016/S0005-2736(01)00382-0
   Lee SH, 1998, J RAMAN SPECTROSC, V29, P73, DOI 10.1002/(SICI)1097-4555(199801)29:1<73::AID-JRS210>3.3.CO;2-F
   Lee SH, 1998, BIOPOLYMERS, V46, P283, DOI 10.1002/(SICI)1097-0282(19981015)46:5<283::AID-BIP2>3.0.CO;2-L
   Liu J, 2005, BIOPHYS J, V89, P2522, DOI 10.1529/biophysj.105.065672
   LUDTKE SJ, 1994, BBA-BIOMEMBRANES, V1190, P181, DOI 10.1016/0005-2736(94)90050-7
   Ma G, 2006, LANGMUIR, V22, P5341, DOI 10.1021/la0535227
   Marsh D, 2000, BIOPHYS J, V78, P2499, DOI 10.1016/S0006-3495(00)76795-6
   MEAD LR, 1984, J MATH PHYS, V25, P2404, DOI 10.1063/1.526446
   Mermut O, 2006, J AM CHEM SOC, V128, P3598, DOI 10.1021/ja056031h
   Moad AJ, 2004, J PHYS CHEM B, V108, P3548, DOI 10.1021/jp035362i
   Mohammad-Djafari A. A, 1992, MAXIMUM ENTROPY BAYE, V50, P221
   Opella SJ, 2004, CHEM REV, V104, P3587, DOI 10.1021/cr0304121
   Rintoul L, 2000, BIOPOLYMERS, V57, P19, DOI 10.1002/(SICI)1097-0282(2000)57:1<19::AID-BIP4>3.0.CO;2-Z
   Shen Y. R., 1984, PRINCIPLES NONLINEAR
   Steinem C, 2000, PHYS CHEM CHEM PHYS, V2, P4580, DOI 10.1039/b003865m
   Tamm LK, 1997, Q REV BIOPHYS, V30, P365, DOI 10.1017/S0033583597003375
   Tatulian SA, 2003, BIOCHEMISTRY-US, V42, P11898, DOI 10.1021/bi034235+
   TERWILLIGER TC, 1982, J BIOL CHEM, V257, P6010
   TERWILLIGER TC, 1982, J BIOL CHEM, V257, P6016
   Toraya S, 2004, BIOPHYS J, V87, P3323, DOI 10.1529/biophysj.104.046102
   Wang J, 2002, J AM CHEM SOC, V124, P7016, DOI 10.1021/ja012387r
   Wang J, 2001, J PHYS CHEM B, V105, P12118, DOI 10.1021/jp013161d
   Wang J, 2003, LANGMUIR, V19, P7862, DOI 10.1021/la0349222
   Wang J, 2003, J AM CHEM SOC, V125, P9914, DOI 10.1021/ja036373s
   Wang J, 2003, ANALYST, V128, P773, DOI 10.1039/b212551j
   WANG J, UNPUB
   Watry MR, 2002, LANGMUIR, V18, P8881, DOI 10.1021/la020463d
   Wei X, 2000, PHYS REV E, V62, P5160, DOI 10.1103/PhysRevE.62.5160
   Wiener MC, 2004, METHODS, V34, P364, DOI 10.1016/j.ymeth.2004.03.025
   Yang L, 2001, BIOPHYS J, V81, P1475, DOI 10.1016/S0006-3495(01)75802-X
   Ye S, 2004, LANGMUIR, V20, P357, DOI 10.1021/la036008e
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Zhuang X, 1999, PHYS REV B, V59, P12632, DOI 10.1103/PhysRevB.59.12632
NR 52
TC 121
Z9 123
U1 2
U2 69
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD FEB 7
PY 2007
VL 129
IS 5
BP 1420
EP 1427
DI 10.1021/ja067446I
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 131AL
UT WOS:000243840100062
PM 17263427
DA 2018-10-19
ER

PT J
AU Georgakoudi, I
   Tsai, I
   Greiner, C
   Wong, C
   DeFelice, J
   Kaplan, D
AF Georgakoudi, Irene
   Tsai, Irene
   Greiner, Cherry
   Wong, Cheryl
   DeFelice, Jordy
   Kaplan, David
TI Intrinsic fluorescence changes associated with the conformational state
   of silk fibroin in biomaterial matrices
SO OPTICS EXPRESS
LA English
DT Article
ID MESENCHYMAL STEM-CELLS; LOG-NORMAL COMPONENTS; IN-VITRO; TRYPTOPHAN
   FLUORESCENCE; 3-D SCAFFOLDS; FILMS; DECOMPOSITION; SPECTRA; DITYROSINE;
   ACTIN
AB Silk fibroin is emerging as an important biomaterial for tissue engineering applications. The ability to monitor non-invasively the structural conformation of silk matrices prior to and following cell seeding could provide important insights with regards to matrix remodeling and cell-matrix interactions that are critical for the functional development of silk-based engineered tissues. Thus, we examined the potential of intrinsic fluorescence as a tool for assessing the structural conformation of silk proteins. Specifically, we characterized the intrinsic fluorescence spectra of silk in solution, gel and scaffold configurations for excitation in the 250 to 335 nm range and emission from 265 to 600 nm. We have identified spectral components that are attributed to tyrosine, tryptophan and crosslinks based on their excitation-emission profiles. We have discovered significant spectral shifts in the emission profiles and relative contributions of these components among the silk solution, gel and scaffold samples that represent enhancements in the levels of crosslinking, hydrophobic and intermolecular interactions that are consistent with an increase in the levels of beta-sheet formation and stacking. This information can be easily utilized for the development of simple, non-invasive, ratiometric methods to assess and monitor the structural conformation of silk in engineered tissues. (c) 2007 Optical Society of America.
C1 Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Georgakoudi, I (reprint author), Tufts Univ, Dept Biomed Engn, 4 Colby Str,Rm 153, Medford, MA 02155 USA.
EM Irene.Georgakoudi@tufts.edu
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Altman GH, 2002, J BIOMECH ENG-T ASME, V124, P742, DOI 10.1115/1.1519280
   Burstein EA, 2001, BIOPHYS J, V81, P1699, DOI 10.1016/S0006-3495(01)75823-7
   Cantor C. R., 1980, BIOPHYSICAL CHEM 3
   Doyle TC, 2001, BIOPHYS J, V80, P427, DOI 10.1016/S0006-3495(01)76025-0
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   KAPLAN DL, 1994, SILK POLYM SCI BIOTE, V544
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Karageorgiou V, 2006, J BIOMED MATER RES A, V78A, P324, DOI 10.1002/jbm.a.30728
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kuznetsova IM, 1999, FEBS LETT, V452, P205, DOI 10.1016/S0014-5793(99)00574-8
   Lakowicz J.R., 1999, PRINCIPLES FLUORESCE
   LOTZ B, 1974, J MOL BIOL, V87, P169, DOI 10.1016/0022-2836(74)90141-7
   Malencik DA, 2003, AMINO ACIDS, V25, P233, DOI 10.1007/s00726-003-0014-z
   Malencik DA, 1996, ANAL BIOCHEM, V242, P202, DOI 10.1006/abio.1996.0454
   MARSH RE, 1955, BIOCHIM BIOPHYS ACTA, V16, P1, DOI 10.1016/0006-3002(55)90178-5
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Ratner B.D., 2004, BIOMATERIALS SCI
   Reshetnyak YK, 2001, BIOPHYS J, V81, P1735, DOI 10.1016/S0006-3495(01)75825-0
   Reshetnyak YK, 2001, BIOPHYS J, V81, P1710, DOI 10.1016/S0006-3495(01)75824-9
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   TAULER R, 1994, ANAL CHEM, V66, P3337, DOI 10.1021/ac00092a009
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
NR 35
TC 32
Z9 33
U1 0
U2 32
PU OPTICAL SOC AMER
PI WASHINGTON
PA 2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA
SN 1094-4087
J9 OPT EXPRESS
JI Opt. Express
PD FEB 5
PY 2007
VL 15
IS 3
BP 1043
EP 1053
DI 10.1364/OE.15.001043
PG 11
WC Optics
SC Optics
GA 142WS
UT WOS:000244682200033
PM 19532332
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Dominguez, MM
   Wathier, M
   Grinstaff, MW
   Schaus, SE
AF Dominguez, Melissa M.
   Wathier, Michel
   Grinstaff, Mark W.
   Schaus, Scott E.
TI Immobilized hydrogels for screening of molecular interactions
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID CELL-ADHESION; PROTEIN IMMOBILIZATION; REACTIVE POLYMER; MICROARRAYS;
   DISCOVERY; ARRAYS; DNA; DENDRIMERS; PATTERNS; SURFACES
AB Spatially arrayed, high-density microarrays enable the rapid assessment of biological recognition events, and this information is of widespread interest for those working in basic research laboratories as well as in the clinic. Today, one can find DNA, protein, or small molecule arrays. Limitations with these systems include covalent modification of the target complement to the array substrate, array- and target-dependent setup conditions, multiple steps, and loss of hydration at the surface. To overcome these limitations, we have designed, prepared, and evaluated immobilized hydrogels as general screening chambers for small molecule-protein, protein-protein, and nucleic acid-nucleic acid interactions. This biomaterial-based approach is facile, rapid, requires only one setup protocol, and physically entraps the target complement within the polymer network and thus offers advantages over the conventional chips.
C1 Boston Univ, Dept Biomed Engn, Metcalf Ctr Sci & Engn, Boston, MA 02215 USA.
   Boston Univ, Dept Chem, Metcalf Ctr Sci & Engn, Boston, MA 02215 USA.
RP Grinstaff, MW (reprint author), Boston Univ, Dept Biomed Engn, Metcalf Ctr Sci & Engn, 590 Commonwealth Ave, Boston, MA 02215 USA.
EM mgrin@bu.edu; seschaus@bu.edu
RI Grinstaff, Mark/U-2829-2017
OI Grinstaff, Mark/0000-0002-5453-3668
CR Abbott A, 1999, NATURE, V402, P715, DOI 10.1038/45350
   Afanassiev V, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e66
   Falsey JR, 2001, BIOCONJUGATE CHEM, V12, P346, DOI 10.1021/bc000141q
   Frechet JMJ, 2003, J POLYM SCI POL CHEM, V41, P3713, DOI 10.1002/pola.10952
   GEROLD D, 1999, TRENDS BIOCHEM SCI, V24, P168
   Gong P, 2004, SURF SCI, V570, P67, DOI 10.1016/j.susc.2004.06.181
   Grinstaff MW, 2002, CHEM-EUR J, V8, P2838, DOI 10.1002/1521-3765(20020703)8:13<2838::AID-CHEM2838>3.0.CO;2-I
   Harris RF, 2000, J AM CHEM SOC, V122, P11270, DOI 10.1021/ja0055763
   Hoever M, 2004, DRUG DISCOV TODAY, V9, P358, DOI 10.1016/S1359-6446(04)03037-5
   Hoff A, 2002, CHEMBIOCHEM, V3, P1183, DOI 10.1002/1439-7633(20021202)3:12<1183::AID-CBIC1183>3.0.CO;2-Q
   Hong YL, 2005, J AM CHEM SOC, V127, P15350, DOI 10.1021/ja055101h
   Ito Y, 2003, BIOMATERIALS, V24, P3021, DOI 10.1016/S0142-9612(03)00134-0
   Kanoh N, 2005, ANGEW CHEM INT EDIT, V44, P3559, DOI 10.1002/anie.200462370
   Kanoh N, 2003, ANGEW CHEM INT EDIT, V42, P5584, DOI 10.1002/anie.200352164
   Kiyonaka S, 2004, NAT MATER, V3, P58, DOI 10.1038/nmat1034
   Ko KS, 2005, J AM CHEM SOC, V127, P13162, DOI 10.1021/ja054811k
   LI LS, 1997, MACROMOLECULES, V30, P2110
   MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037
   MacBeath G, 1999, J AM CHEM SOC, V121, P7967, DOI 10.1021/ja991083q
   MacBeath G, 2000, SCIENCE, V289, P1760
   Min DH, 2004, CURR OPIN CHEM BIOL, V8, P554, DOI 10.1016/j.cbpa.2004.08.007
   NEWKOME GR, 1996, DENDRITIC MOL CONCEP, V2
   Orner BP, 2004, J AM CHEM SOC, V126, P10808, DOI 10.1021/ja0474291
   Peppas N. A., 1987, HYDROGELS MED PHARM, P1
   Proudnikov D, 1998, ANAL BIOCHEM, V259, P34, DOI 10.1006/abio.1998.2620
   Rondelez Y, 2005, NAT BIOTECHNOL, V23, P361, DOI 10.1038/nbt1072
   Schena M, 1998, TRENDS BIOTECHNOL, V16, P301, DOI 10.1016/S0167-7799(98)01219-0
   SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467
   Silva JM, 2004, P NATL ACAD SCI USA, V101, P6548, DOI 10.1073/pnas.0400165101
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Sparks AB, 1996, NAT BIOTECHNOL, V14, P741, DOI 10.1038/nbt0696-741
   Tomalia DA, 2002, J POLYM SCI POL CHEM, V40, P2719, DOI 10.1002/pola.10301
   TOMALIA DA, 2002, DENDRIMERS OTHER DEN, P688
   Tomizaki Kin-ya, 2005, Chembiochem, V6, P782, DOI 10.1002/cbic.200400232
   Vaschetto M, 2003, CURR OPIN DRUG DI DE, V6, P377
   Watzke A, 2006, ANGEW CHEM INT EDIT, V45, P1408, DOI 10.1002/anie.200502057
   Yousaf MN, 2001, P NATL ACAD SCI USA, V98, P5992, DOI 10.1073/pnas.101112898
   Zhang KC, 2005, J AM CHEM SOC, V127, P10136, DOI 10.1021/ja051457h
   Zhao ZY, 2005, J AM CHEM SOC, V127, P8930, DOI 10.1021/ja051053p
   Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114
NR 40
TC 19
Z9 19
U1 0
U2 8
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
J9 ANAL CHEM
JI Anal. Chem.
PD FEB 1
PY 2007
VL 79
IS 3
BP 1064
EP 1066
DI 10.1021/ac061709c
PG 3
WC Chemistry, Analytical
SC Chemistry
GA 131AK
UT WOS:000243839900031
PM 17263336
DA 2018-10-19
ER

PT J
AU Kanayama, Y
   Aoki, C
   Sakai, Y
AF Kanayama, Yoshitaka
   Aoki, Chizuru
   Sakai, Yasuo
TI Development of low endotoxin gelatin for regenerative medicine
SO BIOLOGICAL & PHARMACEUTICAL BULLETIN
LA English
DT Article
DE collagen; gelatin; endotoxin; cell culture; scaffold
AB The basic concept of tissue engineering, an actively applied technology in regenerative medicine, is the coordination between cells, scaffolds, and proliferation factors. Collagen and gelatin are materials that have mostly been used as scaffolds because of their excellent affinity for cells, they are biodegradable, and their ability to form gel. However, very few of the collagen or gelatin preparations used as tissue engineering material have been prepared with low levels of endotoxin, which may trigger fever, shock and a fall in blood pressure even in very minute quantities. Therefore we decided to decrease the content of endotoxin in gelatin so that this biomaterial is not harmful to the body but still maintains its properties, namely, bioaffinity and biodegradation for use in the fields of cell culture and regenerative medicine. In this paper, we describe a method whereby endotoxin could be removed from gelatin solution by using an ultrafiltration membrane with a molecular weight cut-off of 100 kDa and low endotoxin gelatin, endotoxin activity in 0.1% gelatin solution was below 0.03 EU/ml, was obtained as the resulting filtrate solution.
C1 Jellice Co Ltd, Cent Res Inst, Wakabayashi Ku, Sendai, Miyagi 9840826, Japan.
RP Kanayama, Y (reprint author), Jellice Co Ltd, Cent Res Inst, Wakabayashi Ku, 4-1-4 Wakabayashi, Sendai, Miyagi 9840826, Japan.
EM kanayama@jellice.com
CR ABIKO Y, 1997, GLUES GELATINS, P245
   BRNSON KW, 1978, J SUPRAMOL STRUCT, V9, P231
   BROCKUTNE JG, 1989, ANAESTH INTENS CARE, V17, P49
   *COMM METH TEST PH, 1997, PAGI METHOD, P8
   HARLAN JM, 1983, LAB INVEST, V48, P269
   Kirikae T, 1997, INT J IMMUNOPHARMACO, V19, P255, DOI 10.1016/S0192-0561(97)00066-0
   *MIN HLTH LAB WELF, 2006, JAP PHARM, P159
   ONGRADI J, 1984, FOLIA MICROBIOL, V29, P450, DOI 10.1007/BF02873158
   Tabata Y, 1999, BIOMATERIALS, V20, P2169, DOI 10.1016/S0142-9612(99)00121-0
   TABATA Y, 2000, PROTEIN NUCL ACID EN, V45, P2179
   ZIEGLER EJ, 1982, NEW ENGL J MED, V307, P1225, DOI 10.1056/NEJM198211113072001
NR 11
TC 12
Z9 12
U1 0
U2 3
PU PHARMACEUTICAL SOC JAPAN
PI TOKYO
PA 2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN
SN 0918-6158
J9 BIOL PHARM BULL
JI Biol. Pharm. Bull.
PD FEB
PY 2007
VL 30
IS 2
BP 237
EP 241
DI 10.1248/bpb.30.237
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 155MX
UT WOS:000245582600006
PM 17268058
OA Bronze
DA 2018-10-19
ER

PT J
AU Dubruel, P
   Unger, R
   Van Vlierberghe, S
   Cnudde, V
   Jacobs, PJS
   Schacht, E
   Kirkpatrick, CJ
AF Dubruel, Peter
   Unger, R.
   Van Vlierberghe, Sandra
   Cnudde, Veerle
   Jacobs, Patric J. S.
   Schacht, Etienne
   Kirkpatrick, C. J.
TI Porous gelatin hydrogels: 2. In vitro cell interaction study
SO BIOMACROMOLECULES
LA English
DT Article
ID TISSUE ENGINEERING APPLICATIONS; BETA-TRICALCIUM PHOSPHATE;
   TRI-COPOLYMER SCAFFOLD; HUMAN NUCLEUS PULPOSUS; ENDOTHELIAL-CELLS;
   CROSS-LINKING; GROWTH-FACTOR; CULTURE; HYDROXYAPATITE; CHONDROCYTES
AB We report on the feasibility of applying porous gelatin hydrogels, prepared by a novel and controlled cryogenic treatment, as cell-interactive scaffolds for tissue engineering applications. Despite the large number of publications on gelatin as a biomaterial, a detailed study of screening a limited number of gelatin scaffolds for their interaction with a panel of human cells has, to the best of our knowledge, not yet been published. In the present work, we have evaluated two types of porous gelatin scaffolds that differ in their pore geometry and pore size. Type I hydrogels contained top-to-bottom transverse channels (i.e. cones) with a decreasing diameter from the top (330 mu m) to the bottom (20-30 mu m). Type II hydrogels contained spherical pores with a diameter of 135 mu m. Both types of scaffolds were evaluated by confocal laser scanning microscopy in terms of adhesion, spreading, and proliferation of human cells (endothelial, epithelial, fibroblast, glial, and osteoblast) by visualizing cells using calcein-acetoxy methyl ester as a vital stain. The results indicated that cells attached, spread, and proliferated on both types of hydrogels. In addition, the scaffolds developed can be used for the long-term culturing of human cells.
C1 Univ Ghent, Polymer Chem & Biomat Res Grp, B-9000 Ghent, Belgium.
   Univ Mainz, Inst Pathol, D-55101 Mainz, Germany.
   Univ Ghent, Dept Soil Sci & Geol, B-9000 Ghent, Belgium.
RP Dubruel, P (reprint author), Univ Ghent, Polymer Chem & Biomat Res Grp, Krijgslaan 281,Bldg S4 Bis, B-9000 Ghent, Belgium.
EM Peter.Dubruel@UGent.be
RI Jacobs, Patric/E-4067-2012; Dubruel, Peter/A-3440-2009; Cnudde,
   Veerle/K-2026-2016
OI Jacobs, Patric/0000-0001-9154-385X; Cnudde, Veerle/0000-0002-3269-5914
CR Alperin C, 2005, BIOMATERIALS, V26, P7377, DOI 10.1016/j.biomaterials.2005.05.064
   Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   Bloch K, 2005, J BIOMED MATER RES A, V75A, P802, DOI 10.1002/jbm.a.30466
   BORRAS A, 1972, AM J OPHTHALMOL, V73, P390, DOI 10.1016/0002-9394(72)90067-0
   Broderick EP, 2005, J BIOMED MATER RES B, V72B, P37, DOI 10.1002/jbm.b.30119
   Brown RQ, 2005, J BIOMED MATER RES A, V74A, P32, DOI 10.1002/jbm.a.30250
   Cascone MG, 2004, J MATER SCI-MATER M, V15, P1309, DOI 10.1007/s10856-004-5739-z
   Chang CH, 2006, BIOMATERIALS, V27, P1876, DOI 10.1016/j.biomaterials.2005.10.014
   CNUDDE V, 2004, P INT WORKSH XRAY CT, P363
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Gamez E, 2004, CELL TRANSPLANT, V13, P549, DOI 10.3727/000000004783983639
   Guo T, 2006, BIOMATERIALS, V27, P1095, DOI 10.1016/j.biomaterials.2005.08.015
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Holland TA, 2005, J BIOMED MATER RES A, V75A, P156, DOI 10.1002/jbm.a.30379
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Hong L, 2005, ANN BIOMED ENG, V33, P511, DOI 10.1007/s10439-005-2510-7
   HOUGLUM PA, 2005, THERAPEUTIC MUSCULOS
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   ITO A, 2000, J BIOSCI BIOENG, V95, P196
   Ito Y, 2005, J BIOMED MATER RES A, V74A, P659, DOI 10.1002/jbm.a.30360
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   Kim HW, 2005, BIOMATERIALS, V26, P5221, DOI 10.1016/j.biomaterials.2005.01.047
   Kim HW, 2005, J BIOMED MATER RES A, V72A, P136, DOI 10.1002/jbm.a.30168
   Kim S, 2005, J BIOMED MATER RES B, V75B, P442, DOI 10.1002/jbm.b.30324
   Li MY, 2005, IEEE T NANOBIOSCI, V4, P170, DOI 10.1109/TNB.2005.850477
   Li MY, 2005, BIOMATERIALS, V26, P5999, DOI 10.1016/j.biomaterials.2005.03.030
   Liu XH, 2005, J BIOMED MATER RES A, V74A, P84, DOI 10.1002/jbm.a.30367
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Ma ZW, 2005, TISSUE ENG, V11, P1149, DOI 10.1089/ten.2005.11.1149
   Ma ZW, 2005, BIOMATERIALS, V26, P2527, DOI 10.1016/j.biomaterials.2004.07.026
   Mironov V, 2005, BIOMATERIALS, V26, P7628, DOI 10.1016/j.biomaterials.2005.05.061
   Ohya Shoji, 2004, J Artif Organs, V7, P181
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   Steppe K, 2004, J STRUCT BIOL, V148, P11, DOI 10.1016/j.jsb.2004.05.001
   Takahashi Y, 2005, BIOMATERIALS, V26, P4856, DOI 10.1016/j.biomaterials.2005.01.012
   Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046
   Unger RE, 2005, BIOMATERIALS, V26, P1877, DOI 10.1016/j.biomaterials.2004.05.032
   Van den Bulcke AI, 2000, BIOMACROMOLECULES, V1, P31, DOI 10.1021/bm990017d
   Van Vlierberghe S, 2007, BIOMACROMOLECULES, V8, P331, DOI 10.1021/bm060684o
   Vestweber D, 2000, J PATHOL, V190, P281
   Wang YW, 2005, BIOMACROMOLECULES, V6, P566, DOI 10.1021/bm049342d
   Williamson MR, 2006, BIOMATERIALS, V27, P1019, DOI 10.1016/j.biomaterials.2005.06.018
   Witte RP, 2005, BIOMATERIALS, V26, P3673, DOI 10.1016/j.biomaterials.2004.09.054
   Yang SH, 2005, ARTIF ORGANS, V29, P806, DOI 10.1111/j.1525-1594.2005.00133.x
   Yang SH, 2005, J BIOMED MATER RES B, V74B, P468, DOI 10.1002/jbm.b.30200
   Yang SH, 2005, J BIOMED MATER RES B, V74B, P488, DOI 10.1002/jbm.b.30221
   Zhang YZ, 2005, J BIOMED MATER RES B, V72B, P156, DOI 10.1002/jbm.b.30128
   Zhao F, 2006, BIOMATERIALS, V27, P1859, DOI 10.1016/j.biomaterials.2005.09.031
   Zhu HG, 2005, J BIOMAT SCI-POLYM E, V16, P761, DOI 10.1163/1568562053992450
NR 49
TC 120
Z9 123
U1 5
U2 50
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD FEB
PY 2007
VL 8
IS 2
BP 338
EP 344
DI 10.1021/bm0606869
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 134YA
UT WOS:000244119200006
PM 17291056
DA 2018-10-19
ER

PT J
AU Serrano, F
   Lopez-G, L
   Jadraque, M
   Koper, M
   Ellis, G
   Cano, P
   Martin, M
   Garrido, L
AF Serrano, Fernando
   Lopez-G, Laura
   Jadraque, Maria
   Koper, Marielle
   Ellis, Gary
   Cano, Pilar
   Martin, Margarita
   Garrido, Leoncio
TI A Nd : YAG laser-microperforated
   poly(3-hydroxybutyrate-co-3-hydroxyvalerate)-basal membrane matrix
   composite film as substrate for keratinocytes
SO BIOMATERIALS
LA English
DT Article
DE PHBHV; basal membrane matrix; epithelium; microperforated biomaterial
ID HYDROXYBUTYRATE-HYDROXYVALERATE COPOLYMERS; BIODEGRADABLE MEDICAL
   DEVICES; HYDROLYTIC DEGRADATION; RECOMBINANT LAMININ-5;
   EXTRACELLULAR-MATRIX; BIOENGINEERED SKIN; CELL-CULTURE; IN-VITRO;
   POLYMERS; INTEGRIN
AB Epithelia cultured for the treatment of ulcers, burns and for gene therapy applications require a flexible biomaterial for growth and transplantation that is adaptable to body contours. We tested several materials and found that a poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBHV) polyester provided support for keratinocytes, although adhesion to this material proved to be suboptimal. Since epithelia adhere to the mesoderm through basal membranes, we engineered a basal membrane surrogate by preparing composites of PHBHV with basal membrane matrix (BMM). To allow cell migration into injuried areas the polyester film was micromachined to insert high-density micropores through a Nd:YAG laser ablation process. These flexible composites provided firm attachment for keratinocytes from the outer root sheath of human hair allowing keratinocyte migration through micropores. Films of microperforated PHBHV-BMM may be of use for the replacement of diseased or injured skin epithelia. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Fdn Hosp Alcorcon, E-28922 Alcorcon, Spain.
   CSIC, Inst Quim Fis Rocasolano, E-28006 Madrid, Spain.
   CSIC, Inst Ciencia & Tecnol Polimeros, E-28006 Madrid, Spain.
RP Serrano, F (reprint author), Fdn Hosp Alcorcon, Avda Villaviciosa 1, E-28922 Alcorcon, Spain.
EM fserrano@fhalcorcon.es
RI Garrido, Leoncio/K-3092-2014; Martin, Margarita/L-7758-2013; Ellis,
   Gary/C-1617-2010
OI Garrido, Leoncio/0000-0002-7587-1260; Ellis, Gary/0000-0003-4851-6092
CR Baker SE, 1996, EXP CELL RES, V228, P262, DOI 10.1006/excr.1996.0325
   Baker SE, 1996, J CELL SCI, V109, P2509
   BELL E, 1981, SCIENCE, V211, P1052, DOI 10.1126/science.7008197
   Boyce ST, 2002, AM J SURG, V183, P445, DOI 10.1016/S0002-9610(02)00813-9
   Chen M, 2002, NAT GENET, V32, P670, DOI 10.1038/ng1041
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   Daniels JT, 1996, BURNS, V22, P35, DOI 10.1016/0305-4179(95)00085-2
   DeHart GW, 2003, EXP CELL RES, V283, P67, DOI 10.1016/S0014-4827(02)00028-0
   Del Rio M, 2002, HUM GENE THER, V13, P959, DOI 10.1089/10430340252939069
   Eble JA, 1998, BIOCHEMISTRY-US, V37, P10945, DOI 10.1021/bi980175+
   Evans RD, 2003, J CELL BIOL, V160, P589, DOI 10.1083/jcb.200209016
   Falk-Marzillier J, 1998, BIOCHEM BIOPH RES CO, V251, P49, DOI 10.1006/bbrc.1998.9400
   Fleischmajer R, 1998, J CELL SCI, V111, P1929
   GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706
   Grose R, 2002, DEVELOPMENT, V129, P2303
   Haase I, 2001, J CLIN INVEST, V108, P527, DOI 10.1172/JCI200112153
   Hansbrough John F., 1997, Journal of Burn Care and Rehabilitation, V18, P43, DOI 10.1097/00004630-199701000-00008
   Higham MC, 2003, TISSUE ENG, V9, P919, DOI 10.1089/107632703322495565
   HOLLAND SJ, 1987, BIOMATERIALS, V8, P289, DOI 10.1016/0142-9612(87)90117-7
   HOLLAND SJ, 1990, BIOMATERIALS, V11, P206, DOI 10.1016/0142-9612(90)90157-L
   HORMIA M, 1995, J INVEST DERMATOL, V105, P557, DOI 10.1111/1523-1747.ep12323451
   Kariya Y, 2002, J BIOCHEM, V132, P607, DOI 10.1093/oxfordjournals.jbchem.a003263
   Kariya Y, 2003, J CELL BIOCHEM, V88, P506, DOI 10.1002/jcb.10350
   Kirsner RS, 1998, TRENDS BIOTECHNOL, V16, P246, DOI 10.1016/S0167-7799(98)01196-2
   Kruger J, 2002, APPL SURF SCI, V197, P800, DOI 10.1016/S0169-4332(02)00418-X
   Lam PK, 1999, J TRAUMA, V47, P918, DOI 10.1097/00005373-199911000-00017
   LANGHOFER M, 1993, J CELL SCI, V105, P753
   Larcher F, 2001, FASEB J, V15, P1529, DOI 10.1096/fj.01-0082com
   Lefebvre VH, 1998, DIABETES, V47, P134, DOI 10.2337/diabetes.47.1.134
   Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902
   LISSITZKY JC, 1992, J CELL BIOCHEM, V48, P141, DOI 10.1002/jcb.240480206
   Michel O, 2000, HNO, V48, P4, DOI 10.1007/s001060050002
   Muhart M, 1997, LANCET, V350, P1142, DOI 10.1016/S0140-6736(05)63788-9
   Papini Sandra, 2003, Stem Cells (Miamisburg), V21, P481, DOI 10.1634/stemcells.21-4-481
   Patarroyo M, 2002, SEMIN CANCER BIOL, V12, P197, DOI 10.1016/S1044-579X(02)00023-8
   PATTHY L, 1992, FEBS LETT, V298, P182, DOI 10.1016/0014-5793(92)80051-H
   Petitclerc E, 2000, J BIOL CHEM, V275, P8051, DOI 10.1074/jbc.275.11.8051
   RIDDELLE KS, 1992, J CELL SCI, V103, P475
   Saffle JR, 1995, J BURN CARE REHABIL, V16, P288
   Serrano F, 2003, HUM GENE THER, V14, P1579, DOI 10.1089/104303403322495089
   Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006
   Tezcaner A, 2003, BIOMATERIALS, V24, P4573, DOI 10.1016/S0142-9612(03)00302-8
   Tunggal P, 2000, MICROSC RES TECHNIQ, V51, P214, DOI 10.1002/1097-0029(20001101)51:3<214::AID-JEMT2>3.0.CO;2-J
   Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399
   YASIN M, 1990, BIOMATERIALS, V11, P451, DOI 10.1016/0142-9612(90)90057-W
   YASIN M, 1989, BIOMATERIALS, V10, P400, DOI 10.1016/0142-9612(89)90132-4
NR 46
TC 12
Z9 12
U1 4
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2007
VL 28
IS 4
BP 650
EP 660
DI 10.1016/j.biomaterials.2006.09.018
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 120CE
UT WOS:000243060400010
PM 17027945
DA 2018-10-19
ER

PT J
AU Rapoport, HS
   Connolly, JM
   Fulmer, J
   Dai, N
   Murti, BH
   Gorman, RC
   Gorman, JH
   Alferiev, I
   Levy, RJ
AF Rapoport, H. Scott
   Connolly, Jeanne M.
   Fulmer, James
   Dai, Ning
   Murti, Brandon H.
   Gorman, Robert C.
   Gorman, Joseph H.
   Alferiev, Ivan
   Levy, Robert J.
TI Mechanisms of the in vivo inhibition of calcification of bioprosthetic
   porcine aortic valve cusps and aortic wall with
   triglycidylamine/mercapto bisphosphonate
SO BIOMATERIALS
LA English
DT Article
DE calcification; biomineralization; bioprostheses; heart valve;
   cross-linking; alkaline phosphate
ID ALKALINE-PHOSPHATASE ACTIVITY; HEART-VALVE; CROSS-LINKING;
   GLUTARALDEHYDE; TISSUE; PREVENTION; STABILIZATION; RATS
AB Heart valve replacements fabricated from glutaraldehyde (Glut)-crosslinked heterograft materials, porcine aortic valves or bovine pericardium, have been widely used in cardiac surgery to treat heart valve disease. However, these bioprosthetic heart valves often fail in long-term clinical implants due to pathologic calcification of the bioprosthetic leaflets, and for stentless porcine aortic valve bioprostheses, bioprosthetic aortic wall calcification also typically occurs. Previous use of the epoxide-based crosslinker, triglycidyl amine (TGA), on cardiac bioprosthetic valve materials demonstrated superior biocompatibility, mechanics, and calcification resistance for porcine aortic valve cusps (but not porcine aortic wall) and bovine pericardium, vs. Glut-prepared controls. However, TGA preparation did not completely prevent long-term calcification of cusps or pericardium. Herein we report further mechanistic investigations of an added therapeutic component to this system, 2-mercaptoethylidene-1,1-bisphosphonic acid (MABP), a custom synthesized thiol bisphosphonate, which has previously been shown in a preliminary report to prevent bioprosthetic heterograft biomaterial calcification when used in combination with initial TGA crosslinking for 7 days. In the present studies, we have further investigated the effectiveness of MABP in experiments that examined: (1) The use of MABP after optimal TGA crosslinking, in order to avoid any competitive interference of MABP-reactions with TGA during crosslinking; (2) Furthermore, recognizing the importance of alkaline phosphatase (ALP) in the formation of dystrophic calcific nodules, we have investigated the hypothesis that the mechanism by which MABP primarily functions is through the reduction of ALP activity. Results from cell-free model systems, cell culture studies, and rat subcutaneous implants, show that materials functionalized with MABP after TGA crosslinking have reduced ALP activity, and in vivo have no significant calcification in long-term implant studies. It is concluded that bioprosthetic heart valves prepared in this fashion are compelling alternatives for Glut-prepared bioprostheses. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Childrens Hosp Philadelphia, Div Cardiol, Abramson Res Ctr, Philadelphia, PA 19104 USA.
   Univ Penn, Sch Med, Harrison Dept Surg Res, Philadelphia, PA 19104 USA.
RP Levy, RJ (reprint author), Childrens Hosp Philadelphia, Div Cardiol, Abramson Res Ctr, Suite 702,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.
EM levyr@email.chop.edu
FU NHLBI NIH HHS [T32-HL7915, P50-HL74731, T32 HL007915, P50 HL074731]
CR Alferiev I, 2001, BIOMATERIALS, V22, P2683, DOI 10.1016/S0142-9612(01)00010-2
   Alferiev IS, 2005, J ORGANOMET CHEM, V690, P2543, DOI 10.1016/j.jorganchem.2004.10.011
   Chang Y, 2005, J BIOTECHNOL, V120, P207, DOI 10.1016/j.jbiotec.2005.06.029
   Connolly JM, 2005, AM J PATHOL, V166, P1, DOI 10.1016/S0002-9440(10)62227-4
   DUMONT CE, 1993, J SURG RES, V54, P61, DOI 10.1006/jsre.1993.1011
   Fishbein I, 2006, P NATL ACAD SCI USA, V103, P159, DOI 10.1073/pnas.0502945102
   HENTHORN PS, 1987, P NATL ACAD SCI USA, V84, P1234, DOI 10.1073/pnas.84.5.1234
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   Imamura E, 1989, J Card Surg, V4, P50, DOI 10.1111/j.1540-8191.1989.tb00256.x
   Jian B, 2003, ANN THORAC SURG, V75, P457, DOI 10.1016/S0003-4975(02)04312-6
   Lerones C, 2004, CLIN MICROBIOL INFEC, V10, P984, DOI 10.1111/j.1469-0691.2004.00967.x
   Maranto A R, 1988, ASAIO Trans, V34, P827
   MARANTO AR, 1988, CIRC RES, V63, P844, DOI 10.1161/01.RES.63.4.844
   Mirzaie M, 2000, SCAND CARDIOVASC J, V34, P589
   Moore MA, 1996, J BIOMED MATER RES, V32, P209, DOI 10.1002/(SICI)1097-4636(199610)32:2<209::AID-JBM9>3.0.CO;2-X
   Reszka Alfred A, 2003, Curr Osteoporos Rep, V1, P45, DOI 10.1007/s11914-003-0008-5
   RUSSELL HK, 1972, ARCH PATHOL, V94, P187
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   SHEN SH, 1994, J APPL BIOMATER, V5, P159, DOI 10.1002/jab.770050209
   SIMMONS DM, 1993, BIOTECHNOL APPL BIOC, V17, P23
   Sung HW, 1993, ASAIO J, V39, P532
   Vaisman DN, 2005, BIOL TRACE ELEM RES, V104, P131, DOI 10.1385/BTER:104:2:131
   Vyavahare N, 2000, AM J PATHOL, V157, P885, DOI 10.1016/S0002-9440(10)64602-0
   Vyavahare N, 1997, CIRCULATION, V95, P479
   WEBB CL, 1988, ANN THORAC SURG, V46, P309, DOI 10.1016/S0003-4975(10)65932-2
   WEBB CL, 1989, EXP MOL PATHOL, V50, P291, DOI 10.1016/0014-4800(89)90039-7
   XI TF, 1992, J BIOMED MATER RES, V26, P1241
NR 27
TC 24
Z9 25
U1 1
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2007
VL 28
IS 4
BP 690
EP 699
DI 10.1016/j.biomaterials.2006.09.029
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 120CE
UT WOS:000243060400014
PM 17027944
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Converse, GL
   Yue, WM
   Roeder, RK
AF Converse, Gabriel L.
   Yue, Weimin
   Roeder, Ryan K.
TI Processing and tensile properties of hydroxyapatite-whisker-reinforced
   polyetheretherketone
SO BIOMATERIALS
LA English
DT Article
DE composite; elasticity; hydroxyapatite; mechanical properties;
   microstructure; polyetheretherketone
ID BEARING ORTHOPEDIC IMPLANTS; MECHANICAL-PROPERTIES; BONE-CEMENT;
   COMPOSITES; BEHAVIOR; FATIGUE; BIOMATERIAL
AB Polyetheretherketone (PEEK) was reinforced with 0-50 vol% hydroxyapatite (HA) whiskers using a novel powder processing and compression molding technique which enabled uniform mixing at high whisker content. Texture analysis showed that viscous flow during compression molding produced a preferred orientation of whiskers along the specimen tensile axis. Consequently, the elastic modulus or ultimate tensile strength of HA-whisker-reinforced PEEK was able to be tailored to mimic human cortical bone. PEEK reinforced with 40 and 50 vol% HA whiskers exhibited elastic moduli of 17 and 23 GPa, respectively. Elastic constants were measured using ultrasonic wave propagation and revealed an orthotropic anisotropy also similar to that measured in human cortical bone. PEEK reinforced with 10 and 20 vol% HA whiskers exhibited an ultimate tensile strength of 90 and 75 MPa, respectively. Tensile specimen fracture surfaces showed evidence of brittle failure in both reinforced and un-reinforced PEEK. Whisker pullout was observed with PEEK adhered to HA whiskers, suggesting a relatively strong interface between the PEEK matrix and HA whisker reinforcements. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Notre Dame, Dept Aerosp & Mech Engn, Notre Dame, IN 46556 USA.
RP Roeder, RK (reprint author), Univ Notre Dame, Dept Aerosp & Mech Engn, Notre Dame, IN 46556 USA.
EM rroeder@nd.edu
RI Roeder, Ryan/A-9398-2008
OI Roeder, Ryan/0000-0003-1576-6570; Converse, Gabriel/0000-0002-7572-026X
CR Abu Bakar MS, 2003, COMPOS SCI TECHNOL, V63, P421, DOI 10.1016/S0266-3538(02)00230-0
   Abu Bakar MS, 2003, BIOMATERIALS, V24, P2245, DOI 10.1016/S0142-9612(03)00028-0
   [Anonymous], 2001, D63801 ASTM
   [Anonymous], 1999, C37388 ASTM
   Arcis RW, 2002, DENT MATER, V18, P49, DOI 10.1016/S0109-5641(01)00019-7
   ASHMAN RB, 1984, J BIOMECH, V17, P349, DOI 10.1016/0021-9290(84)90029-0
   BOBYN JD, 1992, CLIN ORTHOP RELAT R, P79
   Chu KT, 2004, BIO-MED MATER ENG, V14, P87
   COWIN SC, 1987, HCB BIOENGINEERING
   Di Silvio L, 2002, BIOMATERIALS, V23, P101, DOI 10.1016/S0142-9612(01)00084-9
   Evans SL, 1998, BIOMATERIALS, V19, P1329, DOI 10.1016/S0142-9612(97)00217-2
   Fang LM, 2006, BIOMATERIALS, V27, P3701, DOI 10.1016/j.biomaterials.2006.02.023
   Gao SL, 2000, COMPOS PART A-APPL S, V31, P517, DOI 10.1016/S1359-835X(00)00009-9
   GUO XE, 2001, BONE MECH HDB, DOI DOI 10.5-10.14
   Harper EJ, 1995, J MATER SCI-MATER M, V6, P799, DOI 10.1007/BF00134320
   HASEGAWA K, 1994, CALCIFIED TISSUE INT, V55, P381, DOI 10.1007/BF00299319
   HUISKES R, 1992, CLIN ORTHOP RELAT R, P124
   Ignjatovic N, 2004, J BIOMED MATER RES B, V71B, P284, DOI 10.1002/jbm.b.30093
   Kobayashi M, 1999, J BIOMED MATER RES, V46, P447, DOI 10.1002/(SICI)1097-4636(19990915)46:4<447::AID-JBM2>3.3.CO;2-G
   Liu TY, 2004, J BIOMED MATER RES B, V71B, P116, DOI 10.1002/jbm.b.30072
   MARTIN RB, 1998, SKELETAL TISSUE MECH, P32
   Moursi AM, 2002, BIOMATERIALS, V23, P133, DOI 10.1016/S0142-9612(01)00088-6
   ORIAS EAA, 2005, THESIS U NOTRE DAME
   REILLY DT, 1975, J BIOMECH, V8, P305
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Roeder RK, 2006, J AM CERAM SOC, V89, P2096, DOI 10.1111/j.1551-2916.2006.01067.x
   Roeder RK, 2003, J BIOMED MATER RES A, V67A, P801, DOI 10.1002/jbm.a.10140
   ROEDER RK, 2002, T ORTHOP RES SOC, V27, P1073
   Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519
   SAITO M, 1993, BIOCERAMICS, V6, P475
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   TAKAKURA Y, 1996, J FOOT SURG, V11, P9
   Tang SM, 2004, INT J FATIGUE, V26, P49, DOI 10.1016/S0142-1123(03)00080-X
   TANNER KE, 1994, BRIT CERAM T, V93, P104
   THAT TPT, 2003, J BIOMED MATER RES, V51, P453
   Toth JM, 2006, BIOMATERIALS, V27, P324, DOI 10.1016/j.biomaterials.2005.07.011
   VANBUSKIRK WC, 1981, J BIOMECH ENG-T ASME, V103, P67, DOI 10.1115/1.3138262
   *VICTR PIC, 2006, MAT PROP GUID
   Wang M, 1998, BIOMATERIALS, V19, P2357, DOI 10.1016/S0142-9612(98)00154-9
   Wang M, 2000, J MATER SCI, V35, P1023, DOI 10.1023/A:1004731315328
   Wei GB, 2004, BIOMATERIALS, V25, P4749, DOI 10.1016/j.biomaterials.2003.12.005
   Wenk HR, 1999, BONE, V24, P361, DOI 10.1016/S8756-3282(98)00192-6
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   YUE Q, 2006, THESIS U NOTRE DAME
NR 44
TC 95
Z9 100
U1 2
U2 34
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2007
VL 28
IS 6
BP 927
EP 935
DI 10.1016/j.biomaterials.2006.10.031
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 122II
UT WOS:000243219000004
PM 17113143
DA 2018-10-19
ER

PT J
AU Mygind, T
   Stiehler, M
   Baatrup, A
   Li, H
   Zoua, X
   Flyvbjerg, A
   Kassem, M
   Bunger, C
AF Mygind, Tina
   Stiehler, Maik
   Baatrup, Anette
   Li, Haisheng
   Zoua, Xuenong
   Flyvbjerg, Allan
   Kassem, Moustapha
   Bunger, Cody
TI Mesenchymal stem cell ingrowth and differentiation on coralline
   hydroxyapatite scaffolds
SO BIOMATERIALS
LA English
DT Article
DE stem cell; bioreactor; hydroxyapatite; scaffolds; porosity
ID MARROW STROMAL CELLS; FLOW PERFUSION BIOREACTOR; WALL VESSEL BIOREACTOR;
   OSTEOGENIC DIFFERENTIATION; OSTEOBLASTIC CELLS; MECHANICAL STIMULATION;
   PLGA SCAFFOLDS; BONE-FORMATION; EXPRESSION; CULTURE
AB Culture of osteogenic cells on a porous scaffold could offer a new solution to bone grafting using autologous human mesenchymal stem cells (hMSC) from the patient. We compared coralline hydroxyapatite scaffolds with pore sizes of 200 and 500 mu m for expansion and differentiation of hMSCs. We cultivated the hMSC statically or in spinner flasks for 1, 7, 14 and 21 days and found that the 200-mu m pore scaffolds exhibited a faster rate of osteogenic differentiation than did the 500-mu m pore scaffolds as shown by an alkaline phosphatase activity assay and real-time reverse transcriptase polymerase chain reaction for 10 osteogenic markers. The 500-mu m scaffolds had increased proliferation rates and accommodated a higher number of cells (shown by DNA content, scanning electron microscopy and fluorescence microscopy). Thus the porosity of a 3D microporous biomaterial may be used to steer hMSC in a particular direction. We found that dynamic spinner flask cultivation of hMSC/scaffold constructs resulted in increased proliferation, differentiation and distribution of cells in scaffolds. Therefore, spinner flask cultivation is an easy-to-use inexpensive system for cultivating hMSCs on small to intermediate size 3D scaffolds. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Aarhus Univ Hosp, Inst Clin, Lab Mol Orthoped, Orthoped Res Lab, DK-8000 Aarhus C, Denmark.
   Aarhus Univ Hosp, Inst Clin, Med Res Labs, Med Dept M Diabet & Endocrinol, DK-8000 Aarhus, Denmark.
   Odense Univ Hosp, Dept Endocrinol & Metab, DK-5000 Odense C, Denmark.
RP Mygind, T (reprint author), Aarhus Univ Hosp, Inst Clin, Lab Mol Orthoped, Orthoped Res Lab, Norrebrogade 44,Bldg 1A, DK-8000 Aarhus C, Denmark.
EM tina.mygind@ki.au.dk
RI Kassem, Moustapha/J-7688-2013
OI Kassem, Moustapha/0000-0003-1557-0869
CR Abdallah BM, 2005, BIOCHEM BIOPH RES CO, V326, P527, DOI 10.1016/j.bbrc.2004.11.059
   Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
   Carvalho RS, 1998, J CELL BIOCHEM, V70, P376, DOI 10.1002/(SICI)1097-4644(19980901)70:3<376::AID-JCB11>3.0.CO;2-J
   Chou YF, 2005, J BIOMED MATER RES B, V75B, P81, DOI 10.1002/jbm.b.30261
   Dalby MJ, 2006, BIOMATERIALS, V27, P2980, DOI 10.1016/j.biomaterials.2006.01.010
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025
   Erben RG, 1997, J HISTOCHEM CYTOCHEM, V45, P307, DOI 10.1177/002215549704500215
   Ferrara James L M, 2005, Clin Adv Hematol Oncol, V3, P415
   Ferrari SL, 2000, J BONE MINER RES, V15, P198, DOI 10.1359/jbmr.2000.15.2.198
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   Gomes ME, 2006, TISSUE ENG, V12, P801, DOI 10.1089/ten.2006.12.801
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   Hing KA, 2004, PHILOS T R SOC A, V362, P2821, DOI 10.1098/rsta.2004.1466
   Holtorf HL, 2005, ANN BIOMED ENG, V33, P1238, DOI 10.1007/s10439-005-5536-y
   Holtorf HL, 2005, J BIOMED MATER RES A, V72A, P326, DOI 10.1002/jbm.a.30251
   Holtorf HL, 2005, J BIOMED MATER RES A, V74A, P171, DOI 10.1002/jbm.a.30330
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Kern B, 2001, J BIOL CHEM, V276, P7101, DOI 10.1074/jbc.M006215200
   Li Z, 1999, BONE, V25, P661, DOI 10.1016/S8756-3282(99)00227-6
   Lietman SA, 2000, CLIN ORTHOP RELAT R, P214
   Long AB, 2001, EDUC GERONTOL, V27, P3, DOI 10.1080/036012701750069012
   Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5
   Pavalko FM, 1998, AM J PHYSIOL-CELL PH, V275, pC1591, DOI 10.1152/ajpcell.1998.275.6.C1591
   Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47
   Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842
   Rose FR, 2004, BIOMATERIALS, V25, P5507, DOI 10.1016/j.biomaterials.2004.01.012
   ROY DM, 1974, NATURE, V247, P220, DOI 10.1038/247220a0
   Rucci N, 2002, J CELL BIOCHEM, V85, P167, DOI 10.1002/jcb.10120
   Salim A, 2004, J BIOL CHEM, V279, P40007, DOI 10.1074/jbc.M403715200
   Schiller PC, 2001, BONE, V28, P362, DOI 10.1016/S8756-3282(00)00458-0
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Simonsen JL, 2002, NAT BIOTECHNOL, V20, P592, DOI 10.1038/nbt0602-592
   Sorger JI, 2001, CLIN ORTHOP RELAT R, P66
   Spector JA, 2001, PLAST RECONSTR SURG, V107, P124, DOI 10.1097/00006534-200101000-00018
   Stevens HY, 2003, METH MOLEC MED, V80, P381
   Takahashi Y, 2004, J BIOMAT SCI-POLYM E, V15, P41, DOI 10.1163/156856204322752228
   Utting JC, 2006, EXP CELL RES, V312, P1693, DOI 10.1016/j.yexcr.2006.02.007
   Vance J, 2005, TISSUE ENG, V11, P1832, DOI 10.1089/ten.2005.11.1832
   WEINAND C, 2005, BONE, V38, P555
   WILLIAMS JL, 1994, BIORHEOLOGY, V31, P163
   Wu YC, 2006, BIOMATERIALS, V27, P896, DOI 10.1016/j.biomaterials.2005.07.002
   Young MF, 2003, OSTEOPOROSIS INT, V14, pS35, DOI 10.1007/s00198-002-1342-7
   Zhu JX, 2001, HISTOCHEM J, V33, P25, DOI 10.1023/A:1017587712914
   ZOU X, 2003, APMIS S, V109, P127
NR 46
TC 198
Z9 211
U1 2
U2 50
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2007
VL 28
IS 6
BP 1036
EP 1047
DI 10.1016/j.biomaterials.2006.10.003
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 122II
UT WOS:000243219000015
PM 17081601
DA 2018-10-19
ER

PT J
AU Bolland, F
   Korossis, S
   Wilshaw, SP
   Ingham, E
   Fisher, J
   Kearney, JN
   Southgate, J
AF Bolland, Fiona
   Korossis, Sotiris
   Wilshaw, Stacy-Paul
   Ingham, Eileen
   Fisher, John
   Kearney, John N.
   Southgate, Jennifer
TI Development and characterisation of a full-thickness acellular porcine
   bladder matrix for tissue engineering
SO BIOMATERIALS
LA English
DT Article
DE bladder tissue engineering; mechanical properties; scaffold; smooth
   muscle cells
ID SMALL-INTESTINAL SUBMUCOSA; HUMAN UROTHELIAL CELLS; URINARY-BLADDER;
   SULFATED GLYCOSAMINOGLYCANS; EXTRACELLULAR-MATRIX; IN-VITRO;
   HYDROXYPROLINE; RECONSTRUCTION; AUGMENTATION; MODEL
AB The aim of this study was to produce a natural, acellular matrix from porcine bladder tissue for use as a scaffold in developing a tissue-engineered bladder replacement. Full-thickness, intact porcine bladders were decellularised by distention and immersion in hypotonic buffer containing 0.1% (w/v) SDS and nuclease enzymes. Histological analysis of the resultant matrices showed they were completely acellular; that the major structural proteins had been retained and that there were some residual poorly soluble intracellular proteins. The amount of DNA per mg dry weight of fresh porcine bladder was 2.8 (+/- 0.1) mu g/mg compared to 0.1 (+/- 0.1) mu g/mg in decellularised bladder and biochemical analysis showed proportional differences in the hydroxyproline and glycosaminoglycan content of the tissue before and after decellularisation. Uniaxial tensile testing indicated that decellularisation did not significantly compromise the ultimate tensile strength of the tissue. There was, however, an increase in the collagen and elastin phase slopes indicating decreased extensibility. Cytotoxicity assays using porcine smooth muscle cell cultures excluded the presence of soluble toxins in the biomaterial. In summary, a full-thickness natural acellular matrix retaining the major structural components and strength of the urinary bladder has been successfully developed. The matrix is biocompatible with bladder-derived cells and has potential for use in urological surgery and tissue-engineering applications. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5YW, N Yorkshire, England.
   Univ Leeds, Sch Mech Engn, Biomed Engn Res Ctr, Leeds LS2 9JT, W Yorkshire, England.
   Univ Leeds, Fac Biol Sci, Inst Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.
   Natl Blood Serv, Tissue Serv, Liverpool L24 8RB, Merseyside, England.
RP Southgate, J (reprint author), Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5YW, N Yorkshire, England.
EM js35@york.ac.uk
RI Sano, Michael/E-1715-2011; Korossis, Sotirios/S-4427-2016
OI Korossis, Sotirios/0000-0002-9893-6338; Wilshaw,
   Stacy-Paul/0000-0002-7599-8165; Southgate, Jennifer/0000-0002-0135-480X
FU Biotechnology and Biological Sciences Research Council [E20352];
   Engineering and Physical Sciences Research Council [EP/D073618/1]
CR Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   Bancroft JD, 1990, THEORY PRACTICE HIST
   Bank RA, 1997, MATRIX BIOL, V16, P233, DOI 10.1016/S0945-053X(97)90012-3
   Booth C, 2002, J HEART VALVE DIS, V11, P457
   Brown AL, 2002, BIOMATERIALS, V23, P2179, DOI 10.1016/S0142-9612(01)00350-7
   Brown S, 2001, BIOTECHNIQUES, V30, P38, DOI 10.2144/01301bm06
   CARTWRIGHT PC, 1989, J UROLOGY, V142, P1050, DOI 10.1016/S0022-5347(17)38985-1
   Chen MK, 2001, J SURG RES, V99, P352, DOI 10.1006/jsre.2001.6199
   Comer MT, 1999, ADV EXP MED BIOL, V462, P43
   Cross WR, 2003, BJU INT, V92, P165, DOI 10.1046/j.1464-410X.2003.04280.x
   EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8
   Elbahnasy AM, 1998, J UROLOGY, V159, P628, DOI 10.1016/S0022-5347(01)63690-5
   Enobakhare BO, 1996, ANAL BIOCHEM, V243, P189, DOI 10.1006/abio.1996.0502
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   FEIL G, 2006, EUR UROL        0616
   Fraser M, 2004, BJU INT, V93, P609, DOI 10.1111/j.1464-410X.2004.04675.x
   Freytes DO, 2004, BIOMATERIALS, V25, P2353, DOI 10.1016/j.biomaterials.2003.09.015
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   Harper C, 2001, HOSP MED, V62, P90, DOI 10.12968/hosp.2001.62.2.2379
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Kimuli M, 2004, BJU INT, V94, P859, DOI 10.1111/j.1464-410X.2004.05047.x
   Koenig F, 1999, UROLOGY, V53, P853, DOI 10.1016/S0090-4295(98)00628-1
   Korossis SA, 2002, J HEART VALVE DIS, V11, P463
   Korossis S, 2006, TISSUE ENG, V12, P635, DOI 10.1089/ten.2006.12.635
   Kropp B P, 1995, Urology, V46, P396, DOI 10.1016/S0090-4295(99)80227-1
   Kropp BP, 1998, UROLOGY, V52, P138, DOI 10.1016/S0090-4295(98)00114-9
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   Merguerian PA, 2000, BJU INT, V85, P894, DOI 10.1046/j.1464-410x.2000.00513.x
   Mirsadraee S, 2006, TISSUE ENG, V12, P763, DOI 10.1089/ten.2006.12.763
   MURAKUMO M, 1995, J UROLOGY, V154, P251, DOI 10.1016/S0022-5347(01)67289-6
   Pattison MA, 2005, BIOMATERIALS, V26, P2491, DOI 10.1016/j.biomaterials.2004.07.011
   Piechota HJ, 1999, UROL RES, V27, P206, DOI 10.1007/s002400050111
   Probst M, 1997, BRIT J UROL, V79, P505, DOI 10.1046/j.1464-410X.1997.00103.x
   Scriven SD, 2001, J MATER SCI-MATER M, V12, P991, DOI 10.1023/A:1012869318205
   SOUTHGATE J, 1994, LAB INVEST, V71, P583
   Southgate J, 2003, P I MECH ENG H, V217, P311, DOI 10.1243/095441103322060776
   Southgate J, 2002, CULTURE EPITHELIAL C, P381, DOI DOI 10.1002/0471221201.CH12
   STEGEMAN.H, 1967, CLIN CHIM ACTA, V18, P267, DOI 10.1016/0009-8981(67)90167-2
   U LEEDS U YORK, 2006, Patent No. 06062319
   VANDERREST M, 1991, FASEB J, V5, P2814
   Varley CL, 2004, AM J PATHOL, V164, P1789, DOI 10.1016/S0002-9440(10)63737-6
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
NR 46
TC 107
Z9 126
U1 1
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2007
VL 28
IS 6
BP 1061
EP 1070
DI 10.1016/j.biomaterials.2006.10.005
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 122II
UT WOS:000243219000017
PM 17092557
DA 2018-10-19
ER

PT J
AU Nillesen, STM
   Geutjes, PJ
   Wismans, R
   Schalkwijk, J
   Daamen, WF
   van Kuppevelt, TH
AF Nillesen, Suzan T. M.
   Geutjes, Paul J.
   Wismans, Ronnie
   Schalkwijk, Joost
   Daamen, Willeke F.
   van Kuppevelt, Toin H.
TI Increased angiogenesis and blood vessel maturation in acellular
   collagen-heparin scaffolds containing both FGF2 and VEGF
SO BIOMATERIALS
LA English
DT Article
DE angiogenesis; growth factors; collagen; tissue response; biomaterial;
   tissue engineering
ID ENDOTHELIAL GROWTH-FACTOR; SULFATE; TISSUE; FACTOR-2; GENERATION;
   MATRICES; THERAPY; RATS; BFGF
AB An important issue in tissue engineering is the vascularisation of the implanted construct, which often takes several weeks. In vivo, the growth factors VEGF and FGF2 show a combined effect on both angiogenesis and maturation of blood vessels. Therefore, we hypothesise that the addition of these growth factors to an acellular construct increases blood vessel formation and maturation. To systematically evaluate the contribution of each scaffold component with respect to tissue response and in particular to blood vessel formation, five porous scaffolds were prepared and characterised, viz.: collagen, collagen with heparin, and collagen with heparin plus one or two growth factors (rrFGF2 and rrVEGF). Scaffolds were subcutaneously implanted in 3 months old Wistar rats. Of all scaffolds tested, the one with a combination of growth factors displayed the highest density of blood vessels (type IV collagen) and most mature blood vessels (smooth muscle actin). In addition, no hypoxic cells were found in this scaffold at day 7 and 21 (hypoxia inducible factor 1-alpha). These results indicate that the addition of both FGF2 and VEGF to an acellular construct enhances an early mature vasculature. This opens prospects for (acellular) tissue-engineered constructs in conditions as ischaemic heart disease or diabetic ulcers. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Radboud Univ Nijmegen, Med Ctr, NCMLS, Dept Biochem 280, NL-6500 HB Nijmegen, Netherlands.
   Radboud Univ Nijmegen, Med Ctr, NCMLS, Dept Dermatol 370, NL-6500 HB Nijmegen, Netherlands.
RP van Kuppevelt, TH (reprint author), Radboud Univ Nijmegen, Med Ctr, NCMLS, Dept Biochem 280, Pob 9101, NL-6500 HB Nijmegen, Netherlands.
EM a.vankuppevelt@ncmls.ru.nl
RI Daamen, Willeke/D-5854-2015; Kuppevelt, A.H.M.S.M./L-4463-2015;
   Schalkwijk, Joost/N-1774-2013; Geutjes, P.J./L-4320-2015
OI Daamen, Willeke/0000-0003-3155-3030; 
CR Asahara T., 1995, CIRCULATION, V92, P11365
   Bancroft JD, 1990, THEORY PRACTICE HIST
   Bennett SP, 2003, BRIT J SURG, V90, P133, DOI 10.1002/bjs.4019
   Bicknell R, 2004, ANNU REV PHARMACOL, V44, P219, DOI 10.1146/annurev.pharmtox.44.101802.121650
   Blau HM, 2001, NAT MED, V7, P532, DOI 10.1038/87850
   Bruick RK, 2001, GENE DEV, V15, P2497, DOI 10.1101/gad.931601
   BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
   CALVANI M, 2005, BLOOD
   Daamen WF, 2005, BIOMATERIALS, V26, P81, DOI 10.1016/j.biomaterials.2004.02.011
   Damink LHHO, 1996, BIOMATERIALS, V17, P765, DOI 10.1016/0142-9612(96)81413-X
   Fujita M, 2004, BIOMATERIALS, V25, P699, DOI 10.1016/S0142-9612(03)00557-X
   Fukuda S, 2004, MOL CELL BIOCHEM, V264, P143, DOI 10.1023/B:MCBI.0000044383.01785.05
   Giavazzi R, 2003, AM J PATHOL, V162, P1913, DOI 10.1016/S0002-9440(10)64325-8
   GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093
   Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3
   HUANG LE, 1998, P NATL ACAD SCI USA, V95, P987
   Hughes GC, 2004, ANN THORAC SURG, V77, P812, DOI 10.1016/j.athorasur.2003.09.060
   Komori M, 2005, ANESTH ANALG, V100, P830, DOI 10.1213/01.ANE.0000144426.18235.5A
   Laschke MW, 2006, HUM REPROD, V21, P262, DOI 10.1093/humrep/dei308
   Lee KH, 2000, YONSEI MED J, V41, P774, DOI 10.3349/ymj.2000.41.6.774
   Masaki I, 2002, CIRC RES, V90, P966, DOI 10.1161/01.RES.0000019540.41697.60
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Patel ZS, 2004, J BIOMAT SCI-POLYM E, V15, P701, DOI 10.1163/156856204774196117
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Pieper JS, 2002, J BIOMED MATER RES, V62, P185, DOI 10.1002/jbm.10267
   Presta M, 2005, CYTOKINE GROWTH F R, V16, P159, DOI 10.1016/j.cytogfr.2005.01.004
   Rickert D, 2003, CLIN HEMORHEOL MICRO, V28, P175
   Taylor AP, 2003, INT J CANCER, V105, P158, DOI 10.1002/ijc.11059
   Tonnesen MG, 2000, J INVEST DERM SYMP P, V5, P40, DOI 10.1046/j.1087-0024.2000.00014.x
   Trentin D, 2006, P NATL ACAD SCI USA, V103, P2506, DOI 10.1073/pnas.0505964102
   van Amerongen Machteld J., 2002, Angiogenesis, V5, P173, DOI 10.1023/A:1023822504224
   van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960
   Wissink MJB, 2001, BIOMATERIALS, V22, P151, DOI 10.1016/S0142-9612(00)00164-2
NR 33
TC 259
Z9 274
U1 3
U2 75
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2007
VL 28
IS 6
BP 1123
EP 1131
DI 10.1016/j.biomaterials.2006.10.029
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 122II
UT WOS:000243219000023
PM 17113636
DA 2018-10-19
ER

PT J
AU Lerouge, S
   Major, A
   Girard-Lauriault, PL
   Raymond, MA
   Laplante, P
   Soulez, G
   Mwale, F
   Wertheimer, MR
   Hebert, MJ
AF Lerouge, Sophie
   Major, Annie
   Girard-Lauriault, Pierre-Luc
   Raymond, Marc-Andre
   Laplante, Patrick
   Soulez, Gilles
   Mwale, Fackson
   Wertheimer, Michael R.
   Hebert, Marie-Josee
TI Nitrogen-rich coatings for promoting healing around stent-grafts after
   endovascular aneurysm repair
SO BIOMATERIALS
LA English
DT Article
DE aneurysm; stent-graft; plasma polymerisation; chondroitin sulphate; cell
   adhesion; apoptosis
ID ABDOMINAL AORTIC-ANEURYSMS; CELLS IN-VITRO; GROWTH-FACTOR; PLASMA;
   APOPTOSIS; MIGRATION; EXPRESSION; FIXATION; ANOIKIS; BINDING
AB Complications following endovascular aneurysm repair (EVAR) are related to deficient healing around the stent-graft (SG). New generations of SG with surface properties that foster vascular repair could overcome this limitation. Our goal was to evaluate the potential of a new nitrogen-rich plasma-polymerised biomaterial, designated PPE:N, as an external coating for polyethylene terephtalate (PET)- or polytetrafluoro-ethylene (PTFE)-based SGs, to promote healing around the implant. Thin PPE:N coatings were deposited on PET and PTFE films. Then, adhesion, growth, migration and resistance to apoptosis of vascular smooth muscle cells (VSMCs) and fibroblasts, as well as myofibroblast differentiation, were assessed in vitro. In another experimental group, chondroitin sulphate (CS), a newly described mediator of vascular repair, was added to normal culture medium, to search for possible additional benefit. PPE:N-coatings, especially on PET, increased and accelerated cell adhesion and growth, compared with control PET and with standard polystyrene culture plates (PCP). PPE:N was also found to increase the resistance to apoptosis in VSMC, an important finding as aneurysms are characterised by VMSC depletion caused by a pro-apoptotic phenotype. Addition of CS in solution further increased migration and resistance to apoptosis. In conclusion, PPE:N-coating and/or CS could promote vascular repair around SGs following EVAR. (c) 2006 Elsevier Ltd. All rights reserved.
C1 CHUM, Res Ctr, Montreal, PQ, Canada.
   Univ Montreal, Dept Biol, Inst Genie Biomed, Montreal, PQ H3C 3J7, Canada.
   Ecole Polytech, Dept Engn Phys, Montreal, PQ, Canada.
   McGill Univ, Lady Davis Inst, Montreal, PQ H3A 2T5, Canada.
   McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada.
RP Lerouge, S (reprint author), Hop Notre Dame De Bon Secours, LBeV, JA Seve Bldg,Room Y-1603,1560 Sherbrooke St E, Montreal, PQ H2L 4M1, Canada.
EM sophie.lerouge@umontreal.ca
OI soulez, gilles/0000-0002-5566-3552
CR Bullett NA, 2004, APPL SURF SCI, V235, P395, DOI 10.1016/j.apsusc.2004.02.058
   Cejna M, 2002, J VASC INTERV RADIOL, V13, P823, DOI 10.1016/S1051-0443(07)61992-7
   Christenson EM, 2004, J BIOMED MATER RES A, V69A, P407, DOI 10.1002/jbm.a.30002
   Elkouri S, 2004, J VASC SURG, V39, P497, DOI 10.1016/j.jvs.2003.10.018
   Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9
   Geraghty PJ, 2003, J CARDIOVASC SURG, V44, P543
   Girard-Lauriault PL, 2005, PLASMA PROCESS POLYM, V2, P263, DOI 10.1002/ppap.200400092
   GRASLKRAUPP B, 1995, HEPATOLOGY, V21, P1465, DOI 10.1016/0270-9139(95)90071-3
   Greenhalgh RM, 2004, LANCET, V364, P843, DOI 10.1016/S0140-6736(04)16979-1
   Guimond S, 2002, PLASMAS POLYM, V7, P71, DOI 10.1023/A:1015274118642
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   Hebert MJ, 1996, J IMMUNOL, V157, P3105
   Jacob T, 2001, J SURG RES, V101, P37, DOI 10.1006/jsre.2001.6193
   KAELBLE DH, 1974, PHYS CHEM ADHESION
   Kalliafas S, 2002, J ENDOVASC THER, V9, P743, DOI 10.1583/1545-1550(2002)009<0743:SGMAER>2.0.CO;2
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Laplante P, 2005, J IMMUNOL, V174, P5740, DOI 10.4049/jimmunol.174.9.5740
   Laplante P, 2006, J BIOL CHEM, V281, P30383, DOI 10.1074/jbc.M606412200
   LEROUGE S, 2001, PLASMAS POLYM, V6, P177
   Major A, 2006, J ENDOVASC THER, V13, P457, DOI 10.1583/06-1812MR.1
   Malina M, 2000, EUR J VASC ENDOVASC, V19, P5, DOI 10.1053/ejvs.1999.0867
   Marty B, 2002, J VASC INTERV RADIOL, V13, P601, DOI 10.1016/S1051-0443(07)61654-6
   McArthur C, 2001, J VASC SURG, V33, P733, DOI 10.1067/mva.2001.113980
   MELTON LJ, 1984, AM J EPIDEMIOL, V120, P379, DOI 10.1093/oxfordjournals.aje.a113902
   Michel JB, 2003, ARTERIOSCL THROM VAS, V23, P2146, DOI 10.1161/01.ATV.0000099882.52647.E4
   Mohan IV, 2002, J ENDOVASC THER, V9, P748, DOI 10.1583/1545-1550(2002)009<0748:FAFISG>2.0.CO;2
   Nelea V, 2005, J BIOMED MATER RES A, V75A, P216, DOI 10.1002/jbm.a.30402
   Prinssen M, 2004, NEW ENGL J MED, V351, P1607, DOI 10.1056/NEJMoa042002
   Pu FR, 2002, BIOMATERIALS, V23, P2411, DOI 10.1016/S0142-9612(01)00377-5
   Raymond MA, 2005, BIOCHEM BIOPH RES CO, V338, P1374, DOI 10.1016/j.bbrc.2005.10.105
   Raymond MA, 2004, FASEB J, V18, P705, DOI 10.1096/fj.03-0573fje
   Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053
   Schurink GWH, 1999, BRIT J SURG, V86, P581
   SCHWARTZ MA, 2002, NAT CELL BIOL, V4, P65
   STEHBENS WE, 2000, DEV ANEURYSMS, P84
   Tang PCY, 2005, CIRCULATION, V112, P1098, DOI 10.1161/CIRCULATIONHA.104.511717
   Thompson RW, 1997, CORONARY ARTERY DIS, V8, P623, DOI 10.1097/00019501-199710000-00005
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   van der Bas JMA, 2004, J VASC SURG, V39, P850, DOI 10.1016/j.jvs.2003.11.045
   Veith FJ, 2002, J VASC SURG, V35, P1029, DOI 10.1067/mva.2002.123095
   Xie YB, 2002, J BIOMED MATER RES, V61, P234, DOI 10.1002/jbm.10141
NR 41
TC 35
Z9 36
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2007
VL 28
IS 6
BP 1209
EP 1217
DI 10.1016/j.biomaterials.2006.10.033
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 122II
UT WOS:000243219000032
PM 17129601
DA 2018-10-19
ER

PT J
AU Liu, XD
   Howard, KA
   Dong, MD
   Andersen, MO
   Rahbek, UL
   Johnsen, MG
   Hansen, OC
   Besenbacher, F
   Kjems, J
AF Liu, Xiudong
   Howard, Kenneth A.
   dong, Ming Dong
   Andersen, Morten O.
   Rahbek, Ulrik L.
   Johnsen, Mads G.
   Hansen, Ole C.
   Besenbacher, Flemming
   Kjems, Jorgen
TI The influence of polymeric properties on chitosan/siRNA nanoparticle
   formulation and gene silencing
SO BIOMATERIALS
LA English
DT Article
DE RNA interference; chitosan; siRNA; nanoparticle; delivery; gene
   silencing
ID RNA INTERFERENCE; TRANSFECTION EFFICIENCY; DNA NANOPARTICLES; IN-VITRO;
   MAMMALIAN-CELLS; DELIVERY-SYSTEM; MOLECULAR-MASS; DEACETYLATION;
   VECTORS; THERAPY
AB We have previously introduced the use of the biomaterial chitosan to form chitosan/siRNA nanoparticles for gene silencing protocols. This present study shows that the physicochemical properties (size, zeta potential, morphology and complex stability) and in vitro gene silencing of chitosan/siRNA nanoparticles are strongly dependent on chitosan molecular weight (M,,) and degree of deacetylation (1313). High M-w and DD chitosan resulted in the formation of discrete stable nanoparticles similar to 200 nm in size. Chitosan/siRNA formulations (N:P 50) prepared with low M-w (similar to 10 kDa) showed almost no knockdown of endogenous enhanced green fluorescent protein (EGFP) in H1299 human lung carcinoma cells, whereas those prepared from higher M-w (64.8-170kDa) and DD (similar to 80%) showed greater gene silencing ranging between 45% and 65%. The highest gene silencing efficiency (80%) was achieved using chitosan/siRNA nanoparticles at N:P 150 using higher M,, (114 and 170 kDa) and DD (84%) that correlated with formation of stable nanoparticles of similar to 200 nm. In conclusion, this work confirms the application of chitosan as a non-viral carrier for siRNA and the importance of polymeric properties for the optimisation of gene silencing using chitosan/siRNA nanoparticles. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Aarhus, Dept Mol Biol, iNANO, DK-8200 Aarhus, Denmark.
   Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus, Denmark.
RP Howard, KA (reprint author), Univ Aarhus, Dept Mol Biol, iNANO, Bldg 1130, DK-8200 Aarhus, Denmark.
EM kenh@inano.dk
RI Dong, Mingdong/B-3341-2010; Besenbacher, Flemming/A-9623-2010; Andersen,
   Morten/D-5214-2013
OI Dong, Mingdong/0000-0002-2025-2171; Andersen,
   Morten/0000-0003-4977-3031; Kjems, Jorgen/0000-0003-4128-9317
FU Villum Fonden [7194]
CR Barton GM, 2002, P NATL ACAD SCI USA, V99, P14943, DOI 10.1073/pnas.242594499
   Bitko V, 2005, NAT MED, V11, P50, DOI 10.1038/nm1164
   Borchard G, 2001, ADV DRUG DELIVER REV, V52, P145, DOI 10.1016/S0169-409X(01)00198-3
   CarrenoGomez B, 1997, INT J PHARM, V148, P231, DOI 10.1016/S0378-5173(96)04847-8
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Corsi K, 2003, BIOMATERIALS, V24, P1255, DOI 10.1016/S0142-9612(02)00507-0
   Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703
   Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888
   Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870
   HIRANO S, 1976, CARBOHYD RES, V47, P315, DOI 10.1016/S0008-6215(00)84198-1
   Howard KA, 2006, MOL THER, V14, P476, DOI 10.1016/j.ymthe.2006.04.010
   Huang M, 2005, J CONTROL RELEASE, V106, P391, DOI 10.1016/j.cornel.2005.05.004
   Ichim TE, 2004, AM J TRANSPLANT, V4, P1227, DOI 10.1111/j.1600-6143.2004.00530.x
   ILLUM L, 1994, PHARMACEUT RES, V11, P1186, DOI 10.1023/A:1018901302450
   Ishii T, 2001, BBA-BIOMEMBRANES, V1514, P51, DOI 10.1016/S0005-2736(01)00362-5
   Khan TA, 2002, J PHARM PHARM SCI, V5, P205
   Kiang T, 2004, BIOMATERIALS, V25, P5293, DOI 10.1016/j.biomaterials.2003.12.036
   Koping-Hoggard M, 2004, GENE THER, V11, P1441, DOI 10.1038/sj.gt.3302312
   Li XW, 2003, BBA-GENE STRUCT EXPR, V1630, P7, DOI 10.1016/j.bbaexp.2003.08.011
   Liu WG, 2005, BIOMATERIALS, V26, P2705, DOI 10.1016/j.biomaterials.2004.07.038
   Liu WG, 2002, J CONTROL RELEASE, V83, P1
   Lundstrom K, 2003, TRENDS BIOTECHNOL, V21, P117, DOI 10.1016/S0167-7799(02)00042-2
   Mansouri S, 2004, EUR J PHARM BIOPHARM, V57, P1, DOI 10.1016/s0939-641(03)00155-3
   Mao HQ, 2001, J CONTROL RELEASE, V70, P399, DOI 10.1016/S0168-3659(00)00361-8
   MCLAUGHLIN FC, 1998, J CONTROL RELEASE, V56, P259
   Milhavet O, 2003, PHARMACOL REV, V55, P629, DOI 10.1124/pr.55.4.1
   MUZZARELLI RAA, 1985, CARBOHYD POLYM, V5, P461, DOI 10.1016/0144-8617(85)90005-0
   Ottoy MH, 1996, CARBOHYD POLYM, V31, P253, DOI 10.1016/S0144-8617(96)00096-3
   Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148
   Pouton CW, 2001, ADV DRUG DELIVER REV, V46, P187, DOI 10.1016/S0169-409X(00)00133-2
   Richardson SCW, 1999, INT J PHARMACEUT, V178, P231, DOI 10.1016/S0378-5173(98)00378-0
   Sato T, 2001, BIOMATERIALS, V22, P2075, DOI 10.1016/S0142-9612(00)00385-9
   Schiffelers RM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh140
   Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121
   VARUM KM, 1994, CARBOHYD POLYM, V25, P65, DOI 10.1016/0144-8617(94)90140-6
   VERHOEF JC, 2001, ADV DRUG DELIVER REV, V50, pS91
   Xia HB, 2002, NAT BIOTECHNOL, V20, P1006, DOI 10.1038/nbt739
NR 39
TC 264
Z9 271
U1 1
U2 86
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD FEB
PY 2007
VL 28
IS 6
BP 1280
EP 1288
DI 10.1016/j.biomaterials.2006.11.004
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 122II
UT WOS:000243219000039
PM 17126901
DA 2018-10-19
ER

PT J
AU De Bartolo, L
   Morelli, S
   Piscioneri, A
   Lopez, LC
   Favia, P
   d'Agostino, R
   Drioli, E
AF De Bartolo, Loredana
   Morelli, Sabrina
   Piscioneri, Antonella
   Lopez, Linda C.
   Favia, Pietro
   d'Agostino, Riccardo
   Drioli, Enrico
TI Novel membranes and surface modification able to activate specific
   cellular responses
SO BIOMOLECULAR ENGINEERING
LA English
DT Article; Proceedings Paper
CT Symposium on Nano-Structured and Intelligent Bioactive Materials held at
   the EMRS 2005 Spring Meeting
CY MAY 29-JUN 02, 2005
CL Strasbourg, FRANCE
DE membrane; human hepatocyte; liver specific functions; biotransformation;
   surface modification
ID MODIFIED POLYMERS; HUMAN HEPATOCYTES; PLASMA; ATTACHMENT; FIBRONECTIN;
   VIABILITY; ADHESION; CULTURE; CELLS
AB The design of new polymeric biomaterials together with new strategies to modify membrane surface are crucial to optimise cell-biomaterial interactions in vivo and in vitro biohybrid systems.
   In this study we report on the novel semipermeable membranes synthesised from a polymeric blend of modified polyetheretherketone and polyurethane able to support the long-term maintenance and differentiation of human liver cells and on the surface modification of polyethersulfone membranes by plasma polymerisation of acrylic acid monomers and by immobilization of arginine-glycine-aspartic acid (RGD) peptide through a hydrophilic "spacer arm" molecule.
   The performance of the modified and unmodified membranes was tested by evaluation of the liver function expression of primary human hepatocytes in terms of albumin production, protein secretion and drug biotransformation. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Calabria, Inst Membrane Technol, Natl Res Council Italy, I-87030 Arcavacata Di Rende, CS, Italy.
   Univ Bari, Dept Chem, Bari, Italy.
RP De Bartolo, L (reprint author), Univ Calabria, Inst Membrane Technol, Natl Res Council Italy, Via P Bucci,Cubo 17-C, I-87030 Arcavacata Di Rende, CS, Italy.
EM l.debartolo@itm.cnr.it
RI Piscioneri, Antonella/N-6910-2018; De Bartolo, Loredana/E-5074-2015
OI Piscioneri, Antonella/0000-0002-1052-1550; De Bartolo,
   Loredana/0000-0003-3774-9114; MORELLI, SABRINA/0000-0001-7551-8427;
   Favia, Pietro/0000-0002-5896-895X; Drioli, Enrico/0000-0003-1092-5368
CR Altankov G, 2000, J BIOMED MATER RES, V52, P219, DOI 10.1002/1097-4636(200010)52:1<219::AID-JBM28>3.0.CO;2-F
   Daw R, 1998, BIOMATERIALS, V19, P1717, DOI 10.1016/S0142-9612(98)00080-5
   De Bartolo L, 2005, BIOMATERIALS, V26, P6625, DOI 10.1016/j.biomaterials.2005.04.021
   De Bartolo L, 2005, BIOMATERIALS, V26, P4432, DOI 10.1016/j.biomaterials.2004.11.009
   De Bartolo L, 2000, BIOTECHNOL PROGR, V16, P102, DOI 10.1021/bp990128o
   De Bartolo L, 2002, BIOMATERIALS, V23, P2485, DOI 10.1016/S0142-9612(01)00383-0
   De Bartolo L, 2006, J NANOSCI NANOTECHNO, V6, P2344, DOI 10.1166/jnn.2006.514
   Detomaso L, 2005, BIOMATERIALS, V26, P3831, DOI 10.1016/j.biomaterials.2004.10.011
   Gancarz I, 2003, EUR POLYM J, V39, P1615, DOI 10.1016/S0014-3057(03)00055-7
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   KIMMERLE K, 1990, DESALINATION, V79, P283, DOI 10.1016/0011-9164(90)85012-Y
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Quirk RA, 2003, BIOTECHNOL BIOENG, V81, P625, DOI 10.1002/bit.10502
   Unger RE, 2005, BIOMATERIALS, V26, P1877, DOI 10.1016/j.biomaterials.2004.05.032
   Yin C, 2003, J BIOMED MATER RES A, V67A, P1093, DOI 10.1002/jbm.a.10033
NR 15
TC 32
Z9 33
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1389-0344
J9 BIOMOL ENG
JI Biomol. Eng.
PD FEB
PY 2007
VL 24
IS 1
SI SI
BP 23
EP 26
DI 10.1016/j.bioeng.2006.07.001
PG 4
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 147LQ
UT WOS:000245004900004
PM 16914370
DA 2018-10-19
ER

PT J
AU Eisenbarth, E
   Velten, D
   Breme, J
AF Eisenbarth, E.
   Velten, D.
   Breme, J.
TI Biomimetic implant coatings
SO BIOMOLECULAR ENGINEERING
LA English
DT Article; Proceedings Paper
CT Symposium on Nano-Structured and Intelligent Bioactive Materials held at
   the EMRS 2005 Spring Meeting
CY MAY 29-JUN 02, 2005
CL Strasbourg, FRANCE
DE nanostructure; nanosized topography; osteoblast; biomaterial
   interaction; surface modification
ID TITANIUM SURFACES; GROUND TITANIUM; CELL-ADHESION
AB Biomaterials and tissue engineering technologies are becoming increasingly important in biomedical practice, particularly as the population ages. Cellular responses depend on topographical properties of the biomaterial at the nanometer scale. Structures on biomaterial surfaces are used as powerful tools to influence or even control interactions between implants and the biological system [Kawahara, H., Soeda, Y., Niwa, K., Takahashi, M., Kawahara, D., Araki, N., 2004. J. Mater. Sci. Mater. Med. 15 (12), 1297-1307; Winkelmann, M., Gold, J., Hauert, R., Kasemo, B., Spencer, N.D., Brunette, D.M., Textor, M., 2003. Biomaterials 24 (7), 1133-1145]. The influence of nanometer sized surface structures on osteoblastlike cell interactions was tested with niobium oxide coatings on polished titanium slices (cp-Ti grade 2). The aim of the study was to investigate the influence of nanoscopic surface structures on osteoblast interactions in order to support collagen I production and cell adhesion. The coatings were done by means of the sol-gel process. The surface structure was adjusted by annealing of the metaloxide ceramic coatings due to temperature depended crystal growth. The applied annealing temperatures were 450, 550 and 700 degrees C for 1h, corresponding to Ra-numbers of 7, 15 and 40 nm. The surfaces were characterized by means of AFM, DTA/TG, diffractometry and white light interferometry. The cell reactions were investigated concerning adhesion kinetics, migration, spreading, cell adhesion, and collagen I synthesis. The smooth surface (Ra = 7 nm) resulted in the fastest cell anchorage and cell migration. The closest cell adhesion was reached with the surface structure of Ra = 15 nm. The roughest surface (Ra = 40 nm) impedes the cell migration as well as a proper spreading of the cells. The best results concerning cell adhesion and spreading was reached with an intermediate surface roughness of Ra = 15 nm of the niobium oxide coating on cp-titanium slices. (c) 2006 Elsevier B.V. All rights reserved.
C1 Hamburg Univ Technol, Dept Biomech, Hamburg, Germany.
   Univ Saarland, Dept Met Mat, D-6600 Saarbrucken, Germany.
RP Eisenbarth, E (reprint author), Hamburg Univ Technol, Dept Biomech, Hamburg, Germany.
EM eva.eisenbarth@tuhh.de
CR Catledge SA, 2004, J NANOSCI NANOTECHNO, V4, P986, DOI 10.1166/jnn.2004.137
   Eisenbarth E, 2004, BIOMATERIALS, V25, P5705, DOI 10.1016/j.biomaterials.2004.01.021
   Eisenbarth E, 2002, BIOMOL ENG, V19, P233, DOI 10.1016/S1389-0344(02)00028-X
   Huang HH, 2004, BIOMOL ENG, V21, P93, DOI 10.1016/j.bioeng.2004.05.001
   Kawahara H, 2004, J MATER SCI-MATER M, V15, P1297, DOI 10.1007/s10856-004-5738-0
   Landi E, 2005, BIOMATERIALS, V26, P2835, DOI 10.1016/j.biomaterials.2004.08.010
   Velten D, 2004, J MATER SCI-MATER M, V15, P457, DOI 10.1023/B:JMSM.0000021120.86985.f7
   Winkelmann M, 2003, BIOMATERIALS, V24, P1133, DOI 10.1016/S0142-9612(02)00449-0
   Zhu XL, 2004, CELLS TISSUES ORGANS, V178, P13, DOI 10.1159/000081089
NR 9
TC 61
Z9 65
U1 0
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1389-0344
J9 BIOMOL ENG
JI Biomol. Eng.
PD FEB
PY 2007
VL 24
IS 1
SI SI
BP 27
EP 32
DI 10.1016/j.bioeng.2006.05.016
PG 6
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 147LQ
UT WOS:000245004900005
PM 16828342
DA 2018-10-19
ER

PT J
AU Leguen, E
   Chassepot, A
   Decher, G
   Schaaf, P
   Voegel, JC
   Jessel, N
AF Leguen, Erell
   Chassepot, Armelle
   Decher, Gero
   Schaaf, Pierre
   Voegel, Jean-Claude
   Jessel, Nadia
TI Bioactive coatings based on polyelectrolyte multilayer architectures
   functionalized by embedded proteins, peptides or drugs
SO BIOMOLECULAR ENGINEERING
LA English
DT Article; Proceedings Paper
CT Symposium on Nano-Structured and Intelligent Bioactive Materials held at
   the EMRS 2005 Spring Meeting
CY MAY 29-JUN 02, 2005
CL Strasbourg, FRANCE
DE PEM films; functionalized biomaterial coating; structured materials
ID ATOMIC-FORCE MICROSCOPE; STAPHYLOCOCCUS-AUREUS; BETA-CYCLODEXTRIN;
   GROWTH-FACTOR; FILMS; ADSORPTION; DELIVERY; POLYMER; SURFACE; CELLS
AB DIn recent years, considerable effort has been devoted to the design and controlled fabrication of structured materials with functional properties. The layer by layer buildup of polyelectrolyte multilayer films (PEM films) from oppositely charged polyelectrolytes offers new opportunities for the preparation of functionalized biomaterial coatings. This technique allows the preparation of supramolecular nano-architectures exhibiting specific properties in terms of control of cell activation and may also play a role in the development of local drug delivery systems. Peptides, proteins, chemically bound to polyelectrolytes, adsorbed or embedded in PEM films, have been shown to retain their biological activities. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Strasbourg 1, INSERM Unite 595, F-67085 Strasbourg, France.
   ULP, CNRS, Inst Charles Sadron, F-67083 Strasbourg, France.
RP Jessel, N (reprint author), Univ Strasbourg 1, INSERM Unite 595, 11 Rue Humann, F-67085 Strasbourg, France.
EM nadia.jessel@medecine.u-strasbg.fr
RI SCHAAF, Pierre/J-2751-2016; Decher, Gero/E-7665-2011
OI SCHAAF, Pierre/0000-0001-7423-5492; Decher, Gero/0000-0002-7976-8818;
   Benkirane-Jessel, Nadia/0000-0003-3059-3559
CR Arcos D, 2001, BIOMATERIALS, V22, P701, DOI 10.1016/S0142-9612(00)00233-7
   Braet F, 2001, ULTRAMICROSCOPY, V89, P265, DOI 10.1016/S0304-3991(01)00092-4
   Braet F, 1998, J MICROSC-OXFORD, V190, P328
   Cannizzaro SM, 1998, BIOTECHNOL BIOENG, V58, P529, DOI 10.1002/(SICI)1097-0290(19980605)58:5<529::AID-BIT9>3.3.CO;2-U
   Caruso F, 1997, LANGMUIR, V13, P3427, DOI 10.1021/la9608223
   Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111
   Chluba J, 2001, BIOMACROMOLECULES, V2, P800, DOI 10.1021/bm015529i
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   Decher G., 2003, MULTILAYER THIN FILM
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C
   Doliwa A, 2001, SKIN PHARMACOL APPL, V14, P97, DOI 10.1159/000056339
   FRANKENBERGER M, 1995, J INFLAMM, V45, P56
   Frolich JC, 1997, TRENDS PHARMACOL SCI, V18, P30, DOI 10.1016/S0165-6147(96)01017-6
   Getting SJ, 2002, TRENDS PHARMACOL SCI, V23, P447, DOI 10.1016/S0165-6147(02)02103-X
   Ghose AC, 1999, IMMUNOL LETT, V65, P175, DOI 10.1016/S0165-2478(98)00102-3
   Grayson ACR, 2003, NAT MATER, V2, P767, DOI 10.1038/nmat998
   Hiller J, 2002, NAT MATER, V1, P59, DOI 10.1038/nmat719
   Ho PKH, 2000, NATURE, V404, P481, DOI 10.1038/35006610
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Ito Y, 1996, P NATL ACAD SCI USA, V93, P3598, DOI 10.1073/pnas.93.8.3598
   Ito Y, 1998, BIOCONJUGATE CHEM, V9, P277, DOI 10.1021/bc970190b
   Jessel N, 2003, ADV MATER, V15, P692, DOI 10.1002/adma.200304634
   JESSEL N, 2004, ADV MATER, V16, P1507
   Jessel N., 2004, ADV FUNCT MATER, V14, P174
   Jessel NB, 2004, ADV FUNCT MATER, V14, P963, DOI 10.1002/adfm.200305089
   KLEINFELD ER, 1994, SCIENCE, V265, P370, DOI 10.1126/science.265.5170.370
   KONG W, 1994, J CHEM SOC CHEM COMM, P1297, DOI 10.1039/c39940001297
   KUMAR S, 1992, CANCER LETT, V61, P105, DOI 10.1016/0304-3835(92)90167-T
   Ladam G, 2001, LANGMUIR, V17, P878, DOI 10.1021/la0013087
   Laurencin CT, 2001, BIOMATERIALS, V22, P1271, DOI 10.1016/S0142-9612(00)00279-9
   Lavalle P, 2002, MACROMOLECULES, V35, P4458, DOI 10.1021/ma0119833
   LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026
   LVOV Y, 1994, LANGMUIR, V10, P4232, DOI 10.1021/la00023a052
   McEwen J, 2000, CLIN DRUG INVEST, V19, P27, DOI 10.2165/00044011-200019002-00004
   MEMDELSOHN JD, 2003, BIOMACROMOLECULES, V4, P96
   Miyata T, 1999, NATURE, V399, P766, DOI 10.1038/21619
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Neff JA, 1998, J BIOMED MATER RES, V40, P511, DOI 10.1002/(SICI)1097-4636(19980615)40:4<511::AID-JBM1>3.3.CO;2-M
   Picart C, 2001, J CHEM PHYS, V115, P1086, DOI 10.1063/1.1375156
   RAY PK, 1982, CANCER RES, V42, P4970
   Schwinte P, 2001, J PHYS CHEM B, V105, P11906, DOI 10.1021/jp0123031
   Srivastava AK, 1997, MYCOPATHOLOGIA, V138, P21, DOI 10.1023/A:1006830620523
   Strand BL, 2001, CELL TRANSPLANT, V10, P263, DOI 10.3727/000000001783986800
   SUBBULAKSHMI V, 1998, BIOCH BIOPHYS RES CO, V250
   Szente L, 1999, ADV DRUG DELIVER REV, V36, P17, DOI 10.1016/S0169-409X(98)00092-1
   Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906
   Verma AS, 1999, IMMUNOPHARM IMMUNOT, V21, P89, DOI 10.3109/08923979909016396
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
NR 49
TC 51
Z9 52
U1 0
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1389-0344
J9 BIOMOL ENG
JI Biomol. Eng.
PD FEB
PY 2007
VL 24
IS 1
SI SI
BP 33
EP 41
DI 10.1016/j.bioeng.2006.05.023
PG 9
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 147LQ
UT WOS:000245004900006
PM 16860599
DA 2018-10-19
ER

PT J
AU Garreta, E
   Gasset, D
   Semino, C
   Borros, S
AF Garreta, E.
   Gasset, D.
   Semino, C.
   Borros, S.
TI Fabrication of a three-dimensional nanostructured biomaterial for tissue
   engineering of bone
SO BIOMOLECULAR ENGINEERING
LA English
DT Article; Proceedings Paper
CT Symposium on Nano-Structured and Intelligent Bioactive Materials held at
   the EMRS 2005 Spring Meeting
CY MAY 29-JUN 02, 2005
CL Strasbourg, FRANCE
DE cartilage; hydroxyapatite; bone tissue engineering; nanostructured
   composite
ID PEPTIDE SCAFFOLDS; ACRYLIC-ACID; PLASMA; SURFACES; CELLS
AB A plasma process for the surface modification of HA powders has been developed. Acrylic acid and acrylic acid/octadiene plasma deposited films onto HA particles have demonstrated to interact with SBF allowing the calcium dissolution-precipitation mechanism. Therefore, a nanostructured composite between HA and a self-assembling peptide scaffold (RAD16-I) has been developed. The differentiation of mESC in this scaffold has been studied, in order to test the osteogenic capacity of the new composite material. We have observed that the mESC can be iduced to produce Ca salts (mineralization) in a 3D-microenvironment and moreover, this activity can be enhanced by the presence of HA particules into the nanofiber scaffold. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Ramon Llull, Inst Quim Sarria, Barcelona Bioengn Ctr, Barcelona 08017, Spain.
   MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA.
RP Borros, S (reprint author), Univ Ramon Llull, Inst Quim Sarria, Barcelona Bioengn Ctr, Via Augusta 390, Barcelona 08017, Spain.
EM semino@mit.edu; s.borros@iqs.url.edu
RI Borros, Salvador/A-3950-2016
OI Borros, Salvador/0000-0002-4003-0381; Garreta Bahima,
   Elena/0000-0002-1071-9794
CR BOSKEY AL, 1992, CELL MATER, V2, P209
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   Detomaso L, 2005, BIOMATERIALS, V26, P3831, DOI 10.1016/j.biomaterials.2004.10.011
   FERNANDEZ T, 2003, THESIS I QUIMIC SARR
   Fraser S, 2002, J PHYS CHEM B, V106, P5596, DOI 10.1021/jp012406j
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Hench L. L., 1993, INTRO BIOCERAMICS, V1
   JARCHO M, 1986, DENT CLIN N AM, V30, P25
   LANDIS W, 1995, J BONE MINER RES, V10, pS506
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Ward LJ, 2003, CHEM MATER, V15, P1466, DOI 10.1021/cm020289e
   Whittle JD, 2002, J MATER CHEM, V12, P2726, DOI 10.1039/b201471h
   Zizak I, 2003, J STRUCT BIOL, V141, P208, DOI 10.1016/S1047-8477(02)00635-4
NR 15
TC 36
Z9 39
U1 2
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1389-0344
J9 BIOMOL ENG
JI Biomol. Eng.
PD FEB
PY 2007
VL 24
IS 1
SI SI
BP 75
EP 80
DI 10.1016/j.bioeng.2006.05.017
PG 6
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 147LQ
UT WOS:000245004900012
PM 16846750
DA 2018-10-19
ER

PT J
AU Welle, A
   Chiumiento, A
   Barbucci, R
AF Welle, Alexander
   Chiumiento, Antonio
   Barbucci, Rolando
TI Competitive protein adsorption on micro patterned polymeric
   biomaterials, and viscoelastic properties of tailor made extracellular
   matrices
SO BIOMOLECULAR ENGINEERING
LA English
DT Article; Proceedings Paper
CT Symposium on Nano-Structured and Intelligent Bioactive Materials held at
   the EMRS 2005 Spring Meeting
CY MAY 29-JUN 02, 2005
CL Strasbourg, FRANCE
DE quartz crystal microgravimetry; QCM-D; serum protein adsorption;
   hyaluronic acid; viscoelasticity
ID QUARTZ-CRYSTAL MICROBALANCE; CELL BEHAVIOR; SUBSTRATE; ADHESION;
   SURFACES; FILMS
AB Cell adhesion on biomaterial surfaces and the vitality of anchorage dependent cells is affected by several parameters of an adsorbate layer which is intentionally or spontaneously formed. Surface pre-treatments and several conditioning steps prior and during to the cell/biomaterial contact affect the composition, orientation, quantity and viscoelasticity of the interfacing layer between cells and biomaterial. This work was performed to elucidate the response of cells on two modified biomaterial surfaces based on protein or carbohydrate adsorbates:
   (a) Masked UV irradiations opened a simple route to obtain chemically patterned substrates controlling serum protein adsorption and cell adhesion. It is possible to achieve structures of subcellular size and to produce immobilized gradients. In order to examine the protein matrix deposited on these substrates we applied a quartz microbalance technique (QCM-D) capable to extract viscoelastic data in addition to the mass uptake during plasma protein deposition. It was found that the quantity and viscosity of surface bound albumin is lowered when the surface is modified (patterned) by UV exposure. Hence, the UV modification promotes the competitive adsorption of cell adhesion proteins from the media or upon secretion by the cells and yields to the observed cell patterns.
   (b) Another tissue engineering technique, using immobilized, modified and/or cross linked hyaluronic acid (HA), an important extra cellular matrix component in vivo, is also examined by QCM-D. Our data demonstrate that HA can be modified by an activation with a carbodiimide, followed by the application of an alpha,omega-bisamino polyethyleneglycol. The QCM-D data can be interpreted as a stiffening of the HA layer combined with the release of hydration water. Further, the hydration state and the viscoclastic behaviour of surface bound ultrathin HA hydrogels was examined.
   Quantification of viscoelastic parameters of thin films of ECM by QCM-D is valuable for the interpretation of durotaxis, describing effects of mechanical substrate parameters on the adhesion and motility of cells. (c) 2006 Published by Elsevier B.V.
C1 Forschungszentrum Karlsruhe, Inst Biol Interfaces, D-76021 Karlsruhe, Germany.
   Univ Siena, CRISMA, Dept Chem & Biosyst Sci & Technol, I-53100 Siena, Italy.
RP Welle, A (reprint author), Forschungszentrum Karlsruhe, Inst Biol Interfaces, POB 3640, D-76021 Karlsruhe, Germany.
EM Alexander.Welle@ibg.fzk.de
RI Welle, Alexander/H-2201-2013
OI Welle, Alexander/0000-0002-3454-6509
CR Barbucci R, 2003, BIOMATERIALS, V24, P915, DOI 10.1016/S0142-9612(02)00425-8
   Cans AS, 2001, ANAL CHEM, V73, P5805, DOI 10.1021/ac010777q
   Curtis A, 2001, PHYS MED BIOL, V46, pR47, DOI 10.1088/0031-9155/46/4/201
   Fredriksson C, 1998, LANGMUIR, V14, P248, DOI 10.1021/la971005l
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   Hook F, 2001, ANAL CHEM, V73, P5796, DOI 10.1021/ac0106501
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Magnani A, 2003, MAT SCI ENG C-BIO S, V23, P315, DOI 10.1016/S0928-4931(02)00284-9
   Mendelsohn JD, 2003, BIOMACROMOLECULES, V4, P96, DOI 10.1021/bm0256101
   Richert L, 2002, BIOMACROMOLECULES, V3, P1170, DOI 10.1021/bm.0255490
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Welle A, 2005, J NEUROSCI METH, V142, P243, DOI 10.1016/j.jneumeth.2004.08.011
   Welle A, 2002, BIOMED MICRODEVICES, V4, P33, DOI 10.1023/A:1014267712144
   Zhou T, 2000, BIOTECHNOL PROGR, V16, P268, DOI 10.1021/bp000003f
NR 14
TC 10
Z9 11
U1 1
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1389-0344
J9 BIOMOL ENG
JI Biomol. Eng.
PD FEB
PY 2007
VL 24
IS 1
SI SI
BP 87
EP 91
DI 10.1016/j.bioeng.2006.05.027
PG 5
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 147LQ
UT WOS:000245004900014
PM 16861035
DA 2018-10-19
ER

PT J
AU Bartsch, GC
   Malinova, V
   Volkmer, BE
   Hautmann, RE
   Rieger, B
AF Bartsch, Georg C., Jr.
   Malinova, Violeta
   Volkmer, Bjoern E.
   Hautmann, Richard E.
   Rieger, Bernhard
TI CO-alkene polymers are biocompatible scaffolds for primary urothelial
   cells in vitro and in vivo
SO BJU INTERNATIONAL
LA English
DT Article
DE biocompatibility; biomaterials; CO-alkene polymers; urology; urothelial
   cells
ID SMALL-INTESTINAL SUBMUCOSA; URETERAL REPLACEMENT; CARBON-MONOXIDE;
   URINARY-INCONTINENCE; TUBE GRAFTS; BLADDER; RECONSTRUCTION; PROPENE
AB To investigate CO-alkene polymers, novel synthetic nonbiodegradable polymers, as a potential biomaterial for urological applications.
   Porcine urothelial cells were seeded on cover glasses (96 wells; 10 000 cells/well) coated with CO-alkene polymers [propylene/N-Acetyl-O'-(hex-5-enyl)-L-tyrosine ethyl ester/CO (PTCO) and hexene-CO (HxCO)]. The following conditions were investigated: cells seeded; (i) on PTCO, (ii) on HxCO, (iii) in PTCO-conditioned medium, (iv) in HxCO-conditioned medium, (v) on glass without polymers, (vi) on polystyrene, and (vii) on polystyrene treated with 1.25% NaCl (toxic control). Cell counts, cell death detection assay, and a cell activity assay (XTT, a tetrazolium-based colorimetric assay) were performed after 3, 6 and 9 days. Urothelial-cell seeded-PTCO films (0.5 x 10(6) cells/cm(2)) were implanted into the subcutaneous space of athymic mice for up to 12 weeks and unseeded PTCO polymers were implanted as a negative control.
   The urothelial cell adherence rates on the polymers were similar to those for glass and polystyrene. The cell activity (XTT assay) was higher in cells seeded on the polymers than in cells seeded on polystyrene and glass after 3 and 6 days. There were no significant differences between the apoptosis rates of all groups at the given sample times, except for the high levels in the toxic control. In vivo the urothelial cells survived on the polymers for 12 weeks with no adverse reactions in any of the mice.
   CO-alkene polymers are biocompatible materials for urothelial cells in vitro and in vivo, and thus are potential biomaterials for the urogenital tract.
C1 Univ Ulm, Fac Med, Dept Urol, D-89075 Ulm, Germany.
RP Bartsch, GC (reprint author), Univ Ulm, Fac Med, Dept Urol, Prittwitzstr 43, D-89075 Ulm, Germany.
EM georg.bartsch@uniklinik-ulm.de
RI Rieger, Bernhard/C-1183-2010
OI Rieger, Bernhard/0000-0002-0023-884X
CR AbuSurrah AS, 1997, MACROMOL CHEM PHYSIC, V198, P1197, DOI 10.1002/macp.1997.021980421
   [Anonymous], 1992, ISO109935
   Atala A, 2000, J ENDOUROL, V14, P49, DOI 10.1089/end.2000.14.49
   Ateh DD, 2006, TISSUE ENG, V12, P645, DOI 10.1089/ten.2006.12.645
   Baltaci S, 1998, UROLOGY, V51, P400, DOI 10.1016/S0090-4295(97)00632-8
   Beckstead BL, 2005, BIOMATERIALS, V26, P6217, DOI 10.1016/j.biomaterials.2005.04.010
   Foullerat DP, 2004, MACROMOL CHEM PHYS, V205, P374
   Jones JS, 2005, BJU INT, V96, P103, DOI 10.1111/j.1464-410X.2005.05576.x
   Kassardjian ZG, 2004, BJU INT, V93, P665, DOI 10.1111/j.1464-410X.2004.04691.x
   Kim T., 2000, ADV STUD CONT MATH, V2, P9
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Liatsikos EN, 2001, J UROLOGY, V165, P1719, DOI 10.1016/S0022-5347(05)66401-4
   Malinova V, 2005, MACROMOL RAPID COMM, V26, P945, DOI 10.1002/marc.200500150
   Moncada I, 2004, CURR OPIN UROL, V14, P375, DOI 10.1097/00042307-200411000-00014
   Muller G, 2002, PROG POLYM SCI, V27, P815, DOI 10.1016/S0079-6700(01)00030-2
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Pariente JL, 2002, J UROLOGY, V167, P1867, DOI 10.1016/S0022-5347(05)65251-2
   Pariente JL, 2001, J BIOMED MATER RES, V55, P33, DOI 10.1002/1097-4636(200104)55:1<33::AID-JBM50>3.0.CO;2-7
   Pariente JL, 1998, J BIOMED MATER RES, V40, P31, DOI 10.1002/(SICI)1097-4636(199804)40:1<31::AID-JBM4>3.0.CO;2-S
   Reuter P, 2003, MACROMOL BIOSCI, V3, P123, DOI 10.1002/mabi.200390012
   ROEHLKE W, 2003, MACROMOL BIOSCI, V3, P131
   ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U
   Rutman M, 2006, J UROLOGY, V175, P610, DOI 10.1016/S0022-5347(05)00237-5
   Sabanegh ES, 1996, UROLOGY, V48, P312, DOI 10.1016/S0090-4295(96)00185-9
   SCOTT FB, 1989, UROL CLIN N AM, V16, P105
   SEN A, 1989, MACROMOLECULES, V22, P2012, DOI 10.1021/ma00194a084
   Sievert KD, 2000, J UROLOGY, V163, P1958, DOI 10.1016/S0022-5347(05)67610-0
   Sun T, 2005, TISSUE ENG, V11, P1023, DOI 10.1089/ten.2005.11.1023
   TACHIBANA M, 1985, J UROLOGY, V133, P866, DOI 10.1016/S0022-5347(17)49268-8
   XU FY, 1993, MAKROMOL CHEM, V194, P2579
   Yoo JJ, 1998, UROLOGY, V51, P221, DOI 10.1016/S0090-4295(97)00644-4
NR 31
TC 4
Z9 4
U1 0
U2 4
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1464-4096
J9 BJU INT
JI BJU Int.
PD FEB
PY 2007
VL 99
IS 2
BP 447
EP 453
DI 10.1111/j.1464-410X.2006.06576.x
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA 124ZQ
UT WOS:000243411700040
PM 17092287
OA Bronze
DA 2018-10-19
ER

PT J
AU Lee, WC
   Cho, YH
AF Lee, Won Chul
   Cho, Young-Ho
TI Bio-inspired digital nanoactuators for photon and biomaterial
   manipulation
SO CURRENT APPLIED PHYSICS
LA English
DT Article
DE bio-inspired devices; digital actuators; nanoactuators; mechanical
   modulation; high-precision positioning
AB This paper presents a bio-inspired digital nanoactuation device (DND) for applications to nano-precision digital manipulation of photons and biomolecules. The structures and principles of DND device have been inspired from those of the biological muscle actuator. The bio-inspired DND, composed of a digital actuator and a nonlinear mechanical modulator, purifies the stroke of the digital actuator in order to generate the high-precision motion required for nano-positioning of photonic or bio-molecule devices. We design and fabricate two kind of DNDs: one with a linear modulator (1-DND) and the other with nonlinear modulator (n-DND), both having an identical input and output strokes of 15.2 mu m and 5.4 mu m, respectively. In experimental study, n-DND shows the repeatability of 12.3 +/- 2.9 nm, superior to that of 27.8 +/- 2.9 nm achieved by 1-DND. We experimentally verify that the displacement purifying capability of the bio-inspired n-DND achieves nano-precision motion repeatability, applicable to photon and bio-molecule manipulation. (c) 2006 Elsevier B.V. All rights reserved.
C1 Korea Adv Inst Sci & Technol, Digital Nanolocomot Ctr, Dept Biosyst, Taejon 305701, South Korea.
RP Cho, YH (reprint author), Korea Adv Inst Sci & Technol, Digital Nanolocomot Ctr, Dept Biosyst, 373-1 Guseong Dong, Taejon 305701, South Korea.
EM nanosys@kaist.ac.kr
RI Cho, Young-Ho/C-1529-2011
CR Akiyama T., 1993, Journal of Microelectromechanical Systems, V2, P106, DOI 10.1109/84.260254
   CHO YH, 1999, P 5 WORLD MICR SUMM
   CHO YH, 2000, REALIZATION BIOANALO
   FAN LS, 1987, P TRANSD 87 TOK, P849
   HERZIG HP, 1999, P 3 INT C MICR OPT E, P157
   Hosaka S., 1996, IEEE Transactions on Magnetics, V32, P1873, DOI 10.1109/20.492880
   KOVACS GTA, 1998, MICROMACHINES TRANSD, pCH3
   PISANO AP, 1989, P 5 INT C SOL STAT S
   TOSHIYOSHI H, 1999, P 10 INT C SOL STAT, P994
   VIKTOROVITCH P, 1999, P 3 INT C MICR OPT E, P35
NR 10
TC 6
Z9 6
U1 0
U2 4
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1567-1739
J9 CURR APPL PHYS
JI Curr. Appl. Phys.
PD FEB
PY 2007
VL 7
IS 2
BP 139
EP 146
DI 10.1016/j.cap.2006.03.001
PG 8
WC Materials Science, Multidisciplinary; Physics, Applied
SC Materials Science; Physics
GA 116RA
UT WOS:000242818800005
DA 2018-10-19
ER

PT J
AU Colmati, F
   Yoshioka, SA
   Silva, VLVB
   Varela, H
   Gonzalez, ER
AF Colmati, Flavio
   Yoshioka, Sergio A.
   Silva, Victor L. V. B.
   Varela, Hamilton
   Gonzalez, Ernesto R.
TI Enzymatic based biocathode in a polymer electrolyte membrane fuel cell
SO INTERNATIONAL JOURNAL OF ELECTROCHEMICAL SCIENCE
LA English
DT Article
DE biochemical fuel cell; enzymes; biocatalysts; oxygen reduction reaction
ID BIOFUEL CELL; DIRECT ELECTROCHEMISTRY; LACTATE-DEHYDROGENASE; CARBON;
   ELECTROCATALYSIS; IMMOBILIZATION; PEROXIDASE; REDUCTION; OPERATION;
   CATALYSIS
AB In this communication results of a fuel cell operating with a conventional platinum anode and a peroxidase based biochatode are presented. The biocathode was prepared with peroxidase extracted from vegetal tissue of brazilian zucchini, Cucurbirta pepo, via four different methods. The biomaterial was used either immobilized or adsorbed on carbon cloth and on carbon powder. The tests were carried out at 25 degrees C in a proton exchange membrane fuel cell, in which cathode and anode were fed with oxygen and hydrogen, respectively. The crude extract from brazilian zucchini ( Cucurbirta pepo) was used as peroxidase source in the cathode of the biochemical fuel cell. In spite of the poor stability, evidence of the cathode activity towards oxygen reduction is presented and a maximum power density in the range of 80 to 120 mu W cm(-2) was observed.
C1 [Colmati, Flavio; Yoshioka, Sergio A.; Silva, Victor L. V. B.; Varela, Hamilton; Gonzalez, Ernesto R.] Univ Sao Paulo, Inst Quim Sao Carlos, BR-13560970 Sao Carlos, SP, Brazil.
RP Varela, H (reprint author), Univ Sao Paulo, Inst Quim Sao Carlos, Av Trabalhador Sao Carlense 400,CP-780, BR-13560970 Sao Carlos, SP, Brazil.
EM varela@iqsc.usp.br; ernesto@iqsc.usp.br
RI Gonzalez, Ernesto/C-9422-2012; Varela, Hamilton/C-3901-2012
OI Varela, Hamilton/0000-0002-6237-6068
CR Barton SC, 2004, CHEM REV, V104, P4867, DOI 10.1021/cr020719k
   BRETT AMO, 1696, ELECTROCHEMISTRY PRI
   Chen HJ, 2007, ELECTROCHEM COMMUN, V9, P469, DOI 10.1016/j.elecom.2006.10.019
   Colmati F, 2005, ELECTROCHIM ACTA, V50, P5496, DOI 10.1016/j.electacta.2005.03.030
   Dalla-Vecchia R, 2004, QUIM NOVA, V27, P623, DOI 10.1590/S0100-40422004000400017
   EVERSE J, 1991, PEROXIDASES CHEM BIO, V2, pCH1
   Fatibello O, 2002, QUIM NOVA, V25, P455, DOI 10.1590/S0100-40422002000300019
   Gonzalez ER, 2000, QUIM NOVA, V23, P262, DOI 10.1590/S0100-40422000000200019
   Grzebyk M, 2005, SEP PURIF TECHNOL, V41, P321, DOI 10.1016/j.seppur.2004.04.009
   Halliwell CM, 2002, BIOELECTROCHEMISTRY, V55, P21, DOI 10.1016/S1567-5394(01)00172-4
   Halliwell CM, 2002, ANAL CHIM ACTA, V453, P191, DOI 10.1016/S0003-2670(01)01408-8
   Ikeda T, 2003, BBA-PROTEINS PROTEOM, V1647, P121, DOI 10.1016/S1570-9639(03)00075-X
   Jang JK, 2004, PROCESS BIOCHEM, V39, P1007, DOI 10.1016/S0032-9592(03)00203-6
   KATZ E, 1999, NEW J CHEM, V23, P487
   KATZ E, 2003, HDB FUEL CELL FUNDAM, V1
   Lai ME, 2000, J ELECTROANAL CHEM, V494, P30, DOI 10.1016/S0022-0728(00)00307-7
   Mano N, 2003, J AM CHEM SOC, V125, P6588, DOI 10.1021/ja0346328
   Paganin VA, 1998, ELECTROCHIM ACTA, V43, P3761, DOI 10.1016/S0013-4686(98)00135-2
   Pizzariello A, 2002, BIOELECTROCHEMISTRY, V56, P99, DOI 10.1016/S1567-5394(02)00026-9
   Simon E, 2002, J ELECTROANAL CHEM, V538, P253, DOI 10.1016/S0022-0728(02)00833-1
   Soares CMF, 1999, APPL BIOCHEM BIOTECH, V77-9, P745
   Tarasevich MR, 2003, ELECTROCHEM COMMUN, V5, P491, DOI 10.1016/S1388-2481(03)00104-8
   Wang MK, 2005, J ELECTROANAL CHEM, V578, P121, DOI 10.1016/j.jelechem.2004.12.030
   ZAKS A, 1988, J BIOL CHEM, V263, P3194
   Zhao F, 2004, ANAL CHEM, V76, P4960, DOI 10.1021/ac0494026
NR 25
TC 5
Z9 5
U1 0
U2 8
PU ELECTROCHEMICAL SCIENCE GROUP
PI BELGRADE
PA A SPOMENICE 7/12 , 19210 BOR, BELGRADE, VJ 12, SERBIA
SN 1452-3981
J9 INT J ELECTROCHEM SC
JI Int. J. Electrochem. Sci.
PD FEB
PY 2007
VL 2
IS 2
BP 195
EP 202
PG 8
WC Electrochemistry
SC Electrochemistry
GA 306TM
UT WOS:000256270700007
DA 2018-10-19
ER

PT J
AU Patel, JD
   Krupka, T
   Anderson, JM
AF Patel, Jasmine D.
   Krupka, Tianyi
   Anderson, James M.
TI iNOS-mediated generation of reactive oxygen and nitrogen species by
   biomaterial-adherent neutrophils
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE nitric oxide; superoxide anion; neutrophil; infection; polyurethanes
ID NITRIC-OXIDE SYNTHASE; RABBIT ALVEOLAR MACROPHAGES;
   STAPHYLOCOCCUS-EPIDERMIDIS; POLYMORPHONUCLEAR LEUKOCYTES;
   SUPEROXIDE-DISMUTASE; PEROXYNITRITE; INHIBITION; NITROTYROSINE;
   EXPRESSION; NITRATION
AB Infection due to implanted cardiovascular biomaterials is a serious complication initiated by bacterial adhesion to the surface of the implant. The release of reactive oxygen species by neutrophils, particularly superoxide anion, is a well-known bactericidal mechanism. Additionally, nitric oxide (NO) has also been identified as an important cytotoxic mediator in acute and chronic inflammatory responses with enhanced NO production by upregulation of inducible nitric oxide synthase (iNOS). The interaction of NO and superoxide anion will result in the formation of peroxynitrite (OONO-), a potent cytotoxic oxidant. In this study, we have shown that biomaterial-induced neutrophil activation does not cause upregulation of iNOS and activation of iNOS-mediated pathways. However, NO and O-2(-) production does occur over time upon adhesion to a biomaterial and is modulated by biomaterial surface chemistry. With no stimulus, the polyethylene oxide-modified polyurethane induced greater neutrophil activation than did the control as indicated by the increased production of NO and O-2(-) over time. Adherent-stimulated neutrophils generally produced lower amounts of NO over time in comparison with unstimulated cells. Furthermore, there is no evidence of peroxynitrite activity in unstimulated neutrophils adherent to the Elasthane 80A. However, upon stimulation with adherent Staphylococcus epidermidis, peroxynitrite formation did occur. Our results suggest that bactericidal mechanisms in neutrophils involving NO generation (NOS pathway) are further compromised than O-2(-) producing pathways (NADPH oxidase) upon exposure to biomaterials, resulting in a diminished microbial killing capacity, which can increase the probability of device-centered infections. (c) 2006 Wiley Periodicals, Inc. J Biomed Mater Res 80A: 381-390, 2007.
C1 Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
EM jma6@po.cwru.edu
FU NIBIB NIH HHS [EB-00279]
CR Anstey NM, 1996, J EXP MED, V184, P557, DOI 10.1084/jem.184.2.557
   Babior BM, 2002, ARCH BIOCHEM BIOPHYS, V397, P342, DOI 10.1006/abbi.2001.2642
   BECKMAN JS, 1992, ARCH BIOCHEM BIOPHYS, V298, P438, DOI 10.1016/0003-9861(92)90432-V
   Denicola A, 1998, P NATL ACAD SCI USA, V95, P3566, DOI 10.1073/pnas.95.7.3566
   EVANS TG, 1993, J IMMUNOL, V151, P907
   Evans TJ, 1996, P NATL ACAD SCI USA, V93, P9553, DOI 10.1073/pnas.93.18.9553
   GIRIDHAR G, 1995, J BIOMED MATER RES, V29, P1179, DOI 10.1002/jbm.820291004
   GIRIDHAR G, 1993, BIOMATERIALS, V14, P609, DOI 10.1016/0142-9612(93)90180-A
   GRAY ED, 1984, LANCET, V1, P365
   GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   Higashi JM, 1999, HDB BIOMATERIALS EVA, P493
   HOFFSTEIN ST, 1985, LAB INVEST, V52, P515
   ISCHIROPOULOS H, 1992, ARCH BIOCHEM BIOPHYS, V298, P431, DOI 10.1016/0003-9861(92)90431-U
   Itoh Y, 2000, ANAL BIOCHEM, V287, P203, DOI 10.1006/abio.2000.4859
   KAPLAN SS, 1992, J BIOMED MATER RES, V26, P1039, DOI 10.1002/jbm.820260806
   KLEINSTREUER C, 1997, ENG FLUID DYNAMICS
   KLOCK JC, 1976, BLOOD, V48, P149
   Kojima H, 1999, ANGEW CHEM INT EDIT, V38, P3209, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3209::AID-ANIE3209>3.0.CO;2-6
   LANGREHR JM, 1992, J CLIN INVEST, V90, P679, DOI 10.1172/JCI115911
   Larfars G, 1998, J LAB CLIN MED, V132, P54, DOI 10.1016/S0022-2143(98)90025-7
   Levich V. G., 1962, PHYSICOCHEMICAL HYDR
   MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323
   MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243
   Nagano T, 1999, LUMINESCENCE, V14, P283, DOI 10.1002/(SICI)1522-7243(199911/12)14:6<283::AID-BIO572>3.0.CO;2-G
   OCHOA JB, 1991, ANN SURG, V214, P621, DOI 10.1097/00000658-199111000-00013
   Ou JH, 1997, NITRIC OXIDE-BIOL CH, V1, P404, DOI 10.1006/niox.1997.0136
   Patel JD, 2003, J BIOMAT SCI-POLYM E, V14, P279, DOI 10.1163/156856203763572725
   PRYOR WA, 1993, ANN NY ACAD SCI, V686, P12, DOI 10.1111/j.1749-6632.1993.tb39148.x
   Rees D. D., 1999, NITRIC OXIDE INFECT, P151
   REILING N, 1994, EUR J IMMUNOL, V24, P1941, DOI 10.1002/eji.1830240836
   Sethi S, 2000, THROMB RES, V100, P223, DOI 10.1016/S0049-3848(00)00320-0
   Shive MS, 1999, J BIOMED MATER RES, V46, P511, DOI 10.1002/(SICI)1097-4636(19990915)46:4<511::AID-JBM9>3.0.CO;2-M
   Shive MS, 2000, P NATL ACAD SCI USA, V97, P6710, DOI 10.1073/pnas.110463197
   Stenger S, 1996, J EXP MED, V183, P1501, DOI 10.1084/jem.183.4.1501
   STOSSEL TP, 1971, J CLIN INVEST, V50, P1745, DOI 10.1172/JCI106664
   Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X
   Sugarman B, 1989, Infect Dis Clin North Am, V3, P187
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   vanderVliet A, 1996, METHOD ENZYMOL, V269, P175
   Viera L, 1999, METHOD ENZYMOL, V301, P373
   Wootton DM, 1999, ANNU REV BIOMED ENG, V1, P299, DOI 10.1146/annurev.bioeng.1.1.299
   Xia Y, 1997, P NATL ACAD SCI USA, V94, P6954, DOI 10.1073/pnas.94.13.6954
   Ye YZ, 1996, METHOD ENZYMOL, V269, P201
   ZIMMERLI W, 1982, J INFECT DIS, V146, P487, DOI 10.1093/infdis/146.4.487
NR 45
TC 21
Z9 22
U1 1
U2 9
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2007
VL 80A
IS 2
BP 381
EP 390
DI 10.1002/jbm.a.30907
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 125PW
UT WOS:000243455300013
PM 17001645
DA 2018-10-19
ER

PT J
AU Chang, CF
   Lee, MW
   Kuo, PY
   Wang, YJ
   Tu, YH
   Hung, SC
AF Chang, Ching-Fang
   Lee, Ming-Wei
   Kuo, Pei-Yin
   Wang, Yng-Jiin
   Tu, Yi-Hsien
   Hung, Shih-Chieh
TI Three-dimensional collagen fiber remodeling by mesenchymal stem cells
   requires the integrin-matrix interaction
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE remodeling; mesenchymal stem cells; biomaterials; type II collagen;
   chondrogenesis; integrin; matrix
ID VITRO CARTILAGE FORMATION; BONE-MARROW; IN-VITRO; TISSUE; SCAFFOLDS;
   DIFFERENTIATION; CHONDROGENESIS; REGENERATION; ALGINATE; POROSITY
AB Tissue engineering aiming to repair or regenerate damaged tissues necessitates fabricating three-dimensional biomaterial scaffolds with controlled porosity for delivering cells. To facilitate cell distribution, a strategy using stem cell-based fabrication of biomaterials was tested in type II collagen fibers. Human mesenchymal stem cells when delivered in type II collagen assembled and reorganized these matrices and differentiated into spherical chondrocytes with the synthesis of cartilage proteins. The cell-mediated assembly and reorganization of collagen fibers was not limitless and only restricted to an appropriate ratio of cell number and collagen amount. The blocking of alpha 2 or beta 1-integrin function with specific antibodies significantly impeded the collagen-assembly effects. In vitro chondrogenesis or in vivo cartilage formation of human mesenchymal stem cells was also dependent on the interactions between cells and surrounding matrices. This method for three-dimensional fabricating collagen fibers may generally be applied to other biomaterials, when combined with surface modification or ligand addition for cell adhesion. (c) 2006 Wiley Periodicals, Inc.
C1 Vet Gen Hosp, Stem Cell Lab, Taipei 112, Taiwan.
   Natl Yang Ming Univ, Inst Anat & Cell Biol, Taipei 112, Taiwan.
   Natl Yang Ming Univ, Inst Biomed Engn, Taipei 112, Taiwan.
   Vet Gen Hosp, Dept Orthopaed & Traumatol, Taipei 112, Taiwan.
   Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.
RP Hung, SC (reprint author), Vet Gen Hosp, Stem Cell Lab, 201,Sec 2,Shih Pai Rd, Taipei 112, Taiwan.
EM hungsc@vghtpe.gov.tw
CR Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   De Bari C, 2004, ARTHRITIS RHEUM-US, V50, P142, DOI 10.1002/art.11450
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Hu YH, 2003, J BIOMED MATER RES A, V64A, P583, DOI 10.1002/jbm.a.10438
   Hung SC, 2002, STEM CELLS, V20, P249, DOI 10.1634/stemcells.20-3-249
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Ichinose S, 2005, CELL TISSUE RES, V322, P217, DOI 10.1007/s00441-005-1140-6
   Katoh K, 2004, BIOMATERIALS, V25, P4255, DOI 10.1016/j.biomaterials.2003.11.018
   Li SH, 2003, TISSUE ENG, V9, P535, DOI 10.1089/107632703322066714
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Ma HL, 2005, J BIOMED MATER RES A, V74A, P439, DOI 10.1002/jbm.a.30314
   Ma HL, 2003, J BIOMED MATER RES A, V64A, P273, DOI 10.1002/jbm.a.10370
   Meshel AS, 2005, NAT CELL BIOL, V7, P157, DOI 10.1038/ncb1216
   Mizuno M, 2000, J CELL PHYSIOL, V184, P207, DOI 10.1002/1097-4652(200008)184:2<207::AID-JCP8>3.3.CO;2-L
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   Park KI, 2002, NAT BIOTECHNOL, V20, P1111, DOI 10.1038/nbt751
   Phillips JA, 2005, EXP CELL RES, V310, P79, DOI 10.1016/j.yexcr.2005.03.039
   Pieper JS, 2002, BIOMATERIALS, V23, P3183, DOI 10.1016/S0142-9612(02)00067-4
   Shi ST, 2002, NAT BIOTECHNOL, V20, P587, DOI 10.1038/nbt0602-587
   Tadic D, 2004, BIOMATERIALS, V25, P3335, DOI 10.1016/j.biomaterials.2003.10.007
   Temenoff JS, 2000, BIOMATERIALS, V21, P431, DOI 10.1016/S0142-9612(99)00213-6
   THOROGOOD PV, 1975, J EMBRYOL EXP MORPH, V33, P581
   Yokoyama A, 2005, CELL TISSUE RES, V322, P289, DOI 10.1007/s00441-005-0010-6
   Zimmermann WH, 2004, BIOMATERIALS, V25, P1639, DOI 10.1016/S0142-9612(03)00521-0
NR 26
TC 31
Z9 31
U1 0
U2 5
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2007
VL 80A
IS 2
BP 466
EP 474
DI 10.1002/jbm.a.30963
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 125PW
UT WOS:000243455300022
PM 17013867
DA 2018-10-19
ER

PT J
AU Develioglu, H
   Saraydin, SU
   Dupoirieux, L
   Sahin, ZD
AF Develioglu, Hakan
   Unver Saraydin, Serpil
   Dupoirieux, Laurent
   Deniz Sahin, Zeynep
TI Histological findings of long-term healing of the experimental defects
   by application of a synthetic biphasic ceramic in rats
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE synthetic materials; critical-sized defect; bone formation; rat
ID CALCIUM-PHOSPHATE CERAMICS; MULTINUCLEATED GIANT-CELLS; BONE;
   HYDROXYAPATITE; BIOMATERIALS; PARTICLES; SKELETON; FORMS; MODEL
AB Calcium phosphate ceramics are generally biocompatible and can develop interactions with human recipient bone. Therefore, they can be widely used in the field of periodontology and dentistry. The purpose of this investigation was to assess the long-term histological bone healing results of experimentally created critical size parietal bone defects in rats. Twelve Wistar rats were used in this investigation. Two 6-mm wide, symmetrical, and circular critical size defects were created in each parietal bone of the animals. While the right defects filled with granular implant (Ceraform (R)), the symmetrical defects were taken as controls. Eighteen months after implantation, rats were killed and defects including the biomaterial with surrounding bone was taken for histological examination. Serial histological sections were cut across the defects and stained for the histological analysis. Both control and Ceraform implanted regions contained dense collagenous tissue. In the implantation site, multinuclear giant cells were observed around the material. On the other hand, there were no necrosis, tumour, and infection in the implantation region. There was no statistical difference between the control and ceraform implanted groups when the bone formation results were compared (p > 0.05). In conclusion, the results revealed that this material is biocompatible and does enhance the new bone building despite the long-term observation period. Although this biphasic ceramic shows within the limits of the study as a less resorptive and not osteoconductive properties, it can be considered as a biocompatible bone defect filling material having a limited application alternative in dentistry and medicine. (c) 2006 Wiley Periodicals, Inc.
C1 Cumhuriyet Univ, Fac Med, Dept Histol & Embryol, Sivas, Turkey.
   Cumhuriyet Univ, Fac Dent, Dept Periodontol, Sivas, Turkey.
   Polyclin Marmandais, Marmande, France.
RP Saraydin, SU (reprint author), Cumhuriyet Univ, Fac Med, Dept Histol & Embryol, Sivas, Turkey.
EM usaraydin@cumhuriyet.edu.tr
CR Anderson JM, 2000, CURR OPIN HEMATOL, V7, P40, DOI 10.1097/00062752-200001000-00008
   BASLE MF, 1993, CALCIFIED TISSUE INT, V53, P348, DOI 10.1007/BF01351842
   BELL DH, 1986, J PROSTHET DENT, V56, P322, DOI 10.1016/0022-3913(86)90013-2
   BLOCK MS, 1986, J ORAL MAXIL SURG, V44, P89, DOI 10.1016/0278-2391(86)90187-4
   BOSCH C, 1995, CLEFT PALATE-CRAN J, V269, P284
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   DACULSI G, 1990, BIOMATERIALS, V11, P86
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   DERSOT JM, 1993, CELL MATER, V3, P395
   Develioglu H, 2006, J BIOMED MATER RES A, V77A, P627, DOI 10.1002/jbm.a.30692
   Develioglu Hakan, 2005, J Oral Implantol, V31, P309, DOI 10.1563/1548-1336(2005)31[309:TEOABC]2.0.CO;2
   FRAYSSINET P, 1993, CELL MATER, V3, P383
   Le Guehennec L, 2005, J BIOMED MATER RES B, V72B, P69, DOI 10.1002/jbm.b.30118
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Matheson LA, 2004, J CELL PHYSIOL, V199, P8, DOI 10.1002/jcp.10412
   Merkx MAW, 1999, BIOMATERIALS, V20, P2029, DOI 10.1016/S0142-9612(99)00105-2
   Naaman NBA, 1998, INT J ORAL MAX IMPL, V13, P115
   NAJJAR TA, 1977, J ORAL SURG, V35, P375
   NERY EB, 1992, J PERIODONTOL, V63, P629
   Piattelli A, 1996, BIOMATERIALS, V17, P1767, DOI 10.1016/0142-9612(95)00342-8
   REY C, 1990, Biomaterials, V11, P13
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   WINTER M, 1981, BIOMATERIALS, V2, P159, DOI 10.1016/0142-9612(81)90043-0
   Yuan HP, 2002, J MATER SCI-MATER M, V13, P1271, DOI 10.1023/A:1021191432366
NR 26
TC 11
Z9 11
U1 0
U2 1
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD FEB
PY 2007
VL 80A
IS 2
BP 505
EP 508
DI 10.1002/jbm.a.31121
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 125PW
UT WOS:000243455300027
PM 17120224
DA 2018-10-19
ER

PT J
AU Jalota, S
   Bhaduri, SB
   Tas, AC
AF Jalota, Sahil
   Bhaduri, Sarit B.
   Tas, A. Cuneyt
TI A new rhenanite (beta-NaCaPO4) and hydroxyapatite biophasic biomaterial
   for skeletal repair
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Review
DE bioresorbable; rhenanite; hydroxylapatite; calcium phosphate(s); bone
   graft
ID CALCIUM-PHOSPHATE CERAMICS; POORLY CRYSTALLINE APATITE; SYNTHETIC
   BODY-FLUIDS; X-RAY-DIFFRACTION; TRICALCIUM PHOSPHATE; HUMAN BONE;
   IN-VIVO; OCTACALCIUM PHOSPHATE; CHEMICAL PREPARATION; BIOCERAMIC POWDERS
AB Biphasic beta-rhenanite (beta-NaCaPO4)-hydroxyapatite (Ca-10(PO4)(6)(OH)(2)) biomaterials were prepared by using a one-pot, solution-based synthesis procedure at the physiological pH of 7.4, followed by low-temperature (300-600 degrees C) calcination in air for 6 h. Calcination was for the sole purpose of crystallization. An aqueous solution of Ca(NO3)(2)(.) 4H(2)O was rapidly added to a solution of Na2HPO4 and NaHCO3, followed by immediate removal of gel-like, poorly-crystallized precursor precipitates from the mother liquors of pH 7.4. Freeze-dried precursors were found to be nanosize with an average particle size of 45 nm and a surface area of 128 m(2)/g. Upon calcination in air, precursor powders crystallized into biphasic (60% HA-40% rhenanite) biomaterials, while retaining their submicron particle sizes and high surface areas. beta-rhenanite is a high solubility sodium calcium phosphate phase. Samples were characterized by XRD, FTIR, SEM, TEM, ICP-AES, TG, DTA, DSC, and surface area measurements. (c) 2006 Wiley Periodicals, Inc.
C1 Clemson Univ, Sch Mat Sci & Engn, Clemson, SC 29634 USA.
RP Tas, AC (reprint author), Mersin Univ, Dept Mat Engn, TR-33342 Mersin, Turkey.
EM actas@mersin.edu.tr
RI Tas, A. Cuneyt/B-1966-2008
CR APEL E, Patent No. 20040167006
   Bayraktar D, 1999, J EUR CERAM SOC, V19, P2573, DOI 10.1016/S0955-2219(99)00132-6
   Benaziz L, 2001, J COLLOID INTERF SCI, V238, P48, DOI 10.1006/jcis.2001.7450
   BERMUDEZ O, 1994, BIOMATERIALS, V15, P1019, DOI 10.1016/0142-9612(94)90084-1
   BETTS F, 1975, P NATL ACAD SCI USA, V72, P2088, DOI 10.1073/pnas.72.6.2088
   *BIOM INC, 2006, CALC NAP BON VOID FI
   Bloemers FW, 2003, J BIOMED MATER RES B, V66B, P526, DOI 10.1002/jbm.b.10045
   BLUMENTH.NC, 1972, MATER RES BULL, V7, P1181, DOI 10.1016/0025-5408(72)90097-9
   BLUMENTHAL NC, 1975, CALC TISS RES, V18, P81, DOI 10.1007/BF02546228
   BOSKEY AL, 1974, MATER RES BULL, V9, P907, DOI 10.1016/0025-5408(74)90169-X
   Cazalbou S, 2004, J BONE MINER METAB, V22, P310, DOI 10.1007/s00774-004-0488-0
   DOI Y, 1993, J DENT RES, V72, P1279, DOI 10.1177/00220345930720090401
   Doi Y, 2001, BIOMATERIALS, V22, P847, DOI 10.1016/S0142-9612(00)00248-9
   DRIESSENS FCM, 1992, J MATER SCI-MATER M, V3, P413, DOI 10.1007/BF00701237
   EANES E. D., 1967, CLIN ORTHOP RELATED RESIN COMPLICATIONS OF ORTHOPAEDIC SURGERY, V53, P223
   EANES ED, 1976, CALC TISS RES, V20, P75, DOI 10.1007/BF02546399
   EANES ED, 1977, CALC TISS RES, V23, P259, DOI 10.1007/BF02012795
   EANES ED, 1973, CALC TISS RES, V12, P143, DOI 10.1007/BF02013730
   *EBI LP, 2006, OST RES BON GRAFT SU
   EBRAHIMPOUR A, 1993, J COLLOID INTERF SCI, V159, P158, DOI 10.1006/jcis.1993.1307
   El-Ghannam AR, 2004, J BIOMED MATER RES A, V69A, P490, DOI 10.1002/jbm.a.30022
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Eppley BL, 2002, J CRANIOFAC SURG, V13, P681, DOI 10.1097/01.SCS.0000026423.83739.44
   GLASSER FP, 1982, Patent No. 4363650
   Gong WL, 2001, J BIOMED MATER RES, V54, P320, DOI 10.1002/1097-4636(20010305)54:3<320::AID-JBM20>3.0.CO;2-E
   Goyenvalle E, 2003, J MATER SCI-MATER M, V14, P219, DOI 10.1023/A:1022876522242
   GREENFIELD DJ, 1974, CALC TISS RES, V14, P131, DOI 10.1007/BF02060289
   GREENFIELD DJ, 1972, CALC TISS RES, V9, P152, DOI 10.1007/BF02061953
   HATA K, 1995, J AM CERAM SOC, V78, P1049, DOI 10.1111/j.1151-2916.1995.tb08435.x
   Hiller JC, 2003, BIOMATERIALS, V24, P5091, DOI 10.1016/S0142-9612(03)00427-7
   Hing KA, 2004, J BIOMED MATER RES A, V68A, P187, DOI 10.1002/jbm.a.10050
   Hoshikawa A, 2003, BIOMATERIALS, V24, P4967, DOI 10.1016/S0142-9612(03)00422-8
   *ICDD PDF, 291193 ICDD PDF
   INSKEEP WP, 1988, GEOCHIM COSMOCHIM AC, V52, P1883, DOI 10.1016/0016-7037(88)90012-9
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   JOHANSEN E, 1960, J BIOPHYS BIOCHEM CY, V7, P743, DOI 10.1083/jcb.7.4.743
   Joschek S, 2000, BIOMATERIALS, V21, P1645, DOI 10.1016/S0142-9612(00)00036-3
   Kamakura S, 2002, J BIOMED MATER RES, V59, P29, DOI 10.1002/jbm.1213.abs
   KANGASNIEMI IMO, 1992, J BIOMED MATER RES, V26, P663, DOI 10.1002/jbm.820260508
   KANGASNIEMI IMO, 1993, J BIOMED MATER RES, V27, P1225, DOI 10.1002/jbm.820271003
   KILIAN O, 2002, BIOMATERIALIEN, V3, P126
   Kim HM, 2001, J BIOMED MATER RES, V56, P250, DOI 10.1002/1097-4636(200108)56:2<250::AID-JBM1092>3.0.CO;2-S
   Kivrak N, 1998, J AM CERAM SOC, V81, P2245
   Knaack D, 1998, J BIOMED MATER RES, V43, P399, DOI 10.1002/(SICI)1097-4636(199824)43:4<399::AID-JBM7>3.3.CO;2-A
   Knabe C, 2004, BIOMATERIALS, V25, P335, DOI 10.1016/S0142-9612(03)00525-8
   Knabe C, 1997, BIOMATERIALS, V18, P1339, DOI 10.1016/S0142-9612(97)00078-1
   Kurashina K, 2002, BIOMATERIALS, V23, P407, DOI 10.1016/S0142-9612(01)00119-3
   Kwon SH, 2003, J EUR CERAM SOC, V23, P1039, DOI 10.1016/S0955-2219(02)00263-7
   Le Nihouannen D, 2005, BONE, V36, P1086, DOI 10.1016/j.bone.2005.02.017
   LEE DD, 2001, Patent No. 6331312
   LEGEROS RZ, 1993, INTRO BIOCERAMICS, P144
   Lin SY, 2004, J BIOMED MATER RES B, V70B, P203, DOI 10.1002/jbm.b.30067
   Loong CK, 2000, BONE, V26, P599, DOI 10.1016/S8756-3282(00)00273-8
   MADSEN HEL, 1984, J CRYST GROWTH, V66, P369
   METSGER DS, 1982, J AM DENT ASSOC, V105, P1035, DOI 10.14219/jada.archive.1982.0408
   MOLNAR Z, 1959, J ULTRA MOL STRUCT R, V3, P39, DOI 10.1016/S0022-5320(59)80012-5
   MOLNAR Z, 1960, CLIN ORTHOP RELAT R, V17, P38
   MULLERMAI CM, 1995, J BIOMED MATER RES, V29, P9, DOI 10.1002/jbm.820290103
   Nakahira A, 2003, J APPL PHYS, V93, P8513, DOI 10.1063/1.1557832
   NEUMAN WF, 1958, CHEM DYNAMICS BONE M
   NICHOLAS RW, 1994, CLIN ORTHOP RELAT R, V306, P197
   Nunes CR, 1997, J BIOMED MATER RES, V36, P560
   NYLEN MU, 1972, CALC TISS RES, V9, P95, DOI 10.1007/BF02061948
   PLESHKO N, 1991, BIOPHYS J, V60, P786, DOI 10.1016/S0006-3495(91)82113-0
   POSNER AS, 1963, ARCH ORAL BIOL, V8, P549, DOI 10.1016/0003-9969(63)90071-2
   POSNER AS, 1952, J DENT RES, V31, P371, DOI 10.1177/00220345520310031501
   POSNER AS, 1969, PHYSIOL REV, V49, P760
   Quizat S, 1999, MATER RES BULL, V34, P2279
   RAMSELAAR MMA, 1993, J MATER SCI-MATER M, V4, P311, DOI 10.1007/BF00122287
   RAMSELAAR MMA, 1991, J MATER SCI-MATER M, V2, P63, DOI 10.1007/BF00703460
   REY C, 1991, CALCIFIED TISSUE INT, V49, P383, DOI 10.1007/BF02555847
   REY C, 1991, J BONE MINER RES, V6, P515
   Rey C, 1995, CELL MATER, V5, P345
   ROBINSON RA, 1955, ANN NY ACAD SCI, V60, P596, DOI 10.1111/j.1749-6632.1955.tb40054.x
   ROBINSON RA, 1952, ANAT REC, V114, P383, DOI 10.1002/ar.1091140302
   Rogers KD, 2002, BIOMATERIALS, V23, P2577, DOI 10.1016/S0142-9612(01)00395-7
   Schmitz JP, 1999, J ORAL MAXIL SURG, V57, P1122, DOI 10.1016/S0278-2391(99)90338-5
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, V205, P299
   Skrtic D, 2004, BIOMATERIALS, V25, P1141, DOI 10.1016/j.biomaterials.2003.08.001
   Somrani S, 2003, J MATER CHEM, V13, P888, DOI 10.1039/b210900j
   SPECTOR M, 1994, CLIN PLAST SURG, V21, P437
   Spoerke ED, 2005, BIOMATERIALS, V26, P5120, DOI 10.1016/j.biomaterials.2005.01.039
   STUTMAN JM, 1962, NATURE, V193, P368, DOI 10.1038/193368a0
   Suchanek W, 1998, J EUR CERAM SOC, V18, P1923, DOI 10.1016/S0955-2219(98)00131-9
   Szpalski M, 2002, ORTHOPEDICS, V25, pS601
   Tang RK, 2003, J COLLOID INTERF SCI, V260, P379, DOI 10.1016/S0021-9797(03)00048-12
   Tas AC, 2000, J AM CERAM SOC, V83, P2954, DOI 10.1111/j.1151-2916.2000.tb01666.x
   Tas AC, 2000, BIOMATERIALS, V21, P1429
   Tas AC, 2000, J EUR CERAM SOC, V20, P2389, DOI 10.1016/S0955-2219(00)00129-1
   Tas AC, 2004, J AM CERAM SOC, V87, P2195, DOI 10.1111/j.1151-2916.2004.tb07490.x
   Tas AC, 2004, KEY ENG MAT, V264-268, P1969, DOI 10.4028/www.scientific.net/KEM.264-268.1969
   Tas AC, 2004, J MATER RES, V19, P2742, DOI 10.1557/JMR.2004.0349
   TERMINE J. D., 1967, CALCIFIED TISSUE RES, V1, P8, DOI 10.1007/BF02008070
   TERMINE JD, 1972, CALC TISS RES, V10, P171, DOI 10.1007/BF02012548
   Tofighi A, 2000, KEY ENG MAT, V192-1, P769
   Wenisch S, 2003, J BIOMED MATER RES A, V67A, P713, DOI 10.1002/jbm.a.10091
   WU YT, 1994, J MOL BIOL, V244, P423, DOI 10.1006/jmbi.1994.1740
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Yuan HP, 2002, J MATER SCI-MATER M, V13, P1271, DOI 10.1023/A:1021191432366
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
   ZHOU JM, 1993, J MATER SCI-MATER M, V4, P83, DOI 10.1007/BF00122983
NR 101
TC 22
Z9 24
U1 1
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2007
VL 80B
IS 2
BP 304
EP 316
DI 10.1002/jbm.b.30598
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 131KA
UT WOS:000243866500004
PM 16767721
DA 2018-10-19
ER

PT J
AU Dallan, PRM
   Moreira, PD
   Petinari, L
   Malmonge, SM
   Beppu, MM
   Genari, SC
   Moraes, AM
AF Marreco Dallan, Paula Rulf
   da Luz Moreira, Patricia
   Petinari, Leandro
   Malmonge, Sonia Maria
   Beppu, Marisa Masumi
   Genari, Selma Candelaria
   Moraes, Angela Maria
TI Effects of chitosan solution concentration and incorporation of chitin
   and glycerol on dense chitosan membrane properties
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE chitin; chitosan; glycerol; membrane; burn dressing
ID IN-VITRO; MECHANICAL-PROPERTIES; PHYSICAL-PROPERTIES; SKIN SUBSTITUTES;
   FILMS; SCAFFOLDS; FIBROBLASTS; DEGRADATION; DERIVATIVES; FABRICATION
AB The aim of this work was to perform a systematic study about the effects induced by chitosan solution concentration and by chitin or glycerol incorporation on dense chitosan membranes with potential use as burn dressings. The membrane properties analyzed were total raw material cost, thickness, morphology, swelling ratio, tensile strength, percentage of strain at break, crystallinity, in vitro enzymatic degradation with lysozyme, and in vitro Vero cells adhesion. While the use of the most concentrated chitosan solution (2.5% w/w) increased membrane cost, it also improved the biomaterial mechanical resistance and ductility, as well as reduced membrane degradation when exposed for 2 months to llysozyme. The remaining evaluated properties were not affected by initial chitosan solution concentration. Chitin incorporation, on the other hand, reduced the membranes cost, swelling ratio, mechanical properties, and crystallinity, resulting in thicker biomaterials with irregular surface more easily degradable when exposed to lysozyme. Glycerol incorporation also reduced the membranes cost and crystallinity and increased membranes degradability after exposure to lysozyme. Strong Vero cells adhesion was not observed in any of the tested membrane formulations. The overall results indicate that the majority of the prepared membranes meet the performance requirements of temporary nonbiodegradable burn dressings (e.g. adequate values of mechanical resistance and ductility, low values of in vitro cellular adhesion on their surfaces, low extent of degradation when exposed to lysozyme solution, and high stability in aqueous solutions). (c) 2006 Wiley Periodicals, Inc.
C1 Univ Estadual Campinas, Sch Chem Engn, Dept Biotechnol Proc, BR-13081970 Campinas, SP, Brazil.
   Univ Estadual Campinas, Inst Biol, Dept Cellular Biol, BR-13094970 Campinas, SP, Brazil.
   Univ Estadual Campinas, Sch Chem Engn, Dept Thermofluiddynam, BR-13081970 Campinas, SP, Brazil.
   UNIMEP, Sch Engn Architecture & Urbanism, BR-13450000 Santa Barbara Doeste, SP, Brazil.
RP Moraes, AM (reprint author), Univ Estadual Campinas, Sch Chem Engn, Dept Biotechnol Proc, POB 6066, BR-13081970 Campinas, SP, Brazil.
EM ammoraes@feq.unicamp.br
RI Malmonge, Sonia/I-4610-2012; BEPPU, MARISA/E-1057-2012; Moraes,
   Angela/K-5181-2012
OI Moraes, Angela/0000-0002-5813-332X
CR Averbach BL, 1978, P 1 INT C CHIT CHIT, P199
   Azad AK, 2004, J BIOMED MATER RES B, V69B, P216, DOI 10.1002/jbm.b.30000
   Balasubramani M, 2001, BURNS, V27, P534, DOI 10.1016/S0305-4179(01)00018-3
   Brown CD, 2001, J CONTROL RELEASE, V72, P35, DOI 10.1016/S0168-3659(01)00260-7
   Cervera MF, 2004, EUR J PHARM BIOPHARM, V58, P69, DOI 10.1016/j.ejpb.2004.03.015
   CERVERA MF, 2004, AAPS PHARM SCI TECH, V5
   Chatelet C, 2001, BIOMATERIALS, V22, P261, DOI 10.1016/S0142-9612(00)00183-6
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Chupa JM, 2000, BIOMATERIALS, V21, P2315, DOI 10.1016/S0142-9612(00)00158-7
   Dewez JL, 1998, BIOMATERIALS, V19, P1441, DOI 10.1016/S0142-9612(98)00055-6
   Hansen B, 2002, ARCH DERMATOL, V138, P909, DOI 10.1001/archderm.138.7.909
   HUBELL JA, 1995, BIOTECHNOLOGY, V13, P565
   Khan TA, 2000, J PHARM PHARM SCI, V3, P303
   Kweon H, 2001, J APPL POLYM SCI, V80, P928, DOI 10.1002/app.1172
   LEVENSON SM, 1965, ANN SURG, V161, P293, DOI 10.1097/00000658-196502000-00019
   LIM LY, 2001, DEV CHITIN CHITOSAN
   LYNDON MJ, 1985, BIOMAT, V6, P396
   Ma JB, 2001, BIOMATERIALS, V22, P331, DOI 10.1016/S0142-9612(00)00188-5
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   Mao JS, 2003, BIOMATERIALS, V24, P1621, DOI 10.1016/S0142-9612(02)00549-5
   Marreco PR, 2004, J BIOMED MATER RES B, V71B, P268, DOI 10.1002/jbm.b.30081
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Mi FL, 2003, J MEMBRANE SCI, V212, P237, DOI 10.1016/S0376-7388(02)00505-7
   MU Y, 1999, TSINGHUA SCI TECHNOL, V4, P1578
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   Paul W., 2004, TRENDS BIOMATERIALS, V18, P18
   Qu X, 2000, POLYMER, V41, P4841, DOI 10.1016/S0032-3861(99)00704-1
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   Risbud M, 2000, J BIOSCIENCES, V25, P25, DOI 10.1007/BF02985178
   Santos AR, 2001, ARTIF ORGANS, V25, P7, DOI 10.1046/j.1525-1594.2001.025001007.x
   Senel S, 2004, ADV DRUG DELIVER REV, V56, P1467, DOI 10.1016/j.addr.2004.02.007
   Sheridan RL, 1999, BURNS, V25, P97, DOI 10.1016/S0305-4179(98)00176-4
   Silver F.H., 1994, BIOMATERIALS MED DEV, P46
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   *US C OFF TECHN AS, 1993, OTABPE102 US C, P39
   Wang LH, 2002, J BIOMED MATER RES, V63, P610, DOI 10.1002/jbm.10382
   WISNIEWSKAWRONA M, 2002, FIBRES TEXT EAST EUR, V38, P82
   Wu YB, 2004, CARBOHYD POLYM, V57, P435, DOI 10.1016/j.carbpol.2004.05.013
   Xia WY, 2004, J BIOMED MATER RES B, V71B, P373, DOI 10.1002/jbm.b.30087
   Yang JM, 2004, J MEMBRANE SCI, V236, P39, DOI 10.1016/j.memsci.2004.02.005
   Yang JM, 2004, J MEMBRANE SCI, V243, P1, DOI 10.1016/j.memsci.2004.03.019
   YOSOF NLB, 2001, J BIOMED MATER RES, V54, P59
   Zhang M, 2002, BIOMATERIALS, V23, P2641, DOI 10.1016/S0142-9612(01)00403-3
NR 44
TC 18
Z9 18
U1 1
U2 13
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD FEB
PY 2007
VL 80B
IS 2
BP 394
EP 405
DI 10.1002/jbm.b.30610
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 131KA
UT WOS:000243866500015
PM 16850463
DA 2018-10-19
ER

PT J
AU Le Nihouannen, D
   Saffarzadeh, A
   Aguado, E
   Goyenvalle, E
   Gauthier, O
   Moreau, F
   Pilet, P
   Spaethe, R
   Daculsi, G
   Layrolle, P
AF Le Nihouannen, Damien
   Saffarzadeh, Afchine
   Aguado, Eric
   Goyenvalle, Eric
   Gauthier, Olivier
   Moreau, Francoise
   Pilet, Paul
   Spaethe, Reiner
   Daculsi, Guy
   Layrolle, Pierre
TI Osteogenic properties of calcium phosphate ceramics and fibrin glue
   based composites
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 20th Conference of the European-Society-for-Biomaterials
CY SEP 27-OCT 01, 2006
CL Nantes, FRANCE
SP European Soc Biomat
ID STEM-CELL TRANSPLANTATION; BONE-FORMATION; BIOLOGICAL PERFORMANCE;
   IN-VIVO; GRANULES; PARTICLES; SEALANT; OSTEOINDUCTION; BIOMATERIALS;
   REGENERATION
AB Calcium phosphate (Ca-P) ceramics are currently used in various types of orthopaedic and maxillofacial applications because of their osteoconductive properties. Fibrin glue is also used in surgery due to its haemostatic, chemotactic and mitogenic properties and also as scaffolds for cell culture and transplantation. In order to adapt to surgical sites, bioceramics are shaped in blocks or granules and preferably in porous forms. Combining these bioceramics with fibrin glue provides a mouldable and self-hardening composite biomaterial. The aim of this work is to study the osteogenic properties of this composite material using two different animal models. The formation of newly formed bone (osteoinduction) and bone healing capacity (osteconduction) have been study in the paravertebral muscles of sheep and in critical sized defects in the femoral condyle of rabbits, respectively. The different implantations sites were filled with composite material associating Ca-P granules and fibrin glue. Ca-P granules of 1-2 mm were composed with 60% of hydroxyapatite and 40% of beta tricalcium phosphate in weight. The fibrin glue was composed of fibrinogen, thrombin and other biological factors. After both intramuscular or intraosseous implantations for 24 weeks and 3, 6, 12 and 24 weeks, samples were analyzed using histology and histomorphometry and mechanical test. In all cases, the newly formed bone was observed in close contact and around the ceramic granules. Depending on method of quantification, 6.7% (with BSEM) or 17% (with mu CT) of bone had formed in the sheep muscles and around 40% in the critical sized bone rabbit defect after 24 weeks. The Ca-P/fibrin material could be used for filling bone cavities in various clinical indications.
C1 INSERM, U791, Nantes, France.
   Univ Nantes, Fac Chirurg Dent, Lab Ingn Osteoarticulaire & Dent, F-44042 Nantes, France.
   Ecole Natl Vet, Serv Chirurg, F-44307 Nantes, France.
   INSERM, RIO IFR, F-44042 Nantes, France.
   Baxter BioSci BioSurg, Vienna, Austria.
RP Le Nihouannen, D (reprint author), INSERM, U791, Nantes, France.
EM damien.lenihouannen@mcgill.ca
RI Layrolle, Pierre/K-9257-2015; Paul, Pilet/A-3755-2015; Daculsi,
   Guy/P-1320-2014; Gauthier, Olivier/A-4639-2015
OI Layrolle, Pierre/0000-0001-9800-5210; Daculsi, Guy/0000-0003-1030-3446; 
CR Abiraman S, 2002, BIOMATERIALS, V23, P3023, DOI 10.1016/S0142-9612(02)00064-9
   Albala DM, 2003, CARDIOVASC SURG, V11, P5, DOI 10.1016/S0967-2109(03)00065-6
   Barrere F, 2003, J BIOMED MATER RES A, V66A, P779, DOI 10.1002/jbm.a.10454
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   BIEBER EJ, 1986, CLIN PLAST SURG, V13, P645
   Bluteau G, 2006, BIOMATERIALS, V27, P2934, DOI 10.1016/j.biomaterials.2006.01.004
   BURCHARDT H, 1987, ORTHOP CLIN N AM, V18, P187
   Burstein FD, 2000, PLAST RECONSTR SURG, V105, P34, DOI 10.1097/00006534-200001000-00006
   Daculsi G, 2003, J MATER SCI-MATER M, V14, P195, DOI 10.1023/A:1022842404495
   DACULSI G, 1992, ANN OTO RHINOL LARYN, V101, P669, DOI 10.1177/000348949210100808
   Delloye C, 2003, Chir Organi Mov, V88, P335
   FRAYSSINET P, 1993, BIOMATERIALS, V14, P423, DOI 10.1016/0142-9612(93)90144-Q
   FROST HM, 1969, CALC TISS RES, V3, P211, DOI 10.1007/BF02058664
   Geer DJ, 2002, TISSUE ENG, V8, P787, DOI 10.1089/10763270260424141
   Habibovic P, 2005, BIOMATERIALS, V26, P3565, DOI 10.1016/j.biomaterials.2004.09.056
   Habibovic P, 2005, BIOMATERIALS, V26, P23, DOI 10.1016/j.biomaterials.2004.02.026
   Harasen G, 2002, CAN VET J, V43, P299
   Jegoux F, 2005, ARCH ORTHOP TRAUM SU, V125, P153, DOI 10.1007/s00402-004-0748-4
   Karp JM, 2004, J BIOMED MATER RES A, V71A, P162, DOI 10.1002/jbm.a.30147
   Kumar TRS, 2001, BIOMATERIALS, V22, P2769
   KURZ LT, 1989, SPINE, V14, P1324, DOI 10.1097/00007632-198912000-00009
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Le Guehennec L, 2004, Eur Cell Mater, V8, P1
   Le Guehennec L, 2005, J MATER SCI-MATER M, V16, P29, DOI 10.1007/s10856-005-6443-3
   Le Guehennec L, 2005, J BIOMED MATER RES B, V72B, P69, DOI 10.1002/jbm.b.30118
   Le Nihouannen D, 2006, BIOMATERIALS, V27, P2716, DOI 10.1016/j.biomaterials.2005.11.038
   Le Nihouannen D, 2005, BONE, V36, P1086, DOI 10.1016/j.bone.2005.02.017
   Li G, 2005, J ORTHOP RES, V23, P196, DOI 10.1016/j.prthres.2004.05.006
   Lu JX, 2004, J MATER SCI-MATER M, V15, P361, DOI 10.1023/B:JMSM.0000021102.68509.65
   MATRAS H, 1985, J ORAL MAXIL SURG, V43, P605, DOI 10.1016/0278-2391(85)90129-6
   PEARSON OM, 2004, AM J PHYS ANTHR S, V39, P63
   Pfister RR, 2005, CORNEA, V24, P593, DOI 10.1097/01.ico.0000157402.89032.ad
   RAMRAKHIANI M, 1979, ACTA ANAT, V103, P358
   Ripamonti U, 1999, S AFR J SCI, V95, P335
   Schwarz N, 1993, Ann Chir Gynaecol Suppl, V207, P63
   Spitzer RS, 2002, J BIOMED MATER RES, V59, P690, DOI 10.1002/jbm.1277
   WITTKAMPF ARM, 1989, J CRANIO MAXILL SURG, V17, P179, DOI 10.1016/S1010-5182(89)80019-8
   Yamada Y, 2003, J CRANIO MAXILL SURG, V31, P27, DOI 10.1016/S1010-5182
   YAMASAKI H, 1992, BIOMATERIALS, V13, P308, DOI 10.1016/0142-9612(92)90054-R
   Yuan HP, 2002, J MATER SCI-MATER M, V13, P1271, DOI 10.1023/A:1021191432366
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P717, DOI 10.1023/A:1008998817977
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
NR 42
TC 35
Z9 35
U1 1
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2007
VL 18
IS 2
BP 225
EP 235
DI 10.1007/s10856-006-0684-7
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 140LV
UT WOS:000244507600006
PM 17323153
DA 2018-10-19
ER

PT J
AU Andersson, M
   Hedlund, J
   Berglin, M
   Elwing, H
   Tang, L
AF Andersson, M.
   Hedlund, J.
   Berglin, M.
   Elwing, H.
   Tang, L.
TI Molecular mobility of polymeric implants and acute inflammatory
   response: An experimental study in mice
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 20th Conference of the European-Society-for-Biomaterials
CY SEP 27-OCT 01, 2006
CL Nantes, FRANCE
SP European Soc Biomat
ID IMMUNE COMPLEMENT ACTIVATION; BIOMATERIALS; COAGULATION; SURFACES
AB An overlooked factor in biomaterial research is the surface molecular flexibility for polymer based implants. The mobility of the polymer chains provides a way for the surface to adapt itself to the environment. This is relevant when the implant comes in contact with a biological fluid and its constituents. By changing the length of the alkyl side chain of poly(alkyl methacrylates) (PAMAs) an interesting opportunity is provided where it is possible to study the surface molecular mobility without changing the surface hydrophobicity, nor does it introduce any additives or any changes in the degree of polymer cross-linking. Four variants of PAMAs were implanted in the peritoneum of Balb/c mice using a well described setup. End points were taken after 18 h and estimations of inflammatory cell recruitment and implant-associated cells were studied. Relationship between surface molecular mobility and inflammatory cell recruitment as well as surface-associated cells was noted.
C1 Gothenburg Univ, Lundberg Lab, Dept Cell & Mol Biol Interface Biophys, SE-40530 Gothenburg, Sweden.
   Univ Texas, Dept Bioengn, Arlington, TX 76019 USA.
RP Andersson, M (reprint author), Gothenburg Univ, Lundberg Lab, Dept Cell & Mol Biol Interface Biophys, Box 462, SE-40530 Gothenburg, Sweden.
EM Marcus.Andersson@gmm.gu.se
CR ALTIERI DC, 1993, J BIOL CHEM, V268, P1847
   Andersson M, 2005, BIOSENS BIOELECTRON, V21, P79, DOI 10.1016/j.bios.2004.09.026
   BAIN JA, 1949, P SOC EXP BIOL MED, V72, P9
   Berglin M, 2004, BIOMATERIALS, V25, P4581, DOI 10.1016/j.biomaterials.2003.11.050
   Busuttil SJ, 2004, J THROMB HAEMOST, V2, P1798, DOI 10.1111/j.1538-7836.2004.00916.x
   DAHLGREN C, 1981, J IMMUNOL METHODS, V40, P171, DOI 10.1016/0022-1759(81)90064-8
   Garbassi F., 1994, POLYM SURFACE PHYS T
   HIMMELHOCH SR, 1969, BIOCHEMISTRY-US, V8, P914, DOI 10.1021/bi00831a022
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Mollnes TE, 1998, VOX SANG, V74, P303, DOI 10.1111/j.1423-0410.1998.tb05435.x
   Sellborn A, 2003, COLLOID SURFACE B, V27, P295, DOI 10.1016/S0927-7765(02)00066-8
   TANG LP, 1993, J LAB CLIN MED, V122, P292
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   TORRES JL, 1988, ARCH BIOCHEM BIOPHYS, V267, P271, DOI 10.1016/0003-9861(88)90032-X
   YAM LT, 1971, AM J CLIN PATHOL, V55, P283
NR 15
TC 5
Z9 5
U1 0
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2007
VL 18
IS 2
BP 283
EP 286
DI 10.1007/s10856-006-0690-9
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 140LV
UT WOS:000244507600012
PM 17323159
DA 2018-10-19
ER

PT J
AU Thebaud, NB
   Pierron, D
   Bareille, R
   Le Visage, C
   Letourneur, D
   Bordenave, L
AF Thebaud, Noelie-Brunehilde
   Pierron, Dorothee
   Bareille, Reine
   Le Visage, Catherine
   Letourneur, Didier
   Bordenave, Laurence
TI Human endothelial progenitor cell attachment to polysaccharide-based
   hydrogels: A pre-requisite for vascular tissue engineering
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 20th Conference of the European-Society-for-Biomaterials
CY SEP 27-OCT 01, 2006
CL Nantes, FRANCE
SP European Soc Biomat
ID STEM-CELLS; IN-VITRO; BONE-MARROW; PRECURSOR CELLS; CORD BLOOD;
   NEOVASCULARIZATION; DIFFERENTIATION; PROLIFERATION; EXPRESSION;
   MIGRATION
AB A hydrogel was prepared from polysaccharides (pullulan/dextran/fucoidan) and evaluated as a novel biomaterial for Endothelial Progenitor Cell (EPC) culture. Using a cross-linking process with sodium trimetaphosphate in aqueous solution, homogeneous, transparent and easy to handle gels were obtained with a water content higher than 90%. Circular scaffolds (6 mm diameter and 2 mm thickness discs) were used for cell culture. Different types of EPCs were used: CD34+ derived ECs from cord blood and two sorts of CD133+ derived ECs from human bone marrow, old (30 days) and young (4 days) cells. EPCs were characterised as endothelial cells by immunofluorescent stainings for CD31 and Dil-Ac-LDL. CD133+ derived ECs from bone marrow were characterized by RT-PCR for CD31, VE-cadherin and KDR. HSVECs (Human Saphenous Vein Endothelial Cells) were used as control cells. We evaluated whether different kinds of EPCs could adhere on this novel hydrogel 4 h and 24 h after seeding, by a colorimetric quantitative test. EPCs adhered to hydrogels in serum- free conditions with values being over than 80% for young CD133+ cells at 4 h and 24 h. This pullulan-based hydrogel could constitute a suitable support for vascular cell adhesion as a pre-requisite for vascular tissue engineering.
C1 INSERM, U577, F-33076 Bordeaux, France.
   Univ Victor Segalen Bordeaux 2, F-33076 Bordeaux, France.
   CHU Xavier Bichat, INSERM, U698, F-75877 Paris, France.
RP Thebaud, NB (reprint author), INSERM, U577, F-33076 Bordeaux, France.
EM noelie.thebaud@bordeaux.inserm.fr
RI Didier, letourneur/H-5268-2012; Le Visage, Catherine/E-5460-2011
OI Didier, letourneur/0000-0003-2197-9468; Le Visage,
   Catherine/0000-0003-1816-1649
CR Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221
   AUTISSIER A, IN PRESS J BIOMED MA
   Bagley RG, 2003, CANCER RES, V63, P5866
   Bompais H, 2004, BLOOD, V103, P2577, DOI 10.1182/blood-2003-08-2770
   Bordenave L, 2005, CLIN HEMORHEOL MICRO, V33, P227
   Chaouat M, 2006, BIOMATERIALS, V27, P5546, DOI 10.1016/j.biomaterials.2006.06.032
   Eggermann J, 2003, CARDIOVASC RES, V58, P478, DOI 10.1016/S0008-6363(03)00252-9
   FERNANDEZ P, 2006, TISSUE ENG
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Lake AC, 2006, J BIOL CHEM, V281, P37844, DOI 10.1074/jbc.M600686200
   Leathers TD, 2003, APPL MICROBIOL BIOT, V62, P468, DOI 10.1007/s00253-003-1386-4
   Letourneur D, 2002, J BIOMED MATER RES, V60, P94, DOI 10.1002/jbm.10072
   Levenberg S, 2005, CURR OPIN BIOTECH, V16, P516, DOI 10.1016/j.copbio.2005.08.007
   Liew A, 2006, BIOESSAYS, V28, P261, DOI 10.1002/bies.20372
   Luyt CE, 2003, J PHARMACOL EXP THER, V305, P24, DOI 10.1124/jpet.102.046144
   Maire M, 2005, BIOMATERIALS, V26, P1771, DOI 10.1016/j.biomaterials.2004.06.003
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296
   Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377
   Peichev M, 2000, BLOOD, V95, P952
   Quirici N, 2001, BRIT J HAEMATOL, V115, P186, DOI 10.1046/j.1365-2141.2001.03077.x
   Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327
   Riha GM, 2005, TISSUE ENG, V11, P1535, DOI 10.1089/ten.2005.11.1535
   Shingel KI, 2004, CARBOHYD RES, V339, P447, DOI 10.1016/j.carres.2003.10.034
   Trudel J, 2002, BIOMATERIALS, V23, P3299, DOI 10.1016/S0142-9612(02)00009-1
   Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78
   Vats A, 2005, LANCET, V366, P592, DOI 10.1016/S0140-6736(05)66879-1
   Verrier S, 1996, J MATER SCI-MATER M, V7, P46, DOI 10.1007/BF00121189
   Yang Z, 2006, BIOCHEM BIOPH RES CO, V342, P577, DOI 10.1016/j.bbrc.2006.01.072
   Yow KH, 2006, BRIT J SURG, V93, P652, DOI 10.1002/bjs.5343
NR 31
TC 49
Z9 54
U1 0
U2 16
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2007
VL 18
IS 2
BP 339
EP 345
DI 10.1007/s10856-006-0698-1
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 140LV
UT WOS:000244507600020
PM 17323167
DA 2018-10-19
ER

PT J
AU Biggs, MJP
   Richards, RG
   Gadegaard, N
   Wilkinson, CDW
   Dalby, MJ
AF Biggs, M. J. P.
   Richards, R. G.
   Gadegaard, N.
   Wilkinson, C. D. W.
   Dalby, M. J.
TI The effects of nanoscale pits on primary human osteoblast adhesion
   formation and cellular spreading
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 20th Conference of the European-Society-for-Biomaterials
CY SEP 27-OCT 01, 2006
CL Nantes, FRANCE
SP European Soc Biomat
ID FIBROBLAST RESPONSE; REMOVAL; NANOTOPOGRAPHY; COMPLICATIONS; TOPOGRAPHY;
   FRACTURES; FILOPODIA; METALWORK; SURFACES; CELLS
AB Current understanding of the mechanisms involved in ossesoinegration following implantation of a biomaterial has led to an emphasis being placed on the modification of material topography to control interface reactions. Recent studies have inferred nanoscale topography as an important mediator of cell adhesion and differentiation. Biomimetic strategies in orthopaedic research aim to exploit these influences to regulate cellular adhesion and subsequent bony tissue formation. Here experimental topographies of nanoscale pits demonstrating varying order have been fabricated by electron-beam lithography in (poly)carbonate. Osteoblast adhesion to these nanotopographies was ascertained by quantification of the relation between adhesion complex formation and total cell area. This study is specifically concerned with the effects these nanotopographies have on adhesion formation in S-phase osteoblasts as identified by BrdU incorporation. Nanopits were found to reduce cellular spreading and adhesion formation.
C1 Univ Glasgow, Inst Biomed & Life Sci, Ctr Cell Engn, Glasgow G12 8QQ, Lanark, Scotland.
   AO Fdn, AO Res Inst, Davos, Switzerland.
RP Biggs, MJP (reprint author), Univ Glasgow, Inst Biomed & Life Sci, Ctr Cell Engn, Joseph Black Bldg, Glasgow G12 8QQ, Lanark, Scotland.
EM m.biggs.1@research.gla.ac.uk
RI Dalby, Matthew/G-2426-2012; Biggs, Manus/N-8542-2013; Gadegaard,
   Nikolaj/E-9243-2010; Richards, Robert/I-8235-2015
OI Biggs, Manus/0000-0003-4699-1025; Gadegaard,
   Nikolaj/0000-0002-3396-846X; Richards, Robert/0000-0002-7778-2480;
   Dalby, Matthew/0000-0002-0528-3359
CR BAUMS MH, 2006, KNEE SURG SPORTS TRA
   Bershadsky AD, 2006, EUR J CELL BIOL, V85, P165, DOI 10.1016/j.ejcb.2005.11.001
   Brown OL, 2001, J ORTHOP TRAUMA, V15, P271, DOI 10.1097/00005131-200105000-00006
   Cordioli G, 2000, INT J ORAL MAX IMPL, V15, P668
   CROSS SJ, 1987, CYTOBIOS, V50, P41
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dalby MJ, 2004, INT J BIOCHEM CELL B, V36, P2005, DOI 10.1016/j.biocel.2004.03.001
   Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004
   Dalby MJ, 2003, J BIOMED MATER RES A, V67A, P1025, DOI 10.1002/jbm.a.10139
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   DIEHL KA, 2005, J BIOMED MAT RES A
   Gadegaard N, 2003, MACROMOL MATER ENG, V288, P76, DOI 10.1002/mame.200290037
   GADEGAARD N, 2003, MICROELECTRON ENG, V67, P126
   Gallagher JO, 2002, IEEE T NANOBIOSCI, V1, P24, DOI 10.1109/TNB.2002.806918
   Girish V, 2004, Indian J Cancer, V41, P47
   Heyderman LJ, 2000, MICROELECTRON ENG, V54, P229, DOI 10.1016/S0167-9317(00)00414-7
   Islamoglu K, 2002, ANN PLAS SURG, V48, P265, DOI 10.1097/00000637-200203000-00006
   Jago RD, 1998, INJURY, V29, P439, DOI 10.1016/S0020-1383(98)00080-1
   Liao HH, 2003, BIOMATERIALS, V24, P649, DOI 10.1016/S0142-9612(02)00379-4
   Marchisio M, 2005, J BIOMED MATER RES B, V75B, P251, DOI 10.1002/jbm.b.30287
   MCBEATH R, 2004, DEV CELL, V4, P483
   Meredith DO, 2004, EXP CELL RES, V293, P58, DOI 10.1016/j.yexcr.2003.10.005
   Oleschuk RD, 2000, BIOMATERIALS, V21, P1701, DOI 10.1016/S0142-9612(00)00054-5
   Prather R S, 1999, Cloning, V1, P17, DOI 10.1089/15204559950020067
   SANDERSON PL, 1992, INJURY, V23, P29, DOI 10.1016/0020-1383(92)90121-8
   Santiago A. S., 2005, PESQUI ODONTOL BRAS, V19, P203
   Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902
   Zamir E, 2001, J CELL SCI, V114, P3583
   Zhu BS, 2004, BIOMATERIALS, V25, P4215, DOI 10.1016/j.biomaterials.2003.11.020
   Zimerman B, 2004, CELL MOTIL CYTOSKEL, V58, P143, DOI 10.1002/cm.20005
NR 30
TC 106
Z9 106
U1 0
U2 22
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD FEB
PY 2007
VL 18
IS 2
BP 399
EP 404
DI 10.1007/s10856-006-0705-6
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 140LV
UT WOS:000244507600027
PM 17323174
DA 2018-10-19
ER

PT J
AU Tamura, K
   Sato, S
   Kishida, M
   Asano, S
   Murai, M
   Ito, K
AF Tamura, Kazuaki
   Sato, Shuichi
   Kishida, Mamoru
   Asano, Shoichi
   Murai, Masakazu
   Ito, Koichi
TI The use of porous beta-tricalcium phosphate blocks with platelet-rich
   plasma as an onlay bone graft biomaterial
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE beta-tricalcium phosphate; bone graft; platelet-rich plasma
ID FREEZE-DRIED BONE; MANDIBULAR DEFECTS; RABBIT CALVARIUM; AUTOLOGOUS
   BONE; TITANIUM CAP; REGENERATION; IMPLANTS; COMBINATION; RATS;
   AUGMENTATION
AB Background: An experimental study of rabbit calvaria evaluated the suitability of porous beta-tricalcium phosphate (beta-TCP) block as a biomaterial for onlay bone grafting and determined whether the addition of platelet-rich plasma (PRP) can accelerate bone formation inside the pores of the beta-TCP block.
   Methods: In eight rabbits, the calvarium was exposed, and the marrow was penetrated. The beta-TCP blocks were made of Ca-3(CO4)(3) (porosity, 75%; diameter, 8 mm; thickness, 5 mm). For the experimental group, the blocks were treated with PRP; for the control group, the blocks were treated with venous blood only. Each block was placed in the bone, attached with a titanium screw, and covered with a cutaneous flap. The animals were sacrificed after 3 months, and the tissue ingrowth into the blocks was euthanized.
   Results: Histologic and histomorphometric measurements demonstrated that there was no inflammatory infiltration around the blocks in either group. New bone formation inside the blocks originated from the parent bone in both groups. The mineralized bone generated tended to climb along the inner walls of the block. In addition, mineralized bone formation was noted around the titanium screw. Furthermore, there was no significant difference between the experimental and control groups in the relative amounts of newly generated tissue and mineralized bone generated in the blocks.
   Conclusion: Porous beta-TCP block is a promising biomaterial for clinical situations requiring bone augmentation; however, the addition of PRP did not induce significantly more new bone formation.
C1 Nihon Univ, Sch Dent, Dept Periodontol, Duv Adv Dent Treatment,Dent Res Ctr,Chiyoda Ku, Tokyo 1018310, Japan.
RP Sato, S (reprint author), Nihon Univ, Sch Dent, Dept Periodontol, Duv Adv Dent Treatment,Dent Res Ctr,Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.
EM sato-su@dent.nihon-u.ac.jp
CR Aghaloo TL, 2005, CLIN ORAL IMPLAN RES, V16, P250, DOI 10.1111/j.1600-0501.2004.01075.x
   Araujo MG, 2002, J CLIN PERIODONTOL, V29, P1122, DOI 10.1034/j.1600-051X.2002.291213.x
   BOWERS GM, 1986, J PERIODONTOL, V57, P286, DOI 10.1902/jop.1986.57.5.286
   BOYNE PJ, 1969, J AM DENT ASSOC, V78, P767, DOI 10.1016/S0002-8177(69)84023-7
   BREITBART AS, 1995, PLAST RECONSTR SURG, V96, P699, DOI 10.1097/00006534-199509000-00024
   BURCHARDT H, 1983, CLIN ORTHOP RELAT R, P28
   Buser D, 1990, CLIN ORAL IMPLAN RES, V1, P22, DOI 10.1034/j.1600-0501.1990.010104.x
   Choi BH, 2005, INT J ORAL MAX SURG, V34, P420, DOI 10.1016/j.ijom.2004.10.018
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   Gerard D, 2006, J ORAL MAXIL SURG, V64, P443, DOI 10.1016/j.joms.2005.11.016
   Hokugo A, 2005, TISSUE ENG, V11, P1224, DOI 10.1089/ten.2005.11.1224
   Huse RO, 2004, CLIN ORAL IMPLAN RES, V15, P741, DOI 10.1111/j.1600-0501.2004.01068.x
   Kim SG, 2002, INT J ORAL MAX IMPL, V17, P86
   Kim SG, 2002, J ORAL MAXIL SURG, V60, P1018, DOI 10.1053/joms.2002.34413
   KOSTOPOULOS L, 1994, CLIN ORAL IMPLAN RES, V5, P66, DOI 10.1034/j.1600-0501.1994.050202.x
   LINDE A, 1993, J ORAL MAXIL SURG, V51, P892, DOI 10.1016/S0278-2391(10)80111-9
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   Murai M, 2006, DENT MATER J, V25, P87, DOI 10.4012/dmj.25.87
   NYSTROM E, 1995, INT J ORAL MAX SURG, V24, P20, DOI 10.1016/S0901-5027(05)80851-3
   PHILLIPS JH, 1988, PLAST RECONSTR SURG, V82, P872, DOI 10.1097/00006534-198811000-00023
   Rasmusson L, 1999, CLIN ORAL IMPLAN RES, V10, P267, DOI 10.1034/j.1600-0501.1999.100403.x
   Roldan JC, 2004, BONE, V34, P80, DOI 10.1016/j.bone.2003.09.011
   Sanchez AR, 2003, INT J ORAL MAX IMPL, V18, P93
   Schmid J, 1991, CLIN ORAL IMPLAN RES, V2, P199, DOI 10.1034/j.1600-0501.1991.020407.x
   Schmid J, 1997, CLIN ORAL IMPLAN RES, V8, P75, DOI 10.1034/j.1600-0501.1997.080201.x
   Tamura T, 2005, J PERIODONTAL RES, V40, P269, DOI 10.1111/j.1600-0765.2005.00802.x
   Thorwarth M, 2006, BONE, V38, P30, DOI 10.1016/j.bone.2005.06.020
   TURGEON ML, 1993, CLIN HEMATOLOGY THEO, P352
   URIST MR, 1968, CLIN ORTHOP RELAT R, P59
   WADA T, 1989, J PERIODONTAL RES, V24, P391, DOI 10.1111/j.1600-0765.1989.tb00888.x
   Wiltfang J, 2004, CLIN ORAL IMPLAN RES, V15, P187, DOI 10.1111/j.1600-0501.2004.00980.x
   Yamada Y, 2003, CLIN ORAL IMPLAN RES, V14, P455, DOI 10.1034/j.1600-0501.2003.00832.x
NR 32
TC 16
Z9 18
U1 0
U2 2
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD FEB
PY 2007
VL 78
IS 2
BP 315
EP 321
DI 10.1902/jop.2007.060228
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 137BO
UT WOS:000244268000017
PM 17274721
DA 2018-10-19
ER

PT J
AU Hou, LT
   Liu, CM
   Liu, BY
   Chang, PC
   Chen, MH
   Ho, MH
   Jehng, SM
   Liu, HC
AF Hou, Lein-Tuan
   Liu, Cheng-Meei
   Liu, Bu-Yuan
   Chang, Po-Chun
   Chen, Min-Huei
   Ho, Ming-Hua
   Jehng, Su-Min
   Liu, Hwa-Chang
TI Tissue engineering bone formation in novel recombinant human bone
   morphogenic protein 2-atelocollagen composite scaffolds
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE bone morphogenic protein; bone sialoprotein; osteopontin; tissue
   engineering
ID COLLAGEN SCAFFOLDS; I ATELOCOLLAGEN; ECTOPIC OSTEOINDUCTION; ALVEOLAR
   BONE; RHBMP-2; REGENERATION; BIOMATERIAL; IMPLANT; CARRIER; MATRIX
AB Background: Bone morphogenic proteins (BMPs) are important bone-induction factors, and the development of a suitable carrier for BMPs is a critical step to achieve osteoinductive function. The aims of the present study were to evaluate, at the cellular and molecular levels, the feasibility of recombinant human BMP-2 (rhBMP-2)-collagen composite scaffold and its efficiency for carrying BMP-2 in ectopic bone formation in rats.
   Methods: Scaffolds with (test) or without rhBMP-2 (control) were made and implanted into the calf muscle of 16 5-weekold rats. The tissue responses to the scaffolds were examined by histology. Masson's trichrome and von Kossa stainings were performed to examine collagen matrix deposition and calcification at 3, 7, 10, and 14 days. Expressions of bone phenotypic markers, alkaline phosphatase, osteocalcin, osteopontin, and bone sialoprotein were detected by reverse transcription-polymerase chain reaction and immunohistochemistry.
   Results: No detectable adverse responses were noted around the implanted scaffolds, and the area of the resorbed scaffold had been replaced by young connective tissue by 3 to 7 days in both groups. In the rhBMP-2 composite scaffold, collagen matrix deposition was found in the implanted site on day 7 and initial signs of endochondral differentiation also appeared. Mineralization and the expressions of key bone proteins were demonstrated in chondroblasts and osteoblasts at 7 to 14 days. Molecular cascades of bone induction were not shown in control specimens.
   Conclusion: The rhBMP-2-atelocollagen scaffold showed excellent biocompatibility and possessed a bone-inducing capacity in rat within 2 weeks, and, thus, may provide a potential application in tissue engineering of bone tissue.
C1 Natl Taiwan Univ Hosp, Coll Med, Grad Inst Clin Dent, Taipei 100, Taiwan.
   Natl Taiwan Univ Hosp, Coll Med, Dept Orthoped, Taipei 100, Taiwan.
   Natl Taiwan Univ Hosp, Dept Periodontol, Taipei 100, Taiwan.
   Natl Taiwan Univ, Coll Engn, Grad Inst Chem Engn, Taipei 100, Taiwan.
RP Hou, LT (reprint author), Natl Taiwan Univ, Sch Dent, Dept Periodontol, 1 Chang Te St, Taipei 100, Taiwan.
EM lthou@ha.mc.ntu.edu.tw
OI CHANG, PO-CHUN/0000-0002-4493-6922
CR An YH, 2000, BIOMATERIALS, V21, P2635, DOI 10.1016/S0142-9612(00)00132-0
   Aubin JE, 1995, BONE, V17, P77
   Bessho K, 1999, BRIT J ORAL MAX SURG, V37, P2, DOI 10.1054/bjom.1998.0379
   BIANCO P, 1991, CALCIFIED TISSUE INT, V49, P421, DOI 10.1007/BF02555854
   Bonassar LJ, 1998, J CELL BIOCHEM, P297, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<297::AID-JCB36>3.0.CO;2-6
   BOSS JH, 2000, BIOMATERIALS BIOENGI, P46
   Boyan BD, 1999, J BIOMED MATER RES, V46, P51, DOI 10.1002/(SICI)1097-4636(199907)46:1<51::AID-JBM6>3.0.CO;2-I
   Bunyaratavej P, 2000, EXP CELL RES, V260, P324, DOI 10.1006/excr.2000.5019
   Chakkalakal DA, 2001, TISSUE ENG, V7, P161, DOI 10.1089/107632701300062778
   CHARRIERE G, 1989, J AM ACAD DERMATOL, V21, P1203, DOI 10.1016/S0190-9622(89)70330-3
   Cochran DI, 2000, J PERIODONTOL, V71, P1241, DOI 10.1902/jop.2000.71.8.1241
   DELUSTRO F, 1986, J BIOMED MATER RES, V20, P109, DOI 10.1002/jbm.820200110
   Fiorellini JP, 2005, J PERIODONTOL, V76, P605, DOI 10.1902/jop.2005.76.4.605
   FUJIMURA K, 1995, BIOCHEM BIOPH RES CO, V208, P316, DOI 10.1006/bbrc.1995.1340
   Fujioka K, 1998, ADV DRUG DELIVER REV, V31, P247, DOI 10.1016/S0169-409X(97)00119-1
   Furthmayr H, 1976, Int Rev Connect Tissue Res, V7, P61
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Gersbach CA, 2004, BIOTECHNOL BIOENG, V88, P369, DOI 10.1002/bit.20251
   GRUBER HE, 1992, BIOTECH HISTOCHEM, V67, P30, DOI 10.3109/10520299209110002
   Hanai K, 2004, HUM GENE THER, V15, P263, DOI 10.1089/104303404322886110
   Ho MH, 2005, BIOMATERIALS, V26, P3197, DOI 10.1016/j.biomaterials.2004.08.032
   HUGGINS C, 1970, J EXP MED, V132, P1250, DOI 10.1084/jem.132.6.1250
   Itoh H, 2001, ARTIF ORGANS, V25, P213, DOI 10.1046/j.1525-1594.2001.025003213.x
   Juncosa-Melvin N, 2005, TISSUE ENG, V11, P448, DOI 10.1089/ten.2005.11.448
   Jung RE, 2003, CLIN ORAL IMPLAN RES, V14, P556, DOI 10.1034/j.1600-0501.2003.00921.x
   King GN, 2002, J PERIODONTOL, V73, P925, DOI 10.1902/jop.2002.73.8.925
   Kodama T, 1990, Nihon Shishubyo Gakkai Kaishi, V32, P1
   Kusumoto K, 1996, J CRANIO MAXILL SURG, V24, P360, DOI 10.1016/S1010-5182(96)80037-0
   LAM KH, 1993, J BIOMED MATER RES, V27, P1569, DOI 10.1002/jbm.820271214
   LIAN JB, 1993, J CELL BIOCHEM, V52, P206, DOI 10.1002/jcb.240520212
   Lynn AK, 2004, J BIOMED MATER RES B, V71B, P343, DOI 10.1002/jbm.b.30096
   Masuoka K, 2005, J BIOMED MATER RES B, V75B, P177, DOI 10.1002/jbm.b.30284
   MIYAMOTO S, 1992, CLIN ORTHOP RELAT R, P274
   MIYATA T, 1992, Clinical Materials, V9, P139, DOI 10.1016/0267-6605(92)90093-9
   NUMABE Y, 1993, J PERIODONTOL, V64, P706, DOI 10.1902/jop.1993.64.8.706
   Ochiya Takahiro, 2001, Current Gene Therapy, V1, P31, DOI 10.2174/1566523013348887
   Okubo Y, 2000, INT J ORAL MAX SURG, V29, P62, DOI 10.1016/S0901-5027(00)80127-7
   PIATTELLI A, 1994, BIOMATERIALS, V15, P194, DOI 10.1016/0142-9612(94)90067-1
   PONTZ B, 1970, EUR J BIOCHEM, V16, P50, DOI 10.1111/j.1432-1033.1970.tb01051.x
   REDDI AH, 1987, ORTHOP CLIN N AM, V18, P207
   Ripamonti U, 2001, EUR J ORAL SCI, V109, P241, DOI 10.1034/j.1600-0722.2001.00041.x
   Rousseau CF, 2002, BIOMATERIALS, V23, P1503, DOI 10.1016/S0142-9612(01)00276-9
   Sachlos E, 2003, BIOMATERIALS, V24, P1487, DOI 10.1016/S0142-9612(02)00528-8
   Shukunami C, 1998, EXP CELL RES, V241, P1, DOI 10.1006/excr.1998.4045
   Sigurdsson T J, 1996, Int J Periodontics Restorative Dent, V16, P524
   Snyder A, 2004, J CELL BIOCHEM, V93, P224, DOI 10.1002/jcb.20191
   Song E, 2006, BIOMATERIALS, V27, P2951, DOI 10.1016/j.biomaterials.2006.01.015
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   Suh H, 2001, BIOMATERIALS, V22, P219, DOI 10.1016/S0142-9612(00)00177-0
   Tsujigiwa H, 2005, J BIOMED MATER RES A, V75A, P210, DOI 10.1002/jbm.a.30416
   Uchio Y, 2000, J BIOMED MATER RES, V50, P138, DOI 10.1002/(SICI)1097-4636(200005)50:2<138::AID-JBM7>3.0.CO;2-K
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   van den Bergh JPA, 2000, J CLIN PERIODONTOL, V27, P627, DOI 10.1034/j.1600-051x.2000.027009627.x
   VIZAROVA K, 1995, BIOMATERIALS, V16, P1217, DOI 10.1016/0142-9612(95)98127-Z
   WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220
   Wikesjo UME, 2001, J BONE JOINT SURG AM, V83A, pS136
   Winn SR, 1999, J BIOMED MATER RES, V45, P414, DOI 10.1002/(SICI)1097-4636(19990615)45:4<414::AID-JBM17>3.0.CO;2-Z
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Xiao Y, 2003, TISSUE ENG, V9, P1167, DOI 10.1089/10763270360728071
   Yang CL, 2004, BIODRUGS, V18, P103, DOI 10.2165/00063030-200418020-00004
NR 61
TC 25
Z9 29
U1 0
U2 2
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD FEB
PY 2007
VL 78
IS 2
BP 335
EP 343
DI 10.1902/jop.2007.060106
PG 9
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 137BO
UT WOS:000244268000020
PM 17274724
DA 2018-10-19
ER

PT J
AU Zhu, SL
   Wang, XM
   Qin, FX
   Inoue, A
AF Zhu, Shengli
   Wang, Xinmin
   Qin, Fengxiang
   Inoue, Akihisa
TI Glass-forming ability and thermal stability of Ti-Zr-Cu-Pd-Si bulk
   glassy alloys for biomedical applications
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE titanium alloy; bulk glassy alloy; biomaterial; glass-forming ability
ID SUPERCOOLED LIQUID REGION; AMORPHOUS-ALLOYS; METALLIC GLASSES;
   MECHANICAL-PROPERTIES; NI-CU; CRYSTALLIZATION; CRITERION; CO
AB The thermal properties, glass forming ability (GFA) and mechanical properties of a series of Ti40Zr10Cu40-xPd10Six (x= 0, 1, 2) bulk glassy alloys were examined by differential scanning calorimetry (DSC), differential thermal analysis (I)TA), X-ray diffractometry (XRD) and compression test. The bulk glassy alloys are expected to be used as biomedical materials because of the absence of toxic elements such as Ni, Al and Be. The glass-forming ability and thermal stability of the Ti-Zr-CU-Pd alloy can be unproved by a small amount of Si addition. The critical diameters for glass formation are 5 nun for both Ti40Zr10Cu39Pd10Si1 and Ti40Zr10Cu38Pd10Si2 alloys. A large Supercooled liquid region of 65 K was obtained for the Ti40Zr10Cu38Pd10Si2 bulk glassy alloy. The bulk glassy alloys have higher compressive strength of over 1900 MPa and lower Young's modulus below 85 GPa as compared with conventional biomedical Ti alloys.
C1 Tohoku Univ, Mat Res Inst, Sendai, Miyagi 9808577, Japan.
RP Zhu, SL (reprint author), Tohoku Univ, Mat Res Inst, Sendai, Miyagi 9808577, Japan.
RI Inoue, Akihisa/E-5271-2015; Zhu, Shengli/D-5281-2009; BAI,
   JIE/D-7448-2016; Qin, Fengxiang/A-8359-2011; zhu, shengli/A-8818-2011
OI Zhu, Shengli/0000-0002-0190-2626; 
CR Chen QJ, 2005, CHINESE PHYS LETT, V22, P1736, DOI 10.1088/0256-307X/22/7/048
   Choi-Yim H, 1998, J APPL PHYS, V83, P7993, DOI 10.1063/1.367981
   Hasegawa M, 2004, ACTA MATER, V52, P1799, DOI 10.1016/j.actamat.2003.12.019
   INOUE A, 1994, MATER LETT, V19, P131, DOI 10.1016/0167-577X(94)90057-4
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   INOUE A, 1995, MATER T JIM, V36, P866, DOI 10.2320/matertrans1989.36.866
   INOUE A, 1990, MATER T JIM, V31, P177, DOI 10.2320/matertrans1989.31.177
   Kakiuchi H, 2001, MATER TRANS, V42, P678, DOI 10.2320/matertrans.42.678
   Kim YC, 2004, MAT SCI ENG A-STRUCT, V375, P127, DOI 10.1016/j.msea.2003.10.115
   Liang WZ, 2006, J ALLOY COMPD, V420, P94, DOI 10.1016/j.jallcom.2005.10.018
   Liu CT, 2005, INTERMETALLICS, V13, P415, DOI 10.1016/j.intermet.2004.07.034
   Lu ZP, 2002, ACTA MATER, V50, P3501, DOI 10.1016/S1359-6454(02)00166-0
   Lu ZP, 2001, MAT SCI ENG A-STRUCT, V304, P679, DOI 10.1016/S0921-5093(00)01563-X
   Ma C, 2004, MATER TRANS, V45, P3223, DOI 10.2320/matertrans.45.3223
   MEN H, 2005, MAT T, V10, P2218
   Qin FX, 2004, J ALLOY COMPD, V375, P318, DOI 10.1016/j.jallcom.2003.12.004
   Xia MX, 2005, MAT SCI ENG A-STRUCT, V390, P372, DOI 10.1016/j.msea.2004.08.019
   ZHANG T, 1994, MAT SCI ENG A-STRUCT, V181, P1423, DOI 10.1016/0921-5093(94)90877-X
   Zhang T, 1998, MATER T JIM, V39, P1001, DOI 10.2320/matertrans1989.39.1001
   Zhang T, 2001, MAT SCI ENG A-STRUCT, V304, P771, DOI 10.1016/S0921-5093(00)01592-6
   ZHANG T, 1991, MATER T JIM, V32, P1005, DOI 10.2320/matertrans1989.32.1005
   Zhu S., IN PRESS
NR 22
TC 21
Z9 21
U1 1
U2 20
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD FEB
PY 2007
VL 48
IS 2
BP 163
EP 166
DI 10.2320/matertrans.48.163
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 147PG
UT WOS:000245014300015
OA Bronze
DA 2018-10-19
ER

PT J
AU Moutos, FT
   Freed, LE
   Guilak, F
AF Moutos, Franklin T.
   Freed, Lisa E.
   Guilak, Farshid
TI A biomimetic three-dimensional woven composite scaffold for functional
   tissue engineering of cartilage
SO NATURE MATERIALS
LA English
DT Article
ID TENSION-COMPRESSION NONLINEARITY; INTRINSIC MECHANICAL-PROPERTIES;
   ANTERIOR CRUCIATE LIGAMENT; HUMAN ARTICULAR-CARTILAGE; AGAROSE GELS;
   EXPERIMENTAL-VERIFICATION; EXTRACELLULAR-MATRIX; CONFINED COMPRESSION;
   SHEAR PROPERTIES; POISSONS RATIO
AB Tissue engineering seeks to repair or regenerate tissues through combinations of implanted cells, biomaterial scaffolds and biologically active molecules. The rapid restoration of tissue biomechanical function remains an important challenge, emphasizing the need to replicate structural and mechanical properties using novel scaffold designs. Here we present a microscale 3D weaving technique to generate anisotropic 3D woven structures as the basis for novel composite scaffolds that are consolidated with a chondrocyte-hydrogel mixture into cartilage tissue constructs. Composite scaffolds show mechanical properties of the same order of magnitude as values for native articular cartilage, as measured by compressive, tensile and shear testing. Moreover, our findings showed that porous composite scaffolds could be engineered with initial properties that reproduce the anisotropy, viscoelasticity and tension-compression nonlinearity of native articular cartilage. Such scaffolds uniquely combine the potential for load-bearing immediately after implantation in vivo with biological support for cell-based tissue regeneration without requiring cultivation in vitro.
C1 Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.
   Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC 27710 USA.
   Harvard Univ, MIT, Div Hlth Sci & Technol, MIT, Cambridge, MA 02139 USA.
   Duke Univ, Med Ctr, Dept Mech Engn & Mat Sci, Durham, NC 27710 USA.
RP Moutos, FT (reprint author), Duke Univ, Med Ctr, Dept Surg, 375 MSRB,Box 3093, Durham, NC 27710 USA.
EM guilak@duke.edu
RI Zhou, Gina/D-2837-2009
OI Guilak, Farshid/0000-0001-7380-0330; Freed, Lisa/0000-0002-0720-8432
FU NIAMS NIH HHS [AR48182, AR50245, AR49294]; NIA NIH HHS [AG15768]
CR AKIZUKI S, 1986, J ORTHOPAED RES, V4, P379, DOI 10.1002/jor.1100040401
   Ameer GA, 2002, J ORTHOPAED RES, V20, P16, DOI 10.1016/S0736-0266(01)00074-2
   ATALA A, 1993, J UROLOGY, V150, P745, DOI 10.1016/S0022-5347(17)35603-3
   Ateshian GA, 1997, J BIOMECH ENG-T ASME, V119, P81, DOI 10.1115/1.2796069
   ATHANASIOU KA, 1994, J ORTHOPAED RES, V12, P340, DOI 10.1002/jor.1100120306
   ATHANASIOU KA, 1991, J ORTHOP RES, V9, P330, DOI 10.1002/jor.1100090304
   Aufderheide AC, 2005, TISSUE ENG, V11, P1095, DOI 10.1089/ten.2005.11.1095
   BADER DL, 1981, BIOCHIM BIOPHYS ACTA, V677, P103, DOI 10.1016/0304-4165(81)90150-1
   Below S, 2002, ARTHROSCOPY, V18, P613, DOI 10.1053/jars.2002.29877
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   Caterson EJ, 2002, ANN NY ACAD SCI, V961, P134, DOI 10.1111/j.1749-6632.2002.tb03066.x
   Cohen B, 1998, J BIOMECH ENG-T ASME, V120, P491, DOI 10.1115/1.2798019
   Elliott DM, 1999, J ORTHOP RES, V17, P503, DOI 10.1002/jor.1100170407
   Elliott DM, 2002, J BIOMECH ENG-T ASME, V124, P223, DOI 10.1115/1.1449905
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Freed LE, 1997, P NATL ACAD SCI USA, V94, P13885, DOI 10.1073/pnas.94.25.13885
   Gao Jizong, 2002, Tissue Engineering, V8, P827, DOI 10.1089/10763270260424187
   Gu WY, 2003, J BIOMECH, V36, P593, DOI 10.1016/S0021-9290(02)00437-2
   GUILAK F, 1994, J ORTHOPAED RES, V12, P474, DOI 10.1002/jor.1100120404
   Guilak F, 2001, CLIN ORTHOP RELAT R, pS295
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Huang CY, 2005, J BIOMECH, V38, P799, DOI 10.1016/j.jbiomech.2004.05.006
   Huang CY, 2003, J BIOMECH ENG-T ASME, V125, P84, DOI 10.1115/1.1531656
   Huang CY, 2001, J BIOMECH ENG-T ASME, V123, P410, DOI 10.1115/1.1392316
   Jurvelin JS, 1997, J BIOMECH, V30, P235, DOI 10.1016/S0021-9290(96)00133-9
   KEMPSON GE, 1976, BIOCHIM BIOPHYS ACTA, V428, P741, DOI 10.1016/0304-4165(76)90205-1
   Lee DA, 1997, J ORTHOP RES, V15, P181, DOI 10.1002/jor.1100150205
   LeRoux MA, 1999, J BIOMED MATER RES, V47, P46, DOI 10.1002/(SICI)1097-4636(199910)47:1<46::AID-JBM6>3.0.CO;2-N
   LeRoux MA, 2000, J ORTHOP RES, V18, P383, DOI 10.1002/jor.1100180309
   Li WJ, 2006, TISSUE ENG, V12, P1775, DOI 10.1089/ten.2006.12.1775
   Marijnissen WJCM, 2002, BIOMATERIALS, V23, P1511, DOI 10.1016/S0142-9612(01)00281-2
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   Mohamed MH, 2001, SAMPE J, V37, P8
   Mow V, 2002, ANNU REV BIOMED ENG, V4, P175, DOI 10.1146/annurev.bioeng.4.110701.120309
   MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   Paige KT, 1996, PLAST RECONSTR SURG, V97, P168, DOI 10.1097/00006534-199601000-00027
   Pei M, 2002, FASEB J, V16, P1691, DOI 10.1096/fj.02-0083fje
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   SETTON LA, 1995, J ORTHOPAED RES, V13, P473, DOI 10.1002/jor.1100130402
   SETTON LA, 1994, J ORTHOPAED RES, V12, P451, DOI 10.1002/jor.1100120402
   SETTON LA, 1993, J BIOMECH, V26, P581, DOI 10.1016/0021-9290(93)90019-B
   Soltz MA, 1998, J BIOMECH, V31, P927, DOI 10.1016/S0021-9290(98)00105-5
   Soltz MA, 2000, J BIOMECH ENG-T ASME, V122, P576, DOI 10.1115/1.1324669
   Tognana E, 2005, OSTEOARTHR CARTILAGE, V13, P129, DOI 10.1016/j.joca.2004.10.015
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   WOO SLY, 1979, J BIOMECH, V12, P437, DOI 10.1016/0021-9290(79)90028-9
   ZHU WB, 1993, J ORTHOPAED RES, V11, P771, DOI 10.1002/jor.1100110602
NR 49
TC 394
Z9 409
U1 19
U2 306
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1476-1122
J9 NAT MATER
JI Nat. Mater.
PD FEB
PY 2007
VL 6
IS 2
BP 162
EP 167
DI 10.1038/nmat1822
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Applied; Physics, Condensed Matter
SC Chemistry; Materials Science; Physics
GA 132KN
UT WOS:000243941800024
PM 17237789
DA 2018-10-19
ER

PT J
AU Gentleman, E
   Dee, KC
   Livesay, GA
   Nauman, EA
AF Gentleman, Eileen
   Dee, Kay C.
   Livesay, Glen A.
   Nauman, Eric A.
TI Operating curves to characterize the contraction of fibroblast-seeded
   collagen gel/collagen fiber composite biomaterials: Effect of fiber mass
SO PLASTIC AND RECONSTRUCTIVE SURGERY
LA English
DT Article; Proceedings Paper
CT Annual Fall Meeting of the Biomedical-Engineering-Society
CY OCT 13-16, 2004
CL Philadelphia, PA
SP IEEE Engn Med & Biol, Biomed Engn Soc
ID IN-VITRO; LIGAMENT RECONSTRUCTION; CELL LOCOMOTION; TISSUE; GELS;
   IMPLANTS; PROSTHESIS; SCAFFOLDS; MATRICES; DENSITY
AB Background: Collagen is a well-established and important biomaterial that could be used to help meet significant medical needs for various soft-tissue replacements. Many efforts to create engineered soft-tissue constructs by seeding cells within collagen gels have been hampered because constituent cells contract collagen gels over time, resulting in a construct that is only a fraction of the original size and that contains a cell population that has suffered a large degree of cell death. However, the presence of embedded short collagen fibers has been shown to significantly limit contraction and dramatically enhance permeability in fibroblast-seeded collagen gels.
   Methods: Five volume fractions of short collagen fibers were embedded in fibroblast-seeded collagen gels. Collagen gel contraction (n >= 4 for all groups) and cell viability (n >= 3 for all groups) were examined after up to 2 weeks in culture.
   Results: The present study demonstrated that increasing the volume fraction of short collagen fibers in fibroblast-seeded collagen gels correspondingly reduced the amount of gel contraction without negatively impacting cell viability after 2 weeks of culture. Furthermore, operating curves that describe the quantitative relationships between the contraction of fibroblast-seeded collagen gel/collagen fiber composite biomaterials, time in culture, and volume fraction of embedded fibers were obtained.
   Conclusion: The resulting operating curves enable investigators to tailor initial fabrication procedures to ultimately yield cell-seeded collagen composites of specifically desired sizes-a critical step toward developing clinically useful engineered soft-tissue constructs.
C1 Purdue Univ, Sch Mech Engn, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.
   Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA.
   Rose Hulman Inst Technol, Dept Appl Biol & Biomed Engn, Terre Haute, IN 47803 USA.
RP Nauman, EA (reprint author), Purdue Univ, Sch Mech Engn, Weldon Sch Biomed Engn, 585 Purdue Mall, W Lafayette, IN 47907 USA.
EM enauman@purdue.edu
OI Gentleman, Eileen/0000-0003-0447-5137; Dee, Kay C/0000-0002-9069-4880
CR Allen Matthew, 1994, Clinical Materials, V16, P189, DOI 10.1016/0267-6605(94)90116-3
   *AM SOC PLAST SURG, 2004, 2003 REC SURG PROC
   ANDUJAR MB, 1992, J SUBMICR CYTOL PATH, V24, P145
   BELL E, 1979, P NATL ACAD SCI USA, V76, P1274, DOI 10.1073/pnas.76.3.1274
   Bellincampi LD, 1998, J ORTHOP RES, V16, P414, DOI 10.1002/jor.1100160404
   Cretel E, 2001, RHEUMATOL INT, V20, P129, DOI 10.1007/s002960000088
   CUKIER J, 1993, ANN INTERN MED, V118, P920, DOI 10.7326/0003-4819-118-12-199306150-00002
   De Filippo RE, 2002, J UROLOGY, V168, P1789, DOI 10.1097/01.ju.0000027662.69103.72
   DUNN MG, 1992, AM J SPORT MED, V20, P507, DOI 10.1177/036354659202000504
   DUNN MG, 1994, J ORTHOPAED RES, V12, P128, DOI 10.1002/jor.1100120116
   EHRLICH HP, 1990, TISSUE CELL, V22, P407, DOI 10.1016/0040-8166(90)90070-P
   Gentleman E, 2004, TISSUE ENG, V10, P421, DOI 10.1089/107632704323061780
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   Hafemann B, 2001, J MATER SCI-MATER M, V12, P437, DOI 10.1023/A:1011205221972
   HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0
   HARRIS AK, 1980, SCIENCE, V208, P177, DOI 10.1126/science.6987736
   HOUCK J, 1971, P SOC EXP BIOL MED, V138, P69
   Hunter CJ, 2002, BIOMATERIALS, V23, P1249, DOI 10.1016/S0142-9612(01)00245-9
   Jones R.M., 1975, MECH COMPOSITE MAT, P355
   Katz AJ, 1999, CLIN PLAST SURG, V26, P587
   Liu XD, 1998, AM J PHYSIOL-LUNG C, V274, pL58, DOI 10.1152/ajplung.1998.274.1.L58
   Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219
   PACHENCE JM, 2000, PRINCIPLES TISSUE EN, P263
   Patrick CW, 2004, ANNU REV BIOMED ENG, V6, P109, DOI 10.1146/annurev.bioeng.6.040803.140032
   POSTLETHWAITE AE, 1978, P NATL ACAD SCI USA, V75, P871, DOI 10.1073/pnas.75.2.871
   Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X
   SOO C, 1993, J DERMATOL SURG ONC, V19, P431, DOI 10.1111/j.1524-4725.1993.tb00370.x
   Taira M, 2003, J ORAL REHABIL, V30, P106, DOI 10.1046/j.1365-2842.2003.01001.x
   van Wachem PB, 2001, J BIOMED MATER RES, V55, P368, DOI 10.1002/1097-4636(20010605)55:3<368::AID-JBM1025>3.0.CO;2-5
   Vernon RB, 1996, J CELL BIOCHEM, V60, P185, DOI 10.1002/(SICI)1097-4644(19960201)60:2<185::AID-JCB3>3.0.CO;2-T
   von Heimburg D, 2001, BIOMATERIALS, V22, P429, DOI 10.1016/S0142-9612(00)00186-1
   Zhu YK, 2001, IN VITRO CELL DEV-AN, V37, P10
NR 32
TC 1
Z9 1
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0032-1052
J9 PLAST RECONSTR SURG
JI Plast. Reconstr. Surg.
PD FEB
PY 2007
VL 119
IS 2
BP 508
EP 516
DI 10.1097/01.prs.0000246316.87802.b4
PG 9
WC Surgery
SC Surgery
GA 127KI
UT WOS:000243584300008
PM 17230083
DA 2018-10-19
ER

PT J
AU Martina, M
   Hutmacher, DW
AF Martina, Monique
   Hutmacher, Dietmar W.
TI Biodegradable polymers applied in tissue engineering research: a review
SO POLYMER INTERNATIONAL
LA English
DT Review
DE scaffolds; biodegradable polymers; tissue engineering; matrices
ID SHAPE-MEMORY POLYMERS; EPSILON-CAPROLACTONE; IN-VIVO; 1,3-TRIMETHYLENE
   CARBONATE; BIOMEDICAL APPLICATIONS; POLY(ETHYLENE GLYCOL); MULTIBLOCK
   COPOLYMERS; TRIBLOCK COPOLYMERS; NERVE GUIDE; SCAFFOLDS
AB Typical applications and research areas of polymeric biomaterials include tissue replacement, tissue augmentation, tissue support, and drug delivery. In many cases the body needs only the temporary presence of a device/biomaterial, in which instance biodegradable and certain partially biodegradable polymeric materials are better alternatives than biostable ones. Recent treatment concepts based on scaffold-based tissue engineering principles differ from standard tissue replacement and drug therapies as the engineered tissue aims not only to repair but also regenerate the target tissue. Cells have been cultured outside the body for many years; however, it has only recently become possible for scientists and engineers to grow complex three-dimensional tissue grafts to meet clinical needs. New generations of scaffolds based on synthetic and natural polymers are being developed and evaluated at a rapid pace, aimed at mimicking the structural characteristics of natural extracellular matrix. This review focuses on scaffolds made of more recently developed synthetic polymers for tissue engineering applications. Currently, the design and fabrication of biodegradable synthetic scaffolds is driven by four material categories: (i) common clinically established polymers, including polyglycolide, polylactides, polycaprolactone; (ii) novel di- and tri-block polymers; (iii) newly synthesized or studied polymeric biomaterials, such as polyorthoester, polyanhydrides, polyhydroxyalkanoate, polypyrroles, poly(ether ester amide)s, elastic shape-memory polymers; and (iv) biomimetic materials, supramolecular polymers formed by self-assembly, and matrices presenting distinctive or a variety of biochemical cues. This paper aims to review the latest developments from a scaffold material perspective, mainly pertaining to categories (ii) and (iii) listed above. (c) 2006 Society of Chemical Industry.
C1 Natl Univ Singapore, Yong Loo Lin Sch Med, Fac Engn, Div Bioengn,Dept Orthopaed Surg, Singapore 119260, Singapore.
RP Hutmacher, DW (reprint author), Natl Univ Singapore, Yong Loo Lin Sch Med, Fac Engn, Div Bioengn,Dept Orthopaed Surg, 10 Kent Ridge Crescent, Singapore 119260, Singapore.
EM biedwh@nus.edu.sg
OI Hutmacher, Dietmar Werner/0000-0001-5678-2134
CR AMBROSIO AM, 2003, IEEE ENG MED BIO SEP, P18
   Ambrosio AMA, 2002, BIOMATERIALS, V23, P1667, DOI 10.1016/S0142-9612(01)00293-9
   Barbato F, 2001, BIOMATERIALS, V22, P1371, DOI 10.1016/S0142-9612(00)00291-X
   Bezemer JM, 2000, J BIOMED MATER RES, V52, P8, DOI 10.1002/1097-4636(200010)52:1<8::AID-JBM2>3.0.CO;2-3
   BOURKE SL, 2003, TISSUE ENG, V10, P43
   Cohn D, 2002, J BIOMED MATER RES, V59, P273, DOI 10.1002/jbm.1242
   Cui XY, 2001, J BIOMED MATER RES, V56, P261, DOI 10.1002/1097-4636(200108)56:2<261::AID-JBM1094>3.0.CO;2-I
   Cui XY, 2003, BIOMATERIALS, V24, P777, DOI 10.1016/S0142-9612(02)00415-5
   Deng JS, 2003, PHARM DEV TECHNOL, V8, P31, DOI 10.1081/PDT-120017521
   Deschamps AA, 2003, BIOMATERIALS, V24, P2643, DOI 10.1016/S0142-9612(03)00054-1
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Fabre T, 2001, BIOMATERIALS, V22, P2951, DOI 10.1016/S0142-9612(01)00012-6
   Ferruti P, 2005, BIOMACROMOLECULES, V6, P2229, DOI 10.1021/bm050210+
   Ferruti P, 2005, MACROMOL BIOSCI, V5, P613, DOI 10.1002/mabi.200500020
   Fidkowski C, 2005, TISSUE ENG, V11, P302, DOI 10.1089/ten.2005.11.302
   George PM, 2005, BIOMATERIALS, V26, P3511, DOI 10.1016/j.biomaterials.2004.09.037
   Greish YE, 2005, BIOMATERIALS, V26, P1, DOI 10.1016/j.biomaterials.2004.02.016
   Grijpma DW, 2005, BIOMATERIALS, V26, P2795, DOI 10.1016/j.biomaterials.2004.08.002
   Guan HL, 2005, BIOMACROMOLECULES, V6, P1954, DOI 10.1021/bm0492069
   Guan JJ, 2005, BIOMATERIALS, V26, P3961, DOI 10.1016/j.biomaterials.2004.10.018
   Horch RA, 2004, BIOMACROMOLECULES, V5, P1990, DOI 10.1021/bm049768s
   Huang MH, 2004, J BIOMED MATER RES A, V69A, P417, DOI 10.1002/jbm.a.30008
   Hutmacher DW, 2001, ANN ACAD MED SINGAP, V30, P183
   Hwang MJ, 2005, BIOMACROMOLECULES, V6, P885, DOI 10.1021/bm049347a
   Jabbari E, 2005, BIOMACROMOLECULES, V6, P2503, DOI 10.1021/bm050206y
   Lee SH, 2003, J BIOMED MATER RES A, V66A, P29, DOI 10.1002/jbm.a.10497
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496
   Li SM, 2002, J MATER SCI-MATER M, V13, P81, DOI 10.1023/A:1013651022431
   Lietz M, 2006, BIOTECHNOL BIOENG, V93, P99, DOI 10.1002/bit.20688
   Liu XH, 2004, ANN BIOMED ENG, V32, P477, DOI 10.1023/B:ABME.0000017544.36001.8e
   NAIR SL, 2004, BIOMACROMOLECULES, V5, P2215
   Payne RG, 2002, BIOMATERIALS, V23, P4381, DOI 10.1016/S0142-9612(02)00186-2
   Pego AP, 2003, J BIOMED MATER RES A, V67A, P1044, DOI 10.1002/jbm.a.10121
   Pego AP, 2003, TISSUE ENG, V9, P981, DOI 10.1089/107632703322495628
   Porter BD, 2000, J BIOMECH ENG-T ASME, V122, P286, DOI 10.1115/1.429659
   Schachter DM, 2002, J CONTROL RELEASE, V78, P143, DOI 10.1016/S0168-3659(01)00487-4
   Sharma RI, 2004, J BIOMED MATER RES A, V69A, P114, DOI 10.1002/jbm.a.20125
   Shin H, 2003, BIOMATERIALS, V24, P3201, DOI 10.1016/S0142-9612(03)00168-6
   Stankus JJ, 2004, J BIOMED MATER RES A, V70A, P603, DOI 10.1002/jbm.a.30122
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   Wang C, 2004, NAT MATER, V3, P190, DOI 10.1038/nmat1075
   Wang SF, 2006, BIOMATERIALS, V27, P832, DOI 10.1016/j.biomaterials.2005.07.013
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Zhang JY, 2003, TISSUE ENG, V9, P1143, DOI 10.1089/10763270360728053
   Zhang JY, 2002, TISSUE ENG, V8, P771, DOI 10.1089/10763270260424132
NR 47
TC 248
Z9 260
U1 16
U2 236
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD FEB
PY 2007
VL 56
IS 2
BP 145
EP 157
DI 10.1002/pi.2108
PG 13
WC Polymer Science
SC Polymer Science
GA 128ZZ
UT WOS:000243699500001
DA 2018-10-19
ER

PT J
AU Lai, JCK
   Schoen, MP
   Gracia, AP
   Naidu, DS
   Leung, SW
AF Lai, J. C. K.
   Schoen, M. P.
   Gracia, A. Perez
   Naidu, D. S.
   Leung, S. W.
TI Prosthetic devices: challenges and implications of robotic implants and
   biological interfaces
SO PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART H-JOURNAL OF
   ENGINEERING IN MEDICINE
LA English
DT Article
DE prosthetics; robotic implants; functional prosthetic; robotic hand;
   artificial hand; electromyography signals and control; biocompatibility;
   inflammatory responses of cells to implanted material; interference of
   cells and tissues with implanted sensors; toxicity; nanomaterials
ID CARBON NANOTUBES; DESIGN; HANDS; SIGNALS; MUSCLE
AB Although among designs of prosthetics there have been some successes in the design of functional robotic implants, there remain many issues and challenges concerned with the failure to meet the 'ideal' requirements of a satisfactory prosthetic. These 'ideals' require the device to be easy to control, comfortable to wear, and cosmetically pleasing. Because the literature on prosthetics and robotic implants are voluminous, this review focuses on four topics to determine key challenges and opportunities underlying these interdisciplinary research areas: firstly, an artificial hand as a biomimetic; secondly, prosthetic implants (electromyography signals and control); thirdly, prosthetic implants and tissue reactions to the material(s) of implants; fourthly, how inflammatory responses of cells and tissues surrounding implanted sensors interfere with the signal transmission of such sensors. This review also notes the importance of the biological interfaces that robotic implants and other prosthetic devices are in contact with and how an improved knowledge of pathophysiological changes at such biological interfaces will lead to improved and more biocompatible designs of prosthetics. This review concludes with the vision that, to develop a design that satisfies the above 'ideals', an interdisciplinary team of biomedical and tissue engineers, and biomaterial and biomedical scientists is needed to work together holistically and synergistically.
C1 Idaho State Univ, Coll Pharm, Dept Pharmaceut Sci, Pocatello, ID 83209 USA.
   Idaho State Univ, Coll Engn, Pocatello, ID 83209 USA.
   Idaho State Univ, Measurement & Control Engn Res Ctr, Pocatello, ID 83209 USA.
   Idaho State Univ, Biomed Res Inst, Pocatello, ID 83209 USA.
RP Lai, JCK (reprint author), Idaho State Univ, Coll Pharm, Dept Pharmaceut Sci, 921 S 8th Ave,Stop 8288, Pocatello, ID 83209 USA.
EM lai@otc.isu.edu
RI Perez Gracia, Alba/L-6677-2017
OI Perez Gracia, Alba/0000-0002-6023-7857
FU NCRR NIH HHS [P20 RR16454]
CR Balasubramanian K, 2006, ANAL BIOANAL CHEM, V385, P452, DOI 10.1007/s00216-006-0314-8
   Bento R F, 1995, Ear Nose Throat J, V74, P640
   BICCHI A, 2000, P IEEE INT C ROB AUT, V1, P348
   BINGHAM JT, 2004, P 2004 ASME INT MECH
   Caffaz A, 1998, IEEE INT CONF ROBOT, P2075, DOI 10.1109/ROBOT.1998.680623
   Chan FHY, 2000, IEEE T REHABIL ENG, V8, P305, DOI 10.1109/86.867872
   Cheron G, 1996, IEEE T BIO-MED ENG, V43, P552, DOI 10.1109/10.488803
   CHO KJ, 2006, P IEEE INT C ROB AUT, P706
   Cram J, 1988, INTRO SURFACE ELECTR
   CUTKOSKY MR, 1989, IEEE T ROBOTIC AUTOM, V5, P269, DOI 10.1109/70.34763
   De Laurentis Kathryn J, 2002, Technol Health Care, V10, P91
   DOLLAR AM, 2006, P ASME 2006 INT ENG, P1
   ENGLEHART K, 1999, P 21 ANN INT C IEEE, V1, P569
   FERNANDEZ JJ, 1996, P GEN PROGR C, P63
   Fiorito S, 2006, J NANOSCI NANOTECHNO, V6, P591, DOI 10.1166/jnn.2006.125
   Furukawa N, 2006, IEEE INT CONF ROBOT, P181, DOI 10.1109/ROBOT.2006.1641181
   GIALIAS N, 2004, P IEEE INT C ROB AUT, V4, P3380
   GRACIA AP, 2006, LIT REV HAND RES
   Haynes DR, 1998, CLIN ORTHOP RELAT R, P223
   Huang H P, 1999, P IEEE INT C ROB AUT, V3, P2392
   Kargov A, 2004, DISABIL REHABIL, V26, P705, DOI 10.1080/09638280410001704278
   Karlsson S, 2000, IEEE T BIO-MED ENG, V47, P228, DOI 10.1109/10.821766
   Kim G, 2005, P ANN INT IEEE EMBS, P6908, DOI 10.1109/IEMBS.2005.1616094
   Kyberd P. J., 2003, P 2003 IEEE INT C RO, V3, P3231
   Kyberd PJ, 2001, ROBOTICA, V19, P593
   Lai J. C. K., 2005, ENCY BIOMATERIALS BI, P1
   Lee M. -J., 2006, P 1 IEEE RAS EMBS IN, p1172 1177
   Lee YK, 2002, PROC IEEE MICR ELECT, P702, DOI 10.1109/MEMSYS.2002.984367
   LEUNG SW, 2006, ENCY BIOMATERIALS BI, P1
   LI J, 1999, P IEEE C SYST MAN CY, V6, P792
   Loh CS, 2005, P ANN INT IEEE EMBS, P6900
   LOTTI F, 2005, P 2005 IEEE INT C R
   Luo ZW, 2006, BIOMIMETICS: BIOLOGICALLY INSPIRED TECHNOLOGIES, P399
   MCGREERY D, 2004, NEUROPROSTHETICS THE, P592
   Munichor M, 2003, ACTA CYTOL, V47, P270, DOI 10.1159/000326515
   Murray R. M., 1994, MATH INTRO ROBOTIC M
   Naidu DS, 2003, OPTIMAL CONTROL SYST
   NELSON JR, 2004, NEUROPROSTHETICS THE, P1219
   Northrop R, 2004, ANAL APPL ANALOG ELE, P6
   Okamura A., 2000, P IEEE INT C ROB AUT, VI, P255
   OSTOVSKII AI, 1995, VESTN OTORINOLARYNG, V3, P47
   Ovaska SJ, 2002, IEEE T SYST MAN CY C, V32, P72, DOI 10.1109/TSMCC.2002.801354
   Pennekamp PH, 2006, J ORTHOP RES, V24, P531, DOI 10.1002/jor.20066
   PRINCE MR, 1988, INVEST RADIOL, V23, P294, DOI 10.1097/00004424-198804000-00009
   RODRIGUEZCHEU LE, 2005, P IEEE RSJ INT C INT, P541
   Sebastiani F, 2003, P 2003 IEEE ASME INT, V1, P64
   Shahid S, 2005, IEEE T BIO-MED ENG, V52, P1195, DOI 10.1109/TBME.2005.847525
   Sinha N, 2006, J NANOSCI NANOTECHNO, V6, P573, DOI 10.1166/jnn.2006.121
   Supan TJ, 2003, HAND CLIN, V19, P185, DOI 10.1016/S0749-0712(02)00139-7
   Tian FR, 2006, TOXICOL IN VITRO, V20, P1202, DOI 10.1016/j.tiv.2006.03.008
   Trocciola SA, 2006, J VASC SURG, V43, P109, DOI 10.1016/j.jvs.2005.09.023
   Wang W, 2005, DENT MATER J, V24, P478, DOI 10.4012/dmj.24.478
   Weir RF, 2001, J REHABIL RES DEV, V38, P357
   YANG J, 2004, DES ENG TECHN C COMP
   Zecca M, 2002, Crit Rev Biomed Eng, V30, P459, DOI 10.1615/CritRevBiomedEng.v30.i456.80
   ZHAO J, 2006, P 1 IEEE RAS INT C B
   ZOLLO L, 2006, P 1 IEEE RAS INT C B
NR 57
TC 30
Z9 31
U1 2
U2 24
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0954-4119
EI 2041-3033
J9 P I MECH ENG H
JI Proc. Inst. Mech. Eng. Part H-J. Eng. Med.
PD FEB
PY 2007
VL 221
IS H2
BP 173
EP 183
DI 10.1243/09544119JEIM210
PG 11
WC Engineering, Biomedical
SC Engineering
GA 147FI
UT WOS:000244988400008
PM 17385571
DA 2018-10-19
ER

PT J
AU Narayanan, R
   Seshadri, SK
   Kwon, TY
   Kim, KH
AF Narayanan, R.
   Seshadri, S. K.
   Kwon, T. Y.
   Kim, K. H.
TI Electrochemical nano-grained calcium phosphate coatings on Ti-6Al-4V for
   biomaterial applications
SO SCRIPTA MATERIALIA
LA English
DT Article
DE titanium alloy; ultrasonics; coating; nano; calcium phosphate
ID SIMULATED BODY-FLUID; SPRAYED HYDROXYAPATITE COATINGS; APATITE COATINGS;
   TITANIUM SUBSTRATE; DEPOSITION; MICROSTRUCTURE; TEMPERATURE; MORPHOLOGY;
   BEHAVIOR; ALLOYS
AB Electrochemically deposited nano-grained calcium phosphate coatings were produced on titanium alloy substrates using aqueous electrolyte maintained at acidic pH. Different coatings were produced by using different cathodic current densities and/or ultrasonic agitation of the electrolytic bath. The structure of the coatings was characterized by X-ray diffraction, scanning electron microscopy and transmission electron microscopy. Ultrasonated bath produced coatings containing dicalcium phosphate dehydrate and the grain sizes were in the range of 50-100 nm. (c) 2006 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Indian Inst Technol, Dept Met & Mat Engn, Madras 600036, Tamil Nadu, India.
   Kyungpook Natl Univ, Coll Dent, Dept Dent Biomat, Taegu 702701, South Korea.
RP Narayanan, R (reprint author), Indian Inst Technol, Dept Met & Mat Engn, Madras 600036, Tamil Nadu, India.
EM rnarayan69@hotmail.com
CR Arenas MA, 2000, BRIT CORROS J, V35, P232, DOI 10.1179/000705900101501308
   Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   Ban S, 1998, BIOMATERIALS, V19, P1245, DOI 10.1016/S0142-9612(98)00032-5
   BAN SJ, 1995, BIOMATERIALS, V16, P977, DOI 10.1016/0142-9612(95)94904-Y
   de Sena LA, 2002, J BIOMED MATER RES, V60, P1
   DUCHEYNE P, 1986, BIOMATERIALS, V7, P97, DOI 10.1016/0142-9612(86)90063-3
   Gledhill HC, 2001, BIOMATERIALS, V22, P695, DOI 10.1016/S0142-9612(00)00232-5
   Grassmann O, 2000, J BIOMED MATER RES, V53, P685, DOI 10.1002/1097-4636(2000)53:6<685::AID-JBM11>3.3.CO;2-2
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   Jonasova L, 2002, BIOMATERIALS, V23, P3095, DOI 10.1016/S0142-9612(02)00043-1
   Kasuga T, 2002, J CRYST GROWTH, V235, P235, DOI 10.1016/S0022-0248(01)01782-1
   Khor KA, 2000, MAT SCI ENG A-STRUCT, V281, P221, DOI 10.1016/S0921-5093(99)00717-0
   Kim HW, 2004, BIOMATERIALS, V25, P2533, DOI 10.1016/j.biomaterials.2003.09.041
   Kumta PN, 2005, ACTA BIOMATER, V1, P65, DOI 10.1016/j.actbio.2004.09.008
   Kuo MC, 2002, MAT SCI ENG C-BIO S, V20, P153, DOI 10.1016/S0928-4931(02)00026-7
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Meng XW, 2006, KEY ENG MAT, V309-311, P639, DOI 10.4028/www.scientific.net/KEM.309-311.639
   Montenero A, 2000, J MATER SCI, V35, P2791, DOI 10.1023/A:1004738900778
   Narayanan R, 2006, SURF COAT TECH, V200, P4720, DOI 10.1016/j.surfcoat.2005.04.040
   Peng P, 2006, J BIOMED MATER RES A, V76A, P347, DOI 10.1002/jbm.a.30514
   SHIRKHANZADEH M, 1992, J MATER SCI-MATER M, V3, P322, DOI 10.1007/BF00705362
   Shirkhanzadeh M., 1994, Nanostructured Materials, V4, P677, DOI 10.1016/0965-9773(94)90020-5
   Shirkhanzadeh M, 1998, J MATER SCI-MATER M, V9, P67, DOI 10.1023/A:1008838813120
   Song WH, 2004, BIOMATERIALS, V25, P3341, DOI 10.1016/j.biomaterials.2003.09.103
   WARD BC, 2006, MAT SCI ENG C
   WEBSTER T, 2005, NANOMED-NANOTECHNOL, V1, P251
   Yen S. K., 2002, MATER CHEM PHYS, V77, P70
NR 28
TC 60
Z9 61
U1 0
U2 13
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-6462
J9 SCRIPTA MATER
JI Scr. Mater.
PD FEB
PY 2007
VL 56
IS 3
BP 229
EP 232
DI 10.1016/j.scriptamat.2006.10.004
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 115HX
UT WOS:000242726500013
DA 2018-10-19
ER

PT J
AU Takahashi, Y
   Yamamoto, M
   Yamada, K
   Kawakami, O
   Tabata, Y
AF Takahashi, Yoshitake
   Yamamoto, Masaya
   Yamada, Keisuke
   Kawakami, Osamu
   Tabata, Yasuhiko
TI Skull bone regeneration in nonhuman primates by controlled release of
   bone morphogenetic protein-2 from a biodegradable hydrogel
SO TISSUE ENGINEERING
LA English
DT Article
ID FIBROBLAST-GROWTH-FACTOR; RAT ECTOPIC MODEL; CLINICAL-APPLICATIONS;
   BIOMATERIAL CARRIERS; COLLAGEN SPONGES; RHBMP-2; PHARMACOKINETICS;
   OSTEOINDUCTION; IMPLANTATION; DELIVERY
AB The objective of this study was to investigate the feasibility of biodegradable gelatin hydrogels as the controlled-release carrier of bone morphogenetic protein-2 (BMP-2) to enhance bone regeneration at a skull defect of nonhuman primates. Hydrogels with 3 different water contents were prepared through glutaraldehyde crosslinking of gelatin with an isoelectric point of 9.0 under varied reaction conditions. A critical-sized defect (6 mm in diameter) was prepared at the skull bone of skeletally mature cynomolgus monkeys, and gelatin hydrogels incorporating various doses of BMP-2 were applied to the defects. When the bone regeneration was evaluated by soft radiography and bone mineral density (BMD) examinations, the gelatin hydrogel incorporating BMP-2 exhibited significantly higher osteoinduction activity than did an insoluble bone matrix that incorporated BMP-2 (one of the best osteoinduction systems), although the activity depended on the water content of hydrogels. BMD enhancement was highest for the gelatin hydrogel that had a water content of 97.8 wt% among all types of hydrogels. Moreover, the gelatin hydrogel enabled BMP-2 to induce the bone regeneration in nonhuman primates even at low doses. We conclude that the controlled release of BMP-2 for a certain time period was essential to inducing the osteoinductive potential of BMP-2.
C1 Kyoto Univ, Inst Frontier Med Sci, Dept Biomat, Field Tissue Engn,Sakyo Ku, Kyoto 6068507, Japan.
   Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto 6068507, Japan.
RP Tabata, Y (reprint author), Kyoto Univ, Inst Frontier Med Sci, Dept Biomat, Field Tissue Engn,Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.
EM yasuhiko@frontier.kyoto-u.ac.jp
CR Boden SD, 2000, SPINE, V25, P376, DOI 10.1097/00007632-200002010-00020
   Boyne P J, 1997, Int J Periodontics Restorative Dent, V17, P11
   COOK SD, 1994, J BONE JOINT SURG AM, V76A, P827, DOI 10.2106/00004623-199406000-00006
   Einhorn TA, 2003, J BONE JOINT SURG AM, V85A, P82, DOI 10.2106/00004623-200300003-00014
   Friedlaender GE, 2001, J BONE JOINT SURG S1, V83, P151
   Friess W, 1999, INT J PHARM, V187, P91, DOI 10.1016/S0378-5173(99)00174-X
   Geesink RGT, 1999, J BONE JOINT SURG BR, V81B, P710, DOI 10.1302/0301-620X.81B4.9311
   Geiger M, 2003, ADV DRUG DELIVER REV, V55, P1613, DOI 10.1016/j.addr.2003.08.010
   Gittens SA, 2001, J DRUG TARGET, V9, P407, DOI 10.3109/10611860108998776
   Groeneveld EHJ, 1999, CLIN ORAL IMPLAN RES, V10, P499, DOI 10.1034/j.1600-0501.1999.100608.x
   Hollinger JO, 1998, J BIOMED MATER RES, V43, P356, DOI 10.1002/(SICI)1097-4636(199824)43:4<356::AID-JBM3>3.0.CO;2-7
   Hollinger JO, 1998, ADV DRUG DELIV REV, V31, P303
   Lieberman JR, 2002, J BONE JOINT SURG AM, V84A, P1032, DOI 10.2106/00004623-200206000-00022
   Mont MA, 2004, J BONE JOINT SURG AM, V86A, P41, DOI 10.2106/00004623-200412002-00008
   SEEHERMAN H, 2003, J BONE JOINT SURG S, V3, P96
   Tabata Y, 1999, J NEUROSURG, V91, P851, DOI 10.3171/jns.1999.91.5.0851
   Takita H, 2004, J BIOMED MATER RES A, V71A, P181, DOI 10.1002/jbm.a.30152
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   URIST MR, 1984, CLIN ORTHOP RELAT R, P277
   Valentin-Opran A, 2002, CLIN ORTHOP RELAT R, P110
   VEHOF JW, 2004, J BIOMED MATER RES, V71, P181
   Wheeler DI, 1998, J BIOMED MATER RES, V43, P365, DOI 10.1002/(SICI)1097-4636(199824)43:4<365::AID-JBM4>3.0.CO;2-6
   Wozney JM, 1998, CLIN ORTHOP RELAT R, P26
   Yamada K, 1997, J NEUROSURG, V86, P871, DOI 10.3171/jns.1997.86.5.0871
   Yamamoto M, 2003, BIOMATERIALS, V24, P4375, DOI 10.1016/S0142-9612(03)00337-5
   Yamamoto M, 2006, TISSUE ENG, V12, P1305, DOI 10.1089/ten.2006.12.1305
   Yoon ST, 2002, CLIN ORTHOP RELAT R, P33
   Zegzula HD, 1997, J BONE JOINT SURG AM, V79A, P1778, DOI 10.2106/00004623-199712000-00003
NR 29
TC 56
Z9 60
U1 0
U2 3
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD FEB
PY 2007
VL 13
IS 2
BP 293
EP 300
DI 10.1089/ten.2006.0088
PG 8
WC Cell & Tissue Engineering
SC Cell Biology
GA 136UW
UT WOS:000244250600008
PM 17504062
DA 2018-10-19
ER

PT J
AU Gupta, MK
   Khokhar, SK
   Phillips, DM
   Sowards, LA
   Drummy, LF
   Kadakia, MP
   Naik, RR
AF Gupta, Maneesh K.
   Khokhar, Shama K.
   Phillips, David M.
   Sowards, Laura A.
   Drummy, Lawrence F.
   Kadakia, Madhavi P.
   Naik, Rajesh R.
TI Patterned silk films cast from ionic liquid solubilized fibroin as
   scaffolds for cell growth
SO LANGMUIR
LA English
DT Article
ID FIBROBLASTS; DISSOLUTION; SPECTROSCOPY; SUBSTRATUM; ALIGNMENT; SOLVENTS;
   FIBERS
AB Silk is an attractive biomaterial for use in tissue engineering applications because of its slow degradation, excellent mechanical properties, and biocompatibility. In this report, we demonstrate a simple method to cast patterned films directly from silk fibroin dissolved in an ionic liquid. The films cast from the silk ionic liquid solution were found to support normal cell proliferation and differentiation. The versatility of the silk ionic liquid solutions and the ability to process large amounts of silk into materials with controlled surface topography directly from the dissolved silk ionic liquid solution could enhance the desirability of biomaterials such as silk for a variety of applications.
C1 Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45432 USA.
   Air Force Res Lab, Mat & Mfg Directorate, Dayton, OH 45433 USA.
RP Kadakia, MP (reprint author), Wright State Univ, Dept Biochem & Mol Biol, Dayton, OH 45432 USA.
EM madhavi.kadakia@wright.edu; rajesh.naik@wpafb.af.mil
RI Gupta, Maneesh/E-7492-2010
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Asakura T, 2002, J AM CHEM SOC, V124, P8794, DOI 10.1021/ja020244e
   CANETTI M, 1989, BIOPOLYMERS, V28, P1613, DOI 10.1002/bip.360280910
   Chen X, 2001, BIOPHYS CHEM, V89, P25, DOI 10.1016/S0301-4622(00)00213-1
   CHOU LS, 1995, J CELL SCI, V108, P1563
   CURTIS ASG, 1990, CRIT REV BIOCOMPAT, V5, P343
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   Docherty KM, 2005, GREEN CHEM, V7, P185, DOI 10.1039/b419172b
   DUNN GA, 1986, J CELL SCI, V83, P313
   Grinnell F, 2003, TRENDS CELL BIOL, V13, P264, DOI 10.1016/S0962-8924(03)00057-6
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Lam MT, 2006, BIOMATERIALS, V27, P4340, DOI 10.1016/j.biomaterials.2006.04.012
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Lu JF, 2005, J INVEST DERMATOL, V124, P778, DOI 10.1111/j.0022-202X.2005.23641.x
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V92, P2002, DOI DOI 10.1093/NAR/29.9.E45
   Phillips DM, 2005, J MATER CHEM, V15, P4206, DOI 10.1039/b510069k
   Phillips DM, 2004, J AM CHEM SOC, V126, P14350, DOI 10.1021/ja046079f
   Rogers RD, 2003, SCIENCE, V302, P792, DOI 10.1126/science.1090313
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Servoli E, 2005, MACROMOL BIOSCI, V5, P1175, DOI 10.1002/mabi.200500137
   Stepnowski P, 2004, HUM EXP TOXICOL, V23, P513, DOI 10.1191/0960327104ht480oa
   Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m
   SWATLOSKI RP, 2005, CHEM COMMUN, V1, P668
   Turner MB, 2004, BIOMACROMOLECULES, V5, P1379, DOI 10.1021/bm049748q
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   WENTA S, MICRON
   Xie HB, 2005, GREEN CHEM, V7, P606, DOI 10.1039/b502547h
   Yamada H, 2001, MAT SCI ENG C-BIO S, V14, P41, DOI 10.1016/S0928-4931(01)00207-7
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
   Zhou ZH, 2006, IND ENG CHEM RES, V45, P525, DOI 10.1021/ie050947f
NR 31
TC 78
Z9 83
U1 6
U2 50
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD JAN 30
PY 2007
VL 23
IS 3
BP 1315
EP 1319
DI 10.1021/la062047p
PG 5
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 128UK
UT WOS:000243684100058
PM 17241052
DA 2018-10-19
ER

PT J
AU Hwang, DS
   Gim, Y
   Kang, DG
   Kim, YK
   Cha, HJ
AF Hwang, Dong Soo
   Gim, Youngsoo
   Kang, Dong Gyun
   Kim, Yeon Kyu
   Cha, Hyung Joon
TI Recombinant mussel adhesive protein Mgfp-5 as cell adhesion biomaterial
SO JOURNAL OF BIOTECHNOLOGY
LA English
DT Article
DE mussel adhesive protein; recombinant adhesive; Mgfp-5; cell adhesion;
   cytochemistry
ID TYROSINE-CONTAINING PEPTIDES; DROSOPHILA S2 CELLS; MYTILUS-EDULIS-L;
   ESCHERICHIA-COLI; EXPRESSION; GENE; MICROCAPSULES; OPTIMIZATION;
   POLYLYSINE; INDUCTION
AB Mytilus galloprovincialis foot protein type-5 (Mgfp-5) is one of the mussel adhesive proteins that participate in adhesion with the substratum. We previously reported the production of recombinant Mgfp-5 in Escherichia coli and showed that the recombinant protein had superior adhesion abilities versus those of Cell-Tak, a commercially available mussel adhesive protein mixture. In the present work, we investigated the feasibility of using recombinant Mgfp-5 as a cell adhesion agent. Purified and tyrosinase-modified recombinant Mgfp-5 was used to adhere living anchorage-independent cells such as insect Drosophila S2 cells and human MOLT-4 cells onto glass slides. Our results revealed that these cell lines efficiently attached to recombinant Mgfp-5-coated glass surfaces, and that surface-immobilized S2 cells were viable and able to undergo cell division for up to 1 week. Cytochemical studies with 4',6-diamidino-2-phenylindole (DAPI) staining of nuclei and immunofluorescence for secreted foreign human erythropoietin (hEPO) from recombinant S2 cells and quantitative comparative analyses of S2 cell binding ability with Cell-Tak and poly-L-lysine, the main cell adhesion agent, were performed to demonstrate successful usage of recombinant Mgfp-5 for cell biological applications. Collectively, these results indicate that recombinant Mgfp-5 may be a useful new cell adhesion biomaterial for anchorage-independent cells. (c) 2006 Elsevier B.V. All rights reserved.
C1 Pohang Univ Sci & Technol, Dept Chem Engn, Pohang 790784, South Korea.
   Pohang Univ Sci & Technol, Inst Environm & Energy Technol, Pohang 790784, South Korea.
RP Cha, HJ (reprint author), Pohang Univ Sci & Technol, Dept Chem Engn, Pohang 790784, South Korea.
EM hjcha@postech.ac.kr
RI Hwang, Dong Soo/C-7291-2011
OI Hwang, Dong Soo/0000-0002-2487-2255
CR BENEDICT CV, 1989, ACS SYM SER, V385, P465, DOI 10.1021/bk-1989-0385.ch033
   Benthien JP, 2004, ANN ANAT, V186, P561, DOI 10.1016/S0940-9602(04)80108-0
   CURIEL DT, 1991, P NATL ACAD SCI USA, V88, P8850, DOI 10.1073/pnas.88.19.8850
   Deming TJ, 1999, CURR OPIN CHEM BIOL, V3, P100, DOI 10.1016/S1367-5931(99)80018-0
   DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680
   DOVE J, 1986, J AM DENT ASSOC, V112, P879
   FILPULA DR, 1990, BIOTECHNOL PROGR, V6, P171, DOI 10.1021/bp00003a001
   GRANDE DA, 1988, B HOSP JOINT DIS ORT, V48, P140
   Hill RM, 2001, PROTEIN EXPRES PURIF, V22, P406, DOI 10.1006/prep.2001.1463
   Hwang DS, 2005, BIOTECHNOL PROGR, V21, P965, DOI 10.1021/bp050014e
   Hwang DS, 2004, APPL ENVIRON MICROB, V70, P3352, DOI 10.1128/AEM.70.6.3352-3359.2004
   INOUE K, 1995, J BIOL CHEM, V270, P6698, DOI 10.1074/jbc.270.12.6698
   ISHIYAMA M, 1995, ANALYST, V120, P113, DOI 10.1039/an9952000113
   Jee JG, 2000, RAPID COMMUN MASS SP, V14, P1563, DOI 10.1002/1097-0231(20000830)14:16<1563::AID-RCM45>3.0.CO;2-4
   Kamino K, 2000, J BIOL CHEM, V275, P27360
   King A, 2003, J BIOMED MATER RES A, V64A, P533, DOI 10.1002/jbm.a.10276
   Kitamura M, 1999, J POLYM SCI POL CHEM, V37, P729, DOI 10.1002/(SICI)1099-0518(19990315)37:6<729::AID-POLA8>3.3.CO;2-V
   MARUMO K, 1986, BIOCHIM BIOPHYS ACTA, V872, P98, DOI 10.1016/0167-4838(86)90152-4
   MAZIA D, 1975, J CELL BIOL, V66, P198, DOI 10.1083/jcb.66.1.198
   MINOWADA J, 1972, J NATL CANCER I, V49, P891
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   PAPOV VV, 1995, J BIOL CHEM, V270, P20183, DOI 10.1074/jbc.270.34.20183
   RZEPECKI LM, 1992, BIOL BULL, V183, P123, DOI 10.2307/1542413
   SALERNO AJ, 1993, APPL MICROBIOL BIOT, V39, P221
   SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353
   Shin HS, 2002, BIOTECHNOL PROGR, V18, P1187, DOI 10.1021/bp025533l
   Strand BL, 2001, CELL TRANSPLANT, V10, P263, DOI 10.3727/000000001783986800
   Waite JH, 2005, J ADHESION, V81, P297, DOI 10.1080/00218460590944602
   Waite JH, 2002, INTEGR COMP BIOL, V42, P1172, DOI 10.1093/icb/42.6.1172
   WAITE JH, 1983, J BIOL CHEM, V258, P2911
   Waite JH, 2001, BIOCHEMISTRY-US, V40, P2887, DOI 10.1021/bi002718x
   WAITE JH, 1983, BIOL REV, V58, P209, DOI 10.1111/j.1469-185X.1983.tb00387.x
   WAITE JH, 1984, ANAL CHEM, V56, P1935, DOI 10.1021/ac00275a040
   Yu ME, 1998, MACROMOLECULES, V31, P4739, DOI 10.1021/ma980268z
   Yu ME, 1999, J AM CHEM SOC, V121, P5825, DOI 10.1021/ja990469y
   Yuan J, 2004, ALTEX-ALTERN TIEREXP, V21, P3
NR 36
TC 25
Z9 31
U1 3
U2 14
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1656
J9 J BIOTECHNOL
JI J. Biotechnol.
PD JAN 20
PY 2007
VL 127
IS 4
BP 727
EP 735
DI 10.1016/j.jbiotec.2006.08.005
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 129BY
UT WOS:000243704600017
PM 16979252
DA 2018-10-19
ER

PT J
AU Xue, WC
   Hosick, HL
   Bandyopadhyay, A
   Bose, S
   Ding, CX
   Luk, KDK
   Cheung, KMC
   Lu, WW
AF Xue, Weichang
   Hosick, Howard L.
   Bandyopadhyay, Arnit
   Bose, Susmita
   Ding, Chuanxian
   Luk, K. D. K.
   Cheung, K. M. C.
   Lu, W. W.
TI Preparation and cell-materials interactions of plasma sprayed
   strontium-containing hydroxyapatite coating
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE strontium; hydroxyapatite coating; plasma spraying; bioactivity;
   ostcoblast
ID BONE-FORMATION; IN-VITRO; POSTMENOPAUSAL OSTEOPOROSIS; RANELATE;
   RESORPTION; WOMEN; RATS; CEMENT; GROWTH; MODE
AB The use of strontium-containing hydroxyapatite (Sr-HA) as a biomaterial has been reported recently. In vitro and in vivo studies have shown that Sr-RA promotes osteoblast response and stimulates new bone formation. In order to extend its usage to major load-bearing applications, such as artificial hip replacement, it has been proposed that the material could be used in the form of a coating on implant surfaces. This paper reports a preliminary study of biocompatibility of plasma sprayed Sr-HA coatings on a metallic substrate. Coatings of Sr-HA containing 10 mol% Sr2+ was produced on titanium alloy substrates. The coating exhibited good bonding with the substrate. The bioactivity of Sr-HA coating was evaluated in vitro by immersion in simulated body fluid (SBF). After immersion in SBF, Sr-HA coating exhibited great ability to induce apatite precipitation on its surface. The possible effects of cell-materials interactions of Sr-HA coating were examined by culturing osteoprecursor cells (OPC1) on coating surfaces. The effect of Sr-HA was also compared to a hydroxyapatite (HA) coating, which is widely used in orthopedics and dentistry. The results indicated that Sr-HA coating had good biocompatibility with human osteoblasts. OPC1 cells survived and proliferated well on the surface of coating. Sr-HA coating promoted OPC1 cells attachment, and more local contacts were produced on the surface. The presence of Sr stimulated OPC1 cell differentiation and ALP expression. No deleterious effect on ECM formation and mineralization was found with Sr-HA coating. The results indicated that Sr-HA coating had good mechanical properties and bioactivity in vitro. (c) 2006 Elsevier B.V. All rights reserved.
C1 Washington State Univ, Sch Mech & Mat Engn, Pullman, WA 99164 USA.
   Washington State Univ, WM Keck Biomed Mat Res Lab, Pullman, WA 99164 USA.
   Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.
   Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
   Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.
RP Bose, S (reprint author), Washington State Univ, Sch Mech & Mat Engn, Pullman, WA 99164 USA.
EM sbose@wsu.edu
RI Bandyopadhyay, Amit/A-7780-2012
OI Bandyopadhyay, Amit/0000-0003-0992-5387
CR Ammann P, 2004, J BONE MINER RES, V19, P2012, DOI 10.1359/JBMR.040906
   Ammann P, 2005, OSTEOPOROSIS INT, V16, pS11, DOI 10.1007/s00198-004-1809-9
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Aubin Jane E., 1996, P51
   Barbara A, 2004, METABOLISM, V53, P532, DOI 10.1016/j.metabol.2003.10.022
   BERESFORD JN, 1993, AM J MED GENET, V45, P163, DOI 10.1002/ajmg.1320450205
   Canalis E, 1996, BONE, V18, P517, DOI 10.1016/8756-3282(96)00080-4
   Christoffersen J, 1997, BONE, V20, P47, DOI 10.1016/S8756-3282(96)00316-X
   Delmas PD, 2005, OSTEOPOROSIS INT, V16, pS16, DOI 10.1007/s00198-004-1767-2
   Fu Y.F., 2001, CHIN J STOMA MAT APP, V19, P178
   Grynpas MD, 1996, BONE, V18, P253, DOI 10.1016/8756-3282(95)00484-X
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Kim HW, 2004, J MATER SCI-MATER M, V15, P1129, DOI 10.1023/B:JMSM.0000046395.76435.60
   Lacefield WR, 1993, INTRO BIOCERAMICS
   Leroux L, 2001, J MATER RES, V16, P171, DOI 10.1557/JMR.2001.0028
   Li YW, 2000, J BIOMED MATER RES, V52, P164, DOI 10.1002/1097-4636(200010)52:1<164::AID-JBM21>3.0.CO;2-R
   MALAVAL L, 1994, J CELL PHYSIOL, V158, P555, DOI 10.1002/jcp.1041580322
   MARIE PJ, 1993, J BONE MINER RES, V8, P607
   Marie PJ, 2005, OSTEOPOROSIS INT, V16, pS7, DOI 10.1007/s00198-004-1753.8
   Meunier PJ, 2004, NEW ENGL J MED, V350, P459, DOI 10.1056/NEJMoa022436
   Qiu K, 2006, BIOMATERIALS, V27, P1277, DOI 10.1016/j.biomaterials.2005.08.006
   Reginster JY, 2005, J CLIN ENDOCR METAB, V90, P2816, DOI 10.1210/jc.2004-1774
   Rokusek D, 2005, J BIOMED MATER RES A, V75A, P588, DOI 10.1002/jbm.a.30459
   Stein GS, 1993, CELLULAR MOL BIOL BO, P48
   Storrie H, 2005, BIOMATERIALS, V26, P5492, DOI 10.1016/j.biomaterials.2005.01.043
   Takahashi N, 2003, J BONE MINER RES, V18, P1082, DOI 10.1359/jbmr.2003.18.6.1082
   Winn SR, 1999, J BONE MINER RES, V14, P1721, DOI 10.1359/jbmr.1999.14.10.1721
   Wong CT, 2004, J BIOMED MATER RES A, V68A, P513, DOI 10.1002/jbm.a.20089
   XUE WC, IN PRESS J BIOMED A
   Zamir E, 2001, J CELL SCI, V114, P3583
NR 30
TC 94
Z9 97
U1 3
U2 48
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD JAN 15
PY 2007
VL 201
IS 8
BP 4685
EP 4693
DI 10.1016/j.surfcoat.2006.10.012
PG 9
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 128KF
UT WOS:000243655900026
DA 2018-10-19
ER

PT J
AU Hanif, MA
   Nadeem, R
   Bhatti, HN
   Ahmad, NR
   Ansari, TM
AF Hanif, Muhammad Asif
   Nadeem, Raziya
   Bhatti, Haq Nawaz
   Ahmad, Najum Rashid
   Ansari, Tariq Mehmood
TI Ni(II) biosorption by Cassia fistula (Golden Shower) biomass
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE sorption; Ni(II); equilibrium; kinetics; Cassia fistula
ID HEAVY-METALS; AQUEOUS-SOLUTIONS; ARTHROBACTER-SP; TOXIC METALS; BASIC
   DYE; REMOVAL; EQUILIBRIUM; COPPER; IONS; BIOSORBENT
AB Cassia fistula is a fast-growing, medium-sized, deciduous tree which is now widely cultivated worldwide as an ornamental tree for its beautiful showy yellow flowers. Methods are required to reuse fallen leaves, branches, stem bark and pods when they start getting all over lawn. This investigation studies the use of these non-useful parts of C fistula as naturally occurring biosorbent for the batch removal of Ni(II) in a well stirred system under different experimental conditions. The data showed that the maximum pH (pH(max)) for efficient sorption of Ni(II) was 6 at which evaluated biosorbent dosage, biosorbent particle size, initial concentrations of Ni(II) and sorption time were 0.1 g/100 mL, < 0.255 mm, up to 200 mg/L and 720 min, respectively. The experimental results were analyzed in terms of Langmuir and Freundlich isotherms. The Langnmir isotherm model fitted well to data of Ni(II) biosorption by C. fistula biomass as compared to the model of Freundlich. The kinetic studies showed that the sorption rates could be described better by a second order expression than by a more commonly applied Lagergren equation. The magnitude of the Gibbs free energy values indicates spontaneous nature of the sorption process. The sorption ability of C. fistula biomass for Ni(II) removal tends to be in the order: leaves < stem bark < pods bark. One hundred percent Ni(II) removal was achieved when the initial Ni(II) concentration was 25 mg/L. Due to its outstanding Ni(II) uptake capacity, C. fistula biomass proved to be an excellent biomaterial for accumulating Ni(II) from aqueous solutions. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Agr Faisalabad, Dept Chem, Faisalabad 38040, Pakistan.
   Baha U Din Zakariya Univ, Dept Chem, Multan 60800, Pakistan.
RP Bhatti, HN (reprint author), Univ Agr Faisalabad, Dept Chem, Faisalabad 38040, Pakistan.
EM hnbhatti2005@yahoo.com
RI Bhatti, Haq Nawaz/I-2069-2015; Hanif, Muhammad Asif/G-7242-2015; Ansari,
   Tariq Mahmood/J-2845-2015
OI Bhatti, Haq Nawaz/0000-0002-5445-8338; Ansari, Prof Dr Tariq
   Mahmood/0000-0002-8074-3941
CR Ahalya N, 2005, ELECTRON J BIOTECHN, V8, DOI 10.2225/vol8-issue3-fulltext-10
   Benguella B, 2002, WATER RES, V36, P2463, DOI 10.1016/S0043-1354(01)00459-6
   CHEUNG CW, 1997, PURIF TECHNOL, V19, P55
   Chubar N, 2003, COLLOID SURFACE A, V230, P57, DOI 10.1016/j.colsurfa.2003.09.014
   Cordero B, 2004, ENVIRON CHEM, V1, P180, DOI 10.1071/EN04039
   CRIST RH, 1981, ENVIRON SCI TECHNOL, V15, P1212, DOI 10.1021/es00092a010
   Davis TA, 2000, WATER RES, V34, P4270, DOI 10.1016/S0043-1354(00)00177-9
   Dilek FB, 2002, PROCESS BIOCHEM, V37, P723, DOI 10.1016/S0032-9592(01)00261-8
   Farajzadeh MA, 2003, J CHIN CHEM SOC-TAIP, V50, P245, DOI 10.1002/jccs.200300036
   Gomes NCM, 1996, REV MICROBIOL, V27, P218
   Ho YS, 1996, ENVIRON TECHNOL, V17, P71, DOI 10.1080/09593331708616362
   Loukidou MX, 2004, COLLOID SURFACE A, V242, P93, DOI 10.1016/j.colsurfa.2004.03.030
   Matheickal JT, 1999, BIORESOURCE TECHNOL, V69, P223, DOI 10.1016/S0960-8524(98)00196-5
   MCKAY G, 1980, WATER RES, V14, P15, DOI 10.1016/0043-1354(80)90037-8
   Padmavathy V, 2003, PROCESS BIOCHEM, V38, P1389, DOI 10.1016/S0032-9592(02)00168-1
   Pagnanelli F, 2000, ENVIRON SCI TECHNOL, V34, P2773, DOI 10.1021/es99127g
   POOTS VJP, 1978, J WATER POLLUT CON F, V50, P926
   Prasad MNV, 2000, ENVIRON POLLUT, V110, P277, DOI 10.1016/S0269-7491(99)00306-1
   Quek SY, 1998, PROCESS SAF ENVIRON, V76, P50, DOI 10.1205/095758298529254
   Quek SY, 1998, WATER SA, V24, P251
   Rudresh H. B., 1977, J ENV SCI TECHNOL, V122, P251
   Sag Y, 1998, HYDROMETALLURGY, V50, P297, DOI 10.1016/S0304-386X(98)00065-6
   SAG Y, 1995, PROCESS BIOCHEM, V30, P169, DOI 10.1016/0032-9592(95)95716-V
   SCHIEWER S, 1995, ENVIRON SCI TECHNOL, V29, P3049, DOI 10.1021/es00012a024
   Sheng PX, 2004, J COLLOID INTERF SCI, V275, P131, DOI 10.1016/j.jcis.2004.01.036
   STMIHOVA T, 2001, BIOSORPTION HEAVY ME
   Tarley CRT, 2004, CHEMOSPHERE, V54, P987, DOI 10.1016/j.chemosphere.2003.09.001
   Veglio F, 1997, PROCESS BIOCHEM, V32, P99, DOI 10.1016/S0032-9592(96)00047-7
   Veglio F, 2003, PROCESS BIOCHEM, V38, P953, DOI 10.1016/S0032-9592(02)00235-2
   VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001
   Volesky B., 1990, BIOSORPTION HEAVY ME, P3
   Waranusantigul P, 2003, ENVIRON POLLUT, V125, P385, DOI 10.1016/S0269-7491(03)00107-6
   Zhou JL, 1998, ENVIRON POLLUT, V101, P67, DOI 10.1016/S0269-7491(98)00034-7
   2004, AFR J BIOTECHNOL, V4, P191
   2004, EUR J BIOTECHNOL, V7, P313
NR 35
TC 170
Z9 185
U1 1
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD JAN 10
PY 2007
VL 139
IS 2
BP 345
EP 355
DI 10.1016/j.jhazmat.2006.06.040
PG 11
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 130TP
UT WOS:000243822200023
PM 16860463
DA 2018-10-19
ER

PT J
AU Shi, R
   Liu, QY
   Ding, T
   Han, YM
   Zhang, LQ
   Chen, DF
   Tian, W
AF Shi, Rui
   Liu, Quanyong
   Ding, Tao
   Han, Yanming
   Zhang, Liqun
   Chen, Dafu
   Tian, Wei
TI Ageing of soft thermoplastic starch with high glycerol content
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE thermoplastics; ageing; crystal structures; glass transition; FUR
ID B-TYPE CRYSTALLINITY; POTATO STARCH; MAIZE STARCH;
   MECHANICAL-PROPERTIES; GLASS-TRANSITION; MATRIX IMPLANTS; PLASTIC
   SHEETS; WATER-CONTENT; AMYLOSE; SPECTROSCOPY
AB In this study, a soft and thermoplastic starch with an improved ageing-resistant property was prepared by melt blending method for a biodegradable biomaterial. The glycerol content varies from 30 to 60 wt %. The aging temperature and humidity of the glycerol-plasticized thermoplastic starch (GTPS) was 37 degrees C and 50 +/- 5 RH %, respectively. The retrogradation was characterized by X-ray diffraction (XRD), dynamic mechanical thermal analysis (DMTA), Fourier transform infrared (FTIR), and the stress-strain mechanical properties. The XRD results suggest that high content of glycerol promotes the formation of single helix structure of V-type, but inhibits double helix structure of B-type. Changing of the tan delta, storage modules (P), and the glass transition temperatures as a function of glycerol content and ageing time was detected by DMTA. FUR result shows that the shifting speed of the peak of hydroxyl group stretching fell as the glycerol content increased. The glycerol content has no obvious effect on the mechanical properties when it is high enough. Results from all characterizations demonstrate that the ageing speed is closely relative to the plasticizers content. The higher content of glycerol possesses an obviously inhibitory effect on the ageing. (c) 2006 Wiley Periodicals, Inc. J Appl Polym Sci 103: 574-586, 2007
C1 Beijing Univ Chem Technol, Key Lab Beijing City Preparat & Proc Novel Polyme, Beijing 100029, Peoples R China.
   Beijing Res Inst Traumatol & Orthopaed, Lab Bone Tissue Engn, Beijing 100035, Peoples R China.
   Peking Univ, Clin Med Coll 4, Dept Spine Surg, Beijing JiShuiTan Hosp, Beijing 100035, Peoples R China.
RP Zhang, LQ (reprint author), Beijing Univ Chem Technol, Key Lab Beijing City Preparat & Proc Novel Polyme, Beijing 100029, Peoples R China.
EM zhanglq@mail.buct.edu; chendafugo@yahoo.com.cn
RI zhang, liqun/S-7337-2016; Santos, Jonnatan/K-1862-2013
OI zhang, liqun/0000-0003-0291-4351; Santos, Jonnatan/0000-0003-3789-6229
CR Bogracheva TY, 2001, BIOPOLYMERS, V58, P247, DOI 10.1002/1097-0282(200103)58:3<247::AID-BIP1002>3.0.CO;2-L
   CAEL JJ, 1973, CARBOHYD RES, V29, P123
   CAEL JJ, 1975, J CARBOHYDR RES, V14, P1185
   Cheetham NWH, 1998, CARBOHYD POLYM, V36, P277, DOI 10.1016/S0144-8617(98)00007-1
   Chung HJ, 2004, CARBOHYD POLYM, V57, P15, DOI 10.1016/j.carbpol.2004.01.010
   Desevaux C, 2002, J CONTROL RELEASE, V82, P83, DOI 10.1016/S0168-3659(02)00133-5
   Desevaux C, 2002, J CONTROL RELEASE, V82, P95, DOI 10.1016/S0168-3659(02)00132-3
   EISENHABER F, 1992, BIOPOLYMERS, V32, P1643, DOI 10.1002/bip.360321207
   Forssell PM, 1999, CARBOHYD POLYM, V39, P43, DOI 10.1016/S0144-8617(98)00128-3
   Forssell PM, 1997, CARBOHYD POLYM, V34, P275, DOI 10.1016/S0144-8617(97)00133-1
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Graaf R. A. de, 2003, Starch/Staerke, V55, P80, DOI 10.1002/star.200390020
   Hulleman SHD, 1999, CARBOHYD POLYM, V39, P351, DOI 10.1016/S0144-8617(99)00024-7
   IMBERTY A, 1988, BIOPOLYMERS, V27, P1205, DOI 10.1002/bip.360270803
   KALICHEVSKY MT, 1993, POLYMER, V34, P346, DOI 10.1016/0032-3861(93)90088-R
   Le Bail P, 1999, BIOPOLYMERS, V50, P99, DOI 10.1002/(SICI)1097-0282(199907)50:1<99::AID-BIP9>3.3.CO;2-1
   LIU ZH, 2002, THESIS TIANJIN U TIA, P102
   Lourdin D, 1997, J APPL POLYM SCI, V63, P1047, DOI 10.1002/(SICI)1097-4628(19970222)63:8<1047::AID-APP11>3.0.CO;2-3
   Lourdin D, 1998, CARBOHYD RES, V306, P551, DOI 10.1016/S0008-6215(98)00007-X
   Lu TJ, 1997, CARBOHYD POLYM, V33, P19, DOI 10.1016/S0144-8617(97)00038-6
   MULLARINEN P, 2002, CARBOHYD POLYM, V50, P361
   Otani Y, 1998, BIOMATERIALS, V19, P2167, DOI 10.1016/S0142-9612(98)00123-9
   Salgado AJ, 2004, TISSUE ENG, V10, P465, DOI 10.1089/107632704323061825
   Smits ALM, 1998, STARCH-STARKE, V50, P478, DOI 10.1002/1521-379X(199812)50:11/12<478::AID-STAR478>3.3.CO;2-G
   Tang HR, 2001, CARBOHYD POLYM, V46, P7, DOI 10.1016/S0144-8617(00)00265-4
   vanSoest JJG, 1995, CARBOHYD RES, V279, P201, DOI 10.1016/0008-6215(95)00270-7
   vanSoest JJG, 1997, TRENDS BIOTECHNOL, V15, P208, DOI 10.1016/S0167-7799(97)01021-4
   VanSoest JJG, 1996, J APPL POLYM SCI, V61, P1927
   VanSoest JJG, 1997, J APPL POLYM SCI, V64, P1411, DOI 10.1002/(SICI)1097-4628(19970516)64:7<1411::AID-APP21>3.0.CO;2-Y
   vanSoest JJG, 1997, J MACROMOL SCI PURE, VA34, P1665, DOI 10.1080/10601329708010034
   vanSoest JJG, 1996, CARBOHYD POLYM, V29, P225, DOI 10.1016/0144-8617(96)00011-2
   WU HCH, 1978, CARBOHYD RES, V61, P7
   ZOBEL HF, 1988, STARCH-STARKE, V40, P44, DOI 10.1002/star.19880400203
NR 34
TC 45
Z9 46
U1 5
U2 32
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JAN 5
PY 2007
VL 103
IS 1
BP 574
EP 586
DI 10.1002/app.25193
PG 13
WC Polymer Science
SC Polymer Science
GA 105VQ
UT WOS:000242060800075
DA 2018-10-19
ER

PT J
AU Li, DH
   Liu, LM
   Tian, KL
   Liu, JC
   Fan, XQ
AF Li, Dong-Hong
   Liu, Liang-Ming
   Tian, Kun-Lun
   Liu, Jian-Chang
   Fan, Xiao-Qing
TI Synthesis, biodegradability and cytotoxicity of water-soluble
   isobutylchitosan
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE isobutylchitosan; water solubility; biodegradability; cytotoxicity
ID IN-VITRO; CHITOSAN; CHITIN; DERIVATIVES; PROLIFERATION; ACID
AB The objective of the present study was to improve the solubility of chitosan at neutral aqueous solution without altering its bioactivity. Through an alkylation reaction under mild conditions, isobutyl was introduced to chitosan to form isobutylchitosan, which showed a good solubility in neutral aqueous media resulting from the reduced crystallinity of the product. The structure of isobutylchitosan was characterized by IR, H-1 NMR spectroscopy, and X-ray diffraction. The degradation of the product was evaluated in vivo using a mouse model, and the cytotoxicity of the product in L929 mouse fibroblasts was monitored using the MTT assay and the release of the cytosolic enzyme lactate dehydrogenase (LDH). It was found that the product exhibited the properties of improved biodegradability, increased MTT values and decreased LDH release. The results suggested that isobutylchitosan might be one of promising and safe biomaterial with potential applications. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Mil Med Univ, State Key Lab Trauma Burn & Combined Injury, Dept Res 2, Inst Surg, Chongqing 400042, Peoples R China.
RP Li, DH (reprint author), Mil Med Univ, State Key Lab Trauma Burn & Combined Injury, Dept Res 2, Inst Surg, Chongqing 400042, Peoples R China.
EM lqs_cq@yahoo.com.cn
CR Chung YC, 2003, BIORESOURCE TECHNOL, V88, P179, DOI 10.1016/S0960-8524(03)00002-6
   Chung YC, 2005, BIORESOURCE TECHNOL, V96, P1473, DOI 10.1016/j.biortech.2004.12.001
   DUNG P, 1994, CARBOHYD POLYM, V24, P209
   Graeme I., 2001, BIOMATERIALS, V22, P2959
   HIRANO S, 1985, CARBOHYD RES, V144, P338, DOI 10.1016/S0008-6215(00)90682-7
   Hirano S, 2002, CARBOHYD POLYM, V48, P203, DOI 10.1016/S0144-8617(01)00243-0
   IKEDA I, 1993, J AGR FOOD CHEM, V41, P431, DOI 10.1021/jf00027a016
   Jang MK, 2004, J POLYM SCI POL CHEM, V42, P3423, DOI 10.1002/pola.20179
   KENJI T, 1997, BIOMATERIALS, V18, P567
   KIM JH, 1993, POLYMER, V34, P1952, DOI 10.1016/0032-3861(93)90441-C
   Kurita K, 2002, BIOMACROMOLECULES, V3, P1, DOI 10.1021/bm0101163
   Kurita K, 1998, POLYM DEGRAD STABIL, V59, P117, DOI 10.1016/S0141-3910(97)00160-2
   Lee MY, 2005, INT J BIOL MACROMOL, V36, P152, DOI 10.1016/j.ijbiomac.2005.05.004
   Liu XF, 2001, J APPL POLYM SCI, V79, P1324
   Mao SR, 2005, BIOMATERIALS, V26, P6343, DOI 10.1016/j.biomaterials.2005.03.036
   MOCHIZUKI A, 1989, J APPL POLYM SCI, V37, P3375, DOI 10.1002/app.1989.070371209
   Mori T, 1997, BIOMATERIALS, V18, P947, DOI 10.1016/S0142-9612(97)00017-3
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   MUZZARELLI RAA, 1985, CARBOHYD POLYM, V5, P461, DOI 10.1016/0144-8617(85)90005-0
   NISHIMURA SI, 1986, CARBOHYD RES, V146, P251, DOI 10.1016/0008-6215(86)85044-3
   Nordtveit RJ, 1996, CARBOHYD POLYM, V29, P163, DOI 10.1016/0144-8617(96)00003-3
   Prasitsilp M, 2000, J MATER SCI-MATER M, V11, P773, DOI 10.1023/A:1008997311364
   Terbojevich M, 1996, CARBOHYD POLYM, V29, P63, DOI 10.1016/0144-8617(95)00147-6
   WATANABE K, 1992, CARBOHYD POLYM, V17, P29, DOI 10.1016/0144-8617(92)90020-Q
NR 24
TC 31
Z9 37
U1 1
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
EI 1879-1344
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD JAN 2
PY 2007
VL 67
IS 1
BP 40
EP 45
DI 10.1016/j.carbpol.2006.04.022
PG 6
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 118SD
UT WOS:000242961100005
DA 2018-10-19
ER

PT J
AU Arul, V
   Kartha, R
   Jayakumar, R
AF Arul, Vadivel
   Kartha, Reena
   Jayakumar, Rajadas
TI A therapeutic approach for diabetic wound healing using biotinylated GHK
   incorporated collagen matrices
SO LIFE SCIENCES
LA English
DT Article
DE collagen; wound healing; GHK; fibroblast; antioxidant enzymes
ID GROWTH-FACTOR; HUMAN-SKIN; CELLS; FIBROBLASTS; TRIPEPTIDE; RAT;
   STIMULATION; EXPRESSION; MICE; GLUTATHIONE
AB Chronically elevated blood glucose levels result in reduced leukocyte function and cell malnutrition, which contribute to a high rate of wound infection and associated healing problems in diabetic patients. In the present study, the role of biotinylated GHK peptide (BioGHK) incorporated collagen biomaterial was tested for wound healing in diabetic rats. The rate of wound contraction and the levels of collagen, uronic acid, protein and DNA in the granulation tissue were determined. Further, the concentration of nitric oxide and other skin antioxidants was also monitored during the study. In diabetic rats treated with BioGHK incorporated collagen (Peptide Incorporated Collagen - PIC), the healing process was hastened with an increased rate of wound contraction. Glutathione (GSH) and ascorbic acid levels in the skin of streptozotocin-induced diabetic rats were higher in the PIC group as compared to control (Untreated) and collagen (Collagen Film - CF) treated groups. Superoxide dismutase (SOD) and catalase (CAT) activity was altered in all the groups. In vitro fibroblast cell culture studies suggest that PIC promotes fibroblast growth. Histological evaluation by haematoxylin-eosin and Masson's trichrome method revealed epithelialization, increased synthesis of collagen and activation of fibroblasts and mast cells in the PIC group. This study provides a rationale for the topical application of BioGHK incorporated collagen as a feasible and productive approach to support diabetic wound healing. (c) 2006 Elsevier Inc. All rights reserved.
C1 Cent Leather Res Inst, Bioorgan & Neurochem Lab, Madras 600020, Tamil Nadu, India.
   Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.
RP Jayakumar, R (reprint author), Cent Leather Res Inst, Bioorgan & Neurochem Lab, Madras 600020, Tamil Nadu, India.
EM karkuvi77@yahoo.co.uk
OI Kartha, Reena/0000-0002-1692-1539
CR ALBERTSON S, 1993, SURGERY, V114, P368
   Albuquerque MLC, 2002, EXP BIOL MED, V227, P1006
   Arora PD, 1999, AM J PATHOL, V154, P871, DOI 10.1016/S0002-9440(10)65334-5
   Arul V, 2005, J BIOMED MATER RES B, V73B, P383, DOI 10.1002/jbm.b.30246
   Bab Itai A., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P31
   Bae GU, 1999, J BIOL CHEM, V274, P32596, DOI 10.1074/jbc.274.46.32596
   BERGMEYER HU, 1974, METHOD ENZYMAT AN, V1, P438
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   BODANSKY A, 1984, PRACTICE PEPTIDE SYN, V21
   Chen MM, 2000, J MOL CELL CARDIOL, V32, P1805, DOI 10.1006/jmcc.2000.1215
   CHENG K, 1999, ANIMAL COGNITION, V2, P79
   COLLINS T, 1995, FASEB J, V9, P899
   Deyl ZAM, 1976, METHODOLOGY CONNECTI, P1
   Draye JP, 1998, BIOMATERIALS, V19, P1677, DOI 10.1016/S0142-9612(98)00049-0
   Etscheid M, 2004, EUR J CELL BIOL, V82, P597, DOI 10.1078/0171-9335-00349
   Galiano RD, 2004, AM J PATHOL, V164, P1935, DOI 10.1016/S0002-9440(10)63754-6
   Gopinath D, 2005, J BIOMED MATER RES A, V73A, P320, DOI 10.1002/jbm.a.30303
   Gopinath D, 2004, BIOMATERIALS, V25, P1911, DOI 10.1016/S0142-9612(03)00625-2
   JOHNSON LJ, 1993, SEMINARS PERIOPERATI, V2, P438
   Kamoun A, 1995, CELL ADHES COMMUN, V3, P273, DOI 10.3109/15419069509081013
   Kane J. B., 1996, BIOMATERIALS SCI INT, P360
   Kobuchi H, 1999, AM J PHYSIOL-CELL PH, V277, pC403, DOI 10.1152/ajpcell.1999.277.3.C403
   Komesu Marilena Chinali, 2004, Pathophysiology, V11, P63, DOI 10.1016/j.pathophys.2004.02.002
   LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7
   Lockhart LK, 2001, THROMB HAEMOSTASIS, V85, P882
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Madlener M, 1998, EXP CELL RES, V242, P201, DOI 10.1006/excr.1998.4049
   MAQUART FX, 1988, FEBS LETT, V238, P343, DOI 10.1016/0014-5793(88)80509-X
   MAQUART FX, 1993, J CLIN INVEST, V92, P2368, DOI 10.1172/JCI116842
   MEISTER A, 1983, BIOCHEM SOC T, V11, P793, DOI 10.1042/bst0110793
   MISRA HP, 1972, J BIOL CHEM, V247, P3170
   MORON MS, 1979, BIOCHIM BIOPHYS ACTA, V582, P67, DOI 10.1016/0304-4165(79)90289-7
   Moulin V, 2000, BURNS, V26, P3, DOI 10.1016/S0305-4179(99)00091-1
   Neely Alice N., 1997, Wound Repair and Regeneration, V5, P302
   NEUMAN RE, 1950, J BIOL CHEM, V184, P299
   Nwomeh BC, 1999, J SURG RES, V81, P189, DOI 10.1006/jsre.1998.5495
   Phan TT, 2001, BIOL PHARM BULL, V24, P1373, DOI 10.1248/bpb.24.1373
   PICKART L, 1973, NATURE-NEW BIOL, V243, P85
   Pollard JD, 2005, ARCH FACIAL PLAST S, V7, P27, DOI 10.1001/archfaci.7.1.27
   Rasik AM, 2000, INT J EXP PATHOL, V81, P257, DOI 10.1046/j.1365-2613.2000.00158.x
   REED JA, 1995, LAB INVEST, V72, P215
   SCHNEIDER WC, 1957, J NATL CANCER I, V18, P569
   SCHNIDER SL, 1981, J CLIN INVEST, V67, P1630, DOI 10.1172/JCI110198
   Sidhu GS, 1999, WOUND REPAIR REGEN, V7, P362, DOI 10.1046/j.1524-475X.1999.00362.x
   SPANHEIMER RG, 1988, DIABETES, V37, P371, DOI 10.2337/diabetes.37.4.371
   STOMPRO BE, 1989, J SURG RES, V46, P413, DOI 10.1016/0022-4804(89)90153-4
   TOLSTYKH PI, 1988, KHIRURGIYA, P3
   Vaalamo M, 1999, HUM PATHOL, V30, P795, DOI 10.1016/S0046-8177(99)90140-5
   Wakatsuki T, 2003, BIOPHYS CHEM, V100, P593, DOI 10.1016/S0301-4622(02)00308-3
   Weller R, 1996, J INVEST DERMATOL, V107, P327, DOI 10.1111/1523-1747.ep12363167
   Wilkinson-Berka JL, 2004, CURR PHARM DESIGN, V10, P3313, DOI 10.2174/1381612043383179
   Williams JZ, 2002, ANN SURG, V236, P369, DOI 10.1097/01.SLA.0000027527.01984.00
   Yamasaki K, 1998, J CLIN INVEST, V101, P967, DOI 10.1172/JCI2067
NR 53
TC 35
Z9 35
U1 2
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0024-3205
EI 1879-0631
J9 LIFE SCI
JI Life Sci.
PD JAN 2
PY 2007
VL 80
IS 4
BP 275
EP 284
DI 10.1016/j.lfs.2006.09.018
PG 10
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 127HP
UT WOS:000243576500002
PM 17049946
DA 2018-10-19
ER

PT S
AU Duygulu, O
   Kaya, AA
   Oktay, G
   Sahin, FC
AF Duygulu, Ozgur
   Kaya, Ali Arslan
   Oktay, Gizem
   Sahin, Filiz Cinar
BE Long, S
   Pan, FH
   Kainer, KU
   Han, YF
   Ke, W
   Liu, B
   Zhang, XM
   Peng, CQ
   Zhao, XQ
   Feng, Q
   Lu, YF
   Zhang, PX
   Jiang, CB
TI Diffusion bonding of magnesium, zirconium and titanium as implant
   material
SO 2006 BIMW: 2006 BEIJING INTERNATIONAL MATERIALS WEEK, PTS 1-4: MAGNESIUM
SE Materials Science Forum
LA English
DT Proceedings Paper
CT Beijing International Materials Week
CY JUN 25-30, 2006
CL Beijing, PEOPLES R CHINA
SP Chinese Mat Res Soc, European Mat Res Soc, Gen Res Inst Nonferrous Metals, Pulead Technol Ind Co Ltd, Shanshan Technol Grp, Chongqing Univ, China Magnesium Ctr, Minist Sci & Technol China, Natl Dev & Reform Commiss China, Minist Educ China, Minist Informat Ind China, Natl Nat Sci Fdn China, Chinese Acad Engn, China Assoc Sci & Technol, Int Union Mat Res Soc
DE magnesium; AZ31; biomaterial; titanium; zirconium; diffusion bond
ID IN-VIVO CORROSION; ALLOYS
AB Titanium, zirconium and magnesium alloys are considered to be biocompatible, and can be used as implants such as hip ball and sockets and to make medical equipments. Biomaterials with hybrid structures in some applications utilizing the beneficial properties of different metals together are considered potential implant materials. Therefore, in this study, experimental trials were attempted to bond pure magnesium, AM60 (6 wt% Al-0.27 wt% Mn), and AZ31 (3 wt% Al-1 wt% Zn) alloys to pure zirconium and Ti6Al4V (6 wt% Al-4 wt% V) alloy to experimentally evaluate the forming bimetallic structures by diffusion bonding technique by vacuum hot pressing. SEM analysis showed the presence of a significant diffusion zone and a presence of diffusion bonding in some metallic couples. It may be suggested that novel hybrid implant materials, composed of diffusion couples of magnesium, zirconium and titanium alloys may emerge in the future.
C1 [Duygulu, Ozgur; Kaya, Ali Arslan; Oktay, Gizem] TUBITAK MRC, Mat Inst, POB 21, TR-41470 Gebze, Turkey.
   [Sahin, Filiz Cinar] Istanbul Tech Univ, Dept Met & Mat Engn, TR-34469 Istanbul, Turkey.
RP Duygulu, O (reprint author), TUBITAK MRC, Mat Inst, POB 21, TR-41470 Gebze, Turkey.
EM ozgur.duygulu@mam.gov.tr; aliarslan.kaya@mam.gov.tr;
   gizem.oktay@mam.gov.tr; cinar@itu.edu.tr
RI Duygulu, Ozgur/A-9076-2015
OI Duygulu, Ozgur/0000-0001-8646-0363
CR BHANUMURTHY K, 1994, J NUCL MATER, V217, P67, DOI 10.1016/0022-3115(94)90305-0
   Cordingley R., 2003, Journal of the Australasian Ceramic Society, V39, P20
   DENKENA B, 2005, P 5 EUSP INT C
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Kale GB, 1998, J NUCL MATER, V257, P44, DOI 10.1016/S0022-3115(98)00179-2
   Leyens C, 2003, TITANIUM TITANIUM AL
   Peng L, 2005, MATER LETT, V59, P2001, DOI DOI 10.1016/J.MATLET.2005.02.038
   Somekawa H, 2003, SCRIPTA MATER, V48, P1249, DOI 10.1016/S1359-6462(03)00054-X
   Somekawa H, 2003, MAT SCI ENG A-STRUCT, V339, P328, DOI 10.1016/S0921-5093(02)00127-2
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   YANDONG Y, 2005, MATER SCI FORUM, V488, P227
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
NR 14
TC 6
Z9 6
U1 1
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 978-0-87849-432-3
J9 MATER SCI FORUM
PY 2007
VL 546-549
BP 417
EP +
DI 10.4028/www.scientific.net/MSF.546-549.417
PN 1-4
PG 2
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BGD24
UT WOS:000246145500088
DA 2018-10-19
ER

PT S
AU Duygulu, O
   Kaya, RA
   Oktay, G
   Kaya, AA
AF Duygulu, Ozgur
   Kaya, R. Alper
   Oktay, Gizern
   Kaya, A. Arslan
BE Long, S
   Pan, FH
   Kainer, KU
   Han, YF
   Ke, W
   Liu, B
   Zhang, XM
   Peng, CQ
   Zhao, XQ
   Feng, Q
   Lu, YF
   Zhang, PX
   Jiang, CB
TI Investigation on the potential of magnesium alloy AZ31 as a bone implant
SO 2006 BIMW: 2006 BEIJING INTERNATIONAL MATERIALS WEEK, PTS 1-4: MAGNESIUM
SE Materials Science Forum
LA English
DT Proceedings Paper
CT Beijing International Materials Week
CY JUN 25-30, 2006
CL Beijing, PEOPLES R CHINA
SP Chinese Mat Res Soc, European Mat Res Soc, Gen Res Inst Nonferrous Metals, Pulead Technol Ind Co Ltd, Shanshan Technol Grp, Chongqing Univ, China Magnesium Ctr, Minist Sci & Technol China, Natl Dev & Reform Commiss China, Minist Educ China, Minist Informat Ind China, Natl Nat Sci Fdn China, Chinese Acad Engn, China Assoc Sci & Technol, Int Union Mat Res Soc
DE magnesium; AZ31; biomaterial; bone
ID IN-VIVO CORROSION
AB Degradable implants have been in use for bone surgery for decades. However, degradable metal implants are one of the new research areas of biomaterials science. There is a potential for application of degradable metal implants as screws and plates in bones. Magnesium alloys are one of the new candidate materials for degradable implants. Magnesium has good biocompatibility due to its low toxicity, and it is a corroding, i.e. dissolvable, metal. Furthermore, magnesium is needed in human body, and naturally found in bone tissue. Mechanical properties of magnesium alloys are dimensionally comparable to the cortical bone substance. In this study, corrosion behavior of magnesium metal at the bone interface and the possibility of new bone cell formation have been investigated. Cortical bone screws were machined from magnesium alloy AZ31 extruded rod and implanted to hip-bones of sheep via surgery. Three months after surgery, the bone segments carrying these screws were removed from the sacrificed animals. Samples were sectioned to reveal Mg/bone interfaces and investigated using optical microscope, SEM-EDS and radiography. Optical and SEM images showed that there was a significant amount of corrosion on the magnesium screw. The elemental mapping results indicate, due to the presence of calcium and phosphorus elements, that there exists new bone formation at the interface. From the results of this study, it may be stated that the potential for using magnesium alloys as a bone implant material is expected to be significant.
C1 TUBITAK MRC, Mat Inst, POB 21, TR-41470 Gebze, Turkey.
   [Kaya, R. Alper] Sisli Etfal State Hosp, Clin Neurosurg Dept, TR-34377 Istanbul, Turkey.
RP Duygulu, O (reprint author), TUBITAK MRC, Mat Inst, POB 21, TR-41470 Gebze, Turkey.
EM ozgur.duygulu@mam.gov.tr; alpkaya67@yahoo.com; gizem.oktay@mam.gov.tr;
   aliarslan.kaya@mam.gov.tr
RI Duygulu, Ozgur/A-9076-2015
OI Duygulu, Ozgur/0000-0001-8646-0363
CR *ASTM, 2002, ASTMF54302
   DENKENA B, 2005, P 5 EUSP INT C
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Witte F, 2006, BIOMATERIALS, V27, P1013, DOI 10.1016/j.biomaterials.2005.07.037
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Zartner P, 2005, CATHETER CARDIO INTE, V66, P590, DOI 10.1002/ccd.20520
NR 7
TC 30
Z9 37
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 978-0-87849-432-3
J9 MATER SCI FORUM
PY 2007
VL 546-549
BP 421
EP +
DI 10.4028/www.scientific.net/MSF.546-549.421
PN 1-4
PG 2
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BGD24
UT WOS:000246145500089
DA 2018-10-19
ER

PT S
AU Oktay, G
   Duygulu, O
   Kaya, AA
AF Oktay, Gizem
   Duygulu, Ozgur
   Kaya, Ali Arslan
BE Long, S
   Pan, FH
   Kainer, KU
   Han, YF
   Ke, W
   Liu, B
   Zhang, XM
   Peng, CQ
   Zhao, XQ
   Feng, Q
   Lu, YF
   Zhang, PX
   Jiang, CB
TI Magnesium films deposited on different substrates via arc PVD method
SO 2006 BIMW: 2006 BEIJING INTERNATIONAL MATERIALS WEEK, PTS 1-4: MAGNESIUM
SE Materials Science Forum
LA English
DT Proceedings Paper
CT Beijing International Materials Week
CY JUN 25-30, 2006
CL Beijing, PEOPLES R CHINA
SP Chinese Mat Res Soc, European Mat Res Soc, Gen Res Inst Nonferrous Metals, Pulead Technol Ind Co Ltd, Shanshan Technol Grp, Chongqing Univ, China Magnesium Ctr, Minist Sci & Technol China, Natl Dev & Reform Commiss China, Minist Educ China, Minist Informat Ind China, Natl Nat Sci Fdn China, Chinese Acad Engn, China Assoc Sci & Technol, Int Union Mat Res Soc
DE magnesium; film; biomaterial; PVD
ID CORROSION-RESISTANCE; ALLOYS
AB A hybrid biomaterial was produced by dressing titanium with magnesium in order to utilize the most advantageous properties of both materials. Titanium was coated with magnesium via arc physical vapor deposition (PVD) method, and a third agent between titanium and magnesium, as a bonding medium was also used. The microstructures and chemical compositions of magnesium arc-PVD coated Ti-6Al-4V alloy and silicon wafer were investigated. The experimental results showed that Mg can be deposited onto Ti-6Al-4V alloy and on silicon wafer by using arc-PVD method.
C1 [Oktay, Gizem; Duygulu, Ozgur; Kaya, Ali Arslan] TUBITAK MRC, Mat Inst, POB 21, Kocaeli 41470, Turkey.
RP Oktay, G (reprint author), TUBITAK MRC, Mat Inst, POB 21, Kocaeli 41470, Turkey.
EM gizem.oktay@mam.gov.tr; ozgur.duygulu@mam.gov.tr;
   aliarslan.kaya@mam.gov.tr
RI Duygulu, Ozgur/A-9076-2015
OI Duygulu, Ozgur/0000-0001-8646-0363
CR DENKENA B, 2005, P 5 EUSP INT C
   Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0
   Lee MH, 2003, SURF COAT TECH, V169, P670, DOI 10.1016/S0257-8972(03)00054-9
   Leyens C, 2003, TITANIUM TITANIUM AL
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Yamamoto A, 2001, SCRIPTA MATER, V44, P1039, DOI 10.1016/S1359-6462(01)00662-5
NR 6
TC 1
Z9 1
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 978-0-87849-432-3
J9 MATER SCI FORUM
PY 2007
VL 546-549
BP 519
EP +
DI 10.4028/www.scientific.net/MSF.546-549.519
PN 1-4
PG 2
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BGD24
UT WOS:000246145500111
DA 2018-10-19
ER

PT S
AU Gao, JC
   Xue, Y
   Qiao, LY
   Wang, Y
   Zhang, Y
AF Gao, Jiacheng
   Xue, Yan
   Qiao, Liying
   Wang, Yong
   Zhang, Yan
BE Long, S
   Pan, FH
   Kainer, KU
   Han, YF
   Ke, W
   Liu, B
   Zhang, XM
   Peng, CQ
   Zhao, XQ
   Feng, Q
   Lu, YF
   Zhang, PX
   Jiang, CB
TI Surface modification of magnesium with rare earth conversion films for
   biomedical protection
SO 2006 BIMW: 2006 BEIJING INTERNATIONAL MATERIALS WEEK, PTS 1-4: MAGNESIUM
SE Materials Science Forum
LA English
DT Proceedings Paper
CT Beijing International Materials Week
CY JUN 25-30, 2006
CL Beijing, PEOPLES R CHINA
SP Chinese Mat Res Soc, European Mat Res Soc, Gen Res Inst Nonferrous Metals, Pulead Technol Ind Co Ltd, Shanshan Technol Grp, Chongqing Univ, China Magnesium Ctr, Minist Sci & Technol China, Natl Dev & Reform Commiss China, Minist Educ China, Minist Informat Ind China, Natl Nat Sci Fdn China, Chinese Acad Engn, China Assoc Sci & Technol, Int Union Mat Res Soc
DE rare-earths; conversion film; corrosion; biomaterial; simulated body
   fluid (SBF)
AB The specific gravity and elastic modulus of magnesium alloys are similar to that of human bone. Magnesium is one of the most important elements in the human body and plays a key role in the metabolic process. But the application of magnesium is seriously limited as a biomaterial since it corrodes easily in the physiological environment of the body. In order to reduce the corrosion, we developed protective films using rare earth (RE) conversion processing. The surface of magnesium samples was modified by contact with different rare-earth salt solutions; then the samples were dipped in SBF to test their corrosion resistance. The change of mass and the pH of the solutions were measured continuously using an electronic scale and a pH micrometer. The surface microstructure of the samples was observed by XRD and metallomicroscope. Corrosion rates of the samples in SBF were determined using Taffier curve. The preliminary results show that the conversion treatment with CeCl3 or Y(NO3)(3) can improve the corrosion resistance of magnesium in SBF. The relationship of the RE salts concentration and the corrosion properties were studied,the best combination of parameters was determined, and the formation mechanism of rare-earth conversion film has been also elaborated.
C1 [Gao, Jiacheng; Qiao, Liying] Chongqing Univ, Chongqing Engn Res Ctr Magnesium Alloy, Chongqing 400044, Peoples R China.
   [Xue, Yan; Qiao, Liying; Wang, Yong; Zhang, Yan] Chongqing Univ, Coll Mat Sci & Engn, Chongqing 400044, Peoples R China.
RP Gao, JC (reprint author), Chongqing Univ, Chongqing Engn Res Ctr Magnesium Alloy, Chongqing 400044, Peoples R China.
EM gaojch@cqu.edu.cn
FU Chongqing Science Committee [2004AA40003]
FX This project was sponsored by the Chongqing Science Committee under
   Grant 2004AA40003
CR Gao Jia-cheng, 2004, Chinese Journal of Nonferrous Metals, V14, P1508
   Gray JE, 2002, J ALLOY COMPD, V336, P88, DOI 10.1016/S0925-8388(01)01899-0
   Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9
   LIU ZD, 2002, CHINESE WOUND BONE, V4, P62
   URRAPPA I, 2001, CORROSION PREVENTION, V48, P23
   YOUSEF AA, 2001, MAT T, V42, P1777
   ZHANG M, 2005, THESIS CHONGQING U C
NR 7
TC 2
Z9 8
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 978-0-87849-432-3
J9 MATER SCI FORUM
PY 2007
VL 546-549
BP 601
EP +
DI 10.4028/www.scientific.net/MSF.546-549.601
PN 1-4
PG 2
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BGD24
UT WOS:000246145500130
DA 2018-10-19
ER

PT S
AU Jiang, HC
   Rong, LJ
AF Jiang, H. C.
   Rong, L. J.
BE Long, S
   Pan, FH
   Kainer, KU
   Han, YF
   Ke, W
   Liu, B
   Zhang, XM
   Peng, CQ
   Zhao, XQ
   Feng, Q
   Lu, YF
   Zhang, PX
   Jiang, CB
TI Microstructures and mechanical properties of porous Ti51Ni(49-X)MoX
   shape memory alloys
SO 2006 BIMW: 2006 BEIJING INTERNATIONAL MATERIALS WEEK, PTS 1-4: MAGNESIUM
SE Materials Science Forum
LA English
DT Proceedings Paper
CT Beijing International Materials Week
CY JUN 25-30, 2006
CL Beijing, PEOPLES R CHINA
SP Chinese Mat Res Soc, European Mat Res Soc, Gen Res Inst Nonferrous Metals, Pulead Technol Ind Co Ltd, Shanshan Technol Grp, Chongqing Univ, China Magnesium Ctr, Minist Sci & Technol China, Natl Dev & Reform Commiss China, Minist Educ China, Minist Informat Ind China, Natl Nat Sci Fdn China, Chinese Acad Engn, China Assoc Sci & Technol, Int Union Mat Res Soc
DE porous TiNi shape memory alloy; TiNiMo alloy; compressive properties
ID PHASE-TRANSFORMATION BEHAVIORS; HIGH-TEMPERATURE SYNTHESIS;
   NICKEL-TITANIUM; NITI
AB Porous Ti51Ni(49-x)Mox (x=0, 0.7, 1.0, 1.2) shape memory alloys were successfully fabricated by the self-propagating high-temperature synthesis (SHS) method. The effect of Mo content on micro structures, transformation characteristics and compressive properties of porous TiNiMo alloys was investigated systemically. It has been found that Mo doping into porous TiNi alloys will induce R phase transformation. A small amount of Mo addition (0.7at.%) improves compressive properties of porous TiNiMo alloy due to Mo solution strengthening and the obvious ductile fracture is observed on the fracture photography. However, the compressive strength and compressive strain of porous TiNiMo alloys with excessive Mo content decrease sharply and the failure manner turned into brittle fracture mode, which results from a large amount of Ti2Ni and Ti4Ni2O phases precipitated at grain boundary. Porous Ti51Ni48.3Mo0.7 alloy with suitable transformation temperature and high compressive strength is very promising for use as biomaterial and damping material.
C1 [Jiang, H. C.; Rong, L. J.] Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
RP Jiang, HC (reprint author), Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
EM hcjiang@imr.ac.cn; ljrong@imr.ac.cn
CR Chu CL, 2006, T NONFERR METAL SOC, V16, P49, DOI 10.1016/S1003-6326(06)60009-5
   GYUNTER VE, 1998, MED MAT IMPLANTS SHA
   ITIN VI, 1994, MATER CHARACT, V32, P179, DOI 10.1016/1044-5803(94)90087-6
   Jarfors AEW, 2003, MATER SCI FORUM, V437-4, P475, DOI 10.4028/www.scientific.net/MSF.437-438.475
   JIANG HC, IN PRESS MAT SIC E A
   Li BY, 2000, ACTA MATER, V48, P3895, DOI 10.1016/S1359-6454(00)00184-1
   Li YH, 2002, J MATER SCI TECHNOL, V18, P248
   Liu FS, 2005, INTERMETALLICS, V13, P357, DOI [10.1016/j.intermet.2004.07.024, 10.1016/j.intermet.2005.07.024]
   Nam TH, 2002, MATER LETT, V52, P234, DOI 10.1016/S0167-577X(01)00424-4
   Nam TH, 2001, J MATER SCI, V36, P4181, DOI 10.1023/A:1017964806065
   Rhalmi S, 1999, BIO-MED MATER ENG, V9, P151
   SABURI T, 1979, J IRON STEEL I JPN, V72, P62
   SIMSKE SJ, 1999, J BIOMED MATER RES, V29, P527
NR 13
TC 2
Z9 2
U1 1
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 978-0-87849-432-3
J9 MATER SCI FORUM
PY 2007
VL 546-549
BP 2127
EP +
DI 10.4028/www.scientific.net/MSF.546-549.2127
PN 1-4
PG 2
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA BGD24
UT WOS:000246145503061
DA 2018-10-19
ER

PT S
AU Frischholz, M
   Sarmento, L
   Wenzel, M
   Aquilina, K
   Edwards, R
   Coakham, HB
AF Frischholz, M.
   Sarmento, L.
   Wenzel, M.
   Aquilina, K.
   Edwards, R.
   Coakham, H. B.
GP IEEE
TI Telemetric Implantable pressure sensor for short- and long-term
   monitoring of intracranial pressure
SO 2007 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE
   AND BIOLOGY SOCIETY, VOLS 1-16
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 29th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY AUG 22-26, 2007
CL Lyon, FRANCE
SP IEEE Engn Med & Biol Soc
AB Patients with hydrocephalus, idiopathic intracranial hypertension and head injury frequently require monitoring of intracranial pressure (ICP) and may need repeated episodes of monitoring months or years apart. The gold standard for measurement of ICP remains the external ventricular catheter. This is a fluid-filled. catheter transducer system that allows regular recalibration and correction of zero drift by its position relative to a fixed anatomical reference. It also allows drainage of cerebrospinal fluid (CSF), providing a means of lowering the ICP. Several catheter tip transducer systems are currently in clinical use, including using strain gauges or fiber-optical pressure sensing techniques. In these devices zero drift and calibration cannot be checked in vivo.
   All the ICP monitoring devices in current clinical use require a physical connection between the brain and the external environment. This is a source of infection and limits the duration of monitoring. A number of telemetric monitoring devices, in which data is in some way transmitted transcutaneously, have been developed over the last twenty years, but significant technical problems have precluded their use in routine clinical practice.
   All current ICP monitors are temporary percutaneous implanted devices. Placement of these devices carries significant morbidity, particularly infection. Patients undergoing repeated monitoring require multiple surgical procedures.
   Apart from decreasing the risk of infection in patients with severe head injury, the clinical value of an accurate telemetric ICP monitoring system which maintains its reliability over a long period of implantation is high. Several neurosurgical conditions require close control of ICP over several years to ensure a satisfactory outcome, such as hydrocephalus treated by a VP shunt or endoscopic third ventriculostomy as well as idiopathic intracranial hypertension. Currently, in these situations, ICP is measured by tapping a ventricular access device or by lumbar puncture; these invasive procedures, often necessary in children, carry a risk of infection. Current ICP monitors show a significant zero drift of the sensor over time which excludes them from being used in long-term implants where recalibration of the sensor is not possible.
   An implantable telemetric device would overcome many of the problems currently associated with ICP monitoring. Telemetry would allow the ICP to be measured non-invasively at home; symptoms could then be easily evaluated and the necessary adjustments to a programmable shunt, when present, could be performed and confirmed.
   Utilizing micro- and nanotechnologies as well as advanced packaging technologies, we have developed a fully implantable ICP sensor for long-term use. The sensor implant comprises an absolute capacitive pressure sensor and readout integrated circuit with ultra low power consumption and hence does not require an implanted battery as a power supply, which would otherwise limit the implant's lifetime. The sensor transmits pressure data via inductive coupling to an external device transcutaneously while being powered from outside via radio frequency. The external reader device compensates the absolute pressure data by measuring and subtracting the barometric pressure and displays data representative of intracranial fluid pressure.
   The implant is encapsulated by several functional layers, ensuring a hermetical sealing while at the same time providing high flexibility. A final biomaterial nano-layer to reduce cell growth and impairment of the mechanical functionality of the sensor is in development The use of capacitive sensors and the encapsulation scheme guarantees a drift-free performance over time.
   The implant is designed in a manner so that it can be inserted according to the proven minimally invasive procedures known from current ICP monitors. The measurement tip can be placed either in the ventricle or brain parenchyma while the telemetry unit is located outside the cranial bone directly under the skin for optimal linking to the external unit. Pressure readings can be taken continuously at any time either at home or in hospital. The external read-out device communicates to the clinical periphery or home base station via radio-frequency link. Our device prototypes have successfully passed extensive laboratory tests and are currently tested in vivo in animal trials.
C1 [Frischholz, M.; Sarmento, L.; Wenzel, M.] Campus Micro Technol GmbH, Univ Allee 29, D-28359 Bremen, Germany.
   [Aquilina, K.; Edwards, R.; Coakham, H. B.] Frenchay Hosp, Dept Neurosurg, Bristol BS16 1LE, Avon, England.
RP Frischholz, M (reprint author), Campus Micro Technol GmbH, Univ Allee 29, D-28359 Bremen, Germany.
EM manfred.frischholz@campus-micro-technologies.de
FU European Commission [IST-2002-1-001837]
FX The authors acknowledge financial support from the European Commission
   in the 6th Framework Programme as part of the HEALTHY AIMS Integrated
   Project (Contract No. IST-2002-1-001837).
CR MERCANZINI A, 2007, P 20 IEEE INT C MICR
   Szmigiel D, 2006, MICROELECTRON ENG, V83, P1178, DOI 10.1016/j.mee.2006.01.070
   VANDENBULCKE M, 2006, P 28 IEEE ANN INT C, P2811
NR 3
TC 13
Z9 13
U1 1
U2 15
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 978-1-4244-0787-3
J9 P ANN INT IEEE EMBS
PY 2007
BP 514
EP +
DI 10.1109/IEMBS.2007.4352337
PG 2
WC Engineering, Biomedical; Imaging Science & Photographic Technology;
   Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Imaging Science & Photographic Technology; Radiology,
   Nuclear Medicine & Medical Imaging
GA BHI92
UT WOS:000253467000130
PM 18002003
DA 2018-10-19
ER

PT S
AU Forget, G
   Latxague, L
   Heroguez, V
   Labruegre, C
   Durrieu, MC
AF Forget, G.
   Latxague, L.
   Heroguez, V.
   Labruegre, C.
   Durrieu, M. C.
GP IEEE
TI RGD nanodomains grafting onto titanium surface
SO 2007 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE
   AND BIOLOGY SOCIETY, VOLS 1-16
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 29th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY AUG 22-26, 2007
CL Lyon, FRANCE
SP IEEE Engn Med & Biol Soc
ID CELL-ADHESION; POLYMERS
AB Titanium alloys exhibit excellent biocompatibility and corrosion resistance in the body fluid and possess mechanical properties similar of the bones' properties. When the loss of osseous is important in osseous surgery, large biomaterials are implanted and should be accepted by the organism. For increasing the biomaterials biocompatibility, biological compounds can be linked or deposited on the material surface making them biologically active.
   In order to study the tissue-implant interaction and to favor osteoblast-adhesion onto titanium, our work deals with the grafting of cell-binding peptides containing the Arginine-Glycine-Aspartic acid (RGD) sequence.
   In the present study, we focus on the elaboration of patterned biomaterial surfaces with highly functionalized nanodomains. The strategy of RGD peptide immobilization involves first the grafting if an amino-functional organosilane (APTES). Then, each of the free amino moieties were used as an initiator core for a dendrimer-like synthesis to multiply the number of free groups available for RGD immobilization on the material surface.
C1 [Forget, G.; Latxague, L.; Durrieu, M. C.] Univ Bordeaux 1, INSERM, U577 Lab, Bordeaux, France.
RP Forget, G (reprint author), Univ Bordeaux 1, INSERM, U577 Lab, Bordeaux, France.
EM guillaume.forget@bordeaux.inserm.fr
RI DURRIEU, Marie-Christine/I-4358-2016
OI DURRIEU, Marie-Christine/0000-0003-0583-9289; Latxague,
   Laurent/0000-0002-6115-7437
CR Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   OHKURA Y, 1979, ANAL CHIM ACTA, V106, P89, DOI 10.1016/S0003-2670(01)83708-9
   PLUDMAN EP, 1991, SILANE COUPLING AGEN
   PORTEDURRIEU MC, 2004, J MATER SCI, V15, P779
   Quemener D, 2005, POLYMER, V46, P1067, DOI 10.1016/j.polymer.2004.11.096
   TOMALIA DA, 1985, POLYM J, V17, P117, DOI 10.1295/polymj.17.117
   WHITMORE PM, 1982, J CHEM PHYS, V77, P1560, DOI 10.1063/1.443938
NR 9
TC 1
Z9 2
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 978-1-4244-0787-3
J9 P ANN INT IEEE EMBS
PY 2007
BP 5107
EP 5110
DI 10.1109/IEMBS.2007.4353489
PG 4
WC Engineering, Biomedical; Imaging Science & Photographic Technology;
   Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Imaging Science & Photographic Technology; Radiology,
   Nuclear Medicine & Medical Imaging
GA BHI92
UT WOS:000253467004011
PM 18003155
DA 2018-10-19
ER

PT S
AU Fassina, L
   Saino, E
   Visai, L
   de Angelis, MGC
   Benazzo, F
   Magenes, G
AF Fassina, Lorenzo
   Saino, Enrica
   Visai, Livia
   de Angelis, Maria G. Cusella
   Benazzo, Francesco
   Magenes, Giovanni
GP IEEE
TI Enhanced in vitro culture of human SAOS-2 osteoblasts on a sand-blasted
   titanium surface modified with plastic deformation
SO 2007 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE
   AND BIOLOGY SOCIETY, VOLS 1-16
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 29th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY AUG 22-26, 2007
CL Lyon, FRANCE
SP IEEE Engn Med & Biol Soc
ID POLYURETHANE POROUS SCAFFOLD; CALCIFIED MATRIX PRODUCTION; ACID-ETCHED
   SURFACE; BONE-FORMATION; FIBER MESH; SMALL PROTEOGLYCAN; MINIATURE PIGS;
   CELLS; IMPLANTS; COLLAGEN
AB The titanium surfaces with micro-roughness have been studied to substitute machined titanium, with the focus on enhancing the bone apposition onto the implant. In this study we have followed a biomimetic strategy where human SAOS-2 osteoblasts proliferated and built their extracellutar matrix on a sandblasted titanium surface modified with plastic deformation. In comparison with sandblasted titanium surface, the plastic deformation increased the cell proliferation and the surface coating with bone matrix. The superficially modified biomaterial could be used, in clinical applications, as an implant for bone repair.
C1 [Fassina, Lorenzo; Magenes, Giovanni] Univ Pavia, Dipartimento Informat & Sistemist, CIT, Via Ferrata 1, I-27100 Pavia, Italy.
   [Saino, Enrica; Visai, Livia] Univ Pavia, Dipartimento Biochim, CIT, I-27100 Pavia, Italy.
   [de Angelis, Maria G. Cusella] Univ Pavia, Dipartimento Med Sperimentale, CIT, I-27100 Pavia, Italy.
   [Benazzo, Francesco] Univ Pavia, IRCCS San Matteo, Dipartimento SMEC, CIT, I-27100 Pavia, Italy.
RP Fassina, L (reprint author), Univ Pavia, Dipartimento Informat & Sistemist, CIT, Via Ferrata 1, I-27100 Pavia, Italy.
EM lorenzo.fassina@unipv.it; enrica.saino@unipv.it; livia.visai@unipv.it;
   cusella@unipv.it; francesco.benazzo@unipv.it; giovanni.magenes@unipv.it
RI Fassina, Lorenzo/K-9283-2015; Magenes, Giovanni/C-4202-2012
OI Fassina, Lorenzo/0000-0002-5587-4632; Magenes,
   Giovanni/0000-0002-7558-1490
FU Fondazione Cariplo; PRIN from Italian Ministry MUR; FIRB from Italian
   Ministry MUR [RBIP06FH7J]
FX Manuscript received April 15, 2007. This work was supported by
   Fondazione Cariplo Grant (2004) to F. B., by PRIN Grant (2004) from
   Italian Ministry MUR to L. V., and by FIRB Grant (CINECA no. RBIP06FH7J)
   from Italian Ministry MUR.
CR BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616
   Buser D, 1999, J BIOMED MATER RES, V45, P75, DOI 10.1002/(SICI)1097-4636(199905)45:2<75::AID-JBM1>3.0.CO;2-P
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   BUTLER WT, 1995, ANN NY ACAD SCI, V760, P6, DOI 10.1111/j.1749-6632.1995.tb44615.x
   BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Cochran DL, 1998, J BIOMED MATER RES, V40, P1, DOI 10.1002/(SICI)1097-4636(199804)40:1<1::AID-JBM1>3.0.CO;2-Q
   Fassina L, 2007, Technol Health Care, V15, P33
   Fassina L, 2005, TISSUE ENG, V11, P685, DOI 10.1089/ten.2005.11.685
   Fassina L, 2006, TISSUE ENG, V12, P1985, DOI 10.1089/ten.2006.12.1985
   Ferguson SJ, 2006, J BIOMED MATER RES A, V78A, P291, DOI 10.1002/jbm.a.30678
   FISHER LW, 1989, J BIOL CHEM, V264, P4571
   Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61
   FITZSIMMONS RJ, 1994, CALCIFIED TISSUE INT, V55, P376, DOI 10.1007/BF00299318
   GERICKE A, 2005, CALCIF TISSUE INT
   KASUGAI S, 1992, J CELL PHYSIOL, V152, P467, DOI 10.1002/jcp.1041520305
   Li DH, 2002, J BIOMED MATER RES, V60, P325, DOI 10.1002/jbm.10063
   Li JKJ, 2006, ULTRASOUND MED BIOL, V32, P769, DOI 10.1016/j.ultrasmedbio.2006.01.017
   Luan YJ, 2000, COMP BIOCHEM PHYS A, V126, P213, DOI 10.1016/S1095-6433(00)00200-2
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rossi A, 1996, BIOCHEMISTRY-US, V35, P6048, DOI 10.1021/bi9518151
   Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339
   Sini P, 1997, GLYCOCONJUGATE J, V14, P871, DOI 10.1023/A:1018550307649
   van den Dolder J, 2003, TISSUE ENG, V9, P505, DOI 10.1089/107632703322066688
   Vehof JWM, 2003, J BIOMED MATER RES A, V64A, P417, DOI 10.1002/jbm.a.10288
   Vehof JWM, 2002, CLIN ORAL IMPLAN RES, V13, P94, DOI 10.1034/j.1600-0501.2002.130112.x
   VOGEL KG, 1984, BIOCHEM J, V223, P587, DOI 10.1042/bj2230587
   VOGEL KG, 1987, J BIOL CHEM, V262, P13607
NR 30
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 978-1-4244-0787-3
J9 P ANN INT IEEE EMBS
PY 2007
BP 6411
EP +
PG 2
WC Engineering, Biomedical; Imaging Science & Photographic Technology;
   Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Imaging Science & Photographic Technology; Radiology,
   Nuclear Medicine & Medical Imaging
GA BHI92
UT WOS:000253467005131
PM 18003489
DA 2018-10-19
ER

PT S
AU Fassina, L
   Saino, E
   Visai, L
   Magenes, G
AF Fassina, Lorenzo
   Saino, Enrica
   Visai, Livia
   Magenes, Giovanni
GP IEEE
TI Physically enhanced coating of a titanium plasma-spray surface with
   human SAOS-2 osteoblasts and extracellular matrix
SO 2007 ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE
   AND BIOLOGY SOCIETY, VOLS 1-16
SE PROCEEDINGS OF ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING
   IN MEDICINE AND BIOLOGY SOCIETY
LA English
DT Proceedings Paper
CT 29th Annual International Conference of the
   IEEE-Engineering-in-Medicine-and-Biology-Society
CY AUG 22-26, 2007
CL Lyon, FRANCE
SP IEEE Engn Med & Biol Soc
ID FIBER MESH; BONE-FORMATION; CELLS; ULTRASOUND; IMPLANTS; GROWTH
AB Several studies suggest that the modification of a titanium surface could play an important role in bone tissue engineering. In this study we have followed a biomimetic strategy where ultrasonically or electromagnetically stimulated human SAOS-2 osteoblasts proliferated and built their extracellular matrix on a titanium plasma-spray surface. In comparison with control conditions, the ultrasonic stimulus (power, 149 mW; frequency, 1.5 MHz) and the electromagnetic stimulus (magnetic field, 2 mT; frequency, 75 Hz) increased the cell proliferation and the surface coating with type-I collagen. The physical stimuli aimed at obtaining a better modification of the rough titanium plasma-spray surface in terms of cell colonization and coating with bone matrix. The superficially modified biomaterial could be used, in clinical applications, as an implant for bone repair.
C1 [Fassina, Lorenzo; Magenes, Giovanni] Univ Pavia, Dipartimento Informat & Sistemist, CIT, Via Ferrata 1, I-27100 Pavia, Italy.
   [Saino, Enrica; Visai, Livia] Univ Pavia, Dipartimento Biochim, CIT, I-27100 Pavia, Italy.
RP Fassina, L (reprint author), Univ Pavia, Dipartimento Informat & Sistemist, CIT, Via Ferrata 1, I-27100 Pavia, Italy.
EM lorenzo.fassina@unipv.it; enrica.saino@unipv.it; livia.visai@unipv.it;
   giovanni.magenes@unipv.it
RI Magenes, Giovanni/C-4202-2012; Fassina, Lorenzo/K-9283-2015
OI Magenes, Giovanni/0000-0002-7558-1490; Fassina,
   Lorenzo/0000-0002-5587-4632
FU Fondazione Cariplo; PRIN from Italian Ministry MUR; FIRB from Italian
   Ministry MUR [RBIP06FH7J]
FX This work was supported by Fondazione Cariplo Grant (2004) to F. B., by
   PRIN Grant (2004) from Italian Ministry MUR to L. V., and by FIRB Grant
   (CINECA no. RBIP06FH7J) from Italian Ministry MUR.
CR BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Fassina L, 2007, Technol Health Care, V15, P33
   Fassina L, 2006, TISSUE ENG, V12, P1985, DOI 10.1089/ten.2006.12.1985
   HECKMAN JD, 1994, J BONE JOINT SURG AM, V76A, P26, DOI 10.2106/00004623-199401000-00004
   Li JKJ, 2006, ULTRASOUND MED BIOL, V32, P769, DOI 10.1016/j.ultrasmedbio.2006.01.017
   Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rossi A, 1996, BIOCHEMISTRY-US, V35, P6048, DOI 10.1021/bi9518151
   Sanchez C, 2005, NAT MATER, V4, P277, DOI 10.1038/nmat1339
   van den Dolder J, 2003, TISSUE ENG, V9, P505, DOI 10.1089/107632703322066688
   van den Dolder J, 2003, BIOMATERIALS, V24, P1745, DOI 10.1016/S0142-9612(02)00537-9
   Vehof JWM, 2003, J BIOMED MATER RES A, V64A, P417, DOI 10.1002/jbm.a.10288
   Vehof JWM, 2002, CLIN ORAL IMPLAN RES, V13, P94, DOI 10.1034/j.1600-0501.2002.130112.x
NR 14
TC 4
Z9 4
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1094-687X
BN 978-1-4244-0787-3
J9 P ANN INT IEEE EMBS
PY 2007
BP 6415
EP +
PG 2
WC Engineering, Biomedical; Imaging Science & Photographic Technology;
   Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Imaging Science & Photographic Technology; Radiology,
   Nuclear Medicine & Medical Imaging
GA BHI92
UT WOS:000253467005132
PM 18003490
DA 2018-10-19
ER

PT S
AU Liu, Y
   Ghosh, K
   Sokolov, J
   Rafailovich, M
AF Liu, Ying
   Ghosh, Kaustabh
   Sokolov, Jon
   Rafailovich, Miriam
GP IEEE
TI The effects of the fiber alignment on the behavior of rat osteosarcoma
   and mouse osteoblast cells
SO 2007 IEEE 33RD ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT IEEE 33rd Annual Northeast Bioengineering Conference
CY MAR 10-11, 2007
CL Long Isl, NY
SP IEEE, EMB, AIChE
AB Electrospinning is a promising method to construct biomaterial scaffolds for tissue engineering applications, but the efficacy depends on how the substrate topography affects cell function! In order to test whether the response of normal and cancerous cells differs, we tested the response of mouse osteoblasts (MC3T3-E1) and rat osteosarcoma (ROS). Poly (methyl methacrylate) fibers were electrospun into rectangular meshes with fiber diameters of 8.64 mu on a rigid support. Examination of cell morphology revealed that both types of cells can adhere to the scaffolds. In both cases the cells on the fibers were far more oriented than those on the planar surface. The aspect ration of the MC3T3 cells though was significantly larger than that of the ROS cells, indicating that cancer cells may not be able to adapt to the underlying morphology as easily as normal cells.
C1 [Liu, Ying; Sokolov, Jon; Rafailovich, Miriam] SUNY Stony Brook, Dept Mat Sci & Engn, Stony Brook, NY 11790 USA.
   [Ghosh, Kaustabh] SUNY Stony Brook, Dept Biomed Engn, Stony Brook, NY 11794 USA.
RP Liu, Y (reprint author), SUNY Stony Brook, Dept Mat Sci & Engn, Stony Brook, NY 11790 USA.
FU NSF-MRSEC
FX This study was supported by the (NSF-MRSEC).
CR Baker SC, 2006, BIOMATERIALS, V27, P3136, DOI 10.1016/j.biomaterials.2006.01.026
   BASAMI AS, 2006, BIOMATERIALS, V27, P596
   Sundaray B, 2004, APPL PHYS LETT, V84, P1222, DOI 10.1063/1.1647685
NR 3
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4244-1032-3
J9 NORTHEAST BIOENGIN C
PY 2007
BP 213
EP +
DI 10.1109/ISITAE.2007.4409273
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic; Materials
   Science, Biomaterials; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Materials Science; Radiology, Nuclear Medicine & Medical
   Imaging
GA BHP13
UT WOS:000255100600105
DA 2018-10-19
ER

PT S
AU Pan, H
   Jiang, H
   Chen, W
AF Pan, Hui
   Jiang, Hongliang
   Chen, Weiliam
GP IEEE
TI A fibroblast/macrophage co-culture model for in vitro evaluation of
   material biocompatibility and biodegradability
SO 2007 IEEE 33RD ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT IEEE 33rd Annual Northeast Bioengineering Conference
CY MAR 10-11, 2007
CL Long Isl, NY
SP IEEE, EMB, AIChE
ID SCAFFOLDS; DEXTRAN
AB Fibroblast and macrophage are two major cell types respond cooperatively to implanted biomaterials. They play crucial roles in material degradation, inflammatory response and tissue remodeling(1). However, the interactions of these two cell types with biomaterials have not been fully elucidated. In this study, an in vitro fibroblast/macrophage co-culture system was explored to investigate the biodegradability and biocompatibility of an electrospun PLGA/Dextran scaffold(2-3) as a model biomaterial. Both cell types were capable of degrading the scaffold individually or cooperatively. Lysozyme and nonspecific esterase were involved in scaffold degradation. The scaffold activated macrophages but did not induce server and chronic inflammatory response.
C1 [Pan, Hui; Chen, Weiliam] SUNY Stony Brook, Stony Brook, NY 11794 USA.
   [Jiang, Hongliang] Zhejiang Univ, Hangzhou, Zhejiang, Peoples R China.
RP Pan, H (reprint author), SUNY Stony Brook, Stony Brook, NY 11794 USA.
FU NIH [DK068401]
FX This study was supported by the NIH (DK068401, WC). We would also thank
   Dr. James Quinn on the SEM study, and Dr. Michael Hadjiargyrou and Dr.
   Howard Fleit for their insights.
CR Balakrishnan B, 2005, BIOMATERIALS, V26, P3941, DOI 10.1016/j.biomaterials.2004.10.005
   Hornebeck W, 2003, PATHOL BIOL, V51, P569, DOI 10.1016/j.patbio.2003.09.003
   Jiang HL, 2004, BIOMACROMOLECULES, V5, P326, DOI 10.1021/bm034345w
   Pan H, 2006, BIOMATERIALS, V27, P3209, DOI 10.1016/j.biomaterials.2006.01.032
   Ratner BD, 2004, BIOMATERIALS SCI INT
NR 5
TC 1
Z9 1
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4244-1032-3
J9 NORTHEAST BIOENGIN C
PY 2007
BP 215
EP +
DI 10.1109/NEBC.2007.4413355
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic; Materials
   Science, Biomaterials; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Materials Science; Radiology, Nuclear Medicine & Medical
   Imaging
GA BHP13
UT WOS:000255100600106
DA 2018-10-19
ER

PT S
AU Ranjan, A
   Webster, TJ
AF Ranjan, Ashwini
   Webster, Thomas J.
GP IEEE
TI Nanotechnology-derived hydrogels for cardiac tissue replacement
SO 2007 IEEE 33RD ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT IEEE 33rd Annual Northeast Bioengineering Conference
CY MAR 10-11, 2007
CL Long Isl, NY
SP IEEE, EMB, AIChE
AB The national organ transplant waiting list is growing five times faster than the rate of organ donation, indicating a need to provide a more plentiful source of tissue replacements. Furthermore, the national number one cause for human death is heart disease. Because of the high percentage of heart failure and a low number of successful organ donations, studies are now focusing on the design of new generation biomaterials and functional tissue constructs for specialized tissue repair and replacement. Developing such biomaterials requires the fabrication of scaffolds that mimic in vivo extracellular matrices (ECM). The objective of this study was to design a 'smart' biomaterial that mimics conditions in vivo, creating a micro- and nano-environment suitable for healthy cardiac tissue growth and function.
C1 [Ranjan, Ashwini; Webster, Thomas J.] Brown Univ, Div Engn, Providence, RI 02912 USA.
RP Ranjan, A (reprint author), Brown Univ, Div Engn, Providence, RI 02912 USA.
CR Cadotte AJ, 2005, J NEURAL ENG, V2, P114, DOI 10.1088/1741-2560/2/4/007
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   DEUTSCH J, 1999, ASAIO C P JUN
   He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99
   Miller DC, 2005, J BIOMED MATER RES A, V73A, P476, DOI 10.1002/jbm.a.30318
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   ZHAO Y, 2005, 9 INT C MIN SYST CHE
NR 7
TC 0
Z9 0
U1 0
U2 3
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4244-1032-3
J9 NORTHEAST BIOENGIN C
PY 2007
BP 230
EP 231
DI 10.1109/NEBC.2007.4413362
PG 2
WC Engineering, Biomedical; Engineering, Electrical & Electronic; Materials
   Science, Biomaterials; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Materials Science; Radiology, Nuclear Medicine & Medical
   Imaging
GA BHP13
UT WOS:000255100600113
DA 2018-10-19
ER

PT S
AU Sirivisoot, S
   Yao, C
   Xiao, XC
   Sheldon, BW
   Webster, TJ
AF Sirivisoot, Sirinrath
   Yao, Chang
   Xiao, Xingcheng
   Sheldon, Brian W.
   Webster, Thomas J.
GP IEEE
TI Carbon nanotubes-titanium electrode for detecting calcium deposition by
   osteoblasts
SO 2007 IEEE 33RD ANNUAL NORTHEAST BIOENGINEERING CONFERENCE
SE Annual IEEE Northeast Bioengineering Conference
LA English
DT Proceedings Paper
CT IEEE 33rd Annual Northeast Bioengineering Conference
CY MAR 10-11, 2007
CL Long Isl, NY
SP IEEE, EMB, AIChE
AB The objective of this in vitro present study was to develop an electrode which can detect calcium deposition by osteoblasts. The primary biomaterial for this electrode is anodized Ti, developed by chemical etching and passivation treatments. Carbon nanotubes (CNTs), because of their enhancement in electron transfer reaction [1], are essential to consider when designing the electrodes. For this, parallel multiwall CNTs were grown from the pores of the anodized Ti by a chemical vapor deposition process. Preliminary in vitro results suggest that osteoblast functions (specifically alkaline phosphatase activity and calcium deposition) on CNTs grown on anodized Ti are significantly enhanced when compared to anodized Ti and currently-used Ti; thus, it is anticipated that bone growth could be enhanced on these biomaterial electrodes.
C1 [Sirivisoot, Sirinrath; Yao, Chang; Xiao, Xingcheng; Sheldon, Brian W.; Webster, Thomas J.] Brown Univ, Div Engn, Providence, RI 02912 USA.
RP Sirivisoot, S (reprint author), Brown Univ, Div Engn, Providence, RI 02912 USA.
CR Padigi SK, 2007, BIOSENS BIOELECTRON, V22, P829, DOI 10.1016/j.bios.2006.02.023
   Roy S, 2006, NANOTECHNOLOGY, V17, pS14, DOI 10.1088/0957-4484/17/4/003
   Tang H, 2004, CARBON, V42, P191, DOI [10.1016/j.carbon.2003.10.023, 10.1016/j.carbon.2003.09.023]
   Yao C, 2005, J BIOMED NANOTECHNOL, V1, P68, DOI 10.1166/jbn.2005.008
   Zanello LP, 2006, NANO LETT, V6, P562, DOI 10.1021/nl051861e
NR 5
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 0277-1063
BN 978-1-4244-1032-3
J9 NORTHEAST BIOENGIN C
PY 2007
BP 238
EP 240
DI 10.1109/NEBC.2007.4413366
PG 3
WC Engineering, Biomedical; Engineering, Electrical & Electronic; Materials
   Science, Biomaterials; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Materials Science; Radiology, Nuclear Medicine & Medical
   Imaging
GA BHP13
UT WOS:000255100600117
DA 2018-10-19
ER

PT S
AU Xue, JX
   Gao, J
   Tang, LP
AF Xue, Jiaxing
   Gao, Jean
   Tang, Liping
BE Hu, X
   Mandoiu, I
   Obradovic, Z
   Xia, J
TI Mathematical modeling of phagocyte chemotaxis toward and adherence to
   biomaterial implants
SO 2007 IEEE INTERNATIONAL CONFERENCE ON BIOINFORMATICS AND BIOMEDICINE,
   PROCEEDINGS
SE IEEE International Conference on Bioinformatics and Biomedicine-BIBM
LA English
DT Proceedings Paper
CT IEEE International Conference on Bioinformatics and Biomedicine
CY NOV 02-04, 2007
CL Fremont, CA
SP IEEE Comp Soc Local Chapter, Addison Wesley, AT&T Res, Bell Labs, Brio, Course Technol, Crystal Decis, Dell, Elsevier, Google, HP Res, Hyperion, IBM Silicon Valley, IBM, Intel Corp, Microsoft, NASA, Nokia, Oak Ridge Natl Labs, Oracle, Pfizer, Sony, Verizon, Yahoo
ID ACTIVATION; SYSTEMS; ALPHA
AB Medical implanted devices usually prompt foreign body reactions that lead to the formation of fibrotic capsule surrounding the implanted devices. Cascade phagocyte responses, such as phagocyte chemotaxis and phagocyte adherence, are believed important in pathogenesis of fibrotic responses. Therefore, in-depth understanding of phagocyte chemotaxis and adherence processes is important to successfully reduce the fibrotic responses to improve the stability and functionality of implanted medical devices. This paper hypothesizes the molecular mechanisms governing phagocyte chemotaxis and adherence. To support our hypotheses and to provide the prediction of un-measured dynamic features in phagocyte chemotaxis and adherence processes, mathematical models based on system and control theory are built. To maximize the prediction ability and to guide future experimental design, external controls are provided by the mathematical model. The effectiveness of the mathematical model is demonstrated by computer simulation.
C1 [Xue, Jiaxing; Gao, Jean] Univ Texas Arlington, Dept Comp Sci, Arlington, TX 76019 USA.
   [Tang, Liping] Univ Texas Arlington, Dept Bioengn, Arlington, TX 76019 USA.
RP Xue, JX (reprint author), Univ Texas Arlington, Dept Comp Sci, Arlington, TX 76019 USA.
EM joshjx@yahoo.com; gao@uta.edu; ltang@uta.edu
CR ACERENZA L, 1989, J THEOR BIOL, V137, P423, DOI 10.1016/S0022-5193(89)80038-4
   Bailey JE, 1998, BIOTECHNOL PROGR, V14, P8, DOI 10.1021/bp9701269
   Carro LP, 1999, ARTHROSCOPY, V15, P103, DOI 10.1053/ar.1999.v15.015010
   Cutroneo KR, 2006, J CELL BIOCHEM, V97, P1161, DOI 10.1002/jcb.20750
   FINKELSTEIN L, 1979, MATH MODELING DYNAMI
   Garcia-Ramallo E, 2002, J IMMUNOL, V169, P6467, DOI 10.4049/jimmunol.169.11.6467
   Hannon B, 1997, MODELING DYNAMIC BIO
   HIGGINS J, 1964, DYNAMICS CONTROL CEL
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492
   Lebiedz D., 2004, IEE Systems Biology, V1, P222, DOI 10.1049/sb:20045022
   Nichols M F, 1979, Biomed Sci Instrum, V15, P1
   ROXIN EO, 1979, CONTROL THEORY APPL
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   WEINER N, 1948, CYBERNETICS CONTROL
   WITTHAUT R, 1994, J LEUKOCYTE BIOL, V55, P105
   Wolkenhauer O, 2004, IEEE T NANOBIOSCI, V3, P200, DOI 10.1109/TNB.2004.833694
   XUE JX, 2007, IN PRESS BIBE
   Yan SR, 2004, IMMUNOL CELL BIOL, V82, P435, DOI 10.1111/j.1440-1711.2004.01268.x
NR 19
TC 2
Z9 2
U1 0
U2 0
PU IEEE COMPUTER SOC
PI LOS ALAMITOS
PA 10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1264 USA
SN 2156-1125
EI 2156-1133
BN 978-0-7695-3031-4
J9 IEEE INT C BIOINFORM
PY 2007
BP 302
EP +
DI 10.1109/BIBM.2007.38
PG 2
WC Computer Science, Information Systems; Computer Science,
   Interdisciplinary Applications; Computer Science, Theory & Methods;
   Engineering, Electrical & Electronic
SC Computer Science; Engineering
GA BHD92
UT WOS:000252387400041
DA 2018-10-19
ER

PT B
AU Wang, BQ
   Li, YD
   Deng, CJ
   Wu, MF
AF Wang, Baoqiang
   Li, Yiding
   Deng, Changjian
   Wu, Maofang
BE Ming, A
   Guo, S
   Liu, S
TI Researches on nonlinearity of acoustic parameters in biomaterial
   extraction with ultrasound
SO 2007 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION, VOLS
   I-V, CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT IEEE International Conference on Mechatronics and Automation
CY AUG 05-08, 2007
CL Harbin, PEOPLES R CHINA
SP IEEE Robot & Automat Soc, Harbin Engn Univ, Kagawa Univ, Natl Nat Sci Fdn China, Minist Educ China, Chinese Assoc Automat, Chinese Assoc Artificial Intelligence, Robot Soc Japan, Japan Soc Mech Engineers, Japan Soc Precis Engn, Univ Electro Commun, Univ Elect Sci & Technol China, Changchun Univ Sci & Technol, Beijing Univ Technol, IEEE, Hong Kong Sect, Joint RACS Chapter
DE ultrasonics; nonlinearity; biomaterial processing; acoustic parameter
   detection
ID CAVITATION; SENSOR; PROPAGATION
AB Sonication is one of effective and economical techniques for biomaterial processing in a lot of fields. Chinese traditional medicine extraction assisted with power ultrasound is one of the innovative techniques nowadays in point of fact. An important need is that the ultrasonic intensity must be strong and symmetrical in all over the acoustic field within the large-scale ultrasonic kettles for engineering practice. However the nonlinearity of the acoustic characteristics makes the distribution of ultrasonic energy in the ultrasonic processor asymmetrical-in 4 dimensions D (x, y, z, t). So, the nonlinearity of the spatial and temporal vicissitude of acoustic characters in the bulky ultrasonic kettle must be realized and dealt with seriously. In the paper, the topics involve: (1) To analyse some description methods of nonlinearity; (2) To research on some nonlinear rules about the acoustic parameters of ultrasonic propagation in the mixture of biomaterials and mediums; (3) To make experiments on nonlinearity of acoustic cavitation and sonication yield in fluids. There are 3 aspects introduced in the paper: (1) Besides the rules of wave propagation, some nonlinear relations of momentum for the motion of fluids are discussed, and the second order acoustic nonlinearity parameter B/A of fluids is introduced too; (2) A new free from paraxial approximation and computationally efficient numerical algorithm capable of predicting 4D acoustic fields in lossy and nonlinear media from arbitrary shaped sources is described. (3) The nonlinearity of the spatial distribution of cavitation activity generated within an ultrasonic processing vessel is studied. Based on the researches above, an applied biomaterial extraction vessel has been set up for Chinese traditional medicine extraction manufacture. It was proved that the researches in the paper are rational, effective and useful for biomaterial extraction with ultrasound.
C1 [Wang, Baoqiang; Li, Yiding] Chengdu Univ Informat Technol, Inst Bio Mat Engn, Chengdu 610225, Sichuan, Peoples R China.
   [Deng, Changjian; Wu, Maofang] Chengdu Univ Informat Technol, Dept Control Engn, Chengdu 610225, Peoples R China.
RP Wang, BQ (reprint author), Chengdu Univ Informat Technol, Inst Bio Mat Engn, Chengdu 610225, Sichuan, Peoples R China.
EM bqwang@cuit.edu.cn; jywmfang@126.com
FU NSFC Research Project [30470420]; Sichuan Province Applied Base Research
   Subject
FX The work is supported by the NSFC Research Project (30470420) and
   Sichuan Province Applied Base Research Subject.
CR Bjorno L, 2002, ULTRASONICS, V40, P11, DOI 10.1016/S0041-624X(02)00084-7
   Bloomfield PE, 2005, ULTRASONICS, V43, P421, DOI 10.1016/j.ultras.2004.11.002
   Feng R, 2002, ULTRASON SONOCHEM, V9, P231, DOI 10.1016/S1350-4177(02)00083-4
   Hodnett M, 2004, ULTRASON SONOCHEM, V11, P441, DOI 10.1016/j.ultsonch.2003.09.002
   JCIK JW, 2003, EFFECTIVE ALGORITHM, P246
   Radulescu EG, 2004, ULTRASONICS, V42, P367, DOI 10.1016/j.ultras.2003.11.019
   Wang BQ, 2006, IEEE ICMA 2006: PROCEEDING OF THE 2006 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION, VOLS 1-3, PROCEEDINGS, P463
   WANG BQ, 2003, J CHENGDU U INFORM T, V18, P25
   WANG BQ, 2005, IEEE P ICIMA, P763
   Wang J, 2004, ADV ATMOS SCI, V21, P662, DOI 10.1007/BF02915733
   WO J, ANN J, P1642
   Wojcik J, 2006, ULTRASONICS, V44, P310, DOI [10.1016/j.ultras.2006.04.001, 10.1016/j.ultras.2006.01.001]
   WOJCIK J, 2002, ULTRASONICS, V40, P11
   Yang XM, 2005, J ACOUST SOC AM, V117, P113, DOI 10.1121/1.1828671
   Zemp RJ, 2003, J ACOUST SOC AM, V113, P139, DOI 10.1121/1.1528926
   Zeqiri B, 2003, IEEE T ULTRASON FERR, V50, P1342, DOI 10.1109/TUFFC.2003.1244751
   Zeqiri B, 2003, IEEE T ULTRASON FERR, V50, P1351, DOI 10.1109/TUFFC.2003.1244752
NR 17
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-0827-6
PY 2007
BP 2258
EP +
DI 10.1109/ICMA.2007.4303904
PG 2
WC Automation & Control Systems; Engineering, Electrical & Electronic;
   Robotics
SC Automation & Control Systems; Engineering; Robotics
GA BGX87
UT WOS:000251178102118
DA 2018-10-19
ER

PT S
AU Martynenko, AI
   Yang, SX
AF Martynenko, Alex I.
   Yang, Simon X.
GP IEEE
TI An intelligent control system for thermal processing of biomaterials
SO 2007 IEEE INTERNATIONAL CONFERENCE ON NETWORKING, SENSING, AND CONTROL,
   VOLS 1 AND 2
SE IEEE International Conference on Networking, Sensing and Control
LA English
DT Proceedings Paper
CT IEEE International Conference on Networking, Sensing and Control
CY APR 15-17, 2007
CL London, ENGLAND
SP IEEE Syst Man & Cybernet Soc
ID MACHINE VISION; NEURAL-NETWORKS; TEXTURE MODELS; GRAIN DRYERS; QUALITY;
   CLASSIFICATION; COLOR; PREDICTION; MORPHOLOGY; POTATOES
AB An intelligent control system for thermal processing of natural biomaterials, based on machine vision, sensor fusion and neural network was developed. Experiments with ginseng drying showed advantages of machine vision for real-time imaging of morphological, colour and texture attributes, providing sufficient discriminatory information about biomaterial moisture and quality in the range of 3.2-0.1 g/g and temperatures from 30 to 50 degrees C. Both moisture and quality was estimated by using neural network models: moisture with 6-8% error and quality. with 10-16% error. Online estimates of moisture and quality were used for temperature control in pilot batch dryer. Testing of the intelligent control system with embedded machine-vision observer (IMAQ (TM) Vision Builder) and controller (Lab View 7.0) showed stability and robustness, combined with high accuracy of temperature control. Multi-stage optimization of temperature with respect to quality allowed decrease of drying time from 240 to 90-110 hours with appropriate final quality.
C1 [Martynenko, Alex I.; Yang, Simon X.] Univ Guelph, Sch Engn, Guelph, ON N1G 2W1, Canada.
RP Martynenko, AI (reprint author), Univ Guelph, Sch Engn, Guelph, ON N1G 2W1, Canada.
EM syang@uoguelph.ca
RI Yang, Simon X./A-4399-2008
OI Yang, Simon X./0000-0002-6888-7993
CR Chiang Alpha C., 1992, ELEMENTS DYNAMIC OPT
   Davidson VJ, 1999, J FOOD ENG, V41, P141, DOI 10.1016/S0260-8774(99)00081-3
   Davidson VJ, 2004, J FOOD ENG, V63, P361, DOI 10.1016/j.jfoodeng.2003.08.014
   Davies E., 2000, IMAGE PROCESSING FOO
   DOUGLAS PL, 1994, T I CHEME, V72, P341
   Du CJ, 2006, J FOOD ENG, V72, P39, DOI 10.1016/j.jfoodeng.2004.11.017
   Fernandez L, 2005, J FOOD ENG, V67, P185, DOI 10.1016/j.jfoodeng.2004.05.070
   Gunasekaran S., 2000, NONDESTRUCTIVE FOOD
   Harris C., 1993, INTELLIGENT CONTROL
   Hussain MA, 2002, J FOOD ENG, V51, P239, DOI 10.1016/S0260-8774(01)00063-2
   Kudra T., 1998, THERMAL PROCESSING B
   Kulkarni A. D., 2001, COMPUTER VISION FUZZ
   LI X, 2002, THESIS U GUELPH CANA
   LI YF, 1987, T ASAE, V30, P842
   Majumdar S, 2000, T ASAE, V43, P1669
   Majumdar S, 2000, T ASAE, V43, P1689
   Majumdar S, 2000, T ASAE, V43, P1677
   Majumdar S, 2000, T ASAE, V43, P1681
   Mao ZH, 1999, DRY TECHNOL, V17, P1767, DOI 10.1080/07373939908917651
   MARTYNENKO AI, UNPUB RISK QUALITY D
   MARTYNENKO AI, 2005, THESIS U GUELPH CANA
   Mittal G. S., 1996, COMPUTERIZED CONTROL
   MULET A, 1994, J FOOD ENG, V22, P329, DOI 10.1016/0260-8774(94)90038-8
   Oliveira F.A.R., 1999, PROCESSING FOODS QUA
   Olmos A, 2002, DRY TECHNOL, V20, P1319, DOI 10.1081/DRT-120005855
   Perrot N, 2000, J FOOD PROCESS ENG, V23, P249, DOI 10.1111/j.1745-4530.2000.tb00515.x
   Qiao J, 2007, J FOOD ENG, V79, P1065, DOI 10.1016/j.jfoodeng.2006.03.026
   TAO Y, 1995, T ASAE, V38, P1555
   Trelea IC, 1997, DRY TECHNOL, V15, P1095, DOI 10.1080/07373939708917280
   Trelea IC, 1997, J FOOD ENG, V31, P403, DOI 10.1016/S0260-8774(96)00096-9
   Vasconcelos LGS, 1998, DRY TECHNOL, V16, P2017, DOI 10.1080/07373939808917509
   Yang W, 2005, BIOSYST ENG, V91, P1, DOI 10.1016/j.biosystemseng.2005.02.002
   Zhang Q., 1993, J FOOD PROCESS ENG, V16, P59
   Zhang QH, 2002, BIOSYST ENG, V83, P281, DOI [10.1006/bioe.2002.0123, 10.1016/S1537-S110(02)00190-3]
   1998, GRADE QUALITY STANDA
NR 35
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1810-7869
BN 978-1-4244-1075-0
J9 IEEE INT C NETW SENS
PY 2007
BP 93
EP 98
DI 10.1109/ICNSC.2007.372939
PG 6
WC Automation & Control Systems; Computer Science, Theory & Methods;
   Engineering, Electrical & Electronic
SC Automation & Control Systems; Computer Science; Engineering
GA BHB32
UT WOS:000252065800017
DA 2018-10-19
ER

PT S
AU Nakamura, N
   Mukaiyama, T
   Kawakami, S
   Matsuyama, T
   Wada, K
   Matsunaka, T
   Kono, K
   Horinaka, H
AF Nakamura, N.
   Mukaiyama, T.
   Kawakami, S.
   Matsuyama, T.
   Wada, K.
   Matsunaka, T.
   Kono, K.
   Horinaka, H.
GP IEEE
TI Monitoring device of Au nano-particle distribution in living body using
   ultrasonic velocity change image
SO 2007 IEEE ULTRASONICS SYMPOSIUM PROCEEDINGS, VOLS 1-6
SE ULTRASONICS SYMPOSIUM
LA English
DT Proceedings Paper
CT IEEE Ultrasonics Symposium
CY OCT 28-31, 2007
CL New York, NY
SP IEEE
DE ultrasonic velocity change; Au nano-particles; drug delivery system
   (DDS); optical tomography
ID GOLD NANORODS; SENSITIVITY
AB We could obtain ultrasonic velocity change Images of Au nano-particles In the two phantoms which ware made of highly optical scattering ager and the chicken breast meet by using the remodeled diagnostic ultrasound equipment. All experimental results suggested that our Imaging method could be applied to a practical monitor for the thermal therapy and the drug delivery system (DDS), and could be applied to biomaterial identification.
C1 [Nakamura, N.; Mukaiyama, T.; Kawakami, S.; Matsuyama, T.; Wada, K.; Matsunaka, T.; Kono, K.; Horinaka, H.] Osaka Prefecture Univ, Dept Engn, Naka Ku, Osaka 5998531, Japan.
RP Nakamura, N (reprint author), Osaka Prefecture Univ, Dept Engn, Naka Ku, 1-1 Gakuen Cho, Osaka 5998531, Japan.
EM na-namura@pe.osakafu-u.ac.jp
CR Eghtedari M, 2007, NANO LETT, V7, P1914, DOI 10.1021/nl070557d
   HORINAKA H, 2006, P 2006 IEEE ULTR S V, P2060
   Kono K, 2002, J CONTROL RELEASE, V80, P321, DOI 10.1016/S0168-3659(02)00018-4
   Link S, 1999, J PHYS CHEM B, V103, P3073, DOI 10.1021/jp990183f
   Niidome T, 2006, J CONTROL RELEASE, V114, P343, DOI 10.1016/j.jconrel.2006.06.017
   Petrova H, 2006, PHYS CHEM CHEM PHYS, V8, P814, DOI 10.1039/b514644e
   THERESA MA, 2004, SCIENCE, V303, P1818
NR 7
TC 1
Z9 1
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
SN 1051-0117
BN 978-1-4244-1383-6
J9 ULTRASON
PY 2007
BP 2227
EP 2230
DI 10.1109/ULTSYM.2007.560
PG 4
WC Acoustics; Biophysics; Engineering, Electrical & Electronic; Physics,
   Applied; Imaging Science & Photographic Technology
SC Acoustics; Biophysics; Engineering; Physics; Imaging Science &
   Photographic Technology
GA BHM55
UT WOS:000254281802057
DA 2018-10-19
ER

PT B
AU Chen, ZG
   Mo, XM
AF Chen Zong-Gang
   Mo Xiu-Mei
GP Donghua University
TI Preparation and properties of electrospun collagen-chitosan nanofibers
SO 2007 INTERNATIONAL FORUM ON BIOMEDICAL TEXTILE MATERIALS, PROCEEDINGS
LA English
DT Proceedings Paper
CT International Forum on Biomedical Textile Materials
CY MAY 30-JUN 02, 2007
CL Donghua Univ, Songjiang Campus, Shanghai, PEOPLES R CHINA
SP Shanghai Soc Biomed Engn, Key Lab Textile Sci & Technol, Minist Educ, Engn Res Ctr Tech Textiles, Minist Educ, Donghua Univ, Coll Textiles, Donghua Univ, Inst Biol Sci & Biotechnol, State Key Lab Modificat Chem Fiber & Polymer Mat
HO Donghua Univ, Songjiang Campus
DE collagen; chitosan; electronspinning; FTIR; XRD
ID BENDING INSTABILITY; SCAFFOLDS; POLYMER; MATRICES; GELATIN
AB The collagen-chitosan nanofibers have been prepared by electrospinning from a mixed HFP/TFA(the volume ratio of 90/10) solution. The intermolecular interactions in collagen-chitosan nanofibers were characterized by Fourier transform infrared spectroscopy (FTIR). XRD patterns show that the collagen-chitosan nanofibers have become amorphous phases after electrospinning. Mechanical characterization indicates that the ratio of collagen to chitosan will affect the mechanical properties of electrospun collagen-chitosan fibers. Both the ultimate tensile elongation and the ultimate tensile strength of fibrous. membrane decrease with the increase of chitosan content. All these would be useful to a biomaterial design by electrospinning method.
C1 [Chen Zong-Gang; Mo Xiu-Mei] Donghua Univ, Inst Biol Sci Biotechnol, Shanghai 201620, Peoples R China.
RP Mo, XM (reprint author), Donghua Univ, Inst Biol Sci Biotechnol, Shanghai 201620, Peoples R China.
RI mo, xiumei/C-9340-2013
CR Adekogbe I, 2005, BIOMATERIALS, V26, P7241, DOI 10.1016/j.biomaterials.2005.05.043
   Alberts B, 1994, MOL BIOL CELL
   Chen RN, 2006, BIOMACROMOLECULES, V7, P1058, DOI 10.1021/bm050754b
   Chen ZG, 2006, TISSUE ENG, V12, P1074
   CHEN ZG, 2006, MAT LETTERS
   Gomathi K, 2003, BIOMATERIALS, V24, P2767, DOI 10.1016/S0142-9612(03)00059-0
   HASEGAWA M, 1992, J APPL POLYM SCI, V45, P1857, DOI 10.1002/app.1992.070451020
   Hirano S, 2000, BIOMATERIALS, V21, P997, DOI 10.1016/S0142-9612(99)00258-6
   Huang ZL, 2006, TISSUE ENG, V12, P1070
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Huang ZM, 2004, POLYMER, V45, P5361, DOI 10.1016/j.polymer.2004.04.005
   Kim SH, 2003, POLYM J, V35, P185, DOI 10.1295/polymj.35.185
   Lee SB, 2004, BIOMATERIALS, V25, P2309, DOI 10.1016/j.biomaterials.2003.09.016
   Ma L, 2003, BIOMATERIALS, V24, P4833, DOI 10.1016/S0142-9612(03)00374-0
   MAROIS Y, 1995, BIOMATERIALS, V16, P1131, DOI 10.1016/0142-9612(95)93576-Y
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   Mo X. M., 1997, ACTA POLYM SIN, V46, P222
   Prabu P, 2006, J BIOMED MATER RES A, V79A, P153, DOI 10.1002/jbm.a.30715
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Silver F. H., 1999, BIOMATERIALS SCI BIO
   Sionkowska A, 2004, BIOMATERIALS, V25, P795, DOI 10.1016/S0142-9612(03)00595-7
   Verreck G, 2003, J CONTROL RELEASE, V92, P349, DOI 10.1016/S0168-3659(03)00342-0
   Wang XH, 2003, BIOMATERIALS, V24, P3213, DOI 10.1016/S0142-9612(03)00170-4
   Webster TJ, 2004, NANOTECHNOLOGY, V15, P48, DOI 10.1088/0957-4484/15/1/009
   Yarin AL, 2001, J APPL PHYS, V89, P3018, DOI 10.1063/1.1333035
   Zong XH, 2003, POLYMER, V44, P4959, DOI 10.1016/S0032-3861(03)00464-6
NR 26
TC 1
Z9 1
U1 0
U2 9
PU DONGHUA UNIV PRESS
PI SHANGHAI
PA 1882 YAN AN WEST RD, SHANGHAI, 00000, PEOPLES R CHINA
BN 978-7-81111-065-4
PY 2007
BP 151
EP 155
PG 5
WC Biotechnology & Applied Microbiology; Engineering, Biomedical;
   Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Engineering; Science & Technology
   - Other Topics
GA BHH67
UT WOS:000253308000029
DA 2018-10-19
ER

PT B
AU Anderson, JM
   Jones, JA
AF Anderson, James M.
   Jones, Jacqueline A.
GP Donghua University
TI Inflammatory cell interations with surface-modified biomaterials
SO 2007 INTERNATIONAL FORUM ON BIOMEDICAL TEXTILE MATERIALS, PROCEEDINGS
LA English
DT Proceedings Paper
CT International Forum on Biomedical Textile Materials
CY MAY 30-JUN 02, 2007
CL Donghua Univ, Songjiang Campus, Shanghai, PEOPLES R CHINA
SP Shanghai Soc Biomed Engn, Key Lab Textile Sci & Technol, Minist Educ, Engn Res Ctr Tech Textiles, Minist Educ, Donghua Univ, Coll Textiles, Donghua Univ, Inst Biol Sci & Biotechnol, State Key Lab Modificat Chem Fiber & Polymer Mat
HO Donghua Univ, Songjiang Campus
DE biomaterials; inflammatory cells; foreign body reaction; macrophages;
   cell culture
ID IN-VIVO; CHEMISTRY; APOPTOSIS; MACROPHAGES; ADHESION
AB Implantation of biomedical polymers, devices, and prostheses results in the normal sequence of inflammatory and wound healing events, ultimately resulting in the foreign body reaction at the tissue/material interface. The normal foreign body reaction consists of adherent macrophages and foreign body giant cells at the tissue/material interface. Our studies have focused on developing a mechanistic understanding of the effect of biomaterial surface chemistry on the formation and activity of monocytes, macrophages, lymphocytes, and foreign body giant cells in the foreign body reaction. Studies utilizing materials with a broad range of surface chemistries have been used to investigate the capability of surfaces to enhance or reduce macrophage and foreign body giant cell adhesion, fusion, activation, and apoptosis. Correlative in vitro and in vivo studies will be presented that identify certain surface chemistries that facilitate a reduction in the foreign body reaction while others enhance the foreign body reaction at material/tissue interfaces. Our ultimate goal is to identify biological design criteria that will prove useful in the development of new biomaterials and tissue engineering constructs.
C1 Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA.
CR Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Brodbeck WG, 2002, J LAB CLIN MED, V139, P90, DOI 10.1067/mlc.2002.121260
   Brodbeck WG, 2001, J BIOMED MATER RES, V55, P661, DOI 10.1002/1097-4636(20010615)55:4<661::AID-JBM1061>3.0.CO;2-F
   Dadsetan M, 2004, J BIOMED MATER RES A, V71A, P439, DOI 10.1002/jbm.a.30165
   DeFife KM, 1999, J BIOMED MATER RES, V45, P148, DOI 10.1002/(SICI)1097-4636(199905)45:2<148::AID-JBM10>3.0.CO;2-U
   JONES AJ, 2007, IN PRESS J BIOMED MA, pA81
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   Nakayama Y, 1996, MACROMOLECULES, V29, P8622, DOI 10.1021/ma9606014
NR 10
TC 0
Z9 0
U1 0
U2 0
PU DONGHUA UNIV PRESS
PI SHANGHAI
PA 1882 YAN AN WEST RD, SHANGHAI, 00000, PEOPLES R CHINA
BN 978-7-81111-065-4
PY 2007
BP 197
EP 200
PG 4
WC Biotechnology & Applied Microbiology; Engineering, Biomedical;
   Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Engineering; Science & Technology
   - Other Topics
GA BHH67
UT WOS:000253308000037
DA 2018-10-19
ER

PT B
AU Gang, X
   Du-Yu, N
   Wen-Zu, W
   Pei-Hua, Z
   Jie, S
   Beng-Ti, A
   Guo-Hua, L
   Xue-Gang, L
   Nan-Liang, C
   Zhi-Cheng, X
AF Gang, Xu
   Du-yu, Nie
   Wen-zu, Wang
   Pei-hua, Zhang
   Jie, Shen
   Beng-ti, Ang
   Guo-hua, Liu
   Xue-gang, Luo
   Nan-liang, Chen
   Zhi-cheng, Xiao
GP Donghua University
TI Evaluation of optic nerve regeneration by using polyglycolic
   acid-chitosan conduits coated with recombinant L1-Fc
SO 2007 INTERNATIONAL FORUM ON BIOMEDICAL TEXTILE MATERIALS, PROCEEDINGS
LA English
DT Proceedings Paper
CT International Forum on Biomedical Textile Materials
CY MAY 30-JUN 02, 2007
CL Donghua Univ, Songjiang Campus, Shanghai, PEOPLES R CHINA
SP Shanghai Soc Biomed Engn, Key Lab Textile Sci & Technol, Minist Educ, Engn Res Ctr Tech Textiles, Minist Educ, Donghua Univ, Coll Textiles, Donghua Univ, Inst Biol Sci & Biotechnol, State Key Lab Modificat Chem Fiber & Polymer Mat
HO Donghua Univ, Songjiang Campus
DE optic nerve; regeneration; L1; PGA; chitosan
ID CELL-DEATH; REPAIR; RATS; L1
AB Autografts have been extensively studied to facilitate optic nerve(ON) regeneration in animal experiments, but same approach for clinical application to aid in autoregeneration has not yet been attempted due to its obvious shortcomings. This study aims to explore the guided regeneration by an artificial polyglycolic acid-chitosan conduit coated with recombinant L1-Fc. Consisting with previous studies, in vitro assay showed that both chitosan, a natural biomaterial, and the neural cell adhesion molecule L1-Fc enhanced the neurite outgrowth. Rat optic nerve transection was used as an in vivo model. The implanted PGA-chitosan conduit was progressively degraded and absorbed, accompanied by significant axonal regeneration as revealed by GAP-43 immunohistochemistry and Fluorogold retrograde tracing.. Moreover, the polyglycolic acid-chitosan conduit coated with L1-Fc showed more effective to promote axonal regeneration and remyelination. Taken together, our observations demonstrated that the L1-Fc coated PGA-chitosan conduits provided a compatible and supportive canal to guild the injured nerve regeneration and remyelination.
C1 [Gang, Xu; Du-yu, Nie; Jie, Shen; Beng-ti, Ang; Zhi-cheng, Xiao] Singapore Gen Hosp, Dept Clin Res, Singapore 0316, Singapore.
RP Gang, X (reprint author), Singapore Gen Hosp, Dept Clin Res, Singapore 0316, Singapore.
CR Asher R A, 2001, Prog Brain Res, V132, P611
   BARTSCH U, 2003, FRONT BIOSCI, V8, P477
   Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6
   DOHERTY P, 1995, NEURON, V14, P57, DOI 10.1016/0896-6273(95)90240-6
   Ellezam B, 2003, NEUROBIOL DIS, V12, P1, DOI 10.1016/S0969-9961(02)00013-X
   EVANS GR, 1995, BIOMATERIALS, V20, P1109
   Filbin MT, 2003, NAT REV NEUROSCI, V4, P703, DOI 10.1038/nrn1195
   Haipeng G, 2000, J Biomed Mater Res, V52, P285, DOI 10.1002/1097-4636(200011)52:2<285::AID-JBM7>3.3.CO;2-7
   LANGER R, 1995, ANN BIOMED ENG, V23, P101, DOI 10.1007/BF02368317
   LEMMON V, 1992, J NEUROSCI, V12, P818
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Matsumoto K, 2000, BRAIN RES, V868, P315, DOI 10.1016/S0006-8993(00)02207-1
   Roonprapunt C, 2003, J NEUROTRAUM, V20, P871, DOI 10.1089/089771503322385809
   Sauve Y, 2001, J NEUROSCI, V21, P951
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   SellesNavarro I, 1996, INVEST OPHTH VIS SCI, V37, P2002
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Vasconcelos BCE, 2000, J ORAL MAXIL SURG, V58, P1257, DOI 10.1053/joms.2000.16626
   Whiteley SJO, 1998, EXP NEUROL, V154, P560, DOI 10.1006/exnr.1998.6959
   Xiao ZC, 1996, EUR J NEUROSCI, V8, P766, DOI 10.1111/j.1460-9568.1996.tb01262.x
   Zhang SL, 1995, CHEM J CHINESE U, V16, P193
NR 21
TC 0
Z9 0
U1 0
U2 3
PU DONGHUA UNIV PRESS
PI SHANGHAI
PA 1882 YAN AN WEST RD, SHANGHAI, 00000, PEOPLES R CHINA
BN 978-7-81111-065-4
PY 2007
BP 275
EP 282
PG 8
WC Biotechnology & Applied Microbiology; Engineering, Biomedical;
   Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Engineering; Science & Technology
   - Other Topics
GA BHH67
UT WOS:000253308000052
DA 2018-10-19
ER

PT B
AU Ling, W
   Xin, D
AF Ling, Wang
   Xin, Ding
GP Donghua University
TI Research progressing on the porosity of blood vessels with respect to
   the seeding of endothelial cells
SO 2007 INTERNATIONAL FORUM ON BIOMEDICAL TEXTILE MATERIALS, PROCEEDINGS
LA English
DT Proceedings Paper
CT International Forum on Biomedical Textile Materials
CY MAY 30-JUN 02, 2007
CL Donghua Univ, Songjiang Campus, Shanghai, PEOPLES R CHINA
SP Shanghai Soc Biomed Engn, Key Lab Textile Sci & Technol, Minist Educ, Engn Res Ctr Tech Textiles, Minist Educ, Donghua Univ, Coll Textiles, Donghua Univ, Inst Biol Sci & Biotechnol, State Key Lab Modificat Chem Fiber & Polymer Mat
HO Donghua Univ, Songjiang Campus
DE porosity; blood Vessel; endothelial; cell seeding
ID BONE-MARROW-CELLS; PLATELET-ADHESION; VASCULAR GRAFTS;
   TRANSPORT-PROPERTIES; PROTEIN ADSORPTION; BYPASS GRAFTS; IN-VITRO;
   DIAMETER; SURFACE; POLYMER
AB Biocompatibility is one of the key issues of artificial blood vessels application. The common method to improve the compatibility of the artificial blood vessels is to modify the surface of the biomaterial. Endothelial cell seeding on the surface of blood vessels material has made great progress, and improves the biocompatibility of biomaterial greatly. The application and the performance of textile artificial blood vessels when seeding of endothelial cells on the surface are briefly presented. In addition, it discusses research progressing on the porosity of blood vessels with respect to the seeding of endothelial cells. At last, an effective method using electrospinning is given which makes the surface of textile artificial blood vessels suits for seeding of endothelial cells.
C1 [Ling, Wang; Xin, Ding] Donghua Univ, Coll Text, Shanghai 201620, Peoples R China.
RP Xin, D (reprint author), Donghua Univ, Coll Text, Shanghai 201620, Peoples R China.
CR Bhattacharya V, 2000, BLOOD, V95, P581
   BRINKMAN E, 1990, BIOMATERIALS, V11, P200, DOI 10.1016/0142-9612(90)90156-K
   Chen YM, 2007, BIOMATERIALS, V28, P1752, DOI 10.1016/j.biomaterials.2006.12.005
   FOLEY DP, 1994, CIRCULATION, V90, P1239, DOI 10.1161/01.CIR.90.3.1239
   FUJIMOTO K, 1993, BIOMATERIALS, V14, P442, DOI 10.1016/0142-9612(93)90147-T
   GAYLORD NG, 1975, ADV CHEM SER, V142, P76
   Gibson P, 2001, COLLOID SURFACE A, V187, P469, DOI 10.1016/S0927-7757(01)00616-1
   Gibson PW, 1999, AICHE J, V45, P190, DOI 10.1002/aic.690450116
   Griese DP, 2003, CIRCULATION, V108, P2710, DOI 10.1161/01.CIR.0000096490.16596.A6
   Haimovich B, 1997, J APPL POLYM SCI, V63, P1393
   Harris JM, 1992, POLY ETHYLENE GLYCOL
   He HB, 2003, J THORAC CARDIOV SUR, V126, P455, DOI 10.1016/S0022-5223(02)73264-9
   He W, 2005, BIOMATERIALS, V26, P7606, DOI 10.1016/j.biomaterials.2005.05.049
   HERRING M, 1978, SURGERY, V84, P498
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   KWON K, 2005, BIOMATERIALS, V26, P3929
   Laube HR, 2000, J THORAC CARDIOV SUR, V120, P134, DOI 10.1067/mtc.2000.106327
   LEE JH, 2003, J BIOL MACROMOLECULE, V32, P17
   Leon CALY, 1998, ADV COLLOID INTERFAC, V76, P341, DOI 10.1016/S0001-8686(98)00052-9
   Li DP, 2006, J MEMBRANE SCI, V286, P104, DOI 10.1016/j.memsci.2006.09.020
   Losi P, 2004, BIOMATERIALS, V25, P4447, DOI 10.1016/j.biomaterials.2003.11.025
   LUCH R, 2006, COMPOS SCI TECHNOL, V66, P2436
   Matsumura G, 2003, CIRCULATION, V108, P1729, DOI 10.1161/01.CIR.0000092165.32213.61
   MCENANEY B, 1995, POROSITY CARBONS CHA, P93
   Meinhart J, 1997, ASAIO J, V43, P515
   MORI Y, 1982, T AM SOC ART INT ORG, V28, P459
   Moroni L, 2006, BIOMATERIALS, V27, P4911, DOI 10.1016/j.biomaterials.2006.05.027
   Njatawidjaja E, 2006, SURF COAT TECH, V201, P699, DOI 10.1016/j.surfcoat.2005.12.017
   NOISHIKI Y, 1992, J THORAC CARDIOV SUR, V104, P770
   OKANO T, 1981, J BIOMED MATER RES, V15, P393, DOI 10.1002/jbm.820150310
   Park JH, 1999, BIOMATERIALS, V20, P943, DOI 10.1016/S0142-9612(98)00250-6
   RUY YJ, 2003, EUR POLYM J, V39, P1883
   Ryu YJ, 2003, EUR POLYM J, V39, P1883, DOI 10.1016/S0014-3057(03)00096-X
   SAPSFORD RN, 1981, J THORAC CARDIOV SUR, V81, P860
   SCATTERFIELD CN, 1991, HETEROGENEOUS CATALY, P131
   Schindler M, 2005, BIOMATERIALS, V26, P5624, DOI 10.1016/j.biomaterials.2005.02.014
   Severian D., 2002, POLYM BIOMATERIALS
   Shirota T, 2003, TISSUE ENG, V9, P127, DOI 10.1089/107632703762687609
   SHIROTA T, 2003, FABRICATION ENDOTHEL, V13, P2295
   Steinthorsson G, 1999, ACTA CHIR BELG, V99, P282
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tanaka M., 2000, Japanese Journal of Artificial Organs, V29, P209
   Teebken OE, 2002, EUR J VASC ENDOVASC, V23, P475, DOI 10.1006/ejvs.2002.1654
   Tsuruta T, 1996, ADV POLYM SCI, V126, P1
   VEITH FJ, 1986, J VASC SURG, V3, P104
   Wu HC, 2007, BIOMATERIALS, V28, P1385, DOI 10.1016/j.biomaterials.2006.11.012
   Zhang J, 2003, BIOMATERIALS, V24, P4223, DOI 10.1016/S0142-9612(03)00365-X
   ZILLA P, 1994, J VASC SURG, V19, P540, DOI 10.1016/S0741-5214(94)70083-4
NR 49
TC 0
Z9 0
U1 0
U2 3
PU DONGHUA UNIV PRESS
PI SHANGHAI
PA 1882 YAN AN WEST RD, SHANGHAI, 00000, PEOPLES R CHINA
BN 978-7-81111-065-4
PY 2007
BP 301
EP 305
PG 5
WC Biotechnology & Applied Microbiology; Engineering, Biomedical;
   Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Engineering; Science & Technology
   - Other Topics
GA BHH67
UT WOS:000253308000056
DA 2018-10-19
ER

PT B
AU Ji, HY
   Rao, ZH
AF Ji, Haiyan
   Rao, Zhenhong
GP IEEE
TI Quantitative Analysis the Protein of Millet by Artificial Neural Network
   and Fourier Coefficients of Near Infrared Diffuse Reflectance
   Spectroscopy
SO 2007 SECOND INTERNATIONAL CONFERENCE ON BIO-INSPIRED COMPUTING: THEORIES
   AND APPLICATIONS
LA English
DT Proceedings Paper
CT 2nd International Conference on Bio-Inspired Computing
CY SEP 14-17, 2007
CL Zhengzhou, PEOPLES R CHINA
AB For biomaterial, the signal energy is concentrated at low frequencies, and then the first few Fourier coefficients can represent the whole spectrum. Fourier coefficients are useful wavelength reducing method. The first few Fourier coefficients of millet's near infrared diffuse reflectance spectroscopy were used as the input nodes of artificial neural network, to build the quantitative analysis calibration model of protein in millet. The advantages of this method are that Fourier coefficient can reduce spectrum, filter the high frequency noise with an ideal filter of unity gain and zero phase shift. Better results were obtained from artificial neural network quantitative analysis model, the correlation coefficient and relative standard deviation of protein is 0.971 and 2.40% in calibration set, 0.955 and 2.96% in prediction set respectively. These results were satisfactory.
C1 [Ji, Haiyan] China Agr Univ, Coll Elect & Informat Engn, Beijing 100083, Peoples R China.
   [Rao, Zhenhong] China Agr Univ, Coll Sci, Beijing 100094, Peoples R China.
RP Ji, HY (reprint author), China Agr Univ, Coll Elect & Informat Engn, Beijing 100083, Peoples R China.
EM yuntian@cau.edu.cn
CR Burns D. A., 1992, HDB NEAR INFRARED AN
   JERORE J, 1999, APPL SPECTROSCOPY RE, V34, P1
   JI HY, 1993, CHEM J CHINESE U, V14, P618
   LONG JR, 1990, ANAL CHEM, V62, P1791, DOI 10.1021/ac00216a013
   MARTIN KA, 1992, APPL SPECTROSC REV, V27, P325, DOI 10.1080/05704929208018109
   MCCLURE WF, 1994, ANAL CHEM, V66, pA43, DOI 10.1021/ac00073a002
   MCCLURE WF, 1984, APPL SPECTROSC, V38, P322, DOI 10.1366/0003702844555449
NR 7
TC 0
Z9 0
U1 0
U2 2
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-4105-1
PY 2007
BP 74
EP +
DI 10.1109/BICTA.2007.4806422
PG 2
WC Computer Science, Artificial Intelligence; Engineering, Electrical &
   Electronic
SC Computer Science; Engineering
GA BKH11
UT WOS:000268062100017
DA 2018-10-19
ER

PT S
AU Joyce, TJ
AF Joyce, T. J.
BE Ibrahim, F
   Osman, NAA
   Usman, J
   Kadri, NA
TI Theoretical determination of lubrication regimes in two-piece first
   metatarsophalangeal prostheses
SO 3RD KUALA LUMPUR INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING 2006
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT 3rd Kuala Lumpur International Conference on Biomedical Engineering 2006
   (BioMed 2006)
CY DEC 11-14, 2006
CL Kuala Lumpur, MALAYSIA
SP Int Federat Med & Biol Engn
DE metatarsophalangeal; lubrication regimes; metalon-metal;
   ceramic-on-ceramic; metal-on-polymer
ID 1ST METATARSOPHALANGEAL JOINT; METAL RESURFACING ARTHROPLASTY;
   LOW-FRICTION ARTHROPLASTY; TOTAL HIP PROSTHESES; FOLLOW-UP;
   ELASTOHYDRODYNAMIC LUBRICATION; REPLACEMENT ARTHROPLASTY; FORCES; GAIT;
   PREDICTION
AB The key joint of the forefoot during gait is the first metatarsophalangeal joint. It is subject to high loads and plays an important role in propelling the human form. Unfortunately the first metatarsophalangeal joint can be subject to a number of diseases, such as rheumatoid arthritis, hallux rigidus and hallux valgus, all of which can lead to replacement of the natural joint with a prosthesis. Most commonly, a silicone spacer might be implanted but other designs are available which more closely try to match the natural joint by employing a two-piece ball and socket arrangement. Such designs are available with a range of biomaterial couples including ceramic-on-ceramic, metal-on-metal and metal-on-polymer. Calculation of predicted lubrication regimes applicable to these implant designs was undertaken. Modeling the ball and socket implant as an equivalent ball-on-plane model and employing elastohydrodynamic theory allowed the minimum film thickness to be calculated and in turn the lambda ratio to indicate the lubrication regime. Boundary lubrication is indicated for lambda less than 1, mixed lubrication for lambda between I and 3, and fluid film lubrication for lambda greater than 3. The calculations were undertaken for a 10 to 1500N range of loading values, a 0 to 30mm/s range of entraining velocities, and a 3 to 15mm radius ranger of sizes. Calculations showed that, for the range of loads, sizes and entraining velocities considered, the ceramic-on-ceramic and metal-on-metal implants could operate under fluid film lubrication, whereas the metal-on-polymer combination operated in the boundary lubrication regime. It was also recognized that manufacturing capabilities are critical to the radial clearances and values of surface roughness that can be achieved, and thus the predicted lubrication regime. Inevitably, a range of factors need to be considered when designing or choosing an implant for the first metatarsophalangeal joint.
C1 Univ Newcastle, Sch Mech & Syst Engn, Ctr Rehab Engn Studies, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
RP Joyce, TJ (reprint author), Univ Newcastle, Sch Mech & Syst Engn, Ctr Rehab Engn Studies, Claremont Rd, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.
EM tj.joyce@ncl.ac.uk
RI Joyce, Thomas/G-3689-2013
OI Joyce, Thomas/0000-0002-8497-5790
CR Back DL, 2005, J BONE JOINT SURG BR, V87B, P324, DOI 10.1302/0301-620X.87B3.15556
   BOMMIREDDY R, 2003, FOOT, V13, P151
   GRANBERRY WM, 1991, J BONE JOINT SURG AM, V73A, P1453, DOI 10.2106/00004623-199173100-00002
   HAMROCK BJ, 1978, J LUBRIC TECH-T ASME, V100, P236, DOI 10.1115/1.3453152
   Hanyu T, 2001, J Orthop Sci, V6, P141, DOI 10.1007/s007760100062
   HARRIS WH, 1995, CLIN ORTHOP RELAT R, P46
   HASSAN K, 2006, FOOT, V16, P142
   Hungerford DS, 2005, J ARTHROPLASTY, V20, P68, DOI 10.1016/j.arth.2005.03.023
   Jacob HAC, 2001, CLIN BIOMECH, V16, P783, DOI 10.1016/S0268-0033(01)00070-5
   Jalali-Vahid D, 2001, J BIOMECH, V34, P261, DOI 10.1016/S0021-9290(00)00181-0
   JOHNSON KL, 1972, WEAR, V19, P91, DOI 10.1016/0043-1648(72)90445-0
   Joyce TJ, 2005, EXPERT REV MED DEVIC, V2, P453, DOI 10.1586/17434440.2.4.453
   JOYCE TJ, 2006, J BIOMECH, V39, pS525
   MCBRIDE ID, 1991, FOOT ANKLE, V11, P282, DOI 10.1177/107110079101100505
   MINAMIKAWA Y, 1994, J HAND SURG-AM, V19A, P567, DOI 10.1016/0363-5023(94)90258-5
   Nawoczenski DA, 1999, J BONE JOINT SURG AM, V81A, P370, DOI 10.2106/00004623-199903000-00009
   Nercessian OA, 2005, J ARTHROPLASTY, V20, P162, DOI 10.1016/j.arth.2004.07.006
   Older J, 2002, J ARTHROPLASTY, V17, P675, DOI 10.1054/arth.2002.31973
   Olms K, 1999, INT ORTHOP, V23, P240, DOI 10.1007/s002640050360
   PAVIER J, 2005, FOOT, V15, P47
   PEIMER CA, 1991, J HAND SURG-AM, V16A, P835, DOI 10.1016/S0363-5023(10)80146-7
   Pylios T, 2004, J BIOMECH, V37, P405, DOI 10.1016/S0021-9290(03)00265-3
   Saikko V, 2001, BIOMATERIALS, V22, P1507, DOI 10.1016/S0142-9612(00)00306-9
   Schmalzried TP, 2005, J ARTHROPLASTY, V20, P70, DOI 10.1016/j.arth.2005.03.007
   Scholes SC, 2000, PHYS MED BIOL, V45, P3721, DOI 10.1088/0031-9155/45/12/315
   Scholes SC, 2000, WEAR, V241, P209, DOI 10.1016/S0043-1648(00)00377-X
   Scholes SC, 2000, P I MECH ENG H, V214, P49, DOI 10.1243/0954411001535237
   Smith SL, 2001, P I MECH ENG J-J ENG, V215, P483, DOI 10.1243/1350650011543718
   STOKES IAF, 1979, J ANAT, V129, P579
   Treacy RBC, 2005, J BONE JOINT SURG BR, V87B, P167, DOI 10.1302/0301-620X.87B2.15030
   Udofia IJ, 2003, J BIOMECH, V36, P537, DOI 10.1016/S0021-9290(02)00422-0
   Villar R, 2004, J BONE JOINT SURG BR, V86B, P157, DOI 10.1302/0301-620X.86B2.15231
   Wroblewski BM, 2002, J BONE JOINT SURG BR, V84B, P540, DOI 10.1302/0301-620X.84B4.10293
NR 33
TC 0
Z9 0
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
SN 1680-0737
BN 978-3-540-68016-1
J9 IFMBE PROC
PY 2007
VL 15
BP 651
EP 655
PG 5
WC Computer Science, Artificial Intelligence; Computer Science,
   Interdisciplinary Applications; Engineering, Biomedical
SC Computer Science; Engineering
GA BGF91
UT WOS:000246513200164
DA 2018-10-19
ER

PT J
AU Shapira-Schweitzer, K
   Seliktar, D
AF Shapira-Schweitzer, Keren
   Seliktar, Dror
TI Matrix stiffness affects spontaneous contraction of cardiomyocytes
   cultured within a PEGylated fibrinogen biomaterial
SO ACTA BIOMATERIALIA
LA English
DT Article
DE cardiac cell therapy; mechanical properties; fibrin; polyethylene
   glycol; image analysis; hydrogel
ID HYDROGEL SCAFFOLDS; TISSUE; MYOCARDIUM; MICROENVIRONMENTS; STIMULATION;
   SURVIVAL; MYOCYTES; THERAPY; CELLS
AB Successful implementation of cardiac cell transplantation for treating damaged myocardium relies on the development of improved injectable biomaterials. A novel biomaterial technology using PEGylated fibrinogen has been developed with controllable physicochemical properties based on the poly(ethylene glycol) (PEG) constituent. In addition, the fibrinogen backbone of the material confers inherent bioactivity to cells. The purpose of this investigation was to explore by in vitro techniques the use of this biomaterial as a scaffold for cardiac tissue regeneration. To this end neonatal rat cardiomyocytes were cultivated in PEGylated fibrinogen constructs. The cell-seeding density and biomaterial composition were optimized to obtain maximum spontaneous contraction of the constructs. Quantitative characterization of the contraction pattern was accomplished by video image analysis. It was possible to demonstrate an inverse correlation between the material stiffness and the amplitude of contraction of the tissue constructs by changing the modulus of the matrix using different compositions of PEG and fibrinogen. The relationship between matrix stiffness, cell density and tissue contraction also provided some insight into the mechanism of cellular remodeling that ultimately leads to synchronized contraction of the constructs. These findings indicate that PEGylated fibrinogen hydrogels can be used as a scaffold for cardiomyocytes, and offer the possibility of controlling cellular remodeling via simple compositional modifications to the matrix. (C) 2006 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
RP Seliktar, D (reprint author), Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
EM dror@bm.technion.ac.il
OI Seliktar, Dror/0000-0001-6964-8567
CR Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Davis ME, 2005, CIRC RES, V97, P8, DOI 10.1161/01.RES.0000173376.39447.01
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Eschenhagen T., 2006, CULTURE CELLS TISSUE, P259
   Fazel S, 2005, ANN THORAC SURG, V79, pS2238, DOI 10.1016/j.athoracsur.2005-02-085
   Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131
   Kofidis T, 2003, TISSUE ENG, V9, P517, DOI 10.1089/107632703322066697
   Kofidis T., 2005, CIRCULATION, V112, pI173
   Leor Jonathan, 2006, Expert Rev Cardiovasc Ther, V4, P239, DOI 10.1586/14779072.4.2.239
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491
   Murry CE, 2002, J CARD FAIL, V8, pS532, DOI 10.1054/jcaf.2002.129268
   PELED E, 2006, IN PRESS J BIOMED MA
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   SCHMIDT O, 2006, IN PRESS BIOTECHNOL
   Seliktar D, 2005, ANN NY ACAD SCI, V1047, P386, DOI 10.1196/annals.1341.034
   Shin M, 2004, BIOMATERIALS, V25, P3717, DOI 10.1016/j.biomaterials.2003.10.055
   Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8
   Tekalp AM, 1995, DIGITAL VIDEO PROCES
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann WH, 2003, HEART FAIL REV, V8, P259, DOI 10.1023/A:1024725818835
   Zimmermann WH, 2006, CARDIOVASC RES, V71, P419, DOI 10.1016/j.cardiores.2006.03.023
NR 27
TC 105
Z9 107
U1 0
U2 10
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2007
VL 3
IS 1
BP 33
EP 41
DI 10.1016/j.actbio.2006.09.003
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 121SX
UT WOS:000243178400004
PM 17098488
DA 2018-10-19
ER

PT J
AU Rowe, SL
   Lee, S
   Stegemann, JP
AF Rowe, Shaneen L.
   Lee, SungYun
   Stegemann, Jan P.
TI Influence of thrombin concentration on the mechanical and morphological
   properties of cell-seeded fibrin hydrogels
SO ACTA BIOMATERIALIA
LA English
DT Article
DE fibrin; thrombin; smooth muscle cells; tissue engineering
ID SMOOTH-MUSCLE-CELLS; MEDIA EQUIVALENT; BLOOD-VESSELS; GEL STRUCTURE;
   BEHAVIOR; TURBIDITY; CLOTS
AB Fibrin is a biopolymer that has been used in a variety of biomaterial, cell delivery and tissue engineering applications. The enzyme thrombin catalyzes the formation of fibrin microfibrils, which form a three-dimensional mesh in which cells can be directly embedded at the time of gel formation. In this study, fibrin hydrogels containing vascular smooth muscle cells were created using varying concentrations of thrombin. Over 7 days in culture, all gels decreased in volume as the fibrin matrix compacted, and the degree of gel compaction increased as thrombin concentration decreased. The material modulus and ultimate tensile stress of the gels also increased with decreasing thrombin concentration. Addition of thrombin to similar constructs made using collagen Type I did not show an effect on gel compaction or mechanical properties, suggesting that these effects were a result of thrombin's action on fibrin polymerization, and not cellular functions. Cell proliferation in fibrin hydrogels was not significantly affected by thrombin addition. Matrix examination using scanning electron microscopy showed increasing fibrin fiber diameters as thrombin concentration decreased. Confocal microscopic imaging of the actin cytoskeleton showed that cell morphology on two-dimensional substrates of fibrin showed marked changes, with higher thrombin concentrations producing cells with longer cellular projections. However, these morphological changes were not as apparent in cells embedded in three-dimensional (3-D) matrices, in which cells exhibited a similar morphology independent of thrombin concentration. These results relate features of the matrix and cellular components of 3-D fibrin constructs to mechanical properties, and contribute to the understanding of structure-function relationships in cell-seeded, 3-D protein hydrogels. (C) 2006 Acta Materialia, Inc. Published by Elsevier Ltd. All rights reserved.
C1 Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
RP Stegemann, JP (reprint author), Rensselaer Polytech Inst, Dept Biomed Engn, Troy, NY 12180 USA.
EM stegemann@rpi.edu
FU NIBIB NIH HHS [R21 EB003978, R21-EB003978]
CR Barocas VH, 1998, J BIOMECH ENG-T ASME, V120, P660, DOI 10.1115/1.2834759
   BLOMBACK B, 1982, THROMB RES, V25, P51, DOI 10.1016/0049-3848(82)90214-6
   Blomback B, 2004, BIOPHYS CHEM, V112, P147, DOI 10.1016/j.bpc.2004.07.013
   BLOMBACK B, 1989, BIOCHIM BIOPHYS ACTA, V997, P96, DOI 10.1016/0167-4838(89)90140-4
   Cox S, 2004, TISSUE ENG, V10, P942, DOI 10.1089/1076327041348392
   CUMMINGS CL, 2004, BIOMATERIALS, V17, P3699
   DHALL TZ, 1976, THROMB HAEMOSTASIS, V35, P737, DOI 10.1055/s-0038-1647971
   DIKOVSKY D, 2005, BIOMATERIALS, V19, P1496
   FERRY JD, 1947, J AM CHEM SOC, V69, P388, DOI 10.1021/ja01194a066
   GLOVER CJ, 1975, J LAB CLIN MED, V86, P644
   Grassl ED, 2003, J BIOMED MATER RES A, V66A, P550, DOI 10.1002/jbm.a.10589
   Grassl ED, 2002, J BIOMED MATER RES, V60, P607, DOI 10.1002/jbm.10107
   Herbert CB, 1998, J BIOMED MATER RES, V40, P551, DOI 10.1002/(SICI)1097-4636(19980615)40:4<551::AID-JBM6>3.0.CO;2-E
   Karp JM, 2004, J BIOMED MATER RES A, V71A, P162, DOI 10.1002/jbm.a.30147
   Krishnan LK, 2003, BIOMATERIALS, V24, P321, DOI 10.1016/S0142-9612(02)00322-8
   KUBOTA K, 2004, COLLOID SURFACE B, V38, P104
   MCNAMARA CA, 1993, J CLIN INVEST, V91, P94, DOI 10.1172/JCI116206
   Neidert MR, 2002, BIOMATERIALS, V23, P3717, DOI 10.1016/S0142-9612(02)00106-0
   Pizzo AM, 2005, J APPL PHYSIOL, V98, P1909, DOI 10.1152/japplphysiol.01137.2004
   ROSS JJ, 2003, MATRIX BIOL, P477
   ROWE SL, 2006, IN PRESS BIOMACROMOL, V7
   Schauwienold D, 2003, HYPERTENSION, V41, P546, DOI 10.1161/01.HYP.0000054213.37471.84
   Schmoekel HG, 2005, BIOTECHNOL BIOENG, V89, P253, DOI 10.1002/bit.20168
   Swartz DD, 2005, AM J PHYSIOL-HEART C, V288, pH1451, DOI 10.1152/ajpheart.00479.2004
   Trentin D, 2006, P NATL ACAD SCI USA, V103, P2506, DOI 10.1073/pnas.0505964102
   WEISEL JW, 1992, BIOPHYS J, V63, P111, DOI 10.1016/S0006-3495(92)81594-1
   WESLEY WW, 1974, BIOPHYS CHEM, V1, P152
   Yao L, 2005, TISSUE ENG, V11, P991, DOI 10.1089/ten.2005.11.991
NR 28
TC 109
Z9 117
U1 3
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JAN
PY 2007
VL 3
IS 1
BP 59
EP 67
DI 10.1016/j.actbio.2006.08.006
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 121SX
UT WOS:000243178400007
PM 17085089
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Hamdaoui, O
   Chiha, M
AF Hamdaoui, Oualid
   Chiha, Mahdi
TI Removal of methylene blue from aqueous solutions by wheat bran
SO ACTA CHIMICA SLOVENICA
LA English
DT Article
DE removal; methylene blue; wheat bran; sorption; kinetics
ID WASTE-WATER; AGRICULTURAL RESIDUES; ACTIVATED CARBON; ORANGE PEEL;
   AZO-DYE; ADSORPTION; SORPTION; EQUILIBRIUM; KINETICS; ADSORBENT
AB In this work, a fundamental investigation on the removal of methylene blue from aqueous solutions by wheat bran is conducted in batch conditions. Removal kinetic data are determined, and the effects of different experimental parameters, such as wheat bran mass, initial concentration of methylene blue, agitation speed, solution pH, particle size, temperature, and ionic strength on the kinetics of methylene blue removal are investigated. The cationic dye recovery increases with an increase of sorbent mass, solution pH, and temperature. Methylene blue removal decreases with an increase of initial concentration, particle size, and ionic strength. The agitation speed showed a limited influence on the removal kinetics. Modeling of kinetic results shows that sorption process is best described by the pseudo- second order model, with determination coefficients higher than 0.996 under all experimental conditions. The applicability of both internal and external diffusion models shows that liquid-film and particle diffusion are effective sorption mechanisms. The activation energy of sorption calculated using the pseudo- second order rate constants is found to be 13.41 kJ mol(-1) from an Arrhenius plot. The low value of the activation energy indicates that sorption is an activated and physical process. Thus, wheat bran, a low cost and easily available biomaterial, can be efficiently used as an excellent sorbent for the removal of dyes from wastewater. It can be safely concluded that wheat bran is much economical, effectual, viable, and can be an alternative to more costly adsorbents.
C1 Univ Annaba, Fac Engn, Dept Proc Engn, Annaba 23000, Algeria.
RP Hamdaoui, O (reprint author), Univ Annaba, Fac Engn, Dept Proc Engn, PO Box 12, Annaba 23000, Algeria.
EM ohamdaoui@yahoo.fr
RI Hamdaoui, Oualid/F-8734-2012
OI Hamdaoui, Oualid/0000-0002-5135-0524
CR Adachi A, 2005, CHEMOSPHERE, V58, P817, DOI 10.1016/j.chemosphere.2004.09.077
   Allen SJ, 1997, J CHEM TECHNOL BIOT, V68, P442, DOI 10.1002/(SICI)1097-4660(199704)68:4<442::AID-JCTB643>3.3.CO;2-U
   Arami M, 2005, J COLLOID INTERF SCI, V288, P371, DOI 10.1016/j.jcis.2005.03.020
   Chandran CB, 2002, APPL BIOCHEM BIOTECH, V102, P207, DOI 10.1385/ABAB:102-103:1-6:207
   Chen KC, 2003, J BIOTECHNOL, V101, P241, DOI 10.1016/S0168-1656(02)00362-0
   Farajzadeh MA, 2004, SEP PURIF TECHNOL, V38, P197, DOI 10.1016/j.seppur.2003.11.005
   Ghosh D, 2002, APPL CLAY SCI, V20, P295, DOI 10.1016/S0169-1317(01)00081-3
   Ho YS, 1998, CHEM ENG J, V70, P115, DOI 10.1016/S0923-0467(98)00076-1
   Ho YS, 2000, WATER RES, V34, P735, DOI 10.1016/S0043-1354(99)00232-8
   Ho YS, 2005, PROCESS BIOCHEM, V40, P119, DOI 10.1016/j.procbio.2003.11.035
   Ho YS, 2000, SEPAR PURIF METHOD, V29, P189, DOI 10.1081/SPM-100100009
   HO YS, 1995, THESIS U BIRMINGHAM
   KNOCKE WR, 1981, WATER RES, V15, P275, DOI 10.1016/0043-1354(81)90121-4
   Kumar KV, 2005, J COLLOID INTERF SCI, V284, P14, DOI 10.1016/j.jcis.2004.09.063
   Lagergren S, 1898, KUNGLIGA SVENSKA VET, V24, P1, DOI DOI 10.1007/BF01501332
   MCKAY G, 1982, J CHEM TECHNOL BIOT, V32, P759
   Mohan SV, 2002, J HAZARD MATER, V90, P189
   Nigam P, 2000, BIORESOURCE TECHNOL, V72, P219, DOI 10.1016/S0960-8524(99)00123-6
   Ozer A, 2004, PROCESS BIOCHEM, V39, P2183, DOI 10.1016/j.procbio.2003.11.008
   Ravat C, 2000, WATER RES, V34, P1327, DOI 10.1016/S0043-1354(99)00255-9
   Reid R, 1996, J SOC DYERS COLOUR, V112, P103
   Robinson T, 2002, ENVIRON INT, V28, P29, DOI 10.1016/S0160-4120(01)00131-3
   Senthilkumaar S, 2005, J COLLOID INTERF SCI, V284, P78, DOI 10.1016/j.jcis.2004.09.027
   SESHADRI S, 1994, WASTE MANAGE, V14, P127, DOI 10.1016/0956-053X(94)90005-1
   Shen JC, 2005, SEP PURIF TECHNOL, V44, P69, DOI 10.1016/j.seppur.2004.12.011
   Sivaraj R, 2001, WASTE MANAGE, V21, P105, DOI 10.1016/S0956-053X(00)00076-3
   SPAHN H, 1975, CHEM ENG SCI, V30, P529, DOI 10.1016/0009-2509(75)80023-6
   WEBER EJ, 1987, ENVIRON TOXICOL CHEM, V6, P911, DOI 10.1897/1552-8618(1987)6[911:KSOTRO]2.0.CO;2
   Weber W, 1963, J SANITARY ENGINEERI, V89, P31, DOI DOI 10.1016/J.DESAL.2010.08.036
   WEBER WJ, 1967, PRINCIPLES APPL WATE
   YOUSSEF BM, 1993, AM DYEST REP, V82, P36
NR 31
TC 59
Z9 59
U1 1
U2 14
PU SLOVENSKO KEMIJSKO DRUSTVO
PI LJUBLJANA
PA HAJDRIHOVA 19, LJUBLJANA 1000, SLOVENIA
SN 1318-0207
J9 ACTA CHIM SLOV
JI Acta Chim. Slov.
PY 2007
VL 54
IS 2
BP 407
EP 418
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA 180XL
UT WOS:000247401200026
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Neut, D
   van der Mei, HC
   Bulstra, SK
   Busscher, HJ
AF Neut, Danielle
   van der Mei, Henny C.
   Bulstra, Sjoerd K.
   Busscher, Henk J.
TI The role of small-colony variants in failure to diagnose and treat
   biofilm infections in orthopedics
SO ACTA ORTHOPAEDICA
LA English
DT Review
ID TOTAL HIP-ARTHROPLASTY; C-REACTIVE PROTEIN; COAGULASE-NEGATIVE
   STAPHYLOCOCCI; PROSTHETIC JOINT INFECTION; PSEUDOMONAS-AERUGINOSA;
   ANTIBIOTIC-RESISTANCE; BACTERIAL BIOFILMS; ESCHERICHIA-COLI; PERSISTER
   CELLS; CYSTIC-FIBROSIS
AB Biomaterial-related infection of joint replacements is the second most common cause of implant failure, with serious consequences. Chronically infected replacements cannot be treated without removal of the implant, as the bio film mode of growth protects the bacteria against antibiotics. This review discusses bio film formation on joint replacements and the important clinical phenomenon of small-colony variants (SCVs). These slow-growing phenotypic variants often remain undetected or are misdiagnosed using hospital microbiological analyses due to their unusual morphological appearance and biochemical reactions. In addition, SCVs make the infection difficult to eradicate. They often lead to recurrence since they respond poorly to standard antibiotic treatment and can sometimes survive intracellularly.
C1 Univ Groningen, Med Ctr, Dept Biomed Engn, Groningen, Netherlands.
   Univ Groningen, Med Ctr, Dept Orthopaed Surg, Groningen, Netherlands.
RP Neut, D (reprint author), Univ Groningen, Med Ctr, Dept Biomed Engn, Groningen, Netherlands.
EM d.neut@med.umcg.nl
CR Arciola CR, 2005, BIOMATERIALS, V26, P6530, DOI 10.1016/j.biomaterials.2005.04.031
   ASHBY MJ, 1994, J ANTIMICROB CHEMOTH, V33, P443, DOI 10.1093/jac/33.3.443
   Atkins BL, 1998, J HOSP INFECT, V40, P263, DOI 10.1016/S0195-6701(98)90302-4
   BALWIT JM, 1994, J INFECT DIS, V170, P1033, DOI 10.1093/infdis/170.4.1033
   BARRACK RL, 1997, CLIN ORTHOP RELAT R, V345, P8
   Baumert N, 2002, MICROB DRUG RESIST, V8, P253, DOI 10.1089/10766290260469507
   BAYER AS, 1987, ANTIMICROB AGENTS CH, V31, P70, DOI 10.1128/AAC.31.1.70
   BAYSTON R, 2000, COMMUNITY STRUCTURE, P295
   Bergogne-Berezin E, 2000, PRESSE MED, V29, P2018
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   Cochran WL, 2000, J APPL MICROBIOL, V88, P546, DOI 10.1046/j.1365-2672.2000.00995.x
   Cogan NG, 2006, J THEOR BIOL, V238, P694, DOI 10.1016/j.jtbi.2005.06.017
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   DAROUICHE RO, 1994, J INFECT DIS, V170, P720, DOI 10.1093/infdis/170.3.720
   DAVENPORT DS, 1986, J INFECT DIS, V153, P332, DOI 10.1093/infdis/153.2.332
   Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010
   Gracia E, 1997, INT ORTHOP, V21, P46, DOI 10.1007/s002640050116
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   Haussler S, 1999, CLIN INFECT DIS, V29, P621
   Hudson MC, 1995, MICROB PATHOGENESIS, V19, P409, DOI 10.1006/mpat.1995.0075
   Jefferson KK, 2005, ANTIMICROB AGENTS CH, V49, P2467, DOI 10.1118/AAC.49.6.2467-2473.2005
   JOSEFSSON G, 1993, CLIN ORTHOP RELAT R, P210
   Kahl B, 1998, J INFECT DIS, V177, P1023, DOI 10.1086/515238
   Kahl BC, 2003, J CLIN MICROBIOL, V41, P410, DOI 10.1128/JCM.41.1.410-413.2003
   Kahl BC, 2003, J CLIN MICROBIOL, V41, P4424, DOI 10.1128/JCM.41.9.4424-4427.2003
   Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5
   Kirisits MJ, 2005, APPL ENVIRON MICROB, V71, P4809, DOI 10.1128/AEM.71.8.4809-4821.2005
   KRAGSBJERG P, 1995, EUR J SURG, V161, P17
   Kurtz S, 2005, J BONE JOINT SURG AM, V87A, P1487, DOI 10.2106/JBJS.D.02441
   LANGFORD PR, 1989, FEMS MICROBIOL LETT, V61, P33
   Lewis K, 2005, BIOCHEMISTRY-MOSCOW+, V70, P267, DOI 10.1007/s10541-005-0111-6
   LEWIS LA, 1991, MICROBIOL IMMUNOL, V35, P289, DOI 10.1111/j.1348-0421.1991.tb01558.x
   LIDWELL OM, 1983, J HOSP INFECT, V4, P111, DOI 10.1016/0195-6701(83)90041-5
   Looney WJ, 2000, BRIT J BIOMED SCI, V57, P317
   Mah TF, 2003, NATURE, V426, P306, DOI 10.1038/nature02122
   MCDONALD DJ, 1989, J BONE JOINT SURG AM, V71A, P828, DOI 10.2106/00004623-198971060-00005
   Muli FW, 1998, J MED MICROBIOL, V47, P401, DOI 10.1099/00222615-47-5-401
   MUSHER DM, 1977, J INFECT DIS, V136, P360, DOI 10.1093/infdis/136.3.360
   Neut D, 2003, CLIN ORTHOP RELAT R, P261, DOI 10.1097/01.blo.0000073345.50837.84
   Neut D, 2001, J ANTIMICROB CHEMOTH, V47, P885, DOI 10.1093/jac/47.6.885
   Ng T, 1998, BR J HOSP MED, V58, P521
   Phillips S. E., 1988, ED MEASUREMENT ISSUE, V7, P8
   PHILLIPS WC, 1983, CLIN ORTHOP RELAT R, P141
   PITTET D, 1994, INFECT CONT HOSP EP, V15, P456
   PROCTOR RA, 1995, CLIN INFECT DIS, V20, P95, DOI 10.1093/clinids/20.1.95
   Proctor RA, 2006, NAT REV MICROBIOL, V4, P295, DOI 10.1038/nrmicro1384
   Proctor RA, 1998, CLIN INFECT DIS, V27, pS68, DOI 10.1086/514906
   Proctor RA, 1998, CLIN INFECT DIS, V27, P419, DOI 10.1086/514706
   Proctor Richard A., 1994, P79
   Roberts ME, 2005, MICROBIOL-SGM, V151, P75, DOI 10.1099/mic.0.27385-0
   Roggenkamp A, 1998, J CLIN MICROBIOL, V36, P2530
   RUSTHOVEN JJ, 1979, AM J MED, V67, P702, DOI 10.1016/0002-9343(79)90269-9
   SANZEN L, 1989, J BONE JOINT SURG BR, V71, P638
   Seifert H, 1999, EMERG INFECT DIS, V5, P450, DOI 10.3201/eid0503.990319
   Seifert H, 2003, EMERG INFECT DIS, V9, P1316
   Sendi P, 2006, CLIN INFECT DIS, V43, P961, DOI 10.1086/507633
   Sheldon Albert T Jr, 2005, Clin Lab Sci, V18, P170
   SHIH LY, 1987, CLIN ORTHOP RELAT R, V225, P238
   Spanu T, 2005, CLIN INFECT DIS, V41, pE48, DOI 10.1086/432577
   Stewart PS, 2002, INT J MED MICROBIOL, V292, P107, DOI 10.1078/1438-4221-00196
   Tattevin P, 1999, CLIN INFECT DIS, V29, P292, DOI 10.1086/520202
   Tunney MM, 1998, J BONE JOINT SURG BR, V80B, P568, DOI 10.1302/0301-620X.80B4.8473
   Vaudaux P, 2002, INFECT IMMUN, V70, P5428, DOI 10.1128/IAI.70.10.5428-5437.2002
   Vaudaux P, 2006, CLIN INFECT DIS, V43, P968, DOI 10.1086/507643
   von Eiff C, 1999, CLIN INFECT DIS, V29, P932, DOI 10.1086/520462
   von Eiff C, 2001, CLIN INFECT DIS, V32, P1643, DOI 10.1086/320519
   vonEiff C, 1997, CLIN INFECT DIS, V25, P1250, DOI 10.1086/516962
   VONEIFF C, 2000, INT J CLIN PRACT, V115, pS44
   Walenkamp GHIM, 1997, ACTA ORTHOP SCAND, V68, P497, DOI 10.3109/17453679708996270
   WIDMER AF, 1990, J INFECT DIS, V162, P96, DOI 10.1093/infdis/162.1.96
   Widmer AF, 2001, CLIN INFECT DIS, V33, pS94, DOI 10.1086/321863
   WISE RI, 1956, ANN NY ACAD SCI, V65, P169, DOI 10.1111/j.1749-6632.1956.tb36636.x
   Zheng ZL, 2002, ANTIMICROB AGENTS CH, V46, P900, DOI 10.1128/AAC.46.3.900-903.2002
NR 76
TC 64
Z9 68
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1745-3674
EI 1745-3682
J9 ACTA ORTHOP
JI Acta Orthop.
PY 2007
VL 78
IS 3
BP 299
EP 308
DI 10.1080/17453670710013843
PG 10
WC Orthopedics
SC Orthopedics
GA 200IZ
UT WOS:000248758400001
PM 17611841
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Nilsdotter-Augustinsson, A
   Briheim, G
   Herder, A
   Ljunghusen, O
   Wahlstrom, O
   Ohman, L
AF Nilsdotter-Augustinsson, Asa
   Briheim, Gunnar
   Herder, Anders
   Ljunghusen, Olof
   Wahlstrom, Ola
   Ohman, Lena
TI Inflammatory response in 85 patients with loosened hip prostheses - A
   prospective study comparing inflammatory markers in patients with
   aseptic and septic prosthetic loosening
SO ACTA ORTHOPAEDICA
LA English
DT Article
ID BIOMATERIAL-CENTERED INFECTION; TOTAL KNEE ARTHROPLASTY; JOINT
   INFECTION; REVISION ARTHROPLASTY; SYNOVIAL-FLUID; CYTOKINE PRODUCTION;
   TISSUE INTEGRATION; MICROBIAL ADHESION; DIAGNOSIS; REPLACEMENTS
AB Background The most common complications of prosthetic hip joints are aseptic mechanical failure and infection. Delayed low-grade infections are seen most often, and they are also most difficult to distinguish from aseptic mechanical failures.
   Methods We conducted a prospective study to compare in. ammatory markers in patients diagnosed with aseptic or septic prosthetic loosening. The diagnostic criteria were based on the decisions of experienced orthopedic surgeons and microbiological analysis of periprosthetic tissue samples taken perioperatively.
   Results Coagulase-negative staphylococci were the commonest pathogens in the infected patients. Pre- or perioperative elevation of C-reactive protein and erythrocyte sedimentation rate were significantly greater in the infection group, as were white blood cell count and levels of cytokines in synovial fluid. The patterns of infiltration of inflammatory cells in periprosthetic tissue were also significantly different between the groups.
   Interpretation A combination of clinical judgment and multiple tissue samples constitutes a good platform for distinguishing between septic and aseptic loosening of prostheses. Moreover, the combined use of several laboratory and histopathological markers of inflammation, especially infiltration of polymorphonuclear cells, further helps the diagnosis.
C1 Linkoping Univ, Div Infect Dis, Linkoping, Sweden.
   Linkoping Univ, Div Med Microbiol, Dept Mol Med & Clin Med, Linkoping, Sweden.
   Linkoping Univ, Dept Mol Med & Clin Med, Div Morphol Clin Pathol & Clin Cytol, Linkoping, Sweden.
   Linkoping Univ, Div Orthopaed, Dept Neurosci & Locomot, Linkoping, Sweden.
RP Nilsdotter-Augustinsson, A (reprint author), Linkoping Univ, Div Infect Dis, Linkoping, Sweden.
EM asa.nilsdotter@lio.se
CR ALSAFFAR N, 1994, BRIT J RHEUMATOL, V33, P309
   Atkins BL, 1998, J CLIN MICROBIOL, V36, P2932
   Augustinsson A, 2001, SCAND J INFECT DIS, V33, P408, DOI 10.1080/00365540152029855
   Bernard L, 2004, SCAND J INFECT DIS, V36, P410, DOI 10.1080/00365540410015240
   CHIBA J, 1994, CLIN ORTHOP RELAT R, P114
   COVENTRY MB, 1975, ORTHOP CLIN N AM, V6, P991
   Crowe JF, 2003, CLIN ORTHOP RELAT R, P175, DOI 10.1097/01.blo.0000072469.32680.b6
   El Esper I, 2004, NUCL MED COMMUN, V25, P171, DOI 10.1097/01.mnm.0000109830.10116.61
   Gallo Jiri, 2003, Biomedical Papers (Olomouc), V147, P27
   GLANT TT, 1993, J BONE MINER RES, V8, P1071
   Goodman SB, 1998, J BONE JOINT SURG BR, V80B, P531, DOI 10.1302/0301-620X.80B3.8158
   Gristina A, 2004, CLIN ORTHOP RELAT R, P4, DOI 10.1097/01.blo.0000145156.89115.12
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Hirakawa K, 2004, CLIN ORTHOP RELAT R, P10
   Horowitz SM, 1996, CALCIFIED TISSUE INT, V59, P392, DOI 10.1007/s002239900145
   Lentino Joseph R, 2004, Curr Infect Dis Rep, V6, P388, DOI 10.1007/s11908-004-0038-x
   Li SF, 2004, ACAD EMERG MED, V11, P276, DOI 10.1197/j.aem.2003.09.018
   McEvoy A, 2002, BONE, V30, P171
   Messieh M, 1996, J ARTHROPLASTY, V11, P484, DOI 10.1016/S0883-5403(96)80042-8
   Mirra J M, 1976, Clin Orthop Relat Res, P221
   Musso AD, 2003, POSTGRAD MED J, V79, P590, DOI 10.1136/pmj.79.936.590
   Neut D, 2003, CLIN ORTHOP RELAT R, P261, DOI 10.1097/01.blo.0000073345.50837.84
   Nguyen LL, 2002, CLIN ORTHOP RELAT R, P29, DOI 10.1097/01.blo.0000030073.92399.96
   Nivbrant B, 1999, J BONE JOINT SURG BR, V81B, P163, DOI 10.1302/0301-620X.81B1.8664
   Pandey R, 1999, J CLIN PATHOL, V52, P118, DOI 10.1136/jcp.52.2.118
   Patel R, 2005, CLIN ORTHOP RELAT R, P41, DOI 10.1097/01.blo.0000175714.68624.74
   Sanzen L, 1997, ACTA ORTHOP SCAND, V68, P461, DOI 10.3109/17453679708996263
   Spangehl MJ, 1999, J BONE JOINT SURG AM, V81A, P672, DOI 10.2106/00004623-199905000-00008
   Sundfeldt M, 2006, ACTA ORTHOP, V77, P177, DOI 10.1080/17453670610045902
   Trampuz A, 2004, AM J MED, V117, P556, DOI 10.1016/j.amjmed.2004.06.022
   Trampuz A, 2003, CLIN ORTHOP RELAT R, P69, DOI 10.1097/01.blo.0000087324.60612.93
   Tunney MM, 1998, J BONE JOINT SURG BR, V80B, P568, DOI 10.1302/0301-620X.80B4.8473
   Wang ML, 2004, J ARTHROPLASTY, V19, P1028, DOI 10.1016/j.arth.2004.03.024
   WYMENGA AB, 1992, ACTA ORTHOP SCAND, V63, P665, DOI 10.1080/17453679209169732
   Zheng LM, 2004, J IMMUNOL, V173, P6319, DOI 10.4049/jimmunol.173.10.6319
   Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181
NR 36
TC 38
Z9 39
U1 0
U2 8
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1745-3674
EI 1745-3682
J9 ACTA ORTHOP
JI Acta Orthop.
PY 2007
VL 78
IS 5
BP 629
EP 639
DI 10.1080/17453670710014329
PG 11
WC Orthopedics
SC Orthopedics
GA 225KM
UT WOS:000250516800010
PM 17966022
OA DOAJ Gold
DA 2018-10-19
ER

PT B
AU Koller, B
   Laib, A
AF Koller, Bruno
   Laib, Andres
BE Qin, L
   Griffith, JF
   Leung, KS
TI Calibration of micro-CT data for quantifying bone mineral and
   biomaterial density and microarchitecture
SO ADVANCED BIOIMAGING TECHNOLOGIES IN ASSESSMENT OF THE QUALITY OF BONE
   AND SCAFFOLD MATERIALS: TECHNIQUES AND APPLICATIONS
LA English
DT Proceedings Paper
CT International Symposium on Advanced Biotechnologies for Assessing
   Quality of Bone and Scaffold Biomaterials
CY OCT 17-19, 2005
CL Hong Kong, PEOPLES R CHINA
ID CANCELLOUS BONE; IMAGES
AB With the awareness of the importance of the bone architecture to the overall stability of bone, micro-CT has become the gold standard for 3D static histomorphometry in bone research over the past 10 years. Nevertheless, bone densitometry is still the method of choice in the clinical environment. It is, however, anticipated that only a combination of the two methods, densitometry and morphometry, will improve the diagnosis and treatment of patients. This chapter introduces the calibration of micro-CT for quantification of bone mineral and material density at both organ and tissue levels and its impact in bone and mineral research based on bone biopsy. This approach may also be widely applied to measure the density of other appreciated materials.
C1 [Koller, Bruno; Laib, Andres] Scanco Med AG, Bassersdorf, Switzerland.
RP Koller, B (reprint author), Scanco Med AG, Bassersdorf, Switzerland.
EM bkoller@scanco.ch
CR Gong H, 2005, J BONE MINER METAB, V23, P174, DOI 10.1007/s00774-004-0557-4
   Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x
   Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167
   Hildebrand T, 1997, COMPUTER METH BIOMEC, V1, P15, DOI DOI 10.1080/01495739708936692
   Lai YM, 2005, BONE, V37, P274, DOI 10.1016/j.bone.2005.04.025
   Lai YM, 2005, BONE, V36, P465, DOI 10.1016/j.bone.2004.11.005
   Laib A, 2002, OSTEOPOROSIS INT, V13, P130, DOI 10.1007/s001980200004
   LORENSEN WE, 1987, COMPUT GRAPH, V21, P163, DOI DOI 10.1145/37402.37422
   ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6
NR 9
TC 2
Z9 2
U1 0
U2 1
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
BN 978-3-540-45454-0
PY 2007
BP 79
EP +
DI 10.1007/978-3-540-45456-4_5
PG 2
WC Biochemical Research Methods; Endocrinology & Metabolism; Radiology,
   Nuclear Medicine & Medical Imaging
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism; Radiology,
   Nuclear Medicine & Medical Imaging
GA BGU36
UT WOS:000250578800005
DA 2018-10-19
ER

PT B
AU Chan, CW
   Cheng, JCY
   Yeung, HY
   Qin, L
AF Chan, Chun Wai
   Cheng, Jack Chun-Yiu
   Yeung, Hiu-Yan
   Qin, Ling
BE Qin, L
   Griffith, JF
   Leung, KS
TI Bio-imaging technologies in studying bone-biomaterial interface:
   Applications in experimental spinal fusion model
SO ADVANCED BIOIMAGING TECHNOLOGIES IN ASSESSMENT OF THE QUALITY OF BONE
   AND SCAFFOLD MATERIALS: TECHNIQUES AND APPLICATIONS
LA English
DT Proceedings Paper
CT International Symposium on Advanced Biotechnologies for Assessing
   Quality of Bone and Scaffold Biomaterials
CY OCT 17-19, 2005
CL Hong Kong, PEOPLES R CHINA
ID QUANTITATIVE COMPUTED-TOMOGRAPHY; INTERTRANSVERSE PROCESS FUSION;
   MICROCOMPUTED TOMOGRAPHY; MORPHOGENETIC PROTEIN-2; PARTIAL PATELLECTOMY;
   ELASTIC PROPERTIES; GRAFT SUBSTITUTES; CALCIUM-PHOSPHATE; NONHUMAN
   PRIMATE; MU-CT
AB Spinal fusion in orthopedic surgery is commonly used to treat spinal deformity and degenerative diseases such as scoliosis and degenerative disc disease. To advance surgical and outcome efficacy and study the biological regulations, different animal models of spinal fusion have been established, including rats, rabbits, dogs, sheep, goats, and even non-human primates. With novel biological factors, biomaterials, biophysical devices and gene therapy, and stem-cell-based-therapy being developed, many medical imaging assessment techniques are being adopted further to evaluate their potential in facilitating spinal fusion experimentally before clinical application. Many bio-imaging evaluation technologies have been developed and their potential has been explored in evaluation of bone and biomaterial interface integration both preclinically and clinically. This chapter reviews some of the conventional and advanced techniques being applied for evaluation of rate and quality of spinal fusion, especially the experimental spinal fusion models based on our own studies. These techniques are summarized in the following categories in studying fusion complex or materials properties: (a) low resolution X-ray; quantitative CT, MRI, and clinical densitometry; (b) high-resolution micro-CT, 2D and 3D histomorphometry with both static and dynamic indices; and (c) macro- and microbiomechanical tests. The general advantages and limitations of the technologies are also briefly summarized. This overview might serve as a reference for future studies concerning study design and selection of technologies for qualitative and quantitative evaluation of spinal fusion based on availability of these methods and potential local and international collaborations.
C1 [Chan, Chun Wai; Cheng, Jack Chun-Yiu; Yeung, Hiu-Yan; Qin, Ling] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Musculoskeletal Res Lab, Hong Kong, Hong Kong, Peoples R China.
RP Chan, CW (reprint author), Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Musculoskeletal Res Lab, Hong Kong, Hong Kong, Peoples R China.
EM chanwai@cuhk.edu.hk
RI Chan, Chun Wai/B-5889-2015; Qin, Ling/J-9047-2018; Cheng,
   Jack/J-3878-2018
OI Qin, Ling/0000-0001-6173-6167; Cheng, Jack/0000-0001-8153-364X
CR Boden SD, 1995, SPINE, V20, pS113, DOI 10.1097/00007632-199512151-00007
   Boden SD, 1999, SPINE, V24, P1179, DOI 10.1097/00007632-199906150-00002
   Boden SD, 2002, SPINE, V27, pS26, DOI 10.1097/01.BRS.0000020731.64266.B2
   BODEN SD, 1995, SPINE, V20, P412, DOI 10.1097/00007632-199502001-00003
   Boden SD, 1999, SPINE, V24, P320, DOI 10.1097/00007632-199902150-00003
   BODEN SD, 1998, CLIN ORTHOP S, V355, pS336
   Chan CW, 2005, KEY ENG MAT, V288-289, P491, DOI 10.4028/www.scientific.net/KEM.288-289.491
   CHAN CW, 2004, HONG KONG J ORTHOP S, V8, pS12
   CHAN CW, 2003, HONG KONG J ORTHOP S, V7, pS112
   CHAN CW, 2005, HONG KONG J ORTHOP S, V9, pS28
   Chen WJ, 2002, J TRAUMA, V52, P333, DOI 10.1097/00005373-200202000-00020
   Cheng JCY, 2002, SPINE, V27, P467, DOI 10.1097/00007632-200203010-00006
   CHENG JCY, 2002, P 12 INT RES C BIOM, P70
   COLLIER JH, 2002, J BIOMED MATER RES, V50, P574
   Cook S D, 2001, Spine J, V1, P246, DOI 10.1016/S1529-9430(01)00086-9
   DICKSON GR, 1984, METHODS CALCIFIED PR
   Glazer P A, 2001, Spine J, V1, P395, DOI 10.1016/S1529-9430(01)00108-5
   Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007
   Guo LH, 2001, J BIOMED MATER RES, V54, P554, DOI 10.1002/1097-4636(20010315)54:4<554::AID-JBM120>3.3.CO;2-0
   Guo X, 2002, J ORTHOPAED RES, V20, P740, DOI 10.1016/S0736-0266(01)00167-X
   Hasharoni A, 2005, J NEUROSURG-SPINE, V3, P47, DOI 10.3171/spi.2005.3.1.0047
   Hodges Scott D, 2003, J Am Acad Orthop Surg, V11, P81
   Iyama S, 1997, J PERIODONTOL, V68, P1169, DOI 10.1902/jop.1997.68.12.1169
   Jaecques SVN, 2004, BIOMATERIALS, V25, P1683, DOI 10.1016/S0142-9612(03)00516-7
   Jung H, 2003, INT J ORAL MAX IMPL, V18, P121
   Kandziora F, 2003, EUR SPINE J, V12, P464, DOI 10.1007/s00586-002-0483-x
   Katz JL, 1997, ST HEAL T, V40, P123
   Linovitz RJ, 2002, SPINE, V27, P1383, DOI 10.1097/00007632-200207010-00002
   Linovitz RJ, 2002, ORTHOPEDICS, V25, pS585
   Ludwig SC, 1999, ORTHOP CLIN N AM, V30, P635, DOI 10.1016/S0030-5898(05)70116-4
   Magin MN, 2001, SPINE, V26, P469, DOI 10.1097/00007632-200103010-00009
   MEDING JB, 1993, J SPINAL DISORD, V6, P166
   Moazzaz P, 2005, SPINE, V30, P1706, DOI 10.1097/01.brs.0000172230.01655.55
   Ortiz MC, 2000, KIDNEY INT, V58, P1632, DOI 10.1111/j.1523-1755.2000.00324.x
   Parfitt A, 1983, BONE HISTOMORPHOMETR, P143
   Qin L, 2006, CLIN BIOMECH, V21, P387, DOI 10.1016/j.clinbiomech.2005.11.008
   Qin L, 2004, J BONE MINER METAB, V22, P86, DOI 10.1007/s00774-003-0454-2
   Qin L, 2001, J BONE MINER METAB, V19, P359, DOI 10.1007/s007740170005
   Qin L, 1999, MED SCI SPORT EXER, V31, P502, DOI 10.1097/00005768-199904000-00002
   Salamon ML, 2003, J SPINAL DISORD TECH, V16, P90, DOI 10.1097/00024720-200302000-00014
   Sandhu HS, 1997, SPINE, V22, P1171, DOI 10.1097/00007632-199706010-00001
   Sandhu HS, 2001, EUR SPINE J, V10, pS122, DOI 10.1007/s005860100303
   Schmidt C, 2003, J BONE MINER RES, V18, P1486, DOI 10.1359/jbmr.2003.18.8.1486
   Siu WS, 2004, BONE, V35, P21, DOI 10.1016/j.bone.2004.03.014
   Suh DY, 2002, SPINE, V27, P353, DOI 10.1097/00007632-200202150-00006
   Takagi M, 2001, J BONE MINER RES, V16, P79, DOI 10.1359/jbmr.2001.16.1.79
   Toribatake Y, 1998, SPINE, V23, P1149, DOI 10.1097/00007632-199805150-00015
   Turner CH, 1999, J BIOMECH, V32, P437, DOI 10.1016/S0021-9290(98)00177-8
   Vaccaro AR, 2001, ORTHOPEDICS, V24, P191
   vonRecum AF, 1999, HDB BIOMATERIALS EVA
   Wang RR, 1998, J BIOMED MATER RES, V42, P508, DOI 10.1002/(SICI)1097-4636(19981215)42:4<508::AID-JBM5>3.0.CO;2-V
   Yeung HY, 2005, J BIOMED MATER RES B, V75B, P234
   Yeung HY, 2003, J BONE MINER RES, V18, pS301
   ZERWEKH JE, 1992, J ORTHOPAED RES, V10, P562, DOI 10.1002/jor.1100100411
   ZETTERQVIST L, 1995, CLIN ORAL IMPLAN RES, V6, P104, DOI 10.1034/j.1600-0501.1995.060206.x
NR 55
TC 0
Z9 0
U1 0
U2 4
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
BN 978-3-540-45454-0
PY 2007
BP 333
EP +
DI 10.1007/978-3-540-45456-4_20
PG 5
WC Biochemical Research Methods; Endocrinology & Metabolism; Radiology,
   Nuclear Medicine & Medical Imaging
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism; Radiology,
   Nuclear Medicine & Medical Imaging
GA BGU36
UT WOS:000250578800020
DA 2018-10-19
ER

PT B
AU Cheung, WH
   Qin, L
   Tam, KF
   Siu, WS
   Leung, KS
AF Cheung, Wing-Hoi
   Qin, Ling
   Tam, Kam-Fai
   Siu, Wing-Sum
   Leung, Kwok-Sui
BE Qin, L
   Griffith, JF
   Leung, KS
TI Enhancement of osteoporotic bone using injectable hydroxyapatite in OVX
   goats evaluated by multi-imaging modalities
SO ADVANCED BIOIMAGING TECHNOLOGIES IN ASSESSMENT OF THE QUALITY OF BONE
   AND SCAFFOLD MATERIALS: TECHNIQUES AND APPLICATIONS
LA English
DT Proceedings Paper
CT International Symposium on Advanced Biotechnologies for Assessing
   Quality of Bone and Scaffold Biomaterials
CY OCT 17-19, 2005
CL Hong Kong, PEOPLES R CHINA
ID CALCIUM-PHOSPHATE CEMENT; QUANTITATIVE COMPUTED-TOMOGRAPHY; MINERAL
   DENSITY; FRACTURE TREATMENT; CORTICAL BONE; FIXATION; INTENSITY; WOMEN;
   MODEL; PQCT
AB Osteoporotic fracture is very common in aged population, with an average of 1-3% increase per year in most areas of the world because of increase in aging population. Fixation of osteoporotic fracture is difficult, often with implant loosening or backout. Fixation enhancement with various biomaterials and implants is investigated before clinical application. This chapter describes a study investigating the effect of an optimized injectable hydroxyapatite (HA) on enhancing screw fixation in osteoporotic bones. By using radiography, pQCT and micro-CT, the development of osteoporosis in ovariectomized Chinese goats was confirmed. There was an averaged 25% decrease of bone mineral density in the goats after 6-month ovariectomy as well as a significant reduction of trabecular thickness and connectivity. The established osteoporotic goat model was then used for evaluating the efficacy of an optimized injectable HA in screw fixation. With the application of micro-CT and histomorphometry, it was confirmed that the injectable HA was distributed evenly along the screw threads and new bone formation was detected on HA surface without fibrous tissues. The HA increased the contact area between implants and trabecular bones, and hence the holding power to screws. Mechanical test further confirmed the significant increase of screw pull-out force by HA. This study demonstrated the application of multiple non-invasive bioimaging technologies in biomaterial research.
C1 [Cheung, Wing-Hoi; Qin, Ling; Tam, Kam-Fai; Siu, Wing-Sum; Leung, Kwok-Sui] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Shatin, Hong Kong, Peoples R China.
RP Cheung, WH (reprint author), Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Shatin, Hong Kong, Peoples R China.
EM louis@ort.cuhk.edu.hk
RI Qin, Ling/J-9047-2018; Cheung, Wing Hoi/J-2150-2018
OI Qin, Ling/0000-0001-6173-6167; Cheung, Wing Hoi/0000-0003-3247-8255
CR Blattert TR, 2002, SPINE, V27, P2697, DOI 10.1097/00007632-200212010-00009
   Breusch SJ, 2003, ORTHOPADE, V32, P41, DOI 10.1007/s00132-002-0411-0
   Chan KM, 2004, ARCH PHYS MED REHAB, V85, P717, DOI 10.1016/j.apmr.2003.08.091
   Cheng J. C. Y., 2001, Hong Kong Medical Journal, V7, P241
   Cummings SR, 2002, LANCET, V359, P1761, DOI 10.1016/S0140-6736(02)08657-9
   Dambacher M, 2005, BONE, V36, pS324
   DAMBACHER MA, 2004, J BONE MINER METAB, V3, P2
   Elder S, 2000, J ORTHOP TRAUMA, V14, P386, DOI 10.1097/00005131-200008000-00002
   Goodman SB, 1998, CLIN ORTHOP RELAT R, P42
   [贺颖 He Ying], 2003, [中华妇产科杂志, Chinese Journal of Obstetrics and Gynecology], V38, P405
   Ho KS, 2003, PUBLIC HLTH EPIDEMIO, V12, P13
   ITO M, 1995, RADIOLOGY, V194, P55, DOI 10.1148/radiology.194.1.7997582
   Lai YM, 2005, BONE, V36, P465, DOI 10.1016/j.bone.2004.11.005
   Larsson S, 2002, CLIN ORTHOP RELAT R, P23
   Leung KS, 2006, J BIOMED MATER RES B, V78B, P153, DOI 10.1002/jbm.b.30467
   Leung KS, 2001, J BONE MINER RES, V16, P2348, DOI 10.1359/jbmr.2001.16.12.2348
   Lill CA, 2000, J ORTHOP TRAUMA, V14, P559, DOI 10.1097/00005131-200011000-00007
   Muller R, 1996, BONE, V18, P215, DOI 10.1016/8756-3282(95)00489-0
   NEFF M, 2004, OSTEOLOGY, V13, pS98
   PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617
   PECK WA, 1993, AM J MED, V94, P646
   Qin L, 2006, CLIN BIOMECH, V21, P387, DOI 10.1016/j.clinbiomech.2005.11.008
   Qin L, 2002, OSTEOPOROSIS INT, V13, P962, DOI 10.1007/s001980200134
   Qin L, 2001, J BONE MINER METAB, V19, P359, DOI 10.1007/s007740170005
   Qin L, 1999, ANAT RECORD, V255, P380
   QIN L, 2003, MENOPAUSE STATE ART, P1124
   QIN L, 1998, LAUREATE DRAGON, V2
   Rauch F, 2001, J BONE MINER RES, V16, P597, DOI 10.1359/jbmr.2001.16.4.597
   RUEGSEGGER P, 1976, RADIOLOGY, V121, P93
   SHELDON RS, 1994, ORTHOPAEDIC BASIC SC, P129
   Siu WS, 2004, BONE, V35, P21, DOI 10.1016/j.bone.2004.03.014
   Siu WS, 2003, J BONE MINER METAB, V21, P316, DOI 10.1007/s00774-003-0427-5
   Wilke HJ, 1998, ANAT REC, V251, P15, DOI 10.1002/(SICI)1097-0185(199805)251:1<15::AID-AR4>3.0.CO;2-D
   World Health Organizations, 1994, WHO TECH REP SER, V843
NR 34
TC 0
Z9 0
U1 0
U2 2
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
BN 978-3-540-45454-0
PY 2007
BP 517
EP +
DI 10.1007/978-3-540-45456-4_32
PG 4
WC Biochemical Research Methods; Endocrinology & Metabolism; Radiology,
   Nuclear Medicine & Medical Imaging
SC Biochemistry & Molecular Biology; Endocrinology & Metabolism; Radiology,
   Nuclear Medicine & Medical Imaging
GA BGU36
UT WOS:000250578800032
DA 2018-10-19
ER

PT S
AU Kurosu, S
   Nomura, N
   Chiba, A
AF Kurosu, Shingo
   Nomura, Naoyuki
   Chiba, Akihiko
BE Chang, YW
   Kim, NJ
   Lee, CS
TI Effect of Sigma Phase in Co-29Cr-6Mo Alloy on Corrosion and Mechanical
   Properties
SO ADVANCED MATERIALS AND PROCESSING
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 6th Pacific Rim International Conference on Advanced Materials and
   Processing
CY NOV 05-09, 2007
CL Cheju Isl, SOUTH KOREA
SP Korean Inst Met & Mat, Chinese Soc Met, Japan Inst Met, Minerals, Met & Mat Soc, Inst Mat Engn Australia
DE cobalt-chromium-molybdenum alloy; biomaterial; corrosion; mechanical
   properties; sigma phase (sigma); aging treatment
AB Effect of the sigma (sigma) phase in Co-29Cr-6Mo alloy on corrosion and mechanical behavior has been investigated. The area fraction of the s phase varies depending on the aging time at 1023 K. The area fraction of the sigma phase increases with increasing aging time and reaches 0.6 % after aging at 1023 K for 21.6 ks. Inductively coupled plasma atomic emission spectrometer (ICP-AES) analysis revealed the quantity of released Co ion shows almost the same values regardless of different area fraction of the s phase. In addition, plastic elongation and 0.2% proof strength exhibit almost the same values, although the alloys have different area fraction of the s phase. These results suggest that a small amount of the s phase (<0.6%) hardly affect the corrosion and mechanical properties in the Co-29Cr-6Mo alloy.
C1 [Kurosu, Shingo] Iwate Univ, Grad Sch Engn, Dept Mat Sci, Morioka, Iwate 0208551, Japan.
   [Nomura, Naoyuki] Iwate Univ, Fac Engn, Dept Welf Engn, Morioka, Iwate 0208551, Japan.
   [Chiba, Akihiko] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.
RP Kurosu, S (reprint author), Iwate Univ, Grad Sch Engn, Dept Mat Sci, Morioka, Iwate 0208551, Japan.
EM t5105001@iwate-u.ac.jp; nnomura@iwate-u.ac.jp; a.chiba@imr.tohoku.ac.jp
RI NOMURA, Naoyuki/L-7149-2017
FU Cooperation of Innovative Technology; Cooperation of Innovative
   Technology and Advanced Research in Evolutional Area from Ministry of
   Education, Culture, Sports, Science and Technology of Japan
FX The authors would like to thank to Prof. K. Yamaguchi at Department of
   Materials Science and Engineering, Faculty of engineering, Iwate
   University for the measurement with ICP-AES and technical supports. This
   research was supported by a Cooperation of Innovative Technology and
   Advanced Research in Evolutional Area from Ministry of Education,
   Culture, Sports, Science and Technology of Japan.
CR AGELINI E, 2004, CORROS SCI, V46, P1351
   Hiromoto S, 2005, BIOMATERIALS, V26, P4912, DOI 10.1016/j.biomaterials.2005.01.028
   HOLLEK H, 1995, HDB TERNARY ALLOY PH, V6
   PARK CJ, 2006, MAT SCI ENG A-STRUCT, V418, P1961
   SILVERMAN R, 1957, AM SOC MET, V49, P805
NR 5
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-463-7
J9 ADV MATER RES-SWITZ
PY 2007
VL 26-28
BP 777
EP +
DI 10.4028/www.scientific.net/AMR.26-28.777
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA BOP79
UT WOS:000277260000184
DA 2018-10-19
ER

PT S
AU Oh, MY
   Choe, HC
   Ko, YM
AF Oh, Mi Young
   Choe, Han Cheol
   Ko, Yeong Mu
BE Chang, YW
   Kim, NJ
   Lee, CS
TI AC IMPEDANCE BEHAVIORS OF Ti-Zr BINARY ALLOYS FOR BIOMATERIALS
SO ADVANCED MATERIALS AND PROCESSING
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 6th Pacific Rim International Conference on Advanced Materials and
   Processing
CY NOV 05-09, 2007
CL Cheju Isl, SOUTH KOREA
SP Korean Inst Met & Mat, Chinese Soc Met, Japan Inst Met, Minerals, Met & Mat Soc, Inst Mat Engn Australia
DE Ti-Zr alloy; biomaterial; AC impedance
AB In this study, AC impedance behaviors of Ti-Zr binary alloys for biomaterials have been investigated using by electrochemical impedance spectroscopy. Ti-10wt%, 20wt%, 30wt%, and 40wt% Zr alloys were prepared by arc melting and homogenized for 24 hr at 1000 C in argon atmosphere. Phase constitutions and microstructure of the specimens were conducted by using XRD, OM and SEM. The corrosion properties of the specimens were examined through potentiodynamic test (potential range of -1500 similar to 2000 mV), AC impedance spectroscopy(100kHz similar to 10mHz) in artificial saliva solution by potentiostat (EG&G Co, PARSTAT 2273. USA). In as-cast and homogenized Ti-xZr alloys, alpha-phase was identified by XRD. Microstructures were changed from lamellar structure to needle-like structure as Zr content increased. From the results of polarization behavior in the Ti-xZr alloys, it was found that the corrosion resistance was increased with increasing Zr content. From results of AC impedance spectroscopy, passive film resistance value of homogenized Ti-40Zr specimen(1.60x10(6) Omega cm(2)) showed higher than that of as-cast specimen.
C1 [Oh, Mi Young; Choe, Han Cheol; Ko, Yeong Mu] Chosun Univ, Stage Brain Korea Coll Dent 2 21, Kwangju, South Korea.
RP Oh, MY (reprint author), Chosun Univ, Stage Brain Korea Coll Dent 2 21, Kwangju, South Korea.
EM my4130@nate.com; hcchoe@chosun.ac.kr; ymgo@chosun.ac.kr
CR Aziz-Kerrzo M, 2001, BIOMATERIALS, V22, P1531, DOI 10.1016/S0142-9612(00)00309-4
   JIANG XP, MAT SCI ENG A, V429, P30
   KOBAYASHI E, MAT SCI, V9
   KURODA D, 1998, MATER SCI ENG, V243, P224
   LUCKEY HA, 1998, ASTM PUBLICATION STP, V1, P796
   Park JJ, 2007, MATER SCI FORUM, V539-543, P1270, DOI 10.4028/www.scientific.net/MSF.539-543.1270
   Rao S, 1996, BIO-MED MATER ENG, V6, P79
   WALKER PR, 1989, BIOCHEMISTRY-US, V28, P3911, DOI 10.1021/bi00435a043
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V384, P92, DOI 10.1016/j.msea.2004.05.084
NR 9
TC 3
Z9 3
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-463-7
J9 ADV MATER RES-SWITZ
PY 2007
VL 26-28
BP 817
EP +
DI 10.4028/www.scientific.net/AMR.26-28.817
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA BOP79
UT WOS:000277260000194
DA 2018-10-19
ER

PT S
AU Ye, JJ
   Sun, DH
AF Ye Junjun
   Sun Daoheng
BE Yang, L
   Chen, Y
   Kley, YB
   Li, R
TI Fabrication of electrospun nanofibers bundles - art. no. 6722F
SO ADVANCED OPTICAL MANUFACTURING TECHNOLOGIES, PTS 1 AND 2
SE PROCEEDINGS OF THE SOCIETY OF PHOTO-OPTICAL INSTRUMENTATION ENGINEERS
   (SPIE)
LA English
DT Proceedings Paper
CT 3rd International Symposium on Advanced Optical Manufacturing and
   Testing Technologies
CY JUL 08-12, 2007
CL Chengdu, PEOPLES R CHINA
SP China Opt Soc, CAS, Inst Opt & Elect, SPIE, State Key Lab Opt Technol Microfabricat, Sichuan Opt Soc
DE electrospinning; nanofibers bundles; density; non-uniform
   electricalfield
ID POLYMER NANOFIBERS; NANOLITHOGRAPHY; DIAMETER; FIBERS
AB Aligned nanofibers, filament bundle composed of large number of nanofibers have potential applications such as biomaterial, composite material etc. A series of electrospinning experiments have been conducted to investigate the electrospinning process,in which some parameters such as polymer solution concentration, bias voltage, distance between spinneret and collector, solution flow rate etc have been setup to do the experiment of nanofibers bundles construction. This work firstly reports electrospun nanofiber bundle through non-uniform electrical field, and nanofibers distributed in different density on electrodes from that between them. Thinner nanofibers bundle with a few numbers of nanofiber is collected for 3 seconds; therefore it's also possible that the addressable single nanofiber could be collected to bridge two electrodes.
C1 [Ye Junjun; Sun Daoheng] Xiamen Univ, Dept Mech & Elect Engn, Xiamen 361005, Peoples R China.
RP Ye, JJ (reprint author), Xiamen Univ, Dept Mech & Elect Engn, Xiamen 361005, Peoples R China.
CR Dersch R, 2003, J POLYM SCI POL CHEM, V41, P545, DOI 10.1002/pola.10609
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Kameoka J, 2003, NANOTECHNOLOGY, V14, P1124, DOI 10.1088/0957-4484/14/10/310
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   Li D, 2005, NANO LETT, V5, P913, DOI 10.1021/nl0504235
   Liu HQ, 2004, NANO LETT, V4, P671, DOI 10.1021/nl049826f
   Lodish H., 2000, MOL CELL BIOL, P154
   Lyuksyutov SF, 2003, APPL PHYS LETT, V83, P4405, DOI 10.1063/1.1629787
   Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661
   Pinto NJ, 2003, APPL PHYS LETT, V83, P4244, DOI 10.1063/1.1627484
   Reneker DH, 2000, J APPL PHYS, V87, P4531, DOI 10.1063/1.373532
   Reneker DH, 1996, NANOTECHNOLOGY, V7, P216, DOI 10.1088/0957-4484/7/3/009
   Sarazin P, 2004, BIOMATERIALS, V25, P5965, DOI 10.1016/j.biomaterials.2004.01.065
   Son WK, 2004, POLYMER, V45, P2959, DOI 10.1016/j.polymer.2004.02.006
   Sun ZC, 2003, ADV MATER, V15, P1929, DOI 10.1002/adma.200305136
   Wang XY, 2002, NANO LETT, V2, P1273, DOI 10.1021/nl020216u
   Zhou YX, 2003, APPL PHYS LETT, V83, P3800, DOI 10.1063/1.1622108
NR 17
TC 0
Z9 0
U1 1
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-6879-6
J9 P SOC PHOTO-OPT INS
PY 2007
VL 6722
BP F6722
EP F6722
PN 1-2
PG 5
WC Engineering, Manufacturing; Optics
SC Engineering; Optics
GA BHF71
UT WOS:000252739500050
DA 2018-10-19
ER

PT S
AU Hermansson, L
   Engqvist, H
AF Hermansson, L.
   Engqvist, H.
BE Mizuno, M
TI CHEMICALLY BONDED CERAMICS BASED ON CA-ALUMINATES AS BIOMATERIALS
SO ADVANCES IN BIOCERAMICS AND BIOCOMPOSITES II
SE Ceramic Engineering and Science Proceedings
LA English
DT Proceedings Paper
CT 30th International Conference and Exposition on Advanced Ceramics and
   Composites
CY JAN 22-27, 2006
CL Cocoa Beach, FL
SP Amer Ceram Soc,Engn Ceram Div
ID CEMENT
AB This presentation aims at giving an overview picture of the potential of Ca-aluminate as biomaterial Identified possible applications for Ca-aluminate based materials are within vertebroplasty and odontology An additional field of interest is as an implant coating material Ca-aluminate with oxide particles as well as Ca aluminate with glass particles were examined concerning handling and mechanical properties, biocompatibility and bioactivity For both orthopaedic and dental injectable CA-pastes the working time of 4 minutes and the setting time about 10 minutes are achievable The fracture toughness was determined to be in the range 0 5-1 0 MPam(1/2) and the compressive strength in the interval 150-250 MPa depending on selected w/c ratio, and the flexural strength above 50 MPa The hardness is about 100 HV, and Young s modulus 10-15 GPa The hydrates formed are in the size range of 20 50 nm In lard tissue the Ca-aluminate based materials form a chemical interface totally closing the gap between the biomaterial and the surrounding tissue Two features contribute to this sealing of interfaces, first the general dissolution of Ca-aluminate and precipitation of nanosize hydrates m micro-voids between particles and tissue, and on all possible walls including tissue surfaces, and second the zone formation including possible apatite formation upon which bioactive-induced formation of new tissue including apatite formation Thus both a pure chemical integration and a biologically induced integration contribute to sealing of biomaterial-tissue interfaces
OI Engqvist, Hakan/0000-0001-9529-650X
CR Axen N, 2004, KEY ENG MAT, V254-2, P265, DOI 10.4028/www.scientific.net/KEM.254-256.265
   AXEN N, KEY ENG MAT, V284, P831
   AXEN N, 2005, ADV CER COM IN PRESS
   AXEN N, 2004, CELLS T IN PRESS SEP
   Engqvist H, 2004, BIOMATERIALS, V25, P2781, DOI 10.1016/j.biomaterials.2003.09.053
   ENGQVIST H, 2005, ADV CER COM IN PRESS
   Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1
   Hermansson L, 2003, KEY ENG MAT, V247, P437, DOI 10.4028/www.scientific.net/KEM.247.437
   KRAFT L, 2002, THESIS UPPSALA U SWE
   LIU Y, 2001, IADR CHIB C JAP JUN
   Loof J, 2005, KEY ENG MAT, V284-286, P741
   Loof J, 2004, KEY ENG MAT, V254-2, P51
   NILSSON M, 2003, THESIS LUND
   PATTERSON RJ, MICROSCOPY MIC UNPUB
   Powers T., 1946, J AM CONCRETE I, V43, P492
   Roemhildt ML, 2003, J MATER SCI-MATER M, V14, P137, DOI 10.1023/A:1022067729008
   SPENGLER H, 16 INT RES C B UNPUB
NR 17
TC 0
Z9 0
U1 0
U2 2
PU AMER CERAMIC SOC
PI WESTERVILLE
PA 735 CERAMIC PLACE, WESTERVILLE, OH 43081-8720 USA
SN 0196-6219
BN 978-0-470-08056-6
J9 CERAM ENG SCI PROC
PY 2007
VL 27
IS 6
BP 71
EP 86
PG 16
WC Materials Science, Ceramics; Materials Science, Biomaterials; Materials
   Science, Composites
SC Materials Science
GA BSL63
UT WOS:000284867100007
DA 2018-10-19
ER

PT S
AU Chen, B
   Peng, XH
   Wu, XY
AF Chen, Bin
   Peng, Xianghe
   Wu, Xinyan
BE Kim, JK
   Wo, DZ
   Zhou, LM
   Huang, HT
   Lau, KT
   Wang, M
TI Sheet-layer microstructure and toughness mechanism of shinbone
SO ADVANCES IN COMPOSITE MATERIALS AND STRUCTURES, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 5th Asian/Australasian Conference on Composite Materials (ACCM-5)
CY NOV 27-30, 2006
CL Hong Kong, PEOPLES R CHINA
SP Hong Kong Univ Sci & Technol, Nanjing Univ Aeronaut & Astronaut, Hong Kong Polytech Univ, Univ Hong Kong
DE shinbone; ceramic composite; hydroxyapatite sheet; fracture toughness
ID BONE
AB Most structural materials existing in nature take the form of composite. After centuries' evolution, these materials gain highly optimized microstructures and performances. In this work, a kind of natural biomaterial, shinbone, is observed with a scanning electron microscope (SEM). The observation result shows that the bone is a bioceramic composite consisting of hydroxyapatite layers and collagen matrix. The observation also shows that the hydroxyapatite layers are composed of hydroxyapatite sheets. The hydroxyapatite sheets are of thin and long shape and parallel distribution along the orientation of the maximum main stress of the bone. The shape and distribution of the hydroxyapatite sheets may endow the bone with favorable fracture toughness, which is analyzed and illuminated based a representational model of the hydroxyapatite sheets and the idea of maximum pullout force.
C1 [Chen, Bin] Chongqing Univ, Coll Resources & Environm Sci, Dept Mech Engn, Chongqing 400044, Peoples R China.
RP Chen, B (reprint author), Chongqing Univ, Coll Resources & Environm Sci, Dept Mech Engn, Chongqing 400044, Peoples R China.
EM bchen@cqu.edu.cn; xhpeng@cqu.edu.cn; cdxywu@163.com
FU Natural Science Foundations of China [10572157, 10272120]
FX The authors gratefully acknowledge the financial supports to this work
   from the Natural Science Foundations of China (Grant no. 10572157 and
   10272120).
CR CHONG KP, 1999, MECH AAM, V28, P1
   Currey JD, 2003, J BIOMECH, V36, P1487, DOI 10.1016/S0021-9290(03)00124-6
   HOGAN HA, 1992, P AM SOC COM, P196
   Katti DR, 2001, COMPUT THEOR POLYM S, V11, P397, DOI 10.1016/S1089-3156(01)00012-5
   SARIKAYA M, 1989, P AM COMP, P176
   Zioupos P, 1998, BONE, V22, P57, DOI 10.1016/S8756-3282(97)00228-7
NR 6
TC 3
Z9 3
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-427-9
J9 KEY ENG MATER
PY 2007
VL 334-335
BP 1129
EP +
DI 10.4028/www.scientific.net/KEM.334-335.1129
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Characterization &
   Testing; Materials Science, Composites
SC Materials Science
GA BFV92
UT WOS:000245033100283
DA 2018-10-19
ER

PT S
AU Yeung, HY
   Qin, L
   Lee, KM
   Leung, KS
   Cheng, JCY
AF Yeung, H. Y.
   Qin, L.
   Lee, K. M.
   Leung, K. S.
   Cheng, J. C. Y.
BE Kim, JK
   Wo, DZ
   Zhou, LM
   Huang, HT
   Lau, KT
   Wang, M
TI Objective quantification of porous structure in orthopaedic biomaterial
   implants using micro computed tomography
SO ADVANCES IN COMPOSITE MATERIALS AND STRUCTURES, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 5th Asian/Australasian Conference on Composite Materials (ACCM-5)
CY NOV 27-30, 2006
CL Hong Kong, PEOPLES R CHINA
SP Hong Kong Univ Sci & Technol, Nanjing Univ Aeronaut & Astronaut, Hong Kong Polytech Univ, Univ Hong Kong
DE bioceramics; micro-computed tomography; porosity; porous structure
   quantification
ID BMP-INDUCED OSTEOGENESIS; PORE-SIZE; HYDROXYAPATITE; BONE
AB Porous calcium phosphate ceramics have been widely investigated in orthopaedic surgery as bone extensor. Attention has been given to manufacturing of a porous bioceramic that mimics the trabecular bone structure for proper bone regeneration and integration. Although different methods have been applied to manufacture the porous structure, it was unable to visualize the pores and their interconnections within the ceramic and had objective measurement of the calcium phosphate ceramics. With the advance of biomedical imaging through micro-computed tomography (microCT), the study attempted to quantify the pore structure of different calcium phosphate ceramics. Three kinds of bioceramic blocks, namely BSC, ChronOS, and THA, were synthesized by three methods and tested in the study. Six blocks of each bioceramic were evaluated by conventional water immersion method and microCT. The pore size and connectivity of the pores were evaluated with standardized protocols. The three-dimensional analysis of the pores and their distribution by microCT was presented. The ChronOS had more functional pores (200-400wm in diameter) than the BSC and THA did (p < 0.05). Providing objective information on the functional pores, the microCT evaluation serves as a good standard for specification of the bioceramic-related implants.
C1 [Yeung, H. Y.; Qin, L.; Leung, K. S.; Cheng, J. C. Y.] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.
   [Lee, K. M.] Chinese Univ Hong Kong, Lee Hysan Clin Res Lab, Hong Kong, Hong Kong, Peoples R China.
RP Yeung, HY (reprint author), Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.
EM byeung@cuhk.edu.hk; lingqin@cuhk.edu.hk; simonlee@cuhk.edu.hk;
   ksleung@cuhk.edu.hk; jackcheng@cuhk.edu.hk
RI Qin, Ling/J-9047-2018; Cheng, Jack/J-3878-2018
OI Qin, Ling/0000-0001-6173-6167; Cheng, Jack/0000-0001-8153-364X
FU Hong Kong Jockey Club Osteoporosis Center for Care and Control (JOCOC);
   AO Research Fund of the AO Foundation [AO/ASIF 03-C46]
FX We would like to thank the Hong Kong Jockey Club Osteoporosis Center for
   Care and Control (JOCOC) for providing the funding for the microCT
   machine used for this study. This project (Ref. AO/ASIF 03-C46) was
   supported by the AO Research Fund of the AO Foundation.
CR ANGEL M F, 1985, Microsurgery, V6, P175, DOI 10.1002/micr.1920060309
   GRENGA TE, 1989, PLAST RECONSTR SURG, V84, P245, DOI 10.1097/00006534-198908000-00009
   GUO X, 1993, THESIS U ESSEN GERMA
   Hildebrand T, 1997, J MICROSC-OXFORD, V185, P67, DOI 10.1046/j.1365-2818.1997.1340694.x
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   KLAWITTER JJ, 1979, THESIS CLEMSON U
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Kurioka Kazuhito, 1999, Kobe Journal of Medical Sciences, V45, P149
   ODGAARD A, 1993, BONE, V14, P173, DOI 10.1016/8756-3282(93)90245-6
   Oya M, 2002, AM CERAM SOC BULL, V81, P52
   Shors EC, 1999, ORTHOP CLIN N AM, V30, P599, DOI 10.1016/S0030-5898(05)70113-9
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   VANBLITTERSWIJK CA, 1986, BIOMATERIALS, V7, P137, DOI 10.1016/0142-9612(86)90071-2
NR 13
TC 0
Z9 0
U1 1
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-427-9
J9 KEY ENG MATER
PY 2007
VL 334-335
BP 1205
EP +
DI 10.4028/www.scientific.net/KEM.334-335.1205
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Characterization &
   Testing; Materials Science, Composites
SC Materials Science
GA BFV92
UT WOS:000245033100302
DA 2018-10-19
ER

PT J
AU Richards, RG
   Simpson, AE
   Jaehn, K
   Furlong, PI
   Stoddart, MJ
AF Richards, R. Geoff
   Simpson, Angharad E.
   Jaehn, Katharina
   Furlong, Pamela I.
   Stoddart, Martin J.
TI Establishing a 3D Ex vivo culture system for investigations of bone
   metabolism and biomaterial interactions
SO ALTEX-ALTERNATIVEN ZU TIEREXPERIMENTEN
LA English
DT Article
DE human; bone; osteocytes; osteoblasts; loading culture chamber;
   reduction; replacement; toxicity testing; biomaterials implants;
   validation
AB A 3D load-providing culture system is presented, which enables human cancellous bone explants to be studied ex vivo. Bone integrity and activity was demonstrated during 2 to 3 weeks of culture. Viable osteocytes and bone specific markers could be identified. Culture conditions were improved using a serum free medium containing TGF-beta 3. Therefore this system gives the opportunity to study bone biology, hormonal effects as well as biomaterial interactions ex vivo prior to animal studies.
C1 AO Res Inst, CH-7270 Davos, Switzerland.
RP Richards, RG (reprint author), AO Res Inst, Clavadelerstr 8, CH-7270 Davos, Switzerland.
EM geoff.richards@aofoundation.org
RI Richards, Robert/I-8235-2015; Stoddart, Martin/E-3240-2013
OI Richards, Robert/0000-0002-7778-2480; Stoddart,
   Martin/0000-0002-9538-1517
CR Davies CM, 2006, EUR CELLS MATER, V11, P57, DOI 10.22203/eCM.v011a07
   Jones D. B., 2003, European Cells & Materials, V5, P48
   Stoddart MJ, 2006, EUR CELLS MATER, V12, P16, DOI 10.22203/eCM.v012a02
   TENDIJKE P, 1990, MOL CELL BIOL, V10, P4473, DOI 10.1128/MCB.10.9.4473
   Yang R, 2003, Eur Cell Mater, V6, P57
NR 5
TC 6
Z9 6
U1 0
U2 4
PU SPEKTRUM AKAD VERLAG
PI HEIDELBERG
PA VANGEROWSTR 20, D-69115 HEIDELBERG, GERMANY
SN 0946-7785
J9 ALTEX-ALTERN TIEREXP
JI Altex Altern. Tierexp.
PY 2007
VL 24
SI SI
BP 56
EP 59
PG 4
WC Integrative & Complementary Medicine
SC Integrative & Complementary Medicine
GA 211PG
UT WOS:000249535100019
PM 19835059
DA 2018-10-19
ER

PT J
AU Guzzo, JL
   Bochicchio, GV
   Henry, S
   Keller, E
   Scalea, TM
AF Guzzo, James L.
   Bochicchio, Grant V.
   Henry, Sharon
   Keller, Elena
   Scalea, Thomas M.
TI Incarcerated inguinal hernia in the presence of Fournier's gangrene: A
   novel approach to a complex problem
SO AMERICAN SURGEON
LA English
DT Article
ID INTESTINAL SUBMUCOSA; LAPAROSCOPIC MESH; GROIN HERNIA; DOG-MODEL;
   REPAIR; DEFECTS
AB Fournier's gangrene is an aggressive, polymicrobial soft tissue infection that specifically affects the genital and perineal region. Treatment requires early recognition, broad-spectrum intravenous antibiotics, and radical surgical debridement of all infected tissues. Optimal therapy may necessitate multiple debridements that leave the patient with large tissue defects that require skin grafting for scrotal and perineal reconstruction. The presence of other surgical emergencies, such as an incarcerated inguinal hernia, in the face of Fournier's gangrene presents a rare and challenging dilemma to the general surgeon. With the widespread acceptance of tension-free repair utilizing prosthetic mesh in uncomplicated hernia surgery, outcomes have been improved. However, surgical options for hernia repair may become limited in the face of a regional necrotizing soft tissue infection, for which mesh use in an open repair after debridement of infected tissues is generally contraindicated. In this report, the authors describe three consecutive cases of incarcerated inguinal hernia in the presence of concomitant Fournier's gangrene using a laparoscopic approach and natural biomaterial mesh for abdominal wall reinforcement.
C1 R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA.
   Univ Maryland, Sch Med, Baltimore, MD 21201 USA.
RP Bochicchio, GV (reprint author), R Adams Cowley Shock Trauma Ctr, 22 S Greene St, Baltimore, MD 21201 USA.
CR Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   BADYLAK SF, 1994, J VASC SURG, V19, P465, DOI 10.1016/S0741-5214(94)70073-7
   Birolini C, 2000, J AM COLL SURGEONS, V191, P366, DOI 10.1016/S1072-7515(00)00703-1
   CARKE KM, 1996, J SURG RES, V60, P107
   DAYTON MT, 1986, ARCH SURG-CHICAGO, V121, P954
   Dejardin LM, 1999, J BIOMED MATER RES, V46, P203, DOI 10.1002/(SICI)1097-4636(199908)46:2<203::AID-JBM9>3.0.CO;2-4
   Eke N, 2000, BRIT J SURG, V87, P718, DOI 10.1046/j.1365-2168.2000.01497.x
   FELIX EL, 1995, SURG ENDOSC-ULTRAS, V9, P984
   Ferzli G, 2004, SURG ENDOSC, V18, P228, DOI 10.1007/s00464-003-8185-y
   Ferzli G, 1998, SURG ENDOSC-ULTRAS, V12, P1311, DOI 10.1007/s004649900847
   Franklin M E Jr, 2004, Hernia, V8, P186
   Franklin M E Jr, 2002, Hernia, V6, P171
   GALLEGOS NC, 1991, BRIT J SURG, V78, P1171, DOI 10.1002/bjs.1800781007
   GILBERT AI, 1989, AM J SURG, V157, P331, DOI 10.1016/0002-9610(89)90564-3
   Helton WS, 2005, ARCH SURG-CHICAGO, V140, P549, DOI 10.1001/archsurg.140.6.549
   Ishihara T, 1996, SURG ENDOSC-ULTRAS, V10, P1111, DOI 10.1007/s004649900254
   Jacobs DO, 2004, NEW ENGL J MED, V350, P1895, DOI 10.1056/NEJMe048062
   Johansson B, 1999, ANN SURG, V230, P225, DOI 10.1097/00000658-199908000-00013
   KELLEY ME, 2002, AM SURGEON, V6, P524
   Lantz G C, 1993, J Invest Surg, V6, P297, DOI 10.3109/08941939309141619
   Lavonius MI, 2000, SURG ENDOSC-ULTRAS, V14, P488, DOI 10.1007/s004640000018
   LEIBL BJ, 2000, SURG ENDOSC, V15, P1179
   LICHTENSTEIN IL, 1993, SURG CLIN N AM, V73, P529
   MCKERNAN JB, 1993, SURG ENDOSC-ULTRAS, V7, P26, DOI 10.1007/BF00591232
   Neumayer L, 2004, NEW ENGL J MED, V350, P1819, DOI 10.1056/NEJMoa040093
   Sarikaya A, 2002, TISSUE ENG, V8, P63, DOI 10.1089/107632702753503063
   UNEO T, 2004, J GASTROINTEST SURG, V8, P109
   WATSON SD, SURG LAPAROSC ENDOSC, V3, P106
NR 28
TC 6
Z9 7
U1 0
U2 1
PU SOUTHEASTERN SURGICAL CONGRESS
PI ATLANTA
PA 141 WEST WIEUCA RD, STE B100, ATLANTA, GA 30342 USA
SN 0003-1348
J9 AM SURGEON
JI Am. Surg.
PD JAN
PY 2007
VL 73
IS 1
BP 93
EP 95
PG 3
WC Surgery
SC Surgery
GA 123QR
UT WOS:000243310900022
PM 17249467
DA 2018-10-19
ER

PT J
AU Mack, D
   Davies, AP
   Harris, LG
   Rohde, H
   Horstkotte, MA
   Knobloch, JKM
AF Mack, Dietrich
   Davies, Angharad P.
   Harris, Llinos G.
   Rohde, Holger
   Horstkotte, Matthias A.
   Knobloch, Johannes K-M.
TI Microbial interactions in Staphylococcus epidermidis biofilms
SO ANALYTICAL AND BIOANALYTICAL CHEMISTRY
LA English
DT Review
DE Staphylococcus epidermidis; quorum sensing; polysaccharide intercellular
   adhesin; biomaterial-related infection; biofilms
ID POLYSACCHARIDE INTERCELLULAR ADHESIN; QUORUM-SENSING SYSTEM; GENE
   REGULATOR AGR; COAGULASE-NEGATIVE STAPHYLOCOCCI; ACCUMULATION-ASSOCIATED
   PROTEIN; CATHETER-ASSOCIATED INFECTION; SEQUENCE ELEMENT IS256;
   SIGMA-FACTOR SIGMA(B); ICA LOCUS; IN-VIVO
AB Medical device-associated infections, most frequently caused by coagulase-negative staphylococci, especially Staphylococcus epidermidis, are of increasing importance in modern medicine. The formation of adherent, multilayered bacterial biofilms is the most important factor in the pathogenesis of these infections, which regularly fail to respond to appropriate antimicrobial therapy. Progress in elucidating the factors functional in elaboration of S. epidermidis biofilms and the regulation of their expression with a special emphasis on the role of quorum sensing are reviewed. Significant progress has been made in recent years, which provides the rationale for developing better preventive, therapeutic and diagnostic measures.
C1 Swansea Univ, Sch Med, Swansea SA2 8PP, W Glam, Wales.
   Univ Klinikum Hamburg Eppendorf, Inst Med Mikrobiol Virol & Hyg, Zentrum Klin Pathol, D-20246 Hamburg, Germany.
   Inst Med Diagnost, Reg Labor Moers, D-47441 Moers, Germany.
   Univ Lubeck, Inst Med Mikrobiol & Hyg, D-23538 Lubeck, Germany.
RP Mack, D (reprint author), Swansea Univ, Sch Med, Grove Bldg,Singleton Pk, Swansea SA2 8PP, W Glam, Wales.
EM D.Mack@swansea.ac.uk
RI Knobloch, Johannes/D-6456-2011
OI Knobloch, Johannes/0000-0002-2591-6387; Davies,
   Angharad/0000-0003-4190-8894; Harris, Llinos/0000-0002-0295-3038
CR ABDELNOUR A, 1993, INFECT IMMUN, V61, P3879
   Allignet J, 2001, INFECT IMMUN, V69, P712, DOI 10.1128/IAI.69.2.712-718.2001
   Arciola CR, 2004, BIOMATERIALS, V25, P4117, DOI 10.1016/j.biomaterials.2003.11.027
   Balaban N, 2005, CLIN ORTHOP RELAT R, P48, DOI 10.1097/01.blo.0000175889.82865.67
   Balaban N, 2003, J INFECT DIS, V187, P625, DOI 10.1086/345879
   Balaban N, 1998, SCIENCE, V280, P438, DOI 10.1126/science.280.5362.438
   Bateman A, 2005, BIOINFORMATICS, V21, P1301, DOI 10.1093/bioinformatics/bti206
   Batzilla CF, 2006, PROTEOMICS, V6, P3602, DOI 10.1002/pmic.200500732
   Baveja JK, 2004, BIOMATERIALS, V25, P5003, DOI 10.1016/j.biomaterials.2004.02.051
   Blevins JS, 2003, INFECT IMMUN, V71, P516, DOI 10.1128/IAI.71.1.516-523.2003
   Bowden MG, 2005, MICROBIOL-SGM, V151, P1453, DOI 10.1099/mic.0.27534-0
   Bowden MG, 2002, J BIOL CHEM, V277, P43017, DOI 10.1074/jbc.M207921200
   Carmody AB, 2004, ARCH MICROBIOL, V181, P250, DOI 10.1007/s00203-003-0644-2
   Chen H, 2004, P NATL ACAD SCI USA, V101, P5048, DOI 10.1073/pnas.0401416101
   Chokr A, 2006, INT J MED MICROBIOL, V296, P381, DOI 10.1016/j.ijmm.2006.02.018
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   Cole SP, 2004, J BACTERIOL, V186, P3124, DOI 10.1128/JB.186.10.3124-3132.2004
   Conlon KM, 2004, J BACTERIOL, V186, P6208, DOI 10.1128/JB.186.18.6208-6219.2004
   Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Cramton SE, 1999, INFECT IMMUN, V67, P5427
   Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001
   Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001
   Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295
   DEIGHTON M, 1993, INFECT IMMUN, V61, P4473
   Dobinsky S, 2003, J BACTERIOL, V185, P2879, DOI 10.1128/JB.185.9.2879-2886.2003
   DOBINSKY S, 2004, BIOFILMS, V1, P101
   Doherty N, 2006, J BACTERIOL, V188, P2885, DOI 10.1128/JB.188.8.2885-2897.2006
   Dufour P, 2002, J BACTERIOL, V184, P1180, DOI 10.1128/jb.184.4.1180-1186.2002
   DUNNE WM, 1993, ANTIMICROB AGENTS CH, V37, P2522, DOI 10.1128/AAC.37.12.2522
   Fey PD, 1999, J INFECT DIS, V179, P1561, DOI 10.1086/314762
   Fitzpatrick F, 2002, J HOSP INFECT, V52, P212, DOI 10.1053/jhin.2002.1309
   Frank KL, 2004, J CLIN MICROBIOL, V42, P4846, DOI 10.1128/JCM.42.10.4846-4849.2004
   Galdbart JO, 1999, J CLIN MICROBIOL, V37, P1306
   Galdbart JO, 2000, J INFECT DIS, V182, P351, DOI 10.1086/315660
   Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586
   Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005
   GILLASPY AF, 1995, INFECT IMMUN, V63, P3373
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Gotz F, 2000, INFECT ASS INDWELLIN, P55
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Handke LD, 2004, J MED MICROBIOL, V53, P367, DOI 10.1099/jmm.0.05372-0
   Harris LG, 2004, J MATER SCI-MATER M, V15, P311, DOI 10.1023/B:JMSM.0000021093.84680.bb
   Hartford O, 2001, MICROBIOL-SGM, V147, P2545, DOI 10.1099/00221287-147-9-2545
   Heilmann C, 2003, MICROBIOL-SGM, V149, P2769, DOI 10.1099/mic.0.26527-0
   Heilmann C, 1996, INFECT IMMUN, V64, P277
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366
   Hentzer M, 2002, MICROBIOL-SGM, V148, P87, DOI 10.1099/00221287-148-1-87
   Huber B, 2001, MICROBIOL-SGM, V147, P2517, DOI 10.1099/00221287-147-9-2517
   Hume EBH, 2004, BIOMATERIALS, V25, P5023, DOI 10.1016/j.biomaterials.2004.01.048
   HUSSAIN M, 1992, J HOSP INFECT, V20, P173, DOI 10.1016/0195-6701(92)90085-Z
   Hussain M, 1997, INFECT IMMUN, V65, P519
   Jabra-Rizk MA, 2006, ANTIMICROB AGENTS CH, V50, P1463, DOI 10.1128/AAC.50.4.1463-1469.2006
   Jager S, 2005, APPL ENVIRON MICROB, V71, P5577, DOI 10.1128/AEM.71.9.5577-5581.2005
   Jefferson KK, 2003, MOL MICROBIOL, V48, P889, DOI 10.1046/j.1365-2958.2003.03482.x
   Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027
   Joyce JG, 2003, CARBOHYD RES, V338, P903, DOI 10.1016/S0008-6215(03)00045-4
   Kaufmann GF, 2005, P NATL ACAD SCI USA, V102, P309, DOI 10.1073/pnas.0408639102
   Kilstrup M, 1998, J BACTERIOL, V180, P3907
   Knobloch JKM, 2005, ANTIMICROB AGENTS CH, V49, P1216, DOI 10.1128/AAC.49.3.1216-1219.2005
   Knobloch JKM, 2004, INFECT IMMUN, V72, P3838, DOI 10.1128/IAI.72.7.3838-3848.2004
   Knobloch JKM, 2003, APPL ENVIRON MICROB, V69, P5812, DOI 10.1128/AEM.69.10.5812-5818.2003
   Knobloch JKM, 2002, MED MICROBIOL IMMUN, V191, P101, DOI 10.1007/s00430-002-0124-3
   Knobloch JKM, 2002, MED MICROBIOL IMMUN, V191, P107, DOI 10.1007/s00430-002-0125-2
   Knobloch JKM, 2002, J ANTIMICROB CHEMOTH, V49, P683, DOI 10.1093/jac/49.4.683
   Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001
   Kogan G, 2006, FEMS MICROBIOL LETT, V255, P11, DOI 10.1111/j.1574-6968.2005.00043.x
   Kong KF, 2006, INT J MED MICROBIOL, V296, P133, DOI 10.1016/j.ijmm.2006.01.042
   Kozitskaya S, 2004, INFECT IMMUN, V72, P1210, DOI 10.1128/IAI.72.2.1210-1215.2004
   Lewis K, 2001, ANTIMICROB AGENTS CH, V45, P999, DOI 10.1128/AAC.45.4.999-1007.2001
   Li HL, 2005, INFECT IMMUN, V73, P3188, DOI 10.1128/IAI.73.5.3188-3191.2005
   Mack D, 1996, J INFECT DIS, V174, P881, DOI 10.1093/infdis/174.4.881
   Mack D, 2006, INT J ARTIF ORGANS, V29, P343
   Mack D, 2002, ANTIMICROB AGENTS CH, V46, P178, DOI 10.1128/AAC.46.1.178-183.2002
   MACK D, 1994, INFECT IMMUN, V62, P3244
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   Mack D, 1999, INFECT IMMUN, V67, P1004
   MACK D, 1992, INFECT IMMUN, V60, P2048
   Mack D, 2000, INFECT IMMUN, V68, P3799, DOI 10.1128/IAI.68.7.3799-3807.2000
   Mack D., 2006, BIOFILMS INFECT ANTI, P109
   Mayville P, 1999, P NATL ACAD SCI USA, V96, P1218, DOI 10.1073/pnas.96.4.1218
   McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523
   Mehlin C, 1999, J EXP MED, V189, P907, DOI 10.1084/jem.189.6.907
   Merritt J, 2003, INFECT IMMUN, V71, P1972, DOI 10.1128/IAI.71.4.1972-1979.2003
   Moretro T, 2003, APPL ENVIRON MICROB, V69, P5648, DOI 10.1128/AEM.69.9.5648-5655.2003
   Nilsson M, 1998, INFECT IMMUN, V66, P2666
   Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x
   NOVICK RP, 2000, SCIENCE, V287, pA391
   Otto M, 2004, FEMS MICROBIOL LETT, V241, P135, DOI 10.1016/j.femsle.2004.11.016
   Otto M, 2004, J INFECT DIS, V190, P748, DOI 10.1086/422157
   Otto M, 1999, FEBS LETT, V450, P257, DOI 10.1016/S0014-5793(99)00514-1
   Otto M, 1998, FEBS LETT, V424, P89, DOI 10.1016/S0014-5793(98)00145-8
   Otto M, 2001, PEPTIDES, V22, P1603, DOI 10.1016/S0196-9781(01)00495-8
   Otto M, 2001, INFECT IMMUN, V69, P1957, DOI 10.1128/IAI.69.3.1957-1960.2001
   PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101
   PENG HL, 1988, J BACTERIOL, V170, P4365, DOI 10.1128/jb.170.9.4365-4372.1988
   Qazi S, 2006, INFECT IMMUN, V74, P910, DOI 10.1128/IAI.74.2.910-919.2006
   Rachid S, 2000, J BACTERIOL, V182, P6824, DOI 10.1128/JB.182.23.6824-6826.2000
   Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000
   Rani SA, 2005, ANTIMICROB AGENTS CH, V49, P728, DOI 10.1128/AAC.49.2.728-732.2005
   Rickard AH, 2006, MOL MICROBIOL, V60, P1446, DOI 10.1111/j.1365-2958.2006.05202.x
   Rohde H, 2004, J CLIN MICROBIOL, V42, P5614, DOI 10.1128/JCM.42.12.5614-5619.2004
   Rohde H, 2001, MED MICROBIOL IMMUN, V190, P105, DOI 10.1007/s00430-001-0099-5
   Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.04515.x
   Rupp ME, 2001, J INFECT DIS, V183, P1038, DOI 10.1086/319279
   Rupp ME, 1999, INFECT IMMUN, V67, P2656
   Rupp ME, 1999, INFECT IMMUN, V67, P2627
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   Sadovskaya I, 2005, INFECT IMMUN, V73, P3007, DOI 10.1128/IAI.73.5.3007-3017.2005
   Schauder S, 2001, GENE DEV, V15, P1468, DOI 10.1101/gad.899601
   SCHUMACHERPERDREAU F, 1994, FEMS MICROBIOL LETT, V117, P71
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Sun DQ, 2005, CLIN DIAGN LAB IMMUN, V12, P93, DOI 10.1128/CDLI.12.1.93-100.2005
   Surette MG, 1999, P NATL ACAD SCI USA, V96, P1639, DOI 10.1073/pnas.96.4.1639
   TIMMERMAN CP, 1991, INFECT IMMUN, V59, P4187
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   Tormo MA, 2005, J BACTERIOL, V187, P2348, DOI 10.1128/JB.187.7.2348-2356.2005
   Tormo MA, 2005, MICROBIOL-SGM, V151, P2465, DOI 10.1099/mic.0.27865-0
   Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x
   Veenstra GJC, 1996, J BACTERIOL, V178, P537, DOI 10.1128/jb.178.2.537-541.1996
   Vuong C, 2005, J BACTERIOL, V187, P2967, DOI 10.1128/JB.187.9.2967-2973.2005
   Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200
   Vuong C, 2004, CELL MICROBIOL, V6, P753, DOI 10.1111/j.1462-5822.2004.00401.x
   Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1111/j.1462-5822.2004.00367.x
   Vuong C, 2000, INFECT IMMUN, V68, P1048, DOI 10.1128/IAI.68.3.1048-1053.2000
   Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606
   Vuong C, 2004, J INFECT DIS, V190, P1498, DOI 10.1086/424487
   Vuong C, 2003, J INFECT DIS, V188, P706, DOI 10.1086/377239
   Weng ML, 2000, CURR MICROBIOL, V41, P56, DOI 10.1007/s002840010091
   WENG ML, 1995, P NATL ACAD SCI USA, V92, P7455, DOI 10.1073/pnas.92.16.7455
   Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4
   Williams RJ, 2002, INFECT IMMUN, V70, P6805, DOI 10.1128/IAI.70.12.6805-6810.2002
   Winans SC, 2002, J BACTERIOL, V184, P873, DOI 10.1128/jb.184.4.873-883.2002
   Wright JS, 2005, P NATL ACAD SCI USA, V102, P1691, DOI 10.1073/pnas.0407661102
   Xu L, 2006, INFECT IMMUN, V74, P488, DOI 10.1128/IAI.74.1.488-496.2006
   Yao YF, 2006, J INFECT DIS, V193, P841, DOI 10.1086/500246
   Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x
   Zheng ZL, 2002, ANTIMICROB AGENTS CH, V46, P900, DOI 10.1128/AAC.46.3.900-903.2002
   Ziebuhr W, 1999, MOL MICROBIOL, V32, P345, DOI 10.1046/j.1365-2958.1999.01353.x
   Ziebuhr W, 1997, INFECT IMMUN, V65, P890
NR 142
TC 87
Z9 92
U1 2
U2 13
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1618-2642
EI 1618-2650
J9 ANAL BIOANAL CHEM
JI Anal. Bioanal. Chem.
PD JAN
PY 2007
VL 387
IS 2
BP 399
EP 408
DI 10.1007/s00216-006-0745-2
PG 10
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 124FX
UT WOS:000243354400005
PM 16955256
DA 2018-10-19
ER

PT J
AU Chaieb, K
   Chehab, O
   Zmantar, T
   Rouabhia, M
   Mahdouani, K
   Bakhrouf, A
AF Chaieb, Kamel
   Chehab, Olfa
   Zmantar, Tarek
   Rouabhia, Mahmoud
   Mahdouani, Kacem
   Bakhrouf, Amina
TI In vitro effect of pH and ethanol on biofilm formation by clinical
   ica-positive Staphylococcus epidermidis strains
SO ANNALS OF MICROBIOLOGY
LA English
DT Article
DE Staphylococcus epidermidis; biofilm; ica gene; Congo Red agar; pH;
   ethanol
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; POLYSACCHARIDE INTERCELLULAR ADHESIN;
   ENVIRONMENTAL-REGULATION; SLIME PRODUCTION; INFECTIONS; AUREUS;
   EXPRESSION; PREVENTION; CATHETERS; ADHERENCE
AB Biofilm production is an important step in the pathogenesis of Staphylococcus epidermidis associated biomaterial infections. Staphylococcus epidermidis strains isolated from dialysis fluid (n = 9) and needle cultures (n = 14) were phenotyped and genotyped for extracellular polysaccharide production and were examined for their ability to produce slime in a medium at various pH levels (3, 5, 7, 9 and 12) and with ethanol supplementation (0, 2, 5, 10 and 15%) using a semi-quantitative adherence assay. A total of 23 clinical icaADBC positive S. epidermidis, one reference strain (S. epidermidis CIP 106510) used as positive control, and one icaADBC negative strain (E21) were investigated. Qualitative biofilm production analysis revealed that 15 of the 23 icaADBC positive strains (65.21%) produced slime on Congo Red agar plates. Quantitative biofilm was determined by measuring the optical density at 570 nm (OD(570)). The results show that the slime production depended on the pH value of the medium and the ethanol concentration. At highly acidic (pH 3) and alkaline (pH 12) levels, the OD(570) was lower, while at pH 7 the adhesion was moderate, In addition the cells adhered strongly with 2% ethanol than with the other concentrations. Our results suggest that pH and ethanol were stress factors that led to S. epidermidis biofilm formation and also play a possible role in the pathogenesis of biomaterial-related infections.
C1 Fac Pharm, Lab Anal Traitement & Valorisat Polluants Environ, Monastir, Tunisia.
   Univ Laval, Grp Rech Ecol Buccale, Fac Med Dentaire, Quebec City, PQ, Canada.
RP Chaieb, K (reprint author), Fac Pharm, Lab Anal Traitement & Valorisat Polluants Environ, Monastir, Tunisia.
EM chaieb_mo@yahoo.fr
CR Arciola CR, 2002, BIOMATERIALS, V23, P4233, DOI 10.1016/S0142-9612(02)00171-0
   BAYER ME, 1990, J GEN MICROBIOL, V136, P867, DOI 10.1099/00221287-136-5-867
   Cerca N, 2005, RES MICROBIOL, V156, P506, DOI 10.1016/j.resmic.2005.01.007
   CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996
   Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   DOYLE R, 2000, MICROB INFECT, V2, P39
   ELLIOTT TSJ, 1994, J HOSP INFECT, V28, P163, DOI 10.1016/0195-6701(94)90100-7
   Fitzpatrick F, 2002, J HOSP INFECT, V52, P212, DOI 10.1053/jhin.2002.1309
   FREEMAN DJ, 1989, J CLIN PATHOL, V42, P872, DOI 10.1136/jcp.42.8.872
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   Knobloch JKM, 2001, J BACTERIOL, V183, P2624, DOI 10.1128/JB.183.8.2624-2633.2001
   Lawrence EL, 2005, MED ENG PHYS, V27, P443, DOI 10.1016/j.medengphy.2004.12.013
   Mack D, 2001, METHOD ENZYMOL, V336, P215, DOI 10.1016/S0076-6879(01)36592-8
   Mack D, 2000, INFECT IMMUN, V68, P3799, DOI 10.1128/IAI.68.7.3799-3807.2000
   McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523
   MEINDERS JM, 1994, J COLLOID INTERF SCI, V164, P355, DOI 10.1006/jcis.1994.1177
   Mempel M, 1998, J INVEST DERMATOL, V111, P452, DOI 10.1046/j.1523-1747.1998.00293.x
   Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009
   PATRICK CC, 1992, INFECT IMMUN, V60, P1363
   Pearson ML, 1996, INFECT CONT HOSP EP, V17, P438
   PETERS G, 1982, J INFECT DIS, V146, P479, DOI 10.1093/infdis/146.4.479
   Rachid S, 2000, ADV EXP MED BIOL, V485, P159
   Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000
   RUPP ME, 1994, CLIN INFECT DIS, V19, P231, DOI 10.1093/clinids/19.2.231
   Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81
   Vasudevan P, 2003, VET MICROBIOL, V92, P179, DOI 10.1016/S0378-1135(02)00360-7
   von Eiff C, 1999, EUR J CLIN MICROBIOL, V18, P843, DOI 10.1007/s100960050417
   White A., 1978, PRINCIPLES BIOCH, P196
   Zmantar T, 2006, ANN MICROBIOL, V56, P349, DOI 10.1007/BF03175030
NR 30
TC 20
Z9 21
U1 1
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1590-4261
J9 ANN MICROBIOL
JI Ann. Microbiol.
PY 2007
VL 57
IS 3
BP 431
EP 437
DI 10.1007/BF03175085
PG 7
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 222TK
UT WOS:000250319900022
DA 2018-10-19
ER

PT J
AU Donzelli, E
   Salvade, A
   Mimo, P
   Vigano, M
   Morrone, M
   Papagna, R
   Carini, F
   Zaopo, A
   Miloso, M
   Baldoni, M
   Tredici, G
AF Donzelli, E.
   Salvade, A.
   Mimo, P.
   Vigano, M.
   Morrone, M.
   Papagna, R.
   Carini, F.
   Zaopo, A.
   Miloso, M.
   Baldoni, M.
   Tredici, G.
TI Mesenchymal stem cells cultured on a collagen scaffold: In vitro
   osteogenic differentiation
SO ARCHIVES OF ORAL BIOLOGY
LA English
DT Article
DE mesenchymal stem cells; osteogenic differentiation; collagen scaffold;
   periodontal disease
ID BONE-MARROW; STROMAL CELLS; TISSUE REGENERATION; INVITRO; BIOLOGY;
   MINERALIZATION; CARTILAGE; REPAIR; GRAFT
AB Objective: Management of periodontal defects has always been a challenge in clinical periodontics. Recently mesenchymal stem cells (MSC) have been proposed for tissue regeneration in periodontal disease and repair of large bone defects. Bone regeneration has to be supported by a scaffold which has to be biocompatible, biodegradable, and able to support cell growth and differentiation. The aim of this study was to evaluate osteogenic differentiation of MSC seeded on a Collagen scaffold.
   Design: MSC were obtained from adult rat bone marrow, expanded and cultured in plastic dishes or seeded in a collagen scaffold (Gingistat (R)). MSC were induced towards osteogenic differentiation using osteogenic supplements. Cell differentiation and calcium deposits were evaluated by immunoblotting, immunohistochemistry, histochemical techniques, enzymatic activity assay, and SEM-EDX analysis. Biomaterial in vitro degradation was evaluated by measuring mass reduction after incubation in culture medium.
   Results: Rat MSC osteogenic differentiation was demonstrated by osteopontin and osteocalcin expression and an increase in alkaline phosphatase activity. MSC were distributed homogeneously in the Collagen scaffold. Nodular aggregates and alizarin red stained calcium deposits were observed in MSC induced towards osteogenic differentiation cultured in dishes or seeded in the collagen scaffold. SEM-EDX analysis demonstrated that calcium co-localized with phosphorous. The biomaterial in vitro degraded in 4-5 weeks.
   Conclusions: MSC from bone marrow differentiate towards osteogenic lineage, representing a suitable cell source for bone formation in periodontal regeneration. Gingistat (R) collagen scaffold supports MSC distribution and differentiation, but its short degradation time may be a limitation for a future application in bone tissue regeneration. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Milan, Dipartimento Neurosci & Tecnol Biomed, I-20052 Monza, MI, Italy.
   CORIMAV, I-20126 Milan, Italy.
   Pirelli Labs SpA, I-20126 Milan, Italy.
   Osped San Gerardo, Clin Odontoiatr, Monza, Italy.
RP Donzelli, E (reprint author), Univ Milan, Dipartimento Neurosci & Tecnol Biomed, Via Cadore 48, I-20052 Monza, MI, Italy.
EM elisabetta.donzelli@unimib.it
RI Donzelli, Elisabetta/J-6837-2015
CR AUBIN JE, 1995, BONE, V17, pS77, DOI 10.1016/8756-3282(95)00183-E
   Bartold PM, 2000, PERIODONTOL 2000, V24, P253, DOI 10.1034/j.1600-0757.2000.2240113.x
   BERESFORD JN, 1992, J CELL SCI, V102, P341
   Betz RR, 2002, ORTHOPEDICS, V25, P561
   Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180
   Brekke JH, 1998, J BIOMED MATER RES, V43, P380, DOI 10.1002/(SICI)1097-4636(199824)43:4<380::AID-JBM6>3.0.CO;2-D
   BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412
   Donzelli E, 2004, J NEURO-ONCOL, V67, P65, DOI 10.1023/B:NEON.0000021787.70029.ce
   DRAGOO MR, 1973, J PERIODONTOL, V44, P599, DOI 10.1902/jop.1973.44.10.599
   ELAMIN SF, 2003, BIOMATERIALS, V4, P1213
   Fibbe WE, 2002, ANN RHEUM DIS, V61, P29
   FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001
   Garrett S, 1996, Ann Periodontol, V1, P621, DOI 10.1902/annals.1996.1.1.621
   Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002
   Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Kawaguchi H, 2004, J PERIODONTOL, V75, P1281, DOI 10.1902/jop.2004.75.9.1281
   KENLEY RA, 1993, PHARMACEUT RES, V10, P1393, DOI 10.1023/A:1018902720816
   Khan SN, 2005, J AM ACAD ORTHOP SUR, V13, P77, DOI 10.5435/00124635-200501000-00010
   Kim H, 2003, BIOMATERIALS, V24, P4671, DOI 10.1016/S0142-9612(03)00358-2
   Kotobuki N, 2004, ARTIF ORGANS, V28, P33, DOI 10.1111/j.1525-1594.2004.07320.x
   Laurell L, 1998, J PERIODONTOL, V69, P303, DOI 10.1902/jop.1998.69.3.303
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Long MW, 2001, BLOOD CELL MOL DIS, V27, P677, DOI 10.1006/bcmd.2001.0431
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Marie P, 2000, JOINT BONE SPINE, V67, P150
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Minguell JJ, 2001, EXP BIOL MED, V226, P507
   Mizutani K, 1998, BIOCHEM BIOPH RES CO, V253, P859, DOI 10.1006/bbrc.1998.9870
   MOSKOW BS, 1979, J PERIODONTOL, V50, P291, DOI 10.1902/jop.1979.50.6.291
   Otto WR, 2004, CELL PROLIFERAT, V37, P97, DOI 10.1111/j.1365-2184.2004.00303.x
   OWEN ME, 1987, J CELL SCI, V87, P731
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   Reynolds Mark A, 2003, Ann Periodontol, V8, P227, DOI 10.1902/annals.2003.8.1.227
   SCHALLHORN RG, 1972, J PERIODONTOL, V43, P3, DOI 10.1902/jop.1972.43.1.03
   Seiler J G 3rd, 2000, J South Orthop Assoc, V9, P91
   Sugawara Y, 2002, JPN J PHARMACOL, V88, P262, DOI 10.1254/jjp.88.262
   Yamada Y, 2003, J CRANIO MAXILL SURG, V31, P27, DOI 10.1016/S1010-5182
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
NR 42
TC 113
Z9 124
U1 2
U2 21
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0003-9969
J9 ARCH ORAL BIOL
JI Arch. Oral Biol.
PD JAN
PY 2007
VL 52
IS 1
BP 64
EP 73
DI 10.1016/j.archoralbio.2006.07.007
PG 10
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 125RT
UT WOS:000243460800010
PM 17049335
DA 2018-10-19
ER

PT S
AU Miao, JC
   Sheng, WH
   Li, MZ
   Xie, YF
   Gong, AH
   Yang, JC
AF Miao, Jing-cheng
   Sheng, Wei-hua
   Li, Ming-zhong
   Xie, Yu-feng
   Gong, Ai-hua
   Yang, Ji-cheng
BE Kim, YH
   Cho, CS
   Kang, IK
   Kim, SY
   Kwon, OH
TI Genotoxic potential of regenerated silk fibroin films by different
   cross-linking mode
SO ASBM7: ADVANCED BIOMATERIALS VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th Asian Symposium on Biomedical Materials (ASBM7)
CY AUG 20-23, 2006
CL Cheju Isl, SOUTH KOREA
DE regenerated silk fibroin films (RSFFs); Micronucleus; Comet assay
ID CELLS; ASSAY
AB Emerging studies have showed that silk fibroin might be as a naturally occurring degradable biomaterial for tissue engineering with unique mechanical properties, biocompatib ility and processability. To optimize the formation of the regenerated silk fibroin film, in thi s study. we examined the genotoxic potential of the regenerated silk fibroin films by differe nt cross-linking mode with micronucleus and the single cell gel electrophoresis (comet) assay. The data showed that MNF in group PC and group SD showed significantly no difference with blank group (P > 0.05), and no evident comet tails were observed. However, the result of EC group was significantly different frorn the control group(P < 0.01). Taken together, R SFFs in group PC and group SD have no evident genotoxicity, which is better than group EC.
C1 [Miao, Jing-cheng; Sheng, Wei-hua; Li, Ming-zhong; Xie, Yu-feng; Yang, Ji-cheng] Suzhou Univ, Suzhou 215006, Peoples R China.
   [Gong, Ai-hua] Jiangsu Univ, Zhenjiang, Peoples R China.
RP Yang, JC (reprint author), Suzhou Univ, Suzhou 215006, Peoples R China.
EM mjc@suda.edu.cn; shengweihua@163.com; mzli@suda.edu.cn;
   jcyang@suda.edu.cn
CR Chen X, 1997, J APPL POLYM SCI, V65, P2257, DOI 10.1002/(SICI)1097-4628(19970912)65:11<2257::AID-APP23>3.0.CO;2-Z
   COSTA LG, 1995, TOXICOLOGY, V98, P151, DOI 10.1016/0300-483X(94)02986-5
   FREDDI G, 1995, J APPL POLYM SCI, V56, P1537, DOI 10.1002/app.1995.070561203
   Gregory H., 2003, BIOMATERIALS, V24, P401
   Li MZ, 2003, INT J BIOL MACROMOL, V32, P159, DOI 10.1016/S0141-8130(03)00049-7
   Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   WANG YZ, 2006, BIOMATERIALS, V4, P1
   Wolz L, 2002, ATLA-ALTERN LAB ANIM, V30, P331
NR 9
TC 7
Z9 8
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-436-1
J9 KEY ENG MATER
PY 2007
VL 342-343
BP 257
EP +
DI 10.4028/www.scientific.net/KEM.342-343.257
PG 2
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BGG39
UT WOS:000246657900065
DA 2018-10-19
ER

PT S
AU Kikuchi, M
   Tanaka, J
AF Kikuchi, Masanori
   Tanaka, Junzo
BE Kim, YH
   Cho, CS
   Kang, IK
   Kim, SY
   Kwon, OH
TI Bone regeneration materials
SO ASBM7: ADVANCED BIOMATERIALS VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th Asian Symposium on Biomedical Materials (ASBM7)
CY AUG 20-23, 2006
CL Cheju Isl, SOUTH KOREA
DE tricalcium phosphate; biodegradable polymer; guided bone regeneration;
   hydroxyapatite; collagen; nanocomposite; bone remodeling process
ID L-LACTIDE COMPOSITES; SELF-ORGANIZATION MECHANISM;
   HYDROXYAPATITE/COLLAGEN COMPOSITE; IN-VITRO; NANOCOMPOSITES;
   BIOMATERIAL; PHOSPHATE
AB Biomaterials Center is composed of five groups and collaborate each other to examine interdisciplinary fields of biomaterials. In the ceramics-based biomaterials research, we have been developing three novel bone regeneration materials, i.e., high-porosity hydroxyapatite (HAp) ceramics with high-strength, guided bone regeneration (GBR) membranes and bone-like nanocomposite composed of HAp and collagen. The GBR membrane composed of beta-tricalcium phosphate and biodegradable copolymer of lactide, glycolide and epsilon-caprolactone has thermoplastic, pH auto-adjustment and enough mechanical property to protect an invasion of surrounding tissues. With the membrane, bone defect up to 20 x 10 x 10 mm(3) in length in mandibles and segmental bone defect Lip to 20 mm in length in tibiae of beagles are regenerated without any additional bone fillers or cell transplantations. The bone-like nanocomposite is synthesized by a co-precipitation of HAp and collagen via their self-organization. The dense composite has a half to quarter mechanical strength (40 MPa) to cortical bone and the porous one demonstrates sponge-like viscoelasticity. The composites implanted into bone are incorporated into bone remode ing metabolism like as autogenous bone graft, i.e., they are resorbed by osteolasts followed by osteogenesis by osteoblasts.
C1 [Kikuchi, Masanori] Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 305004, Japan.
   [Tanaka, Junzo] Tokyo Inst Technol, Dept Met & Ceram Sci, Meguro Ku, Tokyo 152, Japan.
RP Kikuchi, M (reprint author), Natl Inst Mat Sci, Ctr Biomat, Tsukuba, Ibaraki 305004, Japan.
EM KIKUCHI.Masanori@nims.go.jp; Junzo.Tanaka@ceram.titech.ac.jp
RI Kikuchi, Masanori/B-5993-2008
OI Kikuchi, Masanori/0000-0002-9451-8147
FU Research Promotion Bureau; Ministry of Education, Culture, Sports,
   Science and Technology, Japan [17-83]
FX The authors are very grateful to Prof Kenichi Shinomiya, Assoc. Prof.
   Soichiro Itoh, Drs. Yoshinori Asou and Shinichi Sotome of Department of
   Orthopedic Surgery and Prof. Kazuo Takakuda, Drs. Yoshihisa Koyama and
   Hiroko N. Matsumoto of Institute of Biomaterials and Bioengineering,
   Tokyo Medical and Dental University, and Prof. Shigeo Tanaka, Drs.
   Katsuyoshi Nagaoka and Takeki Yamada of College of Bioresource Sciences,
   Nihon University for valuable suggestion and help for biological and
   clinical evaluations. The study is supported in part by Research
   Promotion Bureau, Ministry of Education, Culture, Sports, Science and
   Technology, Japan under the contract No.17-83.
CR Itoh S, 2001, J BIOMED MATER RES, V54, P445, DOI 10.1002/1097-4636(20010305)54:3<445::AID-JBM190>3.3.CO;2-0
   Itoh S, 2004, CELL TRANSPLANT, V13, P451, DOI 10.3727/000000004783983774
   Itoh S, 2002, J BIOMED MATER RES, V63, P507, DOI 10.1002/jbm.10305
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kikuchi M, 1999, J BIOMED MATER RES, V48, P108, DOI 10.1002/(SICI)1097-4636(1999)48:2<108::AID-JBM2>3.3.CO;2-6
   Kikuchi M, 2000, J CERAM SOC JPN, V108, P642, DOI 10.2109/jcersj.108.1259_642
   Kikuchi M, 2004, BIOMATERIALS, V25, P5979, DOI 10.1016/j.biomaterials.2004.02.001
   Kikuchi M, 2004, COMPOS SCI TECHNOL, V64, P819, DOI 10.1016/j.compscitech.2003.09.002
   Kikuchi M, 2003, KEY ENG MAT, V240-2, P567, DOI 10.4028/www.scientific.net/KEM.240-242.567
   Kikuchi M, 2004, BIOMATERIALS, V25, P63, DOI 10.1016/S0142-9612(03)00472-1
   Kikuchi M, 2002, J BIOMED MATER RES, V62, P265, DOI 10.1002/jbm.10248
   Kikuchi M, 1997, J MATER SCI-MATER M, V8, P361, DOI 10.1023/A:1018580816388
   Kikuchi M, 2004, KEY ENG MAT, V254-2, P561, DOI 10.4028/www.scientific.net/KEM.254-256.561
   Koyama Y, 2003, JSME INT J C-MECH SY, V46, P1409, DOI 10.1299/jsmec.46.1409
NR 15
TC 2
Z9 2
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-436-1
J9 KEY ENG MATER
PY 2007
VL 342-343
BP 277
EP +
DI 10.4028/www.scientific.net/KEM.342-343.277
PG 2
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BGG39
UT WOS:000246657900070
DA 2018-10-19
ER

PT S
AU Cho, WJ
   Kim, JH
   Oh, SH
   Lee, JH
AF Cho, Wan Jin
   Kim, Jun Ho
   Oh, Se Heang
   Lee, Jin Ho
BE Kim, YH
   Cho, CS
   Kang, IK
   Kim, SY
   Kwon, OH
TI Characterization of hydrophilized PCL electrospun sheet as an effective
   guided bone regeneration membrane
SO ASBM7: ADVANCED BIOMATERIALS VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th Asian Symposium on Biomedical Materials (ASBM7)
CY AUG 20-23, 2006
CL Cheju Isl, SOUTH KOREA
DE guide bone regeneration membrane; nano-fiber; electrospun;
   polycaprolactone; tween 80; selective permeability
AB Electrospinning is a fabrication process that can produce highly porous nano-scale fiber-based matrices using an electrostatically driven jet of polymer solution. This method represents an attractive approach for polymeric biomaterial processing which provides the membrane structure that may retain mechanical strengths, flexibility, and high surface area. In this study, we prepared a guided bone regeneration (GBR) membrane with selective permeability, hydrophilicity, good mechanical strength and adhesiveness with bone using polycaprolactone (PCL) and Tween 80 by the electrospinning method. The prepared PCL and PCL/Tween 80 electrospun sheets were characterized via morphology observation, mechanical property, water absorbability, and model nutrient permeability. It was observed that the PCL/Tween 80 (3 wt%) electrospun sheet have an effective permeation of nutrients as well as the good mechanical strength to maintain a secluded space for the bone regeneration. From the results, the hydrophilized PCL/Tween 80 (3 wt%) electrospun sheet seem to be a good candidate as a GBR membrane.
C1 [Cho, Wan Jin; Kim, Jun Ho; Oh, Se Heang; Lee, Jin Ho] Hannam Univ, Dept Adv Mat, Taejon 306791, South Korea.
RP Cho, WJ (reprint author), Hannam Univ, Dept Adv Mat, Taejon 306791, South Korea.
EM wjcho@hannam.ac.kr; junho1012@hanmail.net; shoh@hanam.ac.kr;
   jhlee@hannam.ac.kr
FU Korea Research Foundation [KRF-2004-202-D00768]
FX This work was supported by a grant from the Korea Research Foundation
   (Grant No. KRF-2004-202-D00768).
CR ASTM - American Society for Testing and Materials, 1996, ANN BOOK ASTM STAND
   BAUMGARTEN PK, 1971, J COLLOID INTERF SCI, V36, P71, DOI 10.1016/0021-9797(71)90241-4
   Formhals A., 1934, U. S. Patent, Patent No. [1,975,504, 1975504]
   Fujihara K, 2005, BIOMATERIALS, V26, P4139, DOI 10.1016/j.biomaterials.2004.09.014
   Hillmann G, 2002, BIOMATERIALS, V23, P1461, DOI 10.1016/S0142-9612(01)00270-8
   Huang ZM, 2003, COMPOS SCI TECHNOL, V63, P2223, DOI 10.1016/S0266-3538(03)00178-7
   Imbronito AV, 2002, BIOMATERIALS, V23, P4079, DOI 10.1016/S0142-9612(02)00145-X
   LARRONDO L, 1981, J POLYM SCI POL PHYS, V19, P909, DOI 10.1002/pol.1981.180190601
   Maeda H, 2006, BIOMATERIALS, V27, P1216, DOI 10.1016/j.biomaterials.2005.08.010
   Piattelli A, 1996, BIOMATERIALS, V17, P1725, DOI 10.1016/0142-9612(96)87653-8
   Tan SH, 2005, POLYMER, V46, P6128, DOI 10.1016/j.polymer.2005.05.068
NR 11
TC 5
Z9 5
U1 0
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-436-1
J9 KEY ENG MATER
PY 2007
VL 342-343
BP 293
EP +
DI 10.4028/www.scientific.net/KEM.342-343.293
PG 2
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BGG39
UT WOS:000246657900074
DA 2018-10-19
ER

PT S
AU Lee, HJ
   Park, KH
   Park, SR
   Min, BH
AF Lee, Hyun Jung
   Park, Keun-Hong
   Park, So Ra
   Min, Byoung-Hyun
BE Kim, YH
   Cho, CS
   Kang, IK
   Kim, SY
   Kwon, OH
TI Chitosan/Heparin polyelectrolyte complex nanoparticles (100 similar to
   200nm) covalently bonded with PEI for enhancement of chondrogenic
   phenotype
SO ASBM7: ADVANCED BIOMATERIALS VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th Asian Symposium on Biomedical Materials (ASBM7)
CY AUG 20-23, 2006
CL Cheju Isl, SOUTH KOREA
DE polyethyleni mine (PEI); chitosan; heparin; nanoparticle culture system
ID HEPARIN
AB Acknowledging the supportive influence of matrix molecules on the chondrocytic phenotype, we combined heparin and chitosan to develop a novel biomaterial, supporting chondrogenesis. Chitosan had been shown as a promising structural material for a number of tissue engineering applications. Similar to heparin, one of the glycosamino-glycans (GAGs) had been known to exert various influences on the biological activities. In this study we evaluated the potential of heparin/chitosan polyelectrolyle complex materials for controlling the proliferation and differentiation of chondrocytes. The heparin/chitosan polyelectrolyte complex was coated over the polyethyleneimine (PEI) layer precoated on the commercial polystyrene dish. When examined by using human chondrocyte cell line (C28/12), the heparin/chitosan surfaces supported well not only the cell proliferation but also the chondrocytic functions, such as expression of collagen type II. These results indicated that the heparin/chitosan complex could be used to modulate the activity of chondrocytes in vitro.
C1 [Lee, Hyun Jung; Min, Byoung-Hyun] Ajou Univ, Dept Mol Sci & Technol, San 5, Wonchon 442749, South Korea.
   [Park, Keun-Hong] Pochon CHA Univ, Coll Med, Cell & Gene Therapy Res Inst, Seoul 135081, South Korea.
   [Park, So Ra] Inha Univ, Coll Med, Dept Physiol, Incheon 440712, South Korea.
   [Min, Byoung-Hyun] Ajou Univ, Dept Orthopaed, Suwon 442749, South Korea.
RP Lee, HJ (reprint author), Ajou Univ, Dept Mol Sci & Technol, San 5, Wonchon 442749, South Korea.
EM queenjung@ajou.ac.kr; phd0410@hanmail.net; srpark@inha.ac.kr;
   bhmin@ajou.ac.kr
FU Ministry of Health & Welfare, Republic of Korea [02-PJ10-PG8-EC01-0022]
FX This work was supported by a grant of the Korea Health 21 R&D Project,
   Ministry of Health & Welfare, Republic of Korea (02-PJ10-PG8-EC01-0022).
CR Lin WC, 2004, BIOMATERIALS, V25, P1947, DOI 10.1016/j.biomaterials.2003.08.027
   ROSA MD, 2004, J CELL PHYSL, V198, P133
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Wang XH, 2003, INT J BIOL MACROMOL, V33, P95, DOI 10.1016/S0141-8130(03)00072-2
NR 4
TC 3
Z9 3
U1 1
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-436-1
J9 KEY ENG MATER
PY 2007
VL 342-343
BP 329
EP +
DI 10.4028/www.scientific.net/KEM.342-343.329
PG 2
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BGG39
UT WOS:000246657900083
DA 2018-10-19
ER

PT S
AU Kim, SH
   Choi, B
   Ko, YK
   Ha, HJ
   Yoon, SJ
   Rhee, JM
   Kim, MS
   Lee, HB
   Khang, G
AF Kim, Soon Hee
   Choi, BangSil
   Ko, Youn Kyung
   Ha, Hyun Jung
   Yoon, Sun Jung
   Rhee, John M.
   Kim, Moon Suk
   Lee, Hai Bang
   Khang, Gilson
BE Kim, YH
   Cho, CS
   Kang, IK
   Kim, SY
   Kwon, OH
TI The characterization of PLGA/small intestinal submucosa composites as
   scaffolds for intervertebral disc
SO ASBM7: ADVANCED BIOMATERIALS VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th Asian Symposium on Biomedical Materials (ASBM7)
CY AUG 20-23, 2006
CL Cheju Isl, SOUTH KOREA
DE PLGA; small intestinal submucosa; pore size; MTT assay; FTIR
ID STEM-CELL; SPONGE; RAT
AB In order to application for the tissue engineered intervertebral disc (IVD), we designed the synthetic/natural hybrid scaffolds with poly(lactide-co-glycolide) (PLGA) and small intestine submucosa (SIS). SIS has been widely used as a biomaterial because :;IS consists of various collagens and cytokines. SIS, however, possesses disadvantages such as their weak mechanical properties and uncontrolled degradation. Novel composite scaffolds of PLGA/SIS were manufactured by simple immersion method of PLGA scaffolds in SIS solution under vacuum. Then SIS was crosslinked. Also, PLGA scaffolds and SIS sponges were minufactured by solvent casting/salt leaching and freeze-dried methods, respectively. We evaluated pore structure, porosity, water absorption ability and cell viability of three types of scaffolds for the application of IVD.
C1 Chonnam Natl Univ, BK 21 Polymer BIN Fus Res Team, Jeonju 561756, South Korea.
   [Kim, Moon Suk; Lee, Hai Bang] Korea Res Inst Chem Technol, Nanobiomat Lab, Taejon 305606, South Korea.
RP Kim, SH (reprint author), Chonnam Natl Univ, BK 21 Polymer BIN Fus Res Team, Jeonju 561756, South Korea.
EM aofurwjr@hanmail.net; apriltime@hanmail.net; youn2129@nate.com;
   greenmail77@hanmail.net; timmons@hanmail.net; limrhee@chonbuk.ac.kr;
   gmskim@krict.re.kr; hblee@krict.re.kr; gskhang@chonbuk.ac.kr
OI Yoon, Sun-Jung/0000-0003-3487-6863
FU KMOHW [0405-BO01-0204-0006]; SCRC [SC3100]
FX This work was supported by KMOHW (0405-BO01-0204-0006) and SCRC
   (SC3100).
CR Chen GP, 2006, MAT SCI ENG C-BIO S, V26, P118, DOI 10.1016/j.msec.2005.07.024
   Crevensten G, 2004, ANN BIOMED ENG, V32, P430, DOI 10.1023/B:ABME.0000017545.84833.7c
   KHANG G, 2004, TISSUE ENG REGEN MED, V1, P9
   Kim MS, 2005, INT J BIOL MACROMOL, V36, P54, DOI 10.1016/j/ijbiomac.2005.03.013
   Kim SH, 2006, POLYM-KOREA, V30, P14
   KIM SH, 2006, IN PRESS ADV EXP BIO
   Shin HW, 2004, POLYM-KOREA, V28, P194
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
NR 8
TC 7
Z9 7
U1 1
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-436-1
J9 KEY ENG MATER
PY 2007
VL 342-343
BP 389
EP +
DI 10.4028/www.scientific.net/KEM.342-343.389
PG 2
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BGG39
UT WOS:000246657900098
DA 2018-10-19
ER

PT S
AU Kim, SK
   Lee, JS
   Chae, GJ
   Jung, UW
   Lee, YK
   Kim, CK
   Choi, SH
AF Kim, Sung-Koo
   Lee, Jung-Seok
   Chae, Gyung-Joon
   Jung, Ui-Won
   Lee, Yong-Keun
   Kim, Chong-Kwan
   Choi, Seong-Ho
BE Kim, YH
   Cho, CS
   Kang, IK
   Kim, SY
   Kwon, OH
TI The effects of calcium phosphate-chitosan block bone graft on the
   periodontal regeneration in one wall intrabony defects in beagle dogs
SO ASBM7: ADVANCED BIOMATERIALS VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th Asian Symposium on Biomedical Materials (ASBM7)
CY AUG 20-23, 2006
CL Cheju Isl, SOUTH KOREA
DE periodontal regeneration; bone graft material; chitosan; intrabony
   defect
AB This study evaluated periodontal repair and biomaterial reaction following implantation of a newly fabricated calcium phosphate chitosan block bone and chitosan membrane on the regeneration of 1- wall intrabony defects in the beagle dogs. The surgical control group received a flap operation only, while experimental group was treated with calcium phosphate chitosan block bone and/or chitosan membrane. All dogs were uneventful healing without any complication. The subjects were sacrificed 8 weeks after the experimental Surgery, and a comparative histological and histometric examination was done. Chitosan membrane group significantly enhanced bone regeneration compared to control, CaP-chitosan block bone and combination group. Chitosan membrane remnants were observed in chitosan and combination group, while CaP-chitosan bone materials were resorbed completely. These results suggest that Chitosan membrane significantly enhanced bone and cementum formation in advanced periodontal defects.
C1 [Kim, Sung-Koo; Lee, Jung-Seok; Chae, Gyung-Joon; Jung, Ui-Won; Kim, Chong-Kwan; Choi, Seong-Ho] Yonsei Univ, Coll Dent, Res Inst Periodontal Regenerat, Dept Periodontol, Seoul 120749, South Korea.
   [Lee, Yong-Keun] Yonsei Univ, Dent Biomat & Bioengn, Dept & Res Inst, Seoul, South Korea.
RP Kim, SK (reprint author), Yonsei Univ, Coll Dent, Res Inst Periodontal Regenerat, Dept Periodontol, Seoul 120749, South Korea.
EM akskdent@hanmail.net; shchoi726@yumc.yonsei.ac.kr
OI Jung, Ui-Won/0000-0001-6371-4172; Lee, Jung-Seok/0000-0003-1276-5978
FU Ministry of Health & Welfare, Republic of Korea [03-PJI-PG1-CH08-001]
FX This study was supported by a grant from the Korean Health 21 R&D
   Project, Ministry of Health & Welfare, Republic of Korea
   (03-PJI-PG1-CH08-001)
CR MUZZARELLI R, 1988, BIOMATERIALS, V14, P39
   Park JS, 2003, J CLIN PERIODONTOL, V30, P443, DOI 10.1034/j.1600-051X.2003.10283.x
   Shin SY, 2005, J PERIODONTOL, V76, P1778, DOI 10.1902/jop.2005.76.10.1778
   ULF ME, 1991, J CLIN PERIODONTOL, V18, P49
   YEO YJ, 1997, J BIOMED MATER RES B, V72, P86
NR 5
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-436-1
J9 KEY ENG MATER
PY 2007
VL 342-343
BP 393
EP +
DI 10.4028/www.scientific.net/KEM.342-343.393
PG 2
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BGG39
UT WOS:000246657900099
DA 2018-10-19
ER

PT S
AU Yu, QF
   Li, ZS
   Yang, BC
   Huang, Y
   Gan, L
   Qu, Y
   Zhang, XD
AF Yu, Q. F.
   Li, Z. S.
   Yang, B. C.
   Huang, Y.
   Gan, L.
   Qu, Y.
   Zhang, X. D.
BE Kim, YH
   Cho, CS
   Kang, IK
   Kim, SY
   Kwon, OH
TI A study on the effect of grain size on the bioactivity of nano-titania
   ceramics
SO ASBM7: ADVANCED BIOMATERIALS VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th Asian Symposium on Biomedical Materials (ASBM7)
CY AUG 20-23, 2006
CL Cheju Isl, SOUTH KOREA
DE nano-titania; bioactivity; hydroxyapatite; grain growth inhibitor; grain
   size
ID NANOPHASE CERAMICS
AB Nano-titania cerarnics is a potential biomaterial for orthopaedic application. In our previous studies, a bioactive nano-titania ceramics was prepared by using alkali-heat treatment. In this paper, hydroxyapatite was used as a grain growth inhibitor additive to get nano-titania ceramics with different grain size, and the effect of grain size on the bioactivity was studied in vitro.
C1 [Yu, Q. F.; Li, Z. S.; Yang, B. C.; Huang, Y.; Gan, L.; Qu, Y.; Zhang, X. D.] Sichuan Univ, Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
RP Yang, BC (reprint author), Sichuan Univ, Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
EM qfyu@microportmedical.com; li.zhensheng@163.com; yangbchengc@126.com;
   huangyi516@yahoo.com; lala1982@sohu.com; quyang1072002@163.com;
   zhangxd@scu.edu.cn
RI Huang, Yi/F-9592-2011
FU Sichuan University, P. R. China.
FX The SEM photographs are supported by Analytical & Testing Center,
   Sichuan University, P. R. China.
CR BRUNSKI JB, 1991, BONE-BIOMATERIAL INTERFACE, P391
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C
   HOLLINGER JO, 1996, CLIN ORTHOP RELAT R, V324, P55
   NAKAMURA T, 1991, KEY ENG MATER, V9, P31
   NEGAMI S, 1988, Journal of the Japanese Orthopaedic Association, V62, P85
   Nonami T, 1998, MATER RES BULL, V33, P125, DOI 10.1016/S0025-5408(97)00197-9
   PIECUCH JF, 1982, J DENT RES, V61, P1458, DOI 10.1177/00220345820610121801
   UEYAMA Y, 1998, KEY ENG MATER, V11, P567
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Yang BC, 2006, KEY ENG MAT, V309-311, P411, DOI 10.4028/www.scientific.net/KEM.309-311.411
NR 11
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-436-1
J9 KEY ENG MATER
PY 2007
VL 342-343
BP 565
EP +
DI 10.4028/www.scientific.net/KEM.342-343.565
PG 2
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BGG39
UT WOS:000246657900142
DA 2018-10-19
ER

PT S
AU Ren, YB
   Wang, H
   Huang, JJ
   Zhang, BC
   Yang, K
AF Ren, Yibin
   Wang, Hao
   Huang, Jingjing
   Zhang, Bingchun
   Yang, Ke
BE Kim, YH
   Cho, CS
   Kang, IK
   Kim, SY
   Kwon, OH
TI Study of biodegradation of pure magnesium
SO ASBM7: ADVANCED BIOMATERIALS VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th Asian Symposium on Biomedical Materials (ASBM7)
CY AUG 20-23, 2006
CL Cheju Isl, SOUTH KOREA
DE magnesium; corrosion; biodegradation; biomaterial; biocompatibility
ID ALLOYS
AB Magnesium and its alloys are possible to develop new type of biodegradable medical magnesium alloys by using their active corrosion potential. The bio-corrosion properties of the high pure magnesium in the Hank's solution were investigated in this paper, the results showed that high pure magnesium had a low corrosion rate and hydrogen release in Hank's solution, when the pH value of Solution was controlled at 7.5, the corrosion rate was under 0.2mm/year, the production of hydrogen was about 0.1 5ml/cm(2) and if the solution wasn't controlled on pH value, the corrosion rate was about 0.02 mm/year, production of hydrogen was about 0.1 ml/cm(2). Result of in vitro Kinetic clotting time test and animal implant prep-test showed that High pure magnesium had good thromboresistant property and tissue compatibility p, pure magnesium can biodegrade lowly in animal body and formed surface apatite, which proportion of Ca/P was similar with bone tissue.
C1 [Ren, Yibin; Huang, Jingjing; Zhang, Bingchun; Yang, Ke] Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
   [Wang, Hao] Univ So Queensland, Toowoomba, Qld A-4350, Australia.
RP Ren, YB (reprint author), Chinese Acad Sci, Inst Met Res, Shenyang 110016, Peoples R China.
EM ybren@imr.ac.cn
RI ren, yibin/M-5508-2014
OI ren, yibin/0000-0002-5422-761X
CR Di Mario Carlo, 2004, J Interv Cardiol, V17, P391, DOI 10.1111/j.1540-8183.2004.04081.x
   Heublein B, 2003, HEART, V89, P651, DOI 10.1136/heart.89.6.651
   Kuwahara H, 2001, MATER TRANS, V42, P1317, DOI 10.2320/matertrans.42.1317
   McBride ED, 1938, J AMER MED ASSOC, V111, P2464, DOI 10.1001/jama.1938.02790530018007
   Stroganov G. B., 1972, [No title captured], Patent No. [3687135, 3, 687, 135]
   [王德永 Wang Deyong], 2002, [生物医学工程学杂志, Journal of Biomedical Engineering], V19, P17
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   YB R, 2005, ACTA METALLURGICA SI, V41, P1228
   YU YT, 2000, BIOMEDICAL MAT
NR 9
TC 8
Z9 10
U1 0
U2 9
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-436-1
J9 KEY ENG MATER
PY 2007
VL 342-343
BP 601
EP +
DI 10.4028/www.scientific.net/KEM.342-343.601
PG 2
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BGG39
UT WOS:000246657900151
OA Green Published
DA 2018-10-19
ER

PT S
AU He, J
   Lu, XY
   Hong, QY
   Lu, ZH
   Huang, Y
   Sun, PZ
AF He Jian
   Lue Xiaoying
   Hong Qingyue
   Lu Zuhong
   Huang Yan
   Sun Paizheng
BE Kim, YH
   Cho, CS
   Kang, IK
   Kim, SY
   Kwon, OH
TI Study of protein adsorption on biomaterial surfaces by SPR
SO ASBM7: ADVANCED BIOMATERIALS VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th Asian Symposium on Biomedical Materials (ASBM7)
CY AUG 20-23, 2006
CL Cheju Isl, SOUTH KOREA
DE surface plasmon resonance; biosensor; protein adsorption;
   biocompatibility
ID PLASMON RESONANCE
AB Object. The aim of this study was to Set Lip a SPR sensor and to investigate protein adsorption onto biomaterial surface using it. Methods. The adsorption of human albumin (Alb), fibrinogen (Fib) and immunoglobulin G (IgG) onto polyurethane (PU) H50-50 and ALL surface were measured using this SPR sensor. Results: The results of protein adsorption showed that the amount of Alb, Fib and IgG adsorbed on PU (H50-50) are smaller than Au, and on these two material surfaces. the amount sequence of adsorbed protein is: IgG > Fib > Alb. Both the Alb/Fib ratio and Alb/IgG ratio on PU (H50-50) surface are higher than Au. Conclusion: The antithrombogenicity of PU (H50-50) is better than Au.
C1 [He Jian; Lue Xiaoying; Hong Qingyue; Lu Zuhong; Huang Yan; Sun Paizheng] Southeast Univ, Dept Biomed Engn, State Key Lab Bioelectron, Nanjing 210096, Peoples R China.
RP He, J (reprint author), Southeast Univ, Dept Biomed Engn, State Key Lab Bioelectron, Nanjing 210096, Peoples R China.
EM luxy@seu.edu.cn
FU NSFC [30270391]; 863 plan [2002AA326064, 2002AA312230]
FX This study is supported by NSFC with Project 30270391 and 863 plan
   2002AA326064 and 2002AA312230.
CR Green RJ, 1999, BIOMATERIALS, V20, P385, DOI 10.1016/S0142-9612(98)00201-4
   Green RJ, 1997, BIOMATERIALS, V18, P405, DOI 10.1016/S0142-9612(96)00141-X
   Hansson KM, 1999, BIOSENS BIOELECTRON, V14, P671, DOI 10.1016/S0956-5663(99)00050-0
   [吕晓迎 Lu Xiaoying], 2003, [中国生物医学工程学报, Chinese Journal of Biomedical Engineering], V22, P165
   STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F
   Wang L, 1996, PROG BIOCHEM BIOPHYS, V23, P483
   XIAO CD, 2000, CHINESE J BIOMEDICAL, V19, P60
NR 7
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-436-1
J9 KEY ENG MATER
PY 2007
VL 342-343
BP 825
EP +
DI 10.4028/www.scientific.net/KEM.342-343.825
PG 2
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BGG39
UT WOS:000246657900207
DA 2018-10-19
ER

PT S
AU Shao, ZY
   Zhao, AS
   Yang, P
   Zhou, HF
   Huang, N
AF Shao Zhenyi
   Zhao Ansha
   Yang Ping
   Zhou Hongfang
   Huang Nan
BE Kim, YH
   Cho, CS
   Kang, IK
   Kim, SY
   Kwon, OH
TI In situ investigation of biomaterial surfaces using LDH and ELISA
SO ASBM7: ADVANCED BIOMATERIALS VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th Asian Symposium on Biomedical Materials (ASBM7)
CY AUG 20-23, 2006
CL Cheju Isl, SOUTH KOREA
DE blood compatibility; platelet adhesion & activation; LDH; ELISA
ID LACTATE-DEHYDROGENASE; ACTIVATION; HEMOCOMPATIBILITY; EXPRESSION;
   ENZYME; FILMS; CD62P
AB Lactate dehydrogenase (LDH) and enzyme-linked immunosorbent assay (ELISA) have attracted much attention recently for the evaluation of blood compatibility of biomaterials due to their convenience and quantifiability. In this paper, the use of LDH and ELISA is described for in suit investigation of platelet behavior on biomaterial surfaces, including quantification of platelet adhesion and platelet activation, after suitable testing conditions have been established. The material samples investigated in these tests included low temperature isotropic carbon (LTIC), Ti-O films, and phosphorus- and aluminum-doped TiO2 films. The evaluation results show that the lowest platelet adhesion and activation are observed on phosphorus-doped TiO2 films while the highest platelet adhesion and activation are observed on LTIC. In addition, conventional platelet adhesion experiments were performed for comparison, and yielding similar evaluation results as LDH and ELISA. It is suggested that LDH and ELISA tests can be successfully applied to evaluate the blood compatibility of biomaterials and can show many advantages, such as quantification, reliability and objectivity, compared with conventional platelet adhesion test.
C1 [Shao Zhenyi; Zhao Ansha; Yang Ping; Zhou Hongfang; Huang Nan] Southwest Jiao Tong Univ, Minist Educ, Key Lab Adv Mat Technol, Key Lab Artific Organ Surface Engn Sichuan, Chengdu 610031, Peoples R China.
RP Yang, P (reprint author), Southwest Jiao Tong Univ, Minist Educ, Key Lab Adv Mat Technol, Key Lab Artific Organ Surface Engn Sichuan, Chengdu 610031, Peoples R China.
EM yangping@home.swjtu.edu.cn; nhuang@263.net
FU G2005CB623904;  [NSFC30318006];  [NSFC30300087];  [NSFC30570502]
FX This work was jointly supported by Key basic research G2005CB623904,
   NSFC30318006, NSFC30300087 and NSFC30570502 Authors would like to thank
   Dr. Ian Brown and Dr. M.Maitz's help.
CR Chen JY, 2002, BIOMATERIALS, V23, P2545, DOI 10.1016/S0142-9612(01)00389-1
   Diamantino TC, 2001, CHEMOSPHERE, V45, P553, DOI 10.1016/S0045-6535(01)00029-7
   Downer J, 2006, J THEOR BIOL, V240, P464, DOI 10.1016/j.jtbi.2005.10.007
   Eriksson Andreas C., 2005, Journal of Pharmacological and Toxicological Methods, V52, P356, DOI 10.1016/j.vascn.2005.06.002
   Fiore MM, 2003, BIOCHEM BIOPH RES CO, V311, P71, DOI 10.1016/j.bbrc.2003.09.171
   GROTH T, 1995, BIOMATERIALS, V16, P1009, DOI 10.1016/0142-9612(95)94909-5
   GROTH T, 1994, COLLOID SURFACE B, V3, P24
   GROTH T, 1994, COLLOID SURFACE B, V3, P241
   Gutensohn K, 1996, TRANSFUS SCI, V17, P489
   Huang N, 1998, BIOMATERIALS, V19, P771, DOI 10.1016/S0142-9612(98)00212-9
   Lalko CC, 2003, VET IMMUNOL IMMUNOP, V91, P119, DOI 10.1016/S0165-2427(02)00287-8
   Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4
   MARIC DM, 1992, BIOMATERIALS, V50, P119
   RADZIWON P, 2000, THROMB RES, V100, P19
   RADZIWON P, 2000, THROMB RES, V100, P4
   WATANABE W, 1995, J VIROL METHODS, V51, P185, DOI 10.1016/0166-0934(94)00103-N
   Yang P, 2003, BIOMATERIALS, V24, P2821, DOI 10.1016/S0142-9612(03)00091-7
NR 17
TC 5
Z9 5
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-436-1
J9 KEY ENG MATER
PY 2007
VL 342-343
BP 841
EP +
DI 10.4028/www.scientific.net/KEM.342-343.841
PG 2
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BGG39
UT WOS:000246657900211
DA 2018-10-19
ER

PT S
AU Wei, QR
   Yang, XD
   Lu, J
   Zhang, B
   Jiang, B
   Fan, HS
   Chen, JY
   Gu, ZW
   Zhang, XD
AF Wei, Qingrong
   Yang, Xiudong
   Lu, Jian
   Zhang, Bo
   Jiang, Bo
   Fan, Hongsong
   Chen, Jiyong
   Gu, Zhongwei
   Zhang, Xingdong
BE Kim, YH
   Cho, CS
   Kang, IK
   Kim, SY
   Kwon, OH
TI Effect of inorganic ions on morphology and crystallinity of collagen
   fibrils
SO ASBM7: ADVANCED BIOMATERIALS VII
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 7th Asian Symposium on Biomedical Materials (ASBM7)
CY AUG 20-23, 2006
CL Cheju Isl, SOUTH KOREA
DE collagen fibril; inorganic ion; morphology; crystallinity
ID INVITRO
AB As a natural biomaterial, collagen especially pepsin-solubilized collagen (type 1) has been used widely in biomedical fields due to its excellent biocompatibility. In this preliminary study, we investigate the effect of some inorganic ions which are frequently utilized in the preparation of collagen on the morphology and crystallinity of fibrils. The scanning electron microscope and x-ray diffraction were applied to analyze the morphology and the crystallization of the reconstituted collagen fibrils, respectively. Although further studies are needed, these initial results indicate that by controlling the self-assembly conditions of collagen molecules, we may achieve the desired properties of fibrillar collagen products.
C1 [Wei, Qingrong; Yang, Xiudong; Lu, Jian; Zhang, Bo; Jiang, Bo; Fan, Hongsong; Chen, Jiyong; Gu, Zhongwei; Zhang, Xingdong] Sichuan Univ, Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
RP Chen, JY (reprint author), Sichuan Univ, Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
EM qingrongwei@gmail.com
RI wei, qingrong/G-5860-2010
CR CLARKE KI, 1993, J MATER SCI-MATER M, V4, P107, DOI 10.1007/BF00120378
   COLLINS KD, 1985, Q REV BIOPHYS, V18, P323, DOI 10.1017/S0033583500005369
   KomsaPenkova R, 1996, BBA-PROTEIN STRUCT M, V1297, P171, DOI 10.1016/S0167-4838(96)00092-1
   MCPHERSON JM, 1985, COLLAGEN REL RES, V5, P119
   MILLER EJ, 1972, BIOCHEMISTRY-US, V11, P119
   NA GC, 1989, BIOCHEMISTRY-US, V28, P7153, DOI 10.1021/bi00444a004
   OUYANG PK, 2004, PRINCIPLE TECHNOLOGY
   Prockop DJ, 1998, J STRUCT BIOL, V122, P111, DOI 10.1006/jsbi.1998.3976
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   WILLIAMS BR, 1978, J BIOL CHEM, V253, P6578
NR 10
TC 0
Z9 0
U1 1
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-436-1
J9 KEY ENG MATER
PY 2007
VL 342-343
BP 929
EP +
DI 10.4028/www.scientific.net/KEM.342-343.929
PG 2
WC Engineering, Biomedical; Materials Science, Ceramics; Materials Science,
   Biomaterials; Materials Science, Composites
SC Engineering; Materials Science
GA BGG39
UT WOS:000246657900233
DA 2018-10-19
ER

PT J
AU Gras, SL
AF Gras, Sally L.
TI Amyloid fibrils: From disease to design. New biomaterial applications
   for self-assembling cross-beta fibrils
SO AUSTRALIAN JOURNAL OF CHEMISTRY
LA English
DT Review
ID PEPTIDE-AMPHIPHILE NANOFIBERS; PROTEIN AGGREGATION RATES;
   EXTRACELLULAR-MATRIX; IN-VITRO; NANOTECHNOLOGICAL APPLICATIONS; FUNGAL
   HYDROPHOBINS; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE;
   POLYPEPTIDE-CHAINS; PROGENITOR CELLS
AB Amyloid fibrils are self-assembling protein aggregates. They are essentially insoluble and resilient nanofibres that offer great potential as materials for nanotechnology and bionanotechnology. Fibrils are associated with several debilitating diseases, for example Alzheimer's disease, but recent advances suggest they also have positive functions in nature and can be formed in vitro from generic proteins. This article explores how the unique nanotopography and advantageous properties of fibrils may be used to develop tools for probing cell behaviour, protein-based biomimetic materials for supporting cells, or platforms for biosensors and enzyme immobilization.
C1 Univ Melbourne, Dept Chem & Biomol Engn, Parkville, Vic 3010, Australia.
   Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic 3010, Australia.
RP Gras, SL (reprint author), Univ Melbourne, Dept Chem & Biomol Engn, Parkville, Vic 3010, Australia.
EM sgras@unimelb.edu.au
RI Gras, Sally/G-2025-2014
OI Gras, Sally/0000-0002-4660-1245
CR Adler-Abramovich L, 2006, LANGMUIR, V22, P1313, DOI 10.1021/la052409d
   Aggeli A, 1997, NATURE, V386, P259, DOI 10.1038/386259a0
   Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198
   Aggeli A, 2003, ANGEW CHEM INT EDIT, V42, P5603, DOI 10.1002/anie.200352207
   Aggeli A, 2003, J AM CHEM SOC, V125, P9619, DOI 10.1021/ja021047i
   Alexandrescu AT, 2005, PROTEIN SCI, V14, P1
   Bader R, 2006, J MOL BIOL, V356, P189, DOI 10.1016/j.jmb.2005.11.034
   Baglioni S, 2006, J NEUROSCI, V26, P8160, DOI 10.1523/JNEUROSCI.4809-05.2006
   Baldwin AJ, 2006, J AM CHEM SOC, V128, P2162, DOI 10.1021/ja0565673
   Barnhart MM, 2006, ANNU REV MICROBIOL, V60, P131, DOI 10.1146/annurev.micro.60.080805.142106
   Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200
   Baxa U, 2002, P NATL ACAD SCI USA, V99, P5253, DOI 10.1073/pnas.082097899
   Bell CJ, 2006, J BIOMED MATER RES A, V78A, P236, DOI 10.1002/jbm.a.30672
   Berry CC, 2005, BIOMATERIALS, V26, P4985, DOI 10.1016/j.biomaterials.2005.01.046
   Berson JF, 2003, J CELL BIOL, V161, P521, DOI 10.1083/jcb.200302072
   Biere AL, 2000, J BIOL CHEM, V275, P34574, DOI 10.1074/jbc.M005514200
   Bieschke J, 2006, ACCOUNTS CHEM RES, V39, P611, DOI 10.1021/ar0500766
   Caflisch A, 2006, CURR OPIN CHEM BIOL, V10, P437, DOI 10.1016/j.cbpa.2006.07.009
   Calamai M, 2005, BIOPHYS J, V89, P4201, DOI 10.1529/biophysj.105.068726
   Chai C, 2007, MOL THER, V15, P467, DOI 10.1038/sj.mt.6300084
   Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484
   Cherny I, 2005, J MOL BIOL, V352, P245, DOI 10.1016/j.jmb.2005.07.028
   Chiti F, 2003, NATURE, V424, P805, DOI 10.1038/nature01891
   Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901
   Claessen D, 2003, GENE DEV, V17, P1714, DOI 10.1101/gad.264303
   COLLINS SR, 2004, PLOS BIOL, V2, pE321
   Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571
   Dalby MJ, 2004, BIOMATERIALS, V25, P5415, DOI 10.1016/j.biomaterials.2003.12.049
   Dallas SL, 2006, CURR TOP DEV BIOL, V75, P1, DOI 10.1016/S0070-2153(06)75001-3
   de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100
   de la Paz ML, 2002, P NATL ACAD SCI USA, V99, P16052, DOI 10.1073/pnas.252340199
   Devlin GL, 2006, J MOL BIOL, V360, P497, DOI 10.1016/j.jmb.2006.05.007
   Ding TT, 2002, BIOCHEMISTRY-US, V41, P10209, DOI 10.1021/bi020139h
   Dirix C, 2005, J MOL BIOL, V347, P903, DOI 10.1016/j.jmb.2005.01.073
   Dobson CM, 2006, PROTEIN PEPTIDE LETT, V13, P219, DOI 10.2174/092986606775338362
   Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0
   DOBSON CM, 2000, Patent No. 017328
   Dos Santos S, 2005, J AM CHEM SOC, V127, P11888, DOI 10.1021/ja052083v
   Duan XD, 2007, BIOMATERIALS, V28, P78, DOI 10.1016/j.biomaterials.2006.08.034
   Dubay KF, 2004, J MOL BIOL, V341, P1317, DOI 10.1016/j.jmb.2004.06.043
   Dumoulin M, 2006, PROTEIN PEPTIDE LETT, V13, P213, DOI 10.2174/092986606775338434
   Eisert R, 2006, ANAL BIOCHEM, V353, P144, DOI 10.1016/j.ab.2006.03.015
   Esteras-Chopo A, 2005, P NATL ACAD SCI USA, V102, P16672, DOI 10.1073/pnas.0505905102
   Esteras-Chopo Alexandra, 2006, V340, P253
   Fandrich M, 2003, P NATL ACAD SCI USA, V100, P15463, DOI 10.1073/pnas.0303758100
   Fandrich M, 2001, NATURE, V410, P165, DOI 10.1038/35065514
   Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012
   Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006
   Fukuma T, 2006, TRIBOL LETT, V22, P233, DOI 10.1007/s11249-006-9086-8
   Gast K, 2003, EUR BIOPHYS J BIOPHY, V32, P710, DOI 10.1007/s00249-003-0336-5
   Gazit E, 2005, FEBS J, V272, P5971, DOI 10.1111/j.1742-4658.2005.05022.x
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Gillmore JD, 2006, NAT CLIN PRACT NEPHR, V2, P263, DOI 10.1038/ncpneph0169
   Gosal WS, 2006, PROTEIN PEPTIDE LETT, V13, P261, DOI 10.2174/092986606775338498
   GRAS SL, UNPUB
   Griffith LG, 2002, ANN NY ACAD SCI, V961, P83, DOI 10.1111/j.1749-6632.2002.tb03056.x
   Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224
   GUIRADOLOPEZ RA, 2006, J CHEM PHYS, V125, DOI DOI 10.1063/1.2357955
   Guler MO, 2005, NANO LETT, V5, P249, DOI 10.1021/nl048238z
   GUSTAVSSON A, 1991, BIOCHEM BIOPH RES CO, V175, P1159, DOI 10.1016/0006-291X(91)91687-8
   Ha C, 2005, BIOTECHNOL BIOENG, V90, P848, DOI 10.1002/bit.20486
   HALTRICH D, 2006, APPL BIOCHEM BIOTECH, V129, P215, DOI DOI 10.1385/ABAB:129:1:215
   HAMADA D, 2004, TRENDS BIOTECHNOL, P22
   Hartgerink JD, 2004, CURR OPIN CHEM BIOL, V8, P604, DOI 10.1016/j.cbpa.2004.10.001
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hartgerink JD, 2002, P NATL ACAD SCI USA, V99, P5133, DOI 10.1073/pnas.072699999
   Hatters DM, 2003, BIOPHYS J, V85, P3979, DOI 10.1016/S0006-3495(03)74812-7
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Inoue Y, 2001, J BIOL CHEM, V276, P35227, DOI 10.1074/jbc.C100304200
   Janssen MI, 2004, BIOMATERIALS, V25, P2731, DOI 10.1016/j.biomaterials.2003.09.060
   Janssen MI, 2002, BIOMATERIALS, V23, P4847, DOI 10.1016/S0142-9612(02)00240-5
   Jaroniec CP, 2004, P NATL ACAD SCI USA, V101, P711, DOI 10.1073/pnas.0304849101
   Jaroniec CP, 2002, P NATL ACAD SCI USA, V99, P16748, DOI 10.1073/pnas.252625999
   JIN LW, 1994, J NEUROSCI, V14, P5461
   Johan K, 1998, P NATL ACAD SCI USA, V95, P2558, DOI 10.1073/pnas.95.5.2558
   Kammerer RA, 2004, P NATL ACAD SCI USA, V101, P4435, DOI 10.1073/pnas.0306786101
   Kasai S, 2004, BIOPOLYMERS, V76, P27, DOI 10.1002/bip.10565
   Katz Eugenii, 2004, Chemphyschem, V5, P1084, DOI 10.1002/cphc.200400193
   Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469
   Kayed R, 2006, METHOD ENZYMOL, V413, P326, DOI 10.1016/S0076-6879(06)13017-7
   KIBBEY MC, 1993, P NATL ACAD SCI USA, V90, P10150, DOI 10.1073/pnas.90.21.10150
   Kishimoto A, 2004, BIOCHEM BIOPH RES CO, V315, P739, DOI 10.1016/j.bbrc.2004.01.117
   Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999
   Knowles TPJ, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.238301
   KODAMA HM, 2004, CHEMCOMM, V24, P2876
   Koga T, 2005, J AM CHEM SOC, V127, P17596, DOI 10.1021/ja0558387
   Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688
   Krebs MRH, 2005, J STRUCT BIOL, V149, P30, DOI 10.1016/j.jsb.2004.08.002
   Krebs MRH, 2004, P NATL ACAD SCI USA, V101, P14420, DOI 10.1073/pnas.0405933101
   Krebs MRH, 2004, PROTEIN SCI, V13, P1933, DOI 10.1110/ps.04707004
   Krishnan R, 2005, NATURE, V435, P765, DOI 10.1038/nature03679
   Kwan AHY, 2006, P NATL ACAD SCI USA, V103, P3621, DOI 10.1073/pnas.0505704103
   LARSEN NG, 2005, Patent No. 033131
   Lazo ND, 1998, BIOCHEMISTRY-US, V37, P1731, DOI 10.1021/bi971016d
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   Linder MB, 2004, BIOCHEMISTRY-US, V43, P11873, DOI 10.1021/bi0488202
   Litvinovich SV, 1998, J MOL BIOL, V280, P245, DOI 10.1006/jmbi.1998.1863
   Lundmark K, 2005, P NATL ACAD SCI USA, V102, P6098, DOI 10.1073/pnas.0501814102
   MacPhee CE, 2004, CURR OPIN SOLID ST M, V8, P141, DOI 10.1016/j.cossms.2004.01.010
   MacPhee CE, 2000, J AM CHEM SOC, V122, P12707, DOI 10.1021/ja0029580
   Makin OS, 2005, FEBS J, V272, P5950, DOI 10.1111/j.1742-4658.2005.05025.x
   Mesquida P, 2005, ADV MATER, V17, P893, DOI 10.1002/adma.200401229
   Mesquida P, 2006, LANGMUIR, V22, P9089, DOI 10.1021/la061485t
   Mineur P, 2005, BBA-MOL CELL RES, V1746, P28, DOI 10.1016/j.bbamcr.2005.07.004
   MOK S, 2005, J NEUROCHEM, V96, P53
   Moreira D, 2002, TRENDS MICROBIOL, V10, P31, DOI 10.1016/S0966-842X(01)02257-0
   Morgan C, 2004, PROG NEUROBIOL, V74, P323, DOI 10.1016/j.pneurobio.2004.10.004
   MOSTAERT AS, 2007, NANOTECHNOLOGY, V18, DOI DOI 10.1088/0957-4484/18/4/0044010
   Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007
   Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012
   Pastor MT, 2005, CURR OPIN STRUC BIOL, V15, P57, DOI 10.1016/j.sbi.2005.01.004
   PAULING L, 1951, P NATL ACAD SCI USA, V37, P251, DOI 10.1073/pnas.37.5.251
   Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016
   Pearce FG, 2007, J AGR FOOD CHEM, V55, P318, DOI 10.1021/jf062154p
   Pepys MB, 2006, ANNU REV MED, V57, P223, DOI 10.1146/annurev.med.57.121304.131243
   Perutz MF, 2002, P NATL ACAD SCI USA, V99, P5591, DOI 10.1073/pnas.042681399
   Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   Prestwich GD, 2002, ANN NY ACAD SCI, V961, P106, DOI 10.1111/j.1749-6632.2002.tb03058.x
   Reches M, 2006, PHYS BIOL, V3, pS10, DOI 10.1088/1478-3975/3/1/S02
   Royal Society/ Royal Academy of Engineering, 2004, NAN NAN OPP UNC
   Scheibel T, 2003, P NATL ACAD SCI USA, V100, P4527, DOI 10.1073/pnas.0431081100
   Scholtmeijer K, 2002, APPL ENVIRON MICROB, V68, P1367, DOI 10.1128/AEM.68.3.1367-1373.2002
   Scholtmeijer K, 2001, APPL MICROBIOL BIOT, V56, P1, DOI 10.1007/s002530100632
   Sedman VL, 2006, J AM CHEM SOC, V128, P6903, DOI 10.1021/ja060358g
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Smith DP, 2003, J MOL BIOL, V330, P943, DOI 10.1016/S0022-2836(03)00687-9
   Smith JF, 2006, P NATL ACAD SCI USA, V103, P15806, DOI 10.1073/pnas.0604035103
   Sohma Y, 2006, CHEMBIOCHEM, V7, P1549, DOI 10.1002/cbic.200600112
   Squires AM, 2006, J AM CHEM SOC, V128, P11738, DOI 10.1021/ja063751v
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348
   Takahashi Y, 2004, BIOORGAN MED CHEM, V12, P693, DOI 10.1016/j.bmc.2003.11.022
   Talbot NJ, 2003, CURR BIOL, V13, pR696, DOI 10.1016/S0960-9822(03)00643-2
   Tartaglia GG, 2005, PROTEIN SCI, V14, P2723, DOI 10.1110/ps.051471205
   Tartaglia GG, 2004, PROTEIN SCI, V13, P1939, DOI 10.1110/ps.04663504
   Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Tjernberg L, 2002, J BIOL CHEM, V277, P43243, DOI 10.1074/jbc.M205570200
   Tycko R, 2000, CURR OPIN CHEM BIOL, V4, P500, DOI 10.1016/S1367-5931(00)00123-X
   Waterhouse SH, 2004, AUST J CHEM, V57, P519, DOI 10.1071/CH04070
   West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211
   Westermark P, 2005, AMYLOID, V12, P1, DOI 10.1080/13506120500032196
   Westermark P, 2005, FEBS J, V272, P5942, DOI 10.1111/j.1742-4658.2005.05024.x
   Wille H, 2002, P NATL ACAD SCI USA, V99, P3563, DOI 10.1073/pnas.052703499
   Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195
   Xu CY, 2004, TISSUE ENG, V10, P1160, DOI 10.1089/ten.2004.10.1160
   Yamada M, 2002, FEBS LETT, V530, P48, DOI 10.1016/S0014-5793(02)03393-8
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Yim EKF, 2005, NANOMED-NANOTECHNOL, V1, P10, DOI 10.1016/j.nano.2004.11.008
   Yip C, 2002, ANN NY ACAD SCI, V961, P109, DOI 10.1111/j.1749-6632.2002.tb03059.x
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
   Zhu M, 2002, J BIOL CHEM, V277, P50914, DOI 10.1074/jbc.M207225200
   Zurdo J, 2001, J AM CHEM SOC, V123, P8141, DOI 10.1021/ja016229b
   ZURDO J, 2003, Patent No. 003019
NR 159
TC 42
Z9 42
U1 0
U2 34
PU CSIRO PUBLISHING
PI COLLINGWOOD
PA 150 OXFORD ST, PO BOX 1139, COLLINGWOOD, VICTORIA 3066, AUSTRALIA
SN 0004-9425
J9 AUST J CHEM
JI Aust. J. Chem.
PY 2007
VL 60
IS 5
BP 333
EP 342
DI 10.1071/CH06485
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA 171ZV
UT WOS:000246774800003
DA 2018-10-19
ER

PT J
AU Luis, AL
   Rodrigues, JM
   Lobato, JV
   Lopes, MA
   Amado, S
   Veloso, AP
   Armada-da-Silva, PAS
   Raimondo, S
   Geuna, S
   Ferreira, AJ
   Varejao, ASP
   Santos, JD
   Mauricio, AC
AF Luis, Ana L.
   Rodrigues, Jorge M.
   Lobato, Jose V.
   Lopes, Maria A.
   Amado, Sandra
   Veloso, Antonio P.
   Armada-da-Silva, Paulo A. S.
   Raimondo, Stefania
   Geuna, Stefano
   Ferreira, Antonio J.
   Varejao, Artur S. P.
   Santos, Jose D.
   Mauricio, Ana C.
TI Evaluation of two biodegradable nerve guides for the reconstruction of
   the rat sciatic nerve
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE nerve entubulation; PLGA; caprolactone; sciatic nerve; rat
ID FRESH SKELETAL-MUSCLE; LONG-TERM EVALUATION; FUNCTIONAL ASSESSMENT;
   NEUROLOGIC EVALUATION; REPAIR; REGENERATION; RECOVERY;
   POLY(DL-LACTIDE-EPSILON-CAPROLACTONE); CONDUITS; DEGRADATION
AB The purpose of this study was to test in vivo two different nerve guides, one of PLGA made of a novel proportion (90:10) of the two polymers, Poly(L-lactide):Poly(glycolide), with (DL-lactide-epsilon-caprolactone) copolyester (Neurolac((R))) tube, in promoting nerve regeneration across a 10 mm-gap of the rat sciatic nerve. Finally, end-to-end coaptation was performed. Motor and sensory functional recovery was assessed throughout the healing period of 20 weeks and the repaired nerves were processed for morphological analysis. Both motor and sensory functions improved significantly in all experimental nerve repair groups, although the rate and extent of recovery was significantly higher in the end-to-end group. No significant differences were detected in the comparison between the two types of tubes. Compatible with results of functional tests, morphological analysis showed that axon regeneration occurred in both PLGA and Neurolac((R)) experimental groups but disclosed a different pattern of degradation of the two types of tubes with larger biodegradation of PLGA material by the end of 20 weeks. These results suggest that both types of biomaterial are a good substrate for preparing tubular nerve guides and the different pattern of degradation does not seem to influence the degree of nerve regeneration.
C1 Univ Porto, CECA, ICETA, P-4485661 Vairao, Portugal.
   Univ Porto, Dept Clin Vet, ICBAS, P-4099003 Oporto, Portugal.
   Univ Tecn Lisboa, FMH, P-1495688 Cruz Quebrada, Dafundo, Portugal.
   Univ Porto, Fac Engn, P-4200465 Oporto, Portugal.
   Univ Turin, Dipartimento Sci Clin & Biol, Osped San Luigi, I-10043 Turin, Italy.
   Univ Tecn Lisboa, FMV, P-1300477 Lisbon, Portugal.
   CHVNG, Dept Estomatol, P-4434502 Vila Nova De Gaia, Portugal.
   Univ Tras Os Montes & Alto Douro, CETAV, Dept Ciencias Vet, P-5001911 Vila Real, Portugal.
RP Mauricio, AC (reprint author), Campus Agrario de Vairao,Rua Padre Armando Quinta, P-4485661 Vairao, Portugal.
EM ana.colette@mail.icav.up.pt
RI Lopes, Cristina/A-4241-2010; Raimondo, Stefania/R-5856-2016;
   Armada-da-Silva, Paulo/L-5675-2013; Amado, Sandra/O-6988-2016; Lopes,
   Maria A./P-4442-2014; Veloso, Antonio/F-5064-2013
OI Raimondo, Stefania/0000-0002-8907-473X; Armada-da-Silva,
   Paulo/0000-0002-3814-6879; Amado, Sandra/0000-0001-8356-4810; Lopes,
   Maria A./0000-0003-4105-8148; Veloso, Antonio/0000-0003-1068-1113;
   Varejao, Artur/0000-0002-0736-3635; Mauricio, Ana
   Colette/0000-0002-0018-9363; Santos, Jose Domingos/0000-0002-6871-9850;
   Ferreira, Antonio/0000-0002-0142-6578; Rodrigues, Jorge
   Manuel/0000-0003-1889-4914; Geuna, Stefano/0000-0002-6962-831X
CR Battiston B, 2005, MICROSURG, V25, P258, DOI 10.1002/micr.20127
   Bertleff MJOE, 2005, J HAND SURG-AM, V30A, P513, DOI 10.1016/j.jhsa.2004.12.009
   Campbell JN, 2001, MUSCLE NERVE, V24, P1261, DOI 10.1002/mus.1143
   DenDunnen WFA, 1996, MICROSURG, V17, P348, DOI 10.1002/(SICI)1098-2752(1996)17:7<348::AID-MICR2>3.0.CO;2-C
   denDunnen WFA, 1997, J BIOMED MATER RES, V36, P337, DOI 10.1002/(SICI)1097-4636(19970905)36:3<337::AID-JBM9>3.3.CO;2-8
   Doolabh VB, 1996, REV NEUROSCIENCE, V7, P47
   Dubey N, 1999, EXP NEUROL, V158, P338, DOI 10.1006/exnr.1999.7095
   FIELDS RD, 1989, PROG NEUROBIOL, V33, P87, DOI 10.1016/0301-0082(89)90036-1
   Hu D, 1997, ANESTHESIOLOGY, V86, P957, DOI 10.1097/00000542-199704000-00026
   Jensen JN, 2004, MICROSURG, V24, P309, DOI 10.1002/micr.20028
   Kannan RY, 2005, BIOTECHNOL APPL BIOC, V41, P193, DOI 10.1042/BA20040137
   Kline DG, 2000, J NEUROSURG, V93, P336
   Koka R, 2001, EXP NEUROL, V168, P192, DOI 10.1006/exnr.2000.7600
   Lundborg G, 2004, Handchir Mikrochir Plast Chir, V36, P1
   Lundborg G, 2002, J PERIPHER NERV SYST, V7, P139, DOI 10.1046/j.1529-8027.2002.02019.x
   Lundborg G., 2003, SEVERE TRAUMATIC DEF, P153
   MACKINNON SE, 1985, PLAST RECONSTR SURG, V75, P384, DOI 10.1097/00006534-198503000-00014
   Madison R.D., 1992, WOUND HEALING BIOCH, P450
   Madorsky SJ, 1998, PLAST RECONSTR SURG, V102, P430, DOI 10.1097/00006534-199808000-00021
   MASTERS DB, 1993, ANESTHESIOLOGY, V79, P340, DOI 10.1097/00000542-199308000-00020
   Matsuyama T, 2000, NEUROL MED-CHIR, V40, P187, DOI 10.2176/nmc.40.187
   MAY M, 1983, OTOLARYNG CLIN N AM, V16, P661
   Meek MF, 1999, MICROSURG, V19, P247, DOI 10.1002/(SICI)1098-2752(1999)19:5<247::AID-MICR7>3.0.CO;2-E
   Meek MF, 2004, J BIOMED MATER RES A, V68A, P43, DOI 10.1002/jbm.a.10157
   Meek MF, 2004, TISSUE ENG, V10, P1027, DOI 10.1089/ten.2004.10.1027
   MILLESI H, 1990, WORLD J SURG, V14, P733, DOI 10.1007/BF01670520
   OLIVER JE, 1987, VET NEUROLOGY, P7
   RODRIGUEZ FJ, 2004, DRUG DISCOV TODAY DI, V1, P177, DOI DOI 10.1016/J.DDMOD.2004.09.008
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Shir Y, 2001, PAIN, V90, P75, DOI 10.1016/S0304-3959(00)00388-2
   THALHAMMER JG, 1995, ANESTHESIOLOGY, V82, P1013, DOI 10.1097/00000542-199504000-00026
   Tos P, 2004, MICROSURG, V24, P459, DOI 10.1002/micr.20064
   Varejao ASP, 2004, NEUROL RES, V26, P186, DOI 10.1179/016164104225013833
   Varejao ASP, 2003, MICROSURG, V23, P346, DOI 10.1002/micr.10148
   Varejao ASP, 2003, MICROSURG, V23, P338, DOI 10.1002/micr.10147
   Varejao ASP, 2003, MUSCLE NERVE, V27, P706, DOI 10.1002/mus.10374
   YOSHII S, 1988, BRAIN RES, V201, P158
NR 37
TC 24
Z9 24
U1 1
U2 14
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2007
VL 17
IS 1
BP 39
EP 52
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 131SN
UT WOS:000243890300005
PM 17264386
DA 2018-10-19
ER

PT J
AU Santoni, BG
   Pluhar, GE
   Motta, T
   Wheeler, DL
AF Santoni, Brandon G.
   Pluhar, G. Elizabeth
   Motta, Tatiana
   Wheeler, Donna L.
TI Hollow calcium phosphate microcarriers for bone regeneration: In vitro
   osteoproduction and ex vivo mechanical assessment
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE biomaterials; biomechanics; drug delivery; bone regeneration; bone
   morphogenic protein; mesenchymal stem cell
ID OSTEOGENIC PROTEIN-1 BMP-7; MESENCHYMAL STEM-CELLS; MORPHOGENETIC
   PROTEIN; TRICALCIUM PHOSPHATE; BIOMATERIAL CARRIERS; HYDROXYAPATITE;
   ALLOGRAFTS; MARROW; DIFFERENTIATION; PROLIFERATION
AB Synthetic grafting materials, such as calcium phosphates (hydroxyapatite, HA; tricalcium phosphate, TCP), polymers, or composites thereof, can be used as osteoconductive scaffolds and delivery vehicles for osteoinductive growth factors. Carrier materials must be engineered to deliver these factors in a controlled fashion at a rate and dose consistent with the biological need and responsiveness of the system to optimize bone formation and ingrowth. They should also simultaneously provide mechanical support and slowly resorb as new bone is formed.
   This investigation assessed the elution characteristics of BMP-7 (OP-1) from hollow calcium phosphate spheres of varying chemical composition (HA/beta-TCP) and porosity (dense/porous). The pharmacokinetics indicated a bimodal trend of protein release with protein elution peaking between fifteen and thirty minutes in solution (bolus release) and continuing through the eight-week time point (sustained release). Eluted OP-1 bioactivity was characterized over a three-week period using mesenchymal stem cell (MSC) cultures and included assessment of the protein's differential, proliferative, and calcified nodule forming abilities. Alkaline phosphatase enzyme (ALP) activity in MSCs peaked between 12 and 16 days post-OP-1 exposure. Elutant from the HA dense treatment group induced the highest degree of ALP expression while elutant from the beta-TCP treatment groups induced the formation of significantly higher numbers of calcified nodules in culture. The aggregate modulus of a clinically relevant 2 cc dose of carriers was quantified using custom designed testing fixtures to investigate the effects of carrier size, porosity, chemical composition, and the presence of a central hole on mechanical integrity. Significant increases in moduli were noted for carrier size and chemical composition (HA >beta-TCP). These preliminary in vitro and ex vivo results indicate the clinical potential of the hollow calcium phosphate carriers as successful load-bearing delivery vehicles for OP-1.
C1 Colorado State Univ, Dept Mech Engn, Orthopaed Bioengn Res Lab, Ft Collins, CO 80523 USA.
   Univ Minnesota, Dept Vet Clin Sci, St Paul, MN 55108 USA.
   Biosolut Consulting LLC, Webster, NY 14580 USA.
RP Santoni, BG (reprint author), Colorado State Univ, Anim Canc Ctr, Dept Clin Sci, 300 W Drake Rd,Campus Delivery Code 1620, Ft Collins, CO 80523 USA.
EM bgsant@holly.colostate.edu
CR Alam MI, 2001, BIOMATERIALS, V22, P1643
   Asahina I, 1996, EXP CELL RES, V222, P38, DOI 10.1006/excr.1996.0005
   Blokhuis TJ, 2001, BIOMATERIALS, V22, P725, DOI 10.1016/S0142-9612(00)00238-6
   BROOKES M, 1971, BLOOD SUPPLY BONE SC
   Cassiede P, 1996, J BONE MINER RES, V11, P1264
   Chu TMG, 2002, BIOMATERIALS, V23, P1283, DOI 10.1016/S0142-9612(01)00243-5
   Cook SD, 1996, CLIN ORTHOP RELAT R, P29
   COWIN SC, 2001, BONE MECH HDB
   DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307
   DELLOYE C, 1992, CLIN ORTHOP RELAT R, P273
   Dennis J E, 1992, Cell Transplant, V1, P23
   Dimitriou R, 2005, INJURY, V36, pS51, DOI 10.1016/j.injury.2005.10.010
   Enneking WE, 2001, J BONE JOINT SURG AM, V83A, P971, DOI 10.2106/00004623-200107000-00001
   Friedlaender Gary E, 2004, Surg Technol Int, V13, P249
   GOLDBERG VM, 1987, CLIN ORTHOP RELAT R, P7
   Habibovic P, 2006, J ORTHOP RES, V24, P867, DOI 10.1002/jor.20115
   Hanada K, 1997, J BONE MINER RES, V12, P1606, DOI 10.1359/jbmr.1997.12.10.1606
   HEIPLE KG, 1963, J BONE JOINT SURG AM, V45, P1593, DOI 10.2106/00004623-196345080-00003
   Itokazu M, 1998, J BIOMED MATER RES, V39, P536, DOI 10.1002/(SICI)1097-4636(19980315)39:4<536::AID-JBM5>3.0.CO;2-K
   Kanayama M, 2006, SPINE, V31, P1067, DOI 10.1097/01.brs.0000216444.01888.21
   Korhonen RK, 2002, J BIOMECH, V35, P903, DOI 10.1016/S0021-9290(02)00052-0
   Kurashina K, 2002, BIOMATERIALS, V23, P407, DOI 10.1016/S0142-9612(01)00119-3
   LENNON DP, 1995, EXP CELL RES, V219, P211, DOI 10.1006/excr.1995.1221
   Li RH, 2001, TRENDS BIOTECHNOL, V19, P255, DOI 10.1016/S0167-7799(01)01665-1
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Manjubala I, 2002, J BIOMED MATER RES, V63, P200, DOI 10.1002/jbm.10128
   Pecina M, 2001, INT ORTHOP, V25, P203, DOI 10.1007/s002640100262
   PELKER RR, 1983, CLIN ORTHOP RELAT R, P54
   Pluhar GE, 2006, J BONE JOINT SURG BR, V88B, P960, DOI 10.1302/0301-620X.88B7.17056
   Salkeld SL, 2001, J BONE JOINT SURG AM, V83A, P803, DOI 10.2106/00004623-200106000-00001
   SAMPATH TK, 1992, J BIOL CHEM, V267, P20352
   SCHOUTENS AJ, 1993, BONE CIRCULATION VAS, P121
   SUMMERS BN, 1989, J BONE JOINT SURG BR, V71, P677
   Taichman RS, 1996, EXP HEMATOL, V24, P509
   TAKAOKA K, 1988, CLIN ORTHOP RELAT R, P250
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   URIST MR, 1984, P NATL ACAD SCI-BIOL, V81, P371, DOI 10.1073/pnas.81.2.371
   URIST MR, 1984, CLIN ORTHOP RELAT R, P277
   Verdonschot N, 2001, J BIOMED MATER RES, V58, P599, DOI 10.1002/jbm.1058
   WESTERGRENTHORSSON G, 1991, J CELL PHYSIOL, V147, P523, DOI 10.1002/jcp.1041470319
   Wozney J M, 1989, Prog Growth Factor Res, V1, P267, DOI 10.1016/0955-2235(89)90015-X
   Zhang Y, 2002, J BIOMED MATER RES, V61, P1, DOI 10.1002/jbm.10176
   Zysset PK, 1999, J BIOMECH, V32, P1005, DOI 10.1016/S0021-9290(99)00111-6
NR 43
TC 27
Z9 34
U1 0
U2 15
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2007
VL 17
IS 5
BP 277
EP 289
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 207LC
UT WOS:000249251600003
PM 17851170
DA 2018-10-19
ER

PT J
AU Padois, K
   Rodriguez, F
AF Padois, K.
   Rodriguez, F.
TI Effects of chitosan addition to self-setting bone cement
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE bone cement; biomaterial; chitosan; mechanical properties;
   gamma-sterilization
ID CALCIUM-PHOSPHATE CEMENT; COMPOSITE SCAFFOLDS; ACID
AB The Cementek((R)) is a self-setting bone cement composed of a solid phase and a liquid phase. After mixing these two phases, it sets in situ to form an hydroxyapatite (HAp) as the only end product. It is difficult to introduce a new component into this cement without modifying the final product and its mechanical properties. In order to improve the mechanical properties of the Cementek((R)), a natural polymer (chitosan) was added in the initial formulation. Two types of chitosan were added into the Cementek((R)), at various concentration, in either the liquid or the solid phase. The effects of chitosan addition on the properties of the self-setting bone cement are examined. The different composites were characterized by the determination of the setting time, the chemical transformation by X-ray diffraction and mechanical tests. The chemical transformations were not affected by the addition of chitosan neither in the liquid nor in the solid phase. The maturation towards HAp appeared to be complete for all the composites. The setting time was decreased by the addition of chitosan in the solid phase. However the setting time value of each composite remained compatible with a practical use in situ. This study shows that the maturation mode of the samples directly affects the mechanical properties of the obtained composites. The sterilization of the cement with chitosan has been studied.
C1 Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.
   Univ Toulouse 3, Fac Pharmaceut Sci, Pharm Galen Lab, F-31062 Toulouse 09, France.
RP Padois, K (reprint author), Stanford Univ, Dept Mat Sci & Engn, 416 Escondido Mall,Bldg 550,Room 555K, Stanford, CA 94305 USA.
EM kpadois@stanford.edu
CR Chappuis J, 1999, COLLOID SURFACE A, V156, P223, DOI 10.1016/S0927-7757(99)00075-8
   DRIESSENS FCM, 1993, J MATER SCI-MATER M, V4, P503, DOI 10.1007/BF00120130
   Fernandez E, 1998, J BIOMED MATER RES, V42, P403, DOI 10.1002/(SICI)1097-4636(19981205)42:3<403::AID-JBM8>3.3.CO;2-0
   Furlan L, 1996, POLYMER, V37, P843, DOI 10.1016/0032-3861(96)87263-6
   GONCALVES S, 2000, P 13 INT S CER MED B
   *GROUP FRANC ETUD, 1989, MAT COMP BAS POLYM
   HATIM Z, 1997, ACTUALITES BIOMATERI, V4, P209
   HATIM Z, 1998, THESIS U CHOUAIB JAD
   Lim LY, 1998, J BIOMED MATER RES, V43, P282
   Ratier A, 2001, BIOMATERIALS, V22, P897, DOI 10.1016/S0142-9612(00)00252-0
   Ren DW, 2005, CARBOHYD RES, V340, P2403, DOI 10.1016/j.carres.2005.07.022
   VIALA S, 1996, THESIS I NATL POLYTE
   Wan ACA, 1998, BIOMATERIALS, V19, P1309
   Xu HHK, 2002, BIOMATERIALS, V23, P193, DOI 10.1016/S0142-9612(01)00095-3
   Yokoyama A, 2002, BIOMATERIALS, V23, P1091, DOI 10.1016/S0142-9612(01)00221-6
   Zahraoui C, 1999, BONE, V25, p63S, DOI 10.1016/S8756-3282(99)00136-2
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
NR 18
TC 5
Z9 6
U1 0
U2 4
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2007
VL 17
IS 5
BP 309
EP 320
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 207LC
UT WOS:000249251600006
PM 17851173
DA 2018-10-19
ER

PT J
AU Zhou, GS
   Su, ZY
   Cai, YR
   Liu, YK
   Dai, LC
   Tang, RK
   Zhang, M
AF Zhou, Guo Shun
   Su, Zhong Yuan
   Cai, Yu Rong
   Liu, Yu Kan
   Dai, Li Cheng
   Tang, Rui Kang
   Zhang, Ming
TI Different effects of nanophase and conventional hydroxyapatite thin
   films on attachment, proliferation and osteogenic differentiation of
   bone marrow derived mesenchymal stem cells
SO BIO-MEDICAL MATERIALS AND ENGINEERING
LA English
DT Article
DE hydroxyapatite; nanophase; mesenchymal stem cells
ID OSTEOBLASTS; RECONSTRUCTION; REGENERATION; INTERFACE; COMPOSITE;
   SCAFFOLDS; RESPONSES; CERAMICS; IMPLANTS; COATINGS
AB It is suggested that nanophase hydroxyapatite (nHAP) might have advantages over conventional hydroxyapatite (cHAP) as a biomaterial for bone regeneration. To be a satisfactory candidate for bone tissue engineering, it is important to support the growth and differentiation of bone marrow-derived mesenchymal stem cells (BMSCs). The purpose of this study is to determine whether nHAP as cell growth substrata could give better support for attachment, proliferation and osteogenic differentiation of BMSCs than cHAP. Materials and Methods: nHAP and cHAP films were prepared as the substrata for the cell growth. BMSCs obtained from rabbit were seeded on the films. Attachment, proliferation and osteogenic differentiation of BMSCs on the two kinds of films were evaluated. Results: Cell attachment ratio on nHAP films was significantly higher than that on cHAP films. Doubling time on nHAP films was significantly shorter than that on cHAP films. Amount of total proteins detected from cells cultured on nHAP films was significantly higher than that on cHAP films. However, alkaline phosphatase activity and osteocalcin content of the two groups showed no significant difference. Conclusions: nHAP films favored cell attachment and proliferation but not osteogenic differentiation of BMSCs compared with cHAP films.
C1 [Su, Zhong Yuan; Liu, Yu Kan; Zhang, Ming] Zhejiang Univ, Coll Life Sci, Dept Biotechnol, Hangzhou 310058, Peoples R China.
   [Zhou, Guo Shun; Dai, Li Cheng] Huzhou Cent Hosp, Huzhou Key Lab Mol Med, Huzhou, Zhejiang, Peoples R China.
   [Cai, Yu Rong; Tang, Rui Kang] Zhejiang Univ, Coll Sci, Dept Chem, Hangzhou, Peoples R China.
RP Zhang, M (reprint author), Zhejiang Univ, Coll Life Sci, Dept Biotechnol, 325 Room,Zi Jin Gang Campus, Hangzhou 310058, Peoples R China.
EM gfz@mail.huptt.zj.cn; Lyk_cn@yahoo.com.cn
CR Baharloo B, 2005, J BIOMED MATER RES A, V74A, P12, DOI 10.1002/jbm.a.30321
   Brett PM, 2004, BONE, V35, P124, DOI 10.1016/j.bone.2004.03.009
   CAI YR, 2007, J MATER CHEM, V17, P1
   Chistolini P, 1999, J MATER SCI-MATER M, V10, P739, DOI 10.1023/A:1008939524807
   Ito Y, 2004, J BIOMED MATER RES A, V69A, P454, DOI 10.1002/jbm.a.30014
   Jha LJ, 1997, J MATER SCI-MATER M, V8, P185, DOI 10.1023/A:1018531505484
   Kim HW, 2005, BIOMATERIALS, V26, P5221, DOI 10.1016/j.biomaterials.2005.01.047
   Kim HW, 2004, J BIOMED MATER RES B, V70B, P270, DOI 10.1002/jbm.b.30032
   Kim HW, 2004, J BIOMED MATER RES A, V68A, P522, DOI 10.1002/jbm.a..20094
   Liu Q, 1996, J MATER SCI-MATER M, V7, P551, DOI 10.1007/BF00122178
   Livingston TL, 2003, J MATER SCI-MATER M, V14, P211, DOI 10.1023/A:1022824505404
   MEHLISCH DR, 1990, ORAL SURG ORAL MED O, V70, P685, DOI 10.1016/0030-4220(90)90001-9
   Montanaro L, 2002, BIOMATERIALS, V23, P3651, DOI 10.1016/S0142-9612(02)00098-4
   NANCOLLAS GH, 1970, ARCH ORAL BIOL, V15, P731, DOI 10.1016/0003-9969(70)90037-3
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Rosa Adalberto Luiz, 2003, Braz. Dent. J., V14, P16, DOI 10.1590/S0103-64402003000100003
   Sakai D, 2005, SPINE, V30, P2379, DOI 10.1097/01.brs.0000184365.28481.e3
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   SHELTON RM, 1988, BIOMATERIALS, V9, P24, DOI 10.1016/0142-9612(88)90065-8
   STEPHEN M, 2004, J CRANIOFAC SURG, V15, P34
   van den Dolder J, 2003, BIOMATERIALS, V24, P1745, DOI 10.1016/S0142-9612(02)00537-9
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
NR 23
TC 18
Z9 21
U1 0
U2 5
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0959-2989
J9 BIO-MED MATER ENG
JI Bio-Med. Mater. Eng.
PY 2007
VL 17
IS 6
BP 387
EP 395
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 242JF
UT WOS:000251720700006
PM 18032820
DA 2018-10-19
ER

PT S
AU Ou, J
   Yin, GF
   Zhou, DL
   Chen, XC
   Yao, YD
   Yang, WZ
   Wu, BL
   Xue, M
   Cui, J
   Zhu, WF
   Kang, YQ
AF Ou, J.
   Yin, G. F.
   Zhou, D. L.
   Chen, X. C.
   Yao, Y. D.
   Yang, W. Z.
   Wu, B. L.
   Xue, M.
   Cui, J.
   Zhu, W. F.
   Kang, Y. Q.
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Preparation of merwinite with apatite-formimg ability by sol-gel process
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE merwinite; hydroxyapatite; powder; simulated body fluid
ID DIOPSIDE
AB Merwinite powders were synthesized by a sol-gel process. The bioactivity in vitro of merwinite was investigated by soaking the powders in simulated body fluid (SBF), the growth of hydroxyapatite(HAp) on the surface of the powder was evaluated in various time. It was found that hydroxyapatite was formed after soaking for 14 days. The results indicate that merwinite possessed apatite-formation ability might be a potential candidate biomaterial for hard tissue repair.
C1 [Ou, J.; Yin, G. F.; Zhou, D. L.; Chen, X. C.; Yao, Y. D.; Yang, W. Z.; Xue, M.; Kang, Y. Q.] Sichuan Univ, Coll Mat Sci & Engn, Chengdu 610064, Peoples R China.
   [Cui, J.] Sichuan Univ, West China Coll Stomatol, Dept Prosthodont, Chengdu 610064, Peoples R China.
   [Ou, J.; Wu, B. L.; Zhu, W. F.] Guin Univ Technol, Dept Mat Engn, Guin 541004, Peoples R China.
RP Yin, GF (reprint author), Sichuan Univ, Coll Mat Sci & Engn, Chengdu 610064, Peoples R China.
EM gloujun@126.com; nic0700@scu.edu.cn
FU National High Technology Research and Development Program of
   China(863programs) [2002AA326080]
FX This study was supported by the National High Technology Research and
   Development Program of China(863programs),Grant no.2002AA326080
CR DeAza PN, 1997, BIOMATERIALS, V18, P1285, DOI 10.1016/S0142-9612(97)00063-X
   FRESA R, 1995, BIOMATERIALS, V16, P1249, DOI 10.1016/0142-9612(95)98132-X
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Iwata NY, 2004, COLLOID SURFACE B, V33, P1, DOI 10.1016/j.colsurfb.2003.07.004
   JUHASZ JA, 2003, J MATER SCI-MATER M, V14, P490
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   MARTINEZ A, 2001, J SOL-GEL SCI TECHN, V21, P13
   Nonami T, 1999, J MATER SCI-MATER M, V10, P475, DOI 10.1023/A:1008996908797
   Vallet-Regi M, 1999, J BIOMED MATER RES, V44, P416, DOI 10.1002/(SICI)1097-4636(19990315)44:4<416::AID-JBM7>3.0.CO;2-S
   Wu CT, 2005, BIOMATERIALS, V26, P2925, DOI 10.1016/j.biomaterials.2004.09.019
NR 10
TC 6
Z9 6
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 67
EP +
DI 10.4028/www.scientific.net/KEM.330-332.67
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800017
DA 2018-10-19
ER

PT S
AU Liao, J
   Mo, AC
   Wu, HK
   Zhang, JC
   Li, YB
   Lv, GY
AF Liao, Juan
   Mo, Anchun
   Wu, Hongkun
   Zhang, Jingchao
   Li, Yubao
   Lv, Guoyu
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Antibacterial activity of silver-hydroxyapatite/titania nanoparticles on
   oral bacteria
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE hydroxyapatite; sliver; TiO2; antibacterial activity; oral bacteria;
   MICs
ID ZEOLITE
AB Since bacterial accumulation surrounding biomaterials has pathogens known to cause the biomaterials centered infection, it may be important to develop some kind of biomaterial with antibacterial activity as well as biocompatibility. This study focused on evaluating the antibacterial activity of silver-hydroxyapatite/Titania nanoparticles (Ag-nHA/nTiO(2)) against oral bacteria with agar dilution method. Bacteria were seeded on agar plate containing antibacterial material with different concentrations after incubation of 48 hours. The antibacterial activity was demonstrated by MICs. The MICs of Ag-nHA/nTiO(2) ranged between 1000 mu g/ml and 7500 mu g/ml under anaerobic conditions. And it also exhibited remarkable antibacterial activity to all the aerobe bacteria (MIC <= 500 mu g/ml). On the other hand, the antibacterial activities of Ag-nHA/nTiO(2) differentiate to some extent with the bacterial strains. This Ag-nHA/nTiO(2) exhibited remarkable antibacterial activity to anaerobic and aerobe bacteria. This antibacterial effect may reduce the potential for bacterial colonisation of oral biomaterials with Ag-nHA/nTiO(2).
C1 [Liao, Juan; Mo, Anchun; Wu, Hongkun; Zhang, Jingchao] Sichuan Univ, West China Coll Stomatol, Chengdu 610041, Peoples R China.
   [Li, Yubao; Lv, Guoyu] Sichuan Univ, Res Ctr Nano BioMat, Chengdu 610041, Peoples R China.
   [Liao, Juan; Mo, Anchun; Wu, Hongkun; Zhang, Jingchao] Minist Educ, Key Lab Oral Biomed Engn, Chengdu 610041, Peoples R China.
RP Lv, GY (reprint author), Sichuan Univ, West China Coll Stomatol, Chengdu 610041, Peoples R China.
EM juan123liao@163.com; moanchun@163.com; whk-mo@263.net;
   joice2000-2004@sohu.com; nic7504@scu.edu.cn; lgyhxy@yahoo.com.cn
CR Bekbolet M, 1996, CHEMOSPHERE, V32, P959, DOI 10.1016/0045-6535(95)00359-2
   Brook I, 1997, J ANTIMICROB CHEMOTH, V39, P763, DOI 10.1093/jac/39.6.763
   Darouiche RO, 1999, CLIN INFECT DIS, V29, P1371, DOI 10.1086/313561
   ELEK SD, 1957, BRIT J EXP PATHOL, V38, P573
   GENCO RJ, 1992, J PERIODONTOL, V63, P338, DOI 10.1902/jop.1992.63.4s.338
   Grier N., 1983, SILVER ITS COMPOUNDS, P375
   Guggenbichler JP, 1999, INFECTION, V27, pS16, DOI 10.1007/BF02561612
   Hotta M, 1998, J ORAL REHABIL, V25, P485, DOI 10.1046/j.1365-2842.1998.00265.x
   Kawahara K, 2000, DENT MATER, V16, P452, DOI 10.1016/S0109-5641(00)00050-6
   SALTON MRJ, 1994, BACTERIAL CELL WALL, P1
   WICKEN AJ, 1985, BACTERIAL ADHESION M, P45
   Yoshinari M, 2000, J BIOMED MATER RES, V52, P388, DOI 10.1002/1097-4636(200011)52:2<388::AID-JBM20>3.0.CO;2-E
NR 12
TC 5
Z9 6
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 299
EP +
DI 10.4028/www.scientific.net/KEM.330-332.299
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800074
DA 2018-10-19
ER

PT S
AU Ploska, U
   Berger, G
AF Ploska, U.
   Berger, G.
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Spongiosa-like specimen and foils of a biomaterial composed of
   fluorapatite and calcium zirconium phosphate
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE apatite; calcium zirconium phosphate; spongiosa-like specimen; foil
AB A long-term stable material, which has two main crystalline phases - fluorapatite (FA) and calcium zirconium phosphate (CZP) [1, 2] and could be processed to dense sintered samples was tested related to the use with two application forms - spongiosa-like specimen and foils. The suitability of various sintering additives was investigated alone and in diverse combinations. During sintering of the spongiosa-like samples volume shrinkage of about 50% was observed whereas the shrinkage in x,y plane was about twice of the shrinkage in z direction. The cuboid form was not affected by the shrinkage. The compression strength of the spongiosa-like materials was in the range of 1MPa up to 1.6MPa. A ceramic foil was generated via foil slip casting of a slip containing about 38vol% of FA-CZP. Temperature programs were created for debindering and sintering of the green foil and the four-fold laminate, respectively.
C1 [Ploska, U.; Berger, G.] Fed Inst Mat Res & Testing, Unter Eichen 87, D-12200 Berlin, Germany.
RP Ploska, U (reprint author), Fed Inst Mat Res & Testing, Unter Eichen 87, D-12200 Berlin, Germany.
EM ute.ploska@bam.de; georg.berger@bam.de
FU German Research Foundation (DFG), Bonn [BE 1339/8-3]
FX Financial support (BE 1339/8-3) by the German Research Foundation (DFG),
   Bonn, is gratefully acknowledged. Special thanks go to Ms. Annika
   Jaenicke for the preparation of the spongiosa-like specimen and Mr.
   Wolfgang Guther for generating the foil.
CR Berger G, 2003, KEY ENG MAT, V240-2, P607, DOI 10.4028/www.scientific.net/KEM.240-242.607
   OVERGAARD S, 1997, CLIN ORTHOP RELAT R, V336, P2866
   PLOSKA U, 2002, P 17 EUR SOC BIOM C, pL54
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   SZMUKLERMONCLER S, 1992, ADV BIOMAT, V10, P377
   VERBEECK RMH, 1980, BER BUNSEN PHYS CHEM, V84, P159, DOI 10.1002/bbpc.19800840209
   Willmann G., 2001, KEY ENG MATER, V192-195, P111
NR 7
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 443
EP +
DI 10.4028/www.scientific.net/KEM.330-332.443
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800109
DA 2018-10-19
ER

PT S
AU Li, J
   Wang, YH
   Huang, Y
   He, F
   Wan, YZ
AF Li, Jian
   Wang, Yuhn
   Huang, Yuan
   He, Fang
   Wan, Yizao
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Study on interface reaction and its control of titanium
   fiber-hydroxyapatite composites
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE interface; titanium fiber; hydroxyapatite; composites
AB Various reinforcements have been used to reinforce hydroxyapatite composites. Bioactivity of hydroxyapatite and excellent mechanical properties of titanium make titanium fiber reinforced hydroxyapatite composite a promising biomaterial. In this work, a titanium fiber was chosen as the reinforcement, and hydroxyapatite powders prepared by wet precipitation method were used as matrix material. The interface between titanium fiber and hydroxyapatite was investigated in terms of microstructure and chemical composition using a combination of scanning electron microscopy (SEM), X-ray diffraction (XRD) and energy disperse spectroscopy (EDS). Experimental results showed that titanium/hydroxyapatite composite with controllable interface could be made by choosing proper preparation method.
C1 [Li, Jian; Wang, Yuhn; Huang, Yuan; He, Fang; Wan, Yizao] Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
RP Li, J (reprint author), Tianjin Univ, Sch Mat Sci & Engn, Tianjin 300072, Peoples R China.
EM yzwantju@yahoo.com
CR HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   JANSEN JA, 1991, J BIOMED MATER RES, V25, P973, DOI 10.1002/jbm.820250805
   JI HX, 1992, J MATER SCI-MATER M, V3, P283, DOI 10.1007/BF00705294
   Knepper M, 1997, BIOMATERIALS, V18, P1523, DOI 10.1016/S0142-9612(97)00066-5
   Miao X, 2001, J MATER SCI, V36, P3323, DOI 10.1023/A:1017915226015
   Ning CQ, 2002, BIOMATERIALS, V23, P2909, DOI 10.1016/S0142-9612(01)00419-7
   Popa C, 2005, J MATER SCI-MATER M, V16, P1165, DOI 10.1007/s10856-005-4724-5
   Ruan Jian-ming, 2003, Chinese Journal of Nonferrous Metals, V13, P1361
   Yang YZ, 2004, BIOMATERIALS, V25, P2927, DOI 10.1016/j.biomaterials.2003.09.072
NR 9
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 507
EP +
DI 10.4028/www.scientific.net/KEM.330-332.507
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800125
DA 2018-10-19
ER

PT S
AU Yang, L
   Van Blitterswijk, CA
   Barrere, F
AF Yang, L.
   Van Blitterswijk, C. A.
   Barrere, F.
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI pDNA and calcium phosphate co-precipitation on titanium alloy plate
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE plasmid DNA; calcium phosphate coating; gene delivery; co-precipitation
AB DNA transfection by biomaterial is a promising strategy to stimulate cells in tissue engineering. Co-precipitation of Calcium Phosphate (CaP) with plasmid DNA (pDNA) is known for several decades as non-viral transfection agent [1]. In this study, we report the co-precipitation of different pDNA into biomimetic calcium phosphate coating onto titanium alloy (Ti) plates in order to evaluate their efficiency of incorporation. And it is possible to tune the rate of coprecipitation by changing the volume of Calcium Phosphate Solution (CPS) and the [pDNA]. The structure of coating was affected by the presence of DNA in CPS solution.
C1 [Yang, L.; Van Blitterswijk, C. A.; Barrere, F.] Univ Twente, Inst Biomed Technol, POB 217, NL-7500 AE Enschede, Netherlands.
RP Yang, L (reprint author), Univ Twente, Inst Biomed Technol, POB 217, NL-7500 AE Enschede, Netherlands.
EM Y.Liang-1@tnw.utwente.nl; C.A.Vanblitterswijk@tnw.utwente.nl;
   F.Y.F.Barrere@tnw.utwente.nl
OI van Blitterswijk, Clemens/0000-0003-2371-4615
FU EC [G5RD-CT-2002-00738]
FX This project is funded by the EC G5RD-CT-2002-00738.
CR Barrere F, 2001, J MATER SCI-MATER M, V12, P529, DOI 10.1023/A:1011271713758
   SAMBROOK J, 2001, MOL CLONING LAB MANU, P1614
NR 2
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 621
EP +
DI 10.4028/www.scientific.net/KEM.330-332.621
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800153
DA 2018-10-19
ER

PT S
AU Chen, WC
   Bao, CY
   Jeyachandran, YL
   Out, GM
   Fan, HS
   Liao, YM
   Zhang, XD
AF Chen, W. C.
   Bao, C. Y.
   Jeyachandran, Y. L.
   Out, G. M.
   Fan, H. S.
   Liao, Y. M.
   Zhang, X. D.
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Exploring antibacterial and antiadhesive activities of titanium surface
   modified with hydroxyapatite sol-gel containing silver
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE percutaneous devices; permucosal devices; antibacterial biomaterial;
   sol-gel
ID ADHESION
AB Circumambient tissues infection is a common complication of implanted percutaneous and permucosal devices (PDs). In order to Counter the infection, the titanium abutment surface of PDs was modified to achieve antibacterial and antiadhesive activities. Titanium discs were immersed into hydroxyapatite (HA) sol containing different mass fraction silver and thermally treated to get modified discs. The modified discs become more smoother and get crystal HA coatings containing silver. Silver ion release test demonstrate the release rate is very slow and the coating is a reservoir of silver. The antibacterial and antiadhesive effects of modified discs on Staphylococcus aureus and Porphyromonas gingivalis were evaluated. Modified titanium discs with silver significantly inhibited the growth of these two bacteria compared with both the polished titanium discs control and modified titanium discs without silver. And titanium discs modified with more silver have higher antibacterial activity and less bacteria adhesion in this study. These findings indicate that titanium surface modified with the HA sol-gel containing silver could achieve antibacterial and antiadhesive activities, and the abutments of PDs are promising to be modified by this method.
C1 [Chen, W. C.; Bao, C. Y.; Out, G. M.; Liao, Y. M.] Sichuan Univ, West China Sch Stomatol, Chengdu 610041, Peoples R China.
   [Jeyachandran, Y. L.] Bharathiar Univ, Dept Phys, Coimbatore 641046, Tamil Nadu, India.
   [Fan, H. S.; Zhang, X. D.] Sichuan Univ, Engn Res Ctr Biomat, Chengdu 610065, Peoples R China.
RP Bao, CY (reprint author), Sichuan Univ, West China Sch Stomatol, Chengdu 610041, Peoples R China.
EM cwc_ren@sohu.com; cybao9933@sina.com
FU Basic Application Research Project of Science and Technology Department
   of Sichuan province, China [05JY029-004-2]
FX This work was supported by the Basic Application Research Project of
   Science and Technology Department of Sichuan province, China. (Contract
   NO. 05JY029-004-2)
CR GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Katsaros D, 2004, IEEE INTERNET COMPUT, V8, P37, DOI 10.1109/MIC.2004.1297272
   Scheideler L, 2003, MAT SCI ENG C-BIO S, V23, P455, DOI 10.1016/S0928-4931(02)00321-1
   Schierholz JM, 1998, J HOSP INFECT, V40, P257, DOI 10.1016/S0195-6701(98)90301-2
   Shibata Y, 2004, J DENT RES, V83, P115, DOI 10.1177/154405910408300206
   Yoshinari M, 2000, J BIOMED MATER RES, V52, P388, DOI 10.1002/1097-4636(200011)52:2<388::AID-JBM20>3.0.CO;2-E
   Zhao BH, 2005, SURF COAT TECH, V193, P366, DOI 10.1016/j.surfcoat.2004.07.041
NR 7
TC 2
Z9 2
U1 0
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 653
EP +
DI 10.4028/www.scientific.net/KEM.330-332.653
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800161
DA 2018-10-19
ER

PT S
AU Chen, B
   Wu, XY
   Peng, XH
AF Chen, Bin
   Wu, Xinyan
   Peng, Xianghe
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Research on the layered microstructure of shankbone
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE shankbone; layered microstructure; hydroxyapatite sheet; pullout force
ID BONE
AB Bone is a kind of biomaterial in nature. It behaves favorable strength, stiffness and fracture toughness which are closely related to its fine microstructure. SEM observation on a shankbone shows that the bone is a kind of natural bioceramic composite consisted of hydroxyapatite layers and collagen matrix. The observation also shows that the hydroxyapatite layers consist of many hydroxyapatite sheets and are arranged in a parallel distribution. The fracture toughness of the bone is analyzed based on the representative model of the microstructure of the bone and the idea of maximum pullout force. The analytical result shows that the long and thin shape as well as the parallel distribution of the hydroxyapatite sheets improves the maximum Pullout force of the sheets and the fracture toughness of the bone.
C1 [Chen, Bin; Wu, Xinyan; Peng, Xianghe] Chongqing Univ, Dept Mech Engn, Coll Resources & Environm Sci, Chongqing 400044, Peoples R China.
RP Chen, B (reprint author), Chongqing Univ, Dept Mech Engn, Coll Resources & Environm Sci, Chongqing 400044, Peoples R China.
EM bchen@cqu.edu.cn; cdxywu@163.com; xpeng@cqu.edu.cn
FU Natural Science Foundations of China [10572157, 10272120]
FX The authors gratefully acknowledge the financial supports to this work
   from the Natural Science Foundations of China (Grant no. 10572157 and
   10272120).
CR CHONG KP, 1999, MECH AAM, V28, P1
   Currey JD, 2003, J BIOMECH, V36, P1487, DOI 10.1016/S0021-9290(03)00124-6
   HOGAN HA, 1992, P AM SOC COM, P196
   Katti DR, 2001, COMPUT THEOR POLYM S, V11, P397, DOI 10.1016/S1089-3156(01)00012-5
   SARIKAYA M, 1989, P AM COMP, P176
   Zioupos P, 1998, BONE, V22, P57, DOI 10.1016/S8756-3282(97)00228-7
NR 6
TC 2
Z9 2
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 785
EP +
DI 10.4028/www.scientific.net/KEM.330-332.785
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800193
DA 2018-10-19
ER

PT S
AU Xu, JL
   Khor, KA
   Chen, WN
AF Xu, J. L.
   Khor, Khiam Aik
   Chen, W. N.
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI A study of osteocalcin production in vitro on various hydroxyapatite
   based biomaterials
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE osteocalcin; hydroxyapatite; in vitro; spark plasma sintering
ID SUBSTITUTED HYDROXYAPATITE; APATITE LAYER; BONE; ADHESION
AB Hydroxyapatite based biomaterials were prepared by a spark plasma sintering technology. The human limb-derived osteoblasts were cultured on the various biomaterial, surfaces (HA, RF21, 1SiHA and 5SiHA) for up to two weeks to investigate the cellular behaviors. The bone gammacarboxyglutamic protein or osteocalcin in the medium were determined at different periods of cell culture. The results indicated that a combined effect of bioceramic surface composition and surface morphology had influenced the osteoblast behaviors. The amount of osteocalcin in the medium increased in the initial periods of culture but decreased in the late periods of culture.
C1 [Xu, J. L.; Khor, Khiam Aik] Nanyang Technol Univ, Sch Mech & Aerosp Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
   [Chen, W. N.] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore.
RP Xu, JL (reprint author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, 50 Nanyang Ave, Singapore 639798, Singapore.
EM jlxu@ntu.edu.sg; mkakhor@ntu.edu.sg; wnchen@ntu.edu.sg
RI Khor, Khiam Aik (Michael)/B-6929-2009; Khor, Khiam Aik/G-2827-2010
OI KHOR, Khiam/0000-0003-1954-8423
CR Deligianni DD, 2001, BIOMATERIALS, V22, P87, DOI 10.1016/S0142-9612(00)00174-5
   Loty C, 2000, J BIOMED MATER RES, V49, P423, DOI 10.1002/(SICI)1097-4636(20000315)49:4<423::AID-JBM1>3.3.CO;2-Z
   Matsuura T, 2000, BIOMATERIALS, V21, P1121, DOI 10.1016/S0142-9612(99)00264-1
   Porter AE, 2004, BIOMATERIALS, V25, P3303, DOI 10.1016/j.biomaterials.2003.10.006
   Rammelt S, 2005, J BIOMED MATER RES A, V73A, P284, DOI 10.1002/jbm.a.30263
   Thian ES, 2006, BIOMATERIALS, V27, P2692, DOI 10.1016/j.biomaterials.2005.12.019
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Weng J, 1997, BIOMATERIALS, V18, P1027, DOI 10.1016/S0142-9612(97)00022-7
   Xu JL, 2005, BIOMATERIALS, V26, P2197, DOI 10.1016/j.biomaterials.2004.06.042
NR 9
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 897
EP +
DI 10.4028/www.scientific.net/KEM.330-332.897
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800220
DA 2018-10-19
ER

PT S
AU Chen, XF
   Wang, YJ
   Zhao, NR
   Yang, CR
AF Chen, Xiaofeng
   Wang, Yingjun
   Zhao, Naru
   Yang, Chunrong
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Investigation on the biomimetic scaffold for bone tissue engineering
   based on bioglass-collagen-hyaluronic acid-phosphatidylserine
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE biomaterial; biomimetics; composite; porous structure; tissue
   engineering
AB The new type of bone tissue engineering scaffold composed of the sol-gel derived bioactive glass particles, type I collagen, hyaluronic acid and phosphatidylserine were prepared through cross-linking and freeze-drying techniques. SEM observation indicated that the scaffold possessed a 3-D interconnected porous structure and a high porosity. The properties of bio-mineralization and cells biocompatibility were investigated using SBF immersion and cells Culture methods combined with SEM, XRD and FTIR techniques. The study revealed that this biomimetic scaffold possessed satisfactory functions of cells attachment, bio-mineralization, and cells biocompatibility. The porous structure and the surface of the scaffold which was covered by a bone-like HA crystal layer due to bio-mineralization were profitable for cells attachment and spread.
C1 [Chen, Xiaofeng; Wang, Yingjun; Zhao, Naru; Yang, Chunrong] South China Univ Technol, Coll Mat Sci & Engn, Biomat Res Inst, Guangzhou 510640, Guangdong, Peoples R China.
   [Chen, Xiaofeng; Wang, Yingjun; Zhao, Naru; Yang, Chunrong] Minst Educ South China Univ Technol, Key Lab Specially Funct Mat, Guangzhou, Peoples R China.
RP Chen, XF (reprint author), South China Univ Technol, Coll Mat Sci & Engn, Biomat Res Inst, Guangzhou 510640, Guangdong, Peoples R China.
EM chenxf@scut.edu.cn
FU National Key Basic Research 973 Program of China [2005CB623902];
   National Natural Science Foundation of China (NSFC) [50472054,
   50572029]; Natural Science Foundation Project Grants of Guangdong
   [4205786, 05006587]; Project of Science and Technology of Guangzhou
   [2003Z1-D0021]
FX The authors acknowledge the financial supports for this study through
   the National Key Basic Research 973 Program of China (Grant
   no.2005CB623902), National Natural Science Foundation of China (NSFC)
   Project Grant 50472054 and 50572029, Natural Science Foundation Project
   Grants of Guangdong (4205786 and 05006587), and the Project of Science
   and Technology of Guangzhou (2003Z1-D0021), P.R. China.
CR Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Kellomaki M, 2000, BIOMATERIALS, V21, P2495, DOI 10.1016/S0142-9612(00)00117-4
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   STAMBOULIS A, 2001, KEY ENG MATER, V192, P729
   Stamboulis AG, 2002, ADV ENG MATER, V4, P105, DOI 10.1002/1527-2648(200203)4:3<105::AID-ADEM105>3.3.CO;2-C
NR 5
TC 1
Z9 1
U1 2
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 939
EP +
DI 10.4028/www.scientific.net/KEM.330-332.939
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800230
DA 2018-10-19
ER

PT S
AU Takemoto, M
   Fujibayashi, S
   Neo, M
   So, K
   Akiyama, N
   Matsushita, T
   Kokubo, T
   Nakamura, T
AF Takemoto, M.
   Fujibayashi, S.
   Neo, M.
   So, K.
   Akiyama, N.
   Matsushita, T.
   Kokubo, T.
   Nakamura, T.
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Bone ingrowth into porous bioactive titanium implant for load-bearing
   use: Experimental study using a novel canine anterior interbody fusion
   model
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE titanium; porous; spine; interbody fuision; animal experiment
AB We have developed a porous titanium implant sintered with spacer particles (porosity = 50 %, average pore size +/- standard deviation = 303 +/- 152 mu m, yield compression strength 100MPa). This porous titanium was successfully treated with chemical and thermal treatment that gives a bioactive inicro-porous titania layer on the titanium surface, and it is expected as effective biomaterial for biological fixation on load bearing condition. In this study, ten adult female beagle dogs underwent anterior lumbar interbody fusion at L6-7 using either BT-implant or non-treated implant (NT-inplant), then followed by posterior interspinous wiring and facet screw fixation. The radiographic evaluations were performed 1, 2 and 3 months postoperatively using X-ray fluoroscopy. Animals were sacrificed after 3 months postoperatively, and fusion status was evaluated by manual palpation. Histological evaluation was also performed. Both histological and radiological evaluation revealed that interbody fusion was achieved in 5 of 5 dogs (100%) in BT-group and 3 of 5 dogs (60%) in NT-group. In BT implants, we could observe a large amount of new bone formation from periphery to the center of the implant, whereas in NT implants, fibrous tissue formation was still observed even in the implants with successful fusion. The results of this study indicate that porous bioactive titanium implant will represent a new osteoconductive biomaterial with improved fusion characteristics.
C1 [Takemoto, M.; Fujibayashi, S.; Neo, M.; So, K.; Akiyama, N.; Nakamura, T.] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan.
   [Matsushita, T.; Kokubo, T.] Chubu Univ, Sci & Technol Res Inst, Nagoya, Aichi, Japan.
RP Takemoto, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan.
EM m.take@kuhp.kyoto-u.ac.jp
CR Fujibayashi S, 2004, BIOMATERIALS, V25, P443, DOI 10.1016/S0142-9612(03)0051-9
   Takemoto M, 2006, BIOMATERIALS, V27, P2682, DOI 10.1016/j.biomaterials.2005.12.014
   Takemoto M, 2005, BIOMATERIALS, V26, P6014, DOI 10.1016/j.biomaterials.2005.03.019
   TAKEMOTO M, 2006, BIOCERAMICS, V18, P1095
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
NR 5
TC 0
Z9 0
U1 1
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 987
EP +
DI 10.4028/www.scientific.net/KEM.330-332.987
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800242
DA 2018-10-19
ER

PT S
AU Wang, G
   Tan, YF
   Zhang, XD
   Zhang, YZ
AF Wang, G.
   Tan, Y. F.
   Zhang, X. D.
   Zhang, Y. Z.
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Development of EGFP-expressing cell line for biocompatibility evaluation
   of osteoinductive CaP ceramics
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE biocompatibility; biomaterial; osteoinductive; EGFP; cell line
ID GREEN FLUORESCENT PROTEIN; MESENCHYMAL STEM-CELLS; MAMMALIAN-CELLS; GFP
AB This study investigated the utility of genetically modified cell line for fast and non-destructive cytotoxicity evaluation of biomaterials. The EGFP(enhanced green fluorescence protein)-expressing plasmid pcDNA-EGFP was constructed, and electroporated into ROS 17/28 osteoblastic cells to generate an EGFP-labeled stable cell line, ROS-EGFP. This genetically modified cell line provided two unique opportunities to qualitative and semi-quantitative evaluation of cell growth on biomaterials without destruction of samples. Firstly, utilizing the fluorescence of EGFP expressed in the cells, the viability state of cells on biomaterials was evaluated using a fluorescent light microscope. Secondly, the proliferation of cells on biomaterials, which was identified by MTT assay, was demonstrated according to the microscopically counted fluorescent cell numbers. From the results, it could be concluded that the ROS-EGFP cell line was an effective tool to trace the fate of cells on biomaterials and to evaluate the biocompatibility of biomaterials to cell growth in vitro.
C1 [Wang, G.; Zhang, Y. Z.] Sichuan Univ, Coll Life Sci, Chengdu 610064, Peoples R China.
   [Tan, Y. F.; Zhang, X. D.] Sichuan Univ, Engn Res Ctr Biomat, Chengdu 610064, Peoples R China.
RP Zhang, YZ (reprint author), Sichuan Univ, Coll Life Sci, Chengdu 610064, Peoples R China.
EM yizzhang@scu.edu.cn
CR Blum JS, 2004, BIOMATERIALS, V25, P5809, DOI 10.1016/j.biomaterials.2004.01.035
   Cheng LZ, 1996, NAT BIOTECHNOL, V14, P606, DOI 10.1038/nbt0596-606
   FARLEY JR, 1991, CALCIFIED TISSUE INT, V48, P297, DOI 10.1007/BF02556147
   Jansen JA, 2004, BIOMATERIALS, V25, P1461, DOI 10.1016/S0142-9612(03)00489-7
   Kotobuki N, 2005, BIOMATERIALS, V26, P779, DOI 10.1016/j.biomaterials.2004.03.020
   PINES J, 1995, TRENDS GENET, V11, P326, DOI 10.1016/S0168-9525(00)89092-7
   WILSON JK, 1990, BRIT J CANCER, V62, P189, DOI 10.1038/bjc.1990.258
   Xia ZD, 2005, BIOMATERIALS, V26, P5790, DOI 10.1016/j.biomaterials.2005.02.018
NR 8
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 1079
EP +
DI 10.4028/www.scientific.net/KEM.330-332.1079
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800264
DA 2018-10-19
ER

PT S
AU Teixeira, S
   Fernandes, HM
   de Boer, J
   Ferraz, MP
   Monteiro, FJ
AF Teixeira, S.
   Fernandes, H. M.
   de Boer, J.
   Ferraz, M. P.
   Monteiro, F. J.
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Mesenchymal stem cell proliferation and morphological analysis on
   interconnected macroporous structures
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE macroporous ceramics; hydroxyapatite; cell adhesion; mesenchymal stem
   cells
AB Calcium phosphate ceramics are widely used as bone substitutes since they are biocompatible and bioactive. Given that their chemical composition is close to natural bone, calcium phosphate ceramics are promising bone substitute materials in orthopaedics, maxillofacial surgery and dentistry. Hvdroxyapatite (HA) and tricalcium phosphate (TCP) are the most commonly used calcium phosphates, because their calcium/phosphorus (Ca/P) ratios are close to that of natural bone and they are relatively stable in physiological environment. Furthermore, other critical parameters must be accomplished when designing a biomaterial for bone regeneration, namely: pore size, shape and interconnectivity [1]. Porosity is one of the most important factors since it influences the adhesion, migration nutrient supply and ultimately, proliferation of mesenchymal stem cells. In this study, HA scaffolds with controlled porosity were obtained and their capacity to support human and rat mesenchymal stem cells attachment and proliferation was evaluated.
C1 [Teixeira, S.] INEB, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
   [Teixeira, S.; Monteiro, F. J.] Faculdade Engenharia Univ, Departamento Engenharia Metalurgica Mat, P-4200465 Oporto, Portugal.
   [Fernandes, H. M.; de Boer, J.] Univ Twente, Inst BioMed Technol, PBM, NL-3723 MB Bilthoven, Netherlands.
   [Ferraz, M. P.] Univ Fernando Pessoa, Faculdade Ciencias Saud, PL-4200150 Oporto, Portugal.
RP Teixeira, S (reprint author), INEB, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.
EM smsilva@ineb.up.pt; h.a.m.fernandes@tnw.utwente.nl;
   j.deboer@tnw.utwente.nl; mpferraz@ufp.pt; fjmont@ineb.up.pt
RI Ferraz, Maria/M-6316-2013; Fernandes, Hugo/H-6192-2014
OI Ferraz, Maria/0000-0002-0274-106X; Fernandes, Hugo/0000-0002-4574-7648;
   Monteiro, Fernando/0000-0002-1361-4605
FU Portuguese Foundation for Science and Technology (FCT)
   [SFRH/BD/17139/2004]; FCT project Col/CPNA [POCTI/SAU - BMA/56061/2004]
FX This work was supported by the Portuguese Foundation for Science and
   Technology (FCT) PhD grant SFRH/BD/17139/2004, and by FCT project
   Col/CPNA ref. POCTI/SAU - BMA/56061/2004.
CR Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031
   Moroni L, 2006, BIOMATERIALS, V27, P4911, DOI 10.1016/j.biomaterials.2006.05.027
   QUEIROZ AC, 2004, MATER SCI FORUM, P455
   QUEIROZ AC, 2004, KEY ENG MATER, P254
NR 4
TC 2
Z9 2
U1 0
U2 6
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 1129
EP +
DI 10.4028/www.scientific.net/KEM.330-332.1129
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800276
DA 2018-10-19
ER

PT S
AU Chan, CW
   Lee, KM
   Qin, L
   Wong, KHK
   Yeung, HY
   Fan, HB
   Hu, YY
   Cheng, JCY
AF Chan, C. W.
   Lee, K. M.
   Qin, L.
   Wong, K. H. K.
   Yeung, H. Y.
   Fan, H. B.
   Hu, Y. Y.
   Cheng, J. C. Y.
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Mesenchymal stem cell derived osteogenic cells is superior to bone
   marrow aspirate impregnated biomaterial complex in posterior spinal
   fusion
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE tricalcium phosphate; mesenchymal stem cell; posterior spinal fusion;
   bioceramics; bone marrow aspirate
ID EXPRESSION; CULTURE
AB The limited Source of autograft has prompted extensive research on bone substitute and biological enhancement of the fusion mass in spinal fusion. Biomaterials impregnated with bone marrow aspirate has been applied to spinal fusion surgery. In this study, the effect of stein cell therapy in enhancing posterior spinal fusion was compared with the bone marrow aspirate method in a standard rabbit model. Bone marrow was aspirated from rabbit proximal femur (BMA group, n=6) and loaded on beta-tricalcium phosphate ceramics (beta-TCP) in excess. The composite was then implanted onto L5 and L6 transverse processes of the same animal in posterior spinal fusion operation with decortication on the same day. For stein cell therapy group, mesenchymal stem cells (MSCs) were isolated from bone marrow aspirate by adherence on plastic culture-ware. The MSCs were treated with osteogenic supplements (OS) during ex vivo cell expansion (MSC group, n=6). The osteogenic cells were seeded on beta-TCP ceramics and Cultured for one day. The cell-ceramics composite was implanted into the same rabbit as BMA group. The ceramics acted as control (n=6). Three fluorochromes, tetracycline, xyelonol orange and caclein were injected at week 2, 4 and 6 sequentially. The spinal segments were harvested at week 7 post-operation. The manual palpation of vertebral joint was assesses for solid fusion. The gap distance of inter-transverse process was measured by microCT and the bone mineral content (BMC) and volume of transverse processes by peripheral quantitative computed tomography. The specimens were undergone undecalcified histological analysis. The mineralization process was examined by fluorescent microscopy. By manual palpation, 50% of MSC group samples were found to have solid fusion in comparison with the incomplete fusion observed in the BMA and control group. The gap distance of inter-transverse processes in MSC group was the shortest. The volume of the transverse processes in MSC group was significantly greater than BMA and control group by 16% and 26% respectively. The BMC of transverse processes in MSC group was 40% greater than control (p < 0.05) and 8% greater than BMA group. In fluorescent microscopy, both green fluorescent signal (labeled at week 6) and orange fluorescent signal (labeled at week 4) were observed in MSC group compare with the predominantly green fluorescent signal in the BMA group. In conclusion, the augmentation of MSC derived osteogenic cells is superior to bone marrow aspirate in rabbit posterior spinal fusion.
C1 [Chan, C. W.; Lee, K. M.; Cheng, J. C. Y.] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.
   [Chan, C. W.; Qin, L.; Wong, K. H. K.; Yeung, H. Y.; Cheng, J. C. Y.] Chinese Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.
   [Lee, K. M.] Chinese Univ Hong Kong, Lee Hysan Clin Res Lab, Hong Kong, Hong Kong, Peoples R China.
   [Fan, H. B.; Hu, Y. Y.] Fourth Mil Med Univ, Inst Orthopaed & Traumatol, Xian, Peoples R China.
RP Chan, CW (reprint author), Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China.
EM chanwai@cuhk.edu.hk; simonlee@cuhk.edu.hk; lingqin@cuhk.edu.hk;
   kenneth@ort.cuhk.edu.hk; byeung@cuhk.edu.hk; fanhb75@yahoo.com.cn;
   orthl@fmmu.edu.cn; jackcheng@cuhk.edu.hk
RI Cheng, Jack/J-3878-2018; Qin, Ling/J-9047-2018; Chan, Chun
   Wai/B-5889-2015
OI Cheng, Jack/0000-0001-8153-364X; Qin, Ling/0000-0001-6173-6167; 
FU AO Research Foundation Switzerland [03-C46]; Li Ka Shing Institute of
   Health Sciences
FX This project was supported by AO Research Foundation, Switzerland (ref.
   no. 03-C46) and The Li Ka Shing Institute of Health Sciences Grant, Hong
   Kong.
CR Bi LX, 1999, CALCIFIED TISSUE INT, V64, P63, DOI 10.1007/s002239900580
   Cao T, 2005, TISSUE CELL, V37, P325, DOI 10.1016/j.tice.2005.03.008
   Chan CW, 2005, KEY ENG MAT, V288-289, P491, DOI 10.4028/www.scientific.net/KEM.288-289.491
   CHEN JCY, 2004, 7 WORLD BIOM C SYDN
   Cheng JCY, 2002, SPINE, V27, P467, DOI 10.1097/00007632-200203010-00006
   Cinotti G, 2004, J BONE JOINT SURG BR, V86B, P135, DOI 10.1302/0301-620X.86B1.14308
   Cotler JM, 1990, SPINAL FUSION SCI TE, P361
   Curylo LJ, 1999, SPINE, V24, P434, DOI 10.1097/00007632-199903010-00004
   Guo X, 2002, J ORTHOPAED RES, V20, P740, DOI 10.1016/S0736-0266(01)00167-X
   KAUFMAN HH, 1989, NEUROSURGERY, V24, P264, DOI 10.1227/00006123-198902000-00018
   Ogura Naomi, 2004, J Oral Sci, V46, P207, DOI 10.2334/josnusd.46.207
   Price CT, 2003, SPINE, V28, P793, DOI 10.1097/00007632-200304150-00012
   van Gaalen SM, 2004, TISSUE ENG, V10, P231, DOI 10.1089/107632704322791871
NR 13
TC 0
Z9 0
U1 0
U2 4
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 1149
EP +
DI 10.4028/www.scientific.net/KEM.330-332.1149
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800281
DA 2018-10-19
ER

PT S
AU Pan, YS
   Xiong, DS
   Chen, XL
AF Pan, Yusong
   Xiong, Dangsheng
   Chen, Xiaolin
BE Zhang, XD
   Li, XD
   Fan, HS
   Liu, XY
TI Friction characteristics of poly(vinyl alcohol) hydrogel as an articular
   cartilage biomaterial
SO BIOCERAMICS, VOL 19, PTS 1 AND 2
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 19th International Symposium on Ceramics in Medicine
CY OCT 10-13, 2006
CL Chengdu, PEOPLES R CHINA
SP Int Soc Ceram Med
DE poly(vinyl alcohol) hydrogel; stainless steel ball; friction coefficient
AB Poly(vinyl alcohol) (PVA) hydrogel is a promising articular cartilage biomaterial. In this paper, the effects of different variable factors on the friction coefficient of Poly(vinyl alcohol) (PVA) hydrogel were investigated when sliding against stainless steel ball by ball-pan tribometer. Factors included lubrication condition, sliding speed, diameter of stainless steel ball, and load. It was shown that the free water in PVA hydrogel has an excellent lubrication on the counterparts. The friction coefficients have little difference between dry and lubricants lubrication condition at initial friction test. With the friction test time prolonged, friction coefficient of PVA hydrogel under dry condition increased rapidly. Friction coefficient decreased with the increase of sliding speed and the diameter of stainless steel ball, and increased with the increasing load. The rising rate of friction coefficient at low load region is obviously larger than that at high load region,
C1 [Pan, Yusong; Xiong, Dangsheng; Chen, Xiaolin] Nanjing Univ Sci & Technol, Dept Mat Sci & Engn, Nanjing 210094, Jiangsu, Peoples R China.
RP Pan, YS (reprint author), Nanjing Univ Sci & Technol, Dept Mat Sci & Engn, Nanjing 210094, Jiangsu, Peoples R China.
EM xiongds@163.com
RI xiong, dangsheng/B-1823-2015
OI xiong, dangsheng/0000-0003-3210-3728
FU National Natural Science Foundation of China [50575106]
FX We are pleased to acknowledge research support from the National Natural
   Science Foundation of China (project number: 50575106).
CR Dowson D, 1986, Eng Med, V15, P63
   KOBAYASHI M, 2005, J BIOMATERIALS, V26, P3243
   Ku DN, 1999, [US Patent, Poly(vinyl alcohol) Cryogel Patent], Patent No. 5981826
   MASANORI K, 2003, J BIOMATERIALS, V24, P639
   Suciu AN, 2004, JSME INT J C-MECH SY, V47, P199, DOI 10.1299/jsmec.47.199
NR 5
TC 4
Z9 4
U1 1
U2 5
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
J9 KEY ENG MATER
PY 2007
VL 330-332
BP 1297
EP +
DI 10.4028/www.scientific.net/KEM.330-332.1297
PN 1-2
PG 2
WC Materials Science, Ceramics; Materials Science, Multidisciplinary;
   Materials Science, Biomaterials; Materials Science, Composites
SC Materials Science
GA BFV88
UT WOS:000245026800317
DA 2018-10-19
ER

PT S
AU Mangold, S
   Harneit, K
   Sand, W
AF Mangold, Stefanie
   Harneit, Kerstin
   Sand, Wolfgang
BE Schippers, A
   Sand, W
   Glombitza, F
   Willscher, S
TI Combined atomic force and fluorescence microscopy of biofilms formed by
   leaching bacteria on opaque substrata
SO BIOHYDROMETALLURY: FROM THE SINGLE CELL TO THE ENVIRONMENT
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 17th International Biohydrometallurgy Symposium
CY SEP 02-05, 2007
CL Frankfurt am Main, GERMANY
DE atomic force microscope; contact mode; tapping mode; cantilever spring
   constant; epifluorescence; biofilm; nanobiotechnology
ID THIOBACILLUS
AB Leaching bacteria attach to their substrates, i.e. mineral sulfides, and form monolayered biofilms. In this study the biofilm formation of Acidithiobacillus ferrooxidans A2 on pyrite was examined using atomic force and epifluorescence microscopy (AFM and EFM, respectively). A novel system by JPK instruments, the BioMaterial Workstation (TM), allows the investigation of the same location on an opaque sample with AFM and EFM. Until recently this was only possible for translucent samples. Sessile bacteria on pyrite coupons were stained with 4',6-diamidino-2-phenylindol (DAPI) and visualized by EFM as well as AFM. The best imaging conditions for AFM were assessed. Scans of bacteria attached to pyrite were performed in contact mode in air as well as in tapping mode in fluid. Imaging in fluid was more challenging than imaging in air as bacteria tend to detach from their substratum. To avoid the dislocation of microorganisms by the AFM probe the sample was dried in air for 1 h prior to scanning in fluid. Scanning in air was performed with the whole range of cantilever spring constants tested (k = 0.03 N/m to k = 0.65 N/m) while, for scanning in fluid, best results were achieved using stiffer cantilevers (k = 0.65 N/m).
C1 [Mangold, Stefanie] Univ Duisburg Essen, Biofilm Ctr, Duisburg, Germany.
RP Mangold, S (reprint author), Univ Duisburg Essen, Biofilm Ctr, Duisburg, Germany.
EM thore.rohwerder@uni-due.de; kerstin.harneit@uni-due.de;
   wolfgang.sand@uni-due.de
FU BioMine European project [NMP1-CT-500329-1]; European commision under
   the Sixth Frame work Programme for Research and Development
FX This work was carried out in the frame of the BioMine(European project
   contract NMP1-CT-500329-1).The authors acknowledge the financial support
   given to this project by the European commision under the Sixth Frame
   work Programme for Research and Development.We also wish to thank our
   various partners for their contributions to the work reported in this
   paper.
CR Beech IB, 2002, COLLOID SURFACE B, V23, P231, DOI 10.1016/S0927-7765(01)00233-8
   Dufrene YF, 2002, J BACTERIOL, V184, P5205, DOI 10.1128/JB.184.19.5205-5213.2002
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   Kelly DP, 2000, INT J SYST EVOL MICR, V50, P511, DOI 10.1099/00207713-50-2-511
   MACKINTOSH ME, 1978, J GEN MICROBIOL, V105, P215, DOI 10.1099/00221287-105-2-215
   Rawlings DE, 2002, ANNU REV MICROBIOL, V56, P65, DOI 10.1146/annurev.micro.56.012302.161052
   Sand W, 2001, HYDROMETALLURGY, V59, P159, DOI 10.1016/S0304-386X(00)00180-8
NR 7
TC 1
Z9 1
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-452-1
J9 ADV MATER RES-SWITZ
PY 2007
VL 20-21
BP 371
EP +
DI 10.4028/www.scientific.net/AMR.20-21.371
PG 2
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA BGU37
UT WOS:000250578900084
DA 2018-10-19
ER

PT J
AU Czaja, WK
   Young, DJ
   Kawecki, M
   Brown, RM
AF Czaja, Wojciech K.
   Young, David J.
   Kawecki, Marek
   Brown, R. Malcolm, Jr.
TI The future prospects of microbial cellulose in biomedical applications
SO BIOMACROMOLECULES
LA English
DT Review
ID IN-VIVO BIOCOMPATIBILITY; BACTERIAL CELLULOSE; ACETOBACTER-XYLINUM; SKIN
   SUBSTITUTES; WOUND DRESSINGS; MECHANICAL-PROPERTIES; VASCULAR GRAFTS;
   WATER-VAPOR; TISSUE; MEMBRANES
AB Microbial cellulose has proven to be a remarkably versatile biomaterial and can be used in wide variety of applied scientific endeavors, such as paper products, electronics, acoustics, and biomedical devices. In fact, biomedical devices recently have gained a significant amount of attention because of an increased interest in tissue-engineered products for both wound care and the regeneration of damaged or diseased organs. Due to its unique nanostructure and properties, microbial cellulose is a natural candidate for numerous medical and tissue-engineered applications. For example, a microbial cellulose membrane has been successfully used as a wound-healing device for severely damaged skin and as a small-diameter blood vessel replacement. The nonwoven ribbons of microbial cellulose microfibrils closely resemble the structure of native extracellullar matrices, suggesting that it could function as a scaffold for the production of many tissue-engineered constructs. In addition, microbial cellulose membranes, having a unique nanostructure, could have many other uses in wound healing and regenerative medicine, such as guided tissue regeneration (GTR), periodontal treatments, or as a replacement for dura mater (a membrane that surrounds brain tissue). In effect, microbial cellulose could function as a scaffold material for the regeneration of a wide variety of tissues, showing that it could eventually become an excellent platform technology for medicine. If microbial cellulose can be successfully mass produced, it will eventually become a vital biomaterial and will be used in the creation of a wide variety of medical devices and consumer products.
C1 Univ Texas, Sect Mol Genet & Microbiol, Austin, TX 78713 USA.
   Tech Univ Lodz, Inst Tech Biochem, PL-90924 Lodz, Poland.
   Ctr Burn Healing, Siemianowice Slaskie, Poland.
RP Brown, RM (reprint author), Univ Texas, Sect Mol Genet & Microbiol, Austin, TX 78713 USA.
OI Kawecki, Marek/0000-0001-9925-5297
CR Alvarez OM, 2004, WOUNDS, V16, P224
   Aung B. J., 2004, PODIATRY TODAY, V17, P20
   Backdahl H, 2006, BIOMATERIALS, V27, P2141, DOI 10.1016/j.biomaterials.2005.10.026
   Balasubramani M, 2001, BURNS, V27, P534, DOI 10.1016/S0305-4179(01)00018-3
   BROWN RM, 1982, SCIENCE, V218, P1141, DOI 10.1126/science.218.4577.1141
   BROWN RM, 2006, Patent No. 2914
   Buttafoco L, 2006, BIOMATERIALS, V27, P2380, DOI 10.1016/j.biomaterials.2005.10.017
   Capes JS, 2005, J MATER SCI-MATER M, V16, P1069, DOI 10.1007/s10856-005-4708-5
   Chanliaud E, 1999, PLANT J, V20, P25, DOI 10.1046/j.1365-313X.1999.00571.x
   Charpentier PA, 2006, APPL SURF SCI, V252, P6360, DOI 10.1016/j.apsusc.2005.09.064
   CHEN WYJ, 1992, J INVEST DERMATOL, V99, P559, DOI 10.1111/1523-1747.ep12667378
   Ciechanska D, 2004, FIBRES TEXT EAST EUR, V12, P69
   Czaja W, 2006, BIOMATERIALS, V27, P145, DOI 10.1016/j.biomaterials.2005.07.035
   Czaja W, 2007, CELLULOSE MOL STRUCT
   CZAJA W, 2004, 227 NAT M AM CHEM SO
   DAHLIN C, 1988, PLAST RECONSTR SURG, V81, P672, DOI 10.1097/00006534-198805000-00004
   DAVIDSON S, INDEPENDENT EQUITY R
   Delatte SJ, 2001, J PEDIATR SURG, V36, P113, DOI 10.1053/jpsu.2001.20024
   Demling RH, 1999, BURNS, V25, P256, DOI 10.1016/S0305-4179(98)00165-X
   dos Anjos B, 1998, J PERIODONTOL, V69, P454, DOI 10.1902/jop.1998.69.4.454
   Drury JL, 2003, BIOMATERIALS, V24, P4337, DOI 10.1016/S0142-9612(03)00340-5
   Eming SA, 2002, CELLS TISSUES ORGANS, V172, P105, DOI 10.1159/000065611
   FARQUHAR C, 2000, COCHRANE DB SYST REV, V2
   FONTANA JD, 1990, APPL BIOCHEM BIOTECH, V24-5, P253, DOI 10.1007/BF02920250
   *FRANH I SYST INN, 2003, HUM TISS ENG PROD TO
   Frankel Victor H, 2004, Surg Technol Int, V12, P27
   Frantz VK, 1943, ANN SURG, V119, P116
   Fricain JC, 2002, BIOMATERIALS, V23, P971, DOI 10.1016/S0142-9612(01)00152-1
   Gallin WJ, 1998, BURNS, V24, P613, DOI 10.1016/S0305-4179(98)00089-8
   Granja P L, 2005, Eur Cell Mater, V10, P31
   Granja PL, 2001, J MATER SCI-MATER M, V12, P785, DOI 10.1023/A:1013960601330
   HAIGLER CH, 1982, J CELL BIOL, V94, P64, DOI 10.1083/jcb.94.1.64
   HAIGLER CH, 1980, SCIENCE, V210, P903, DOI 10.1126/science.7434003
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Heyligers JMM, 2005, ANN VASC SURG, V19, P448, DOI 10.1007/s10016-005-0026-0
   Ishihara Masayuki, 2006, J Artif Organs, V9, P8, DOI 10.1007/s10047-005-0313-0
   Iwata T, 1998, CELLULOSE, V5, P215, DOI 10.1023/A:1009237401548
   JONES DW, 1960, J POLYM SCI, V42, P173, DOI 10.1002/pol.1960.1204213920
   Jones I, 2002, BRIT J PLAST SURG, V55, P185, DOI 10.1054/bjps.2002.3800
   JONKMAN MF, 1990, J INVEST DERMATOL, V94, P477, DOI 10.1111/1523-1747.ep12874624
   Kai A, 1997, INT J BIOL MACROMOL, V20, P221, DOI 10.1016/S0141-8130(97)01167-7
   Kakisis JD, 2005, J VASC SURG, V41, P349, DOI 10.1016/j.jvs.2004.12.026
   Kawecki M, 2004, INT REV C BIOT VIENN
   Kino Y, 1998, J SURG RES, V79, P71, DOI 10.1006/jsre.1998.5389
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   KLEMM D, 2003, Patent No. 0113163
   KOLODZIEJCZYK M, 1999, FINAL REPORT REALIZA
   Krystynowicz A, 2002, J IND MICROBIOL BIOT, V29, P189, DOI 10.1038/sj.jim.7000303
   LATARJET J, 1995, BURNS, V21, P221, DOI 10.1016/0305-4179(95)80015-G
   Legeza VI, 2004, B EXP BIOL MED+, V138, P311
   LOURES BR, 2004, Patent No. 2004045458
   Macedo N., 2004, BRAZ J ORAL SCI, V3, P395
   Martson M, 1998, EUR SURG RES, V30, P419, DOI 10.1159/000008608
   Martson M, 1999, BIOMATERIALS, V20, P1989, DOI 10.1016/S0142-9612(99)00094-0
   MAYALL RC, 1990, REV BRAS CIR, V80
   Mello LR, 1997, J NEUROSURG, V86, P143, DOI 10.3171/jns.1997.86.1.0143
   Novaes A B Jr, 1993, Clin Oral Implants Res, V4, P106, DOI 10.1034/j.1600-0501.1993.040207.x
   NOVAES AB, 1993, BRAZ DENT J, V4, P65
   Ong ATL, 2004, HERZ, V29, P187, DOI 10.1007/s00059-004-2574-4
   OSTER GA, 2003, Patent No. 6599518
   OSullivan AC, 1997, CELLULOSE, V4, P173, DOI 10.1023/A:1018431705579
   Park SN, 2004, BIOMATERIALS, V25, P3689, DOI 10.1016/j.biomaterials.2003.10.072
   Prasanna M, 2004, BURNS, V30, P169, DOI 10.1016/j.burns.2003.09.028
   QUINN KJ, 1985, BIOMATERIALS, V6, P369, DOI 10.1016/0142-9612(85)90095-X
   Ratcliffe A, 2000, MATRIX BIOL, V19, P353, DOI 10.1016/S0945-053X(00)00080-9
   REBELLO C, 1987, Revista Brasileira de Cirurgia, V77, P407
   Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039
   ROBERTS EM, 1986, Patent No. 0186495
   ROSS P, 1991, MICROBIOL REV, V55, P35
   RuizCardona L, 1996, BIOMATERIALS, V17, P1639, DOI 10.1016/0142-9612(95)00324-X
   RUSZCZAK Z, 2004, EMEDICINE       0415
   Salata LA, 2001, CLIN ORAL IMPLAN RES, V12, P62, DOI 10.1034/j.1600-0501.2001.012001062.x
   Sawada T, 2000, J REPROD MED, V45, P387
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shirai A, 1997, CARBOHYD POLYM, V32, P223, DOI 10.1016/S0144-8617(97)00009-X
   Slezak A, 2004, MED ENG PHYS, V26, P53, DOI 10.1016/j.medengphy.2003.08.003
   Sokolnicki AM, 2006, J MEMBRANE SCI, V272, P15, DOI 10.1016/j.memsci.2005.06.065
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Tokoh C, 1998, CELLULOSE, V5, P249, DOI 10.1023/A:1009211927183
   Tomizawa Yasuko, 2005, J Artif Organs, V8, P137, DOI 10.1007/s10047-005-0296-x
   VANDERHART DL, 1984, MACROMOLECULES, V17, P1465, DOI 10.1021/ma00138a009
   VANDERZIJPP JYT, 2003, ARCH PHYSIOL BIOCHEM, V111, P415
   Walker M, 2003, BIOMATERIALS, V24, P883, DOI 10.1016/S0142-9612(02)00414-3
   Wan YZ, 2006, COMPOS SCI TECHNOL, V66, P1825, DOI 10.1016/j.compscitech.2005.11.027
   Watanabe K, 1998, CELLULOSE, V5, P187, DOI 10.1023/A:1009272904582
   WATANABE K, 1993, CYTOTECHNOLOGY, V13, P107, DOI 10.1007/BF00749937
   Whitney SEC, 1999, PLANT PHYSIOL, V121, P657, DOI 10.1104/pp.121.2.657
   Whitney SEC, 1998, CARBOHYD RES, V307, P299, DOI 10.1016/S0008-6215(98)00004-4
   Winslow RD, 2005, MT SINAI J MED, V72, P81
   WINTER GD, 1962, NATURE, V193, P293, DOI 10.1038/193293a0
   Wiseman DM, 1999, J INVEST SURG, V12, P141
   WOODCOCK C, 1980, MACROMOLECULES, V13, P1183, DOI 10.1021/ma60077a030
   WOUK AFP, 1998, ARCH VET SCI, V3, P31
   WU P, 1995, BIOMATERIALS, V16, P171, DOI 10.1016/0142-9612(95)92114-L
   Yamanaka S, 1990, Production of hollow cellulose produced by microorganisms for artificial blood vessels, Patent No. [0396344, EP 0396344, CAN 114:235093]
   Yarlagadda PKDV, 2005, BIO-MED MATER ENG, V15, P159
   Yasuda K, 2005, BIOMATERIALS, V26, P4468, DOI 10.1016/j.biomaterials.2004.11.021
NR 98
TC 549
Z9 582
U1 14
U2 286
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN
PY 2007
VL 8
IS 1
BP 1
EP 12
DI 10.1021/bm060620d
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 123ZX
UT WOS:000243337600001
PM 17206781
OA Bronze
DA 2018-10-19
ER

PT J
AU Tortora, M
   Cavalieri, F
   Chiessi, E
   Paradossi, G
AF Tortora, Mariarosaria
   Cavalieri, Francesca
   Chiessi, Ester
   Paradossi, Gaio
TI Michael-type addition reactions for the in situ formation of poly(vinyl
   alcohol)-based hydrogels
SO BIOMACROMOLECULES
LA English
DT Article
ID GLYCIDYL METHACRYLATE; VITREOUS BODY; BEHAVIOR; DEXTRAN; POLYMERIZATION;
   RHEOLOGY; DELIVERY
AB Michael-type addition reactions offer the possibility to obtain in situ formation of polymeric hydrogels in the absence of a radical mechanism for the networking process. We explored such a synthetic route for obtaining a poly(vinyl alcohol) (PVA)-based hydrogel as a potential biomaterial for applications in vitro-retinal replacement surgery. The presence of radicals in the reaction medium can represent a risk for in situ surgical treatment. To circumvent this problem we have applied nucleophilic addition to ad hoc modified PVA macromers. The gel formation has been studied with respect to the timing required in this surgery and in terms of the structural characteristics of the obtained network.
C1 Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, I-00133 Rome, Italy.
RP Paradossi, G (reprint author), Univ Roma Tor Vergata, Dipartimento Sci & Tecnol Chim, Via Ric Sci, I-00133 Rome, Italy.
EM paradossi@stc.uniroma2.it
RI Paradossi, Gaio/B-8330-2014
OI Paradossi, Gaio/0000-0003-3051-3811; CAVALIERI,
   FRANCESCA/0000-0001-5391-5069; Chiessi, Ester/0000-0001-7529-2755
CR BALAZS EA, 1983, HEALON GUIDE ITS USE, P5
   Barretta P, 2000, J PHYS CHEM B, V104, P11019, DOI 10.1021/jp001863h
   Cavalieri F, 2004, BIOMACROMOLECULES, V5, P2439, DOI 10.1021/bm049654g
   Chirila TV, 1998, PROG POLYM SCI, V23, P475, DOI 10.1016/S0079-6700(97)00045-2
   Colthurst MJ, 2000, BIOMATERIALS, V21, P649, DOI 10.1016/S0142-9612(99)00220-3
   DE SMEDT SC, 1995, MACROMOLECULES, V28, P5082, DOI 10.1021/ma00118a042
   Elbert DL, 2001, J CONTROL RELEASE, V76, P11, DOI 10.1016/S0168-3659(01)00398-4
   ERMAN B, 1982, MACROMOLECULES, V15, P806, DOI 10.1021/ma00231a023
   FRIEDMAN M, 1965, J AM CHEM SOC, V87, P3672, DOI 10.1021/ja01094a025
   LEE B, 1992, BIORHEOLOGY, V29, P521
   LEE B, 1994, BIORHEOLOGY, V31, P339
   LONNGREN J, 1989, PURE APPL CHEM, V61, P1313, DOI 10.1351/pac198961071313
   LUTHOLF MP, 2003, BIOMACROMOLECULES, V4, P713
   Lutolf MP, 2001, BIOCONJUGATE CHEM, V12, P1051, DOI 10.1021/bc015519e
   Meyvis TKL, 1999, J RHEOL, V43, P933, DOI 10.1122/1.551012
   Paradossi G, 2002, BIOMACROMOLECULES, V3, P1255, DOI 10.1021/bm0256247
   ROZENBERG ME, 1992, POLYVINYL ALCOHOL DE, P689
   Rydholm AE, 2005, BIOMATERIALS, V26, P4495, DOI 10.1016/j.biomaterials.2004.11.046
   Seal BL, 2006, MACROMOLECULES, V39, P2268, DOI 10.1021/ma0524528
   SILVER FH, 1996, POLYSACCHARIDES MED, P689
   vanDijkWolthuis WNE, 1997, MACROMOLECULES, V30, P3411, DOI 10.1021/ma961764v
   VANDIJKWOLTHUIS WNE, 1995, MACROMOLECULES, V28, P6317, DOI 10.1021/ma00122a044
   YAMAUCHI A, 1991, POLYMER GELS, P127
NR 23
TC 27
Z9 27
U1 1
U2 17
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD JAN
PY 2007
VL 8
IS 1
BP 209
EP 214
DI 10.1021/bm0607269
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 123ZX
UT WOS:000243337600029
PM 17206809
DA 2018-10-19
ER

PT J
AU Dornburg, V
   van Dam, J
   Faaij, A
AF Dornburg, Veronika
   van Dam, Jinke
   Faaij, Andre
TI Estimating GHG emission mitigation supply curves of large-scale biomass
   use on a country level
SO BIOMASS & BIOENERGY
LA English
DT Article
DE biomass; cost supply curve; GHG emission mitigation; market prices;
   own-price elasticity
ID CARBON SEQUESTRATION; DEMAND; NETHERLANDS; ELECTRICITY; SYSTEMS; CROPS;
   COST
AB This study evaluates the possible influences of a large-scale introduction of biomass material and energy systems and their market volumes on land, material and energy market prices and their feedback to greenhouse gas (GHG) emission mitigation costs. GHG emission mitigation supply curves for large-scale biomass use were compiled using a methodology that combines a bottom-up analysis of biomass applications, biomass cost supply curves and market prices of land, biornaterials and bioenergy carriers. These market prices depend on the scale of biomass use and the market volume of materials and energy carriers and were estimated using own-price elasticities of demand. The methodology was demonstrated for a case study of Poland in the year 2015 applying different scenarios on economic development and trade in Europe. For the key technologies considered, i.e. medium density fibreboard, poly lactic acid, electricity and methanol production, GHG emission mitigation costs increase strongly with the scale of biomass production. Large-scale introduction of biomass use decreases the GHG emission reduction potential at costs below 50EURO/Mg CO2eq with about 13-70% depending on the scenario. Biomaterial production accounts for only a small part of this GHG emission reduction potential due to relatively small material markets and the subsequent strong decrease of biomaterial market prices at large scale of production. GHG emission mitigation costs depend strongly on biomass supply curves, own-price elasticity of land and market volumes of bioenergy carriers. The analysis shows that these influences should be taken into account for developing biomass implementations strategies. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Utrecht, Copernicus Inst, Dept Sci Technol & Soc, NL-3584 CS Utrecht, Netherlands.
RP Dornburg, V (reprint author), Mid Sweden Univ, Dept Ecotecnol, S-83125 Ostersund, Sweden.
EM Sweden.V.Dornburg@0chem.uu.nl
RI Faaij, Andre/E-8424-2014; van Dam, Jinke/A-8802-2010
CR *APME, 2003, PLAST AN PLAST CONS
   Biewinga E. E., 1996, SUSTAINABILITY ENERG
   Bollen J., 2004, 4 FUTURES ENERGY MAR
   CIAIAN P, 2002, 5 INT WORKSH EUR EC
   CRANK M, 2002, UN IND COMMODITY PRO
   De La Torre Ugarte D., 2003, EC IMPACTS BIOENERGY
   *DEFR, 2003, GROW SRC BEST PRACT
   Dornburg V, 2005, CLIMATIC CHANGE, V71, P373, DOI 10.1007/s10584-005-5934-z
   Dornburg V, 2005, BIOMASS BIOENERG, V28, P454, DOI 10.1016/j.biombioe.2004.11.012
   DORNBURG V, IN PRESS RESOURCES C
   *EC BREC, 2003, BIOM EN DEV POL
   ECCP, 2001, EUR CLIM CHANG PROGR
   *EN RES FDN ECN, 2001, ECN EN VERSL NED 200
   ESPEY M, 1998, ENERG ECON, V20, P295
   *EUR, 2004, CODED EUR CONC DEF D
   *EUR, 2003, AGR EUR UN
   Faaij A., 1998, LONG TERM PERSPECTIV
   *FAO, 2003, FERT SU CROP POL
   *FAO, FAO STAT DAT FOR DAT
   FINKE R, 1984, ECON LETT, V14, P137, DOI 10.1016/0165-1765(84)90073-9
   Forintek, 1993, RAW MAT BAL EN PROF
   Gielen D, 2003, BIOMASS BIOENERG, V25, P177, DOI 10.1016/S0961-9534(02)00188-5
   GIELN DJ, 2000, BIOMASS GREENHOUSE G
   GOERTEN J, 2004, ELECT PRICES EU HOUS
   GOERTEN J, 2004, ELECT PRICES EU IND
   GROENENBERG H, 2002, THESIS UTRECHT U UTR
   HAMELINCK C, 2004, THESIS UTRECHT U
   Hamelinck CN, 2002, J POWER SOURCES, V111, P1, DOI 10.1016/S0378-7753(02)00220-3
   Haygreen J. G, 1996, FOREST PRODUCTS WOOD
   HEKKERT MP, 1998, TECHNOLOGY CHARACTER
   HOOGWIJK MM, 2004, THESIS UTRECHT U UTR
   *IEA, 2004, END US PETR PROD PRI
   *IEA, 2002, END US PETR PROD PRI
   *IEA, 2003, EN BAL NONOECD COUNT
   IEA, 2002, EN BAL OECD COUNTR 1
   *ILO, 2001, YEARL STAT EMPL UN H
   *IPCC, 2001, IPCC 3 ASS CLIM MIT
   IPCC [Intergovernmental Panel on Climate Change], 2001, CLIM CHANG 2001 CLIM
   IPCC (Intergovernmental Panel on Climate Change), 2000, SPEC REP EM SCEN, p[96, 98]
   Johansson D., 2000, RENEWABLE RAW MAT WA
   Kaltschmitt M., 1997, NACHWACHSENDE ENERGI
   Kamerschen DR, 2004, ENERG ECON, V26, P87, DOI 10.1016/S0140-9883(03)00033-1
   Keith DW, 2001, CLIMATIC CHANGE, V49, P1, DOI 10.1023/A:1010617015484
   Larsson S, 2003, FULL SCALE IMPLEMENT
   Ledin S, 1996, BIOMASS BIOENERG, V11, P75, DOI 10.1016/0961-9534(96)00022-0
   Lewandowski I, 2003, EUR J AGRON, V19, P45, DOI 10.1016/S1161-0301(02)00018-7
   LONDO M, 2002, THESIS UTRECHT U UTR
   MCALOON A, 2000, DETERMINING COSTS PR
   Nonhebel S, 2002, BIOMASS BIOENERG, V22, P159, DOI 10.1016/S0961-9534(01)00071-X
   OTTO D, 2001, EFFECTS EXPANDING ET
   Patel M, 2005, TECHNO EC FEASIBILIT
   *PAV, 2000, KWANT INF AKK VOLL
   *REU FAL, 1996, REU TECHN SER, V46
   Richards KR, 2004, CLIMATIC CHANGE, V63, P1, DOI 10.1023/B:CLIM.0000018503.10080.89
   RICHTER K, 1995, ENERGIE STOFFBILANZE
   *RIVM, 2001, CDROM PUBL
   SEDJO R., 2001, ESTIMATING CARBON SU
   *SEO, 1998, 483 SEO
   SMEETS E, 2006, AGR CLIMATE 2015 NEW, V46, P147
   STANCZYK K, 2003, ENERGY FOREST DEV AR
   Stavins RN, 1999, AM ECON REV, V89, P994, DOI 10.1257/aer.89.4.994
   SZCZUKOWSKI S, 2000, COSTS PROFITABILITY
   *UBA, BAS UMW
   USDA National Agricultural Statistics Service, 2003, AGR LAND VAL CASH RE
   VanDriel H, 1997, J APPL ECONOM, V12, P509, DOI 10.1002/(SICI)1099-1255(199709/10)12:5<509::AID-JAE451>3.0.CO;2-P
   Vink ETH, 2003, POLYM DEGRAD STABIL, V80, P403, DOI 10.1016/S0141-3910(02)00372-5
   Walsh ME, 2000, BIOMASS BIOENERG, V18, P283, DOI 10.1016/S0961-9534(99)00094-X
   Wolfram CD, 1999, AM ECON REV, V89, P805, DOI 10.1257/aer.89.4.805
   Wooley R, 1999, LIGNOCELLULOSIC BIOM
   *WSRC, 2004, HARV DIR CONT COPP H
NR 70
TC 16
Z9 17
U1 2
U2 8
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0961-9534
J9 BIOMASS BIOENERG
JI Biomass Bioenerg.
PD JAN
PY 2007
VL 31
IS 1
BP 46
EP 65
DI 10.1016/j.biombioe.2006.04.006
PG 20
WC Agricultural Engineering; Biotechnology & Applied Microbiology; Energy &
   Fuels
SC Agriculture; Biotechnology & Applied Microbiology; Energy & Fuels
GA 129DX
UT WOS:000243709700006
DA 2018-10-19
ER

PT J
AU Pompe, T
   Keller, K
   Mothes, G
   Nitschke, M
   Teese, M
   Zimmermann, R
   Werner, C
AF Pompe, Tilo
   Keller, Kristin
   Mothes, Gisela
   Nitschke, Mirko
   Teese, Mark
   Zimmermann, Ralf
   Werner, Carsten
TI Surface modification of poly(hydroxybutyrate) films to control
   cell-matrix adhesion
SO BIOMATERIALS
LA English
DT Article
DE polyhydroxybutyric acid; fibronectin; endothelial cells; extracellular
   matrix (ECM)
ID POLYMER SUBSTRATES CONTROLS; BACTERIAL POLYHYDROXYALKANOATES;
   FIBRONECTIN ANCHORAGE; INTEGRIN BINDING; ACID;
   POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYVALERATE); BIOMATERIAL; PROTEINS;
   PHBHHX
AB Tailoring surface properties of degradable polymer scaffolds is key to progress in various tissue engineering strategies. Poly(3hydroxybutyrate) and poly(3-hydroxybutyrate-co-4-hydroxybutyrate) thin films were modified by low pressure ammonia plasma, low pressure water vapour plasma, or immersion in a sodium hydroxide solution to elaborate means to control the cell-matrix adhesion of human umbilical cord vein endothelial cells grown on these materials. Fibronectin (FN) heteroexchange and cell adhesion were correlated to the physicochemical characteristics of the modified polymer surfaces which were investigated by X-ray photoelectron spectroscopy (XPS), scanning force microscopy (SFM), electrokinetic measurements, and contact angle measurements. All treatments increased the hydrophilicity of the polymer samples, which could be accounted to newly created amine or carboxyl functionalities for ammonia plasma or water vapour plasma treatments, respectively, and ester hydrolysis for treatments with alkaline aqueous solutions. Main features of cell adhesion and FN reorganisation-evaluated after 1 h and after 5 days-could be attributed to the anchorage strength of pre-coated FN layers at the polymer surface, which was, in turn found to be triggered by the type of modification applied. In line with earlier studies referring to different materials cell adhesion and matrix reorganisation were shown to be sensitively controlled through the physicochemical profile of poly(hydroxybutyrate) surfaces. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Max Bergmann Ctr Biomat Dresden, Leibniz Inst Polymer Res Dresden, D-01069 Dresden, Germany.
   Sachs Inst Angew Biotechnol Leipzig, D-04318 Leipzig, Germany.
RP Pompe, T (reprint author), Max Bergmann Ctr Biomat Dresden, Leibniz Inst Polymer Res Dresden, Hohe Str 6, D-01069 Dresden, Germany.
EM pompe-tilo@ipfdd.de
RI Teese, Mark/B-4307-2008; Umlauf, Ursula/D-3356-2014; Werner,
   Carsten/F-8127-2010; Nitschke, Mirko/E-6486-2011
OI Teese, Mark/0000-0002-8003-4918; Werner, Carsten/0000-0003-0189-3448;
   Pompe, Tilo/0000-0003-1508-4959
CR ANDERSON AJ, 1990, MICROBIOL REV, V54, P450
   Brew Shelsa A., 1994, Journal of Tissue Culture Methods, V16, P197, DOI 10.1007/BF01540650
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   DOI Y, 1995, MACROMOL SYMP, V98, P585, DOI 10.1002/masy.19950980150
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Grondahl L, 2005, BIOMACROMOLECULES, V6, P2197, DOI 10.1021/bm050127m
   HAYNES CA, 1994, COLLOID SURFACE B, V2, P517
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kim HW, 2002, INT J BIOL MACROMOL, V30, P129, DOI 10.1016/S0141-8130(02)00012-0
   Kose GT, 2003, BIOMATERIALS, V24, P1949, DOI 10.1016/S0142-9612(02)00613-0
   Lee SY, 1996, BIOTECHNOL BIOENG, V49, P1
   Li J, 2005, J BIOMED MATER RES A, V75A, P985, DOI 10.1002/jbm.a.30504
   Martin DP, 2003, BIOCHEM ENG J, V16, P97, DOI 10.1016/S1369-703X(03)00040-8
   McClary KB, 2000, J BIOMED MATER RES, V50, P428, DOI 10.1002/(SICI)1097-4636(20000605)50:3<428::AID-JBM18>3.0.CO;2-H
   Mothes G, 2005, ENG LIFE SCI, V5, P58, DOI 10.1002/elsc.200420056
   Nebe B, 2001, BIOMATERIALS, V22, P2425, DOI 10.1016/S0142-9612(00)00430-0
   Nitschke M, 2002, J BIOMED MATER RES, V59, P632, DOI 10.1002/jbm.1274.abs
   Osaki T, 2003, LANGMUIR, V19, P5787, DOI 10.1021/la034439r
   Pompe T, 2005, EUR BIOPHYS J BIOPHY, V34, P1049, DOI 10.1007/s00249-005-0490-z
   Pompe T, 2004, TISSUE ENG, V10, P841, DOI 10.1089/1076327041348356
   Pompe T, 2003, J BIOMED MATER RES A, V67A, P647, DOI 10.1002/jbm.a.10130
   Poulouin L, 1999, PROTEIN EXPRES PURIF, V17, P146, DOI 10.1006/prep.1999.1103
   Qu XH, 2005, BIOMATERIALS, V26, P6991, DOI 10.1016/j.biomaterials.2005.05.034
   Renner L, 2004, LANGMUIR, V20, P2928, DOI 10.1021/la0362627
   Rouxhet L, 1998, J BIOMAT SCI-POLYM E, V9, P1279, DOI 10.1163/156856298X00398
   Salchert K, 2003, J CHROMATOGR A, V1005, P113, DOI 10.1016/S0021-9673(03)00932-4
   Shishatskaya EI, 2005, J BIOMAT SCI-POLYM E, V16, P643, DOI 10.1163/1568562053783678
   Vert M, 2005, BIOMACROMOLECULES, V6, P538, DOI 10.1021/bm0494702
   WEIS JR, 1991, THROMB RES, V61, P171, DOI 10.1016/0049-3848(91)90245-R
   Werner C, 1998, J COLLOID INTERF SCI, V208, P329, DOI 10.1006/jcis.1998.5787
   Yang XS, 2002, BIOMATERIALS, V23, P1391, DOI 10.1016/S0142-9612(01)00260-5
   Zhang DM, 2000, SURF COAT TECH, V131, P350, DOI 10.1016/S0257-8972(00)00810-0
NR 33
TC 79
Z9 85
U1 0
U2 24
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 1
BP 28
EP 37
DI 10.1016/j.biomaterials.2006.08.028
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 111BE
UT WOS:000242424900004
PM 16963116
DA 2018-10-19
ER

PT J
AU Shin, H
AF Shin, Heungsoo
TI Fabrication methods of an engineered microenvironment for analysis of
   cell-biomaterial interactions
SO BIOMATERIALS
LA English
DT Review
DE micropattering; cell/biomaterial interactions; microfabrication; cell
   adhesion; biomaterial microarray
ID FOCAL ADHESIONS; MICROPATTERNED SURFACES; INTEGRIN BINDING; IN-VITRO;
   MATRIX; SUBSTRATE; HYDROGELS; MECHANOTRANSDUCTION; CYTOSKELETON;
   STIFFNESS
AB Success in tissue engineering requires an understanding of how cells integrate the signals presented from the microenvironment created by biomaterial scaffolds to alter their responses. Besides the presence of chemical stimuli, there is growing evidence that the spatial organization of cells and tissue within a 3-dimensional (3-D) extracellular matrix (ECM) context is a critical element in controlling cellular function. Therefore, in order to direct cells toward a desirable tissue structure, it is necessary to engineer biomaterials to have spatiotemporal control of the presentation of regulatory signals. Given that, micro-patterning techniques have profited by combining micro-fabrication technology with the chemical conjugation of biologically active molecules to provide new culture systems where cells can be cultured within a specific geometry. The micro-engineered environments have been developed as 2- and 3-D structures, which have proven greatly useful as versatile platforms to study cell, biomaterial, and ECM interactions on both macroscopic and microscopic levels. The main focus of this review is a brief summary of the use of micro-engineered substrates in the analysis of cell-biomaterial interactions with the aim to provide an introductory overview of practical applications available in the literature. In particular, topics regarding (1) the soft-lithography technique to prepare micro-patterned substrates for the spatial control of cell adhesion, (2) biomaterials stiffness-dependent cellular responses, and (3) the microarray techniques for analysis of cell/biomaterials interactions are discussed. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Hanyang Univ, Dept Bioengn, Seoul 133791, South Korea.
RP Shin, H (reprint author), Hanyang Univ, Dept Bioengn, 17 Haengdang Dong, Seoul 133791, South Korea.
EM hshin@hanyang.ac.kr
CR Abbott A, 2003, NATURE, V424, P870, DOI 10.1038/424870a
   Albrecht DR, 2005, LAB CHIP, V5, P111, DOI 10.1039/b406953f
   Anderson DG, 2004, SCIENCE, V305, P1923, DOI 10.1126/science.1099987
   Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Andersson H, 2004, LAB CHIP, V4, P98, DOI 10.1039/b314469k
   Anselme K, 2006, BIOMATERIALS, V27, P1187, DOI 10.1016/j.biomaterials.2005.10.009
   Bailey SN, 2004, P NATL ACAD SCI USA, V101, P16144, DOI 10.1073/pnas.0404425101
   Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532
   Bianchi F, 2006, J BIOMAT SCI-POLYM E, V17, P37, DOI 10.1163/156856206774879117
   Brock A, 2003, LANGMUIR, V19, P1611, DOI 10.1021/la026394k
   Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014
   Chen CS, 2004, ANNU REV BIOMED ENG, V6, P275, DOI 10.1146/annurev.bioeng.6.040803.140040
   Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Chin VI, 2004, BIOTECHNOL BIOENG, V88, P399, DOI 10.1002/bit.20254
   ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403
   Clark P, 1997, EXP CELL RES, V230, P275, DOI 10.1006/excr.1996.3429
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Damljanovic V, 2005, BIOTECHNIQUES, V39, P847, DOI 10.2144/000112026
   DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1
   den Braber ET, 1998, J BIOMED MATER RES, V40, P291, DOI 10.1002/(SICI)1097-4636(199805)40:2<291::AID-JBM14>3.3.CO;2-8
   Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Doh J, 2006, P NATL ACAD SCI USA, V103, P5700, DOI 10.1073/pnas.0509404103
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153
   Gallant ND, 2002, LANGMUIR, V18, P5579, DOI 10.1021/la025554p
   Gallant ND, 2005, MOL BIOL CELL, V16, P4329, DOI 10.1091/mbc.E05-02-0170
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o
   Geissler M, 2004, ADV MATER, V16, P1249, DOI 10.1002/adma.200400835
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   KHATIWALA CB, 2006, AM J PHYSL CELL PHYS
   Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836
   Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236
   Liu WF, 2005, MATER TODAY, V8, P28, DOI 10.1016/S1369-7021(05)71222-0
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Matsuzawa M, 1996, J NEUROSCI METH, V69, P189, DOI 10.1016/S0165-0270(96)00052-0
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   McDevitt TC, 2003, J BIOMED MATER RES A, V66A, P586, DOI 10.1002/jbm.a.10504
   McDevitt TC, 2002, J BIOMED MATER RES, V60, P472, DOI 10.1002/jbm.1292
   Meredith JC, 2003, J BIOMED MATER RES A, V66A, P483, DOI 10.1002/jbm.a.10004
   Mrksich M, 1996, P NATL ACAD SCI USA, V93, P10775, DOI 10.1073/pnas.93.20.10775
   Oliva AA, 2003, NEUROCHEM RES, V28, P1639
   Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661
   Peyton SR, 2005, J CELL PHYSIOL, V204, P198, DOI 10.1002/jcp.20274
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Revzin A, 2001, LANGMUIR, V17, P5440, DOI 10.1021/la010075w
   Revzin A, 2004, LANGMUIR, V20, P2999, DOI 10.1021/la035827w
   Revzin A, 2005, LAB CHIP, V5, P30, DOI 10.1039/b405557h
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3
   Stegemann JP, 2003, ANN BIOMED ENG, V31, P391, DOI 10.1114/1.1558031
   Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307
   Thomas JA, 2004, ASTM STAND NEWS, V32, P8
   Vogt AK, 2004, J NEUROSCI METH, V134, P191, DOI 10.1016/j.jneumeth.2003.11.004
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   Wang YL, 1998, METHOD ENZYMOL, V298, P489, DOI 10.1016/S0076-6879(98)98041-7
   Whitesides George M, 2005, Sci Prog, V88, P17, DOI 10.3184/003685005783238462
   Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335
NR 71
TC 81
Z9 85
U1 1
U2 46
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 2
BP 126
EP 133
DI 10.1016/j.biomaterials.2006.08.007
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 109LV
UT WOS:000242310500002
PM 16945407
DA 2018-10-19
ER

PT J
AU Gilbert, TW
   Stewart-Akers, AM
   Badylak, SF
AF Gilbert, Thomas W.
   Stewart-Akers, Ann M.
   Badylak, Stephen F.
TI A quantitative method for evaluating the degradation of biologic
   scaffold materials
SO BIOMATERIALS
LA English
DT Article
DE extracellular matrix scaffold; radioactive labeling; degradation
ID SMALL-INTESTINAL SUBMUCOSA; ACCELERATOR MASS-SPECTROMETRY;
   EXTRACELLULAR-MATRIX; DOG-MODEL; TISSUE; RECONSTRUCTION; BIOMATERIAL;
   REPAIR
AB Scaffolds derived from naturally occurring extracellular matrix (ECM) have found extensive use in the fields of tissue engineering and regenerative medicine. Many of these scaffolds are designed to degrade rapidly as they are replaced by new host tissue. Other scaffolds are chemically crosslinked to slow the rate of degradation or add strength to the scaffold. Commercially available ECM scaffolds have considerable variability with regards to tissue origin and methods of processing, and little is known about their rate of degradation and the fate of their degradation products. A novel method is described herein to integrally label ECM with a radioactive isotope (C-14). It was found that a number of tissues are efficiently labeled, including heart, liver, trachea, pancreas, small intestine, and urinary bladder tissue. Of the tissues analyzed, only spleen was not found to contain detectable levels of 14C. The technique is extremely sensitive, accurate, and safe, but requires access to accelerator mass spectrometry, and is expensive and time consuming. This model represents the first described quantitative method to determine the rate of degradation for an ECM scaffold and to track the fate of the degradation products. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA.
RP Badylak, SF (reprint author), Univ Pittsburgh, McGowan Inst Regenerat Med, 100 Technol Dr,Suite 200, Pittsburgh, PA 15219 USA.
EM badylaks@upmc.edu
OI Badylak, Stephen/0000-0003-3555-0689
CR BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak SF, 2005, J SURG RES, V128, P87, DOI 10.1016/j.jss.2005.03.002
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Brown K, 2006, MASS SPECTROM REV, V25, P127, DOI 10.1002/mas.20059
   Chen F, 1999, UROLOGY, V54, P407, DOI 10.1016/S0090-4295(99)00179-X
   Colvert JR, 2002, J UROLOGY, V168, P1872, DOI 10.1097/01.ju.0000027285.05828.e6
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014
   GILBERT TW, 2006, UNPUB J BONE JOINT S
   Harper C, 2001, HOSP MED, V62, P90, DOI 10.12968/hosp.2001.62.2.2379
   Hillegonds DJ, 2001, RADIOCARBON, V43, P305
   Huber JE, 2003, ANN OTO RHINOL LARYN, V112, P428, DOI 10.1177/000348940311200508
   KOCHUPURA PV, 2005, CIRCULATION, V112, P1144
   Kropp BP, 1996, J UROLOGY, V155, P2098, DOI 10.1016/S0022-5347(01)66117-2
   Lappin G, 2004, ANAL BIOANAL CHEM, V378, P356, DOI 10.1007/s00216-003-2348-5
   Lee JM, 2004, CARDIOVASC INTER RAD, V27, P151, DOI 10.1007/s00270-003-0048-3
   Liang HC, 2004, BIOMATERIALS, V25, P3541, DOI 10.1016/j.biomaterials.2003.09.109
   McCready RA, 2005, J VASC SURG, V41, P782, DOI 10.1016/j.jvs.2005.02.035
   Metcalf M. H., 2002, OPER TECH ORTHOP, V12, P204, DOI DOI 10.1053/OTOR.2002.36298
   Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042
   MUNTING E, 1988, ACTA ORTHOP SCAND, V59, P34, DOI 10.3109/17453678809149340
   Niezgoda Jeffrey A, 2005, Adv Skin Wound Care, V18, P258, DOI 10.1097/00129334-200506000-00012
   Ong SR, 2006, BIOMATERIALS, V27, P1930, DOI 10.1016/j.biomaterials.2005.10.018
   Record RD, 2001, BIOMATERIALS, V22, P2653, DOI 10.1016/S0142-9612(01)00007-2
   STETTEN MR, 1949, J BIOL CHEM, V181, P31
   WAINWRIGHT DJ, 1995, BURNS, V21, P243, DOI 10.1016/0305-4179(95)93866-I
NR 26
TC 67
Z9 69
U1 1
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 2
BP 147
EP 150
DI 10.1016/j.biomaterials.2006.08.022
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 109LV
UT WOS:000242310500004
PM 16949150
DA 2018-10-19
ER

PT J
AU Allen, J
   Liu, Y
   Kim, YL
   Turzhitsky, VM
   Backman, V
   Ameer, GA
AF Allen, Josephine
   Liu, Yang
   Kim, Young L.
   Turzhitsky, Vladimir M.
   Backman, Vadim
   Ameer, Guillermo A.
TI Spectroscopic translation of cell-material interactions
SO BIOMATERIALS
LA English
DT Article
DE light scattering; optics; tissue engineering; cell characterization;
   cell morphology; cell-substrate interaction
ID SMOOTH-MUSCLE-CELLS; LIGHT-SCATTERING SPECTROSCOPY; ENDOTHELIAL-CELLS;
   IN-SITU; PHENOTYPIC MODULATION; FIBRONECTIN; ORGANIZATION; APOPTOSIS;
   MATRIX; DEATH
AB The characterization of cellular interactions with a biomaterial surface is important to the development of novel biomaterials. Traditional methods used to characterize processes such as cellular adhesion and differentiation on biomaterials can be time consuming, and destructive, and are not amenable to quantitative assessment in situ. As the development of novel biomaterials shifts towards small-scale, combinatorial, and high throughput approaches, new techniques will be required to rapidly screen and characterize cell/biomaterial interactions. Towards this goal, we assessed the feasibility of using 4-dimensional elastic light-scattering fingerprinting (4D-ELF) to describe the differentiation of human aortic smooth muscle cells (HASMCs), as well as the adhesion, and apoptotic processes of human aortic endothelial cells (HAECs), in a quantitative and non-perturbing manner. HASMC and HAEC were cultured under conditions to induce cell differentiation, attachment, and apoptosis which were evaluated via immunohistochemistry, microscopy, biochemistry, and 4D-ELF. The results show that 4D-ELF detected changes in the size distributions of subcellular organelles and structures that were associated with these specific cellular processes. 4D-ELF is a novel way to assess cell phenotype, strength of adhesion, and the onset of apoptosis on a biomaterial surface and could potentially be used as a rapid and quantitative screening tool to provide a more in-depth understanding of cell/biomaterial interactions. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Northwestern Univ, Dept Biomed Engn, Evanston, IL 60208 USA.
RP Ameer, GA (reprint author), Northwestern Univ, Dept Biomed Engn, 2145 Sheridan Rd,Room E310, Evanston, IL 60208 USA.
EM g-ameer@northwestern.edu
RI Backman, Vadim/B-6689-2009; Ameer, Guillermo/B-6765-2009; Liu,
   Yang/D-9305-2011
OI Liu, Yang/0000-0002-6388-9674
FU NHLBI NIH HHS [R21 HL071921-03]; NIGMS NIH HHS [2T32GM008449-11]
CR AUSPRUNK DH, 1978, TISSUE CELL, V10, P707, DOI 10.1016/0040-8166(78)90057-5
   Backman V, 1999, IEEE J SEL TOP QUANT, V5, P1019, DOI 10.1109/2944.796325
   Backman V, 2000, NATURE, V406, P35
   Backman V, 2001, IEEE J SEL TOP QUANT, V7, P887, DOI 10.1109/2944.983289
   BORSE GJ, 1991, FORTRAN 77 NUMERICAL
   Boustany NN, 2004, BIOPHYS J, V87, P4163, DOI 10.1529/biophysj.104.048736
   Boustany NN, 2001, OPT LETT, V26, P1063, DOI 10.1364/OL.26.001063
   Bozzola J.J., 1999, ELECT MICROSCOPY PRI
   Chang SY, 2004, GASTROENTEROLOGY, V126, pA342
   Christopher RA, 1997, J CELL SCI, V110, P569
   Christopher RA, 1999, J CELL SCI, V112, P3225
   Consigny PM, 1998, J VASC INTERV RADIOL, V9, P479, DOI 10.1016/S1051-0443(98)70303-3
   DEJANA E, 1987, J CELL BIOL, V104, P1403, DOI 10.1083/jcb.104.5.1403
   Drexler W, 1999, OPT LETT, V24, P1221, DOI 10.1364/OL.24.001221
   Gurjar RS, 2001, NAT MED, V7, P1245, DOI 10.1038/nm1101-1245
   HEDIN U, 1990, DIFFERENTIATION, V44, P222, DOI 10.1111/j.1432-0436.1990.tb00621.x
   Hu WY, 2000, ARTERIOSCL THROM VAS, V20, P1500, DOI 10.1161/01.ATV.20.6.1500
   Hug TS, 2003, ASSAY DRUG DEV TECHN, V1, P479, DOI 10.1089/154065803322163795
   INGBER DE, 1990, P NATL ACAD SCI USA, V87, P3579, DOI 10.1073/pnas.87.9.3579
   Jean RP, 2004, J BIOMECH ENG-T ASME, V126, P552, DOI 10.1115/1.1800559
   Kim YL, 2003, IEEE J SEL TOP QUANT, V9, P243, DOI 10.1109/JSTQE.2003.814183
   Notingher I, 2002, SPECTROSC-INT J, V16, P43, DOI 10.1155/2002/408381
   PRATT KJ, 1988, J VASC SURG, V7, P591, DOI 10.1067/mva.1988.avs0070591
   Reinhart-King CA, 2005, BIOPHYS J, V89, P676, DOI 10.1529/biophysj.104.054320
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   ROBAYE B, 1991, AM J PATHOL, V138, P447
   Roy HK, 2004, GASTROENTEROLOGY, V126, P1071, DOI 10.1053/j.gastro.2004.01.009
   SCHWARTZMAN RA, 1993, ENDOCR REV, V14, P133, DOI 10.1210/er.14.2.133
   Shortliffe E.H., 1998, MEDINFO, V9, P8
   Suarez-Huerta N, 2000, CELL PROLIFERAT, V33, P101, DOI 10.1046/j.1365-2184.2000.00169.x
   Thyberg J, 1998, HISTOL HISTOPATHOL, V13, P871, DOI 10.14670/HH-13.871
   Thyberg J, 2002, J HISTOCHEM CYTOCHEM, V50, P185, DOI 10.1177/002215540205000206
   THYBERG J, 1994, CELL TISSUE RES, V276, P263, DOI 10.1007/BF00306112
   VANDERHULST HC, 1981, LIGHT SCATTERING SMA
   Verrier S, 2004, BIOPOLYMERS, V74, P157, DOI 10.1002/bip.20063
   Wax A, 2002, BIOPHYS J, V82, P2256, DOI 10.1016/S0006-3495(02)75571-9
   Worth NF, 2001, CELL MOTIL CYTOSKEL, V49, P130, DOI 10.1002/cm.1027
NR 37
TC 8
Z9 8
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 2
BP 162
EP 174
DI 10.1016/j.biomaterials.2006.07.002
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 109LV
UT WOS:000242310500006
PM 16884769
DA 2018-10-19
ER

PT J
AU Doroski, DM
   Brink, KS
   Temenoff, JS
AF Doroski, Derek M.
   Brink, Kelly S.
   Temenoff, Johnna S.
TI Techniques for biological characterization of tissue-engineered tendon
   and ligament
SO BIOMATERIALS
LA English
DT Review
DE tendon tissue engineering; ligament tissue engineering; biomaterial
   scaffold; characterization techniques
ID ANTERIOR CRUCIATE LIGAMENT; MEDIAL COLLATERAL LIGAMENT; SEEDED COLLAGEN
   SCAFFOLDS; SMALL-INTESTINE SUBMUCOSA; MARROW STROMAL CELL; IN-VITRO;
   EXTRACELLULAR-MATRIX; PATELLAR TENDON; HUMAN TENOCYTES; ANIMAL-MODELS
AB Injuries to tendons and ligaments are prevalent and result in a significant decrease in quality of patient life. Tissue-engineering strategies hold promise as alternatives to current treatments for these injuries, which often fail to fully restore proper joint biomechanics and produce significant donor site morbidity. Commonly, tissue engineering involves the use of a three-dimensional scaffold seeded with cells that can be directed to form tendon/ligament tissue. When determining the success of such approaches, the viability and proliferation of the cells in the construct, as well as extracellular matrix production and structure should be taken into account. Histology and histochemistry, microscopy, colorimetric assays, and real-time reverse transcriptase-polymerase chain reaction (RT-PCR) are techniques that are employed to assess these biological characteristics. This review provides an overview of each of these methods, including specific examples of how they have been used in evaluation of tissue-engineered tendon and ligament tissue. Basic physical principles underlying each method and advantages and disadvantages of the various techniques are summarized. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Georgia Tech, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   Emory Univ, Atlanta, GA 30332 USA.
RP Temenoff, JS (reprint author), Georgia Tech, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr,Room 2112, Atlanta, GA 30332 USA.
EM johnna.temenoff@bme.gatech.edu
CR Ahmed Z, 2000, CELL MOTIL CYTOSKEL, V46, P6
   Alberts B, 2002, MOL BIOL CELL
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Altman GH, 2002, J BIOMECH ENG-T ASME, V124, P742, DOI 10.1115/1.1519280
   Altman GH, 2001, FASEB J, V15, P270, DOI 10.1096/fj.01-0656fje
   Anderson G, 2002, THEORY PRACTICE HIST, P85
   *APPL BIOS, 2006, REAL TIM PCR VS TRAD
   Arvind CHV, 2006, J SHOULDER ELB SURG, V15, P500, DOI 10.1016/j.jse.2005.11.014
   Awad HA, 2003, J ORTHOPAED RES, V21, P420, DOI 10.1016/S0736-0266(02)00163-8
   Awad HA, 2000, J BIOMED MATER RES, V51, P233, DOI 10.1002/(SICI)1097-4636(200008)51:2<233::AID-JBM12>3.0.CO;2-B
   BRADSHAW AD, 2000, PRINCIPLES TISSUE EN, P119
   Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169
   Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023
   Butler DL, 2004, CLIN ORTHOP RELAT R, pS190, DOI 10.1097/01.blo.0000144585.65450.d2
   Butler DL, 2004, ANNU REV BIOMED ENG, V6, P303, DOI 10.1146/annurev.bioeng.6.040803.140240
   Butler DL, 2003, FUNCTIONAL TISSUE ENGINEERING, P213, DOI 10.1007/0-387-21547-6_16
   BUTLER DL, 1999, CLIN ORTHOP RELAT R, V1, pS324
   Carpenter JE, 1999, CLIN ORTHOP RELAT R, pS296
   Carpenter JE, 2004, BIOMATERIALS, V25, P1715, DOI 10.1016/S0142-9612(03)00507-6
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Cooper JA, 2006, BIOMATERIALS, V27, P2747, DOI 10.1016/j.biomaterials.2005.12.013
   Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014
   Cormier G, 2006, JOINT BONE SPINE, V73, P411, DOI 10.1016/j.jbspin.2006.01.021
   Cornwell KG, 2004, J BIOMED MATER RES A, V71A, P55, DOI 10.1002/jbm.a.30132
   COVEY DC, 1994, CLIN SPORT MED, V13, P509
   Cristino S, 2005, J BIOMED MATER RES A, V73A, P275, DOI 10.1002/jbm.a.30261
   Curtis A S G, 2005, Eur Cell Mater, V9, P50
   Dawes C.J., 1979, BIOL TECHNIQUES TRAN
   Dejardin LM, 2001, AM J SPORT MED, V29, P175, DOI 10.1177/03635465010290021001
   Derwin K, 2004, CLIN ORTHOP RELAT R, P245, DOI 10.1097/01.blo.0000131235.91264.d7
   Derwin KA, 2001, J ORTHOPAED RES, V19, P269, DOI 10.1016/S0736-0266(00)00032-2
   Ebrahim FS, 2006, RADIOGRAPHICS, V26, P1007, DOI 10.1148/rg.264055117
   Funakoshi T, 2005, J BIOMED MATER RES A, V74A, P338, DOI 10.1002/jbm.a.30237
   Funakoshi T, 2005, AM J SPORT MED, V33, P1193, DOI 10.1177/036354650427689
   Ge ZG, 2005, CELL TRANSPLANT, V14, P573, DOI 10.3727/000000005783982819
   Gentleman E, 2006, ANN BIOMED ENG, V34, P726, DOI 10.1007/s10439-005-9058-4
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   Goulet F, 2000, PRINCIPLES TISSUE EN, P711
   Gu J., 1995, IN SITU POLYM CHAIN, P1
   Haller J, 2006, EUR J RADIOL, V58, P450, DOI 10.1016/j.ejrad.2006.03.008
   HALLIDAY D, 1997, FUNDAMENTALS PHYS 4
   Hansen DB, 2005, CHEM SOC REV, V34, P408, DOI 10.1039/b315496n
   Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508
   HARLEY J, 1954, INSTRUMENTAL ANAL
   HARTL D, 2005, GENETICS
   HARWOOD FL, 1992, J APPL PHYSIOL, V72, P1687
   Heftmann E., 2004, CHROMATOGRAPHY FUNDA
   Henshaw DR, 2006, J ORTHOP RES, V24, P481, DOI 10.1002/jor.20050
   Hidalgo FJ, 2004, ANAL BIOCHEM, V334, P155, DOI 10.1016/j.jab.2004.08.001
   Hildebrand KA, 2002, MICROSC RES TECHNIQ, V58, P34, DOI 10.1002/jemt.10114
   Homsi C, 2006, SKELETAL RADIOL, V35, P673, DOI 10.1007/s00256-006-0136-y
   Hopwood D., 2002, THEORY PRACTICE HIST, P63
   HOROBIN RW, 2002, THEORY PRACTICE HIST, P109
   Ide A, 2001, MAT SCI ENG C-BIO S, V17, P95, DOI 10.1016/S0928-4931(01)00315-0
   JENNER J, 2005, 51 ANN M ORTH RES SO
   Jin CZ, 2006, J TRAUMA, V60, P1358, DOI 10.1097/01.ta.0000220385.34197.f9
   Karamuk E, 2004, COMPOS SCI TECHNOL, V64, P885, DOI 10.1016/j.compscitech.2003.09.004
   KHANDPUR R, 1981, HDB MODERN ANAL INST
   KHATOD M, 2003, DANIELS KNEE INJURIE, P31
   KHATOD M, 2003, DANIELS KNEE INJURIE, P185
   Kiernan JA, 1999, HISTOLOGICAL HISTOCH
   KIM CW, 2003, DANIELS KNEE INJURIE, P435
   Knott L, 1997, BIOCHEM J, V322, P535, DOI 10.1042/bj3220535
   Knott L, 1999, BRIT POULTRY SCI, V40, P371, DOI 10.1080/00071669987476
   Koob TJ, 2002, COMP BIOCHEM PHYS A, V133, P1171, DOI 10.1016/S1095-6433(02)00247-7
   Kuhn K., 1987, STRUCTURE FUNCTION C, P1
   KUO C, 2005, 51 ANN M ORTH RES SO
   Landis WJ, 2005, ORTHOP CLIN N AM, V36, P97, DOI 10.1016/j.ocl.2004.06.006
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Laurencin CT, 2005, BIOMATERIALS, V26, P7530, DOI 10.1016/j.biomaterials.2005.05.073
   Lee CH, 2005, BIOMATERIALS, V26, P1261, DOI 10.1016/j.biomaterials.2004.04.037
   LIGHT ND, 1980, BIOL COLLAGEN, P15
   Lin TW, 2004, J BIOMECH, V37, P865, DOI 10.1016/j.jbiomech.2003.11.005
   Lin Wei-Ching, 2006, Chang Gung Med J, V29, P182
   Lu HH, 2005, BIOMATERIALS, V26, P4805, DOI 10.1016/j.biomaterials.2004.11.050
   Majima T, 2005, J ORTHOP SCI, V10, P302, DOI 10.1007/s00776-005-0891-y
   MARTIN RB, 1998, MECH PROPERTIES LIGA, P309
   Martinek V, 2002, J BONE JOINT SURG AM, V84A, P1123, DOI 10.2106/00004623-200207000-00005
   MARTINEZHERNAND, 1994, PATHOLOGY, P69
   MELOAN C, 1968, INSTRUMENTAL ANAL US
   MEYER V, 1988, ION EXCHANGE CHROMAT, P157
   MILLER K, 2002, THEORY PRACTICE HIST, P421
   Milz S, 2006, J ANAT, V208, P671, DOI 10.1111/j.1469-7580.2006.00552.x
   *MOL PROB, 2006, PICOGREEN PROD MAN
   *MOL PROB, 2005, LIVE DEAD PROD MAN
   *MOL PROB, 2005, HOESCHT STAINS PROD
   *MOL PROB, 2006, PHALL PHALL PROD MAN
   *MOL PROB, 2005, AL FLUOR 55 DYE SUP
   *MOL PROB, 2006, DAPI NUCL AC STAIN D
   *MOL PROB, 2005, QUANT IT PICOGREEN D
   Monto Raymond Rocco, 2006, J Knee Surg, V19, P187
   Muller M., 2006, INTRO CONFOCAL FLUOR
   Murray MM, 2006, J ORTHOP RES, V24, P508, DOI 10.1002/jor.20054
   Murray MM, 2001, BIOMATERIALS, V22, P2393
   Murray MM, 2003, J ORTHOPAED RES, V21, P238, DOI 10.1016/S0736-0266(02)00142-0
   Musahl V, 2004, J ORTHOP RES, V22, P214, DOI 10.1016/S0736-0266(03)00163-3
   Nakasa T, 2006, J COMPUT ASSIST TOMO, V30, P543, DOI 10.1097/00004728-200605000-00032
   NELSON DL, 2005, PRINCIPLES BIOCH
   Nikiforov YE, 2001, MORPHOLOGY METHODS, P181
   Ouyang HW, 2005, J BIOMED MATER RES B, V75B, P264, DOI 10.1002/jbm.b.30281
   Patrick Jr C., 1998, FRONTIERS TISSUE ENG, P413
   Persikov AV, 2002, P NATL ACAD SCI USA, V99, P1101, DOI 10.1073/pnas.042707899
   Pesez M., 1974, COLORIMETRIC FLUORIM
   Probstmeier R, 1999, GLYCOBIOLOGY, V9, P101, DOI 10.1093/glycob/9.2.101
   Qin TW, 2005, BIOMATERIALS, V26, P6635, DOI 10.1016/j.biomaterials.2005.04.023
   Rodeo SA, 2004, J BONE JOINT SURG AM, V86A, P2085, DOI 10.2106/00004623-200409000-00034
   Schulze-Tanzil G, 2004, HISTOCHEM CELL BIOL, V122, P219, DOI 10.1007/s00418-004-0694-9
   SCOTTBURDEN T, 1994, NEWS PHYSIOL SCI, V9, P110
   Sheng PY, 2006, ACTA ORTHOP, V77, P512, DOI 10.1080/17453670610012520
   SPALAZZI J, 2005, 51 ANN M ORTH RES SO
   SPALAZZI J, 2006, 52 ANN M ORTH RES SO
   Tanzer M. L., 1976, BIOCH COLLAGEN, P137
   Thomopoulos S, 2003, J ORTHOPAED RES, V21, P413, DOI 10.1016/S0736-0266(03)00057-3
   Torres DS, 2000, BIOMATERIALS, V21, P1607
   Triantafillopoulos IK, 2004, AM J SPORT MED, V32, P934, DOI 10.1177/0363546503261700
   Trieb K, 2004, EUR SURG RES, V36, P148, DOI 10.1159/000077256
   Vanderploeg EJ, 2004, J BIOMECH, V37, P1941, DOI 10.1016/j.jbiomech.2004.02.048
   VIIDIK A, 1980, BIOL COLLAGEN, P257
   Voet D., 1995, BIOCHEMISTRY
   Vogel K. G., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P202
   Vogel KG, 1999, CLIN ORTHOP RELAT R, pS344, DOI 10.1097/00003086-199910001-00033
   Vunjak-Novakovic G, 2004, ANNU REV BIOMED ENG, V6, P131, DOI 10.1146/annurev.bioeng.6.040803.140037
   WANG I, 2005, 51 ANN M ORTH RES SO
   WANG I, 2004, 50 ANN M ORTH RES SO
   Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011
   WILSON I, 2002, THEORY PRACTICE HIST, P125
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
   Wong MWN, 2004, J BIOMED MATER RES B, V70B, P362, DOI 10.1002/jbm.b.30049
   Woo SLY, 2006, J BIOMECH, V39, P1, DOI 10.1016/j.jbiomech.2004.10.025
   Woo SLY, 2004, ANN BIOMED ENG, V32, P342, DOI 10.1023/B:ABME.0000017551.93144.1a
   Yadao Melissa A, 2004, Instr Course Lect, V53, P607
   Yang Z, 2000, Hand Surg, V5, P49, DOI 10.1142/S0218810400000132
   Yoon J. H., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P22
NR 134
TC 70
Z9 74
U1 1
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 2
BP 187
EP 202
DI 10.1016/j.biomaterials.2006.08.040
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 109LV
UT WOS:000242310500008
PM 16982091
DA 2018-10-19
ER

PT J
AU Underhill, GH
   Chen, AA
   Albrecht, DR
   Bhatia, SN
AF Underhill, Gregory H.
   Chen, Alice A.
   Albrecht, Dirk R.
   Bhatia, Sangeeta N.
TI Assessment of hepatocellular function within PEG hydrogels
SO BIOMATERIALS
LA English
DT Article
DE hydrogel; hepatocyte; progenitor cell; liver
ID TISSUE-ENGINEERING APPLICATIONS; MICROCARRIER-ATTACHED HEPATOCYTES;
   POLYETHYLENE-GLYCOL HYDROGELS; GAP JUNCTIONAL COMMUNICATION; LINKING
   DENSITY INFLUENCES; EPIDERMAL-GROWTH-FACTOR; CELL-CELL INTERACTIONS;
   RAT-LIVER CELLS; POLY(ETHYLENE GLYCOL); STEM-CELLS
AB Tissue-engineered therapies for liver failure offer the potential to augment or replace whole organ transplantation; however, fabrication of hepatic tissue poses unique challenges largely stemming from the complexity of liver structure and function. In this study, we illustrate the utility of highly-tunable, photopolymerizable poly(ethylene glycol) (PEG) hydrogels for 3D encapsulation of hepatic cells and highlight a range of techniques important for examining hepatocellular function in this platform. Owing to our long-term interest in incorporating proliferative progenitor cell types (e.g. hepatoblasts, oval cells, or cells derived from embryonic stem cells) and maintaining the phenotype of differentiated cells, we explored the behavior of bipotential mouse embryonic liver (BMEL) cells as a model progenitor cell and mature, fully differentiated, primary hepatocytes in this biomaterial system. We demonstrated the importance of cell-cell and cell-matrix interactions in the survival and function of these cell types, and the capacity to influence encapsulated cell phenotypes through modulation of hydrogel characteristics or gene silencing. Additionally, we demonstrated imaging techniques critical for the in situ assessment of encapsulated hepatocyte function combined with the ability to control cellular organization and overall architecture through microscale patterning technologies. Further analysis of liver progenitor as well as mature hepatocyte processes within the versatile PEG hydrogel platform will aid in the development of tissue engineered implantable liver systems. (c) 2006 Elsevier Ltd. All rights reserved.
C1 MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   Brigham & Womens Hosp, Div Med, Boston, MA 02115 USA.
RP Bhatia, SN (reprint author), MIT, Harvard Mit Div Hlth Sci & Technol, 77 Massachusetts Ave,E19-502D, Cambridge, MA 02139 USA.
EM sbhatia@mit.edu
RI Albrecht, Dirk/B-9941-2011
CR Albrecht DR, 2005, LAB CHIP, V5, P111, DOI 10.1039/b406953f
   Albrecht DR, 2006, NAT METHODS, V3, P369, DOI 10.1038/NMETH873
   Alhadlaq A, 2005, TISSUE ENG, V11, P556, DOI 10.1089/ten.2005.11.556
   Allen JW, 2002, SEMIN CELL DEV BIOL, V13, P447, DOI 10.1016/S1084-9521(02)00133-7
   Allen JW, 2002, TISSUE ENG, V8, P725, DOI 10.1089/10763270260424097
   Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501
   Anseth KS, 2002, J CONTROL RELEASE, V78, P199, DOI 10.1016/S0168-3659(01)00500-4
   Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7
   Balis UJ, 1999, METAB ENG, V1, P49, DOI 10.1006/mben.1998.0105
   Bates RC, 2000, CRIT REV ONCOL HEMAT, V36, P61, DOI 10.1016/S1040-8428(00)00077-9
   Beebe DJ, 2000, NATURE, V404, P588, DOI 10.1038/35007047
   Behravesh E, 2003, J BIOMED MATER RES A, V66A, P698, DOI 10.1002/jbm.a.10003
   Bhatia SN, 1999, FASEB J, V13, P1883
   Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca
   Bryant SJ, 2004, BIOTECHNOL BIOENG, V86, P747, DOI 10.1002/bit.20160
   Bryant SJ, 2004, J ORTHOPAED RES, V22, P1143, DOI 10.1016/j.orthres.2004.02.001
   Burdick JA, 2002, J CONTROL RELEASE, V83, P53, DOI 10.1016/S0168-3659(02)00181-5
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Corlu A, 1997, CELL BIOL TOXICOL, V13, P235, DOI 10.1023/A:1007475122321
   Cruise GM, 1998, BIOMATERIALS, V19, P1287, DOI 10.1016/S0142-9612(98)00025-8
   Davis KA, 2003, BIOMATERIALS, V24, P2485, DOI 10.1016/S0142-9612(02)00582-3
   DeLong SA, 2005, BIOMATERIALS, V26, P3227, DOI 10.1016/j.biomaterials.2004.09.021
   DEMETRIOU AA, 1986, SCIENCE, V233, P1190, DOI 10.1126/science.2426782
   DEMETRIOU AA, 1986, P NATL ACAD SCI USA, V83, P7475, DOI 10.1073/pnas.83.19.7475
   DIXIT V, 1992, ARTIF ORGANS, V16, P336
   DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007
   Dvir-Ginzberg M, 2003, TISSUE ENG, V9, P757, DOI 10.1089/107632703768247430
   Eugenin EA, 1998, AM J PHYSIOL-GASTR L, V274, pG1109, DOI 10.1152/ajpgi.1998.274.6.G1109
   FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269
   Fittkau MH, 2005, BIOMATERIALS, V26, P167, DOI 10.1016/j.biomaterials.2004.02.012
   Gobin AS, 2003, BIOTECHNOL PROGR, V19, P1781, DOI 10.1021/bp0341390
   Grossmann J, 2002, APOPTOSIS, V7, P247, DOI 10.1023/A:1015312119693
   Hahn MS, 2006, BIOMATERIALS, V27, P2519, DOI 10.1016/j.biomaterials.2005.11.045
   Hamazaki K, 2002, HEPATO-GASTROENTEROL, V49, P1514
   Hammond JS, 2006, EXPERT REV MED DEVIC, V3, P21, DOI 10.1586/17434440.3.1.21
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024
   Itle LJ, 2005, BIOTECHNOL PROGR, V21, P926, DOI 10.1021/bp049681i
   James R, 2004, J HISTOTECHNOL, V27, P133, DOI 10.1179/his.2004.27.2.133
   Jun HW, 2005, TISSUE ENG, V11, P1133, DOI 10.1089/ten.2005.11.1133
   Kaihara S, 2000, TISSUE ENG, V6, P105, DOI 10.1089/107632700320739
   Khademhosseini A, 2003, ADV MATER, V15, P1995, DOI 10.1002/adma.200305433
   Khetani SR, 2004, HEPATOLOGY, V40, P545, DOI 10.1002/hep.20351
   LAKE B D, 1970, Histochemical Journal, V2, P441, DOI 10.1007/BF01004725
   LANDRY J, 1985, J CELL BIOL, V101, P914, DOI 10.1083/jcb.101.3.914
   Lee SH, 2005, BIOTECHNOL PROGR, V21, P1736, DOI 10.1021/bp0502429
   Lemaigre F, 2004, CURR OPIN GENET DEV, V14, P582, DOI 10.1016/j.gde.2004.08.004
   Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100
   Mahoney MJ, 2006, BIOMATERIALS, V27, P2265, DOI 10.1016/j.biomaterials.2005.11.007
   Mann BK, 2001, BIOMATERIALS, V22, P3045, DOI 10.1016/S0142-9612(01)00051-5
   Mann BK, 2002, J BIOMED MATER RES, V60, P86, DOI 10.1002/jbm.10042
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Martens PJ, 2003, BIOMACROMOLECULES, V4, P283, DOI 10.1021/bm025666v
   Mi LX, 2006, BIOMACROMOLECULES, V7, P38, DOI 10.1021/bm050157p
   Moghe P. V., 1994, Molecular Biology of the Cell, V5, p177A
   Moghe PV, 1996, BIOMATERIALS, V17, P373, DOI 10.1016/0142-9612(96)85576-1
   Moghe PV, 1997, BIOTECHNOL BIOENG, V56, P706, DOI 10.1002/(SICI)1097-0290(19971220)56:6<706::AID-BIT14>3.0.CO;2-5
   MOGHE PV, 1995, MOL BIOL CELL S, V6, pA238
   Mooney DJ, 1997, J BIOMED MATER RES, V37, P413, DOI 10.1002/(SICI)1097-4636(19971205)37:3<413::AID-JBM12>3.0.CO;2-C
   Moore K, 2006, TISSUE ENG, V12, P267, DOI 10.1089/ten.2006.12.267
   Nguyen KT, 2002, BIOMATERIALS, V23, P4307, DOI 10.1016/S0142-9612(02)00175-8
   Nuttelman CR, 2006, J BIOMED MATER RES A, V76A, P183, DOI 10.1002/jbm.a.30537
   Nuttelman CR, 2005, MATRIX BIOL, V24, P208, DOI 10.1016/j.matbio.2005.03.004
   Nuttelman CR, 2004, J BIOMED MATER RES A, V68A, P773, DOI 10.1002/jbm.a.20112
   Park Y, 2004, TISSUE ENG, V10, P515, DOI 10.1089/107632704323061870
   Park YD, 2003, BIOMATERIALS, V24, P893, DOI 10.1016/S0142-9612(02)00420-9
   Patel PN, 2005, TISSUE ENG, V11, P1498, DOI 10.1089/ten.2005.11.1498
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Powers MJ, 2002, BIOTECHNOL BIOENG, V78, P257, DOI 10.1002/bit.10143
   Powers MJ, 2002, TISSUE ENG, V8, P499, DOI 10.1089/107632702760184745
   Quek CH, 2004, BIOMATERIALS, V25, P3531, DOI 10.1016/j.biomaterials.2003.09.112
   Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682
   Revzin A, 2001, LANGMUIR, V17, P5440, DOI 10.1021/la010075w
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Riley SL, 2001, J MATER SCI-MATER M, V12, P983, DOI 10.1023/A:1012817317296
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   SAITO S, 1992, TRANSPLANT P, V24, P1520
   SAWHNEY AS, 1993, MACROMOLECULES, V26, P581, DOI 10.1021/ma00056a005
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Siddiqui MU, 1999, HEPATOLOGY, V29, P1147, DOI 10.1002/hep.510290443
   Strick-Marchand H, 2004, P NATL ACAD SCI USA, V101, P8360, DOI 10.1073/pnas.0401092101
   Strick-Marchand H, 2002, HEPATOLOGY, V36, P794, DOI 10.1053/jhep.2002.36123
   Suh KY, 2004, BIOMATERIALS, V25, P557, DOI 10.1016/S0142-9612(03)00543-X
   Tan W, 2004, BIOMATERIALS, V25, P1355, DOI 10.1016/j.biomaterials.2003.08.021
   Tan W, 2003, BIOMED MICRODEVICES, V5, P235, DOI 10.1023/A:1025764310391
   VACANTI JP, 1988, J PEDIATR SURG, V23, P3, DOI 10.1016/S0022-3468(88)80529-3
   VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625
   Wang DA, 2003, BIOMATERIALS, V24, P3969, DOI 10.1016/S0142-9612(03)00280-1
   Wang DA, 2005, TISSUE ENG, V11, P201, DOI 10.1089/ten.2005.11.201
   Wang F, 1998, P NATL ACAD SCI USA, V95, P14821, DOI 10.1073/pnas.95.25.14821
   Wang XH, 2006, TISSUE ENG, V12, P83, DOI 10.1089/ten.2006.12.83
   Webster SS, 2003, J HISTOTECHNOL, V26, P57
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Zahir N, 2004, CURR OPIN GENET DEV, V14, P71, DOI 10.1016/j.gde.2003.12.005
   Zakim D, 1990, HEPATOLOGY TXB LIVER
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 100
TC 121
Z9 125
U1 2
U2 54
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 2
BP 256
EP 270
DI 10.1016/j.biomaterials.2006.08.043
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 109LV
UT WOS:000242310500014
PM 16979755
DA 2018-10-19
ER

PT J
AU Gomez, N
   Lu, Y
   Chen, SC
   Schmidt, CE
AF Gomez, Natalia
   Lu, Yi
   Chen, Shaochen
   Schmidt, Christine E.
TI Immobilized nerve growth factor and microtopography have distinct
   effects on polarization versus axon elongation in hippocampal cells in
   culture
SO BIOMATERIALS
LA English
DT Article
DE polarization; axon growth; hippocampal neurons; contact guidance; nerve
   growth factor
ID ARTIFICIAL JUXTACRINE STIMULATION; P75 NEUROTROPHIN RECEPTOR; GUIDE
   NEURITE OUTGROWTH; TOPOGRAPHICAL CONTROL; NEURONAL POLARITY;
   CONCENTRATION GRADIENTS; TRK RECEPTORS; PC12 CELLS; GUIDANCE; SURFACES
AB Cell interfacing with biomaterial surfaces dictates important aspects of cell behavior. In particular, axon extension in neurons is effectively influenced by surface properties, both for the initial formation of an axon as well as for the maintenance of axon growth. Here, we investigated how neurons behaved on poly(dimethyl siloxane) (PDMS) surfaces decorated with biochemical and physical cues presented individually or in combination. In particular, nerve growth factor (NGF) was covalently tethered to PDMS to create a bioactive surface, and microtopography was introduced to the material in the form of microchannels. Embryonic hippocampal neurons were used to investigate the impact of these surface cues on polarization (i.e., axon initiation or axogenesis) and overall axon length. We found that topography had a more pronounced effect on polarization (68% increase over controls) compared to immobilized NGF (0.1 ng/mm(2)) (27% increase). However, the effect of NGF was negligible when both types of stimuli were simultaneously presented on the biomaterial surface. In addition to axon formation, chemical and physical cues are also involved in axon growth following the initiation process. Interestingly, for the same studies described above, the effects of microchannels and NGF were opposite from the effects on polarization; the most evident effect was for the immobilized growth factor (10% increase in axon length with respect to controls) whereas there was no effect in general for the micro topography. More importantly, when the two surface stimuli were presented in combination, a synergistic increase in axon length was detected (25% increase with respect to controls), which could be a result of faster polarization triggered by topography plus enhanced growth from NGF. Additionally, axon orientation was also analyzed and we found the well-known tendency of perpendicular or parallel axonal alignment to be dependent on the width and depth of the channels. This investigation thoroughly compared and distinguished the individual and combined impact of material surface properties (chemical and physical) on axogenesis from the effects on axon length. Overall, topography dominated polarization mechanisms, whereas NGF, and particularly a synergy of immobilized NGF plus topography, dominated axon length. These results could be potentially applied for the design of biomaterials in applications were axon growth is critical. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
   Univ Texas, Dept Mech Engn, Austin, TX 78712 USA.
   Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
   Univ Texas, Mat Inst, Austin, TX 78712 USA.
   Univ Texas, Ctr Nano & Mol Sci & Technol, Austin, TX 78712 USA.
RP Schmidt, CE (reprint author), Univ Texas, Dept Chem Engn, Austin, TX 78712 USA.
EM schmidt@che.utexas.edu
RI Schmidt, Christine/P-1613-2016
CR AHMED L, 2006, J BIOMED MATER RES A, V76, P851
   Aoki K, 2004, J BIOL CHEM, V279, P713, DOI 10.1074/jbc.M306382200
   BLOCHL A, 1995, EUR J NEUROSCI, V7, P1220, DOI 10.1111/j.1460-9568.1995.tb01112.x
   Brann AB, 2002, J BIOL CHEM, V277, P9812, DOI 10.1074/jbc.M109862200
   Brann AB, 1999, J NEUROSCI, V19, P8199
   Bronfman FC, 2003, J NEUROSCI, V23, P3209
   CAMPENOT RB, 1994, J NEUROBIOL, V25, P599, DOI 10.1002/neu.480250603
   Chen GP, 2001, BIOMATERIALS, V22, P2453, DOI 10.1016/S0142-9612(00)00432-4
   Chen GP, 1997, BBA-MOL CELL RES, V1358, P200, DOI 10.1016/S0167-4889(97)00065-7
   Chung TW, 2002, BIOMATERIALS, V23, P4803, DOI 10.1016/S0142-9612(02)00231-4
   CLARK P, 1990, DEVELOPMENT, V108, P635
   CLARK P, 1991, J CELL SCI, V99, P73
   CLARK P, 1993, J CELL SCI, V105, P203
   CLARK P, 1987, DEVELOPMENT, V99, P439
   Curtis A., 1995, Journal of Cellular Engineering Incorporating Molecular Engineering, V1, P35
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dalby MJ, 2005, MED ENG PHYS, V27, P730, DOI 10.1016/j.medengphy.2005.04.005
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   DOBROWSKY RT, 1995, J BIOL CHEM, V270, P22135, DOI 10.1074/jbc.270.38.22135
   DOTTI CG, 1988, J NEUROSCI, V8, P1454
   Dowell-Mesfin NM, 2004, J NEURAL ENG, V1, P78, DOI 10.1088/1741-2560/1/2/003
   Drotleff S, 2004, EUR J PHARM BIOPHARM, V58, P385, DOI 10.1016/j.ejpb.2004.03.018
   Ebadi M, 1997, NEUROCHEM INT, V30, P347, DOI 10.1016/S0197-0186(96)00071-X
   Foley JD, 2005, BIOMATERIALS, V26, P3639, DOI 10.1016/j.biomaterials.2004.09.048
   Friedman WJ, 2000, J NEUROSCI, V20, P6340, DOI 10.1523/JNEUROSCI.20-17-06340.2000
   Fukata Y, 2002, NEUROSCI RES, V43, P305, DOI 10.1016/S0168-0102(02)00062-7
   Gallo G, 1997, J NEUROSCI, V17, P5445
   Gallo G, 1998, J NEUROSCI, V18, P5403
   GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507
   Harrison RG, 1907, J EXP ZOOL, V4, P239, DOI 10.1002/jez.1400040205
   Ito Y, 1997, FEBS LETT, V403, P159, DOI 10.1016/S0014-5793(97)00045-8
   Ito Y, 1998, BIOCONJUGATE CHEM, V9, P277, DOI 10.1021/bc970190b
   Ito Y, 1998, MAT SCI ENG C-BIO S, V6, P267, DOI 10.1016/S0928-4931(98)00061-7
   Ito Yoshihiro, 1998, Japanese Journal of Artificial Organs, V27, P541
   Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033
   Kapur TA, 2003, J BIOMAT SCI-POLYM E, V14, P383, DOI 10.1163/156856203321478883
   Kapur TA, 2004, J BIOMED MATER RES A, V68A, P235, DOI 10.1002/jbm.a.10168
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Lamoureux P, 2002, J CELL BIOL, V159, P499, DOI 10.1083/jcb.200207174
   LEACH JK, 2006, BIOMATERIALS, V27, P3749
   LEIN PJ, 1992, DEV BRAIN RES, V69, P191, DOI 10.1016/0165-3806(92)90159-T
   LETOURNEAU PC, 1978, DEV BIOL, V66, P183, DOI 10.1016/0012-1606(78)90283-X
   Liao W, 2004, SENSOR ACTUAT B-CHEM, V101, P361, DOI 10.1016/j.snb.2004.04.006
   Mahoney MJ, 2005, BIOMATERIALS, V26, P771, DOI 10.1016/j.biomaterials.2004.03.015
   MATSUDA T, 1995, LANGMUIR, V11, P2272
   Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x
   Miller C, 2002, TISSUE ENG, V8, P367, DOI 10.1089/107632702760184646
   Miller C, 2001, TISSUE ENG, V7, P705, DOI 10.1089/107632701753337663
   Moore K, 2006, TISSUE ENG, V12, P267, DOI 10.1089/ten.2006.12.267
   Naka Y, 2004, J BIOSCI BIOENG, V98, P348, DOI 10.1016/S1389-1723(04)00294-4
   Nishimura T, 2004, NAT CELL BIOL, V6, P328, DOI 10.1038/ncb1118
   NORRIS CR, 1991, J NEUROSCI, V11, P3492
   Patai S., 1971, CHEM AZIDO GROUP
   Rajnicek AM, 1997, J CELL SCI, V110, P2905
   Rajnicek AM, 1997, J CELL SCI, V110, P2915
   Saneinejad S, 1998, J BIOMED MATER RES, V42, P13, DOI 10.1002/(SICI)1097-4636(199810)42:1<13::AID-JBM3>3.0.CO;2-R
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295
   Schwarz A, 1997, J NEUROSCI, V17, P2929
   Scriven EFV, 1984, AZIDES NITRENES REAC
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Simmons CA, 2004, BONE, V35, P562, DOI 10.1016/j.bone.2004.02.027
   SINGER M, 1979, J COMP NEUROL, V185, P1, DOI 10.1002/cne.901850102
   SIROIS E, 1993, INT J ARTIF ORGANS, V16, P609
   Xu XY, 2003, BIOMATERIALS, V24, P2405, DOI 10.1016/S0142-9612(03)00109-1
   Zhang N, 2005, BRAIN RES REV, V49, P48, DOI 10.1016/j.brainresrev.2004.11.002
   Zhang YZ, 2000, J NEUROSCI, V20, P5671
   Zhang ZP, 2005, BIOMATERIALS, V26, P47, DOI 10.1016/j.biomaterials.2004.02.004
   ZISCH AH, 2001, J CONTROLL RELEASE, V71, P101
NR 70
TC 123
Z9 126
U1 1
U2 45
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 2
BP 271
EP 284
DI 10.1016/j.biomaterials.2006.07.043
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 109LV
UT WOS:000242310500015
PM 16919328
DA 2018-10-19
ER

PT J
AU Chung, A
   Gao, Q
   Kao, WJ
AF Chung, Amy
   Gao, Qiang
   Kao, Weiyuan John
TI Macrophage matrix metalloproteinase-2/-9 gene and protein expression
   following adhesion to ECM-derived multifunctional matrices via integrin
   complexation
SO BIOMATERIALS
LA English
DT Article
DE cell adhesion; matrix metalloproteinase; macrophage; RGD peptide;
   gelatin
ID MELANOMA CELL INVASION; IN-VIVO; FIBRONECTIN; TISSUE; MMP-9;
   PARTICIPATION; ANGIOGENESIS; GELATIN; PROFILE; AND-9
AB Macrophages are commonly observed at the biomaterial-tissue interface and interact with the extracellular matrix (ECM) mainly by integrin receptors to play a critical role in ECM turnover by secreting matrix metalloprotemases (MMPs). To investigate beta 1 and beta 3 containing integrin-mediated adhesion and subsequent MMP-2/-9 protein and gene expression in human blood-derived monocytes, biofunctional peptides immobilized onto flexible polyethylene glycol (PEG) arms were grafted onto a gelatin-based interpenetrating network (IPN). Adherent monocyte density was dramatically greater in the presence of RGD immobilized onto flexible PEG arms of the gelatin-based IPN. Pretreatment of monocytes with either anti-integrin beta 1 or beta 3 led to a significant decrease in adherent cell density on RGD-PEG-grafted IPNs. MMP-2 and MMP-9 protein and MMP-9 mRNA expression increased in the presence of IPNs initially, independent of ligand identity. Anti-integrin beta 1 or beta 3 antibody pretreatment of monocytes led to a general decrease in MMP-2/-9 protein expression. These results demonstrate the importance of beta 1 and beta 3 containing integrins in mediating monocyte adhesion onto RGD immobilized onto flexible PEG arms of the IPN. The results also reveal that MMP-2/-9 protein and gene expression is influenced by the presence of gelatin and not the ligands immobilized on the PEG arms of the IPN. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA.
   Univ Wisconsin, Coll Engn, Dept Biomed Engn, Madison, WI USA.
RP Kao, WJ (reprint author), Univ Wisconsin, Sch Pharm, 425 N Charter St, Madison, WI 53706 USA.
EM wjkao@pharmacy.wisc.edu
FU NIBIB NIH HHS [EB6613]; NHLBI NIH HHS [HL77825]
CR Chintala SK, 1996, CANCER LETT, V103, P201, DOI 10.1016/0304-3835(96)04215-2
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   DiPersio C. M., 2005, WOUND HEALING, P49
   Einerson N. J., 2002, BIOMATERIALS, V24, P509
   Elshaw SR, 2001, BRIT J OPHTHALMOL, V85, P732, DOI 10.1136/bjo.85.6.732
   Gao Q, 2005, DIGEST LIVER DIS, V37, P584, DOI 10.1016/j.dld.2005.02.011
   Gattas-Asfura KM, 2005, BIOMACROMOLECULES, V6, P1503, DOI 10.1021/bm049238w
   Gillard JA, 2004, WOUND REPAIR REGEN, V12, P295, DOI 10.1111/j.1067-1927.2004.012314.x
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   KAO WYJ, 1994, J BIOMED MATER RES, V28, P73, DOI 10.1002/jbm.820280110
   KJELDSEN L, 1994, BLOOD, V83, P1640
   Laquerriere P, 2004, BIOMATERIALS, V25, P2515, DOI 10.1016/j.biomaterials.2003.09.034
   Leroy-Dudal J, 2005, INT J CANCER, V114, P531, DOI 10.1002/ijc.20778
   Lin-Gibson S, 2004, BIOMACROMOLECULES, V5, P1280, DOI 10.1021/bm0498777
   Liu YP, 2002, CELL SIGNAL, V14, P145, DOI 10.1016/S0898-6568(01)00246-7
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MAILLARD JL, 1995, CLIN CHIM ACTA, V233, P61, DOI 10.1016/0009-8981(94)05955-R
   McNally AK, 2002, AM J PATHOL, V160, P621, DOI 10.1016/S0002-9440(10)64882-1
   MCNALLY AK, 1994, P NATL ACAD SCI USA, V91, P10119, DOI 10.1073/pnas.91.21.10119
   Phillips JM, 2005, TISSUE ENG, V11, P964, DOI 10.1089/ten.2005.11.964
   SEFTOR REB, 1992, P NATL ACAD SCI USA, V89, P1557, DOI 10.1073/pnas.89.5.1557
   Silletti S, 2001, P NATL ACAD SCI USA, V98, P119, DOI 10.1073/pnas.011343298
   WELGUS HG, 1990, J CLIN INVEST, V86, P1496, DOI 10.1172/JCI114867
   Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8
   Whatling C, 2004, ARTERIOSCL THROM VAS, V24, P10, DOI 10.1161/01.ATV.0000100562.63144.C1
   Xie B, 1998, J BIOL CHEM, V273, P11576, DOI 10.1074/jbc.273.19.11576
   YANG H, IN PRESS INT J NANOM
   Zhang HY, 2002, INVEST OPHTH VIS SCI, V43, P955
NR 28
TC 19
Z9 20
U1 1
U2 9
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 2
BP 285
EP 298
DI 10.1016/j.biomaterials.2006.08.038
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 109LV
UT WOS:000242310500016
PM 16979234
DA 2018-10-19
ER

PT J
AU Yoon, DM
   Hawkins, EC
   Francke-Carroll, S
   Fisher, JP
AF Yoon, Diana M.
   Hawkins, Emily C.
   Francke-Carroll, Sabine
   Fisher, John P.
TI Effect of construct properties on encapsulated chondrocyte expression of
   insulin-like growth factor-1
SO BIOMATERIALS
LA English
DT Article
DE alginate; cell signaling; chondrocyte; insulin-like growth factor-1
ID ARTICULAR-CARTILAGE; STIMULATION; SCAFFOLDS; CULTURE; SERUM
AB Hydrogels are a promising type of biomaterial for articular cartilage constructs since they have been shown to enable encapsulated chondrocytes to express their predominant phenotypic marker, type II collagen. Endogenously expressed signaling molecules, such as insulin-like growth factor-1 (IGF-1), are also known to facilitate the retention of this chondrocytic phenotype. Recent investigations have attempted to enhance the ability of encapsulated chondrocytes to regenerate cartilage through delivery of exogenous signaling molecules. However, we hypothesize that by altering construct properties, such as cell density and polymer concentration, we can augment the expression of endogenous IGF-1 in chondrocytes. To this end, bovine articular chondrocytes were encapsulated within alginate hydrogels at two different cell densities (25,000 and 100,000 cells/bead) and various alginate concentrations (0.8%, 1.2%, and 2.0% w/v). These parameters were chosen to simultaneously investigate cell-to-cell distance on paracrine signaling and water content on IGF-1 diffusion by chondrocytes. At 1, 4, and 8 d, chondrocytes were analyzed for protein and mRNA expression of IGF-1 as well as type II collagen. Results suggest that cell density and alginate concentration at high cell density can significantly affect the endogenous IGF-1 expression by chondrocytes. Therefore, these results indicate that construct properties can impact chondrocyte gene expression and should be considered in order to create a proper engineered articular cartilage construct. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Maryland, Fischell Dept Bioengn, College Pk, MD 20742 USA.
   Univ Maryland, Dept Chem & Biomol Engn, College Pk, MD 20742 USA.
   US FDA, Pathol Branch, Ctr Food Safety & Appl Nutr, College Pk, MD 20740 USA.
RP Fisher, JP (reprint author), Univ Maryland, Fischell Dept Bioengn, 3238 Jeong H Kim Engn Bldg, College Pk, MD 20742 USA.
EM jpfisher@umd.edu
RI Fisher, John/F-8078-2012
CR Blunk T, 2002, TISSUE ENG, V8, P73, DOI 10.1089/107632702753503072
   Bunn RC, 2003, TRENDS ENDOCRIN MET, V14, P176, DOI 10.1016/S1043-2760(03)00049-3
   Claeys I, 2002, PEPTIDES, V23, P807, DOI 10.1016/S0196-9781(01)00666-0
   Dupont Joelle, 2003, Birth Defects Research, V69, P257, DOI 10.1002/bdrc.10022
   Elisseeff JH, 2002, ANN NY ACAD SCI, V961, P118, DOI 10.1111/j.1749-6632.2002.tb03062.x
   Fisher JP, 2004, J BIOMED MATER RES A, V71A, P268, DOI 10.1002/jbm.a.30148
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901
   Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P564, DOI 10.1053/joca.2002.0814
   Lin Z, 2006, TISSUE ENG, V12, P1971, DOI 10.1089/ten.2006.12.1971
   Loeser RF, 2005, ARTHRITIS RHEUM, V52, P3910, DOI 10.1002/art.21472
   MCQUILLAN DJ, 1986, BIOCHEM J, V240, P423, DOI 10.1042/bj2400423
   Murphy CL, 2001, TISSUE ENG, V7, P791, DOI 10.1089/107632701753337735
   Randolph MA, 2003, CLIN PLAST SURG, V30, P519, DOI 10.1016/S0094-1298(03)00070-1
   SCHALKWIJK J, 1989, ARTHRITIS RHEUM, V32, P66, DOI 10.1002/anr.1780320111
   Ulrich-Vinther Michael, 2003, J Am Acad Orthop Surg, V11, P421
   VACANTI CA, 1991, PLAST RECONSTR SURG, V88, P753, DOI 10.1097/00006534-199111000-00001
   van Susante JLC, 2000, J ORTHOP RES, V18, P68, DOI 10.1002/jor.1100180111
   Woodfield TBF, 2002, CRIT REV EUKAR GENE, V12, P209, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i3.40
   Yasuda A, 2006, TISSUE ENG, V12, P1237, DOI 10.1089/ten.2006.12.1237
   Yoon D.M., 2006, POLYM SCAFFOLDS TISS
   YOON DM, 2006, CHONDROCYTE SIGNALIN
NR 23
TC 30
Z9 32
U1 0
U2 7
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 2
BP 299
EP 306
DI 10.1016/j.biomaterials.2006.08.039
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 109LV
UT WOS:000242310500017
PM 16982090
DA 2018-10-19
ER

PT J
AU Harrison, BS
   Atala, A
AF Harrison, Benjamin S.
   Atala, Anthony
TI Carbon nanotube applications for tissue engineering
SO BIOMATERIALS
LA English
DT Review
DE carbon nanotubes; nanocomposite; biosensor; gene transfer; scaffold
ID MRI CONTRAST AGENTS; OPTICAL SENSORS; QUANTUM DOTS; GENE-THERAPY;
   SINGLE; CELLS; FUNCTIONALIZATION; NANOPARTICLES; PURIFICATION;
   TRANSPORTERS
AB As the field of tissue engineering advances, new tools for better monitoring and evaluating of engineered tissues along with new biomaterials to direct tissue growth are needed. Carbon nanotubes may be an important tissue engineering material for improved tracking of cells, sensing of microenvironments, delivering of transfection agents, and scaffolding for incorporating with the host's body. Using carbon nanotubes for optical, magnetic resonance and radiotracer contrast agents would provide better means of evaluating tissue formation. In addition, monitoring and altering intra and intercellular processes would be useful for design of better engineered tissues. Carbon nanotubes can also be incorporated into scaffolds providing structural reinforcement as well as imparting novel properties such as electrical conductivity into the scaffolds may aid in directing cell growth. Potential cytotoxic effects associated with carbon nanotubes may be mitigated by chemically functionalizing the surface. Overall, carbon nanotubes may play an integral role as unique biomaterial for creating and monitoring engineered tissue. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Wake Forest Univ, Wake Forest Inst Regenerat Med, Winston Salem, NC 27157 USA.
RP Harrison, BS (reprint author), Wake Forest Univ, Wake Forest Inst Regenerat Med, Med Ctr Blvd, Winston Salem, NC 27157 USA.
EM bharriso@wfubmc.edu
OI Atala, Anthony/0000-0001-8186-2160
CR Andrews R, 2001, CARBON, V39, P1681, DOI 10.1016/S0008-6223(00)00301-8
   Ayutsede J, 2006, BIOMACROMOLECULES, V7, P208, DOI 10.1021/bm0505888
   Ballou B, 2004, BIOCONJUGATE CHEM, V15, P79, DOI 10.1021/bc034153y
   Barone PW, 2005, NAT MATER, V4, P86, DOI 10.1038/nmat1276
   Besteman K, 2003, NANO LETT, V3, P727, DOI 10.1021/nl034139u
   Bolskar RD, 2003, J AM CHEM SOC, V125, P5471, DOI 10.1021/ja03400984
   Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141
   Bulte JWM, 1999, P NATL ACAD SCI USA, V96, P15256, DOI 10.1073/pnas.96.26.15256
   Cassell AM, 1999, J PHYS CHEM B, V103, P6484, DOI 10.1021/jp990957sCCC:$18.00
   Chattopadhyay D, 2002, CARBON, V40, P985, DOI 10.1016/S0008-6223(01)00234-2
   Chen RJ, 2004, J AM CHEM SOC, V126, P1563, DOI 10.1021/ja038702m
   Chen RJ, 2003, P NATL ACAD SCI USA, V100, P4984, DOI 10.1073/pnas.0837064100
   Cherukuri P, 2004, J AM CHEM SOC, V126, P15638, DOI 10.1021/ja0466311
   Correa-Duarte MA, 2004, NANO LETT, V4, P2233, DOI 10.1021/nl048574f
   Denis MC, 2004, P NATL ACAD SCI USA, V101, P12634, DOI 10.1073/pnas.040437101
   DILLON A, 1999, ADV MATER, V16, P1354
   Ding LH, 2005, NANO LETT, V5, P2448, DOI 10.1021/nl051748o
   GABAY T, 2005, PHYSICA A, V250, P611
   Gao XH, 2004, NAT BIOTECHNOL, V22, P969, DOI 10.1038/nbt994
   GUPTAA AK, 2005, BIOMATERIALS, V26, P3559
   Heller DA, 2005, ADV MATER, V17, P2793, DOI 10.1002/adma.200500477
   Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d
   Huczko A, 2001, FULLERENE SCI TECHN, V9, P247, DOI 10.1081/FST-100102972
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Jia G, 2005, ENVIRON SCI TECHNOL, V39, P1378, DOI 10.1021/es048729l
   Joseph S, 2003, NANO LETT, V3, P1399, DOI 10.1021/nl0346326
   Journet C, 1997, NATURE, V388, P756, DOI 10.1038/41972
   Jung HI, 2004, BIOCONJUGATE CHEM, V15, P983, DOI 10.1021/bc049899q
   Kaempgen M, 2006, J ELECTROANAL CHEM, V586, P72, DOI 10.1016/j.jelechem.2005.09.009
   Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059
   Kam NWS, 2005, J AM CHEM SOC, V127, P12492, DOI 10.1021/ja053962k
   Kam NWS, 2005, P NATL ACAD SCI USA, V102, P11600, DOI 10.1073/pnas.0502680102
   Lovat V, 2005, NANO LETT, V5, P1107, DOI 10.1021/nl050637m
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   Manna SK, 2005, NANO LETT, V5, P1676, DOI 10.1021/nl0507966
   Martin CR, 2003, NAT REV DRUG DISCOV, V2, P29, DOI 10.1038/nrd988
   Maynard AD, 2004, J TOXICOL ENV HEAL A, V67, P87, DOI 10.1080/15287390490253688
   Mornet S, 2004, J MATER CHEM, V14, P2161, DOI 10.1039/b402025a
   Nimmagadda A, 2006, J BIOMED MATER RES A, V76A, P614, DOI 10.1002/jbm.a.30577
   Ostuni E, 2001, LANGMUIR, V17, P6336, DOI 10.1021/la010552a
   Radosavljevic M, 2002, NANO LETT, V2, P761, DOI 10.1021/nl025584c
   Reynolds CH, 2000, J AM CHEM SOC, V122, P8940, DOI 10.1021/ja001426g
   Rochette JF, 2005, ANAL BIOCHEM, V336, P305, DOI 10.1016/j.ab.2004.10.027
   Schellenberger EA, 2004, CHEMBIOCHEM, V5, P275, DOI 10.1002/cbic.200300713
   Schmieder AH, 2005, MAGN RESON MED, V53, P621, DOI 10.1002/mrm.20391
   Shi DL, 2006, ADV MATER, V18, P189, DOI 10.1002/adma.200501680
   Shvedova AA, 2003, J TOXICOL ENV HEAL A, V66, P1909, DOI 10.1080/15287390390231566
   Singh R, 2005, J AM CHEM SOC, V127, P4388, DOI 10.1021/ja0441561
   Singh R, 2006, P NATL ACAD SCI USA, V103, P3357, DOI 10.1073/pnas.0509009103
   Sitharaman B, 2005, CHEM COMMUN, P3915, DOI 10.1039/b504435a
   SORKIN R, 2006, J NEURAL ENG, V3, P1
   Strong KL, 2003, CARBON, V41, P1477, DOI 10.1016/S0008-6223(03)00014-9
   Supronowicz PR, 2002, J BIOMED MATER RES, V59, P499, DOI 10.1002/jbm.10015
   Tan XC, 2005, ANAL BIOCHEM, V337, P111, DOI 10.1016/j.ab.2004.10.040
   Thess A., 1996, SCIENCE, V273, P5274
   Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066
   Toth E, 2005, J AM CHEM SOC, V127, P799, DOI 10.1021/ja044688h
   Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410
   Wang SF, 2005, BIOMACROMOLECULES, V6, P3067, DOI 10.1021/bm050378v
   Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228
   Winter PM, 2003, CIRCULATION, V108, P2270, DOI 10.1161/01.CIR.0000093185.16083.95
   Xian YZ, 2005, J CHROMATOGR B, V817, P239, DOI 10.1016/j.jchromb.2004.12.014
   Yokoyama A, 2005, NANO LETT, V5, P157, DOI 10.1021/nl0484752
   Zhao B, 2005, CHEM MATER, V17, P3235, DOI 10.1021/cm0500399
   Zhao M, 2001, NAT MED, V7, P1241, DOI 10.1038/nm1101-1241
NR 65
TC 634
Z9 647
U1 12
U2 263
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 2
BP 344
EP 353
DI 10.1016/j.biomaterials.2006.07.044
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 109LV
UT WOS:000242310500022
PM 16934866
DA 2018-10-19
ER

PT J
AU Schmidt, DR
   Kao, WJ
AF Schmidt, David Richard
   Kao, Weiyuan John
TI The interrelated role of fibronectin and interleukin-1 in
   biomaterial-modulated macrophage function
SO BIOMATERIALS
LA English
DT Review
DE monocyte; alveolar macrophage; tyrosine phosphorylation; inflammation;
   RGD; PHSRN; cytokine
ID TUMOR-NECROSIS-FACTOR; EXTRACELLULAR-MATRIX PROTEINS; GROWTH-FACTOR
   PRODUCTION; FACTOR-ALPHA; ALVEOLAR MACROPHAGES; PROINFLAMMATORY
   CYTOKINES; ACTIVATED MONOCYTES; RECEPTOR ANTAGONIST;
   SIGNAL-TRANSDUCTION; INTEGRIN BINDING
AB Macrophages play a critical role in mediating the host response to biomaterials, perhaps most notably by guiding the host inflammatory response through the release of inflammatory molecules such as the cytokine interleukin-1 (IL-1). The extent of the macrophage response following interaction with the biomaterial surface contributes greatly to device efficacy, yet the molecular mechanisms of this interaction are still unclear. The extracellular matrix (ECM) protein fibronectin (FN) is recognized by macrophages and frequently used in biomaterial modification to elicit greater cellular adhesion and tissue integration. Macrophage interaction with FN and other ECM molecules on the biomaterial surface has been shown to induce a variety of inflammatory responses, thus both FN and IL-1 can be utilized as model molecules to better understand the mechanisms of material-mediated macrophage responses. This literature review presents a comprehensive survey of past and current research on the interrelated role of IL-1 FN, and FN-derivatives in determining biomaterial-modulated macrophage function. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA.
   Univ Wisconsin, Coll Engn, Dept Biomed Engn, Madison, WI 53705 USA.
RP Kao, WJ (reprint author), Univ Wisconsin, Sch Pharm, 777 Highland Ave, Madison, WI 53705 USA.
EM wjkao@pharmacy.wisc.edu
FU NIBIB NIH HHS [EB6613]; NHLBI NIH HHS [HL77825]
CR ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.immunol.2.1.283
   ALSUMIDAIE AM, 1986, J IMMUNOL METHODS, V91, P237, DOI 10.1016/0022-1759(86)90484-9
   Altroff H, 2001, J BIOL CHEM, V276, P38885, DOI 10.1074/jbc.M105868200
   ANDERSON JM, 1995, J BIOMAT SCI-POLYM E, V7, P159, DOI 10.1163/156856295X00670
   Anderson JM, 2004, BIOMATERIALS SCI INT, P296
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Arend WR, 2002, CYTOKINE GROWTH F R, V13, P323, DOI 10.1016/S1359-6101(02)00020-5
   Bailey LO, 2006, J BIOMED MATER RES A, V76A, P491, DOI 10.1002/jbm.a.30527
   Barilla ML, 2000, SEMIN ARTHRITIS RHEU, V29, P252, DOI 10.1016/S0049-0172(00)80012-8
   Barnes PJ, 2004, CELL MOL BIOL, V50, P627
   Bazan JF, 1996, NATURE, V379, P591, DOI 10.1038/379591a0
   BEEKHUIZEN H, 1993, J LEUKOCYTE BIOL, V54, P363
   BEEZHOLD DH, 1987, IMMUNOL INVEST, V16, P437, DOI 10.3109/08820138709087097
   Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   Bird S, 2002, CYTOKINE GROWTH F R, V13, P483, DOI 10.1016/S1359-6101(02)00028-X
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P837, DOI 10.1002/jbm.820260702
   BONFIELD TL, 1992, J BIOMED MATER RES, V26, P457, DOI 10.1002/jbm.820260404
   BORASCHI D, 1995, FRONT BIOSCI, V1, pD270
   BRUGGER W, 1991, INT IMMUNOL, V3, P221, DOI 10.1093/intimm/3.3.221
   CARR I, 1981, MANUAL MACROPHAGE ME, P187
   CHUNG A, 2006, IN PRESS BIOMATERIAL
   Delaleu N, 2004, PERIODONTOL 2000, V35, P42, DOI 10.1111/j.0906-6713.2004.003569.x
   DEVLIN RB, 1994, AM J PHYSIOL, V266, P612
   DINARELLO CA, 1991, J INFECT DIS, V163, P1177, DOI 10.1093/infdis/163.6.1177
   Dinarello CA, 1996, BLOOD, V87, P2095
   DRISCOLL KE, 1995, J TOXICOL ENV HEALTH, V46, P155, DOI 10.1080/15287399509532026
   DRISCOLL KE, 1991, TOXICOL APPL PHARM, V111, P201, DOI 10.1016/0041-008X(91)90024-9
   DRISCOLL KE, 1991, TOXICOL PATHOL, V19, P398, DOI 10.1177/0192623391019004-108
   ERICKSON C, 1989, CLIN IMMUNOLOGY, P27
   FFRENCHCONSTANT C, 1995, EXP CELL RES, V221, P261, DOI 10.1006/excr.1995.1374
   Furth R, 1988, INFLAMMATION BASIC P, P281
   GAO Q, 2006, IN PRESS TISSUE ENG
   Graves KL, 1996, AM J PHYSIOL-LUNG C, V271, pL61
   Gretzer C, 1996, BIOMATERIALS, V17, P851, DOI 10.1016/0142-9612(96)83279-0
   Gwinn MR, 2006, J TOXICOL ENV HEAL B, V9, P27, DOI 10.1080/15287390500196081
   HAZUDA DJ, 1988, J BIOL CHEM, V263, P8473
   Henderson RF, 2005, EXP TOXICOL PATHOL, V57, P155, DOI 10.1016/j.etp.2005.05.004
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hojo K, 2001, BIOORG MED CHEM LETT, V11, P1429, DOI 10.1016/S0960-894X(01)00225-6
   HUAUX F, 1995, TOXICOL APPL PHARM, V132, P53, DOI 10.1006/taap.1995.1086
   Hynes RO, 1999, P NATL ACAD SCI USA, V96, P2588, DOI 10.1073/pnas.96.6.2588
   Kao WJ, 2001, FRONT BIOSCI, V6, pD992, DOI 10.2741/Kao
   KAO WJ, 2001, J CONTROL RELEASE, V78, P219
   KAO WJ, 1998, BIOTECHNOL BIOENG, V59
   Kosmehl H, 1996, VIRCHOWS ARCH, V429, P311
   Labat-Robert J, 2002, SEMIN CANCER BIOL, V12, P187, DOI 10.1016/S1044-579X(02)00022-6
   Levine JS, 1998, J AUTOIMMUN, V11, P141, DOI 10.1006/jaut.1997.0182
   LIN TH, 1994, J CELL BIOL, V126, P1585, DOI 10.1083/jcb.126.6.1585
   LIN TH, 1995, J BIOL CHEM, V270, P16179
   Liu YP, 2002, CELL SIGNAL, V14, P145, DOI 10.1016/S0898-6568(01)00246-7
   LOPEZMORATALLA N, 1995, BBA-MOL CELL RES, V1265, P181, DOI 10.1016/0167-4889(94)00199-O
   MCCOLL SR, 1992, J EXP MED, V176, P593, DOI 10.1084/jem.176.2.593
   McNally AK, 1996, AM J PATHOL, V149, P975
   Murakami Y, 1996, INFECT IMMUN, V64, P2571
   Palsson BO, 2004, TISSUE ENG, P270
   Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059
   PEAT EB, 1995, IMMUNOLOGY, V84, P440
   PENDINO KJ, 1994, AM J RESP CELL MOL, V11, P279, DOI 10.1165/ajrcmb.11.3.8086166
   PEREZARELLANO JL, 1990, ALLERGOL IMMUNOPATH, V18, P175
   Romberger DJ, 1997, INT J BIOCHEM CELL B, V29, P939, DOI 10.1016/S1357-2725(96)00172-0
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Schiffer R, 1999, PATHOBIOLOGY, V67, P233, DOI 10.1159/000028099
   SCHWARTZ DA, 1993, AM REV RESPIR DIS, V148, P68, DOI 10.1164/ajrccm/148.1.68
   Simms H, 1996, J IMMUNOL, V157, P3605
   Simms HH, 1997, ANN SURG, V225, P757, DOI 10.1097/00000658-199706000-00013
   STANDIFORD TJ, 1991, AM J RESP CELL MOL, V5, P579, DOI 10.1165/ajrcmb/5.6.579
   TAKEMURA R, 1984, AM PHYSL SOC, pC1
   THOMPSON PN, 1992, AM J PHYSIOL, V263, pG437
   Wang ACC, 2001, INFLAMM RES, V50, P142, DOI 10.1007/s000110050738
   Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670
   Yamada KM, 2000, J CLIN INVEST, V105, P1507, DOI 10.1172/JCI10119
   YAMADA KM, 2001, J CELL PHYSL, V189, P1
   Yamaguchi Y, 2001, J DERMATOL, V28, P521, DOI 10.1111/j.1346-8138.2001.tb00025.x
   YUROCHKO AD, 1992, P NATL ACAD SCI USA, V89, P9034, DOI 10.1073/pnas.89.19.9034
   ZHANG Y, 1993, J IMMUNOL, V150, P4188
   Zhu P, 1998, BIOCHEM J, V330, P975, DOI 10.1042/bj3300975
   Zuckerman ST, 2006, BIOMATERIALS, V27, P3745, DOI 10.1016/j.biomaterials.2006.02.028
   ZUCKERMAN ST, 2006, UNPUB J BIOMEDICAL M
NR 78
TC 42
Z9 44
U1 4
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 3
BP 371
EP 382
DI 10.1016/j.biomaterials.2006.08.041
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 118SB
UT WOS:000242960900001
PM 16978691
DA 2018-10-19
ER

PT J
AU Sawyer, AA
   Hennessy, KM
   Bellis, SL
AF Sawyer, Amber A.
   Hennessy, Kristin M.
   Bellis, Susan L.
TI The effect of adsorbed serum proteins, RGD and proteoglycan-binding
   peptides on the adhesion of mesenchymal stem cells to hydroxyapatite
SO BIOMATERIALS
LA English
DT Article
DE cell adhesion; hydroxyapatite; mesenchymal stem cell; protein
   adsorption; RGD peptide; bone
ID OSTEOBLAST ADHESION; SYNTHETIC PEPTIDE; HUMAN BONE; CYTOSKELETAL
   ORGANIZATION; IN-VITRO; FIBRONECTIN; ATTACHMENT; BIOMATERIALS; DOMAIN;
   SURFACES
AB Prior studies from our laboratory have shown that RGD peptides increase the attachment of mesenchymal stem cells (MSCs) to hydroxyapatite (HA), however, RGD does not induce cell spreading when coupled to this type of biomaterial. In all effort to improve MSC spreading, and possibly cell attachment, proteoglycan-binding peptides (KRSR or FHRRIKA) were combined with RGD in the current study. It was found that the peptide combinations did not enhance MSC attachment relative to RGD alone, although a slight amount of spreading was elicited by both KRSR and FHRRIKA. Similar results were obtained with proteoglycan-binding peptides modified with a heptaglutamate domain, a motif that improves peptide tethering to HA. To determine whether differentiation status affected cell responses, MSCs were in vitro differentiated into osteoblasts, and evaluated as before. These experiments revealed that, like MSCs, osteoblasts did not adhere in greater numbers to the peptide combinations. Finally, none of the peptides or peptide combinations were able to stimulate the robust amount of cell adhesion and spreading elicited by serum-coated HA surfaces (of note, five different species of serum were tested). Given the propensity of HA to adsorb proadhesive proteins from blood/serum, we question the utility of functionalizing HA with RGD and/or proteoglycan-binding peptides. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Alabama, Dept Physiol & Biophys, MCLM, Birmingham, AL 35294 USA.
   Univ Alabama, Dept Biomed Engn, Birmingham, AL 35294 USA.
RP Bellis, SL (reprint author), Univ Alabama, Dept Physiol & Biophys, MCLM, Rm 982A,1918 Univ Blvd, Birmingham, AL 35294 USA.
EM bellis@physiology.uab.edu
FU NIAMS NIH HHS [AR51539]
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   AOTA S, 1991, J BIOL CHEM, V266, P15938
   Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21
   Couchman JR, 1999, J CELL SCI, V112, P3415
   DALTON BA, 1995, J CELL SCI, V108, P2083
   Dee KC, 1998, J BIOMED MATER RES, V40, P371, DOI 10.1002/(SICI)1097-4636(19980605)40:3<371::AID-JBM5>3.0.CO;2-C
   Dettin M, 2002, J BIOMED MATER RES, V60, P466, DOI 10.1002/jbm.10066
   Dettin M, 2005, BIOMATERIALS, V26, P4507, DOI 10.1016/j.biomaterials.2004.11.023
   Durrieu MC, 2004, J MATER SCI-MATER M, V15, P779, DOI 10.1023/B:JMSM.0000032818.09569.d9
   Fujisawa R, 1997, MATRIX BIOL, V16, P21, DOI 10.1016/S0945-053X(97)90113-X
   Garcia AJ, 2002, CRIT REV EUKAR GENE, V12, P151, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i2.50
   Gilbert M, 2003, J BIOMED MATER RES A, V67A, P69, DOI 10.1002/jbm.a.10053
   Gilbert M, 2000, J BIOL CHEM, V275, P16213, DOI 10.1074/jbc.M001773200
   GRZESIK WJ, 1994, J BONE MINER RES, V9, P487, DOI 10.1002/jbmr.5650090408
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   HOWLETT CR, 1994, BIOMATERIALS, V15, P213, DOI 10.1016/0142-9612(94)90070-1
   Itoh D, 2002, J BIOMED MATER RES, V62, P292, DOI 10.1002/jbm.10338
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Kilpadi KL, 2004, J BIOMED MATER RES A, V68A, P273, DOI 10.1002/jbm.a.20043
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   PEARSON BS, 1988, J DENT RES, V67, P515, DOI 10.1177/00220345880670021701
   PULEO DA, 1991, BONE, V12, P271, DOI 10.1016/8756-3282(91)90075-T
   RABINOVITCH PS, 1993, ANN NY ACAD SCI, V677, P252, DOI 10.1111/j.1749-6632.1993.tb38782.x
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Sagnella S, 2005, TISSUE ENG, V11, P226, DOI 10.1089/ten.2005.11.226
   Sawyer AA, 2005, BIOMATERIALS, V26, P1467, DOI 10.1016/j.biomaterials.2004.05.008
   Sawyer AA, 2005, BIOMATERIALS, V26, P7046, DOI 10.1016/j.biomaterials.2005.05.006
   Schvartz I, 1999, INT J BIOCHEM CELL B, V31, P539, DOI 10.1016/S1357-2725(99)00005-9
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   STEELE JG, 1993, J BIOMAT SCI-POLYM E, V5, P245
   Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1
   WOODS A, 1993, MOL BIOL CELL, V4, P605
   WOODS A, 1986, EMBO J, V5, P665, DOI 10.1002/j.1460-2075.1986.tb04265.x
NR 34
TC 85
Z9 87
U1 1
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JAN
PY 2007
VL 28
IS 3
BP 383
EP 392
DI 10.1016/j.biomaterials.2006.08.031
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 118SB
UT WOS:000242960900002
PM 16952395
DA 2018-10-19
ER

PT J
AU Nomizu, M
   Yamagata, N
   Mochizuki, M
   Kikkawa, Y
   Kadoya, Y
AF Nomizu, M.
   Yamagata, N.
   Mochizuki, M.
   Kikkawa, Y.
   Kadoya, Y.
TI Peptide-chitosan matrix: a new multifunctional biomaterial
SO BIOPOLYMERS
LA English
DT Meeting Abstract
CT 20th American-Peptide-Society Symposium
CY JUN 26-30, 2007
CL Montreal, CANADA
SP Amer Peptide Soc
C1 Tokyo Univ Pharm & Life Sci, Hachioji, Tokyo 1920392, Japan.
   Kitasato Univ, Sch Med, Sagamihara, Kanagawa 2288555, Japan.
NR 0
TC 0
Z9 0
U1 1
U2 2
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3525
J9 BIOPOLYMERS
JI Biopolymers
PY 2007
VL 88
IS 4
SI SI
BP 518
EP 518
PG 1
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 181GT
UT WOS:000247425900020
DA 2018-10-19
ER

PT J
AU Kidane, AG
   Edirisinghe, MJ
   Bonhoeffer, P
   Seifalian, AM
AF Kidane, Asmeret G.
   Edirisinghe, Mohan J.
   Bonhoeffer, Philipp
   Seifalian, Alexander M.
TI Flow behaviour of a POSS biopolymer solution
SO BIORHEOLOGY
LA English
DT Article
DE biomaterial; biopolymer; solution; viscosity; flow behaviour;
   nanocomposite
ID POLYHEDRAL OLIGOMERIC SILSESQUIOXANE; IN-VITRO; NANOCOMPOSITE;
   POLYURETHANES; POLYMERS; IMPLANTS
AB A non-biodegradable polyhedral oligomeric silsesquioxane (POSS) nanocomposite biopolymer has been developed for fabrication of medical devices and for tissue engineering human organs. The polymer in solution, containing 2 wt% of POSS, has been synthesized, characterized and investigated to determine its key rheological properties. Thus, the variation of shear stress and viscosity as a function of shear rate has been determined at ambient temperature to estimate yield stress and the index of pseudoplasticity, respectively. The temperature dependence of viscosity and the effect of ageing on the viscosity of the polymer have also been investigated. Results are compared with those of a conventional polycarbonate urethane (PCU) polymer solution. The POSS-PCU polymer solution shows near-Newtonian behaviour in the shear rate range to 1000 s(-1), having an apparent viscosity of similar to 3000 mPa s and a pseudoplasticity index of 0.90, decreasing slightly as the polymer solution is aged over 9 months. The temperature dependence of viscosity of the POSS polymer is extremely low and does not change with ageing but the yield strength increases from 2.7 Pa to 8.3 Pa.
C1 [Edirisinghe, Mohan J.] UCL, Dept Mech Engn, London WC1E 7JE, England.
   [Kidane, Asmeret G.; Seifalian, Alexander M.] UCL, BTEC, Acad Div Surg & Intervent Sci, London, England.
   [Bonhoeffer, Philipp] Great Ormond St Hosp Sick Children, London WC1N 3JH, England.
   [Bonhoeffer, Philipp] Inst Child Hlth, London, England.
RP Edirisinghe, MJ (reprint author), UCL, Dept Mech Engn, Torrington Pl, London WC1E 7JE, England.
EM m.edirisinghe@ucl.ac.uk
RI Seifalian, Alexander/I-6028-2013
OI Seifalian, Alexander/0000-0002-1180-3322
CR EDIRISINGHE MJ, 1987, BRIT CERAM TRANS J, V86, P18
   Fina A, 2006, POLYM DEGRAD STABIL, V91, P2275, DOI 10.1016/j.polymdegradstab.2006.04.014
   Gupta A, 2007, J BIOACT COMPAT POL, V22, P265, DOI 10.1177/0883911507078268
   Kannan RY, 2007, PLAST RECONSTR SURG, V119, P1653, DOI 10.1097/01.prs.0000246404.53831.4c
   Kannan RY, 2006, CELL BIOCHEM BIOPHYS, V45, P129, DOI 10.1385/CBB:45:2:129
   Kannan RY, 2006, BIOMATERIALS, V27, P4618, DOI 10.1016/j.biomaterials.2006.04.024
   Kannan RY, 2006, BIOMACROMOLECULES, V7, P215, DOI 10.1021/bm050590z
   Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006
   Li GZ, 2001, J INORG ORGANOMET P, V11, P123, DOI 10.1023/A:1015287910502
   Liu YH, 2006, MACROMOL CHEM PHYSIC, V207, P1842, DOI 10.1002/macp.200600241
   Lligadas G, 2006, BIOMACROMOLECULES, V7, P3521, DOI 10.1021/bm060703u
   Ni Y, 2004, POLYMER, V45, P5557, DOI 10.1016/j.polymer.2004.06.008
   Petro M, 2004, MACROMOL RAPID COMM, V25, P178, DOI 10.1002/marc.200300229
   Pielichowski K, 2006, ADV POLYM SCI, V201, P225, DOI 10.1007/12_077
   Pu KY, 2006, PROG CHEM, V18, P609
   Santerre JP, 2005, BIOMATERIALS, V26, P7457, DOI 10.1016/j.biomaterials.2005.05.079
   Seifalian AM, 2005, Patent, Patent No. [WO2005070998, 2005070998]
NR 17
TC 7
Z9 7
U1 0
U2 3
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 0006-355X
EI 1878-5034
J9 BIORHEOLOGY
JI Biorheology
PY 2007
VL 44
IS 4
BP 265
EP 272
PG 8
WC Biophysics; Engineering, Biomedical; Hematology
SC Biophysics; Engineering; Hematology
GA 254TN
UT WOS:000252611000003
PM 18094450
DA 2018-10-19
ER

PT J
AU Sieminski, AL
   Was, AS
   Kim, G
   Gong, H
   Kamm, RD
AF Sieminski, A. L.
   Was, A. S.
   Kim, G.
   Gong, H.
   Kamm, R. D.
TI The stiffness of three-dimensional ionic self-assembling peptide gels
   affects the extent of capillary-like network formation
SO CELL BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Article
DE capillary morphogenesis; endothelial cell; biomaterial; self assembly;
   mechanical properties; adhesion
ID ENDOTHELIAL-CELLS; IN-VITRO; MECHANICAL-PROPERTIES; COMPLEMENTARY
   OLIGOPEPTIDE; EXTRACELLULAR MATRICES; LUMEN FORMATION; NONPARENCHYMAL
   CELLS; FIBRIN MATRICES; COLLAGEN GELS; ANGIOGENESIS
AB Improving our ability to control capillary morphogenesis has implications for not only better understanding of basic biology, but also for applications in tissue engineering and in vitro testing. Numerous biomaterials have been investigated as cellular supports for these applications and the biophysical environment biomaterials provide to cells has been increasingly recognized as an important factor in directing cell function. Here, the ability of ionic self-assembling peptide gels to support capillary morphogenesis and the effect of their mechanical properties is investigated. When placed in a physiological salt solution, these oligo-peptides spontaneously self-assemble into gels with an extracellular matrix (ECM)-like microarchitecture. To evaluate the ability of three-dimensional (3D) self-assembled peptide gels to support capillary-like network formation, human umbilical vein endothelial cells (HUVECs) were embedded within RAD16-I ((RADA)4) or RAD16-II ((RARADADA)2) peptide gels with various stiffness values. As peptide stiffness is decreased cells show increased elongation and are increasingly able to contract gels. The observation that capillary morphogenesis is favored in more malleable substrates is consistent with previous reports using natural biomaterials. The structural properties of peptide gels and their ability to support capillary morphogenesis in vitro make them promising biomaterials to investigate for numerous biomedical applications.
C1 MIT, Dept Biol Engn, Cambridge, MA 02139 USA.
   MIT, Dept Mech Engn, Cambridge, MA 02139 USA.
   Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA.
RP Sieminski, AL (reprint author), Franklin W Olin Coll Engn, Needham, MA 02492 USA.
EM alisha.sieminski@olin.edu
OI /0000-0002-7232-304X; Gong, Haiyan/0000-0002-7204-5019
FU NIBIB NIH HHS [R01 EB003805, R01-EB003805]
CR Bayless KJ, 2000, AM J PATHOL, V156, P1673, DOI 10.1016/S0002-9440(10)65038-9
   Bhatia SN, 1999, FASEB J, V13, P1883
   Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478
   Davis GE, 1996, EXP CELL RES, V224, P39, DOI 10.1006/excr.1996.0109
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Egginton S, 2003, MICROCIRCULATION, V10, P45, DOI 10.1038/sj.mn.7800174
   Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5
   Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Gibson L. G., 1997, CELLULAR SOLIDS STRU
   Gobin AS, 2002, FASEB J, V16, P751, DOI 10.1096/fj.01-0759fje
   GONG H, 2002, EXPT EYE RES, V75, P374
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Holder WD, 1997, TISSUE ENG, V3, P149, DOI 10.1089/ten.1997.3.149
   Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728
   Holmes TC, 2002, TRENDS BIOTECHNOL, V20, P16, DOI 10.1016/S0167-7799(01)01840-6
   INGBER DE, 1989, J CELL BIOL, V109, P317, DOI 10.1083/jcb.109.1.317
   Kaihara S, 2000, J PEDIATR SURG, V35, P1287, DOI 10.1053/jpsu.2000.9298
   Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923
   KANZAWA S, 1993, ANN PLAS SURG, V30, P244, DOI 10.1097/00000637-199303000-00008
   Knapp DM, 1999, AICHE J, V45, P2628, DOI 10.1002/aic.690451219
   Korff T, 1999, J CELL SCI, V112, P3249
   Lafleur MA, 2002, J CELL SCI, V115, P3427
   Leon EJ, 1998, J BIOMAT SCI-POLYM E, V9, P297, DOI 10.1163/156856298X00668
   MADRI JA, 1988, J CELL BIOL, V106, P1375, DOI 10.1083/jcb.106.4.1375
   Narmoneva DA, 2004, CIRCULATION, V110, P962, DOI 10.1161/01.CIR.0000140667.37070.07
   Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005
   Nave BT, 2002, DRUG DISCOV TODAY, V7, P419, DOI 10.1016/S1359-6446(02)02212-2
   Nehls V, 1996, MICROVASC RES, V51, P347, DOI 10.1006/mvre.1996.0032
   Nor JE, 2001, LAB INVEST, V81, P453
   OPAS M, 1994, DEV BIOL, V161, P440, DOI 10.1006/dbio.1994.1043
   Ozerdem B, 1995, J BIOMECH ENG-T ASME, V117, P397, DOI 10.1115/1.2794198
   Park HJ, 2002, CIRC RES, V91, P143, DOI 10.1161/01.RES.0000028149.15986.4C
   Park J, 2006, BIOPHYS J, V90, P2510, DOI 10.1529/biophysj.105.074906
   Ponec M, 2002, ADV DRUG DELIVER REV, V54, pS19, DOI 10.1016/S0169-409X(02)00112-6
   Pratt AB, 2004, BIOTECHNOL BIOENG, V86, P27, DOI 10.1002/bit.10897
   Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904
   Satake S, 1998, BIOCHEM BIOPH RES CO, V244, P642, DOI 10.1006/bbrc.1998.8313
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Sieminski AL, 2005, TISSUE ENG, V11, P1332, DOI 10.1089/ten.2005.11.1332
   Sieminski AL, 2004, EXP CELL RES, V297, P574, DOI 10.1016/j.yexcr.2004.03.035
   Sieminski AL, 2002, TISSUE ENG, V8, P1057, DOI 10.1089/107632702320934155
   Sivaraman A, 2005, CURR DRUG METAB, V6, P569, DOI 10.2174/138920005774832632
   Urech L, 2005, BIOMATERIALS, V26, P1369, DOI 10.1016/j.biomaterials.2004.04.045
   Xin XH, 2001, AM J PATHOL, V158, P1111, DOI 10.1016/S0002-9440(10)64058-8
   Yang S, 1999, AM J PATHOL, V155, P887, DOI 10.1016/S0002-9440(10)65188-7
   ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508
   ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334
   ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y
NR 50
TC 74
Z9 74
U1 2
U2 39
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 1085-9195
J9 CELL BIOCHEM BIOPHYS
JI Cell Biochem. Biophys.
PY 2007
VL 49
IS 2
BP 73
EP 83
DI 10.1007/s12013-007-0046-1
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 216DT
UT WOS:000249859100002
PM 17906362
DA 2018-10-19
ER

PT B
AU Zghoul, N
   van Griensven, M
   Zeichen, J
   Dittmar, KEJ
   Rohde, M
   Jager, V
AF Zghoul, Nadla
   van Griensven, Martijn
   Zeichen, Johannes
   Dittmar, Kurt E. J.
   Rohde, Manfred
   Jaeger, Volker
BE Smith, R
TI In vitro bone formation of multipotential human mesenchymal cells in
   fixed bed perfusion bioreactors
SO CELL TECHNOLOGY FOR CELL PRODUCTS
LA English
DT Proceedings Paper
CT 19th Meeting of the European-Society-for-Animal-Cell-Technology (ESACT)
CY JUN 05-08, 2005
CL Harrogate, ENGLAND
SP European Soc Anim Cell Technol
DE tissue engineering; trabecular bene; bone marrow; biomaterial;
   bioreactor; flow cytometry; adipogenesis; osteogenesis
ID STEM-CELLS
AB The objective of this study was to characterize growth and differentiation of human bone marrow-derived mesenchymal cells and trabecular bone-derived cells regarding their expansion and their multipotential capacity as well as their ability, to eventually form bone tissue in vitro in combination with a PLGA/CaP scaffold.
C1 [Zghoul, Nadla; Dittmar, Kurt E. J.; Rohde, Manfred; Jaeger, Volker] German Res Ctr Biotechnol, Mascheroder Weg 1, D-38124 Braunschweig, Germany.
   [van Griensven, Martijn] Ludwig Boltzmann Inst Exp & Clinic Traumatol, Vienna, Austria.
   [Zeichen, Johannes] Hannover Med Sch, D-30625 Hannover, Germany.
RP Zghoul, N (reprint author), German Res Ctr Biotechnol, Mascheroder Weg 1, D-38124 Braunschweig, Germany.
EM vja@gbf.de
RI van Griensven, Martijn/F-5808-2012
OI van Griensven, Martijn/0000-0001-5104-9881
CR Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001
   Barthold M, 2005, Animal Cell Technology Meets Genomics, P199
   Dragoo JL, 2003, J BONE JOINT SURG BR, V85B, P740, DOI 10.1302/0301-620X.85B5.13587
NR 3
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013, UNITED STATES
BN 978-1-4020-5475-4
PY 2007
BP 343
EP +
DI 10.1007/978-1-4020-5476-1_56
PG 2
WC Biotechnology & Applied Microbiology; Cell Biology
SC Biotechnology & Applied Microbiology; Cell Biology
GA BGB45
UT WOS:000245916900056
DA 2018-10-19
ER

PT J
AU Ramsden, JJ
   Allen, DM
   Stephenson, DJ
   Alcock, JR
   Peggs, GN
   Fuller, G
   Goch, G
AF Ramsden, J. J.
   Allen, D. M.
   Stephenson, D. J.
   Alcock, J. R.
   Peggs, G. N.
   Fuller, G.
   Goch, G.
TI The design and manufacture of biomedical surfaces
SO CIRP ANNALS-MANUFACTURING TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 57th General Assmbly of CIRP
CY AUG 19-25, 2007
CL Dresden, GERMANY
DE biomedical; surface; metrology
ID ATOMIC-FORCE MICROSCOPY; GUIDE LIGHTMODE SPECTROSCOPY; PROTEIN
   ADSORPTION-KINETICS; SCANNING PROBE MICROSCOPY; HIP-JOINT
   ENDOPROSTHESES; ION MASS-SPECTROMETRY; SOFT CONTACT-LENSES; MEDICAL
   DEVICES; IN-SITU; SOLID/LIQUID INTERFACE
AB Surfaces are the primary place of contact between a biomaterial and its host organism. Typically, prostheses have to fulfil demanding structural and mechanical requirements, yet the material best for those functions may be bio-incompatible. Surface treatment or coating provides a means to overcome that problem, which means both integration within the host physiology and stabilization with respect to corrosion and wear. The adsorption of biomacromolecules is pivotal for biocompatibility. The impossibility of keeping proteins away from most implants means that very careful consideration has to be given to this aspect, and both prevention (for bloodstream implants) and promotion (for bone replacement and repair) occur with equal importance. This paper also considers the metrology of relevant physical and chemical aspects of surfaces.
C1 [Ramsden, J. J.; Alcock, J. R.; Fuller, G.] Cranfield Univ, Cranfield MK43 0AL, Beds, England.
RP Ramsden, JJ (reprint author), Cranfield Univ, Cranfield MK43 0AL, Beds, England.
CR ADEMOVIC Z, 2005, SURFACES INTERFACES, P150
   ALLEN DM, 2004, ANN CIRP, V53, P559
   ALLEN DM, 1987, ELECTROCHEMICAL SOC, P685
   Aslanidis D, 2001, MATER SCI FORUM, V394-3, P169
   Belu AM, 2003, BIOMATERIALS, V24, P3635, DOI 10.1016/S0142-9612(03)00159-5
   BENNETT CA, 1982, APPL OPTICS, V21, P49, DOI 10.1364/AO.21.000049
   BERGER S, 2004, ENCY NANOSCIENCE NAN, V6, P1
   BHUYAN A, 2005, P IEEE C SENS IRV CA, P314, DOI DOI 10.1109/ICSENS.2005.1597699SENSORSIEEE
   BLACKWOOD DJ, 2004, ENG MAT BIOMEDICAL A, V3, P1
   Bottomley LA, 1998, ANAL CHEM, V70, p425R
   Bowsher JG, 2001, WEAR, V250, P167, DOI 10.1016/S0043-1648(01)00619-6
   Brizuela M, 2002, J MATER SCI-MATER M, V13, P1129, DOI 10.1023/A:1021129718737
   Brunette D. M., 2001, TITANIUM MED, P145
   Cacace MG, 1997, Q REV BIOPHYS, V30, P241, DOI 10.1017/S0033583597003363
   Calonder C, 2001, J PHYS CHEM B, V105, P725, DOI 10.1021/jp0024120
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chang E, 1997, J MATER SCI-MATER M, V8, P193, DOI 10.1023/A:1018583522322
   CHOWDHURY DF, 2007, P 7 EUSP INT C 20 24, V1, P49
   Clifford CA, 2006, NANOTECHNOLOGY, V17, P5283, DOI 10.1088/0957-4484/17/21/001
   Daniel S, 2006, MRS BULL, V31, P536, DOI 10.1557/mrs2006.139
   de Maeztu MA, 2003, CLIN ORAL IMPLAN RES, V14, P57, DOI 10.1034/j.1600-0501.2003.140108.x
   DECHIFFRE L, 2003, ANN CIRP, V52, P561
   DECHIFFRE L, 2000, ANN CIRP, V49, P635
   DICKINSON ME, 2005, MAT RES SOC P, V841
   Disegi JA, 1997, SO BIOMM ENGN CONF P, P129, DOI 10.1109/SBEC.1997.583231
   Donlan RM, 2001, EMERG INFECT DIS, V7, P277, DOI 10.3201/eid0702.010226
   Dornfeld D, 2006, CIRP ANN-MANUF TECHN, V55, P745, DOI 10.1016/j.cirp.2006.10.006
   Dowson D, 1986, Eng Med, V15, P63
   Dumitrascu N, 2005, IEEE T PLASMA SCI, V33, P1710, DOI 10.1109/TPS.2005.856335
   Durakbasa M. N., 2005, MEASUREMENT SCI REV, V5, P1
   Ebenstein DM, 2004, J MATER RES, V19, P273, DOI 10.1557/jmr.2004.0031
   Emerson RJ, 2006, LANGMUIR, V22, P11311, DOI 10.1021/la061984u
   EVANS CJ, 1999, ANN CIRP, V48, P2
   Ewald A, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-22
   Fang Y, 2006, ASSAY DRUG DEV TECHN, V4, P583, DOI 10.1089/adt.2006.4.583
   Fernandez A, 2003, BIOPHYS J, V85, P1914, DOI 10.1016/S0006-3495(03)74619-0
   FERNANDEZ A, 2003, P NATL ACAD SCI USA, V100, P6445
   Fernandez Ariel, 2001, Journal of Biological Physics and Chemistry, V1, P81, DOI 10.4024/12FE01L.01.02
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Fragneto-Cusani G, 2001, J PHYS-CONDENS MAT, V13, P4973, DOI 10.1088/0953-8984/13/21/322
   Frost MC, 2005, BIOMATERIALS, V26, P1685, DOI 10.1016/j.biomaterials.2004.06.006
   Fujisawa N, 1999, BIOMATERIALS, V20, P955, DOI 10.1016/S0142-9612(98)00251-8
   Furey MJ, 1997, LUBR SCI, V9, P255, DOI DOI 10.1002/IS.3010090303
   Gale MFR, 2004, J OPT A-PURE APPL OP, V6, P187, DOI 10.1088/1464-4258/6/2/006
   GAONA M, 2006, INT THERM SPRAY C 15
   GIGLIO M, 1979, OPT COMMUN, V28, P166, DOI 10.1016/0030-4018(79)90259-1
   GILL HS, 2006, AM I CHEM ENG C 16 N
   GITIS N, 2004, P TRIB2004 ASME STLE, P1
   Goch G, 2004, CIRP ANN-MANUF TECHN, V53, P471, DOI 10.1016/S0007-8506(07)60742-2
   Goch G, 1999, PRECIS ENG, V23, P9, DOI 10.1016/S0141-6359(98)00021-X
   GOCH G, 1999, P 1 C EUR SOC PREC E, V2, P479
   GOCH G, 1994, ANN CIRP, V43, P487
   Goodridge RD, 2006, P I MECH ENG H, V220, P57, DOI 10.1243/095441105X69051
   Grewe PH, 2002, MINIM INVASIV THER, V11, P157, DOI 10.1080/136457002760273368
   Grobe GL, 1996, J BIOMED MATER RES, V32, P45, DOI 10.1002/(SICI)1097-4636(199609)32:1<45::AID-JBM6>3.0.CO;2-P
   Groenendijk M, 2006, J LASER APPL, V18, P227, DOI 10.2351/1.2227020
   Guemouri L, 1998, J CHEM PHYS, V109, P3265, DOI 10.1063/1.476917
   Guipont V, 2002, MAT SCI ENG A-STRUCT, V325, P9, DOI 10.1016/S0921-5093(01)01414-9
   HAKIM RM, 1996, REPLACEMENT RENAL FU
   HEINZELMANN H, 1999, 3 INT WORKSH MOL REC
   HIDAKA K, 2006, ANN CIRP, V55, P567
   Hilal N, 2006, CHEM ENG RES DES, V84, P282, DOI 10.1205/cherd05053
   HILLMAN P, 1991, CASE NEW PARADIGMS C
   Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477
   HOCKEN RJ, 2005, ANN CIRP, V54, P705
   HOLLY FJ, 1994, ADV EXP MED BIOL, V350, P275
   Hook F, 2002, COLLOID SURFACE B, V24, P155, DOI 10.1016/S0927-7765(01)00236-3
   HOWELL JR, 2000, J BONE SURG B, V82, P52
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Hubler R, 1999, SURF COAT TECH, V116, P1111, DOI 10.1016/S0257-8972(99)00221-2
   Iwaki M., 1999, P C ION IMPL TECHN I, V2, P824
   Iwasaki Y, 2005, SURFACES INTERFACES, P389
   Jacobson A, 2003, TRIBOL LUBR TECHNOL, V59, P32
   JENA BP, 1999, PAPERS MICROSCOPY RE, V44
   Jiang XQ, 2001, WEAR, V250, P217, DOI 10.1016/S0043-1648(01)00644-5
   Jin ZM, 2005, P I MECH ENG J-J ENG, V219, P367, DOI 10.1243/135065005X33982
   Jin ZM, 2006, CURR ORTHOPAED, V20, P32, DOI 10.1016/j.cuor.2005.09.005
   Johansson B, 2006, SURF INTERFACE ANAL, V38, P1401, DOI 10.1002/sia.2361
   Kannan RY, 2006, J BIOMATER APPL, V21, P5, DOI 10.1177/0885328206065728
   Kasemo B, 1999, Adv Dent Res, V13, P8
   KOHL M, 1996, SPIE P, V2880, P108
   Kohles SS, 2004, INT J ORAL MAX IMPL, V19, P510
   Kruse D, 2006, P 9 INT C INFR SENS, P341
   Kurrat R, 1998, COLLOID SURFACE B, V11, P187, DOI 10.1016/S0927-7765(98)00039-3
   LANDIS FA, 2004, P IEEE INT S BIOM IM, V2, P1533
   Lang HP, 1999, ANAL CHIM ACTA, V393, P59, DOI 10.1016/S0003-2670(99)00283-4
   Larsson C, 1997, J MATER SCI-MATER M, V8, P721, DOI 10.1023/A:1018548225899
   Leadley SR, 1998, BIOMATERIALS, V19, P1353, DOI 10.1016/S0142-9612(97)00239-1
   Lehmann P, 2002, APPL OPTICS, V41, P2008, DOI 10.1364/AO.41.002008
   Lehmann P, 1999, APPL OPTICS, V38, P1144, DOI 10.1364/AO.38.001144
   Lehmann P, 1997, APPL OPTICS, V36, P2188, DOI 10.1364/AO.36.002188
   LEHMANN P, 2000, ANN CIRP, V49, P419
   Li DJ, 2002, B MATER SCI, V25, P7, DOI 10.1007/BF02704587
   LI SY, 1994, BIOTECHNOL PROGR, V10, P520, DOI 10.1021/bp00029a010
   LIU Q, 2002, SOFT SCI, V16, P75
   Liu X, 2004, MEAS SCI TECHNOL, V15, P91, DOI 10.1088/0957-0233/15/1/013
   LU JR, 2005, SURFACES INTERFACES, P299
   Luthi PO, 1997, PHYS REV E, V55, P3111, DOI 10.1103/PhysRevE.55.3111
   Lyman D, 2002, INTEGRATED BIOMATERIALS SCIENCE, P325, DOI 10.1007/0-306-47583-9_8
   Mamalis A. G., 2007, Journal of Biological Physics and Chemistry, V7, P3, DOI 10.4024/10701.jbpc.07.01
   Mamalis A. G., 2006, Journal of Biological Physics and Chemistry, V6, P113
   MANN AB, 2005, SURFACES INTERFACES, P225
   MARTANO W, 2005, THESIS GEORGIA I TEC
   Mathieu HJ, 2003, ADV POLYM SCI, V162, P1
   MAZUSAWA T, 2000, ANN CIRP, V49, P473
   McAllister DV, 2000, ANNU REV BIOMED ENG, V2, P289, DOI 10.1146/annurev.bioeng.2.1.289
   McArthur SL, 2006, SURF INTERFACE ANAL, V38, P1380, DOI 10.1002/sia.2498
   MCCOLL IR, 1993, DIAM RELAT MATER, V3, P83
   MCGUIRE GE, 1993, ANAL CHEM, V65, pR311
   McLucas E, 2006, ENDOTHELIUM-J ENDOTH, V13, P35, DOI 10.1080/10623320600660185
   Mentre Pascale, 2004, Journal of Biological Physics and Chemistry, V4, P115
   Merrett K, 2002, J BIOMAT SCI-POLYM E, V13, P593, DOI 10.1163/156856202320269111
   Michel R, 2006, SURF INTERFACE ANAL, V38, P1386, DOI 10.1002/sia.2382
   Moseler M, 2005, SCIENCE, V309, P1545, DOI 10.1126/science.1114577
   Narayana P, 2006, MAT SCI ENG A-STRUCT, V430, P79, DOI 10.1016/j.msea.2006.05.135
   NEMES C, 1999, PHYS REV E, V60, P1166
   Ning CY, 2006, J MATER SCI-MATER M, V17, P875, DOI 10.1007/s10856-006-0176-9
   NORDE W, 1991, Journal of Biomaterials Science Polymer Edition, V2, P183
   Ogilvy J. A., 1991, THEORY WAVE SCATTERI
   Ohashi Y, 2006, CLIN CHIM ACTA, V369, P17, DOI 10.1016/j.cca.2005.12.035
   Onate JI, 2001, SURF COAT TECH, V142, P1056, DOI 10.1016/S0257-8972(01)01074-X
   PATZELT S, 2004, INT OB CHEMN, V1, P214
   Patzelt S., 2006, 18 IMEKO WORLD C MET
   Paulsen F, 2006, INT REV CYTOL, V249, P229, DOI 10.1016/S0074-7696(06)49005-7
   Pelka A., 2001, Journal of Wide Bandgap Materials, V8, P189, DOI 10.1106/152451102024661
   Pierson H. O., 1999, HDB CHEM VAPOR DEPOS
   Piotter V, 1997, MICROSYST TECHNOL, V3, P129, DOI 10.1007/s005420050069
   PIOTTER V, 2005, INJ MOULD C 1 2 MARC
   Ponsonnet L, 2002, MAT SCI ENG C-BIO S, V21, P157, DOI 10.1016/S0928-4931(02)00097-8
   Prekel H, 2006, CIRP ANN-MANUF TECHN, V55, P585, DOI 10.1016/S0007-8506(07)60488-0
   Prekel H, 2003, REV SCI INSTRUM, V74, P670, DOI 10.1063/1.1512770
   Ramsden J. J., 1998, BIOPOLYMERS INTERFAC, P321
   Ramsden J. J., 2006, PROTEINS SOLID LIQUI, P23
   Ramsden J.J., 2002, ENCY SURFACE COLLOID, P240
   Ramsden JJ, 1997, RRD PHYS CHEM, V1, P133
   RAMSDEN JJ, 1995, CYTOMETRY, V19, P97, DOI 10.1002/cyto.990190202
   Ramsden JJ, 1997, J MOL RECOGNIT, V10, P109, DOI 10.1002/(SICI)1099-1352(199705/06)10:3<109::AID-JMR361>3.0.CO;2-D
   RAMSDEN JJ, 1994, Q REV BIOPHYS, V27, P41, DOI 10.1017/S0033583500002900
   RAMSDEN JJ, 1993, J STAT PHYS, V73, P853, DOI 10.1007/BF01052813
   Ramsden JJ, 1999, COLLOID SURFACE B, V14, P77, DOI 10.1016/S0927-7765(99)00026-0
   Ramsden JJ, 1998, J CHEM SOC FARADAY T, V94, P783, DOI 10.1039/a708384j
   RAMSDEN JJ, 1995, CHEM SOC REV, V24, P73, DOI 10.1039/cs9952400073
   RAMSDEN JJ, 1995, J AM CHEM SOC, V117, P8511, DOI 10.1021/ja00138a003
   RAMSDEN JJ, 1998, QUANTITATIVE ANAL BI, P149
   RAMSDEN JJ, 2004, BIOINFORMATICS INTRO
   RAMSDEN JJ, 2006, FRONTIERS DRUG DESIG, V2, P211
   RATNER BD, 1980, J BIOMED MATER RES, V14, P665, DOI 10.1002/jbm.820140512
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Raval A, 2005, J BIOMATER APPL, V19, P197, DOI 10.1177/0885328205046564
   Rennie AC, 2005, TRIBOL LETT, V18, P499, DOI 10.1007/s11249-005-3610-0
   Revell P. A., 2006, Nanotechnology Perceptions, V2, P283
   Rickerby D. S., 1991, ADV SURFACE COATINGS
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   ROSENCWAIG A, 1976, J APPL PHYS, V47, P64, DOI 10.1063/1.322296
   Rudolph W, 1997, J MOD OPTIC, V44, P1617
   Sanders JE, 2000, J BIOMED MATER RES, V52, P231, DOI 10.1002/1097-4636(200010)52:1<231::AID-JBM29>3.0.CO;2-E
   Santavirta Seppo, 2003, Acta Orthopaedica Scandinavica, V74, P1, DOI 10.1080/00016470310018108
   Santin M, 2004, J MATER SCI-MATER M, V15, P473, DOI 10.1023/B:JMSM.0000021123.51752.11
   SCHALASTA G, 1998, DADE BEHRING NEWS, V1, P3
   SCHLUESSLER A, 2003, INT ORG SHAP MEM SUP
   Schmidt T, 1999, MICROSC RES TECHNIQ, V44, P339
   Scott RS, 2006, J HUM EVOL, V51, P339, DOI 10.1016/j.jhevol.2006.04.006
   Secomb TW, 2002, MICROCIRCULATION, V9, P189, DOI 10.1038/sj.mn.7800132
   SEITAVUOPIO P, 2006, THESIS U HELSINKI
   Shanshiashvili LV, 2003, ARCH BIOCHEM BIOPHYS, V419, P170, DOI 10.1016/j.abb.2003.09.020
   Shard AG, 2006, REGEN MED, V1, P789, DOI 10.2217/17460751.1.6.789
   Shaw JE, 2006, SURF INTERFACE ANAL, V38, P1459, DOI 10.1002/sia.2444
   SIOSHANSI P, 1987, NUCL INSTRUM METH B, V19-20, P204, DOI 10.1016/S0168-583X(87)80043-5
   Smith G. T., 2002, IND METROLOGY SURFAC
   Soboyejo WO, 2001, KEY ENG MAT, V198-1, P203, DOI 10.4028/www.scientific.net/KEM.198-199.203
   Spijker HT, 2003, BIOMATERIALS, V24, P4717, DOI 10.1016/S0142-9612(03)00380-6
   STEEGMUELLER R, 2005, ASM C SESS 4B SURF E
   Steffen HJ, 2000, SURF INTERFACE ANAL, V29, P386, DOI 10.1002/1096-9918(200006)29:6<386::AID-SIA882>3.0.CO;2-0
   Stickler DJ, 1996, BIOFOULING, V94, P293
   Stout K., 2000, 3 DIMENSIONAL SURFAC
   Stout K. J., 1993, DEV METHODS CHARACTE
   STROBEL M, 2004, INT ORG SHAP MEM SUP
   Sul YT, 2002, BIOMATERIALS, V23, P1809, DOI 10.1016/S0142-9612(01)00307-6
   SUZUKI Y, 1991, NUCL INSTRUM METH B, V59, P698, DOI 10.1016/0168-583X(91)95306-X
   SUZUKI Y, 1994, NUCL INSTRUM METH B, V91, P588
   TAUSENDFREUND A, 2006, SPIE P, V6195
   Teague E. Clayton, 1981, ANN CIRP, V30, P563
   TEAGUE EC, 1982, WEAR, V83, P1, DOI 10.1016/0043-1648(82)90335-0
   TEOH SH, 2004, ENG MAT BIOMEDICAL A
   Thai LC, 2002, OPHTHAL PHYSL OPT, V22, P319, DOI 10.1046/j.1475-1313.2002.00042.x
   Theilade URA, 2004, THESIS TU DENMARK
   TOMLINS PE, 2005, SURFACES INTERFACES, P693
   TOPALA IC, 2004, 15 INT C GAS DISCH T, V2, P1105
   TOPALA IC, 2005, M CUR SCH KNOWL BAS
   Vadgama P, 2005, ANN RP CH C, V101, P14, DOI 10.1039/b408906p
   Vadgama P, 2005, SURFACES INTERFACES, P200
   Vadiraj A, 2006, J MATER ENG PERFORM, V15, P553, DOI 10.1361/105994906X136115
   Van Oss CJ, 1999, CLAY CLAY MINER, V47, P697, DOI 10.1346/CCMN.1999.0470603
   Van Tassel PR, 1998, J COLLOID INTERF SCI, V207, P317, DOI 10.1006/jcis.1998.5781
   VANOEVEREN W, 2005, SURFACES INTERFACES, P414
   VANOSS CJ, 1996, FORCES INTERFACIALES
   VEDRINE L, 2003, MED DEVICE TECHN MAY, P35
   VEDRINE L, 2003, MED DEVICE TECHN MAY, P32
   Vickerman J. C., 1997, SURFACE ANAL PRINCIP
   VORBURGER TV, 1981, PRECIS ENG, V3, P61, DOI 10.1016/0141-6359(81)90038-6
   VORBURGER TV, 1997, ANN CIRP, V46, P587
   Vroman L, 1969, J Biomed Mater Res, V3, P43, DOI 10.1002/jbm.820030106
   Wang JG, 1997, MACROMOLECULES, V30, P1906, DOI 10.1021/ma961412o
   WANG W, 1995, J FLUID MECH, V283, P287, DOI 10.1017/S0022112095002321
   Weckenmann A., 2004, ANN CIRP, V54, P657
   Wennerberg A, 1996, MED ENG PHYS, V18, P548, DOI 10.1016/1350-4533(95)00005-4
   Werner C, 1999, INT J ARTIF ORGANS, V22, P160
   Whitehouse D.J., 1994, HDB SURFACE METROLOG
   Wiggins Philippa M., 2002, Journal of Biological Physics and Chemistry, V2, P25, DOI 10.4024/12020205.jbpc.02.01
   Wright CJ, 2006, SURF INTERFACE ANAL, V38, P1419, DOI 10.1002/sia.2506
   Youngblood JP, 2003, BIOFOULING, V19, P91, DOI 10.1080/0892701021000053381
NR 211
TC 76
Z9 76
U1 0
U2 12
PU TECHNISCHE RUNDSCHAU EDITION COLIBRI LTD
PI BERN
PA NORDRING 4, CH-3001 BERN, SWITZERLAND
SN 0007-8506
J9 CIRP ANN-MANUF TECHN
JI CIRP Ann-Manuf. Technol.
PY 2007
VL 56
IS 2
BP 687
EP 711
DI 10.1016/j.cirp.2007.10.001
PG 25
WC Engineering, Industrial; Engineering, Manufacturing
SC Engineering
GA 311DX
UT WOS:000256581800005
DA 2018-10-19
ER

PT J
AU Kakou, A
   Louis, H
   Cattan, V
   Lacolley, P
   Thornton, SN
AF Kakou, Augustine
   Louis, Huguette
   Cattan, Valerie
   Lacolley, Patrick
   Thornton, Simon N.
TI Correlation between arterial mechanical properties, vascular biomaterial
   and tissue engineering
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article; Proceedings Paper
CT 1st Meeting on Cardiovascular Biology - Endothelial Cell in Cell Health
   and Hypertension
CY JUN 30-JUL 01, 2006
CL Prague, CZECH REPUBLIC
DE cardiovascular; tissue engineering; vascular graft; biomaterial;
   mechanical strength
ID SPONTANEOUSLY HYPERTENSIVE-RATS; SMOOTH-MUSCLE-CELLS; HUMAN
   BLOOD-VESSEL; VIVO IN-VITRO; WALL VISCOSITY; CONSTRUCTS; COLLAGEN;
   STRAIN; MODEL; TONE
AB This review presents some of the recent technological developments in biomaterials used for the construction of synthetic cardiovascular vessels that are capable of simulating specific biological responses. However, with respect to the problems of stiffness, a major hypertensive risk factor, it is necessary to underline the important role of mechanical properties, such as vessel strength and composition, in vascular reconstructive surgery. Biomaterials occupy a central place in many cardiovascular disease treatments and they depend on the chemical nature of the polymers, on the biotechnology used, and also on cellular and gene therapy. Several methodologies using animal or human cells have emerged for constructing blood vessel replacements. Tissue-engineered blood vessel (TEBV) substitutes begin to motivate much work and have contributed to the restoration, maintenance, and/or improvement in tissue and organ function. Each methodology has it benefits, its promises, and holds many challenges in future biological, biomaterial and clinical research.
C1 INSERM, U684, Fac Med, F-54505 Vandoeuvre Les Nancy, France.
   Henri Poincare Univ, Nancy, France.
RP Kakou, A (reprint author), INSERM, U684, Fac Med, 9 Ave Foret Haye,BP 184, F-54505 Vandoeuvre Les Nancy, France.
EM kakoutina@yahoo.fr
RI Lacolley, Patrick/G-3118-2013
CR Berglund JD, 2003, BIOMATERIALS, V24, P1241, DOI 10.1016/S0142-9612(02)00506-9
   Bezie Y, 1998, ARTERIOSCL THROM VAS, V18, P1027, DOI 10.1161/01.ATV.18.7.1027
   Boutouyrie P, 1997, ARTERIOSCL THROM VAS, V17, P1346, DOI 10.1161/01.ATV.17.7.1346
   Boutouyrie P, 1998, HYPERTENSION, V32, P360, DOI 10.1161/01.HYP.32.2.360
   Campbell JH, 1999, CIRC RES, V85, P1173
   Cummings CL, 2004, BIOMATERIALS, V25, P3699, DOI 10.1016/j.biomaterials.2003.10.073
   GAMBLE JR, 1993, J CELL BIOL, V121, P931, DOI 10.1083/jcb.121.4.931
   GRENIER G, 2003, IN VITRO CELL DEV-AN, V39, P131, DOI DOI 10.1007/S11626-003-0007-Y
   L'Heureux N, 1998, FASEB J, V12, P47
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   LACOLLEY P, 1995, BRIT J PHARMACOL, V115, P1235, DOI 10.1111/j.1476-5381.1995.tb15031.x
   Lacolley P, 2001, J AM COLL CARDIOL, V37, P662, DOI 10.1016/S0735-1097(00)01129-3
   Lajemi M, 1999, PATHOL BIOL, V47, P614
   Leon Luis, 2003, Expert Rev Cardiovasc Ther, V1, P581, DOI 10.1586/14779072.1.4.581
   LHEUREUX N, 1993, J VASC SURG, V17, P499, DOI 10.1016/0741-5214(93)90150-K
   McKee JA, 2003, EMBO REP, V4, P633, DOI 10.1038/sj.embor.embor847
   Meddahi-Pelle A, 2004, M S-MED SCI, V20, P679, DOI 10.1051/medsci/2004206-7679
   Mercier N, 2006, CARDIOVASC RES, V72, P349, DOI 10.1016/j.cardiores.2006.08.008
   Nerem RM, 2001, ANNU REV BIOMED ENG, V3, P225, DOI 10.1146/annurev.bioeng.3.1.225
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   ROSS J, 1993, BIOCHEM PHARMACOL, V46, P511, DOI 10.1016/0006-2952(93)90528-5
   Safar ME, 2005, HYPERTENSION, V46, P205, DOI 10.1161/01.HYP.0000167992.80876.26
   Schmedlen RH, 2003, CLIN PLAST SURG, V30, P507, DOI 10.1016/S0094-1298(03)00069-5
   Seliktar D, 2003, TISSUE ENG, V9, P657, DOI 10.1089/107632703768247359
   Seliktar D, 2001, ANN BIOMED ENG, V29, P923, DOI 10.1114/1.1415522
   Stoclet JC, 1996, CELL BIOL TOXICOL, V12, P223, DOI 10.1007/BF00438149
   THYBERG J, 1990, ARTERIOSCLEROSIS, V10, P966, DOI 10.1161/01.ATV.10.6.966
   Vara DS, 2005, PATHOL BIOL, V53, P599, DOI 10.1016/j.patbio.2004.12.006
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
NR 29
TC 3
Z9 3
U1 0
U2 1
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2007
VL 37
IS 1-2
BP 71
EP 75
PG 5
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 204OA
UT WOS:000249052700009
PM 17641397
DA 2018-10-19
ER

PT J
AU Rickert, D
   Scheithauer, MO
   Coskun, S
   Kelch, S
   Lendlein, A
   Franke, RP
AF Rickert, Dorothee
   Scheithauer, Marc O.
   Coskun, Saadet
   Kelch, Steffen
   Lendlein, Andreas
   Franke, Ralf-Peter
TI The influence of a multifunctional, polymeric biomaterial on the
   concentration of acute phase proteins in an animal model
SO CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
LA English
DT Article
DE acute phase proteins; alpha(1)-acid glycoprotein; haptoglobin; animal
   model; multifunctional polymeric biomaterial; gastric wall
   reconstruction; tissue integration
ID ALPHA-1-ACID GLYCOPROTEIN; TISSUE; IMPLANTATION; INHIBITION; MODULATION;
   NETWORKS; MICE
AB The concentrations of the acute phase proteins alpha(1)-Acid Glycoprotein (AAG) and haptoglobin were determined in Sprague-Dawley-rats after implantation of a novel biodegradable multifunctional polymeric biomaterial for the reconstruction of a gastric wall defect (polymer group; n=42). For comparison, the concentrations of AAG and haptoglobin were measured as well after primary wound closure of the gastric wall defect without biomaterial implantation (control group; n=21) and in rats without any surgical procedure (baseline group; n=21). The implantation periods were 1 week, 4 weeks and 6 months. The concentrations of AAG and haptoglobin were measured by an ELISA assay. Gastrointestinal complications like fistula, perforation or peritonitis did not occur in any of the animals. No statistically significant differences in the concentrations of AAG and haptoglobin were detected between the polymer and the control group. An adequate mechanical stability of the polymeric biomaterial was detectable under the extreme pathophysiological conditions of the stomach milieu. In further examinations the correlation between the intraperitoneal cytokine levels of the animals and the following systemic inflammatory markers should be analysed. Further investigations are needed to analyse the mechanisms of the tissue integration of a biomaterial as well as the process of the tissue remodeling and the influence of the immune system on these mechanisms. The knowledge of these processes is necessary to adapt the multifunctional biomaterial and prepare it thus for the use and implantation in different body locations and to develop novel therapeutical options in medicine.
C1 Univ Ulm, Dept Otorhinolaryngol Head & Neck Surg, D-89075 Ulm, Germany.
   Univ Ulm, Dept Biomat, Cent Inst Biomed Engn, D-89081 Ulm, Germany.
   GKSS Forschungszentrum GmbH, Ctr Biomat Dev, Inst Polymer Res, D-14513 Teltow, Germany.
   Forschungszentrum Karlsruhe GmbH, Inst Biol Interfaces, D-76344 Eggenstein Leopoldshafen, Germany.
RP Rickert, D (reprint author), Univ Ulm, Dept Otorhinolaryngol Head & Neck Surg, Frauenstr 12, D-89075 Ulm, Germany.
EM dorothee.rickert@uniklinik-ulm.de
RI Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670
CR Ahsan T, 2005, Orthod Craniofac Res, V8, P134, DOI 10.1111/j.1601-6343.2005.00326.x
   Atala A, 2004, REJUV RES, V7, P15, DOI 10.1089/154916804323105053
   Baquey C, 2005, CLIN HEMORHEOL MICRO, V33, P303
   Binzen E, 2004, CLIN HEMORHEOL MICRO, V30, P283
   Binzen E, 2003, CLIN HEMORHEOL MICRO, V28, P183
   Busuttil SJ, 2005, VASCULAR, V13, P230, DOI 10.1258/rsmvasc.13.4.230
   Ceron JJ, 2005, VET CLIN PATH, V34, P85, DOI 10.1111/j.1939-165X.2005.tb00019.x
   Chlebovska K, 1999, MECH AGEING DEV, V108, P127, DOI 10.1016/S0047-6374(98)00155-9
   Clark R., 1996, Mezhdunarodnyi Sel'skokhozyaistvennyi Zhurnal, P3
   COSTELLO M, 1979, NATURE, V281, P677, DOI 10.1038/281677a0
   Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9
   Gheorghiu I, 2001, J BIOL CHEM, V276, P44331, DOI 10.1074/jbc.M107591200
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045
   Hochepied T, 2003, CYTOKINE GROWTH F R, V14, P25, DOI 10.1016/S1359-6101(02)00054-0
   Johnson RW, 1997, J ANIM SCI, V75, P1244
   Kanikowska D, 2005, CHRONOBIOL INT, V22, P591, DOI 10.1081/CBI-200062419
   LAINE E, 1990, INFLAMMATION, V14, P1, DOI 10.1007/BF00914025
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Mertsching H, 2005, BIOMATERIALS, V26, P6610, DOI 10.1016/j.biomaterials.2005.04.048
   Mulari K, 2004, Scand J Surg, V93, P204
   POS O, 1990, INFLAMMATION, V14, P133, DOI 10.1007/BF00917452
   Rickert D, 2006, BIOMED TECH, V51, P116, DOI 10.1515/BMT.2006.020
   Tran N, 2005, CLIN HEMORHEOL MICRO, V33, P263
   VANOSS CJ, 1974, IMMUNOL COMMUN, V3, P321, DOI 10.3109/08820137409061112
   Wang YP, 2001, REDOX REP, V6, P379, DOI 10.1179/135100001101536580
   Williams JP, 1997, AM J PHYSIOL-GASTR L, V273, pG1031
   Yamamoto T, 2005, DIS COLON RECTUM, V48, P1005, DOI 10.1007/s10350-004-0866-7
NR 29
TC 17
Z9 17
U1 0
U2 1
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1386-0291
J9 CLIN HEMORHEOL MICRO
JI Clin. Hemorheol. Microcirc.
PY 2007
VL 36
IS 4
BP 301
EP 311
PG 11
WC Hematology; Peripheral Vascular Disease
SC Hematology; Cardiovascular System & Cardiology
GA 168PV
UT WOS:000246537400004
PM 17502700
DA 2018-10-19
ER

PT J
AU Browaeys, H
   Bouvry, P
   De Bruyn, H
AF Browaeys, Hilde
   Bouvry, Peter
   De Bruyn, Hugo
TI A literature review on biomaterials in sinus augmentation procedures
SO CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH
LA English
DT Review
DE autogenous bone; bone regeneration; dental implant; grafting material;
   platelet-rich plasma; sinus lift
ID PLATELET-RICH PLASMA; DIFFERENT GRAFTING MATERIALS; ANORGANIC BOVINE
   BONE; HUMAN OSTEOGENIC PROTEIN-1; MAXILLARY SINUS; DENTAL IMPLANTS;
   AUTOGENOUS BONE; POROUS HYDROXYAPATITE; SIMULTANEOUS PLACEMENT; FLOOR
   AUGMENTATION
AB Sinus augmentation is a common procedure to increase bone volume and allow for proper implant placement in the atrophic posterior maxilla. Although the patient's own bone is considered the best grafting material, various synthetic or bovine-derived alternatives are used to simplify the grafting procedure.
   The overall objective of this review was to assess the efficacy of different graft materials used in sinus augmentation procedures as demonstrated in animal studies.
   A specific and sensitive database was initially created via PUBMED, focusing on studies published in English peer-reviewed journals between 1995 and 2004 and kept updated until 2006.
   Twenty-six articles were available for comparison and discussion; none concerned the use of alloplastic materials; 24 were comparative histomorphometric; and two were biomechanical studies. Because of a great variability in study designs, different implant types, great range in follow-up, and lack of specific integration or loading period, a comparison of the studies and the biomaterials used was difficult.
   In general, autogenous bone is the most predictable material of choice for augmentation procedures, despite a 40% resorption, because it is highly osteoconductive and less dependent on sinus floor endosteal bone migration. The addition of bovine bone mineral to autogenous bone can be beneficial for graft success because it acts as a slowly resorbing space maintainer. Porous hydroxyapatite is suitable when mixed with autogenous bone because it enhances bone formation and bone-to-implant contact in augmented sinuses. Histological evaluation showed that demineralized freeze-dried bone is inferior to other materials. Within the limitation of the animal studies examined in this review and only based on histological examination, the initial osseointegration of implants seems independent of the biomaterial used in grafting procedures.
C1 Univ Ghent, Sch Dent, Dept Maxillofacial Surg, Ghent, Belgium.
   Univ Ghent, Sch Med, Ghent, Belgium.
   Univ Ghent, Sch Dent, Dept Periodontol & Oral Implantol, Ghent, Belgium.
RP Browaeys, H (reprint author), De Pintelaan 185-P8, B-9000 Ghent, Belgium.
EM hilde.browaeys@ugent.be
RI De Bruyn, Hugo/B-3628-2018
OI De Bruyn, Hugo/0000-0003-0200-9546
CR ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P233
   Aghaloo TL, 2004, INT J ORAL MAX IMPL, V19, P59
   Bahat O, 1993, Int J Oral Maxillofac Implants, V8, P151
   Block MS, 1997, J ORAL MAXIL SURG, V55, P1281, DOI 10.1016/S0278-2391(97)90185-3
   Blomqvist J E, 1996, Int J Oral Maxillofac Implants, V11, P512
   BOYNE PJ, 1980, J ORAL SURG, V38, P613
   BRANEMARK PI, 1984, J ORAL MAXIL SURG, V42, P497, DOI 10.1016/0278-2391(84)90008-9
   Butterfield KJ, 2005, J ORAL MAXIL SURG, V63, P370, DOI 10.1016/j.joms.2004.07.017
   Fuerst G, 2004, CLIN ORAL IMPLAN RES, V15, P733, DOI 10.1111/j.1600-0501.2004.01077.x
   Furst G, 2003, CLIN ORAL IMPLAN RES, V14, P500, DOI 10.1034/j.1600-0501.2003.00859.x
   GREGADA E, 2005, J ORAL IMPLANTOL, V31, P2
   Haas R, 1998, CLIN ORAL IMPLAN RES, V9, P107, DOI 10.1034/j.1600-0501.1998.090206.x
   Haas R, 1998, CLIN ORAL IMPLAN RES, V9, P117, DOI 10.1034/j.1600-0501.1998.090207.x
   Haas R, 2002, CLIN ORAL IMPLAN RES, V13, P581, DOI 10.1034/j.1600-0501.2002.130602.x
   Haas R, 2002, INT J ORAL MAX IMPL, V17, P337
   Haas R, 2002, CLIN ORAL IMPLAN RES, V13, P396, DOI 10.1034/j.1600-0501.2002.130408.x
   Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P476, DOI 10.1034/j.1600-0501.1997.080606.x
   Hurzeler MB, 1997, CLIN ORAL IMPLAN RES, V8, P401, DOI 10.1034/j.1600-0501.1997.080507.x
   Jakse N, 2003, CLIN ORAL IMPLAN RES, V14, P578, DOI 10.1034/j.1600-0501.2003.00928.x
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P11
   Kaufman Eliaz, 2003, J Esthet Restor Dent, V15, P272, DOI 10.1111/j.1708-8240.2003.tb00298.x
   Klongnoi B, 2006, J CLIN PERIODONTOL, V33, P500, DOI 10.1111/j.1600-051X.2006.00938.x
   Klongnoi B, 2006, CLIN ORAL IMPLAN RES, V17, P312, DOI 10.1111/j.1600-0501.2005.01215.x
   Margolin MD, 1998, J PERIODONTOL, V69, P911, DOI 10.1902/jop.1998.69.8.911
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   McAllister BS, 1999, INT J ORAL MAX IMPL, V14, P361
   MELLONIG JT, 1981, J PERIODONTOL, V52, P297, DOI 10.1902/jop.1981.52.6.297
   Misch C E, 1987, Int J Oral Implantol, V4, P49
   PIERCE GF, 1989, J CELL BIOL, V109, P429, DOI 10.1083/jcb.109.1.429
   QUATTLEBAUM JB, 1988, J PERIODONTOL, V59, P394, DOI 10.1902/jop.1988.59.6.394
   Quinones CR, 1997, CLIN ORAL IMPLAN RES, V8, P497, DOI 10.1034/j.1600-0501.1997.080608.x
   Quinones CR, 1997, CLIN ORAL IMPLAN RES, V8, P487, DOI 10.1034/j.1600-0501.1997.080607.x
   Roldan JC, 2004, CLIN ORAL IMPLAN RES, V15, P716, DOI 10.1111/j.1600-0501.2004.01070.x
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P53
   Terheyden H, 1999, CLIN ORAL IMPLAN RES, V10, P510, DOI 10.1034/j.1600-0501.1999.100609.x
   Valentini P, 2003, INT J ORAL MAX IMPL, V18, P556
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
   Weibrich G, 2000, Mund Kiefer Gesichtschir, V4, P148, DOI 10.1007/s100060050187
   WETZEL AC, 1995, CLIN ORAL IMPLAN RES, V6, P155, DOI 10.1034/j.1600-0501.1995.060304.x
   WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241
   Xu H, 2004, CLIN ORAL IMPLAN RES, V15, P126, DOI 10.1111/j.1600-0501.2004.01003.x
   Xu H, 2003, CLIN ORAL IMPLAN RES, V14, P548, DOI 10.1034/j.1600-0501.2003.00933.x
NR 42
TC 140
Z9 155
U1 0
U2 30
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1523-0899
EI 1708-8208
J9 CLIN IMPLANT DENT R
JI Clin. Implant Dent. Relat. Res.
PY 2007
VL 9
IS 3
BP 166
EP 177
DI 10.1111/j.1708-8208.2007.00050
PG 12
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 203IU
UT WOS:000248969100007
PM 17716261
DA 2018-10-19
ER

PT S
AU Cristescu, R
   Jelinek, M
   Kocourek, T
   Axente, E
   Grigorescu, S
   Moldovan, A
   Mihaiescu, DE
   Albulescu, M
   Buruiana, T
   Dybal, J
   Stamatin, I
   Mihailescu, IN
   Chrisey, DB
AF Cristescu, R.
   Jelinek, M.
   Kocourek, T.
   Axente, E.
   Grigorescu, S.
   Moldovan, A.
   Mihaiescu, D. E.
   Albulescu, M.
   Buruiana, T.
   Dybal, J.
   Stamatin, I.
   Mihailescu, I. N.
   Chrisey, D. B.
BE Hess, WP
   Herman, PR
   Bauerle, D
   Koinuma, H
TI Matrix assisted pulsed laser evaporation of pullulan tailor-made
   biomaterial thin films for controlled drug delivery systems
SO COLA'05: 8TH INTERNATIONAL CONFERENCE ON LASER ABLATION
SE Journal of Physics Conference Series
LA English
DT Proceedings Paper
CT 8th International Conference on Laser Ablation
CY SEP 11-16, 2005
CL Banff, CANADA
ID DEPOSITION
AB We report the first successful deposition of cinnamate-pullulan polysaccharide thin films by Matrix Assisted Pulsed Laser Evaporation (MAPLE). Thin film depositions were performed in vacuum using a KrF* excimer laser source (lambda = 248 nm, tau approximate to 20 ns) operated at a repetition rate of 10 Hz. The dependence on incident laser fluence of the induced surface morphology is studied. We demonstrated by Raman spectroscopy that our MAPLE-deposited cinnamate-pullulan thin films are composed of starting materials preserving their chemical structures, with no impurities.
C1 [Cristescu, R.; Axente, E.; Grigorescu, S.; Moldovan, A.; Mihailescu, I. N.] Natl Inst Laser Plasma & Radiat Phys, MG-36, RO-77125 Bucharest, Romania.
   [Cristescu, R.; Jelinek, M.; Kocourek, T.] Inst Phys ASCR, Prague, Czech Republic.
   [Mihaiescu, D. E.] Univ Agr Sci & Veterinary Med, Bucharest, Romania.
   [Albulescu, M.] Natl Inst Chem Pharmaceut R&D, Bucharest 74373, Romania.
   [Buruiana, T.] Petru Poni Inst Macromol Chem, R-6600 Iasi, Romania.
   [Dybal, J.] Acad Sci Czech Republic, Inst Macromol Chem, Prague, Czech Republic.
   [Stamatin, I.] Univ Bucharest, Fac Phys, Bucharest, Romania.
   [Chrisey, D. B.] Naval Res Lab, Washington, DC 20375 USA.
RP Cristescu, R (reprint author), Natl Inst Laser Plasma & Radiat Phys, MG-36, RO-77125 Bucharest, Romania.
EM rodica.cristescu@inflpr.ro
RI Kocourek, Tomas/G-8432-2014; Jelinek, Miroslav/G-8367-2014; Moldovan,
   Antoniu/I-8411-2012; AXENTE, Emanuel/C-4812-2011; Stamatin,
   ioan/A-7948-2011; Dybal, Jiri/A-8290-2008; Cristescu,
   Rodica/F-1961-2010; Mihailescu, Ion/A-5403-2011; Mihaiescu, Dan
   Eduard/I-5523-2014
OI Moldovan, Antoniu/0000-0001-7953-9268; Dybal, Jiri/0000-0002-9148-3655;
   Cristescu, Rodica/0000-0002-3092-6168; Mihaiescu, Dan
   Eduard/0000-0001-9873-3912; AXENTE, Emanuel/0000-0003-1946-5863;
   Jelinek, Miroslav/0000-0001-9824-1117; stamatin,
   ioan/0000-0002-9168-7180
FU GA ASCR [A1010110]; Institutional Research Plan [AVOZ 101000522]; CTU
   [6640770030]; CERES [4-178/15.11.2004]; Office of Naval
FX Experiments were carried out in the frame of the exchanges between
   Romanian and Czech Republic Academies. This project was supported by the
   GA ASCR, Project No. A1010110 and the Institutional Research Plan AV CR
   No. AVOZ 101000522. Our thanks should be also expressed to CTU Research
   Project No. 6640770030 and No. 88/1. RC, EA, SG, MA, T.B, DM, IS, and
   INM acknowledge with thanks the financial support of Contracts CERES
   4-178/15.11.2004. One of us (DBC) gratefully acknowledges the financial
   support of the Office of Naval .Research.
CR Borchardt RT, 1985, DIRECTED DRUG DELIVE
   Cristescu R, 2006, APPL SURF SCI, V252, P4647, DOI 10.1016/j.apsusc.2005.07.152
   Cristescu R, 2004, THIN SOLID FILMS, V453, P262, DOI 10.1016/j.tsf.2003.11.145
   Ho RYJ, 2003, BIOTECHNOLOGY BIOPHA
   McGill R.A., 2000, Patent, Patent No. [6,025,036, 6025036]
   Moscovici M, 1996, BIOTECHNOL LETT, V18, P787, DOI 10.1007/BF00127889
   MUZYKANTOV VR, 2002, BIOMEDICAL ASPECTS D
   NARAYAN R, 2005, LAMBDA PHYS HIGHLIGH, V65, P1
   Pique A, 1999, THIN SOLID FILMS, V355, P536, DOI 10.1016/S0257-8972(99)00376-X
   Ringeisen BR, 2001, LANGMUIR, V17, P3472, DOI 10.1021/la0016874
   Saltzman W. M., 2001, DRUG DELIVERY ENG PR
   Singh RK, 2002, APPL SURF SCI, V197, P610, DOI 10.1016/S0169-4332(02)00408-7
   Talton J. D., 2000, RESP DRUG DELIV, V7, P67
NR 13
TC 6
Z9 6
U1 0
U2 15
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1742-6588
J9 J PHYS CONF SER
PY 2007
VL 59
BP 144
EP +
DI 10.1088/1742-6596/59/1/031
PG 3
WC Optics
SC Optics
GA BGP13
UT WOS:000249266200031
OA Bronze
DA 2018-10-19
ER

PT J
AU Cheung, HY
   Lau, KT
   Lu, TP
   Hui, D
AF Cheung, Hoi-Yan
   Lau, Kin-Tak
   Lu, Tung-Po
   Hui, David
TI A critical review on polymer-based bio-engineered materials for scaffold
   development
SO COMPOSITES PART B-ENGINEERING
LA English
DT Article
DE recycling; environmental degradation; biocomposites
ID ARTICULAR-CARTILAGE; MECHANICAL-PROPERTIES; TISSUE; REPAIR;
   CHONDROCYTES; ADHESION; CELL; PROLIFERATION; BIOMATERIALS; FABRICATION
AB dSince the last decade, tissue engineering has shown a sensational promise in providing more viable alternatives to surgical procedures for harvested tissues, implants and prostheses. Due to the fast development on biomaterial technologies, it is now possible for doctors to use patients' cells to repair orthopedic defects such as focal articular cartilage lesions. In order to support the three-dimensional tissue formation, scaffolds made by biocompatible and bioresorbable polymers and composite materials, for providing temporary support of damaged body and cell structures have been developed recently. Although ceramic and metallic materials have been widely accepted for the development of implants, its non-resorbability and necessity of second surgical operation, which induces extra for the patients, limit their wide applications. This review article aims at introducing (i) concept of cartilage tissue engineering, (ii) common types of bio-engineered materials and (iii) future development of biomaterial scaffolds. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Hong Kong Polytech Univ, Dept Mech Engn, Kowloon, Hong Kong, Peoples R China.
   EBM Biodegradable Mat Ltd, Hong Kong, Hong Kong, Peoples R China.
   Univ New Orleans, Dept Mech Engn, New Orleans, LA 70148 USA.
RP Lau, KT (reprint author), Hong Kong Polytech Univ, Dept Mech Engn, Kowloon, Hong Kong, Peoples R China.
EM mmktlau@polyu.edu.hk
OI LAU, Kin Tak/0000-0001-5138-6079
CR BELGACEM BY, 1999, P 1 JOINT BMES EMBS, P13
   Chapekar MS, 2000, J BIOMED MATER RES, V53, P617, DOI 10.1002/1097-4636(2000)53:6<617::AID-JBM1>3.3.CO;2-3
   CHEN VJ, 1996, BIOMATERIALS, V25, P2065
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Darling E. M., 2004, BIOMEDICAL TECHNOLOG
   Dausse Y, 2003, OSTEOARTHR CARTILAGE, V11, P16, DOI 10.1053/joca.2002.0859
   Dounchis JS, 2000, CLIN ORTHOP RELAT R, P248
   Frenkel SR, 1997, J BONE JOINT SURG BR, V79B, P831, DOI 10.1302/0301-620X.79B5.7278
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   HENDRICKSON DA, 1994, J ORTHOPAED RES, V12, P485, DOI 10.1002/jor.1100120405
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Honda M, 2000, J ORAL MAXIL SURG, V58, P767, DOI 10.1053/joms.2000.7262
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   Katstra WE, 2000, J CONTROL RELEASE, V66, P1, DOI 10.1016/S0168-3659(99)00225-4
   Kuo CK, 2001, BIOMATERIALS, V22, P511, DOI 10.1016/S0142-9612(00)00201-5
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lee SM, 2005, COMPOS SCI TECHNOL, V65, P647, DOI 10.1016/j.compscitech.2004.09.023
   LIGN HY, IN PRESS J MAT SCI M
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   MIZUNO K, 2005, P 8 POL ADV TECHN IN
   Mow V. C., 2001, BASIC BIOMECHANICS M
   Murphy CL, 2001, TISSUE ENG, V7, P791, DOI 10.1089/107632701753337735
   NAM YS, 1999, J BIOMED MATER RES, P8
   Neves NM, 2005, MAT SCI ENG C-BIO S, V25, P195, DOI 10.1016/j.msec.2005.01.009
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   ODRISCOLL S, 1980, J BONE JOINT SURG
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Paige KT, 1996, PLAST RECONSTR SURG, V97, P168, DOI 10.1097/00006534-199601000-00027
   Pieper JS, 2002, BIOMATERIALS, V23, P3183, DOI 10.1016/S0142-9612(02)00067-4
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Sims CD, 1998, PLAST RECONSTR SURG, V101, P1580, DOI 10.1097/00006534-199805000-00022
   Slivka MA, 2001, TISSUE ENG, V7, P767, DOI 10.1089/107632701753337717
   Stile RA, 2002, BIOMACROMOLECULES, V3, P591, DOI 10.1021/bm0101466
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Taboas JM, 2003, BIOMATERIALS, V24, P181, DOI 10.1016/S0142-9612(02)00276-4
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   WEISSER J, 2001, OSTEOARTHR CARTILAGE, V9, P48
   Wimmer MA, 2004, TISSUE ENG, V10, P1436, DOI 10.1089/ten.2004.10.1436
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P2127, DOI 10.1016/0142-9612(96)00008-7
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zimmermann J, 2002, BIOMATERIALS, V23, P2127, DOI 10.1016/S0142-9612(01)00343-X
NR 42
TC 250
Z9 265
U1 7
U2 65
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-8368
J9 COMPOS PART B-ENG
JI Compos. Pt. B-Eng.
PY 2007
VL 38
IS 3
BP 291
EP 300
DI 10.1016/j.compositesb.2006.06.014
PG 10
WC Engineering, Multidisciplinary; Materials Science, Composites
SC Engineering; Materials Science
GA 137KV
UT WOS:000244292400002
DA 2018-10-19
ER

PT S
AU Garavelli, M
AF Garavelli, Marco
BE Simos, TE
   Maroulis, G
TI Modelling complex molecular and biomaterial systems: Simulation of
   reactive processes, methodological advances and interplay with the
   experiments
SO COMPUTATION IN MODERN SCIENCE AND ENGINEERING VOL 2, PTS A AND B
SE AIP CONFERENCE PROCEEDINGS
LA English
DT Proceedings Paper
CT International Conference on Computational Methods in Science and
   Engineering
CY SEP 25-30, 2007
CL Corfu, GREECE
SP European Soc Computat Methods Sci & Engn, Minist Natl Educ & Religious Affairs, E4 Comp Engn
C1 Univ Bologna, Dipartimento Chim G Ciamician, I-40126 Bologna, Italy.
RP Garavelli, M (reprint author), Univ Bologna, Dipartimento Chim G Ciamician, Via F Selmi 2, I-40126 Bologna, Italy.
RI GARAVELLI, MARCO/P-5510-2015
OI GARAVELLI, MARCO/0000-0002-0796-289X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER INST PHYSICS
PI MELVILLE
PA 2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA
SN 0094-243X
BN 978-0-7354-0476-2
J9 AIP CONF PROC
PY 2007
VL 2
BP 581
EP 582
PN A - B
PG 2
WC Computer Science, Hardware & Architecture; Computer Science, Theory &
   Methods; Engineering, Electrical & Electronic; Physics, Applied
SC Computer Science; Engineering; Physics
GA BHF06
UT WOS:000252602900143
DA 2018-10-19
ER

PT S
AU Li, Y
AF Li, Yi
BE Zeng, X
   Li, Y
   Ruan, D
   Koehl, L
TI Computational textile bioengineering
SO COMPUTATIONAL TEXTILE
SE Studies in Computational Intelligence
LA English
DT Proceedings Paper
CT 17th IMACS World Congress
CY JUL 11-15, 2005
CL Paris, FRANCE
DE computation; informatics; bioengineering; biosensory; biomechanical;
   thermal; biomedical; biomaterial and textiles
AB Computational textile bioengineering is the integration of physical, chemical, mathematical, and computational sciences and engineering principles to study relationship between clothing and human biology, medicine, behavior and health. It advances fundamental concepts; creates knowledge from molecules to body-clothing systems; and develops innovative materials, devices, and apparel products for healthy lifestyle fashion with functions of comfort, protection, prevention, diagnosis, and treatment of disease, and healthcare. It is application of a systematic, quantitative and integrative way of approaching the solutions of how clothing and textiles can be engineered to the benefits of biology, physiology, medicine, behavior and health of human populations.
C1 Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Hong Kong, Peoples R China.
RP Li, Y (reprint author), Hong Kong Polytech Univ, Inst Text & Clothing, Hong Kong, Hong Kong, Peoples R China.
EM tcliyi@polyu.edu.hk
RI LI, YI/G-4421-2012
OI LI, YI/0000-0002-2092-4505
CR Angnew B, 1998, SCIENCE, V280, P1516
   BISHOP DP, 1994, TEXTILE PROGRESS, V26, P1
   Fanger P., 1970, THERMAL COMFORT COPE
   Fourt L., 1970, CLOTHING COMFORT FUN
   HA M, 1996, EUR J APPL PHYSL, V71, P266
   Hollies N.R.S., 1977, CLOTHING COMFORT
   HONGU T, 1999, HIGH TECH FIBERS
   Hongu T, 1997, NEW FIBERS
   KAJIWARA K, 2000, NEW FIBERS JAPAN, V32
   Li Y, 2006, WOODHEAD TEXT SER, P1, DOI 10.1201/9781439824269
   LI Y, 2002, CLOTHING COMFORT PRO, P1
   Li Y., 2002, P 10 INT C ENV ERG F, P299
   LI Y, 2001, SCI CLOTHING COMFORT, V31, P1
   LI Y, 2002, J TEXT I, V93, P56
   NAGAMACHI M, 1994, SEN-I GAKKAISHI, V50, P468
   SHIMIZU Y, 1996, P 96 SPEC S SENS REC
   SLATER K, 1986, J TEXT I, V77, P157, DOI 10.1080/00405008608658406
   Slater K, 1985, HUMAN COMFORT
   Slater K, 1977, COMFORT PROPERTIES T, V9, P1
   Sone Yoshiaki, 2000, Journal of Physiological Anthropology and Applied Human Science, V19, P157, DOI 10.2114/jpa.19.157
   TAO X, 2001, SMART FABRICS CLOTHI
   TOKURA H, 1989, P I S CLOTH COMF STU
   WOO JL, 2001, P 6 AS TEXT C HONG K
NR 23
TC 3
Z9 3
U1 0
U2 2
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 1860-949X
BN 978-3-540-70656-4
J9 STUD COMPUT INTELL
PY 2007
BP 203
EP 221
PG 19
WC Computer Science, Artificial Intelligence; Computer Science, Software
   Engineering; Engineering, Manufacturing; Mathematics, Applied; Materials
   Science, Textiles
SC Computer Science; Engineering; Mathematics; Materials Science
GA BGK53
UT WOS:000247968500012
DA 2018-10-19
ER

PT J
AU Hollister, SJ
   Lin, CY
AF Hollister, Scott J.
   Lin, Cheng Yu
TI Computational design of tissue engineering scaffolds
SO COMPUTER METHODS IN APPLIED MECHANICS AND ENGINEERING
LA English
DT Article
DE tissue engineering; scaffolds; topology design; effective property
   bounds; homogenization theory
ID ELASTIC PROPERTIES; HOMOGENIZATION; OPTIMIZATION; ARCHITECTURE;
   FABRICATION; POROSITY; BOUNDS
AB Tissue engineering utilizes porous biomaterial scaffolds to deliver biological factors that accelerate tissue healing. These two functions require scaffolds be designed for mechanical loading and mass transport. The purpose of this paper was to apply both ad hoe and topology optimization homogenization based design approaches to create scaffold architectures, and to determine how these architectures compare to theoretical bounds on effective stiffness. Open cell scaffold architectures demonstrated a wide range of permeability, but were all below isotropic effective stiffness bounds. Wavy fiber architectures provide a means to approach the lower bounds. Using image-based techniques, designed architectures may be incorporated in anatomic shapes. (c) 2007 Elsevier B.V. All rights reserved.
C1 Univ Michigan, Dept Biomed Engn, Scaffold Tissue Engn Grp, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Mech Engn, Scaffold Tissue Engn Grp, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Surg, Scaffold Tissue Engn Grp, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Neurosurg, Scaffold Tissue Engn Grp, Ann Arbor, MI 48109 USA.
RP Hollister, SJ (reprint author), Univ Michigan, Dept Biomed Engn, Scaffold Tissue Engn Grp, 1107 Gerstacker Bldg,2200 Bonisteel Blvd, Ann Arbor, MI 48109 USA.
EM scottho@umich.edu
CR AVELLANEDA M, 1987, SIAM J APPL MATH, V47, P1216, DOI 10.1137/0147082
   Bendsoe MP, 2003, TOPOLOGY OPTIMIZATIO
   Diaz AR, 2003, INT J NUMER METH ENG, V57, P301, DOI 10.1002/nme.677
   Guedes JM, 2003, STRUCT MULTIDISCIP O, V25, P446, DOI 10.1007/s00158-003-0305-8
   HASHIN Z, 1963, J MECH PHYS SOLIDS, V11, P127, DOI 10.1016/0022-5096(63)90060-7
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   HOLLISTER SJ, 1994, BIOTECHNOL BIOENG, V43, P586, DOI 10.1002/bit.260430708
   Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421
   Hutmacher DW, 2001, J BIOMAT SCI-POLYM E, V12, P107, DOI 10.1163/156856201744489
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Lin CY, 2004, J BIOMECH, V37, P623, DOI 10.1016/j.jbiomech.2003.09.029
   LIN CY, 2005, THESIS U MICHIGAN
   Milton G. W., 2001, THEORY COMPOSITES
   Sanchez-Palencia E., 1980, NONHOMOGENEOUS MEDIA
   SIGMUND O, 1994, INT J SOLIDS STRUCT, V31, P2313, DOI 10.1016/0020-7683(94)90154-6
   Sigmund O., 1999, SYNTHESIS BIO SOLID, P221
   Steven GP, 2000, COMPUT MECH, V26, P129, DOI 10.1007/s004660000160
   SVANBERG K, 1987, INT J NUMER METH ENG, V24, P359, DOI 10.1002/nme.1620240207
   Terada K, 1997, COMPUT MECH, V20, P331, DOI 10.1007/s004660050255
   Terada K, 1998, COMPUT METHOD APPL M, V153, P223, DOI 10.1016/S0045-7825(97)00071-6
   Torquato S., 2002, RANDOM HETEROGENOUS
   WETTERGREEN MA, 2005, ANN BIOMED ENG, V10, P1333
NR 23
TC 57
Z9 60
U1 0
U2 17
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0045-7825
J9 COMPUT METHOD APPL M
JI Comput. Meth. Appl. Mech. Eng.
PY 2007
VL 196
IS 31-32
BP 2991
EP 2998
DI 10.1016/j.cma.2006.09.023
PG 8
WC Engineering, Multidisciplinary; Mathematics, Interdisciplinary
   Applications; Mechanics
SC Engineering; Mathematics; Mechanics
GA 180BO
UT WOS:000247335100005
DA 2018-10-19
ER

PT B
AU Turrer, CL
   Pimentel, AR
   Orefice, RL
   Maciel, PE
   Silveira, MA
   Barbi, JS
AF Turrer, C. L.
   Pimentel, A. R.
   Orefice, R. L.
   Maciel, P. E.
   Silveira, M. A.
   Barbi, J. S.
BE Wolfe, SA
TI Bioceramic and polimeric bioactive composite implants in orbit zygomatic
   complex reconstruction: A new prospect in biomaterials
SO CRANIOFACIAL SURGERY: PROCEEDINGS OF THE TWELFTH INTERNATIONAL CONGRESS
   OF THE INTERNATIONAL SOCIETY OF CRANIOFACIAL SURGERY
LA English
DT Proceedings Paper
CT 12 Biennial Meeting of the International-Society-Craniofacial-Surgery
CY AUG 25-27, 2007
CL Bahia, BRAZIL
SP Int Soc Craniofacial Surg
AB Anoplithalmic socket patients resulting from facial trauma or retinoblastoma treatment (enucleation and radiotherapy) in infancy present complex orbital zygomatic deformities. The surgical reconstruction of these deformities have been accomplished with autogeneous bone grafts as well as some biomaterials (porous polyethylene or bioceramics) to enhance orbital zygomatic contour. In collaboration with the Department of Metallurgy and Biomaterial Sciences of the School of Engineering research group, a porous composite implant consisting of a high density porous polyethylene matrix and 10% of bioceramic was developed and tested experimentally. After satisfactory results from the biomaterials comparative experimental studies a phase I clinical trial using human subjects was designed to test the effectiveness of this material. Clinical data and tomographic images were utilized to assess the outcome of this study.
C1 [Turrer, C. L.; Pimentel, A. R.; Orefice, R. L.; Maciel, P. E.; Silveira, M. A.; Barbi, J. S.] Univ Fed Minas Gerais, Hosp Sao Geraldo, Belo Horizonte, MG, Brazil.
RP Turrer, CL (reprint author), Univ Fed Minas Gerais, Hosp Sao Geraldo, Belo Horizonte, MG, Brazil.
CR DUSKOVA M., 2000, J CRANIOF SURG, V11
   França Valênio Pérez, 2005, Arq. Bras. Oftalmol., V68, P425, DOI 10.1590/S0004-27492005000400003
   Potter JK, 2004, J ORAL MAXIL SURG, V62, P1280, DOI 10.1016/j.joms.2004.04.018
   SALYER K, 1989, PLASTIC RECONSTR SUR, V84
   Wang M, 2003, BIOMATERIALS, V24, P2133, DOI 10.1016/S0142-9612(03)00037-1
   WHITAKER L, 1987, PLASTIC RECONTRUC SU, V80
NR 6
TC 0
Z9 0
U1 0
U2 0
PU MEDIMOND S R L
PI 40128 BOLOGNA
PA VIA MASERATI 5, 40128 BOLOGNA, 00000, ITALY
BN 978-88-7587-407-0
PY 2007
BP 241
EP 242
PG 2
WC Surgery
SC Surgery
GA BHX90
UT WOS:000257312900058
DA 2018-10-19
ER

PT J
AU Sommerdijk, NAJM
   van Leeuwen, ENM
   Vos, MRJ
   Jansen, JA
AF Sommerdijk, Nico A. J. M.
   van Leeuwen, Ellen N. M.
   Vos, Matthijn R. J.
   Jansen, John A.
TI Calcium carbonate thin films as biomaterial coatings using DNA as
   crystallization inhibitor
SO CRYSTENGCOMM
LA English
DT Article
ID ORGANIC/INORGANIC COMPOSITES; IN-VITRO; CACO3; DEPOSITION; GROWTH;
   TEMPLATES; CRYSTALS; PHASE; BONE; ACID
AB Synthetic, bio-inspired organic-inorganic composites are emerging as new materials for bone regeneration, offering more possibilities to tune biocompatibility, biodegradability and mechanical properties. Also thin films of calcium carbonate have been shown to have potential as models for bone replacement biomaterials. These calcium carbonate thin films can be formed using anionic macromolecules as a crystallization inhibitor. Here we demonstrate that also DNA is a powerful inhibitor of calium carbonate crystallization which can be used to prepare amorphous films that slowly crystallize to form calcite with a preferred (11.0) orientation. We show that the DNA-based hybrid material can be grown as inorganic coatings on polymer substrates of high molecular weight polyethylene and poly( caprolactone). The layer-by-layer deposition of a DNA-surfactant double layer was used as an interfacial layer minimizing the observed polymer specific surface roughness. This coating increased the crystallization rate but did not affect the preferred ( 11.0) orientation. Using this technique we were able to apply this coating as a smooth calcium carbonate coating on the surface of a porous 3D polycaprolactone scaffold.
C1 Eindhoven Univ Technol, Biomed Engn Dept, Soft Matter CryoTEM Res Unit, NL-5600 MB Eindhoven, Netherlands.
   Radboud Univ Med Ctr, Dept Periodontol & Biomat, NL-6500 HB Nijmegen, Netherlands.
RP Sommerdijk, NAJM (reprint author), Eindhoven Univ Technol, Biomed Engn Dept, Soft Matter CryoTEM Res Unit, POB 513, NL-5600 MB Eindhoven, Netherlands.
EM N.Sommerdijk@tue.nl
RI Jansen, John/H-8055-2014; Sommerdijk, Nico/B-7239-2013
OI Sommerdijk, Nico/0000-0002-8956-195X
CR Addadi L, 2003, ADV MATER, V15, P959, DOI 10.1002/adma.200300381
   ADDADI L, 1987, P NATL ACAD SCI USA, V84, P2732, DOI 10.1073/pnas.84.9.2732
   Aizenberg J, 1999, J AM CHEM SOC, V121, P4500, DOI 10.1021/ja984254k
   AIZENBERG J, 2000, DALTON T, P3963
   Ajikumar PK, 2004, CRYST GROWTH DES, V4, P331, DOI 10.1021/cg034128e
   Archibald DD, 1996, LANGMUIR, V12, P538, DOI 10.1021/la950330a
   Buijnsters PJJA, 2001, LANGMUIR, V17, P3623, DOI 10.1021/la001765n
   DiMasi E, 2002, LANGMUIR, V18, P8902, DOI 10.1021/la0260032
   Donners JJJM, 2000, CHEM COMMUN, P1937, DOI 10.1039/b004867o
   Donners JJJM, 2002, CHEM-EUR J, V8, P2561, DOI 10.1002/1521-3765(20020603)8:11<2561::AID-CHEM2561>3.0.CO;2-3
   Donners JJJM, 2002, J AM CHEM SOC, V124, P9700, DOI 10.1021/ja0267573
   Gower LA, 1998, J CRYST GROWTH, V191, P153, DOI 10.1016/S0022-0248(98)00002-5
   Gower LB, 2000, J CRYST GROWTH, V210, P719, DOI 10.1016/S0022-0248(99)00749-6
   Green D, 2002, BONE, V30, P810, DOI 10.1016/S8756-3282(02)00727-5
   Han JT, 2005, ADV FUNCT MATER, V15, P475, DOI 10.1002/adfm.200400037
   Hosoda N, 2003, MACROMOLECULES, V36, P6449, DOI 10.1021/ma025869b
   Hosoda N, 2001, CHEM MATER, V13, P688, DOI 10.1021/cm000817r
   Kato T, 2000, ADV MATER, V12, P1543, DOI 10.1002/1521-4095(200010)12:20<1543::AID-ADMA1543>3.0.CO;2-P
   Kato T, 1998, SUPRAMOL SCI, V5, P411, DOI 10.1016/S0968-5677(98)00041-8
   Kato T, 1999, CHEM LETT, P199, DOI 10.1246/cl.1999.199
   Kato T, 2002, ADV MATER, V14, P869, DOI 10.1002/1521-4095(20020618)14:12<869::AID-ADMA869>3.0.CO;2-E
   Kotachi A, 2004, CHEM MATER, V16, P3191, DOI 10.1021/cm049832c
   LARSSON C, 2001, TITANIUM MED, P587
   Politi Y, 2004, SCIENCE, V306, P1161, DOI 10.1126/science.1102289
   Politi Y, 2006, ADV FUNCT MATER, V16, P1289, DOI 10.1002/adfm.200600134
   Popescu DC, 2006, ANGEW CHEM INT EDIT, V45, P1762, DOI 10.1002/anie.200502602
   Ruhe P.Q, 2007, CALCIUM PHOSPHATE CE
   Sugawara A, 2003, ANGEW CHEM INT EDIT, V42, P5299, DOI 10.1002/anie.200351541
   van den Beucken JJJP, 2007, ACTA BIOMATER, V3, P587, DOI 10.1016/j.actbio.2006.12.007
   Van den Beucken JJJP, 2007, J BIOMED MATER RES A, V80A, P612, DOI 10.1002/jbm.a.30971
   van den Beucken JJJR, 2007, J BIOMED MATER RES B, V81B, P231, DOI 10.1002/jbm.b.30658
   van den Beucken JJJP, 2006, J BIOMED MATER RES A, V77A, P202, DOI 10.1002/jbm.a.30583
   van den Beucken JJJP, 2006, BIOMATERIALS, V27, P691, DOI 10.1016/j.biomaterials.2005.06.015
   Volkmer D, 2005, ANGEW CHEM INT EDIT, V44, P639, DOI 10.1002/anie.200461386
   Volkmer D, 2004, CHEM COMMUN, P1872, DOI 10.1039/b405613b
   Vos MRJ, 2005, J AM CHEM SOC, V127, P16768, DOI 10.1021/ja055075n
   VOS MRJ, UNPUB
   Wakayama H, 2005, J MATER CHEM, V15, P1134, DOI 10.1039/b418569b
   Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798
   Xu AW, 2005, ADV MATER, V17, P2217, DOI 10.1002/adma.200500747
   Xu GF, 1998, J AM CHEM SOC, V120, P11977, DOI 10.1021/ja9819108
   Xu XR, 2005, LANGMUIR, V21, P4801, DOI 10.1021/la047069v
   Zhang SK, 1998, LANGMUIR, V14, P6761, DOI 10.1021/la970962s
   ZHANG SK, 1995, J APPL POLYM SCI, V56, P687, DOI 10.1002/app.1995.070560606
NR 44
TC 31
Z9 31
U1 3
U2 26
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1466-8033
J9 CRYSTENGCOMM
JI Crystengcomm
PY 2007
VL 9
IS 12
BP 1209
EP 1214
DI 10.1039/b710277a
PG 6
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA 235XX
UT WOS:000251268700019
DA 2018-10-19
ER

PT J
AU Joshi, JM
   Sinha, VK
AF Joshi, Jigar M.
   Sinha, Vijay Kumar
TI Study of the effect of reaction variables on grafting of acrylic acid
   onto carboxymethyl chitosan
SO DESIGNED MONOMERS AND POLYMERS
LA English
DT Article
DE carboxymethyl chitosan; acrylic acid; CAN; graft co-polymerization
ID COPOLYMERIZATION; CHITIN; METHACRYLATE; BIOMATERIAL; TISSUE
AB -Carboxymethyl chitosan (CMCH) was prepared and characterized by FT-IR spectroscopy. Grafting of acrylic acid (AA) onto CMCH using ceric ammonium nitrate (CAN) as an initiator was carried under nitrogen atmosphere in aqueous solution. Evidence of grafting was confirmed by comparing the FT-IR spectra of CMCH and the grafted co-polymer, as well as scanning electron microscopy (SEM) and X-ray diffraction of the products. The effects of concentration of CAN, concentration of acrylic acid, reaction time and temperature on graft co-polymerization were studied by determining the grafting percentage, grafting efficiency, percentage add-on and percentage total conversion. Keeping the other conditions constant, the optimum grafting conditions were obtained as follows: CMCH = 2 g, CAN = 0.2 M and AA = 0.729 M, reaction temperature = 35 degrees C and reaction time = 4 h.
C1 VP & RPTP Sci Coll, Dept Ind Chem, Vallabh Vidyanagar 388120, Gujarat, India.
RP Sinha, VK (reprint author), VP & RPTP Sci Coll, Dept Ind Chem, Vallabh Vidyanagar 388120, Gujarat, India.
EM drvijaysinha@rediffmail.com
CR Brugnerotto J, 2001, POLYMER, V42, P3569, DOI 10.1016/S0032-3861(00)00713-8
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Dodane V, 1998, PHARM SCI TECHNOL TO, V1, P246, DOI 10.1016/S1461-5347(98)00059-5
   Don TM, 2001, J POLYM SCI POL CHEM, V39, P1646, DOI 10.1002/pola.1142
   EYLER RW, 1947, ANAL CHEM, V19, P24, DOI 10.1021/ac60001a007
   Fanta G. F., 1973, BLOCK GRAFT COPOLYME, V1, P1
   Illum L, 1998, PHARMACEUT RES, V15, P1326
   Jenkins DW, 2001, CHEM REV, V101, P3245, DOI 10.1021/cr000257f
   Khor E, 2002, CURR OPIN SOLID ST M, V6, P313, DOI 10.1016/S1359-0286(02)00002-5
   KOJIMA K, 1994, J APPL POLYM SCI, V53, P1587
   Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7
   Lindmark T, 1998, J PHARMACOL EXP THER, V284, P362
   MISHRA BN, 1980, J POLYM SCI POL CHEM, V18, P341
   Pavlath A. E., 1996, POLYM MAT ENCY, P1230
   Pourjavadi A, 2003, J APPL POLYM SCI, V88, P2048, DOI 10.1002/app.11820
   POURJAVADI A, 2001, P 5 AUSTR POL M LEOB, P77
   POURJAVADI A, 2003, P 1 NAT C NOV DRUG D, P26
   Prashanth KVH, 2003, CARBOHYD POLYM, V54, P343, DOI 10.1016/S0144-8617(03)00191-7
   RAVIKUMAR MNV, 2000, REACT FUNCT POLYM, V46, P1
   REN LD, 1994, CARBOHYD POLYM, V23, P19, DOI 10.1016/0144-8617(94)90086-8
   Shanthi C, 2001, CARBOHYD POLYM, V44, P123, DOI 10.1016/S0144-8617(00)00201-0
   SHIGEMASA Y, 1995, BIOTECHNOL GENET ENG, V13, P383
   SHUKLA JS, 1987, J POLYM SCI POL CHEM, V25, P595, DOI 10.1002/pola.1987.080250213
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Sun T, 2003, EUR POLYM J, V39, P189, DOI 10.1016/S0014-3057(02)00174-X
   VANLUYEN D, 1996, POLYM MAT ENCY, V2, P1205
   XIE W, 2002, J APPL POLYM SCI, V39, P1357
   Xie WM, 2002, CARBOHYD POLYM, V50, P35, DOI 10.1016/S0144-8617(01)00370-8
   Xie WM, 2002, POLYM BULL, V49, P47, DOI 10.1007/s00289-002-0076-1
   YUI T, 1994, MACROMOLECULES, V27, P7601, DOI 10.1021/ma00104a014
NR 30
TC 8
Z9 8
U1 0
U2 1
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 1385-772X
J9 DES MONOMERS POLYM
JI Des. Monomers Polym.
PY 2007
VL 10
IS 3
BP 207
EP 219
DI 10.1163/156855507780949182
PG 13
WC Polymer Science
SC Polymer Science
GA 188GI
UT WOS:000247907200002
OA Bronze
DA 2018-10-19
ER

PT S
AU Ohtsu, N
   Saito, K
   Asami, K
   Hanawa, T
   Kimura, H
AF Ohtsu, Naofumi
   Saito, Kesami
   Asami, Katsuhiko
   Hanawa, Takao
   Kimura, Hisamichi
BE Naka, M
TI Characterization and dissolution behavior in a physiological solution of
   heat-treated CaTiO3 thin films with different thicknesses
SO DESIGNING OF INTERFACIAL STRUCTURES IN ADVANCED MATERIALS AND THEIR
   JOINTS
SE Solid State Phenomena
LA English
DT Proceedings Paper
CT International Workshop on Designing of Interfacial Structures in
   Advanced Materials and Their Joints
CY MAY 18-20, 2006
CL Osaka, JAPAN
DE CaTiO3 thin film; biomaterial application; heat treatment; dissolution
   behavior
ID COATINGS; SUBSTRATE; CERAMICS
AB Characterization of heat-treated CaTiO3 thin films of 10, 20, 30 and 50 nm in thickness and their change after immersion in a simulated body fluid were investigated by grazing incident angle X-ray diffractometry and Auger electron spectroscopy (AES). The CaTiO3 films were prepared on titanium substrate by sputter-deposition of CaTiO3 target followed by heating in an electric furnace at 873 Kin air for 7.2 ks. The CaTiO3 films were immersed in 0.8%NaCl solution for 14 d. All the films before heat treatment were non-crystallized films and after heat treatment, only the 50-nm film was crystallized to perovskite-type CaTiO3. In AES in-depth profiles after heating, Ca diffusion was not observed in the 50-nm film, whereas Ca diffusion toward the Ti substrate was observed in the 10-, 20- and 30-nm films. After immersion for 14 d, the vicinity of surface of the 10, 20 and 30 nm thick CaTiO3 films were dissolved into the NaCl solution, while the 50-nm thick CaTi03 film was scarcely dissolved. Since dissolution from biomaterials in a human body has possibility to harm, the CaTi03 film should be deposited more than 50 nm in thickness and heat-treated at 873 K.
C1 [Ohtsu, Naofumi; Saito, Kesami; Asami, Katsuhiko; Kimura, Hisamichi] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 980, Japan.
   [Ohtsu, Naofumi; Hanawa, Takao] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan.
RP Ohtsu, N (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 980, Japan.
EM nohtsu@imr.tohoku.ac.jp
RI Ohtsu, Naofumi/L-6021-2018
OI Ohtsu, Naofumi/0000-0001-7935-3949
CR Asami K, 2005, SURF COAT TECH, V200, P1005, DOI 10.1016/j.surfcoat.2005.02.189
   Asami K, 2003, SURF INTERFACE ANAL, V35, P483, DOI 10.1002/sia.1554
   DENISSEN HW, 1980, J BIOMED MATER RES, V14, P713, DOI 10.1002/jbm.820140603
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   KHOR KA, 2003, SURF COAT TECH, V168, P95
   LOCARDI B, 1993, BIOMATERIALS, V14, P437, DOI 10.1016/0142-9612(93)90146-S
   Manso M, 2003, MAT SCI ENG C-BIO S, V23, P447, DOI 10.1016/S0928-4931(02)00319-3
   Ohtsu N, 2006, SURF COAT TECH, V200, P5455, DOI 10.1016/j.surfcoat.2005.07.003
   Ohtsu N, 2004, MATER TRANS, V45, P1778, DOI 10.2320/matertrans.45.1778
   Tsui YC, 1998, BIOMATERIALS, V19, P2015, DOI 10.1016/S0142-9612(98)00103-3
   vanDijk K, 1996, BIOMATERIALS, V17, P405, DOI 10.1016/0142-9612(96)89656-6
   Wang CK, 1997, BIOMATERIALS, V18, P1331, DOI 10.1016/S0142-9612(97)00024-0
   Yamashita K, 1998, J BIOMED MATER RES, V43, P46, DOI 10.1002/(SICI)1097-4636(199821)43:1<46::AID-JBM5>3.0.CO;2-M
NR 13
TC 0
Z9 0
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1012-0394
BN 978-3-908451-33-4
J9 SOLID STATE PHENOMEN
PY 2007
VL 127
BP 209
EP +
DI 10.4028/www.scientific.net/SSP.127.209
PG 3
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Metallurgy & Metallurgical Engineering; Physics
GA BGE49
UT WOS:000246323100034
DA 2018-10-19
ER

PT J
AU Clayton, SA
   Wheeler, RA
   Hoadley, AFA
AF Clayton, S. A.
   Wheeler, R. A.
   Hoadley, A. F. A.
TI Pore destruction resulting from mechanical thermal expression
SO DRYING TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT 9th International Conference on Process Integration, Modelling and
   Optimization for Energy Saving and Pollution Reduction
CY AUG 27-31, 2006
CL Prague, CZECH REPUBLIC
DE brown coal; compression dewatering; compressive strength; mercury
   porosimetry; MTE; permeability; porosity; shrinkage; wax
ID MERCURY INTRUSION POROSIMETRY; PARTICLES; METAL
AB Mechanical thermal expression (MTE) is a dewatering technology ideally suited for the dewatering of internally porous biomaterials. For such materials, the combined application of temperature and compressive force in the MTE process enhances the collapse of the porous structure, resulting in effective water removal. In this article, a comparison of the dewatering of titanium dioxide, which is an ideal incompressible, non-porous material, and lignite, which is a porous plant-based biomaterial, is presented. The comparison is based on the parameters critical to dewatering, namely the material compressibility and the permeability. With the aid of mercury porosimetry results, a detailed discussion of the pore destruction of lignite resulting from MTE processing is presented. It is illustrated that there is a well-defined relationship between the pore size distribution after MTE dewatering and the MTE temperature and pressure. The discussion is extended to an investigation of the effects of MTE processing conditions on the effective and noneffective porosity. The effective porosity is defined as the interconnected porosity, which contributes to flow through the compressed matrix, while the non-effective porosity is the remaining porosity, which does not contribute to flow. It is illustrated that there is a linear relationship in both the effective and non-effective porosity with the total porosity. The linear relationship is independent of the processing conditions. It is also shown that MTE processing collapses the effective and non-effective pores at roughly the same rate.
C1 Monash Univ, Dept Chem Engn, Cooperat Res Ctr Clean Power Lignite, Clayton, Vic 3800, Australia.
RP Hoadley, AFA (reprint author), Monash Univ, Dept Chem Engn, Cooperat Res Ctr Clean Power Lignite, Bldg 36,Clayton Campus,Wellington Rd, Clayton, Vic 3800, Australia.
EM andrew.hoadley@eng.monash.edu.au
OI Hoadley, Andrew/0000-0001-9605-6858
CR Bergins C, 1999, CHEM ENG TECHNOL, V22, P923, DOI 10.1002/(SICI)1521-4125(199911)22:11<923::AID-CEAT923>3.0.CO;2-6
   Bergins C, 2003, FUEL, V82, P355, DOI 10.1016/S0016-2361(02)00310-1
   Clayton SA, 2006, DRY TECHNOL, V24, P819, DOI 10.1080/07373930600733093
   CODY GD, 1991, ENERG FUEL, V5, P776, DOI 10.1021/ef00030a001
   deWith G, 1997, J EUR CERAM SOC, V17, P753, DOI 10.1016/S0955-2219(96)00181-1
   DULHUNTY JA, 1960, FUEL, V39, P115
   Durie RA, 1991, SCI VICTORIAN BROWN
   EVANS ML, 1973, PLANT PHYSIOL, V52, P186, DOI 10.1104/pp.52.2.186
   Gane PA, 1996, IND ENG CHEM RES, V35, P1753, DOI 10.1021/ie950413m
   GUO J, 2000, HYDROTHERMAL MECH DE
   Hulston J, 2005, COAL PREP, V25, P269, DOI 10.1080/07349340500444505
   JOHNSTON GP, 1990, POWDER TECHNOL, V61, P289, DOI 10.1016/0032-5910(90)80093-E
   Li YH, 1999, PART PART SYST CHAR, V16, P25, DOI 10.1002/(SICI)1521-4117(199905)16:1<25::AID-PPSC25>3.0.CO;2-T
   MANGA M, 2004, J GEOPHYS RES, V109
   MCINTOSH MJ, 2005, 22 ANN INT COAL PREP, P323
   Ragnarsson R, 1996, PHYS REV LETT, V76, P3456, DOI 10.1103/PhysRevLett.76.3456
   SCHOLES ON, 2005, MECH THERMAL EXPRESS
   Washburn EW, 1921, P NATL ACAD SCI USA, V7, P115, DOI 10.1073/pnas.7.4.115
   Willis KL, 1998, CEMENT CONCRETE RES, V28, P1695, DOI 10.1016/S0008-8846(98)00159-8
   WINSLOW DN, 1978, J COLLOID INTERF SCI, V67, P42, DOI 10.1016/0021-9797(78)90212-6
NR 20
TC 22
Z9 23
U1 0
U2 14
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0737-3937
J9 DRY TECHNOL
JI Dry. Technol.
PY 2007
VL 25
IS 4-6
BP 533
EP 546
DI 10.1080/07373930701226914
PG 14
WC Engineering, Chemical; Engineering, Mechanical
SC Engineering
GA 184XZ
UT WOS:000247677200004
DA 2018-10-19
ER

PT J
AU Martynenko, A
   Yang, SX
   Pan, L
AF Martynenko, Alex
   Yang, Simon X.
   Pan, Leilei
TI Intelligent computation of moisture content in shrinkable biomaterials
SO DRYING TECHNOLOGY
LA English
DT Article
DE drying; ginseng; modeling; neural network; predictors
ID NEURAL-NETWORK; PERFORMANCE; PREDICTION
AB A technique of intelligent computation of moisture content in shrinkable biomaterials from multiple predictors was developed. All measurable predictors were structured in three sets: biomaterial properties (volume, density, porosity, diffusivity); drying conditions (time, air temperature, humidity, velocity, pressure); and drying technologies. Two typical drying models were considered: time-dependent (thermodynamical) and time-independent (relational). The relationship between predictors and moisture content was established on the basis of multi-factorial linear regression (MLR) and neural networks (NN). Accuracy of statistical approximation was strongly dependent on drying model and chosen set of predictors. Time-independent models demonstrated better accuracy (MSE = 0.214) than time-dependent models (MSE = 0.254). Redundant predictors did not affect the accuracy and generalization ability of statistical models.
   Results of NN training and testing showed superior accuracy with respect to statistical models. NN worked perfectly well for any combination of non-correlated predictors, improving accuracy to MSE = 0.01. Elimination of redundant predictors further improved accuracy and generalization ability of NN models.
   The performance of both models was tested for drying of ginseng roots in the range of temperatures from 38 to 50 degrees C, sizes from 10 to 32 mm, and relative humidity from 12 to 40%. Due to the high accuracy and computational efficiency, NN can be used as online estimator of moisture content in drying process.
C1 Univ Guelph, Sch Engn, Guelph, ON N1G 2W1, Canada.
RP Martynenko, A (reprint author), Univ Guelph, Sch Engn, Guelph, ON N1G 2W1, Canada.
EM omartyne@uoguelph.ca
RI Yang, Simon X./A-4399-2008
OI Yang, Simon X./0000-0002-6888-7993
CR Balasubramanian A, 1996, DRY TECHNOL, V14, P1881, DOI 10.1080/07373939608917180
   BENING VE, 2000, ASYMPOTIC THEORY TES
   BOGER Z, 1997, P IEEE INT C SYST MA, P3030
   BROOKER DB, 1974, DRYING CEREAL GRAIN
   Crank J, 1975, MATH DIFFUSION
   HERNANDEZPEREZ JA, 2003, PREDICTION DURING DR, P183
   HUANG B, 1993, DRY TECHNOL, V11, P525, DOI 10.1080/07373939308916842
   Ishikawa M, 1996, NEURAL NETWORKS, V9, P509, DOI 10.1016/0893-6080(96)83696-3
   Katekawa ME, 2006, DRY TECHNOL, V24, P5, DOI [10.1080/07373930500538519, 10.1080/03773930500538519]
   KOLMOGOROV AN, 1957, DOKL AKAD NAUK SSSR+, V114, P953
   Kosko B., 1992, NEURAL NETWORKS FUZZ
   Krokida MK, 1997, DRY TECHNOL, V15, P2441, DOI 10.1080/07373939708917369
   MARTYNENKO AI, 2005, THESIS U GUELPH ONTA
   McLaughlin CP, 1998, FOOD BIOPROD PROCESS, V76, P138, DOI 10.1205/096030898531945
   McMinn WAM, 1997, J FOOD ENG, V33, P37, DOI 10.1016/S0260-8774(97)00039-3
   MUJUMDAR A, 1997, MATH MODELING NUMERI
   Pan LL, 2006, BIOSYST ENG, V94, P87, DOI 10.1016/j.biosystemseng.2006.02.005
   RATTI C, 1994, J FOOD ENG, V23, P91, DOI 10.1016/0260-8774(94)90125-2
   Spalding DB, 1963, CONVECTIVE MASS TRAN
   STRUMILLO C, 1995, DRYING PRINCIPLES AP
   SUZUKI K, 1976, J FOOD SCI, V41, P1189, DOI 10.1111/j.1365-2621.1976.tb14414.x
   Torrecilla JS, 2004, J FOOD ENG, V62, P89, DOI 10.1016/S0260-8774(03)00174-2
   Welty J.R., 2002, FUNDAMENTALS MOMENTU
   Wu HW, 2006, DRY TECHNOL, V24, P1541, DOI 10.1080/07373930601047584
   Zhang QH, 2002, BIOSYST ENG, V83, P281, DOI [10.1006/bioe.2002.0123, 10.1016/S1537-S110(02)00190-3]
   Zurada JM, 1997, NEUROCOMPUTING, V14, P177, DOI 10.1016/S0925-2312(96)00031-8
NR 26
TC 6
Z9 6
U1 0
U2 3
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0737-3937
J9 DRY TECHNOL
JI Dry. Technol.
PY 2007
VL 25
IS 10
BP 1667
EP 1676
DI 10.1080/07373930701590871
PG 10
WC Engineering, Chemical; Engineering, Mechanical
SC Engineering
GA 216HJ
UT WOS:000249868800011
DA 2018-10-19
ER

PT J
AU Pearce, AI
   Richards, RG
   Milz, S
   Schneider, E
   Pearce, SG
AF Pearce, A. I.
   Richards, R. G.
   Milz, S.
   Schneider, E.
   Pearce, S. G.
TI Animal models for implant biomaterial research in bone: A review
SO EUROPEAN CELLS & MATERIALS
LA English
DT Review
DE animal; models; biomaterials; osseointegration; bone; implant; dog; pig;
   sheep; goat; rabbit
ID TRABECULAR BONE; CORTICAL BONE; POTENTIAL IMPLICATIONS; MINIATURE PIGS;
   IN-VIVO; RABBITS; GOATS; TITANIUM; WEIGHT; HIP
AB Development of an optimal interface between bone and orthopaedic or dental implants has taken place for many years. In order to determine whether a newly developed implant material conforms to the requirements of biocompatibility, mechanical stability and safety, it must undergo rigorous testing both in vitro and in vivo. Results from in vitro studies can be difficult to extrapolate to the in vivo situation. For this reason the use of animal models is often an essential step in the testing of orthopaedic and dental implants prior to clinical use in humans. This review discusses some of the more commonly available and frequently used animal models such as the dog, sheep, goat, pig and rabbit models for the evaluation of bone-implant interactions. Factors for consideration when choosing an animal model and implant design are discussed. Various bone specific features are discussed including the usage of the species, bone macrostructure and microstructure and bone composition and remodelling, with emphasis being placed on the similarity between the animal model and the human clinical situation. While the rabbit was the most commonly used of the species discussed in this review, it is clear that this species shows the least similarities to human bone. There were only minor differences in bone composition between the various species and humans. The pig demonstrates a good likeness with human bone, however difficulties may be encountered in relation to their size and ease of handling. In this respect the dog and sheep/goat show more promise as animal models for the testing of bone implant materials. While no species fulfils all of the requirements of an ideal model, an understanding of the differences in bone architecture and remodelling will assist in the selection of a suitable model for a defined research question.
C1 AO Fdn, AO Res Inst, CH-7270 Davos, Switzerland.
RP Pearce, AI (reprint author), AO Fdn, AO Res Inst, Clavadeleerstr 8, CH-7270 Davos, Switzerland.
EM alexandra.pearce@aofoundation.org
RI Milz, Stefan/J-8218-2012
OI Milz, Stefan/0000-0002-3859-2107; Richards, Robert/0000-0002-7778-2480
CR Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663
   Aerssens J, 1997, J ENDOCRINOL, V155, P411, DOI 10.1677/joe.0.1550411
   An YH, 1999, ANIMAL MODELS ORTHOP, P39
   Anderson MLC, 1999, CLIN ORTHOP RELAT R, P231
   BLOEBAUM RD, 1993, J BIOMED MATER RES, V27, P1149, DOI 10.1002/jbm.820270905
   BLOEBAUM RD, 1991, CLIN ORTHOP RELAT R, P97
   BUSER D, 1991, J BIOMED MATER RES, V25, P889, DOI 10.1002/jbm.820250708
   CARLSSON L, 1988, ACTA ORTHOP SCAND, V59, P272, DOI 10.3109/17453678809149361
   Castaneda S, 2006, SKELETAL RADIOL, V35, P34, DOI 10.1007/s00256-005-0022-z
   CHAVASSIEUX P, 1987, J BONE MINER RES S1, V2
   Dai KR, 2005, CALCIFIED TISSUE INT, V77, P55, DOI 10.1007/s00223-004-0095-z
   Davies CM, 2006, EUR CELLS MATER, V11, P57, DOI 10.22203/eCM.v011a07
   DEKLEER V, 2006, BONE CLIN ORTHOPEDIC, P1
   den Boer FC, 1999, J ORTHOPAED RES, V17, P654, DOI 10.1002/jor.1100170506
   Egermann M, 2005, OSTEOPOROSIS INT, V16, P129
   EITEL F, 1981, ARCH ORTHOP TRAUM SU, V99, P59, DOI 10.1007/BF00400911
   Fernandez-Tresguerres-Hernandez-Gil Isabel, 2006, Med Oral Patol Oral Cir Bucal, V11, pE47
   GILSANZ V, 1988, AM J PHYSIOL, V255, pE416
   GONG JK, 1964, ANAT REC, V149, P325, DOI 10.1002/ar.1091490303
   Hanks CT, 1996, DENT MATER, V12, P186, DOI 10.1016/S0109-5641(96)80020-0
   HAZZARD DG, 1992, J GERONTOL, V47, pB63, DOI 10.1093/geronj/47.3.B63
   HUFFER WE, 2006, P 52 ORTH RES SOC, V2, P890
   International Organization for Standardization, 1994, BRAZ STREET CHIL SUM, P1
   Jee W. S. S., 1970, BEAGLE EXPT DOG, P162
   KIMMEL DB, 1982, ANAT REC, V203, P31, DOI 10.1002/ar.1092030104
   Kirkpatrick CJ, 2002, BIOMOL ENG, V19, P211, DOI 10.1016/S1389-0344(02)00019-9
   KRAGSTRUP J, 1989, BONE, V10, P421, DOI 10.1016/8756-3282(89)90073-2
   KUHN JL, 1989, J BIOMECH, V22, P95, DOI 10.1016/0021-9290(89)90032-8
   LAIBLIN C, 1979, BERL MUNCH TIERARZTL, V92, P124
   Lamerigts NMP, 2000, BIOMATERIALS, V21, P741, DOI 10.1016/S0142-9612(99)00247-1
   Leung KS, 2001, J BONE MINER RES, V16, P2348, DOI 10.1359/jbmr.2001.16.12.2348
   Liebschner MAK, 2004, BIOMATERIALS, V25, P1697, DOI 10.1016/S0142-9612(03)00515-5
   MAGEE FP, 1989, T ORTH RES SOC, V14, P575
   Martini L, 2001, COMPARATIVE MED, V51, P292
   Martiniakova M, 2005, FOLIA BIOL-PRAGUE, V51, P140
   MOSEKILDE L, 1993, BONE, V14, P379, DOI 10.1016/8756-3282(93)90167-9
   MOSEKILDE L, 1987, CALCIFIED TISSUE INT, V40, P318, DOI 10.1007/BF02556693
   Nafei A, 2000, J BONE JOINT SURG BR, V82B, P910, DOI 10.1302/0301-620X.82B6.9836
   Nahid Mohebbian, 2003, Rev Belge Med Dent (1984), V58, P189
   NEWMAN E, 1995, BONE, V16
   Neyt J G, 1998, Iowa Orthop J, V18, P118
   Pastoureau PME, 1989, J BONE MINER RES   S, V4, P237
   Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7
   POLIG E, 1989, RADIAT RES, V120, P83, DOI 10.2307/3577636
   Qin L, 1999, ANAT RECORD, V255, P380
   RAAB DM, 1991, J BONE MINER RES, V6, P741
   Ravaglioli A, 1996, BIOMATERIALS, V17, P617, DOI 10.1016/0142-9612(96)88712-6
   Richards RG, 2001, CELL BIOL INT, V25, P1237, DOI 10.1006/cbir.2001.0807
   SCHIMANDLE JH, 1994, SPINE, V19, P1998, DOI 10.1097/00007632-199409000-00023
   Schmidt C, 2001, J BIOMED MATER RES, V54, P209, DOI 10.1002/1097-4636(200102)54:2<209::AID-JBM7>3.0.CO;2-7
   SPAARGAREN DH, 1994, ACTA BIOTHEOR, V42, P263, DOI 10.1007/BF00707392
   Sun CT, 1999, CHINESE MED J-PEKING, V112, P456
   Swindle M M, 1988, J Invest Surg, V1, P65, DOI 10.3109/08941938809141077
   Thorwarth M, 2005, J ORAL MAXIL SURG, V63, P1626, DOI 10.1016/j.joms.2005.06.010
   Turner A. Simon, 2001, European Cells & Materials, V1, P66
   Turner AS, 1993, ACVS, P413
   Urban RM, 2000, J BONE JOINT SURG AM, V82A, P457, DOI 10.2106/00004623-200004000-00002
   van der Donk S, 2001, COMPARATIVE MED, V51, P336
   VICO L, 1987, BONE MINER, V2, P383
   Wang XD, 1998, BIO-MED MATER ENG, V8, P1
   WATAHA JC, 1994, DENT MATER, V10, P156, DOI 10.1016/0109-5641(94)90025-6
   Willie BM, 2004, J BIOMED MATER RES A, V69A, P567, DOI 10.1002/jbm.a.30038
NR 62
TC 534
Z9 544
U1 1
U2 96
PU SWISS SOCIETY FOR BIOMATERIALS, AO RESEARCH INSTITUTE
PI DAVOS
PA BIO-PERFORMANCE MATERIALS & DEVICES, AO RESEARCH INSTITUTE,
   CLAVADELERSTRASSE 8, DAVOS, CH 7270, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JAN-JUN
PY 2007
VL 13
BP 1
EP 10
PG 10
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 175GQ
UT WOS:000247002200001
PM 17334975
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Parvizi, J
   Antoci, V
   Hickok, NJ
   Shapiro, IM
AF Parvizi, Javad
   Antoci, Valentin, Jr.
   Hickok, Noreen J.
   Shapiro, Irving M.
TI Selfprotective smart orthopedic implants
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Review
DE device; implant; orthopedic; peri-prosthetic infection; selfprotective;
   smart; surgery
ID TOTAL HIP-ARTHROPLASTY; ACRYLIC BONE-CEMENT; REVISION TOTAL HIP;
   PROSTHETIC JOINT INFECTION; TOTAL KNEE ARTHROPLASTY; SILICA SOL-GEL;
   IN-VITRO; CONTROLLED-RELEASE; BIOMEDICAL APPLICATIONS;
   STAPHYLOCOCCUS-AUREUS
AB In this review, we discuss current advances leading to an exciting change in implant design for orthopedic surgery. The initial biomaterial approaches in implant design are being replaced by cellular-molecular interactions and nanoscale chemistry. New designs address implant complications, particularly loosening and infection. For infection, local delivery systems are an important first step in the process. Selfprotective 'smart' devices are an example of the next generation of orthopedic implants. If proven to be effective, antibiotics or other active molecules that are tethered to the implant surface through a permanent covalent bond and tethering of antibiotics or other biotactors are likely to transform the practice of orthopedic surgery and other medical specialties. This new technology has the potential to eliminate periprosthetic infection, a major and growing problem in orthopedic practice.
C1 Thomas Jefferson Univ, Rothman Inst Orthoped, Philadelphia, PA 19107 USA.
   Thomas Jefferson Univ, Dept Orthoped Surg, Philadelphia, PA 19107 USA.
RP Parvizi, J (reprint author), Thomas Jefferson Univ, Rothman Inst Orthoped, 925 Chestnut St, Philadelphia, PA 19107 USA.
EM parvj@aol.com
CR Anglen J., 2002, TECH ORTHOPAEDICS, V17, P506
   [Anonymous], 2004, J BONE JOINT SURG AM, V86-A, P1328
   ANTOCI V, 2007, IN PRESS J ORTHOPAED
   ANTOCI V, 2007, IN PRESS CLIN ORTHOP
   Arciola CR, 2004, BIOMATERIALS, V25, P4825, DOI 10.1016/j.biomaterials.2003.11.056
   Arciola CR, 2005, INT J ARTIF ORGANS, V28, P1119
   Assis SL, 2005, J BIOMED MATER RES B, V73B, P109, DOI 10.1002/jbm.b.30205
   Aughenbaugh W, 2001, J BIOMED MATER RES, V57, P321, DOI 10.1002/1097-4636(20011205)57:3<321::AID-JBM1174>3.0.CO;2-S
   Bagno A, 2004, J MATER SCI-MATER M, V15, P935, DOI 10.1023/B:JMSM.0000042679.28493.7f
   Baker C, 2005, J NANOSCI NANOTECHNO, V5, P244, DOI 10.1166/jnn.2005.034
   Balint L, 2006, ORTHOPEDICS, V29, P432
   Bar-Cohen Y, 2005, EXPERT REV MED DEVIC, V2, P731, DOI 10.1586/17434440.2.6.731
   Barber Clifton E., 1993, Clinical Gerontologist, V12, P3, DOI 10.1300/J018v12n04_02
   BARRACK RL, 1995, CLIN ORTHOP RELAT R, V319, P209
   BATTAN PC, 1919, LUMINESCENCE, V5, P265
   Bauer TW, 2006, J BONE JOINT SURG AM, V88A, P869, DOI 10.2106/JBJS.E.01149
   Berbari EF, 1998, CLIN INFECT DIS, V27, P1247, DOI 10.1086/514991
   BERGER RA, 1996, AM ACAD ORTHOPAEDIC, V44, P1
   Beyer M, 2006, BIOMATERIALS, V27, P3505, DOI 10.1016/j.biomaterials.2006.01.046
   Block JE, 2005, ORTHOPEDICS, V28, P1334
   Borsari V, 2005, BIOMATERIALS, V26, P4948, DOI 10.1016/j.biomaterials.2005.01.010
   Bozic KJ, 2005, J BONE JOINT SURG AM, V87A, P1746, DOI 10.2106/JBJS.D.02937
   Burny F, 2000, MED ENG PHYS, V22, P469, DOI 10.1016/S1350-4533(00)00062-X
   Buttaro M, 2004, ACTA ORTHOP SCAND, V75, P427
   Caldwell Douglas E., 2002, International Microbiology, V5, P107, DOI 10.1007/s10123-002-0083-y
   Calhoun JH, 1997, CLIN ORTHOP RELAT R, P206
   Campoccia D, 2006, BIOMATERIALS, V27, P2331, DOI 10.1016/j.biomaterials.2005.11.044
   *CAN JOINT REPL RE, 2003, ANN REP
   CANDLISH JK, 1993, PATHOLOGY, V25, P148, DOI 10.3109/00313029309084790
   Carpi F, 2005, IEEE T INF TECHNOL B, V9, P295, DOI 10.1109/TITb.2005.854514
   CHARNLEY J, 1970, CLIN ORTHOP RELAT R, P7
   CHARNLEY J, 1969, BRIT J SURG, V56, P641, DOI 10.1002/bjs.1800560902
   Chopp DL, 2002, J IND MICROBIOL BIOT, V29, P339, DOI 10.1038/sj.jim.7000316
   Cierny G, 2002, CLIN ORTHOP RELAT R, P23, DOI 10.1097/01.blo.0000030334.53928.23
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1994, J BACTERIOL, V176, P2137
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415
   Darouiche RO, 2003, CLIN INFECT DIS, V36, P1284, DOI 10.1086/374842
   Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   DUCHEYNE P, 1985, J BIOMED MATER RES, V19, P273, DOI 10.1002/jbm.820190309
   DUCHEYNE P, 1986, BIOMATERIALS, V7, P97, DOI 10.1016/0142-9612(86)90063-3
   Duggan JM, 2001, INFECT MED, V18, P534
   Dyce J, 2002, VET SURG, V31, P552, DOI 10.1053/jvet.2002.34670
   El-Ghannam AR, 2004, J BIOMED MATER RES A, V68A, P615, DOI 10.1002/jbm.a.20051
   Eliades T, 2004, AM J ORTHOD DENTOFAC, V125, P24, DOI 10.1016/j.ajodo.2003.09.009
   Fairman R, 2005, CURR OPIN STRUC BIOL, V15, P453, DOI 10.1016/j.sbi.2005.07.005
   Faria ACL, 2003, INT J ORAL MAX IMPL, V18, P820
   Fear J, 1997, BRIT J RHEUMATOL, V36, P74
   Ferdinand M, 1994, J Healthc Mater Manage, V12, P20
   FOISNER J, 1920, LANGMUIR, V7, P2701
   Fruh HJ, 2002, ORTHOPADE, V31, P454, DOI 10.1007/s00132-001-0295-4
   Garvin K, 2005, CLIN ORTHOP RELAT R, P105, DOI 10.1097/01.blo.0000175720.99118.fe
   Geipel U, 2004, ORTHOPADE, V33, P1411, DOI 10.1007/s00132-004-0741-1
   Ginalska G, 2005, INT J PHARM, V288, P131, DOI 10.1016/j.ijpharm.2004.09.021
   Ginalska G, 2004, J BIOMATER APPL, V18, P279, DOI 10.1177/0885328204041443
   Gomez MPR, 2004, J CLIN MICROBIOL, V42, P3371, DOI 10.1128/JCM.42.7.3371-3373.2004
   Gough JE, 2004, J BIOMED MATER RES A, V68A, P640, DOI 10.1002/jbm.a.20075
   Greenland S, 2000, ANN EPIDEMIOL, V10, P205, DOI 10.1016/S1047-2797(00)00037-5
   Grzybowski J, 1997, J BIOMED MATER RES, V36, P163, DOI 10.1002/(SICI)1097-4636(199708)36:2<163::AID-JBM4>3.0.CO;2-I
   Hallan G, 2006, J BONE JOINT SURG BR, V88B, P1143, DOI 10.1302/0301-620X.88B9.18008
   HAMMES WP, 1974, ANTIMICROB AGENTS CH, V6, P722, DOI 10.1128/AAC.6.6.722
   Hanssen AD, 2004, CLIN ORTHOP RELAT R, P79, DOI 10.1097/01.blo.0000143806.72379.7d
   Hansson KM, 2005, BIOMATERIALS, V26, P861, DOI 10.1016/j.biomaterials.2004.03.036
   Hartley RC, 2002, J BONE JOINT SURG BR, V84B, P994, DOI 10.1302/0301-620X.84B7.12607
   HENCH LL, 1980, J BIOMED MATER RES, V14, P803, DOI 10.1002/jbm.820140611
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   Herndon JH, 2001, J BONE JOINT SURG AM, V83A, P1097, DOI 10.2106/00004623-200107000-00018
   Howe L, 1999, BRIT DENT J, V187, P593
   Huang ZH, 2005, MOL THER, V11, P409, DOI 10.1016/j.ymthe.2004.10.013
   Jiranek W, 2005, ORTHOPEDICS, V28, pS873
   Jose B, 2005, CHEM BIOL, V12, P1041, DOI 10.1016/j.chembiol.2005.06.013
   Kalicke T, 2006, J ORTHOP RES, V24, P1622, DOI 10.1002/jor.20193
   Kalteis T, 2004, Z ORTHOP GRENZGEB, V142, P666, DOI 10.1055/s-2004-832317
   Kim HW, 2004, J BIOMED MATER RES B, V71B, P66, DOI 10.1002/jbm.b.30064
   Kim J, 2005, J AM CHEM SOC, V127, P9588, DOI 10.1021/ja0519076
   Kumazawa R, 2002, BIOMATERIALS, V23, P3757, DOI 10.1016/S0142-9612(02)00115-1
   Kurtz S, 2005, J BONE JOINT SURG AM, V87A, P1487, DOI 10.2106/JBJS.D.02441
   Langais F, 2006, INT J ANTIMICROB AG, V28, P84, DOI 10.1016/j.ijantimicag.2006.05.020
   LEE DH, 1920, LANGMUIR, V19, P8124
   Lee SB, 2004, BIOMACROMOLECULES, V5, P877, DOI 10.1021/bm034352k
   Lee TM, 2006, J MATER SCI-MATER M, V17, P15, DOI 10.1007/s10856-006-6325-3
   LEGEROS RZ, 1993, J BONE MINER RES, V8, pS583
   Lehn JM, 2002, SCIENCE, V295, P2400, DOI 10.1126/science.1071063
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2005, Med Device Technol, V16, P12
   Lewis K, 2005, TRENDS BIOTECHNOL, V23, P343, DOI 10.1016/j.tibtech.2005.05.004
   Li JP, 2004, J MATER SCI-MATER M, V15, P951, DOI 10.1023/B:JMSM.0000042680.10087.15
   Lin HY, 2004, J BIOMED MATER RES A, V68A, P717, DOI 10.1002/jbm.a.20092
   Loll PJ, 2000, ANNU REV BIOPH BIOM, V29, P265, DOI 10.1146/annurev.biophys.29.1.265
   Mante Francis K, 2004, J Oral Implantol, V30, P343, DOI 10.1563/0.667.1
   MARRIE TJ, 1982, CIRCULATION, V66, P1339, DOI 10.1161/01.CIR.66.6.1339
   McLaren AC, 2004, CLIN ORTHOP RELAT R, P25, DOI 10.1097/01.blo.0000143556.41472.2a
   McLaren AC, 2002, CLIN ORTHOP RELAT R, P54, DOI 10.1097/01.blo.0000030069.92399.9b
   McLaren AC, 2004, CLIN ORTHOP RELAT R, P101, DOI 10.1097/01.blo.0000143554.56897.26
   MCPHERSON EJ, 2002, CLIN ORTHOP RELAT R, V1, P8
   Milovic NM, 2005, BIOTECHNOL BIOENG, V90, P715, DOI 10.1002/bit.20454
   Moradian-Oldak J, 2006, PERIODONTOL 2000, V41, P157, DOI 10.1111/j.1600-0757.2006.00153.x
   Morikawa K, 2005, INT J ANTIMICROB AG, V25, P44, DOI 10.1016/j.ijantimicag.2004.07.015
   MOS AJ, 1991, VITAL HLTH STAT NATL, V191, P5
   Mukherjee PK, 2004, DRUG RESIST UPDATE, V7, P301, DOI 10.1016/j.drup.2004.09.002
   Natali AN, 2006, CLIN ORAL IMPLAN RES, V17, P67, DOI 10.1111/j.1600-0501.2005.01162.x
   Nelson CL, 2004, CLIN ORTHOP RELAT R, P72, DOI 10.1097/01.bio.0000143741.92384.18
   Neut D, 2001, J ANTIMICROB CHEMOTH, V47, P885, DOI 10.1093/jac/47.6.885
   Ng BD, 2005, BIOMATERIALS, V26, P1087, DOI 10.1016/j.biomaterials.2004.04.022
   NICKEL JC, 1985, ANTIMICROB AGENTS CH, V27, P619, DOI 10.1128/AAC.27.4.619
   Nordon JI, 2005, MED J AUSTRALIA, V182, P312
   Novikova LN, 2003, CURR OPIN NEUROL, V16, P711, DOI 10.1097/01.wco.0000102620.38669.3e
   Ong KL, 2006, CLIN ORTHOP RELAT R, P22, DOI 10.1097/01.blo.0000214439.95268.59
   Pagnano MW, 2003, MAYO CLIN PROC, V78, P285, DOI 10.4065/78.3.285
   Park D, 2006, BIOTECHNOL PROGR, V22, P584, DOI 10.1021/bp0503383
   Parvizi J, 2004, CLIN ORTHOP RELAT R, P33, DOI 10.1097/01.blo.0000150116.65231.45
   Parvizi J, 2004, J BONE JOINT SURG AM, V86A, P783, DOI 10.2106/00004623-200404000-00017
   Patel KR, 2006, BIOMATERIALS, V27, P1519, DOI 10.1016/j.biomaterials.2005.08.009
   Phillips K, 1995, J Healthc Resour Manag, V13, P40
   Piasecki P, 1988, Orthop Nurs, V7, P20, DOI 10.1097/00006416-198807000-00007
   PICKNELL B, 1977, J BONE JOINT SURG BR, V59, P302
   Powers KA, 2002, SURGERY, V132, P391, DOI 10.1067/msy.2002.126508
   Puolakka TJS, 2001, ACTA ORTHOP SCAND, V72, P433, DOI 10.1080/000164701753532745
   Radin S, 2002, BIOMATERIALS, V23, P3113, DOI 10.1016/S0142-9612(02)00051-0
   Radin S, 2001, J BIOMED MATER RES, V57, P313, DOI 10.1002/1097-4636(200111)57:2<313::AID-JBM1173>3.0.CO;2-E
   RITTER MA, 1980, CLIN ORTHOP RELAT R, P204
   Roberts ME, 2005, MICROBIOL-SGM, V151, P75, DOI 10.1099/mic.0.27385-0
   Rokkanen PU, 2000, BIOMATERIALS, V21, P2607, DOI 10.1016/S0142-9612(00)00128-9
   Ronold HJ, 2003, J BIOMED MATER RES A, V67A, P524, DOI 10.1002/jbm.a.10580
   Russell A D, 1969, Prog Med Chem, V6, P135, DOI 10.1016/S0079-6468(08)70198-X
   Saleh KJ, 2006, CLIN ORTHOP RELAT R, P15, DOI 10.1097/01.blo.0000214416.91216.77
   Saravanapavan P, 2004, BIO-MED MATER ENG, V14, P467
   SHIM HS, 1976, J BIOENG, V1, P45
   SOUTHWOOD RT, 1987, CLIN ORTHOP RELAT R, P33
   SOUTHWOOD RT, 1985, J BONE JOINT SURG BR, V67, P229
   Steinberg PD, 2002, J CHEM ECOL, V28, P1935, DOI 10.1023/A:1020789625989
   Stevens CM, 2005, J ORTHOP RES, V23, P27, DOI 10.1016/j.orthres.2004.03.003
   Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1
   Swenson R M, 1970, Adv Intern Med, V16, P373
   Tadic D, 2004, MATERIALWISS WERKST, V35, P1001, DOI 10.1002/mawe.200400841
   Tattevin P, 1999, CLIN INFECT DIS, V29, P292, DOI 10.1086/520202
   Tenover FC, 2006, AM J MED, V119, pS3, DOI 10.1016/j.amjmed.2006.03.011
   Tunney MM, 1999, J CLIN MICROBIOL, V37, P3281
   Vinh Donald C, 2005, J Long Term Eff Med Implants, V15, P467, DOI 10.1615/JLongTermEffMedImplants.v15.i5.20
   Von Eiff C, 2005, INT J ARTIF ORGANS, V28, P1146
   Wagner M, 1993, Mod Healthc, V23, P34
   Wang L, 2005, J CHEM THEORY COMPUT, V1, P201, DOI 10.1021/ct049932+
   Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821
   Whittaker CJ, 1996, ANNU REV MICROBIOL, V50, P513, DOI 10.1146/annurev.micro.50.1.513
   Widmer AF, 2001, CLIN INFECT DIS, V33, pS94, DOI 10.1086/321863
   Wildemann B, 2004, J CONTROL RELEASE, V95, P249, DOI 10.1016/j.jconrel.2003.11.014
   Xie H, 2000, J BACTERIOL, V182, P7067, DOI 10.1128/JB.182.24.7067-7069.2000
   Zhuang HM, 2002, EUR J NUCL MED MOL I, V29, P1328, DOI 10.1007/s00259-002-0886-2
   2001, OR MANAGER, V17, P8
NR 153
TC 18
Z9 18
U1 0
U2 15
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1743-4440
EI 1745-2422
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD JAN
PY 2007
VL 4
IS 1
BP 55
EP 64
DI 10.1586/17434440.4.1.55
PG 10
WC Engineering, Biomedical
SC Engineering
GA 129WW
UT WOS:000243761800011
PM 17187471
DA 2018-10-19
ER

PT J
AU Di Bonaventura, G
   Stepanovic, S
   Picciani, C
   Pompilio, A
   Piccolomini, R
AF Di Bonaventura, G.
   Stepanovic, S.
   Picciani, C.
   Pompilio, A.
   Piccolomini, R.
TI Effect of environmental factors on biofilm formation by clinical
   Stenotrophomonas maltophilia isolates
SO FOLIA MICROBIOLOGICA
LA English
DT Article
ID XANTHOMONAS-MALTOPHILIA; DYNAMIC CONDITIONS; INFECTIONS; ATMOSPHERE;
   DISEASE; CELLS; PH
AB The influence of environmental factors (temperature, aerobiosis-anaerobiosis, static-dynamic conditions, pH) was determined on biofilm formation by 51 S. maltophilia clinical isolates. The strains produced more biofilm at 32 degrees C than at 37 or 18 degrees C. Aerobic and 6 % CO2 atmosphere yielded comparable biofilm amounts, higher than under anaerobic conditions. Biofilm production was not affected by static vs. agitated culture conditions. Biofilm production at pH 7.5 and 8.5 was comparable but significantly higher than at pH 5.5. The capacity of individual strains to form biofilm and thus contribute to the severity of some diseases is influenced by host traits and environmental conditions at the site of infection, and play an important role in the pathogenesis of biomaterial-related disease caused by S. maltophilia.
C1 Gabriele Annunzio Univ, Fac Med, Dept Biomed Sci, Chieti, Italy.
   Gabriele Annunzio Univ Fdn, Aging Res Ctr, Ctr Studio Invecchiamento, Chieti, Italy.
   Sch Med, Inst Microbiol & Immunol, Dept Bacteriol, Belgrade, Serbia.
RP Di Bonaventura, G (reprint author), Gabriele Annunzio Univ, Fac Med, Dept Biomed Sci, Chieti, Italy.
EM giovannidibo@hotmail.com
OI Di Bonaventura, Giovanni/0000-0001-5850-2810
CR Biswas SK, 2005, CURR MICROBIOL, V51, P100, DOI 10.1007/s00284-005-4552-3
   Cernohorska L, 2004, FOLIA MICROBIOL, V49, P75, DOI 10.1007/BF02931650
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Dancer SJ, 1999, J HOSP INFECT, V43, P85, DOI 10.1053/jhin.1999.0616
   Denton M, 1998, CLIN MICROBIOL REV, V11, P57
   Di Bonaventura G, 2004, ANTIMICROB AGENTS CH, V48, P151, DOI 10.1128/AAC.48.1.151-160.2004
   Donaldson SH, 2003, CURR OPIN PULM MED, V9, P486, DOI 10.1097/00063198-200311000-00007
   Guiney DG, 1997, J CLIN INVEST, V99, P565, DOI 10.1172/JCI119196
   Harjai K, 2005, FOLIA MICROBIOL, V50, P99, DOI 10.1007/BF02931455
   Jucker BA, 1996, J BACTERIOL, V178, P5472, DOI 10.1128/jb.178.18.5472-5479.1996
   Kellum JA, 2000, CRIT CARE, V4, P6, DOI 10.1186/cc644
   Oie S, 1996, AM J INFECT CONTROL, V24, P389, DOI 10.1016/S0196-6553(96)90027-9
   Ruzicka F, 2004, FOLIA MICROBIOL, V49, P596, DOI 10.1007/BF02931540
   Senol E, 2002, CLIN INFECT DIS, V34, P1653, DOI 10.1086/340707
   Squier, 2000, Curr Infect Dis Rep, V2, P490, DOI 10.1007/s11908-000-0049-1
   Stepanovic S, 2003, CLIN MICROBIOL INFEC, V9, P955, DOI 10.1046/j.1469-0691.2003.00676.x
   Stepanovic S, 2003, FOOD MICROBIOL, V20, P339, DOI 10.1016/S0740-0020(02)00123-5
   Stepanovic S, 2001, EUR J CLIN MICROBIOL, V20, P502
   SVABICVLAHOVIC M, 2003, 13 EUR C CLIN MICR I
   VANCOUWENBERGHE C, 1994, INFECT CONT HOSP EP, V15, P691
   Vidipo LD, 2001, MICROBIOL IMMUNOL, V45, P563
   Walencka E, 2006, FOLIA MICROBIOL, V51, P381, DOI 10.1007/BF02931580
   WOODARD OM, 1990, APPL ENVIRON MICROB, V56, P3766
   Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI200213870
NR 24
TC 24
Z9 25
U1 1
U2 2
PU FOLIA MICROBIOLOGICA
PI PRAGUE 4
PA INST MICROBIOLOGY, VIDENSKA 1083, PRAGUE 4 142 20, CZECH REPUBLIC
SN 0015-5632
J9 FOLIA MICROBIOL
JI Folia Microbiol.
PY 2007
VL 52
IS 1
BP 86
EP 90
DI 10.1007/BF02932144
PG 5
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 160IN
UT WOS:000245934200014
PM 17571802
DA 2018-10-19
ER

PT J
AU Altun, GD
   Cetinus, SA
AF Altun, Gamze Durgun
   Cetinus, Senay Akkus
TI Immobilization of pepsin on chitosan beads
SO FOOD CHEMISTRY
LA English
DT Article
DE chitosan; pepsin; enzyme immobilization
ID PORCINE PEPSIN; ENZYMES; STABILIZATION; BIOMATERIAL; CATALASE; LIPASE;
   CHITIN; YEAST; FILMS; FORM
AB In this study, chitosan beads were prepared by using a cross-linking agent and the resulting beads were employed in immobilization process. Studies on free and immobilized pepsin systems for determination of optimum temperature, optimum pH, thermal stability, pH stability, operational stability, storage stability and kinetic parameters were carried out. The optimum temperature interval for free pepsin and immobilized pepsin were 30-40 and 40-50 degrees C, respectively. Free and immobilized pepsin showed higher activity at pH 2.0-4.0. Apparent K-m = 12.0 g L-1 haemoglobin (1.56 mM tyrosine) and V-max = 5220 mu mol (mg protein min)(-1) values were obtained for free pepsin, while apparent K-m = 20.0 g L-1 haemoglobin (2.16 mM tyrosine) and V-max = 2780 mu mol (mg protein min)(-1) values were obtained for immobilized pepsin. Thermal stability and storage stability of immobilized pepsin were higher than that of free pepsin. Milk clotting activity was used for evaluation of the applicability of pepsin immobilization to industrial process. Optimum milk clotting temperature was found as 40 degrees C for free pepsin and 50 degrees C for immobilized pepsin. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Cumhuriyet Univ, Fac Sci & Literature, Dept Chem, TR-58140 Sivas, Turkey.
RP Cetinus, SA (reprint author), Cumhuriyet Univ, Fac Sci & Literature, Dept Chem, TR-58140 Sivas, Turkey.
EM scetinus@cumhuriyet.edu.tr
CR ABDELNABY MA, 1993, APPL BIOCHEM BIOTECH, V38, P69, DOI 10.1007/BF02916413
   BERGKVIST R, 1963, ACTA CHEM SCAND, V17, P1521, DOI 10.3891/acta.chem.scand.17-1521
   BERRIDGE NJ, 1952, ANAL LONDON, V17, P57
   Betigeri SS, 2002, BIOMATERIALS, V23, P3627, DOI 10.1016/S0142-9612(02)00095-9
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cao LQ, 2003, CURR OPIN BIOTECH, V14, P387, DOI 10.1016/S0958-1669(03)00096-X
   Cetinus SA, 2003, ENZYME MICROB TECH, V32, P889, DOI 10.1016/S0141-0229(03)00065-6
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   Chiou SH, 2004, BIOMATERIALS, V25, P197, DOI 10.1016/S0142-9612(03)00482-4
   COOPER JB, 1990, J MOL BIOL, V214, P199, DOI 10.1016/0022-2836(90)90156-G
   DEANS JR, 1992, ADVANCES IN CHITIN AND CHITOSAN, P648
   FREEMAN A, 1994, BIOTECHNOL BIOENG, V44, P1083, DOI 10.1002/bit.260440909
   Frydlova J, 2004, J CHROMATOGR B, V800, P109, DOI 10.1016/j.jchromb.2003.07.007
   Gemeiner P, 1992, ENZYME ENG, P13
   HASEM AM, 2000, BIORESOURCE TECHNOLO, V75, P219
   HASEM AM, 1999, BIORESOURCE TECHNOLO, V70, P203
   JIANG B, 1993, EUR POLYM J, V29, P1251, DOI 10.1016/0014-3057(93)90157-B
   Kamatari YO, 2003, PROTEIN SCI, V12, P717, DOI 10.1110/ps.0219903
   Kennedy J.F., 1990, CHEM ENG PROG, V45, P81
   Khor E, 2002, CURR OPIN SOLID ST M, V6, P313, DOI 10.1016/S1359-0286(02)00002-5
   Kittur FS, 1998, Z LEBENSM UNTERS F A, V206, P44, DOI 10.1007/s002170050211
   KRAJEWSKA B, 1990, J CHEM TECHNOL BIOT, V48, P337
   Kurimoto E, 2001, J BIOCHEM-TOKYO, V130, P295, DOI 10.1093/oxfordjournals.jbchem.a002985
   Li SJ, 2004, BIOSYSTEMS, V77, P25, DOI 10.1016/j.biosystems.2004.03.001
   MARTINEK K, 1977, BIOCHIM BIOPHYS ACTA, V485, P1, DOI 10.1016/0005-2744(77)90188-7
   Oztop HN, 2002, APPL BIOCHEM BIOTECH, V101, P239, DOI 10.1385/ABAB:101:3:239
   PAPINEAU AM, 1991, FOOD BIOTECHNOL, V5, P45, DOI 10.1080/08905439109549790
   Pinotti A, 1997, J FOOD ENG, V32, P69, DOI 10.1016/S0260-8774(97)00003-4
   SHAHIDI F, 1991, J AGR FOOD CHEM, V39, P1527, DOI 10.1021/jf00008a032
   SOTOPERALTA NV, 1989, J FOOD SCI, V54, P495, DOI 10.1111/j.1365-2621.1989.tb03119.x
   Spagna G, 1996, FOOD RES INT, V29, P241, DOI 10.1016/0963-9969(96)00025-7
   Ticu EL, 2005, PROCESS BIOCHEM, V40, P2841, DOI 10.1016/j.procbio.2005.01.003
NR 32
TC 70
Z9 77
U1 2
U2 32
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0308-8146
J9 FOOD CHEM
JI Food Chem.
PY 2007
VL 100
IS 3
BP 964
EP 971
DI 10.1016/j.foodchem.2005.11.005
PG 8
WC Chemistry, Applied; Food Science & Technology; Nutrition & Dietetics
SC Chemistry; Food Science & Technology; Nutrition & Dietetics
GA 089GY
UT WOS:000240869800013
DA 2018-10-19
ER

PT S
AU Setejkin, AY
   Krasnikov, IV
AF Setejkin, A. Yu.
   Krasnikov, I. V.
BE Kulchin, YN
   Ou, J
   Vitrik, OB
   Zhou, Z
TI The analysis of the thermal effects arising at interaction of laser
   radiation with the multilayered biomaterial by using Monte Carlo method
SO FUNDAMENTAL PROBLEMS OF OPTOELECTRONICS AND MICROELECTRONICS III, PTS 1
   AND 2
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Fundamental Problems of Optoelectronics and
   Microelectronics III
CY SEP 12-14, 2006
CL Harbin, PEOPLES R CHINA
SP SPIE Russia Chapter, Russian Fdn Basic Res
DE Monte Carlo; heat conduction; multilayer tissue; finite element; laser
   irradiation
ID TISSUES
AB In this work we tried to create a mathematical model of thermal response of laser irradiated multilayer biological tissue. The tissue has 4 horizontal radial symmetric layers with its own optical-physical characteristics. We used the results of Monte Carlo modeling to describe the propagation of light (laser beams) in tissue and receive the function of heat source after we multiply the density of thermal emission by absorption coefficient. As we usually have radial symmetric laser beams we can use cylindrical coordinates. The solution of the 2D heat conduction equation is based on finite-element theory with using square finite elements. We simulated constant laser fluency and as result there are temperature fields. The analysis of the results represents, that heat does not localize on the surface, but collects inside of the tissue. By varying the boundary condition on the surface and type of laser irradiation we can reach high temperature inside the tissue without formation of necrosis at the same time.
C1 [Setejkin, A. Yu.; Krasnikov, I. V.] Amur State Univ, 21 Ignatevskoye Shosse, Blagoveshensk 675000, Amur Reg, Russia.
RP Setejkin, AY (reprint author), Amur State Univ, 21 Ignatevskoye Shosse, Blagoveshensk 675000, Amur Reg, Russia.
CR ASTAFIEVA LG, 2006, GEOMETRICAL APPL OPT, V100, P855
   JACQUES S, 1995, OPTICAL THERMAL RESP, V12, P301
   ROIDER J, 1995, OPTICAL THERMAL RESP, V12, P385
   SETEIKIN AY, 2006, OPTICAL J, V73, P31
   SETEIKIN AY, 2005, NEWS HIGH SCH PHYS, P53
   SHCHERBAKOV YN, 1994, OPT SPEKTROSK+, V76, P845
   WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F
   Wang LH, 1997, COMPUT METH PROG BIO, V54, P141, DOI 10.1016/S0169-2607(97)00021-7
NR 8
TC 1
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-6727-0
J9 PROC SPIE
PY 2007
VL 6595
AR UNSP 659520
DI 10.1117/12.725801
PN 1-2
PG 6
WC Engineering, Electrical & Electronic; Optics
SC Engineering; Optics
GA BGD42
UT WOS:000246171000071
DA 2018-10-19
ER

PT J
AU Prins, MH
   Smits, KM
   Smits, LJ
AF Prins, Martin H.
   Smits, Kim M.
   Smits, Luc J.
TI Methodologic ramifications of paying attention to sex and gender
   differences in clinical research
SO GENDER MEDICINE
LA English
DT Article; Proceedings Paper
CT IEEE Information Theory and Applications Workshop
CY JAN, 2007
CL San Diego, CA
SP IEEE
DE sex and gender differences; methodology; study design and reporting;
   study quality; effect modification
ID RANDOMIZED CONTROLLED-TRIALS; QUALITY
AB Background: Methodologic standards for studies on sex and gender differences should be developed to improve reporting of studies and facilitate their inclusion in systematic reviews. The essence of these studies lies within the concept of effect modification.
   Objective: This article reviews important methodologic issues in the design and reporting of pharmacogenetic studies.
   Results: Differences in effect based on sex or gender should preferably be expressed in absolute terms (risk differences) to facilitate clinical decisions on treatment. Information on the distribution of potential effect modifiers or prognostic factors should be available to prevent a biased comparison of differences in effect between genotypes. Other considerations included the possibility of selective nonavailability of biomaterial and the choice of a statistical model to study effect modification.
   Conclusion: To ensure high study quality, additional methodologic issues should be taken into account when designing and reporting studies on sex and gender differences. (Gend Med. 2007;4 [Suppl B]:S106-S110) Copyright (c) 2007 Excerpta Medica Inc.
C1 [Prins, Martin H.; Smits, Kim M.; Smits, Luc J.] Univ Maastricht, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands.
RP Prins, MH (reprint author), Univ Maastricht, Dept Epidemiol, POB 616, NL-6200 MD Maastricht, Netherlands.
EM Mh.Prins@EPID.unimaas.nl
RI Smits, Luc/C-5331-2008
CR Bogardus ST, 1999, JAMA-J AM MED ASSOC, V281, P1919, DOI 10.1001/jama.281.20.1919
   COOK RJ, 1995, BRIT MED J, V310, P452, DOI 10.1136/bmj.310.6977.452
   Doyal L, 2003, INT J HEALTH SERV, V33, P569, DOI 10.2190/CWK2-U7R6-VCE0-E47P
   Fletcher R.H., 1996, CLIN EPIDEMIOLOGY
   Greenland S, 1983, Stat Med, V2, P243, DOI 10.1002/sim.4780020219
   Kim DK, 2000, NEUROREPORT, V11, P215, DOI 10.1097/00001756-200001170-00042
   KOOPMAN JS, 1981, AM J EPIDEMIOL, V113, P716, DOI 10.1093/oxfordjournals.aje.a113153
   Martinez FD, 1997, J CLIN INVEST, V100, P3184, DOI 10.1172/JCI119874
   Moher D, 1998, JAMA-J AM MED ASSOC, V279, P1489, DOI 10.1001/jama.279.18.1489
   MOHER D, 1995, CONTROL CLIN TRIALS, V16, P62, DOI 10.1016/0197-2456(94)00031-W
   Rothman K.J, 1998, MODERN EPIDEMIOLOGY
   Sackett D. Straus  S. E, 2000, EVIDENCE BASED MED P
   Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0
NR 13
TC 13
Z9 13
U1 0
U2 1
PU EXCERPTA MEDICA INC-ELSEVIER SCIENCE INC
PI BRIDGEWATER
PA 685 ROUTE 202-206 STE 3, BRIDGEWATER, NJ 08807 USA
SN 1550-8579
J9 GENDER MED
JI Gend. Med.
PY 2007
VL 4
SU B
BP S106
EP S110
DI 10.1016/S1550-8579(07)80051-9
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA 256BI
UT WOS:000252702300005
PM 18156096
DA 2018-10-19
ER

PT S
AU Zheng, HD
   Wang, YJ
   Yang, CR
   Chen, XF
   Zhao, NR
AF Zheng Huade
   Wang Yingjun
   Yang Chunrong
   Chen Xiaofeng
   Zhao Naru
BE Pan, W
   Gong, JH
TI Investigation on the porous biomaterial for bone reconstruction with
   addition of bio-mimetic Nano-Sized inorganic particles
SO HIGH-PERFORMANCE CERAMICS IV, PTS 1-3
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 4th China International Conference on High-Performance Ceramics (CICC-4)
CY OCT 23-26, 2005
CL Chengdu, PEOPLES R CHINA
SP Chinese Ceram Soc, Tsinghua Univ
DE bio-mimetic synthesis; hydroxy-carbonate-apatite; bioactivity;
   nano-sized particles
ID HYDROXYAPATITE
AB The spherical nano-sized bioactive particles in the system of CaO-P(2)O(5)-SiO(2) were bio-mimetically synthesized using micro-emulsion method. The microstructures and properties of the bio-mimetic nano-materials were characterized using XRD, FTIR, SEM/EDAX and TEM techniques. It was indicated that the nano-particles possessed glassy structural characteristics. The porous composite for bone tissue reconstruction was prepared by compounding poly (hydroxybutyrate-2-co-2-hydroxyvalerate) (PHBV) and the nano-particles of bio-mimetic bioactive glasses (BMBG). Bone-like hydroxyl-carbonate-apatite (HCA) could formed on the surface of porous composite by immersing the composite in simulated body fluid (SBF) at 37 degrees C for 8 hours. With increase of immersion time, the morphology of HCA changed from spherical into flake-like crystals. The study on cells attachment of the porous PHBV/BMBG composite proved that the material possessed satisfactory bioactivity, bio-mineralization function and cells biocompatibility.
C1 S China Univ Technol, Coll Mat Sci & Engn, Biomat Res Inst, Guangzhou 510640, Peoples R China.
   S China Univ Technol, Minist Educ, Key Lab Specially Funct Mat & Adv Mfg Technol, Guangzhou 510640, Peoples R China.
RP Zheng, HD (reprint author), S China Univ Technol, Coll Mat Sci & Engn, Biomat Res Inst, Guangzhou 510640, Peoples R China.
CR Bose S, 2003, CHEM MATER, V15, P4464, DOI 10.1021/cm0303437
   Chen F, 2002, MATER LETT, V57, P858, DOI 10.1016/S0167-577X(02)00885-6
   Costa N, 1998, MED ENG PHYS, V20, P602, DOI 10.1016/S1350-4533(98)00056-3
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Milev AS, 2004, LANGMUIR, V20, P1888, DOI 10.1021/la0355601
   Tas AC, 2000, BIOMATERIALS, V21, P1429
   Uota M, 2005, LANGMUIR, V21, P4724, DOI 10.1021/la050029m
   Wang L, 2004, J NANOPART RES, V6, P91, DOI 10.1023/B:NANO.0000023228.49670.86
NR 8
TC 5
Z9 5
U1 1
U2 7
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-410-1
J9 KEY ENG MAT
PY 2007
VL 336-338
BP 1534
EP 1537
DI 10.4028/www.scientific.net/KEM.336-338.1534
PN 1-3
PG 4
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BGD27
UT WOS:000246148001185
DA 2018-10-19
ER

PT S
AU Ning, CY
   Wan, YJ
   Chen, XF
   Ye, JD
   Wu, G
   Zhao, NR
AF Ning, Chengyun
   Wan, Yingjun
   Chen, Xiaofeng
   Ye, Jiandong
   Wu, Gang
   Zhao, Naru
BE Pan, W
   Gong, JH
TI TEM analysis on bio-functional gradient Hydroxyapatite/ZrO2 coatings
SO HIGH-PERFORMANCE CERAMICS IV, PTS 1-3
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 4th China International Conference on High-Performance Ceramics (CICC-4)
CY OCT 23-26, 2005
CL Chengdu, PEOPLES R CHINA
SP Chinese Ceram Soc, Tsinghua Univ
DE TEM; bio-functional gradient coating; biomaterial; hydroxyapatite
AB In the present study, bioactive functional gradient coatings were prepared using net-energy controlled plasma spraying technology. The microstructure and phases of the bioactive functional gradient coating were examined by means of transmission electron microscope, scanning electron microscopy and X-ray diffraction. The results revealed that: (1) as-sprayed coatings contained a large amount of amorphous phases and some nano-sized HA crystals formed during rapid solidification, (2) surface of the coating was very rough with different-sized micropores, and the gradient layer was much denser which firmly bonded to the substrate without gaps and obvious interface between the coating and the substrate
C1 S China Univ Technol, Inst Mat Sci & Engn, Guangzhou 510641, Peoples R China.
   S China Univ Technol, Minist Educ, Key Lab Specially Funct Mat & Adv Mfg Technol, Guangzhou 510641, Guangdong, Peoples R China.
RP Ning, CY (reprint author), S China Univ Technol, Inst Mat Sci & Engn, Guangzhou 510641, Peoples R China.
OI Wu, Gang/0000-0002-4730-4971
CR Bayliss SC, 1999, ADV MATER, V11, P318, DOI 10.1002/(SICI)1521-4095(199903)11:4<318::AID-ADMA318>3.0.CO;2-Z
   Ding SJ, 2000, J MATER SCI-MATER M, V11, P183, DOI 10.1023/A:1008983709472
   Jinno T, 2002, J ARTHROPLASTY, V17, P902, DOI 10.1054/arth.2002.34821
   LEI F, 2000, SURF TECHNOL, V127, P66
   MASATO U, 2002, ADV MATER, V14, P591
   MCPHERSON R, 1995, J MATER SCI-MATER M, V6, P327, DOI 10.1007/BF00120300
   Ong JL, 2002, INT J ORAL MAX IMPL, V17, P581
   Wei M, 2001, J SOL-GEL SCI TECHN, V21, P39, DOI 10.1023/A:1011201414651
NR 8
TC 0
Z9 0
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-410-1
J9 KEY ENG MAT
PY 2007
VL 336-338
BP 1676
EP 1678
DI 10.4028/www.scientific.net/KEM.336-338.1676
PN 1-3
PG 3
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BGD27
UT WOS:000246148001226
DA 2018-10-19
ER

PT S
AU Deng, X
   He, G
   Liao, YM
   Yao, YY
   Chen, ZQ
   Li, G
   Zhao, Y
   Nie, RR
   Liang, ZH
   Qu, YL
   Tian, K
AF Deng, Xia
   He, Gang
   Liao, Yunmao
   Yao, Yongyi
   Chen, Zhiqing
   Li, Gang
   Zhao, Yong
   Nie, Rongrong
   Liang, Zhihong
   Qu, Yili
   Tian, Kun
BE Pan, W
   Gong, JH
TI Development of ultrafine fibrous hydroxyapatite/polymer scaffold by
   electrospinning
SO High-Performance Ceramics IV, Pts 1-3
SE KEY ENGINEERING MATERIALS
LA English
DT Proceedings Paper
CT 4th China International Conference on High-Performance Ceramics (CICC-4)
CY OCT 23-26, 2005
CL Chengdu, PEOPLES R CHINA
SP Chinese Ceram Soc, Tsinghua Univ
DE hydroxyapatite; polyesteramide; electrospinning; scaffold
AB A three-dimensional biomimetic electrospun scaffold was prepared from a nanohydroxyapatite/polymer blend in the present study. Viscosity of n-HA/PEA compound solution determined by PEA concentration and additives of n-HA was investigated while other parameters were fixed in the electrospinning process. The fiber diameter increased with the increasing viscosity of solution. 20wt% n-HA in the composite ultrafine fibrous scaffold was proved to be a preferable ratio. The n-HA/PEA scaffold was characterized by XRD, SEM and EDX. The fibrous electrospun scaffold, which is made up of ultrafine fibers with average diameter 400 +/- 50 nm and well-interconnected pores, was characterized with high surface-to-volume ratio, which is conducive to cell and tissue growth. A comparatively uniform distribution of n-HA crystals in a single fiber even in the whole scaffold was confirmed by EDX. The biocompatibility of the composite was investigated by culturing osteobalsts on the scaffold. Good cell adhesion and proliferation manner was observed on the fibrous scaffold by SEM and MTT assay. It could be expected that the electrospun HA/PEA composite scaffold would be a potential biomimetic extracellular matrix biomaterial for bone tissue engineering.
C1 Sichuan Univ, W China Coll Stomatol, Chengdu 610041, Peoples R China.
   Sichuan Univ, Coll Text, Chengdu 610065, Peoples R China.
   Kunming Med Univ, Kunming 650031, Peoples R China.
RP Deng, X (reprint author), Sichuan Univ, W China Coll Stomatol, Chengdu 610041, Peoples R China.
CR Deng XM, 2001, BIOMATERIALS, V22, P2867, DOI 10.1016/S0142-9612(01)00031-X
   Fujihara K, 2005, BIOMATERIALS, V26, P4139, DOI 10.1016/j.biomaterials.2004.09.014
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Li Y. B., 1994, J MATER SCI-MATER M, V5, P252, DOI DOI 10.1007/BF00122393)
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Qian ZY, 2003, POLYM DEGRAD STABIL, V81, P279, DOI 10.1016/S0141-3910(03)00098-3
NR 6
TC 2
Z9 2
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-410-1
J9 KEY ENG MAT
PY 2007
VL 336-338
BP 1703
EP 1706
DI 10.4028/www.scientific.net/KEM.336-338.1703
PN 1-3
PG 4
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BGD27
UT WOS:000246148001233
DA 2018-10-19
ER

PT S
AU Hua, YH
   Wang, TF
   Zhou, DL
   Li, DY
   Lin, JL
   Zheng, CQ
AF Hua, Yahui
   Wang, Tianfu
   Zhou, Dali
   Li, Deyu
   Lin, Jiangli
   Zheng, Changqiong
BE Pan, W
   Gong, JH
TI Quantitative evaluation for new bone growth of bone repairing
   biomaterial based on color image segmentation
SO HIGH-PERFORMANCE CERAMICS IV, PTS 1-3
SE Key Engineering Materials
LA English
DT Proceedings Paper
CT 4th China International Conference on High-Performance Ceramics (CICC-4)
CY OCT 23-26, 2005
CL Chengdu, PEOPLES R CHINA
SP Chinese Ceram Soc, Tsinghua Univ
DE color image segmentation; BMP/alpha-TCP; HSI color space; bone repairing
   material
AB Quantitative evaluation of repairing effect of bone grafting material is one of the essential studying subjects. However, traditional evaluation methods are subjective and qualitative. In this paper, the region of new bone from a bone repairing biomaterial planted image is extracted based on color image segmentation and then statistically analyzed to evaluate the property of bone grafting material quantitatively. HSI color model, which corresponds with people's vision system for color is used to achieve ideal segmental results and effective utilization of color information. The S and I variable are used as thresholding condition for image segmentation, thereby obtaining the area of new bone. The effect of BMP contained in BMP/alpha-TCP is estimated furthermore. Experimental results show that the composite BMP/alpha-TCP induce more bone than pure alpha-TCP in virtue of BMP. This study provides theoretical and experimental suggestions for clinical applications of BMP/alpha-TCP.
C1 [Hua, Yahui; Wang, Tianfu; Zhou, Dali; Li, Deyu; Lin, Jiangli; Zheng, Changqiong] Sichuan Univ, Coll Mat Sci & Engn, Chengdu 610065, Peoples R China.
RP Wang, TF (reprint author), Sichuan Univ, Coll Mat Sci & Engn, Chengdu 610065, Peoples R China.
EM tfwang@scu.edu.cn
CR Belkasim S, 2003, DIGIT SIGNAL PROCESS, V13, P636, DOI 10.1016/S1051-2004(02)00032-5
   Cheng HD, 2001, PATTERN RECOGN, V34, P2259, DOI 10.1016/S0031-3203(00)00149-7
   GUO YZ, 2005, CHIN J CLIN REHABILI, V9, P37
   Hoy DEP, 1997, EXP TECHNIQUES, V21, P17, DOI 10.1111/j.1747-1567.1997.tb00534.x
   OHTA Y, 1980, COMPUT VISION GRAPH, V13, P222, DOI 10.1016/0146-664X(80)90047-7
   SAHOO PK, 1988, COMPUT VISION GRAPH, V41, P233, DOI 10.1016/0734-189X(88)90022-9
NR 6
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1013-9826
BN 978-0-87849-410-1
J9 KEY ENG MATER
PY 2007
VL 336-338
BP 2493
EP +
DI 10.4028/www.scientific.net/KEM.336-338.2493
PN 1-3
PG 2
WC Materials Science, Ceramics; Materials Science, Composites
SC Materials Science
GA BGD27
UT WOS:000246148002197
DA 2018-10-19
ER

PT B
AU Wang, BQ
   Li, YD
   Wu, YJ
AF Wang Baoqiang
   Li Yiding
   Wu Yanjie
BE Cui, J
   Jiming, Q
TI Analysis on nonlinearity of ultrasonic parameters in biomaterial
   engineering
SO ICEMI 2007: PROCEEDINGS OF 2007 8TH INTERNATIONAL CONFERENCE ON
   ELECTRONIC MEASUREMENT & INSTRUMENTS, VOL I
LA English
DT Proceedings Paper
CT 8th International Conference on Electronic Measurement and Instruments
CY AUG 16-18, 2007
CL Xian, PEOPLES R CHINA
SP IEEE Beijing Sect, Chinese Inst Elect, Measurement & Instruments Soc
DE ultrasonics; ultrasonic parameter detection; nonlinearity; biomaterial
   processing
AB Sonication with ultrasonic cavitation is one of effective and economical techniques for biomaterial processing in a lot of fields. Ultrasonic cavitation has become an important research subject. The latest research advances of ultrasonic cavitation and the reactions between cavitation and biomaterial are widely used in biornaterial engineering. Chinese traditional medicine extraction assisted with power ultrasound is one of the innovative techniques nowadays in point of fact. However, the nonlinearity and the spatio-temporal vicissitude of acoustic characters within the ultrasonic kettle are very complicated and variational. The nonlinearity of the acoustic characteristics makes the distribution of ultrasonic energy in the ultrasonic processor not symmetrical in spatial and time dimensions (x, y, z, t). So, the parameter nonlinearity will cause some difficulties in the applied ultrasonic engineering. It must be well realized and dealt with seriously. Two respects of nonlinearity problems are introduced in the paper, which involve the nonlinearity analysis and nonlinear compensation methods. The topics are: (1) analysis on description methods of nonlinearity and research on some nonlinearity rules about the acoustic parameters of ultrasonic propagation in the mixture of biomaterials and mediums; (2) carry out experiments on nonlinearity of acoustic cavitation in fluid medium. The analysis methods are: (1) with mathematics, some rules of wave propagation and nonlinear relations of momentum in fluids are discussed; (2) in lossy and nonlinear media from arbitrary shaped sources, a free from paraxial approximation and efficient numerical algorithm capable of acoustic fields is described; (3) the nonlinearity of the spatial distribution of cavitation activity generated within ultrasonic processing vessel is studied. Based on the data of experiments, some applied biornaterial extraction vessels were set up for Chinese traditional herb medicine extraction. The results have been proved with experiments that the analyses on ultrasonic nonlinearity are practical and correct, and the methods of nonlinear compensation are proper, effective and useful for biomaterial extraction in practical engineering.
C1 [Wang Baoqiang; Li Yiding; Wu Yanjie] Chengdu Univ Informat Technol, Chengdu 610225, Peoples R China.
RP Wang, BQ (reprint author), Chengdu Univ Informat Technol, Chengdu 610225, Peoples R China.
CR BJOMO L, 2002, ULTRADSONICS, V40, P11
   Bloomfield PE, 2005, ULTRASONICS, V43, P421, DOI 10.1016/j.ultras.2004.11.002
   Feng R, 2002, ULTRASON SONOCHEM, V9, P231, DOI 10.1016/S1350-4177(02)00083-4
   JCIK JWO, 2003, ULTRASONIC INT ABSTR, P246
   Radulescu EG, 2004, ULTRASONICS, V42, P367, DOI 10.1016/j.ultras.2003.11.019
   Wang BQ, 2006, IEEE ICMA 2006: PROCEEDING OF THE 2006 IEEE INTERNATIONAL CONFERENCE ON MECHATRONICS AND AUTOMATION, VOLS 1-3, PROCEEDINGS, P463
   WANG BQ, 2003, J CHENGDU U INFORM T, V18, P25
   WANG BQ, 2005, IEEE P ICIMA, P763
   Wang J, 2004, ADV ATMOS SCI, V21, P662, DOI 10.1007/BF02915733
   WOJCIK C, 2006, ULTRASONICS, V44, P310
   WOJCIK J, 2006, ULTRACONICS, P320
   YANG X, 2005, J ACOUST SOC AM, P113
   Zemp RJ, 2003, J ACOUST SOC AM, V113, P139, DOI 10.1121/1.1528926
NR 13
TC 0
Z9 0
U1 0
U2 1
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
BN 978-1-4244-1135-1
PY 2007
BP 151
EP 156
PG 6
WC Automation & Control Systems; Engineering, Electrical & Electronic;
   Instruments & Instrumentation; Optics
SC Automation & Control Systems; Engineering; Instruments &
   Instrumentation; Optics
GA BGX80
UT WOS:000251162900034
DA 2018-10-19
ER

PT B
AU Wang, BQ
   Kang, JH
   Wu, YJ
AF Wang, Bangqiang
   Kang, Jianhua
   Wu, Yanjie
BE Cui, J
   Jiming, Q
TI Utirasonic intensity detection and cavitation estimation in biologic
   engineering
SO ICEMI 2007: PROCEEDINGS OF 2007 8TH INTERNATIONAL CONFERENCE ON
   ELECTRONIC MEASUREMENT & INSTRUMENTS, VOL IV
LA English
DT Proceedings Paper
CT 8th International Conference on Electronic Measurement and Instruments
CY AUG 16-18, 2007
CL Xian, PEOPLES R CHINA
SP IEEE Beijing Sect, Chinese Inst Elect, Measurement & Instruments Soc
DE ultrasonic intensity detection; DSP; cavitation estimation
AB Sonochemistry is widely used in material science and technology. Acoustic cavitation in the liquid medium is one of the most important factors of sonochemistry for biomaterial processing, with ultrasound. It is well known that the degree of acoustic cavitation is determined with some physical parameters (such as ultrasonic intensity, wave type, vibration frequency and medium characters). Detection and control of the relative parameters are necessary for ultrasonic processing engineering. In the paper, the methods of detecting acoustic intensity are discussed and an intelligent method of estimating acoustic cavitation degree is introduced. The intensity detection system is made up of hydrophone, signal buffer, programmable amplifier, filter, amplitude demodulation, frequency detection, and temperature compensation circuits. The soflware for system management, control and digital signal processing is designed in assembly and C language. Based on the hardware and software, mentioned above, an intelligent system is set tip. The advantage, stability and reliability of the system are proof-tested through debugging and application. It is proved that the measurement precision of acoustic intensity is better than +/- 3% in 10-100kHz. The performance is better than what of expectation.
C1 [Wang, Bangqiang; Kang, Jianhua; Wu, Yanjie] Chengdu Univ Informat Technol, Chengdu 610225, Peoples R China.
RP Wang, BQ (reprint author), Chengdu Univ Informat Technol, Chengdu 610225, Peoples R China.
CR BAO GL, 2005, ACOUSTICS TECHNOLOGY, P25
   Feng R, 2002, ULTRASON SONOCHEM, V9, P231, DOI 10.1016/S1350-4177(02)00083-4
   WANG BQ, 2004, IEEE P ICIMA, P763
   WANG BQ, 2003, J CHENGDU U INFORM T, V18, P25
   Wang J, 2004, ADV ATMOS SCI, V21, P662, DOI 10.1007/BF02915733
   YANG X, 2005, J ACOUST SOC AM, P113
NR 6
TC 0
Z9 0
U1 0
U2 0
PU IEEE
PI NEW YORK
PA 345 E 47TH ST, NEW YORK, NY 10017 USA
PY 2007
BP 476
EP 480
PG 5
WC Computer Science, Interdisciplinary Applications; Engineering,
   Electrical & Electronic; Instruments & Instrumentation
SC Computer Science; Engineering; Instruments & Instrumentation
GA BGX86
UT WOS:000251177300110
DA 2018-10-19
ER

PT J
AU Massarelli, I
   Murgia, L
   Bianucci, AM
   Chiellini, F
   Chiellini, E
AF Massarelli, Ilaria
   Murgia, Laura
   Bianucci, Anna Maria
   Chiellini, Federica
   Chiellini, Emo
TI Understanding the selectivity mechanism of the human asialoglycoprotein
   receptor (ASGP-R) toward gal- and man-type ligands for predicting
   interactions with exogenous sugars
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE human asialoglycoprotein receptor; molecular docking; DelPhi; natural
   sugar polymers
ID ALGINATE; RECOGNITION; BINDING; MODEL; OLIGOSACCHARIDES;
   POLYSACCHARIDES; COMPLEX; ULVAN
AB A practical approach for addressing the computer simulation of protein-carbohydrate interactions is described here. An articulated computational protocol was set up and validated by checking its ability to predict experimental data, available in the literature, and concerning the selectivity shown by the Carbohydrate Recognition Domain (CRD) of the human asialoglycoprotein receptor (ASGP-R) toward Gal-type ligands. Some required features responsible for the interactions were identified. Subsequently the same protocol was applied to monomer sugar molecules that constitute the building blocks for alginates and ulvans. Such sugar polymers may supply a low-cost source of rare sugars with a potential impact on several industrial applications, from pharmaceutical to fine chemical industry. An example of their applicative exploitation could be given by their use in developing biomaterial with adhesion properties toward hepatocytes, through interaction with the ASGP-R. Such a receptor has been already proposed as a target for exogenous molecules, specifically in the case of hepatocytes, for diagnostic and therapeutic purposes. The DOCK5.2 program was used to search optimal locations of the above ligands of interest into CRD binding site and to roughly estimate interaction energies. Finally, the binding Delta G of theoretical protein-ligand complexes was estimated by using the DelPhi program in which the solvation free energy is accounted for with a continuum solvent model, by solving the Poisson-Boltzmann equation. The structure analysis of the obtained complexes and their D G values suggest that one of the sugar monomers of interest shows the desired characteristics.
C1 Univ Pisa, Dipartimento Chim & Chim Ind, I-56126 Pisa, Italy.
   Univ Pisa, Dipartimento Sci Farmaceut, I-56126 Pisa, Italy.
RP Chiellini, E (reprint author), Univ Pisa, Dipartimento Chim & Chim Ind, Via Risorgimento 35, I-56126 Pisa, Italy.
EM ilaria@dcci.unipi.it; lauram@dcci.unipi.it; bianucci@farm.unipi.it;
   federica@dcci.unipi.it; emochie@dcci.unipi.it
RI Chiellini, Federica/F-3233-2010
OI Chiellini, Federica/0000-0003-4680-9975
CR *ACC INC, 1999, INSIGHTII
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Bianucci AM, 2000, J BIOMOL STRUCT DYN, V18, P435, DOI 10.1080/07391102.2000.10506679
   Ewing TJA, 1997, J COMPUT CHEM, V18, P1175, DOI 10.1002/(SICI)1096-987X(19970715)18:9<1175::AID-JCC6>3.0.CO;2-O
   Fadden AJ, 2003, GLYCOBIOLOGY, V13, P529, DOI 10.1093/glycob/cwg068
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   Illapakurthy AC, 2003, J PHARM SCI, V92, P649, DOI 10.1002/jps.10319
   Iobst ST, 1996, J BIOL CHEM, V271, P6686, DOI 10.1074/jbc.271.12.6686
   Kaeffer B, 1999, PLANTA MED, V65, P527, DOI 10.1055/s-1999-14009
   Kolatkar AR, 1996, J BIOL CHEM, V271, P6679, DOI 10.1074/jbc.271.12.6679
   Lahaye M, 1998, CARBOHYD RES, V314, P1, DOI 10.1016/S0008-6215(98)00293-6
   LAHAYE M, 1993, CARBOHYD POLYM, V22, P261, DOI 10.1016/0144-8617(93)90129-R
   LEE YC, 1983, J BIOL CHEM, V258, P199
   Meier M, 2000, J MOL BIOL, V300, P857, DOI 10.1006/jmbi.2000.3853
   Onoda A, 2004, INORG CHEM, V43, P4447, DOI 10.1021/ic035075t
   Qiu D, 1997, J PHYS CHEM A, V101, P3005, DOI 10.1021/jp961992r
   Rocchia W, 2002, J COMPUT CHEM, V23, P128, DOI 10.1002/jcc.1161
   Selzer T, 1999, J MOL BIOL, V287, P409, DOI 10.1006/jmbi.1999.2615
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Yang J, 2002, BIOMATERIALS, V23, P471, DOI 10.1016/S0142-9612(01)00129-6
   Zmora S, 2002, BIOMATERIALS, V23, P4087, DOI 10.1016/S0142-9612(02)00146-1
NR 21
TC 3
Z9 4
U1 0
U2 4
PU MDPI AG
PI BASEL
PA POSTFACH, CH-4005 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JAN
PY 2007
VL 8
IS 1
BP 13
EP 28
DI 10.3390/i8010013
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA 131PY
UT WOS:000243883400002
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Milner, KR
   Siedlecki, CA
AF Milner, Keith R.
   Siedlecki, Christopher A.
TI Fibroblast response is enhanced by poly(L-lactic acid) nanotopography
   edge density and proximity
SO INTERNATIONAL JOURNAL OF NANOMEDICINE
LA English
DT Article
DE nanotopography; replication; biomaterials; cell adhesion; roughness
ID POLY(LACTIC-CO-GLYCOLIC ACID); ENDOTHELIAL-CELLS; SURFACE-FEATURES;
   FOCAL ADHESIONS; TOPOGRAPHY; PROLIFERATION; SCAFFOLDS; SCALE;
   POLYCAPROLACTONE; POLYURETHANE
AB The development of scaffolds for use in tissue engineering applications requires careful choice of macroscale properties, such as mechanical characteristics, porosity and biodegradation. The micro- and nano-scale properties of the scaffold surface are also an important design criterion as these influence cell adhesion, proliferation, and differentiation. The cellular response is known to be affected by surface topography but the mechanisms governing this remain unclear. Homogenous poly(L-lactic acid) was textured with surface nanotopographies by two-stage replication molding of heterogeneous demixed polymer films. Initial cell adhesion was improved on nanotextured surfaces compared with smooth controls, but subsequent cell density was significantly reduced on the roughest surfaces. Improvements in cell response were found. to correlate with focal contact and actin microfilament development. Cell response was found to trend both with the surface density of topography edges and with inter-topography spacing, indicating possible roles for edges stimulating cell adhesion/proliferation or for spacing to modulate the ability of integrin-ligand bonds to cluster and form focal adhesions. This study furthers understanding of the geometric properties of surface nanotopographies that affect cellular response. It is hoped that identification of the mechanisms governing cell-topography interactions will allow rule-based design of biomaterial surface to engineer specific cellular responses.
C1 [Milner, Keith R.; Siedlecki, Christopher A.] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Surg,Biomed Engn Inst, Hershey, PA 17033 USA.
   [Siedlecki, Christopher A.] Penn State Univ, Coll Med, Dept Bioengn, Hershey, PA 17033 USA.
RP Milner, KR (reprint author), Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Surg,Biomed Engn Inst, H151,500 Univ Dr, Hershey, PA 17033 USA.
EM kmilner@psu.edu
CR Affrossman S, 1996, MACROMOLECULES, V29, P5010, DOI 10.1021/ma9516910
   Choong CSN, 2006, TISSUE ENG, V12, P2521, DOI 10.1089/ten.2006.12.2521
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191
   Dalby MJ, 2004, EUR J CELL BIOL, V83, P159, DOI 10.1078/0171-9335-00369
   Dalby MJ, 2003, J BIOMED MATER RES A, V67A, P1025, DOI 10.1002/jbm.a.10139
   Dalby MJ, 2004, BIOMATERIALS, V25, P77, DOI 10.1016/S0142-9612(03)00475-7
   Dalby MJ, 2003, BIOMATERIALS, V24, P927, DOI 10.1016/S0142-9612(02)00427-1
   Fan YW, 2002, J NEUROSCI METH, V120, P17, DOI 10.1016/S0165-0270(02)00181-4
   FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619
   Heriot SY, 2005, NAT MATER, V4, P782, DOI 10.1038/nmat1476
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146
   L'Heureux N, 2006, NAT MED, V12, P361, DOI 10.1038/nm1364
   Lim JY, 2005, BIOMACROMOLECULES, V6, P3319, DOI 10.1021/bm0503423
   Miller DC, 2005, J BIOMED MATER RES A, V73A, P476, DOI 10.1002/jbm.a.30318
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Milner KR, 2007, J BIOMED MATER RES A, V82A, P80, DOI 10.1002/jbm.a.31049
   Milner KR, 2006, J BIOMED MATER RES A, V76A, P561, DOI 10.1002/jbm.a.30554
   Norman J, 2006, ANN BIOMED ENG, V34, P89, DOI 10.1007/s10439-005-9005-4
   Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043
   Uttayarat P, 2005, J BIOMED MATER RES A, V75A, P668, DOI 10.1002/jbm.a.30478
   Vance RJ, 2004, BIOMATERIALS, V25, P2095, DOI 10.1016/j.biomaterials.2003.08.064
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Wang HJ, 2003, TISSUE ENG, V9, P909, DOI 10.1089/107632703322495556
   Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792
NR 28
TC 23
Z9 24
U1 1
U2 4
PU DOVE MEDICAL PRESS LTD
PI ALBANY
PA PO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND
SN 1176-9114
J9 INT J NANOMED
JI Int. J. Nanomed.
PY 2007
VL 2
IS 2
BP 201
EP 211
PG 11
WC Nanoscience & Nanotechnology; Pharmacology & Pharmacy
SC Science & Technology - Other Topics; Pharmacology & Pharmacy
GA 247BH
UT WOS:000252051600008
PM 17722548
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Nie, X
   Zhang, YJ
   Tian, WD
   Jiang, M
   Dong, R
   Chen, JW
   Jin, Y
AF Nie, X.
   Zhang, Y. J.
   Tian, W. -D.
   Jiang, M.
   Dong, R.
   Chen, J. -W.
   Jin, Y.
TI Improvement of peripheral nerve regeneration by a tissue-engineered
   nerve filled with ectomesenchymal stem cells
SO INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
DE peripheral nerve; regeneration; ectomesenchymal stem cell; tissue
   engineering; biomaterial
ID SCHWANN-CELLS; MULTILINEAGE DIFFERENTIATION; GROWTH-FACTOR;
   PROLIFERATION; RAT; NEUREGULIN; MITOGEN
AB Ectomesenchymal stem cells (EMSCs) originate from the cranial neural crest. They are a potential source of neuronal and Schwann cells (SCs) of the peripheral nervous system (PNS) during embryonic development. The third passage of EMSCs enzymatically isolated from the mandibular processes of Sprague-Dawley rats were cultured in forskolin and bovine pituitary extract for 6 days to generate functional Schwann cell phenotypes. Next, 10-mm defects in the sciatic nerves were bridged with an autograft, tissue-engineered nerve filled with differentiated cells in collagen, or a PLGA conduit alone in 18 rats, and the nerve defects of another four rats were left untreated. The regenerated nerves were evaluated by the sciatic functional index (SFI) monthly and by histological analysis 4 months after grafting. The recovery index of the sciatic nerve improved significantly in the autograft and tissue-engineered nerve groups, both of which were superior to the PLGA group. In animals transplanted with the EMSCs, there was greater regeneration than with conduit alone during the same period of implantation. These results show that when EMSCs are transplanted to a peripheral nerve defect they differentiate into supportive cells that contribute to the promotion of axonal regeneration.
C1 Fourth Mil Med Univ, Qin Du Stomatol Coll, Dept Oral Histol & Pathol, Xian 710032, Shaanxi, Peoples R China.
   Sichuan Univ, W China Stomatol Coll, Dept Oral & Maxillofacial Surg, Chengdu 610041, Peoples R China.
   Fourth Mil Med Univ, Coll Stomatol, Res & Dev Ctr Tissue Engn, Xian 710032, Shaanxi, Peoples R China.
RP Jin, Y (reprint author), Fourth Mil Med Univ, Qin Du Stomatol Coll, Dept Oral Histol & Pathol, Xian 710032, Shaanxi, Peoples R China.
EM yanjinfmmu@vip.sina.com
RI Jin, Yan/I-4204-2013; Yu, Mei/G-4994-2015
OI Yu, Mei/0000-0003-0306-6817
CR BAIN JR, 1989, PLAST RECONSTR SURG, V83, P129, DOI 10.1097/00006534-198901000-00024
   Baron W, 2000, MOL CELL NEUROSCI, V15, P314, DOI 10.1006/mcne.1999.0827
   Bryan DJ, 2003, J RECONSTR MICROSURG, V19, P125, DOI 10.1055/s-2003-37820
   Bryan DJ, 2000, TISSUE ENG, V6, P129, DOI 10.1089/107632700320757
   Buchstaller J, 2004, J NEUROSCI, V24, P2357, DOI 10.1523/JNEUROSCI.4083-03.2004
   Chen JW, 2005, CELL TISSUE RES, V319, P429, DOI 10.1007/s00441-004-1025-0
   Deng MJ, 2004, TISSUE ENG, V10, P1597, DOI 10.1089/1076327042500409
   Fansa H, 2004, NEUROL RES, V26, P167, DOI 10.1179/016164104225013842
   FoidartDessalle M, 1997, EXP NEUROL, V148, P236, DOI 10.1006/exnr.1997.6542
   Fregien NL, 2005, GLIA, V49, P24, DOI 10.1002/glin.20091
   Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   Hermanns S, 1997, GLIA, V21, P299
   Jeffery WR, 2004, NATURE, V431, P696, DOI 10.1038/nature02975
   Jessen KR, 1998, MICROSC RES TECHNIQ, V41, P393, DOI 10.1002/(SICI)1097-0029(19980601)41:5<393::AID-JEMT6>3.0.CO;2-R
   Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429
   Maro GS, 2004, NAT NEUROSCI, V7, P930, DOI 10.1038/nn1299
   Mauritz C, 2004, J NEUROSCI RES, V77, P453, DOI 10.1002/jnr.20166
   Millette E, 2005, CIRC RES, V96, P172, DOI 10.1161/01.RES.0000154595.87608.db
   Mimura T, 2004, J NEUROSURG, V101, P806, DOI 10.3171/jns.2004.101.5.0806
   Pollock GS, 1999, EUR J NEUROSCI, V11, P769, DOI 10.1046/j.1460-9568.1999.00484.x
   Rodriguez FJ, 2000, EXP NEUROL, V161, P571, DOI 10.1006/exnr.1999.7315
   Schmidt U, 1998, MOL CELL NEUROSCI, V11, P9, DOI 10.1006/mcne.1998.0668
   Sen SY, 2005, PLAST RECONSTR SURG, V115, P823, DOI 10.1097/01.PRS.0000153032.68405.DA
   Sieber-Blum M, 2004, DEV DYNAM, V231, P258, DOI 10.1002/dvdy.20129
   Suwa Fumihiko, 2001, Okajimas Folia Anatomica Japonica, V78, P179
   Terzis JK, 1997, J RECONSTR MICROSURG, V13, P215, DOI 10.1055/s-2007-1006407
   ZHANG BT, 1995, J NEUROSCI RES, V41, P648, DOI 10.1002/jnr.490410511
NR 28
TC 50
Z9 62
U1 2
U2 15
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0901-5027
J9 INT J ORAL MAX SURG
JI Int. J. Oral Maxillofac. Surg.
PD JAN
PY 2007
VL 36
IS 1
BP 32
EP 38
DI 10.1016/j.ijom.2006.06.005
PG 7
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 127UQ
UT WOS:000243612200007
PM 17169530
DA 2018-10-19
ER

PT J
AU Sinikovic, B
   Kramer, FJ
   Swennen, G
   Lubbers, HT
   Dempf, R
AF Sinikovic, B.
   Kramer, F. J.
   Swennen, G.
   T Luebbers, H.
   Dempf, R.
TI Reconstruction of orbital wall defects with calcium phosphate cement:
   clinical and histological findings in a sheep model
SO INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
DE orbita; defect fracture; bone replacement; calcium phosphate cement;
   osseoconcluction; sheep
ID FLOOR RECONSTRUCTION; HYDROXYAPATITE CEMENT; BONE; REPLACEMENT;
   IMPLANTS; ENOPHTHALMOS; FRACTURES; GROWTH; REPAIR; PASTE
AB The aim of this pilot study was to investigate the potential of calcium phosphate cement in the treatment of orbital wall defect fractures in an adult sheep model, and to compare this alloplastic material to autologous calvaria split-bone grafts. Clinical, volumetric and histological examinations were carried out of both reconstruction materials. The use of cement made intraoperative corrections easier to perform, and increased the precision of reconstruction of the orbital volume. This material also proved to be osseoconductive. The two materials were used successfully in combination. Regions of most intensive remodelling were the anterior orbital floor and the adjacent orbital rim. The preliminary results of this study demonstrate the potential of calcium phosphate cement as a useful biomaterial in the reconstruction of the anterior orbital region. Further animal and clinical trials are necessary to investigate its ability as a carrier for mediators where bone healing requires influence or support.
C1 Hannover Med Sch, Dept Oral & Maxillofacial Surg, D-30625 Hannover, Germany.
   Univ Zurich, Dept Craniomaxillofacial Surg, CH-8091 Zurich, Switzerland.
   Univ Gottingen, Dept Oral & Maxillofacial Surg, D-3400 Gottingen, Germany.
RP Sinikovic, B (reprint author), Hannover Med Sch, Dept Oral & Maxillofacial Surg, Carl Neuberg Str 1, D-30625 Hannover, Germany.
EM sinikovic.branko@mh-hannover.de
RI Lubbers, Heinz-Theo/B-4800-2010
OI Lubbers, Heinz-Theo/0000-0002-2884-4008
CR Baumann A, 2002, INT J ORAL MAX SURG, V31, P367, DOI 10.1054/ijom.2001.0219
   Chan CH, 2000, BRIT J ORAL MAX SURG, V38, P437, DOI 10.1054/bjom.2000.0337
   Choi JC, 1999, OPHTHALMIC PLAST REC, V15, P56, DOI 10.1097/00002341-199901000-00012
   Chowdhury K, 1998, ARCH OTOLARYNGOL, V124, P1398, DOI 10.1001/archotol.124.12.1398
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   Dupoirieux L, 2000, ORAL SURG ORAL MED O, V89, P140, DOI 10.1067/moe.2000.103532
   Fahrmeir L., 1996, MULTIVARIATE STAT VE
   FORBES G, 1985, AM J ROENTGENOL, V145, P149, DOI 10.2214/ajr.145.1.149
   Gellrich NC, 2002, PLAST RECONSTR SURG, V110, P1417, DOI 10.1097/01.PRS.0000029807.35391.E5
   HAMMER B, 1995, ORBITAL FRACTURES DI
   HASSFELD S, 1995, INT J ORAL MAX SURG, V24, P111
   JANSEN JA, 1995, J MATER SCI-MATER M, V6, P653, DOI 10.1007/BF00123447
   Kashkouli Mohsen Bahmani, 2003, Orbit, V22, P239, DOI 10.1076/orbi.22.4.239.17245
   Kontio R, 2001, INT J ORAL MAX SURG, V30, P278, DOI 10.1054/ijom.2001.0067
   KURASHINA K, 1995, J MATER SCI-MATER M, V6, P340, DOI 10.1007/BF00120302
   Lee Jing-Wei, 1993, Journal of the Formosan Medical Association, V92, P349
   NIEDHART C, 2004, J BIOMED MATER RES B, V15, P123
   ONO I, 1994, SCAND J PLAST RECONS, V28, P193, DOI 10.3109/02844319409015980
   Oreffo ROC, 1998, BIOMATERIALS, V19, P1845, DOI 10.1016/S0142-9612(98)00084-2
   RADOMSKY ML, 1998, CLIN ORTHOP S, V355, P283
   RAHN BA, 1976, ZEISS INFORMATION, V22, P36
   Raskin EM, 1998, OPHTHALMIC PLAST REC, V14, P19, DOI 10.1097/00002341-199801000-00006
   ROZEMA FR, 1990, J ORAL MAXIL SURG, V48, P1305, DOI 10.1016/0278-2391(90)90487-M
   Rueger JM, 1998, ORTHOPADE, V27, P72
   Schliephake H, 2002, INT J ORAL MAX SURG, V31, P469, DOI 10.1054/ijom.2002.0244
   Tanag MA, 2006, PLAST RECONSTR SURG, V117, P1186, DOI 10.1097/01.prs.0000204582.76322.05
   Tanag MA, 2004, PLAST RECONSTR SURG, V114, P1826
NR 27
TC 29
Z9 32
U1 0
U2 3
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0901-5027
J9 INT J ORAL MAX SURG
JI Int. J. Oral Maxillofac. Surg.
PD JAN
PY 2007
VL 36
IS 1
BP 54
EP 61
DI 10.1016/j.ijom.2006.07.014
PG 8
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 127UQ
UT WOS:000243612200010
PM 16965899
DA 2018-10-19
ER

PT B
AU Nakayama, M
AF Nakayama, Mitsuyuki
GP ASME
TI A study of acoustic emission produced by strength test on bio-ceramics
   similar to dependency of AE duration time and mean frequency on the
   material property similar to
SO IPACK 2007: PROCEEDINGS OF THE ASME INTERPACK CONFERENCE 2007, VOL 2
LA English
DT Proceedings Paper
CT ASME InterPACK Conference
CY JUL 08-12, 2007
CL Vancouver, CANADA
SP ASME, Elect & Photon Packaging Div
AB Comparing the mechanical characteristics of bio-ceramics with a elaborate bone, there are two important conditions required for biomaterial. First, the strength must be three times larger than that of a elaborate bone. Second, Young's modulus must be two or three times larger than that. However, still the biomaterial hasn't developed which satisfies these conditions. The purpose of this research is to improve the strength of bio-ceramics. It was discussed how the duration time and mean frequency of acoustic emission (AE) parameters depend on time. These parameters are calculated with AE wave on breaking test of a bio-ceramics. The following main results were obtained. First, AE generating pattern is changed by the property of the materials. Second, in tetragonal zirconia polycrystals(TZP), the phase transformation has affected AE parameters. Consequently, it was shown that AE parameters had the material dependability.
C1 Oyama Natl Coll Technol, Dept Elect Informat Engn, Oya, Shizuoka, Japan.
RP Nakayama, M (reprint author), Oyama Natl Coll Technol, Dept Elect Informat Engn, Oya, Shizuoka, Japan.
CR *KYOCERA, 2002, KYOCERA CEREMIC FEMO
   MUNEMIYA M, 1992, UCHIDA ROUHOEN, P189
   NAKAYAMA M, 2002, IECE, pA11
NR 3
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4278-2
PY 2007
BP 961
EP 964
PG 4
WC Engineering, Mechanical
SC Engineering
GA BHM79
UT WOS:000254379900119
DA 2018-10-19
ER

PT J
AU Mohammadi, Y
   Mirzadeh, H
   Moztarzadeh, F
   Soleimani, M
   Jabbari, E
AF Mohammadi, Yousef
   Mirzadeh, Hamid
   Moztarzadeh, Fathollah
   Soleimani, Masoud
   Jabbari, Esmaiel
TI Osteogenic differentiation of mesenchymal stem cells on novel
   three-dimensional poly(L-lactic acid)/chitosan/gelatin/beta-tricalcium
   phosphate hybrid scaffolds
SO IRANIAN POLYMER JOURNAL
LA English
DT Article
DE bone; chitosan; hybrid scaffold; tissue engineering; stem cell
ID MARROW STROMAL CELLS; BETA-TRICALCIUM PHOSPHATE; BONE-MARROW; IN-VITRO;
   COMPOSITE SCAFFOLDS; FABRICATION; COLLAGEN; DESIGN; FOAMS; IMPLANTS
AB The concept of combining synthetic polymers with naturally derived biopolymers and resorbable bioceramics has been recently considered as an effective solution for orthopedic tissue engineering. In the. present study, based on a biomimetic approach, a novel 3D biodegradable porous hybrid biomaterial consisting of poly(L-lactic acid) (PLLA), chitosan, gelatin, and beta-tricalcium phosphate (beta-TCP) was developed. Macroporous PLLA/beta-TCP scaffolds were prepared by freeze-extraction/particulate leaching method and embedded with porous chitosan/gelatin/PTCP sponges. The influences of chemical, physical, and structural properties of the scaffolds prepared on the attachment and differentiation of mesenchymal stem cells into osteoblasts and the proliferation of the differentiated cells were investigated. Osteogenically induced cultures revealed that cells were well-attached, penetrated into the scaffold and uniformly distributed. The expression of early and late phenotypic markers of osteoblastic differentiation was upregulated in the scaffolds cultured in osteogenic medium.
C1 Amir Kabir Univ Technol, Fac Biomed Engn, Tehran, Iran.
   Iran Polymer & Petrochem Inst, Biomat Dept, Tehran, Iran.
   Tarbiat Modares Univ, Sch Med Sci, Dept Hematol, Tehran, Iran.
   Univ S Carolina, Dept Chem Engn, Biomat & Tissue Engn Labs, Columbia, SC 29208 USA.
RP Mirzadeh, H (reprint author), Amir Kabir Univ Technol, Fac Biomed Engn, POB 15875-4413, Tehran, Iran.
EM h.mirzadeh@ippi.ac.ir
OI Mohammadi, Yousef/0000-0001-9401-3715; Moztarzadeh,
   Fathollah/0000-0001-9109-0264
CR ATALA A, 2002, METHODS TISSUE ENG, pCH1
   Betz RR, 2002, ORTHOPEDICS, V25, P561
   Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   Chen GP, 2002, MACROMOL BIOSCI, V2, P67, DOI 10.1002/1616-5195(20020201)2:2<67::AID-MABI67>3.0.CO;2-F
   Chen GP, 2001, J BIOMED MATER RES, V57, P8, DOI 10.1002/1097-4636(200110)57:1<8::AID-JBM1135>3.0.CO;2-H
   Chen Y, 2006, SURF COAT TECH, V201, P575, DOI 10.1016/j.surfcoat.2005.12.005
   Ciapetti G, 2006, BIOMATERIALS, V27, P6150, DOI 10.1016/j.biomaterials.2006.08.025
   Derubeis AR, 2004, ANN BIOMED ENG, V32, P160, DOI 10.1023/B:ABME.0000007800.89194.95
   DILLOW AK, 2002, BIOMIMETIC MAT DESIG, pCH8
   ELICES M, 2000, STRUCTURAL BIOL MAT, pCH1
   Fan HB, 2006, BIOMATERIALS, V27, P4573, DOI 10.1016/j.biomaterials.2006.04.013
   Fialkov JA, 2003, J CRANIOFAC SURG, V14, P324, DOI 10.1097/00001665-200305000-00010
   Georgiou G, 2007, J BIOMED MATER RES B, V80B, P322, DOI 10.1002/jbm.b.30600
   GOLDBERG VM, 2004, ORTHOPEDIC TISSUE EN, pCH1
   Guan LM, 2004, J BIOMED MATER RES A, V71A, P480, DOI 10.1002/jbm.a.30173
   Helm G.A., 2001, NEUROSURG FOCUS, V10, P1
   Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   HOLLINGER JO, 2005, BONE TISSUE ENG, pCH6
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Hsu FY, 1999, BIOMATERIALS, V20, P1931
   Hsu YY, 1997, J BIOMED MATER RES, V35, P107, DOI 10.1002/(SICI)1097-4636(199704)35:1<107::AID-JBM11>3.0.CO;2-G
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Karp JM, 2003, J CRANIOFAC SURG, V14, P317, DOI 10.1097/00001665-200305000-00009
   Kruyt MC, 2004, BIOMATERIALS, V25, P1463, DOI 10.1016/S0142-9612(03)00490-3
   LEWANDROWSKI KU, 2002, TISSUE ENG BIODEGRAD, pCH1
   Lin HR, 2004, J BIOMED MATER RES B, V71B, P52, DOI 10.1002/b.30065
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Mao JS, 2003, BIOMATERIALS, V24, P1067, DOI 10.1016/S0142-9612(02)00442-8
   Martin I, 2001, J BIOMED MATER RES, V55, P229, DOI 10.1002/1097-4636(200105)55:2<229::AID-JBM1009>3.3.CO;2-H
   Martino A, 2005, BIOMATERIALS, V26, P5983, DOI [10.1016/j.biomaterials.2005.03.016, DOI 10.1016/J.BIOMATERIALS.2005.03.016]
   Mauney JR, 2004, TISSUE ENG, V10, P81, DOI 10.1089/107632704322791727
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   MIKOS AG, 1994, POLYMER, V35, P1068, DOI 10.1016/0032-3861(94)90953-9
   Mirzadeh H, 2000, IRAN POLYM J, V9, P73
   NAGASE M, 1989, J ORAL MAXIL SURG, V47, P40, DOI 10.1016/0278-2391(89)90122-5
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Shen F, 2000, POLYM INT, V49, P1596, DOI 10.1002/1097-0126(200012)49:12<1596::AID-PI553>3.3.CO;2-J
   Sous M, 1998, BIOMATERIALS, V19, P2147, DOI 10.1016/S0142-9612(98)00118-5
   Spitzer RS, 2002, J BIOMED MATER RES, V59, P690, DOI 10.1002/jbm.1277
   SUGAYA A, 1989, J PERIODONTAL RES, V24, P284, DOI 10.1111/j.1600-0765.1989.tb01795.x
   Vaccaro AR, 2002, ORTHOPEDICS, V25, P571
   Wan Y, 2007, J BIOMED MATER RES A, V80A, P776, DOI 10.1002/jbm.a.31025
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Yin YJ, 2003, J BIOMED MATER RES A, V67A, P844, DOI 10.1002/jbm.a.10153
   Yuan J, 2007, BIOMATERIALS, V28, P1005, DOI 10.1016/j.biomaterials.2006.10.015
   Zhang Y, 2002, J BIOMED MATER RES, V61, P1, DOI 10.1002/jbm.10176
   Zhao F, 2002, BIOMATERIALS, V23, P3227, DOI 10.1016/S0142-9612(02)00077-7
NR 48
TC 17
Z9 18
U1 0
U2 7
PU POLYMER RESEARCH CENTER IRAN
PI TEHRAN
PA PO BOX 14185-515, TEHRAN, IRAN
SN 1026-1265
J9 IRAN POLYM J
JI Iran. Polym. J.
PD JAN
PY 2007
VL 16
IS 1
BP 57
EP 69
PG 13
WC Polymer Science
SC Polymer Science
GA 153TZ
UT WOS:000245459600007
DA 2018-10-19
ER

PT J
AU Chao, J
   Gonzalez-Carrasco, JL
   Capdevila, C
AF Chao, Jesus
   Gonzalez-Carrasco, Jose L.
   Capdevila, Carlos
TI Influence of annealing at 1100 degrees C and 475 degrees C on the
   mechanical properties at room temperature of an iron base ODS alloy
SO ISIJ INTERNATIONAL
LA English
DT Article
DE 475 degrees C embrittlement; FeCrAl oxide dispersion strengthened alloy;
   fatigue; mechanical properties
ID FERRITIC STAINLESS-STEEL; 475 DEGREES-C; TENSILE BEHAVIOR; COOLING RATE;
   MA-956; EMBRITTLEMENT
AB In the last few years the Fe-base oxide dispersion strengthened (ODS) PM 2000 alloy has been shown to be a biomaterial for its outstanding combination of mechanical properties and corrosion resistance. In this work, we are describing the effect of high temperature annealing at 1100 degrees C (pre-oxidation) and low temperature annealing at 475 degrees C on the main mechanical properties at room temperature, with particular emphasis on tensile and fatigue properties, which are suitable for achieving the required biofunctionality of load bearing implants. It has been shown that annealing at 475 degrees C is responsible for an increase in the YS and UTS with the subsequent decrease in ductility. However, despite of the loss of ductility, the material shows ductile behaviour as is observed in the necked zone of tensile specimens, which contrasts with the so-called "475 degrees C embrittlement" observed for another ferritic alloys. Moreover," aged material at 475 degrees C exhibits a better fatigue limit than that non aged pre-oxidised material.
C1 Ctr Nacl Invest Met, CSIC, Dept Met Phys, E-28040 Madrid, Spain.
RP Gonzalez-Carrasco, JL (reprint author), Ctr Nacl Invest Met, CSIC, Dept Met Phys, Avda Gregorio Amo 8, E-28040 Madrid, Spain.
EM ccm@cenim.csic.es
RI Capdevila, Carlos/B-6970-2015; Gonzalez Carrasco, Jose Luis/A-7971-2008
OI Capdevila, Carlos/0000-0002-1869-4085; Gonzalez-Carrasco, Jose
   Luis/0000-0003-2004-4505
CR Chao J, 2003, METALL MATER TRANS A, V34A, P2681, DOI 10.1007/s11661-003-0028-x
   Chao J, 2002, SCRIPTA MATER, V47, P423, DOI 10.1016/S1359-6462(02)00168-9
   Chao J, 1998, MATER SCI TECH SER, V14, P440, DOI 10.1179/mst.1998.14.5.440
   Chao J, 1996, METALL MATER TRANS A, V27, P3809, DOI 10.1007/BF02595630
   CHAO J, 2002, P 7 C PROP MEC SOL U, P385
   CHAO J, 2004, SCRIPTA MATER, V49, P1457
   Ciapetti G, 2005, BIOMATERIALS, V26, P849, DOI 10.1016/j.biomaterials.2004.03.032
   CIAPETTI G, 2000, DEV ALUMINA FORMING, P1
   EVANS HE, 1989, MAT SCI ENG A-STRUCT, V120, P139, DOI 10.1016/0921-5093(89)90731-4
   Florentine SK, 2004, LAND DEGRAD DEV, V15, P1, DOI 10.1002/ldr.586
   Gonzalez-Carrasco JL, 2005, BIOMATERIALS, V26, P3861, DOI 10.1016/j.biomaterials.2004.09.058
   GROBNER PJ, 1973, METALL TRANS, V4, P251, DOI 10.1007/BF02649625
   HAHN GT, 1984, METALL TRANS A, V15, P947, DOI 10.1007/BF02644685
   KATO M, 1981, ACTA METALL MATER, V29, P79, DOI 10.1016/0001-6160(81)90088-2
   LUKAS P, 1996, MINERAL METALS MAT S, P279
   PARK KH, 1986, ACTA METALL MATER, V34, P1853, DOI 10.1016/0001-6160(86)90130-6
   PETERSON RE, 1973, STRESS CONCENTRATION, P210
   Read HG, 1997, SCRIPTA MATER, V36, P355, DOI 10.1016/S1359-6462(96)00388-0
   Read HG, 1996, APPL SURF SCI, V94-5, P334, DOI 10.1016/0169-4332(95)00524-2
   Strehl G, 2006, SURF COAT TECH, V201, P148, DOI 10.1016/j.surfcoat.2005.11.073
   WILLIAMS D F, 1991, Mammalian Species, P1
   1996, METALLURGICAL THERMO, P1
NR 22
TC 5
Z9 5
U1 1
U2 8
PU IRON STEEL INST JAPAN KEIDANREN KAIKAN
PI TOKYO
PA 9-4 OTEMACHI 1-CHOME CHIYODA-KU, TOKYO, 100, JAPAN
SN 0915-1559
J9 ISIJ INT
JI ISIJ Int.
PY 2007
VL 47
IS 8
BP 1214
EP 1220
DI 10.2355/isijinternational.47.1214
PG 7
WC Metallurgy & Metallurgical Engineering
SC Metallurgy & Metallurgical Engineering
GA 203RV
UT WOS:000248992600018
OA Bronze
DA 2018-10-19
ER

PT J
AU Belouafa, S
   Chaair, H
   Digua, K
   Sallek, B
   Essaadani, A
   Oudadesse, H
AF Belouafa, Soumia
   Chaair, Hassan
   Digua, Khalid
   Sallek, Brahim
   Essaadani, Ali
   Oudadesse, Hassane
TI Synthesis, characterization and thermal behaviour of a phosphocalcic
   oxygenated apatite
SO JOURNAL OF ADVANCED MATERIALS
LA English
DT Article
ID DIFFERENT OXIDATION-STATES; CALCIUM; HYDROXYAPATITE; BIOCERAMICS;
   EXISTENCE; LATTICE
AB A new route for preparing an antiseptic biomaterial has been described. An oxygenated apatite-based calcium phosphate powder that had a Ca/P ratio of 1.55 was synthesized from calcium nitrate and phosphoric acid in oxygenated water via a precipitation method. The X-ray diffraction and FTIR analysis of the as-dried powder reveals that the apatite is poorly crystalline and is converted into a biphasic calcium phosphate (HAP/beta-TCP) when calcined at a temperature higher than 600 degrees C. The chemical analysis of oxygenated species shows the disappearance of these species at 400 degrees C.
C1 Fac Sci & Tech Mohammadia, Lab Genie Proc, Mohammadia, Morocco.
   Fac Sci Kenitra, Lab Physicochim Mat, Kenitra, Morocco.
   Fac Sci & Tech Settat, Lab Instrumentat & Anal Mat, Settat, Morocco.
   Univ Rennes, Lab Cristallochim & Biomat, Rennes, France.
RP Belouafa, S (reprint author), Fac Sci & Tech Mohammadia, Lab Genie Proc, Mohammadia, Morocco.
EM hchaair@yahoo.fr
CR BEGANSKIENE A, 2003, MAT SCI, V9, P1392
   BELOUAFA S, IN PRESS PHOSPHORUS
   Britel O, 2004, PHOSPHORUS SULFUR, V179, P1857, DOI 10.1080/10426500490466625
   BUCHOLZ RW, 1987, ORTHOP CLIN N AM, V18, P323
   Chaair H, 2001, PHOSPHORUS SULFUR, V173, P163, DOI 10.1080/10426500108045267
   CHAAIR H, 1995, J MATER CHEM, V5, P895, DOI 10.1039/jm9950500895
   CHAAIR H, 1993, THESIS TOULOUSE
   EANES ED, 1977, CALC TISS RES, V23, P259, DOI 10.1007/BF02012795
   GEE A, 1954, LIEBIGS ANN CHEM, V25, P1320
   Gomez-Morales J, 2001, CRYST RES TECHNOL, V36, P15, DOI 10.1002/1521-4079(200101)36:1<15::AID-CRAT15>3.3.CO;2-5
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HEUGHEBA.JC, 1970, B SOC CHIM FR, P2923
   HEUGHEBAERT JC, 1977, THESIS TOULOUSE
   *ICDD, 702065 ICDD
   *ICDD, 730293 ICDD
   Kwon SH, 2003, J EUR CERAM SOC, V23, P1039, DOI 10.1016/S0955-2219(02)00263-7
   LEDARD C, 1992, Patent No. 514156
   LEGEROS RZ, 1981, PROG CRYST GROWTH CH, V4, P1
   LI YB, 1994, BIOMATERIALS, V15, P835
   Manjubala I, 2002, J BIOMED MATER RES, V63, P200, DOI 10.1002/jbm.10128
   MONTREJAUD M, 1973, THESIS TOULOUSE
   Peters F, 2000, THERMOCHIM ACTA, V361, P131, DOI 10.1016/S0040-6031(00)00554-2
   REY C, 1984, THESIS TOULOUSE
   SIMPSON DR, 1968, AM MINERAL, V53, P432
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Tanaka H, 2000, PHYS CHEM CHEM PHYS, V2, P2647, DOI 10.1039/b001877p
   TROMBE JC, 1978, J INORG NUCL CHEM, V40, P15, DOI 10.1016/0022-1902(78)80298-X
   TROMBE JC, 1973, ANN CHIM FRANCE, V8, P335
NR 29
TC 0
Z9 0
U1 0
U2 2
PU SAMPE PUBLISHERS
PI COVINA
PA 1161 PARKVIEW DRIVE, COVINA, CA 91722 USA
SN 1070-9789
J9 J ADV MATER-COVINA
JI J. Adv. Mater.
PD JAN
PY 2007
SI 2
BP 139
EP 142
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA 129LH
UT WOS:000243730500023
DA 2018-10-19
ER

PT J
AU Shuler, MS
   Rooks, MD
   Roberson, JR
AF Shuler, Michael S.
   Rooks, Michael D.
   Roberson, James R.
TI Porous tantalum implant in early osteonecrosis of the hip - Preliminary
   report on operative, survival, and outcomes results
SO JOURNAL OF ARTHROPLASTY
LA English
DT Article
DE osteonecrosis avascular necrosis; early outcomes; porous tantalum metal;
   vascularized fibular graft; total hip arthroplasty
ID DONOR-SITE MORBIDITY; FEMORAL-HEAD; CORE DECOMPRESSION; AVASCULAR
   NECROSIS; BIOMATERIAL; SYSTEM
AB Porous tantalum implants are used in early osteonecrosis of the hip. Device evaluation included surgical time, blood loss, hospitalization, patient-controlled analgesia use, transfusions, implant survival, and outcomes. Mean blood loss was 70 mL. Mean operative time was 36 minutes. Average hospitalization was less than I day. No patient required patient-controlled analgesia use or transfusions. Results were compared to a historical vascularized fibular graft population. All parameters were less than the fibular graft groups (P <.00001). All surviving implants (86%) resulted in good to excellent outcomes. Kaplan-Meier analysis at 39 months was 86% and 67% for the implant and fibular graft, respectively (P =.21). Early Outcomes demonstrate that porous tantalum implants are a safe option for femoral head salvage. Continued follow-up is necessary to determine the longterm success.
C1 Emory Univ, Dept Orthopaed, Atlanta, GA 30322 USA.
RP Shuler, MS (reprint author), 4620 Wieuca Rd, Atlanta, GA 30342 USA.
CR AARON RK, 1989, CLIN ORTHOP RELAT R, V249, P209
   Aldridge J Mack 3rd, 2004, Am J Orthop (Belle Mead NJ), V33, P327
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   CAMP JF, 1986, J BONE JOINT SURG AM, V68A, P1313, DOI 10.2106/00004623-198668090-00002
   Cohen Robert, 2002, Am J Orthop (Belle Mead NJ), V31, P216
   FAIRBANK AC, 1995, J BONE JOINT SURG BR, V77B, P42
   GORE DR, 1987, CLIN ORTHOP RELAT R, V220, P206
   HARRIS WH, 1969, J BONE JOINT SURG AM, VA 51, P737, DOI 10.2106/00004623-196951040-00012
   Heiner A. D., 1998, Journal of Musculoskeletal Research, V2, P267, DOI 10.1142/S0218957798000263
   JUDET H, 2001, CLIN ORTHOP RELAT R, V386, P114
   KOO KH, 1995, J BONE JOINT SURG BR, V77B, P870
   Markel DC, 1996, CLIN ORTHOP RELAT R, P226, DOI 10.1097/00003086-199602000-00031
   Mont M A, 1996, Clin Orthop Relat Res, P169, DOI 10.1097/00003086-199603000-00020
   Plakseychuk AY, 2003, J BONE JOINT SURG AM, V85A, P589, DOI 10.2106/00004623-200304000-00001
   Scully SP, 1998, J BONE JOINT SURG AM, V80A, P1270, DOI 10.2106/00004623-199809000-00004
   SHANNON BD, 2004, CLIN ORTHOP RELAT R, V418, P34
   SMITH SW, 1995, J BONE JOINT SURG AM, V77A, P674, DOI 10.2106/00004623-199505000-00003
   Soderman P, 2001, Clin Orthop Relat Res, P189
   STEINBERG ME, 1995, J BONE JOINT SURG BR, V77B, P34
   Steinberg ME, 1989, CLIN ORTHOP RELAT R, V249, P199
   SUGIOKA Y, 1992, CLIN ORTHOP RELAT R, V277, P111
   Tang CL, 1998, MICROSURG, V18, P383, DOI 10.1002/(SICI)1098-2752(1998)18:6<383::AID-MICR8>3.0.CO;2-5
   UCHIO Y, 2001, CLIN ORTHOP RELAT R, V384, P217
   URBANIAK JR, 1995, J BONE JOINT SURG AM, V77A, P681, DOI 10.2106/00004623-199505000-00004
   Vail TP, 1996, J BONE JOINT SURG AM, V78A, P204, DOI 10.2106/00004623-199602000-00006
NR 26
TC 73
Z9 101
U1 1
U2 10
PU CHURCHILL LIVINGSTONE INC MEDICAL PUBLISHERS
PI PHILADELPHIA
PA CURTIS CENTER, INDEPENDENCE SQUARE WEST, PHILADELPHIA, PA 19106-3399 USA
SN 0883-5403
EI 1532-8406
J9 J ARTHROPLASTY
JI J. Arthroplast.
PD JAN
PY 2007
VL 22
IS 1
BP 26
EP 31
DI 10.1016/j.arth.2006.03.007
PG 6
WC Orthopedics
SC Orthopedics
GA 142MT
UT WOS:000244654700005
PM 17197305
DA 2018-10-19
ER

PT J
AU Sawa, Y
   Horiuchi, T
   Kishida, A
   Masuzawa, T
   Nishimura, M
   Tatsumi, E
   Tomizawa, Y
   Watanabe, H
AF Sawa, Y.
   Horiuchi, T.
   Kishida, A.
   Masuzawa, T.
   Nishimura, M.
   Tatsumi, E.
   Tomizawa, Y.
   Watanabe, H.
TI Journal of Artificial Organs 2006: the year in review
SO JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Review
DE artificial heart (basic); artificial heart (clinical); cardiopulmonary
   bypass; artificial lung; blood vessel prosthesis; pacemaker; artificial
   valve; biomaterial; tissue engineering; dialysis; Apheresis; artificial
   liver; artificial pancreas; artificial skin; artificial muscle;
   artificial bone; artificial neuron
C1 [Sawa, Y.] Osaka Univ, Grad Sch Med, Div Cardiovasc Surg, Dept Surg, Suita, Osaka 5650871, Japan.
   [Horiuchi, T.] Mie Univ, Fac Engn, Dept Chem Mat, Tsu, Mie 514, Japan.
   [Kishida, A.] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan.
   [Masuzawa, T.] Ibaraki Univ, Dept Mech Engn, Ibaraki, Japan.
   [Nishimura, M.] Tottori Univ, Sch Med, Dept Surg, Div Organ Regenerat Surg, Yonago, Tottori 683, Japan.
   [Tatsumi, E.] Natl Cardiovasc Ctr, Res Inst, Lab Res Evaluat, Suita, Osaka 565, Japan.
   [Tomizawa, Y.] Tokyo Womens Med Univ, Dept Cardiovasc Surg, Tokyo, Japan.
   [Watanabe, H.] Niigata Univ, Grad Sch Med & Dent Sci, Div Thorac & Cardiovasc Surg, Niigata, Japan.
RP Sawa, Y (reprint author), Osaka Univ, Grad Sch Med, Div Cardiovasc Surg, Dept Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
EM sawa@surgl.med.osaka-u.ac.jp
CR Agishi Tetsuzo, 2006, J Artif Organs, V9, P123, DOI 10.1007/s10047-006-0337-0
   Akutsu Toshinosuke, 2006, J Artif Organs, V9, P165, DOI 10.1007/s10047-006-0340-5
   Baba Atsushi, 2006, J Artif Organs, V9, P203, DOI 10.1007/s10047-006-0353-0
   Feng Zhonggang, 2006, J Artif Organs, V9, P220, DOI 10.1007/s10047-006-0354-z
   Fukuda Makoto, 2006, J Artif Organs, V9, P192, DOI 10.1007/s10047-006-0344-1
   Hamamoto Masaki, 2006, J Artif Organs, V9, P144, DOI 10.1007/s10047-006-0335-2
   Ichimori Shinji, 2006, J Artif Organs, V9, P105, DOI 10.1007/s10047-005-0326-8
   Igari Tsuguo, 2006, J Artif Organs, V9, P267, DOI 10.1007/s10047-006-0346-z
   Igawa Kazuyo, 2006, J Artif Organs, V9, P234, DOI 10.1007/s10047-006-0347-y
   Ishihara Masayuki, 2006, J Artif Organs, V9, P8, DOI 10.1007/s10047-005-0313-0
   Kaneda Ken-ichi, 2006, J Artif Organs, V9, P241, DOI 10.1007/s10047-006-0350-3
   Kawamura Akio, 2006, J Artif Organs, V9, P226, DOI 10.1007/s10047-006-0351-2
   Kim N, 2006, J HIGH ENERGY PHYS
   Komoda Takeshi, 2006, J Artif Organs, V9, P29, DOI 10.1007/s10047-005-0322-z
   KONAGAI N, 2006, J ARTIF ORGANS, V64, P161
   Kuramochi Gen, 2006, J Artif Organs, V9, P114, DOI 10.1007/s10047-005-0325-9
   Lee Hwansung, 2006, J Artif Organs, V9, P154, DOI 10.1007/s10047-006-0332-5
   Murakami Daisuke, 2006, J Artif Organs, V9, P185, DOI 10.1007/s10047-006-0342-3
   Murayama Hiroomi, 2006, J Artif Organs, V9, P259, DOI 10.1007/s10047-006-0348-x
   Nishimura Motonobu, 2006, J Artif Organs, V9, P209, DOI 10.1007/s10047-006-0355-y
   Nomura Shinobu, 2006, J Artif Organs, V9, P90, DOI 10.1007/s10047-006-0329-0
   Okamoto Eiji, 2006, J Artif Organs, V9, P77, DOI 10.1007/s10047-006-0330-7
   Okamura Yosuke, 2006, J Artif Organs, V9, P251, DOI 10.1007/s10047-006-0345-0
   Onodera Kazuhiko, 2006, J Artif Organs, V9, P17, DOI 10.1007/s10047-005-0320-1
   Saito Akira, 2006, J Artif Organs, V9, P130, DOI 10.1007/s10047-006-0336-1
   Sakamoto Yoshimasa, 2006, J Artif Organs, V9, P199, DOI 10.1007/s10047-006-0334-3
   Sakurai Koji, 2006, J Artif Organs, V9, P149, DOI 10.1007/s10047-006-0341-4
   Sasaki Masatomi, 2006, J Artif Organs, V9, P50, DOI 10.1007/s10047-005-0318-8
   Sato Toshio, 2006, J Artif Organs, V9, P97, DOI 10.1007/s10047-005-0327-7
   SAWA Y, 2005, J ARTIF ORGANS, V9, P1
   Sawada Rumi, 2006, J Artif Organs, V9, P179, DOI 10.1007/s10047-006-0338-z
   Shiiya Norihiko, 2006, J Artif Organs, V9, P214, DOI 10.1007/s10047-006-0349-9
   Sugiki Hiroshi, 2006, J Artif Organs, V9, P42, DOI 10.1007/s10047-005-0319-7
   TANAKA H, 2006, ARTIF ORGANS, V9, P136
   Tayama Eiki, 2006, J Artif Organs, V9, P118, DOI 10.1007/s10047-006-0331-6
   Terasawa Yasuo, 2006, J Artif Organs, V9, P263, DOI 10.1007/s10047-006-0352-1
   Tomizawa Yasuko, 2006, J Artif Organs, V9, P61, DOI 10.1007/s10047-005-0321-0
   Watanabe Kuniyoshi, 2006, J Artif Organs, V9, P84, DOI 10.1007/s10047-006-0328-1
   YAMANAKA A, 2005, J ARTIF ORGANS, V9, P67
   Yokoyama Yuichi, 2006, J Artif Organs, V9, P71, DOI 10.1007/s10047-005-0324-x
NR 40
TC 9
Z9 9
U1 1
U2 4
PU SPRINGER TOKYO
PI TOKYO
PA 3-3-13, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN
SN 1434-7229
J9 J ARTIF ORGANS
JI J. Artif. Organs
PY 2007
VL 10
IS 2
BP 53
EP 59
DI 10.1007/s10047-007-0386-z
PG 7
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 281JG
UT WOS:000254492100001
PM 17574506
DA 2018-10-19
ER

PT J
AU Sacar, M
   Onem, G
   Baltalarli, A
   Sacar, S
   Turgut, H
   Goksin, I
   Ozean, V
   Sakarya, S
AF Sacar, Mustafa
   Onem, Gokhan
   Baltalarli, Ahmet
   Sacar, Suzan
   Turgut, Huseyin
   Goksin, Ibrahim
   Ozean, Vefa
   Sakarya, Serhan
TI Neuraminidase produces a decrease of adherence of slime-forming
   Staphylococcus aureus to gelatin-impregnated polyester fiber graft
   fabric: an experimental study
SO JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE prosthetic graft; bacterial adherence; slime; neuraminidase
ID EPIDERMIDIS; INFECTION; SIALIDASE; CELLS; ANTIBIOTICS; EXPRESSION;
   PREVENTION; RESISTANCE; VIRULENCE; SURFACES
AB Because slime-forming microorganisms are the major causative agents of graft infections, we aimed to investigate bacterial adherence in. slime-forming and nonslime-forming Staphylococcus aureus and to determine the role of neuraminidase (NANase) on adherence to gelatin-impregnated polyester fiber graft fabric. An in vitro model was developed to quantitatively measure bacterial adherence to the surface of the graft. The grafts were divided into two groups - those colonized with slime-forming S. aureus and those colonized with nonslime-forming S. aureus. The grafts were put into sterile tubes and human plasma was instilled and incubated at 37 degrees C to perform fibrin deposition on the grafts. After 48 h of incubation, grafts were drained and inoculated with slime-forming or nonslime-forming S. aureus in triptic soy broth in the presence or absence of NANase. Following 36h of incubation at 36 degrees C, grafts were vortexed and cultured to perform a colony count. Bacterial counts were expressed as total colony-forming units per square centimeter of graft. Slime-forming S. aureus had greater affinity with the graft compared with nonslime-forming S. aureus (P < 0.05). The adherence of slime-forming S. aureus was impaired by NANase treatment (P < 0.001) but NANase treatment of nonslime-forming S. aureus did not change the adherence to the graft (P > 0.05). These results show that slime plays an important role in the pathogenesis of vascular graft infection. Adherence of slime-forming S. aureus can be decreased by NANase treatment. This may have implications for the development of neuraminidase-embedded vascular grafts to diminish biomaterial-related infections.
C1 [Sacar, Suzan; Turgut, Huseyin] Pamukkale Univ, Sch Med, Dept Infect Dis & Clin Microbiol, TR-20070 Kinikli, Denizli, Turkey.
   [Sacar, Mustafa; Onem, Gokhan; Baltalarli, Ahmet; Goksin, Ibrahim; Ozean, Vefa] Pamukkale Univ, Sch Med, Dept Cardiovasc Surg, Denizli, Turkey.
   [Sakarya, Serhan] Adnan Menderes Univ, Sch Med, Dept Infect Dis & Clin Microbiol, Aydin, Turkey.
   [Sakarya, Serhan] Adnan Menderes Univ, Ctr Res & Dev, Aydin, Turkey.
RP Sacar, S (reprint author), Pamukkale Univ, Sch Med, Dept Infect Dis & Clin Microbiol, TR-20070 Kinikli, Denizli, Turkey.
EM suzansacar@yahoo.com
CR Abdulrahman Ibrahiem Saeed, 2002, Journal of Infection and Chemotherapy, V8, P242
   Alksne LE, 2000, CURR OPIN BIOTECH, V11, P625, DOI 10.1016/S0958-1669(00)00155-5
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   An YH, 2000, HDB BACTERIAL ADHESI, P609
   Arciola C R, 1999, New Microbiol, V22, P337
   BERGAMINI TM, 1994, J SURG RES, V56, P393
   BERGAMINI TM, 1992, J SURG RES, V52, P101, DOI 10.1016/0022-4804(92)90286-9
   BERGAMINI TM, 1988, J VASC SURG, V7, P21, DOI 10.1067/mva.1988.avs0070021
   CHRISTENSEN GD, 1990, J INFECT DIS, V161, P1153, DOI 10.1093/infdis/161.6.1153
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CHRISTENSEN GD, 1990, INFECT IMMUN, V58, P2906
   CROSS AS, 1991, J CLIN INVEST, V88, P2067, DOI 10.1172/JCI115536
   EVERS BM, 1989, MATER RES SOC S P, V110, P71
   FERRARI J, 1994, GLYCOBIOLOGY, V4, P367, DOI 10.1093/glycob/4.3.367
   Foster T. J., 1994, P31
   Francois P, 1996, INFECT CONT HOSP EP, V17, P514
   Gerberding J, 1999, AM J INFECT CONTROL, V27, P520
   Hoyle B D, 1991, Prog Drug Res, V37, P91
   Hussain M, 1993, FEMS Microbiol Rev, V10, P191
   Jones L, 1997, Cardiovasc Surg, V5, P486, DOI 10.1016/S0967-2109(97)00056-2
   Jurcisek J, 2005, INFECT IMMUN, V73, P3210, DOI 10.1128/IAI.73.6.3210-3218.2005
   KARAMANOS NK, 1995, BIOCHIMIE, V77, P217, DOI 10.1016/0300-9084(96)88127-2
   KLOOS WE, 1999, MANUAL CLIN MICROBIO, P264
   LICHTMAN MA, 1972, BLOOD-J HEMATOL, V39, P301
   LICHTMAN MA, 1976, FUNDAMENTAL ASPECTS, P319
   LIEKWEG WG, 1977, SURGERY, V81, P335
   Lowy FD, 2003, J CLIN INVEST, V111, P1265, DOI 10.1172/JC1200318535
   MIYAGI T, 1992, TOHOKU J EXP MED, V168, P223, DOI 10.1620/tjem.168.223
   Sacar M, 2005, J SURG RES, V129, P329, DOI 10.1016/j.jss.2005.05.017
   Sakarya S, 2004, ARCH MED RES, V35, P275, DOI 10.1016/j.arcmed.2004.03.008
   SCHAUER R, 1982, ADV CARBOHYD CHEM BI, V40, P131, DOI 10.1016/S0065-2318(08)60109-2
   TAIRA S, 1988, J IMMUNOL, V141, P440
   TAKEDA A, 1987, EUR J IMMUNOL, V17, P281, DOI 10.1002/eji.1830170220
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   Turgut H, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-91
   Vaudaux P, 1990, J Biomater Appl, V5, P134, DOI 10.1177/088532829000500204
   von Eiff C, 1999, EUR J CLIN MICROBIOL, V18, P843, DOI 10.1007/s100960050417
NR 37
TC 2
Z9 2
U1 0
U2 0
PU SPRINGER TOKYO
PI TOKYO
PA 3-3-13, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN
SN 1434-7229
J9 J ARTIF ORGANS
JI J. Artif. Organs
PY 2007
VL 10
IS 3
BP 177
EP 180
DI 10.1007/s10047-007-0383-2
PG 4
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 281JI
UT WOS:000254492300008
PM 17846717
DA 2018-10-19
ER

PT J
AU Hirata, I
   Nomura, Y
   Ito, M
   Shimazu, A
   Okazaki, M
AF Hirata, Isao
   Nomura, Yuji
   Ito, Manabu
   Shimazu, Atsushi
   Okazaki, Masayuki
TI Acceleration of bone formation with BMP2 in frame-reinforced carbonate
   apatite-collagen sponge scaffolds
SO JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article
DE CO(3)apatite; collagen sponge; scaffold; HAp frame; BMP2
ID COMPOSITES; CELLS; BEHAVIOR; MARROW
AB The development is expected of scaffold biomaterials that feature a shape-maintaining property in addition to high porosity and large pores that cells can easily invade. To develop a new biodegradable scaffold biomaterial reinforced with a frame, synthesized carbonate apatite (CO(3)Ap) was mixed with neutralized collagen gel, and the CO(3)Ap-collagen mixtures were lyophilized into sponges in a porous hydroxyapatite (HAp) frame ring. X-ray diffraction and Fourier transform infrared spectroscopy (FT-IR) analyses together with chemical analysis indicated that the synthesized CO(3)Ap had a crystalline nature and a chemical composition similar to that of bone. Scanning electron microscope (SEM) observation showed that the CO(3)Ap-collagen sponge had a sui pore size for cell invasion. In proliferation and differentiation experiments with osteoblasts, alkaline phosphatase and osteopontin activity were clearly detected. When these sponge-frame complexes with bone morphogenic protein (rh-BMP2) were implanted beneath the periosteurn cranii of rats, significant new bone was created at the surface of the periosteum cranii after 4 weeks of implantation. These reinforced CO(3)Ap-collagen sponges with rh-BMP2 are expected to be used as hard tissue scaffold biomaterials for the therapeutic purpose of the rapid cure of bone defects.
C1 [Hirata, Isao; Nomura, Yuji; Okazaki, Masayuki] Hiroshima Univ, Dept Biomat Sci, Grad Sch Biomed Sci, Hiroshima 7348553, Japan.
   [Ito, Manabu] Ishizuka Ito Dent Clin, Yokaichi, Japan.
   [Shimazu, Atsushi] Hiroshima Univ, Dept Mucosal Immunol, Grad Sch Biomed Sci, Hiroshima, Japan.
RP Okazaki, M (reprint author), Hiroshima Univ, Dept Biomat Sci, Grad Sch Biomed Sci, 1-2-3 Kasumi, Hiroshima 7348553, Japan.
EM okazakix@hiroshima-u.ac.jp
CR Bokhari M, 2003, ADV EXP MED BIOL, V534, P247
   CONSTANTZ BR, 1995, SCIENCE, V267, P1796, DOI 10.1126/science.7892603
   CONWAY EJ, 1950, MICRODIFFUSION ANAL
   Du C, 2000, J BIOMED MATER RES, V50, P518, DOI 10.1002/(SICI)1097-4636(20000615)50:4<518::AID-JBM7>3.0.CO;2-W
   EASTOE JE, 1965, METHOD DETERMINATION
   Hattori H, 2006, J BIOMED MATER RES B, V76B, P230, DOI 10.1002/jbm.b.30357
   Hirata I, 2005, DENT MATER J, V24, P460, DOI 10.4012/dmj.24.460
   Ignatius AA, 2001, J BIOMED MATER RES, V58, P564, DOI 10.1002/jbm.1055
   Itoh M, 2004, BIOMATERIALS, V25, P2577, DOI 10.1016/j.biomaterials.2003.09.071
   Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870
   Legeros R.Z., 1991, MONOGRAPHS ORAL SCI, V15
   LEGEROS RZ, 1977, P 1 INT C PHOSPH COM, P347
   Miles A. E. W., 1967, STRUCTURAL CHEM ORG, VII
   NERY EB, 1975, J PERIODONTOL, V46, P328, DOI 10.1902/jop.1975.46.6.328
   OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   OKAZAKI M, 1989, BIOMATERIALS, V10, P564, DOI 10.1016/0142-9612(89)90064-1
   OKAZAKI M, 1981, CARIES RES, V15, P477, DOI 10.1159/000260555
   OKAZAKI M, 1990, BIOMATERIALS, V11, P568, DOI 10.1016/0142-9612(90)90080-A
   Service RF, 2000, SCIENCE, V289, P1498, DOI 10.1126/science.289.5484.1498
   Tanahashi M, 1996, BIOMATERIALS, V17, P47, DOI 10.1016/0142-9612(96)80754-X
   TENHUISEN KS, 1994, J BIOMED MATER RES, V28, P27, DOI 10.1002/jbm.820280105
   Tieliewuhan Y, 2004, DENT MATER J, V23, P258, DOI 10.4012/dmj.23.258
   URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893
   Watson J. D., 1994, MOL BIOL CELL
   Yamasaki Y, 2003, BIOMATERIALS, V24, P4913, DOI 10.1016/S0142-9612(03)00414-9
   Yamasaki Y, 2002, J BIOMED MATER RES, V62, P99, DOI 10.1002/jbm.10220
   Zheng XB, 2000, BIOMATERIALS, V21, P841, DOI 10.1016/S0142-9612(99)00255-0
NR 28
TC 16
Z9 20
U1 0
U2 5
PU SPRINGER TOKYO
PI TOKYO
PA 3-3-13, HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN
SN 1434-7229
J9 J ARTIF ORGANS
JI J. Artif. Organs
PY 2007
VL 10
IS 4
BP 212
EP 217
DI 10.1007/s10047-007-0391-2
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 281JK
UT WOS:000254492500005
PM 18071850
DA 2018-10-19
ER

PT J
AU Pereira-Junior, OCM
   Rahal, SC
   Iamaguti, P
   Felisbino, SL
   Pavan, PT
   Vulcano, LC
AF Marques Pereira-Junior, Oduvaldo Camara
   Rahal, Sheila Canevese
   Iamaguti, Paulo
   Felisbino, Sergio Luis
   Pavan, Priscila Teodoro
   Vulcano, Luiz Carlos
TI Comparison between polyurethanes containing castor oil (soft segment)
   and cancellous bone autograft in the treatment of segmental bone defect
   induced in rabbits
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Article
DE biomaterial; segmental bone defect; bone; polyurethane
AB The aim of this study is to compare polyurethanes containing castor oil (soft segment) in granular form compared to cancellous bone autograft applied to a segmental bone defect. Norfolk adult female rabbits - approximately 13 months of age with a mean body weight of 4.5 kg - are used. In both radial diaphyses, 1 cm osteoperiosteal segmental defects are created. The defect in the left radius is filled with the castor-oil-based polyurethane, and the right one, filled with cancellous bone autograft, collected from the left proximal humerus. The rabbits are euthanazed at 15, 30, 60, and 120 days postsurgery (5 animals/period), for histological analyses. By radiographic analyses, at these time points, the bone regeneration is more evident and accelerated in the bone defects treated with the cancellous, bone autograft. At 120 days postsurgery, the segmental bone defects treated with the cancellous bone autograft are totally reconstituted and remodeled, while the bone defects treated with polyurethane polymer have bone formation of 79%. Histological study shows that the polyurethane acts as a space filler, minimizing the local production of fibrous tissue. No granule degradation, resorption or any inflammatory reaction is detected. Thus, it is possible to conclude that the castor-oil-plant-based polyurethane - in the granule presentation - is biocompatible and osteointegrated, but does not show the same bone regeneration capacity as the cancellous bone autograft.
C1 Univ Sao Paulo, Dept Vet Surg & Anesthesiol, Fac Vet Med & Anim Sci, BR-18618000 Botucatu, SP, Brazil.
   Univ Sao Paulo, Dept Anim Reprod & Vet Radiol, Fac Vet Med & Anim Sci, BR-18618000 Botucatu, SP, Brazil.
   Univ Sao Paulo, Dept Morphol, Inst Biosci Sao Paulo, BR-18618000 Botucatu, SP, Brazil.
RP Pereira-Junior, OCM (reprint author), Univ Sao Paulo, Dept Vet Surg & Anesthesiol, Fac Vet Med & Anim Sci, Rubiac Jr S-N, BR-18618000 Botucatu, SP, Brazil.
EM odujunior@yahoo.com.br
RI Felisbino, Sergio/K-7641-2012; Rahal, Sheila/E-9264-2012
OI Rahal, Sheila/0000-0002-9211-4093
CR Bauer TW, 2002, CLIN ORTHOP RELAT R, P11
   Bauer TW, 2000, CLIN ORTHOP RELAT R, P10
   Bucholz RW, 2002, CLIN ORTHOP RELAT R, P44
   Calixto R F, 2001, Pesqui Odontol Bras, V15, P257
   Del Carlo Ricardo Junqueira, 2003, Cienc. Rural, V33, P1081, DOI 10.1590/S0103-84782003000600013
   Ereno D, 2003, PESQUI FAPESP, V91, P66
   FIGUEIREDO AS, 2004, ACTA CIR BRAS, V19
   Fitch R, 1997, COMP CONT EDUC PRACT, V19, P558
   GREENWALD A, 2001, BONE JOINT SURG AM S, V83, pS98
   IGNACIO H, 1999, ESTUDO EXPT CAES
   IGNACIO H, 1996, RES ORTOP, V2, P10
   IGNACIO H, UTILIZACAO CIMENTO D
   LANE JM, 1999, CLIN ORTHOP S, V367, P107
   Leonel Elaine Cristina de Freitas, 2004, Acta Cir. Bras., V19, P342, DOI 10.1590/S0102-86502004000400005
   Lu JX, 1999, J MATER SCI-MATER M, V10, P111, DOI 10.1023/A:1008973120918
   Maria Patricia Popak, 2003, Acta Cir. Bras., V18, P332, DOI 10.1590/S0102-86502003000400013
   Martinez SA, 1999, VET CLIN N AM-SMALL, V29, P1207, DOI 10.1016/S0195-5616(99)50110-1
   Mastrantonio SDS, 2003, REV ODONTOL UNESP, V32, P31
   Mendoza-Barrera C, 2004, REV MEX FIS, V50, P19
   MERCK, 2005, OSSEOINTEGRATION
   Moore AC, 2001, CIVIL ENG, V71, P6
   Ohara GH, 1995, ACTA ORTOP BRAS, V3, P62
   OLIVEIRA MF, 1995, P 9 AR AC JOURN UNES, P74
   Silva MJA, 1997, REV FOB, V5, P69
   TEIXEIRA HM, 1995, P 9 AR AC JOURN UNES, P117
   Zellin G, 1996, BIOMATERIALS, V17, P695, DOI 10.1016/0142-9612(96)86739-1
   Ziliotto Liane, 2003, Acta Cir. Bras., V18, P107, DOI 10.1590/S0102-86502003000200007
   2004, BIOOSTEO
NR 28
TC 26
Z9 27
U1 0
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JAN
PY 2007
VL 21
IS 3
BP 283
EP 297
DI 10.1177/0885328206063526
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 126QB
UT WOS:000243528400005
PM 16543284
DA 2018-10-19
ER

PT J
AU Yunoki, S
   Ikoma, T
   Monkawa, A
   Marukawa, E
   Sotome, S
   Shinomiya, K
   Tanaka, J
AF Yunoki, Shunji
   Ikoma, Toshiyuki
   Monkawa, Akira
   Marukawa, Eriko
   Sotome, Shinichi
   Shinomiya, Kenichi
   Tanaka, Junzo
TI Three-dimensional porous hydroxyapatite/collagen composite with
   rubber-like elasticity
SO JOURNAL OF BIOMATERIALS SCIENCE-POLYMER EDITION
LA English
DT Article
DE hydroxyapatite; collagen; nanocomposite; bone regeneration; porosity;
   compression
ID BONE; COLLAGEN; SCAFFOLDS; BIOMATERIAL; FABRICATION
AB A three-dimensional porous hydroxyapatite/collagen (HAp/Col) composite with a random pore structure was fabricated using freeze-drying processes; the self-organized HAp/Col nanocomposite with a weight ratio of 80.5:19.5, freeze-dried, was kneaded in 100 mM sodium phosphate buffer, frozen at -20 degrees C and freeze-dried. The cross-linkage of Col molecules was introduced dehydrothermally at 140 degrees C in vacuo. The porous composite had a porosity of 94.7% with pore sizes between 200 and 500 pm. The compressive stress for the wet porous composite in phosphate buffer saline (PBS) was gradually decreased during 20 days incubation with a small amount of weight loss. The cyclic and time-course compression tests showed good repeatability of stress and well-recovery of its height, and caused no collapse of the porous composite. The implantation of the porous composite in rat bone holes showed the biodegradable property and new bone formation occurred in the pores without inflammatory response. The porous composite fabricated has good flexibility and rubber-like elasticity, and is a promising bone regenerative material.
C1 Natl Inst Mat Sci, Biomat Ctr, Tsukuba, Ibaraki 3050044, Japan.
   Tokyo Med & Dent Univ, Dept Orthoped Surg, Bunkyo Ku, Tokyo 1138510, Japan.
   Hokkaido Univ, Creat Res Initiat SOUSEI, Div Frontier Res, Kita Ku, Sapporo, Hokkaido 0010021, Japan.
RP Ikoma, T (reprint author), Natl Inst Mat Sci, Biomat Ctr, Mamiki 1-1, Tsukuba, Ibaraki 3050044, Japan.
EM ikoma.toshiyuki@nims.go.jp
RI Ikoma, Toshiyuki/E-4288-2012
OI Ikoma, Toshiyuki/0000-0003-3154-1777
CR Burg KJL, 2000, BIOMATERIALS, V21, P2347, DOI 10.1016/S0142-9612(00)00102-2
   DAMINK LHHO, 1995, J MATER SCI-MATER M, V6, P460, DOI 10.1007/BF00123371
   Du C, 1998, J BIOMED MATER RES, V42, P540, DOI 10.1002/(SICI)1097-4636(19981215)42:4<540::AID-JBM9>3.3.CO;2-U
   Gao CY, 2003, POLYM ADVAN TECHNOL, V14, P373, DOI 10.1002/pat.342
   Hollinger JO, 1996, BIOMATERIALS, V17, P187, DOI 10.1016/0142-9612(96)85763-2
   Hu YH, 2002, J BIOMED MATER RES, V59, P563, DOI 10.1002/jbm.1269
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Itoh S, 2002, BIOMATERIALS, V23, P3919, DOI 10.1016/S0142-9612(02)00126-6
   KAWASAKI T, 1991, J CHROMATOGR, V544, P147, DOI 10.1016/S0021-9673(01)83984-4
   Kikuchi M, 2001, BIOMATERIALS, V22, P1705, DOI 10.1016/S0142-9612(00)00305-7
   Kikuchi M, 2003, KEY ENG MAT, V240-2, P567, DOI 10.4028/www.scientific.net/KEM.240-242.567
   Kikuchi M, 2004, KEY ENG MAT, V254-2, P561, DOI 10.4028/www.scientific.net/KEM.254-256.561
   Kim HW, 2004, J BIOMED MATER RES B, V70B, P240, DOI 10.1002/jbm.b.30038
   Letic-Gavrilovic A, 2003, J MATER SCI-MATER M, V14, P95, DOI 10.1023/A:1022099208535
   Lickorish D, 2004, J BIOMED MATER RES A, V68A, P19, DOI 10.1002/jbm.a..20031
   Mythili J, 2000, BIOTECHNOL APPL BIOC, V32, P155, DOI 10.1042/BA20000055
   Nagai N, 2004, J BIOSCI BIOENG, V97, P389, DOI 10.1263/jbb.97.389
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   OKAZAKI M, 1990, BIOMATERIALS, V11, P568, DOI 10.1016/0142-9612(90)90080-A
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Ren L, 2002, BIOMATERIALS, V23, P4765, DOI 10.1016/S0142-9612(02)00226-0
   Sasaki N, 1997, CALCIFIED TISSUE INT, V60, P361, DOI 10.1007/s002239900244
   SILVER FH, 1979, J BIOMED MATER RES, V13, P701, DOI 10.1002/jbm.820130504
   Tampieri A, 2003, J BIOMED MATER RES A, V67A, P618, DOI 10.1002/jbm.a.10039
   WEADOCK K, 1983, BIOMATER ARTIF CELL, V11, P293, DOI 10.3109/10731198309118815
   Wu TJ, 2004, BIOMATERIALS, V25, P651, DOI 10.1016/S0142-9612(03)00576-3
   YUNOKI S, 2007, J NANOSCI NANOTECHNO, V7, P1
   Zhang LJ, 2004, MATER LETT, V58, P719, DOI 10.1016/j.matlet.2003.07.009
   Zhao L, 2004, J MATER SCI-MATER M, V15, P625, DOI 10.1023/B:JMSM.0000026103.44687.d0
NR 29
TC 16
Z9 17
U1 1
U2 13
PU VSP BV
PI LEIDEN
PA BRILL ACADEMIC PUBLISHERS, PO BOX 9000, 2300 PA LEIDEN, NETHERLANDS
SN 0920-5063
J9 J BIOMAT SCI-POLYM E
JI J. Biomater. Sci.-Polym. Ed.
PY 2007
VL 18
IS 4
BP 393
EP 409
DI 10.1163/156856207780425077
PG 17
WC Engineering, Biomedical; Materials Science, Biomaterials; Polymer
   Science
SC Engineering; Materials Science; Polymer Science
GA 189PE
UT WOS:000248000200004
PM 17540116
DA 2018-10-19
ER

PT J
AU Yang, J
   Xiang, HJ
AF Yang, Jie
   Xiang, Hong-Jun
TI A three-dimensional finite element study on the biomechanical behavior
   of an FGBM dental implant in surrounding bone
SO JOURNAL OF BIOMECHANICS
LA English
DT Article
DE functionally graded biomaterial (FGBM); dental implant; finite element
   method; biomechanical response
ID NUMERICAL APPROACH; DESIGN
AB Dental implants made of functionally graded biontaterials (FGBM) have been receiving increasing attention due to their unique advantage of being able to simultaneously satisfy biocompatibility, strength, corrosion resistance, etc., which a single composition with a uniform structure cannot satisfy. This paper investigates the biomechanical behavior of a threaded FGBM dental implant/surrounding bone system under static and hartrionic occlusal forces by using a three-dimensional finite element method. The implant is a mixture of a bioceramic and a biometal with a smooth gradient in both the material composition and properties in the longitudinal direction. The interaction of the implant and the supporting bone tissues is considered. Three contact conditions at the implant-bone interface are used to model different osseointegration stages. A comprehensive parametric study is conducted to highlight the influence of the material properties, the volume fraction index, the occlusal force orientation, and the osseointegration quality on the maximum von-Mises stress, deformation distribution, natural frequencies, and harmonic response. (c) 2007 Elsevier Ltd. All rights reserved.
C1 City Univ Hong Kong, Dept Bldg & Construct, Hong Kong, Hong Kong, Peoples R China.
   Beijing Jiaotong Univ, Sch Civil Engn, Beijing 100044, Peoples R China.
RP Yang, J (reprint author), City Univ Hong Kong, Dept Bldg & Construct, Hong Kong, Hong Kong, Peoples R China.
EM jyang2@city.edu.hk
RI XIANG, HONGJUN/A-9949-2011
OI XIANG, HONGJUN/0000-0002-8471-0805; Yang, Jie/0000-0001-9147-1489
CR BISHOP A, 1993, J MATER SCI LETT, V12, P1516
   CHEN CC, 2005, J BIOMEDICAL MAT R B, V78, P146
   Chun HJ, 2002, J ORAL REHABIL, V29, P565, DOI 10.1046/j.1365-2842.2002.00891.x
   Hedia HS, 2005, J BIOMED MATER RES B, V75B, P74, DOI 10.1002/jbm.b.30275
   Hedia HS, 2004, BIO-MED MATER ENG, V14, P133
   Huang HM, 2002, CLIN ORAL IMPLAN RES, V13, P65, DOI 10.1034/j.1600-0501.2002.130108.x
   Ivanoff CJ, 1999, INT J ORAL MAX IMPL, V14, P173
   Lin CL, 2006, J BIOMECH, V39, P453, DOI 10.1016/j.jbiomech.2004.12.020
   MA P, 2006, CHINESE J MED AESTHE, V12, P28
   Meijer H. J. A., 1993, Archives of Oral Biology, V38, P491
   Natali AN, 2006, J ORAL REHABIL, V33, P674, DOI 10.1111/j.1365-2842.2006.01610.x
   Natali AN, 2006, DENT MATER, V22, P388, DOI 10.1016/j.dental.2005.08.001
   Natali AN, 2006, CLIN ORAL IMPLAN RES, V17, P67, DOI 10.1111/j.1600-0501.2005.01162.x
   Nonami T, 2000, J CERAM SOC JPN, V108, P1122, DOI 10.2109/jcersj.108.1264_1122
   RHO JY, 1993, J BIOMECH, V26, P111, DOI 10.1016/0021-9290(93)90042-D
   Steigenga Jennifer T, 2003, Implant Dent, V12, P306, DOI 10.1097/01.ID.0000091140.76130.A1
   Tada S, 2003, INT J ORAL MAX IMPL, V18, P357
   Thieme M, 2001, J MATER SCI-MATER M, V12, P225, DOI 10.1023/A:1008958914818
   Watari F, 2004, COMPOS SCI TECHNOL, V64, P893, DOI 10.1016/j.compscitech.2003.09.005
   Watari F, 1998, J JPN I MET, V62, P1095, DOI 10.2320/jinstmet1952.62.11_1095
   Watari F, 1997, COMPOS PART B-ENG, V28, P5, DOI 10.1016/S1359-8368(96)00021-2
   Williams KR, 1997, BIOMATERIALS, V18, P715, DOI 10.1016/S0142-9612(96)00186-X
NR 22
TC 71
Z9 78
U1 0
U2 14
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0021-9290
EI 1873-2380
J9 J BIOMECH
JI J. Biomech.
PY 2007
VL 40
IS 11
BP 2377
EP 2385
DI 10.1016/j.jbiomech.2006.11.019
PG 9
WC Biophysics; Engineering, Biomedical
SC Biophysics; Engineering
GA 203RB
UT WOS:000248990600004
PM 17241637
DA 2018-10-19
ER

PT J
AU Yoshida, M
   Mata, J
   Babensee, JE
AF Yoshida, Mutsumi
   Mata, Jessica
   Babensee, Julia E.
TI Effect of poly(lactic-co-glycolic acid) contact on maturation of murine
   bone marrow-derived dendritic cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE dendritic cells; poly(lactic-co-glycolic acid); adjuvant; murine
ID TOLL-LIKE RECEPTOR-4; HEAT-SHOCK PROTEINS; VACCINE ADJUVANTS;
   IMMUNE-RESPONSE; IN-VITRO; MICROSPHERES; ACTIVATION; DELIVERY;
   BIOCOMPATIBILITY; OLIGOSACCHARIDES
AB Understanding of biomaterial adjuvant effect and its mechanisms is essential for the effective design and selection of appropriate materials for specific applications. We have previously shown that poly(lactic-co-glycolic acid) (PLGA), one of the most commonly studied polymers in tissue engineering, supports an adjuvant effect as measured by enhanced immune response against a co-delivered model antigen, which was dependent on the form of the biomaterial. Furthermore, we have shown that PLGA induces the maturation of human peripheral blood mononuclear cell-derived dendritic cells (DCs) in vitro. In this study, the effect of PLGA contact on the maturation of murine bone marrow-derived DCs was investigated in part to explain the biomaterial adjuvant effect observed. Treatment of bone marrow-derived DCs from C57BL6 mice with PLGA microparticles or films lead to maturation of these cells as exemplified by increased expression of co-stimulatory molecules CD80 and CD86 and production of proinflammatory cytokines TNF-alpha and IL-6. These results suggest that PLGA contact induces maturation of murine DCs, supporting our observations with human DCs. With the techniques developed in this study and given the results, our future goal is to utilize transgenic murine models to delineate the mechanisms of biomaterial-induced DC maturation. (c) 2006 Wiley Periodicals, Inc.
C1 Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   Emory Univ, Atlanta, GA 30332 USA.
RP Babensee, JE (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM julia.babensee@bme.gatech.edu
FU NIBIB NIH HHS [1R01EB004633-01A1]
CR Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Basu S, 2000, INT IMMUNOL, V12, P1539, DOI 10.1093/intimm/12.11.1539
   Bethke K, 2002, J IMMUNOL, V169, P6141, DOI 10.4049/jimmunol.169.11.6141
   Elamanchili P, 2004, VACCINE, V22, P2406, DOI 10.1016/j.vaccine.2003.12.032
   ELDRIDGE JH, 1991, MOL IMMUNOL, V28, P287, DOI 10.1016/0161-5890(91)90076-V
   Ertl HCJ, 1996, VACCINE, V14, P879, DOI 10.1016/0264-410X(96)00005-9
   Flo TH, 2002, J BIOL CHEM, V277, P35489, DOI 10.1074/jbc.M201366200
   Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618
   Hunter RL, 2002, VACCINE, V20, pS7, DOI 10.1016/S0264-410X(02)00164-0
   HUTCHINSON FG, 1986, BIODEGRADABLE POLYM
   INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Jilek S, 2004, PHARM RES, V21, P1240, DOI 10.1023/B:PHAM.0000033012.16152.5d
   Johnson GB, 2002, J IMMUNOL, V168, P5233, DOI 10.4049/jimmunol.168.10.5233
   Kranzer K, 2005, INFECT IMMUN, V73, P4180, DOI 10.1128/IAI.73.7.4180-4189.2005
   MIKOS AG, 2000, EJB ELECT J BIOTECHN, V3, P114
   Mikos AG, 1998, ADV DRUG DELIV REV, V33, P111
   Newman KD, 2002, J BIOMED MATER RES, V60, P480, DOI 10.1002/jbm.10019
   Raghuvanshi RJ, 2001, J MICROENCAPSUL, V18, P723
   Rihova B, 2000, ADV DRUG DELIVER REV, V42, P65
   SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389
   Singh M, 1999, NAT BIOTECHNOL, V17, P1075, DOI 10.1038/15058
   Sun HF, 2003, VACCINE, V21, P849, DOI 10.1016/S0264-410X(02)00531-5
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858
   Termeer CC, 2000, J IMMUNOL, V165, P1863, DOI 10.4049/jimmunol.165.4.1863
   Waeckerle-Men Y, 2004, J IMMUNOL METHODS, V287, P109, DOI 10.1016/j.jim.2004.01.010
   Wake MC, 1998, BIOMATERIALS, V19, P1255
   Walker KB, 1998, DEV BIOL STAND, V92, P259
   Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   YOSHIDA M, IN PRESS J BIOMATER
   YOSHIDA M, IN PRESS J BIOMED MA
NR 36
TC 41
Z9 41
U1 0
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2007
VL 80A
IS 1
BP 7
EP 12
DI 10.1002/jbm.a.30832
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 114PN
UT WOS:000242678200002
PM 16958042
OA Bronze
DA 2018-10-19
ER

PT J
AU Sellaro, TL
   Hildebrand, D
   Lu, QJ
   Vyavahare, N
   Scott, M
   Sacks, MS
AF Sellaro, Tiffany L.
   Hildebrand, Daniel
   Lu, Qijin
   Vyavahare, Naren
   Scott, Michael
   Sacks, Michael S.
TI Effects of collagen fiber orientation on the response of biologically
   derived soft tissue biomaterials to cyclic loading
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE collagenous biomaterials; bioprosthetic heart valve; collagen fiber
   orientation; cyclic loading; fatigue
ID BIOPROSTHETIC HEART-VALVE; AMIDE-I-BAND; INFRARED-SPECTROSCOPY;
   MECHANICAL-PROPERTIES; BOVINE PERICARDIUM; CROSS-LINKING; INPLANE SHEAR;
   CALCIFICATION; BEHAVIOR; FATIGUE
AB In the present study, the effects of initial collagen fiber orientation on the medium-term (up to 50 x 10(6) cycles) fatigue response of heart valve soft tissue biomaterials was investigated. Glutaraldehyde treated bovine pericardium (GLBP), preselected for uniform structure and collagen fiber orientation, was used as the representative heart valve biomaterial. Using specialized instrumentation, GLBP specimens were subjected to cyclic tensile loading to maximum stress levels of 500 +/- 50 kPa at a frequency of 22 Hz. Two sample groups were examined, one with the preferred collagen fiber direction parallel (PD) and perpendicular (XD) to the direction of applied strain. The primary findings indicated that GLBP fatigue response was highly sensitive to the direction of loading with respect to fiber orientation. Specifically, when loading perpendicular to the preferred collagen fiber orientation, fiber reorientation is the dominant mechanism. In contrast, when loaded parallel to the preferred fiber direction a reduction in both collagen fiber crimp and fiber reorientation occurred. Moreover, alterations in the degree and direction of mechanical anisotropy can be inducted by cyclic loading when specimens are loaded perpendicular to the preferred fiber direction. Fourier Transform Infrared Spectroscopy (FT-IR) results indicate that molecular-level damage to collagen occurs in both groups after only 20 x 10(6) cycles. Taken as a whole, the results of this study suggest that initial collagen orientation plays a critical role in bioprosthetic heart valve biomaterial fatigue response. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Pittsburgh, Dept Bioengn, Engineered Tissue Mech Lab, Pittsburgh, PA USA.
   Clemson Univ, Dept Bioengn, Clemson, SC USA.
   Edwards Lifesci, Irvine, CA USA.
RP Sacks, MS (reprint author), Univ Pittsburgh, Dept Bioengn, Engineered Tissue Mech Lab, Pittsburgh, PA USA.
EM msacks@pitt.edu
CR Bailey M, 2001, AM J PATHOL, V159, P1981, DOI 10.1016/S0002-9440(10)63048-9
   BENGTSSON LA, 1995, ANN THORAC SURG, V60, pS365, DOI 10.1016/0003-4975(95)00316-D
   Billiar KL, 1997, J BIOMECH, V30, P753, DOI 10.1016/S0021-9290(97)00019-5
   BLACK MM, 1991, J BIOMECH, V24, P793, DOI 10.1016/0021-9290(91)90304-6
   BROOM ND, 1980, BIOMATERIALS, V1, P3, DOI 10.1016/0142-9612(80)90049-6
   BROOM ND, 1977, J BIOMECH, V10, P707, DOI 10.1016/0021-9290(77)90086-0
   Connolly JM, 2005, AM J PATHOL, V166, P1, DOI 10.1016/S0002-9440(10)62227-4
   DOYLE BB, 1975, BIOPOLYMERS, V14, P937, DOI 10.1002/bip.1975.360140505
   FULCHIERO G, IN PRESS BIOMATERIAL
   GEORGE A, 1991, BIOCHEMISTRY-US, V30, P2372, DOI 10.1021/bi00223a011
   Grauss RW, 2003, J THORAC CARDIOV SUR, V126, P2003, DOI 10.1016/S0022-5223(03)00956-5
   HILBERT SL, 1986, J BIOMED MATER RES, V20, P1411, DOI 10.1002/jbm.820200914
   Iyengar AKS, 2001, ANN BIOMED ENG, V29, P963, DOI 10.1114/1.1415523
   JAKOBSEN RJ, 1983, SCIENCE, V220, P1288, DOI 10.1126/science.6857249
   KRUCINSKI S, 1993, J BIOMECH, V26, P929, DOI 10.1016/0021-9290(93)90055-J
   Langdon SE, 1999, BIOMATERIALS, V20, P137, DOI 10.1016/S0142-9612(98)00142-2
   LAZAREV YA, 1985, BIOPOLYMERS, V24, P1449, DOI 10.1002/bip.360240804
   Legare JF, 2004, J THORAC CARDIOV SUR, V127, P1850, DOI 10.1016/S0022-5223(03)00597-X
   Levy R J, 1994, J Heart Valve Dis, V3, P101
   MEYERS DJ, 1994, STENTLESS BIOPROSTHE, P100
   Pathak CP, 2004, J BIOMED MATER RES A, V69A, P140, DOI 10.1002/jbm.a.20129
   PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105
   Prosthetic Devices Branch D.o.C., 1993, RESP NEUR DEV REPL H
   PURINYA B, 1994, J BIOMECH, V27, P1, DOI 10.1016/0021-9290(94)90027-2
   Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017
   Sacks M S, 2001, J Long Term Eff Med Implants, V11, P231
   Sacks MS, 2002, J BIOMED MATER RES, V62, P359, DOI 10.1002/jbm.10293
   Sacks MS, 1997, ANN BIOMED ENG, V25, P678, DOI 10.1007/BF02684845
   Sacks MS, 1998, ANN BIOMED ENG, V26, P892, DOI 10.1114/1.135
   Sacks MS, 2003, ANNU REV BIOMED ENG, V5, P251, DOI 10.1146/annurev.bioeng.5.011303.120714
   Sacks MS, 1999, J BIOMECH ENG-T ASME, V121, P551, DOI 10.1115/1.2835086
   Sacks MS, 2003, J BIOMECH ENG-T ASME, V125, P280, DOI 10.1115/1.1544508
   Schoen FJ, 1999, J BIOMED MATER RES, V47, P439, DOI 10.1002/(SICI)1097-4636(19991215)47:4<439::AID-JBM1>3.0.CO;2-O
   SCHOEN FJ, 2001, CARDIOVASCULAR PATHO, pCH21
   Silver FH, 2003, J BIOMECH, V36, P1529, DOI 10.1016/S0021-9290(03)00135-0
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1006
   Sun W, 2004, J BIOMED MATER RES A, V69A, P658, DOI 10.1002/jbm.a.30031
   Sun W, 2003, J BIOMECH ENG-T ASME, V125, P372, DOI 10.1115/1.1572518
   Sun W, 2005, J BIOMECH ENG-T ASME, V127, P905, DOI 10.1115/1.2049337
   SUSI H, 1971, BIOPOLYMERS, V10, P1597, DOI 10.1002/bip.360100913
   Thubrikar MJ, 1990, AORTIC VALVE
   Tower TT, 2001, BIOPHYS J, V81, P2964, DOI 10.1016/S0006-3495(01)75936-X
   TROWBRIDGE EA, 1987, J BIOMED ENG, V9, P345, DOI 10.1016/0141-5425(87)90084-7
   TURINA J, 1993, CIRCULATION, V88, P775, DOI 10.1161/01.CIR.88.2.775
   Vesely I, 2001, J HEART VALVE DIS, V10, P471
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
   Vyavahare N, 1999, J BIOMED MATER RES, V46, P44
   Wells SM, 2005, BIOMATERIALS, V26, P2611, DOI 10.1016/j.biomaterials.2004.06.046
   Wells SM, 2002, BIOMATERIALS, V23, P2389, DOI 10.1016/S0142-9612(01)00375-1
NR 50
TC 44
Z9 44
U1 1
U2 10
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JAN
PY 2007
VL 80A
IS 1
BP 194
EP 205
DI 10.1002/jbm.a.30871
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 114PN
UT WOS:000242678200021
PM 17041913
OA Bronze
DA 2018-10-19
ER

PT J
AU Yang, JM
   Yang, SJ
   Lin, HT
   Chen, JK
AF Yang, Jen Ming
   Yang, Shu Jyuan
   Lin, Hao Tzu
   Chen, Jan Kan
TI Modification of HTPB-based polyurethane with temperature-sensitive
   Poly(N-isopropyl acrylamide) for biomaterial usage
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE polyurethane; poly(N-isopropyl acrylamide); thermosensitivity; cell
   culture; wound dressing
ID SBS-G-VP; DMAEMA COPOLYMER MEMBRANE; POLY(N-ISOPROPYLACRYLAMIDE)-GRAFTED
   SURFACES; OXYGEN PERMEATION; CULTURED-CELLS; UV-RADIATION; MANIPULATION;
   PLATELET; RECOVERY; HEPARIN
AB Hydroxyl-terminated polybutadiene (HTPB)-based polyurethane with dimethyol propionic acid (DPA) as chain extender was synthesized by solution polymerization. The HTPB-based polyurethane was modified by UV radiation with N-isopropyl acrylamide monomer to get poly(N-isopropyl acrylamide)-modified polyurethane (PUDPANIPAAm). The cohesive energy (E-coh), molar volume (V), solubility parameter (delta), molecular weight (W-M), volume per gram (V-g), and the density (1/V-g) of PUDPANIPAAm were calculated by group contribution methods. To evaluate the application of PUDPANIPAAm for wound dressing and transplantation of cell sheet, the measurement of water content, water vapor transmission rate, and gas permeation on the PUDPANIPAAm membrane was evaluated. The biocompatibility of these membranes, cell adhesion, and proliferation assay were conducted in the cell culture. The effect of thermosensitivity of poly(N-isopropyl acrylamide) on cell detachment was also evaluated in the primary study. The results showed that these PUDPANIPAAm membranes are thermosensitive. The modification of PU with poly(N-isopropyl acrylamide) reduced the water vapor transmission rate and permeability of gas through PUDPANIPAAm membrane. PUDPANHIPAAm membranes could support cell adhesion and growth. Owing to the thermosensitive nature of poly(N-isopropyl acrylamide), the relative cell numbers detached from PUDPANIPAAm membranes were larger than those detached from the polystyrene dish. (c) 2006 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 80B: 43-51, 2007
C1 Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 33302, Taiwan.
   Chang Gung Univ, Dept Physiol, Tao Yuan 33302, Taiwan.
RP Yang, JM (reprint author), Chang Gung Univ, Dept Chem & Mat Engn, Tao Yuan 33302, Taiwan.
EM jmyang@mail.cgu.edu.tw
CR CARDONA LR, 1996, BIOMATERIALS, V17, P1639
   CHEN CC, 2000, Patent No. 6022330
   HSIUE GH, 1988, J BIOMED MATER RES, V22, P405, DOI 10.1002/jbm.820220504
   Kikuchi A, 1998, J BIOMAT SCI-POLYM E, V9, P1331, DOI 10.1163/156856298X00424
   Kwon OH, 2003, BIOMATERIALS, V24, P1223, DOI 10.1016/S0142-9612(02)00469-6
   Lin FH, 2000, MATER CHEM PHYS, V64, P189, DOI 10.1016/S0254-0584(99)00262-X
   MINOURA N, 1993, BIOMEDICAL APPL POLY, P118
   Nandkumar MA, 2002, BIOMATERIALS, V23, P1121, DOI 10.1016/S0142-9612(01)00225-3
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   OKANO T, 1995, J CONTROL RELEASE, V36, P125, DOI 10.1016/0168-3659(95)00054-C
   PARK JB, 1992, BIOMATERIALS INTRO, P255
   TAKEI YG, 1995, BIOMATERIALS, V16, P667, DOI 10.1016/0142-9612(95)99692-F
   Uchida K, 2000, BIOMATERIALS, V21, P923, DOI 10.1016/S0142-9612(99)00260-4
   Yakushiji T, 1999, ANAL CHEM, V71, P1125, DOI 10.1021/ac980677t
   YAMADA N, 1990, MAKROMOL CHEM-RAPID, V11, P571
   Yamato M, 2001, TISSUE ENG, V7, P473, DOI 10.1089/10763270152436517
   Yamato M, 2004, MATER TODAY, V7, P42, DOI 10.1016/S1369-7021(04)00234-2
   Yang JM, 1996, J BIOMED MATER RES, V31, P281
   Yang JM, 2002, J MEMBRANE SCI, V208, P105, DOI 10.1016/S0376-7388(02)00180-1
   Yang JM, 1998, J MEMBRANE SCI, V138, P19
   Yang JM, 1997, J BIOMED MATER RES, V35, P175, DOI 10.1002/(SICI)1097-4636(199705)35:2<175::AID-JBM5>3.0.CO;2-K
   Yang JM, 1997, J APPL POLYM SCI, V65, P109
   YANG JM, 1995, ANGEW MAKROMOL CHEM, V231, P1, DOI 10.1002/apmc.1995.052310101
   YANG JM, 1990, J APPL POLYM SCI, V39, P1475, DOI 10.1002/app.1990.070390706
   Yang JM, 2003, J BIOMED MATER RES A, V64A, P138, DOI 10.1002/jbm.a.10245
   Yang JM, 1997, J MEMBRANE SCI, V128, P133, DOI 10.1016/S0376-7388(96)00312-2
   Yang JM, 1998, J BIOMED MATER RES, V39, P86, DOI 10.1002/(SICI)1097-4636(199801)39:1<86::AID-JBM11>3.0.CO;2-M
   Yang JM, 1999, J MEMBRANE SCI, V153, P175, DOI 10.1016/S0376-7388(98)00261-0
   Yang JM, 2005, J MEMBRANE SCI, V258, P97, DOI 10.1016/j.memsci.2005.02.033
   Yang JM, 2001, J MEMBRANE SCI, V187, P159, DOI 10.1016/S0376-7388(01)00340-4
   Yang JM, 1999, J BIOMED MATER RES, V45, P133, DOI 10.1002/(SICI)1097-4636(199905)45:2<133::AID-JBM8>3.3.CO;2-4
   Yang JM, 2001, J MEMBRANE SCI, V183, P37, DOI 10.1016/S0376-7388(00)00550-0
   YANG JM, 1990, J APPL POLYM SCI, V41, P1141, DOI 10.1002/app.1990.070410523
   Yang JM, 2004, J MEMBRANE SCI, V243, P1, DOI 10.1016/j.memsci.2004.03.019
NR 34
TC 10
Z9 10
U1 1
U2 18
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4973
EI 1552-4981
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JAN
PY 2007
VL 80B
IS 1
BP 43
EP 51
DI 10.1002/jbm.b.30566
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 119NE
UT WOS:000243018200006
PM 16649182
OA Bronze
DA 2018-10-19
ER

PT J
AU Jager, M
   Zilkens, C
   Zanger, K
   Krauspe, R
AF Jaeger, M.
   Zilkens, C.
   Zanger, K.
   Krauspe, R.
TI Significance of nano- and microtopography for cell-surface interactions
   in orthopaedic implants
SO JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
LA English
DT Review
ID MOLECULAR-WEIGHT POLYETHYLENE; OSTEOBLAST-LIKE CELLS; HELICAL ROSETTE
   NANOTUBES; TI-6AL-4V TITANIUM-ALLOY; WALLED CARBON NANOTUBES; VEIN
   ENDOTHELIAL-CELLS; IN-VITRO BIOCORROSION; MARROW STROMAL CELLS; WEAR
   DEBRIS; PROTEIN ADSORPTION
AB Cell-surface interactions play a crucial role for biomaterial application in orthopaedics. It is evident that not only the chemical composition of solid substances influence cellular adherence, migration, proliferation and differentiation but also the surface topography of a biomaterial. The progressive application of nanostructured surfaces in medicine has gained increasing interest to improve the cytocompatibility and osteointegration of orthopaedic implants. Therefore, the understanding of cell-surface interactions is of major interest for these substances. In this review, we elucidate the principle mechanisms of nano- and microscale cell-surface interactions in vitro for different cell types onto typical orthopaedic biomaterials such as titanium (Ti), cobalt-chrome-molybdenum (CoCrMo) alloys, stainless steel (SS), as well as synthetic polymers (UHMWPE, XLPE, PEEK, PLLA). In addition, effects of nano- and microscaled particles and their significance in orthopaedics were reviewed. The significance for the cytocompatibility of nanobiomaterials is discussed critically. Copyright (C) 2007.
C1 [Jaeger, M.; Zilkens, C.; Krauspe, R.] Univ Dusseldorf, Sch Med, Dept Orthopaed, D-40225 Dusseldorf, Germany.
   [Zanger, K.] Univ Dusseldorf, Inst Anat 2, D-40225 Dusseldorf, Germany.
RP Jager, M (reprint author), Univ Dusseldorf, Sch Med, Dept Orthopaed, Moorenstr 5, D-40225 Dusseldorf, Germany.
EM drjaegermarcus@yahoo.de
RI Luong-Van, Emma/A-8685-2012
CR ABERCROM.M, 1971, EXP CELL RES, V67, P359, DOI 10.1016/0014-4827(71)90420-4
   Akisue T, 2002, J BIOMED MATER RES, V59, P507, DOI 10.1002/jbm.1264
   Alivisatos AP, 2005, ANNU REV BIOMED ENG, V7, P55, DOI 10.1146/annurev.bioeng.7.060804.100432
   Andrade J D, 1973, Med Instrum, V7, P110
   ANDRADE JD, 1987, ANN NY ACAD SCI, V516, P158, DOI 10.1111/j.1749-6632.1987.tb33038.x
   Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 2006, J MATER SCI-MATER M, V17, P471, DOI 10.1007/s10856-006-8475-8
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Anselme K, 2004, BIO-MED MATER ENG, V14, P545
   Anselme K, 1999, J MATER SCI-MATER M, V10, P815, DOI 10.1023/A:1008992109670
   Badami AS, 2006, BIOMATERIALS, V27, P596, DOI 10.1016/j.biomaterials.2005.05.084
   Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532
   Balcerzak M, 2003, ACTA BIOCHIM POL, V50, P1019
   Barrias CC, 2005, J BIOMED MATER RES A, V72A, P57, DOI 10.1002/jbm.a.30217
   Baumann B, 2004, ACTA ORTHOP SCAND, V75, P295, DOI 10.1080/00016470410001222
   Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   Ber S, 2005, BIOMATERIALS, V26, P1977, DOI 10.1016/j.biomaterials.2004.07.007
   Bibby JK, 2005, J MATER SCI-MATER M, V16, P379, DOI 10.1007/s10856-005-6975-6
   BIEBUYCK HA, 1994, LANGMUIR, V10, P2790, DOI 10.1021/la00020a047
   Bierbaum S, 2003, J BIOMED MATER RES A, V67A, P421, DOI 10.1002/jbm.a.10080
   Bigerelle M, 2005, ACTA BIOMATER, V1, P499, DOI 10.1016/j.actbio.2005.06.001
   Bigerelle M, 2005, J BIOMED MATER RES A, V75A, P530, DOI 10.1002/jbm.a.30473
   Bigerelle M, 2005, J BIOMED MATER RES A, V72A, P36, DOI 10.1002/jbm.a.30212
   Bigerelle M, 2002, BIOMOL ENG, V19, P79, DOI 10.1016/S1389-0344(02)00048-5
   Boyan BD, 1996, BIOMATERIALS, V17, P137, DOI 10.1016/0142-9612(96)85758-9
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Bruni S, 2005, ACTA BIOMATER, V1, P223, DOI 10.1016/j.actbio.2004.11.001
   Bumgardner JD, 2003, J BIOMAT SCI-POLYM E, V14, P1401, DOI 10.1163/156856203322599734
   Chun AL, 2005, BIOMATERIALS, V26, P7304, DOI 10.1016/j.biomaterials.2005.05.080
   Cooper LF, 2000, J PROSTHET DENT, V84, P522, DOI 10.1067/mpr.2000.111966
   Coppolino MG, 2000, INT J BIOCHEM CELL B, V32, P171, DOI 10.1016/S1357-2725(99)00043-6
   CORNELL R, 1969, EXP CELL RES, V58, P289, DOI 10.1016/0014-4827(69)90507-2
   Curtis A, 1999, BIOCHEM SOC SYMP, V65, P15
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   CURTIS ASG, 1964, J NATL CANCER I, V33, P15
   Cutler SM, 2003, BIOMATERIALS, V24, P1759, DOI 10.1016/S0142-9612(02)00570-7
   Dalby MJ, 2000, J MATER SCI-MATER M, V11, P805, DOI 10.1023/A:1008957630020
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   DANEN EHJ, 1995, J BIOL CHEM, V270, P21612, DOI 10.1074/jbc.270.37.21612
   Das K, 2007, ACTA BIOMATER, V3, P573, DOI 10.1016/j.actbio.2006.12.003
   de Oliveira PT, 2004, BIOMATERIALS, V25, P403, DOI 10.1016/S0142-9612(03)00539-8
   Dean DD, 1999, J BONE JOINT SURG AM, V81A, P452, DOI 10.2106/00004623-199904000-00002
   Di Iorio D, 2005, J BIOMED MATER RES B, V74B, P636, DOI 10.1002/jbm.b.30251
   Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   Domke J, 2000, COLLOID SURFACE B, V19, P367, DOI 10.1016/S0927-7765(00)00145-4
   Eisenbarth E, 2006, J BIOMED MATER RES A, V79A, P166, DOI 10.1002/jbm.a.30823
   ELGHANNAM AR, 2004, J BIOMEDICAL MAT R A, V68, P415
   ERIKSSON AS, 1991, BIOMATERIALS, V12, P827, DOI 10.1016/0142-9612(91)90069-M
   Fenniri H, 2001, J AM CHEM SOC, V123, P3854, DOI 10.1021/ja0058861
   Garcia AJ, 1999, BIOMATERIALS, V20, P2427, DOI 10.1016/S0142-9612(99)00170-2
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Gau H, 1999, SCIENCE, V283, P46, DOI 10.1126/science.283.5398.46
   Germain MA, 2003, BIOMATERIALS, V24, P469, DOI 10.1016/S0142-9612(02)00360-5
   Germanier Y, 2006, CLIN ORAL IMPLAN RES, V17, P251, DOI 10.1111/j.1600-0501.2005.01222.x
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Giudiceandrea F, 1998, J CRANIOFAC SURG, V9, P254, DOI 10.1097/00001665-199805000-00015
   Gleiche M, 2000, NATURE, V403, P173, DOI 10.1038/35003149
   Goldstein AS, 2003, J BIOMED MATER RES A, V67A, P658, DOI 10.1002/jbm.a.10125
   Granchi D, 2005, BIOMATERIALS, V26, P2371, DOI 10.1016/j.biomaterials.2004.07.0145
   Granchi D, 2004, BIOMATERIALS, V25, P4037, DOI 10.1016/j.biomaterials.2003.10.100
   Green TR, 1998, BIOMATERIALS, V19, P2297, DOI 10.1016/S0142-9612(98)00140-9
   Green TR, 2000, J BIOMED MATER RES, V53, P490, DOI 10.1002/1097-4636(200009)53:5<490::AID-JBM7>3.0.CO;2-7
   Grizon F, 2002, J DENT, V30, P195, DOI 10.1016/S0300-5712(02)00018-0
   Gul RM, 2003, BIOMATERIALS, V24, P3193, DOI 10.1016/S0142-9612(03)00165-0
   Hakansson M, 2002, CURR PROTEIN PEPT SC, V3, P629, DOI 10.2174/1389203023380459
   Hallgren C, 2001, J BIOMED MATER RES, V57, P485, DOI 10.1002/1097-4636(20011215)57:4<485::AID-JBM1194>3.0.CO;2-1
   Hamilton DW, 2006, CALCIFIED TISSUE INT, V78, P314, DOI 10.1007/s00223-005-0238-x
   HEIDE H, 1994, CELLS MAT, V4, P263
   Hendrich C, 2002, CLIN ORTHOP RELAT R, P278
   Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0
   Howling GI, 2004, J MATER SCI-MATER M, V15, P91, DOI 10.1023/B:JMSM.0000010102.26218.d1
   Howling GI, 2003, J BIOMED MATER RES B, V67B, P758, DOI 10.1002/jbm.b.10068
   Huang J, 2004, J MATER SCI-MATER M, V15, P441, DOI 10.1023/B:JMSM.0000021117.67205.cf
   HUNTER A, 1995, BIOMATERIALS, V16, P287, DOI 10.1016/0142-9612(95)93256-D
   Huveneers S, 2007, CANCER RES, V67, P2693, DOI 10.1158/0008-5472.CAN-06-3654
   Ikarashi Y, 2000, BIOL PHARM BULL, V23, P1470
   Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333
   Ingham E, 2005, BIOMATERIALS, V26, P1271, DOI 10.1016/j.biomaterials.2004.04.035
   Inoue K, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-106
   Isa ZM, 2006, INT J ORAL MAX IMPL, V21, P203
   Isama K, 2003, BIOMATERIALS, V24, P3303, DOI 10.1016/S0142-9612(03)00216-3
   IULIANO DJ, 1993, J BIOMED MATER RES, V27, P1103, DOI 10.1002/jbm.820270816
   IZZARD CS, 1976, J CELL SCI, V21, P129
   Jager M, 2006, J BIOMED MATER RES A, V76A, P310, DOI 10.1002/jbm.a.30515
   Jager M, 2005, ANN BIOMED ENG, V33, P1319, DOI 10.1007/s10439-005-5889-2
   Jager M, 2003, J BIOMAT SCI-POLYM E, V14, P1283, DOI 10.1163/156856203322553491
   JAGER M, IN PRESS J BIOMEDI A
   Jayaraman M, 2004, BIOMATERIALS, V25, P625, DOI 10.1016/S0142-9612(03)00571-4
   Jilka RL, 1998, J BONE MINER RES, V13, P793, DOI 10.1359/jbmr.1998.13.5.793
   Kaplan F. S., 1994, ORTHOPEDIC BASIC SCI, P460
   Kern T, 2005, IMPLANT DENT, V14, P70, DOI 10.1097/01.id.0000154795.93155.ee
   Keselowsky BG, 2007, J BIOMED MATER RES A, V80A, P700, DOI 10.1002/jbm.a.30898
   Keselowsky BG, 2007, BIOMATERIALS, V28, P3626, DOI 10.1016/j.biomaterials.2007.04.035
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Kim D, 2005, COLLOID SURFACE B, V40, P83, DOI 10.1016/j.colsurfb.2004.05.007
   KIM E, 1995, NATURE, V376, P581, DOI 10.1038/376581a0
   Kim HW, 2004, BIOMATERIALS, V25, P3351, DOI 10.1016/j.biomaterials.2003.09.104
   Kim Kyo-Han, 2006, J Oral Implantol, V32, P8, DOI 10.1563/741.1
   KONONEN M, 1992, J BIOMED MATER RES, V26, P1325
   Koyama S, 2006, SMALL, V2, P1406, DOI 10.1002/smll.200500416
   Kuroda S, 2003, DENT MATER J, V22, P507, DOI 10.4012/dmj.22.507
   Lai CY, 2003, J AM CHEM SOC, V125, P4451, DOI 10.1021/ja028650l
   Lenhert S, 2005, BIOMATERIALS, V26, P563, DOI 10.1016/j.biomaterials.2004.02.068
   Li D, 2001, Implant Dent, V10, P132
   Li JP, 2005, J BIOMED MATER RES A, V73A, P223, DOI 10.1002/jbm.a.30278
   Lim YJ, 2001, BIO-MED MATER ENG, V11, P325
   Lin HY, 2004, J BIOMED MATER RES A, V68A, P717, DOI 10.1002/jbm.a.20092
   Lin HY, 2004, J ORTHOP RES, V22, P1231, DOI 10.1016/j.orthres.2004.04.005
   Lin HY, 2004, BIOMATERIALS, V25, P1233, DOI 10.1016/j.biomaterials.2003.08.016
   Liopo AV, 2006, J NANOSCI NANOTECHNO, V6, P1365, DOI 10.1166/jnn.2006.155
   LIU H, 2006, J BIOMEDICAL MAT R A, V78, P789
   MacDonald DE, 2004, BIOMATERIALS, V25, P3135, DOI 10.1016/j.biomaterials.2003.10.029
   Macdonald W, 2004, J BIOMED MATER RES B, V70B, P262, DOI 10.1002/jbm.b.30036
   MANCINI L, 2007, ANN NEW YORK ACAD SC
   Manlapaz M, 1996, J ORTHOP RES, V14, P465, DOI 10.1002/jor.1100140317
   MARTIN JY, 1995, J BIOMED MATER RES, V29, P389, DOI 10.1002/jbm.820290314
   Martines E, 2004, IEEE T NANOBIOSCI, V3, P90, DOI [10.1109/TNB.2004.828268, 10.1109/10.1109/TNB.2004.828268]
   Martinesi M, 2005, J BIOMED MATER RES A, V74A, P197, DOI 10.1002/jbm.a.30366
   MEREDITH L, 2007, J ORTHOPAEDIC RES
   Meyer U, 1998, J MATER SCI-MATER M, V9, P301, DOI 10.1023/A:1008894612021
   Meyer U, 2005, Eur Cell Mater, V9, P39
   Miyanishi K, 2003, J BONE MINER RES, V18, P1573, DOI 10.1359/jbmr.2003.18.9.1573
   Morais S, 1998, BIOMATERIALS, V19, P999, DOI 10.1016/S0142-9612(97)00234-2
   Morais S, 1999, J BIOMED MATER RES, V44, P176, DOI 10.1002/(SICI)1097-4636(199902)44:2<176::AID-JBM8>3.0.CO;2-6
   Morra M, 2003, BIOMATERIALS, V24, P4639, DOI 10.1016/S0142-9612(03)00360-0
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Muller U, 2006, EUR CELLS MATER, V11, P8, DOI 10.22203/eCM.v011a02
   Mustafa K, 2000, CLIN ORAL IMPLAN RES, V11, P116, DOI 10.1034/j.1600-0501.2000.011002116.x
   Mustafa K, 2001, CLIN ORAL IMPLAN RES, V12, P515, DOI 10.1034/j.1600-0501.2001.120513.x
   Nagai M, 2002, DENT MATER J, V21, P250, DOI 10.4012/dmj.21.250
   Nahar M, 2006, CRIT REV THER DRUG, V23, P259, DOI 10.1615/CritRevTherDrugCarrierSyst.v23.i4.10
   Nakashima Y, 1999, J BONE JOINT SURG AM, V81A, P603, DOI 10.2106/00004623-199905000-00002
   O'Connor DT, 2004, J ORTHOP RES, V22, P229, DOI 10.1016/S0736-0266(03)00167-0
   Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722
   Park JM, 2006, INT J ORAL MAX IMPL, V21, P859
   Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284
   PEREZWILLARD F, IN PRESS MICRON
   Persson Leif G, 2004, Clin Implant Dent Relat Res, V6, P230, DOI 10.1111/j.1708-8208.2004.tb00039.x
   Peters K, 2004, J MATER SCI-MATER M, V15, P321, DOI 10.1023/B:JMSM.0000021095.36878.1b
   Petit A, 2006, J MATER SCI-MATER M, V17, P667, DOI 10.1007/s10856-006-9230-x
   PHILLIPS TW, 1988, J BONE JOINT SURG BR, V70, P750
   PULEO DA, 1995, J APPL BIOMATER, V6, P109, DOI 10.1002/jab.770060205
   Qu Z, 2007, J BIOMED MATER RES A, V82A, P658, DOI 10.1002/bjm.a.31023
   Rader CP, 2002, BIOMED TECH, V47, P111, DOI 10.1515/bmte.2002.47.5.111
   Rammelt S, 2006, BIOMATERIALS, V27, P5561, DOI 10.1016/j.biomaterials.2006.06.034
   Redey SA, 2000, J BIOMED MATER RES, V50, P353, DOI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
   Refai AK, 2004, J BIOMED MATER RES A, V70A, P194, DOI 10.1002/jbm.a.30075
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Rice JM, 2003, BIOMATERIALS, V24, P4799, DOI 10.1016/S0142-9612(03)00381-8
   Rouahi M, 2006, BIOMATERIALS, V27, P2829, DOI 10.1016/j.biomaterials.2006.01.001
   Rouahi M, 2006, COLLOID SURFACE B, V47, P10, DOI 10.1016/j.colsurfb.2005.11.015
   Rouahi M, 2006, J BIOMED MATER RES A, V78A, P222, DOI 10.1002/jbm.a.30682
   Santavirta S, 1998, ARCH ORTHOP TRAUM SU, V118, P89, DOI 10.1007/s004020050319
   Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964
   Sayes CM, 2006, TOXICOL LETT, V161, P135, DOI 10.1016/j.toxlet.2005.08.011
   Schliephake H, 2003, J BIOMED MATER RES A, V64A, P225, DOI 10.1002/jbm.a.10363
   Schmidt C, 2002, J BIOMED MATER RES, V63, P252, DOI 10.1002/jbm.10185
   Schwartz Z, 1997, J PERIODONTAL RES, V32, P166, DOI 10.1111/j.1600-0765.1997.tb01399.x
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   SCHWEIKL H, 2007, J MAT SCI MAT MED
   Scotchford CA, 2003, BIOMATERIALS, V24, P1147, DOI 10.1016/S0142-9612(02)00488-X
   Shalabi MM, 2006, J DENT RES, V85, P496, DOI 10.1177/154405910608500603
   Shanbhag AS, 1997, CLIN ORTHOP RELAT R, P205
   Shi HQ, 1999, NATURE, V398, P593
   Slaets E, 2006, J PERIODONTOL, V77, P1015, DOI 10.1902/jop.2006.050196
   Sohn SH, 2006, J ORAL REHABIL, V33, P898, DOI 10.1111/j.1365-2842.2006.01643.x
   STEELE JG, 1995, BIOMATERIALS, V16, P1057, DOI 10.1016/0142-9612(95)98901-P
   Stock K, 2005, OSTERR MUSIKZ, V60, P83
   Sun JS, 1999, J BIOMED MATER RES, V45, P311
   Tan WB, 2007, J COLLOID INTERF SCI, V310, P464, DOI 10.1016/j.jcis.2007.01.083
   Teixeira S, 2007, J BIOMED MATER RES A, V81A, P920, DOI 10.1002/jbm.a.31073
   Toworfe GK, 2004, J BIOMED MATER RES A, V71A, P449, DOI 10.1002/jbm.a.30164
   Valles G, 2006, BIOMATERIALS, V27, P5199, DOI 10.1016/j.biomaterials.2006.05.045
   van den Dolder J, 2003, TISSUE ENG, V9, P505, DOI 10.1089/107632703322066688
   Veis AA, 2007, CLIN ORAL IMPLAN RES, V18, P153, DOI 10.1111/j.1600-0501.2006.01316.x
   VONRECUM AF, 1995, J BIOMAT SCI-POLYM E, V7, P181, DOI 10.1163/156856295X00698
   VROMAN L, 1987, SEMIN THROMB HEMOST, V13, P79, DOI 10.1055/s-2007-1003477
   Wan YQ, 2005, BIOMATERIALS, V26, P4453, DOI 10.1016/j.biomaterials.2004.11.016
   Wang JH, 2000, J BIOMED MATER RES, V51, P761, DOI 10.1002/1097-4636(20000915)51:4<761::AID-JBM26>3.3.CO;2-U
   Warashina H, 2003, BIOMATERIALS, V24, P3655, DOI 10.1016/S0142-9612(03)00120-0
   Ward BC, 2006, BIOMATERIALS, V27, P3064, DOI 10.1016/j.biomaterials.2005.12.027
   Ward BC, 2004, MATER RES SOC SYMP P, V823, P249
   WARD BC, 2005, TMS C P, V3, P13
   Webb K, 2000, J BIOMED MATER RES, V49, P362, DOI 10.1002/(SICI)1097-4636(20000305)49:3<362::AID-JBM9>3.0.CO;2-S
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Webster TJ, 2005, J BIOMED MATER RES A, V74A, P677, DOI 10.1002/jbm.a.30358
   Weyts FAA, 2003, CALCIFIED TISSUE INT, V72, P505, DOI 10.1007/s00223-002-2027-0
   Wilke A, 2002, Z ORTHOP GRENZGEB, V140, P83, DOI 10.1055/s-2002-22096
   Woo KM, 2007, BIOMATERIALS, V28, P335, DOI 10.1016/j.biomaterials.2006.06.013
   Xia YN, 1997, LANGMUIR, V13, P2059, DOI 10.1021/la960936e
   Yan YG, 2007, CLIN ORAL IMPLAN RES, V18, P345, DOI 10.1111/j.1600-0501.2006.01332.x
   YANG CY, 2007, J BIOMEDICAL MAT R A
   Yang YZ, 2003, J BIOMED MATER RES A, V67A, P344, DOI 10.1002/jbm.a.10578
   YAO JL, 1995, J BONE MINER RES, V10, P1417
   Zhang SG, 2002, CURR OPIN CHEM BIOL, V6, P865, DOI 10.1016/S1367-5931(02)00391-5
   Zhao G, 2005, J BIOMED MATER RES A, V74A, P49, DOI 10.1002/jbm.a.30320
   ZHU L, 2007, J BIOMEDICAL MAT R A
NR 201
TC 65
Z9 67
U1 3
U2 69
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1110-7243
EI 1110-7251
J9 J BIOMED BIOTECHNOL
JI J. Biomed. Biotechnol.
PY 2007
AR 69036
DI 10.1155/2007/69036
PG 19
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 247BQ
UT WOS:000252052500001
PM 18274618
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Stevens, KNJ
   Aldenhoff, YBJ
   van der Veen, FH
   Maessen, JG
   Koole, LH
AF Stevens, Kris N. J.
   Aldenhoff, Yvette B. J.
   van der Veen, Frederik H.
   Maessen, Jos G.
   Koole, Leo H.
TI Bioengineering of improved biomaterials coatings for extracorporeal
   circulation requires extended observation of blood-biomaterial
   interaction under flow
SO JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
LA English
DT Article
ID IN-VITRO MODEL; CARDIOPULMONARY BYPASS CIRCUITS; COMPLEMENT INHIBITION;
   HEPARIN; SURFACE; HEMOCOMPATIBILITY; COAGULATION; ACTIVATION;
   DYSFUNCTION; LEUKOCYTE
AB Extended use of cardiopulmonary bypass (CPB) systems is often hampered by thrombus formation and infection. Part of these problems relates to imperfect hemocompatibility of the CPB circuitry. The engineering of biomaterial surfaces with genuine long-term hemocompatibility is essentially virgin territory in biomaterials science. For example, most experiments with the well-known Chandler loop model, for evaluation of blood-biomaterial interactions under flow, have been described for a maximum duration of 2 hours only. This study reports a systematic evaluation of two commercial CPB tubings, each with a hemocompatible coating, and one uncoated control. The experiments comprised (i) testing over 5 hours under flow, with human whole blood from 4 different donors; (ii) measurement of essential blood parameters of hemocompatibility; (iii) analysis of the luminal surfaces by scanning electron microscopy and thrombin generation time measurements. The dataset indicated differences in hemocompatibility of the tubings. Furthermore, it appeared that discrimination between biomaterial coatings can be made only after several hours of blood-biomaterial contact. Platelet counting, myeloperoxidase quantification, and scanning electron microscopy proved to be the most useful methods. These findings are believed to be relevant with respect to the bioengineering of extracorporeal devices that should function in contact with blood for extended time. Copyright (c) 2007.
C1 [Stevens, Kris N. J.; van der Veen, Frederik H.; Maessen, Jos G.; Koole, Leo H.] Univ Limburg, Acad Hosp Maastricht, Dept Cardiothorac Surg, NL-6200 MD Maastricht, Netherlands.
   [Aldenhoff, Yvette B. J.] Univ Maastricht, Ctr Biomat Res, NL-6200 MD Maastricht, Netherlands.
RP Koole, LH (reprint author), Univ Limburg, Acad Hosp Maastricht, Dept Cardiothorac Surg, POB 5800, NL-6200 MD Maastricht, Netherlands.
EM l.koole@bioch.unimaas.nl
CR Aldenhoff YBJ, 1997, BIOMATERIALS, V18, P167, DOI 10.1016/S0142-9612(96)00095-6
   Aldenhoff YBJ, 2004, BIOMATERIALS, V25, P3125, DOI 10.1016/j.biomaterials.2003.10.012
   Andersson J, 2003, J BIOMED MATER RES A, V67A, P458, DOI 10.1002/jbm.a.10104
   Asberg AE, 2005, ARTIF ORGANS, V29, P927, DOI 10.1111/j.1525-1594.2005.00162.x
   Asberg AE, 2006, EUR J CARDIO-THORAC, V30, P744, DOI 10.1016/j.ejcts.2006.08.019
   Barrowcliffe TW, 2006, HAEMOPHILIA, V12, P76, DOI 10.1111/j.1365-2516.2006.01262.x
   Baykut D, 2001, EUR J MED RES, V6, P297
   CHANDLER AB, 1958, LAB INVEST, V7, P110
   CRIPPS CM, 1968, J CLIN PATHOL, V21, P110, DOI 10.1136/jcp.21.1.110
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   Kawahito K, 1997, ARTIF ORGANS, V21, P1105
   Kopp R, 2005, INT J ARTIF ORGANS, V28, P1272
   Kutay V, 2006, J CARDIAC SURG, V21, P572, DOI 10.1111/j.1540-8191.2006.00298.x
   Lappegard KT, 2004, ANN THORAC SURG, V78, P38, DOI 10.1016/j.athorascur.2004.02.005
   Lappegard KT, 2004, ANN THORAC SURG, V77, P932, DOI 10.1016/S0003-4975(03)01519-4
   Malinauskas RA, 1997, ARTIF ORGANS, V21, P1255
   Mangoush O, 2007, EUR J CARDIO-THORAC, V31, P1058, DOI 10.1016/j.ejcts.2007.01.029
   Mason DP, 2006, J THORAC CARDIOV SUR, V132, P954, DOI 10.1016/j.jtcvs.2006.06.010
   Mueller XM, 2002, INT J ARTIF ORGANS, V25, P223
   Ninomiya M, 2003, ANN THORAC SURG, V75, P913, DOI 10.1016/S0003-4975(02)04407-7
   O'Neill JM, 2001, INTENS CARE MED, V27, P1247, DOI 10.1007/s001340101029
   Ohkawa R, 2005, CLIN BIOCHEM, V38, P1023, DOI 10.1016/j.clinbiochem.2005.07.008
   RIJKERS DTS, 1995, THROMB RES, V79, P491, DOI 10.1016/0049-3848(95)00139-I
   RINDER CS, 1992, BLOOD, V79, P1201
   Rubens FD, 2002, J BIOMAT SCI-POLYM E, V13, P485, DOI 10.1163/156856202320253974
   Skinner Sean C, 2006, Semin Pediatr Surg, V15, P242, DOI 10.1053/j.sempedsurg.2006.07.003
   Sreeram GM, 2001, J CARDIOTHOR VASC AN, V15, P237, DOI 10.1053/jcan.2001.21991
   Sung K, 2006, ANN THORAC SURG, V82, P651, DOI 10.1016/j.athoracsur.2006.03.017
   van Oeveren W, 2002, ARTIF ORGANS, V26, P506, DOI 10.1046/j.1525-1594.2002.06872.x
   Weber N, 2002, BIOMATERIALS, V23, P429, DOI 10.1016/S0142-9612(01)00122-3
   Weber N, 2000, J BIOMATER APPL, V15, P8, DOI 10.1106/DUYU-CEL6-529C-WUL9
   Wendel HP, 1999, EUR J CARDIO-THORAC, V16, P342, DOI 10.1016/S1010-7940(99)00210-9
   Wu YP, 1997, ARTERIOSCL THROM VAS, V17, P3202, DOI 10.1161/01.ATV.17.11.3202
NR 33
TC 12
Z9 13
U1 1
U2 9
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1110-7243
J9 J BIOMED BIOTECHNOL
JI J. Biomed. Biotechnol.
PY 2007
AR 29464
DI 10.1155/2007/29464
PG 10
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 259PV
UT WOS:000252952100001
PM 18317517
OA DOAJ Gold, Green Published
DA 2018-10-19
ER

PT J
AU Kim, JS
   Song, JH
   Chang, MG
   Yum, YJ
   Lee, JK
   Kwon, YS
AF Kim, Ji Soon
   Song, Jun Ho
   Chang, Myung Gyu
   Yum, Young Jin
   Lee, Jeong-Keun
   Kwon, Young Soon
TI The effect of heating schedule and the size of the powder compact on the
   pore structure, mechanical and fatigue properties of porous TiNi
   produced by a self-propagating high-temperature synthesis method
SO JOURNAL OF CERAMIC PROCESSING RESEARCH
LA English
DT Article
DE TiNi; porous body; SHS; ignition; heating schedule; compact size
ID BIOMATERIAL
AB Porous TiNi bodies with different porous microstructures were produced from (Ti + Ni) powder mixtures by self-propagating high-temperature synthesis (SHS). Three different heating schedules were used to change the microstructure. Tensile strength, compression strength and elastic modulus were measured. Fatigue tests were performed. The relationship between the porous microstructure and mechanical properties are discussed.
C1 Univ Ulsan, Sch Mat Sci & Engn, Res Ctr Machine Parts & Mat Proc, Ulsan 680749, South Korea.
   Univ Ulsan, Sch Mech & Automot Engn, Res Ctr Machine Parts & Mat Proc, Ulsan 680749, South Korea.
   Korea Agcy Technol & Stand, Machinery & Construct Stand Team, Gwacheon 427716, Gyonggido, South Korea.
RP Kim, JS (reprint author), Univ Ulsan, Sch Mat Sci & Engn, Res Ctr Machine Parts & Mat Proc, San 29 Mugeo Dong, Ulsan 680749, South Korea.
EM jskim@ulsan.ac.kr
CR Black J., 1998, HDB BIOMATERIAL PROP
   DUERIG T, 1999, MAT SCI ENG A-STRUCT, V149, P273, DOI DOI 10.1016/S0921-5093(99)00294-4
   Kang SB, 2002, MATER TRANS, V43, P1045, DOI 10.2320/matertrans.43.1045
   Kim JS, 2004, MATER SCI FORUM, V449-4, P1097, DOI 10.4028/www.scientific.net/MSF.449-452.1097
   Kim JS, 2004, ADV ENG MATER, V6, P403, DOI 10.1002/adem.200405151
   KIM JS, 2000, P SMST 2000 CAL US, P77
   MERZHANOV AG, 1997, EXPT HEAT TRANSFER F, P1869
   MOORE JJ, 1995, PROG MATER SCI, V39, P243, DOI 10.1016/0079-6425(94)00011-5
NR 8
TC 2
Z9 3
U1 0
U2 2
PU KOREAN ASSOC CRYSTAL GROWTH, INC
PI SEOUL
PA SUNGDONG POST OFFICE, P O BOX 27, SEOUL 133-600, SOUTH KOREA
SN 1229-9162
J9 J CERAM PROCESS RES
JI J. Ceram. Process. Res.
PY 2007
VL 8
IS 1
BP 70
EP 73
PG 4
WC Materials Science, Ceramics
SC Materials Science
GA 174FN
UT WOS:000246927500013
DA 2018-10-19
ER

PT J
AU Yoo, MK
   Choi, YJ
   Lee, JH
   Wee, WR
   Cho, CS
AF Yoo, M. K.
   Choi, Y. J.
   Lee, J. H.
   Wee, W. R.
   Cho, C. S.
TI Injectable intraocular lens using hydrogels
SO JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY
LA English
DT Article
DE injectable; intraocular lens; hydrogel; poloxamer; cataract
ID POSTERIOR CAPSULE OPACIFICATION; IN-VIVO; POLOXAMER HYDROGEL;
   CONTACT-LENSES; BIOCOMPATIBILITY; SILICONE; SURFACE; BIOMATERIALS;
   ADHESION
AB Presbyopia is an age-related condition that begins to develop in humans around the age of forty, resulting in anatomical and physiological changes in the choroids, ciliary body, vitreous, lens capsule, and lens fibers. A suitable biomaterial is needed for the implantation of intraocular lenses (IOL) that could be used to treat the symptoms of presbyopia in people everywhere. In this paper, the characteristics of silicone polymer, polyether, poly acrylic derivatives, polyalcohol, poly(vinyl pyrrolidone) (PVP), and poly(acryl amide) hydrogels were explained, and then their biocompatibilities were compared. These types of hydrogel materials have several advantages over the current fixed-focus IOL including restoration of accommodation, minimal corneascleral trauma, improved physiological position of the IOL, and possible use in the surgical correction of cataracts.
C1 Seoul Natl Univ, Sch Agr Biotechnol, Seoul 151921, South Korea.
   Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul 110744, South Korea.
RP Cho, CS (reprint author), Seoul Natl Univ, Sch Agr Biotechnol, Seoul 151921, South Korea.
EM chocs@plaza.snu.ac.kr
RI Wee, Won Ryang/J-2769-2012; Choi, Yunjaie/B-4697-2014
CR Aliyar HA, 2005, BIOMACROMOLECULES, V6, P204, DOI 10.1021/bm049574c
   AMON M, 1994, EYE, V8, P649, DOI 10.1038/eye.1994.161
   CASTILLO EJ, 1986, BIOMATERIALS, V7, P89, DOI 10.1016/0142-9612(86)90062-1
   Chehade M, 1997, AUST NZ J OPHTHALMOL, V25, P255, DOI 10.1111/j.1442-9071.1997.tb01512.x
   de Groot JH, 2003, BIOMACROMOLECULES, V4, P608, DOI 10.1021/bm0257053
   de Groot JH, 2001, BIOMACROMOLECULES, V2, P628, DOI 10.1021/bm005622r
   Dorey MW, 2003, AM J OPHTHALMOL, V135, P591, DOI 10.1016/S0002-9394(02)02154-2
   HAEFLIGER E, 1994, J REFRACT CORNEAL S, V10, P550
   Han YK, 2003, BRIT J OPHTHALMOL, V87, P1399, DOI 10.1136/bjo.87.11.1399
   Hayashi K, 2004, BRIT J OPHTHALMOL, V88, P182, DOI 10.1136/bjo.2003.023580
   Hollick EJ, 1999, ARCH OPHTHALMOL-CHIC, V117, P872
   Hollick EJ, 1998, J CATARACT REFR SURG, V24, P361, DOI 10.1016/S0886-3350(98)80324-6
   Hollick EJ, 1999, OPHTHALMOLOGY, V106, P49, DOI 10.1016/S0161-6420(99)90047-7
   Hong Y, 1996, J BIOMED MATER RES, V30, P441, DOI 10.1002/(SICI)1097-4636(199604)30:4<441::AID-JBM2>3.0.CO;2-P
   JIRGENSONS B, 1952, J POLYM SCI, V8, P519, DOI 10.1002/pol.1952.120080508
   KABAYASHI H, 2000, AM J OPHTHALMOL, V130, P310
   KIM SW, 1992, PHARMACEUT RES, V9, P283, DOI 10.1023/A:1015887213431
   Kodjikian L, 2002, INVEST OPHTH VIS SCI, V43, P3717
   Kodjikian L, 2003, INVEST OPHTH VIS SCI, V44, P4388, DOI 10.1167/iovs-03-0186
   KOLARIK J, 1983, J BIOMED MATER RES, V17, P757, DOI 10.1002/jbm.820170504
   Kopecek J, 2003, EUR J PHARM SCI, V20, P1, DOI 10.1016/S0928-0987(03)00164-7
   Kweon HY, 2003, J APPL POLYM SCI, V88, P2670, DOI 10.1002/app.12108
   Kwon JW, 2005, J CATARACT REFR SURG, V31, P607, DOI 10.1016/j.jcrs.2004.05.051
   Learning DV, 1999, J CATARACT REFR SURG, V25, P851
   Lenis K, 1998, ACTA OPHTHALMOL SCAN, V76, P184, DOI 10.1034/j.1600-0420.1998.760212.x
   Linnola RJ, 2003, J CATARACT REFR SURG, V29, P146, DOI 10.1016/S0886-3350(02)01422-0
   Murthy KS, 2001, CURR EYE RES, V22, P384, DOI 10.1076/ceyr.22.5.384.5493
   Nishi O, 1998, J CATARACT REFR SURG, V24, P975, DOI 10.1016/S0886-3350(98)80054-0
   POHLMANN T, 1997, Patent No. 5665840
   Seward HC, 1997, BRIT J OPHTHALMOL, V81, P340, DOI 10.1136/bjo.81.5.340
   Tehrani M, 2004, OPHTHALMOLOGICA, V218, P57, DOI 10.1159/000074568
   Tognetto D, 2002, J CATARACT REFR SURG, V28, P644, DOI 10.1016/S0886-3350(01)01158-0
   Ursell PG, 1998, J CATARACT REFR SURG, V24, P352, DOI 10.1016/S0886-3350(98)80323-4
   WENZEL M, 1994, EUR J IMPLANT REFRAC, V6, P184
   Wesendahl T. A., 1996, Ophthalmologe, V93, P22
   WICHTERLE O, 1960, NATURE, V185, P117, DOI 10.1038/185117a0
   Yasuda H, 2006, MACROMOL BIOSCI, V6, P121, DOI 10.1002/mabi.200500153
   Yong JL, 2004, CLIN EXP OPHTHALMOL, V32, P492, DOI 10.1111/j.1442-9071.2004.00869.x
NR 38
TC 6
Z9 6
U1 2
U2 14
PU EDITIONS SANTE
PI PARIS
PA 47 RUE GALILEE, 75116 PARIS, FRANCE
SN 1773-2247
J9 J DRUG DELIV SCI TEC
JI J. Drug Deliv. Sci. Technol.
PD JAN-FEB
PY 2007
VL 17
IS 1
BP 81
EP 85
DI 10.1016/S1773-2247(07)50011-0
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 149NO
UT WOS:000245153800011
DA 2018-10-19
ER

PT J
AU Rapoport, HS
   Shadwick, RE
AF Rapoport, H. Scott
   Shadwick, Robert E.
TI Reversibly labile, sclerotization-induced elastic properties in a
   keratin analog from marine snails: whelk egg capsule biopolymer (WECB)
SO JOURNAL OF EXPERIMENTAL BIOLOGY
LA English
DT Article
DE whelk egg capsule biopolymer; elastomer; mechanical properties; marine
   snail
ID HAGFISH SLIME THREADS; MECHANICAL CHARACTERIZATION;
   INTERMEDIATE-FILAMENTS; FIBERS; MODEL; WOOL; MICROFIBRILS; BIOMATERIAL;
   TRANSITION; PROTEINS
AB Egg capsules from two caenogastropod whelks, Busycon canaliculatum and Kelletia kelletii, were studied to investigate the genesis of mechanical properties of nascent capsules and to formulate a biomechanical model of this material. Scanning electron microscopy revealed that the capsules possess fibrous hierarchical arrangements at all stages during processing while the mechanical integrity is developing. This suggests that an as yet uncharacterized sclerotization mechanism occurring in the ventral pedal gland primarily binds these fibrous components together. Decomposing the mechanical behavior of WECB through various physical and chemical treatments led us to develop a model for the structure and mechanical properties of this material that supports its designation as a keratin analog. Keratin mechanical models were applied to WECB in its representation as an intermediate state between matrix-free intermediate filament (IF)-type proteins and the more complex composite materials incorporating IFs such as keratin.
C1 Childrens Hosp Philadelphia, Div Cardiol, Philadelphia, PA 19104 USA.
RP Rapoport, HS (reprint author), Childrens Hosp Philadelphia, Div Cardiol, 3615 Civic Ctr Blvd,Abramson Res Bldg, Philadelphia, PA 19104 USA.
EM rapoports@email.chop.edu
CR ANKEL W. E., 1929, ZOOL ANZ SUPPL BD, V4, P219
   CHAPMAN BM, 1969, TEXT RES J, V39, P1102, DOI 10.1177/004051756903901204
   Denny MW, 1988, BIOL MECH WAVE SWEPT
   FEUGHELMAN M, 1979, J MACROMOL SCI PHYS, VB16, P155, DOI 10.1080/00222347908212288
   FEUGHELMAN M, 1964, TEXT RES J, V34, P539
   FEUGHELMAN M, 1997, MECH PROPERTEIS STRU
   Feughelman M, 1959, TEXT RES J, V29, P223, DOI DOI 10.1177/004051755902900305
   FLOWER NE, 1969, J ULTRA MOL STRUCT R, V26, P262, DOI 10.1016/S0022-5320(69)80006-7
   FRETTER V, 1994, BRITISH PROSOBRANCH
   Fudge DS, 2004, P ROY SOC B-BIOL SCI, V271, P291, DOI 10.1098/rspb.2003.2591
   Fudge DS, 2003, BIOPHYS J, V85, P2015, DOI 10.1016/S0006-3495(03)74629-3
   GATHERCOLE L, 1969, THESIS U LEEDS UK
   GOSLINE JM, 1971, J EXP BIOL, V55, P775
   GOSLINE JM, 1980, MECH PROPERTIES BIOL, P331
   Hearle JWS, 2000, INT J BIOL MACROMOL, V27, P123, DOI 10.1016/S0141-8130(00)00116-1
   JOSEFSSON L, 1966, BIOCHIM BIOPHYS ACTA, V115, P148, DOI 10.1016/0304-4165(66)90059-6
   JOSEFSSON L, 1962, BIOCHIM BIOPHYS ACTA, V59, P128, DOI 10.1016/0006-3002(62)90703-5
   Keeley FW, 2002, PHILOS T R SOC B, V357, P185, DOI 10.1098/rstb.2001.1027
   Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092
   Kreplak L, 2004, BIOPHYS J, V87, P640, DOI 10.1529/biophysj.103.036749
   RAM JL, 1977, BIOL BULL-US, V152, P221, DOI 10.2307/1540561
   Rapoport H. S., 2003, THESIS U CALIFORNIA
   Rapoport HS, 2002, BIOMACROMOLECULES, V3, P42, DOI 10.1021/bm0155470
   Rawlings TA, 1999, AM ZOOL, V39, P230
   STOLL VS, 1990, METHOD ENZYMOL, V182, P24
   Szulgit GK, 2000, J EXP BIOL, V203, P1539
   van Steensel MAM, 2000, P SOC EXP BIOL MED, V223, P1, DOI 10.1046/j.1525-1373.2000.22301.x
   Vincent JFV., 1990, STRUCTURAL BIOMATERI
   VOGEL S, 1988, LIFES DEVICES
   VONHIPPE.PH, 1965, J BIOL CHEM, V240, P3909
   WHITELEY KJ, 1977, J TEXT I, V68, P384, DOI 10.1080/00405007708631416
   WORTMANN FJ, 1994, TEXT RES J, V64, P737, DOI 10.1177/004051759406401206
NR 32
TC 19
Z9 19
U1 0
U2 6
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0022-0949
EI 1477-9145
J9 J EXP BIOL
JI J. Exp. Biol.
PD JAN 1
PY 2007
VL 210
IS 1
BP 12
EP 26
DI 10.1242/jeb.02613
PG 15
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 134GA
UT WOS:000244070300011
PM 17170144
OA Bronze
DA 2018-10-19
ER

PT J
AU Martineau, L
   Davis, SC
AF Martineau, Lucie
   Davis, Stephen C.
TI Controlling methicillin resistant Staphyloccocus aureus and Pseudomonas
   aeruginosa wound infections with a novel biomaterial
SO JOURNAL OF INVESTIGATIVE SURGERY
LA English
DT Article
ID IN-VITRO; ANTIMICROBIAL AGENTS; CADEXOMER IODINE; WAR WOUNDS; INJURY;
   VIVO; EPIDEMIOLOGY; BATTLEFIELD; MICROSCOPY; BIOFILMS
AB Wound infections, especially those associated with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa, offer considerable challenges for clinicians. Our laboratory has recently developed novel composite biomaterials (DRDC) for wound dressing applications, and demonstrated their in vitro bactericidal efficacy. In the present study, we assessed the proliferation of planktonic and sessile Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus in porcine full-thickness wounds covered for up to 48 h with either saline- or mafenide acetate-loaded DRDC puffs and meshes. All biomaterials were applied 4 h following bacterial inoculation of the wounds with methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa, to allow colonization of the tissues and initiation of biofilm formation. The drug-loaded biomaterials eradicated both the planktonic and biofilm bacteria in the wounds within 24 h ( p < .05), irrespective of the bacterial strain or architecture of the dressing. While the wound bioburdens increased in the ensuing 24 h, they remained approximately 2 log(10) colony-forming units (CFU) below ( p < .05) their respective baseline values. Similarly, less than 4 log10 CFU was recovered in the drug-loaded DRDC biomaterials throughout the study. These data show that the DRDC puffs and meshes are effective in delivering certain medications, such as antimicrobial agents, to the wound bed, suggesting considerable value of this material for treating wounds, especially those with irregular shapes, contours, and depths.
C1 DRDC Valcartier, Vulnerabil Lethal Grp, Weapons Effects Sect, Quebec City, PQ G3J 1X5, Canada.
   Univ Miami, Miller Sch Med, Miami, FL 33152 USA.
RP Martineau, L (reprint author), DRDC Valcartier, Vulnerabil Lethal Grp, Weapons Effects Sect, 2459 Pie-11 Blvd N, Quebec City, PQ G3J 1X5, Canada.
EM lucie.martineau@drdc-rddc.gc.ca
CR Akiyama H, 2004, J DERMATOL, V31, P529, DOI 10.1111/j.1346-8138.2004.tb00549.x
   Akiyama H, 1996, J DERMATOL SCI, V11, P234, DOI 10.1016/0923-1811(95)00448-3
   Announ N, 2004, JOINT BONE SPINE, V71, P240, DOI 10.1016/S1297-319X(03)00126-X
   Barillo DJ, 2002, OSTOMY WOUND MANAG S, P5
   BELLAMY RF, 1986, ANN EMERG MED, V15, P1384, DOI 10.1016/S0196-0644(86)80920-9
   Bowler PG, 2001, CLIN MICROBIOL REV, V14, P244, DOI 10.1128/CMR.14.2.244-269.2001
   Bowler Philip G, 2003, Ostomy Wound Manage, V49, P44
   Champion HR, 2003, J TRAUMA, V54, pS13, DOI 10.1097/01.TA.0000057151.02906.27
   Cutting Keith F, 2003, Br J Community Nurs, V8, P4
   Davis SC, 2005, ARCH DERMATOL RES, V297, P190, DOI 10.1007/s00403-005-0612-6
   Davis SC, 2004, WOUNDS, V16, P344
   Davis Stephen C, 2006, Curr Diab Rep, V6, P439, DOI 10.1007/s11892-006-0076-x
   Ellis MW, 2004, CLIN INFECT DIS, V39, P971, DOI 10.1086/423965
   GILCHRIST JE, 1973, APPL ENVIRON MICROB, V23, P244
   Harrison-Balestra C, 2003, DERMATOL SURG, V29, P631, DOI 10.1046/j.1524-4725.2003.29146.x
   Kauvar DS, 2005, J BURN CARE REHABIL, V26, P357, DOI 10.1097/01.BCR.0000170276.33207.B4
   KUCAN JO, 2006, J BURNS WOUNDS, V4, P63
   Kucan John O., 1993, Journal of Burn Care and Rehabilitation, V14, P158, DOI 10.1097/00004630-199303000-00006
   LEcuyer PB, 1996, CLIN INFECT DIS, V22, P424, DOI 10.1093/clinids/22.3.424
   Lio PA, 2004, INFECT DIS CLIN N AM, V18, P717, DOI 10.1016/j.idc.2004.04.008
   Mabry RL, 2000, J TRAUMA, V49, P515, DOI 10.1097/00005373-200009000-00021
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Martineau L, 2006, BURNS, V32, P172, DOI 10.1016/j.burns.2005.08.012
   MENDELSON JA, 2001, PREHOSP DIS MED, V16, P130
   Mertz PM, 1999, DERMATOL SURG, V25, P89, DOI 10.1046/j.1524-4725.1999.08055.x
   Mertz PM, 2003, J CUTAN MED SURG, V7, P1, DOI 10.1007/s10227-002-1154-6
   MONAFO WW, 1990, DRUGS, V40, P364, DOI 10.2165/00003495-199040030-00004
   Murray CK, 2006, MIL MED, V171, P826, DOI 10.7205/MILMED.171.9.826
   PENG HT, J MAT SCI MAT MED, V18, P975
   PENG HT, 2005, P 4 ANN C POLYM MED
   Rashid MH, 2000, P NATL ACAD SCI USA, V97, P9636, DOI 10.1073/pnas.170283397
   Robson MC, 1997, SURG CLIN N AM, V77, P637, DOI 10.1016/S0039-6109(05)70572-7
   Scott P. T., 2004, Morbidity and Mortality Weekly Report, V53, P1063
   Serralta VW, 2001, WOUNDS, V13, P29
   Smoot E C 3rd, 1992, J Burn Care Rehabil, V13, P198, DOI 10.1097/00004630-199203000-00004
   Southey-Pillig CJ, 2005, J BACTERIOL, V187, P8114, DOI 10.1128/JB.187.23.8114-8126.2005
   TONG MJ, 1972, J AMER MED ASSOC, V219, P1044, DOI 10.1001/jama.219.8.1044
   Tredget EE, 1998, J BURN CARE REHABIL, V19, P531, DOI 10.1097/00004630-199811000-00013
   Valencia IC, 2004, J AM ACAD DERMATOL, V50, P845, DOI 10.1016/j.jaad.2003.11.064
   Wall BM, 2003, J SPINAL CORD MED, V26, P248, DOI 10.1080/10790268.2003.11753692
NR 40
TC 8
Z9 8
U1 0
U2 5
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0894-1939
J9 J INVEST SURG
JI J. Invest. Surg.
PY 2007
VL 20
IS 4
BP 217
EP 227
DI 10.1080/10717540701481275
PG 11
WC Surgery
SC Surgery
GA 201CS
UT WOS:000248809700003
PM 17710602
DA 2018-10-19
ER

PT J
AU Ansaloni, L
   Cambrini, P
   Catena, F
   Di Saverio, S
   Gagliardi, S
   Gazzotti, F
   Hodde, JP
   Metzger, DW
   D'Alessandro, L
   Pinna, AD
AF Ansaloni, Luca
   Cambrini, Paolo
   Catena, Fausto
   Di Saverio, Salomone
   Gagliardi, Stefano
   Gazzotti, Filippo
   Hodde, Jason P.
   Metzger, Dennis W.
   D'Alessandro, Luigi
   Pinna, Antonio Daniele
TI Immune response to small intestinal submucosa (Surgisis) implant in
   humans: Preliminary observations
SO JOURNAL OF INVESTIGATIVE SURGERY
LA English
DT Article
DE body wall; collagen; galactosyl-alpha(1,3) galactose epitope;
   extracellular matrix; inguinal hernioplasty; small intestinal submucosa
ID XENOGENEIC EXTRACELLULAR-MATRIX
AB Surgisis IHM is an acellular biomaterial derived from porcine small intestinal submucosa (SIS) that induces site-specific remodeling in the organ or tissue into which it is placed. Previous animal studies have shown that the graft recipient mounts a helper T type 2-restricted immune response to the SIS xenograft without signs of rejection. The aims of this study were to evaluate the immune response to the SIS implant in a small series of humans and to examine the long-term clinical acceptance of the xenograft in these patients. Five consecutive male patients (mean age 56 years, range 34-68) who underwent inguinal hernioplasty with Surgisis IHM were assessed at 2 weeks, 6 weeks, and 6 months after implant for SIS-specific, alpha-1,3-galactose (alpha-gal) epitope and type I collagen specific antibodies. All five patients were also clinically assessed up to 2 years for signs of clinical rejection, hernia recurrence, and other complications. All 5 patients implanted with Surgisis IHM produced antibodies specific for SIS and a-gal with a peak between 2 and 6 weeks after implantation. By 6 months, all patients showed decreasing levels of anti-SIS antibodies. Two patients developed a transient, mild local seroma that resolved spontaneously. None of the patients showed any clinical signs of rejection, wound infection, hernia recurrence, or other complications in the follow-up out to 2 years. Thus, this study showed that in a small series of patients the SIS elicits an antibody response without clinical rejection of the xenograft and minimal postoperative complications.
C1 Univ Bologna, Sant Orsola Malpighi Hosp, Unit Gen Surg, I-40138 Bologna, Italy.
   Cook Biotech Incorp, W Lafayette, IN USA.
   Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA.
RP Ansaloni, L (reprint author), Univ Bologna, Sant Orsola Malpighi Hosp, Unit Gen Surg, Via Massarenti 9, I-40138 Bologna, Italy.
EM lansaloni@aosp.bo.it
RI di saverio, salomone/G-1437-2012
OI di saverio, salomone/0000-0001-5685-5022; Metzger,
   Dennis/0000-0002-8000-9907; Ansaloni, Luca/0000-0001-6427-0307
CR Allman AJ, 2001, TRANSPLANTATION, V71, P1631, DOI 10.1097/00007890-200106150-00024
   Ansaloni Luca, 2003, Acta Biomed, V74 Suppl 2, P10
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Hodde J P, 1996, Tissue Eng, V2, P209, DOI 10.1089/ten.1996.2.209
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Hodde JP, 2001, WOUNDS, V13, P195
   McPherson TB, 2000, TISSUE ENG, V6, P233, DOI 10.1089/10763270050044416
   McPherson TB, 1998, TISSUE ENG, V4, P75, DOI 10.1089/ten.1998.4.75
   Palmer EM, 2002, TISSUE ENG, V8, P893, DOI 10.1089/10763270260424259
   Raeder RH, 2002, TRANSPL IMMUNOL, V10, P15, DOI 10.1016/S0966-3274(01)00044-2
   Sakorafas G H, 2001, BMC Surg, V1, P3, DOI 10.1186/1471-2482-1-3
   VoytikHarbin SL, 1997, J CELL BIOCHEM, V67, P478, DOI 10.1002/(SICI)1097-4644(19971215)67:4<478::AID-JCB6>3.0.CO;2-P
   Yamamoto Shunji, 2002, Asian J Surg, V25, P121, DOI 10.1016/S1015-9584(09)60158-5
   Yang YG, 1998, J EXP MED, V187, P1335, DOI 10.1084/jem.187.8.1335
NR 15
TC 66
Z9 72
U1 2
U2 11
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0894-1939
J9 J INVEST SURG
JI J. Invest. Surg.
PY 2007
VL 20
IS 4
BP 237
EP 241
DI 10.1080/08941930701481296
PG 5
WC Surgery
SC Surgery
GA 201CS
UT WOS:000248809700005
PM 17710604
DA 2018-10-19
ER

PT J
AU Hoffmann, B
   Volkmer, E
   Kokott, A
   Weber, M
   Hamisch, S
   Schieker, M
   Mutschler, W
   Ziegler, G
AF Hoffmann, Bettina
   Volkmer, Elias
   Kokott, Andreas
   Weber, Markus
   Hamisch, Sabine
   Schieker, Matthias
   Mutschler, Wolf
   Ziegler, Gunter
TI A new biodegradable bone wax substitute with the potential to be used as
   a bone filling material
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID CHITOSAN; DEACETYLATION
AB A novel biomaterial consisting of the biodegradable compounds hydroxyapatite, chitosan and starch was developed. Hydroxyapatite particles were modified in a layer-to-layer reaction with oxidised starch and deacetylated chitosan. In this manner, two kinds of particles with different surfaces were generated, one featuring deacetylated chitosan, the other one exhibiting oxidised starch at the outermost layer. Mixed together, these two kinds of particles form a homogeneous powder, which can be transformed into a paste by adding water. In contact with water the amino groups of deacetylated chitosan and the aldehyde groups of oxidised starch form a Schiff's base bonding the particles together. Particle size distribution of powder modified with polysaccharides was characterised by using a CILAS granulometer. Burn-out experiments carried out by TG-MS provided the organic/inorganic ratio. The morphology of the particles was analysed by SEM. The cytotoxicity of the new composite was examined in vitro by culturing MC3T3 mouse fibroblasts directly on the new material. The viability of MC3T3 cells was largely unaffected, and cells proliferated well on the surface of the new substance indicating excellent biocompatibility. In view of its mechanical stability, the new composite may also be used as a bone filling material in orthopedic surgery
C1 Univ Bayreuth, Friedrich Baur Res Inst Biomat, D-95440 Bayreuth, Germany.
   Univ Munich, Dept Surg, D-80336 Munich, Germany.
RP Hoffmann, B (reprint author), Univ Bayreuth, Friedrich Baur Res Inst Biomat, Ludwig Thoma Str 36c, D-95440 Bayreuth, Germany.
EM bettina.hoffmann@fbi-biomaterialien.de;
   elias.volkmer@med.uni-muenchen.de
RI Schieker, Matthias/J-6511-2015
OI Schieker, Matthias/0000-0002-1230-3653
CR AURELIO J, 1984, ORAL SURG ORAL MED O, V58, P98, DOI 10.1016/0030-4220(84)90371-2
   Bhatti Farah, 2003, Interact Cardiovasc Thorac Surg, V2, P410, DOI 10.1016/S1569-9293(03)00180-4
   Bohy Bart, 2002, Arthroscopy, V18, pE45, DOI 10.1053/jars.2002.36463
   Brockenbrough JM, 2003, OTOLARYNG HEAD NECK, V128, P726, DOI 10.1016/S1094-5998(03)23289-1
   Fu JH, 2005, BIOMATERIALS, V26, P6684, DOI 10.1016/j.biomaterials.2005.04.034
   HIRAI A, 1991, POLYM BULL, V26, P87, DOI 10.1007/BF00299352
   HOWARD TC, 1969, CLIN ORTHOP RELAT R, P226
   Khor E., 2001, CHITIN FULFILLING BI
   KOKOTT A, 2003, Patent No. 10357460
   Lavertu M, 2003, J PHARMACEUT BIOMED, V32, P1149, DOI 10.1016/S0731-7085(03)00115-9
   Liu H, 2004, INT J FOOD MICROBIOL, V95, P147, DOI 10.1016/j.ijfoodmicro.2004.01.022
   Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016
   REINER RH, 1981, MAKROMOL CHEM, V182, P1641
   RINAUDO M, 1993, INT J BIOL MACROMOL, V15, P281, DOI 10.1016/0141-8130(93)90027-J
   Schmitt M, 2002, BIOMATERIALS, V23, P2789, DOI 10.1016/S0142-9612(02)00015-7
   STURUP J, 1995, BIOMATERIALS, V16, P845
   Wolvius EB, 2003, INT J ORAL MAX SURG, V32, P656, DOI 10.1054/ijom.2002.0394
   Zhang L, 2005, J MATER SCI-MATER M, V16, P213, DOI 10.1007/s10856-005-6682-3
NR 18
TC 20
Z9 21
U1 0
U2 21
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
EI 1364-5501
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2007
VL 17
IS 38
BP 4028
EP 4033
DI 10.1039/b707992n
PG 6
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 214LW
UT WOS:000249740300018
DA 2018-10-19
ER

PT J
AU Grablowitz, H
   Lendlein, A
AF Grablowitz, Hans
   Lendlein, Andreas
TI Synthesis and characterization of alpha,omega-dihydroxy-telechelic
   oligo(p-dioxanone)
SO JOURNAL OF MATERIALS CHEMISTRY
LA English
DT Article
ID RING-OPENING POLYMERIZATION; DIOLS
AB The homopolymer of 1,4-dioxane-2-one (pDO) is well known as an established biomaterial, especially for degradable surgical sutures. Well-defined alpha,omega-dihydroxy telechelics based on pDO are introduced in this paper. pDO was synthesized via a one step reaction modified to a literature procedure with a yield of 50-60%. The monomer was polymerized in bulk to oligomeric products via ring-opening polymerization. The polymerization was performed without or with dibutyltin oxide as catalyst using low molecular weight alcohols as initiators. The oligomeric products have number average molecular weights (M-n) between 1800 g mol 21 and 4200 g mol(-1). They were soluble in 1,2-dichloroethane or chloroform as common solvents for further reaction in solution. The alpha,omega-dihydroxy-functionality of the obtained telechelics was investigated by MALDI-TOF MS and H-1 NMR spectroscopy. Polymerization in the presence of the catalyst lead to macrocyclic byproducts which have been detected by MALDI-TOF MS. The telechelics were semicrystalline with melting points T-m between 86 degrees C and 95 degrees C, increasing with increasing molecular weight. The 0melting enthalpies Delta H-m ranged from 67.7 to 82.3 Jg(-1). An example of the synthetic opportunities arising from the availability of well-defined telechelic oligomers as starting materials are multiblock copolymers, which were synthesized successfully from oligo(p-dioxane) diol, poly[(rac-lactide)-ran-glycolide]diol and trimethylhexane diisocyanate with weight average molecular weights M-w between 62 000 and 149 000 g mol(-1).
C1 Bayer Mat Sci AG, Leverkusen, Germany.
RP Lendlein, A (reprint author), Bayer Mat Sci AG, Leverkusen, Germany.
EM andreas.lendlein@gkss.de
RI Lendlein, Andreas/K-9553-2013
OI Lendlein, Andreas/0000-0003-4126-4670
CR Duda A., 2000, ACS SYM SER, V764, P160
   Hiltunen K, 1998, J APPL POLYM SCI, V67, P1017, DOI 10.1002/(SICI)1097-4628(19980207)67:6<1017::AID-APP8>3.0.CO;2-L
   Hirt TD, 1996, MACROMOL CHEM PHYSIC, V197, P1609, DOI 10.1002/macp.1996.021970503
   Ishikiriyama K, 1998, J MACROMOL SCI PHYS, VB37, P27, DOI 10.1080/00222349808220453
   Kricheldorf HR, 2000, MACROMOL RAPID COMM, V21, P528, DOI 10.1002/1521-3927(20000601)21:9<528::AID-MARC528>3.0.CO;2-S
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 1998, MACROMOL CHEM PHYSIC, V199, P2785, DOI 10.1002/macp.1998.021991222
   Lendlein A, 2000, MACROMOL CHEM PHYS, V201, P1067
   NADA T, 1993, TOXICOLOGY, V85, P149
   Nishida H, 2000, MACROMOLECULES, V33, P6982, DOI 10.1021/ma000457t
   Nishida H, 2000, J POLYM SCI POL CHEM, V38, P1560, DOI 10.1002/(SICI)1099-0518(20000501)38:9<1560::AID-POLA20>3.0.CO;2-F
   PALOMAA MH, 1932, CHEM BER, V65, P923
   REMPP P, 1991, POLYM SYNTHESIS
   SHALABY SW, 1994, BIOMEDICAL POLYM
   STOREY RF, 1991, J POLYM SCI POL CHEM, V29, P1759, DOI 10.1002/pola.1991.080291209
   WEAST RC, 1993, HDB CHEM PHYS
NR 16
TC 27
Z9 27
U1 4
U2 19
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0959-9428
J9 J MATER CHEM
JI J. Mater. Chem.
PY 2007
VL 17
IS 38
BP 4050
EP 4056
DI 10.1039/b707104c
PG 7
WC Chemistry, Physical; Materials Science, Multidisciplinary
SC Chemistry; Materials Science
GA 214LW
UT WOS:000249740300021
DA 2018-10-19
ER

PT J
AU Guicciardi, S
   Shimozono, T
   Pezzotti, G
AF Guicciardi, Stefano
   Shimozono, Takayoshi
   Pezzotti, Giuseppe
TI Ageing effects on the nanoindentation response of sub-micrometric 3Y-TZP
   ceramics
SO JOURNAL OF MATERIALS SCIENCE
LA English
DT Letter
ID Y-TZP CERAMICS; ZIRCONIA; HARDNESS; INDENTATION; BIOMATERIAL;
   DEGRADATION
C1 CNR, ISTEC, Inst Sci & Technol Ceram, I-48018 Faenza, Italy.
   Kyoto Inst Technol, Ceram Phys La, Sakyo Ku, Kyoto 6068585, Japan.
   Kyoto Inst Technol, RIN, Sakyo Ku, Kyoto 6068585, Japan.
RP Guicciardi, S (reprint author), CNR, ISTEC, Inst Sci & Technol Ceram, Via Granarolo 64, I-48018 Faenza, Italy.
EM stefano@istec.cnr.it
CR BOX GEP, 1978, STAT EXPT INTRO DESI, P165
   Bull SJ, 2005, J PHYS D APPL PHYS, V38, pR393, DOI 10.1088/0022-3727/38/24/R01
   Catledge SA, 2003, J MATER SCI-MATER M, V14, P863, DOI 10.1023/A:1025678525474
   CHAN SK, 1991, J AM CERAM SOC, V74, P1742, DOI 10.1111/j.1151-2916.1991.tb07177.x
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Chevalier J, 1999, J AM CERAM SOC, V82, P2150
   Din SU, 1998, MATER CHEM PHYS, V53, P48, DOI 10.1016/S0254-0584(97)02057-9
   Green D. J., 1989, TRANSFORMATION TOUGH
   GUICCIARDI S, IN PRESS
   Ingel RP, 1984, ADV CERAM, V12, P408
   JOHNSON KL, 1985, CONTACT MECH, P171
   LAWSON S, 1995, J EUR CERAM SOC, V15, P485, DOI 10.1016/0955-2219(95)00035-S
   LAWSON S, 1994, 8 CIMTEC WORLD CER C, P899
   Lilley E., 1990, CERAMIC T, V10, P387
   Ma YX, 2001, J AM CERAM SOC, V84, P399
   NAKAJIMA K, 1984, ADV CERAM, V12, P399
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Pecharroman C, 2003, ADV MATER, V15, P507, DOI 10.1002/adma.200390117
   Pezzotti G, 2005, ANAL BIOANAL CHEM, V381, P577, DOI 10.1007/s00216-004-2780-1
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Piconi C, 1998, BIOMATERIALS, V19, P1489, DOI 10.1016/S0142-9612(98)00064-7
   SCHMAUDER S, 1986, J AM CERAM SOC, V69, P534, DOI 10.1111/j.1151-2916.1986.tb04789.x
   Tsukuma K., 1984, ADV CERAM, P382
   ZHU WC, 1999, SCRIPTA MATER, V10, P1229
NR 24
TC 18
Z9 18
U1 1
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0022-2461
J9 J MATER SCI
JI J. Mater. Sci.
PD JAN
PY 2007
VL 42
IS 2
BP 718
EP 722
DI 10.1007/s10853-006-1177-2
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 132EQ
UT WOS:000243925700039
DA 2018-10-19
ER

PT J
AU Mwenifumbo, S
   Li, MW
   Chen, JB
   Beye, A
   Soboyejo, W
AF Mwenifumbo, Steven
   Li, Mingwei
   Chen, Jianbo
   Beye, Aboubaker
   Soboyejo, Wole
TI Cell/surface interactions on laser micro-textured titanium-coated
   silicon surfaces
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT Annual Winter Meeting of the American-Society-Mechanical-Engineers
CY NOV, 2003
CL Chicago, IL
SP Amer Soc Mech Engineers
ID HUMAN OSTEOBLAST ADHESION; CELL BEHAVIOR; TOPOGRAPHICAL CONTROL;
   IN-VITRO; BIOMATERIAL SURFACES; MORPHOLOGIC ASPECTS; CONTACT GUIDANCE;
   FIBROBLASTS; ORIENTATION; ATTACHMENT
AB This paper examines the effects of nano-scale titanium coatings, and micro-groove/micro-grid patterns on cell/surface interactions on silicon surfaces. The nature of the cellular attachment and adhesion to the coated/uncoated micro-textured surfaces was elucidated by the visualization of the cells and relevant cytoskeletal & focal adhesion proteins through scanning electron microscopy and immunofluorescence staining. Increased cell spreading and proliferation rates are observed on surfaces with 50 nm thick Ti coatings. The micro-groove geometries have been shown to promote contact guidance, which leads to reduced scar tissue formation. In contrast, smooth surfaces result in random cell orientations and the increased possibility of scar tissue formation. Immunofluorescence cell staining experiments also reveal that the actin stress fibers are aligned along the groove dimensions, with discrete focal adhesions occurring along the ridges, within the grooves and at the ends of the cell extensions. The implications of the observed cell/surface interactions are discussed for possible applications of silicon in implantable biomedical systems.
C1 Princeton Univ, Princeton Mat Inst, Princeton, NJ 08544 USA.
   Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA.
   Spectra Phys Inc, Mountain View, CA 94043 USA.
   Cheikh Anta Diop Univ, Dept Phys, Dakar, Senegal.
RP Soboyejo, W (reprint author), Princeton Univ, Princeton Mat Inst, Princeton, NJ 08544 USA.
EM soboyejo@princeton.edu
CR Anselme K, 2000, J BIOMED MATER RES, V49, P155, DOI 10.1002/(SICI)1097-4636(200002)49:2<155::AID-JBM2>3.3.CO;2-A
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   Anselme K, 1999, J MATER SCI-MATER M, V10, P815, DOI 10.1023/A:1008992109670
   Anselme K, 2000, BIOMATERIALS, V21, P1567, DOI 10.1016/S0142-9612(00)00042-9
   Brunette D. M., 2001, TITANIUM MED MAT SCI
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1089, DOI 10.1002/jbm.820290909
   CHESMEL KD, 1995, J BIOMED MATER RES, V29, P1101, DOI 10.1002/jbm.820290910
   Chicurel ME, 1998, CURR OPIN CELL BIOL, V10, P232, DOI 10.1016/S0955-0674(98)80145-2
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Clark P, 1997, EXP CELL RES, V230, P275, DOI 10.1006/excr.1996.3429
   CLARK P, 1987, DEVELOPMENT, V99, P439
   Craighead H.G., 1998, J BIOMED MICRODEVICE, V1, P49
   CULLIS AG, 1985, REP PROG PHYS, V48, P1155, DOI 10.1088/0034-4885/48/8/002
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   CURTIS ASG, 1990, CRIT REV BIOCOMPAT, V5, P343
   DENBRABER ET, 1995, J BIOMED MATER RES, V29, P511, DOI 10.1002/jbm.820290411
   Dow J A, 1987, J Cell Sci Suppl, V8, P55
   Feng B, 2002, J MATER SCI-MATER M, V13, P457, DOI 10.1023/A:1014737831371
   FENG B, 2003, MATER CHARACT, V49, P129, DOI DOI 10.1016/S1044-5803(02)00341-8
   Gardner J.W., 2002, MICROSENSORS MEMS SM
   GREEN AM, 1994, J BIOMED MATER RES, V28, P647, DOI 10.1002/jbm.820280515
   Hanein Y, 2001, SENSOR ACTUAT B-CHEM, V81, P49, DOI 10.1016/S0925-4005(01)00925-X
   LI M, 2002, P SOC PHOTO-OPT INS, V4830, P206
   LIEPMANN D, 2001, P 3 KOR MEMS C, P13
   MEYLE J, 1995, J BIOMED MATER RES, V29, P81, DOI 10.1002/jbm.820290112
   MILBURN C, UNPUB EFFECTS BIOCOM
   MOSBACHER M, 2002, PARTICLES SURFACES, V7, P275
   MWENIFUMBO S, 2003, SURFACE ENG MAT SCI, V2, P141
   MWENIFUMBO S, 2004, THESIS PRINCETON U, P41
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   Ricci J.L., 2000, BONE ENG, P1
   Ricci JL, 2001, KEY ENG MAT, V198-1, P179, DOI 10.4028/www.scientific.net/KEM.198-199.179
   RICCI JL, 1994, P 20 ANN M SOC BIOM, P401
   Ruoslahti E, 1996, EXP CELL RES, V227, P1, DOI 10.1006/excr.1996.0243
   Soboyejo WO, 2002, J BIOMED MATER RES, V62, P56, DOI 10.1002/jbm.10221
   Soboyejo WO, 2001, KEY ENG MAT, V198-1, P203, DOI 10.4028/www.scientific.net/KEM.198-199.203
   SPENCER ND, 1998, SURFACE MODIFICATION
   Strong ZA, 2002, BIOMED MICRODEVICES, V4, P97, DOI 10.1023/A:1014627029818
   Turner AMP, 2000, J BIOMED MATER RES, V51, P430, DOI 10.1002/1097-4636(20000905)51:3<430::AID-JBM18>3.0.CO;2-C
   Vercaigne S, 1998, J BIOMED MATER RES, V41, P41, DOI 10.1002/(SICI)1097-4636(199807)41:1<41::AID-JBM5>3.0.CO;2-Q
   Voskerician G, 2003, BIOMATERIALS, V24, P1959, DOI 10.1016/S0142-9612(02)00565-3
   Walboomers XF, 1999, J BIOMED MATER RES, V46, P212, DOI 10.1002/(SICI)1097-4636(199908)46:2<212::AID-JBM10>3.0.CO;2-Y
   Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893
   Wang JHC, 2000, J BIOMECH, V33, P729, DOI 10.1016/S0021-9290(00)00013-0
   Wang JHC, 2000, CONNECT TISSUE RES, V41, P29, DOI 10.3109/03008200009005639
   WOOD RF, 1984, SEMICONDUCTORS SEMIM, V23
   ZIAIE B, 2001, BIOMED MICR, V3, P109
   Ziaie B, 2001, BIOMED MICRODEVICES, V3, P285, DOI 10.1023/A:1012452613720
NR 48
TC 30
Z9 31
U1 0
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JAN
PY 2007
VL 18
IS 1
BP 9
EP 23
DI 10.1007/s10856-006-0658-9
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 122WH
UT WOS:000243257600003
PM 17200810
DA 2018-10-19
ER

PT J
AU Liu, DH
   Tomasko, DL
AF Liu, Dehua
   Tomasko, David L.
TI Carbon dioxide sorption and dilation of poly(lactide-co-glycolide)
SO JOURNAL OF SUPERCRITICAL FLUIDS
LA English
DT Article
DE carbon dioxide; sorption; dilation; poly(lactide-co-glycolide) (PLGA);
   Axisymmetric Drop Shape Analysis (ADSA); Sanchez-Lacombe EOS(SLEOS)
ID SANCHEZ-LACOMBE MODEL; SUPERCRITICAL FLUIDS; CONTROLLED-RELEASE;
   RESIDUAL SOLVENT; POLYMER MELTS; CO2; MICROPARTICLES; BIOMATERIALS;
   ANTISOLVENT; PRESSURE
AB Recently, CO2 has been intensely studied as a promising fluid to process or modify biomaterials. The thermodynamic behavior Of CO2-polymer mixtures plays an essential role in further progress of this field. In this study, CO2 sorption isotherms and the induced polymer swelling were studied, respectively, by the pressure decay technique and a volumetric approach derived from the ADSA (Axisymmetric Drop Shape Analysis) method used for interfacial tension measurements. The polymer of interest in this work was Poly (lactide-co-glycolide) (PLGA), an important biomaterial already approved by the FDA. To the best of our knowledge, CO2 sorption and dilation isotherms in PLGA are very limited in the literature. This work provides data for PLGA5050, PLGA7525 and PLA100DL over a useful range of processing conditions (temperatures of 30, 40 and 60 degrees C, and pressures up to 10 MPa). PLGA is shown to have a relatively high affinity for CO, and the resulting volumetric expansion upon CO2 sorption is closely related to the percentage of the lactide component in the copolymer. The Sanchez-Lacombe equation of state (SLEOS) was applied to correlate the experimental data, and the nearly equivalent fitting quality employing various optimization routes verified that the SLEOS is a robust thermodynamic model to describe the CO2-polymer mixture. In addition, the combination of a group contribution method and the isobaric density data of the pure polymer obtained by the ADSA offers a simple way of estimating the characteristic parameters for the SLEOS model. The approach is verified by the satisfactory prediction of PMMA density, and then applied to PLGA copolymers. (C) 2006 Elsevier B.V. All rights reserved.
C1 Ohio State Univ, Dept Chem & Biomol Engn, Columbus, OH 43210 USA.
RP Tomasko, DL (reprint author), Ohio State Univ, Dept Chem & Biomol Engn, 140 W 19th Ave, Columbus, OH 43210 USA.
EM tomasko.1@osu.edu
CR BLEICH J, 1993, INT J PHARM, V97, P111, DOI 10.1016/0378-5173(93)90131-X
   Boudouris D, 1997, IND ENG CHEM RES, V36, P3968, DOI 10.1021/ie970242g
   Conway SE, 2001, J APPL POLYM SCI, V80, P1155, DOI 10.1002/app.1199
   Cooper AI, 2001, ADV MATER, V13, P1111, DOI 10.1002/1521-4095(200107)13:14<1111::AID-ADMA1111>3.0.CO;2-L
   Dillow AK, 1999, P NATL ACAD SCI USA, V96, P10344, DOI 10.1073/pnas.96.18.10344
   Falk R, 1997, J CONTROL RELEASE, V44, P77, DOI 10.1016/S0168-3659(96)01508-8
   Falk RF, 1998, PHARMACEUT RES, V15, P1233, DOI 10.1023/A:1011991808423
   Guney O, 2002, AICHE J, V48, P856, DOI 10.1002/aic.690480419
   Hile DD, 2000, J CONTROL RELEASE, V66, P177, DOI 10.1016/S0168-3659(99)00268-0
   Howdle SM, 2001, CHEM COMMUN, P109, DOI 10.1039/b008188o
   Jain RA, 2000, BIOMATERIALS, V21, P2475, DOI 10.1016/S0142-9612(00)00115-0
   Kazarian SG, 2002, INT J PHARM, V232, P81, DOI 10.1016/S0378-5173(01)00905-X
   Kazarian SG, 1996, J AM CHEM SOC, V118, P1729, DOI 10.1021/ja950416q
   KIRAN E, 1993, J SUPERCRIT FLUID, V6, P193, DOI 10.1016/0896-8446(93)90027-U
   Koushik K, 2004, PHARM RES-DORDR, V21, P524, DOI 10.1023/B:PHAM.0000019308.25479.a4
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Li HB, 2004, IND ENG CHEM RES, V43, P509, DOI 10.1021/ie034092n
   Liu DH, 2005, MACROMOLECULES, V38, P4416, DOI 10.1021/ma047319e
   Reverchon E, 2000, J SUPERCRIT FLUID, V18, P239, DOI 10.1016/S0896-8446(00)00069-3
   SANCHEZ IC, 1977, J POLYM SCI POL LETT, V15, P71, DOI 10.1002/pol.1977.130150202
   SANCHEZ IC, 1978, MACROMOLECULES, V11, P1145, DOI 10.1021/ma60066a017
   SANCHEZ IC, 1976, J PHYS CHEM-US, V80, P2352, DOI 10.1021/j100562a008
   SANCHEZ IC, 1994, MODELS THERMODYNAMIC, P187
   Sato Y, 1996, FLUID PHASE EQUILIBR, V125, P129, DOI 10.1016/S0378-3812(96)03094-4
   SATO Y, 2000, P 21 HAP S THERM PRO, P196
   SPARACIO D, 1998, ACS SYM SER, V173, P181
   Sproule TL, 2004, J SUPERCRIT FLUID, V28, P241, DOI 10.1016/S0896-8446(03)00044-5
   Thies J, 1998, EUR J PHARM BIOPHARM, V45, P67, DOI 10.1016/S0939-6411(97)00124-0
   Tomasko DL, 2003, IND ENG CHEM RES, V42, P6431, DOI 10.1021/ie030199z
   WISSINGER RG, 1987, J POLYM SCI POL PHYS, V25, P2497, DOI 10.1002/polb.1987.090251206
   Witschi C, 1998, J CONTROL RELEASE, V51, P327, DOI 10.1016/S0168-3659(97)00188-0
   Woods HM, 2004, J MATER CHEM, V14, P1663, DOI 10.1039/b315262f
   Wulf M, 1999, J COLLOID INTERF SCI, V210, P172, DOI 10.1006/jcis.1998.5942
   XIONG Y, 1994, POLYMER, V35, P4408, DOI 10.1016/0032-3861(94)90100-7
   Yang Y, 2004, ADV MATER, V16, P560, DOI 10.1002/adma.200306159
   YANG Y, 2004, P ANN TECHN C SOC PL, P3095
NR 36
TC 47
Z9 47
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0896-8446
J9 J SUPERCRIT FLUID
JI J. Supercrit. Fluids
PD JAN
PY 2007
VL 39
IS 3
BP 416
EP 425
DI 10.1016/j.supflu.2006.02.014
PG 10
WC Chemistry, Physical; Engineering, Chemical
SC Chemistry; Engineering
GA 114BU
UT WOS:000242642500015
DA 2018-10-19
ER

PT J
AU Ignjatovic, N
   Ninkov, P
   Ajdukovic, Z
   Vasijevic-Radovic, D
   Uskokovic, D
AF Ignjatovic, Nenad
   Ninkov, Petar
   Ajdukovic, Zorica
   Vasijevic-Radovic, Dana
   Uskokovic, Dragan
TI Biphasic calcium phosphate coated with poly-D,L-lactide-co-glycolide
   biomaterial as a bone substitute
SO JOURNAL OF THE EUROPEAN CERAMIC SOCIETY
LA English
DT Article; Proceedings Paper
CT 9th Conference and Exhibition of the European-Ceramic-Society
CY JUN 19-23, 2005
CL Portoroz, SLOVENIA
SP European Ceram Soc
DE powders-chemical preparation; composites; interfaces; chemical
   properties; biomedical applications
ID BIODEGRADABLE POLYMERS; COMPOSITES; TISSUE; NANOPARTICLES; DEVICES
AB A calcium phosphate/poly-D,L-lactide-co-glycolide (BCP/DLPLG) composite biomaterial was synthesized in the shape of spherical granules (150-200 mu m) and nanostructured particles (30-40 nm) by an emulsilication/evaporation procedure. Calcium phosphate components were coated with amorphous polymer phase. The influence of the processing technique on the structure and characteristics of the BCP/DLPLG composite biomaterial was studied by X-ray diffraction analysis (XRD), differential scanning calorimetry (DSC), scanning electronic microscopy (SEM), and atomic force microscopy (AFM). In vitro cytotoxicity research was conducted on cellular cultures of fibroblasts of animals. The possibility of BCP/DLPLG application was examined by its use in reparation of lost bone tissue of patients. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Serbian Acad Arts & Sci, Inst Tech Sci, Belgrade, Serbia.
   Univ Novi Sad, Fac Med, Clin Stomatol, Novi Sad, Serbia.
   Univ Nis, Fac Med, Clin Stomatol, Nish, Serbia.
   Inst Microelect Technol & Single Crystals, IHTM, Belgrade, Serbia.
RP Uskokovic, D (reprint author), Serbian Acad Arts & Sci, Inst Tech Sci, K Mihajlova 35-4, Belgrade, Serbia.
EM uskok@itn.sanu.ac.yu
RI Uskokovic, Dragan/B-4129-2008; Ignjatovic, Nenad/C-4489-2008;
   Vasiljevic-Radovic, Dana/C-8034-2016
OI Uskokovic, Dragan/0000-0002-0421-4968; Ignjatovic,
   Nenad/0000-0002-5749-094X; Vasiljevic-Radovic, Dana/0000-0002-7609-8599
CR Ara M, 2002, BIOMATERIALS, V23, P2479, DOI 10.1016/S0142-9612(01)00382-9
   Bauer TW, 2002, CLIN ORTHOP RELAT R, P11
   Calandrelli L, 2000, POLYMER, V41, P8027, DOI 10.1016/S0032-3861(00)00165-8
   Durucan C, 2000, J BIOMED MATER RES, V51, P726, DOI 10.1002/1097-4636(20000915)51:4<726::AID-JBM22>3.0.CO;2-L
   ELGENDY HM, 1993, BIOMATERIALS, V14, P263, DOI 10.1016/0142-9612(93)90116-J
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Ignjatovic N, 2005, MATER SCI FORUM, V494, P519, DOI 10.4028/www.scientific.net/MSF.494.519
   IGNJATOVIC N, 2005, J MATER SCI-MATER M, V16, P624
   Ignjatovic NL, 1999, J MICROSC-OXFORD, V196, P243
   Jeon HJ, 2000, INT J PHARMACEUT, V207, P99, DOI 10.1016/S0378-5173(00)00537-8
   Kikuchi M, 1997, J MATER SCI-MATER M, V8, P361, DOI 10.1023/A:1018580816388
   LANGER R, 2003, FOOD NATURAL PRODUCT, V19, P2990
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Liu Q, 1997, BIOMATERIALS, V18, P1263, DOI 10.1016/S0142-9612(97)00069-0
   Lu LC, 1996, MRS BULL, V21, P28
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Oliveira JM, 2005, J MATER SCI-MATER M, V16, P253, DOI 10.1007/s10856-005-6687-y
   Parker J.R., 1992, British Arachnological Society Newsletter, P1
   RAVIKUMAR MNV, 2004, BIOMATERIALS, V25, P1771
   Raynaud S, 2001, J AM CERAM SOC, V84, P359
   Seo SA, 2002, INT J PHARM, V239, P93, DOI 10.1016/S0378-5173(02)00074-1
   Shikinami Y, 1999, BIOMATERIALS, V20, P859, DOI 10.1016/S0142-9612(98)00241-5
   SISHENG E, 2004, CURRENT MED CHEM, V11, P413
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Tosi G, 2005, BIOMATERIALS, V26, P4189, DOI [10.1016/j.biomaterials.2004.10.025, 10.1016/biomaterials.2004.10.025]
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
NR 27
TC 28
Z9 28
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0955-2219
J9 J EUR CERAM SOC
JI J. Eur. Ceram. Soc.
PY 2007
VL 27
IS 2-3
BP 1589
EP 1594
DI 10.1016/j.jeurceramsoc.2006.04.104
PG 6
WC Materials Science, Ceramics
SC Materials Science
GA 122ZC
UT WOS:000243265100194
DA 2018-10-19
ER

PT J
AU Jameson, CA
AF Jameson, Carol A.
TI Autologous platelet concentrate for the production of platelet gel
SO LABMEDICINE
LA English
DT Review
ID RICH PLASMA; FIBRIN GLUE; SURGERY; SEQUESTRATION
AB Platelets are attracted to a wound or injury site stimulating the clotting and healing cascades. Degranulated platelets release numerous substances including proteins known as growth factors. Growth factors signal undifferentiated stem cells to the site, promote cell mitosis, and stimulate osteogenesis and angiogenesis. Cytokines, which attract neutrophils, are also released from platelet granules. Concentrating platelets 4x to 5x the baseline level accelerates the healing process. When platelet rich plasma is mixed with an activator, a platelet gel will form. Clinical applications of platelet gel are numerous. Some benefits include a marked decrease in post-surgical swelling and bruising, reduction in surgical site pain, elimination of drains, and acceleration of bone growth and soft tissue healing. Scientific publications support that autologous biomaterial accelerates the the healing process.
C1 Platelet Gel Technol, Lexington, OH USA.
RP Jameson, CA (reprint author), Platelet Gel Technol, Lexington, OH USA.
EM cjameson@plateletgeltech.com
CR Adler Stephen C, 2002, Facial Plast Surg Clin North Am, V10, P129, DOI 10.1016/S1064-7406(02)00005-6
   AMINIAN B, ROLE AUTOLOGOUS PLAT
   BANCO RJ, 2005, 2005 ANN M AM AC ORT
   BARRETT SL, 2004, PODIATRY TODAY, P37
   BARRETT SL, NEW APPROACH USING G
   Bhanot Sumeet, 2002, Facial Plast Surg, V18, P27, DOI 10.1055/s-2002-19824
   BOLDT J, 1990, ANESTHESIOLOGY, V72, P282, DOI 10.1097/00000542-199002000-00013
   CLEVENS RA, 2002, P 8 INT S FAC PLAST
   COETZEE JC, 2005, 2005 ANN M AM AC ORT
   GAUDRIC A, AUTOLOGOUS PLATELET
   GREEN DM, 1997, PROACT HEM MAN EM RO
   Haynesworth S, 2002, 48 ANN M ORTH RES SO
   HILL AG, 1993, P AM AC CAR, V14, P122
   HOOD AG, 1993, P AM AC CAR, V14, P126
   HOOD AG, 1995, MECH PERF 10 MAY
   KEATING RF, 1992, AM ASS NEUR SURG PED
   KERNER MM, 2001, AM RHIN SOC SEPT
   KERNER MM, INTRANASAL SINUS SUR
   KERNER MM, 2003, PLASTIC SURG PRODUCT, P20
   KEVY S, 2001, SOC BIOM M 27 ANN AP
   KEVY S, 2001, TECHV C TISS REP REP
   KEVY S, IN VITRO EVALUATION
   Kevy Sherwin V, 2004, J Extra Corpor Technol, V36, P28
   KEVY SV, 2002, PLATELET CONCENTRATE
   KEVY SV, 2000, ORTH TISS ENG M 4 AN
   Man D, 2001, PLAST RECONSTR SURG, V107, P229, DOI 10.1097/00006534-200101000-00037
   MANCUSO JD, 2003, J ORAL MAXILLOFAC SU, V61
   Marx R E, 2001, Implant Dent, V10, P225
   Marx RE, 2004, J ORAL MAXIL SURG, V62, P489, DOI 10.1016/j.joms.2003.12.003
   Marx RE, 1998, ORAL SURG ORAL MED O, V85, P638, DOI 10.1016/S1079-2104(98)90029-4
   MARX RE, 2001, PLATELET CONCENTRATE
   Mazzucco L, 2004, TRANSFUSION, V44, P1013, DOI 10.1111/j.1537-2995.2004.03366.x
   MONTELEONE K, 2000, 82 ANN AM AC OR MAX
   MOOAR PA, 2000, AAOS MARCH
   OZ MC, 1992, ANN THORAC SURG, V53, P530, DOI 10.1016/0003-4975(92)90291-B
   RIEMAN P, 2000, COSMETIC SURG TIMES, V38
   STOVER EP, 1996, TRANSFUSION AABB, V36
   TROWBRIDGE CC, 2004, SOC CARD AN M 9 ANN
   Whitman DH, 1997, J ORAL MAXIL SURG, V55, P1294, DOI 10.1016/S0278-2391(97)90187-7
NR 39
TC 14
Z9 17
U1 0
U2 1
PU AMER SOC CLINICAL PATHOLOGY
PI CHICAGO
PA 2100 W HARRISON ST, CHICAGO, IL 60612 USA
SN 0007-5027
J9 LABMEDICINE
JI Labmedicine
PD JAN
PY 2007
VL 38
IS 1
BP 39
EP 42
DI 10.1309/3U15HWYVKNCE01AR
PG 4
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA 121HV
UT WOS:000243149600011
DA 2018-10-19
ER

PT S
AU Major, B
   Major, R
   Lackner, JM
   Waldhauser, W
AF Major, Boguslaw
   Major, Roman
   Lackner, Juergen M.
   Waldhauser, Wolfgang
BE Wolinski, WL
   Jankiewicz, Z
   Romaniuk, RS
TI Using of laser ablation to fabrication nanocrystalline multilayer
   coatings for biomedical and tribological application
SO LASER TECHNOLOGY VIII: APPLICATIONS OF LASERS
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Laser Technology VIII
CY SEP 25-29, 2006
CL Szczecin Swinoujscie, POLAND
SP SPIE Poland Chapter, Szczecin Univ Technol, Fdn Dev, Polish Acad Sci, Comm Elect & Telecommun, Assoc Polish Elect Engineers, Polish Comm Optoelect, Warsaw Univ Technol, Mil Univ Technol
DE laser ablation; nanomaterials; coatings; TiN; CrN; BN
ID NITRIDE THIN-LAYERS; PULSED-LASER; FILMS; GROWTH; DEPOSITION;
   POLYURETHANE; SUBSTRATE
AB Titanium nitride (TiN) is regarded as a potential biomaterial for blood-contact applications. TiN thin films were fabricated by pulsed laser deposition with the Nd:YAG laser on biologically applied polyurethane. Transmission electron microscopy (TEM) study of 350 nm thick films revealed columnar structure. Such films were observed to be brittle. In order to improve the coatings elasticity, the thickness was reduced to 50 nm, which limited the deposition mechanism operation to the early stage. A biological test showed that TiN surface film produced on polyurethane is characterized by good biocompatibility and decreased surface affinity for cell adhesion. The physical explanation of TEM images was based on the performed finite element calculations of the temperature and stress distribution using the ADINA program. Boron nitride thin layers were produced by means of the pulsed laser deposition technique from hexagonal boron nitride target. Two types of laser i.e. Nd:YAG with Q-switch as well as KrF coupled with RF generator were used. Influence of deposition parameters on surface morphology, phase composition as well as mechanical properties is discussed.
   There are an increasing number of applications in tribology where the properties of a single material are not sufficient. One way to surmount this problem is to use a multilayer coating. Application of metallic interlayers improves adhesion of nitride hard layer in multilayer systems. Tribological coatings consisted of 4, 8 and 32 layers of Cr/CrN and Ti/TiN types were fabricated with the PLD technique. It is found in transmission electron examinations on thin foils prepared from cross-section that both nitride-based multilayer structures studied are characterized by small columnar crystallite sizes and high defect density, what might raise their hardness but compromise coating adhesion. The intermediate metallic layers contained larger sized and less defective columnar structure compared to the nitride layers, which should improve the coatings toughness. Switching from single layer to multi-layer metal/nitride composition improved resistance to delamination.
C1 [Major, Boguslaw; Major, Roman] Polish Acad Sci, Inst Met & Mat Sci, 25 Reymonta Str, PL-30059 Krakow, Poland.
   [Lackner, Juergen M.; Waldhauser, Wolfgang] Joanneum Research Ltd, Laser Ctr Leoben, A-8712 Niklasdorf, Austria.
RP Major, B (reprint author), Polish Acad Sci, Inst Met & Mat Sci, 25 Reymonta Str, PL-30059 Krakow, Poland.
FU State Committee for Scientific Research of Poland
   [PBZ-KBN-100/T08/2003]; Polish Ministry of Science; Knowledge-based
   Multicomponent Materials for Durable; Safe Performance KMM NoE project
FX The work was supported by the State Committee for Scientific Research of
   Poland under Project: PBZ-KBN-100/T08/2003 project from the means
   provided by the Polish Ministry of Science and Informatization as well
   as by the Knowledge-based Multicomponent Materials for Durable and Safe
   Performance KMM NoE project.
CR BATHE KJ, 1993, P 9 ADINA C JUN, P511
   Bauerle D., 2000, LASER PROCESSING CHE
   BIENFAIT M, 1984, PHYS REV B, V29, P983, DOI 10.1103/PhysRevB.29.983
   BREME J, 1989, MEM ETUD SCI REV MET, V10, P625
   Bull SJ, 1996, SURF COAT TECH, V78, P173, DOI 10.1016/0257-8972(94)02407-3
   BULL SJ, 1990, SURF COAT TECH, V43-4, P732, DOI 10.1016/0257-8972(90)90016-6
   Chrisey D., 1994, PULSED LASER DEPOSIT
   Costerton B, 2004, BIOMATERIALS SCI INT, P345
   Gilmer GH, 1998, COMP MATER SCI, V12, P354, DOI 10.1016/S0927-0256(98)00022-6
   GREENE JE, 1993, NATO ADV SCI INST E, V39, P234
   Haubner R, 2002, STRUCT BOND, V102, P1
   HELSEN JA, 1998, METALS BIOMATERIALS, P273
   KUSTOSZ, 2004, ACADEMIA, V3, P14
   Lackner J. M., 2006, Bulletin of the Polish Academy of Sciences, Technical Sciences, V54, P175
   Lackner J. M., 2005, IND SCALED HYBRID PU
   Lackner JM, 2004, THIN SOLID FILMS, V453, P195, DOI 10.1016/j.tsf.2003.11.106
   Ma DJ, 1998, THIN SOLID FILMS, V323, P183, DOI 10.1016/S0040-6090(97)01054-7
   Major B, 2004, SURF COAT TECH, V180, P580, DOI 10.1016/j.surfcoat.2003.10.154
   MAJOR B, 2004, ANN TRANSPLANTATIO S, V9, P30
   MAJOR B, 2002, ABLACJA I OSADZANIE
   Major L, 2006, SURF COAT TECH, V200, P6190, DOI 10.1016/j.surfcoat.2005.11.021
   Major R, 2006, SURF COAT TECH, V200, P6340, DOI 10.1016/j.surfcoat.2005.11.003
   Major R, 2005, ARCH METALL MATER, V50, P379
   Major R, 2005, E-POLYMERS
   MAJOR R, 2006, B POL ACAD SCI TECHN, V2
   MAJOR R, 2005, 3 MIT C COMP FLUID S, P242
   Miller J. C., 1998, LASER ABLATION DESOR, V30
   Mirkarimi PB, 1997, MAT SCI ENG R, V21, P47, DOI 10.1016/S0927-796X(97)00009-0
   Mroz W, 2006, SURF COAT TECH, V200, P6438, DOI 10.1016/j.surfcoat.2005.11.095
   Mroz W, 2005, SOL ST PHEN, V101-102, P187, DOI 10.4028/www.scientific.net/SSP.101-102.187
   REISSE G, 1999, THIN SOLID FILMS, V105, P355
   Rickerby D. S., 1991, ADV SURFACE COATINGS
   Ronning C, 2000, DIAM RELAT MATER, V9, P1767, DOI 10.1016/S0925-9635(00)00299-5
   SCHULZ HA, 1991, MED DEVICE TECHNOL, V2, P432
   SU SH, 2004, ENCY BIOMAT BIOMED E, V2, P1412
   VENABLES JA, 1975, EPITAXIAL GROWTH B
   Weissmantel S, 2000, APPL SURF SCI, V154, P428, DOI 10.1016/S0169-4332(99)00456-0
   Wierzchon T., 2004, INZYNIERIA POWIERZCH
   Yap YK, 2000, DIAM RELAT MATER, V9, P592, DOI 10.1016/S0925-9635(00)00215-6
   YIN B, 1997, COMPUT STRUCT, V5, P931
NR 40
TC 0
Z9 0
U1 2
U2 12
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-6734-8
J9 PROC SPIE
PY 2007
VL 6598
AR 659807
DI 10.1117/12.726530
PG 12
WC Optics; Physics, Applied
SC Optics; Physics
GA BGF02
UT WOS:000246384400006
DA 2018-10-19
ER

PT J
AU van Kralingen, L
   Bredenkamp, MW
   Sanderson, RD
AF van Kralingen, Leon
   Bredenkamp, Martin W.
   Sanderson, Ron D.
TI Synthesis of novel a PEG-lysine polymer
SO MACROMOLECULAR SYMPOSIA
LA English
DT Proceedings Paper
CT 9th Annual UNESCO/IUPAC Conference on Marcomolecules
CY NOV 20-23, 2006
CL Staellenbosch, SOUTH AFRICA
SP UNESCO, IUPAC
DE biocompatible; biomaterial; carboxylic acid; PEG; poly-lysine
AB A novel PEG functionalized-L-lysine-alpha-amino-N-carboxy anhydride monomer (L-Lys(PEG-(COOBzl))-NCA) is prepared for the synthesis of carboxylic acid terminated, PEG-sheathed poly-lysine biopolymers.
C1 Univ Stellenbosch, Dept Chem, ZA-7602 Matieland, South Africa.
   Univ Stellenbosch, UNESCO Assoc Ctr Macromol & Mat, Chem & Polymer Sci Dept, ZA-7602 Matieland, South Africa.
RP van Kralingen, L (reprint author), Univ Stellenbosch, Dept Chem, Private Bag X1, ZA-7602 Matieland, South Africa.
CR VandeVondele S, 2003, BIOTECHNOL BIOENG, V82, P784, DOI 10.1002/bit.10625
   Yang ZG, 2005, EUR POLYM J, V41, P267, DOI 10.1016/j.europolymj.2004.09.023
   Yu M, 1999, J AM CHEM SOC, V121, P12210, DOI 10.1021/ja993637v
NR 3
TC 0
Z9 0
U1 0
U2 2
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1022-1360
J9 MACROMOL SYMP
JI Macromol. Symp.
PY 2007
VL 255
BP 90
EP 93
DI 10.1002/masy-200750910
PG 4
WC Polymer Science
SC Polymer Science
GA 233GI
UT WOS:000251078000011
DA 2018-10-19
ER

PT J
AU Distel, DL
AF Distel, D. L.
TI Molecular biorepositories and biomaterials management: enhancing the
   value of high-throughput molecular methodologies for the natural
   sciences
SO MARINE ECOLOGY PROGRESS SERIES
LA English
DT Article
DE genomic conservation; biobanking; biological banking; genome banking;
   genome resource repositiory; biorepository; biodiversity;
   bioinformatics; archiving
ID DNA; GENOME
AB Genomics, proteomics, metabolomics and a rapidly growing list of 'omic' methodologies have the capacity to transform our view of biology and ecology by tapping the enormous information content of biomolecules. Although procedurally diverse, these approaches share common elements. All use high-throughput technologies to explore a given class of biomolecules in its totality in a given organism, species or community. All generate large quantities of data from individual and often minute samples. All hold promise to provide new insights into the ontogeny, phylogeny, physiology and ecology of organisms and their communities. However, the full potential of these new technologies is unlikely to be realized unless renewed attention is paid to description, preservation, authentication and distribution of biological source materials: issues that have long been of fundamental concern to traditional biologists but that have received less attention in recent years. This renewed emphasis on biomaterial management will require new methods and new types of biological collections (i.e. molecular biorepositories) specifically designed to address and anticipate the needs of these rapidly evolving technologies. Such biorepositories can help advance the nascent 'omics revolution' by allowing researchers to better access and preserve source materials, disseminate research products and data, share ideas, control financial and environmental costs, integrate with traditional methods and knowledge bases, and extract more meaningful data from biological specimens.
C1 Ocean Genome Legacy, Ipswich, MA 01938 USA.
RP Distel, DL (reprint author), Ocean Genome Legacy, 240 County Rd, Ipswich, MA 01938 USA.
EM distel@oglf.org
RI Distel, Daniel/A-8047-2017
OI Distel, Daniel/0000-0002-3860-194X
CR Dalton R, 2006, NATURE, V441, P260, DOI 10.1038/441260b
   Lamb RA, 2005, NAT MED, V11, P1154, DOI 10.1038/nm1105-1154
   LANDER E, 2002, SEQUENCING RESEQUENC
   Noonan JP, 2005, SCIENCE, V309, P597, DOI 10.1126/science.1113485
   Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360
   Ryder OA, 2005, CYTOGENET GENOME RES, V108, P6, DOI 10.1159/000080796
   Ryder OA, 2000, SCIENCE, V288, P275, DOI 10.1126/science.288.5464.275
NR 7
TC 2
Z9 3
U1 0
U2 6
PU INTER-RESEARCH
PI OLDENDORF LUHE
PA NORDBUNTE 23, D-21385 OLDENDORF LUHE, GERMANY
SN 0171-8630
J9 MAR ECOL PROG SER
JI Mar. Ecol.-Prog. Ser.
PY 2007
VL 332
BP 307
EP 310
DI 10.3354/meps332307
PG 4
WC Ecology; Marine & Freshwater Biology; Oceanography
SC Environmental Sciences & Ecology; Marine & Freshwater Biology;
   Oceanography
GA 154XU
UT WOS:000245542400029
OA Bronze
DA 2018-10-19
ER

PT J
AU Nilsson, B
   Ekdahl, KN
   Mollnes, TE
   Lambris, JD
AF Nilsson, Bo
   Ekdahl, Kristina Nilsson
   Mollnes, Tom Eirik
   Lambris, John D.
TI The role of complement in biomaterial-induced inflammation
SO MOLECULAR IMMUNOLOGY
LA English
DT Article; Proceedings Paper
CT 21st International Complement Workshop
CY OCT 20-27, 2006
CL Beijing, PEOPLES R CHINA
DE complement; biomaterial; coagulation; inflammation; cross-talk
ID C5A RECEPTOR ANTAGONIST; COATED CARDIOPULMONARY BYPASS;
   ISCHEMIA-REPERFUSION INJURY; AORTIC-ANEURYSM REPAIR; WHOLE-BLOOD MODEL;
   SURFACES IN-VITRO; EXTRACORPOREAL-CIRCULATION; PLATELET ACTIVATION;
   PROTEIN ADSORPTION; FACTOR-H
AB Biomaterials are regularly used in various types of artificial tissues and organs, such as oxygenators, plasmapheresis equipment, hemodialysers, catheters, prostheses, stents, vascular grafts, miniature pumps, sensors and heart aids. Although progress has been made regarding bioincompatibility, many materials and procedures are associated with side effects, in particular bioincompatibility-induced inflammation, infections and subsequent loss of function. After cardiopulmonary bypass, coagulopathies can occur and lead to cognitive disturbances, stroke and extended hospitalization. Hemodialysis is associated with anaphylatoid reactions that cause whole-body inflammation and may contribute to accelerated arteriosclerosis. Stents cause restenosis and, in severe cases, thrombotic reactions. This situation indicates that there is still a need to try to understand the mechanisms involved in these incompatibility reactions in order to be able to improve the biomaterials and to develop treatments that attenuate the reactions and thereby reduce patients' discomfort, treatment time and cost. This overview deals with the role of complement in the incompatibility reactions that occur when biomaterials come in contact with blood and other body fluids. (C) 2006 Published by Elsevier Ltd.
C1 Univ Uppsala Hosp, Dept Radiol Oncol & Clin Immunol, Div Clin Immunol, Rudbeck Lab, Uppsala, Sweden.
   Univ Kalmar, Dept Chem & Biomed Sci, Kalmar, Sweden.
   Rikshosp Univ Hosp, Inst Immunol, Oslo, Norway.
   Univ Oslo, N-0316 Oslo, Norway.
   Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.
RP Ekdahl, KN (reprint author), Univ Uppsala Hosp, Dept Radiol Oncol & Clin Immunol, Div Clin Immunol, Rudbeck Lab, Uppsala, Sweden.
EM Kristina.Nilsson_Ekdahl@klinimm.uu.se
RI Nilsson Ekdahl, Kristina/B-5301-2012; Nilsson, Bo/B-3102-2012
OI Nilsson, Bo/0000-0003-0057-2730; Lambris, John/0000-0002-9370-5776
FU NIAID NIH HHS [AI066343-01]
CR AMIJI M, 1992, BIOMATERIALS, V13, P682, DOI 10.1016/0142-9612(92)90128-B
   Amore A, 2002, NEPHROL DIAL TRANSPL, V17, P16, DOI 10.1093/ndt/17.suppl_8.16
   Anderson AL, 2006, INFECT IMMUN, V74, P1196, DOI 10.1128/IAI.74.2.1196-1203.2006
   Andersson J, 2006, J BIOMED MATER RES A, V76A, P25, DOI 10.1002/jbm.a.30377
   Andersson J, 2005, BIOMATERIALS, V26, P1477, DOI 10.1016/j.biomaterials.2004.05.011
   Andersson J, 2003, J BIOMED MATER RES A, V67A, P458, DOI 10.1002/jbm.a.10104
   Andersson J, 2002, J IMMUNOL, V168, P5786, DOI 10.4049/jimmunol.168.11.5786
   Andersson J, 2001, BIOMATERIALS, V22, P2435, DOI 10.1016/S0142-9612(00)00431-2
   ANDO B, 1989, BLOOD, V73, P462
   Arumugam TV, 2002, J SURG RES, V103, P260, DOI 10.1006/jsre.2002.6369
   ATKINSON JP, 1987, IMMUNOL TODAY, V8, P212, DOI 10.1016/0167-5699(87)90167-8
   Bao LH, 2005, EUR J IMMUNOL, V35, P2496, DOI 10.1002/eji.200526327
   Bown MJ, 2003, J VASC SURG, V37, P600, DOI 10.1067/mva.2003.39
   Carroll MC, 2005, ADV IMMUNOL, V86, P137, DOI 10.1016/S0065-2776(04)86004-8
   CHENOWETH DE, 1987, ANN NY ACAD SCI, V516, P306, DOI 10.1111/j.1749-6632.1987.tb33051.x
   Collard CD, 2000, AM J PATHOL, V156, P1549, DOI 10.1016/S0002-9440(10)65026-2
   Deppisch R, 1998, NEPHROL DIAL TRANSPL, V13, P1354, DOI 10.1093/oxfordjournals.ndt.a027892
   EKDAHL KN, 1993, J COLLOID INTERF SCI, V158, P121, DOI 10.1006/jcis.1993.1236
   EKDAHL KN, 1992, SCAND J IMMUNOL, V35, P85, DOI 10.1111/j.1365-3083.1992.tb02837.x
   EMBER JA, 1992, J IMMUNOL, V148, P3165
   Fiane AE, 1999, XENOTRANSPLANTATION, V6, P52, DOI 10.1034/j.1399-3089.1999.00007.x
   Fiane AE, 2003, CIRCULATION, V108, P849, DOI 10.1161/01.CIR.0000084550.16565.01
   Finch AM, 1999, J MED CHEM, V42, P1965, DOI 10.1021/jm9806594
   Fitch JCK, 1999, CIRCULATION, V100, P2499, DOI 10.1161/01.CIR.100.25.2499
   Fleming Sherry D., 2002, International Immunopharmacology, V2, P1308
   FOSSELLA FV, 1997, ONCOLOGY, V11, P11
   Gerber BO, 2001, J BIOL CHEM, V276, P3394, DOI 10.1074/jbc.M007748200
   GHEBREHIWET B, 1983, J CLIN INVEST, V71, P1450, DOI 10.1172/JCI110898
   Girardi Guillermina, 2002, International Immunopharmacology, V2, P1239
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Hansson KM, 2005, BIOMATERIALS, V26, P861, DOI 10.1016/j.biomaterials.2004.03.036
   Harboe M, 2004, CLIN EXP IMMUNOL, V138, P439, DOI 10.1111/j.1365-2249.2004.02627.x
   Haynes DR, 2000, BIOCHEM PHARMACOL, V60, P729, DOI 10.1016/S0006-2952(00)00361-0
   HED J, 1984, IMMUNOL LETT, V8, P295, DOI 10.1016/0165-2478(84)90013-0
   Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039
   Higgins PJ, 1997, J IMMUNOL, V158, P2872
   Hill A, 2006, BLOOD, V107, P2131, DOI 10.1182/blood-2005-02-0782
   Hill GE, 1997, J CARDIOTHOR VASC AN, V11, P367, DOI 10.1016/S1053-0770(97)90107-5
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   Hourcade D, 2000, IMMUNOPHARMACOLOGY, V49, P103, DOI 10.1016/S0162-3109(00)80296-9
   Hsu LC, 2001, PERFUSION-UK, V16, P417, DOI 10.1177/026765910101600512
   Huang J, 1999, SCIENCE, V285, P595, DOI 10.1126/science.285.5427.595
   Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419
   Huber-Lang MS, 2002, FASEB J, V16, P1567, DOI 10.1096/fj.02-0209com
   Ikeda K, 1997, THROMB HAEMOSTASIS, V77, P394
   Kaplan Mariana, 2002, Curr Opin Investig Drugs, V3, P1017
   Karpman D, 2006, SEMIN THROMB HEMOST, V32, P128, DOI 10.1055/s-2006-939769
   Katragadda M, 2006, J MED CHEM, V49, P4616, DOI 10.1021/jm0603419
   KAWAI M, 1991, J MED CHEM, V34, P2068, DOI 10.1021/jm00111a022
   KAZATCHKINE MD, 1984, ADV EXP MED BIOL, V167, P235
   Keshavjee S, 2005, J THORAC CARDIOV SUR, V129, P423, DOI 10.1016/j.jtcvs.2004.06.048
   Kidane A, 1999, J BIOMED MATER RES, V48, P640, DOI 10.1002/(SICI)1097-4636(1999)48:5<640::AID-JBM7>3.3.CO;2-O
   KILGORE KS, 1995, J IMMUNOL, V155, P1434
   KIRSCHFINK M, 1988, MOL IMMUNOL, V25, P505, DOI 10.1016/0161-5890(88)90171-X
   KONTEATIS ZD, 1994, J IMMUNOL, V153, P4200
   Lappegard KT, 2005, ANN THORAC SURG, V79, P917, DOI 10.1016/j.athoracsur.2004.08.015
   Lappegard KT, 2004, ANN THORAC SURG, V78, P38, DOI 10.1016/j.athorascur.2004.02.005
   Lappegard KT, 2004, ANN THORAC SURG, V77, P932, DOI 10.1016/S0003-4975(03)01519-4
   Laudes IJ, 2002, AM J PATHOL, V160, P1867, DOI 10.1016/S0002-9440(10)61133-9
   Lhotta K, 1998, KIDNEY INT, V53, P1044
   Marie C, 1998, BLOOD, V91, P3439
   Mastellos D, 2001, J IMMUNOL, V166, P2479, DOI 10.4049/jimmunol.166.4.2479
   Moen O, 1997, ANN THORAC SURG, V63, P105
   Mojcik CF, 2001, ANN THORAC SURG, V71, P745, DOI 10.1016/S0003-4975(00)02218-9
   MOLLISON KW, 1989, P NATL ACAD SCI USA, V86, P292, DOI 10.1073/pnas.86.1.292
   MOLLNES TE, 1995, ARTIF ORGANS, V19, P909, DOI 10.1111/j.1525-1594.1995.tb02450.x
   Mollnes TE, 2002, BLOOD, V100, P1869
   Morikis D, 2002, BIOCHEM SOC T, V30, P1026, DOI 10.1042/BST0301026
   Neff JA, 1999, BIOMATERIALS, V20, P2377, DOI 10.1016/S0142-9612(99)00166-0
   Nilsson B, 1998, BLOOD, V92, P1661
   Nilsson UR, 2001, MOL IMMUNOL, V38, P151, DOI 10.1016/S0161-5890(01)00039-6
   Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103
   Nussmeier Nancy A, 2002, J Extra Corpor Technol, V34, P4
   NYDEGGER UE, 1984, ADV EXP MED BIOL, V167, P227
   OHTSUKA H, 1993, IMMUNOLOGY, V80, P140
   Ozmen L, 2002, DIABETES, V51, P1779, DOI 10.2337/diabetes.51.6.1779
   PEKNA M, 1993, CLIN EXP IMMUNOL, V91, P404
   POLLEY MJ, 1979, J EXP MED, V150, P633, DOI 10.1084/jem.150.3.633
   Rinder CS, 1999, CIRCULATION, V100, P553, DOI 10.1161/01.CIR.100.5.553
   RINDER CS, 1995, J CLIN INVEST, V96, P1564, DOI 10.1172/JCI118195
   Roos A, 2001, J IMMUNOL, V167, P2861, DOI 10.4049/jimmunol.167.5.2861
   SAHU A, 1993, MOL IMMUNOL, V30, P679, DOI 10.1016/0161-5890(93)90079-Q
   Sahu A, 1996, J IMMUNOL, V157, P884
   Sahu A, 2000, J IMMUNOL, V165, P2491, DOI 10.4049/jimmunol.165.5.2491
   Sahu A, 2000, IMMUNOPHARMACOLOGY, V49, P133, DOI 10.1016/S0162-3109(00)80299-4
   Santoro A, 2002, NEPHROL DIAL TRANSPL, V17, P10, DOI 10.1093/ndt/17.suppl_8.10
   Selander B, 2006, J CLIN INVEST, V116, P1425, DOI 10.1172/JCI25982
   Short A, 1999, BRIT J PHARMACOL, V126, P551, DOI 10.1038/sj.bjp.0702338
   Smith RAG, 2002, BIOCHEM SOC T, V30, P1037, DOI 10.1042/bst0301037
   Soulika AM, 2000, CLIN IMMUNOL, V96, P212, DOI 10.1006/clim.2000.4903
   Strachan AJ, 2001, BRIT J PHARMACOL, V134, P1778, DOI 10.1038/sj.bjp.0704417
   Strey C. W., 2002, International Immunopharmacology, V2, P1241
   SUNDSMO JS, 1983, SPRINGER SEMIN IMMUN, V6, P231
   Szebeni J, 2001, INT IMMUNOPHARMACOL, V1, P721, DOI 10.1016/S1567-5769(01)00006-6
   Szebeni Janos, 2005, Current Drug Delivery, V2, P443, DOI 10.2174/156720105774370212
   Tedesco F, 1997, J EXP MED, V185, P1619, DOI 10.1084/jem.185.9.1619
   Tempero RM, 1997, J IMMUNOL, V158, P1377
   Tengvall P, 1998, BIOMATERIALS, V19, P935, DOI 10.1016/S0142-9612(98)00005-2
   Tengvall P, 2001, COLLOID SURFACE B, V20, P51, DOI 10.1016/S0927-7765(00)00174-0
   Torzewski M, 2000, ARTERIOSCL THROM VAS, V20, P2094, DOI 10.1161/01.ATV.20.9.2094
   Videm V, 1999, J THORAC CARDIOV SUR, V117, P803, DOI 10.1016/S0022-5223(99)70302-8
   VLAICU R, 1985, ATHEROSCLEROSIS, V57, P163, DOI 10.1016/0021-9150(85)90030-9
   Wagner E, 1999, J IMMUNOL, V163, P3549
   WEISMAN HF, 1990, T ASSOC AM PHYSICIAN, V103, P64
   Wettero J, 2002, BIOMATERIALS, V23, P981, DOI 10.1016/S0142-9612(01)00203-4
   Wong AK, 1998, J MED CHEM, V41, P3417, DOI 10.1021/jm9800651
   Woodruff TM, 2001, INFLAMMATION, V25, P171, DOI 10.1023/A:1011036414353
NR 108
TC 210
Z9 217
U1 3
U2 43
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0161-5890
J9 MOL IMMUNOL
JI Mol. Immunol.
PD JAN
PY 2007
VL 44
IS 1-3
SI SI
BP 82
EP 94
DI 10.1016/j.molimm.2006.06.020
PG 13
WC Biochemistry & Molecular Biology; Immunology
SC Biochemistry & Molecular Biology; Immunology
GA 096WV
UT WOS:000241408400010
PM 16905192
DA 2018-10-19
ER

PT J
AU Castro, GR
   Panilaitis, B
   Bora, E
   Kaplan, DL
AF Castro, Guillermo R.
   Panilaitis, Bruce
   Bora, Emilia
   Kaplan, David L.
TI Controlled release biopolymers for enhancing the immune response
SO MOLECULAR PHARMACEUTICS
LA English
DT Review
DE emulsan; beta-glucan; controlled release; immunopotentiation; drug
   delivery; Acinetobacter
ID ACINETOBACTER-CALCOACETICUS RAG-1; SALMO-SALAR L; PARTIALLY DEACETYLATED
   CHITIN; TUMOR-NECROSIS-FACTOR; BETA-GLUCAN RECEPTOR; MACROPHAGES
   IN-VITRO; BINDING LECTIN SITE; CURDLAN SULFATE; ATLANTIC SALMON;
   FATTY-ACIDS
AB Controlled release of biologically active compounds in the context of drug and vaccine delivery is an important area of research with broad implications in many areas of medicine. In particular, the challenges of oral delivery are of specific interest to reduce the cost and potential health risks related to parenteral administration of pharmaceuticals and vaccine formulations. We discuss the biological activities of two biopolymers, beta-glucans and emulsans, both of which offer significant potential for individual formulations related to drug impact, while in combination offer synergistic opportunities in terms of formulation and delivery. beta-Glucans have been established as potent immunomodulatory and biologically active compounds with application in a wide range of disease systems. The emulsan family of biopolymers also has significant potential in vaccine and drug delivery based on recent studies. Each of these biopolymers offers exciting opportunities to modulate biological responses via control of chemistry and physical properties achieved during biosynthesis or postsynthesis modifications. When combined into a delivery system for controlled release, synergistic outcomes may be achieved that offer new and exciting opportunities as described in the present paper. These outcomes represent the combined improvements of solubility in physiological environments and immunomodulation due to the specific chemistry and structures involved. Overall, this approach provides a new direction in controlled release wherein the biomaterial carrier, in this case emulsan, and the drug, in this case beta-glucan, play an active role both in biological activation as well as in delivery profiles.
C1 Tufts Univ, Dept Biomed Engn, Bioengn & Biotechnol Ctr, Medford, MA 02155 USA.
   PROIMI, Lab Biocatalysis, RA-4000 San Miguel De Tucuman, Argentina.
   INIFTA, RA-1900 La Plata, Argentina.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Bioengn & Biotechnol Ctr, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
RI Castro, Guillermo/E-9982-2014; Castro, Guillermo/D-1199-2013
OI Castro, Guillermo/0000-0002-6187-7805; Castro,
   Guillermo/0000-0002-6187-7805
CR Alban S, 2000, THROMB RES, V99, P377, DOI 10.1016/S0049-3848(00)00264-4
   Ariizumi K, 2000, J BIOL CHEM, V275, P20157, DOI 10.1074/jbc.M909512199
   BELSKY I, 1979, FEBS LETT, V101, P175, DOI 10.1016/0014-5793(79)81320-4
   Bernkop-Schnurch A, 1999, J DRUG TARGET, V7, P55, DOI 10.3109/10611869909085492
   Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745
   Brown GD, 2003, IMMUNITY, V19, P311, DOI 10.1016/S1074-7613(03)00233-4
   Casadevall A, 2004, NAT REV MICROBIOL, V2, P695, DOI 10.1038/nrmicro974
   Castro GR, 2005, J CONTROL RELEASE, V109, P149, DOI 10.1016/j.jconrel.2005.09.042
   CASTRO GR, 2006, DEGRADABLE POLYM MAT, P14
   CHATTERJEE S, 1991, BIOCHEM BIOPH RES CO, V181, P554, DOI 10.1016/0006-291X(91)91225-2
   CHEN D, 1992, J FISH DIS, V15, P295, DOI 10.1111/j.1365-2761.1992.tb00667.x
   Cheung NKV, 2002, CANCER IMMUNOL IMMUN, V51, P557, DOI 10.1007/s00262-002-0321-3
   Cheung NKV, 2002, CLIN CANCER RES, V8, P1217
   Chourasia MK, 2004, DRUG DELIV, V11, P129, DOI 10.1080/10717540490280778
   Coulter A, 2003, VACCINE, V21, P946, DOI 10.1016/S0264-410X(02)00545-5
   Dilraj A, 2000, LANCET, V355, P798, DOI 10.1016/S0140-6736(99)95140-1
   Dobashi T, 2005, LANGMUIR, V21, P2, DOI 10.1021/la047901w
   Dornish M, 2001, ANN NY ACAD SCI, V944, P388
   Dushkin MI, 1996, CELL BIOCHEM FUNCT, V14, P209, DOI 10.1002/cbf.685
   Engstad R. E., 1992, Fish & Shellfish Immunology, V2, P287, DOI 10.1016/S1050-4648(06)80033-1
   Fujiki K, 2000, FISH SHELLFISH IMMUN, V10, P229, DOI 10.1006/fsim.1999.0253
   Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787
   Gombotz WR, 1998, ADV DRUG DELIVER REV, V31, P267, DOI 10.1016/S0169-409X(97)00124-5
   Gong NL, 2004, P NATL ACAD SCI USA, V101, P6490, DOI 10.1073/pnas.0308684101
   Gorkovenko A, 1997, CAN J MICROBIOL, V43, P384, DOI 10.1139/m97-053
   Gorkovenko A, 1999, CARBOHYD POLYM, V39, P79, DOI 10.1016/S0144-8617(98)00156-8
   GORKOVENKO A, 1995, POLYM MAT SCI ENG, V72, P92
   GUTNICK DL, 1987, EXOPOLYSACCHARIDE BI, V25, P211
   Hahn PY, 2003, J BIOL CHEM, V278, P2043, DOI 10.1074/jbc.M209715200
   Haupt S, 2002, CRIT REV THER DRUG, V19, P499
   Havlik I, 2005, T ROY SOC TROP MED H, V99, P333, DOI 10.1016/j.trstmh.2004.05.005
   HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990
   Hong F, 2003, CANCER RES, V63, P9023
   Igarashi I, 1998, EXP PARASITOL, V90, P290, DOI 10.1006/expr.1998.4331
   Isaka M, 2003, VACCINE, V21, P1165, DOI 10.1016/S0264-410X(02)00516-9
   Ishibashi K, 2005, FEMS IMMUNOL MED MIC, V44, P99, DOI 10.1016/j.femsim.2004.12.012
   Ishibashi K, 2001, BIOSCI BIOTECH BIOCH, V65, P1993, DOI 10.1271/bbb.65.1993
   JENEY G, 1993, AQUACULTURE, V116, P315, DOI 10.1016/0044-8486(93)90416-V
   Jenkins DJA, 2002, AM J CLIN NUTR, V75, P834
   Johri AK, 2003, BIOCHEM ENG J, V16, P175, DOI 10.1016/S1369-703X(03)00034-2
   Johri AK, 2002, APPL MICROBIOL BIOT, V59, P217, DOI 10.1007/s00253-002-0994-8
   JORGENSEN JB, 1995, DEV COMP IMMUNOL, V19, P43, DOI 10.1016/0145-305X(94)00045-H
   Kiho T, 1998, BIOSCI BIOTECH BIOCH, V62, P570, DOI 10.1271/bbb.62.570
   LEAHY JG, 1993, J BACTERIOL, V175, P1838
   LEAHY JG, 1994, CAN J MICROBIOL, V40, P233, DOI 10.1139/m94-038
   Lee KB, 2001, ARCH PHARM RES, V24, P109, DOI 10.1007/BF02976477
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   Lehne G, 2006, CLIN EXP IMMUNOL, V143, P65, DOI 10.1111/j.1365-2249.2005.02962.x
   Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5
   Lerouge I, 2002, FEMS MICROBIOL REV, V26, P17, DOI 10.1111/j.1574-6976.2002.tb00597.x
   MATSUYAMA H, 1992, AQUACULTURE, V101, P197, DOI 10.1016/0044-8486(92)90023-E
   Motoi Masuro, 2004, International Journal of Medicinal Mushrooms, V6, P41, DOI 10.1615/IntJMedMushr.v6.i1.40
   Na K, 2000, J CONTROL RELEASE, V69, P225, DOI 10.1016/S0168-3659(00)00256-X
   Naito T, 2001, J ACQ IMMUN DEF SYND, V26, P512
   NISHIMURA K, 1986, J BIOMED MATER RES, V20, P1359, DOI 10.1002/jbm.820200910
   NISHIMURA K, 1986, VACCINE, V4, P151, DOI 10.1016/0264-410X(86)90002-2
   NISHIMURA K, 1987, VACCINE, V5, P136, DOI 10.1016/0264-410X(87)90061-2
   OKAZAKI M, 1995, BIOL PHARM BULL, V18, P1320
   Panilaitis B, 2002, CLIN DIAGN LAB IMMUN, V9, P1240, DOI 10.1128/CDLI.9.6.1240-1247.2002
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   Rice PJ, 2002, J LEUKOCYTE BIOL, V72, P140
   ROBERTSEN B, 1990, J FISH DIS, V13, P391, DOI 10.1111/j.1365-2761.1990.tb00798.x
   Ross GD, 1999, IMMUNOPHARMACOLOGY, V42, P61, DOI 10.1016/S0162-3109(99)00013-2
   SAEED MO, 1986, DIS AQUAT ORGAN, V2, P21, DOI 10.3354/dao002021
   Sepulveda-Amor J, 2002, VACCINE, V20, P2790, DOI 10.1016/S0264-410X(02)00179-2
   Shibata Y, 1997, INFECT IMMUN, V65, P1734
   Shimizu J, 2002, NUTR RES, V22, P867, DOI 10.1016/S0271-5317(02)00388-3
   Sier CFM, 2004, INT J CANCER, V109, P900, DOI 10.1002/ijc.20029
   Sinha VR, 2003, J CONTROL RELEASE, V90, P261, DOI 10.1016/S0168-3659(03)00194-9
   SIWICKI AK, 1994, VET IMMUNOL IMMUNOP, V41, P125, DOI 10.1016/0165-2427(94)90062-0
   SOLEM ST, 1995, FISH SHELLFISH IMMUN, V5, P475, DOI 10.1016/S1050-4648(95)80049-2
   STORER JB, 1966, J GERONTOL, V21, P404, DOI 10.1093/geronj/21.3.404
   Suda M, 1996, FEMS IMMUNOL MED MIC, V15, P93, DOI 10.1016/0928-8244(96)00046-6
   SUTMULLER RPM, 2006, IN PRESS TRENDS IMMU
   Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003
   Taylor PR, 2002, J IMMUNOL, V169, P3876, DOI 10.4049/jimmunol.169.7.3876
   Thornton BP, 1996, J IMMUNOL, V156, P1235
   Torosantucci A, 2005, J EXP MED, V202, P597, DOI 10.1084/jem.20050749
   Tzianabos AO, 2000, CLIN MICROBIOL REV, V13, P523, DOI 10.1128/CMR.13.4.523-533.2000
   Usui S, 1999, BIOL PHARM BULL, V22, P353
   van Burik JAH, 2001, ANNU REV MICROBIOL, V55, P743, DOI 10.1146/annurev.micro.55.1.743
   Vereschagin EI, 1998, SHOCK, V9, P193, DOI 10.1097/00024382-199803000-00006
   Vetvicka V, 2002, JANA, V5, P1
   Wakshull E, 1999, IMMUNOPHARMACOLOGY, V41, P89, DOI 10.1016/S0162-3109(98)00059-9
   Willment JA, 2001, J BIOL CHEM, V276, P43818, DOI 10.1074/jbc.M107715200
   Wursch P, 1997, DIABETES CARE, V20, P1774, DOI 10.2337/diacare.20.11.1774
   Xia Y, 1999, J IMMUNOL, V162, P7285
   Xiao ZG, 2004, VET IMMUNOL IMMUNOP, V102, P315, DOI 10.1016/j.vetimm.2004.09.013
   YANO T, 1991, J FISH DIS, V14, P577, DOI 10.1111/j.1365-2761.1991.tb00613.x
   YOSHIDA T, 1995, J FISH DIS, V18, P195, DOI 10.1111/j.1365-2761.1995.tb00278.x
   YOSHIDA T, 1995, CARBOHYD RES, V276, P425, DOI 10.1016/0008-6215(95)00186-W
   Young SH, 2001, J BIOL CHEM, V276, P20781, DOI 10.1074/jbc.M101111200
   Yun CH, 2003, FEMS IMMUNOL MED MIC, V35, P67, DOI 10.1016/S0928-8244(02)00460-1
   Zhang JW, 1997, INT J BIOL MACROMOL, V20, P9, DOI 10.1016/S0141-8130(97)01147-1
   Zhang MX, 2001, INFECT IMMUN, V69, P7559, DOI 10.1128/IAI.69.12.7559-7564.2001
   Zimmerman JW, 1998, J BIOL CHEM, V273, P22014, DOI 10.1074/jbc.273.34.22014
NR 96
TC 24
Z9 24
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1543-8384
J9 MOL PHARMACEUT
JI Mol. Pharm.
PD JAN-FEB
PY 2007
VL 4
IS 1
BP 33
EP 46
DI 10.1021/mp060100x
PG 14
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 178TA
UT WOS:000247241800004
PM 17274664
DA 2018-10-19
ER

PT J
AU Worth, AJ
   Thompson, KG
   Owen, MC
   Mucalo, MR
   Firth, EC
AF Worth, A. J.
   Thompson, K. G.
   Owen, M. C.
   Mucalo, M. R.
   Firth, E. C.
TI Combined xeno/auto-grafting of a benign osteolytic lesion in a dog,
   using a novel bovine cancellous bone biomaterial
SO NEW ZEALAND VETERINARY JOURNAL
LA English
DT Article
DE bovine cancellous bone; xenograft
ID ANIMAL-DERIVED BONE; BIOMEDICAL APPLICATIONS; YIELD MATERIALS; CYST;
   AUGMENTATION; IMPLANTS
AB CASE HISTORY: A 4-year-old female Labrador Retriever was diagnosed with an osteolytic lesion of the right distal radius.
   CLINICAL FINDINGS: Radiographs indicated a well-circumscribed radiolucent area 18 x 15 x 8 mm, centred on the distal radial physeal scar.
   DIAGNOSIS: Histopathology, performed via Jamshidi needle biopsy and following surgical curettage, was inconclusive but suggested either an aneurysmal bone cyst or fibrous dysplasia.
   CLINICAL RELEVANCE: A novel processed cancellous bovine bone xenograft was used in conjunction with autogenous cancellous bone (at a ratio of approximately 4: 1) to fill the curetted defect. There were no observed complications associated with the use of this new biomaterial. Osteointegration of the bone graft was followed using conventional radiographs and peripheral quantitative computed tomography (pQCT) for 10 months post-operatively. Radiographically, the osteolytic lesion modelled to resemble metaphyseal trabeculation. The cross-sectional area and the average bone density of the grafted lesion determined using pQCT data increased over time, suggesting healthy osteoconduction and native bone production.
C1 Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand.
   Univ Waikato, Dept Chem, Hamilton, New Zealand.
RP Worth, AJ (reprint author), Massey Univ, Inst Vet Anim & Biomed Sci, Private Bag 11222, Palmerston North, New Zealand.
EM a.j.worth@massey.ac.nz
RI Mucalo, Michael/E-5263-2013
OI Mucalo, Michael/0000-0002-7655-9885
CR Anderson LA, 2000, J MATER SCI-MATER M, V11, P743
   ANDERSON LA, 2001, J MATER SCI-MATER M, V12, P371
   Artzi Z, 2004, INT J ORAL MAX IMPL, V19, P357
   Barnhart MD, 2002, VET SURG, V31, P519, DOI 10.1053/jvet.2002.36014
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   Dowdle SM, 2003, VET COMP ORTHOPAED, V16, P116
   Grace ND, 2003, NEW ZEAL VET J, V51, P165, DOI 10.1080/00480169.2003.36359
   Halliwell W.H., 1993, DIS MECH SMALL ANIMA, P933
   Hallman M, 2001, Clin Implant Dent Relat Res, V3, P87, DOI 10.1111/j.1708-8208.2001.tb00236.x
   Hallman M, 2001, CLIN ORAL IMPLAN RES, V12, P135, DOI 10.1034/j.1600-0501.2001.012002135.x
   Johnson GS, 2000, J MATER SCI-MATER M, V11, P427, DOI 10.1023/A:1008987908917
   KERWIN SC, 1991, COMP CONT EDUC PRACT, V13, P1558
   Kraus KH, 2006, VET SURG, V35, P232, DOI 10.1111/j.1532-950X.2006.00142.x
   Ladd A L, 1999, J Am Acad Orthop Surg, V7, P279
   Millis DA, 2003, TXB SMALL ANIMAL SUR, P1875
   OHYAMA T, 2004, NEUROLOGIA MEDICO CH, V44, P134
   Pemell RT, 1992, J AM VETERINARY MED, V201, P1897
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   SCHRADER SC, 1983, J AM VET MED ASSOC, V182, P490
   SLOWICK FA, 1968, J BONE JOINT SURG AM, VA 50, P1142, DOI 10.2106/00004623-196850060-00005
   Worth A, 2005, CLIN ORAL IMPLAN RES, V16, P379, DOI 10.1111/j.1600-0501.2005.01113.x
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   2006, OFFICIAL ANIMAL HLTH
NR 23
TC 10
Z9 10
U1 0
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0048-0169
EI 1176-0710
J9 NEW ZEAL VET J
JI N. Z. Vet. J.
PY 2007
VL 55
IS 3
BP 143
EP 148
DI 10.1080/00480169.2007.36758
PG 6
WC Veterinary Sciences
SC Veterinary Sciences
GA 226GE
UT WOS:000250575100009
PM 17534418
DA 2018-10-19
ER

PT S
AU Gomes, ASL
   Falcao, EL
   de Araujo, CB
   Rativa, D
   de Araujo, RE
AF Gomes, Anderson S. L.
   Falcao Filho, Edilson L.
   de Araujo, Cid B.
   Rativa, Diego
   de Araujo, Renato. E.
BE Powers, PE
TI Novel high sensitivity thermal managed eclipse Z-scan technique
SO NONLINEAR FREQUENCY GENERATION AND CONVERSION: MATERIALS, DEVICES, AND
   APPLICATIONS VI
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Nonlinear Frequency Generation and Conversion - Materials,
   Devices, and Applications VI
CY JAN 23-24, 2007
CL San Jose, CA
DE nonlinear optics; thermal management; Z-scan
ID HIGH-REPETITION-RATE; RESOLVED Z-SCAN; SINGLE-BEAM; OPTICAL
   NONLINEARITIES; RATE LASERS; ABSORPTION; REFRACTION
AB The field of Nonlinear Optics has provided many techniques to characterize photonic materials. The Z-scan method is a well estabileshed technique that exploits front wave distortions of the light beam to determine the nonlinear properties of optical materials. Several variations of the methods have been developed, as the eclipse Z-scan that can provide up to two orders of magnitude higher sensitivity than the original Z-scan set-up. We report a new variation of the Z-scan method to characterize the third-order optical nonlinearity of photonic materials. By exploiting the combination of the eclipse Z-scan with thermal nonlinearity management, we demonstrate an improvement in sensitivity and flexibility of the method to simultaneously characterize the thermal and nonthermal nonlinearity of optical materials. The method is demonstrated by measuring the nonlinear refractive index in CS2, SiO2 and H2O as standard materials, and also of a biomaterial, the amino acid Tryptophan in water solution, using the same experimental set up based on a femtosecond Ti-saphire laser operating at 76MHz repetition rate.
C1 [Gomes, Anderson S. L.; Falcao Filho, Edilson L.; de Araujo, Cid B.] Univ Fed Pernambuco, Dept Phys, BR-50000 Recife, PE, Brazil.
   [Rativa, Diego; de Araujo, Renato. E.] Univ Fed Pernambuco, Dept Elect & Syst, Recife, PE, Brazil.
RP Gomes, ASL (reprint author), Univ Fed Pernambuco, Dept Phys, BR-50000 Recife, PE, Brazil.
EM anderson@df.ufpe.br
RI de Araujo, Renato/G-8540-2014; de Araujo, Cid/A-5565-2009; Falcao-Filho,
   Edilson/K-6851-2013
OI de Araujo, Renato/0000-0003-2026-070X; de Araujo,
   Cid/0000-0003-1205-9467; Falcao-Filho, Edilson/0000-0003-0600-4523
FU CNPq; CAPES; The Nanofoton Network; Millenium Institute of Nonlinear
   Optics, Photonics and Biophotonics, as part of the MCT/CNPq Millenium
   Institute program
FX The authors wish to thank the Brazilian Agencies CNPq and CAPES for
   financial support to this work, which was also carried out under support
   of the The Nanofoton Network and Millenium Institute of Nonlinear
   Optics, Photonics and Biophotonics, as part of the MCT/CNPq Millenium
   Institute program.
CR CASTILLO J, 1994, OPT LETT, V19, P171, DOI 10.1364/OL.19.000171
   DESALVO R, 1993, OPT LETT, V18, P194, DOI 10.1364/OL.18.000194
   Falconieri M, 1999, APPL PHYS B-LASERS O, V69, P133, DOI 10.1007/s003400050785
   Falconieri M, 1999, J OPT A-PURE APPL OP, V1, P662, DOI 10.1088/1464-4258/1/6/302
   Gnoli A, 2005, OPT EXPRESS, V13, P7976, DOI 10.1364/OPEX.13.007976
   MA H, 1991, APPL PHYS LETT, V59, P2666, DOI 10.1063/1.105933
   OLIVEIRA LC, 1994, APPL PHYS LETT, V65, P2121, DOI 10.1063/1.112809
   PETROV DV, 1994, APPL PHYS LETT, V65, P1067, DOI 10.1063/1.112175
   Rodrigues JJ, 2002, OPT MATER, V20, P153, DOI 10.1016/S0925-3467(02)00062-9
   SHEIKBAHAE M, 1990, IEEE J QUANTUM ELECT, V26, P760, DOI 10.1109/3.53394
   SHEIKBAHAE M, 1992, OPT LETT, V17, P260
   Tai SP, 2006, OPT EXPRESS, V14, P6178, DOI 10.1364/OE.14.006178
   Taylor AJ, 1996, OPT LETT, V21, P1812, DOI 10.1364/OL.21.001812
   WANG J, 1994, J OPT SOC AM B, V11, P1009, DOI 10.1364/JOSAB.11.001009
   XIA T, 1994, OPT LETT, V19, P317, DOI 10.1364/OL.19.000317
NR 15
TC 0
Z9 0
U1 0
U2 3
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 978-0-8194-6568-9
J9 PROC SPIE
PY 2007
VL 6455
AR 64550Z
DI 10.1117/12.700348
PG 7
WC Materials Science, Multidisciplinary; Materials Science,
   Characterization & Testing; Optics
SC Materials Science; Optics
GA BGA80
UT WOS:000245827000028
DA 2018-10-19
ER

PT S
AU Ishii, K
   Ma, Z
   Ninomiya, Y
   Takegoshi, M
   Kushibiki, T
   Yamamoto, M
   Hinds, M
   Tabata, Y
   Wang, RKK
   Awazu, K
AF Ishii, Katsunori
   Ma, Zhenhe
   Ninomiya, Yoshihisa
   Takegoshi, Minori
   Kushibiki, Toshihiro
   Yamamoto, Masaya
   Hinds, Monica
   Tabata, Yasuhiko
   Wang, Ruikang K.
   Awazu, Kunio
BE Kirkpatrick, SJ
   Wang, RK
TI Control of guided hard tissue regeneration using phosphorylated gelatin
   and OCT imaging of calcification
SO OPTICS IN TISSUE ENGINEERING AND REGENERATIVE MEDICINE
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Optics in Tissue Engineering and Regenerative Medicine
CY JAN 21-23, 2007
CL San Jose, CA
DE phosphorylated gelatin; calcification; Fourier transform infrared
   spectroscopy (FT-IR); Simulate Body Fluid (SBF) soaking; Spectral Domain
   Optical Coherence Tomography (SD-OCT)
ID OPTICAL COHERENCE TOMOGRAPHY; IN-VITRO; PHOSPHATE; HYDROGELS; POLYMERS;
   CAPACITY; GROWTH
AB Tendon and ligament are the transition tissues from a hard tissue to a soft tissue. The regenerative medicine of tendons needs reasonable biomaterials to regenerate precisely from the view point of composition and adhesion properties. In regenerative medicine of hard tissues (e.g. bone, tooth, tendon, ligament), it has been reported that calcifications are influenced by phosphorylated proteins (phosphate groups) and the biomaterial possessing phosphate groups promote or inhibit the formation of HAP. We have studied to develop and evaluate the phosphorylated soft biomaterials, which is possible to control a calcification by the introduction ratio of phosphate groups, as biomaterials for tendon regeneration. In addition, we have studied measurement technologies. In the present study, we studied a FT-IR analysis of gelatins with different introduction ratio of phosphate groups, an evaluation of calcifications by the difference of introduction ratio of phosphate groups, and a fundamental survey on OCT imaging for calcifications of a gelatin and a phosphorylated gelatin. We use phosphorylated gelatins with different introduction ratios of phosphate group linked by ester bonds. The introduction ratios are measured by the Fourier transform infrared spectroscopy (FT-IR) calibrated by a molybdenum blue method. Phosphorylated gelatin sheets were calcified using Simulate Body Fluid (SBF) soaking process and alternative soaking process. These gelatin sheets with different calcification conditions were measured using Spectral Domain Optical Coherence Tomography (SD-OCT) systems with 843mn centered wavelength Super Luminescent Diode (SLD). As a result, we demonstrated that it was possible to measure the calcification on/in the gelatin sheets and sponges and phosphorylated using OCT. The main mechanism is the strong back scattering and the high scattering of deposited calcium particles.
C1 [Ishii, Katsunori; Ninomiya, Yoshihisa; Kushibiki, Toshihiro; Awazu, Kunio] Osaka Univ, Grad Sch Engn, Div Sustainable Energy & Environm Engn, Osaka, Osaka, Japan.
   [Takegoshi, Minori; Yamamoto, Masaya] Oregon Hlth & Sci Univ, OGI Sch Sci & Engn, Dept Biomed Engn, Oregon, OR USA.
   [Tabata, Yasuhiko] Kyoto Univ, Inst Frontier Med Sci, Dept Biomat Field Tissue Engn, Kyoto 6068501, Japan.
   [Takegoshi, Minori; Yamamoto, Masaya; Tabata, Yasuhiko] PRESTO, Japan Sci & Technol Agcy, Saitama, Japan.
RP Ishii, K (reprint author), Osaka Univ, Grad Sch Engn, Div Sustainable Energy & Environm Engn, Osaka, Osaka, Japan.
RI Awazu, Koichi/M-8133-2018
OI Awazu, Koichi/0000-0002-1993-1708
CR Chang S, 2006, CALCIFIED TISSUE INT, V78, P55, DOI 10.1007/s00223-005-0118-4
   Chirila TV, 2007, ACTA BIOMATER, V3, P95, DOI 10.1016/j.actbio.2006.07.011
   Grassmann O, 2004, BIOMATERIALS, V25, P277, DOI 10.1016/S0142-9612(03)00526-X
   HERMANSON GT, BIO CONJUGATE TECHNI
   Miyazaki T, 2003, J MATER SCI-MATER M, V14, P569, DOI 10.1023/A:1024000821368
   OHTSUKI C, 1991, J BIOMED MATER RES, V25, P1363, DOI 10.1002/jbm.820251105
   Saito T, 1997, BONE, V21, P305, DOI 10.1016/S8756-3282(97)00149-X
   Smetana K, 1996, BIOMATERIALS, V17, P1563, DOI 10.1016/0142-9612(95)00345-2
   Stancu IC, 2004, BIOMATERIALS, V25, P205, DOI 10.1016/S0142-9612(03)00485-X
   Taguchi T, 1998, CHEM LETT, P711, DOI 10.1246/cl.1998.711
   Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046
   TANAHASHI M, 1994, J AM CERAM SOC, V77, P2805, DOI 10.1111/j.1151-2916.1994.tb04508.x
   Tomlins PH, 2005, J PHYS D APPL PHYS, V38, P2519, DOI 10.1088/0022-3727/38/15/002
   Yang Y, 2005, J PHYS D APPL PHYS, V38, P2590, DOI 10.1088/0022-3727/38/15/009
   Yokogawa Y, 1997, J MATER SCI-MATER M, V8, P407, DOI 10.1023/A:1018549404092
   Yun SH, 2004, OPT EXPRESS, V12, P2977, DOI 10.1364/OPEX.12.002977
NR 16
TC 1
Z9 1
U1 0
U2 0
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-6552-8
J9 PROC SPIE
PY 2007
VL 6439
AR 64390D
DI 10.1117/12.701485
PG 10
WC Engineering, Biomedical; Optics
SC Engineering; Optics
GA BGF73
UT WOS:000246493100006
DA 2018-10-19
ER

PT J
AU Blouin, S
   Gallois, Y
   Moreau, MF
   Basle, MF
   Chappard, D
AF Blouin, S.
   Gallois, Y.
   Moreau, M. F.
   Basle, M. F.
   Chappard, D.
TI Disuse and orchidectomy have additional effects on bone loss in the aged
   male rat
SO OSTEOPOROSIS INTERNATIONAL
LA English
DT Article
DE botulinum toxin; castration; disuse; microCT; osteoporosis; TRAcP
ID ACID-PHOSPHATASE 5B; ANDROGEN DEFICIENCY; PHYSICAL-ACTIVITY; MINERAL
   DENSITY; OSTEOPOROSIS; MICROARCHITECTURE; MEN; SERUM; MODEL; METABOLISM
AB Introduction A severely osteopenic rat model was obtained by combining orchidectomy (ORX) and disuse (due to local paralysis induced by botulinum toxin [BTX] in the quadriceps muscle).
   Methods Forty-two aged male rats (5-6 months old) were randomized into three groups: 18 were SHAM operated; 6 were ORX; and 18 were ORX and BTX injected in the right hindlimb. One, two, and three months after surgery, bone mass (BV/TV) and microarchitectural parameters (Tb.Th, Tb.N, Tb.Sp, Tb.Pf, and structure model index [SMI]) were measured by microcomputed tomography (microCT) on the primary and secondary spongiosa of the femur. Osteoid parameters (OS/BS, O.Th), the number of osteoclasts (Nb.Oc), and the mineral apposition rate (Ct.MAR, Cn.MAR) were measured by histology. The serum tartrate-resistant acid phosphatase (TRAcP) 5b activity was measured by immunoassay.
   Results ORX induced a decrease of BV/TV, Tb.N and an increase of Tb.Sp, Tb.Pf, and SMI on both primary and secondary spongiosa. ORX and BTX had cumulative effects on bone loss, since differences were maximized on the right femur. The decrease in BV/TV reached -65%. Osteoid parameters and mineral apposition rate increased during the time course of the study. A peak of serum TRAcP was found at 7 days post-ORX. TRAcP levels reached the highest values in the ORX-BTX groups and the effect lasted longer than in the group with ORX alone. The association of ORX-BTX induced a greater bone resorption, due to the removal of complete trabeculae, compared to ORX alone.
   Conclusion This model induced a severe and rapid bone loss and can be used to explore pharmacological- and biomaterial-based countermeasures.
C1 Fac Med, INSERM, EMI 0335, LHEA, F-49045 Angers, France.
   Fac Med, Biochim Lab, F-49045 Angers, France.
RP Chappard, D (reprint author), Fac Med, INSERM, EMI 0335, LHEA, F-49045 Angers, France.
EM stephane.blouin@etud.univ-angers.fr; daniel.chappard@univ-angers.fr
OI Blouin, Stephane/0000-0001-6575-8443
CR Alatalo SL, 2003, J BONE MINER RES, V18, P134, DOI 10.1359/jbmr.2003.18.1.134
   Audran M, 2001, CALCIFIED TISSUE INT, V69, P214, DOI 10.1007/s00223-001-1058-2
   Blouin S, 2006, J BIOMED MATER RES A, V78A, P570, DOI 10.1002/jbm.a.30721
   Boonen S, 1997, J BONE MINER RES, V12, P2119, DOI 10.1359/jbmr.1997.12.12.2119
   CHAPPARD D, 1983, BASIC APPL HISTOCHEM, V27, P75
   Chappard D, 2001, BONE, V28, P72, DOI 10.1016/S8756-3282(00)00438-5
   CHAPPARD D, 1985, P 2 INT C SPAC PHYS
   De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022
   Erben RG, 2000, J BONE MINER RES, V15, P1085, DOI 10.1359/jbmr.2000.15.6.1085
   Gregg EW, 2000, J AM GERIATR SOC, V48, P883, DOI 10.1111/j.1532-5415.2000.tb06884.x
   HAHN M, 1992, BONE, V13, P327, DOI 10.1016/8756-3282(92)90078-B
   Halleen JM, 2002, CALCIFIED TISSUE INT, V71, P20, DOI 10.1007/s00223-001-2122-7
   Halleen JM, 2000, J BONE MINER RES, V15, P1337, DOI 10.1359/jbmr.2000.15.7.1337
   HODKINSON HM, 1967, J AM GERIATR SOC, V15, P59, DOI 10.1111/j.1532-5415.1967.tb05337.x
   IJIRI K, 1995, BONE, V17, pS213, DOI 10.1016/8756-3282(95)00294-N
   Iwamoto J, 2002, BONE, V30, P360, DOI 10.1016/S8756-3282(01)00687-1
   Iwamoto J, 2003, J BONE MINER RES, V18, P776, DOI 10.1359/jbmr.2003.18.4.776
   Jee W.S.S., 1999, Morphologie, V83, P25
   Jinnai H, 2002, BONE, V30, P191, DOI 10.1016/S8756-3282(01)00672-X
   Kaija H, 1999, J BONE MINER RES, V14, P424, DOI 10.1359/jbmr.1999.14.3.424
   KANNUS P, 1994, J BONE MINER RES, V9, P1729
   Li CY, 2005, BONE, V37, P287, DOI 10.1016/j.bone.2005.04.041
   LIN BY, 1994, BONE MINER, V25, P199, DOI 10.1016/S0169-6009(08)80239-5
   MINAIRE P, 1974, CALC TISS RES, V17, P57, DOI 10.1007/BF02547214
   Moreau M. F., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P209
   OKUMURA H, 1991, CELLS MATER S, V1, P125
   Orwoll ES, 2004, CALCIFIED TISSUE INT, V75, P114, DOI 10.1007/s00223-004-0288-5
   PANUSH RS, 1993, AM J MED, V95, P1, DOI 10.1016/0002-9343(93)90225-E
   Prior JC, 1996, CAN MED ASSOC J, V155, P940
   Surve VV, 2001, CALCIFIED TISSUE INT, V69, P274, DOI 10.1007/s002230020044
   THOMPSON DD, 1995, BONE, V17, pS125, DOI 10.1016/8756-3282(95)00285-L
   VAN PT, 1982, ANAT REC, V202, P445, DOI 10.1002/ar.1092020403
   VANDERSCHUEREN D, 1992, ENDOCRINOLOGY, V130, P2906, DOI 10.1210/en.130.5.2906
   VERHAS M, 1986, CALCIFIED TISSUE INT, V39, P74, DOI 10.1007/BF02553294
   Waarsing JH, 2004, BONE, V34, P163, DOI 10.1016/j.bone.2003.08.012
   Warner SE, 2006, BONE, V38, P257, DOI 10.1016/j.bone.2005.08.009
   WINK CS, 1980, CALCIFIED TISSUE INT, V32, P77, DOI 10.1007/BF02408524
NR 37
TC 27
Z9 33
U1 0
U2 2
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0937-941X
EI 1433-2965
J9 OSTEOPOROSIS INT
JI Osteoporosis Int.
PD JAN
PY 2007
VL 18
IS 1
BP 85
EP 92
DI 10.1007/s00198-006-0197-8
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 111PL
UT WOS:000242465400009
PM 17019521
DA 2018-10-19
ER

PT S
AU Prendergast, U
   Kudzma, S
   Sherlock, R
   O'Connell, C
   Glynn, T
AF Prendergast, Una
   Kudzma, Sylwester
   Sherlock, Richard
   O'Connell, Claire
   Glynn, Thomas
BE Arnold, CB
   Okada, T
   Meunier, M
   Holmes, AS
   Geohegan, DB
   Trager, F
   Dubowski, JJ
TI TEM investigation of Laser Induced Periodic Surface Structures on
   polymer surfaces
SO PHOTON PROCESSING IN MICROELECTRONICS AND PHOTONICS VI
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT Conference on Photon Processing in Microelectronics and Photonics VI
CY JAN 22-25, 2007
CL San Jose, CA
DE LIPSS; polymer; excimer laser; melt zone; TEM
ID POLYIMIDE SURFACE; POLARIZED LASER; MICROSTRUCTURE; RADIATION; ALIGNMENT
AB Laser Induced Periodic Surface Structures (LIPSS) may have numerous applications, ranging from biomaterial applications to LCDs, microelectronic fabrication and photonics. However, in order to control the development of these structures for their particular application, it is necessary to understand how they are generated.
   We report our work on investigating the melting that occurs during LIPSS formation. LIPSS were generated on three polymer surfaces - polyethylene terephthalate (PET), amorphous polycarbonate (APC) and oriented crystalline polycarbonate (OPC) - which were irradiated with a polarized ArF excimer laser (193 nm) beam with fluences between 3 and 5 mJ/cm(2).
   The structures were imaged using a Transmission Electron Microscope (TEM), which facilitated investigation of changes in the polymer structures and consequently the depth of the melt zone that accompanies LIPSS generation.
   We also present theoretical calculations of the temperature-depth profile due to the interaction of the low fluence 193 nm laser beam with the polymer surfaces and compare these calculations with our experimental results.
C1 [Prendergast, Una; Kudzma, Sylwester; Sherlock, Richard; O'Connell, Claire; Glynn, Thomas] Natl Univ Ireland, Natl Ctr Laser Applicat, Galway, Ireland.
RP Prendergast, U (reprint author), Natl Univ Ireland, Natl Ctr Laser Applicat, Galway, Ireland.
EM una.prendergast@nuigalway.ie
FU Enterprise Ireland [CFTD/2003/413]
FX This work has been supported by Enterprise Ireland grant CFTD/2003/413.
   The authors would like to thank Mr. Nicholas Donoghue for his assistance
   with sample sectioning and TEM investigation, and Dr. Hugh Byrne and Ms.
   Anne Shanahan of Dublin Institute of Technology for access to their
   Raman instrument and useful discussions on Raman spectroscopy.
CR ANTHONY TR, 1977, J APPL PHYS, V48, P3888, DOI 10.1063/1.324260
   BAUERLE D, 2000, LASER PROCESSING CHE, P671
   Behdani M, 2003, APPL PHYS LETT, V82, P2553, DOI 10.1063/1.1565703
   BOLLE M, 1993, J APPL PHYS, V73, P3516, DOI 10.1063/1.352957
   CRAWFORD RJ, 1987, PLAST ENG, P1
   Csete M, 2003, MAT SCI ENG C-BIO S, V23, P939, DOI 10.1016/j.msec.2003.09.091
   Csete M, 1998, APPL SURF SCI, V133, P5, DOI 10.1016/S0169-4332(98)00192-5
   Csete M, 2001, APPL PHYS A-MATER, V73, P521, DOI 10.1007/s003390100973
   DAVIS CR, 1995, CHEMTECH, V25, P44
   DYER PE, 1990, APPL PHYS LETT, V57, P765, DOI 10.1063/1.103414
   Fiorini C, 2000, SYNTHETIC MET, V115, P121, DOI 10.1016/S0379-6779(00)00332-5
   HIRAOKA H, 1994, APPL PHYS LETT, V64, P563, DOI 10.1063/1.111104
   Holme NCR, 1999, APPL PHYS LETT, V74, P519, DOI 10.1063/1.123173
   Lazare S, 1995, NUCL INSTRUM METH B, V105, P159, DOI 10.1016/0168-583X(95)00630-3
   LAZARE S, 1993, J APPL PHYS, V74, P4953, DOI 10.1063/1.354333
   Li M, 2002, CHINESE PHYS LETT, V19, P255, DOI 10.1088/0256-307X/19/2/336
   Lu QH, 2000, APPL PHYS LETT, V76, P1237, DOI 10.1063/1.125995
   Lu XM, 2003, J POLYM SCI POL PHYS, V41, P1273, DOI 10.1002/polb.10461
   OSSWALD TA, 2003, MAT SCI POLYM ENG, P591
   Safonov AN, 2001, SYNTHETIC MET, V116, P145, DOI 10.1016/S0379-6779(00)00474-4
   SENDOVA M, 1993, JPN J APPL PHYS 1, V32, P6182, DOI 10.1143/JJAP.32.6182
   Simon P, 1997, APPL SURF SCI, V109, P25, DOI 10.1016/S0169-4332(96)00615-0
   TEMPLE PA, 1981, IEEE J QUANTUM ELECT, V17, P2067, DOI 10.1109/JQE.1981.1070638
   Tsutsumi N, 2004, APPL PHYS LETT, V85, P4582, DOI 10.1063/1.1823013
   Wong WYY, 1997, APPL PHYS A-MATER, V65, P519, DOI 10.1007/s003390050618
   Yip J, 2003, MATER RES INNOV, V7, P302, DOI 10.1007/s10019-003-0268-9
NR 26
TC 1
Z9 1
U1 0
U2 8
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
EI 1996-756X
BN 978-0-8194-6571-9
J9 PROC SPIE
PY 2007
VL 6458
AR 64581V
DI 10.1117/12.699999
PG 10
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Optics
SC Engineering; Science & Technology - Other Topics; Optics
GA BGC49
UT WOS:000246026600041
DA 2018-10-19
ER

PT J
AU Lynch, I
AF Lynch, Iseult
TI Are there generic mechanisms governing interactions between
   nanoparticles and cells? Epitope mapping the outer layer of the
   protein-material interface
SO PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS
LA English
DT Article
DE protein adsorption; biomaterial-cell interaction; epitope mapping;
   nanoparticles; surface protein layer
ID RECEPTOR-MEDIATED ENDOCYTOSIS; SCANNING FORCE MICROSCOPY; WALL CARBON
   NANOTUBES; CONFORMATIONAL-CHANGES; PULMONARY TOXICITY;
   SURFACE-CHEMISTRY; ADSORPTION; ADHESION; DELIVERY; MODEL
AB In this paper we discuss the possibility of a general paradigm for cell-biomaterial and cell-nanoparticle interactions. The basis of the paradigm is that the nature of the biomaterial or nanoparticle surface is not the important parameter, but rather the nature of the outermost layer of adsorbed proteins as well as long-lived misfolded proteins shed from the surfaces. If the adsorbed protein is irreversibly adsorbed onto the surface it may be sufficiently disrupted so that a variety of peptide units (here termed "cryptic epitopes") not usually expressed in nature at the surface of the protein become exposed. Similarly, where there is a slow exchange time with the surface, surface-induced perturbations may lead to long-lived misfolded proteins being shed from the surface and continuing to express altered surface peptide sequences. In cases where the proteins have lost most of their tertiary structure, anomalous peptide sequences and geometries that are not displayed at the surface by the native protein may in fact be presented after surface adsorption of a protein. Such anomalous surface expressions could contain novel epitopes that trigger various signalling pathways or even diseases. Thus, future approaches to understanding cell-biomaterial and cell-nanoparticle interactions should focus on characterising the outer layer of the adsorbed proteins, or "epitope mapping" as well as examining the possibility of formation of essentially "new" proteins as a result of desorption of conformationally or geometrically altered proteins. (c) 2006 Published by Elsevier B.V.
C1 Univ Coll Dublin, Dept Chem, Irish Ctr Colloid Sci & Biomat, Dublin 4, Ireland.
   Lund Univ, S-22100 Lund, Sweden.
RP Lynch, I (reprint author), Univ Coll Dublin, Sch Chem & Chem Biol, Irish Ctr Colloid Sci & Biomat, Dublin 4, Ireland.
EM Iseult@fiachra.ucd.ie
RI Lynch, Iseult/I-3915-2014
OI Lynch, Iseult/0000-0003-4250-4584
CR Ahmad A, 2005, J GENE MED, V7, P739, DOI 10.1002/jgm.717
   Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   Allen LT, 2003, P NATL ACAD SCI USA, V100, P6331, DOI 10.1073/pnas.1031426100
   Andersson H, 2001, J APPL ELECTROCHEM, V31, P1, DOI 10.1023/A:1004105622558
   ANDRADE JD, 1986, ADV POLYM SCI, V79, P1
   Aoyama Y, 2003, J AM CHEM SOC, V125, P3455, DOI 10.1021/ja029608t
   Baugh L, 2004, J BIOMED MATER RES A, V69A, P525, DOI 10.1002/jbm.a.30026
   BENNETT MJ, 1994, P NATL ACAD SCI USA, V91, P3127, DOI 10.1073/pnas.91.8.3127
   Bhatia SN, 1999, FASEB J, V13, P1883
   Brewer SH, 2005, LANGMUIR, V21, P9303, DOI 10.1021/la050588t
   Byrne A, 1998, NUOVO CIMENTO D, V20, P2289
   Ciesielski MJ, 2005, CANCER IMMUNOL IMMUN, V54, P107, DOI 10.1007/s00262-004-0576-y
   Collier T O, 1997, Biomed Sci Instrum, V33, P178
   Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334
   Desai MP, 1997, PHARMACEUT RES, V14, P1568, DOI 10.1023/A:1012126301290
   Dittmer WU, 2005, SMALL, V1, P709, DOI 10.1002/smll.200500074
   ELY KR, 1995, PROTEIN ENG, V8, P823, DOI 10.1093/protein/8.8.823
   Engel MFM, 2004, P NATL ACAD SCI USA, V101, P11316, DOI 10.1073/pnas.0401603101
   Engel MFM, 2003, LANGMUIR, V19, P2929, DOI 10.1021/la026767h
   *EUR COMM, 2005, NAN PREL RISK AN BAS, P143
   Faivre V, 2001, FEBS LETT, V492, P14, DOI 10.1016/S0014-5793(01)02218-9
   Fragneto G, 2000, PHYS CHEM CHEM PHYS, V2, P5214, DOI 10.1039/b004221h
   Gao HJ, 2005, P NATL ACAD SCI USA, V102, P9469, DOI 10.1073/pnas.0503879102
   Garcia AJ, 2002, CRIT REV EUKAR GENE, V12, P151, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i2.50
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Hakansson M, 2002, CURR PROTEIN PEPT SC, V3, P629, DOI 10.2174/1389203023380459
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Heungoso S., 2003, BIOMATERIALS, V24, P4353
   Hubbell JA, 2003, CURR OPIN BIOTECH, V14, P551, DOI 10.1016/j.copbio.2003.09.004
   HYTON DM, 2005, J BIOMED MATER RES A, V73, P349
   JOHANSSON S, 1997, FRONT BIOSCI, V2, P126
   Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059
   Kechadi MT, 1998, NUOVO CIMENTO D, V20, P2383
   KONDO A, 1992, BIOTECHNOL BIOENG, V40, P889, DOI 10.1002/bit.260400804
   Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Larsericsdotter H, 2005, J COLLOID INTERF SCI, V289, P26, DOI 10.1016/j.jcis.2005.03.064
   Leffers KW, 2005, BIOL CHEM, V386, P569, DOI 10.1515/BC.2005.067
   LENK TJ, 1991, LANGMUIR, V7, P1755, DOI 10.1021/la00056a030
   Lundqvist M, 2005, BIOCHEMISTRY-US, V44, P10093, DOI 10.1021/bi0500067
   LYNCH I, 2006, SCI STKE, V327
   Mossman BT, 1998, AM J RESP CRIT CARE, V157, P1666, DOI 10.1164/ajrccm.157.5.9707141
   Nakai T, 2003, J AM CHEM SOC, V125, P8465, DOI 10.1021/ja035636f
   Nanoscience and Nanotechnologies, 2004, NAN NAN OPP UNC
   *NIOSH, NAN SIT
   Oberdorster E, 2004, ENVIRON HEALTH PERSP, V112, P1058, DOI 10.1289/ehp.7021
   Osaki F, 2004, J AM CHEM SOC, V126, P6520, DOI 10.1021/ja048792a
   Pantarotto D, 2004, ANGEW CHEM INT EDIT, V43, P5242, DOI 10.1002/anie.200460437
   Pantarotto D, 2004, CHEM COMMUN, P16, DOI 10.1039/b311254c
   Park JS, 2001, FASEB J, V15, P1625, DOI 10.1096/fj.00-0723fje
   PITT WG, 1988, J BIOMED MATER RES, V22, P359, DOI 10.1002/jbm.820220502
   Prabha S, 2002, INT J PHARM, V244, P105, DOI 10.1016/S0378-5173(02)00315-0
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   Rodeberg DA, 2005, CLIN CANCER RES, V11, P4545, DOI 10.1158/1078-0432.CCR-04-2235
   Sayes CM, 2004, NANO LETT, V4, P1881, DOI 10.1021/nl0489586
   Shah AK, 1999, BONE, V24, P499, DOI 10.1016/S8756-3282(99)00077-0
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   STUPP SI, 2004, J BIOMED MATER RES, V11, P237
   Ta TC, 2000, ANAL CHEM, V72, P2627, DOI 10.1021/ac991137e
   TABORELLI M, 1995, J BIOMED MATER RES, V29, P707, DOI 10.1002/jbm.820290606
   Tsuda Y, 2004, J BIOMED MATER RES A, V69A, P70, DOI 10.1002/jbm.a.20114
   Vreeland WN, 2002, CURR OPIN BIOTECH, V13, P87, DOI 10.1016/S0958-1669(02)00292-6
   Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945
   Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228
   Weber N, 2004, J BIOMED MATER RES A, V68A, P496, DOI 10.1002/jbm.a.20086
   Wilson K, 2004, J BIOMED MATER RES A, V69A, P686, DOI 10.1002/jbm.a.30042
   WONG AJ, 1987, P NATL ACAD SCI USA, V84, P6899, DOI 10.1073/pnas.84.19.6899
   Zerulla D, 2003, ELECTROCHIM ACTA, V48, P2943, DOI 10.1016/S0013-4686(03)00359-1
NR 71
TC 42
Z9 45
U1 1
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0378-4371
J9 PHYSICA A
JI Physica A
PD JAN 1
PY 2007
VL 373
BP 511
EP 520
DI 10.1016/j.physa.2006.06.008
PG 10
WC Physics, Multidisciplinary
SC Physics
GA 109NU
UT WOS:000242316000044
DA 2018-10-19
ER

PT J
AU Kim, YJ
   Uyama, H
AF Kim, Young-Jin
   Uyama, Hiroshi
TI Biocompatible hydrogel formation of gelatin from cold water fish via
   enzymatic networking
SO POLYMER JOURNAL
LA English
DT Article
DE Crosslinking; enzyme; gelatin; hydrogel; transglutaminase
ID CROSS-LINKING; PHYSICAL-PROPERTIES; POLY(AMINO ACID)S; TRANSGLUTAMINASE;
   MATRICES; RHEOLOGY
AB Biocompatible hydrogel formation of gelatin from cold water fish skin has been examined using enzyme catalyst. Due to the large number of functional groups in the side chain, gelatin readily undergoes chemical crosslinking, which is important for its possible use as biomaterial. In addition, transglutaminase (TGase) provides an alternative method for creating a gelatin gel and may offer interesting opportunities as injectable material for various applications. The aim of this study was to investigate the effect of the reaction conditions on theological and mechanical properties of the hydrogels in the enzymatic curing of gelatin from cold water fish skin. The theological measurements showed that TGase catalyzed the transformation of gelatin solutions into hydrogels, and the gel points were between 3.3 and 144 min depending on the concentration of gelatin and TGase. Furthermore, the buffer pH strongly affected the theological properties. Mechanical tests of the resulting hydrogels exhibited that the elastic modulus ranged from 21 to 292 kPa, which were influenced by the concentrations of gelatin and TGase. The theological and mechanical properties of the gelatin gels were closely related to the degree of the crosslinking.
C1 [Uyama, Hiroshi] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan.
   [Kim, Young-Jin] Catholic Univ Daegu, Dept Biomed Engn, Gyongsan 712702, Gyeongbuk, South Korea.
RP Uyama, H (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
EM uyama@chem.eng.osaka-u.ac.jp
CR Bailey JE, 1986, BIOCH ENG FUNDAMENTA
   Chen TH, 2003, BIOMATERIALS, V24, P2831, DOI 10.1016/S0142-9612(03)00096-6
   CLARK AH, 1987, ADV POLYM SCI, V83, P58
   Crescenzi V, 2002, BIOMACROMOLECULES, V3, P1384, DOI 10.1021/bm025657m
   DIGENIS GA, 1994, J PHARM SCI, V83, P915, DOI 10.1002/jps.2600830702
   Draye JP, 1998, BIOMATERIALS, V19, P99, DOI 10.1016/S0142-9612(97)00164-6
   Eissa AS, 2004, J AGR FOOD CHEM, V52, P4456, DOI 10.1021/jf0355304
   ESPOSITO E, 1995, BIOMATERIALS, V20, P2009
   Fuchsbauer HL, 1996, BIOMATERIALS, V17, P1481, DOI 10.1016/0142-9612(96)89772-9
   Gilsenan PM, 2000, FOOD HYDROCOLLOID, V14, P191, DOI 10.1016/S0268-005X(99)00050-8
   Gong JP, 2001, J AM CHEM SOC, V123, P5582, DOI 10.1021/ja003794q
   Kakugo A, 2002, ADV MATER, V14, P1124, DOI 10.1002/1521-4095(20020816)14:16<1124::AID-ADMA1124>3.0.CO;2-M
   Kim SH, 1999, J BIOMED MATER RES, V46, P160, DOI 10.1002/(SICI)1097-4636(199908)46:2<160::AID-JBM4>3.0.CO;2-P
   Kuijpers AJ, 2000, J BIOMAT SCI-POLYM E, V11, P225, DOI 10.1163/156856200743670
   Lee KY, 2000, MACROMOLECULES, V33, P97, DOI 10.1021/ma991286z
   Lee KY, 2001, CHEM REV, V101, P1869, DOI 10.1021/cr000108x
   MARTINSEN A, 1989, BIOTECHNOL BIOENG, V33, P79, DOI 10.1002/bit.260330111
   McDermott MK, 2004, BIOMACROMOLECULES, V5, P1270, DOI 10.1021/bm034529a
   Motoki M, 1998, TRENDS FOOD SCI TECH, V9, P204, DOI 10.1016/S0924-2244(98)00038-7
   Nielsen PM, 1995, FOOD BIOTECHNOL, V9, P119, DOI 10.1080/08905439509549889
   Otani Y, 1998, BIOMATERIALS, V19, P2091, DOI 10.1016/S0142-9612(98)00121-5
   PEPPAS NA, 1996, BIOMATERIALS SCI INT, P60
   PEZRON I, 1991, POLYMER, V32, P3201, DOI 10.1016/0032-3861(91)90143-7
   PISANO JJ, 1968, SCIENCE, V160, P892, DOI 10.1126/science.160.3830.892
   Ross P. I., 1987, ENCY POLYM SCI ENG, V7, P488
   ROSSMURPHY SB, 1992, POLYMER, V33, P2622, DOI 10.1016/0032-3861(92)91146-S
   SHALABY SW, 1994, BIOMEDICAL POLYM DES, P213
   Sheu MT, 2001, BIOMATERIALS, V22, P1713, DOI 10.1016/S0142-9612(00)00315-X
   SPEER DP, 1980, J BIOMED MATER RES, V14, P753, DOI 10.1002/jbm.820140607
   Swatschek D, 2002, EUR J PHARM BIOPHARM, V54, P125, DOI 10.1016/S0939-6411(02)00046-2
   Tachibana Y, 2003, CHEM LETT, V32, P374, DOI 10.1246/cl.2003.374
   Takeuchi Y, 2006, J POLYM SCI POL CHEM, V44, P671, DOI 10.1002/pola.21189
   Winter HH, 1997, ADV POLYM SCI, V134, P165
   Yoshimura K, 2000, J AGR FOOD CHEM, V48, P2023, DOI 10.1021/jf990887m
NR 34
TC 10
Z9 10
U1 0
U2 14
PU SOC POLYMER SCIENCE JAPAN
PI TOKYO
PA TSUKIJI DAISAN NAGAOKA BLDG, 2-4-2 TSUKIJI, CHUO-KU, TOKYO, 104, JAPAN
SN 0032-3896
J9 POLYM J
JI Polym. J.
PY 2007
VL 39
IS 10
BP 1040
EP 1046
DI 10.1295/polymj.PJ2007007
PG 7
WC Polymer Science
SC Polymer Science
GA 240OB
UT WOS:000251595800007
OA Bronze
DA 2018-10-19
ER

PT J
AU El-Ola, SMA
AF El-Ola, Samiha Mohamed Abo
TI New approach for imparting antimicrobial properties for polyamide and
   wool containing fabrics
SO POLYMER-PLASTICS TECHNOLOGY AND ENGINEERING
LA English
DT Article
DE biomaterial; doxymycin; durability; reusing; wool; wool blends
ID INFECTION; ANTIBIOTICS
AB Direct fiber polymer/antibiotic interaction is a promising means of providing infection resistance textile fabrics. Ionic interaction between cationic reactive groups (antibiotic) and carboxylic groups in wool, wool/polyamide, wool/polyester, and polyamide was used as a tool to develop desirable, durable antimicrobial fabrics.
   The finishing conditions such as pH, finishing temperature, and time were studied.
   The results revealed that pH of the finishing bath and the antibiotic concentration as well as finishing temperature were very critical parameters in affecting exhaustion of the antibiotic by the fabric along with the extent of ionic interactions. Sorption of doxymycin antibiotic follows the descending order: wool wool blends polyamide. Zone of inhibition of all treated fabrics is governed by the pH and follows the descending order: pH 6.5 pH9 pH 2.3.
   FTIR Spectroscopy confirmed the ionic interaction between wool 100%, wool/polyamide (50%/50%) and doxymycin, because of appearance of new bands at 1641 cm(-1) which attributed to NH2 deformation amide I and band at 1514 cm(-1) corresponding to amide II (in case of wool 100%). For wool/polyamide blend it is noticed that appearance of new bands at 1415 cm(-1) corresponding to C-N stretching (amide III band for CONH2, in addition to the appearance of new band at 927 cm(-1) which could be assignments for CO-NH in plane.
   Reusing of the treatment bath was tried and proved to be very effective approach to produce infection-resistant biomaterials for medical applications.
C1 Natl Res Ctr, Text Res Div, Cairo, Egypt.
RP El-Ola, SMA (reprint author), Natl Res Ctr, Text Res Div, Cairo, Egypt.
EM samiham_2000@yahoo.com
OI Abo El-Ola, Samiha/0000-0001-5612-7674
CR *AATCC TECHN MAN, TEST METH 124 1996 A
   AGGARWAL P, 2005, DEV INFECTION RESIST, P224
   Choi HM, 2004, TEXT RES J, V74, P333, DOI 10.1177/004051750407400409
   Choi HM, 2004, J APPL POLYM SCI, V92, P3343, DOI 10.1002/app.20332
   CHOPRA I, 1992, J ANTIMICROB CHEMOTH, V29, P245, DOI 10.1093/jac/29.3.245
   El Ola SMA, 2004, J BIOMAT SCI-POLYM E, V15, P1545
   El Ola SMA, 2004, POLYMER, V45, P3215, DOI 10.1016/j.polymer.2004.02.041
   ERICSSON HM, 1971, ACTA PATHHOLOGIC B S, V217
   GAGLIARDI DD, 1962, AM DYEST REP, V51, P49
   Ghiselli R, 2002, EUR J VASC ENDOVASC, V24, P230, DOI 10.1053/ejvs.2002.1713
   Kim YH, 2002, TEXT RES J, V72, P1052
   Lambert J. B., 1987, INTRO ORGANIC SPECTR
   Son YA, 2003, J APPL POLYM SCI, V90, P2194, DOI 10.1002/app.12876
   SUN G, 2001, DURABLE REGENERABLE, P243
   VANDENDAELE P, 2006, PUBLISHED MED TEXTIL, P177
   Vasanthan N, 2001, J POLYM SCI POL PHYS, V39, P536, DOI 10.1002/1099-0488(20010301)39:5<536::AID-POLB1027>3.0.CO;2-8
   YUAN C, 2001, AATCC REV        AUG, P35
NR 17
TC 8
Z9 8
U1 1
U2 8
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0360-2559
J9 POLYM-PLAST TECHNOL
JI Polym.-Plast. Technol. Eng.
PY 2007
VL 46
IS 9
BP 831
EP 839
DI 10.1080/03602550701278095
PG 9
WC Polymer Science
SC Polymer Science
GA 214GM
UT WOS:000249724100003
DA 2018-10-19
ER

PT J
AU Chiu, HT
   Chen, RL
   Wu, PY
   Chiang, TY
AF Chiu, Hsien-Tang
   Chen, Ray-Lun
   Wu, Pei-Yi
   Chiang, Tzong-Yiing
TI A study on the effects of the degree of deacetylation of chitosan films
   on physical and antibacterial properties
SO POLYMER-PLASTICS TECHNOLOGY AND ENGINEERING
LA English
DT Article
DE antibacterial; chitosan; degree of deacetylation; sterilization
ID METHYLPYRROLIDINONE CHITOSAN; CHITIN; MICROSPHERES; BIOMATERIAL;
   SURFACE; WATER
AB The principal aim of this research study is to discuss the influences and effects of the acetylation degree of chitosan on antibacterial properties, mechanism, and thermal properties. Various chitosan with different degrees of deacetylation (DD%) were dissolved in acetic acid solution to produce films. The basic structure of chitosan consists of different ratios of amine (-NH2) and acetic (R-HNCO-R). The discussion in this research paper also includes bacteriostasis, sterilization antibacterial capabilities, thermal manufacturing properties, and mechanisms.
C1 [Chiu, Hsien-Tang; Chen, Ray-Lun; Wu, Pei-Yi; Chiang, Tzong-Yiing] Natl Taiwan Univ Sci & Technol, Grad Sch Polymer Engn, Taipei, Taiwan.
RP Chiu, HT (reprint author), 43 Sec 4,Keelung Rd, Taipei 106, Taiwan.
EM hchiu@mail.ntust.edu.tw
CR Aiedeh K, 1997, J MICROENCAPSUL, V14, P567, DOI 10.3109/02652049709006810
   CHANDY T, 1990, BIOMATER ARTIF CELL, V18, P1, DOI 10.3109/10731199009117286
   CHANDY T, 1990, Q17, V18, P1
   Chang SJ, 1996, PLANT MOL BIOL, V31, P693, DOI 10.1007/BF00042242
   CLAIRE C, 2001, BIOMATERIALS, V22, P261
   DARMADJI P, 1994, MEAT SCI, V38, P243, DOI 10.1016/0309-1740(94)90114-7
   DESHPANDE MV, 1986, J SCI IND RES INDIA, V45, P273
   Giunchedi P, 1998, BIOMATERIALS, V19, P157, DOI 10.1016/S0142-9612(97)00181-6
   Gokoo C, 1993, Decubitus, V6, P42
   GRASEL TG, 1989, J BIOMED MATER RES, V23, P311, DOI 10.1002/jbm.820230304
   HERGENROTHER RW, 1992, J MATER SCI-MATER M, V3, P313, DOI 10.1007/BF00705361
   HIRANO S, 1985, J BIOMED MATER RES, V19, P413, DOI 10.1002/jbm.820190406
   HIRANO S, 1984, CHITIN CHITOSAN RELA, P77
   Huh MW, 2001, J APPL POLYM SCI, V81, P2769, DOI 10.1002/app.1723
   Hutmacher D, 1996, Int J Oral Maxillofac Implants, V11, P667
   Jumaa M, 1999, INT J PHARM, V183, P175, DOI 10.1016/S0378-5173(99)00086-1
   KENJI T, 1997, BIOMATERIALS, V18, P567
   Klokkevold PR, 1996, J PERIODONTOL, V67, P1170, DOI 10.1902/jop.1996.67.11.1170
   KNORR D, 1984, FOOD TECHNOL-CHICAGO, V38, P85
   Kratz G, 1998, SCAND J PLAST RECONS, V32, P381, DOI 10.1080/02844319850158462
   Kratz G, 1997, SCAND J PLAST RECONS, V31, P119, DOI 10.3109/02844319709085478
   Kuen YL, 1995, BIOMATERIALS, V16, P1211
   LANZA RP, 1995, TRANSPLANTATION, V59, P1377, DOI 10.1097/00007890-199505270-00003
   Mi FL, 2001, BIOMATERIALS, V22, P165, DOI 10.1016/S0142-9612(00)00167-8
   Milot C, 1998, J APPL POLYM SCI, V68, P571, DOI 10.1002/(SICI)1097-4628(19980425)68:4<571::AID-APP8>3.0.CO;2-J
   MIYAZAKI S, 1981, CHEM PHARM BULL, V29, P3067
   MUZZARELLI RAA, 1993, BIOMATERIALS, V14, P39, DOI 10.1016/0142-9612(93)90073-B
   PARK GB, 1978, BIOMATER ARTIF CELL, V6, P1
   QUEEN D, 1987, BURNS, V13, P218, DOI 10.1016/0305-4179(87)90170-7
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Rhoades J, 2000, APPL ENVIRON MICROB, V66, P80, DOI 10.1128/AEM.66.1.80-86.2000
   RORRER GL, 1993, IND ENG CHEM RES, V32, P2170, DOI 10.1021/ie00021a042
   SEO H, 1992, ELSEVIER APPL SCI, P34
   Sundararajan V. M., 1999, BIOMATERIALS, V20, P1133
   TARAREL MN, 1993, BIOMATERIALS, V14, P928
   Tarsi R, 1997, J DENT RES, V76, P665, DOI 10.1177/00220345970760020701
   Wan ACA, 1996, BIOMATERIALS, V17, P1529, DOI 10.1016/0142-9612(96)89778-X
   Wu LQ, 2002, LANGMUIR, V18, P8620, DOI 10.1021/la020381p
   Yoda R, 1998, J BIOMAT SCI-POLYM E, V9, P561, DOI 10.1163/156856298X00046
NR 39
TC 6
Z9 7
U1 0
U2 10
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0360-2559
J9 POLYM-PLAST TECHNOL
JI Polym.-Plast. Technol. Eng.
PY 2007
VL 46
IS 10-12
BP 1121
EP 1127
DI 10.1080/03602550600916209
PG 7
WC Polymer Science
SC Polymer Science
GA 245JV
UT WOS:000251931800027
DA 2018-10-19
ER

PT J
AU Huang, J
   Foo, CWP
   Kaplan, DL
AF Huang, Jia
   Foo, C. Wong Po
   Kaplan, David L.
TI Biosynthesis and applications of silk-like and collagen-like proteins
SO POLYMER REVIEWS
LA English
DT Review
DE recombinant; spider silk; silkworm silk; collagen; application
ID SPIDER DRAGLINE SILK; YEAST PICHIA-PASTORIS; HUMAN TYPE-I; BOMBYX-MORI
   SILK; RECOMBINANT PROCOLLAGEN-II; AMINO-ACID-COMPOSITION; BACULOVIRUS
   EXPRESSION SYSTEM; BONE MORPHOGENETIC PROTEIN-2; GENETICALLY-ENGINEERED
   SILK; AMORPHOUS CODING SEQUENCES
AB Genetic engineering provides a useful strategy to generate native and designed fibrous proteins, such as silks and collagens, for fundamental and applied studies. Recent studies on biosynthesized spider and silkworm silks, and human collagens, are reviewed with a focus on genes, expression systems and biomaterial applications. Genetically engineered silks and collagens can be exploited for fundamental biophysical studies of the relationships between primary sequence chemistry, self-assembly and structure, as well as processing into new materials. Insights into these relationships are feasible due to the precision of genetic template control of protein polymer details. In addition, these same proteins can be utilized in biomaterials and tissue engineering due to their novel material features as key structural elements in the human body (collagens) and as external spun fibers in Nature (silks).
C1 Tufts Univ, Dept Biol & Chem Engn, Medford, MA 02155 USA.
   Tufts Univ, Dept Chem, Medford, MA 02155 USA.
   Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
CR ALAKOKKO L, 1991, J BIOL CHEM, V266, P14175
   Albarran B, 2005, PROTEIN ENG DES SEL, V18, P147, DOI 10.1093/protein/gzi014
   Arcidiacono S, 2002, MACROMOLECULES, V35, P1262, DOI 10.1021/ma011471o
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Arnold WV, 1998, J BIOL CHEM, V273, P31822, DOI 10.1074/jbc.273.48.31822
   Asai T, 2005, BIOMOL ENG, V21, P145, DOI 10.1016/j.bioeng.2004.10.001
   Asakura T, 2004, BIOMATERIALS, V25, P617, DOI 10.1016/S0142-9612(03)00570-2
   Asakura T, 2003, BIOMACROMOLECULES, V4, P815, DOI 10.1021/bm034020f
   Asakura T. K., 1994, ENCY AGR SCI
   Barr LA, 2004, MOL BREEDING, V13, P345, DOI 10.1023/B:MOLB.0000034089.92263.ff
   Bernocco S, 2001, J BIOL CHEM, V276, P48930, DOI 10.1074/jbc.M108611200
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Brittingham R, 2005, J BIOL CHEM, V280, P191, DOI 10.1074/jbc.M406210200
   Brott LL, 2001, NATURE, V413, P291, DOI 10.1038/35095031
   Buechter DD, 2003, J BIOL CHEM, V278, P645, DOI 10.1074/jbc.M209364200
   Casem ML, 1999, INT J BIOL MACROMOL, V24, P103, DOI 10.1016/S0141-8130(98)00078-6
   Chanut-Delalande H, 2001, J BIOL CHEM, V276, P24352, DOI 10.1074/jbc.M101182200
   Chen M, 2002, J BIOL CHEM, V277, P2118, DOI 10.1074/jbc.M108779200
   Craig CL, 2000, MOL BIOL EVOL, V17, P1904, DOI 10.1093/oxfordjournals.molbev.a026292
   Cunniff P. M., 1994, SILK POLYM, V544, P234
   de Bruin EC, 2000, ENZYME MICROB TECH, V26, P640, DOI 10.1016/S0141-0229(00)00153-8
   dePaepe A, 1996, THROMB HAEMOSTASIS, V75, P379
   Dubrovsky T, 1996, THIN SOLID FILMS, V284, P698, DOI 10.1016/S0040-6090(95)08426-6
   Fahnestock S R, 2000, J Biotechnol, V74, P105, DOI 10.1016/S1389-0352(00)00008-8
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   Fertala A, 1996, J BIOL CHEM, V271, P14864, DOI 10.1074/jbc.271.25.14864
   FERTALA A, 1994, J BIOL CHEM, V269, P11584
   FERTALA A, 1994, BIOCHEM J, V298, P31, DOI 10.1042/bj2980031
   Fertala A, 2001, BIOCHEMISTRY-US, V40, P14422, DOI 10.1021/bi0109109
   Fichard A, 1997, J BIOL CHEM, V272, P30083, DOI 10.1074/jbc.272.48.30083
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   Foo CWP, 2006, APPL PHYS A-MATER, V82, P223, DOI 10.1007/s00339-005-3426-7
   Foo CWP, 2006, APPL PHYS A-MATER, V82, P193, DOI 10.1007/s00339-005-3425-8
   Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644
   Frey W, 2003, ADV MATER, V15, P248, DOI 10.1002/adma.200390058
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Fukui N, 2002, J BIOL CHEM, V277, P2193, DOI 10.1074/jbc.M105485200
   GAGE LP, 1980, J BIOL CHEM, V255, P9444
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   GOLDBERG I, 1989, GENE, V80, P305, DOI 10.1016/0378-1119(89)90294-1
   GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112
   Heslot H, 1998, BIOCHIMIE, V80, P19, DOI 10.1016/S0300-9084(98)80053-9
   HINMAN MB, 1992, J BIOL CHEM, V267, P19320
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   HUANG J, EFFECT GENETICALLY E
   Huemmerich D, 2006, APPL PHYS A-MATER, V82, P219, DOI 10.1007/s00339-005-3428-5
   Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005
   Huemmerich D, 2004, BIOCHEMISTRY-US, V43, P13604, DOI 10.1021/bi048983q
   Icke C, 2002, MOL PHARMACOL, V62, P203, DOI 10.1124/mol.62.2.203
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Ito H, 2006, J BIOMED MATER RES A, V76A, P551, DOI 10.1002/jbm.a.30551
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   John DCA, 1999, NAT BIOTECHNOL, V17, P385, DOI 10.1038/7945
   Junghans F, 2006, APPL PHYS A-MATER, V82, P253, DOI 10.1007/s00339-005-3432-9
   KADLER K, 1995, PROTEIN PROFILE, V2, P491
   KAPLAN D, 1994, ACS SYM SER, V544, P2
   KAPLAN DL, 1992, HIERARCHICALLY STRUC, P19
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   KARATZAS CN, 2003, BIOPOLYMERS POLYAMID, P97
   Keizer-Gunnink I, 2000, MATRIX BIOL, V19, P29, DOI 10.1016/S0945-053X(99)00059-1
   KERKAM K, 1991, MATER RES SOC SYMP P, V218, P239
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   KIVIRIKKO KI, 1989, FASEB J, V3, P1609
   Kivirikko KI, 1992, POSTTRANSLATIONAL MO, P1
   KUCHARZ EJ, 1992, BIOCH PATHOPHYSIOLOG
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Lamberg A, 1996, J BIOL CHEM, V271, P11988, DOI 10.1074/jbc.271.20.11988
   Lawrence BA, 2004, BIOMACROMOLECULES, V5, P689, DOI 10.1021/bm0342640
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   LEE ST, 1988, J BIOL CHEM, V263, P13414
   Lewis RV, 1996, PROTEIN EXPRES PURIF, V7, P400, DOI 10.1006/prep.1996.0060
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Linsenmayer TF, 1991, CELL BIOL EXTRACELLU, P7
   LIZUKA E, 1985, SILKAN OVERVIEW, P163
   LOMBARDI SJ, 1990, J ARACHNOL, V18, P297
   LOTZ B, 1974, J MOL BIOL, V87, P169, DOI 10.1016/0022-2836(74)90141-7
   Madsen B, 1999, INT J BIOL MACROMOL, V24, P301, DOI 10.1016/S0141-8130(98)00094-4
   Magoshi J, 1996, ABSTR PAP AM CHEM S, V212, P53
   MANNING RF, 1980, J BIOL CHEM, V255, P9451
   MARSH RE, 1955, BIOCHIM BIOPHYS ACTA, V16, P1, DOI 10.1016/0006-3002(55)90178-5
   Mazzorana M, 1996, J BIOL CHEM, V271, P29003, DOI 10.1074/jbc.271.46.29003
   McGrath K. P., 1997, PROTEIN BASED MAT
   Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390
   Mello CM, 2004, BIOMACROMOLECULES, V5, P1849, DOI 10.1021/bm049815g
   MELLO CM, 1994, ACS SYM SER, V544, P67
   Menassa R, 2004, PLANT BIOTECHNOL J, V2, P431, DOI 10.1111/j.1467-7652.2004.00087.x
   Merle C, 2002, FEBS LETT, V515, P114, DOI 10.1016/S0014-5793(02)02452-3
   MITA K, 1988, J MOL BIOL, V203, P917, DOI 10.1016/0022-2836(88)90117-9
   MITA K, 1994, J MOL EVOL, V38, P583
   Mizuno K, 2004, J BIOL CHEM, V279, P38072, DOI 10.1074/jbc.M402953200
   Myllyharju J, 1997, J BIOL CHEM, V272, P21824, DOI 10.1074/jbc.272.35.21824
   Myllyharju J, 2000, BIOCHEM SOC T, V28, P353, DOI 10.1042/0300-5127:0280353
   Naik RR, 2003, CHEM COMMUN, P238, DOI 10.1039/b210635c
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   NIMNI ME, 1993, EXTRACELLULAR MATRIX, P121
   Nokelainen M, 2001, YEAST, V18, P797, DOI 10.1002/yea.730
   NOKELAINEN M, 1997, MATRIX BIOL, V16, P923
   Notbohm H, 1999, J BIOL CHEM, V274, P8988, DOI 10.1074/jbc.274.13.8988
   Olsen D, 2003, ADV DRUG DELIVER REV, V55, P1547, DOI 10.1016/j.addr.2003.08.008
   Olsen DR, 2001, J BIOL CHEM, V276, P24038, DOI 10.1074/jbc.M101613200
   Oroudjev E, 2002, P NATL ACAD SCI USA, V99, P6460, DOI 10.1073/pnas.082526499
   Padilla JE, 2001, P NATL ACAD SCI USA, V98, P2217, DOI 10.1073/pnas.041614998
   Pakkanen O, 2006, J BIOTECHNOL, V123, P248, DOI 10.1016/j.jbiotec.2005.11.012
   Pakkanen O, 2003, J BIOL CHEM, V278, P32478, DOI 10.1074/jbc.M304405200
   Park E, 1998, J DRUG TARGET, V6, P53, DOI 10.3109/10611869808997881
   Paternolli C, 2002, MAT SCI ENG C-BIO S, V22, P155, DOI 10.1016/S0928-4931(02)00164-9
   Perret S, 2001, J BIOL CHEM, V276, P43693, DOI 10.1074/jbc.M105507200
   Pihlajamaa T, 1999, J BIOL CHEM, V274, P22464, DOI 10.1074/jbc.274.32.22464
   PIHLAJANIEMI T, 1981, BIOCHEMISTRY-US, V20, P7409, DOI 10.1021/bi00529a014
   PRASHAD B, 1972, INDIAN J BIOCHEM BIO, V9, P351
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Rammensee S, 2006, APPL PHYS A-MATER, V82, P261, DOI 10.1007/s00339-005-3431-x
   Ricard-Blum S., 2000, UNCONVENTIONAL COLLA
   Rising A, 2005, ZOOL SCI, V22, P273, DOI 10.2108/zsj.22.273
   Roughley P. J., 2003, European Cells & Materials, V5, P41
   Ruggiero F, 2000, FEBS LETT, V469, P132, DOI 10.1016/S0014-5793(00)01259-X
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   SCHNIEKE A, 1987, P NATL ACAD SCI USA, V84, P764, DOI 10.1073/pnas.84.3.764
   Sieron AL, 2002, CYTOKINE, V18, P214, DOI 10.1006/cyto.2002.1035
   SIERON AL, 1993, J BIOL CHEM, V268, P21232
   Sleytr UB, 2003, IEEE ENG MED BIOL, V22, P140, DOI 10.1109/MEMB.2003.1213637
   Slocik JM, 2005, J MATER CHEM, V15, P749, DOI 10.1039/b413074j
   Snellman A, 2000, J BIOL CHEM, V275, P8936, DOI 10.1074/jbc.275.12.8936
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Stephens JS, 2005, BIOMACROMOLECULES, V6, P1405, DOI 10.1021/bm049296h
   Steplewski A, 2004, J STRUCT BIOL, V148, P326, DOI 10.1016/j.jsb.2004.07.006
   Steplewski A, 2004, J MOL BIOL, V338, P989, DOI 10.1016/j.jmb.2004.03.037
   Szela S, 2000, BIOMACROMOLECULES, V1, P534, DOI 10.1021/bm0055697
   Tanaka K, 1999, INSECT BIOCHEM MOLEC, V29, P269, DOI 10.1016/S0965-1748(98)00135-0
   TILLET E, 1994, EUR J BIOCHEM, V221, P177, DOI 10.1111/j.1432-1033.1994.tb18727.x
   Toman PD, 1999, TRANSGENIC RES, V8, P415, DOI 10.1023/A:1008959924856
   Toman PD, 2000, J BIOL CHEM, V275, P23303, DOI 10.1074/jbc.M002284200
   Tomita M, 1995, BIOCHEM J, V312, P847, DOI 10.1042/bj3120847
   Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771
   TRYGGVASON K, 1980, BIOCHEMISTRY-US, V19, P1284, DOI 10.1021/bi00548a003
   Valluzzi R, 1996, MACROMOLECULES, V29, P8606, DOI 10.1021/ma9517759
   Valluzzi R, 1999, J PHYS CHEM B, V103, P11382, DOI 10.1021/jp991363s
   van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299
   Vaughan PR, 1998, DNA CELL BIOL, V17, P511, DOI 10.1089/dna.1998.17.511
   VOLLRATH F, 1992, SCI AM, V266, P70, DOI 10.1038/scientificamerican0392-70
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Vuorela A, 1997, EMBO J, V16, P6702, DOI 10.1093/emboj/16.22.6702
   Vuorela A, 1999, MATRIX BIOL, V18, P519, DOI 10.1016/S0945-053X(99)00040-2
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   Winkler S, 1999, INT J BIOL MACROMOL, V24, P265, DOI 10.1016/S0141-8130(98)00088-9
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   YAMAGUCHI K, 1989, J MOL BIOL, V210, P127, DOI 10.1016/0022-2836(89)90295-7
   Yang CL, 2004, BIODRUGS, V18, P103, DOI 10.2165/00063030-200418020-00004
   Yang JJ, 2005, TRANSGENIC RES, V14, P313, DOI 10.1007/s11248-005-0272-5
   Yang MY, 2005, J BIOCHEM, V137, P721, DOI 10.1093/jb/mvi090
   Yao JM, 2004, J BIOCHEM, V136, P643, DOI 10.1093/jb/mvh172
   Zafarullah K, 1997, MATRIX BIOL, V16, P245, DOI 10.1016/S0945-053X(97)90013-5
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhou YT, 2001, BIOMACROMOLECULES, V2, P111, DOI 10.1021/bm005598h
NR 160
TC 38
Z9 39
U1 4
U2 37
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1558-3724
EI 1558-3716
J9 POLYM REV
JI Polym. Rev.
PY 2007
VL 47
IS 1
BP 29
EP 62
DI 10.1080/15583720601109560
PG 34
WC Polymer Science
SC Polymer Science
GA 142YY
UT WOS:000244688400003
DA 2018-10-19
ER

PT S
AU Miyazaki, S
   Kim, HY
AF Miyazaki, Shuichi
   Kim, Hee Young
BE Chang, YW
   Kim, NJ
   Lee, CS
TI TiNi-base and Ti-base shape memory alloys
SO PRICM 6: SIXTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, PTS 1-3
SE MATERIALS SCIENCE FORUM
LA English
DT Proceedings Paper
CT 6th Pacific Rim International Conference on Advanced Materials and
   Processing
CY NOV 05-09, 2007
CL Cheju Isl, SOUTH KOREA
SP Korean Inst Met & Mat, Chinese Soc Met, Japan Inst Met, Minerals, Met & Mat Soc, Inst Mat Engn Australia
DE shape memory alloy; superelastic alloy; TiNi; NiTi; Ti alloy;
   biomaterial; shape memory effect; superelasticity; martensitic
   transformation
ID NI SINGLE-CRYSTALS; R-PHASE TRANSITION; MARTENSITIC-TRANSFORMATION;
   THIN-FILM; MECHANICAL-PROPERTIES; THERMOMECHANICAL PROPERTIES;
   BIOMEDICAL ALLOYS; NB ALLOYS; BEHAVIOR; SUPERELASTICITY
AB The basic characteristics of TiNi-based and Ni-free Ti-based shape memory alloys are reviewed. They include the crystal structures of the parent and martensite phases in both the alloys, the recoverable strain associated with the martensitic transformation, the transformation temperatures, the temperature and orientation dependence of deformation behavior, etc. The sputter-deposited Ti-Ni thin films are also reviewed briefly because of their possibility of expanding into rnicromechanical system applications as the most powerful microactuator.
C1 [Miyazaki, Shuichi; Kim, Hee Young] Univ Tsukuba, Inst Mat Sci, Tsukuba, Ibaraki 3058573, Japan.
RP Miyazaki, S (reprint author), Univ Tsukuba, Inst Mat Sci, Tsukuba, Ibaraki 3058573, Japan.
RI Miyazaki, Shuichi/A-3113-2012; Kim, Hee Young/F-6065-2011
OI Miyazaki, Shuichi/0000-0003-3849-4176; Kim, Hee
   Young/0000-0003-1981-6678
CR Baker C., 1971, Metal Science Journal, V5, P92
   BOWLES JS, 1954, ACTA METALL MATER, V2, P224, DOI 10.1016/0001-6160(54)90163-7
   BOWLES JS, 1954, ACTA METALL MATER, V2, P129, DOI 10.1016/0001-6160(54)90102-9
   BOWLES JS, 1954, ACTA METALL, V2, P138
   BROWN ARG, 1964, NATURE, V201, P914, DOI 10.1038/201914a0
   DUERIG TW, 1982, ACTA METALL MATER, V30, P2161, DOI 10.1016/0001-6160(82)90137-7
   Fu YQ, 2001, SURF COAT TECH, V145, P107, DOI 10.1016/S0257-8972(01)01324-X
   Fukui Y, 2004, MATER TRANS, V45, P1077, DOI 10.2320/matertrans.45.1077
   Gilfrich JV, 1963, J APPL PHYS, V34, P1467
   HAUNG WM, 2004, SENSOR ACTUAT A-PHYS, V114, P118
   HIRANO M, 2001, T MAT RES SOC JAPAN, V26, P133
   Inamura T, 2004, MATER TRANS, V45, P1083, DOI 10.2320/matertrans.45.1083
   Ishida A, 1999, J ENG MATER-T ASME, V121, P2, DOI 10.1115/1.2815996
   Kim HY, 2006, MAT SCI ENG A-STRUCT, V438, P839, DOI 10.1016/j.msea.2006.02.136
   Kim HY, 2007, MATER TRANS, V48, P400, DOI 10.2320/matertrans.48.400
   Kim HY, 2006, ACTA MATER, V54, P2419, DOI 10.1016/j.actamat.2006.01.019
   Kim HY, 2006, MAT SCI ENG A-STRUCT, V417, P120, DOI 10.1016/j.msea.2005.10.065
   Kim HY, 2006, ACTA MATER, V54, P423, DOI 10.1016/j.actamat.2005.09.014
   Kim HY, 2004, MATER TRANS, V45, P2443, DOI 10.2320/matertrans.45.2443
   Kim HY, 2004, MATER TRANS, V45, P1090, DOI 10.2320/matertrans.45.1090
   Kim JI, 2006, MATER TRANS, V47, P505, DOI 10.2320/matertrans.47.505
   Kim JI, 2005, MAT SCI ENG A-STRUCT, V403, P334, DOI 10.1016/j.msea.2005.05.050
   Kim JI, 2005, MATER TRANS, V46, P852, DOI 10.2320/matertrans.46.852
   KNOWLES KM, 1981, ACTA METALL MATER, V29, P101, DOI 10.1016/0001-6160(81)90091-2
   Kohl M, 1995, J PHYS IV, V5, P1187, DOI 10.1051/jp4/1995581187
   Kohl M, 2000, SENSOR ACTUAT A-PHYS, V83, P208, DOI 10.1016/S0924-4247(99)00385-4
   Kohl M, 2000, SENSOR ACTUAT A-PHYS, V83, P214, DOI 10.1016/S0924-4247(99)00386-6
   Kohl M, 1999, MAT SCI ENG A-STRUCT, V273, P784, DOI 10.1016/S0921-5093(99)00416-5
   LIEBERMAN DS, 1955, J APPL PHYS, V26, P473, DOI 10.1063/1.1722021
   Maeshima T, 2004, MATER TRANS, V45, P1096, DOI 10.2320/matertrans.45.1096
   Makino E, 2000, SENSOR ACTUAT A-PHYS, V79, P251, DOI 10.1016/S0924-4247(99)00290-3
   Makino E, 1999, SENSOR ACTUAT A-PHYS, V75, P156, DOI 10.1016/S0924-4247(99)00003-5
   Makino E, 1999, SENSOR ACTUAT A-PHYS, V78, P163, DOI 10.1016/S0924-4247(99)00222-8
   MATSUMOTO H, MAT T, V46
   MATSUMOTO O, 1987, ACTA METALL MATER, V35, P2137, DOI 10.1016/0001-6160(87)90042-3
   Miyazaki S, 1999, MAT SCI ENG A-STRUCT, V273, P106, DOI 10.1016/S0921-5093(99)00292-0
   MIYAZAKI S, 1984, PHILOS MAG A, V50, P393
   Miyazaki S., 2002, Materials Science Forum, V394-395, P467
   MIYAZAKI S, 1988, PHILOS MAG A, V57, P467, DOI 10.1080/01418618808204680
   MIYAZAKI S, 1988, ACTA METALL MATER, V36, P181, DOI 10.1016/0001-6160(88)90037-5
   MIYAZAKI S, 1986, ACTA METALL MATER, V34, P2045, DOI 10.1016/0001-6160(86)90263-4
   MIYAZAKI S, 1989, ACTA METALL MATER, V37, P1885, DOI 10.1016/0001-6160(89)90073-4
   MIYAZAKI S, 1986, METALL TRANS A, V17, P53, DOI 10.1007/BF02644442
   MIYAZAKI S, 1984, SCRIPTA METALL MATER, V18, P883, DOI 10.1016/0036-9748(84)90254-0
   Miyazaki S, 2000, INT J PLASTICITY, V16, P1135, DOI 10.1016/S0749-6419(00)00004-8
   MIYAZAKI S, 1982, PHYS S, V12, pC4
   Miyazaki S., 1990, BUTTERWORTH HEINEMAN, P394
   Shin DD, 2005, SENSOR ACTUAT A-PHYS, V119, P151, DOI [10.1016/j.sna.2004.01.025, 10.1016/j.sna.2004.10.025]
   Shin DD, 2004, SENSOR ACTUAT A-PHYS, V111, P166, DOI 10.1016/j.sna.2003.09.026
   Takahashi E, 2002, MATER TRANS, V43, P2978, DOI 10.2320/matertrans.43.2978
   TAKEI F, 1983, SCRIPTA METALL MATER, V17, P987, DOI 10.1016/0036-9748(83)90436-2
   TAN SM, 1997, ACTA MAT, V46, P2729
   Tomozawa M, 2005, MATER SCI FORUM, V475-479, P2037, DOI 10.4028/www.scientific.net/MSF.475-479.2037
   Tomozawa M, 2006, J INTEL MAT SYST STR, V17, P1049, DOI 10.1177/1045389X06064883
   WECHSLER MS, 1953, T AM I MIN MET ENG, V197, P1503
   Xu D, 2001, SENSOR ACTUAT A-PHYS, V93, P87, DOI 10.1016/S0924-4247(01)00628-8
   Zhou T, 2004, SCRIPTA MATER, V50, P343, DOI 10.1016/j.scriptamat.2003.10.012
NR 57
TC 9
Z9 10
U1 0
U2 8
PU TRANS TECH PUBLICATIONS LTD
PI STAFA-ZURICH
PA LAUBLSRUTISTR 24, CH-8717 STAFA-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2007
VL 561-565
BP 5
EP 21
DI 10.4028/www.scientific.net/MSF.561-565.5
PN 1-3
PG 17
WC Metallurgy & Metallurgical Engineering; Materials Science, Composites
SC Metallurgy & Metallurgical Engineering; Materials Science
GA BHE49
UT WOS:000252473300001
DA 2018-10-19
ER

PT S
AU Lee, SH
   Chiba, H
   Syuto, B
   Nomura, N
   Chiba, A
AF Lee, Sang-Hak
   Chiba, Hisae
   Syuto, Bunei
   Nomura, Naoyuki
   Chiba, Akihiko
BE Chang, YW
   Kim, NJ
   Lee, CS
TI Effect of iron addition on Co-29Cr-6Mo alloys for biomedical
   applications
SO PRICM 6: SIXTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, PTS 1-3
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 6th Pacific Rim International Conference on Advanced Materials and
   Processing
CY NOV 05-09, 2007
CL Cheju Isl, SOUTH KOREA
SP Korean Inst Met & Mat, Chinese Soc Met, Japan Inst Met, Minerals, Met & Mat Soc, Inst Mat Engn Australia
DE Co-based alloys; iron addition; mechanical properties; cytotoxicity;
   biomaterial
AB The effects of Fe addition on the mechanical properties, corrosion resistance, and cytotoxicity of Co-29Cr-6Mo alloys were studied for the possibility of new biomaterial applications. The amount of Fe addition was varied from 0 to 20 wt%. Increasing Fe content up to 10 wt% increases tensile strength and ductility of Co-29Cr-6Mo alloy. Anodic polarization test in the saline and the flank's solution shows that Fe added Co-29Cr-6Mo alloys remains in passive state before breakdown.,Moreover, it is found from a cytotoxicity test that Fe added Co-29Cr-6Mo alloys shows a good biocompatibility. These results concluded that Fe added Co-29Cr-6Mo alloys have a reasonable mechanical properties, good corrosion resistance and biocompatibility.
C1 [Lee, Sang-Hak; Syuto, Bunei] Iwate Ind Promot Ctr, Iwate, Japan.
   [Chiba, Hisae; Nomura, Naoyuki] Iwate Univ, Dept Welfare Engn, Iwate, Japan.
   [Chiba, Akihiko] Tohoku Univ, Inst Mat Res, Sendai, Miyagi, Japan.
RP Lee, SH (reprint author), Iwate Ind Promot Ctr, Iwate, Japan.
EM shlee@iwate-u.ac.jp; t3705011@iwate-u.ac.jp; shuto@iwate-u.ac.jp;
   nnomura@iwate-u.ac.jp; a.chiba@imr.tohoku.ac.jp
RI NOMURA, Naoyuki/L-7149-2017
CR SHI LQ, 1993, J MATER SCI, V28, P1312, DOI 10.1007/BF01191970
   WOODYATT LR, 1966, T METALL SOC AIME, V236, P519
NR 2
TC 0
Z9 0
U1 0
U2 0
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2007
VL 561-565
BP 1497
EP +
DI 10.4028/www.scientific.net/MSF.561-565.1497
PN 1-3
PG 2
WC Metallurgy & Metallurgical Engineering; Materials Science, Composites
SC Metallurgy & Metallurgical Engineering; Materials Science
GA BHE49
UT WOS:000252473301166
DA 2018-10-19
ER

PT S
AU Nakai, M
   Niinomi, M
   Akahori, T
   Ohtsu, N
   Nishimura, H
   Toda, H
   Fukui, H
   Ogawa, M
AF Nakai, M.
   Niinomi, M.
   Akahori, T.
   Ohtsu, N.
   Nishimura, H.
   Toda, H.
   Fukui, H.
   Ogawa, M.
BE Chang, YW
   Kim, NJ
   Lee, CS
TI Hard-ceramic layer formed on Ti-29Nb-13Ta-4.6Zr and Ti-6Al-4V ELI during
   gas nitriding
SO PRICM 6: SIXTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, PTS 1-3
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 6th Pacific Rim International Conference on Advanced Materials and
   Processing
CY NOV 05-09, 2007
CL Cheju Isl, SOUTH KOREA
SP Korean Inst Met & Mat, Chinese Soc Met, Japan Inst Met, Minerals, Met & Mat Soc, Inst Mat Engn Australia
DE biomaterial; titanium alloy; Ti-29Nb-13Ta-4.6Zr; Ti-6Al-4V; nitriding;
   surface
AB The surface of Ti-29Nb-13Ta-4.6Zr (TNTZ) subjected to gas nitriding at 1023-1223 K was investigated in comparison with the conventional biomedical titanium alloy, Ti-6Al-4V ELI (Ti64). After gas nitriding, the microstructures near the surface of these alloys were observed by optical microscopy, X-ray diffraction, Auger electron spectroscopy, and X-ray photoelectron spectroscopy. In both alloys, two titanium nitrides (TiN and Ti2N) are formed and the a phase precipitated by gas nitriding. Furthermore, oxygen impurity in the gas nitriding atmosphere reacts with the titanium nitrides; thus, TiO2 is formed at the outermost titanium nitride layer. The surface hardening was also evaluated by Vickers hardness measurement. The Vickers hardness near the surface of TNTZ and Ti64 increases significantly by gas nitriding.
C1 [Nakai, M.; Niinomi, M.; Akahori, T.; Ohtsu, N.] Tohoku Univ, Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.
   [Nishimura, H.] Toyohashi Univ Technol, Toyohashi, Aichi 4418580, Japan.
   [Toda, H.] Toyohashi Univ Technol, Dept Prod Syst Engn, Toyohashi, Aichi 4418580, Japan.
   [Fukui, H.] Aichi Gakuin Univ, Sch Dent, Nagoya, Aichi 4648650, Japan.
   [Ogawa, M.] Daido Steel Co Ltd, R&D, Nagoya, Aichi 4578584, Japan.
RP Nakai, M (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.
EM nakai@imr.tohoku.ac.jp; niinomi@imr.tohoku.ac.jp;
   akahori@imr.tohoku.ac.jp; nohtsu@imr.tohoku.ac.jp;
   nishimura@sp-Mac4.pse.tut.ac.jp; toda@pse.tut.ac.jp;
   fukui@dpc.aichi-gakuin.ac.jp; m-ogawa@ds.daido.co.jp
OI Ohtsu, Naofumi/0000-0001-7935-3949
CR Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   NAKAYAMA T, 1996, KINZOKU, V66, P986
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
NR 3
TC 3
Z9 3
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2007
VL 561-565
BP 1509
EP +
DI 10.4028/www.scientific.net/MSF.561-565.1509
PN 1-3
PG 2
WC Metallurgy & Metallurgical Engineering; Materials Science, Composites
SC Metallurgy & Metallurgical Engineering; Materials Science
GA BHE49
UT WOS:000252473301169
DA 2018-10-19
ER

PT S
AU Inamura, T
   Shimizu, R
   Kim, JI
   Hee, YK
   Wakashima, K
   Miyazaki, S
   Hosoda, H
AF Inamura, Tomonari
   Shimizu, Ryutaro
   Kim, Jae Il
   Hee, Young Kim
   Wakashima, Kenji
   Miyazaki, Shuichi
   Hosoda, Hideki
BE Chang, YW
   Kim, NJ
   Lee, CS
TI Rolling texture of alpha"-phase in Ti-22mol%Nb-3mol%Al biomedical shape
   memory alloy
SO PRICM 6: SIXTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, PTS 1-3
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 6th Pacific Rim International Conference on Advanced Materials and
   Processing
CY NOV 05-09, 2007
CL Cheju Isl, SOUTH KOREA
SP Korean Inst Met & Mat, Chinese Soc Met, Japan Inst Met, Minerals, Met & Mat Soc, Inst Mat Engn Australia
DE titanium; martensite; biomaterial; texture; shape memory alloy
ID STRAIN
AB Rolling texture of alpha"(C-orthorhombic) martensite phase in Ti-22mol%Nb-3mol%Al P.-titanium based shape memory alloy was examined using X-ray pole figure measurement. The alloy was dual phase of alpha" and beta(bcc) at room temperature (RT) and was cold-rolled with reduction rates of 40%similar to 99% at RT. Stress-induced martensitic transformation occurred during the rolling and then the material was fully transformed into martensite phase. Subscript alpha" and P indicate martensite and parent phase hereafter. The major texture was close to {411}(alpha") (73)(alpha") when the reduction rate was lower than 60%. This texture is a result of a preferential formation of specific variants which have a higher interaction with the macroscopic deformation. As the reduction rate was increased, ND moved toward {101}(alpha '') whereas RD was around (010)(alpha '') regardless of the reduction rate. {101}(alpha '')(010)(alpha '') texture was confirmed when the reduction rate was 99%.
C1 [Inamura, Tomonari; Wakashima, Kenji; Hosoda, Hideki] Tokyo Inst Technol, Precis & Intelligence Lab, Tokyo, Japan.
   [Shimizu, Ryutaro] Tokyo Inst Technol, Tokyo, Japan.
   [Kim, Jae Il] Dong A Univ, Dept Met Sci & Engn, Busan, South Korea.
   [Miyazaki, Shuichi] Univ Tsukuba, Inst Mat Sci, Tsukuba, Ibaraki, Japan.
RP Inamura, T (reprint author), Tokyo Inst Technol, Precis & Intelligence Lab, Tokyo, Japan.
EM inamura.t.aa@m.titech.ac.jp; hosoda.h.aa@m.titech.ac.jp
RI Inamura, Tomonari/E-5712-2014
FU Ministry of Education, Culture, Sports, Science and Technology, Japan
   [18760522];  [17360334]
FX This work was partially supported by a Grant-in-Aid for Fundamental
   Scientific Research Kiban B (No.17360334, 2005-2007), Wakate B (No.
   18760522, 2006-2007) and the 21st COE program from the Ministry of
   Education, Culture, Sports, Science and Technology, Japan.
CR Baker C., 1971, Metal Science Journal, V5, P92
   DUERIG TW, 1982, SCRIPTA METALL MATER, V16, P957, DOI 10.1016/0036-9748(82)90133-8
   Fukui Y, 2004, MATER TRANS, V45, P1077, DOI 10.2320/matertrans.45.1077
   Inamura T, 2006, MAT SCI ENG A-STRUCT, V438, P865, DOI 10.1016/j.msea.2006.02.092
   Inamura T, 2004, MATER TRANS, V45, P1083, DOI 10.2320/matertrans.45.1083
   Kim HY, 2006, ACTA MATER, V54, P423, DOI 10.1016/j.actamat.2005.09.014
   Kim JI, 2005, MAT SCI ENG A-STRUCT, V403, P334, DOI 10.1016/j.msea.2005.05.050
   KIMURA H, 1985, J JPN SOC DENT MAT D, V4, P377
   Otsuka K., 1998, SHAPE MEMORY MAT
NR 9
TC 3
Z9 3
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2007
VL 561-565
BP 1517
EP +
DI 10.4028/www.scientific.net/MSF.561-565.1517
PN 1-3
PG 2
WC Metallurgy & Metallurgical Engineering; Materials Science, Composites
SC Metallurgy & Metallurgical Engineering; Materials Science
GA BHE49
UT WOS:000252473301171
DA 2018-10-19
ER

PT S
AU Ayers, R
   Ferguson, V
   Belk, D
   Moore, J
AF Ayers, Reed
   Ferguson, Virginia
   Belk, Denise
   Moore, John
BE Chang, YW
   Kim, NJ
   Lee, CS
TI Self-propagating high-temperature synthesis of porous nickel-titanium
SO PRICM 6: SIXTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED
   MATERIALS AND PROCESSING, PTS 1-3
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 6th Pacific Rim International Conference on Advanced Materials and
   Processing
CY NOV 05-09, 2007
CL Cheju Isl, SOUTH KOREA
SP Korean Inst Met & Mat, Chinese Soc Met, Japan Inst Met, Minerals, Met & Mat Soc, Inst Mat Engn Australia
DE combustion synthesis; NiTi; porous; biomaterial; nanoindentation
ID SHAPE-MEMORY ALLOYS; COMBUSTION SYNTHESIS; APPOSITION; INGROWTH;
   IMPLANT; NITINOL; FIELD
AB Porous equiatomic Nickel-Titanium (NiTi) is a strong candidate material for bone engineering applications because its mechanical properties are within the range of bone and its porosity allows for biologic interlock of the material to the surrounding tissue. Self-propagating high-temperature synthesis (SHS) is one method for producing porous NiTi. Nickel and titanium powders, -325 mesh, were mixed for 24 hours then pressed into cylindrical pellets (0.5 inch diameter, 0.5 inch height) to a theoretical green density of approximately 53%. The pellets were preheated in flowing argon for one hour then ignited using a tungsten coil. Scanning electron microscopy and electron dispersive spectroscopy (EDS) show localized differences of stoichiometry suggesting variations in the crystal structure where the Ni to Ti atomic ratio varied between 48.5:51.5 and 50.7:49.3. X-ray diffraction (XRD) (Philips X'Pert PRO) confirmed the presence crystalline equiatomic NiTi as well as other intermetallic compounds including NiTi2 and Ni4Ti3. Nanoindentation (MTS Nano Indenter XP) of this heterogeneous material indicates a mean range indentation modulus of 89.6 +/- 9.4 GPa. This is on the same order of magnitude as bone, which has an elastic modulus range of 14-20 GPa.
C1 [Ayers, Reed; Belk, Denise; Moore, John] Colorado Sch Mines, Dept Met & Mat Engn, Golden, CO 80401 USA.
   [Ferguson, Virginia] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA.
RP Ayers, R (reprint author), Colorado Sch Mines, Dept Met & Mat Engn, Golden, CO 80401 USA.
EM ruayers@mines.edu; Virginia.Freguson@Colorado.edu; jjmoore@mines.edu
RI Ferguson, Virginia/K-6962-2012; Ayers, Reed/E-5558-2011
OI Ferguson, Virginia/0000-0002-8448-4406; 
CR Airoldi G, 1996, BIO-MED MATER ENG, V6, P299
   Ayers RA, 1999, J BIOMED MATER RES, V45, P42
   Dai KR, 1996, BIO-MED MATER ENG, V6, P233
   Frick CP, 2005, MAT SCI ENG A-STRUCT, V405, P34, DOI 10.1016/j.msea.2005.05.102
   ITIN VI, 1994, MATER CHARACT, V32, P179, DOI 10.1016/1044-5803(94)90087-6
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   KNYAZIK VA, 1985, COMBUST EXPLO SHOCK+, V21, P333, DOI 10.1007/BF01463853
   Li BY, 2000, ACTA MATER, V48, P3895, DOI 10.1016/S1359-6454(00)00184-1
   MOORE JJ, 1994, MINERALS METALS MAT, P817
   Munir ZA, 2000, MAT SCI ENG A-STRUCT, V287, P125, DOI 10.1016/S0921-5093(00)00765-6
   Munir ZA, 1996, METALL MATER TRANS A, V27, P2080, DOI 10.1007/BF02651861
   Otsuka K, 2005, PROG MATER SCI, V50, P511, DOI 10.1016/j.pmatsci.2004.10.001
   Schuller E, 2003, ADV ENG MATER, V5, P918, DOI 10.1002/adem.200300366
   Shabalovskaya SA, 1996, BIO-MED MATER ENG, V6, P267
   SIMSKE SJ, 1995, J BIOMED MATER RES, V29, P527, DOI 10.1002/jbm.820290413
   Yamada O, 1986, J MATER RES, V1, P275, DOI 10.1557/JMR.1986.0275
   YI HC, 1990, JOM-J MIN MET MAT S, V42, P31
   YI HC, 1990, COMBUSTION SYNTHESIS
   ZHANG X, 2002, COMBUSTION SYNTHESIS
NR 19
TC 4
Z9 4
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2007
VL 561-565
BP 1643
EP +
DI 10.4028/www.scientific.net/MSF.561-565.1643
PN 1-3
PG 3
WC Metallurgy & Metallurgical Engineering; Materials Science, Composites
SC Metallurgy & Metallurgical Engineering; Materials Science
GA BHE49
UT WOS:000252473302001
DA 2018-10-19
ER

PT B
AU Sundararaghavan, HG
   Shreiber, DI
AF Sundararaghavan, Harini G.
   Shreiber, David I.
GP ASME
TI Directing neurite growth in 3d collagen scaffolds with gradients of
   mechanical properties
SO PROCEEDING OF THE ASME SUMMER BIOENGINEERING CONFERENCE - 2007
LA English
DT Proceedings Paper
CT ASME Summer Bioengineering Conference
CY JUN 24-28, 2007
CL Keystone, CO
SP ASME, Bioengn Div
AB Biomaterial scaffolds for nerve and spinal cord regeneration must riot only promote neurite re-growth but also direct it. Several cell types, including neurons, respond to the mechanical properties of the Substrate on which they are grown. We believe that gradients of mechanical properties can be used to direct neurons. To spatially control the mechanical properties, gradients of genipin - a naturally occurring, cell-tolerated crosslinking agent - are created in 3D through a compliant collagen gel using microfluidics. Gradients of mechanical properties are evaluated by measuring genipin-induced fluorescence, which we have previously correlated to mechanical properties. Growth of neurites was evaluated in gels Of uniform stiffness and a gradient generated by incubation in 0 to 1 mM genipin for 12hrs to produce approximately an order of magnitude change in the shear modulus. Neurite growth was evaluated 5 days after gradient formation. Neurites demonstrated a directional bias against the gradient of stiffness. These results demonstrate that neurites can respond to subtle gradients of mechanical properties within a 3D scaffold and point to opportunities to manipulate properties for directed nerve and spinal cord regeneration.
C1 [Sundararaghavan, Harini G.; Shreiber, David I.] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
RP Sundararaghavan, HG (reprint author), Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ 08854 USA.
OI Shreiber, David/0000-0001-8248-419X
CR Almog J, 2004, J FORENSIC SCI, V49, P255
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   SUNDARARAGHAVAN HG, 2006, UNPUB J BIOMEDICAL M
NR 3
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4798-5
PY 2007
BP 59
EP 60
PG 2
WC Engineering, Biomedical
SC Engineering
GA BHB85
UT WOS:000252105700030
DA 2018-10-19
ER

PT B
AU Chen, F
   Liu, LF
   Qiu, LJ
   He, CL
   Mo, XM
AF Chen Feng
   Liu Lifu
   Qiu Lijun
   He Chuanglong
   Mo Xiumei
GP Chem Ind Press
TI Electrospun fibrous P(LLA-CL) tubular scaffold
SO PROCEEDINGS OF THE 2007 INTERNATIONAL CONFERENCE ON ADVANCED FIBERS AND
   POLYMER MATERIALS VOLS 1 AND 2
LA English
DT Proceedings Paper
CT International Conference on Advanced Fibers and Polymer Materials
CY OCT 15-17, 2007
CL Shanghai, PEOPLES R CHINA
DE electrospinning; P(LLA-CL); gelatine; tissue engineering; tubular
   scaffold
AB Electrospinning has been recognized as an efficient technique for fabricating polymer nanofibers. In this study, small diameter fibrous tubular scaffolds have been obtained from P(LLA-CL) nanofibers through multi-jets electrospinning. As SEM images shown, the scaffolds with excellent morphology were constructed with nanofibers absolutely. The pore size is a very important factor for nanofibers tube application in tissue engineering. Therefore, gelatin which is a: biocompatible and biodegradable biomaterial was selected to adjust the pore size of the scaffold during electrospinning process, After taken off from collector, the scaffold was put into water to remove gelatin, After drying under vacuum, a tubular scaffold with better pore size property can be received. Mechanical properties of this kind of nanofibers composited films were tested. The broken stress increased with increasing content of P(LLA-CL) nanofibers, and the broken strain decreased with this changing. The films at wet condition have less broken stress and more strain than at dry condition.
C1 [Chen Feng; Liu Lifu; Qiu Lijun; He Chuanglong; Mo Xiumei] Donghua Univ, Inst Biol Sci & Biotechnol, Shanghai 201620, Peoples R China.
RP Mo, XM (reprint author), Donghua Univ, Inst Biol Sci & Biotechnol, Shanghai 201620, Peoples R China.
RI mo, xiumei/C-9340-2013; Chen, Feng/D-6406-2012; He,
   Chuanglong/C-2976-2011
OI Chen, Feng/0000-0002-1162-1684; He, Chuanglong/0000-0001-8330-8542
CR HANG ZM, 2004, POLYMER, V45, P5361
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   PRATT GH, 1984, AM J SURG, V1, P136
   Reneker DH, 2002, POLYMER, V43, P6785, DOI 10.1016/S0032-3861(02)00595-5
   WNEK GE, 2003, NANO LETT, V3, P216
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 7
TC 0
Z9 0
U1 0
U2 4
PU CHEMICAL INDUSTRY PRESS
PI BEIJING
PA NO. 3 HUIXINLI CHAOYANGQU, BEIJING 100029, PEOPLES R CHINA
BN 978-7-122-01223-4
PY 2007
BP 685
EP 687
PG 3
WC Polymer Science
SC Polymer Science
GA BHA72
UT WOS:000251952000215
DA 2018-10-19
ER

PT B
AU Boland, T
   Cui, X
   Chaubey, A
   Burg, TC
   Groff, RE
   Burg, KJL
AF Boland, Thomas
   Cui, Xiaofeng
   Chaubey, Aditya
   Burg, Timothy C.
   Groff, Richard E.
   Burg, Karen J. L.
GP ASME
TI Precision printing of cells and biomaterials onto 3D matrices
SO PROCEEDINGS OF THE ASME INTERNATIONAL CONFERENCE ON MANUFACTURING
   SCIENCE AND ENGINEERING - 2007
LA English
DT Proceedings Paper
CT ASME International Conference on Manufacturing Science and Engineering
CY OCT 15-18, 2007
CL Atlanta, GA
SP ASME, Mfg Engn Div
AB The long term goal of our work is to develop a fabrication technique that allows precision placement of cells inside biomaterial constructs. Such spatial and temporal control of the chemistry and pattern geometry can provide new insights into fundamental aspects of cell-surface interactions. For example, cellular development can be dramatically effected by constraining cells to spread over a specific cell-surface contact area. The cell and biomaterial printing techniques developed here may prove particularly useful for exploring the interactions of anchorage-dependent cells with their environment in vitro. Our recent studies addressed the simultaneous printing of endothelial cells and biomaterials. The studies further demonstrated that cells can be printed onto polymer scaffolds or fibers without significant loss of cell activity. A combination of these methods may result in the construction of vascularized tissue with mechanical properties approaching those of native tissue.
C1 [Boland, Thomas; Cui, Xiaofeng; Chaubey, Aditya; Burg, Karen J. L.] Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
RP Boland, T (reprint author), Clemson Univ, Dept Bioengn, Clemson, SC 29634 USA.
RI Cui, Xiaofeng/A-7208-2012
OI Cui, Xiaofeng/0000-0003-2761-3934
CR Burg KJL, 2003, IEEE ENG MED BIOL, V22, P84, DOI 10.1109/MEMB.2003.1256277
   BURG KJL, 2006, IEEE EMBS
   CHAUBEY A, IN PRESS J BIOMEDICA
   Cummings CL, 2004, BIOMATERIALS, V25, P3699, DOI 10.1016/j.biomaterials.2003.10.073
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Odde DJ, 2000, BIOTECHNOL BIOENG, V67, P312, DOI 10.1002/(SICI)1097-0290(20000205)67:3<312::AID-BIT7>3.0.CO;2-F
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Xu T, 2006, BIOMATERIALS, V27, P3580, DOI 10.1016/j.biomaterials.2006.01.048
   Xu T, 2005, BIOMATERIALS, V26, P93, DOI 10.1016/j.biomaterials.2004.04.011
NR 9
TC 1
Z9 1
U1 0
U2 2
PU AMER SOC MECHANICAL ENGINEERS
PI NEW YORK
PA THREE PARK AVENUE, NEW YORK, NY 10016-5990 USA
BN 978-0-7918-4290-4
PY 2007
BP 77
EP 81
PG 5
WC Engineering, Manufacturing
SC Engineering
GA BHB71
UT WOS:000252104300009
DA 2018-10-19
ER

PT B
AU Ramakrishnan, V
AF Ramakrishnan, V.
BE Amde, AM
   Sabnis, G
   Tan, JSY
TI Performance characteristics of bacterial concrete - A smart biomaterial
SO PROCEEDINGS OF THE FIRST INTERNATIONAL CONFERENCE ON RECENT ADVANCES IN
   CONCRETE TECHNOLOGY
LA English
DT Proceedings Paper
CT 1st International Conference on Recent Advances in Concrete Technology
CY SEP 19-21, 2007
CL Washington, DC
SP Univ Maryland, Howard Univ, CI Premier Conf Org
DE biomineralization; B.pasteurii; alkali aggregate reactivity; sulfate
   attack; deicing chemicals; freeze thaw durability
AB Biomineralization is a process by which living organisms produce inorganic solids. Living organisms including bacteria form bones and teeth to natural pearls and shells. Bacteria are found everywhere in the universe and when they are present in concrete they form a biomaterial, a self-repairing material that can remediate the cracks and fissures in concrete. This paper presents the results of a novel technique in remediating cracks and fissures in concrete by utilizing microbiologically induced calcite (CaCo3). Bacillus Pasteruii, a common soil bacterium was used to induce calcite precipitation. This technique is highly desirable because the mineral precipitation induced as a result of microbial activities, is pollution free and natural. The effectiveness of this technique was evaluated by comparing the compressive strength and stiffness of cracked specimens remediated with bacteria and those of the control specimens (without bacteria). Experimental investigation was also conducted to determine the strength regaining capacity (modulus of rupture) of cracked beams remediated with different concentrations of bacteria. This paper also presents the results of a durability study on cement mortar beams treated with bacteria, exposed to alkaline, sulfate and freeze-thaw environments. Different concentrations of bacteria were used for the investigation. It was found that the use of bacteria improved the stiffness, compressive strength, modulus of rupture and durability of concrete. Scanning electron microscope (SEM) was used to document the role of microbiologically induced mineral precipitation in improving the strength and durability aspects of concrete. EDX spectrometer analysis of the precipitated crystals indicated abundance of calcium and the precipitation was confirmed to be calcite.
C1 S Dakota Sch Mines & Technol, Rapid City, SD 57701 USA.
RP Ramakrishnan, V (reprint author), S Dakota Sch Mines & Technol, Rapid City, SD 57701 USA.
CR GOLLAPUDI UK, 1995, CHEMOSPHERE, V30, P695, DOI 10.1016/0045-6535(94)00435-W
   KANTZAS A, 1992, CIM ANN TECHN C CALG
   Ramachandran SK, 2001, ACI MATER J, V98, P3
   Ramakrishnan V., 2003, P 25 INT C CEM MICR
   RAMAKRISHNAN V, 2000, SPIES 2000 S SMART M
   RAMAKRISHNAN V, 2001, P 10 INT C POLYM CON
   RAMAKRISHNAN V, 2002, P 24 INT C CEM MICRO
   Stocks-Fischer S, 1999, SOIL BIOL BIOCHEM, V31, P1563, DOI 10.1016/S0038-0717(99)00082-6
   Zhong L, 1995, 70 ANN TECHN C EXH S
NR 9
TC 11
Z9 12
U1 0
U2 6
PU DESTECH PUBLICATIONS, INC
PI LANCASTER
PA 439 DUKE STREET, LANCASTER, PA 17602-4967 USA
BN 978-1-932078-76-3
PY 2007
BP 67
EP 78
PG 12
WC Construction & Building Technology; Engineering, Civil
SC Construction & Building Technology; Engineering
GA BHI76
UT WOS:000253444700006
DA 2018-10-19
ER

PT S
AU Wen, HC
   Lin, YN
   Jian, SR
   Tseng, SC
   Weng, MX
   Liu, YP
   Lee, PT
   Chen, PY
   Hsu, RQ
   Wu, WF
   Chou, CP
AF Wen, Hua-Chiang
   Lin, Yao-Nan
   Jian, Sheng-Rui
   Tseng, Shih-Chun
   Weng, Ming-Xiang
   Liu, Yu-Pin
   Lee, Po-Te
   Chen, Pai-Yen
   Hsu, Ray-Quan
   Wu, Wen-Fa
   Chou, Chang-Pin
BE Meyer, E
   Hegner, M
   Gerber, C
   Guntherodt, HJ
TI Observation of Growth of Human Fibroblasts on Silver Nanoparticles
SO PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON NANOSCIENCE AND
   TECHNOLOGY
SE Journal of Physics Conference Series
LA English
DT Proceedings Paper
CT International Conference on Nanoscience and Technology
CY JUL 30-AUG 04, 2006
CL Basel, SWITZERLAND
DE Human Fibroblasts; Sliver; Nanoparticles
AB Silver nanoparticles have drawn extensive attention as biomaterial components. Human fibroblasts were grown on various concentrations of silver nanoparticles during the period observation. Normal viability (0% silver particles) was increased from 6 to 72 hours, increasing the amount of human fibroblasts (1.5x10(4) to 7x10(6) cells/well) normally. Nevertheless, at higher concentrations of silver nanoparticles (50%) 1.11x10(5) cells/well remained after 72 hours. Results indicated that the increase in the concentration of silver nanoparticles reduced the number of fibroblasts and affected their fission. Silver nanoparticles were found under the membranes of fibroblast following dry treatment. The number of tissues declined because the silver nanoparticles interrupted the fission mechanism during their development in vivo.
C1 [Wen, Hua-Chiang; Lin, Yao-Nan; Tseng, Shih-Chun; Weng, Ming-Xiang; Lee, Po-Te; Hsu, Ray-Quan; Chou, Chang-Pin] Natl Chiao Tung Univ, Inst Engn Mech, Hsinchu 300, Taiwan.
   [Jian, Sheng-Rui] Natl Chiao Tung Univ, Dept Electrophys, Hsinchu 300, Taiwan.
   [Liu, Yu-Pin; Chen, Pai-Yen; Wu, Wen-Fa] Natl Nano Device Lab, Hsinchu 300, Taiwan.
RP Wen, HC (reprint author), Natl Chiao Tung Univ, Inst Engn Mech, Hsinchu 300, Taiwan.
EM hcwen.me93g@nctu.edu.tw
FU National Science Council in Taiwan [NSC 94-2216-E-009-027]; National
   Nano Device Laboratories [NDL-95S-C-067]
FX This research was supported in part by the National Science Council in
   Taiwan under contract NSC 94-2216-E-009-027. Technical support from the
   National Nano Device Laboratories contract NDL-95S-C-067 is also
   acknowledged.
CR BECKER RO, 1978, J BONE JOINT SURG AM, V60, P871, DOI 10.2106/00004623-197860070-00001
   CUSACK L, 1997, ANGEW CHEM INT ED EN, V848
   de la Fuente JM, 2005, BIOCONJUGATE CHEM, V16, P1176, DOI 10.1021/bc050033+
   Farokhzad OC, 2005, ANAL CHEM, V77, P5453, DOI 10.1021/ac050312q
   Forster S, 1998, ADV MATER, V10, P195, DOI 10.1002/(SICI)1521-4095(199802)10:3<195::AID-ADMA195>3.0.CO;2-V
   MURRAY CB, 1995, SCIENCE, V270, P1335, DOI 10.1126/science.270.5240.1335
   SAUVAGE JPL, 1999, TRANSITION METALS SU, V5, P420
   SEARLE AB, 1913, BRIT MED J, P83
NR 8
TC 32
Z9 33
U1 0
U2 7
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1742-6588
J9 J PHYS CONF SER
PY 2007
VL 61
BP 445
EP 449
DI 10.1088/1742-6596/61/1/089
PG 5
WC Chemistry, Physical; Nanoscience & Nanotechnology; Physics, Atomic,
   Molecular & Chemical; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Physics
GA BVG12
UT WOS:000291445400089
OA Bronze
DA 2018-10-19
ER

PT S
AU Pareta, RA
   Webster, TJ
AF Pareta, Rajesh A.
   Webster, Thomas J.
GP ISOPE
TI Structural nanomaterials for the regeneration of numerous tissues
SO PROCEEDINGS OF THE SEVENTEENTH (2007) INTERNATIONAL OFFSHORE AND POLAR
   ENGINEERING CONFERENCE, VOL 1- 4, PROCEEDINGS
SE International Offshore and Polar Engineering Conference Proceedings
LA English
DT Proceedings Paper
CT 17th International Offshore and Polar Engineering Conference (ISOPE
   2007)
CY JUL 01-06, 2007
CL Lisbon, PORTUGAL
DE titanium; helical rosette nanotubes; nano-patterning; nano-roughness;
   osteoblasts; stem cells; macrophages
ID OSTEOBLAST ADHESION; NANOPHASE CERAMICS
AB Nanotechnology is being used to mimic structural components of our tissues in synthetic materials intended for various implant applications. Nanomaterials have increased surface area, surface roughness, and energy which optimally interact with proteins that control cell functions to regenerate tissues. Coupled with such unique surface properties that promote cell functions, nanomaterials can now be fabricated to possess structural properties necessary for supporting physiological loads (as in the case of orthopedic implants) and/or viscoelastic properties (as in the case of vascular grafts). Novel fabrication methods are being used (such as 3D printing) to create hierarchical tissue substitutes which mimic the micron and nano structure of our tissues. Recent studies have highlighted that when compared to currently implanted materials, nanomaterials with random and oriented nanofeatures promote optimal initial protein interactions necessary to mediate cell adhesion and subsequent tissue growth. This has been demonstrated for a wide range of implant chemistries (from ceramics to metals to polymers) and for a wide range of tissues (including bone, vascular, cartilage, bladder, and the central and peripheral nervous system). Recent results have even incorporated the use of stem cells with carbon nanotubes to heal stroke damage in rats. importantly, these results have been seen at the in vitro and in vivo level. Lastly, through the use of existing antimicrobial chemistries, decreased bacteria infection has been observed through the use of nanomaterials. Since implant infection is a major cause of biomaterial failure, such promoted functions of cells to regenerate tissues coupled with decreased bacteria infection highlights a promising future for nanomaterials in tissue engineering applications. Such materials may also show promise for any application in which bacteria functions should be minimized (i.e., for naval and offshore applications).
C1 [Pareta, Rajesh A.] Brown Univ, Div Engn, Providence, RI 02912 USA.
   Brown Univ, Div Orthoped, Providence, RI 02912 USA.
RP Pareta, RA (reprint author), Brown Univ, Div Engn, Providence, RI 02912 USA.
CR Balasundaram G, 2006, BIOMATERIALS, V27, P2798, DOI 10.1016/j.biomaterials.2005.12.008
   Chun AL, 2005, BIOMATERIALS, V26, P7304, DOI 10.1016/j.biomaterials.2005.05.080
   Gutwein LG, 2004, BIOMATERIALS, V25, P4175, DOI 10.1016/j.biomaterials.2003.10.090
   LEE JE, 2006, MATER RES SOC S P, V915, pR7
   Park GE, 2005, BIOMATERIALS, V26, P3075, DOI 10.1016/j.biomaterials.2004.08.005
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002
   Webster TJ, 2001, BIOMATERIALS, V22, P1327, DOI 10.1016/S0142-9612(00)00285-4
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
NR 9
TC 0
Z9 0
U1 1
U2 7
PU INTERNATIONAL SOCIETY OFFSHORE& POLAR ENGINEERS
PI CUPERTINO
PA PO BOX 189, CUPERTINO, CA 95015-0189 USA
SN 1098-6189
BN 978-1-880653-68-5
J9 INT OFFSHORE POLAR E
PY 2007
BP 2846
EP +
PG 2
WC Energy & Fuels; Engineering, Marine; Engineering, Ocean; Engineering,
   Petroleum; Engineering, Mechanical
SC Energy & Fuels; Engineering
GA BGU91
UT WOS:000250717703008
DA 2018-10-19
ER

PT J
AU Lyons, RE
   Lesieur, E
   Kim, M
   Wong, DCC
   Huson, MG
   Nairn, KM
   Brownlee, AG
   Pearson, RD
   Elvin, CM
AF Lyons, Russell E.
   Lesieur, Emmanuelle
   Kim, Misook
   Wong, Darren C. C.
   Huson, Mickey G.
   Nairn, Kate M.
   Brownlee, Alan G.
   Pearson, Roger D.
   Elvin, Christopher M.
TI Design and facile production of recombinant resilin-like polypeptides:
   gene construction and a rapid protein purification method
SO PROTEIN ENGINEERING DESIGN & SELECTION
LA English
DT Article
DE expression; purification; repetitive polypeptides; resilin; synthetic
   genes
ID RUBBER-LIKE PROTEIN; ELASTIC PROTEINS; EXPRESSION; SILK; POLYMERS;
   CUTICLE; MODEL
AB Resilin is an elastic protein found in specialized regions of the cuticle of insects, which displays unique resilience and fatigue lifetime properties. As is the case with many elastomeric proteins, including elastin, gliadin and spider silks, resilin contains distinct repetitive domains that appear to confer elastic properties to the protein. Recent work within our laboratory has demonstrated that cloning and expression of exon 1 of the Drosophila melanogaster CG15920 gene, encoding a putative resilin-like protein, results in a recombinant protein that can be photochemically crosslinked to form a highly resilient, elastic biomaterial (Rec1 resilin). The current study describes a recursive cloning strategy for generating synthetic genes encoding multiple copies of consensus polypeptides, based on the repetitive domains within resilin-like genes from D. melanogaster and Anopheles gambiae. A simple non-chromatographic purification method that can be applied to these synthetic proteins and Rec1 is also reported. These methods for the design and purification of resilin-like periodic polypeptides will facilitate the future investigation of structural and functional properties of resilin, and the development of novel highly resilient biomaterials.
C1 CSIRO Livestock Ind, Queensland Biosci Precinct, St Lucia, Qld 4072, Australia.
   CSIRO Text & Fibre Technol, Geelong, Vic 3216, Australia.
   CSIRO Mfg & Infrastruct Technol, Clayton, Vic 3168, Australia.
RP Lyons, RE (reprint author), CSIRO Livestock Ind, Queensland Biosci Precinct, St Lucia, Qld 4072, Australia.
EM Russell.Lyons@csiro.au
RI Russell, Lyons/H-7942-2013; Lyons, Russell/A-7051-2011; elvin,
   chris/H-2333-2013; Huson, Mickey/K-2474-2012
OI Russell, Lyons/0000-0002-0795-7994; Huson, Mickey/0000-0003-1859-7805
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   ANDERSEN SO, 1964, BIOCHIM BIOPHYS ACTA, V93, P213, DOI 10.1016/0304-4165(64)90289-2
   ANDERSEN SO, 1995, INSECT BIOCHEM MOLEC, V25, P153, DOI 10.1016/0965-1748(94)00052-J
   Ardell DH, 2001, INSECT BIOCHEM MOLEC, V31, P965, DOI 10.1016/S0965-1748(01)00044-3
   Bennet-Clark HC, 1999, J EXP BIOL, V202, P3347
   BENNETCLARK HC, 1967, J EXP BIOL, V47, P59
   COLES GC, 1966, J INSECT PHYSIOL, V12, P679, DOI 10.1016/0022-1910(66)90114-4
   Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541
   ELLIOTT GF, 1965, J MOL BIOL, V13, P791, DOI 10.1016/S0022-2836(65)80144-9
   Elmorjani K, 1997, BIOCHEM BIOPH RES CO, V239, P240, DOI 10.1006/bbrc.1997.7464
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Fievet J, 2004, PROTEOMICS, V4, P1939, DOI 10.1002/pmic.200300731
   GIBSON W, 1974, J VIROL, V13, P155
   Gosline J, 2002, PHILOS T ROY SOC B, V357, P121, DOI 10.1098/rstb.2001.1022
   GROSS AJ, 1959, J BIOL CHEM, V234, P1611
   JENSEN M, 1962, PHILOS T ROY SOC B, V245, P137, DOI 10.1098/rstb.1962.0008
   Kim M, 2007, PROTEIN EXPRES PURIF, V52, P230, DOI 10.1016/j.pep.2006.11.003
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lewis RV, 1996, PROTEIN EXPRES PURIF, V7, P400, DOI 10.1006/prep.1996.0060
   Martino M, 2002, MACROMOL BIOSCI, V2, P319, DOI 10.1002/1616-5195(200209)2:7<319::AID-MABI319>3.0.CO;2-L
   Meyer DE, 2002, BIOMACROMOLECULES, V3, P357, DOI 10.1021/bm015630n
   Meyer DE, 2004, BIOMACROMOLECULES, V5, P846, DOI 10.1021/bm034215n
   Neylon C, 2000, BIOCHEMISTRY-US, V39, P11989, DOI 10.1021/bi001174w
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Rabilloud T., 2000, PROTEOME RES 2 DIMEN, P107
   Rousseau R, 2004, BIOPHYS J, V86, P1393, DOI 10.1016/S0006-3495(04)74210-1
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Sensenig AT, 2003, J EXP BIOL, V206, P771, DOI 10.1242/jeb.00182
   Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016
   TAL M, 1985, J BIOL CHEM, V260, P9976
   Tatham AS, 2002, PHILOS T ROY SOC B, V357, P229, DOI 10.1098/rstb.2001.1031
   Topilina NI, 2006, BIOMACROMOLECULES, V7, P1104, DOI 10.1021/bm0509016
   URRY DW, 1969, NATURE, V222, P795, DOI 10.1038/222795a0
   Vrhovski B, 1998, EUR J BIOCHEM, V258, P1, DOI 10.1046/j.1432-1327.1998.2580001.x
   Weber K, 1972, Methods Enzymol, V26, P3
   WEISFOGH T, 1961, J MOL BIOL, V3, P520, DOI 10.1016/S0022-2836(61)80018-1
   WEISFOGH T, 1961, J MOL BIOL, V3, P648, DOI 10.1016/S0022-2836(61)80028-4
   WEISFOGH T, 1960, J EXP BIOL, V37, P889
   Yoda R, 1998, J BIOMAT SCI-POLYM E, V9, P561, DOI 10.1163/156856298X00046
NR 39
TC 63
Z9 65
U1 4
U2 29
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1741-0126
EI 1741-0134
J9 PROTEIN ENG DES SEL
JI Protein Eng. Des. Sel.
PD JAN
PY 2007
VL 20
IS 1
BP 25
EP 32
DI 10.1093/protein/gzl050
PG 8
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 139KR
UT WOS:000244431200004
PM 17218334
OA Bronze
DA 2018-10-19
ER

PT J
AU Archakov, AI
   Ivanov, YD
   Lisitsa, AV
   Zgoda, VG
AF Archakov, Alexander Ivanovich
   Ivanov, Yurii Dmitrievich
   Lisitsa, Andrey Valerevich
   Zgoda, Victor Gavrilovich
TI AFM fishing nanotechnology is the way to reverse the Avogadro number in
   proteomics
SO PROTEOMICS
LA English
DT Editorial Material
DE atomic-force microscopy; biospecific fishing; molecular detectors;
   nanobiotechnology
ID MASS-SPECTROMETRY; ELECTRICAL DETECTION; PLASMA-PROTEOME; PROTEINS; DNA;
   PLATFORM; ARRAYS
AB Future development of proteomics may be hindered by limitations in the concentration sensitivity of widespread technological approaches. The concentration sensitivity limit (CSL) of currently used approaches, like 2-DE/LC separation coupled with MS detection, etc., varies from 10(-9) to 10(-12) M. Therefore, proteomic technologies enable detection of up to 20% of the protein species present in the plasma. New technologies, like atomic force microscopy (AFM molecular detector), enable the counting of single molecules, whereas biospecific fishing can be used to capture these molecules from the biomaterial. At the same time, fishing also has thermodynamic limitations due to the reversibility of the binding. In cases where the fishing becomes irreversible, its combination with an AFM detector enables the registration of single protein molecules, and that opens up a way to lower the CSL down to the reverse Avogadro number.
C1 Russian Acad Med Sci, Inst Biomed Chem, Moscow 119121, Russia.
RP Archakov, AI (reprint author), Russian Acad Med Sci, Inst Biomed Chem, Pogodinskaya St 10, Moscow 119121, Russia.
EM archak@ibmc.msk.ru
CR Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511
   ALBRECHTBUEHLER G, 1990, INT REV CYTOL, V120, P191
   Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200
   Bjorhall K, 2005, PROTEOMICS, V5, P307, DOI 10.1002/pmic.20040900
   Cutler P, 2003, PROTEOMICS, V3, P3, DOI 10.1002/pmic.200390007
   Fologea D, 2005, NANO LETT, V5, P1905, DOI 10.1021/nl051199m
   Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473
   Garcia-Parajo MF, 1999, CYTOMETRY, V36, P239, DOI 10.1002/(SICI)1097-0320(19990701)36:3<239::AID-CYTO14>3.0.CO;2-Y
   Ivanov YD, 2006, PROTEOMICS, V6, P1399, DOI 10.1002/pmic.200402087
   JONSSON U, 1991, BIOTECHNIQUES, V11, P620
   Kanaeva IP, 2005, TOXICOL IN VITRO, V19, P805, DOI 10.1016/j.tiv.2005.03.016
   Kuster B, 1998, CURR OPIN STRUC BIOL, V8, P393, DOI 10.1016/S0959-440X(98)80075-4
   Lee DH, 1996, NATURE, V382, P525, DOI 10.1038/382525a0
   LEVIS V, 1977, BIOCHEMISTRY-US, V16, P5650
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   MULLIS K, 1985, Patent No. 4683202
   Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358
   OMENN GS, 2004, WORKING SUMMARY  MAR
   Patolsky F, 2004, P NATL ACAD SCI USA, V101, P14017, DOI 10.1073/pnas.0406159101
   RUZICKA V, 1993, SCIENCE, V260, P698, DOI 10.1126/science.8480182
   Schweitzer B, 2000, P NATL ACAD SCI USA, V97, P10113, DOI 10.1073/pnas.170237197
   Sonksen CP, 1998, ANAL CHEM, V70, P2731, DOI 10.1021/ac9800457
   VORDERWULBECKE S, 2005, SYST NAT METHODS, V2, P393
   White IR, 2004, ELECTROPHORESIS, V25, P3048, DOI 10.1002/elps.200405947
   Wiese R, 2001, CLIN CHEM, V47, P1451
   Wilkins MR, 2006, PROTEOMICS, V6, P4, DOI 10.1002/pmic.200500856
   Wu GH, 2001, NAT BIOTECHNOL, V19, P856, DOI 10.1038/nbt0901-856
   Xiang R, 2004, J PROTEOME RES, V3, P1278, DOI 10.1021/pr049852e
   Zgoda V, 2006, PROTEOMICS, V6, P4662, DOI 10.1002/pmic.200600342
   Zheng GF, 2005, NAT BIOTECHNOL, V23, P1294, DOI 10.1038/nbt1138
NR 30
TC 51
Z9 70
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD JAN
PY 2007
VL 7
IS 1
BP 4
EP 9
DI 10.1002/pmic.200600467
PG 6
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 129XH
UT WOS:000243762900001
PM 17154275
OA Bronze
DA 2018-10-19
ER

PT J
AU Yilmaz, E
   Adali, T
   Yilmaz, O
   Bengisu, M
AF Yilmaz, E.
   Adali, T.
   Yilmaz, O.
   Bengisu, M.
TI Grafting of poly(triethylene glycol dimethacrylate) onto chitosan by
   ceric ion initiation
SO REACTIVE & FUNCTIONAL POLYMERS
LA English
DT Article
DE redox initiation; cerium ammonium nitrate; copolymerization; water
   soluble; cross linking; oxidation
ID COPOLYMERIZATION; BIOMATERIAL; ACRYLATE
AB Grafting of poly(triethylene glycol dimethacrylate) (poly(TriEGDMA)), onto chitosan by ceric ion initiation has been investigated. The grafting conditions were optimized by studying the effect of monomer and initiator concentrations as well as time and temperature. Products with lower grafting yields (90-261%) were water and acid soluble. Those with higher grafting yields (350-868%) were insoluble, indicating a cross linked structure. Chitosan-graft-poly(TriEGDMA) products had a lower thermal stability than chitosan as revealed by DSC analysis. C-13 NMR and FTIR analyses suggested a grafting mechanism that proceeds via oxidation and chain scission of chitosan. The products are degraded by the enzymes lysozyme, lipase and alpha-amylase-protease. (c) 2006 Elsevier B.V. All rights reserved.
C1 Eastern Mediterranean Univ, Dept Chem, Gazimagusa, Turkey.
   Girne Amer Univ, Grad Sch Social & Appl Sci, Karaoglanoglu Girne, Turkey.
   Eastern Mediterranean Univ, Dept Ind Engn, Gazimagusa, Turkey.
RP Yilmaz, E (reprint author), Eastern Mediterranean Univ, Dept Chem, Via Mersin 10, Gazimagusa, Turkey.
EM elvan.yilmaz@emu.edu.tr
RI Yilmaz, Elvan/A-8528-2008; YILMAZ, OSMAN/A-3285-2008
CR Berger J, 2004, EUR J PHARM BIOPHARM, V57, P19, DOI 10.1016/s0939-6411(03)00161-9
   Bhattacharyya S. N., 1983, PROG POLYM SCI, V10, P171
   Caner H, 1998, EUR POLYM J, V34, P493
   Don TM, 2002, J APPL POLYM SCI, V86, P3057, DOI 10.1002/app.11329
   EBERT A, 1997, CHITIN HDB, P137
   El-Tahlawy K, 2001, J APPL POLYM SCI, V82, P683, DOI 10.1002/app.1896
   ELTAHLAWY K, 2001, J APPL POLYM SCI, V89, P2003
   Gorochovceva N, 2004, EUR POLYM J, V40, P685, DOI 10.1016/j.eurpolymj.2003.12.005
   Hsu SC, 2002, POLYM DEGRAD STABIL, V75, P73, DOI 10.1016/S0141-3910(01)00205-1
   Kurita K, 2001, PROG POLYM SCI, V26, P1921, DOI 10.1016/S0079-6700(01)00007-7
   Lee JW, 2004, J BIOMAT SCI-POLYM E, V15, P1065, DOI 10.1163/1568562041526496
   Liu YH, 2003, J APPL POLYM SCI, V89, P2283, DOI 10.1002/app.12102
   MANSOUR OY, 1985, PROG POLYM SCI, V11, P91
   McDowall D. J., 1984, PROG POLYM SCI, V10, P1, DOI DOI 10.1016/0079-6700(84)90005-4
   Nordborg A, 2005, J SEP SCI, V28, P2401, DOI 10.1002/jssc.200500222
   Sashiwa H, 2004, PROG POLYM SCI, V29, P887, DOI 10.1016/j.progpolymsci.2004.04.001
   Schanzenbach D., 1997, CHITIN HDB, P199
   Singh V, 2005, J APPL POLYM SCI, V95, P820, DOI 10.1002/app.21245
   Sinha VR, 2004, INT J PHARM, V274, P1, DOI 10.1016/j.ijpharm.2003.12.026
   Tsubokawa N, 2000, REACT FUNCT POLYM, V43, P341, DOI 10.1016/S1381-5148(99)00065-6
   Xie WM, 2002, CARBOHYD POLYM, V50, P35, DOI 10.1016/S0144-8617(01)00370-8
   YazdaniPedram M, 1997, J APPL POLYM SCI, V63, P1321, DOI 10.1002/(SICI)1097-4628(19970307)63:10<1321::AID-APP11>3.0.CO;2-7
   Yilmaz E, 2004, ADV EXP MED BIOL, V553, P59
   Yu L, 2003, J APPL POLYM SCI, V90, P2855, DOI 10.1002/app.13011
   Zohuriaan-Mehr MJ, 2003, POLYM ADVAN TECHNOL, V14, P508, DOI 10.1002/pat.362
NR 25
TC 26
Z9 26
U1 2
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1381-5148
J9 REACT FUNCT POLYM
JI React. Funct. Polym.
PD JAN
PY 2007
VL 67
IS 1
BP 10
EP 18
DI 10.1016/j.reactfunctpolym.2006.08.003
PG 9
WC Chemistry, Applied; Engineering, Chemical; Polymer Science
SC Chemistry; Engineering; Polymer Science
GA 130VS
UT WOS:000243827700002
DA 2018-10-19
ER

PT S
AU Milicevic, D
   Trifunovic, S
   Ignjatovic, N
   Suljovrujic, E
AF Milicevic, D.
   Trifunovic, S.
   Ignjatovic, N.
   Suljovrujic, E.
BE Uskokovic, DP
   Milonjic, SK
   Rakovic, DI
TI The influence of gamma radiation on the glass transition of
   hydroxyapatite/poly L-lactide composite
SO RESEARCH TRENDS IN CONTEMPORARY MATERIALS SCIENCE
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 8th Conference of the Yugoslav-Materials-Research-Society (Yu-MRS)
CY SEP 04-08, 2006
CL Herceg Novi, MONTENEGRO
SP Yugoslav Mat Res Soc
DE apparent activation energy; gamma radiation; glass transition;
   hydroxyapatite/poly L-lactide
ID STRUCTURAL RELAXATION; ENTHALPY RELAXATION; POLY(L-LACTIDE);
   STERILIZATION; MICROSPHERES; DSC
AB Hydroxyapatite/poly L-lactide (HAp/PLLA) is a composite biomaterial which has been widely utilized for substitution and reparation of the hard bone tissue. It is well known that gamma irradiation has been successfully employed in the modification/sterilization of such porous composites and that it has advantages over other procedures. In this study, differential scanning calorimetry (DSC) measurements were made to investigate the influence of the radiation on glass transition behavior and structural relaxation, as well as to estimate the activation energy for this process. The apparent activation energy Delta H* for structural relaxation in the glass transition region was determined on the basis of the heating rate dependence of the glass transition temperature T-g. Furthermore, the results were correlated with those obtained by gel permeation chromatography (GPC). Our findings support the fact that the radiation-induced chain scission in the PLLA phase is the main reason for the decrease of the glass transition temperature and/or activation energy with the absorbed dose.
C1 [Milicevic, D.; Trifunovic, S.; Suljovrujic, E.] Vinca Inst Nucl Sci, POB 522, Belgrade 11001, Serbia.
   [Ignjatovic, N.] Serbian Acad Arts & Sci, Inst Tech Sci, Belgrade, Serbia.
RP Milicevic, D (reprint author), Vinca Inst Nucl Sci, POB 522, Belgrade 11001, Serbia.
EM dejanmilicevic@vin.bg.ac.yu; sasatsj@vin.bg.ac.yu;
   advamat@itn.sanu.ac.yu; edin@vin.bg.ac.yu
RI Ignjatovic, Nenad/C-4489-2008
OI Ignjatovic, Nenad/0000-0002-5749-094X; Suljovrujic,
   Edin/0000-0001-8774-4341
CR ALBANO C, 2006, NUCL INSTRUM METH B, V247, P331, DOI DOI 10.1016/J.NIMB.2006.03.004
   BLACK J, 1992, BIOL PERFORMANCE MAT, P21
   Godard ME, 1998, J NON-CRYST SOLIDS, V235, P635, DOI 10.1016/S0022-3093(98)00571-7
   Grimau M, 2001, J CHEM PHYS, V114, P6417, DOI 10.1063/1.1355288
   HODGE IM, 1994, J NON-CRYST SOLIDS, V169, P211, DOI 10.1016/0022-3093(94)90321-2
   Ignjatovic N, 2004, J BIOMED MATER RES B, V71B, P284, DOI 10.1002/jbm.b.30093
   Isama K, 2002, J BIOMAT SCI-POLYM E, V13, P153, DOI 10.1163/156856202317414348
   Loo JSC, 2005, BIOMATERIALS, V26, P1359, DOI 10.1016/j.biomaterials.2004.05.001
   Mano JF, 2005, POLYMER, V46, P8258, DOI 10.1016/j.polymer.2005.06.096
   Montanari L, 1998, J CONTROL RELEASE, V56, P219, DOI 10.1016/S0168-3659(98)00082-0
   Moynihan CT, 1996, THERMOCHIM ACTA, V280, P153, DOI 10.1016/0040-6031(95)02781-5
   MOYNIHAN CT, 1974, J PHYS CHEM-US, V78, P2673, DOI 10.1021/j100619a008
   Nazhat SN, 2001, J BIOMED MATER RES, V58, P335, DOI 10.1002/jbm.1026
   Nijsen JFW, 2001, BIOMATERIALS, V22, P3073, DOI 10.1016/S0142-9612(01)00055-2
   PARK JB, 1992, BIOMATERIALS INTRO, P162
   PRIVALKO VP, 1986, MACROMOLECULES, V19, P901, DOI 10.1021/ma00157a071
   Rabek J., 1980, EXPT METHODS POLYM C
   Shikinami Y, 2005, BIOMATERIALS, V26, P5542, DOI 10.1016/j.biomaterials.2005.02.016
   SINGH A, 1991, RAD PROCESSING POLYM, P9
   Sintzel MB, 1997, DRUG DEV IND PHARM, V23, P857, DOI 10.3109/03639049709148693
   Suljovrujic E., 2003, RADIAT PHYS CHEM, V67, P375
   SULJOVRUJIC E, 2006, IN PRESS RAD PHYS CH
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P433, DOI 10.1002/jbm.820270404
   Weir NA, 2004, BIOMATERIALS, V25, P3939, DOI 10.1016/j.biomaterials.2003.10.076
NR 24
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
J9 MATER SCI FORUM
PY 2007
VL 555
BP 497
EP +
DI 10.4028/www.scientific.net/MSF.555.497
PG 2
WC Materials Science, Multidisciplinary; Physics, Applied; Physics,
   Condensed Matter
SC Materials Science; Physics
GA BGQ01
UT WOS:000249653700080
DA 2018-10-19
ER

PT J
AU Andronescu, E
   Nicola, O
   Barsan, C
   Ghitulica, C
AF Andronescu, Ecaterina
   Nicola, Oana
   Barsan, Costel
   Ghitulica, Cristina
TI Ferrimagnetic biomaterials with applications in medicine
SO REVISTA ROMANA DE MATERIALE-ROMANIAN JOURNAL OF MATERIALS
LA English
DT Article
DE ferrimagnetic; biomaterials; saturation magnetization
AB The ferrimagnetic biomaterials have interesting applications in the treatment of cancerous tumors, by local heating in magnetic field. The present paper shows obtaining and characterization methods for ferrimagnetic biomaterials. The compounds of the biomaterial are magnetite and a bioactive glass from the system CaO - SiO2 - P2O5 - MgO - CaF2.
   The obtained powders have been obtained by solid state reactions of the raw materials, in different proportions and conditions of thermal treatment The specific ceramic properties, chemical stability and magnetic properties of the obtained materials have been investigated.
   The connections between the composition of the ceramic materials and the conditions of thermal treatment have been studied.
C1 [Andronescu, Ecaterina; Nicola, Oana; Barsan, Costel; Ghitulica, Cristina] Univ POLITEHN Bucuresti, Bucharest, Romania.
RP Ghitulica, C (reprint author), Univ POLITEHN Bucuresti, Str G Polizu Nr 1,Sect 1, Bucharest, Romania.
EM cghitulica@yahoo.com
RI Ghitulica, Cristina/J-1879-2012
CR BIRSAN M, 2003, 8 ECERS 29 JUN 03 JU
   Bretcanu O, 2006, J MAGN MAGN MATER, V300, P412, DOI 10.1016/j.jmmm.2005.05.030
   HENESS G, 2004, MATER FORUM, V27, P104
   Lee YK, 2003, J MATER SCI, V38, P4221, DOI 10.1023/A:1026346109737
   Leventouri T, 2005, BIOMATERIALS, V26, P4924, DOI 10.1016/j.biomaterials.2005.01.017
   Safarikova M, 2001, MAGN ELECT SEP, V10, P223, DOI DOI 10.1155/2001/57434
   STAUFFER PR, 1982, NATL CANC I MONOGR, V61, P483
NR 7
TC 3
Z9 3
U1 0
U2 4
PU SERBAN SOLACOLU FOUNDATION
PI BUCUREST
PA STR GHEORGHE POLIZU NR 1, COD 011061 SECTOR 1, BUCUREST, 00000, ROMANIA
SN 1583-3186
J9 REV ROM MAT
JI Rev. Rom. Mat.
PY 2007
VL 37
IS 2
BP 122
EP 127
PG 6
WC Construction & Building Technology; Materials Science, Multidisciplinary
SC Construction & Building Technology; Materials Science
GA 289BX
UT WOS:000255031100005
DA 2018-10-19
ER

PT J
AU Zielak, JC
   Mathias, SA
   Giovanini, AF
   Mathias, AL
AF Zielak, J. C.
   Mathias, S. A.
   Giovanini, A. F.
   Mathias, A. L.
TI Oral bone grafting in a rat model and the use of scanning electron
   Microscopy for tissue morphology evaluation
SO SCANDINAVIAN JOURNAL OF LABORATORY ANIMAL SCIENCE
LA English
DT Article
ID PERIODONTAL-LIGAMENT CELLS; IN-VITRO; DEMINERALIZED BONE; REGENERATION;
   MATRIX; EXPRESSION; INTERFACE; DEFECTS
AB Oral bone grafting is a procedure widely performed in current dentistry. Several biomaterials fit this purpose. The aim of this study was to use scanning electron microscopy (SEM) to evaluate the ultrastructural aspects of bone repair in a rat model, with periodontal tissues involved. Two groups (I and 11) of 20 animals each were operated on to create a surgical defect with a round carbide burr (3mm) on the right side of their mandible, anterior to the mental foramen. Both groups were evenly divided with 5 animals each to receive the application of either bifasic calcium phosphate bioceramic (B), lyophilized deproteinated bovine bone (L), bifasic bioceramic associated with lyophilized deproteinated bovine bone (BL), or no biomaterial (control or Q. Group I was monitored for one week and group 11 for three weeks prior to euthanasia. Hemi-mandibles were prepared for SEM analysis. Parameters such as exposure of incisive root surface, width of the cross-section of filiform structures and presence of mineralized-like globuli (area) were evaluated. The findings of this study suggested that surgical procedures for introduction or not of biomaterial did not cause problems with normal feeding to the animals. Both of the biomaterials used promoted a periodontal ligament involvement. Fibers (single filiform structures) could be detected in a range from 0.07 to 0. 18 mu m of diameter, except for L that was larger - considered to be due to residual fibers of bovine origin. C bundles (groups of fibers) showed larger width of cross-section than with the use of biomaterials. Globuli areas (mineralization) were smaller to C than with the biontaterials use. B showed larger globuli areas, suggesting slow incorporation. It was concluded that the use of these biontaterials favored maintenance of tissue volume although slowing remodeling, and the combination (BL) presented the best performance.
C1 Univ Fed Parana, Ctr Politecn, Dept Chem Engn, Postgrad Biotechnol Proc, BR-81539990 Curitiba, Parana, Brazil.
   Univ Fed Parana, Tech Sch, Curitiba, Parana, Brazil.
   Positivo Univ Ctr, Fac Dent, Curitiba, Parana, Brazil.
RP Zielak, JC (reprint author), Univ Fed Parana, Ctr Politecn, Dept Chem Engn, Postgrad Biotechnol Proc, R Francisco H Santos 100,Caixa Postal 19081, BR-81539990 Curitiba, Parana, Brazil.
EM jzielak@unicenp.edu.br
RI Giovanini, Allan/K-5215-2012
OI Giovanini, Allan/0000-0002-1637-2955
CR Bartee B K, 1995, J Oral Implantol, V21, P88
   Benhayoune H, 2000, BIOMATERIALS, V21, P235, DOI 10.1016/S0142-9612(99)00138-6
   Bohning BP, 1999, J ENDODONT, V25, P81, DOI 10.1016/S0099-2399(99)80001-6
   Bosch C, 1998, J CRANIOFAC SURG, V9, P310, DOI 10.1097/00001665-199807000-00004
   Brett PM, 2002, J DENT RES, V81, P776, DOI 10.1177/154405910208101111
   CAVALIERE I, 2001, REV BRAS CIRURG IMPL, V8, P64
   Edwards JT, 1998, CLIN ORTHOP RELAT R, P219
   Ferreira Rivea Ines, 2002, J Dent Educ, V66, P1381
   GENDLER E, 1986, J BIOMED MATER RES, V20, P687, DOI 10.1002/jbm.820200603
   GREENE E, 1959, ANATOMY RAT
   Hulshoff JEG, 1998, J BIOMED MATER RES, V40, P464, DOI 10.1002/(SICI)1097-4636(19980605)40:3<464::AID-JBM18>3.0.CO;2-J
   Karimbux N Y, 1995, J Oral Implantol, V21, P107
   Kihara Isao, 1998, Congenital Anomalies, V38, P259, DOI 10.1111/j.1741-4520.1998.tb00809.x
   Knabe C, 2000, J BIOMED MATER RES, V52, P498, DOI 10.1002/1097-4636(20001205)52:3<498::AID-JBM8>3.0.CO;2-P
   Legeros RZ, 2003, J MATER SCI-MATER M, V14, P201, DOI 10.1023/A:1022872421333
   Matsuzaka K, 1999, BIOMATERIALS, V20, P1293, DOI 10.1016/S0142-9612(99)00029-0
   MORAES SH, 2006, REV ABO NAC, V14, P156
   Ohlsson C, 1998, ENDOCR REV, V19, P55, DOI 10.1210/er.19.1.55
   ORR RD, 1992, CELL MATER, V2, P241
   RODRIGUEZ Y, 1997, MINERVA STOMATOL, V46, P635
   Service RF, 2000, SCIENCE, V289, P1498, DOI 10.1126/science.289.5484.1498
   SHEN X, 1993, CELL MATER, V3, P257
   Shimazu A, 2003, J PERIODONTAL RES, V38, P122, DOI 10.1034/j.1600-0765.2003.01645.x
   Silveira M., 1998, TECNICAS BASICAS MIC
   Suda K, 1999, ARCH HISTOL CYTOL, V62, P231, DOI 10.1679/aohc.62.231
   Van de Putte K A, 1965, Clin Orthop Relat Res, V43, P257
   Wikesjo UME, 1999, J CLIN PERIODONTOL, V26, P392, DOI 10.1034/j.1600-051X.1999.260610.x
   Zahedi S, 1998, J PERIODONTOL, V69, P1238, DOI 10.1902/jop.1998.69.11.1238
NR 28
TC 3
Z9 3
U1 0
U2 0
PU SCANDINAVIAN FEDERATION LABORATORY ANIMAL SCIENCE
PI SOBORG
PA C/O MARGARETA BERTRAM, NATIONAL FOOD AGENCY, MORKHOJ BYGHADE 19, DK-2860
   SOBORG, DENMARK
SN 0901-3393
J9 SCAND J LAB ANIM SCI
JI Scand. J. Lab. Anim. Sci.
PY 2007
VL 34
IS 3
BP 201
EP 210
PG 10
WC Veterinary Sciences
SC Veterinary Sciences
GA 223FI
UT WOS:000250354600005
DA 2018-10-19
ER

PT J
AU Saha, D
   Dhabal, S
   Bose, PK
   Banthia, AK
AF Saha, D.
   Dhabal, S.
   Bose, P. K.
   Banthia, A. K.
TI Production and biocompatibility evaluation of carbon fiber reinforced
   polyethylene composite for acetabular cup
SO SCIENCE AND ENGINEERING OF COMPOSITE MATERIALS
LA English
DT Article
DE hip joint prosthesis; biomaterial; composite; wear; biocompatibility
ID WEAR
AB Composites of Ultra High Molecular Weight Polyethylene (UHMWPE) and High Density Polyethylene (HDPE) reinforced with 10,15 and 20 percent of carbon fiber were prepared by a technique of uniform mixing and moulding. Acetabular cups were produced by compression moulding methods. A new walk simulator was also developed in-house for testing the tribological performances of these cups. The result from walk simulator test is encouraging. Using human walk simulator machine did in vitro wear testing. Characterizations were performed to analyze the microstructure, composition, phase purity and crystalline by using XRD, DSC/TGA. Biocompatibility test was done by cytotoxicity and MTT assay methods. Above these experiments show that developed composites may be used as bone substitute materials of hard tissue replacement.
C1 Jadavpur Univ, Dept Mech Engn, Kolkata 700032, W Bengal, India.
   Indian Inst Technol, Dept Phys, Kharagpur 721302, W Bengal, India.
   Indian Inst Technol, Ctr Mat Sci, Kharagpur 721302, W Bengal, India.
RP Saha, D (reprint author), Jadavpur Univ, Dept Mech Engn, Kolkata 700032, W Bengal, India.
EM dhananjoy1@yahoo.co.in
CR BONFIELD W, 1987, MET MATER, V3, P712
   DOWELL J, 1993, J MATER SCI LETT, V12, P1473, DOI 10.1007/BF00591612
   DUMBLETON JH, 1974, WEAR, V29, P163, DOI 10.1016/0043-1648(74)90067-2
   FRIEDRICH K, 1993, J MATER SCI-MATER M, V4, P266, DOI 10.1007/BF00122279
   Kaddick C, 2001, P I MECH ENG H, V215, P429, DOI 10.1243/0954411011536019
   Kirkpatrick CJ, 1997, J MATER SCI-MATER M, V8, P131, DOI 10.1023/A:1018567018688
   KIRKPATRICK CJ, 1990, J MATER SCI-MATER M, V1, P9, DOI 10.1007/BF00705347
   Learmonth I. D., 2000, INTERFACE TOTAL HIP
   Marrs H, 1999, J MATER SCI-MATER M, V10, P333, DOI 10.1023/A:1026469522868
   PAR JB, 1992, BIOMATERIALS INTRO
   RAMASUBRAMANIAN N, 1993, WEAR, V162, P631, DOI 10.1016/0043-1648(93)90555-Z
   Suska F, 2001, J MATER SCI-MATER M, V12, P939, DOI 10.1023/A:1012844612753
   TEOH SH, 1998, THERMOPLASTIC POLYM
   Tipper J L, 2000, J Mater Sci Mater Med, V11, P117, DOI 10.1023/A:1008901302646
   UNSOWRTH A, 1975, T ASME, V97, P377
   Williams DF, 1987, PROGR BIOMEDICAL ENG, V4, P54
NR 16
TC 0
Z9 0
U1 2
U2 5
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 0792-1233
EI 2191-0359
J9 SCI ENG COMPOS MATER
JI Sci. Eng. Compos. Mater.
PY 2007
VL 14
IS 1
BP 47
EP 55
PG 9
WC Materials Science, Composites
SC Materials Science
GA 156AE
UT WOS:000245619400004
DA 2018-10-19
ER

PT J
AU Cao, N
   Li, M
   Ma, Q
   Bai, Y
   Wang, C
AF Cao, Ning
   Li, Musen
   Ma, Quansheng
   Bai, Yunqiang
   Wang, Chengxiang
TI Biomedical coatings prepared on Carbon/Carbon composites
SO SCIENCE AND ENGINEERING OF COMPOSITE MATERIALS
LA English
DT Article
DE biomedical coatings; carbon/carbon composites; preparation
ID SPRAYED HYDROXYAPATITE COATINGS; CARBON-CARBON COMPOSITE;
   CALCIUM-PHOSPHATE; IN-VIVO; TITANIUM; IMPLANT; DEPOSITION; INDUCTION;
   POWER
AB Carbon/carbon composites are a new biomaterial known for its excellent biocompatibility and elasticity modulus similar to that of human bones. However, carbon particle desquamation always occurs on the surface of this material and causes the "Black Skin Effect". In order to solve this problem, many types of biomedical coatings were prepared. This paper reviews the researches on this field in recent years, analyzing the advantages and disadvantages of the coatings, and presents the essential features of good biomedical coatings on Carbon/Carbon composites as well as the further works that should be carried out.
C1 Shandong Univ, Sch Mat Sci & Engn, Jinan 250061, Peoples R China.
   Shandong Provincial Hosp, Jinan 250061, Peoples R China.
RP Li, M (reprint author), Shandong Univ, Sch Mat Sci & Engn, Jinan 250061, Peoples R China.
EM caoning1982@gmail.com
CR ADAMS D, 1978, J BIOMED MATER RES, V12, P35, DOI 10.1002/jbm.820120104
   *ASTM COMM, 2005, STAND TEST METH SHEA
   Bartuli C, 2002, SURF COAT TECH, V155, P260, DOI 10.1016/S0257-8972(02)00058-0
   BLAZEWICZ M, 2000, 10 INT C BIOM ENG SI
   BRANDWOOD A, 1992, BIOMATERIALS, V13, P646, DOI 10.1016/0142-9612(92)90035-M
   CHRISTEL PS, 1986, CRITICAL REV COMPATI, V21, P89
   COOK SD, 1988, CLIN ORTHOP RELAT R, P225
   Devlin D., 1995, P 1995 ASME INT MECH, P31
   Evans SL, 1998, BIOMATERIALS, V19, P1329, DOI 10.1016/S0142-9612(97)00217-2
   FRIDRICH C, 2002, SURFACE COATINGS TEC, V151, P405
   Fu QG, 2006, SURF COAT TECH, V200, P3473, DOI 10.1016/j.surfcoat.2004.11.022
   Fu T, 2003, MATER LETT, V57, P3500, DOI 10.1016/S0167-577X(03)00115-0
   Fu T, 2002, MATER LETT, V57, P77, DOI 10.1016/S0167-577X(02)00702-4
   Gross KA, 1998, J BIOMED MATER RES, V39, P407, DOI 10.1002/(SICI)1097-4636(19980305)39:3<407::AID-JBM9>3.0.CO;2-N
   HYANG KK, 2006, MAT SCI ENG A-STRUCT, V428, P336
   Kettunen J, 1999, J BIOMAT SCI-POLYM E, V10, P715, DOI 10.1163/156856299X00603
   KLEIN CPAT, 1994, BIOMATERIALS, V15, P146, DOI 10.1016/0142-9612(94)90264-X
   Kostikov V.I., 1989, ZH VSES KHIM VA DI M, V34, P492
   Li SH, 1998, J BIOMED MATER RES, V40, P520
   Ling SJ, 2005, KEY ENG MAT, V297-300, P233, DOI 10.4028/www.scientific.net/KEM.297-300.233
   Lucie B., 2001, J BIOMED MATER RES, V54, P567
   MA C, 2004, RARE METAL MAT ENG, V12, P1274
   Moene R, 1997, APPL CATAL A-GEN, V162, P181, DOI 10.1016/S0926-860X(97)00096-3
   MORRANCHO R, 1983, MAT SCI MONOGRAPHYS, V17, P97
   MUKHERJEE DP, 1993, J LONG-TERM EFF MED, V3, P131
   Roveri N, 2003, MAT SCI ENG C-BIO S, V23, P441, DOI 10.1016/S0928-4931(02)00318-1
   SANTAVIRTA S, 1998, CLIN EXPT FORUM, V117, P89
   Sui JL, 2005, SURF COAT TECH, V190, P287, DOI 10.1016/j.surfcoat.2004.02.042
   Sui JL, 2004, SURF COAT TECH, V176, P188, DOI 10.1016/S0257-8972(03)00646-7
   SUI JL, 2004, FABRICATION TECHNOLO, V4, P13
   SZARANIEC B, 2005, E-POLYMERS, V30, P1
   VIRGILEV YS, 2004, INORGANIC MAT, V40, P33
   Wang H, 2006, BIOMATERIALS, V27, P4192, DOI 10.1016/j.biomaterials.2006.03.034
   WEI T, 1999, ACAD J SUN YS U MED, V20, P42
   Wen J, 2000, BIOMATERIALS, V21, P1339, DOI 10.1016/S0142-9612(99)00273-2
   Wu TM, 1996, SURF COAT TECH, V78, P64, DOI 10.1016/0257-8972(94)02393-X
   XIONG DB, 2003, J NW POLYTECHNICICAL, V21, P356
   Xiong XB, 2004, NEW CARBON MATER, V19, P33
   YANG GH, 1999, CARBON MAT, P79
   Yip CS, 1997, J MATER PROCESS TECH, V65, P73, DOI 10.1016/0924-0136(95)02244-9
   ZHENG YH, 1999, J BIOMEDICAL ENG, V16, P14
NR 41
TC 2
Z9 6
U1 0
U2 3
PU FREUND PUBLISHING HOUSE LTD
PI TEL AVIV
PA PO BOX 35010, TEL AVIV 61350, ISRAEL
SN 0334-181X
J9 SCI ENG COMPOS MATER
JI Sci. Eng. Compos. Mater.
PY 2007
VL 14
IS 3
BP 241
EP 249
PG 9
WC Materials Science, Composites
SC Materials Science
GA 211HL
UT WOS:000249514800008
DA 2018-10-19
ER

PT S
AU Mancini, L
   Tamma, R
   Settanni, M
   Camerino, C
   Patano, N
   Greco, G
   Strippoli, M
   Zallone, A
AF Mancini, Lucia
   Tamma, Roberto
   Settanni, Maria
   Camerino, Claudia
   Patano, Nicola
   Greco, Giovanni
   Strippoli, Maurizio
   Zallone, Alberta
BE Zaidi, M
TI Osteoblasts cultured on three-dimensional synthetic hydroxyapatite
   implanted on a chick allantochorial membrane induce ectopic bone marrow
   differentiation
SO SKELETAL BIOLOGY AND MEDICINE, PT A: ASPECTS OF BONE MORPHOGENESIS AND
   REMODELING
SE ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
LA English
DT Article; Proceedings Paper
CT 2nd Conference on Skeletal Biology and Medicine
CY APR 25-28, 2007
CL New York, NY
SP Mt Sinai Sch Med, New York Acad Sci
DE osteoblast; bone implants; allantochorion; hematopoietic niche
ID MINERALIZED MATRIX DEPOSITION; 3D PERFUSION CULTURE; STEM-CELL NICHE;
   EXTRACELLULAR-MATRIX; GROWTH; PROLIFERATION; INCREASES; CYTOKINES;
   PROTEINS; FLOW
AB Osteoblast (OB) activities have been studied on hydroxyapatite three-dimensional (3D) scaffolds in comparison with traditional planar substrata. OBs cultured on 3D displayed increased proliferation, differentiation, and matrix protein synthesis, when compared to 2D cultures on the same substrata. Confluent cultures, however, could not be maintained for long, due to insufficient fluid diffusion within 3D scaffolds that impaired cell viability. Thus, confluent OB 3D cultures were implanted on the allantochorial membrane of chick embryos. Vessels from the embryo colonized the bone-like network giving rise in the presence of OBs to an ectopic bone marrow formation in the intratrabecular spaces. In the absence of OBs, when the biomaterial alone was implanted, blood vessels were still present but hematopoietic marrow was absent. In both cases osteoclasts (OCs) derived from the host were found on the implant surface. These results indicated that scaffolds with cells can be easily vascularized and confirmed the role of OBs in the definition of the microenvironment that induce blood marrow differentiation in the intratrabecular spaces.
C1 [Mancini, Lucia; Tamma, Roberto; Settanni, Maria; Camerino, Claudia; Patano, Nicola; Greco, Giovanni; Strippoli, Maurizio; Zallone, Alberta] Univ Bari, Dept Human Anat & Histol, Sch Med, I-70124 Bari, Italy.
RP Zallone, A (reprint author), Univ Bari, Dept Human Anat & Histol, Sch Med, Piazza G Cesare 11, I-70124 Bari, Italy.
EM a.zallone@anatomia.uniba.it
RI tamma, roberto/C-3679-2016
OI Camerino, Claudia/0000-0001-7217-9327
CR Balduino A, 2005, CELL TISSUE RES, V319, P255, DOI 10.1007/s00441-004-1006-3
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Bilbe G, 1996, BONE, V19, P437, DOI 10.1016/S8756-3282(96)00254-2
   Blair HC, 1999, BIOCHEM BIOPH RES CO, V255, P778, DOI 10.1006/bbrc.1999.0260
   Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545
   Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   Friedl P, 2000, CELL MOL LIFE SCI, V57, P41, DOI 10.1007/s000180050498
   GEHRONROBEY P, 1985, CALCIFIED TISSUE INT, V37, P453
   Gomi K, 2004, J BIOMED MATER RES A, V71A, P602, DOI 10.1002/jbm.a.30174
   Huang WB, 2004, EXP CELL RES, V299, P325, DOI 10.1016/j.yexcr.2004.04.051
   Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349
   Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006
   ROBEY PG, 1987, J CELL BIOL, V105, P457, DOI 10.1083/jcb.105.1.457
   Roskelley CD, 1995, BIOCHEM CELL BIOL, V73, P391, DOI 10.1139/o95-046
   Shen F, 2005, J LEUKOCYTE BIOL, V77, P388, DOI 10.1189/jlb.0904490
   Sikavitsas VI, 2003, P NATL ACAD SCI USA, V100, P14683, DOI 10.1073/pnas.2434367100
   Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480
   Tischer T, 2004, Z ORTHOP GRENZGEB, V142, P344, DOI 10.1055/s-2004-822817
   Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444
   ZAMBONIN G, 1995, BIOMATERIALS, V16, P397, DOI 10.1016/0142-9612(95)98857-A
NR 23
TC 1
Z9 1
U1 0
U2 2
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXEN, ENGLAND
SN 0077-8923
BN 978-1-57331-684-2
J9 ANN NY ACAD SCI
JI Ann.NY Acad.Sci.
PY 2007
VL 1116
BP 306
EP 315
DI 10.1196/annals.1402.008
PG 10
WC Endocrinology & Metabolism; Multidisciplinary Sciences; Orthopedics
SC Endocrinology & Metabolism; Science & Technology - Other Topics;
   Orthopedics
GA BHA44
UT WOS:000251898900025
PM 17584987
DA 2018-10-19
ER

PT S
AU Thissen, H
   Johnson, G
   McFarland, G
   Verbiest, BCH
   Gengenbach, T
   Voelckera, NH
AF Thissen, H.
   Johnson, G.
   McFarland, G.
   Verbiest, B. C. H.
   Gengenbach, T.
   Voelckera, N. H.
BE Voelcker, NH
TI Microarrays for the evaluation of cell-biomaterial surface interactions
SO SMART MATERIALS IV
SE Proceedings of SPIE
LA English
DT Proceedings Paper
CT SPIE International Symposium on Smart Materials, Nano- and Micro-Smart
   System
CY DEC 11-13, 2006
CL Adelaide Univ, Adelaide, AUSTRALIA
SP Defence Sci & Technol Org, Global Off Naval Res Sci & Technol, Off Naval Res, Asian Off Aerosp Res & Dev, AF Off Sci Res, Australian Nanotechnol Network, Australian Res Council, Complex Open Syst Res Network, SPIE, Australian Govt Dept Def, COSNet-ARC Complex Open Syst Res Network
HO Adelaide Univ
DE microarrays; high-throughput; biomaterials; cell culture; in vitro
ID PROTEIN
AB The evaluation of cell-material surface interactions is important for the design of novel biomaterials which are used in a variety of biomedical applications. While traditional in vitro test methods have routinely used samples of relatively large size, microarrays representing different biomaterials offer many advantages, including high throughput and reduced sample handling. Here, we describe the simultaneous cell-based testing of matrices of polymeric biomaterials, arrayed on glass slides with a low cell-attachment background coating. Arrays were constructed using a microarray robot at 6 fold redundancy with solid pins having a diameter of 375 pm. Printed solutions contained at least one monomer, an initiator and a bifunctional crosslinker. After subsequent UV polymerisation, the arrays were washed and characterised by X-ray photoelectron spectroscopy. Cell culture experiments were carried out over 24 hours using HeLa cells. After labelling with CellTracker(R) Green for the final hour of incubation and subsequent fixation, the arrays were scanned. In addition, individual spots were also viewed by fluorescence microscopy. The evaluation of cell-surface interactions in high-throughput assays as demonstrated here is a key enabling technology for the effective development of future biomaterials.
C1 [Thissen, H.; Voelckera, N. H.] CSIRO Food Futures Flagship, Riverside Corp Pk,5 Julius Ave, N Ryde, NSW 2113, Australia.
   [Thissen, H.; Verbiest, B. C. H.; Gengenbach, T.] CSIRO Mol & Hlth Technol, Clayton, Vic 3168, Australia.
   [Johnson, G.; McFarland, G.] CSIRO Mol & Hlth Technol, N Ryde, NSW 2113, Australia.
   [Verbiest, B. C. H.] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands.
   [Voelckera, N. H.] Flinders Univ S Australia, Sch Chem Phys & Earth Sci, Bedford Pk, SA 5042, Australia.
RP Thissen, H (reprint author), CSIRO Food Futures Flagship, Riverside Corp Pk,5 Julius Ave, N Ryde, NSW 2113, Australia.
EM Helmut.Thissen@csiro.au
RI Thissen, Helmut/D-3835-2011; Voelcker, Nicolas/D-6199-2012
OI Voelcker, Nicolas/0000-0002-1536-7804
CR Anderson DG, 2005, BIOMATERIALS, V26, P4892, DOI 10.1016/j.biomaterials.2004.11.052
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Cretich M, 2006, BIOMOL ENG, V23, P77, DOI 10.1016/j.bioeng.2006.02.001
   Drotleff S, 2004, EUR J PHARM BIOPHARM, V58, P385, DOI 10.1016/j.ejpb.2004.03.018
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Garcia AJ, 2006, ADV POLYM SCI, P171, DOI 10.1007/12_071
   GRIESSER HJ, 1989, VACUUM, V39, P485, DOI 10.1016/0042-207X(89)90272-8
   Hook AL, 2006, TRENDS BIOTECHNOL, V24, P471, DOI 10.1016/j.tibtech.2006.08.001
   Kingshott P, 1999, CURR OPIN SOLID ST M, V4, P403, DOI 10.1016/S1359-0286(99)00018-2
   Lamartine J, 2006, MAT SCI ENG C-BIO S, V26, P354, DOI 10.1016/j.msec.2005.10.068
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Thissen H, 2002, SMART MATER STRUCT, V11, P792, DOI 10.1088/0964-1726/11/5/326
   Thissen H, 2006, BIOMATERIALS, V27, P35, DOI 10.1016/j.biomaterials.2005.05.037
   Venkatasubbarao S, 2004, TRENDS BIOTECHNOL, V22, P630, DOI 10.1016/j.tibtech.10.008
NR 16
TC 2
Z9 2
U1 0
U2 2
PU SPIE-INT SOC OPTICAL ENGINEERING
PI BELLINGHAM
PA 1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98227-0010 USA
SN 0277-786X
BN 978-0-8194-6521-4
J9 PROC SPIE
PY 2007
VL 6413
AR 64130B
DI 10.1117/12.696030
PG 9
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA BFZ92
UT WOS:000245717600008
DA 2018-10-19
ER

PT J
AU Fan, VH
   Au, A
   Tamama, K
   Littrell, R
   Richardson, LB
   Wright, JW
   Wells, A
   Griffith, LG
AF Fan, Vivian H.
   Au, Ada
   Tamama, Kenichi
   Littrell, Romie
   Richardson, Llewellyn B.
   Wright, John W.
   Wells, Alan
   Griffith, Linda G.
TI Tethered epidermal growth factor provides a survival advantage to
   mesenchymal stem cells
SO STEM CELLS
LA English
DT Article
DE mesenchymal stem cells; epidermal growth factor; extracellular
   signal-regulated protein kinase; Fas ligand; cell death; cell spreading;
   bone graft
ID HUMAN BONE-MARROW; RECEPTOR TYROSINE KINASE; ACTIVATED PROTEIN-KINASE;
   FAS LIGAND EXPRESSION; TUMOR NECROSIS FACTOR; STROMAL CELLS; EGF
   RECEPTOR; MYOCARDIAL-INFARCTION; EXTRACELLULAR-MATRIX; SIGNALING PATHWAY
AB MSC can act as a pluripotent source of reparative cells during injury and therefore have great potential in regenerative medicine and tissue engineering. However, the response of MSC to many growth factors and cytokines is unknown. Many envisioned applications of MSC, such as treating large defects in bone, involve in vivo implantation of MSC attached to a scaffold, a process that creates an acute inflammatory environment that may be hostile to MSC survival. Here, we investigated cellular responses of MSC on a biomaterial surface covalently modified with epidermal growth factor (EGF). We found that surface-tethered EGF promotes both cell spreading and survival more strongly than saturating concentrations of soluble EGF. By sustaining mitogen-activated protein kinase kinase-extracellular-regulated kinase signaling, tethered EGF increases the contact of MSC with an otherwise moderately adhesive synthetic polymer and confers resistance to cell death induced by the proinflammatory cytokine, Fas ligand. We concluded that tethered EGF may offer a protective advantage to MSC in vivo during acute inflammatory reactions to tissue engineering scaffolds. The tethered EGF-modified polymers described here could be used together with structural materials to construct MSC scaffolds for the treatment of hard-tissue lesions, such as large bony defects.
C1 MIT, Dept Biol Engn, Cambridge, MA 02139 USA.
   MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   MIT, Dept Engn Mech, Cambridge, MA 02139 USA.
   Harvard Univ, Sch Dent Med, Cambridge, MA 02138 USA.
   Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA.
RP Griffith, LG (reprint author), MIT, Dept Biol Engn, 77 Massachusetts Ave,16-429, Cambridge, MA 02139 USA.
EM griff@mit.edu
OI Wells, Alan/0000-0002-1637-8150
FU NIGMS NIH HHS [R01-GM59870, U54-GM064346]; NIAMS NIH HHS [R01-AR42997]
CR Allan LA, 2003, NAT CELL BIOL, V5, P647, DOI 10.1038/ncb1005
   Asthagiri AR, 1999, J BIOL CHEM, V274, P27119, DOI 10.1074/jbc.274.38.27119
   Asthagiri AR, 2000, J CELL SCI, V113, P4499
   Avruch J, 1998, MOL CELL BIOCHEM, V182, P31, DOI 10.1023/A:1006823109415
   Ballif BA, 2001, CELL GROWTH DIFFER, V12, P397
   Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001
   Beerli RR, 1996, J BIOL CHEM, V271, P6071, DOI 10.1074/jbc.271.11.6071
   Bharti AC, 2004, APOPTOSIS, V9, P677, DOI 10.1023/B:APPT.0000045780.10463.c6
   Bodor J, 2002, EUR J IMMUNOL, V32, P203, DOI 10.1002/1521-4141(200201)32:1<203::AID-IMMU203>3.0.CO;2-C
   Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749
   Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358
   Brazil JJ, 2002, BLOOD CELL MOL DIS, V29, P94, DOI 10.1006/bcmd.2002.0539
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   Bu RF, 2003, BONE, V33, P760, DOI 10.1016/j.bone.2003.07.006
   Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198
   CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2
   Chua HL, 2004, HUM IMMUNOL, V65, P317, DOI 10.1016/j.humimm.2004.01.004
   Crea F, 2006, J BIOTECHNOL, V121, P109, DOI 10.1016/j.jbiotec.2005.07.021
   Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103
   Dinarello CA, 1996, BLOOD, V87, P2095
   Ehrbar M, 2005, J CONTROL RELEASE, V101, P93, DOI 10.1016/j.jconrel.2004.07.018
   ENGEL J, 1989, FEBS LETT, V251, P1, DOI 10.1016/0014-5793(89)81417-6
   Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623
   FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381
   FRY DW, 1994, SCIENCE, V265, P1093, DOI 10.1126/science.8066447
   Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008
   Gaudet S, 2005, MOL CELL PROTEOMICS, V4, P1569, DOI 10.1074/mcp.M500158-MCP200
   GRONTHOS S, 1995, BLOOD, V85, P929
   Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002
   Hofbauer LC, 2001, J MOL MED-JMM, V79, P243, DOI 10.1007/s001090100226
   Holmstrom TH, 2000, EMBO J, V19, P5418, DOI 10.1093/emboj/19.20.5418
   Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513
   Inatomi O, 2006, INT J MOL MED, V18, P497
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645
   Janes KA, 2006, CELL, V124, P1225, DOI 10.1016/j.cell.2006.01.041
   Kempiak SJ, 2003, J CELL BIOL, V162, P781, DOI 10.1083/job.200303144
   Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701
   Klees RF, 2005, MOL BIOL CELL, V16, P881
   Krampera M, 2005, BLOOD, V106, P59, DOI 10.1182/blood-2004-09-3645
   Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   LASTER SM, 1988, J IMMUNOL, V141, P2629
   LE BK, 2004, LANCET, V363, P1439
   LEMBACH KJ, 1976, P NATL ACAD SCI USA, V73, P183, DOI 10.1073/pnas.73.1.183
   Li S, 2006, LEUKEMIA, V20, P1270, DOI 10.1038/sj.leu.2404251
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Majors AK, 1997, J ORTHOPAED RES, V15, P546, DOI 10.1002/jor.1100150410
   Mastrogiacomo M, 2005, Orthod Craniofac Res, V8, P277, DOI 10.1111/j.1601-6343.2005.00350.x
   MEREDITH JE, 1993, MOL BIOL CELL, V4, P953
   Meuleman N, 2006, EUR J HAEMATOL, V76, P309, DOI 10.1111/j.1600-0609.2005.00611.x
   Misaghi S, 2004, CHEM BIOL, V11, P1677, DOI 10.1016/j.chembiol.2004.11.010
   Mitsiades N, 2000, CANCER RES, V60, P4122
   Mitsiades N, 1999, J CLIN ENDOCR METAB, V84, P2924, DOI 10.1210/jc.84.8.2924
   Miwa K, 1998, NAT MED, V4, P1287, DOI 10.1038/3276
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029
   Muschler GF, 2001, J ORTHOPAED RES, V19, P117, DOI 10.1016/S0736-0266(00)00010-3
   Muschler GF, 2003, CLIN ORTHOP RELAT R, P102, DOI 10.1097/01.blo.0000030504.43495.46
   Nakagawa K, 2004, TISSUE ENG, V10, P93, DOI 10.1089/107632704322791736
   Okamoto T, 2002, BIOCHEM BIOPH RES CO, V295, P354, DOI 10.1016/S0006-291X(02)00661-7
   Olayioye MA, 1998, MOL CELL BIOL, V18, P5042, DOI 10.1128/MCB.18.9.5042
   Park H, 2005, J IMMUNOL, V175, P7193, DOI 10.4049/jimmunol.175.11.7193
   Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Prewett M, 1996, J IMMUNOTHER, V19, P419, DOI 10.1097/00002371-199611000-00006
   Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516
   Rahman R, 2005, ONCOGENE, V24, P1320, DOI 10.1038/sj.onc.1208232
   Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026
   Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V
   Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004
   Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744
   Sato H, 2005, CANCER GENE THER, V12, P757, DOI 10.1038/sj.cgt.7700827
   Satomura K, 1998, J CELL PHYSIOL, V177, P426, DOI 10.1002/(SICI)1097-4652(199812)177:3<426::AID-JCP6>3.0.CO;2-F
   Schenk S, 2003, J CELL BIOL, V161, P197, DOI 10.1083/jcb.200208145
   Schepers E J, 1993, Implant Dent, V2, P151, DOI 10.1097/00008505-199309000-00002
   Shakesheff KM, 1998, J BIOMAT SCI-POLYM E, V9, P507, DOI 10.1163/156856298X00596
   SUDA T, 1995, J IMMUNOL, V154, P3806
   Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x
   Swindle CS, 2001, J CELL BIOL, V154, P459, DOI 10.1083/jcb.200103103
   Tamama K, 2006, STEM CELLS, V24, P686, DOI 10.1634/stemcells.2005-0176
   Tanaka S, 2005, IMMUNOL REV, V208, P30, DOI 10.1111/j.0105-2896.2005.00327.x
   Thiery Jean Paul, 1992, Current Opinion in Cell Biology, V4, P782, DOI 10.1016/0955-0674(92)90101-H
   VROUWENVELDER WCA, 1993, J BIOMED MATER RES, V27, P465, DOI 10.1002/jbm.820270407
   WAHL SM, 1989, J CELL BIOCHEM, V40, P193, DOI 10.1002/jcb.240400208
   WARD WHJ, 1994, BIOCHEM PHARMACOL, V48, P659, DOI 10.1016/0006-2952(94)90042-6
   Wells A, 1999, INT J BIOCHEM CELL B, V31, P637, DOI 10.1016/S1357-2725(99)00015-1
   Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8
   Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8
   YARDEN Y, 2001, NAT REV MOL CELL BIO, V2, P137
   ZHU XY, 1995, MOL BIOL CELL, V6, P273
   Zisch AH, 2003, FASEB J, V17, P2260, DOI 10.1096/fj.02-1041fje
NR 92
TC 189
Z9 193
U1 0
U2 23
PU ALPHAMED PRESS
PI DURHAM
PA 318 BLACKWELL ST, STE 260, DURHAM, NC 27701-2884 USA
SN 1066-5099
J9 STEM CELLS
JI Stem Cells
PY 2007
VL 25
IS 5
BP 1241
EP 1251
DI 10.1634/stemcells.2006-0320
PG 11
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology;
   Oncology; Cell Biology; Hematology
SC Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology
GA 165GR
UT WOS:000246292700018
PM 17234993
OA Bronze
DA 2018-10-19
ER

PT S
AU Nebe, JQB
   Luethen, F
   Lange, R
   Beck, U
AF Nebe, J. Q. Barbara
   Luethen, Frank
   Lange, Regina
   Beck, Ulrich
BE Chandra, T
   Tsuzaki, K
   Militzer, M
   Ravindran, C
TI Cellular activity and biomaterial's surface topography
SO THERMEC 2006, PTS 1-5
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 5th International Conference on Processing and Manufacturing of Advanced
   Materials
CY JUL 04-08, 2006
CL Vancouver, CANADA
SP Minerals, Met & Mat Soc
DE titanium topography; electro-chemical characteristics; human
   osteoblasts; initial adhesion; integrin; actin; protein adsorption
ID TITANIUM; CELLS; ROUGHNESS
AB The contact of a cell on the biomaterial's surface is mediated by its adhesion components. The topography of titanium surfaces influences these adhesion components of osteoblasts, e.g. the integrins, the adapter proteins and the actin cytoskeleton. In our current experiments we were interested in why osteoblasts were strongly aligned to the grooves of a structured pure titanium surface (grade 2). The titanium was characterized by EIS to get insights in the electro-chemically active surface. We used MG-63 human bone cells, cultured in DMEM with 10% FCS at 37 degrees C. For protein adsorption the titanium discs were incubated for 24h with complete medium containing soluble fibronectin at 37 degrees C. Interestingly, only in the grooves cells adhered and were aligned and this is not dependent on the gravitation. The cell adhesion seems to depend on the protein adsorption of fibronectin which we could find to be adsorbed exclusively in the valleys. We speculate that there are local differences in clectro-chemical characteristics of this structured titanium surface.
C1 [Nebe, J. Q. Barbara; Luethen, Frank] Univ Rostock, Dept Internal Med, Ernst Heydemann Str 6, D-18057 Rostock, Germany.
   [Lange, Regina; Beck, Ulrich] Univ Rostock, Dept Elect Elect & Informat Technol, D-18051 Rostock, Germany.
RP Nebe, JQB (reprint author), Univ Rostock, Dept Internal Med, Ernst Heydemann Str 6, D-18057 Rostock, Germany.
EM barbara.nebe@med.uni-rostock.de; ulrich.beck@uni-rostock.de
RI Nebe, Barbara/C-3577-2015
OI Nebe, Barbara/0000-0003-2662-0905
FU Deutsche Forschungsgemeinschaft (DFG) [SPP 322 1100, NE560/3-3, 3-4]
FX We appreciate the generous support of Frank Luethen and Regina Lange by
   the Deutsche Forschungsgemeinschaft (DFG): SPP 322 1100: NE 560/3-3, 3-4
   (Priority Program Biosystem and Material). We are very thankful to
   Patrick Elter of the University of Wuerzburg, Department for Functional
   Materials and Dentistry (Wuerzburg, Germany) for the AFM investigation.
   We thank Annelie Peters for excellent technical assistance.We
   acknowledge technical help of Gerhard Fulda of the Electron Microscopic
   Centre of the Medical Faculty of the University of Rostock.
CR Hynes RO, 1999, P NATL ACAD SCI USA, V96, P2588, DOI 10.1073/pnas.96.6.2588
   Kilpadi KL, 2001, J BIOMED MATER RES, V57, P258, DOI 10.1002/1097-4636(200111)57:2<258::AID-JBM1166>3.0.CO;2-R
   Kirbs A, 2003, MAT SCI ENG C-BIO S, V23, P413, DOI 10.1016/S0928-4931(02)00313-2
   Lange R, 2002, BIOMOL ENG, V19, P255, DOI 10.1016/S1389-0344(02)00047-3
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054
   Nebe B, 2004, MAT SCI ENG C-BIO S, V24, P619, DOI 10.1016/j.msec.2004.08.034
   Nebe B, 2001, BIOMATERIALS, V22, P2425, DOI 10.1016/S0142-9612(00)00430-0
   NEBE B, 2005, BIOMATERIALIEN, V6, P35
   Valois CRA, 2005, J ENDODONT, V31, P882, DOI 10.1097/01.don.0000164132.27285.2c
   Wiesner S, 2005, CELL MOL LIFE SCI, V62, P1081, DOI 10.1007/s00018-005-4522-8
   Yamada KM, 2003, BRAZ J MED BIOL RES, V36, P959, DOI 10.1590/S0100-879X2003000800001
NR 12
TC 3
Z9 3
U1 0
U2 1
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 978-0-87849-428-6
J9 MATER SCI FORUM
PY 2007
VL 539-543
BP 517
EP +
DI 10.4028/www.scientific.net/MSF.539-543.517
PN 1-5
PG 2
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BFW58
UT WOS:000245106100081
DA 2018-10-19
ER

PT S
AU Jarry, C
   Shive, M
   Chenite, A
AF Jarry, Claire
   Shive, Matthew
   Chenite, Abdellatif
BE Chandra, T
   Tsuzaki, K
   Militzer, M
   Ravindran, C
TI An injectable biomaterial for bone repair
SO THERMEC 2006, PTS 1-5
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 5th International Conference on Processing and Manufacturing of Advanced
   Materials
CY JUL 04-08, 2006
CL Vancouver, CANADA
SP Minerals, Met & Mat Soc
DE chitosan; glycerophosphate; biphasic calcium phosphate; composite;
   injectable; thermosensitive; hydrogel
ID IN-VITRO; CHITOSAN; GELS
AB The primary purpose of this study was to characterize the main features of a BCP-loaded chitosan-GP composite. The two-syringe design improves the storage conditions, facilitates the sterilization procedure and provides an easy-to-use injectable biomaterial, ensuring reproducible properties with minimal manipulation. Rheological measurements confirm that the chitosan-GP/BCP composite retains the thermosensitive properties already described for chitosan-GP hydrogels. At 37 degrees C, the system gels within 10 minutes and reaches sufficient consistency after 30 minutes to prevent the mineral granules from migration into the surrounding tissues in vivo. The compressive force needed for the injection of chitosan-GP/BCP before gelation is approximately 6.6 N, only about 6 times that required for water and much lower than the average force that the majority of adults can exert. Morphology was investigated by environmental scanning electron microscopy (ESEM), which revealed 3-D dispersion of BCP granules embedded in chitosan-GP hydrogel. This open, porous structure affords complete access for body fluids and cells to each mineral granule immediately following implantation. The design using disposable syringes equipped with 16G hypodermic needles described here allows easy in vivo delivery of a fully injectable biornaterial containing porous scaffold that naturally enhances the osteogenic activity recognized for both chitosan and BCP.
C1 [Jarry, Claire; Shive, Matthew; Chenite, Abdellatif] Biosyntech Canada Inc, 475 Armand Frappier Blvd, Laval, PQ H7V 4B3, Canada.
RP Jarry, C (reprint author), Biosyntech Canada Inc, 475 Armand Frappier Blvd, Laval, PQ H7V 4B3, Canada.
EM jarry@biosyntech.com; shive@biosyntech.com; chenite@biosyntech.com
CR Bouler JM, 2000, J BIOMED MATER RES, V51, P680, DOI 10.1002/1097-4636(20000915)51:4<680::AID-JBM16>3.0.CO;2-#
   Chenite A, 2001, CARBOHYD POLYM, V46, P39, DOI 10.1016/S0144-8617(00)00281-2
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Delecrin J, 2000, SPINE, V25, P563, DOI 10.1097/00007632-200003010-00006
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Jarry C, 2001, J BIOMED MATER RES, V58, P127, DOI 10.1002/1097-4636(2001)58:1<127::AID-JBM190>3.0.CO;2-G
   Klokkevold PR, 1996, J PERIODONTOL, V67, P1170, DOI 10.1902/jop.1996.67.11.1170
   Lavertu M, 2003, J PHARMACEUT BIOMED, V32, P1149, DOI 10.1016/S0731-7085(03)00115-9
   MATHIOWETZ V, 1985, ARCH PHYS MED REHAB, V66, P69
   Rao SB, 1997, J BIOMED MATER RES, V34, P21, DOI 10.1002/(SICI)1097-4636(199701)34:1<21::AID-JBM4>3.0.CO;2-P
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
NR 11
TC 0
Z9 0
U1 1
U2 8
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 978-0-87849-428-6
J9 MATER SCI FORUM
PY 2007
VL 539-543
BP 535
EP +
DI 10.4028/www.scientific.net/MSF.539-543.535
PN 1-5
PG 2
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BFW58
UT WOS:000245106100084
DA 2018-10-19
ER

PT S
AU Kim, YM
   Gao, J
   Zern, B
   Wang, YD
AF Kim, Yu Mi
   Gao, Jin
   Zern, Blaine
   Wang, Yadong
BE Chandra, T
   Tsuzaki, K
   Militzer, M
   Ravindran, C
TI Biofunctional materials for nerve regeneration
SO THERMEC 2006, PTS 1-5
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 5th International Conference on Processing and Manufacturing of Advanced
   Materials
CY JUL 04-08, 2006
CL Vancouver, CANADA
SP Minerals, Met & Mat Soc
DE biofunctional; biomaterial; biodegradable; neurotransmitter; nerve
ID NEURITE OUTGROWTH; CONDUCTING POLYMER; SCHWANN-CELLS; DOPAMINE;
   NEUROTRANSMITTERS; NEURONS; GROWTH; MODEL
AB Most biomaterials widely used in nerve regeneration are either inert or modified with ECM proteins or their epitopes. Neurotransmitters play a key role in neuronal development and function. Thus we decided to investigate the feasibility of using neurotransmitters to create biofunctional materials that actively engage nerve cells to achieve functional restoration after injury of the nervous system. Our data indicated that a properly designed biodegradable polymer with dopamine functional groups was more capable of promoting neurite growth. Such biofunctional materials can potentially provide a new strategy for nerve regeneration.
C1 [Kim, Yu Mi; Gao, Jin; Zern, Blaine; Wang, Yadong] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.
   [Kim, Yu Mi] Kyungpook Natl Univ, Dept Biomed Engn, Daegu, South Korea.
RP Wang, YD (reprint author), Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA.
EM yandme77@qmail.com; jin.gao@bme.gatech.edu; gtg713n@mail.gatech.edu;
   ywang@gatech.edu
OI Wang, Yadong/0000-0003-2067-382X
FU Georgia Institute of Technology, National Science Foundation
   [EEC-9731643]; International Research Internship of the Korea Science
   and Engineering Foundation
FX This work was supported by the Georgia Institute of Technology, National
   Science Foundation grant EEC-9731643, and the International Research
   Internship of the Korea Science and Engineering Foundation (YMK).
CR Asanuma M, 2003, NEUROTOX RES, V5, P165, DOI 10.1007/BF03033137
   Boyd JG, 2005, FASEB J, V19, P694, DOI 10.1096/fj.04-2833rev
   Bryan DJ, 2000, TISSUE ENG, V6, P129, DOI 10.1089/107632700320757
   Evans GRD, 2000, SEMIN SURG ONCOL, V19, P312, DOI 10.1002/1098-2388(200010/11)19:3<312::AID-SSU13>3.0.CO;2-M
   Filogamo G, 1971, Neurosci Res (N Y), V4, P29
   GRIGORIADIS N, 2004, DEV BRAIN RES, V153, P79
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   HOKFELT T, 1994, TRENDS NEUROSCI, V17, P22, DOI 10.1016/0166-2236(94)90031-0
   Kato K, 2002, BIOCHEMISTRY-US, V41, P10747, DOI 10.1021/bi020180k
   Kawakami Hiroyoshi, 2004, J Artif Organs, V7, P83
   Li B, 2005, BIOMATERIALS, V26, P1487, DOI 10.1016/j.biomaterials.2004.05.004
   Lundborg G, 1988, NERVE INJURY REPAIR
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   MACKUNNON SE, 1988, SURG PERIPHERAL NERV
   MATTSON MP, 1988, BRAIN RES REV, V13, P179, DOI 10.1016/0165-0173(88)90020-3
   Resnick N, 2003, PROG BIOPHYS MOL BIO, V81, P177, DOI 10.1016/S0079-6107(02)00052-4
   Sanghvi AB, 2005, NAT MATER, V4, P496, DOI 10.1038/nmat1397
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Sombers LA, 2002, ANN NY ACAD SCI, V971, P86, DOI 10.1111/j.1749-6632.2002.tb04439.x
   Stokes AH, 1999, J NEUROSCI RES, V55, P659, DOI 10.1002/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C
   VALENTINI RF, 1992, BIOMATERIALS, V13, P183, DOI 10.1016/0142-9612(92)90069-Z
   van Kesteren RE, 2003, REV NEUROSCIENCE, V14, P217
   Wang XY, 2002, ANAL SCI, V18, P931, DOI 10.2116/analsci.18.931
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Zigmond RE, 1997, ANN NY ACAD SCI, V814, P181, DOI 10.1111/j.1749-6632.1997.tb46157.x
NR 27
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 978-0-87849-428-6
J9 MATER SCI FORUM
PY 2007
VL 539-543
BP 547
EP +
DI 10.4028/www.scientific.net/MSF.539-543.547
PN 1-5
PG 2
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BFW58
UT WOS:000245106100087
DA 2018-10-19
ER

PT S
AU Akahori, T
   Niinomi, M
   Fukui, H
   Ogawa, M
AF Akahori, Toshikazu
   Niinomi, Mitsuo
   Fukui, Hisao
   Ogawa, Michiharu
BE Chandra, T
   Tsuzaki, K
   Militzer, M
   Ravindran, C
TI Mechanical properties and microstructures of beta-type titanium alloy
   for biomedical applicaitons
SO THERMEC 2006, PTS 1-5
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 5th International Conference on Processing and Manufacturing of Advanced
   Materials
CY JUL 04-08, 2006
CL Vancouver, CANADA
SP Minerals, Met & Mat Soc
DE beta-type titanium alloy; biomaterial; notch-fatigue strength; run-out;
   in vitro
AB Plain and notch fatigue properties of a beta-type titanium alloy, Ti-29Nb-13Ta-4.6Zr (TNTZ), which was subjected to various thermomechanical treatments, were investigated in order to judge its potential for biomedical applications. Microstructures of TNTZ aged at 723 K for 259.2 ks after cold rolling and those aged at 723 K for 259.2 ks after solution treatment are composed of a precipitated alpha phase in the beta phase. However, microstructures of TNTZ aged at 598 and 673 K for 259.2 ks after cold rolling and aged at 598 K and 673 K for 259.2 ks after solution treatment are composed of a precipitated to phase, and precipitated alpha and omega phases in the beta phase, respectively. Futher, plain fatigue strengths of TNTZ aged after solution treatment and those of TNTZ aged after cold rolling increase with the aging temperature. In particular, TNTZ aged at 723 K after cold rolling exhibits the highest fatigue strength in both the low- and high-cycle fatigue life regions. Futher, the run-out, which is about 770 MPa, is nearly equal to that of hot-rolled Ti-6Al-4V ELI conducted with aging, which is one of the representative alpha+beta-type titanium alloys for biomedical applications. The notch fatigue strengths of TNTZ aged at stress concentration factors of 2 and 6 decrease by 30% - 40% and 50% - 60%, respectively, as compared with the plain fatigue strengths in the low-cycle fatigue life region. Futher, the notch run-out range from 450 to 490 MPa and from 220 to 300 NIPa, respectilvely; an exception to this is TNTZ aged at 598 K after cold rolling, which has a high volume fraction of the omega phase. Single- and multi- fatigue cracks initiate at the bottom of the notch at stress concentration factors of 2 and 6, respectively.
C1 [Akahori, Toshikazu] Toyohashi Univ Technol, Dept Prod Syst Engn, 1-1,Higarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.
   [Niinomi, Mitsuo] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808574, Japan.
   [Fukui, Hisao] Aichi Gakuin Univ, Sch Dent, Chikusa Ku, Nagoya, Aichi 4648650, Japan.
   [Ogawa, Michiharu] Daldo Steel CO Ltd, Nagoya, Aichi 4578545, Japan.
RP Akahori, T (reprint author), Toyohashi Univ Technol, Dept Prod Syst Engn, 1-1,Higarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.
EM akahori@sp-mac4.pse.tut.ac.jp; niinomi@imr.tohoku.ac.jp;
   fukui@dpc.aichi-gakuin.ac.jp; m-ogawa@ds.daido.co.jp
CR Akahori T, 2004, MATER TRANS, V45, P1540, DOI 10.2320/matertrans.45.1540
   Akahori T, 2000, METALL MATER TRANS A, V31, P1937, DOI 10.1007/s11661-000-0221-0
   GASSER B, 2001, TITANIUM MED, P673
   Hamanaka H., 1997, FERAMU JAPAN, V2, P30
   HAYASHI K, 1999, J JAPAN SOC MECH A, V65, P64
   Jha SK, 2000, METALL MATER TRANS A, V31, P703, DOI 10.1007/s11661-000-0012-7
   Niinomi M, 2002, MATER TRANS, V43, P2970, DOI 10.2320/matertrans.43.2970
   Niinomi M, 1999, JOM-J MIN MET MAT S, V51, P32, DOI 10.1007/s11837-999-0091-x
   Niinomi M, 2002, METALL MATER TRANS A, V33, P477, DOI 10.1007/s11661-002-0109-2
   NIINOMI M, 2002, MAT T, V43, P2790
   Okazaki Y, 1997, MATER T JIM, V38, P163, DOI 10.2320/matertrans1989.38.163
   OKAZAKI Y, 1998, MAT JAPAN, V37, P838
   Okazaki Y., 1997, MAT JAPAN, V36, P1092
   SCHENK R, 2001, TITANIUM MED, P144
NR 14
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 978-0-87849-428-6
J9 MATER SCI FORUM
PY 2007
VL 539-543
BP 557
EP +
DI 10.4028/www.scientific.net/MSF.539-543.557
PN 1-5
PG 2
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BFW58
UT WOS:000245106100089
DA 2018-10-19
ER

PT S
AU Tsai, SP
   Hsieh, CY
   Hsieh, CY
   Chang, YN
   Wang, DM
   Hsieh, HJ
AF Tsai, Sung-Pei
   Hsieh, Chien-Yang
   Hsieh, Chung-Yu
   Chang, Yaw-Nan
   Wang, Da-Ming
   Hsieh, Hsyue-Jen
BE Chandra, T
   Tsuzaki, K
   Militzer, M
   Ravindran, C
TI Gamma-poly(glutamic acid)/chitosan composite scaffolds for tissue
   engineering applications
SO THERMEC 2006, PTS 1-5
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 5th International Conference on Processing and Manufacturing of Advanced
   Materials
CY JUL 04-08, 2006
CL Vancouver, CANADA
SP Minerals, Met & Mat Soc
DE chitosan; gamma-PGA; glutamic acid; composite scaffolds; tissue
   engineering
ID CHITOSAN; GELATION
AB The development of tissue engineering provides a novel approach to restore bodily functions by seeding cells onto various scaffolds. Although chitosan is a non-toxic biomaterial. its cytocompatibility still needs to be improved. In this Study, gamma-poly(glutamic acid) (gamma-PGA) was blended with chitosan to prepare both dense and porous gamma-PGA/chitosan composite scaffolds using the freeze-gelation method. This method saves time and energy, and there is less residual solvent. SEM micrographs demonstrated that an interconnected porous structure with a pore size of 30-100 micrometer was present in the scaffolds. The hydrophilicity of the scaffolds was significantly improved by gamma-PGA. Further. the tensile strength of the porous gamma-PGA-modified chitosan scaffolds was about 50% higher than that of the unmodified chitosan scaffolds. The number of osteosarcoma cells cultured on the gamma-PGA-modified scaffolds was about double that on the unmodified chitosan scaffolds on day 7. Thus, the gamma-PGA/chitosan composite scaffolds, due to their better hydrophilicity, cytocompatibility. and mechanical strength, are very promising biomaterials for tissue engineering applications. We further demonstrated the use of glutamic acid to enhance the tensile strength of chitosan-based composite porous scaffolds. The tensile strength of the chitosan/collagen composite scaffolds was increased by more than 2 times with the addition of glutamic acids as cross-linking bridges. We found that the hepatocytes attached and proliferated well on these composite scaffolds, demonstrating that the glutamic acid modified-chitosan composite scaffolds are also potential tissue engineering biomaterials.
C1 [Tsai, Sung-Pei; Hsieh, Chien-Yang; Hsieh, Chung-Yu; Wang, Da-Ming; Hsieh, Hsyue-Jen] Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan.
   [Chang, Yaw-Nan] Da Yeh Univ, Dept Bioind Technol, Changhua, Taiwan.
RP Tsai, SP (reprint author), Natl Taiwan Univ, Dept Chem Engn, Taipei 10617, Taiwan.
EM d88524007@ntu.edu.tw; pofn@pofn.url.com.tw; r94524008@ntu.edu.tw;
   nelson@mail.dyu.edu.tw; daming@ntu.edu.tw; hjhsieh@ntu.edu.tw
FU National Science Council, Taiwan [NSC94-2214-E-002-011]
FX The authors thank Prof. Lein-Tuan Hou at the Graduate Institute of
   Clinical Dentistry, School of Dentistry, National Taiwan University and
   Department of Periodontology, National Taiwan University Hospital,
   Taipei, Taiwan for providing the rat osteosarcoma (ROS) cells. This
   study was financially supported by the National Science Council, Taiwan
   (grant no.: NSC94-2214-E-002-011).
CR Ho MH, 2004, BIOMATERIALS, V25, P129, DOI 10.1016/S0142-9612(03)00483-6
   Hsieh CY, 2005, BIOMATERIALS, V26, P5617, DOI 10.1016/j.biomaterials.2005.02.012
   HSIEH CY, IN PRESS DENT MAT
   Iwata H, 1998, BIOMATERIALS, V19, P1869, DOI 10.1016/S0142-9612(98)00095-7
   Khor E, 2003, BIOMATERIALS, V24, P2339, DOI 10.1016/S0142-9612(03)00026-7
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   Li C, 2000, CLIN CANCER RES, V6, P2829
   Ma JB, 2001, BIOMATERIALS, V22, P331, DOI 10.1016/S0142-9612(00)00188-5
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Matsusaki M, 2005, J BIOMED MATER RES A, V73A, P485, DOI 10.1002/jbm.a.30305
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Noishiki Y, 1986, ASAIO Trans, V32, P309
   Roller S, 1999, INT J FOOD MICROBIOL, V47, P67, DOI 10.1016/S0168-1605(99)00006-9
   Szende B, 1993, Acta Biomed Ateneo Parmense, V64, P139
NR 14
TC 0
Z9 0
U1 0
U2 2
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 978-0-87849-428-6
J9 MATER SCI FORUM
PY 2007
VL 539-543
BP 567
EP +
DI 10.4028/www.scientific.net/MSF.539-543.567
PN 1-5
PG 2
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BFW58
UT WOS:000245106100091
DA 2018-10-19
ER

PT S
AU Sato, H
   Umaoka, SI
   Watanabe, Y
   Kim, IS
   Kawahara, M
   Tokita, M
AF Sato, Hisashi
   Umaoka, Sei-ichiro
   Watanabe, Yoshimi
   Kim, Ick-Soo
   Kawahara, Masakazu
   Tokita, Masao
BE Chandra, T
   Tsuzaki, K
   Militzer, M
   Ravindran, C
TI Biodegradable fiber reinforced ti composite fabricated by spark plasma
   sintering method
SO THERMEC 2006, PTS 1-5
SE Materials Science Forum
LA English
DT Proceedings Paper
CT 5th International Conference on Processing and Manufacturing of Advanced
   Materials
CY JUL 04-08, 2006
CL Vancouver, CANADA
SP Minerals, Met & Mat Soc
DE SPS; PLLA; biomaterial; Biodegradable material; Implant material;
   composite; Ti alloy; wear; hardness; sintering
ID MECHANICAL-PROPERTIES
AB Ti and Ti alloys are particularly attractive materials as the metallic implant-material. This is because that these alloys have low shear modulus and the good biological compatibility with bone. However, interfacial adhesion ability of bone and Ti alloy is low. As improvement method of the interfacial adhesion ability, bioaffinity material like hydroxyapatite has been coated on surface of the Ti alloys. However, such bioaffinity materials have low strength and wear resistance. In this study, Ti composites containing biodegradable poly-L-lactic-acid (PLLA) fiber were fabricated by spark plasma sintering (SPS) method. The PLLA fiber plays a role as reinforcement in Ti matrix, and can be gradually decomposed inside body with progress of time. By the decomposition of PLLA, pore is generated in Ti matrix, and bone simultaneously penetrates into the pore. Therefore, tightly bond between bone and Ti matrix can be expected. Using the Ti-PLLA composites fabricated by SPS method, microstructural observation and mechanical tests were performed. It was found that Ti-PLLA composite has laminate-layer structure with plate-like shape PLLA. Hardness and wear behavior of Ti-PLLA composite has anisotropy due to its structure. However, strength of the Ti-PLLA composite is low because of the imperfect sintering of Ti matrix. Since sintering of Ti matrix can be improved by changing the temperature of SPS, Ti-PLLA composite with anisotropic mechanical properties can be expected by SPS method.
C1 [Sato, Hisashi; Watanabe, Yoshimi] Nagoya Inst Technol, Omohi Coll, Showa Ku, Nagoya, Aichi 4668555, Japan.
   [Umaoka, Sei-ichiro; Kim, Ick-Soo] Shinshu Univ, Dept Fucnt Machinery & Mech, Ueda, Nagano 3868567, Japan.
   [Kawahara, Masakazu; Tokita, Masao] SPS Syntex Inc, Takatsu Ku, Kawasaki, Kanagawa 2130012, Japan.
RP Sato, H (reprint author), Nagoya Inst Technol, Omohi Coll, Showa Ku, Nagoya, Aichi 4668555, Japan.
EM sato.hisashi@nitech.ac.jp; f05a403@amail.shinshu-u.ac.jp;
   yoshimi@nitech.ac.jp; kim@giptc.shinshu-u.ac.jp; kawahara@spssyntex.com;
   tokita@spssyntex.com
FU Ministry of Education, Culture, Sports, Science and Technology of Japan;
    [17560604]
FX This study was supported by a Grant-in-Aid for Scientific Research
   C(2)(17560604) and 21st Century COE Program Advanced Fiber Science and
   Textile Technology by the Ministry of Education, Culture, Sports,
   Science and Technology of Japan. Pure Ti powder was kindly supplied by
   The Light Metal Educational Foundation, Inc., Japan.
CR An YB, 2005, MATER LETT, V59, P2178, DOI 10.1016/j.matlet.2005.02.059
   BONFIELD W, 1977, NATURE, V270, P453, DOI 10.1038/270453a0
   HANAWA T, 2004, MAT JAPAN, V43, P176
   Ignjatovic N, 1999, BIOMATERIALS, V20, P809, DOI 10.1016/S0142-9612(98)00234-8
   Junjie H., 2004, J AM CERAM SOC, V87, P1404, DOI DOI 10.1111/J.1151-2916.2004.TB07749.X
   KUORDA D, 2001, TETSU TO HAGANE, V87, P34
   Kuroda D, 1998, MAT SCI ENG A-STRUCT, V243, P244, DOI 10.1016/S0921-5093(97)00808-3
   Watanabe Y, 2004, MATER TRANS, V45, P1005, DOI 10.2320/matertrans.45.1005
NR 8
TC 6
Z9 6
U1 0
U2 3
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 0255-5476
BN 978-0-87849-428-6
J9 MATER SCI FORUM
PY 2007
VL 539-543
BP 3201
EP +
DI 10.4028/www.scientific.net/MSF.539-543.3201
PN 1-5
PG 2
WC Engineering, Manufacturing; Materials Science, Multidisciplinary
SC Engineering; Materials Science
GA BFW58
UT WOS:000245106103012
DA 2018-10-19
ER

PT S
AU Hermawan, H
   Dube, D
   Mantovani, D
AF Hermawan, H.
   Dube, D.
   Mantovani, D.
BE Chandra, T
   Tsuzaki, K
   Militzer, M
   Ravindran, C
TI Development of Degradable Fe-35Mn Alloy for Biomedical Application
SO THERMEC 2006 SUPPLEMENT: 5TH INTERNATIONAL CONFERENCE ON PROCESSING AND
   MANUFACTURING OF ADVANCED MATERIALS
SE Advanced Materials Research
LA English
DT Proceedings Paper
CT 5th International Conference on Processing and Manufacturing of Advanced
   Materials
CY JUL 04-08, 2006
CL Vancouver, CANADA
SP Minerals, Met & Mat Soc
DE Degradable biomaterial; powder metallurgy; Fe-35Mn alloy
ID NICKEL-TITANIUM; MAGNESIUM; TRANSFORMATION; CORROSION
AB As some biomedical problems require only temporary intervention, there is a clinical need for degradable biomaterials with excellent mechanical properties and controllable degradation behaviour. Although several works were carried out on both polymeric and metallic materials, no proposed degradable biomaterial fully satisfied these requirements. Therefore a new Fe-35Mn alloy has been developed as a valid and well suited alternative. The alloy was fabricated through powder metallurgy route followed by successive cold rolling and sintering cycles. This austenitic alloy exhibits a high strength and ductility, comparable to that of type 316L stainless steel. Its antiferromagnetic behaviour is not changed by cold deformation process. The alloy shows suitable degradation behaviour with a uniform corrosion mechanism and a slow release of ions that make it particularly well suited for the development of a new class of biodegradable stents.
C1 [Hermawan, H.] Univ Laval, Lab Biomat & Bioengn, Dept Min Met & Mat Engn, Quebec City, PQ G1K 7P4, Canada.
   [Hermawan, H.; Dube, D.; Mantovani, D.] Univ Hosp, Res Ctr, Quebec City, PQ G1K 7P4, Canada.
RP Hermawan, H (reprint author), Univ Laval, Lab Biomat & Bioengn, Dept Min Met & Mat Engn, Quebec City, PQ G1K 7P4, Canada.
EM hendra.hermawan.1@ulaval.ca; dominique.dube@gmn.ulaval.ca;
   diego.mantovani@gmn.ulaval.ca
RI Hermawan, Hendra/G-5892-2010
OI Hermawan, Hendra/0000-0002-5596-9949; Mantovani,
   Diego/0000-0001-9672-895X
CR [Anonymous], 2004, E804 ASTM
   BREME HJ, 1998, METALS BIOMATERIALS
   Di Mario Carlo, 2004, J Interv Cardiol, V17, P391, DOI 10.1111/j.1540-8183.2004.04081.x
   ELLENHORN MJ, 1997, ELLENHORNS MED TOXIC
   Emsley J., 1998, ELEMENTS
   Erne P, 2006, CARDIOVASC INTER RAD, V29, P11, DOI 10.1007/s00270-004-0341-9
   German R. M., 1996, SINTERING THEORY PRA
   HUANG WM, 1989, CALPHAD, V13, P243, DOI 10.1016/0364-5916(89)90004-7
   *JCPDS ICDD, 2004, POWD DIFFR FIL DAT
   Kujala S, 2003, BIOMATERIALS, V24, P4691, DOI 10.1016/S0142-9612(03)00359-4
   Lee YK, 1997, ISIJ INT, V37, P1023, DOI 10.2355/isijinternational.37.1023
   Levesque J, 2003, MATER SCI FORUM, V426-4, P521, DOI 10.4028/www.scientific.net/MSF.426-432.521
   Li CM, 2002, MAT SCI ENG A-STRUCT, V325, P307, DOI 10.1016/S0921-5093(01)01459-9
   *MPIF, 1990, 15 MPIF
   Mueller PP, 2006, BIOMATERIALS, V27, P2193, DOI 10.1016/j.biomaterials.2005.10.042
   Mumtaz K, 2004, J MATER SCI, V39, P85, DOI 10.1023/B:JMSC.0000007731.38154.e1
   Pais I., 1997, HDB TRACE ELEMENTS
   Rhalmi S, 1999, BIO-MED MATER ENG, V9, P151
   Staiger MP, 2006, BIOMATERIALS, V27, P1728, DOI 10.1016/j.biomaterials.2005.10.003
   Tanguay Jean Francois, 1994, Cardiology Clinics, V12, P699
   Witte F, 2005, BIOMATERIALS, V26, P3557, DOI 10.1016/j.biomaterials.2004.09.049
   Witusiewicz VT, 2004, J PHASE EQUILIB DIFF, V25, P346, DOI 10.1361/15477030420115
   YAN JY, 1998, Patent No. 5843172
NR 23
TC 32
Z9 35
U1 0
U2 13
PU TRANS TECH PUBLICATIONS LTD
PI DURNTEN-ZURICH
PA KREUZSTRASSE 10, 8635 DURNTEN-ZURICH, SWITZERLAND
SN 1022-6680
BN 978-0-87849-429-3
J9 ADV MATER RES-SWITZ
PY 2007
VL 15-17
BP 107
EP 112
DI 10.4028/www.scientific.net/AMR.15-17.107
PG 6
WC Thermodynamics; Materials Science, Multidisciplinary
SC Thermodynamics; Materials Science
GA BOL59
UT WOS:000276951800019
DA 2018-10-19
ER

PT J
AU Chan, BP
   Hui, TY
   Chan, OCM
   So, KF
   Lu, W
   Cheung, KMC
   Salomatina, E
   Yaroslavsky, A
AF Chan, B. P.
   Hui, T. Y.
   Chan, O. C. M.
   So, K. -F.
   Lu, W.
   Cheung, K. M. C.
   Salomatina, E.
   Yaroslavsky, A.
TI Photochemical cross-linking for collagen-based scaffolds: A study on
   optical properties, mechanical properties, stability, and
   hematocompatibility
SO TISSUE ENGINEERING
LA English
DT Article
ID INTEGRATING-SPHERE MEASUREMENTS; PHOTODYNAMIC THERAPY;
   PHYSICAL-PROPERTIES; SINGLET OXYGEN; TISSUE; REPAIR; BLOOD; GRAFT
AB Collagen presents an attractive biomaterial for tissue engineering because of its excellent biocompatibility and negligible immunogenicity. However, some intrinsic features related to the mechanical stability and thrombogenicity limit its applications in orthopedic and vascular tissue engineering. Photochemical crosslinking is an emerging technique able to stabilize tissue grafts and improve the physicochemical properties of collagen-based structures. However, other important properties of collagen-based structures and the effect of processing parameters on these properties have not been explored. In this study, we aim to investigate the dose dependence of tensile and swelling properties on two parameters, namely, laser energy fluence and rose Bengal photosensitizer concentration. We also study the compression properties using cyclic compression test, long-term stability using subcutaneous implantation, and hematocompatibility using platelets adhesion test, of cross-linked collagen structures. Moreover, because limited optical penetration in turbid media is the major obstacle for light-based techniques, we also characterize the optical properties, which partially determine the effective optical penetration depth in collagen gel samples, during photochemical cross-linking. Laser energy fluence and rose Bengal concentration are important parameters affecting the cross-linking efficiency, which was characterized as the mechanical and the swelling properties, in a dose-dependent manner. Under the experimental conditions in this study, the peak fluence was 12.5J/cm(2) and the minimal rose Bengal concentration for effective cross-linking was > 0.00008 % (0.786 mu mol). Photochemical cross-linking also enhanced the compression strength and long-term stability of collagen structures without compromising the tissue compatibility. Furthermore, photochemical cross-linking reduced platelet adhesion and abolished fibrin mesh formation, thereby improving the hematocompatibility of collagen structures. These results suggest the feasibility of using the photochemically cross-linked collagen structures for orthopedic and vascular tissue engineering. Finally, the effective optical penetration depth in collagen gel samples is wavelength and rose Bengal concentration dependent, and was similar to 12 mm at 514 nm at 0.001 % (9.825 mu mol), the rose Bengal concentration mostly used in this study.
C1 Univ Hong Kong, Med Engn Program, Dept Mech Engn, Hong Kong, Peoples R China.
   Univ Hong Kong, Dept Anat, Hong Kong, Peoples R China.
   Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Peoples R China.
   Harvard Univ, Sch Med, Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02115 USA.
RP Chan, BP (reprint author), Univ Hong Kong, Med Engn Program, Dept Mech Engn, Room 711,Haking Wong Bldg,Pokfulam Rd, Hong Kong, Peoples R China.
EM bpchan@hkucc.hku.hk
RI So, Kwok Fai/C-4399-2009; Chan, BP/C-1886-2009
CR Abela GS, 2001, LASER SURG MED, V29, P455, DOI 10.1002/lsm.10000
   Adams AK, 2001, J BIOMED MATER RES, V57, P582, DOI 10.1002/1097-4636(20011215)57:4<582::AID-JBM1205>3.0.CO;2-6
   Aziz Omer, 2005, Surg Technol Int, V14, P35
   BALASUBRAMANIAN D, 1990, PHOTOCHEM PHOTOBIOL, V52, P761, DOI 10.1111/j.1751-1097.1990.tb08679.x
   Billiar K, 2001, J BIOMED MATER RES, V56, P101, DOI 10.1002/1097-4636(200107)56:1<101::AID-JBM1074>3.0.CO;2-6
   Chan BP, 2005, J BIOMED MATER RES A, V75A, P689, DOI 10.1002/jbm.a.30469
   Chan BP, 2005, J SURG RES, V124, P274, DOI 10.1016/j.jss.2004.09.019
   Chan BP, 2002, J SURG RES, V108, P77, DOI 10.1006/jsre.2002.6516
   CHAN BP, 2005, 8 TESI ANN M OCT 22
   Charulatha V, 2003, BIOMATERIALS, V24, P759, DOI 10.1016/S0142-9612(02)00412-X
   Clemetson KJ, 2001, THROMB HAEMOSTASIS, V86, P189
   Douven LFA, 2000, PROC SPIE, V3914, P312, DOI 10.1117/12.388058
   Du H, 1998, PHOTOCHEM PHOTOBIOL, V68, P141, DOI 10.1562/0031-8655(1998)068<0141:PACADA>2.3.CO;2
   Elliott DM, 2004, SPINE, V29, P713, DOI 10.1097/01.BRS.0000116982.19331.EA
   Grewal R, 1996, HAND CLIN, V12, P195
   He W, 2005, TISSUE ENG, V11, P1574, DOI 10.1089/ten.2005.11.1574
   HENDERSON BW, 1992, PHOTOCHEM PHOTOBIOL, V55, P145, DOI 10.1111/j.1751-1097.1992.tb04222.x
   Itoh S, 2002, BIOMATERIALS, V23, P4475, DOI 10.1016/S0142-9612(02)00166-7
   JACQUEZ JA, 1955, J OPT SOC AM, V45, P460, DOI 10.1364/JOSA.45.000460
   Kahn ML, 2004, SEMIN THROMB HEMOST, V30, P419, DOI 10.1055/s-2004-833477
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   KIRCHHOFER D, 1995, BLOOD, V86, P3815
   Kochevar IE, 2000, METHOD ENZYMOL, V319, P20
   KOCHEVAR IE, 1992, PHOTOSENSITIVITY, P9
   LANSCHE RK, 1965, AM J OPHTHALMOL, V60, P520, DOI 10.1016/0002-9394(65)90721-X
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Li S.-T., 2000, BIOMEDICAL ENG HDB
   Lin CW, 2001, J BIOMAT SCI-POLYM E, V12, P543, DOI 10.1163/156856201300194270
   Mulroy L, 2000, INVEST OPHTH VIS SCI, V41, P3335
   NIEMZ MH, 2004, LASER TISSUE INTERAC, P17
   PICKERING JW, 1992, J OPT SOC AM A, V9, P621, DOI 10.1364/JOSAA.9.000621
   PICKERING JW, 1993, APPL OPTICS, V32, P399, DOI 10.1364/AO.32.000399
   PIEPER JS, 1999, BIOMATERIALS, V20, P47
   Prahl S., 1988, THESIS U TEXAS AUSTI
   Ramshaw J. A. M., 2000, BIOMATERIALS BIOENGI, P717
   RAMSHAW JAM, 1994, BBA-PROTEIN STRUCT M, V1206, P225, DOI 10.1016/0167-4838(94)90212-7
   Ritz JP, 2001, LASER SURG MED, V29, P205, DOI 10.1002/lsm.1134
   SIMMONS DM, 1993, BIOTECHNOL APPL BIOC, V17, P23
   Star WM, 1997, PHYS MED BIOL, V42, P763, DOI 10.1088/0031-9155/42/5/003
   Tomizawa Yasuko, 2005, J Artif Organs, V8, P137, DOI 10.1007/s10047-005-0296-x
   Tuchin VV, 2002, HDB OPTICAL BIOMEDIC
   ULBRICHT R, 1900, ELEKTROTECH Z, V29, P595
   Vargas G, 2001, LASER SURG MED, V29, P213, DOI 10.1002/lsm.1110
   WEBSTER A, 1989, ANAL BIOCHEM, V179, P154, DOI 10.1016/0003-2697(89)90216-9
   Yannas I. V., 1996, BIOMATERIALS SCI INT, V1, P84
   Yaroslavsky AN, 1999, J BIOMED OPT, V4, P47, DOI 10.1117/1.429920
   Yaroslavsky AN, 2002, PHYS MED BIOL, V47, P2059, DOI 10.1088/0031-9155/47/12/305
   Yaroslavsky IV, 1996, APPL OPTICS, V35, P6797, DOI 10.1364/AO.35.006797
   Yeh AT, 2003, J INVEST DERMATOL, V121, P1332, DOI 10.1046/j.1523-1747.2003.12634.x
   Zdrahala RJ, 1996, J BIOMATER APPL, V10, P309, DOI 10.1177/088532829601000402
   Zhu TC, 2005, PHOTOCHEM PHOTOBIOL, V81, P96, DOI 10.1562/2004-06-25-RA-216.1
NR 51
TC 35
Z9 36
U1 1
U2 15
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JAN
PY 2007
VL 13
IS 1
BP 73
EP 85
DI 10.1089/ten.2006.004
PG 13
WC Cell & Tissue Engineering
SC Cell Biology
GA 130PU
UT WOS:000243812300008
PM 17518582
DA 2018-10-19
ER

PT J
AU Allan, KS
   Pilliar, RM
   Wang, J
   Grynpas, MD
   Kandel, RA
AF Allan, K. S.
   Pilliar, R. M.
   Wang, J.
   Grynpas, M. D.
   Kandel, R. A.
TI Formation of biphasic constructs containing cartilage with a calcified
   zone interface
SO TISSUE ENGINEERING
LA English
DT Article
ID TISSUE-ENGINEERED CARTILAGE; CALCIUM POLYPHOSPHATE SCAFFOLDS; BONE
   SUBSTITUTE APPLICATIONS; FORMED IN-VITRO; ARTICULAR-CARTILAGE;
   SUBCHONDRAL BONE; BETA-GLYCEROPHOSPHATE; DYNAMIC COMPRESSION; AGAROSE
   CULTURE; MINERALIZATION
AB The zone of calcified cartilage is the mineralized region of articular cartilage that anchors the hyaline cartilage to the subchondral bone and serves to disperse mechanical forces across this interface. In an attempt to mimic this zonal organization, we have developed the methodology to form biphasic constructs composed of cartilaginous tissue anchored to the top surface of a bone substitute (porous calcium polyphosphate, CPP) with a calcified interface. To accomplish this, chondrocytes were selectively isolated from the deep zone of bovine articular cartilage, placed on top of the CPP substrate, and grown in the presence of beta-glycerophosphate (10mM, beta-GP). By 8 weeks, cartilage tissue had formed with two zones: a calcified region adjacent to the CPP substrate and a hyaline-like zone above. Little or no mineralization occurred in the absence of beta-GP. The mineral that formed in vitro was identified as hydroxyapatite, similar in composition and crystal size to that found in vivo. The tissue stiffness was seven times greater, and the interfacial shear properties at the cartilage-CPP interface were at least two times greater in the presence of this mineralized zone within the in vitro-formed cartilage than in tissue lacking a mineral zone. In conclusion, developing a biphasic construct with a calcified zone at the tissue-biomaterial interface resulted in significantly better cartilage load-bearing (compressive) properties and interfacial shear strength, emphasizing the importance of the presence of a mineralized zone in bioengineered cartilage. Because failure due to shear occurred at the cartilage-CPP interface instead of the tidemark, as occurs with osteochondral tissue, further study is required to optimize this system so that it more closely mimics the native tissue.
C1 Mt Sinai Hosp, Dept Pathol & Lab Med, CIHR BioEngn Skeletal Tissues Team, Toronto, ON M5G 1X5, Canada.
   Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
RP Kandel, RA (reprint author), Mt Sinai Hosp, Dept Pathol & Lab Med, CIHR BioEngn Skeletal Tissues Team, 600 Univ Ave,Suite 6-500, Toronto, ON M5G 1X5, Canada.
EM rkandel@mtsinai.on.ca
RI Grynpas, Marc/E-4576-2013; Allan, Katherine/D-2531-2014; Kandel,
   Rita/E-2149-2017
OI Allan, Katherine/0000-0002-0511-0765; Kandel, Rita/0000-0003-4047-3913
CR ARSENAULT AL, 1988, CALCIFIED TISSUE INT, V43, P219, DOI 10.1007/BF02555138
   BAGINSKI E S, 1975, Annals of Clinical and Laboratory Science, V5, P399
   BAGINSKI ES, 1982, SELECTED METHODS SMA
   Bonassar LJ, 2001, J ORTHOPAED RES, V19, P11, DOI 10.1016/S0736-0266(00)00004-8
   BOSKEY AL, 1992, BONE MINER, V16, P11, DOI 10.1016/0169-6009(92)90819-Y
   BUSCHMANN MD, 1995, J CELL SCI, V108, P1497
   BUSCHMANN MD, 1992, J ORTHOPAED RES, V10, P745, DOI 10.1002/jor.1100100602
   CHUNG CH, 1992, CALCIFIED TISSUE INT, V51, P305, DOI 10.1007/BF00334492
   CROUCH SR, 1967, ANAL CHEM, V39, P1084, DOI 10.1021/ac60254a027
   DEGEMA TR, 1992, ARTICULAR CARTILAGE, P319
   Duda GN, 2000, J BIOMED MATER RES, V53, P673, DOI 10.1002/1097-4636(2000)53:6<673::AID-JBM9>3.0.CO;2-V
   Ferguson VL, 2003, J ANAT, V203, P191, DOI 10.1046/j.1469-7580.2003.00193.x
   FLACHSMANN R, 2002, CLIN ORTHOP RELAT RE, V212
   Frank EH, 2000, J BIOMECH, V33, P1523, DOI 10.1016/S0021-9290(00)00100-7
   GLIMCHER MJ, 1981, J CRYST GROWTH, V53, P100, DOI 10.1016/0022-0248(81)90058-0
   GRONOWICZ G, 1989, J BONE MINER RES, V4, P313
   Grynpas MD, 2002, BIOMATERIALS, V23, P2063, DOI 10.1016/S0142-9612(01)00336-2
   Hamilton DJ, 2006, BIOMATERIALS, V27, P397, DOI 10.1016/j.biomaterials.2005.07.007
   Hung CT, 2004, ANN BIOMED ENG, V32, P35, DOI 10.1023/B:ABME.0000007789.99565.42
   HUNTER GK, 1993, J CELL SCI, V104, P1031
   Jin M, 2001, ARCH BIOCHEM BIOPHYS, V395, P41, DOI 10.1006/abbi.2001.2543
   Kandel R, 1999, TISSUE ENG, V5, P25, DOI 10.1089/ten.1999.5.25
   Kandel R A, 1997, In Vitro Cell Dev Biol Anim, V33, P174
   Kandel RA, 2006, BIOMATERIALS, V27, P4120, DOI 10.1016/j.biomaterials.2006.03.005
   KATO Y, 1988, P NATL ACAD SCI USA, V85, P9552, DOI 10.1073/pnas.85.24.9552
   KIM YJ, 1994, ARCH BIOCHEM BIOPHYS, V311, P1, DOI 10.1006/abbi.1994.1201
   Mauck RL, 2002, ANN BIOMED ENG, V30, P1046, DOI 10.1114/1.1512676
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   MENTE PL, 1994, J ORTHOPAED RES, V12, P637, DOI 10.1002/jor.1100120506
   PALMOSKI MJ, 1984, ARTHRITIS RHEUM, V27, P675, DOI 10.1002/art.1780270611
   Pilato L. A., 1994, ADV COMPOSITE MAT
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   Qiu YS, 2003, OSTEOARTHR CARTILAGE, V11, P810, DOI 10.1016/S1063-4584(03)00164-X
   SAH RLY, 1989, J ORTHOPAED RES, V7, P619, DOI 10.1002/jor.1100070502
   SCHWARZENBACH G, 1955, ANALYST, V80, P713, DOI 10.1039/an9558000713
   Sun YL, 1999, J BONE MINER RES, V14, P1916, DOI 10.1359/jbmr.1999.14.11.1916
   TACCHETTI C, 1989, DEV BIOL, V132, P442, DOI 10.1016/0012-1606(89)90240-6
   von Rechenberg B, 2003, OSTEOARTHR CARTILAGE, V11, P265, DOI 10.1016/S1063-4584(03)00006-2
   WAINWRIGHT SA, 1976, MECH DESIGN ORG
   Waldman SD, 2006, OSTEOARTHR CARTILAGE, V14, P323, DOI 10.1016/j.joca.2005.10.007
   Waldman SD, 2004, TISSUE ENG, V10, P1323, DOI 10.1089/1076327042500210
   Waldman SD, 2003, J ORTHOPAED RES, V21, P590, DOI 10.1016/S0736-0266(03)00009-3
   Waldman SD, 2003, J ORTHOPAED RES, V21, P132, DOI 10.1016/S0736-0266(02)00105-5
   Waldman SD, 2002, J BIOMED MATER RES, V62, P323, DOI 10.1002/jbm.10235
   ZIMMERMANN B, 1992, CALCIFIED TISSUE INT, V51, P54, DOI 10.1007/BF00296218
   Zizak I, 2003, J STRUCT BIOL, V141, P208, DOI 10.1016/S1047-8477(02)00635-4
NR 46
TC 67
Z9 73
U1 0
U2 23
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JAN
PY 2007
VL 13
IS 1
BP 167
EP 177
DI 10.1089/ten.2006.0081
PG 11
WC Cell & Tissue Engineering
SC Cell Biology
GA 130PU
UT WOS:000243812300016
PM 17518590
DA 2018-10-19
ER

PT J
AU Gao, Q
   Chung, AS
   Kao, WYJ
AF Gao, Qiang
   Chung, Amy S.
   Kao, Weiyuan John
TI Monocytic U937 adhesion, tumor necrosis factor-alpha and interleukin-1
   beta expression in response to gelatin-based networks grafted with
   arginine-glycine-aspartic acid and
   proline-histidine-serine-arginine-asparagine oligopeptides
SO TISSUE ENGINEERING
LA English
DT Article
ID POLY(ETHYLENE GLYCOL) DIACRYLATE; CELL-LINE U-937; INTERPENETRATING
   NETWORKS; MACROPHAGE ADHESION; PHYSICOCHEMICAL ANALYSIS; FIBRONECTIN;
   PHOSPHORYLATION; HYDROGELS; IL-1; RGD
AB In this study we synthesized gelatin-based, tissue-engineering, interpenetrating network (IPN) scaffolds immobilized with fibronectin (FN)-derived peptides to assess monocyte-biomaterial interaction. Human promonocytic U937 cells were seeded onto peptide-grafted IPN or tissue-culture polystyrene plate (TCPS) pre-adsorbed with FN or FN-derived peptides. The presence of RGD influenced U937 density on IPN. Interleukin-1 beta (IL-1 beta) messenger ribonucleic acid (mRNA) expression in adherent U937 on treated TCPS was slightly upregulated at 4 h. Tumor necrosis factor alpha (TNF-alpha) and IL-1 beta mRNA expression in adherent U937 on all IPNs was generally downregulated at 4 h. This downregulation of IL-1 beta mRNA apparently varied in IPNs grafted with different ligand and was still present at 24h. TNF-alpha and IL-1 beta proteins released from U937 on treated TCPS were comparable with the control at 24h, but TNF-alpha and IL-1 beta protein expression in U937 on IPNs was lower at 24h than on the TCPS control. The results indicate that the tissue-engineering substrate and the bioactive peptides modulate the initial U937 adhesion and the subsequent inflammatory cytokine gene and protein expression.
C1 Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA.
   Univ Wisconsin, Dept Biomed Engn, Madison, WI 53705 USA.
RP Kao, WYJ (reprint author), Univ Wisconsin, Sch Pharm, Madison, WI 53705 USA.
EM wjkao@pharmacy.wisc.edu
FU NHLBI NIH HHS [R01 HL77825]; NIBIB NIH HHS [R01 EB6613]
CR AOTA S, 1994, J BIOL CHEM, V269, P24756
   Baugh J A, 2001, Curr Opin Drug Discov Devel, V4, P635
   Burmania JA, 2003, J BIOMED MATER RES A, V67A, P224, DOI 10.1002/jbm.a.10106
   Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001
   Chen XX, 2005, BIOMATERIALS, V26, P873, DOI 10.1016/j.biomaterials.2004.04.002
   CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
   Dinarello CA, 2002, CLIN EXP RHEUMATOL, V20, pS1
   EIERMAN DF, 1989, J IMMUNOL, V142, P1970
   Einerson NJ, 2003, BIOMATERIALS, V24, P509, DOI 10.1016/S0142-9612(02)00369-1
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   HARRIS P, 1985, J LEUKOCYTE BIOL, V37, P407
   Idriss HT, 2000, MICROSC RES TECHNIQ, V50, P184, DOI 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H
   Kao WJ, 2003, BIOMATERIALS, V24, P1183, DOI 10.1016/S0142-9612(02)00489-1
   Kao WUJ, 2002, J BIOMED MATER RES, V62, P478, DOI 10.1002/jbm.10317
   Kitamura H, 2004, FEBS LETT, V578, P180, DOI 10.1016/j.febslet.2004.11.008
   KOREN HS, 1979, NATURE, V279, P328, DOI 10.1038/279328a0
   Li J, 2003, BIOMACROMOLECULES, V4, P1055, DOI 10.1021/bm034069l
   Liu YP, 2002, CELL SIGNAL, V14, P145, DOI 10.1016/S0898-6568(01)00246-7
   Nakayama Y, 1999, J BIOMED MATER RES, V48, P511, DOI 10.1002/(SICI)1097-4636(1999)48:4<511::AID-JBM17>3.3.CO;2-M
   Okino H, 2002, J BIOMED MATER RES, V59, P233, DOI 10.1002/jbm.1237
   OLSSON IL, 1982, CANCER RES, V42, P3924
   Phillips JM, 2005, TISSUE ENG, V11, P964, DOI 10.1089/ten.2005.11.964
   Rosenwasser LJ, 1998, J ALLERGY CLIN IMMUN, V102, P344
   Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Stevens KR, 2002, J BIOMAT SCI-POLYM E, V13, P1353, DOI 10.1163/15685620260449741
   SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504
   Witte RP, 2004, J BIOMED MATER RES A, V71A, P508, DOI 10.1002/jbm.a.30179
   Zilinski JL, 2004, J BIOMED MATER RES A, V68A, P392, DOI 10.1002/jbm.a.20079
NR 29
TC 6
Z9 6
U1 0
U2 1
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JAN
PY 2007
VL 13
IS 1
BP 179
EP 185
DI 10.1089/ten.2006.0007
PG 7
WC Cell & Tissue Engineering
SC Cell Biology
GA 130PU
UT WOS:000243812300017
PM 17518591
DA 2018-10-19
ER

PT J
AU Foutz, TL
   Griffin, AK
   Halper, JT
   Rowland, GN
AF Foutz, T. L.
   Griffin, A. K.
   Halper, J. T.
   Rowland, G. N.
TI Effects of increased physical activity on juvenile avian bone
SO TRANSACTIONS OF THE ASABE
LA English
DT Article
DE animal husbandry; biomaterial; bone; chicken; mechanical properties;
   physical activity
ID IN-VIVO; TREADMILL EXERCISE; BROILER-CHICKENS; ACHILLES-TENDON; WALKING
   ABILITY; GROWING BONE; STRAIN; GROWTH; IMMOBILIZATION; BEHAVIOR
AB Commercial meat-type chickens (broilers) have become less active as production practices have increased the rate at which these birds gain weight. This inactivity could result in skeletal abnormalities that adversely affect animal health and production cost. This study investigated a treadmill regimen to increase the bone movement of broilers and force the broilers into an abnormally high level of physical activity. Beginning at 3 weeks of age, treatment birds were required to walk 5 days a week on a treadmill at a pace of 0.45 m/s for 30 min. The working hypothesis was that increased bone movement of broiler chicken accelerates skeletal development and strength. Results indicated that treadmill pacing did not affect the body mass of the bird during normal growth but did affect (p <= 0.05) the length and width of the bird's shank. The treatment reduced tibia length by approximately 8% and tibia midpoint cross-sectional area by 25%. The shear strength and bone mineralization of the tibia was not affected by the increased bone movement. Overall, the increased activity did not impact the structural integrity of the broiler's tibiae.
C1 Univ Georgia, Fac Engn, Driftmer Engn Ctr 120, Athens, GA 30602 USA.
   Poultry Diagnost Res Ctr, Athens, GA USA.
   Univ Georgia, Dept Vet Pathol, Athens, GA 30602 USA.
   Univ Georgia, Dept Biol & Agr Engn, Athens, GA 30602 USA.
RP Foutz, TL (reprint author), Univ Georgia, Fac Engn, Driftmer Engn Ctr 120, Athens, GA 30602 USA.
EM tfoutz@engr.uga.edu
CR Adams JE, 1997, EUR RADIOL, V7, P20
   Almeida-Silveira MI, 2000, EUR J APPL PHYSIOL, V81, P252
   Arnould C, 2004, APPL ANIM BEHAV SCI, V87, P155
   *ASAE STAND, 1997, SHEAR 3 POINT BEND T
   BIEWENER AA, 1993, J EXP BIOL, V185, P51
   BIEWENER AA, 1986, CALCIFIED TISSUE INT, V39, P390, DOI 10.1007/BF02555177
   BIEWENER AA, 1994, J APPL PHYSIOL, V76, P946
   Bizeray D, 2002, APPL ANIM BEHAV SCI, V79, P27, DOI 10.1016/S0168-1591(02)00083-7
   BRACKENBURY JH, 1990, BRIT POULTRY SCI, V31, P207, DOI 10.1080/00071669008417247
   CURWIN SL, 1988, J APPL PHYSIOL, V65, P2297
   Foutz TL, 1997, T ASAE, V40, P1719
   Foutz TL, 1997, T ASAE, V40, P1727
   Gosselin LE, 1998, J APPL PHYSIOL, V85, P1011
   GRIFFIN AK, 1998, ANN BIOMED ENG, V26, P81
   HESTER PY, 1994, POULTRY SCI, V73, P904, DOI 10.3382/ps.0730904
   Iwamoto J, 1999, BONE, V24, P163, DOI 10.1016/S8756-3282(98)00189-6
   Judex S, 2000, J APPL PHYSIOL, V88, P2183
   Judex S, 1997, J BONE MINER RES, V12, P1737, DOI 10.1359/jbmr.1997.12.10.1737
   Julian RJ, 1998, POULTRY SCI, V77, P1773, DOI 10.1093/ps/77.12.1773
   Kaneps AJ, 1997, BONE, V21, P419, DOI 10.1016/S8756-3282(97)00167-1
   Kersting UG, 1999, CLIN BIOMECH, V14, P494, DOI 10.1016/S0268-0033(98)90100-0
   Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003
   Konieczynski DD, 1998, J ORTHOP RES, V16, P29, DOI 10.1002/jor.1100160106
   Kopher RA, 2003, ANN BIOMED ENG, V31, P1125, DOI 10.1114/1.1603259
   Lieberman DE, 2003, J EXP BIOL, V206, P3125, DOI 10.1242/jeb.00514
   Main RP, 2006, PHYSIOL BIOCHEM ZOOL, V79, P57, DOI 10.1086/498184
   Martin R. B, 1998, SKELETAL TISSUE MECH
   Mitchell AD, 1997, POULTRY SCI, V76, P1746, DOI 10.1093/ps/76.12.1746
   Moraska A, 2000, AM J PHYSIOL-REG I, V279, pR1321
   *NAT OST FDN, 1998, OSTEOPOROS INT S4, V8, P3
   Noble DO, 1996, POULTRY SCI, V75, P833, DOI 10.3382/ps.0750833
   Palmes D, 2002, J ORTHOPAED RES, V20, P939, DOI 10.1016/S0736-0266(02)00032-3
   PattersonKane JC, 1997, EQUINE VET J, V29, P121, DOI 10.1111/j.2042-3306.1997.tb01653.x
   Prayitno DS, 1997, POULTRY SCI, V76, P452, DOI 10.1093/ps/76.3.452
   RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012
   SAS, 1990, SAS US GUID STAT
   Skalicky M, 2000, EXP GERONTOL, V35, P595, DOI 10.1016/S0531-5565(00)00097-8
   THORP BH, 1994, AVIAN PATHOL, V23, P203, DOI 10.1080/03079459408418991
   TOMMERUP LJ, 1993, J BONE MINER RES, V8, P1053
   TURNER CH, 1994, J BONE MINER RES, V9, P87
   van Harreveld PD, 2002, AM J VET RES, V63, P276, DOI 10.2460/ajvr.2002.63.276
   Weeks CA, 2000, APPL ANIM BEHAV SCI, V67, P111, DOI 10.1016/S0168-1591(99)00102-1
   Yalcin S, 1998, BRIT POULTRY SCI, V39, P251, DOI 10.1080/00071669889213
   Yoon JH, 2004, ARCH TOXICOL, V78, P599, DOI 10.1007/s00204-004-0574-z
NR 44
TC 9
Z9 9
U1 0
U2 5
PU AMER SOC AGRICULTURAL & BIOLOGICAL ENGINEERS
PI ST JOSEPH
PA 2950 NILES RD, ST JOSEPH, MI 49085-9659 USA
SN 0001-2351
J9 T ASABE
JI Trans. ASABE
PD JAN-FEB
PY 2007
VL 50
IS 1
BP 213
EP 219
PG 7
WC Agricultural Engineering
SC Agriculture
GA 156NP
UT WOS:000245656500025
DA 2018-10-19
ER

PT B
AU Yamamoto, T
   Matsunaga, Y
   Hosoda, H
   Miyazaki, S
   Sakuma, T
AF Yamamoto, T.
   Matsunaga, Y.
   Hosoda, H.
   Miyazaki, S.
   Sakuma, T.
BE Somiya, S
   Doyama, M
TI Mechanical properties of Ti-Nb-Mo-Al alloys
SO TRANSACTIONS OF THE MATERIALS RESEARCH SOCIETY OF JAPAN, VOL 32, NO 3
SE TRANSACTIONS OF THE MATERIALS RESEARCH SOCIETY OF JAPAN
LA English
DT Proceedings Paper
CT Joint Symposia of the Materials-Research-Society-of-Japan
CY DEC 08-10, 2006
CL Nihon Univ, Tokyo, JAPAN
SP Mat Res Soc Japan
HO Nihon Univ
DE biomaterial; Ti-Nb-Mo-Al alloy; superelasticity; effect of Mo content;
   effect of Nb content
AB This paper describes effects of Mo and Nb contents on mechanical properties of Ni-free Ti-Nb-Mo-Al alloys. The materials are Ti-8Nb-4Mo-3Al, Ti-8Nb-(5-6)Mo-5A1 and Ti-(10-12)Nb-4Mo-5Al (mol%). Loading-unloading tensile tests were carried out at 173K, 296K and 413K. Young's modulus decreases with increasing Mo and Nb contents, and the Ti-8Nb-6Mo-5A1 and Ti-12Nb-4Mo-5A1 alloys show low Young's modulus. Also, there is scarcely an effect of temperature on Young' modulus. The elastic strain increases with increasing Mo and Nb contents. The Ti-8Nb-SMo-Al and Ti-12Nb-4Mo-5Al alloys show the large superelastic recovery strain at 173K and 296K. However, there is scarcely the superelastic recovery strain at 413K. The large total recovery strain is seen in the Ti-8Nb-(5-6)Mo-5A1 and Ti-12M-4Mo-5A1 alloys at 173K and 296K.
C1 [Yamamoto, T.; Matsunaga, Y.; Sakuma, T.] Oita Univ, Fac Engn, Oita 8701192, Japan.
RP Yamamoto, T (reprint author), Oita Univ, Fac Engn, Oita 8701192, Japan.
CR Inamura T, 2005, MAT SCI ENG C-BIO S, V25, P426, DOI 10.1016/j.msec.2005.01.025
   INAMURA T, 2006, IEEJ T SM, V126, P164
   Kim JI, 2005, MATER TRANS, V46, P852, DOI 10.2320/matertrans.46.852
   Maeshima T, 2006, MATER TRANS, V47, P513, DOI 10.2320/matertrans.47.513
   Miyazaki S., 1990, ENG ASPECTS SHAPE ME, P394
   Shabalovskaya S., 1994, P 1 INT C SHAP MEM S, P209
NR 6
TC 0
Z9 0
U1 0
U2 1
PU MATERIALS RESEARCH SOCIETY JAPAN-MRS-J
PI TOKYO
PA C/O SOCIETY NON-TRADITIONAL TECHNOLOGY, SAKURA BLDG 9F, 2-5-5,
   TORANOMON, MINATO-KU, TOKYO, 105-0001, JAPAN
J9 T MRS JAP
PY 2007
VL 32
IS 3
BP 631
EP 634
PG 4
WC Materials Science, Multidisciplinary
SC Materials Science
GA BHK85
UT WOS:000253931500007
DA 2018-10-19
ER

PT J
AU Brehmer, B
   Rohrmann, D
   Becker, C
   Rau, G
   Jakse, G
AF Brehmer, Bernhard
   Rohrmann, Dorothea
   Becker, Christoph
   Rau, Guenther
   Jakse, Gerhard
TI Different types of scaffolds for reconstruction of the urinary tract by
   tissue engineering
SO UROLOGIA INTERNATIONALIS
LA English
DT Article
DE tissue engineering; urinary tract reconstruction; biomatrix; scaffold;
   scaffold types : carrier, fleece and sponge
ID SMALL-INTESTINAL SUBMUCOSA; DERMAL COLLAGEN IMPLANTS; IN-VITRO;
   UROLOGICAL SURGERY; PORE-SIZE; MEMBRANE; BLADDER; CELLS; REGENERATION;
   INVITRO
AB Introduction: Tissue engineering is an important and expanding field in reconstructive surgery. The ideal biomaterial for urologic tissue engineering should be biodegradable and support autologous cell growth. We examined different scaffolds to select the ideal material for the reconstruction of the bladder wall by tissue engineering. Materials and Methods: We seeded mouse fibroblasts and human keratinocytes in a co-culture model on 13 different scaffolds. The cell-seeded scaffolds were fixed and processed for electron microscopy, hematoxylin and eosin stain, and immunohistochemistry. Cell density and epithelial cell layers were evaluated utilizing a computer-assisted optical measurement system. Results: Depending on the growth pattern, scaffolds were classified into the following three distinct scaffold types: carrier-type scaffolds with very small pore sizes and no ingrowth of the cells. This scaffold type induces a well-differentiated epithelium. Fleece-type scaffolds with fibers and huge pores. We found cellular growth inside the scaffold but no epithelium on top of it. Sponge-type scaffolds with pores between 20 and 40 mu m. Cellular growth was observed inside the scaffold and well-differentiated epithelium on top of it. Conclusion: To our knowledge, this is the first time three distinct scaffold types have been reported. All types supported the cell growth. The structure of the scaffolds affects the pattern of cell growth. Copyright (c) 2007 S. Karger AG, Basel.
C1 Univ Clin Aachen, Dept Urol, Aachen, Germany.
   Rhein Westfal Tech Univ Aachen, Helmholtz Inst Biomed Engn, Aachen, Germany.
RP Brehmer, B (reprint author), Univ Bonn, Univ Clin, Urol Clin, Pauwelsstr 30, DE-52074 Aachen, Germany.
EM Bernhard.Brehmer@post.rwth-aachen.de
CR ATALA A, 1992, J UROLOGY, V148, P658, DOI 10.1016/S0022-5347(17)36685-5
   Atala A, 2001, Curr Urol Rep, V2, P83, DOI 10.1007/s11934-001-0030-z
   Atala A, 1999, UROL CLIN N AM, V26, P157, DOI 10.1016/S0094-0143(99)80013-5
   Badylak SF, 1998, TISSUE ENG, V4, P379, DOI 10.1089/ten.1998.4.379
   BOAG AH, 1994, AM J PATHOL, V144, P585
   Eaglstein W H, 1998, Adv Wound Care, V11, P1
   Falke G, 2000, WORLD J UROL, V18, P36, DOI 10.1007/s003450050007
   FUJIYAMA C, 1995, J UROLOGY, V153, P2060, DOI 10.1016/S0022-5347(01)67402-0
   GORHAM S, 1984, UROL RES, V12, P295, DOI 10.1007/BF00258039
   GORHAM SD, 1990, BIOMATERIALS, V11, P113, DOI 10.1016/0142-9612(90)90125-A
   GORHAM SD, 1987, UROL RES, V15, P53
   Hafemann B, 2001, J MATER SCI-MATER M, V12, P437, DOI 10.1023/A:1011205221972
   Hafemann B, 1999, BURNS, V25, P373, DOI 10.1016/S0305-4179(98)00162-4
   HAKIM S, 1994, UROLOGY, V44, P139, DOI 10.1016/S0090-4295(94)80028-6
   Kehe K, 1999, ARCH DERMATOL RES, V291, P600, DOI 10.1007/s004030050461
   Kropp BP, 2000, J ENDOUROL, V14, P59, DOI 10.1089/end.2000.14.59
   Kuberka M, 2002, INT J ARTIF ORGANS, V25, P67
   MCDOUGAL WS, 1992, J UROLOGY, V147, P1199, DOI 10.1016/S0022-5347(17)37517-1
   Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149
   OLIVER RF, 1982, BIOMATERIALS, V3, P38, DOI 10.1016/0142-9612(82)90059-X
   REBEL JM, 1994, J PATHOL, V173, P283, DOI 10.1002/path.1711730312
   Sabbagh W, 1998, BRIT J UROL, V82, P888
   Schaefer BM, 1998, J UROLOGY, V159, P284, DOI 10.1016/S0022-5347(01)64083-7
   SCOTT R, 1991, BRIT J UROL, V68, P421, DOI 10.1111/j.1464-410X.1991.tb15365.x
   SHAKESPEARE PG, 1980, LANCET, V1, P795
   Wefer J, 2001, J UROLOGY, V165, P1755, DOI 10.1016/S0022-5347(05)66408-7
   Yoo JJ, 2000, YONSEI MED J, V41, P789, DOI 10.3349/ymj.2000.41.6.789
   Zeltinger J, 2001, TISSUE ENG, V7, P557, DOI 10.1089/107632701753213183
NR 28
TC 25
Z9 33
U1 1
U2 5
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0042-1138
J9 UROL INT
JI Urol.Int.
PY 2007
VL 78
IS 1
BP 23
EP 29
DI 10.1159/000096930
PG 7
WC Urology & Nephrology
SC Urology & Nephrology
GA 121OP
UT WOS:000243167200004
PM 17192728
DA 2018-10-19
ER

PT J
AU Teixeira, CR
   Rahal, SC
   Volpi, RS
   Taga, R
   Cestari, IM
   Granieiro, JM
   Vulcano, LC
   Correa, MA
AF Teixeira, C. R.
   Rahal, S. C.
   Volpi, R. S.
   Taga, R.
   Cestari, I. M.
   Granieiro, J. M.
   Vulcano, L. C.
   Correa, M. A.
TI Tibial segmental bone defect treated with bone plate and cage filled
   with either xenogeneic composite or autologous cortical bone graft
SO VETERINARY AND COMPARATIVE ORTHOPAEDICS AND TRAUMATOLOGY
LA English
DT Article
DE bone defect; treatment; biomaterials; bone graft; sheep
ID TITANIUM MESH CAGE; MORPHOGENETIC PROTEINS; DIAPHYSEAL DEFECTS;
   REGENERATION; SHEEP; SUBSTITUTE; MODEL
AB Tibia segmental defect healing in sheep were clinically, radiographically and histologically evaluated. Twelve young sheep aged four to five months were divided into two groups, G1 and G2. A 3.5 cm long segmental defect was created in the right tibial diaphysis with maintenance of the periosteum. The bone defects in both groups were stabilized with a bone plate combined with a titanium cage. In G1 the cage was filled with pieces of autologous cortical bone graft. In G2 it was filled with a composite biomaterial which consisted of inorganic bovine bone, demineralized bovine bone, a pool of bovine bone morphogenetic proteins bound to absorbable ultra-thin powdered hydroxyapatiteand bone-derived denaturized collagen. Except for one G1 animal, all of them showed normal limb function 60 days after surgery. Radiographic examination showed initial formation of periosteal callus in both groups at osteo-tomy sites, over the plate or cage 15 days postoperatively. At 60 and 90 days callus remodeling occurred. Histological and morphometric analysis at 90 days after surgery showed that the quantity of implanted materials in G1 and G2 were similar, and the quantity of new bone formation was less (p = 0.0048) and more immature in G1 than G2, occupying 51 +/- 3.46% and 62 +/- 6.26% of the cage space, respectively. These results suggest that the composite biomaterial tested was a good alternative to autologous cartical bone graft in this experimental ovine tibial defect. However, additional evaluation is warranted prior to its clinical usage.
C1 [Teixeira, C. R.; Rahal, S. C.; Correa, M. A.] Sao Paulo State Univ, Sch Vet Med & Anim Sci, Dept Vet Surg & Anesthesiol, Sao Paulo, Brazil.
   [Volpi, R. S.] Sao Paulo State Univ, Sch Med, Dept Orthoped Surg, Sao Paulo, Brazil.
   [Taga, R.; Cestari, I. M.] Univ Sao Paulo, Sch Dent Bauru, Dept Biol Sci, Sao Paulo, Brazil.
   [Granieiro, J. M.] Univ Fed Fluminense, Inst Biol, Dept Mol Cell Biol, Sao Paulo, Brazil.
   [Vulcano, L. C.] Sao Paulo State Univ, Sch Vet Med & Anim Sci, Dept Reprod & Radiol, Sao Paulo, Brazil.
RP Teixeira, CR (reprint author), Sao Paulo State Univ, Sch Vet Med & Anim Sci, Dept Vet Surg & Anesthesiol, Sao Paulo, Brazil.
RI Taga, Rumio/E-5794-2012; Rahal, Sheila/E-9264-2012; Granjeiro,
   Jose/D-8289-2012
OI Rahal, Sheila/0000-0002-9211-4093; Granjeiro, Jose/0000-0002-8027-8293
CR Attias N, 2005, J ORTHOP TRAUMA, V19, P211, DOI 10.1097/00005131-200503000-00011
   Benke D, 2001, BIOMATERIALS, V22, P1005, DOI 10.1016/S0142-9612(00)00323-9
   Cobos JA, 2000, J ORTHOP TRAUMA, V14, P54, DOI 10.1097/00005131-200001000-00011
   den Boer FC, 2003, J ORTHOPAED RES, V21, P521, DOI 10.1016/S0736-0266(02)00205-X
   EHRNBERG A, 1993, J ORTHOP RES, V11, P438, DOI 10.1002/jor.1100110317
   EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016
   Elshahat A, 2005, PLAST RECONSTR SURG, V116, P1068, DOI 10.1097/01.prs.0000178783.44190.ec
   FILHO CLC, 2001, INT J ORAL MAXILLOF, V16, P799
   FORELL EB, 1993, VET COMP ORTHOPAED, V6, P166
   Fujibayashi S, 2003, BIOMATERIALS, V24, P3445, DOI 10.1016/S0142-9612(03)00221-7
   *GEN, 2001, MOG MIR
   GERHART TN, 1993, CLIN ORTHOP RELAT R, P317
   Granjeiro JM, 2005, BRAZ J MED BIOL RES, V38, P1463, DOI 10.1590/S0100-879X2005001000003
   Grob D, 2005, EUR SPINE J, V14, P211, DOI 10.1007/s00586-004-0748-7
   Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009
   Gugala Z, 1999, J ORTHOP TRAUMA, V13, P187, DOI 10.1097/00005131-199903000-00006
   Guimarães Maria do Carmo Machado, 2004, J. Appl. Oral Sci., V12, P70, DOI 10.1590/S1678-77572004000100013
   Johnson KD, 1996, J ORTHOP TRAUMA, V10, P28, DOI 10.1097/00005131-199601000-00005
   Keating JF, 2001, J BONE JOINT SURG BR, V83B, P3, DOI 10.1302/0301-620X.83B1.11952
   KIRKERHEAD CA, 1995, VET SURG, V24, P408, DOI 10.1111/j.1532-950X.1995.tb01352.x
   LANE JM, 2001, J BONE JOINT SURG S1, V83, P161
   LIMA AFM, 2003, THESIS SCH VET MED A
   McKee Michael D, 2006, J Am Acad Orthop Surg, V14, pS163
   Merkx MAW, 1999, BIOMATERIALS, V20, P639, DOI 10.1016/S0142-9612(98)00219-1
   Morgan J, 1995, RADIOLOGY SMALL ANIM, P34
   Pou Anna M, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P240, DOI 10.1097/00020840-200308000-00004
   Sciadini MF, 1997, J ORTHOP TRAUMA, V11, P496, DOI 10.1097/00005131-199710000-00007
   Taga R, 2000, J BRAS ENDO PERIO, V1, P78
   Weng D, 2000, CLIN ORAL IMPLAN RES, V11, P546, DOI 10.1034/j.1600-0501.2000.011006546.x
   WOLFE MW, 1999, LU PENN OTHOP J, V12, P1
   Zevgaridis Dimitris, 2002, Neurosurg Focus, V12, pE2
NR 31
TC 15
Z9 18
U1 0
U2 2
PU SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN
PI STUTTGART
PA HOLDERLINSTRASSE 3, D-70174 STUTTGART, GERMANY
SN 0932-0814
J9 VET COMP ORTHOPAED
JI Vet. Comp. Orthop. Traumatol.
PY 2007
VL 20
IS 4
BP 269
EP 276
DI 10.1160/VCOT-06-12-0093
PG 8
WC Veterinary Sciences; Zoology
SC Veterinary Sciences; Zoology
GA 242VU
UT WOS:000251755100005
PM 18038002
DA 2018-10-19
ER

PT S
AU Wang, JH
   Nonami, T
AF Wang, Junhu
   Nonami, Toru
BE Kim, SI
   Suh, TS
TI Iron Containing Hydroxyapatite Prepared by a Modified Pseudo-Body
   Solution
SO WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING 2006, VOL
   14, PTS 1-6
SE IFMBE Proceedings
LA English
DT Proceedings Paper
CT World Congress on Medical Physics and Biomedical Engineering
CY AUG 27-SEP 01, 2006
CL Seoul, SOUTH KOREA
SP IUPSEM, IFMBE, IOMP, KSMP, KSMBE, AAPM, AFOMP, BMES, EFOMP, IAEA, AIMBE, IEEE EMB, WHO, SIEMENS, TomoTherapy, Philips, iba, Varian, CIVCO, elekta, Samsung
DE Iron containing hydroxyapatite; modified pseudo-body solution; apatitic
   structure; photo-absorption; biomaterial
AB We are interested in developing novel multifunctional biomaterials applied for dental surgery and the fabrication of artificial bone scaffolds with a controlled pore structure. Hydroxyapatite (noted HAp) is a useful biomaterial due to its good biocompatibility. Small amount of iron has been known to influence the crystallinity and solubility of HAp. In this study, various kinds of trace iron containing HAp (noted FeHAp) were synthesized by adding an aqueous solution of iron nitrate into a modified pseudo-body solution with an excess of phosphate ion concentration. The crystal structures of FeHAp were refined by the Rietveld analysis. The optical properties of FeHAp were measured by UV-vis spectroscopy. The results indicate that the cell parameters become longer and the photo-absorption become stronger with increasing iron within the studied composition range. This implies that FeHAp is possible to have additional functions comparing with plain HAp when is used as a biomaterial. In this paper, syntheses and characterization of the novel FeHAp are reported.
C1 [Wang, Junhu; Nonami, Toru] Chukyo Univ, Sch Life Syst Sci & Technol, Toyota 4700393, Japan.
RP Nonami, T (reprint author), Chukyo Univ, Sch Life Syst Sci & Technol, 101 Tokodachi, Toyota 4700393, Japan.
CR Anee TK, 2004, MATER LETT, V58, P478, DOI 10.1016/S0167-577X(03)00529-9
   IZUMI F, 1993, RIETVELD METHOD, pCH13
   KAY MI, 1964, NATURE, V204, P1050, DOI 10.1038/2041050a0
   Morrissey R, 2005, J MATER SCI-MATER M, V16, P387, DOI 10.1007/s10856-005-6976-5
   Nishikawa H., 2004, J MOL CATAL A-CHEM, V207, P147
   Nonami T, 2004, CATAL TODAY, V96, P113, DOI 10.1016/j.cattod.2004.06.112
   OKAZAKI M, 1986, J BIOMED MATER RES, V20, P879, DOI 10.1002/jbm.820200703
   Okazaki M, 1985, J Osaka Univ Dent Sch, V25, P17
   Pauling L., 1960, NATURE CHEM BOND
   WAKAMURA M, 2003, LANGMUIR, V19, P3248
NR 10
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 1680-0737
BN 978-3-540-36839-7
J9 IFMBE PROC
PY 2007
VL 14
BP 3365
EP 3368
PN 1-6
PG 4
WC Engineering, Biomedical; Physics, Applied; Imaging Science &
   Photographic Technology
SC Engineering; Physics; Imaging Science & Photographic Technology
GA BIM52
UT WOS:000260855901334
DA 2018-10-19
ER

PT J
AU Tilocca, A
   de Leeuw, NH
AF Tilocca, Antonio
   de Leeuw, Nora H.
TI Ab initio molecular dynamics study of 45S5 bioactive silicate glass
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID ELECTRONIC-PROPERTIES; PHOSPHATE-GLASSES; AMORPHOUS SILICA;
   COMPUTER-SIMULATION; SODIUM METASILICATE; VITREOUS SIO2; SURFACE; CAR;
   APPROXIMATION; BIOMATERIALS
AB Bioglass 45S5, the prototype of bioactive melt-quenched silicate glasses, was modeled by means of Car-Parrinello molecular dynamics (CPMD) simulations. Although long-range structural properties cannot be modeled by using this ab initio approach, the accuracy of CPMD simulations is exploited here to provide insight into the short-range structure and to analyze vibrational and electronic properties of this biomaterial. Detailed structural analysis in the short-range scale provided insight into the local environment of modifier Na and Ca ions: a possible key role of these cations in organizing the glass network by connecting different chains and fragments into specific, rather flexible geometries was proposed. The individual contributions of different species to the vibrational density of states were separated and discussed, allowing the identification of specific features in the vibrational spectrum, such as those related to phosphate groups. The components of the electronic density of states were also analyzed, enabling us to identify correlations between the electronic structure and the structural properties, such as the different bonding character of Si-O bonds involving bridging or nonbridging oxygen atoms.
C1 UCL, Dept Chem, London, England.
   Univ London Birkbeck Coll, Sch Crystallog, London, England.
RP Tilocca, A (reprint author), UCL, Dept Chem, Mortimer St, London, England.
EM a.tilocca@ucl.ac.uk
RI Tilocca, Antonio/B-6460-2008
OI Tilocca, Antonio/0000-0002-8689-7044
FU Engineering and Physical Sciences Research Council [GR/S77714/01,
   GR/R77711/02, GR/S77714/02]
CR Arcos D, 2002, CHEM MATER, V14, P1515, DOI 10.1021/cmO11119p
   Black J., 1998, HDB BIOMATERIALS PRO
   BRAWER S, 1975, PHYS REV B, V11, P3173, DOI 10.1103/PhysRevB.11.3173
   Brow RK, 2000, J NON-CRYST SOLIDS, V263, P1, DOI 10.1016/S0022-3093(99)00620-1
   CAR R, 1985, PHYS REV LETT, V55, P2471, DOI 10.1103/PhysRevLett.55.2471
   CAR R, 2005, HDB MAT MODELING
   Cerruti M, 2005, J PHYS CHEM B, V109, P14496, DOI 10.1021/jp050705t
   Cerruti M, 2005, BIOMATERIALS, V26, P1665, DOI 10.1016/j.biomaterials.2004.07.009
   Charpentier T, 2004, J PHYS CHEM B, V108, P4147, DOI 10.1021/jp0367225
   CHING WY, 1983, PHYS REV B, V28, P4724, DOI 10.1103/PhysRevB.28.4724
   Clayden NJ, 2005, J NON-CRYST SOLIDS, V351, P195, DOI 10.1016/j.jnoncrysol.2004.11.009
   Donadio D, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.214205
   Du JC, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.092201
   Dubiel M, 1997, J NON-CRYST SOLIDS, V220, P30, DOI 10.1016/S0022-3093(97)00230-5
   ElBatal HA, 2003, MATER CHEM PHYS, V80, P599, DOI 10.1016/S0254-0584(03)00082-8
   Elgayar I, 2005, J NON-CRYST SOLIDS, V351, P173, DOI 10.1016/j.jnoncrysol.2004.07.067
   Gaigeot MP, 2003, J PHYS CHEM B, V107, P10344, DOI 10.1021/jp034788u
   Ganster P, 2004, J CHEM PHYS, V120, P10172, DOI 10.1063/1.1724815
   Gonzalez P, 2003, J NON-CRYST SOLIDS, V320, P92, DOI 10.1016/S0022-3093(03)00013-9
   GROTENDORST J, 2005, NIC SERIES, V25
   HENCH LL, 1984, SCIENCE, V226, P630, DOI 10.1126/science.6093253
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   HENCH LL, 1993, INTRO BIOCERAMICS
   Hoppe U, 2000, J NON-CRYST SOLIDS, V263, P29, DOI 10.1016/S0022-3093(99)00621-3
   Horbach J, 1999, J PHYS CHEM B, V103, P4104, DOI 10.1021/jp983898b
   Ispas S, 2005, J NON-CRYST SOLIDS, V351, P1144, DOI 10.1016/j.jnoncrysol.2005.01.051
   Ispas S, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevLett.87.214206
   Koslowski T, 1997, PHYS REV B, V56, P9469, DOI 10.1103/PhysRevB.56.9469
   LI D, 1995, J NON-CRYST SOLIDS, V188, P181, DOI 10.1016/0022-3093(95)00100-X
   Lin CC, 2005, J NON-CRYST SOLIDS, V351, P3195, DOI 10.1016/j.jnoncrysol.2005.08.020
   Lin KSK, 2005, CHEM MATER, V17, P4493, DOI 10.1021/cm0505654c
   Linati L, 2005, J PHYS CHEM B, V109, P4989, DOI 10.1021/jp046631n
   LIU F, 1993, CHEM PHYS LETT, V215, P401, DOI 10.1016/0009-2614(93)85736-8
   Martinez A, 2000, CHEM MATER, V12, P3080, DOI 10.1021/cm001107o
   MCMILLAN P, 1984, AM MINERAL, V69, P622
   Mead RN, 2006, J PHYS CHEM B, V110, P14273, DOI 10.1021/jp0628939
   Oliveira JM, 2002, BIOMATERIALS, V23, P371, DOI 10.1016/S0142-9612(01)00115-6
   Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865
   Plotnichenko VG, 2002, J NON-CRYST SOLIDS, V306, P209, DOI 10.1016/S0022-3093(02)01172-9
   SARNTHEIN J, 1995, PHYS REV LETT, V74, P4682, DOI 10.1103/PhysRevLett.74.4682
   Sarnthein J, 1997, SCIENCE, V275, P1925, DOI 10.1126/science.275.5308.1925
   SARNTHEIN J, 1995, PHYS REV B, V52, P12690, DOI 10.1103/PhysRevB.52.12690
   Scandolo S, 2005, Z KRISTALLOGR, V220, P574, DOI 10.1524/zkri.220.5.574.65062
   Serra J, 2003, J NON-CRYST SOLIDS, V332, P20, DOI 10.1016/j.jnoncrysol.2003.09.013
   SIEGEL GH, 1971, J PHYS CHEM SOLIDS, V32, P2373
   SIEGEL GH, 1974, J NONCRYST SOLIDS, V13, P363
   SMITH W, 1995, J CHEM PHYS, V103, P3091, DOI 10.1063/1.470498
   Smith W, 1996, J MOL GRAPHICS, V14, P136, DOI 10.1016/S0263-7855(96)00043-4
   Tangney P, 2002, J CHEM PHYS, V116, P14, DOI 10.1063/1.1423331
   Tilocca A, 2005, J PHYS CHEM B, V109, P20963, DOI 10.1021/jp0544181
   Tilocca A, 2005, CHEMPHYSCHEM, V6, P1911, DOI 10.1002/cphc.200400570
   Tilocca A, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.104209
   TILOCCA A, 2006, UNPUB CHEM MAT
   Tilocca A, 2006, J MATER CHEM, V16, P1950, DOI [10.1039/b517362k, 10.1039/B517362K]
   Tischendorf BC, 2003, J NON-CRYST SOLIDS, V316, P261, DOI 10.1016/S0022-3093(02)01795-7
   TRUKHIN AN, 1995, J NONCRYST SOLIDS, V109, P1
   UCHINO T, 1991, J PHYS CHEM-US, V95, P5455, DOI 10.1021/j100167a021
   VALLETREGI M, 2003, EUR J INORG CHEM, V6, P1029
   Van Ginhoven RM, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.024208
   VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892
   Vollmayr K, 1996, PHYS REV B, V54, P15808, DOI 10.1103/PhysRevB.54.15808
   Wathelet V, 1997, CHEM PHYS LETT, V275, P506, DOI 10.1016/S0009-2614(97)00753-7
   Wright AC, 2001, GLASS PHYS CHEM+, V27, P97, DOI 10.1023/A:1011366508857
   Yuan XL, 2001, J NON-CRYST SOLIDS, V283, P69, DOI 10.1016/S0022-3093(01)00363-5
NR 64
TC 47
Z9 48
U1 0
U2 30
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD DEC 28
PY 2006
VL 110
IS 51
BP 25810
EP 25816
DI 10.1021/jp065146k
PG 7
WC Chemistry, Physical
SC Chemistry
GA 118WN
UT WOS:000242974300043
PM 17181225
DA 2018-10-19
ER

PT J
AU Sutou, Y
   Yamauchi, K
   Takagi, T
   Maeshima, T
   Nishida, M
AF Sutou, Y.
   Yamauchi, K.
   Takagi, T.
   Maeshima, T.
   Nishida, M.
TI Mechanical properties of Ti-6 at.% Mo-4 at.% Sn alloy wires and their
   application to medical guidewire
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article; Proceedings Paper
CT International Conference on Martensitic Transformations (ICOMAT05)
CY JUN 13-17, 2005
CL Shanghai, PEOPLES R CHINA
DE Ti-Mo-Sn alloy; shape memory alloy; superelasticity; biomaterial;
   minimally invasive device
ID SHAPE-MEMORY BEHAVIOR
AB Effects of heat treatment conditions on mechanical and superelastic properties of Ti-6 at.% Mo-4 at.% Sn alloy were investigated mainly by cyclic tensile testing. The cold-drawn wires were heat-treated in the temperature range of 773-1273 K for 300 s. Young's modulus and ultimate tensile strength of the wires heat-treated at over 823 K decreased with increasing heat treatment temperature, while premature failure was observed in the wire heat-treated at 773 K. A maximum recovery strain of about 4%, including both genuine elastic and superelastic strain, was obtained in the wires heat-treated in the temperature range of 1073-1273 K. On the other hand, the wire heat-treated at 823 K showed a high Young's modulus of 77 GPa and a high tensile strength of 1698 MPa. Given these characteristics, it is expected that a new class of Ni-free Ti-based guidewire possessing mechanical properties graded from the tip to the end can be developed. (c) 2006 Elsevier B.V. All rights reserved.
C1 Tohoku Univ, Biomed Engn Res Org, Aoba Ku, Sendai, Miyagi 9808575, Japan.
   Tohoku Univ, Grad Sch Engn, Dept Met, Sendai, Miyagi 9808579, Japan.
   Kumamoto Univ, Dept Mat Sci & Engn, Kumamoto 8608555, Japan.
RP Yamauchi, K (reprint author), Tohoku Univ, Biomed Engn Res Org, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.
EM yamauchi@tubero.tohoku.ac.jp
RI nishida, minoru/E-4027-2012
OI Takagi, Toshiyuki/0000-0003-1283-4320
CR DEURIG TW, 1982, ACTA METALL, V30, P2161
   Fukui Y, 2004, MATER TRANS, V45, P1077, DOI 10.2320/matertrans.45.1077
   Hosoda H, 2005, MATER SCI FORUM, V475-479, P2329, DOI 10.4028/www.scientific.net/MSF.475-479.2329
   Hosoda H, 2003, MATER SCI FORUM, V426-4, P3121, DOI 10.4028/www.scientific.net/MSF.426-432.3121
   Kim HY, 2004, MATER TRANS, V45, P2443, DOI 10.2320/matertrans.45.2443
   Kim HY, 2004, MATER TRANS, V45, P1090, DOI 10.2320/matertrans.45.1090
   Maeshima T, 2004, MATER TRANS, V45, P1101, DOI 10.2320/matertrans.45.1101
   Maeshima T, 2004, MATER TRANS, V45, P1096, DOI 10.2320/matertrans.45.1096
   Nitta K, 2001, STRUCTURAL BIOMATERIALS FOR THE 21ST CENTURY, P25
   Ohmatsu Y, 2001, PRICM 4: FORTH PACIFIC RIM INTERNATIONAL CONFERENCE ON ADVANCED MATERIALS AND PROCESSING, VOLS I AND II, P1627
   Schmalz G, 1998, BIOMATERIALS, V19, P1689, DOI 10.1016/S0142-9612(98)00075-1
   Sutou Y, 2004, J BIOMED MATER RES B, V69B, P64, DOI 10.1002/jbm.b.10079
NR 12
TC 18
Z9 18
U1 0
U2 14
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD DEC 25
PY 2006
VL 438
SI SI
BP 1097
EP 1100
DI 10.1016/j.msea.2006.01.116
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 117VH
UT WOS:000242900900243
DA 2018-10-19
ER

PT J
AU Schmidt, O
   Mizrahi, J
   Elisseeff, J
   Seliktar, D
AF Schmidt, Orit
   Mizrahi, Joseph
   Elisseeff, Jennifer
   Seliktar, Dror
TI Immobilized fibrinogen in PEG hydrogels does not improve
   chondrocyte-mediated matrix deposition in response to mechanical
   stimulation
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE mechanotransduction; compressive strain; poly(ethylene glycol);
   bioreactor; cartilage
ID TISSUE-ENGINEERED CARTILAGE; POLY(ETHYLENE GLYCOL) HYDROGELS; NEWLY
   SYNTHESIZED PROTEOGLYCANS; LINKING DENSITY INFLUENCES; DYNAMIC
   COMPRESSION; AGAROSE CONSTRUCTS; PHYSICAL STIMULATION;
   POLYETHYLENE-GLYCOL; ARTICULAR-CARTILAGE; EXPLANTS
AB The present investigation aims to explore the role of cell-scaffold interactions and whole cell compression in chondrocyte mechanotransduction using encapsulating poly(ethylene glycol) (PEG) hydrogel scaffolds and primary bovine chondrocytes. Scaffolds made from PEG hydrogels with immobilized fibrinogen molecules were seeded with chondrocytes and subjected to 15% dynamic compressive strain at 1-Hz frequency. Dynamic strain stimulation resulted in a 37% increase in the levels of sulfated glycosaminoglycan (sGAG) after 2 weeks of stimulation, when compared to static controls. Comparing results of the PEG-fibrinogen scaffolds with their respective PEG control group did not show significant differences between the two, even following 2 weeks of dynamic mechanical stimulation. Accordingly, these findings indicate that while cell deformations cause metabolic changes in chondrocytes seeded in PEG hydrogels, it is difficult to ascertain the role of matrix bioactivity in enhancing chondrocyte mechanotransduction in encapsulating scaffolds subjected to physical deformations. This study shows how interactions between mechanical stimulation and scaffold composition are evaluated using an experimental approach and customized biomaterial scaffolds. (c) 2006 Wiley Periodicals, Inc.
C1 Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
   Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA.
RP Seliktar, D (reprint author), Technion Israel Inst Technol, Fac Biomed Engn, IL-32000 Haifa, Israel.
EM dror@bm.technion.ac.il
OI Seliktar, Dror/0000-0001-6964-8567
CR Almany L, 2005, BIOMATERIALS, V26, P2467, DOI 10.1016/j.biomaterials.2004.06.047
   Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Bryant SJ, 2004, ANN BIOMED ENG, V32, P407, DOI 10.1023/B:ABME.0000017535.00602.ca
   Bryant SJ, 2004, J ORTHOPAED RES, V22, P1143, DOI 10.1016/j.orthres.2004.02.001
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Chowdhury TT, 2003, ARCH BIOCHEM BIOPHYS, V417, P105, DOI 10.1016/S0003-9861(03)00340-0
   Darling EM, 2003, TISSUE ENG, V9, P9, DOI 10.1089/107632703762687492
   Demarteau O, 2003, BIOCHEM BIOPH RES CO, V310, P580, DOI 10.1016/j.bbrc.2003.09.099
   Demarteau O, 2003, BIORHEOLOGY, V40, P331
   Dikovsky D, 2006, BIOMATERIALS, V27, P1496, DOI 10.1016/j.biomaterials.2005.09.038
   Elisseeff J, 1999, PLAST RECONSTR SURG, V104, P1014, DOI 10.1097/00006534-199909040-00017
   Evans RC, 2006, J BIOMECH, V39, P1048, DOI 10.1016/j.jbiomech.2005.02.017
   Farndale R.W., 1986, BIOCHIM BIOPHYS ACTA, V883, P173
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   Griffith LG, 2002, SCIENCE, V295, P1009, DOI 10.1126/science.1069210
   Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Hunter CJ, 2004, OSTEOARTHR CARTILAGE, V12, P117, DOI 10.1016/j.joca.2003.08.009
   Hunter CJ, 2002, BIORHEOLOGY, V39, P79
   Hunter CJ, 2002, BIOMATERIALS, V23, P1249, DOI 10.1016/S0142-9612(01)00245-9
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   KLEIN TJ, 2005, IN PRESS J BIOMECH
   Knight M. M., 1996, Cellular Engineering, V1, P97
   Lee DA, 1998, J ORTHOP RES, V16, P726, DOI 10.1002/jor.1100160615
   Lee DA, 1997, J ORTHOP RES, V15, P181, DOI 10.1002/jor.1100150205
   Lee DA, 2000, J BIOMECH, V33, P81, DOI 10.1016/S0021-9290(99)00160-8
   Loeser RF, 2002, BIORHEOLOGY, V39, P119
   Lum L. Y., 2003, TOPICS TISSUE ENG
   Lum LY, 2003, IEEE ENG MED BIOL, V22, P71, DOI 10.1109/MEMB.2003.1256275
   Martem'yanov VI, 2001, J EVOL BIOCHEM PHYS+, V37, P141, DOI 10.1023/A:1017680829971
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   Mizuno S, 1998, MAT SCI ENG C-BIO S, V6, P301, DOI 10.1016/S0928-4931(98)00068-X
   Parenteau NL, 2002, ANN NY ACAD SCI, V961, P27, DOI 10.1111/j.1749-6632.2002.tb03042.x
   Quinn TM, 1998, J CELL SCI, V111, P573
   Roberts SR, 2001, J APPL PHYSIOL, V90, P1385
   SAH RLY, 1991, ARCH BIOCHEM BIOPHYS, V286, P20, DOI 10.1016/0003-9861(91)90004-3
   SAH RLY, 1989, J ORTHOPAED RES, V7, P619, DOI 10.1002/jor.1100070502
   SAH RLY, 1990, BIOCHEM J, V267, P803, DOI 10.1042/bj2670803
   Saini S, 2003, BIOTECHNOL PROGR, V19, P510, DOI 10.1021/bp0256519
   Svoboda KKH, 1998, MICROSC RES TECHNIQ, V43, P111, DOI 10.1002/(SICI)1097-0029(19981015)43:2<111::AID-JEMT4>3.0.CO;2-O
   Vunjak-Novakovic G, 2005, Orthod Craniofac Res, V8, P209, DOI 10.1111/j.1601-6343.2005.00334.x
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   Williams CG, 2005, BIOMATERIALS, V26, P1211, DOI 10.1016/j.biomaterials.2004.04.024
   Woodfield TBF, 2002, CRIT REV EUKAR GENE, V12, P209, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i3.40
   Yang F, 2005, BIOMATERIALS, V26, P5991, DOI 10.1016/j.biomaterials.2005.03.018
NR 46
TC 34
Z9 34
U1 1
U2 7
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD DEC 20
PY 2006
VL 95
IS 6
BP 1061
EP 1069
DI 10.1002/bit.21072
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 106RQ
UT WOS:000242118800006
PM 16921532
DA 2018-10-19
ER

PT J
AU Klenkler, BJ
   Sheardown, H
AF Klenkler, Bettina J.
   Sheardown, Heather
TI Characterization of EGF coupling to aminated silicone rubber surfaces
SO BIOTECHNOLOGY AND BIOENGINEERING
LA English
DT Article
DE EGF; PEG; surface modification; SDS-PAGE; homobifunctional;
   heterobifunctional
ID EPIDERMAL-GROWTH-FACTOR; POLYETHYLENE-GLYCOL; FACTOR DELIVERY;
   ADSORPTION; PROTEINS; PEGYLATION; ALLYLAMINE; POLYMERS; CELLS
AB Tethering of growth factors to biomaterial substrates via a polyethylene glycol (PEG) spacer has been established as a means of controlling dosage and conformation of the protein at the material surface, while retaining biological activity. However, the extent of modification through a comparison of bound versus unbound protein has not generally been characterized. In this work, covalent tethering of epidermal growth factor (EGF) to allylamine plasma modified polydimethylsiloxane (PDMS) substrates is characterized to determine the nature of the bound growth factor and to optimize the conditions for the reaction. Tethering is achieved via conjugation of EGF with homobifunctional N-hydroxy-succinimide (NHS) ester of PEG-butanoic acid (SBA(2)-PEG) in solution, followed by exposure of the pegylated EGF to the aminated surfaces (solution first reaction). SDS-PAGE analysis indicates that a low ratio of EGF:PEG is required to maximize the yield of the EGF-PEG reaction; a relatively short reaction time is needed to limit hydrolysis of the NHS ester. With increasing amounts of PEG and a higher reaction time, a higher fraction of the EGF can be covalently tethered to the surfaces, as shown by binding of I-125-labeled EGF and subsequent washing with sodium dodecyl sulfate (SDS) to remove adsorbed protein. However, even under the optimal reaction conditions established by the SDS-PAGE analysis, higher molecular weight EGF-PEG complexes are observed by SDS-PAGE and matrix-assisted laser desorption/ionization (MALDI). The presence of these complexes, as well as unreacted growth factor, can lead to a surface of heterogeneous composition. While these surfaces were found to have biological activity, stimulating the adhesion and growth of corneal epithelial cells versus PDMS controls, further optimization of reaction conditions, including the use of a homobifunctional PEG linker and possibly separation of reaction species are required to achieve a uniformly active and well-defined biomaterial surface. (c) 2006 Wiley Periodicals, Inc.
C1 McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
   McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8S 4L7, Canada.
RP Sheardown, H (reprint author), McMaster Univ, Dept Chem Engn, Hamilton, ON L8S 4L7, Canada.
EM sheardow@mcmaster.ca
CR Aizawa H, 2000, MAT SCI ENG C-BIO S, V12, P49, DOI 10.1016/S0928-4931(00)00157-0
   Babensee JE, 2000, PHARMACEUT RES, V17, P497, DOI 10.1023/A:1007502828372
   Belcheva N, 1999, BIOCONJUGATE CHEM, V10, P932, DOI 10.1021/bc990001k
   Bentz H, 1998, J BIOMED MATER RES, V39, P539, DOI 10.1002/(SICI)1097-4636(19980315)39:4<539::AID-JBM6>3.0.CO;2-K
   Calderon JG, 1998, J BIOMED MATER RES, V42, P597, DOI 10.1002/(SICI)1097-4636(19981215)42:4<597::AID-JBM16>3.0.CO;2-R
   Chen RR, 2003, PHARMACEUT RES, V20, P1103, DOI 10.1023/A:1025034925152
   Diwan M, 2003, INT J PHARMACEUT, V252, P111, DOI 10.1016/S0378-5173(02)00636-1
   Fang F, 2002, LANGMUIR, V18, P5497, DOI 10.1021/la020027r
   Gobin AS, 2003, BIOTECHNOL PROGR, V19, P1781, DOI 10.1021/bp0341390
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   Halperin A, 1999, LANGMUIR, V15, P2525, DOI 10.1021/la981356f
   Ito Y, 1998, MAT SCI ENG C-BIO S, V6, P267, DOI 10.1016/S0928-4931(98)00061-7
   Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8
   KAPUR TA, 2003, J BIOMED MATER RES A, V68, P235
   KATRE NV, 1993, ADV DRUG DELIVER REV, V10, P91, DOI 10.1016/0169-409X(93)90005-O
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Klenkler BJ, 2005, BIOMATERIALS, V26, P7286, DOI 10.1016/j.biomaterials.2005.05.045
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Lee H, 2002, PHARMACEUT RES, V19, P845, DOI 10.1023/A:1016113117851
   Mann BK, 2001, BIOMATERIALS, V22, P439, DOI 10.1016/S0142-9612(00)00196-4
   Merrett K, 2003, J BIOMED MATER RES A, V67A, P981, DOI 10.1002/jbm.a.10165
   *NEKT THER, 2003, PEG REAG CAT
   Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4
   SIUZDAK G, 2003, EXPANDING ROLE MASS, pCH4
   Wickson BM, 1999, COLLOID SURFACE A, V156, P201, DOI 10.1016/S0927-7757(99)00071-0
   Zisch AH, 2001, J CONTROL RELEASE, V72, P101, DOI 10.1016/S0168-3659(01)00266-8
NR 26
TC 22
Z9 22
U1 3
U2 20
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0006-3592
J9 BIOTECHNOL BIOENG
JI Biotechnol. Bioeng.
PD DEC 20
PY 2006
VL 95
IS 6
BP 1158
EP 1166
DI 10.1002/bit.21083
PG 9
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 106RQ
UT WOS:000242118800016
PM 16817187
DA 2018-10-19
ER

PT J
AU Emerson, RJ
   Bergstrom, TS
   Liu, YT
   Soto, ER
   Brown, CA
   McGimpsey, WG
   Camesano, TA
AF Emerson, Ray J.
   Bergstrom, Torbjorn S.
   Liu, Yatao
   Soto, Ernesto R.
   Brown, Christopher A.
   McGimpsey, W. Grant
   Camesano, Terri A.
TI Microscale correlation between surface chemistry, texture, and the
   adhesive strength of Staphylococcus epidermidis
SO LANGMUIR
LA English
DT Article
ID ATOMIC-FORCE-MICROSCOPY; SENSITIVE FRACTAL ANALYSIS;
   PSEUDOMONAS-AERUGINOSA; MICROBIAL ADHESION; BACTERIAL ADHESION;
   ESCHERICHIA-COLI; PATCHWORK METHOD; ROUGHNESS; BIOMATERIAL; CANTILEVERS
AB Staphylococcus epidermidis is among the most commonly isolated microbes from medical implant infections, particularly in the colonization of blood-contacting devices. We explored the relationships between surface wettability and root-mean-square roughness (Rq) on microbial adhesive strength to a substrate. Molecular-level interactions between S. epidermidis and a variety of chemically and texturally distinct model substrata were characterized using a cellular probe and atomic force microscopy (AFM). Substrata included gold, aliphatic and aromatic self-assembled monolayers, and polymeric and proteinaceous materials. Substrate hydrophobicity, described in terms of the water contact angle, was an insufficient parameter to explain the adhesive force of the bacterium for any of the surfaces. Correlations between adhesion forces and Rq showed weak relationships for most surfaces. We used an alternate methodology to characterize the texture of the surface that is based on a fractal tiling algorithm applied to images of each surface. The relative area as a function of the scale of observation was calculated. The discrete bonding model (DBM) was applied, which describes the area available for bonding interactions over the full range of observational scales contained in the measured substrate texture. Weak negative correlations were obtained between the adhesion forces and the area available for interaction, suggesting that increased roughness decreases bacterial adhesion when nano- to micrometer scales are considered. We suggest that modification of the DBM is needed in order to include discontinuous bonding. The adhesive strength is still related to the area available for bonding on a particular scale, but on some very fine scales, the bacteria may not be able to conform to the valleys or pits of the substrate. Therefore, the bonding between the bacterium and substrate becomes discontinuous, occurring only on the tops of ridges or asperities.
C1 Worcester Polytech Inst, Dept Chem Engn, Worcester, MA 01609 USA.
   Worcester Polytech Inst, Dept Mech Engn, Worcester, MA 01609 USA.
   Worcester Polytech Inst, Dept Chem & Biochem, Worcester, MA 01609 USA.
   Worcester Polytech Inst, Bioengn Inst, Worcester, MA 01609 USA.
RP Camesano, TA (reprint author), Worcester Polytech Inst, Dept Chem Engn, 100 Inst Rd, Worcester, MA 01609 USA.
EM terric@wpi.edu
RI Liu, Yatao/D-1702-2010
OI Liu, Yatao/0000-0003-3623-1030
CR Abu-Lail NI, 2003, ENVIRON SCI TECHNOL, V37, P2173, DOI 10.1021/es026159o
   *AM SOC MECH ENG, 2002, SURF TEXT SURF ROUGH
   Arciola CR, 2004, BIOMATERIALS, V25, P4825, DOI 10.1016/j.biomaterials.2003.11.056
   Articus K, 2001, SKIN RES TECHNOL, V7, P164, DOI 10.1034/j.1600-0846.2001.70304.x
   Barnes LM, 1999, APPL ENVIRON MICROB, V65, P4543
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   Brown CA, 2001, INT J MACH TOOL MANU, V41, P1927, DOI 10.1016/S0890-6955(01)00057-8
   BROWN CA, 1993, WEAR, V161, P61, DOI 10.1016/0043-1648(93)90453-S
   BROWN CA, 1994, 17 ANN M S PART ADH
   BROWN CA, 1996, ANN CIRP, V45, P515
   Bruinsma GM, 2003, BIOMATERIALS, V24, P1663, DOI 10.1016/S0142-9612(02)00542-2
   Buchko CJ, 2001, BIOMATERIALS, V22, P1289, DOI 10.1016/S0142-9612(00)00281-7
   Burnham NA, 2003, NANOTECHNOLOGY, V14, P1, DOI 10.1088/0957-4484/14/1/301
   BUSSCHER HJ, 1994, COLLOID SURFACE B, V2, P73, DOI 10.1016/0927-7765(94)80020-0
   Butt HJ, 1999, LANGMUIR, V15, P2559, DOI 10.1021/la981503+
   Cail TL, 2005, GEOCHIM COSMOCHIM AC, V69, P2959, DOI 10.1016/j.gca.2005.01.017
   Correa L, 2000, J HOSP INFECT, V46, P89, DOI 10.1053/jhin.2000.0803
   Denis FA, 2002, LANGMUIR, V18, P819, DOI 10.1021/la011011o
   Dupres V, 2005, NAT METHODS, V2, P515, DOI 10.1038/NMETH769
   Emerson RJ, 2004, APPL ENVIRON MICROB, V70, P6012, DOI 10.1128/AEM.70.10.6012-6022.2004
   Emerson RJ, 2006, ULTRAMICROSCOPY, V106, P413, DOI 10.1016/j.ultramic.2005.11.008
   Flint SH, 2000, J FOOD ENG, V43, P235, DOI 10.1016/S0260-8774(99)00157-0
   FOLKERS JP, 1992, LANGMUIR, V8, P1330, DOI 10.1021/la00041a015
   FRIEDLI GL, 1996, INTERACTION DEAMIDAT
   Grasso D., 2002, Re/Views in Environmental Science and Bio/Technology, V1, P17, DOI 10.1023/A:1015146710500
   GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258
   Heard SO, 2001, ANN ACAD MED SINGAP, V30, P419
   HOGT AH, 1983, J GEN MICROBIOL, V129, P2959
   Hu J, 1999, J ORG CHEM, V64, P4959, DOI 10.1021/jo990076h
   HUNTER RJ, 1986, FDN COLLOIDS SCI, V1
   HUNTER RJ, 1986, FDN COLLOIDS SCI, V2
   Jordan SE, 2006, WEAR, V261, P398, DOI 10.1016/j.wear.2005.12.011
   Kennedy FE, 1999, J TRIBOL-T ASME, V121, P968, DOI 10.1115/1.2834163
   KHARDORI N, 1995, J IND MICROBIOL, V15, P141, DOI 10.1007/BF01569817
   Liu YT, 2006, BIOTECHNOL BIOENG, V93, P297, DOI 10.1002/bit.20675
   Lower SK, 2001, SCIENCE, V292, P1360, DOI 10.1126/science.1059567
   Mandelbrot B., 1977, FRACTALS FORM CHANCE
   ORDAL MA, 1983, APPL OPTICS, V22, P1099, DOI 10.1364/AO.22.001099
   Pedreschi F, 2002, INT J FOOD PROP, V5, P523, DOI 10.1081/JFP-120015489
   QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x
   Scott RS, 2005, NATURE, V436, P693, DOI 10.1038/nature03822
   SIEGMANN S, 1999, SURFACE TEXTURE CORR
   Soto E, 2003, J AM CHEM SOC, V125, P2838, DOI 10.1021/ja0289548
   Taylor RL, 1998, J MATER SCI-MATER M, V9, P17, DOI 10.1023/A:1008874326324
   Thoreson EJ, 2004, REV SCI INSTRUM, V75, P1359, DOI 10.1063/1.1710697
   Tide C, 1999, J FOOD ENG, V42, P85, DOI 10.1016/S0260-8774(99)00109-0
   Touhami A, 2006, J BACTERIOL, V188, P370, DOI 10.1128/JB.188.2.370-377.2006
   Tsang PH, 2006, P NATL ACAD SCI USA, V103, P5764, DOI 10.1073/pnas.0601705103
   Vadillo-Rodriguez V, 2003, LANGMUIR, V19, P2372, DOI 10.1021/la020658l
   Vadillo-Rodriguez V, 2006, ENVIRON SCI TECHNOL, V40, P2983, DOI 10.1021/es052365v
   VANOSS CJ, 1994, INTERFACIAL FORCES A
   *VEEC METR GROUP, 1997, DIM 3100 MAN VERS 4
   *VEEC METR GROUP, 1998, SCANN PROB MICR TRAI, P39
   Wilson WW, 2001, J MICROBIOL METH, V43, P153, DOI 10.1016/S0167-7012(00)00224-4
NR 54
TC 67
Z9 69
U1 0
U2 33
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD DEC 19
PY 2006
VL 22
IS 26
BP 11311
EP 11321
DI 10.1021/la061984u
PG 11
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 115ZB
UT WOS:000242771200070
PM 17154620
DA 2018-10-19
ER

PT J
AU Muller, R
   Hiller, KA
   Schmalz, G
   Ruhl, S
AF Mueller, Rainer
   Hiller, Karl-Anton
   Schmalz, Gottfried
   Ruhl, Stefan
TI Chemiluminescence-based detection and comparison of protein amounts
   adsorbed on differently modified silica surfaces
SO ANALYTICAL BIOCHEMISTRY
LA English
DT Article
DE protein adsorption; protein quantification; surface analysis; amino
   groups; chemiluminescence; serum; saliva
ID QUARTZ-CRYSTAL MICROBALANCE; SELF-ASSEMBLED MONOLAYERS; SOLID-SURFACES;
   ADSORPTION; CELLS; ELLIPSOMETRY; TITANIUM; ADHESION; IDENTIFICATION;
   ORGANIZATION
AB The biological consequences of protein adsorption on biomaterial surfaces are considered to be of utmost importance for their biocompatibility. A new method based on amino group-labeling coupled to a chemilummescence reaction for direct determination of proteins adsorbed on material surfaces was employed. This method was used to explore the effects of surface chemistry and surface roughness on protein adsorption in a silicon oxide model system. Corundum sandblasting was applied to silicon wafers to create roughened surfaces while immobilization of fluorocarbon-, hydrocarbon-, and poly(ethylene glycol)-containing silanes produced surfaces of varying wettability. The adsorption behavior of two complex body fluids, human serum and saliva, and of two purified components, human serum albumin and fibronectin, was strongly influenced by the surface parameters. A general tendency to higher amounts of adsorbed protein was found on roughened surfaces and modification with poly(ethylene glycol) or with fluorocarbon moieties reduced protein adsorption. The values obtained with the new method could be confirmed by a colorimetric determination of protein amounts adsorbed on identically modified silica beads and were in accordance with those previously reported utilizing established methods for protein quantification. The presented method, which was methodically simple to perform and allowed the simultaneous measurement of a large number of samples, may be of future value for high-throughput surveying of the protein adsorption characteristics of biomaterials. (c) 2006 Elsevier Inc. All rights reserved.
C1 Univ Regensburg, Dept Operat Dent & Periodontol, Sch Dent, D-93053 Regensburg, Germany.
   Univ Regensburg, Inst Phys & Theoret Chem, D-93053 Regensburg, Germany.
RP Ruhl, S (reprint author), Univ Regensburg, Dept Operat Dent & Periodontol, Sch Dent, Franz Josef Str Allee 11, D-93053 Regensburg, Germany.
EM stefan.ruhl@klinik.uni-regensburg.de
RI Mueller, Rainer/D-3326-2009
OI Mueller, Rainer/0000-0001-9641-7780; Ruhl, Stefan/0000-0003-3888-4908
CR An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Arnebrant T., 2003, BIOPOLYMERS INTERFAC, P811
   BECKER JM, 1971, P NATL ACAD SCI USA, V68, P2604, DOI 10.1073/pnas.68.10.2604
   Chapman RG, 2000, J AM CHEM SOC, V122, P8303, DOI 10.1021/ja000774f
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   EDGERTON M, 1993, J PROSTHET DENT, V69, P406, DOI 10.1016/0022-3913(93)90190-Y
   Eisenbarth E, 2002, BIOMOL ENG, V19, P233, DOI 10.1016/S1389-0344(02)00028-X
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   Gessner A, 2003, J BIOMED MATER RES A, V65A, P319, DOI 10.1002/jbm.a.10371
   GOMBOTZ WR, 1991, J BIOMED MATER RES, V25, P1547, DOI 10.1002/jbm.820251211
   GRINNELL F, 1987, ANN NY ACAD SCI, V516, P280, DOI 10.1111/j.1749-6632.1987.tb33048.x
   Ho CH, 1996, J MOL RECOGNIT, V9, P444, DOI 10.1002/(SICI)1099-1352(199634/12)9:5/6<444::AID-JMR281>3.0.CO;2-I
   Horbett Thomas A., 1996, P133
   HORVOLGYI Z, 1993, COLLOID SURFACE A, V71, P327, DOI 10.1016/0927-7757(93)80048-J
   Kingshott P, 1999, ANAL BIOCHEM, V273, P156, DOI 10.1006/abio.1999.4201
   Luthen F, 2005, BIOMATERIALS, V26, P2423, DOI 10.1016/j.biomaterials.2004.07.054
   MALMSTEN M, 1995, COLLOID SURFACE B, V3, P371
   MALMSTEN M, 1995, COLLOID SURFACE B, V3, P297
   MANDENIUS CF, 1984, ANAL BIOCHEM, V137, P106, DOI 10.1016/0003-2697(84)90354-3
   Milleding P, 2001, BIOMATERIALS, V22, P2545, DOI 10.1016/S0142-9612(00)00445-2
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Murray BS, 2000, J COLLOID INTERF SCI, V227, P32, DOI 10.1006/jcis.2000.6882
   Nakanishi K, 2001, J BIOSCI BIOENG, V91, P233, DOI 10.1016/S1389-1723(01)80127-4
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   PRIME KL, 1991, SCIENCE, V252, P1164, DOI 10.1126/science.252.5009.1164
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Ruhl S, 2004, J DENT RES, V83, P505, DOI 10.1177/154405910408300614
   Sigal GB, 1998, J AM CHEM SOC, V120, P3464, DOI 10.1021/ja970819l
   SILBERZAN P, 1991, LANGMUIR, V7, P1647, DOI 10.1021/la00056a017
   SLACK SM, 1995, PROTEINS INTERFACES, V2, P112
   Tengvall P, 1998, BIOMATERIALS, V19, P407, DOI 10.1016/S0142-9612(97)00110-5
   VERGNAT M, 1995, THIN SOLID FILMS, V255, P231, DOI 10.1016/0040-6090(94)05660-6
   WAHLGREN M, 1991, TRENDS BIOTECHNOL, V9, P201, DOI 10.1016/0167-7799(91)90064-O
   Walz A, 2005, GLYCOBIOLOGY, V15, P700, DOI 10.1093/glycob/cwi049
   Yao Y, 2003, J BIOL CHEM, V278, P5300, DOI 10.1074/jbc.M206333200
   Zhang MQ, 1998, BIOMATERIALS, V19, P953, DOI 10.1016/S0142-9612(98)00026-X
   Zhang YY, 2005, SENSOR ACTUAT B-CHEM, V108, P933, DOI 10.1016/j.snb.2004.12.123
NR 37
TC 21
Z9 21
U1 2
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0003-2697
EI 1096-0309
J9 ANAL BIOCHEM
JI Anal. Biochem.
PD DEC 15
PY 2006
VL 359
IS 2
BP 194
EP 202
DI 10.1016/j.ab.2006.09.032
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 115MA
UT WOS:000242737200007
PM 17087913
DA 2018-10-19
ER

PT J
AU Wisse, E
   Spiering, AJH
   van Leeuwen, ENM
   Renken, RAE
   Dankers, PYW
   Brouwer, LA
   van Luyn, MJA
   Harmsen, MC
   Sommerdijk, NAJM
   Meijer, EW
AF Wisse, Eva
   Spiering, A. J. H.
   van Leeuwen, Ellen N. M.
   Renken, Raymond A. E.
   Dankers, Patricia Y. W.
   Brouwer, Linda A.
   van Luyn, Marja J. A.
   Harmsen, Martin C.
   Sommerdijk, Nico A. J. M.
   Meijer, E. W.
TI Molecular recognition in poly(epsilon-caprolactone)-based thermoplastic
   elastomers
SO BIOMACROMOLECULES
LA English
DT Article
ID INFRARED TEMPERATURE; POLYURETHANE; COPOLYMERS; POLYMERS; HYDROGELS;
   BLENDS; BULK
AB The molecular recognition properties of the hydrogen bonding segments in biodegradable thermoplastic elastomers were explored, aiming at the further functionalization of these potentially interesting biomaterials. A poly(epsilon-caprolactone)-based poly(urea) 2 was synthesized and characterized in terms of mechanical properties, processibility and histocompatibility. Comparison of the data with those obtained from the structurally related poly( urethane urea) 1 revealed that the difference in hard segment structure does not significantly affect the potency for application as a biomaterial. Nevertheless, the small differences in hard block composition had a strong effect on the molecular recognition properties of the hydrogen bonding segments. High selectivity was found for poly(urea) 2 in which bisureidobutylene-functionalized azobenzene dye 3 was selectively incorporated while bisureidopentylene-functionalized azobenzene dye 4 was completely released. In contrast, the incorporation of both dyes in poly(urethane urea) 1 led in both cases to their gradual release in time. Thermal analysis of the polymers in combination with variable temperature infrared experiments indicated that the hard blocks in 1 showed a sharp melting point, whereas those in 2 showed a very broad melting trajectory. This suggests a more precise organization of the hydrogen bonding segments in the hard blocks of poly(urea) 2 compared to poly(urethane urea) 1 and explains the results from the molecular recognition experiments. Preliminary results revealed that a bisureidobutylene-functionalized GRGDS peptide showed more supramolecular interaction with the PCL-based poly(urea), containing the bisureidobutylene recognition unit, as compared to HMW PCL, lacking this recognition unit.
C1 Eindhoven Univ Technol, Lab Macromol & Organ Chem, NL-5600 MB Eindhoven, Netherlands.
   Univ Groningen, Med Ctr, Med Biol Sect, Dept Pathol & Lab Med, NL-9713 GZ Groningen, Netherlands.
RP Meijer, EW (reprint author), Eindhoven Univ Technol, Lab Macromol & Organ Chem, POB 513, NL-5600 MB Eindhoven, Netherlands.
EM e.w.meijer@tue.nl
RI Sommerdijk, Nico/B-7239-2013; Meijer, E.W./K-7632-2013
OI Sommerdijk, Nico/0000-0002-8956-195X; Meijer, E.W./0000-0003-4126-7492
CR Camacho-Zuniga C, 2003, IND ENG CHEM RES, V42, P1530, DOI 10.1021/ie0205389
   Chebotareva N, 2005, CHEM COMMUN, P4967, DOI 10.1039/b507171b
   COLEMAN MM, 1988, MACROMOLECULES, V21, P59, DOI 10.1021/ma00179a014
   Coleman MM, 1997, MACROMOL CHEM PHYSIC, V198, P117, DOI 10.1002/macp.1997.021980110
   COLEMAN MM, 1986, MACROMOLECULES, V19, P2149, DOI 10.1021/ma00162a008
   Dankers PYW, 2005, NAT MATER, V4, P568, DOI 10.1038/nmat1418
   Esch J., 1999, CHEM-EUR J, V5, P937
   Fromstein JD, 2002, J BIOMAT SCI-POLYM E, V13, P391, DOI 10.1163/156856202320253929
   Garrett JT, 2001, MACROMOLECULES, V34, P7066, DOI 10.1021/ma0102114
   Guan JJ, 2002, J BIOMED MATER RES, V61, P493, DOI 10.1002/jbm.10204
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Koevoets RA, 2005, J AM CHEM SOC, V127, P2999, DOI 10.1021/ja0451160
   KOH JY, 1987, J NEUROSCI METH, V20, P83, DOI 10.1016/0165-0270(87)90041-0
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   MOORE JS, 1990, MACROMOLECULES, V23, P65, DOI 10.1021/ma00203a013
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Park H, 2005, BIOMATERIALS, V26, P7095, DOI 10.1016/j.biomaterials.2005.05.083
   Parrish B, 2005, J AM CHEM SOC, V127, P7404, DOI 10.1021/ja050310n
   Pfau A, 1999, SURF INTERFACE ANAL, V27, P410, DOI 10.1002/(SICI)1096-9918(199905/06)27:5/6<410::AID-SIA542>3.0.CO;2-E
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   SHAH JH, 1995, J MED CHEM, V38, P4284, DOI 10.1021/jm00021a018
   Sheth JP, 2005, MACROMOLECULES, V38, P5681, DOI 10.1021/ma048222v
   Spaans CJ, 1998, POLYM BULL, V41, P131, DOI 10.1007/s002890050343
   Tai NRM, 1999, J VASC SURG, V30, P936, DOI 10.1016/S0741-5214(99)70020-0
   Thubrikar MJ, 1990, AORTIC VALVE
   Vos MRJ, 2005, J AM CHEM SOC, V127, P16768, DOI 10.1021/ja055075n
   Ward I. M., 2004, INTRO MECH PROPERTIE
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   Wu W, 2005, LANGMUIR, V21, P9721, DOI 10.1021/la051130u
   Yamaguchi N, 2005, BIOMACROMOLECULES, V6, P1921, DOI 10.1021/bm050003+
NR 30
TC 41
Z9 42
U1 2
U2 28
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD DEC 11
PY 2006
VL 7
IS 12
BP 3385
EP 3395
DI 10.1021/bm060688t
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 114YM
UT WOS:000242701600015
PM 17154467
DA 2018-10-19
ER

PT J
AU Cho, J
   Grant, J
   Piquette-Miller, M
   Allen, C
AF Cho, Jaepyoung
   Grant, Justin
   Piquette-Miller, Micheline
   Allen, Christine
TI Synthesis and physicochemical and dynamic mechanical properties of a
   water-soluble chitosan derivative as a biomaterial (vol 7, pg 2845,
   2006)
SO BIOMACROMOLECULES
LA English
DT Correction
CR Cho J, 2006, BIOMACROMOLECULES, V7, P2845, DOI 10.1021/bm060436s
NR 1
TC 7
Z9 7
U1 1
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD DEC 11
PY 2006
VL 7
IS 12
BP 3548
EP 3548
DI 10.1021/bm068002k
PG 1
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 114YM
UT WOS:000242701600036
PM 17154488
OA Bronze
DA 2018-10-19
ER

PT J
AU Mitura, K
   Niedzielski, P
   Bartosz, G
   Moll, J
   Walkowiak, B
   Pawlowska, Z
   Louda, P
   Kiec-Swierczynska, M
   Mitura, S
AF Mitura, Katarzyna
   Niedzielski, Piotr
   Bartosz, Grzegorz
   Moll, Jacek
   Walkowiak, Bogdan
   Pawlowska, Zofia
   Louda, Petr
   Kiec-Swierczynska, Marta
   Mitura, Stanislaw
TI Interactions between carbon coatings and tissue
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article; Proceedings Paper
CT Symposium on Thin Film and Nanostructured Materials for Photovoltaics
   held at the 2005 EMRS Meeting
CY MAY 31-JUN 03, 2005
CL Strasbourg, FRANCE
SP EMRS
DE biocompatibility; carbon films; Nanocrystalline Diamond Coatings (NCD);
   Diamond Powder Particles (DPP); medical implants
ID NANOCRYSTALLINE DIAMOND; ANTIOXIDANT; SURFACE; PLASMA; LAYERS; CVD
AB The unique properties of thin diamond layers make them perspective candidates for producing advanced micro-electronic devices, coatings for cutting tools and optics. However, due to the highest biocompatibility of carbon resulting from the presence of this element in the human body, it appears to be a potential biomaterial.
   Carbon, especially in the form of the nanocrystalline diamond film, have found industrial applications in the area of medical implants. The studies of carbon films as coatings for implants in surgery were aimed at the investigations of biological resistance of implants, histopathological investigations on laboratory animals, tests of corrosion resistance, measurements of mechanical properties and a breakdown test in Tyrode's solution.
   Different medical implants are covered by Nanocrystalline Diamond Coatings (NCD). NCD forms the barrier diffusion between implant and human environment. The research on NCD proved that diamond layers are biocompatible with living organisms. Diamond Powder Particles (DPP) is an extended surface of NCD. Biological research with diamond powder can answer the basic question: what is the influence of DPP on cells, tissues and organs in human organism? (c) 2005 Elsevier B.V. All rights reserved.
C1 Tech Univ Lodz, Inst Mat Sci & Engn, PL-90924 Lodz, Poland.
   Univ Lodz, Dept Mol Biophys, PL-90131 Lodz, Poland.
   Polish Mother Mem Hosp, Res Inst, Lodz, Poland.
   Med Univ Lodz, Dept Med & Mol Biol, PL-90131 Lodz, Poland.
   Nofer Inst Occupat Med, Lodz, Poland.
RP Mitura, S (reprint author), Tech Univ Lodz, Inst Mat Sci & Engn, PL-90924 Lodz, Poland.
EM mitura@p.lodz.pl
RI Mitura, Stanislaw/L-6013-2014; Mitura, Katarzyna/C-5174-2018;
   Kiec-Swierczynska, Marta/G-4928-2010
OI Mitura, Stanislaw/0000-0001-9280-3748; Mitura,
   Katarzyna/0000-0002-2658-2542; Bartosz, Grzegorz/0000-0002-0347-0740;
   Niedzielski, Piotr/0000-0002-6966-9154; Walkowiak,
   Bogdan/0000-0003-4867-5456
CR Bakowicz K., 2002, Journal of Wide Bandgap Materials, V9, P261, DOI 10.1106/152451102024429
   BAKOWICZ K, 2003, THESIS POL LODZK
   BARTOSZ G, 1995, DRUGA TWARZ TLENU
   Bartosz M, 1997, FREE RADICAL BIO MED, V23, P729, DOI 10.1016/S0891-5849(97)00014-2
   CIFRE J, 1995, DIAM RELAT MATER, V4, P798, DOI 10.1016/0925-9635(94)05271-9
   GUSEVA MB, 1995, DIAM RELAT MATER, V4, P1142, DOI 10.1016/0925-9635(95)00292-8
   HOLLAND L, 1976, Patent No. 1582231
   Jakubowski W, 2004, DIAM RELAT MATER, V13, P1761, DOI 10.1016/j.diamond.2004.03.003
   LETTINGTON AH, 1992, DIAM RELAT MATER, V1, P805, DOI 10.1016/0925-9635(92)90104-V
   LOURDIN P, 1996, J CHEM VAPOR DEPOS, V4, P232
   McLaughlin JA, 1996, DIAM RELAT MATER, V5, P486, DOI 10.1016/0925-9635(96)80065-3
   MITURA E, 1994, DIAM RELAT MATER, V3, P896, DOI 10.1016/0925-9635(94)90295-X
   Mitura E, 1996, DIAM RELAT MATER, V5, P998, DOI 10.1016/0925-9635(95)00469-6
   Mitura S, 1997, P SOC PHOTO-OPT INS, V3179, P79, DOI 10.1117/12.276200
   MITURA S, 1987, J CRYST GROWTH, V80, P417, DOI 10.1016/0022-0248(87)90090-X
   Mitura S, 1996, DIAM RELAT MATER, V5, P1185, DOI 10.1016/0925-9635(95)00525-0
   MITURA S, 1995, DIAM RELAT MATER, V4, P302, DOI 10.1016/0925-9635(94)05203-4
   MITURA S, 2000, NANOTECHNOLOGY MAT S
   Ristein J, 2001, J PHYS-CONDENS MAT, V13, P8979, DOI 10.1088/0953-8984/13/40/314
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   ZOLYNSKI K, 1996, J CHEM VAPOR DEPOS, V4, P253
   Zou CG, 2001, LIFE SCI, V69, P75, DOI 10.1016/S0024-3205(01)01112-2
NR 22
TC 27
Z9 27
U1 2
U2 28
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD DEC 4
PY 2006
VL 201
IS 6
BP 2117
EP 2123
DI 10.1016/j.surfcoat.2005.10.023
PG 7
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 144YF
UT WOS:000244831800002
DA 2018-10-19
ER

PT J
AU Kwakman, PHS
   Velde, AAT
   Vandenbroucke-Grauls, CMJE
   Van Deventer, SJH
   Zaat, SAJ
AF Kwakman, Paulus H. S.
   Velde, Anje A. te
   Vandenbroucke-Grauls, Christina M. J. E.
   Van Deventer, Sander J. H.
   Zaat, Sebastian A. J.
TI Treatment and prevention of Staphylococcus epidermidis experimental
   biomaterial-associated infection by bactericidal peptide 2
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID CATIONIC ANTIMICROBIAL PEPTIDES; SUBCUTANEOUS ABSCESS FORMATION;
   ANTIBIOTIC-RESISTANCE; NEUTROPHIL DEFENSINS; INHIBITING PEPTIDE;
   ESCHERICHIA-COLI; GRAFT INFECTION; ALPHA-DEFENSINS; IN-VITRO;
   COLONIZATION
AB Biomaterial-associated infections (BAI) are the major cause of failure of indwelling medical devices and are predominantly caused by staphylococci, especially Staphylococcus epidermidis. We investigated the in vitro microbicidal activity of the synthetic antimicrobial peptide bactericidal peptide 2 (BP2) and its efficacy in a murine model of S. epidermidis BAI. BP2 showed potent microbicidal activity at micromolar concentrations against a broad spectrum of microorganisms, including antibiotic-resistant bacteria. The staphylocidal activity of BP2 was not affected by physiological salt concentrations and was only slightly affected by the presence of human plasma. In the BAI model, injection of BP2 (5 mg/kg of body weight) 1 h after challenge with S. epidermidis resulted in an 80% reduction in the number of culture-positive implants and a 100-fold reduction in survival of S. epidermidis in peri-implant tissue at 24 h postchallenge. When BP2 was injected along implants 3 h prior to bacterial challenge, the median numbers of CFU cultured from biomaterial implants and peri-implant tissue were reduced by 85% and 90%, respectively. In conclusion, BP2 has potent, broad-spectrum in vitro microbicidal activity and showed potent in vivo activity in a murine model of S. epidermidis biomaterial-associated infection.
C1 Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, CINIMA, NL-1105 AZ Amsterdam, Netherlands.
   Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, CINIMA, NL-1105 AZ Amsterdam, Netherlands.
   Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands.
   VU Med Ctr, Dept Med Microbiol & Infect Dis, Amsterdam, Netherlands.
RP Zaat, SAJ (reprint author), Univ Amsterdam, Acad Med Ctr, Dept Med Microbiol, CINIMA, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.
EM s.a.zaat@amc.uva.nl
CR Aarbiou J, 2006, INFLAMM RES, V55, P119, DOI 10.1007/s00011-005-0062-9
   Abraham P. R., 2003, Patent No. US, Patent No. [6624140, 6624140B1]
   Balaban N, 2004, ANTIMICROB AGENTS CH, V48, P2544, DOI 10.1128/AAC.487.2544-2550.2004
   Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541
   Barie PS, 1998, WORLD J SURG, V22, P118, DOI 10.1007/s002689900359
   Belas R, 2004, INFECT IMMUN, V72, P5159, DOI 10.1128/IAI.72.9.5159-5167.2004
   Boelens JJ, 2000, INFECT IMMUN, V68, P1692, DOI 10.1128/IAI.68.3.1692-1695.2000
   Boelens JJ, 2000, J BIOMED MATER RES, V50, P546, DOI 10.1002/(SICI)1097-4636(20000615)50:4<546::AID-JBM10>3.0.CO;2-Y
   Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369
   BOMAN HG, 1993, INFECT IMMUN, V61, P2978
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   Cirioni O, 2003, CIRCULATION, V108, P767, DOI 10.1161/01.CIR.0000083717.85060.16
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   COX AD, 1991, MOL MICROBIOL, V5, P641, DOI 10.1111/j.1365-2958.1991.tb00735.x
   Da Costa A, 1998, CIRCULATION, V97, P1796, DOI 10.1161/01.CIR.97.18.1796
   DANKERT J, 1995, INFECT IMMUN, V63, P663
   DANKERT J, 1986, CRIT REV BIOCOMPAT, V2, P219
   Gotz F, 2000, ADV EXP MED BIOL, V485, P103
   GRISTINA AG, 1987, BIOMATERIALS, V8, P423, DOI 10.1016/0142-9612(87)90077-9
   Hancock R. E. W., 2002, Current Drug Targets - Infectious Disorders, V2, P79, DOI 10.2174/1568005024605855
   Hancock REW, 2000, P NATL ACAD SCI USA, V97, P8856, DOI 10.1073/pnas.97.16.8856
   Hancock REW, 2000, EXPERT OPIN INV DRUG, V9, P1723, DOI 10.1517/13543784.9.8.1723
   Hanssen AD, 1999, CLIN ORTHOP RELAT R, P124
   HARWIG SSL, 1994, METHOD ENZYMOL, V236, P160
   Henke PK, 1998, AM SURGEON, V64, P39
   Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313
   Isaacson Richard E, 2003, Curr Opin Investig Drugs, V4, P999
   Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05
   Kobayashi S, 2000, BIOCHEMISTRY-US, V39, P8648, DOI 10.1021/bi0004549
   LEHRER RI, 1989, J CLIN INVEST, V84, P553, DOI 10.1172/JCI114198
   Levy O, 2000, BLOOD, V96, P2664
   Levy S.B., 2002, J APPL MICROBIOL S, V92, P65
   MACK D, 1992, INFECT IMMUN, V60, P2048
   Maisetta G, 2006, ANTIMICROB AGENTS CH, V50, P806, DOI 10.1128/AAC.50.2.806.809.2006
   Movahed MR, 2004, J CARDIOVASC PHARM T, V9, P13, DOI 10.1177/107424840400900i103
   Nagaoka I, 2000, INFLAMM RES, V49, P73, DOI 10.1007/s000110050561
   Sampath LA, 2001, INFECT CONT HOSP EP, V22, P640, DOI 10.1086/501836
   Schierholz JM, 2001, J HOSP INFECT, V49, P87, DOI 10.1053/jhin.2001.1052
   Seifert H., 1997, CATHETER RELATED INF
   Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X
   SIDORCZYK Z, 1983, EUR J BIOCHEM, V137, P15, DOI 10.1111/j.1432-1033.1983.tb07789.x
   Subbalakshmi C, 1998, FEMS MICROBIOL LETT, V160, P91, DOI 10.1016/S0378-1097(98)00008-1
   TOJO M, 1988, J INFECT DIS, V157, P713, DOI 10.1093/infdis/157.4.713
   Tossi A, 2000, BIOPOLYMERS, V55, P4
   Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206
   vanWetering S, 1997, AM J PHYSIOL-LUNG C, V272, pL888
   Vuong C, 2004, J INFECT DIS, V190, P1498, DOI 10.1086/424487
   WALDVOGEL FA, 2000, INFECT ASSOCIATED IN
   Yang L, 2000, BIOPHYS J, V79, P2002, DOI 10.1016/S0006-3495(00)76448-4
   Yu QT, 2000, J BIOL CHEM, V275, P3943, DOI 10.1074/jbc.275.6.3943
   ZAAT SAJ, 1994, PATHOGENIC STREPTOCO, P473
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Zhang LJ, 2004, EXPERT OPIN INV DRUG, V13, P97
NR 53
TC 24
Z9 27
U1 0
U2 9
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD DEC
PY 2006
VL 50
IS 12
BP 3977
EP 3983
DI 10.1128/AAC.00575-06
PG 7
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA 111QX
UT WOS:000242470200002
PM 17000746
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Gallagher, WM
   Lynch, I
   Allen, LT
   Miller, I
   Penney, SC
   O'Connor, DP
   Pennington, S
   Keenan, AK
   Dawson, KA
AF Gallagher, William M.
   Lynch, Iseult
   Allen, Lorcan T.
   Miller, Ian
   Penney, Stephen C.
   O'Connor, Darran P.
   Pennington, Stephen
   Keenan, Alan K.
   Dawson, Kenneth A.
TI Molecular basis of cell-biomaterial interaction: Insights gained from
   transcriptomic and proteomic studies
SO BIOMATERIALS
LA English
DT Review
DE biocompatibility; transcriptomics; DNA microarrays; proteomics; mass
   spectrometry; cell interaction
ID PLASMA-PROTEIN ADSORPTION; IONIZATION-MASS-SPECTROMETRY; MESSENGER-RNA
   EXPRESSION; BIOACTIVE GLASS-CERAMICS; SMOOTH-MUSCLE-CELLS; PLUM-PUDDING
   GELS; GENE-EXPRESSION; IN-VITRO; POLYMERIC BIOMATERIALS; DRUG-DELIVERY
AB With the growing interest in clinical interventions that involve medical devices, the role for new biomaterials in modern medicine is currently expanding at a phenomenal rate. Failure of most implant materials stems from an inability to predict and control biological phenomena, such as protein adsorption and cell interaction, resulting in an inappropriate host response to the materials. Contemporary advances in biological investigation are starting to shift focus in the biomaterials field, in particular with the advent of high-throughput methodologies for gene and protein expression profiling. Here, we examine the role that emerging transcriptomic and proteomic technologies could play in relation to biomaterial development and usage. Moreover, a number of studies are highlighted which have utilized such approaches in order to try to create a deeper understanding of cell-biomaterial interactions and, hence, improve our ability to predict and control the biocompatibility of new materials. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Coll Dublin, Sch Biomol & Biomed Sci, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland.
   Univ Coll Dublin, Sch Chem & Chem Biol, Irish Ctr Colloid Sci & Biomat, Dublin 4, Ireland.
   Lund Univ, Ctr Chem & Chem Engn, S-22100 Lund, Sweden.
   Univ Coll Dublin, Proteome Res Ctr, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland.
RP Gallagher, WM (reprint author), Univ Coll Dublin, Sch Biomol & Biomed Sci, Conway Inst Biomol & Biomed Res, Dublin 4, Ireland.
EM william.gallagher@ucd.ie
RI Lynch, Iseult/I-3915-2014; Dawson, Kenneth A./L-2540-2016; Sanguansri,
   Luz/B-6630-2011
OI Lynch, Iseult/0000-0003-4250-4584; Dawson, Kenneth
   A./0000-0002-0568-6588; Sanguansri, Luz/0000-0003-1908-7604; Miller,
   Ian/0000-0003-2118-6345; Gallagher, William/0000-0002-4307-5999;
   Pennington, Stephen/0000-0001-7529-1015
FU Wellcome Trust
CR Ademovic Z, 2002, BIOMOL ENG, V19, P177, DOI 10.1016/S1389-0344(02)00020-5
   Alaerts JA, 2001, BIOMATERIALS, V22, P1635, DOI 10.1016/S0142-9612(00)00321-5
   Allen LT, 2006, BIOMATERIALS, V27, P3096, DOI 10.1016/j.biomaterials.2006.01.019
   Allen LT, 2003, P NATL ACAD SCI USA, V100, P6331, DOI 10.1073/pnas.1031426100
   Anderson DG, 2004, NAT BIOTECHNOL, V22, P863, DOI 10.1038/nbt981
   Anderson L, 1997, ELECTROPHORESIS, V18, P533, DOI 10.1002/elps.1150180333
   Armitage DA, 2003, J BIOMED MATER RES A, V66A, P129, DOI 10.1002/jbm.a.10549
   BLUNK T, 1993, ELECTROPHORESIS, V14, P1382, DOI 10.1002/elps.11501401214
   Boraldi F, 2003, ELECTROPHORESIS, V24, P1292, DOI 10.1002/elps.200390166
   Bosetti M, 2003, BIOMATERIALS, V24, P1419, DOI 10.1016/S0142-9612(02)00526-4
   Brodbeck WG, 2003, J BIOMED MATER RES A, V64A, P320, DOI 10.1002/jbm.a.10425
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   Bruining MJ, 2002, BIOMATERIALS, V23, P1213, DOI 10.1016/S0142-9612(01)00237-X
   Butany J, 2003, CARDIOVASC PATHOL, V12, P322, DOI 10.1016/S1054-8807(02)00105-4
   Carinci F, 2004, BIOMATERIALS, V25, P215, DOI 10.1016/S0142-9612(03)00486-1
   Carinci F, 2003, J BIOMED MATER RES B, V66B, P341, DOI 10.1002/jbm.b.10021
   Carlson AN, 1998, SURV OPHTHALMOL, V42, P417, DOI 10.1016/S0039-6257(97)00140-9
   Carulli JP, 1998, J CELL BIOCHEM, P286, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<286::AID-JCB35>3.0.CO;2-D
   Casaletto MP, 2001, APPL SURF SCI, V172, P167, DOI 10.1016/S0169-4332(00)00844-8
   Celis JE, 2000, FEBS LETT, V480, P2, DOI 10.1016/S0014-5793(00)01771-3
   Chang EJ, 2005, EXP CELL RES, V303, P197, DOI 10.1016/j.yexcr.2004.09.024
   Chaussabel Damien, 2004, Am J Pharmacogenomics, V4, P383, DOI 10.2165/00129785-200404060-00005
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P613, DOI 10.1016/S0169-409X(02)00041-8
   Chittur KK, 1998, BIOMATERIALS, V19, P301, DOI 10.1016/S0142-9612(97)00107-5
   Clarke PA, 2001, BIOCHEM PHARMACOL, V62, P1311, DOI 10.1016/S0006-2952(01)00785-7
   Dalby MJ, 2002, EXP CELL RES, V276, P1, DOI 10.1006/EXCR.2002.5498
   Dalby MJ, 2003, EXP CELL RES, V284, P274, DOI 10.1016/S0014-4827(02)00053-8
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   De Vriendt K, 2005, PROTEOMICS, V5, P1308, DOI 10.1002/pmic.200400989
   Derhami K, 2001, J BIOMED MATER RES, V56, P234, DOI 10.1002/1097-4636(200108)56:2<234::AID-JBM1090>3.3.CO;2-R
   DeRisi J, 1996, NAT GENET, V14, P457
   Dewez JL, 1999, BIOMATERIALS, V20, P547, DOI 10.1016/S0142-9612(98)00207-5
   Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025
   Doorty KB, 2003, CARDIOVASC PATHOL, V12, P105, DOI 10.1016/S1054-8807(02)00165-5
   Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005
   Duffy Michael J., 2005, Current Pharmacogenomics, V3, P289, DOI 10.2174/157016005774913158
   El-Amin SF, 2003, BIOMATERIALS, V24, P1213, DOI 10.1016/S0142-9612(02)00451-9
   Faucheux N, 2001, BIOMATERIALS, V22, P2993, DOI 10.1016/S0142-9612(01)00045-X
   Galaev IY, 1999, TRENDS BIOTECHNOL, V17, P335, DOI 10.1016/S0167-7799(99)01345-1
   Gao TJ, 2001, BIOMATERIALS, V22, P1475, DOI 10.1016/S0142-9612(00)00288-X
   Garbis S, 2005, J CHROMATOGR A, V1077, P1, DOI 10.1016/j.chroma.2005.04.059
   Garrigues GE, 2005, BIOMATERIALS, V26, P2933, DOI 10.1016/j.biomaterials.2004.06.034
   Gessner A, 2000, INT J PHARM, V196, P245, DOI 10.1016/S0378-5173(99)00432-9
   Gessner A, 2003, J BIOMED MATER RES A, V65A, P319, DOI 10.1002/jbm.a.10371
   Glokler J, 2003, J CHROMATOGR B, V797, P229, DOI 10.1016/j.jchromb.2003.08.034
   Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031
   Granchi D, 1999, BIOMATERIALS, V20, P1079, DOI 10.1016/S0142-9612(99)00004-6
   Griesser HJ, 2004, BIOMATERIALS, V25, P4861, DOI 10.1016/j.biomaterials.2004.01.049
   Groth T, 1996, BIOMATERIALS, V17, P1227, DOI 10.1016/0142-9612(96)84943-X
   Healy KE, 1999, CURR OPIN SOLID ST M, V4, P381, DOI 10.1016/S1359-0286(99)00038-8
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1980, SCIENCE, V208, P826, DOI 10.1126/science.6246576
   Hildebrand G, 2001, ANN BIOMED ENG, V29, P1100, DOI 10.1114/1.1424919
   Holland NB, 2000, J BIOMED MATER RES, V51, P307, DOI 10.1002/1097-4636(20000905)51:3<307::AID-JBM3>3.0.CO;2-H
   Hubbell JA, 2004, NAT BIOTECHNOL, V22, P828, DOI 10.1038/nbt0704-828
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Hunt JA, 1997, BIOMATERIALS, V18, P1449, DOI 10.1016/S0142-9612(97)00091-4
   Hwang D, 2005, P NATL ACAD SCI USA, V102, P17302, DOI 10.1073/pnas.0508649102
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Iwasaki Y, 1999, BIOMATERIALS, V20, P2185, DOI 10.1016/S0142-9612(99)00123-4
   Jagur-Grodzinski J, 1999, REACT FUNCT POLYM, V39, P99, DOI 10.1016/S1381-5148(98)00054-6
   Kato S, 2000, J BIOMAT SCI-POLYM E, V11, P333, DOI 10.1163/156856200743733
   Kato S, 2000, BIOMATERIALS, V21, P521, DOI 10.1016/S0142-9612(99)00214-8
   Kato S, 1998, BIOMATERIALS, V19, P821, DOI 10.1016/S0142-9612(97)00240-8
   Kavanagh CA, 2004, PHARMACOL THERAPEUT, V102, P1, DOI 10.1016/j.pharmthera.2003.01.001
   Kavanagh CA, 2005, J BIOMED MATER RES A, V72A, P25, DOI 10.1002/jbm.a.30192
   Kingshott P, 1999, ANAL BIOCHEM, V273, P156, DOI 10.1006/abio.1999.4201
   Kingshott P, 2000, J BIOMED MATER RES, V49, P36, DOI 10.1002/(SICI)1097-4636(200001)49:1<36::AID-JBM5>3.0.CO;2-B
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   Klapperich CM, 2004, BIOMATERIALS, V25, P5631, DOI 10.1016/j.biomaterials.2004.01.025
   Klee D, 2003, BIOMATERIALS, V24, P3663, DOI 10.1016/S0142-9612(03)00235-7
   Knabe C, 2005, CLIN ORAL IMPLAN RES, V16, P119, DOI 10.1111/j.1600-0501.2004.01066.x
   Korke R, 2002, J BIOTECHNOL, V94, P73, DOI 10.1016/S0168-1656(01)00420-5
   Ku CH, 2002, BIOMATERIALS, V23, P4193, DOI 10.1016/S0142-9612(02)00161-8
   Kumble KD, 2003, ANAL BIOANAL CHEM, V377, P812, DOI 10.1007/s00216-003-2088-6
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062
   Lee JH, 1999, J BIOMAT SCI-POLYM E, V10, P283
   Lee KH, 2001, TRENDS BIOTECHNOL, V19, P217, DOI 10.1016/S0167-7799(01)01639-0
   Leize EM, 1999, ANAL BIOCHEM, V272, P19, DOI 10.1006/abio.1999.4142
   Lennon AB, 2003, MED ENG PHYS, V25, P833, DOI 10.1016/S1350-4533(03)00120-6
   Lhoest JB, 2001, J BIOMED MATER RES, V57, P432, DOI 10.1002/1097-4636(20011205)57:3<432::AID-JBM1186>3.0.CO;2-G
   Li YW, 2005, BIOMATERIALS, V26, P1081, DOI 10.1016/j.biomaterials.2004.04.018
   LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393
   Lindblad M, 1997, BIOMATERIALS, V18, P1059, DOI 10.1016/S0142-9612(97)00029-X
   Luck M, 1998, J BIOMED MATER RES, V39, P478
   Lynch I, 2005, CHEM MATER, V17, P3889, DOI 10.1021/cm0506959
   Lynch I, 2005, J PHYS CHEM B, V109, P6257, DOI 10.1021/jp0502149
   LYNCH I, 2006, IN PRESS PHYSICA
   MALMSTEN M, 1995, J COLLOID INTERF SCI, V172, P485, DOI 10.1006/jcis.1995.1279
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   McArthur SL, 2001, BIOMATERIALS, V22, P3295, DOI 10.1016/S0142-9612(01)00166-1
   McGillicuddy F, 2004, AM J CARDIOL, V94, p224E
   MCGILLICUDDY F, 2006, IN PRESS J BIOMED  A
   Merrett K, 2002, J BIOMAT SCI-POLYM E, V13, P593, DOI 10.1163/156856202320269111
   Mitchell P, 2003, NAT BIOTECHNOL, V21, P233, DOI 10.1038/nbt0303-233
   Munch K, 2000, J BIOMAT SCI-POLYM E, V11, P1147, DOI 10.1163/156856200744246
   Ohgaki M, 2001, J BIOMED MATER RES, V57, P366, DOI 10.1002/1097-4636(20011205)57:3<366::AID-JBM1179>3.0.CO;2-X
   Ohya S, 2005, BIOMATERIALS, V26, P3105, DOI 10.1016/j.biomaterials.2004.08.006
   Oleschuk RD, 2000, BIOMATERIALS, V21, P1701, DOI 10.1016/S0142-9612(00)00054-5
   Paron I, 2004, BIOCHEM J, V378, P929, DOI 10.1042/BJ20031190
   PARZER S, 1993, J BIOMED MATER RES, V27, P455, DOI 10.1002/jbm.820270406
   Piehler H R, 1992, J Invest Surg, V5, P179, DOI 10.3109/08941939209012436
   Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7
   Qiu Y, 2001, ADV DRUG DELIVER REV, V53, P321, DOI 10.1016/S0169-409X(01)00203-4
   Qiu Yong, 2003, AAPS PharmSciTech, V4, pE51
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Ratner BD, 2002, J CONTROL RELEASE, V78, P211, DOI 10.1016/S0168-3659(01)00502-8
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Resing KA, 2002, ANN NY ACAD SCI, V971, P608, DOI 10.1111/j.1749-6632.2002.tb04537.x
   Roos A, 2003, BIOMATERIALS, V24, P4417, DOI 10.1016/S0142-9612(03)00342-9
   Rosengren A, 2003, BIOMATERIALS, V24, P147, DOI 10.1016/S0142-9612(02)00272-7
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   SAMMONS RL, 1994, BIOMATERIALS, V15, P842, DOI 10.1016/0142-9612(94)90040-X
   Schneider GB, 2004, BIOMATERIALS, V25, P3023, DOI 10.1016/j.biomaterials.2003.09.084
   Seal BL, 2001, MAT SCI ENG R, V34, P147, DOI 10.1016/S0927-796X(01)00035-3
   Shastri V. Prasad, 2003, Current Pharmaceutical Biotechnology, V4, P331, DOI 10.2174/1389201033489694
   Sirolli V, 2000, INT J ARTIF ORGANS, V23, P356
   Soltys-Robitaille CE, 2001, BIOMATERIALS, V22, P3257, DOI 10.1016/S0142-9612(01)00163-6
   Somiari RI, 2003, PROTEOMICS, V3, P1863, DOI 10.1002/pmic.200300560
   Tanahashi K, 2002, J BIOMED MATER RES, V62, P558, DOI 10.1002/jbm.10284
   Tengvall P, 1998, BIOMATERIALS, V19, P407, DOI 10.1016/S0142-9612(97)00110-5
   Tyan YC, 2005, J PROTEOME RES, V4, P748, DOI 10.1021/pr0497780
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   Unsworth LD, 2005, BIOMATERIALS, V26, P5927, DOI 10.1016/j.biomaterials.2005.03.010
   van Kooten TG, 2004, BIOMATERIALS, V25, P1735, DOI 10.1016/j.biomaterials.2003.08.071
   Vasmatzis G, 1998, P NATL ACAD SCI USA, V95, P300, DOI 10.1073/pnas.95.1.300
   VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484
   Wagner M, 1998, J BIOMED MATER RES, V42, P443, DOI 10.1002/(SICI)1097-4636(19981205)42:3<443::AID-JBM14>3.0.CO;2-H
   Wagner MS, 2003, J BIOMED MATER RES A, V64A, P1, DOI 10.1002/jbm.a.10263
   Wang CY, 2004, BIOMATERIALS, V25, P2949, DOI 10.1016/j.biomaterials.2003.09.088
   Ward WK, 2002, BIOMATERIALS, V23, P4185, DOI 10.1016/S0142-9612(02)00160-6
   Werner C, 1999, INT J ARTIF ORGANS, V22, P160
   Wilson DS, 2002, CURR OPIN CHEM BIOL, V6, P81, DOI 10.1016/S1367-5931(01)00281-2
   Wilson SJ, 2003, J BIOMED MATER RES A, V67A, P667, DOI 10.1002/jbm.a.10137
   Wroblewski BM, 2002, J BONE JOINT SURG BR, V84B, P540, DOI 10.1302/0301-620X.84B4.10293
   Xie J, 2002, BIOMATERIALS, V23, P3609, DOI 10.1016/S0142-9612(02)00090-X
   Xie JW, 2005, J BIOMED MATER RES A, V73A, P39, DOI 10.1002/jbm.a.30246
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
   Yanagisawa K, 2003, LANCET, V362, P433, DOI 10.1016/S0140-6736(03)14068-8
   Zreiqat H, 1999, J BIOMED MATER RES, V47, P360, DOI 10.1002/(SICI)1097-4636(19991205)47:3<360::AID-JBM10>3.0.CO;2-K
NR 143
TC 47
Z9 51
U1 4
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2006
VL 27
IS 35
BP 5871
EP 5882
DI 10.1016/j.biomaterials.2006.07.040
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 099YK
UT WOS:000241633500001
PM 16938344
DA 2018-10-19
ER

PT J
AU Liu, H
   Lin, J
   Roy, K
AF Liu, Hui
   Lin, Jian
   Roy, Krishnendu
TI Effect of 3D scaffold and dynamic culture condition on the global gene
   expression profile of mouse embryonic stem cells
SO BIOMATERIALS
LA English
DT Article
DE embryonic stem cells; differentiation; spinner culture; gene expression;
   cDNA microarray
ID SMOOTH-MUSCLE-CELLS; MATRIX METALLOPROTEINASES; TISSUE INHIBITOR;
   GROWTH-FACTORS; MOLECULAR RESPONSES; POLYMER SCAFFOLDS;
   BINDING-PROTEINS; TGF-BETA; DIFFERENTIATION; NICHE
AB We have previously demonstrated that mouse embryonic stem (ES) cells differentiated on three-dimensional (3D), highly porous, tantalum-based scaffolds (Cytomatrix (TM)) have significantly higher hematopoietic differentiation efficiency than those cultured under conventional two-dimensional (2D) tissue culture conditions. In addition, ES cell-seeded scaffolds cultured inside spinner bioreactors showed further enhancement in hematopolesis compared to static conditions. In the present study, we evaluated how these various biomaterial-based culture conditions, e.g. 2D vs. 3D scaffolds and static vs. dynamic, influence the global gene expression profile of differentiated ES cells. We report that compared to 2D tissue culture plates, cells differentiated on porous, Cytomatrix (TM) scaffolds possess significantly higher expression levels of extracellular matrix (ECM)-related genes, as well as genes that regulate cell growth, proliferation and differentiation. In addition, these differences in gene expression were more pronounced in 3D dynamic culture compared to 3D static culture. We report specific genes that are either uniquely expressed under each condition or are quantitatively regulated, i.e. over expressed or inhibited by a specific culture environment. We conclude that that biomaterial-based 3D cultures, especially under dynamic conditions, might favor efficient hematopoietic differentiation of ES cells by stimulating increased expression of specific ECM proteins, growth factors and cell adhesion related genes while significantly down-regulating genes that act to inhibit expression of these molecules. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
   Univ Texas, Dept Microbiol & Mol Genet, Austin, TX 78712 USA.
   Univ Texas, Inst Mol & Cellular Biol, Austin, TX 78712 USA.
RP Roy, K (reprint author), Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
EM kroy@mail.utexas.edu
CR Ahn JI, 2004, J CELL BIOCHEM, V93, P563, DOI 10.1002/jcb.20168
   Alexander CM, 1996, J CELL BIOL, V135, P1669, DOI 10.1083/jcb.135.6.1669
   Allan GJ, 2001, REPRODUCTION, V122, P31, DOI 10.1530/rep.0.1220031
   Allen LT, 2003, P NATL ACAD SCI USA, V100, P6331, DOI 10.1073/pnas.1031426100
   Bagley J, 1999, EXP HEMATOL, V27, P496, DOI 10.1016/S0301-472X(98)00053-8
   Battista S, 2005, BIOMATERIALS, V26, P6194, DOI 10.1016/j.biomaterials.2005.04.003
   Borene ML, 2004, ANN BIOMED ENG, V32, P274, DOI 10.1023/B:ABME.0000012747.97620.3a
   Bourell D, 2004, RAPID PROTOTYPING J, V10, P5
   Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040
   CHESLER L, 1995, BLOOD, V86, P4506
   Clemmons D. R., 1995, Progress in Growth Factor Research, V6, P357, DOI 10.1016/0955-2235(95)00013-5
   Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012
   Duan CM, 2005, GEN COMP ENDOCR, V142, P44, DOI 10.1016/j.ygcen.2004.12.022
   Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745
   Furstenberger G, 2002, LANCET ONCOL, V3, P298, DOI 10.1016/S1470-2045(02)00731-3
   Gerecht-Nir S, 2004, BIOTECHNOL BIOENG, V86, P493, DOI 10.1002/bit.20045
   Gerecht-Nir S, 2004, BIOTECHNOL BIOENG, V88, P313, DOI 10.1002/bit.20248
   Globus R K, 1995, ASGSB Bull, V8, P19
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995
   Gooch KJ, 2001, BIOTECHNOL BIOENG, V72, P402, DOI 10.1002/1097-0290(20000220)72:4<402::AID-BIT1002>3.0.CO;2-Q
   Hackney JA, 2002, P NATL ACAD SCI USA, V99, P13061, DOI 10.1073/pnas.192124499
   Horiuchi K, 2003, MOL CELL BIOL, V23, P5614, DOI 10.1128/MCB.23.16.5614-5624.2003
   Huang W, 1997, J BIOL CHEM, V272, P22086, DOI 10.1074/jbc.272.35.22086
   Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024
   JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3
   Kelly DL, 2000, MOL REPROD DEV, V56, P113, DOI 10.1002/(SICI)1098-2795(200006)56:2<113::AID-MRD1>3.0.CO;2-Q
   Killion PJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-32
   Kim Y, 2004, BIOTECHNOL LETT, V26, P399, DOI 10.1023/B:BILE.0000018258.58314.5c
   King-Briggs KE, 2000, DIFFERENTIATION, V66, P43, DOI 10.1046/j.1432-0436.2000.066001043.x
   Kriz V, 2003, EXP CELL RES, V286, P40, DOI 10.1016/S0014-4827(03)00099-5
   Lawrence JB, 1999, P NATL ACAD SCI USA, V96, P3149, DOI 10.1073/pnas.96.6.3149
   Lelievre S, 1996, RECENT PROG HORM RES, V51, P417
   Leven RM, 2004, J BIOMED MATER RES A, V70A, P391, DOI 10.1002/jbm.a.30082
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004.07.2681
   Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3
   Liu H, 2005, TISSUE ENG, V11, P319, DOI 10.1089/ten.2005.11.319
   Liu JW, 2004, J NEUROCHEM, V90, P1050, DOI 10.1111/j.1471-4159.2004.02570.x
   Lynch CC, 2002, DIFFERENTIATION, V70, P561, DOI 10.1046/j.1432-0436.2002.700909.x
   Moore KA, 2004, CURR OPIN HEMATOL, V11, P107, DOI 10.1097/01.moh.0000133652.06863.47
   Moses HL, 1996, CURR OPIN GENET DEV, V6, P581, DOI 10.1016/S0959-437X(96)80087-6
   MOSES MA, 1990, SCIENCE, V248, P1408, DOI 10.1126/science.1694043
   Nguyen KT, 2004, J BIOMED MATER RES A, V69A, P513, DOI 10.1002/jbm.a.30020
   Nguyen KT, 2004, BIOMATERIALS, V25, P5333, DOI 10.1016/j.biomaterials.2003.12.033
   Nur E. K. A., 2006, STEM CELLS, V24, P426, DOI DOI 10.1634/STEMCELLS.2005-0170)
   Poznansky MC, 2000, NAT BIOTECHNOL, V18, P729
   Pyle AD, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-235
   Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530
   Roberts LM, 2002, DEVELOPMENT, V129, P1487
   Schneider-Stock R, 2006, J PATHOL, V209, P95, DOI 10.1002/path.1951
   Schwartz MA, 2005, J BIOMED MATER RES A, V73A, P30, DOI 10.1002/jbm.a.30228
   Shin DM, 2004, NEUROREPORT, V15, P1959, DOI 10.1097/00001756-200408260-00025
   Sikavitsas VI, 2002, J BIOMED MATER RES, V62, P136, DOI 10.1002/jbm.10150
   Stickens D, 2004, DEVELOPMENT, V131, P5883, DOI 10.1242/dev.01461
   Tanaka TS, 2002, GENOME RES, V12, P1921, DOI 10.1101/gr.670002
   Taylor KB, 1996, J BIOL CHEM, V271, P23938, DOI 10.1074/jbc.271.39.23938
   Thompson LJ, 2003, INFECT IMMUN, V71, P2643, DOI 10.1128/IAI.71.5.2643-2655.2003
   Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520
   Vogel G, 2003, SCIENCE, V302, P371
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427
   Wurtz SO, 2005, ENDOCR-RELAT CANCER, V12, P215, DOI 10.1677/erc.1.00719
   Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761
   Zucker S, 2003, CURR TOP DEV BIOL, V54, P1, DOI 10.1016/S0070-2153(03)54004-2
NR 65
TC 87
Z9 91
U1 2
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2006
VL 27
IS 36
BP 5978
EP 5989
DI 10.1016/j.biomaterials.2006.05.053
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 106SU
UT WOS:000242121900003
PM 16824594
DA 2018-10-19
ER

PT J
AU Taqvi, S
   Roy, K
AF Taqvi, Sabia
   Roy, Krishnendu
TI Influence of scaffold physical properties and stromal cell coculture on
   hematopoietic differentiation of mouse embryonic stem cells
SO BIOMATERIALS
LA English
DT Article
DE embryonic stem cells; PLGA; scaffold; hematopoiesis
ID IN-VITRO; EXTRACELLULAR-MATRIX; SPATIAL DEVELOPMENT; NONWOVEN FABRICS;
   CULTURE; GENERATION; CONSTRUCTS; EFFICIENCY; PROTEINS
AB Recent studies have suggested that three-dimensional (3D) biomaterial-based scaffolds and dynamic culture conditions could provide significant enhancement in the differentiation efficiency of embryonic stem cells (ESCs). Here we report that scaffold physical properties, like pore size, polymer concentration and compression modulus as well as specific culture conditions, e.g. cell seeding density and coculture with stromal cells can significantly influence hematopoietic, differentiation of ESCs. PLLA scaffolds of various polymer concentrations (7.5%, 10% and 20% w/v) and pore size distributions (< 150 mu m, 150-425 mu m, > 425 mu m) were fabricated using a standard solvent casting-salt leaching method. Mouse RI ESCs were allowed to differentiate on these scaffolds either alone or in coculture with OP9 cells, a bone-marrow derived murine stromal cell line. Following one week of culture, cells were detached and analyzed using flow cytometry to evaluate the frequency of hematopoietic progenitor cells (HPC). Our results indicate that decreasing scaffold pore size increases hematopoietic differentiation of ESCs. In addition, increasing polymer concentration which resulted in increased scaffold compression modulus also provided significantly enhanced hematopoiesis. Furthermore, higher cell seeding densities as well as coculture with marrow-derived stromal cells increased HPC generation. Collectively, these results indicate that physical and mechanical properties of the 3D microenvironment as well as cell-cell and cell-stromal interactions might play a significant role in ESC differentiation and therefore warrants further investigation to elucidate the molecular mechanisms. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
RP Roy, K (reprint author), Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
EM kroy@mail.utexas.edu
CR Bagley J, 1999, EXP HEMATOL, V27, P496, DOI 10.1016/S0301-472X(98)00053-8
   Battista S, 2005, BIOMATERIALS, V26, P6194, DOI 10.1016/j.biomaterials.2005.04.003
   Cho SK, 1999, P NATL ACAD SCI USA, V96, P9797, DOI 10.1073/pnas.96.17.9797
   Dang SM, 2004, STEM CELLS, V22, P275, DOI 10.1634/stemcells.22-3-275
   Dang SM, 2002, BIOTECHNOL BIOENG, V78, P442, DOI 10.1002/bit.10220
   Gerecht-Nir S, 2004, BIOTECHNOL BIOENG, V86, P493, DOI 10.1002/bit.20045
   Gerecht-Nir S, 2004, BIOTECHNOL BIOENG, V88, P313, DOI 10.1002/bit.20248
   Goldsby RA, 2003, IMMUNOLOGY
   Ishaug-Riley SL, 1998, BIOMATERIALS, V19, P1405, DOI 10.1016/S0142-9612(98)00021-0
   Johkura K, 2003, CARDIOVASC RES, V58, P435, DOI 10.1016/S0008-6363(02)00730-7
   Kaufman DS, 2001, P NATL ACAD SCI USA, V98, P10716, DOI 10.1073/pnas.191362598
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Liu H, 2005, TISSUE ENG, V11, P319, DOI 10.1089/ten.2005.11.319
   Ma ZW, 2003, J BIOMED MATER RES B, V67B, P610, DOI 10.1002/jbm.b.10049
   Mantalaris A, 1998, BIOTECHNOL PROGR, V14, P126, DOI 10.1021/bp970136+
   Nakano T, 1996, INT J HEMATOL, V65, P1
   NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449
   Nilsson SK, 1998, J HISTOCHEM CYTOCHEM, V46, P371, DOI 10.1177/002215549804600311
   O'Shea KS, 1999, ANAT REC, V257, P32, DOI 10.1002/(SICI)1097-0185(19990215)257:1<32::AID-AR6>3.0.CO;2-2
   Poznansky MC, 2000, NAT BIOTECHNOL, V18, P729
   Sasaki T, 2003, J BIOSCI BIOENG, V96, P76, DOI 10.1016/S1389-1723(03)90100-9
   Sasaki T, 2002, CYTOTHERAPY, V4, P285, DOI 10.1080/146532402320219808
   Sternberg S.S., 1997, HISTOLOGY PATHOLOGIS
   Tsai RYL, 2000, J NEUROSCI, V20, P3725
   Vituri CL, 2000, BRAZ J MED BIOL RES, V33, P889, DOI 10.1590/S0100-879X2000000800004
   Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649
   WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0
   Wilson CE, 2002, J MATER SCI-MATER M, V13, P1265, DOI 10.1023/A:1021139415528
   Wognum AW, 2003, ARCH MED RES, V34, P461, DOI 10.1016/j.arcmed.2003.09.008
   Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129
NR 30
TC 42
Z9 43
U1 2
U2 12
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2006
VL 27
IS 36
BP 6024
EP 6031
DI 10.1016/j.biomaterials.2006.05.052
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 106SU
UT WOS:000242121900007
PM 16959314
DA 2018-10-19
ER

PT J
AU Wang, YZ
   Kim, HJ
   Vunjak-Novakovic, G
   Kaplan, DL
AF Wang, Yongzhong
   Kim, Hyeon-Joo
   Vunjak-Novakovic, Gordana
   Kaplan, David L.
TI Stem cell-based tissue engineering with silk biomaterials
SO BIOMATERIALS
LA English
DT Review
DE silk; stem cell; scaffold; tissue engineering; mesenchymal stem cell
ID SPIDER DRAGLINE SILK; BOMBYX-MORI SILK; MESENCHYMAL PROGENITOR CELLS;
   MARROW STROMAL CELLS; ORAL DOSAGE FORM; POLY(3-HYDROXYBUTYRIC
   ACID-CO-3-HYDROXYVALERIC ACID); 3-DIMENSIONAL NANOFIBROUS SCAFFOLD;
   HUMAN ARTICULAR CHONDROCYTES; NORMAL HUMAN KERATINOCYTES; IN-VITRO
   CHARACTERIZATION
AB Silks are naturally occurring polymers that have been used clinically as sutures for centuries. When naturally extruded from insects or worms, silk is composed of a filament core protein, termed fibroin, and a glue-like coating consisting of sericin proteins. In recent years, silk fibroin has been increasingly studied for new biomedical applications due to the biocompatibility, slow degradability and remarkable mechanical properties of the material. In addition, the ability to now control molecular structure and morphology through versatile processability and surface modification options have expanded the utility for this protein in a range of biomaterial and tissue-engineering applications. Silk fibroin in various formats (films, fibers, nets, meshes, membranes, yarns, and sponges) has been shown to support stem cell adhesion, proliferation, and differentiation in vitro and promote tissue repair in vivo. In particular, stem cell-based tissue engineering using 3D silk fibroin scaffolds has expanded the use of silk-based biomaterials as promising scaffolds for engineering a range of skeletal tissues like bone, ligament, and cartilage, as well as connective tissues like skin. To date fibroin from Bombyx mori silkworm has been the dominant source for silk-based biomaterials studied. However, silk fibroins from spiders and those formed via genetic engineering or the modification of native silk fibroin sequence chemistries are beginning to provide new options to further expand the utility of silk fibroin-based materials for medical applications. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Chem & Biol Engn, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
OI Vunjak-Novakovic, Gordana/0000-0002-9382-1574
FU NIBIB NIH HHS [P41 EB002520]
CR Agarwal A, 2001, TISSUE ENG, V7, P191, DOI 10.1089/107632701300062813
   Aigner T, 2003, ADV DRUG DELIVER REV, V55, P1569, DOI 10.1016/j.addr.2003.08.009
   Alsalameh S, 2004, ARTHRITIS RHEUM, V50, P1522, DOI 10.1002/art.20269
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Altman GH, 2002, J BIOMECH ENG-T ASME, V124, P742, DOI 10.1115/1.1519280
   Altman Greg, 2002, FASEB Journal, V16, P270
   Ambrosio AMA, 2002, BIOMATERIALS, V23, P1667, DOI 10.1016/S0142-9612(01)00293-9
   Aoki H, 2003, BIO-MED MATER ENG, V13, P309
   Arai T, 2002, J APPL POLYM SCI, V84, P1963, DOI 10.1002/app.10491
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Asakura T, 2003, BIOMACROMOLECULES, V4, P815, DOI 10.1021/bm034020f
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Auger FA, 2004, BIOTECHNOL APPL BIOC, V39, P263
   AYUB ZH, 1994, POLYMER, V35, P2197, DOI 10.1016/0032-3861(94)90250-X
   AYUB ZH, 1993, BIOSCI BIOTECH BIOCH, V57, P1910, DOI 10.1271/bbb.57.1910
   Ayutsede J, 2005, POLYMER, V46, P1625, DOI 10.1016/j.poplymer.2004.11.029
   Barbero A, 2004, OSTEOARTHR CARTILAGE, V12, P476, DOI 10.1016/j.joca.2004.02.010
   Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001
   Bet MR, 2001, BIOMACROMOLECULES, V2, P1074, DOI 10.1021/bm0001188
   BIAGINI G, 1991, BIOMATERIALS, V12, P281, DOI 10.1016/0142-9612(91)90035-9
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202
   Bruder SP, 1998, J BONE JOINT SURG AM, V80A, P985, DOI 10.2106/00004623-199807000-00007
   Bruder SP, 1998, CLIN ORTHOP RELAT R, V355, P247
   Butler CE, 1999, BRIT J PLAST SURG, V52, P127, DOI 10.1054/bjps.1997.3047
   Butler DL, 1999, CLIN ORTHOP RELAT R, pS324
   Cai KY, 2002, BIOMATERIALS, V23, P1603, DOI 10.1016/S0142-9612(01)00287-3
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Calve S, 2004, TISSUE ENG, V10, P755, DOI 10.1089/1076327041348464
   Cancedda R, 2003, MATRIX BIOL, V22, P81, DOI 10.1016/S0945-053X(03)00012-X
   Cao YL, 2002, PLAST RECONSTR SURG, V110, P1280, DOI 10.1097/01.PRS.0000025290.49889.4D
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   CAPPELLO J, 1990, BIOTECHNOL PROGR, V6, P198, DOI 10.1021/bp00003a006
   Causa F, 2006, J BIOMED MATER RES A, V76A, P151, DOI 10.1002/jbm.a.30528
   Chakir J, 2001, J ALLERGY CLIN IMMUN, V107, P36, DOI 10.1067/mai.2001.111929
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Chen P, 2005, TISSUE ENG, V11, P1436, DOI 10.1089/ten.2005.11.1436
   Chen X, 1997, J APPL POLYM SCI, V65, P2257, DOI 10.1002/(SICI)1097-4628(19970912)65:11<2257::AID-APP23>3.0.CO;2-Z
   Chen X, 1997, J POLYM SCI POL PHYS, V35, P2293, DOI 10.1002/(SICI)1099-0488(199710)35:14<2293::AID-POLB9>3.0.CO;2-X
   Chiarini A, 2003, BIOMATERIALS, V24, P789, DOI 10.1016/S0142-9612(02)00417-9
   COHEN S, 1993, CLIN MATER, V13, P3, DOI 10.1016/0267-6605(93)90082-I
   Coombes AGA, 2004, BIOMATERIALS, V25, P315, DOI 10.1016/S0142-9612(03)00535-0
   Dai NT, 2005, BIOCHEM BIOPH RES CO, V329, P905, DOI 10.1016/j.bbrc.2005.02.059
   Dai NT, 2004, BIOMATERIALS, V25, P4263, DOI 10.1016/j.biomaterials.2003.11.022
   Dal Pra I, 2003, TISSUE ENG, V9, P1113, DOI 10.1089/10763270360728026
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   De Bari C, 2001, ARTHRITIS RHEUM, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P
   Dean D, 2003, TISSUE ENG, V9, P495, DOI 10.1089/107632703322066679
   DEMURA M, 1991, J MEMBRANE SCI, V59, P39, DOI 10.1016/S0376-7388(00)81220-X
   Diduch DR, 2000, ARTHROSCOPY, V16, P571, DOI 10.1053/jars.2000.4827
   Dinerman AA, 2002, BIOMATERIALS, V23, P4203, DOI 10.1016/S0142-9612(02)00164-3
   Dinerman AA, 2002, J CONTROL RELEASE, V82, P277, DOI 10.1016/S0168-3659(02)00134-7
   DOYLE C, 1991, BIOMATERIALS, V12, P841, DOI 10.1016/0142-9612(91)90072-I
   Dugan SA, 2005, AM J PHYS MED REHAB, V84, P122, DOI 10.1097/01.PHM.0000154183.40640.93
   Endres M, 2003, TISSUE ENG, V9, P689, DOI 10.1089/107632703768247386
   ERTEL SI, 1995, J BIOMED MATER RES, V29, P1337, DOI 10.1002/jbm.820291105
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   Fidkowski C, 2005, TISSUE ENG, V11, P302, DOI 10.1089/ten.2005.11.302
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Fisher JP, 2002, J BIOMED MATER RES, V59, P547, DOI 10.1002/jbm.1268
   Fisher JP, 2004, J BIOMED MATER RES A, V68A, P428, DOI 10.1002/jbm.a.20073
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131
   Fragonas E, 2000, BIOMATERIALS, V21, P795, DOI 10.1016/S0142-9612(99)00241-0
   FREDDI G, 1995, J APPL POLYM SCI, V56, P1537, DOI 10.1002/app.1995.070561203
   Freddi G, 1999, J APPL POLYM SCI, V71, P1563, DOI 10.1002/(SICI)1097-4628(19990307)71:10<1563::AID-APP4>3.0.CO;2-E
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   FREED LE, 1993, J CELL BIOCHEM, V51, P257, DOI 10.1002/jcb.240510304
   Fuchs JR, 2004, J PEDIATR SURG, V39, P834, DOI 10.1016/j.jpedsurg.2004.02.014
   Fukumoto T, 2003, OSTEOARTHR CARTILAGE, V11, P55, DOI 10.1053/joca.2002.0869
   Funakoshi T, 2005, AM J SPORT MED, V33, P1193, DOI 10.1177/036354650427689
   Garvin J, 2003, TISSUE ENG, V9, P967, DOI 10.1089/107632703322495619
   Gil ES, 2005, MACROMOL BIOSCI, V5, P702, DOI 10.1002/mabi.200500076
   Gil ES, 2005, BIOMACROMOLECULES, V6, P3079, DOI 10.1021/bm050396c
   Gobin AS, 2005, J BIOMED MATER RES A, V74A, P465, DOI 10.1002/jbm.a.30382
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Gotoh Y, 1997, POLYMER, V38, P487, DOI 10.1016/S0032-3861(96)00665-9
   Gotoh Y, 1998, J BIOMED MATER RES, V39, P351, DOI 10.1002/(SICI)1097-4636(19980305)39:3<351::AID-JBM2>3.0.CO;2-I
   Grande DA, 1997, J BIOMED MATER RES, V34, P211, DOI 10.1002/(SICI)1097-4636(199702)34:2<211::AID-JBM10>3.0.CO;2-L
   GUO JF, 1989, CONNECT TISSUE RES, V19, P277, DOI 10.3109/03008208909043901
   Haider M, 2004, J CONTROL RELEASE, V95, P1, DOI 10.1016/j.jconrel.2003.11.011
   Haider M, 2005, MOL PHARMACEUT, V2, P139, DOI 10.1021/mp049906s
   HANAWA T, 1995, CHEM PHARM BULL, V43, P872
   Hanawa T, 2000, DRUG DEV IND PHARM, V26, P1091, DOI 10.1081/DDC-100100273
   HANAWA T, 1995, CHEM PHARM BULL, V43, P284
   HAUSELMANN HJ, 1994, J CELL SCI, V107, P17
   HAUSELMANN HJ, 1994, FEBS LETT, V352, P361, DOI 10.1016/0014-5793(94)00994-5
   Hildebrand KA, 2002, MICROSC RES TECHNIQ, V58, P34, DOI 10.1002/jemt.10114
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   HORAN RL, 2005, J BIOMECH       0921
   Hu K, 2006, J BIOACT COMPAT POL, V21, P23, DOI 10.1177/0883911506060455
   Huang Q, 2002, TISSUE ENG, V8, P469, DOI 10.1089/107632702760184727
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Im SY, 2003, ARCH PHARM RES, V26, P76, DOI 10.1007/BF03179936
   in 't Anker Pieternella S., 2003, Experimental Hematology (New York), V31, P881, DOI 10.1016/S0301-472X(03)00202-9
   in 't Anker Pieternella S., 2003, Haematologica, V88, P845
   Inouye K, 1998, J BIOCHEM BIOPH METH, V37, P159, DOI 10.1016/S0165-022X(98)00024-4
   Ishizuya T, 1997, J CLIN INVEST, V99, P2961, DOI 10.1172/JCI119491
   James K, 1999, BIOMATERIALS, V20, P2203, DOI 10.1016/S0142-9612(99)00151-9
   Jankowski RJ, 2002, GENE THER, V9, P642, DOI 10.1038/sj/gt/3301719
   Ji JF, 2004, STEM CELLS, V22, P415, DOI 10.1634/stemcells.22-3-415
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Juncosa N, 2003, J BIOMECH, V36, P483, DOI 10.1016/S0021-9290(02)00459-1
   Kanemaru SI, 2003, ANN OTO RHINOL LARYN, V112, P492, DOI 10.1177/000348940311200602
   Kang GD, 2000, MACROMOL RAPID COMM, V21, P788, DOI 10.1002/1521-3927(20000701)21:11<788::AID-MARC788>3.3.CO;2-O
   KAPLAN D, 1994, ACS SYM SER, V544, P2
   KAPLAN DL, 1992, MRS BULL, V17, P41
   Kaplan DL, 1998, POLYM DEGRAD STABIL, V59, P25, DOI 10.1016/S0141-3910(97)00000-1
   KAPLAN DL, 1998, PROTEIN BASED MAT, P103
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kardestuncer T, 2006, CLIN ORTHOP RELAT R, P234, DOI 10.1097/01.blo.0000205879.50834.fe
   KARDESTUNCER T, 2006, CLIN ORTHOP RELAT RE
   Kenar H, 2006, BIOMATERIALS, V27, P885, DOI 10.1016/j.biomaterials.2005.07.001
   Kesenci K, 2001, J BIOMAT SCI-POLYM E, V12, P337, DOI 10.1163/156856201750180852
   Khor HL, 2003, J MATER SCI-MATER M, V14, P113, DOI 10.1023/A:1022059511261
   Kim HJ, 2005, AUST J CHEM, V58, P716, DOI 10.1071/CH05170
   Kim KH, 2005, J BIOTECHNOL, V120, P327, DOI 10.1016/j.jbiotec.2005.06.033
   Kim SJ, 2005, BIOPHARM DRUG DISPOS, V26, P21, DOI 10.1002/bdd.427
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Koob TJ, 2002, COMP BIOCHEM PHYS A, V133, P1171, DOI 10.1016/S1095-6433(02)00247-7
   Kose GT, 2005, BIOMATERIALS, V26, P5187, DOI 10.1016/j.biomaterials.2005.01.037
   Kose GT, 2004, TISSUE ENG, V10, P1234, DOI 10.1089/ten.2004.10.1234
   Kose GT, 2003, J MATER SCI-MATER M, V14, P121
   Kose GT, 2003, BIOMATERIALS, V24, P4999, DOI 10.1016/S0142-9612(03)00417-4
   Kose GT, 2003, BIOMATERIALS, V24, P1949, DOI 10.1016/S0142-9612(02)00613-0
   Kweon HY, 2001, J APPL POLYM SCI, V80, P1848, DOI 10.1002/app.1281
   Landis W J, 2005, Orthod Craniofac Res, V8, P303, DOI 10.1111/j.1601-6343.2005.00353.x
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Laurencin CT, 2005, BIOMATERIALS, V26, P7530, DOI 10.1016/j.biomaterials.2005.05.073
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee HK, 1999, PROSTATE, V40, P14, DOI 10.1002/(SICI)1097-0045(19990615)40:1<14::AID-PROS2>3.0.CO;2-6
   Lee JY, 2000, J CELL BIOL, V150, P1085, DOI 10.1083/jcb.150.5.1085
   Lee KY, 1998, J BIOMAT SCI-POLYM E, V9, P905, DOI 10.1163/156856298X00235
   Lewis RV, 1996, PROTEIN EXPRES PURIF, V7, P400, DOI 10.1006/prep.1996.0060
   Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li XM, 2006, BIOMATERIALS, V27, P1917, DOI 10.1016/j.biomaterials.2005.11.013
   Livingston T, 2002, J BIOMED MATER RES, V62, P1, DOI 10.1002/jbm.10157
   Ma HL, 2003, J BIOMED MATER RES A, V64A, P273, DOI 10.1002/jbm.a.10370
   Majima T, 2005, J ORTHOP SCI, V10, P302, DOI 10.1007/s00776-005-0891-y
   Marijnissen WJCM, 2002, BIOMATERIALS, V23, P1511, DOI 10.1016/S0142-9612(01)00281-2
   Martin I, 1998, J ORTHOPAED RES, V16, P181, DOI 10.1002/jor.1100160205
   Megeed Z, 2004, J CONTROL RELEASE, V94, P433, DOI 10.1016/j.jconrel.2003.10.027
   Megeed Z, 2002, PHARMACEUT RES, V19, P954, DOI 10.1023/A:1016406120288
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   MELLO CM, 1994, ABSTR PAP AM CHEM S, V207, P80
   Min BM, 2004, INT J BIOL MACROMOL, V34, P281, DOI 10.1016/j.ijbiomac.2004.08.004
   Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   MINOURA N, 1990, POLYMER, V31, P265, DOI 10.1016/0032-3861(90)90117-H
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100
   MOK SS, 1994, J BIOL CHEM, V269, P33021
   Morita Y, 2006, J BIOMECH, V39, P103, DOI 10.1016/j.jbiomech.2004.10.031
   Morita Y, 2002, BIO-MED MATER ENG, V12, P291
   Motta A, 2004, J BIOMAT SCI-POLYM E, V15, P851, DOI 10.1163/1568562041271075
   Mueller SM, 1999, BIOMATERIALS, V20, P701, DOI 10.1016/S0142-9612(98)00189-6
   Nagarsekar A, 2003, BIOMACROMOLECULES, V4, P602, DOI 10.1021/bm0201082
   Nair LS, 2004, BIOMACROMOLECULES, V5, P2212, DOI 10.1021/bm049759j
   NAKAHARA H, 1990, BONE, V11, P181, DOI 10.1016/8756-3282(90)90212-H
   Nathan S, 2003, TISSUE ENG, V9, P733, DOI 10.1089/107632703768247412
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Ng Kee Woei, 2001, Tissue Engineering, V7, P441, DOI 10.1089/10763270152436490
   Ng KW, 2004, BIOMATERIALS, V25, P2807, DOI 10.1016/j.biomaterials.2003.09.058
   Noort WA, 2002, EXP HEMATOL, V30, P870, DOI 10.1016/S0301-472X(02)00820-2
   Noth U, 2005, CYTOTHERAPY, V7, P447, DOI 10.1080/14653240500319093
   Noth U, 2002, J ORTHOPAED RES, V20, P1060, DOI 10.1016/S0736-0266(02)00018-9
   Ogawa A, 2004, J BIOSCI BIOENG, V98, P217
   Ohgo K, 2003, POLYMER, V44, P841, DOI 10.1016/S0032-3861(02)00819-4
   Pachence JM, 1996, J BIOMED MATER RES, V33, P35, DOI 10.1002/(SICI)1097-4636(199621)33:1<35::AID-JBM6>3.0.CO;2-N
   Paige KT, 1996, PLAST RECONSTR SURG, V97, P168, DOI 10.1097/00006534-199601000-00027
   Paquette JS, 2003, IN VITRO CELL DEV-AN, V39, P213
   Payne RG, 2002, BIOMATERIALS, V23, P4381, DOI 10.1016/S0142-9612(02)00186-2
   Pennisi E, 2002, SCIENCE, V295, P1011, DOI 10.1126/science.295.5557.1011
   Perka C, 2000, J BIOMED MATER RES, V49, P305, DOI 10.1002/(SICI)1097-4636(20000305)49:3<305::AID-JBM2>3.3.CO;2-0
   Perka C, 2000, J BIOMED MATER RES, V52, P543, DOI 10.1002/1097-4636(20001205)52:3<543::AID-JBM13>3.0.CO;2-2
   Petrini P, 2001, J MATER SCI-MATER M, V12, P849, DOI 10.1023/A:1012847301850
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Puelacher WC, 1996, INT J ORAL MAX SURG, V25, P223, DOI 10.1016/S0901-5027(96)80035-X
   Rising A, 2005, ZOOL SCI, V22, P273, DOI 10.2108/zsj.22.273
   Rohner D, 2003, J BIOMED MATER RES B, V66B, P574, DOI 10.1002/jbm.b.10037
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   SAHOO S, 2006, TISSUE ENG      0101
   Sakabe H., 1989, SEN-I GAKKAISHI, V45, P487
   Sandy C, 2002, PRINCIPLES BONE BIOL, V1, P3
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Schantz JT, 2002, INT J ORAL MAX IMPL, V17, P161
   Schantz JT, 2003, TISSUE ENG, V9, pS113, DOI 10.1089/10763270360697021
   Schantz JT, 2005, J MATER SCI-MATER M, V16, P807, DOI 10.1007/s10856-005-3584-3
   Schantz JT, 2003, TISSUE ENG, V9, pS127, DOI 10.1089/10763270360697030
   Schek RM, 2006, BIOMATERIALS, V27, P1160, DOI 10.1016/j.biomaterials.2005.07.029
   Scheller J, 2004, TRANSGENIC RES, V13, P51, DOI 10.1023/B:TRAG.0000017175.78809.7a
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Sezutsu H, 2000, J MOL EVOL, V51, P329, DOI 10.1007/s002390010095
   Shin M, 2004, TISSUE ENG, V10, P33, DOI 10.1089/107632704322791673
   SIMMONS A, 1994, MACROMOLECULES, V27, P5235, DOI 10.1021/ma00096a060
   Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Solchaga LA, 2005, OSTEOARTHR CARTILAGE, V13, P297, DOI 10.1016/j.joca.2004.12.016
   Stamm C, 2003, LANCET, V361, P45, DOI 10.1016/S0140-6736(03)12110-1
   Sugihara A, 2000, P SOC EXP BIOL MED, V225, P58, DOI 10.1046/j.1525-1373.2000.22507.x
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   Szela S, 2000, BIOMACROMOLECULES, V1, P534, DOI 10.1021/bm0055697
   Tamada Y, 2005, BIOMACROMOLECULES, V6, P3100, DOI 10.1021/bm050431f
   Terada S, 2005, J BIOSCI BIOENG, V100, P667, DOI 10.1263/jbb.100.667
   Tohill M, 2004, NEUROSCI LETT, V362, P200, DOI 10.1016/j.neulet.2004.03.077
   Torres DS, 2000, BIOMATERIALS, V21, P1607
   Tsubouchi K, 2005, BIOSCI BIOTECH BIOCH, V69, P403, DOI 10.1271/bbb.69.403
   TSUKADA M, 1994, J POLYM SCI POL PHYS, V32, P243, DOI 10.1002/polb.1994.090320205
   Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   UZAWA T, 1995, BONE, V16, P477
   Valluzzi R, 1999, J PHYS CHEM B, V103, P11382, DOI 10.1021/jp991363s
   Vance RJ, 2004, BIOMATERIALS, V25, P2095, DOI 10.1016/j.biomaterials.2003.08.064
   Venugopal J, 2005, TISSUE ENG, V11, P847, DOI 10.1089/ten.2005.11.847
   Vollrath F, 2005, CURR BIOL, V15, pR364, DOI 10.1016/j.cub.2005.05.014
   Vollrath F, 2000, J Biotechnol, V74, P67
   Vollrath F, 1999, INT J BIOL MACROMOL, V24, P243, DOI 10.1016/S0141-8130(98)00095-6
   Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   Vunjak-Novakovic G, 2005, Orthod Craniofac Res, V8, P209, DOI 10.1111/j.1601-6343.2005.00334.x
   Vunjak-Novakovic G, 2004, ANNU REV BIOMED ENG, V6, P131, DOI 10.1146/annurev.bioeng.6.040803.140037
   Wada MR, 2002, DEVELOPMENT, V129, P2987
   Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504
   Wakitani S, 2002, MICROSC RES TECHNIQ, V58, P14, DOI 10.1002/jemt.10111
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   Wang DA, 2005, TISSUE ENG, V11, P201, DOI 10.1089/ten.2005.11.201
   Wang M, 2004, MACROMOLECULES, V37, P6856, DOI 10.1021/ma048988v
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang YB, 2001, APPL MATH MECH-ENGL, V22, P10, DOI 10.1023/A:1015566715317
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Wang YW, 2004, BIOMATERIALS, V25, P669, DOI 10.1016/S0142-9612(03)00561-1
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wang ZH, 2005, ATOM SPECTROSC, V26, P34
   Weber M, 2002, BIOMATERIALS, V23, P2003, DOI 10.1016/S0142-9612(01)00329-5
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   Winkler S, 2000, J Biotechnol, V74, P85
   Winkler S, 1999, INT J BIOL MACROMOL, V24, P265, DOI 10.1016/S0141-8130(98)00088-9
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Xu XL, 2005, J BIOMED MATER RES B, V75B, P289, DOI 10.1002/jbm.b.30299
   Xu XY, 2003, BIOMATERIALS, V24, P2405, DOI 10.1016/S0142-9612(03)00109-1
   Yang F, 2004, BIOMATERIALS, V25, P1891, DOI 10.1016/j.biomaterials.2003.08.062
   Yang G, 2000, J MEMBRANE SCI, V177, P153, DOI 10.1016/S0376-7388(00)00467-1
   YANNAS IV, 1994, J CELL BIOCHEM, V56, P188, DOI 10.1002/jcb.240560212
   Yeo JH, 2000, BIOL PHARM BULL, V23, P1220
   Yoo MK, 2004, INT J BIOL MACROMOL, V34, P263, DOI 10.1016/j.ijbiomac.2004.06.002
   Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X
   Young HE, 2001, ANAT REC, V264, P51, DOI 10.1002/ar.1128
   Young RG, 1998, J ORTHOPAED RES, V16, P406, DOI 10.1002/jor.1100160403
   ZHU L, 2006, TISSUE ENG      0301
   ZHU L, 2006, TISSUE ENG      0301
NR 270
TC 591
Z9 637
U1 20
U2 393
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD DEC
PY 2006
VL 27
IS 36
BP 6064
EP 6082
DI 10.1016/j.biomaterials.2006.07.008
PG 19
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 106SU
UT WOS:000242121900011
PM 16890988
DA 2018-10-19
ER

PT J
AU Bai, JM
   Ma, T
   Chu, W
   Wang, RZ
   Silva, L
   Michal, C
   Chiao, JC
   Chiao, M
AF Bai, Jiamei
   Ma, Tim
   Chu, Winnie
   Wang, Rizhi
   Silva, Leandro
   Michal, Carl
   Chiao, Jung-Chih
   Chiao, Mu
TI Regenerated spider silk as a new biomaterial for MEMS
SO BIOMEDICAL MICRODEVICES
LA English
DT Article; Proceedings Paper
CT 19th IEEE International Conference on Micro Electro Mechanical Systems
   (MEMS 2006)
CY JAN 22-26, 2006
CL Istanbul, TURKEY
SP IEEE, Robot & Automat Soc
DE regenerated spider silk; biomaterial; MEMS; micro and nano mechanical
   testing; bioMEMS
ID MECHANICAL-PROPERTIES; RAMAN-SPECTROSCOPY; DRAGLINE SILK;
   NANOINDENTATION; SUBSTRATE; SEQUENCE; FILM; C-13; NMR
AB Spider drag-line silk is introduced for the first time as a new biomaterial for Micro-Electro-Mechanical Systems (MEMS). The tasks accomplished in this paper were focused on mechanical characterization of regenerated spider silk under two conditions: (1) spin-coated thin film formed onto a silicon substrate; and (2) formation of a free-standing microbridge (800 x 800 x 40 mu m(3)) obtained by a surface micromachining process. Micromechanical tests using a nano indentation machine showed the spider silk film having an elastic modulus of 7.3 GPa, a loss tangent of 0.044 and an UTS (Ultimate Tensile Strength) of 85.1 MPa.
C1 Univ British Columbia, Dept Mech Engn, Vancouver, BC V6T 1Z4, Canada.
   Univ British Columbia, Sch Occupat & Environm Hyg, Vancouver, BC V5Z 1M9, Canada.
   Univ British Columbia, Dept Met & Mat Engn, Vancouver, BC V5Z 1M9, Canada.
   Univ British Columbia, Dept Phys & Astron, Vancouver, BC V5Z 1M9, Canada.
   Univ Texas, Dept Elect Engn, Arlington, TX 76019 USA.
RP Chiao, M (reprint author), Univ British Columbia, Dept Mech Engn, 6250 Appl Sci Lane, Vancouver, BC V6T 1Z4, Canada.
EM muchiao@mech.ubc.ca
RI Chu, Winnie/F-8449-2014; Michal, Carl/G-5288-2012
OI Chu, Winnie/0000-0003-4962-4132; Michal, Carl/0000-0002-5764-3221
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Chen SH, 2004, ACTA MATER, V52, P1089, DOI 10.1016/j.actamat.2003.10.039
   Fukushima Y, 2000, POLYM BULL, V45, P237, DOI 10.1007/s002890070026
   Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Grayson ACR, 2004, P IEEE, V92, P6, DOI 10.1109/JPROC.2003.820534
   HIBBLER RC, 1999, MECH MAT
   Hijirida DH, 1996, BIOPHYS J, V71, P3442, DOI 10.1016/S0006-3495(96)79539-5
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kojic N, 2004, BIOMACROMOLECULES, V5, P1698, DOI 10.1021/bm034280x
   Kubik S, 2002, ANGEW CHEM INT EDIT, V41, P2721, DOI 10.1002/1521-3773(20020802)41:15<2721::AID-ANIE2721>3.0.CO;2-3
   LI SFY, 1994, J VAC SCI TECHNOL A, V12, P1891, DOI 10.1116/1.578978
   Li XD, 2002, MATER CHARACT, V48, P11
   *MIT, 2003, MIT OP COURS DES MED, pCH8
   *MTS SYST CORP, NAN IND XP
   Saha R, 2002, ACTA MATER, V50, P23, DOI 10.1016/S1359-6454(01)00328-7
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Seidel A, 1998, MACROMOLECULES, V31, P6733, DOI 10.1021/ma9808880
   Seidel A, 2000, MACROMOLECULES, V33, P775, DOI 10.1021/ma990893j
   Shao Z, 1999, POLYMER, V40, P2493, DOI 10.1016/S0032-3861(98)00475-3
   Shao ZZ, 1999, POLYMER, V40, P1799, DOI 10.1016/S0032-3861(98)00266-3
   Shao ZZ, 2003, MACROMOLECULES, V36, P1157, DOI 10.1021/ma0214660
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Stephens JS, 2005, BIOMACROMOLECULES, V6, P1405, DOI 10.1021/bm049296h
   TANG WC, 1990, SENSOR ACTUAT A-PHYS, V21, P328, DOI 10.1016/0924-4247(90)85065-C
   Tsui TY, 1997, MATER RES SOC SYMP P, V473, P57
   WANG R, 2005, MRS P, V874
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Yang ZT, 2000, J AM CHEM SOC, V122, P9019, DOI 10.1021/ja0017099
NR 29
TC 16
Z9 19
U1 1
U2 30
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1387-2176
J9 BIOMED MICRODEVICES
JI Biomed. Microdevices
PD DEC
PY 2006
VL 8
IS 4
BP 317
EP 323
DI 10.1007/s10544-006-9820-x
PG 7
WC Engineering, Biomedical; Nanoscience & Nanotechnology
SC Engineering; Science & Technology - Other Topics
GA 101NQ
UT WOS:000241747900005
PM 16927024
DA 2018-10-19
ER

PT J
AU Stojkovic, SG
   Lim, M
   Burke, D
   Finan, PJ
   Sagar, PM
AF Stojkovic, S. G.
   Lim, M.
   Burke, D.
   Finan, P. J.
   Sagar, P. M.
TI Intra-anal collagen injection for the treatment of faecal incontinence
SO BRITISH JOURNAL OF SURGERY
LA English
DT Article
ID INJECTABLE SILICONE BIOMATERIAL; CROSS-LINKED COLLAGEN; SPHINCTER
   DYSFUNCTION; SENSATION; MANAGEMENT
AB Background: Intra-anal injectable agents have been used to treat faecal incontinence. The aim of this study was to report the experience of a cohort of patients who underwent intra-anal injection of collagen and to determine which patients benefited from the technique.
   Methods: Data, including age, sex, incontinence score, classification of incontinence, baseline resting pressure and vector volume, were collected prospectively for 73 consecutive patients (59 women) undergoing intra-anal collagen injection. Patients were reviewed after treatment and incontinence scores documented. A proportion of patients also underwent repeat anorectal physiological testing 8 weeks after the procedure.
   Results: At a median follow-up of 12 months after the intra-anal injection, 63 per cent of patients had an improved incontinence score and 73 per cent reported an overall improvement in symptoms. Logistic regression showed that older age and idiopathic faecal incontinence were predictors of a successful outcome (P = 0.042 and P = 0.048 respectively).
   Conclusion: Intra-anal collagen injection appears to have a role in the treatment of faecal incontinence. The majority of patients can expect both objective and subjective improvement. The best results are achieved in older patients and in those with idiopathic incontinence.
C1 Gen Infirm, Dept Colorectal Surg, Ctr Digest Dis, Clarendon Wing, Leeds LS1 3EX, W Yorkshire, England.
RP Sagar, PM (reprint author), Gen Infirm, Dept Colorectal Surg, Ctr Digest Dis, Clarendon Wing, B Floor,Great George St, Leeds LS1 3EX, W Yorkshire, England.
EM petersagar@aol.com
CR COOPERMAN L, 1984, J AM ACAD DERMATOL, V10, P638, DOI 10.1016/S0190-9622(84)80271-6
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
   Kleinubing H, 2000, DIS COLON RECTUM, V43, P1572, DOI 10.1007/BF02236741
   Kumar D, 1998, BRIT J SURG, V85, P978
   LUBOWSKI DZ, 1988, BRIT J SURG, V75, P1086, DOI 10.1002/bjs.1800751112
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   MILLER R, 1987, BRIT J SURG, V74, P511, DOI 10.1002/bjs.1800740632
   Reay Jones NH, 2003, BRIT J SURG, V90, P466
   ROE AM, 1986, BRIT J SURG, V73, P310, DOI 10.1002/bjs.1800730421
   ROGERS J, 1988, GUT, V29, P5, DOI 10.1136/gut.29.1.5
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   SHORTLIFFE LMD, 1989, J UROLOGY, V141, P538
   STOJKOVIC S, 2002, COLORECTAL DIS S1, V4, P67
   Stojkovic SG, 2002, DIS COLON RECTUM, V45, P668, DOI 10.1007/s10350-004-6265-2
   SWASH M, 2002, PELVIC FLOOR ITS FUN, P213
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Uitenbroek D. G., 1997, SISA BINOMIAL
   Vaizey CJ, 2005, BRIT J SURG, V92, P521, DOI 10.1002/bjs.4997
NR 21
TC 30
Z9 30
U1 0
U2 1
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0007-1323
J9 BRIT J SURG
JI Br. J. Surg.
PD DEC
PY 2006
VL 93
IS 12
BP 1514
EP 1518
DI 10.1002/bjs.5394
PG 5
WC Surgery
SC Surgery
GA 118RY
UT WOS:000242960600012
PM 17048278
DA 2018-10-19
ER

PT J
AU Kanias, T
   Acker, JP
AF Kanias, Tamir
   Acker, Jason P.
TI Mammalian cell desiccation: Facing the challenges
SO CELL PRESERVATION TECHNOLOGY
LA English
DT Review
ID RED-BLOOD-CELLS; FREEZE-DRIED SPERMATOZOA; INTRACELLULAR TREHALOSE
   IMPROVES; REHYDRATED LYOPHILIZED PLATELETS; FEMTOSECOND LASER-PULSES;
   LIVING CELLS; STEM-CELLS; SACCHAROMYCES-CEREVISIAE; COLLAPSE
   TEMPERATURE; RECONSTITUTED HUMAN
AB The current techniques for the biopreservation of mammalian cells, such as red blood cells, human platelets, sperm cells, and stem cells, rely on hypothermic storage, which has many disadvantages including high cost of maintenance and limited transportation ability. Preservation of biomaterial in the dry state at room temperature is a novel approach to meeting the growing demand for human mammalian cells in regenerative medicine. Presently, many proteins, bacteria, pharmaceutical drugs, and foods are successfully preserved in the dried state. However, mammalian cells are desiccation sensitive and cannot be stabilized in the dried state without the use of biotechnology. Several techniques have been developed to overcome this challenge including the introduction of sugars into the cells. To date there has been encouraging, but limited, success in the development of techniques for the desiccation and dry storage of human platelets and sperm cells. This review summarizes the current state of the preservation of mammalian cells in the dried state, including the major achievements with red blood cells, platelets, stem cells, and spermatozoa.
C1 Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada.
   Canadian Blood Serv, Res & Dev, Edmonton, AB T6G 2R8, Canada.
RP Acker, JP (reprint author), Canadian Blood Serv Bldg,8249-114 St, Edmonton, AB T6G 2R8, Canada.
EM jacker@ualberta.ca
RI Kanias, Tamir/K-2384-2016
OI Kanias, Tamir/0000-0001-6558-0913; Acker, Jason/0000-0002-1445-827X
CR Acker JP, 2004, LIFE IN THE FROZEN STATE, P563, DOI 10.1201/9780203647073.ch20
   ACKER JP, 2002, CELL PRESERV TECHNOL, V1, P129
   Allison SD, 1998, ARCH BIOCHEM BIOPHYS, V358, P171, DOI 10.1006/abbi.1998.0832
   Alpert P, 2005, INTEGR COMP BIOL, V45, P685, DOI 10.1093/icb/45.5.685
   Anchordoquy TJ, 1996, ARCH BIOCHEM BIOPHYS, V332, P231, DOI 10.1006/abbi.1996.0337
   Auh J.-H., 2004, CELL PRESERV TECHNOL, V2, P180
   Bakaltcheva I, 2000, CRYOBIOLOGY, V40, P343, DOI 10.1006/cryo.2000.2257
   Bayley H, 2001, NATURE, V413, P226, DOI 10.1038/35093038
   Benson EE, 2004, LIFE IN THE FROZEN STATE, P205, DOI 10.1201/9780203647073.ch6
   Bhowmick S, 2003, BIOL REPROD, V68, P1779, DOI 10.1095/biolreprod.102.009407
   Bode AP, 2000, TRANSFUS SCI, V22, P99, DOI 10.1016/S0955-3886(00)00028-X
   Bonazzi C, 1996, DRY TECHNOL, V14, P2135, DOI 10.1080/07373939608917199
   Buchanan SS, 2004, STEM CELLS DEV, V13, P295, DOI 10.1089/154732804323099226
   CARPENTER JF, 1987, BIOCHIM BIOPHYS ACTA, V923, P109, DOI 10.1016/0304-4165(87)90133-4
   Cerrutti P, 2000, APPL MICROBIOL BIOT, V54, P575, DOI 10.1007/s002530000428
   CHANG BS, 1993, PHARMACEUT RES, V10, P1478, DOI 10.1023/A:1018979410338
   Chang LQ, 2005, J PHARM SCI-US, V94, P1427, DOI 10.1002/jps.20364
   Chen T, 2001, CRYOBIOLOGY, V43, P168, DOI 10.1006/cryo.2001.2360
   Chua KJ, 2003, BIORESOURCE TECHNOL, V90, P285, DOI 10.1016/S0960-8524(03)00133-0
   Clegg JS, 2005, INTEGR COMP BIOL, V45, P715, DOI 10.1093/icb/45.5.715
   CLEGG JS, 1982, CRYOBIOLOGY, V19, P306, DOI 10.1016/0011-2240(82)90159-6
   Crowe JH, 2001, CRYOBIOLOGY, V43, P89, DOI 10.1006/cryo.2001.2353
   Crowe JH, 2003, CHEM PHYS LIPIDS, V122, P41, DOI 10.1016/S0009-3084(02)00177-9
   Crowe JH, 2005, INTEGR COMP BIOL, V45, P810, DOI 10.1093/icb/45.5.810
   Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73
   Crowe JH, 2000, NAT BIOTECHNOL, V18, P145, DOI 10.1038/72580
   CROWE JH, 1990, CRYOBIOLOGY, V27, P219, DOI 10.1016/0011-2240(90)90023-W
   CROWE JH, 1982, CRYOBIOLOGY, V19, P317, DOI 10.1016/0011-2240(82)90160-2
   CROWE JH, 1988, BIOCHIM BIOPHYS ACTA, V947, P367, DOI 10.1016/0304-4157(88)90015-9
   Crowe LM, 1996, BIOPHYS J, V71, P2087, DOI 10.1016/S0006-3495(96)79407-9
   CULLIS PR, 1978, NATURE, V271, P672, DOI 10.1038/271672a0
   de Castro AG, 2000, NAT BIOTECHNOL, V18, P473, DOI 10.1038/75237
   de Castro AG, 2000, FEBS LETT, V487, P199
   De Paoli P, 2005, FEMS MICROBIOL REV, V29, P897, DOI 10.1016/j.femsre.2005.01.005
   Duddu SP, 1997, PHARMACEUT RES, V14, P591, DOI 10.1023/A:1012144810067
   ELEUTHERIO ECA, 1993, BIOCHIM BIOPHYS ACTA, V1156, P263, DOI 10.1016/0304-4165(93)90040-F
   Elliott GD, 2006, CRYOBIOLOGY, V52, P114, DOI 10.1016/j.cryobiol.2005.10.009
   Elster J, 2004, LIFE IN THE FROZEN STATE, P111, DOI 10.1201/9780203647073.ch3
   Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608
   Fischer TH, 2004, MICROSC RES TECHNIQ, V65, P62, DOI 10.1002/jemt.20106
   Fischer TH, 2000, BRIT J HAEMATOL, V111, P167, DOI 10.1046/j.1365-2141.2000.02343.x
   FISCHER TH, 2002, THROMBUS FORMATION R, V7, P359
   Fonseca F, 2004, BIOTECHNOL PROGR, V20, P229, DOI 10.1021/bp034136n
   Franks F, 1998, EUR J PHARM BIOPHARM, V45, P221, DOI 10.1016/S0939-6411(98)00004-6
   FRANKS F, 1989, PROCESS BIOCHEM, V64, P3
   Fuller BJ, 2004, CRYOLETTERS, V25, P375
   Gao D, 2000, ILAR J, V41, P187
   Gardiner GE, 2000, APPL ENVIRON MICROB, V66, P2605, DOI 10.1128/AEM.66.6.2605-2612.2000
   GOODRICH RP, 1992, P NATL ACAD SCI USA, V89, P967, DOI 10.1073/pnas.89.3.967
   GOODRICH RP, 1993, ADV LOW TEMPERATURE, V2, P53
   Gordon SL, 2001, CRYOBIOLOGY, V43, P182, DOI 10.1006/cryo.2001.2361
   GRIFFITHS JB, 1978, CRYOBIOLOGY, V15, P517, DOI 10.1016/0011-2240(78)90073-1
   Guo N, 2000, NAT BIOTECHNOL, V18, P168, DOI 10.1038/72616
   Han Y, 2005, CRYOBIOLOGY, V51, P152, DOI 10.1016/j.cyrobiol.2005.06.002
   Hand SC, 1996, ANNU REV PHYSIOL, V58, P539, DOI 10.1146/annurev.ph.58.030196.002543
   Hess JR, 2004, TRANSFUSION MED, V14, P1, DOI 10.1111/j.0958-7578.2004.00472.x
   Hirabayashi M, 2005, ZYGOTE, V13, P79, DOI 10.1017/S096719940500300X
   Jamil K., 2005, CELL PRESERV TECHNOL, V3, P244, DOI DOI 10.1089/CPT.2005.3.244
   Janik M, 2000, CRYOBIOLOGY, V41, P25, DOI 10.1006/cryo.2000.2261
   Kawase Y, 2005, BIOL REPROD, V72, P568, DOI 10.1095/biolreprod.104.035279
   Keskintepe L, 2002, BIOL REPROD, V67, P409, DOI 10.1095/biolreprod67.2.409
   Kett VL, 2005, CURR PHARM BIOTECHNO, V6, P239, DOI 10.2174/1389201054022850
   Kirchmaier A L, 2001, Methods Mol Biol, V174, P137
   KLEIN E, 1956, J PEDIATR-US, V49, P517, DOI 10.1016/S0022-3476(56)80138-8
   Kohli V, 2005, BIOTECHNOL BIOENG, V92, P889, DOI 10.1002/bit.20689
   Kohli V, 2005, LASER SURG MED, V37, P227, DOI 10.1002/lsm.20220
   KOSTER KL, 1991, PLANT PHYSIOL, V96, P302, DOI 10.1104/pp.96.1.302
   Kramer M, 2002, J PHARM SCI, V91, P433, DOI 10.1002/jps.10035
   Krokida MK, 1998, J FOOD ENG, V35, P369, DOI 10.1016/S0260-8774(98)00031-4
   Kwon IK, 2004, BIOL REPROD, V71, P1430, DOI 10.1095/biolreprod.104.031260
   LECAK J, 2005, CRYOBIOLOGY, V51, P393
   LECAK J, 2005, CRYOBIOLOGY, V51, P391
   Lee Geoffrey, 2002, Pharm Biotechnol, V13, P135
   Li Jun, 2005, Cryo Letters, V26, P193
   Liao YH, 2002, PHARM RES-DORDR, V19, P1847, DOI 10.1023/A:1021445608807
   Liu JL, 2004, BIOL REPROD, V70, P1776, DOI 10.1095/biolreprod.103.025957
   Liu QC, 2005, BIOCHEM BIOPH RES CO, V328, P824, DOI 10.1016/j.bbrc.2005.01.034
   Liu XH, 2005, BBA-BIOMEMBRANES, V1717, P21, DOI 10.1016/j.bbamem.2005.09.012
   Lovell-Badge R, 1998, NAT BIOTECHNOL, V16, P618, DOI 10.1038/nbt0798-618
   LOVELOCK JE, 1959, NATURE, V183, P1394, DOI 10.1038/1831394a0
   LOVELOCK JE, 1953, BIOCHIM BIOPHYS ACTA, V10, P414, DOI 10.1016/0006-3002(53)90273-X
   Mackenzie A P, 1966, Bull Parenter Drug Assoc, V20, P101
   MACKENZIE AP, 1971, CRYOBIOLOGY, V8, P384, DOI 10.1016/0011-2240(71)90161-1
   MACKENZIE AP, 1977, DEV BIOL STAND, V36, P51
   MADIN KAC, 1975, J EXP ZOOL, V193, P335, DOI 10.1002/jez.1401930309
   MAKINO S, 1991, BONE MARROW TRANSPL, V8, P239
   MANSELL JL, 1983, CRYOBIOLOGY, V20, P591, DOI 10.1016/0011-2240(83)90048-2
   Matejtschuk P, 2005, CRYOLETTERS, V26, P223
   MAY JC, 1982, J BIOL STAND, V10, P249, DOI 10.1016/S0092-1157(82)80026-7
   MAY JC, 1989, CRYOBIOLOGY, V26, P277, DOI 10.1016/0011-2240(89)90023-0
   MAZUR P, 1984, AM J PHYSIOL, V247, pC125
   McGinnis LK, 2005, BIOL REPROD, V73, P627, DOI 10.1095/biolreprod.105.042291
   Menze MA, 2005, AM J PHYSIOL-REG I, V288, pR501, DOI 10.1152/ajpregu.00490.2004
   Meryman H T, 1976, Dev Biol Stand, V36, P29
   MERYMAN HT, 1960, ANN NY ACAD SCI, V85, P729, DOI 10.1111/j.1749-6632.1960.tb49993.x
   MERYMAN HT, 1974, ANNU REV BIOPHYS BIO, V3, P341, DOI 10.1146/annurev.bb.03.060174.002013
   MERYMAN HT, 1971, CRYOBIOLOGY, V8, P173, DOI 10.1016/0011-2240(71)90024-1
   MERYMAN HT, 1966, CRYOBIOLOGY, P609
   Meryman HT, 1970, FROZEN CELL, P51
   Mir LM, 2001, BIOELECTROCHEMISTRY, V53, P1, DOI 10.1016/S0302-4598(00)00112-4
   MITTAL M, 2006, IN PRESS BIOTECHNOL
   MULDREW K, 1994, BIOPHYS J, V66, P532, DOI 10.1016/S0006-3495(94)80806-9
   Oliver A.E., 2004, CELL PRESERV TECHNOL, V2, P35, DOI DOI 10.1089/153834404322708745
   Oliver AE, 2001, CRYOBIOLOGY, V43, P151, DOI 10.1006/cryo.2001.2359
   Oliver MJ, 2000, PLANT ECOL, V151, P85, DOI 10.1023/A:1026550808557
   Pearce RS, 2004, LIFE IN THE FROZEN STATE, P171, DOI 10.1201/9780203647073.ch5
   Pegg DE, 2002, SEMIN REPROD MED, V20, P5, DOI 10.1055/s-2002-23515
   PIKAL MJ, 1990, INT J PHARM, V62, P165, DOI 10.1016/0378-5173(90)90231-R
   POLGE C, 1949, NATURE, V164, P666, DOI 10.1038/164666a0
   Ponder M, 2004, LIFE IN THE FROZEN STATE, P151, DOI 10.1201/9780203647073.ch4
   POTTS M, 1994, MICROBIOL REV, V58, P755
   Potts M, 2005, INTEGR COMP BIOL, V45, P800, DOI 10.1093/icb/45.5.800
   Puhlev I, 2001, CRYOBIOLOGY, V42, P207, DOI 10.1006/cryo.2001.2324
   READ MS, 1995, P NATL ACAD SCI USA, V92, P397, DOI 10.1073/pnas.92.2.397
   Rindler V, 1999, CRYOBIOLOGY, V38, P2, DOI 10.1006/cryo.1998.2143
   Rindler V, 1999, CRYOBIOLOGY, V39, P228, DOI 10.1006/cryo.1999.2204
   Rothschild LJ, 2001, NATURE, V409, P1092, DOI 10.1038/35059215
   Royere D, 1996, HUM REPROD UPDATE, V2, P553, DOI 10.1093/humupd/2.6.553
   Satpathy GR, 2004, CRYOBIOLOGY, V49, P123, DOI 10.1016/j.cryobiol.2004.06.001
   Scott KL, 2005, TRANSFUS MED REV, V19, P127, DOI 10.1016/j.tmrv.2004.11.004
   Shamblin SL, 1999, J PHYS CHEM B, V103, P4113, DOI 10.1021/jp983964+
   SHERMAN JK, 1957, AM J PHYSIOL, V190, P281
   Singer MA, 1998, TRENDS BIOTECHNOL, V16, P460, DOI 10.1016/S0167-7799(98)01251-7
   SOWEMIMOCOKER SO, 1993, TRANSFUSION, V33, P322, DOI 10.1046/j.1537-2995.1993.33493242640.x
   Spieles G, 1996, CRYO-LETT, V17, P43
   Steponkus P. L., 1981, Effects of low temperatures on biological membranes [Morris, G.J.; Clarke, A. (Editors)], P307
   Storey KB, 2004, LIFE IN THE FROZEN STATE, P243, DOI 10.1201/9780203647073.ch7
   Stupnikova I, 2006, PLANT PHYSIOL, V140, P326
   Tang MK, 2006, TRANSFUSION, V46, P1029, DOI 10.1111/j.1537-2995.2006.00838.x
   Tang XL, 2005, PHARM RES, V22, P685, DOI 10.1007/s11095-005-2505-y
   Tang XL, 2004, PHARM RES, V21, P191, DOI 10.1023/B:PHAM.0000016234.73023.75
   TIMASHEFF SN, 1982, CONTROL PROTEIN STAB, P70
   TOROK Z, 2005, CELL PRESERV TECHNOL, V3, P96, DOI DOI 10.1089/CPT.2005.3.96]
   TOWNS JK, 1995, J CHROMATOGR A, V705, P115, DOI 10.1016/0021-9673(94)01257-F
   TOWNSEND MW, 1990, J PHARM SCI, V79, P1083, DOI 10.1002/jps.2600791209
   TULLIS JL, 1959, BLOOD, V14, P456
   VAGENAS GK, 1992, FLUID PHASE EQUILIBR, V78, P191, DOI 10.1016/0378-3812(92)87034-K
   Valeri CR, 2005, VOX SANG, V88, P122, DOI 10.1111/j.1423-0410.2005.00592.x
   Valeri CR, 2004, TRANSFUSION, V44, P1505, DOI 10.1111/j.1537-2995.2004.04135.x
   Verdonck E, 1999, INT J PHARM, V192, P3, DOI 10.1016/S0378-5173(99)00267-7
   Wakayama T, 1998, NAT BIOTECHNOL, V16, P639, DOI 10.1038/nbt0798-639
   Wang W, 2000, INT J PHARMACEUT, V203, P1, DOI 10.1016/S0378-5173(00)00423-3
   Weinstein R, 1995, TRANSFUS CLIN BIOL, V2, P427, DOI 10.1016/S1246-7820(05)80067-9
   Wharton DA, 2003, J COMP PHYSIOL B, V173, P621, DOI 10.1007/s00360-003-0378-0
   Wolfe J, 1999, CRYOBIOLOGY, V39, P103, DOI 10.1006/cryo.1999.2195
   Wolkers WF, 2002, MOL MEMBR BIOL, V19, P201, DOI 10.1080/09687680210152582
   Wolkers WF, 2002, COMP BIOCHEM PHYS A, V131, P535, DOI 10.1016/S1095-6433(01)00505-0
   Wolkers WF, 2001, CRYOBIOLOGY, V42, P79, DOI 10.1006/cryo.2001.2306
   WOLKERS WF, 2002, CELL PRESERV TECHNOL, V1, P175, DOI DOI 10.1089/153834402765035617
   WOMERSLEY C, 1986, CRYOBIOLOGY, V23, P245, DOI 10.1016/0011-2240(86)90050-7
   WONG TK, 1982, BIOCHEM BIOPH RES CO, V107, P584, DOI 10.1016/0006-291X(82)91531-5
   Xiao HH, 2004, CRYOLETTERS, V25, P111
   YU JP, 2004, CELL PRESERV TECHNOL, V2, P270
   ZADEOPPEN AM, 1968, ACTA PHYSIOL SCAND, V73, P341, DOI 10.1111/j.1748-1716.1968.tb04113.x
NR 154
TC 29
Z9 29
U1 0
U2 24
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1538-344X
J9 CELL PRESERV TECHNOL
JI Cell Preserv. Technol.
PD WIN
PY 2006
VL 4
IS 4
BP 253
EP 277
DI 10.1089/cpt.2006.9996
PG 25
WC Cell Biology; Medical Laboratory Technology
SC Cell Biology; Medical Laboratory Technology
GA 142BI
UT WOS:000244623200004
DA 2018-10-19
ER

PT J
AU Ensenat-Waser, R
   Santana, A
   Paredes, B
   Zenke, M
   Reig, JA
   Roche, E
AF Ensenat-Waser, Roberto
   Santana, Alfredo
   Paredes, Beatriz
   Zenke, Martin
   Reig, Juan Antonio
   Roche, Enrique
TI Embryonic stem cell processing in obtaining insulin-producing cells: A
   technical review
SO CELL PRESERVATION TECHNOLOGY
LA English
DT Review
ID IN-VITRO DIFFERENTIATION; PANCREATIC BETA-CELLS; SECRETING CELLS; ISLET
   TRANSPLANTATION; DEFINITIVE ENDODERM; ENDOCRINE PANCREAS;
   DIABETES-MELLITUS; TRANSCRIPTION; PROINSULIN; EXPRESSION
AB Diabetes mellitus derives from the absence of insulin hormone in the organism, usually due to the destruction of insulin-producing pancreatic beta-cells either by immune attack or glucolipotoxic mechanisms. Insulin is a key hormone in controlling nutrient (glucose and fatty acids) homeostasis, as well as modulating both their uptake and metabolism by peripheral target tissues, such as skeletal muscle and adipose tissue. Insulin injection can partially mimic endogenous hormone function, although it does not avoid the appearance of secondary complications such as retinopathy, nephropathy, neuropathy, and cardiovascular disorders. Implantation of de novo insulin-producing cells in the organism could be a long-term solution in the treatment of the disease, restoring the lost function. Transplantation of highly pure isolated islets (pancreatic cell clusters where beta-cells are located) from cadaveric donors is a possibility, although there are still many problems to resolve, such as immune rejection, low isolation yields, implant survival, and biomaterial scarcity. Altogether, this suggests that alternative sources for insulin-producing cells have to be considered, such as embryonic and adult stem cells. In this context, embryonic stem (ES) cells offer an interesting alternative due to two main properties: self-renewal capability and high differentiation potential. However, during the first culture phases, there are many factors that may affect the amount of differentiated insulin-positive cells obtained following certain protocols. Taking into account those early factors will help to improve present working methods and, consequently, the design of a definite protocol for cell therapy. This review will summarize key practical issues of generating insulin-secreting cells from ES cells based on the experience accumulated by different laboratories, including ours, in this area.
C1 Univ Miguel Hernandez, Inst Bioingn, Alicante 03202, Spain.
   Childhood Hosp Canary Isl, Genet & Cytogenet Unit, Las Palmas Gran Canaria, Spain.
   Univ Aachen, Sch Med, Rhein Westfal TH Aachen, Inst Biomed Engn Cell Biol, D-5100 Aachen, Germany.
RP Roche, E (reprint author), Univ Miguel Hernandez, Inst Bioingn, Avda Univ SN, Alicante 03202, Spain.
EM eroche@umh.es
CR Baharvand Hossein, 2006, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V6, P219, DOI 10.2174/187152206776359920
   Bai L, 2005, J ENDOCRINOL, V186, P343, DOI 10.1677/joe.1.06078
   Blyszczuk P, 2003, P NATL ACAD SCI USA, V100, P998, DOI 10.1073/pnas.0237371100
   Chakrabarti SK, 2003, TRENDS ENDOCRIN MET, V14, P78, DOI 10.1016/S1043-2760(02)00039-5
   D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163
   DEFRONZO RA, 2004, INT TXB DIABETES MEL
   *DIAB CONTR COMPL, 1993, NEW ENGL J MED, V329, P977
   Ensenat-Waser R, 2006, IN VITRO CELL DEV-AN, V42, P115
   Hansson M, 2004, DIABETES, V53, P2603, DOI 10.2337/diabetes.53.10.2603
   Hernandez-Sanchez C, 2006, DIABETOLOGIA, V49, P1142, DOI 10.1007/s00125-006-0232-5
   Hernandez-Sanchez C, 2002, DIABETES, V51, P770, DOI 10.2337/diabetes.51.3.770
   Hori Y, 2002, P NATL ACAD SCI USA, V99, P16105, DOI 10.1073/pnas.252618999
   Hori Y, 2005, PLOS MED, V2, P347, DOI 10.1371/journal.pmed.0020103
   Ku HT, 2004, STEM CELLS, V22, P1205, DOI 10.1634/stemcells.2004-0027
   Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044
   Leon-Quinto T, 2004, DIABETOLOGIA, V47, P1442, DOI 10.1007/s00125-004-1458-8
   Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866
   McKinnon CM, 2001, DIABETOLOGIA, V44, P1203, DOI 10.1007/s001250100628
   Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y
   Milene HM, 2005, BIOCHEM BIOPH RES CO, V328, P399, DOI 10.1016/j.bbrc.2004.12.183
   Miyazaki S, 2004, DIABETES, V53, P1030, DOI 10.2337/diabetes.53.4.1030
   Moritoh Y, 2003, DIABETES, V52, P1163, DOI 10.2337/diabetes.52.5.1163
   Perez-Villamil B, 1999, ENDOCRINOLOGY, V140, P3857, DOI 10.1210/en.140.8.3857
   Rajagopal J, 2003, SCIENCE, V299, P363
   Richards M, 2002, NAT BIOTECHNOL, V20, P933, DOI 10.1038/nbt726
   Roche E, 2005, TRANSPL IMMUNOL, V15, P113, DOI 10.1016/j.trim.2005.09.008
   Roche E, 2005, FASEB J, V19, P1341, DOI 10.1096/fj.04-3024fje
   Roche E, 2005, PANMINERVA MED, V47, P39
   Roche E, 2004, CELL BIOCHEM BIOPHYS, P113
   Roche E, 2003, MED BIOL ENG COMPUT, V41, P384, DOI 10.1007/BF02348079
   Roche E, 2003, CYTOTECHNOLOGY, V41, P145, DOI 10.1023/A:1024878807264
   ROCHE E, 2007, IN PRESS METHODS MOL
   Roche E, 2006, BIOORGAN MED CHEM, V14, P6466, DOI 10.1016/j.bmc.2006.06.015
   Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   Shi Y, 2005, STEM CELLS, V23, P656, DOI 10.1634/stemcells.2004-0241
   Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435
   Soria B, 2001, DIFFERENTIATION, V68, P205, DOI 10.1046/j.1432-0436.2001.680408.x
   Soria B, 2000, DIABETES, V49, P157, DOI 10.2337/diabetes.49.2.157
   Vaca P, 2006, STEM CELLS, V24, P258, DOI 10.1634/stemcells.2005-0058
   Wilson CA, 1998, J VIROL, V72, P3082
   Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167
   Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780
NR 43
TC 2
Z9 2
U1 3
U2 4
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1538-344X
J9 CELL PRESERV TECHNOL
JI Cell Preserv. Technol.
PD WIN
PY 2006
VL 4
IS 4
BP 278
EP 289
DI 10.1089/cpt.2006.9997
PG 12
WC Cell Biology; Medical Laboratory Technology
SC Cell Biology; Medical Laboratory Technology
GA 142BI
UT WOS:000244623200005
DA 2018-10-19
ER

PT J
AU Wiegand, C
   Elsner, P
   Hipler, UC
   Klemm, D
AF Wiegand, Cornelia
   Elsner, Peter
   Hipler, Uta-Christina
   Klemm, Dieter
TI Protease and ROS activities influenced by a composite of bacterial
   cellulose and collagen type I in vitro
SO CELLULOSE
LA English
DT Article
DE bacterial cellulose; collagen; gluconacetobacter xylinus; matrix
   metalloprotease; PMN elastase; reactive oxygen species
ID CHRONIC WOUNDS; MATRIX; ENVIRONMENT; DRESSINGS; MECHANISM; ELASTASE;
   ULCERS
AB The application of bacterial cellulose as a dressing for chronic and burn wounds has been described as beneficial for healing. However, this study and other tests have shown that bacterial cellulose has no significant influence on the biochemical state of chronic wounds. Such wounds persist in the inflammatory phase of the normal healing process and fail to heal. Exudates from non-healing wounds show elevated levels of proteolytic enzymes, cytokines and reactive oxygen species (ROS), leading to a reduced concentration of growth factors and proteinase inhibitors and to a degradation of tissue and severe damage. Thus, the reduction of protein degrading enzymes and proinflammatory interleukins as well as scavenging of ROS appears to be a suitable way to support the healing process. The aim of the present study was to improve the positive features of bacterial cellulose as wound dressing by incorporation of collagen type I into the cellulose pellicle. The research focussed on the possible in situ formation of a composite of bacterial cellulose and collagen type I. This biomaterial is able to reduce the amount of selected proteases and interleukins significantly and possesses a distinct antioxidant capacity as well.
C1 Univ Jena, Dept Dermatol, D-07743 Jena, Germany.
RP Wiegand, C (reprint author), Univ Jena, Dept Dermatol, Erfurterstr 35, D-07743 Jena, Germany.
EM C.Wiegand@med.uni-jena.de
CR Barrick B, 1999, WOUND REPAIR REGEN, V7, P410, DOI 10.1046/j.1524-475X.1999.00410.x
   BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620
   BOEKENKAMP D, 2002, Patent No. 10064314
   BORZANI W, 1995, BIOTECHNOL LETT, V17, P1271, DOI 10.1007/BF00128400
   Brown A. J., 1886, J CHEM SOC, V49, P432, DOI DOI 10.1039/CT8864900432
   Cullen B, 2002, WOUND REPAIR REGEN, V10, P16, DOI 10.1046/j.1524-475X.2002.10703.x
   Dobb M. G., 1998, Patent No. [GB 2.314.856, 2314856]
   FONTANA JD, 1990, APPL BIOCHEM BIOTECH, V24-5, P253, DOI 10.1007/BF02920250
   Frankenfeld K, 2001, Procedure for the production of specific molded shapes or layers from bacterial cellulose, Patent No. [DE 10022751 A1 CAN 135:256211, 10022751]
   Friess W, 1998, EUR J PHARM BIOPHARM, V45, P113, DOI 10.1016/S0939-6411(98)00017-4
   Herold S, 2001, CHIMIA, V55, P870
   Herrick S, 1997, LAB INVEST, V77, P281
   Jonas R, 1998, POLYM DEGRAD STABIL, V59, P101, DOI 10.1016/S0141-3910(97)00197-3
   Koehler KP, 2003, Microbial cellulose wound dressing for treating chronic wounds patent, Patent No. [EP 1356831 A1, 1356831]
   Krystynowicz A., 2000, Mededelingen Faculteit Landbouwkundige en Toegepaste Biologische Wetenschappen Universiteit Gent, V65, P213
   Mast Bruce A., 1996, Wound Repair and Regeneration, V4, P411, DOI 10.1046/j.1524-475X.1996.40404.x
   Moseley R, 2003, BIOMATERIALS, V24, P1549, DOI 10.1016/S0142-9612(02)00540-9
   Nwomeh BC, 1998, CLIN PLAST SURG, V25, P341
   Ovington L, 2002, WOUNDS, V14, P3
   REBELLO C, 1987, Revista Brasileira de Cirurgia, V77, P407
   Ring DF, 1986, USA, patent, Patent No. [US 4588400 A, 4588400]
   Rojkind M, 2002, CELL MOL LIFE SCI, V59, P1872, DOI 10.1007/PL00012511
   Schonfelder U, 2005, BIOMATERIALS, V26, P6664, DOI 10.1016/j.biomaterials.2005.04.030
   SCHRAMM M, 1954, J GEN MICROBIOL, V11, P123, DOI 10.1099/00221287-11-1-123
   Schultz GS, 1998, WOUNDS, V10, p1F
   Serafica G, 2002, APPL MICROBIOL BIOT, V58, P756, DOI 10.1007/s00253-002-0978-8
   Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x
   Walker M, 2003, BIOMATERIALS, V24, P883, DOI 10.1016/S0142-9612(02)00414-3
   Waring MJ, 2001, BIOMATERIALS, V22, P903, DOI 10.1016/S0142-9612(00)00254-4
   Yager DR, 1999, WOUND REPAIR REGEN, V7, P433, DOI 10.1046/j.1524-475X.1999.00433.x
   Yamanaka S, 1990, Production of hollow cellulose produced by microorganisms for artificial blood vessels, Patent No. [0396344, EP 0396344, CAN 114:235093]
NR 31
TC 47
Z9 49
U1 2
U2 23
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0969-0239
J9 CELLULOSE
JI Cellulose
PD DEC
PY 2006
VL 13
IS 6
BP 689
EP 696
DI 10.1007/s10570-006-9073-0
PG 8
WC Materials Science, Paper & Wood; Materials Science, Textiles; Polymer
   Science
SC Materials Science; Polymer Science
GA 089RD
UT WOS:000240897400009
DA 2018-10-19
ER

PT J
AU Dufrene, YF
AF Dufrene, Yves F.
TI Nanoscale exploration of microbial surfaces using the atomic force
   microscope
SO FUTURE MICROBIOLOGY
LA English
DT Review
DE adhesion; atomic force microscopy; cell surfaces; elasticity; force
   spectroscopy; imaging; membrane proteins; molecular recognition; single
   molecule; ultrastructure
ID PSEUDOMONAS-PUTIDA KT2442; LACTIC-ACID BACTERIA; ESCHERICHIA-COLI;
   SINGLE-MOLECULE; STAPHYLOCOCCUS-AUREUS; CELL-WALL;
   CONFORMATIONAL-CHANGE; ELECTRON-MICROSCOPY; UNFOLDING PATHWAYS;
   PERIPLASMIC SPACE
AB Atomic force microscopy (AFM) has recently opened a variety of novel possibilities for imaging and manipulating microbial surfaces in their native environment. While AFM imaging offers a means to visualize surface structures at high resolution and in physiological conditions, AFM force spectroscopy enables researchers to probe a variety of properties, including the unfolding pathways of single-membrane proteins, the elasticity of cell walls and surface macromolecules, and the molecular forces responsible for cell-cell and cell-solid interactions. These nanoscale analyses enable us to answer a number of questions that were difficult to address previously, such as: how does the surface architecture of microbes change as they grow or interact with antibiotics; what is the force required to unfold and extract a single membrane protein; and what are the molecular forces driving the interaction between a pathogen and a host or biomaterial surface? This review will expand on these issues.
C1 Univ Catholique Louvain, Unite Chim Interfaces Nanobio Team, B-1348 Louvain, Belgium.
RP Dufrene, YF (reprint author), Univ Catholique Louvain, Unite Chim Interfaces Nanobio Team, Croix Sud 2-18, B-1348 Louvain, Belgium.
EM dufrene@cifa.udac.be
OI Dufrene, Yves/0000-0002-7289-4248
CR Abu-Lail NI, 2006, COLLOID SURFACE B, V51, P62, DOI 10.1016/j.colsurfb.2006.05.009
   Abu-Lail NI, 2002, LANGMUIR, V18, P4071, DOI 10.1021/la015695b
   Ahimou FO, 2003, YEAST, V20, P25, DOI 10.1002/yea.923
   Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898
   Bahatyrova S, 2004, NATURE, V430, P1058, DOI 10.1038/nature02823
   Beech IB, 2002, COLLOID SURFACE B, V23, P231, DOI 10.1016/S0927-7765(01)00233-8
   Bell CH, 2005, ENVIRON ENG SCI, V22, P629, DOI 10.1089/ees.2005.22.629
   Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000
   BEVERIDGE TJ, 1991, MICROBIOL REV, V55, P684
   Beveridge TJ, 1999, J BACTERIOL, V181, P4725
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Bowen WR, 2002, BIOTECHNOL BIOENG, V79, P170, DOI 10.1002/bit.10321
   Bowen WR, 2001, J COLLOID INTERF SCI, V237, P54, DOI 10.1006/jcis.2001.7437
   Boyle-Vavra S, 2000, ANTIMICROB AGENTS CH, V44, P3456, DOI 10.1128/AAC.44.12.3456-3460.2000
   Braga PC, 1998, ANTIMICROB AGENTS CH, V42, P18, DOI 10.1128/AAC.42.1.18
   Braga PC, 2000, CHEMOTHERAPY, V46, P15, DOI 10.1159/000007251
   Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003
   Chada VGR, 2003, J BACTERIOL, V185, P6255, DOI 10.1128/JB.185.21.6255-6261.2003
   Crawford SA, 2001, J PHYCOL, V37, P543, DOI 10.1046/j.1529-8817.2001.037004543.x
   DOKRYCZ MJ, 2003, ULTRAMICROSCOPY, V97, P209
   Dufrene YF, 1999, J BACTERIOL, V181, P5350
   Dufrene YF, 2004, NAT REV MICROBIOL, V2, P451, DOI 10.1038/nrmicro905
   Dupres V, 2005, NAT METHODS, V2, P515, DOI 10.1038/NMETH769
   Emerson RJ, 2004, APPL ENVIRON MICROB, V70, P6012, DOI 10.1128/AEM.70.10.6012-6022.2004
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   Gaboriaud F, 2005, J BACTERIOL, V187, P3864, DOI 10.1128/JB.187.11.3864-3868.2005
   Gyorvary ES, 2003, J MICROSC-OXFORD, V212, P300, DOI 10.1111/j.1365-2818.2003.01270.x
   Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871
   Janovjak H, 2006, NEUROBIOL AGING, V27, P546, DOI 10.1016/j.neurobiolaging.2005.03.031
   Janovjak H, 2003, EMBO J, V22, P5220, DOI 10.1093/emboj/cdg509
   Jena B. P., 2002, METHODS CELL BIOL, V68
   Kedrov A, 2004, J MOL BIOL, V340, P1143, DOI 10.1016/j.jmb.2004.05.026
   Kienberger F, 2005, STRUCTURE, V13, P1247, DOI 10.1016/j.str.2005.06.012
   Liu YT, 2006, BIOTECHNOL BIOENG, V93, P297, DOI 10.1002/bit.20675
   Lower SK, 2001, SCIENCE, V292, P1360, DOI 10.1126/science.1059567
   Ma H, 2005, MICROBIOL-SGM, V151, P3679, DOI 10.1099/mic.0.28328-0
   Malkin AJ, 2003, J VIROL, V77, P6332, DOI 10.1128/JVI.77.11.6332-6340.2003
   Matias VRF, 2006, J BACTERIOL, V188, P1011, DOI 10.1128/JB.188.3.1011-1021.2006
   Matias VRF, 2005, MOL MICROBIOL, V56, P240, DOI 10.1111/j.1365-2958.2005.04535.x
   Morris VJ, 1999, ATOMIC FORCE MICROSC
   Muller DJ, 2006, CURR OPIN STRUC BIOL, V16, P489, DOI 10.1016/j.sbi.2006.06.001
   Muller DJ, 1999, P NATL ACAD SCI USA, V96, P13170, DOI 10.1073/pnas.96.23.13170
   Muller DJ, 1996, J BACTERIOL, V178, P3025
   MULLER DJ, 1995, J MOL BIOL, V249, P239, DOI 10.1006/jmbi.1995.0292
   MULLER DJ, 1995, BIOPHYS J, V68, P1681
   Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359
   Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143
   Plomp M, 2005, BIOPHYS J, V88, P603, DOI 10.1529/biophysj.104.049312
   Sapra KT, 2006, J MOL BIOL, V355, P640, DOI 10.1016/j.jmb.2005.10.080
   SCHABERT FA, 1995, SCIENCE, V268, P92, DOI 10.1126/science.7701347
   Schaer-Zammaretti P, 2003, ULTRAMICROSCOPY, V97, P199, DOI 10.1016/S0304-3991(03)00044-5
   Schar-Zammaretti P, 2003, BIOPHYS J, V85, P4076, DOI 10.1016/S0006-3495(03)74820-6
   Scheuring S, 2006, J MOL BIOL, V358, P83, DOI 10.1016/j.jmb.2006.01.085
   Scheuring S, 2005, BBA-BIOMEMBRANES, V1712, P109, DOI 10.1016/j.bbamem.2005.04.005
   Scheuring S, 2005, SCIENCE, V309, P484, DOI 10.1126/science.1110879
   Scheuring S, 2004, EMBO J, V23, P4127, DOI 10.1038/sj.emboj.7600429
   Scheuring S, 2005, J BIOL CHEM, V280, P1426, DOI 10.1074/jbc.M411334200
   Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100
   Scheuring S, 1999, EMBO J, V18, P4981, DOI 10.1093/emboj/18.18.4981
   Touhami A, 2006, J BACTERIOL, V188, P370, DOI 10.1128/JB.188.2.370-377.2006
   Touhami A, 2004, J BACTERIOL, V186, P3286, DOI 10.1128/JB.186.11.3286-3295.2004
   Touhami A, 2003, MICROBIOL-SGM, V149, P2873, DOI 10.1099/mic.0.26431-0
   Touhami A, 2003, LANGMUIR, V19, P4539, DOI 10.1021/la034136x
   Ubbink J, 2005, MICRON, V36, P293, DOI 10.1016/j.micron.2004.11.005
   Vadillo-Rodriguez V, 2004, MICROBIOL-SGM, V150, P1015, DOI 10.1099/mic.0.26828-0
   van der Aa BC, 2001, LANGMUIR, V17, P3116, DOI 10.1021/la001573s
   Verbelen C, 2006, FEMS MICROBIOL LETT, V264, P192, DOI 10.1111/j.1574-6968.2006.00443.x
   Xu W, 1996, J BACTERIOL, V178, P3106, DOI 10.1128/jb.178.11.3106-3112.1996
   Yao X, 2002, COLLOID SURFACE B, V23, P213, DOI 10.1016/S0927-7765(01)00249-1
NR 69
TC 8
Z9 8
U1 0
U2 11
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0913
J9 FUTURE MICROBIOL
JI Future Microbiol.
PD DEC
PY 2006
VL 1
IS 4
BP 387
EP 396
DI 10.2217/17460913.1.4.387
PG 10
WC Microbiology
SC Microbiology
GA 205LY
UT WOS:000249116600012
PM 17661630
DA 2018-10-19
ER

PT J
AU Kenefick, NJ
   Vaizey, CJ
   Malouf, AJ
   Norton, CS
   Marshall, M
   Kamm, MA
AF Kenefick, N. J.
   Vaizey, C. J.
   Malouf, A. J.
   Norton, C. S.
   Marshall, M.
   Kamm, M. A.
TI Injectable silicone biomaterial for faecal incontinence due to internal
   anal sphincter dysfunction (Retraction of vol 51, pg 225, 2002)
SO GUT
LA English
DT Correction
CR Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
NR 1
TC 4
Z9 4
U1 3
U2 9
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0017-5749
J9 GUT
JI Gut
PD DEC
PY 2006
VL 55
IS 12
BP 1824
EP 1824
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 108IV
UT WOS:000242234400030
PM 17171815
DA 2018-10-19
ER

PT J
AU Poland, K
   Topoglidis, E
   Durrant, JR
   Palomares, E
AF Poland, Keira
   Topoglidis, Emmanuel
   Durrant, James R.
   Palomares, Emilio
TI Optical sensing of cyanide using hybrid biomolecular films
SO INORGANIC CHEMISTRY COMMUNICATIONS
LA English
DT Article
DE Bioinorganic chemistry; mesoporous materials; cyanide sensing
ID HEME-PROTEINS; NANOCRYSTALLINE TIO2; NANOPOROUS TIO2; HEMOGLOBIN;
   MYOGLOBIN; IMMOBILIZATION; ELECTRODES; BIOSENSORS; COMPLEXES; REAGENTS
AB The selective sensing of cyanide anions in water has been studied using a hybrid biomaterial composed of a mesoporous TiO2 film of crystalline nanoparticles and the protein hemoglobin. The mesoporous structure of the film prevents protein unfolding and also stabilizes the oxidized form of the prosthetic groups. Low-levels of cyanide anions (<0.2 ppm (0.2 mgr/L)) can be detected by monitoring the changes in the optical properties of the hybrid biomolecular films upon cyanide binding to the heme groups. (C) 2006 Elsevier B.V. All rights reserved.
C1 Univ London Imperial Coll Sci Technol & Med, Ctr Elect Mat & Devices, London SW7 2AY, England.
   Acrongenom Inc, Athens 17455, Greece.
   Univ Valencia, Inst Ciencia Mol, E-46100 Valencia, Spain.
RP Palomares, E (reprint author), Inst Chem Res Catalonia ICIQ, Avda Paisos Catalans,16 Tarragona, Tarragona 43007, Spain.
EM epalomares@iciq.es
RI Palomares, Emilio/G-5251-2012; Palomares, Emilio/G-3531-2015
OI Palomares, Emilio/0000-0002-5092-9227; Palomares,
   Emilio/0000-0002-5092-9227; Topoglidis, Emmanuel/0000-0002-0009-9309
CR Agrawal O, 2005, J CHIN CHEM SOC-TAIP, V52, P51, DOI 10.1002/jccs.200500008
   ALDRIDGE WN, 1945, ANALYST, V70, P474
   Antonini G, 1996, BIOCHEM J, V314, P533, DOI 10.1042/bj3140533
   AZENBADRER P, 2002, J AM CHEM SOC, V124, P6232
   Badugu R, 2005, J AM CHEM SOC, V127, P3635, DOI 10.1021/ja044421i
   Badugu R, 2004, ANAL BIOCHEM, V327, P82, DOI 10.1016/j.ab.2003.12.026
   Beer PD, 2001, ANGEW CHEM INT EDIT, V40, P486, DOI 10.1002/1521-3773(20010202)40:3<486::AID-ANIE486>3.3.CO;2-G
   Chow CF, 2004, INORG CHEM, V43, P8387, DOI 10.1021/ic0492587
   Coronado E, 2005, J AM CHEM SOC, V127, P12351, DOI 10.1021/ja0517724
   Drochioiu G, 2002, ANAL BIOANAL CHEM, V372, P744, DOI 10.1007/s00216-002-1238-6
   EPSTEIN J, 1947, ANAL CHEM, V19, P272, DOI 10.1021/ac60004a018
   Gale PA, 2001, COORDIN CHEM REV, V213, P79, DOI 10.1016/S0010-8545(00)00364-7
   GRACIA F, 2005, CHEM COMMUN, P2790
   LAMBERT JL, 1975, ANAL CHEM, V47, P916, DOI 10.1021/ac60356a036
   Lan EH, 1999, J MATER CHEM, V9, P45, DOI 10.1039/a805541f
   Legako JA, 2003, SENSOR ACTUAT B-CHEM, V91, P128, DOI 10.1016/S0925-4005(03)00076-5
   Li QW, 2001, ELECTROANAL, V13, P359, DOI 10.1002/1521-4109(200104)13:5<359::AID-ELAN359>3.0.CO;2-J
   LUNDQUIST P, 1989, CLIN CHEM, V35, P617
   Mak KKW, 2005, BIOSENS BIOELECTRON, V20, P2581, DOI 10.1016/j.bios.2004.09.015
   Martinez-Manez R, 2003, CHEM REV, V103, P4419, DOI 10.1021/cr010421e
   McCool BA, 2004, J NON-CRYST SOLIDS, V333, P143, DOI 10.1016/j.jnoncrysol.2003.09.061
   MIYAJI H, 2001, ANGEW CHEM INT EDIT, V40, P155
   NAGASHIMA S, 1984, ANAL CHEM, V56, P1944, DOI 10.1021/ac00275a042
   Palomares E, 2004, CHEM COMMUN, P362, DOI 10.1039/b314138a
   Palomares E, 2004, ADV FUNCT MATER, V14, P111, DOI 10.1002/adfm.200304444
   Reddy KS, 1996, BIOCHEMISTRY-US, V35, P5562, DOI 10.1021/bi952596m
   Ros-Lis JV, 2002, CHEM COMMUN, P2248, DOI 10.1039/b206500b
   SUKUSAI C, 2003, CHEM SOC REV, V32, P192
   Tomasulo M, 2005, ORG LETT, V7, P4633, DOI 10.1021/ol051750m
   Topoglidis E, 2006, ELECTROANAL, V18, P882, DOI 10.1002/elan.200503473
   Topoglidis E, 2003, LANGMUIR, V19, P6894, DOI 10.1021/la034466h
   Topoglidis E, 2001, J ELECTROANAL CHEM, V517, P20, DOI 10.1016/S0022-0728(01)00673-8
   Topoglidis E, 2000, FARADAY DISCUSS, V116, P35, DOI 10.1039/b003313h
NR 33
TC 24
Z9 24
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1387-7003
J9 INORG CHEM COMMUN
JI Inorg. Chem. Commun.
PD DEC
PY 2006
VL 9
IS 12
BP 1239
EP 1242
DI 10.1016/j.inoche.2006.07.037
PG 4
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA 113RU
UT WOS:000242615800022
DA 2018-10-19
ER

PT J
AU Cardaropoli, D
   Re, S
   Manuzzi, W
   Gaveglio, L
   Cardaropoli, G
AF Cardaropoli, Daniele
   Re, Stefania
   Manuzzi, William
   Gaveglio, Lorena
   Cardaropoli, Giuseppe
TI Bio-oss collagen and orthodontic movement for the treatment of infrabony
   defects in the esthetic zone
SO INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
LA English
DT Article
ID GUIDED TISSUE REGENERATION; ADULT PERIODONTAL PATIENTS; INTRABONY
   DEFECTS; BONE DEFECTS; HISTOLOGIC EVALUATION; BIO-OSS(R); INTRUSION;
   INCISORS; DISEASE
AB The aim of the present study was to evaluate whether it is possible to orthodontically move migrated teeth into infrabony defects augmented with a biomaterial. Three adult patients suffering from chronic periodontitis were treated. Each of the patients presented with an infrabony defect adjacent to a migrated maxillary central incisor. After cause-related therapy was completed, a surgical procedure was performed using the papilla preservation technique. The defects were filled with a collagen bovine bone mineral; after 2 weeks, an orthodontic device was activated using light, continuous forces. Orthodontic treatment time varied from 4 to 9 months; during this period, patients were enrolled in an oral hygiene recall program. At baseline and 6 months after the end of therapy, probing pocket depths (PPD) and clinical attachment levels (CAL) were assessed. In addition, the vertical and horizontal dimensions of the defects were measured on standardized radiographs. Residual mean PPD was 3.33 mm, with a mean reduction of 3.67 mm. Mean CAL gain was 4.67 mm. Radiologic vertical and horizontal bone fills were, on average, 3.17 mm and 2.0 mm, respectively. The present case series shows the effectiveness of a combined periodontic-orthodontic approach for the treatment of infrabony defects. Reduction of PPD to physiologic values, CAL gain, and radiologic defect resolution were obtained. No detrimental effects from the orthodontic movement were observed on the augmentation material.
C1 Univ Gothenburg, Gothenburg, Sweden.
RP Cardaropoli, D (reprint author), Via Baltimora 122, I-10137 Turin, Italy.
EM dacardar@tin.it
CR Aguirre-Zorzano LA, 1999, QUINTESSENCE INT, V30, P769
   Araujo MG, 2001, J CLIN PERIODONTOL, V28, P73, DOI 10.1034/j.1600-051x.2001.280111.x
   AXELSSON P, 1981, J CLIN PERIODONTOL, V8, P281, DOI 10.1111/j.1600-051X.1981.tb02039.x
   Berglundh T, 1997, CLIN ORAL IMPLAN RES, V8, P117, DOI 10.1034/j.1600-0501.1997.080206.x
   BURSTONE CJ, 1982, AM J ORTHOD DENTOFAC, V82, P361, DOI 10.1016/0002-9416(82)90185-3
   Camargo PM, 2000, J CLIN PERIODONTOL, V27, P889, DOI 10.1034/j.1600-051x.2000.027012889.x
   Camelo M, 1998, INT J PERIODONT REST, V18, P321
   Cardaropoli D, 2004, J CLIN PERIODONTOL, V31, P79, DOI 10.1111/j.0303-6979.2004.00451.x
   Cardaropoli D, 2001, AM J ORTHOD DENTOFAC, V120, P671, DOI 10.1067/mod.2001.119385
   CARDAROPOLI D, 2004, ORTHOD CRANIOFAC RES, V7, P35
   Carvalho RS, 2003, AM J ORTHOD DENTOFAC, V123, P455, DOI 10.1067/mod.2003.59
   Corrente G, 2003, J PERIODONTOL, V74, P1104, DOI 10.1902/jop.2003.74.8.1104
   CORTELLINI P, 1995, J PERIODONTOL, V66, P261, DOI 10.1902/jop.1995.66.4.261
   Diedrich P R, 1996, Semin Orthod, V2, P39, DOI 10.1016/S1073-8746(96)80038-7
   Geraci T F, 1990, Int J Periodontics Restorative Dent, V10, P184
   Hossain MZ, 1996, CLEFT PALATE-CRAN J, V33, P277, DOI 10.1597/1545-1569(1996)033<0277:BROABA>2.3.CO;2
   Mellonig JT, 2000, INT J PERIODONT REST, V20, P19
   MELSEN B, 1989, AM J ORTHOD DENTOFAC, V96, P232, DOI 10.1016/0889-5406(89)90460-5
   Nemcovsky C E, 1996, Int J Adult Orthodon Orthognath Surg, V11, P347
   Nevins M, 1990, Int J Periodontics Restorative Dent, V10, P198
   Nevins ML, 2003, INT J PERIODONT REST, V23, P9
   OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38
   PAPAPANOU PN, 1991, J CLIN PERIODONTOL, V18, P317, DOI 10.1111/j.1600-051X.1991.tb00435.x
   POLSON A, 1984, J PERIODONTOL, V55, P197, DOI 10.1902/jop.1984.55.4.197
   Re Stefania, 2002, Int J Periodontics Restorative Dent, V22, P138
   RICKETTS RM, 1976, AM J ORTHOD DENTOFAC, V70, P241, DOI 10.1016/0002-9416(76)90332-8
   ROBERTS WE, 1981, J DENT RES, V60, P174
   Stelzel MJ, 1998, INT J PERIODONT REST, V18, P189
   Thilander B, 1996, Semin Orthod, V2, P55, DOI 10.1016/S1073-8746(96)80040-5
   WENNSTROM JL, 1993, AM J ORTHOD DENTOFAC, V103, P313, DOI 10.1016/0889-5406(93)70011-C
NR 30
TC 22
Z9 23
U1 0
U2 8
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0198-7569
J9 INT J PERIODONT REST
JI Int. J. Periodontics Restor. Dent.
PD DEC
PY 2006
VL 26
IS 6
BP 553
EP 559
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 125DX
UT WOS:000243423400004
PM 17243328
DA 2018-10-19
ER

PT J
AU Soria, JM
   Ramos, CM
   Sanchez, MS
   Benavent, V
   Fernandez, AC
   Ribelles, JLG
   Verdugo, JMG
   Pradas, MM
   Barcia, JA
AF Soria, Jose Miguel
   Martinez Ramos, Cristina
   Salmeron Sanchez, Manuel
   Benavent, Veronique
   Campillo Fernandez, Alberto
   Gomez Ribelles, Jose Luis
   Garcia Verdugo, Jose Manuel
   Monleon Pradas, Manuel
   Barcia, Juan Antonio
TI Survival and differentiation of embryonic neural explants on different
   biomaterials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE neural progenitor cell; hydrogel; biomaterial; biocompatibility; culture
   substrate
ID CENTRAL-NERVOUS-SYSTEM; CELL-ADHESION; STEM-CELLS; FIBRONECTIN
   CONFORMATION; EXTRACELLULAR-MATRIX; NEURITE EXTENSION; INTEGRIN BINDING;
   NEURONS; LAMININ; SURFACES
AB Biomaterials prepared from polyacrylamide, ethyl acrylate (EA), and hydroxyethyl acrylate (HEA) in various blend ratios, methyl acrylate and chitosan, were tested in vitro as culture substrates and compared for their ability to be colonized by the cells migrating from embryonic brain explants. Neural explants were isolated from proliferative areas of the medial ganglionic eminence and the cortical ventricular zone of embryonic rat brains and cultured in vitro on the different biomaterials. Chitosan, poly(methyl acrylate), and the 50% wt copolymer of EA and HEA were the most suitable substrates to promote cell attachment and differentiation of the neural cells among those tested. Immunofluorescence microscopy analysis showed that progenitor cells had undergone differentiation and that the resulting glial and neuronal cells expressed their intrinsic morphological characteristics in culture. (c) 2006 Wiley Periodicals, Inc.
C1 Fdn Hosp Gen Univ Valencia, Valencia 46014, Spain.
   Ctr Invest Principe Felipe, Valencia 46013, Spain.
   Univ Politecn Valencia, Ctr Biomat, E-46071 Valencia, Spain.
   Univ Valencia, Inst Cavanilles Biodiversidad & Biol Evolut, Valencia 46980, Spain.
   Hosp Gen Univ, Serv Neurocirugia, Valencia 46014, Spain.
RP Soria, JM (reprint author), Fdn Hosp Gen Univ Valencia, Avda Tres Cruces S-N, Valencia 46014, Spain.
EM soria_jos@gva.es
RI soria, jose/K-6722-2014; Garcia-Verdugo, Jose Manuel/L-8421-2017;
   Salmeron-Sanchez, Manuel/E-4680-2010; Campillo-Fernandez, Alberto
   J./A-4885-2015; MartiAnez-Ramos, Cristina/G-1591-2015; Gomez Ribelles,
   Jose Luis/L-5629-2014; Martinez-Ramos, Cristina/B-8917-2015
OI soria, jose/0000-0001-9144-5096; Garcia-Verdugo, Jose
   Manuel/0000-0001-9872-6499; Salmeron-Sanchez,
   Manuel/0000-0002-8112-2100; Campillo-Fernandez, Alberto
   J./0000-0002-2978-5994; MartiAnez-Ramos, Cristina/0000-0002-6540-4714;
   Gomez Ribelles, Jose Luis/0000-0001-9099-0885; Martinez-Ramos,
   Cristina/0000-0001-7981-2324; MONLEON PRADAS,
   MANUEL/0000-0001-6457-0414; Barcia Albacar, Juan
   Antonio/0000-0001-6562-4568
CR Anderson SA, 2001, DEVELOPMENT, V128, P353
   Balgude AP, 2001, BIOMATERIALS, V22, P1077, DOI 10.1016/S0142-9612(00)00350-1
   Belkas JS, 2005, BIOMATERIALS, V26, P1741, DOI 10.1016/j.biomaterials.2004.05.031
   Bini TB, 2005, J MATER SCI-MATER M, V16, P367, DOI 10.1007/s10856-005-0637-6
   Brown NL, 2001, DEVELOPMENT, V128, P2497
   CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0
   Fried A, 1996, J CELL BIOCHEM, V61, P246
   Garcia AJ, 2005, BIOMATERIALS, V26, P7525, DOI 10.1016/j.biomaterials.2005.05.029
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Gray DS, 2003, J BIOMED MATER RES A, V66A, P605, DOI 10.1002/jbm.a.10585
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   Gronthos S, 2001, BONE, V28, P174, DOI 10.1016/S8756-3282(00)00424-5
   Haddow DB, 2003, J BIOMED MATER RES A, V64A, P80, DOI 10.1002/jbm.a.10356
   He W, 2005, BIOMATERIALS, V26, P2983, DOI 10.1016/j.biomaterials.2004.08.021
   Heiduschka P, 2001, ELECTROCHIM ACTA, V47, P299, DOI 10.1016/S0013-4686(01)00573-4
   Jarvis RA, 2005, J BIOMED MATER RES A, V75A, P41, DOI 10.1002/jbm.a.30404
   Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Keselowsky BG, 2004, BIOMATERIALS, V25, P5947, DOI 10.1016/j.biomaterials.2004.01.062
   Klee D, 1999, ADV POLYM SCI, V149, P1
   KLEINMAN HK, 1985, J CELL BIOCHEM, V27, P317, DOI 10.1002/jcb.240270402
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Lavdas AA, 1999, J NEUROSCI, V19, P7881
   Li B, 2005, BIOMATERIALS, V26, P4956, DOI 10.1016/j.biomaterials.2005.01.018
   Li B, 2005, BIOMATERIALS, V26, P1487, DOI 10.1016/j.biomaterials.2004.05.004
   LIESI P, 1984, J NEUROSCI RES, V11, P241, DOI 10.1002/jnr.490110304
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   LuckenbillEdds L, 1997, BRAIN RES REV, V23, P1, DOI 10.1016/S0165-0173(96)00013-6
   Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058
   Matsuda A, 2005, BIOMATERIALS, V26, P2273, DOI 10.1016/j.biomaterials.2004.07.032
   Meyer G, 1998, J COMP NEUROL, V397, P493
   Mozzetti S, 2005, CLIN CANCER RES, V11, P298
   MULLEN RJ, 1992, DEVELOPMENT, V116, P201
   Qian LC, 2004, BIOMATERIALS, V25, P1331, DOI 10.1016/j.biomaterials.2003.08.013
   REEVES SA, 1989, P NATL ACAD SCI USA, V86, P5178, DOI 10.1073/pnas.86.13.5178
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   ROGERS SL, 1983, DEV BIOL, V98, P212, DOI 10.1016/0012-1606(83)90350-0
   Sherratt MJ, 2004, BIOPHYS J, V86, P3211, DOI 10.1016/S0006-3495(04)74369-6
   Sherratt MJ, 2005, BIOMATERIALS, V26, P7192, DOI 10.1016/j.biomaterials.2005.05.010
   Soria Jose Miguel, 2000, Cerebral Cortex, V10, P400, DOI 10.1093/cercor/10.4.400
   Tate MC, 2004, MOL CELL NEUROSCI, V27, P22, DOI 10.1016/j.men.2004.05.001
   TOMASELLI KJ, 1987, J CELL BIOL, V105, P2347, DOI 10.1083/jcb.105.5.2347
   Tziampazis E, 2000, BIOMATERIALS, V21, P511, DOI 10.1016/S0142-9612(99)00212-4
   Woerly S, 1998, J BIOMAT SCI-POLYM E, V9, P681, DOI 10.1163/156856298X00091
   Young TH, 2005, BIOMATERIALS, V26, P4291, DOI 10.1016/j.biomaterials.2004.10.043
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
NR 46
TC 37
Z9 38
U1 0
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2006
VL 79A
IS 3
BP 495
EP 502
DI 10.1002/jbm.a.30803
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 106XG
UT WOS:000242134700006
PM 16788975
DA 2018-10-19
ER

PT J
AU Ruiz-Hernandez, E
   Serrano, MC
   Arcos, D
   Vallet-Regi, M
AF Ruiz-Hernandez, E.
   Serrano, M. C.
   Arcos, D.
   Vallet-Regi, M.
TI Glass-glass ceramic thermoseeds for hyperthermic treatment of bone
   tumors
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE magnetic bioceramics; bioactivity; biocompatibility; hyperthermia; bone
   cancer treatment
ID SELF-REGULATING THERMOSEEDS; IRON-OXIDE NANOPARTICLES; SYSTEM
   FEO-FE2O3-CAO-SIO2; FERROMAGNETIC IMPLANTS; MAGNETIC NANOPARTICLES;
   CANCER-TREATMENT; BIOACTIVE GLASS; IN-VITRO; TEMPERATURE; GROWTH
AB Implantable thermoseeds are synthesised from mixtures of a melt-derived glass with composition SiO2 (40)-CaO(40)-Fe2O3(20) (mol%) and a sol-gel glass with composition SiO2(58)-P2O5(6)-CaO(36) (mol%). Structural, textural and magnetic properties of the samples are evaluated. In vitro bioactivity is assessed in order to determine the potential capability to bond to living bone. In spite of the low textural properties of the material, a bioactive behavior is observed as a result of the sol-gel glass content. Although the crystallization of the glass ceramic provides the magnetic phase, the presence of sol-gel glass modifies the magnetic properties, improving the heating power. For the first time, hyperthermia heating experiments as well as preliminary biocompatibility assays have been carried out for this kind of material. The ability to reach hyperthermic temperature range together with the bioactive behavior makes this biomaterial a very promising candidate for bone cancer treatment. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Complutense Madrid, Dept Quim Inorgan & Bioinorgan, Fac Farm, E-28040 Madrid, Spain.
   Univ Complutense Madrid, Dept Bioquim & Biol Mol 1, Fac CC Quim, E-28040 Madrid, Spain.
   CSIC, CENIM, E-28040 Madrid, Spain.
   Renfe UMC, IMA, Madrid 28230, Spain.
RP Vallet-Regi, M (reprint author), Univ Complutense Madrid, Dept Quim Inorgan & Bioinorgan, Fac Farm, E-28040 Madrid, Spain.
EM vallet@farm.ucm.es
RI Arcos, Daniel/L-6167-2014; Vallet-Regi, Maria/M-3378-2014; Serrano,
   Maria Concepcion/D-7442-2014
OI Arcos, Daniel/0000-0002-5367-7272; Vallet-Regi,
   Maria/0000-0002-6104-4889; Serrano, Maria Concepcion/0000-0002-5010-644X
CR Arcos D, 2003, J BIOMED MATER RES A, V65A, P71, DOI 10.1002/jbm.a.10445
   Arcos D, 2002, BIOMATERIALS, V23, P2151, DOI 10.1016/S0142-9612(01)00346-5
   B Physica, 1992, PHYSICA B, V55, P192
   Berry CC, 2003, BIOMATERIALS, V24, P4551, DOI 10.1016/S0142-9612(03)00237-0
   Berry CC, 2003, J PHYS D APPL PHYS, V36, pR198, DOI 10.1088/0022-3727/36/13/203
   BREZOVICH IA, 1989, RADIOL CLIN N AM, V27, P589
   Cannas C, 2002, J MATER CHEM, V12, P3141, DOI 10.1039/b204292d
   Case JA, 2000, J BIOMED MATER RES, V53, P791, DOI 10.1002/1097-4636(2000)53:6<791::AID-JBM21>3.0.CO;2-A
   Christophi C, 1998, SURG ONCOL, V7, P83, DOI 10.1016/S0960-7404(99)00007-9
   Deger S, 2004, EUR UROL, V45, P574, DOI 10.1016/j.eururo.2003.11.012
   Deger S, 2002, EUR UROL, V42, P147, DOI 10.1016/S0302-2838(02)00277-4
   del Real RP, 2002, CHEM MATER, V14, P64, DOI 10.1021/cm011020i
   Ebisawa Y, 1997, BIOMATERIALS, V18, P1277, DOI 10.1016/S0142-9612(97)00067-7
   Ebisawa Y, 1997, J CERAM SOC JPN, V105, P947, DOI 10.2109/jcersj.105.947
   EBISAWA Y, 1991, SERAMIKKUSU RONBUNSH, V1, P7
   Eniu D, 2005, J MAGN MAGN MATER, V293, P310, DOI 10.1016/j.jmmm.2005.02.025
   Frayssinet P, 1997, J BIOMED MATER RES, V35, P337, DOI 10.1002/(SICI)1097-4636(19970605)35:3<337::AID-JBM8>3.3.CO;2-H
   Grasset F, 2002, LANGMUIR, V18, P8209, DOI 10.1021/la020322b
   GREENSPAN DC, 1998, BIOCERAMICS, V11, P345
   Gupta AK, 2005, BIOMATERIALS, V26, P3995, DOI 10.1016/j.biomaterials.2004.10.012
   Hamadouche M, 2001, J BIOMED MATER RES, V54, P560, DOI 10.1002/1097-4636(20010315)54:4<560::AID-JBM130>3.3.CO;2-A
   Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2
   IKENAGA I, 1991, BIOCERAMICS, V4, P255
   IKENAGA M, 1993, J ORTHOP RES, V11, P849, DOI 10.1002/jor.1100110611
   Kaatee RSJP, 1997, INT J RADIAT ONCOL, V37, P189, DOI 10.1016/S0360-3016(96)00476-2
   Kawashita M, 2005, BIOMATERIALS, V26, P2231, DOI 10.1016/j.biomaterials.2004.07.014
   Kim DH, 2004, J MATER SCI, V39, P6847, DOI 10.1023/B:JMSC.0000045617.92955.12
   KOKUBO T, 1992, J MATER SCI-MATER M, V3, P79, DOI 10.1007/BF00705272
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Konaka H, 1997, J CERAM SOC JPN, V105, P833, DOI 10.2109/jcersj.105.833
   Lee WK, 2003, MACROMOL RES, V11, P511, DOI 10.1007/BF03218985
   LIN IN, 1984, IEEE T MAGN, V20, P134
   Mornet S, 2004, J MATER CHEM, V14, P2161, DOI 10.1039/b402025a
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nadobny J, 2005, IEEE T BIO-MED ENG, V52, P505, DOI 10.1109/TBME.2004.843291
   Nielsen OS, 2001, EUR J CANCER, V37, P1587, DOI 10.1016/S0959-8049(01)00193-9
   Oh SH, 2001, J BIOMED MATER RES, V54, P360, DOI 10.1002/1097-4636(20010305)54:3<360::AID-JBM70>3.0.CO;2-Y
   OVERGAARD J, 1977, CANCER-AM CANCER SOC, V39, P2637, DOI 10.1002/1097-0142(197706)39:6<2637::AID-CNCR2820390650>3.0.CO;2-S
   Pankhurst QA, 2003, J PHYS D APPL PHYS, V36, pR167, DOI 10.1088/0022-3727/36/13/201
   Rodriguez-Carvajal J., 2001, NEWSLETTER, V26, P12
   STAUFFER PR, 1984, IEEE T BIO-MED ENG, V31, P76, DOI 10.1109/TBME.1984.325373
   Vallet-Regi M, 2000, J BIOMED MATER RES, V51, P23, DOI 10.1002/(SICI)1097-4636(200007)51:1<23::AID-JBM4>3.0.CO;2-B
   Van Vulpen M, 2002, INT J RADIAT ONCOL, V53, P116, DOI 10.1016/S0360-3016(01)02828-0
   Wust P, 2002, LANCET ONCOL, V3, P487, DOI 10.1016/S1470-2045(02)00818-5
NR 44
TC 27
Z9 31
U1 1
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2006
VL 79A
IS 3
BP 533
EP 543
DI 10.1002/jbm.a.30889
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 106XG
UT WOS:000242134700010
PM 16788969
DA 2018-10-19
ER

PT J
AU Lin, H
   Chen, B
   Wang, B
   Zhao, YN
   Sun, WJ
   Dai, JW
AF Lin, Hang
   Chen, Bing
   Wang, Bin
   Zhao, Yannan
   Sun, Wenjie
   Dai, Jianwu
TI Novel nerve guidance material prepared from bovine aponeurosis
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE spinal cord injury; axon regeneration; collagen; aponeurosis; nerve
   guidance
ID SPINAL-CORD-INJURY; IN-VIVO BIOCOMPATIBILITY; AXONAL REGENERATION;
   FUNCTIONAL RECOVERY; ENSHEATHING CELLS; MECHANICAL-PROPERTIES;
   STEM-CELLS; COLLAGEN; RAT; REPAIR
AB Spinal cord injury (SCI) creates an adverse environment for axon regeneration. As a result, the axons at the injury sites begin to be atrophy, retract and lose their functions. Several strategies to promote axon regeneration at the injury site have been tested, but the progress is very limited. One of the major reasons is that the regenerated axons often extend randomly and do not reach the proper place. Fabricating linearly ordered materials as nerve guidance would be important to solve such problems. In this study, a novel type of nerve guidance material was prepared from the bovine aponeurosis, which mainly consisted of ordered collagen fibers. The processed material showed good cell compatibility and low immunogenisity. Moreover, the processed material guided the neurites outgrowth of in vitro cultured cortical neurons along its fibers. The results suggested that the processed aponeurosis would be a proper nerve guidance biomaterial for SCI repair. (c) 2006 Wiley Periodicals, Inc.
C1 Chinese Acad Sci, Key Lab Mol Dev Biol, Inst Genet & Dev Biol, Beijing 100080, Peoples R China.
   Chinese Acad Sci, Grad Sch, Beijing 100080, Peoples R China.
RP Dai, JW (reprint author), Chinese Acad Sci, Key Lab Mol Dev Biol, Inst Genet & Dev Biol, Beijing 100080, Peoples R China.
EM jwdai@genetics.ac.cn
RI Lin, Hang/D-3003-2012
OI Lin, Hang/0000-0002-0781-6630
CR Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002
   ANDERSON DK, 1995, BRAIN PATHOL, V5, P451, DOI 10.1111/j.1750-3639.1995.tb00624.x
   Cartmell JS, 2000, J BIOMED MATER RES, V49, P134, DOI 10.1002/(SICI)1097-4636(200001)49:1<134::AID-JBM17>3.3.CO;2-4
   GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.ne.18.030195.001111
   Gautier SE, 1998, J BIOMED MATER RES, V42, P642, DOI 10.1002/(SICI)1097-4636(19981215)42:4<642::AID-JBM22>3.0.CO;2-K
   Geller HM, 2002, EXP NEUROL, V174, P125, DOI 10.1006/exnr.2002.7865
   Huber M, 1998, J BIOMED MATER RES, V41, P278, DOI 10.1002/(SICI)1097-4636(199808)41:2<278::AID-JBM13>3.0.CO;2-H
   Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002
   Imaizumi T, 1998, J NEUROSCI, V18, P6176
   Imaizumi T, 2000, NAT BIOTECHNOL, V18, P949
   Kakulas BA, 1999, SPINAL CORD, V37, P79, DOI 10.1038/sj.sc.3100807
   Kempermann G, 1999, SCI AM, V280, P48, DOI 10.1038/scientificamerican0599-48
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126
   Liu S, 2001, NEUROSURGERY, V49, P143, DOI 10.1097/00006123-200107000-00022
   Liu S, 1998, J NEUROSCI RES, V51, P723, DOI 10.1002/(SICI)1097-4547(19980315)51:6<723::AID-JNR6>3.0.CO;2-D
   MARCHAND R, 1993, BRAIN RES BULL, V30, P415, DOI 10.1016/0361-9230(93)90273-E
   Marois Y, 1999, TISSUE ENG, V5, P369, DOI 10.1089/ten.1999.5.369
   McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1
   Mikami Y, 2004, J NEUROSCI RES, V76, P453, DOI 10.1002/jnr.20086
   Nash HH, 2002, J NEUROSCI, V22, P7111
   Nash HH, 2001, GLIA, V34, P81, DOI 10.1002/glia.1043
   Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X
   NOMIZU M, 1995, FEBS LETT, V365, P227, DOI 10.1016/0014-5793(95)00475-O
   Novikov LN, 2002, BIOMATERIALS, V23, P3369, DOI 10.1016/S0142-9612(02)00037-6
   Novikova LN, 2003, CURR OPIN NEUROL, V16, P711, DOI 10.1097/01.wco.0000102620.38669.3e
   Novikova LN, 2002, J COMP NEUROL, V452, P255, DOI 10.1002/cne.10381
   Patist CM, 2004, BIOMATERIALS, V25, P1569, DOI 10.1016/S0142-9612(03)00503-9
   Phillips JB, 2004, BIOMATERIALS, V25, P2769, DOI 10.1016/j.biomaterias.2003.09.052
   Ramer MS, 2000, NATURE, V403, P312, DOI 10.1038/35002084
   Sankar V, 2003, NEUROSCIENCE, V118, P11, DOI 10.1016/S0306-4522(02)00929-6
   Schwab ME, 2002, SCIENCE, V295, P1029, DOI 10.1126/science.1067840
   SHAHAR A, 1989, PREPARATION PRIMARY, P183
   SILVER FH, 1992, J LONG-TERM EFF MED, V2, P165
   Silver FH, 2003, J BIOMECH, V36, P1529, DOI 10.1016/S0021-9290(03)00135-0
   Stang F, 2005, BIO-MED MATER ENG, V15, P3
   STEDMAN TL, 2000, STEDMANS MED DICT, P29
   Stokols S, 2004, BIOMATERIALS, V25, P5839, DOI 10.1016/j.biomaterials.2004.01.041
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Van Minnen B, 2005, J MATER SCI-MATER M, V16, P221, DOI 10.1007/s10856-005-6683-2
   von Heimburg D, 2001, BIOMATERIALS, V22, P429, DOI 10.1016/S0142-9612(00)00186-1
   Wang ZX, 2004, J BIOMED MATER RES A, V70A, P28, DOI 10.1002/jbm.a.30047
   Wickelgren I, 2002, SCIENCE, V297, P178, DOI 10.1126/science.297.5579.178
   Woerly S, 1999, TISSUE ENG, V5, P467, DOI 10.1089/ten.1999.5.467
   Woerly S, 1998, J BIOMAT SCI-POLYM E, V9, P681, DOI 10.1163/156856298X00091
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Yoshii S, 2004, J BIOMED MATER RES A, V70A, P569, DOI 10.1002/jbm.a.30120
   Yu TT, 2005, BIOMATERIALS, V26, P1507, DOI 10.1016/j.biomaterials.2004.05.012
NR 48
TC 40
Z9 41
U1 1
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2006
VL 79A
IS 3
BP 591
EP 598
DI 10.1002/jbm.a.30862
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 106XG
UT WOS:000242134700017
PM 16817216
DA 2018-10-19
ER

PT J
AU Kidane, AG
   Punshon, G
   Salacinski, HJ
   Ramesh, B
   Dooley, A
   Olbrich, M
   Heitz, J
   Hamilton, G
   Seifalian, AM
AF Kidane, Asmeret G.
   Punshon, Geoffrey
   Salacinski, Henryk J.
   Ramesh, Bala
   Dooley, Audrey
   Olbrich, Michael
   Heitz, Johannes
   Hamilton, George
   Seifalian, Alexander M.
TI Incorporation of a lauric acid-conjugated GRGDS peptide directly into
   the matrix of a poly(carbonate-urea)urethane polymer for use in
   cardiovascular bypass graft applications
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE amphiphilic; controlled release; arginine-glycine-aspartic acid (RGD);
   lauric-acid-GRGDS conjugate; poly-urethane;
   poly(carbonate-urea)urethane; solvent casting; endothelial cell(s) (EC);
   cytocompatibility; nanoparticulate dispersion; two-stage-seeding; tissue
   engineering; biomaterial(s)
ID ENDOTHELIAL-CELL GROWTH; BIOMEDICAL APPLICATIONS; RGD-PEPTIDES;
   POLYURETHANE BIOMATERIALS; BLOOD COMPATIBILITY; ARTIFICIAL-HEART;
   GLOW-DISCHARGE; ADHESION; SURFACE; ATTACHMENT
AB Gly-Arg-Gly-Asp-Ser (GRGDS) was modified by conjugation to lauric acid (LA) to facilitate incorporation into the matrix of a poly(carbonate-urea)urethane (PCU) used in vascular bypass grafts. GRGDS and LA-GRGDS were synthesized using solid phase Fmoc chemistry and characterized by high performance liquid chromatography and Fourier transform infrared spectroscopy. LA-GRGDS was passively coated and incorporated as nanoparticle dispersion on the PCU films. Biocompatibility of the modified surfaces was investigated. Endothelial cells seeded on LA-GRGDS coated and incorporated PCU showed after 48 h and 72 h a significant (p < 0.05) increase in metabolism compared with unmodified PCU. The platelet adhesion and hemolysis studies showed that the modification of PCU had no adverse effect. In conclusion, LA-conjugated RGD derivatives, such as LA-GRGDS, that permit solubility into solvents used in solvent casting methodologies should have wide applicability in polymer development for use in coronary, vascular, and dialysis bypass grafts, and furthermore scaffolds utilized for tissue regeneration and tissue engineering. (c) 2006 Wiley Periodicals, Inc.
C1 UCL, BTEC, Acad Div Surg & Intervent Sci, London NW3 2PF, England.
   Royal Free & Univ Coll Med Sch, Dept Prot & Mol Biol, London NW3 2PF, England.
   Johannes Kepler Univ Linz, Inst Appl Phys, A-4040 Linz, Austria.
   Royal Free Hampstead NHS Trust Hosp, Vasc Unit, London NW3 2QG, England.
RP Seifalian, AM (reprint author), UCL, BTEC, Acad Div Surg & Intervent Sci, Hampstead Campus, London NW3 2PF, England.
EM A.Seifalian@MedSch.UCL.AC.Uk
RI Seifalian, Alexander/I-6028-2013; Heitz, Johannes/O-8637-2015; Punshon,
   Geoffrey/K-5352-2013
OI Seifalian, Alexander/0000-0002-1180-3322; Heitz,
   Johannes/0000-0002-5608-5133; Punshon, Geoffrey/0000-0001-9247-9546
CR Bae JS, 1999, BIOMATERIALS, V20, P529, DOI 10.1016/S0142-9612(98)00204-X
   Baguneid M, 2004, BIOTECHNOL APPL BIOC, V39, P151, DOI 10.1042/BA20030148
   Belanger MC, 2000, ARTIF ORGANS, V24, P879, DOI 10.1046/j.1525-1594.2000.06504.x
   CLARK EA, 1995, SCIENCE, V268, P233, DOI 10.1126/science.7716514
   COURY AJ, 1987, LIFE SUPPORT SYST, V5, P25
   Curti T, 1989, Ann Vasc Surg, V3, P351, DOI 10.1016/S0890-5096(06)60159-3
   DAL PI, 2003, TISSUE ENG, V9, P1113
   FARRAR DJ, 1988, J THORAC CARDIOV SUR, V95, P191
   HARIS PI, 1994, FEBS LETT, V349, P371, DOI 10.1016/0014-5793(94)00704-7
   Hsu SH, 2000, BIOMATERIALS, V21, P359, DOI 10.1016/S0142-9612(99)00191-X
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Kannan RY, 2005, ACCOUNTS CHEM RES, V38, P879, DOI 10.1021/ar050055b
   Kasai S, 2004, BIOPOLYMERS, V76, P27, DOI 10.1002/bip.10565
   Kidane AG, 2003, MED BIOL ENG COMPUT, V41, P740, DOI 10.1007/BF02349983
   Korossis SA, 2000, BIO-MED MATER ENG, V10, P83
   Krijgsman B, 2002, TISSUE ENG, V8, P673, DOI 10.1089/107632702760240580
   Lee PC, 1996, J BIOMED MATER RES, V32, P645, DOI 10.1002/(SICI)1097-4636(199612)32:4<645::AID-JBM18>3.0.CO;2-C
   LELAH MD, 1993, POLYURETHANE MED, P57
   LIN HB, 1992, J BIOMAT SCI-POLYM E, V3, P217, DOI 10.1163/156856292X00132
   LIN HB, 1992, BIOMATERIALS, V13, P905, DOI 10.1016/0142-9612(92)90113-3
   Lin YS, 2001, ARTIF ORGANS, V25, P617, DOI 10.1046/j.1525-1594.2001.025008617.x
   Mann BK, 1999, BIOMATERIALS, V20, P2281, DOI 10.1016/S0142-9612(99)00158-1
   Massia SP, 2001, J BIOMED MATER RES, V56, P390, DOI 10.1002/1097-4636(20010905)56:3<390::AID-JBM1108>3.0.CO;2-L
   Mei Y, 2004, J AM CHEM SOC, V126, P3472, DOI 10.1021/ja039583d
   Moon HT, 2002, J BIOMAT SCI-POLYM E, V13, P817, DOI 10.1163/156856202760197438
   Moon HT, 2001, BIOMATERIALS, V22, P281
   OKOR RS, 1987, J PHARM PHARMACOL, V39, P547, DOI 10.1111/j.2042-7158.1987.tb03174.x
   Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0
   PARK JB, 1992, BIOMATERIALS INTRO, P255
   PATTERSON RB, 1995, ASAIO J, V41, pM625, DOI 10.1097/00002480-199507000-00086
   Seifalian AM, 2001, J BIOMED MATER RES, V55, P637, DOI 10.1002/1097-4636(20010615)55:4<637::AID-JBM1058>3.0.CO;2-Z
   Tiwari A, 2003, EUR J VASC ENDOVASC, V25, P325, DOI 10.1053/ejvs.2002.1854
   Tiwari A, 2002, FASEB J, V16, DOI 10.1096/fj.01-0826com
   Tiwari A, 2002, CARDIOVASC SURG, V10, P191, DOI 10.1016/S0967-2109(02)00004-2
   WALTON AG, 1981, POLYPEPTIDES PROTEIN, P122
   Wang DA, 2003, J BIOMED MATER RES A, V65A, P498, DOI 10.1002/jbm.a.10533
   Wang DA, 2002, BIOMACROMOLECULES, V3, P1286, DOI 10.1021/bm0255950
   Wetzels GMR, 1999, BIOMATERIALS, V20, P1879, DOI 10.1016/S0142-9612(99)00067-8
   Yang JM, 1999, J BIOMED MATER RES, V45, P133, DOI 10.1002/(SICI)1097-4636(199905)45:2<133::AID-JBM8>3.3.CO;2-4
   Zdrahala RJ, 1996, J BIOMATER APPL, V11, P37, DOI 10.1177/088532829601100102
   Zdrahala RJ, 1999, J BIOMATER APPL, V14, P67, DOI 10.1177/088532829901400104
NR 41
TC 18
Z9 20
U1 2
U2 16
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2006
VL 79A
IS 3
BP 606
EP 617
DI 10.1002/jbm.a.30817
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 106XG
UT WOS:000242134700019
PM 16826599
DA 2018-10-19
ER

PT J
AU Suri, S
   Banerjee, R
AF Suri, S.
   Banerjee, R.
TI In vitro evaluation of in situ gels as short term vitreous substitutes
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE gellan; in situ gel; ocular biomaterial; vitreous
ID RHEOLOGICAL PROPERTIES; INTRAOCULAR-PRESSURE; PSEUDOMONAS-ELODEA;
   DELIVERY-SYSTEMS; HYALURONIC-ACID; GELLAN GUM; SILICONE;
   BIOCOMPATIBILITY; BIODEGRADATION; IMPLANTS
AB Dysfunction of the vitreous humor, present in the posterior cavity of the eye, leads to its detachment from the retina and vision loss. In this study, biopolymers were evaluated as in situ gels for short term vitreous substitution. Biophysical characterization revealed that the viscosity of the vitreous was > 4000 cP at a shear rate of 0.15/s and it formed a gel with elastic modulus G' greater than the viscous modulus G". Biopolymers of gellan and hyaluronic acid (8:2 w/w, 1% concentration) were low viscosity liquids at 37 degrees C and gelation was triggered both by the addition of 0.18 mM CaCl2 as well as. ocular temperature, thus making them feasible as in situ gels. Gelation was confirmed by viscoelastic moduli where G' was greater than G", similar to the vitreous and unlike that of silicone oil, a common vitreous substitute. The gels had a viscosity > 5000 cP at a shear rate of 0.512/s, excellent light transmittance and absence of syneresis. Contact angle studies with water and simulated ocular fluids showed that gellan hyaluromc acid gels had similar wetting properties to that of vitreous with contact angles of 27 degrees +/- 1 degrees, 36.7 degrees +/- 1.6 degrees, and 33.7 degrees +/- 0.5 degrees for water, simulated tear fluid, and simulated aqueous humor, respectively. The results of this study suggest that biopolymers of gellan and hylauronic acid are suitable as in situ gels, have biophysical properties similar to that of the vitreous, and may be promising as alternatives to silicone oil as short-term vitreous substitutes. (c) 2006 Wiley Periodicals, Inc.
C1 Indian Inst Technol, Sch Biosci & Bioengn, Bombay 400076, Maharashtra, India.
RP Banerjee, R (reprint author), Indian Inst Technol, Sch Biosci & Bioengn, Bombay 400076, Maharashtra, India.
EM rinti@iitb.ac.in
CR Aichinger PA, 2003, COLLOID SURFACE B, V31, P243, DOI 10.1016/S0927-7765(03)00144-9
   Ali MK, 1997, BBA-BIOMEMBRANES, V1326, P124, DOI 10.1016/S0005-2736(97)00020-5
   Arrigoni C, 2006, BIOMATERIALS, V27, P623, DOI 10.1016/j.biomaterials.2005.06.009
   ATKINS EDT, 1973, SCIENCE, V179, P562, DOI 10.1126/science.179.4073.562
   Avitabile T, 2001, BIOMATERIALS, V22, P195, DOI 10.1016/S0142-9612(00)00169-1
   Bettelheim FA, 2001, EXP EYE RES, V73, P133, DOI 10.1006/exer.2001.1021
   Bishop PN, 2000, PROG RETIN EYE RES, V19, P323, DOI 10.1016/S1350-9462(99)00016-6
   Cai Q, 2003, BIOMATERIALS, V24, P629, DOI 10.1016/S0142-9612(02)00377-0
   Carafa M, 2004, J CONTROL RELEASE, V95, P67, DOI 10.1016/j.jconrel.2003.10.022
   CHANDRASEKARAN R, 1988, CARBOHYD RES, V175, P1, DOI 10.1016/0008-6215(88)80151-4
   Chirila Traian V, 2005, Cont Lens Anterior Eye, V28, P21, DOI 10.1016/j.clae.2004.09.004
   Chirila TV, 1998, PROG POLYM SCI, V23, P475, DOI 10.1016/S0079-6700(97)00045-2
   Cohen S, 1997, J CONTROL RELEASE, V44, P201, DOI 10.1016/S0168-3659(96)01523-4
   CRIPPS CM, 1968, J CLIN PATHOL, V21, P110, DOI 10.1136/jcp.21.1.110
   Dalton PD, 1995, POLYM GELS NETW, V3, P429, DOI 10.1016/0966-7822(94)00011-5
   DENLINGER JL, 1982, AGING HUMAN VISUAL F, P45
   Giordano GG, 1998, PROG POLYM SCI, V23, P509, DOI 10.1016/S0079-6700(97)00046-4
   Holzer MP, 2001, J CATARACT REFR SURG, V27, P213, DOI 10.1016/S0886-3350(00)00568-X
   JANSSON PE, 1983, CARBOHYD RES, V124, P135, DOI 10.1016/0008-6215(83)88361-X
   KUBLIK H, 1993, EUR J PHARM BIOPHARM, V39, P192
   LEE B, 1994, BIORHEOLOGY, V31, P339
   Liu HF, 2004, BIOMATERIALS, V25, P3523, DOI 10.1016/j.biomaterials.2003.09.102
   Lloyd AW, 2001, BIOMATERIALS, V22, P769, DOI 10.1016/S0142-9612(00)00237-4
   Malinauskas RA, 1997, ARTIF ORGANS, V21, P1255
   Miyoshi E, 1998, POLYM GELS NETW, V6, P273, DOI 10.1016/S0966-7822(98)00019-7
   NAKAMURA K, 1991, INVEST OPHTH VIS SCI, V32, P3007
   Nickerson MT, 2003, FOOD HYDROCOLLOID, V17, P577, DOI 10.1016/S0268-005X(02)00075-9
   OHIRA A, 1991, RETINA-J RET VIT DIS, V11, P259, DOI 10.1097/00006982-199111020-00012
   Ohkawa K, 1998, BIOMATERIALS, V19, P1855, DOI 10.1016/S0142-9612(98)00091-X
   ONEILL MA, 1983, CARBOHYD RES, V124, P123, DOI 10.1016/0008-6215(83)88360-8
   Papazisis KT, 1997, J IMMUNOL METHODS, V208, P151, DOI 10.1016/S0022-1759(97)00137-3
   PEYMAN GA, 1995, SURV OPHTHALMOL, V39, P375
   Schenker HI, 2000, AM J OPHTHALMOL, V130, P145, DOI 10.1016/S0002-9394(00)00458-X
   SINTZEL MB, 1996, EUR J PHARM BIOPHARM, V42, P368
   Solomon A, 1998, J OCUL PHARMACOL TH, V14, P497, DOI 10.1089/jop.1998.14.497
   SOLONI FG, 1986, AM J CLIN PATHOL, V85, P3427
   Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981
   Williams JM, 2003, J ORTHOPAED RES, V21, P305, DOI 10.1016/S0736-0266(02)00156-0
NR 38
TC 57
Z9 58
U1 0
U2 18
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2006
VL 79A
IS 3
BP 650
EP 664
DI 10.1002/jbm.a.30917
PG 15
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 106XG
UT WOS:000242134700024
PM 16826595
DA 2018-10-19
ER

PT J
AU Taqvi, S
   Dixit, L
   Roy, K
AF Taqvi, Sabia
   Dixit, Lena
   Roy, Krishnendu
TI Biomaterial-based notch signaling for the differentiation of
   hematopoietic stem cells into T cells
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE notch; T cell; biomaterials; microbeads; stem cells
ID DELTA-LIKE-1 IN-VITRO; EX-VIVO EXPANSION; PROGENITOR CELLS; LYMPHOCYTE
   DEVELOPMENT; B-CELL; LIGAND; GENERATION; INDUCTION; PRECURSORS; RECEPTOR
AB Thymocyte development takes place in a complex milieu of supportive cells and ECM that are responsible for the proliferation, adhesion, migration, and selection processes these cells undergo before reaching maturity. In recent years, the role of notch signaling in lymphocyte development, specifically T-cell development, has been extensively characterized. Although notch ligand mediated signals have been shown to be a necessary component of T-cell generation from stem cells, high-throughput, synthetic biomaterial-based systems for notch-directed stem-cell differentiation into lymphocytes are yet to be reported. Here, we present a microbead-based, artificial notch signaling system to study stem-cell differentiation into the T-cell lineage. Magnetic microbeads were functionalized with the notch ligand DLL4 using streptavidin-biotin binding and antibody-antigen coupling. Immunohistochemistry and flow cytometry analysis indicated similar to 65% conjugation efficiency. Efficient notch signaling through these functionalhibition assay in C2C12 myoblasts. Thy1.2+ early T cells were successfully generated from mouse bone marrow hematopoietic stem cells (BMHSCs) using DLL4 functionalized beads using both insert-based and mixed stromal cell (OP9) coculture conditions, indicating that stem cell-stromal cell physical contact is not necessary for DLL4 directed T-cell differentiation. Coculture studies with beadto-cell ratios of 1:1 generated higher T-cell differentiation efficiencies, compared to bead-to-cell ratios of 5:1. These data demonstrate the promising potential of this biomaterial-based notch signaling system to generate T cells from stem cells and to elucidate the molecular interactions in T-cell development. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
RP Roy, K (reprint author), Univ Texas, Dept Biomed Engn, Austin, TX 78712 USA.
EM kroy@mail.utexas.edu
CR Anderson G, 2000, SEMIN IMMUNOL, V12, P457, DOI 10.1006/smim.2000.0260
   Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230
   Dallas MH, 2005, J EXP MED, V201, P1361, DOI 10.1084/jem.20042450
   de la Coste A, 2006, IMMUNOL LETT, V102, P1, DOI 10.1016/j.imlet.2005.06.014
   de La Coste A, 2005, J IMMUNOL, V174, P2730, DOI 10.4049/jimmunol.174.5.2730
   De Smedt M, 2004, BLOOD CELL MOL DIS, V33, P227, DOI 10.1016/j.bcmd.2004.08.007
   Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798
   Goldsby RA, 2003, IMMUNOLOGY
   Han W, 2000, BLOOD, V95, P1616
   Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075
   Hozumi K, 2003, J IMMUNOL, V170, P4973, DOI 10.4049/jimmunol.170.10.4973
   Ito F, 2003, J IMMUNOTHER, V26, P222, DOI 10.1097/00002371-200305000-00006
   Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365
   KOPAN R, 1994, DEVELOPMENT, V120, P2385
   La Motte-Mohs RN, 2005, BLOOD, V105, P1431, DOI 10.1182/blood-2004-04-1293
   Lehar SM, 2005, BLOOD, V105, P1440, DOI 10.1182/blood-2004-08-3257
   Lehar SM, 2002, IMMUNITY, V17, P689, DOI 10.1016/S1074-7613(02)00477-6
   LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5
   Liu H, 2005, TISSUE ENG, V11, P319, DOI 10.1089/ten.2005.11.319
   Luo B, 1997, MOL CELL BIOL, V17, P6057, DOI 10.1128/MCB.17.10.6057
   Maillard I, 2005, ANNU REV IMMUNOL, V23, P945, DOI 10.1146/annurev.immunol.23.021704.115747
   Maus MV, 2003, CLIN IMMUNOL, V106, P16, DOI 10.1016/S1521-6616(02)00017-7
   Maus MV, 2002, NAT BIOTECHNOL, V20, P143, DOI 10.1038/nbt0202-143
   NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449
   Nakano T, 1995, Semin Immunol, V7, P197, DOI 10.1016/1044-5323(95)90047-0
   Parreira L, 2003, SEMIN IMMUNOL, V15, P81, DOI 10.1016/S1044-5323(03)00004-6
   Poznansky MC, 2000, NAT BIOTECHNOL, V18, P729
   Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045
   Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0
   Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055
   Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394
   Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0
   Tan-Pertel HT, 2000, J IMMUNOL, V165, P4428, DOI 10.4049/jimmunol.165.8.4428
   Trickett A, 2003, J IMMUNOL METHODS, V275, P251, DOI 10.1016/S0022-1759(03)00010-3
   Trickett AE, 2002, J IMMUNOL METHODS, V262, P71, DOI 10.1016/S0022-1759(02)00018-2
   Varnum-Finney B, 2003, BLOOD, V101, P1784, DOI 10.1182/blood-2002-06-1862
   Varnum-Finney B, 2000, J CELL SCI, V113, P4313
   Zuniga-Pflucker JC, 2004, NAT REV IMMUNOL, V4, P67, DOI 10.1038/nri1257
NR 38
TC 35
Z9 35
U1 1
U2 5
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2006
VL 79A
IS 3
BP 689
EP 697
DI 10.1002/jbm.a.30916
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 106XG
UT WOS:000242134700028
PM 16845670
DA 2018-10-19
ER

PT J
AU Kim, HW
   Song, JH
   Kim, HE
AF Kim, Hae-Won
   Song, Ju-Ha
   Kim, Hyoun-Ee
TI Bioactive glass nanofiber-collagen nanocomposite as a novel bone
   regeneration matrix
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE bioactive glass; nanofiber; collagen; nanocomposite; bone regeneration
ID IN-VITRO; COMPOSITES; EXPRESSION; PROTEINS
AB Nanoscale organized organic-inorganic nanocomposite systems have great potential in the development of biomaterials with advanced properties. Herein, we developed a novel nanocomposite biomaterial consisting of bioactive glass nanofiber (BGNF) and collagen reconstituted fibrous matrix for bone regenerative medicine. A sol-gel derived glass with a bioactive composition (58SiO(2)center dot 38CaO center dot 4P(2)O(5)) was electrospun to a nanoscale fiber with an average diameter of similar to 320 nm. The BGNF was subsequently hybridized with type I collagen, which is the main organic constituent of bone matrix. The BGNF and self-assembled collagen sol were combined in aqueous solution, and then crosslinked to produce a BGNF-collagen nanocomposite, in the form of either a thin membrane or a macroporous scaffold, by adopting appropriate processing conditions. The BGNF was observed to be distributed uniformly within the collagen reconstituted nanofibrous matrix. The nanocomposite matrices induced rapid formation of bone-like apatite minerals on their surfaces when incubated in a simulated body fluid, exhibiting excellent bioactivity in vitro. Osteoblastic cells showed favorable growth on the BGNF-collagen nanocomposite. In particular, the alkaline phosphatase activity of the cells on the nanocomposite was significantly higher than that on the collagen. This novel BGNF-collagen nanocomposite is believed to have significant potential in bone regeneration and tissue engineering applications. (c) 2006 Wiley Periodicals, Inc.
C1 Dankook Univ, Sch Dent, Dept Dent Biomat, Cheonan 330714, South Korea.
   Seoul Natl Univ, Sch Mat Sci & Engn, Seoul 151742, South Korea.
RP Kim, HW (reprint author), Dankook Univ, Sch Dent, Dept Dent Biomat, Cheonan 330714, South Korea.
EM kimhw@dku.edu
RI Song, Juha/P-1927-2017
OI Song, Juha/0000-0002-3503-680X
CR Ali NN, 1996, J BONE MINER RES, V11, P512
   Brinker C. J., 1990, SOL GEL SCI PHYS CHE
   DEDIEGO MA, 2004, J MATER SCI-MATER M, V15, P803
   Dorozhkin SV, 2002, ANGEW CHEM INT EDIT, V41, P3130, DOI 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1
   Elliott JC, 1994, STRUCTURE CHEM APATI
   Hamadouche M, 2000, J BIOMED MATER RES, V52, P422, DOI 10.1002/1097-4636(200011)52:2<422::AID-JBM24>3.3.CO;2-G
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Kim HW, 2005, BIOMATERIALS, V26, P4395, DOI 10.1016/j.biomaterials.2004.11.008
   Kim HW, 2005, J BIOMED MATER RES A, V75A, P629, DOI 10.1002/jbm.a.30463
   KIM HW, IN PRESS ADV FUNCT M
   KLAWITTER JJ, 1971, J BIOMED MATER RES S, V2, P161, DOI DOI 10.1002/JBM.820050613
   Knabe C, 2005, CLIN ORAL IMPLAN RES, V16, P119, DOI 10.1111/j.1600-0501.2004.01066.x
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Rich J, 2002, BIOMATERIALS, V23, P2143, DOI 10.1016/S0142-9612(01)00345-3
   Salinas AJ, 2002, J BIOMED MATER RES, V61, P524, DOI 10.1002/jbm.10229
   Santos EM, 1999, BIOMATERIALS, V20, P1695, DOI 10.1016/S0142-9612(99)00066-6
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   STENZEL KH, 1974, ANNU REV BIOPHYS BIO, V3, P231, DOI 10.1146/annurev.bb.03.060174.001311
   WILSON J, 1993, INTRO BIOCERAMICS, P63
   Yao J, 2005, BIOMATERIALS, V26, P1935, DOI 10.1016/j.biomaterials.2004.06.027
   Zhong JP, 2000, J BIOMED MATER RES, V53, P694, DOI 10.1002/1097-4636(2000)53:6<694::AID-JBM12>3.0.CO;2-6
NR 23
TC 83
Z9 85
U1 0
U2 27
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD DEC 1
PY 2006
VL 79A
IS 3
BP 698
EP 705
DI 10.1002/jbm.a.30848
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 106XG
UT WOS:000242134700029
PM 16850456
DA 2018-10-19
ER

PT J
AU Neethling, WML
   Hodge, AJ
   Clode, P
   Glancy, R
AF Neethling, W. M. L.
   Hodge, A. J.
   Clode, P.
   Glancy, R.
TI A multi-step approach in anti-calcification of glutaraldehyde-preserved
   bovine pericardium
SO JOURNAL OF CARDIOVASCULAR SURGERY
LA English
DT Article
DE pericardium; biocompatible materials; surgery
ID CARDIAC-VALVE BIOPROSTHESES; CROSS-LINKING; HEART-VALVES; ETHANOL
   PREINCUBATION; TISSUE; PREVENTION; BIOMATERIAL; MECHANISMS; COLLAGEN;
   MINERALIZATION
AB Aim. Bioprosthetic cardiovascular substitutes, manufactured from glutaraldehyde-preserved bovine or porcine tissues, are prone to calcification after implantation. The aim of the study was to evaluate the ultrastructure, material stability and calcification behaviour of glutaraldehyde-preserved bovine pericardium, treated with a multi-step anti-calcification process which addresses each of the major causes of calcification and tissue degeneration.
   Methods. Bovine pericardium samples were divided into 2 groups. Group I (control) consisted of tissue fixed with 0.625% glutaraldehyde and Group II (study group) consisted of tissue fixed with 0.625% glutaraldehyde and exposed to a multi-step anti-calcification process. Ultrastructure was examined by scanning electron microscopy and material stability was assessed by mechanical testing, shrinkage temperature and enzymatic degradation. Calcification was assessed by histology (Von Kossa stain) and by atomic absorption spectrophotometry in the subcutaneous rat model.
   Results. Bovine pericardium in the study group revealed less visible changes in the ultrastructure of the collagen matrix, improved material stability (P<0.05) and significantly (P<0.001) reduced calcification compared to control tissues (4.5 +/- 1.2 versus 136.03 +/- 11.39 ug/mg tissue).
   Conclusions. In conclusion, results demonstrate that the multi-step anticalcification process improved the material stability and reduced the calcification potential of bovine pericardial tissue. These improvements in the quality of the bovine pericardium should enhance the long-term durability of the tissue as a bioprosthetic substitute for cardiovascular application.
C1 Univ Western Australia, Fremantle Hear Inst, Fremantle Hosp, Sch Surg & Pathol, Fremantle, WA, Australia.
   Fremantle Hosp, Dept Cardiothorac Surg, Fremantle, WA, Australia.
   Univ Western Australia, Ctr Microscopy & Microanal, Perth, WA 6009, Australia.
   Fremantle Hosp, Dept Histopathol, Fremantle, WA, Australia.
RP Neethling, WML (reprint author), Fremantle Hosp, Fremantle Hear Inst, Cell Biol Res Unit, Z Block,Alma St, Fremantle, WA 6959, Australia.
EM Leon.Neethling@health.wa.gov.au
RI Clode, Peta/C-4482-2011
OI Clode, Peta/0000-0002-5188-4737
CR BERNACCA GM, 1992, BIOMATERIALS, V13, P345
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   Cunanan CM, 2001, ANN THORAC SURG, V71, pS417, DOI 10.1016/S0003-4975(01)02493-6
   Deiwick M, 1998, ANN THORAC SURG, V66, pS206, DOI 10.1016/S0003-4975(98)01125-4
   FOLCH J, 1957, J BIOL CHEM, V226, P597
   Girardot JMD, 1996, J HEART VALVE DIS, V5, P518
   GOLOMB G, 1991, J BIOMED MATER RES, V25, P85, DOI 10.1002/jbm.820250107
   GOLOMB G, 1987, AM J PATHOL, V127, P122
   GOTT JP, 1992, ANN THORAC SURG, V53, P207, DOI 10.1016/0003-4975(92)91321-Y
   Herijgers P, 1999, Semin Thorac Cardiovasc Surg, V11, P171
   HUANGLEE LLH, 1990, J BIOMED MATER RES, V24, P1185, DOI 10.1002/jbm.820240905
   Hughes H, 1994, J Heart Valve Dis, V3, P111
   Jayakrishnan A, 1996, BIOMATERIALS, V17, P471, DOI 10.1016/0142-9612(96)82721-9
   LEVY RJ, 1991, J BIOMED MATER RES, V25, P905, DOI 10.1002/jbm.820250802
   LEVY RJ, 1987, J THORAC CARDIOV SUR, V94, P551
   LIAO KX, 1992, ARTIF ORGANS, V16, P361
   MILANO A, 1984, AM J CARDIOL, V53, P1066, DOI 10.1016/0002-9149(84)90638-6
   MILLER DC, 1982, CIRCULATION, V66, P172
   NEETHLING WML, 1992, J CARDIOVASC SURG, V33, P285
   Neethling WML, 2003, J BIOMED MATER RES B, V66B, P356, DOI 10.1002/jbm.b.10015
   PETITE H, 1990, J BIOMED MATER RES, V24, P179, DOI 10.1002/jbm.820240205
   RICHARDS FM, 1968, J MOL BIOL, V37, P231, DOI 10.1016/0022-2836(68)90086-7
   ROSSI MA, 1990, J EXP PATHOL, V71, P187
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   SCHOEN FJ, 1986, AM J PATHOL, V123, P134
   SCHOEN FJ, 1988, J BIOMED MATER RES-A, V22, P11
   Singla A, 2002, J BIOMED MATER RES, V60, P368, DOI 10.1002/jbm.10077
   STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9
   TALMAN EA, 1995, ANN THORAC SURG, V60, pS369, DOI 10.1016/0003-4975(95)00250-O
   Thoma R J, 1995, J Heart Valve Dis, V4, P214
   THUBRIKAR MJ, 1983, J THORAC CARDIOV SUR, V86, P115
   Valente M, 1998, J HEART VALVE DIS, V7, P180
   Vasudev SC, 2000, ARTIF ORGANS, V24, P129, DOI 10.1046/j.1525-1594.2000.06348.x
   Vyavahare N, 1997, CIRCULATION, V95, P479
   Vyavahare NR, 1998, J BIOMED MATER RES, V40, P577, DOI 10.1002/(SICI)1097-4636(19980615)40:4<577::AID-JBM9>3.3.CO;2-B
   Westaby S, 1999, Semin Thorac Cardiovasc Surg, V11, P206
   Zeeman R, 1999, BIOMATERIALS, V20, P921, DOI 10.1016/S0142-9612(98)00242-7
NR 37
TC 14
Z9 14
U1 0
U2 6
PU EDIZIONI MINERVA MEDICA
PI TURIN
PA CORSO BRAMANTE 83-85 INT JOURNALS DEPT., 10126 TURIN, ITALY
SN 0021-9509
J9 J CARDIOVASC SURG
JI J. Cardiovasc. Surg.
PD DEC
PY 2006
VL 47
IS 6
BP 711
EP 718
PG 8
WC Cardiac & Cardiovascular Systems; Surgery; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology; Surgery
GA 127BU
UT WOS:000243561100015
PM 17043620
DA 2018-10-19
ER

PT J
AU Leysen, I
   Coeckelbergh, T
   Gobin, L
   Smet, H
   Daniel, Y
   De Groot, V
   Tassignon, MJ
AF Leysen, Inge
   Coeckelbergh, Tanja
   Gobin, Laure
   Smet, Helena
   Daniel, Yves
   De Groot, Veva
   Tassignon, Marie-Jose
TI Cumulative neodymium : YAG laser rates after bag-in-the-lens and
   lens-in-the-bag intraocular lens implantation - Comparative study
SO JOURNAL OF CATARACT AND REFRACTIVE SURGERY
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the
   American-Society-of-Cataract-and-Refractive-Surgery
CY APR, 2005
CL Washington, DC
SP Amer Soc Cataract & Refract Surg
ID POSTERIOR CAPSULE OPACIFICATION; CATARACT-SURGERY; CEEON EDGE; ACRYSOF;
   SILICONE; EYES
AB PURPOSE: To study the cumulative neodymium:YAG (Nd:YAG) laser rate after bag-in-the-lens implantation (Morcher 89A) and lens-in-the-bag implantation (Morcher 92S) of 2 intraocular lenses (IOLs) of the same biomaterial.
   SETTING: Department of Ophthalmology, University Hospital of Antwerp, Eclegem, Belgium.
   METHODS: This study comprised 100 eyes of 87 patients who had the bag-in-the-lens IOL implantation between January 2000 and August 2004. The postoperative follow-up ranged between 17 and 72 months. One hundred eyes of 94 patients of the same age and with the same follow-up period received the lens-in-the-bag IOL. The cumulative Nd:YAG laser frequency rates in both groups were calculated, and the cumulative incidence rates were defined by Kaplan-Meier survival analysis.
   RESULTS: No Nd:YAG laser capsulotomy was performed in eyes having bag-in-the-lens IOL implantation. A laser capsulotomy was performed in 20 eyes having lens-in-the-bag IOL implantation; the cumulative frequency in this group was 2% at 1 year and 20% at 71 months, with a plateau beginning at 42 months. The cumulative incidence rate of Nd:YAG posterior capsulotomy was approximately 2% at I year, increasing to approximately 28% at 42 months.
   CONCLUSIONS: The cumulative Nd:YAG laser rate after bag-in-the-lens implantation was zero. A zero rate has not been reported with lens-in-the-bag implantation of an IOL of the same biomaterial or of other biomaterials, as published in the literature. Thus, it can be concluded that the bag-in-the-lens implantation technique has 100% effectiveness against posterior capsule opacification.
C1 Univ Antwerp Hosp, Dept Ophthalmol, B-2650 Edegem, Belgium.
RP Tassignon, MJ (reprint author), Univ Antwerp Hosp, Dept Ophthalmol, Wilrijkstr 10, B-2650 Edegem, Belgium.
EM marie-jose.tassignon@uza.be
RI De Groot, Veva/S-8542-2016
OI De Groot, Veva/0000-0003-3445-6295; Tassignon,
   Marie-Jose/0000-0001-8302-8006
CR APPLE DJ, 1992, SURV OPHTHALMOL, V37, P73, DOI 10.1016/0039-6257(92)90073-3
   Apple DJ, 1999, ARCH OPHTHALMOL-CHIC, V117, P827
   Aslam TM, 2003, SURV OPHTHALMOL, V48, P594, DOI 10.1016/j.survophthal.2003.08.002
   Billotte C, 2004, J CATARACT REFR SURG, V30, P2064, DOI 10.1016/j.jcrs.2004.05.003
   Davison JA, 2004, J CATARACT REFR SURG, V30, P1492, DOI 10.1016/j.jcrs.2003.011.042
   De Groot V, 2005, J CATARACT REFR SURG, V31, P398, DOI 10.1016/j.jcrs.2004.04.061
   Ernest PH, 2003, J CATARACT REFR SURG, V29, P1546, DOI 10.1016/S0886-3350(02)01974-0
   FINE IH, 1992, J CATARACT REFR SURG, V18, P508, DOI 10.1016/S0886-3350(13)80108-3
   Holladay JT, 1999, J CATARACT REFR SURG, V25, P748, DOI 10.1016/S0886-3350(99)00038-3
   Hollick EJ, 1999, OPHTHALMOLOGY, V106, P49, DOI 10.1016/S0161-6420(99)90047-7
   Mester U, 2004, J CATARACT REFR SURG, V30, P978, DOI 10.1016/j.jcrs.2003.09.052
   Missier KAA, 2003, J CATARACT REFR SURG, V29, P1569, DOI 10.1016/S0886-3350(02)02046-1
   Nishi O, 1999, J CATARACT REFR SURG, V25, P521, DOI 10.1016/S0886-3350(99)80049-2
   NISHI O, 1986, J CATARACT REFR SURG, V12, P519, DOI 10.1016/S0886-3350(86)80126-2
   Peng Q, 2000, J CATARACT REFR SURG, V26, P198, DOI 10.1016/S0886-3350(99)00352-1
   Prosdocimo G, 2003, J CATARACT REFR SURG, V29, P1551, DOI 10.1016/S0886-3350(02)02051-5
   Rakic JM, 1997, EXP EYE RES, V64, P67, DOI 10.1006/exer.1996.0179
   Spalton DJ, 1999, EYE, V13, P489
   Sundelin K, 2001, J CATARACT REFR SURG, V27, P1586, DOI 10.1016/S0886-3350(01)00998-1
   Tassignon MJBR, 2002, J CATARACT REFR SURG, V28, P1182, DOI 10.1016/S0886-3350(02)01375-5
NR 20
TC 29
Z9 30
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0886-3350
J9 J CATARACT REFR SURG
JI J. Cataract. Refract. Surg.
PD DEC
PY 2006
VL 32
IS 12
BP 2085
EP 2090
DI 10.1016/j.jcrs.2006.07.025
PG 6
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA 116RL
UT WOS:000242819900029
PM 17137988
DA 2018-10-19
ER

PT J
AU Tamimi, FM
   Torres, J
   Tresguerres, I
   Clemente, C
   Lopez-Cabarcos, E
   Blanco, LJ
AF Tamimi, Faleh Marino
   Torres, Jesus
   Tresguerres, Isabel
   Clemente, Celia
   Lopez-Cabarcos, Enrique
   Blanco, Luis Jerez
TI Bone augmentation in rabbit calvariae: comparative study between Bio-Oss
   (R) and a novel beta-TCP/DCPD granulate
SO JOURNAL OF CLINICAL PERIODONTOLOGY
LA English
DT Article
DE Bio-Oss (R); Brushite; beta-tricalcium phosphate; glycolic acid;
   titanium bone cylinder; vertical bone augmentation
ID OSTEOBLAST-LIKE CELLS; GUIDED BONE; TRICALCIUM PHOSPHATE; BOVINE BONE;
   SUBSTITUTE BIOMATERIALS; REGENERATION; IMPLANTS; RESORPTION; CEMENTS;
   SYSTEM
AB Aim: In the present in vivo study, we compare the bone regeneration capacity of a novel brushite cement synthesized in our laboratory (DTG) with Bio-Oss(R) using rabbits as an animal model.
   Methods: The study was performed in a group of 14 adult New Zealand rabbits using the bone conduction model. Two titanium cylinders were fixed into perforated slits made on the parietal cortical bone of each rabbit. One cylinder was left empty (negative control) and the other was filled with either Bio-Oss(R) or brushite set-cement granules (test cylinder). Four weeks after the intervention, the animals were sacrificed and biopsies were taken. The following parameters were analysed: bone tissue augmentation, bone mineral density and biomaterial resorption. The comparison of data between the different groups was performed using the Mann-Whitney test with a significance level of p<0.05.
   Results: The mean bone mineral density and augmented mineral tissue inside the test cylinders were similar but higher than those of negative controls. Material resorption and bone tissue augmentation were significantly higher in the defects treated with the brushite-based set cement (p<0.05).
   Conclusions: Brushite cement granules were more resorbable and generated more bone tissue than Bio-Oss(R) inside the titanium cylinders placed in the rabbit calvaria.
C1 Univ Complutense Madrid, Fac Farm, Dept Quim Fis 2, E-28040 Madrid, Spain.
   Univ Complutense Madrid, Dept Estomatol 3, E-28040 Madrid, Spain.
   URJC, Dept Ciencias Salud 3, Alcorcon, Spain.
   UAH, Dept Anat & Embriol Humana, Alcala De Henares, Spain.
RP Tamimi, FM (reprint author), Univ Complutense Madrid, Fac Farm, Dept Quim Fis 2, Ramon & Cajal SN, E-28040 Madrid, Spain.
EM fdamimim@farm.ucm.es
RI Lopez Cabarcos, Enrique/L-5802-2014
OI Lopez Cabarcos, Enrique/0000-0003-2939-4130; TORRES GARCIA DENCHE,
   JESUS/0000-0002-8310-9209
CR Acil Y, 2000, J BIOMED MATER RES, V51, P703, DOI 10.1002/1097-4636(20000915)51:4<703::AID-JBM19>3.0.CO;2-A
   Block MS, 1997, J ORAL MAXIL SURG, V55, P1281, DOI 10.1016/S0278-2391(97)90185-3
   Bohner M, 2005, BIOMATERIALS, V26, P6423, DOI 10.1016/j.biomaterials.2005.03.049
   Boo JS, 2002, J CRANIOFAC SURG, V13, P231, DOI 10.1097/00001665-200203000-00009
   Chow LC, 2003, J BIOMED MATER RES B, V65B, P245, DOI 10.1002/jmb.b.10009
   De Boever AL, 2005, CLIN ORAL IMPLAN RES, V16, P549, DOI 10.1111/j.1600-0501.2005.01154.x
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Duda Mariusz, 2004, Ann Univ Mariae Curie Sklodowska Med, V59, P269
   Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029
   HERRON S, 2003, AM J ORTHOPEDICS, V12, P581
   Lieberman Isador H, 2005, Spine J, V5, p305S, DOI 10.1016/j.spinee.2005.02.020
   Lundgren A K, 1999, Clin Implant Dent Relat Res, V1, P41, DOI 10.1111/j.1708-8208.1999.tb00090.x
   Lundgren AK, 2000, CLIN ORAL IMPLAN RES, V11, P99, DOI 10.1034/j.1600-0501.2000.011002099.x
   MIRTCHI AA, 1989, BIOMATERIALS, V10, P475, DOI 10.1016/0142-9612(89)90089-6
   Nevins M, 1996, INT J PERIODONT REST, V16, P9
   Pautke C, 2005, BONE, V37, P441, DOI 10.1016/j.bone.2005.05.008
   Rosen VB, 2002, BIOMATERIALS, V23, P921
   Schilling AF, 2004, BIOMATERIALS, V25, P3963, DOI 10.1016/j.biomaterials.2003.10.079
   Schmid J, 1997, CLIN ORAL IMPLAN RES, V8, P244, DOI 10.1034/j.1600-0501.1997.080311.x
   Schwartz Z, 1998, J PERIODONTOL, V69, P470, DOI 10.1902/jop.1998.69.4.470
   Slotte C, 2003, INT J ORAL MAX IMPL, V18, P795
   Slotte C, 1999, CLIN ORAL IMPLAN RES, V10, P468, DOI 10.1034/j.1600-0501.1999.100605.x
   Stavropoulos A, 2004, J CLIN PERIODONTOL, V31, P30, DOI 10.1111/j.0303-6979.2004.00434.x
   Suba Z, 2004, INT J ORAL MAX IMPL, V19, P832
   Suzuki T, 2000, J BIOSCI BIOENG, V89, P18, DOI 10.1016/S1389-1723(00)88045-7
   TAMIMI FM, 2005, Patent No. 2005030945
   Tas AC, 2004, J AM CERAM SOC, V87, P2195, DOI 10.1111/j.1151-2916.2004.tb07490.x
   Taylor JC, 2002, INT J ORAL MAX IMPL, V17, P321
   Trisi P, 2003, INT J PERIODONT REST, V23, P69
   von Arx T, 2001, CLIN ORAL IMPLAN RES, V12, P260, DOI 10.1034/j.1600-0501.2001.012003260.x
   Wiltfang Joerg, 2003, Clin Oral Implants Res, V14, P213, DOI 10.1034/j.1600-0501.2003.140212.x
   Zaffe D, 2005, J MATER SCI-MATER M, V16, P789, DOI 10.1007/s10856-005-3574-5
NR 32
TC 53
Z9 56
U1 1
U2 13
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0303-6979
J9 J CLIN PERIODONTOL
JI J. Clin. Periodontol.
PD DEC
PY 2006
VL 33
IS 12
BP 922
EP 928
DI 10.1111/j.1600-051X.2006.01004.x
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 111HI
UT WOS:000242441600009
PM 17092243
DA 2018-10-19
ER

PT J
AU Domergue, S
   Psomas, C
   Yachouh, J
   Lesnik, A
   Reynes, J
   Goudot, P
   Jammet, P
AF Domergue, Sophie
   Psomas, Christina
   Yachouh, Jacques
   Lesnik, Alvian
   Reynes, Jacques
   Goudot, Patrick
   Jammet, Patrick
TI Fat microinfiltration autografting for facial restructuring in HIV
   patients
SO JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
LA English
DT Article
DE human immunodeficiency virus; lipodystrophy; Coleman's surgical
   technique; fat panniculus
ID LIPODYSTROPHY
AB Introduction: Antiretroviral drugs used to treat HIV infection are closely associated with faciocervical and peripheral lipodystrophies. There are several options for surgical treatment of facial lipodystrophy, one of these was described by S. R.Coleman in 1994, the technique of fat transplantation. Material and methods: A retrospective study of 23 seropositive patients is presented, who were treated according to Coleman's technique. The surgical procedure was evaluated by clinical and CT analysis. The longest follow-up was 3 years. Results: The technique was well tolerated from both a clinical and psychological point of view. 74% were successful. Multiple fat transplantation procedures were required to obtain a satisfactory result for the remaining patients. No complications were observed. Discussion: Coleman's method is very simple. It is performed without using any biomaterial. There are aesthetic and social benefits for the patients. A limitation of this procedure is that some patients do not have enough fat at the donor site. Conclusion: The results of this procedure after a maximum of 3 years postoperatively have been positive. However, there is a need of long-term experience with this method. (C) 2006 European Association for Cranio-Maxillofacial Surgery.
C1 Univ Hosp Montpellier, Dept Maxillofacial & Oral Surg, Montpellier, France.
   Univ Hosp Montpellier, Dept Imaging, Montpellier, France.
   Univ Hosp Montpellier, Dept Infect Dis, Montpellier, France.
RP Jammet, P (reprint author), Univ Hosp Montpellier, Dept Maxillofacial & Oral Surg, Montpellier, France.
EM c-luna@chu-montpellier.fr
CR Amar R E, 1999, Ann Chir Plast Esthet, V44, P593
   Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2
   Caye N, 2003, Ann Chir Plast Esthet, V48, P2, DOI 10.1016/S0294-1260(02)00176-0
   COLEMAN SR, 1995, AESTHET PLAST SURG, V19, P421, DOI 10.1007/BF00453875
   Heath KV, 2001, AIDS, V15, P231, DOI 10.1097/00002030-200101260-00013
   Jauffret J L, 2001, Ann Chir Plast Esthet, V46, P31, DOI 10.1016/S0294-1260(01)80006-6
   SAVES M, 2002, CLIN INFECT DIS, V3, P1396
   Shevitz A, 2001, AIDS, V15, P1917, DOI 10.1097/00002030-200110190-00003
NR 8
TC 12
Z9 12
U1 0
U2 0
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1010-5182
J9 J CRANIO MAXILL SURG
JI J. Cranio-MaxilloFac. Surg.
PD DEC
PY 2006
VL 34
IS 8
BP 484
EP 488
DI 10.1016/j.jcms.2006.07.857
PG 5
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 130KO
UT WOS:000243798700005
PM 17157518
DA 2018-10-19
ER

PT J
AU Venegas, C
   Palacios, JM
   Apella, MC
   Morando, PJ
   Blesa, MA
AF Venegas, C.
   Palacios, J. M.
   Apella, M. C.
   Morando, P. J.
   Blesa, M. A.
TI Calcium modulates interactions between bacteria and hydroxyapatite
SO JOURNAL OF DENTAL RESEARCH
LA English
DT Article
DE hydroxyapatite; bacteria; surface properties; interactions
ID CELL-SURFACE HYDROPHOBICITY; STREPTOCOCCUS-SALIVARIUS HB;
   ELECTROPHORETIC MOBILITY; ORAL BACTERIA; ADHESION; ADHERENCE; BINDING;
   ENAMEL
AB Bacterial adhesion onto hydroxyapatite is known to depend on the surface properties of both the biomaterial and the bacterial strain, but less is known about the influence of the composition of the aqueous medium. Here, the adhesion of Streptococcus mutans and 3 different Lactobacilli on powdered hydroxyapatite was shown to change with Ca2+ concentration. The effect depends on the surface properties of each strain. Adhesion of Lactobacillus fermentum and salivarius ( and of Streptococcus mutans at low Ca2+) was enhanced with increasing Ca2+ concentration. Lactobacillus casei was efficiently removed by adhesion on hydroxyapatite, even without Ca2+ addition, and the effect of this ion was only marginal. The results are interpreted in terms of Ca2+-mediated adhesion, and relative to the hydrophobic properties of each strain and the electrical properties of the bacterial and solid surfaces ( electrophoretic mobility).
C1 CERELA, San Miguel De Tucuman, Argentina.
   Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina.
   Univ Nacl Tucuman, Fac Ciencias Nat, San Miguel De Tucuman, Argentina.
   Univ Nacl Tucuman, Inst Miguel Lillo, San Miguel De Tucuman, Argentina.
RP Apella, MC (reprint author), CERELA, Chacabuco 145,4000 San Miguel Tucuman, San Miguel De Tucuman, Argentina.
EM mapella@cerela.org.ar
CR BLESA MA, 1993, CHEM DISSOLUTION MET, P153
   BUSSCHER HJ, 1995, FEMS MICROBIOL LETT, V128, P229, DOI 10.1016/0378-1097(95)00103-C
   Cann J R, 1978, Methods Enzymol, V48, P299
   DEAZA PN, 2004, BIOMATERIALS, P54
   EIFERT R, 1984, INFECT IMMUN, V44, P287
   Guggenheim M, 2001, APPL ENVIRON MICROB, V67, P1343, DOI 10.1128/AEM.67.3.1343-1350.2001
   Hunter R.J., 1981, ZETA POTENTIAL COLLO, P59
   KAMBARA M, 1978, J DENT RES, V57, P306, DOI 10.1177/00220345780570022701
   Pelletier C, 1997, APPL ENVIRON MICROB, V63, P1725
   RAIBAUD P, 1961, J APPL BACTERIOL, V24, P285, DOI 10.1111/j.1365-2672.1961.tb00262.x
   Rodenas LG, 2005, J COLLOID INTERF SCI, V290, P145, DOI 10.1016/j.jcis.2005.04.041
   ROSE RK, 1994, J DENT RES, V73, P1742, DOI 10.1177/00220345940730111001
   ROSE RK, 1993, J DENT RES, V72, P78, DOI 10.1177/00220345930720011201
   ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x
   SONOHARA R, 1995, BIOPHYS CHEM, V55, P273, DOI 10.1016/0301-4622(95)00004-H
   Stumm W, 1996, AQUAT CHEM, P516
   SWEET SP, 1987, FEMS MICROBIOL LETT, V48, P159, DOI 10.1016/0378-1097(87)90154-6
   VANDERMEI HC, 1988, J BACTERIOL, V170, P2462, DOI 10.1128/jb.170.6.2462-2466.1988
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1898
   Verwey E. J., 1948, THEORY STABILITY LYO, P120
   WEERKAMP AH, 1988, J DENT RES, V67, P1483, DOI 10.1177/00220345880670120801
   WEERKAMP AH, 1980, INFECT IMMUN, V30, P150
   Yoshida Y, 1998, J MATER SCI-MATER M, V9, P117, DOI 10.1023/A:1008807300825
NR 23
TC 27
Z9 27
U1 0
U2 5
PU INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R
PI ALEXANDRIA
PA 1619 DUKE ST, ALEXANDRIA, VA 22314-3406 USA
SN 0022-0345
J9 J DENT RES
JI J. Dent. Res.
PD DEC
PY 2006
VL 85
IS 12
BP 1124
EP 1128
DI 10.1177/154405910608501211
PG 5
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 108JG
UT WOS:000242235500012
PM 17122166
DA 2018-10-19
ER

PT J
AU Chollet, C
   Lazare, S
   Brouillaud, B
   Labrugere, C
   Bareille, R
   Durrieu, MC
AF Chollet, Celine
   Lazare, Sylvain
   Brouillaud, Brigitte
   Labrugere, Christine
   Bareille, Reine
   Durrieu, Marie-Christine
TI RGD Peptide Grafting onto Micro-patterned PET: Peptide Distribution
   Impact on Cell Attachment
SO JOURNAL OF LASER MICRO NANOENGINEERING
LA English
DT Article
DE Peptide; biomaterial; KrF laser; micro-pattern; cell/material
   interaction
AB The aim of this study was to evaluate the impact of different RGD peptides densities and spatial distribution on Human Osteoblasts Progenitors (HOP) attachment onto Poly (ethylene terephthalate) (PET) film surfaces. Biomimetic modifications were performed by means of a four-step reaction procedure: surface hydrolyse, oxidation in order to create COOH functions, coupling agent grafting and finally immobilization of peptides. To validate modification steps we used physico-chemical techniques: XPS was used to prove covalent grafting at each step of the RGD grafting, toluidine blue and high-resolution mu-imager (using [H-3]-Lys) were used to evaluate densities and spatial molecules distribution, optical profilometer and Scanning Electron Microscopy were used to characterize ablated patterns. Moreover, mu-imager has exhibited the stability of peptides grafted onto the surface when treated in harsh conditions. The efficiency of this new route for biomimetic modification of PET surface was demonstrated by measuring the adhesion between 1 and 24 h of osteoprogenitor cells isolated from HBMSC. Benefits of the as-proposed method were related to the different concentrations and distribution of peptides grafted onto the surface as well as the capacity of RGD peptide to interact with integrin receptors.
C1 [Chollet, Celine; Brouillaud, Brigitte; Bareille, Reine; Durrieu, Marie-Christine] INSERM, U577, F-33076 Bordeaux, France.
   [Chollet, Celine; Brouillaud, Brigitte; Bareille, Reine; Durrieu, Marie-Christine] Univ Bordeaux 2, F-33076 Bordeaux, France.
   [Lazare, Sylvain] Univ Bordeaux 1, LPCM, UMR 5803, CNRS, F-33405 Talence, France.
   [Labrugere, Christine] CNRS, ICMCB, Ctr Caracterisat Mat Avances, F-33608 Pessac, France.
RP Chollet, C (reprint author), INSERM, U577, F-33076 Bordeaux, France.
EM celine.chollet@bordeaux.inserm.fr
RI DURRIEU, Marie-Christine/I-4358-2016
OI DURRIEU, Marie-Christine/0000-0003-0583-9289
FU INSERM; CNRS; Conseil Regional Aquitaine
FX This work was supported by INSERM, CNRS and Conseil Regional Aquitaine.
CR Barthe N, 1999, J NUCL MED, V40, P868
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   CHARON Y, 1991, NUCL INSTRUM METH A, V310, P379, DOI 10.1016/0168-9002(91)91064-3
   CHOLLET C, 2006, BIOMATERIALS UNPUB
   CrumeyrolleArias M, 1996, HISTOCHEM J, V28, P801, DOI 10.1007/BF02272153
   Duncan AC, 2004, APPL SURF SCI, V221, P93, DOI 10.1016/S0169-4332(03)00819-5
   HUBBELL JA, 1992, ANN NY ACAD SCI, V665, P253, DOI 10.1111/j.1749-6632.1992.tb42589.x
   HUBBELL JA, 1991, BIO-TECHNOL, V9, P568, DOI 10.1038/nbt0691-568
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Irvine DJ, 2002, BIOPHYS J, V82, P120, DOI 10.1016/S0006-3495(02)75379-4
   LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MASSIA SP, 1990, ANN NY ACAD SCI, V589, P261, DOI 10.1111/j.1749-6632.1990.tb24251.x
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   Porte-Durrieu MC, 2004, BIOMATERIALS, V25, P4837, DOI 10.1016/j.biomaterials.2003.11.037
   UCHIDA E, 1993, LANGMUIR, V9, P1121, DOI 10.1021/la00028a040
   VILAMITJANAAMEDEE J, 1993, IN VITRO CELL DEV-AN, V29, P699
NR 18
TC 5
Z9 5
U1 1
U2 10
PU JAPAN LASER PROCESSING SOC
PI OSAKA
PA OSAKA UNIV, 11-1 MIHOGAOKA, IBARAKI C/O KATAYAMA LAB, JOINING & WELDING
   RES INST, OSAKA, 567-0047, JAPAN
SN 1880-0688
J9 J LASER MICRO NANOEN
JI J. Laser Micro Nanoeng.
PD DEC
PY 2006
VL 1
IS 3
BP 226
EP 230
DI 10.2961/jlmn.2006.03.0015
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Optics; Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Optics; Physics
GA V04KO
UT WOS:000207057500015
OA Bronze
DA 2018-10-19
ER

PT J
AU Tiainen, J
   Soini, Y
   Suokas, E
   Veiranto, M
   Tormala, P
   Waris, T
   Ashammakhi, N
AF Tiainen, Johanna
   Soini, Ylermi
   Suokas, Esa
   Veiranto, Minna
   Tormala, Pertti
   Waris, Timo
   Ashammakhi, Nureddin
TI Tissue reactions to bioabsorbable ciprofloxacin-releasing
   polylactide-polyglycolide 80/20 screws in rabbits' cranial bone
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 10th International Conference on Polymers in Medicine and Surgery
   (PIMS2004)
CY SEP 06-08, 2004
CL Cambridge, ENGLAND
ID CELLS IN-VITRO; DELIVERY SYSTEM; OSTEOMYELITIS; FIXATION; POLYMER;
   TROVAFLOXACIN; LEVOFLOXACIN; BIOMATERIALS; ANTIBIOTICS; IMPLANT
AB The aim of this study was to assess tissue reactions to bioabsorbable self-reinforced ciprofloxacin-releasing polylactide/polyglycolide (SR-PLGA) 80/20 screws in rabbits' cranial bone. Two screws were implanted in each rabbit, one screw on either side of the sagittal suture (n = 28 rabbits). Animals were sacrificed after 2, 4, 8, 16, 24, 54 and 72 weeks, four animals per group. On histological examination the number of macrophages, giant cells, active osteoblasts and fibrous tissue layers were assessed and degradation of the screws was evaluated. At 2 weeks, the highest number of macrophages and giant cells were seen near the heads of the screws. After 4 and 8 weeks, the number of giant cells decreased but that of macrophages decreased from 16 weeks and on. Screws were surrounded by fibrous tissue capsule that progressively was growing in thickness by time. Active osteoblasts were seen around the shaft of the screws with the highest number seen at 4 weeks postoperatively. At 16 weeks, compact fragmentation of the screw heads was seen with macrophages seen inside the screw matrices. After 24 weeks, no polarization of the screws was seen. After one year, PLGA screws had been replaced by adipose tissue, fibrous tissue and "foamy macrophages" which had PLGA particles inside them. After 1 1/2 years, the amount of biomaterial remaining had decreased remarkably. The particles of biomaterial were inside "foamy macrophages." Ciprofloxacin-releasing SR-PLGA 80/20 screws elicited a mild inflammatory reaction but did not interfere with osteoblast activity. No complications were seen when implanted in cranial bone of rabbit.
C1 Oulu Univ Hosp, Div Plast Surg, Dept Surg, FIN-90014 Oulu, Finland.
   Oulu Univ Hosp, Dept Pathol, FIN-90014 Oulu, Finland.
   Linvatec Biomat Ltd, Tampere, Finland.
   Tampere Univ Technol, Inst Biomat, FIN-33101 Tampere, Finland.
RP Tiainen, J (reprint author), Oulu Univ Hosp, Div Plast Surg, Dept Surg, POB 5000, FIN-90014 Oulu, Finland.
EM jtiainen@cc.oulu.fi
CR Ashammakhi N, 2001, PLAST RECONSTR SURG, V108, P167, DOI 10.1097/00006534-200107000-00027
   Ashammakhi N, 2005, J CRANIOFAC SURG, V16, P195, DOI 10.1097/00001665-200503000-00002
   Ashammakhi NA, 1996, J BIOMED MATER RES, V33, P297, DOI 10.1002/(SICI)1097-4636(199624)33:4<297::AID-JBM10>3.0.CO;2-C
   BECKER PL, 1994, J ORTHOPAED RES, V12, P737, DOI 10.1002/jor.1100120517
   Calhoun JH, 1997, CLIN ORTHOP RELAT R, P206
   EPPLEY BL, 1995, PLAST RECONSTR SURG, V96, P316, DOI 10.1097/00006534-199508000-00009
   Gumusderelioglu M, 2000, J BIOMAT SCI-POLYM E, V11, P1039, DOI 10.1163/156856200743562
   Habal MB, 1999, J CRANIOFAC SURG, V10, P491, DOI 10.1097/00001665-199911000-00008
   Holtom PD, 2000, J ORTHOPAED RES, V18, P721, DOI 10.1002/jor.1100180507
   HUMPHREY SJ, 1998, CLIN ORTHOP RELAT R, V349, P218
   HUNT JA, 1995, BIOMATERIALS, V16, P167, DOI 10.1016/0142-9612(95)92113-K
   JACOB E, 1991, CLIN ORTHOP RELAT R, P237
   KITCHELL JP, 1985, METHOD ENZYMOL, V112, P436
   KNUUTILA K, 2004, SOC BIOM S BIOM REG, V10, P16
   Leinonen S, 2002, J CRANIOFAC SURG, V13, P212, DOI 10.1097/00001665-200203000-00005
   Miclau T, 1998, J ORTHOPAED RES, V16, P509, DOI 10.1002/jor.1100160417
   Nie L, 1998, J ORTHOPAED RES, V16, P76, DOI 10.1002/jor.1100160113
   NIEMELA SM, IN PRESS J BIOMED MA
   OSTERMANN PAW, 1993, CLIN ORTHOP RELAT R, P102
   OVERBECK JP, 1995, J INVEST SURG, V8, P155, DOI 10.3109/08941939509023138
   Perry AC, 2003, CLIN ORTHOP RELAT R, P95, DOI 10.1097/01.blo.0000087322.60612.14
   Pietrzak WS, 1997, J CRANIOFAC SURG, V8, P87, DOI 10.1097/00001665-199703000-00004
   SHINTO Y, 1992, J BONE JOINT SURG BR, V74, P600
   TEUPE C, 1992, ARCH ORTHOP TRAUM SU, V112, P33, DOI 10.1007/BF00431041
   Tiainen J, 2004, J BIOMED MATER RES B, V70B, P49, DOI 10.1002/jbm.b.30013
   Tiainen J, 2002, J CRANIOFAC SURG, V13, P427, DOI 10.1097/00001665-200205000-00013
   TORMALA P, 1992, Clinical Materials, V10, P29, DOI 10.1016/0267-6605(92)90081-4
   Veiranto M, 2004, ADV EXP MED BIOL, V553, P197
   VERT M, 1992, J MATER SCI-MATER M, V3, P432, DOI 10.1007/BF00701240
   VINCE DG, 1991, BIOMATERIALS, V12, P731, DOI 10.1016/0142-9612(91)90021-2
NR 30
TC 14
Z9 15
U1 1
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2006
VL 17
IS 12
BP 1315
EP 1322
DI 10.1007/s10856-006-0606-8
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 112FM
UT WOS:000242511100016
PM 17143763
DA 2018-10-19
ER

PT J
AU Wolf, C
   Lederer, K
   Bergmeister, H
   Losert, U
   Bock, P
AF Wolf, C.
   Lederer, K.
   Bergmeister, H.
   Losert, U.
   Boeck, P.
TI Animal experiments with ultra-high molecular weight polyethylene
   (UHMW-PE) stabilised with alpha-tocopherol used for articulating
   surfaces in joint endoprostheses
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 10th International Conference on Polymers in Medicine and Surgery
   (PIMS2004)
CY SEP 06-08, 2004
CL Cambridge, ENGLAND
ID ANTIOXIDANT ROLE; GAMMA-RADIATION; IN-VIVO; BIODEGRADATION;
   STERILIZATION; OXIDATION; POLYMERS
AB Numerous investigations proved the impressive suitability of alpha-tocopherol as a stabilizer for ultra-high molecular weight polyethylene (UHMW-PE) used for endoprostheses. Regarding the biocompatibility of this new biomaterial, in-vitro celltoxicity tests gave no hint for a cyto- or genotoxic activity. In this study, animal experiments are carried out to further ensure the biocompatibility of this biomaterial.
   Thin UHMW-PE-films (20 x 6 x 0.23 mm(3)) were implanted subcutaneously into rats. Morphology and reactivity of surrounding connective tissue against either pure UHMW-PE material or UHMW-PE containing alpha-tocopherol were studied at timed intervals (2 weeks, 3 month, and 6 month after operation) in 3 groups of animals, each group comprising 10 animals. Parallel to these tests, material changes were investigated in these 3 groups of 10 animals at the same intervals after operation with the help of infrared spectroscopy (FTIR). Within the implantation time, no noteworthy oxidative degradation could be observed. The amount of lost alpha-tocopherol due to diffusion is low enough to ensure a lifetime stabilisation of the UHMW-PE.
   The implants were all well tolerated and definitely encapsulated already 2 weeks after operation. Presence or absence of alpha-tocopherol in the implants did not evince morphological differences. Therefore, negative consequences were not manifest in the presence of alpha-tocopherol.
C1 Univ Min & Met Leoben, Dept Chem Polymer Mat, A-8700 Leoben, Austria.
   Polymer Competence Ctr Leoben GmbH PCCL, A-8700 Leoben, Austria.
   Univ Vienna, Inst Biomed Res, Vienna, Austria.
   Univ Vet Med Vienna, Dept Histol & Embryol, Vienna, Austria.
RP Lederer, K (reprint author), Univ Min & Met Leoben, Dept Chem Polymer Mat, A-8700 Leoben, Austria.
EM christian.wolf@unileoben.ac.at; polychem@unileoben.ac.at
CR Al-Malaika S, 1999, POLYM DEGRAD STABIL, V64, P145, DOI 10.1016/S0141-3910(98)00187-6
   ALMALAIKA S, 1994, J POLYM SCI POL CHEM, V32, P3099, DOI 10.1002/pola.1994.080321610
   Buchanan FJ, 1998, PLAST RUB COMPOS PRO, V27, P148
   CASANI R, 1997, KIRKOTHMER ENCY CHEM, V25, P256
   Costa L, 1998, BIOMATERIALS, V19, P1371, DOI 10.1016/S0142-9612(98)00013-1
   Costa L, 1998, BIOMATERIALS, V19, P659, DOI 10.1016/S0142-9612(97)00160-9
   Crank J., 1968, DIFFUSION POLYM, P15
   delPrever EB, 1996, BIOMATERIALS, V17, P873, DOI 10.1016/0142-9612(96)83282-0
   EYERER P, 1987, KUNSTST-GER PLAST+, V77, P617
   Frei B., 1994, NATURAL ANTIOXIDANTS, P107
   Goldman M, 1996, POLYMER, V37, P2909, DOI 10.1016/0032-3861(96)89386-4
   Goldman M, 1997, J BIOMED MATER RES, V37, P43, DOI 10.1002/(SICI)1097-4636(199710)37:1<43::AID-JBM6>3.0.CO;2-J
   Romeis B., 1989, MIKROSKOPISCHE TECHN
   Schaffner S., [No title captured], Patent No. [US 6 277 390 B1, 6277390]
   Wolf C, 2002, J MATER SCI-MATER M, V13, P701, DOI 10.1023/A:1015750112343
   Wolf C, 2002, J MATER SCI-MATER M, V13, P185, DOI 10.1023/A:1013834113967
   WOLF C, UNPUB J MAT SCI MAT
   0995450
NR 18
TC 9
Z9 9
U1 0
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2006
VL 17
IS 12
BP 1341
EP 1347
DI 10.1007/s10856-006-0609-5
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 112FM
UT WOS:000242511100019
PM 17143766
DA 2018-10-19
ER

PT J
AU Lv, Q
   Feng, QL
AF Lv, Qiang
   Feng, QingLing
TI Preparation of 3-D regenerated fibroin scaffolds with freeze drying
   method and freeze drying/foaming technique
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 10th International Conference on Polymers in Medicine and Surgery
   (PIMS2004)
CY SEP 06-08, 2004
CL Cambridge, ENGLAND
ID BIODEGRADABLE POLYMERIC SCAFFOLDS; SILK FIBROIN; FABRICATION;
   ATTACHMENT; ACID)
AB Although three-dimensional fibroin scaffolds have been prepared with freeze drying method, the porosity and pore sizes still can not satisfy the requirement of tissue engineering. In this article, fibroin porous scaffold with high porosity and > 100 mu m diameter interconnected pores was firstly prepared with freeze drying method through adjusting fibroin concentration. The morphology of different scaffolds lyophilized from different fibroin concentration was observed by SEM. A novel freeze drying improved method, freeze drying/foaming technique, was also devised to prepare fibroin scaffolds at different fibroin concentrations. Using the said method, the porosity and pore size of fibroin scaffolds prepared from 12% concentration were 85.8 +/- 4% and 109 +/- 20 mu m respectively with yield strength up to 450 +/- 6 KPa while the porosity and pore size of fibroin scaffolds prepared from 8% concentration were 96.9 +/- 3.6% and 120 +/- 30 mu m respectively with yield strength up to 30 +/- 1 KPa. The freeze drying/foaming technique produced scaffolds with a useful combination of high yield strength, interconnected pores, and pore sizes greater than 100 mu m in diameter. Through adjusting fibroin concentration and thawing time, the porosity, pore sizes and mechanical properties could be controlled to satisfy the different requirements of tissue engineering. The results suggested that fibroin scaffolds prepared with the above methods could be formed for utility in biomaterial application.
C1 Tsing Hua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
RP Feng, QL (reprint author), Tsing Hua Univ, Dept Mat Sci & Engn, Beijing 100084, Peoples R China.
EM biomater@mail.tsinghua.edu.cn
OI Feng, Qingling/0000-0003-1288-300X
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Giordano RA, 1996, J BIOMAT SCI-POLYM E, V8, P63, DOI 10.1163/156856297X00588
   Gotoh Y, 2004, BIOMATERIALS, V25, P1131, DOI 10.1016/S0142-9612(03)00633-1
   GREGORY HA, 2002, BIOMATERIALS, V23, P4131
   LANGER R, 1993, TISSUE ENG SCI, V260, P920
   Liao CJ, 2002, J BIOMED MATER RES, V59, P676, DOI 10.1002/jbm.10030
   Lu Q, 2004, CHEM J CHINESE U, V25, P1752
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   MINGZHONG L, 2001, J APPL POLYM SCI, V79, P2192
   MINGZHONG L, 2001, J APPL POLYM SCI, V79, P2185
   Mooney DJ, 1996, BIOMATERIALS, V17, P1417, DOI 10.1016/0142-9612(96)87284-X
   Nam YS, 1999, J BIOMED MATER RES, V47, P8, DOI 10.1002/(SICI)1097-4636(199910)47:1<8::AID-JBM2>3.0.CO;2-L
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Nerem R M, 1995, Tissue Eng, V1, P3, DOI 10.1089/ten.1995.1.3
   Perez-Rigueiro J, 1998, J APPL POLYM SCI, V70, P2439, DOI 10.1002/(SICI)1097-4628(19981219)70:12<2439::AID-APP16>3.0.CO;2-J
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5
NR 18
TC 60
Z9 62
U1 0
U2 24
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD DEC
PY 2006
VL 17
IS 12
BP 1349
EP 1356
DI 10.1007/s10856-006-0610-z
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 112FM
UT WOS:000242511100020
PM 17143767
DA 2018-10-19
ER

PT J
AU Orsini, G
   Scarano, A
   Piattelli, M
   Piccirilli, M
   Caputi, S
   Piattelli, A
AF Orsini, Giovanna
   Scarano, Antonio
   Piattelli, Maurizio
   Piccirilli, Marcello
   Caputi, Sergio
   Piattelli, Adriano
TI Histologic and ultrastructural analysis of regenerated bone in maxillary
   sinus augmentation using a porcine bone-derived biomaterial
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE biomaterial; bone regeneration; histology; transmission electron
   microscopy
ID IMPLANT PLACEMENT; INTERFACE; HYDROXYAPATITE; OSTEOPONTIN; BIO-OSS(R);
   ELEVATION
AB Background: The purpose of the present study was the histologic and ultrastructural evaluation of a biomaterial composed of cortical pig bone in the form of granules.
   Methods: After maxillary sinus augmentation using this biomaterial, 10 specimens were retrieved after 5 months in 10 patients using this biomaterial. The specimens were processed to be observed under light microscopy (LM) and transmission electron microscopy (TEM). Histomorphometric measurements were presented by means standard deviations.
   Results: LM showed that most of the particles were surrounded by newly formed bone. In some areas, the osteoid matrix was present; however, mainly compact bone was present at the interface. There was no evidence of an acute inflammatory infiltrate. The newly formed bone was 36% +/- 2.8% and marrow spaces were 38%+/- 1.6%, whereas residual grafted material was 31%+/- 1.6%. Under TEM, all phases of bone formation (osteoid matrix, woven, and lamellar bone) were observed in proximity with the biomaterial particles. The bone-biomaterial interface showed a close contact between the porcine bone particles and the surrounding bone that had mainly features of mature bone with numerous osteocytes. A lamina limitans was sometimes present at this interface.
   Conclusions: According to our knowledge, this is the first study presenting data on TEM of a porcine bone-derived biomaterial used in sinus augmentation procedures in humans. Our findings show that this is a biocompatible biomaterial that can be used for maxillary sinus augmentation procedures without interfering with the normal reparative bone processes.
C1 Univ G dAnnunzio, Dept Stomatol & Oral Sci, Chieti, Italy.
RP Piattelli, A (reprint author), Univ G dAnnunzio, Dept Stomatol & Oral Sci, Chieti, Italy.
EM apiattelli@unich.it
RI Scarano, Antonio/F-6961-2017; Orsini, Giovanna/B-5470-2016
OI Scarano, Antonio/0000-0003-1374-6146; Orsini,
   Giovanna/0000-0002-2641-0695
CR Artzi Z, 2002, CLIN ORAL IMPLAN RES, V13, P420, DOI 10.1034/j.1600-0501.2002.130411.x
   Ayukawa Y, 1998, J BIOMED MATER RES, V41, P111
   Barone A, 2006, INT J ORAL MAX IMPL, V21, P81
   Barone A, 2005, INT J ORAL MAX IMPL, V20, P519
   Brunski J B, 1999, Adv Dent Res, V13, P99
   Brunski JB, 2000, INT J ORAL MAX IMPL, V15, P15
   Davies JE, 1996, ANAT REC, V245, P426
   DELANGE GL, 1990, J BIOMED MATER RES, V24, P829, DOI 10.1002/jbm.820240704
   Froum SJ, 1998, INT J PERIODONT REST, V18, P529
   Hallman M, 2002, INT J ORAL MAX IMPL, V17, P635
   Imbronito AV, 2005, J BIOMED MATER RES A, V74A, P215, DOI 10.1002/jbm.a.30350
   Jensen OT, 1998, INT J ORAL MAX IMPL, V13, P11
   Landi L, 2000, INT J PERIODONT REST, V20, P575
   McKee MD, 1996, MICROSC RES TECHNIQ, V33, P141, DOI 10.1002/(SICI)1097-0029(19960201)33:2<141::AID-JEMT5>3.0.CO;2-W
   Orsini G, 2005, J BIOMED MATER RES B, V74B, P448, DOI 10.1002/jbm.b.30196
   Rosen VB, 2002, BIOMATERIALS, V23, P921
   Tapety FI, 2004, CLIN ORAL IMPLAN RES, V15, P315, DOI 10.1111/j.1600-0501.2004.01012.x
   Valentini P, 2000, INT J PERIODONT REST, V20, P245
   Valentini P, 1998, CLIN ORAL IMPLAN RES, V9, P59, DOI 10.1034/j.1600-0501.1998.090108.x
   Valentini P, 1997, INT J PERIODONT REST, V17, P233
   van den Bergh JPA, 1998, CLIN ORAL IMPLAN RES, V9, P429, DOI 10.1034/j.1600-0501.1996.090608.x
   Wallace SS, 1996, INT J PERIODONT REST, V16, P47
   Wallace Stephen S, 2003, Ann Periodontol, V8, P328, DOI 10.1902/annals.2003.8.1.328
NR 23
TC 86
Z9 86
U1 0
U2 3
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
EI 1943-3670
J9 J PERIODONTOL
JI J. Periodont.
PD DEC
PY 2006
VL 77
IS 12
BP 1984
EP 1990
DI 10.1902/jop.2006.060181
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 130LO
UT WOS:000243801300007
PM 17209782
DA 2018-10-19
ER

PT J
AU Wang, XY
   Kim, HJ
   Wong, C
   Vepari, C
   Matsumoto, A
   Kaplan, DL
AF Wang, Xianyan
   Kim, Hyeon Joo
   Wong, Cheryl
   Vepari, Charu
   Matsumoto, Akira
   Kaplan, David L.
TI Fibrous proteins and tissue engineering
SO MATERIALS TODAY
LA English
DT Review
ID MESENCHYMAL STEM-CELLS; ELASTIN-LIKE POLYPEPTIDE; CONTROLLED
   DRUG-DELIVERY; MARROW STROMAL CELL; BOMBYX-MORI SILK; IN-VITRO; SPIDER
   SILK; COILED-COILS; POLYURETHANE SCAFFOLDS; TRANSGENIC PLANTS
AB Fibrous proteins are finding broad impact in biomaterial systems for a range of cell and tissue studies. This impact derives from an improved insight into fundamental structure-function relationships, as well as the unique material properties attained with these protein polymers. Recent advances in the use of these protein systems in a variety of biomaterial and tissue engineering applications are reviewed, with a focus on approaches to control the structure, chemistry, and morphology of the biomaterials formed and enable cell and tissue outcomes to be directed in vitro and in vivo.
C1 Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
EM David.Kaplan@tufts.edu
RI Matsumoto, Akira/B-6935-2011
CR ABRAHAM LC, 2006, IN PRESS BIOMATERIAL
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Altman GH, 2002, J BIOMECH ENG-T ASME, V124, P742, DOI 10.1115/1.1519280
   Arnold WV, 1998, J BIOL CHEM, V273, P31822, DOI 10.1074/jbc.273.48.31822
   Bellingham CM, 2003, BIOPOLYMERS, V70, P445, DOI 10.1002/bip.10512
   Ber S, 2005, BIOMATERIALS, V26, P1977, DOI 10.1016/j.biomaterials.2004.07.007
   Bini E, 2004, J MOL BIOL, V335, P27, DOI 10.1016/j.jmb.2003.10.043
   Cai KY, 2002, BIOMATERIALS, V23, P1153, DOI 10.1016/S0142-9612(01)00230-7
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Chen MC, 2005, J CONTROL RELEASE, V108, P178, DOI 10.1016/j.jconrel.2005.07.022
   Chiarini A, 2003, BIOMATERIALS, V24, P789, DOI 10.1016/S0142-9612(02)00417-9
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P613, DOI 10.1016/S0169-409X(02)00041-8
   Chrobak KM, 2006, MICROVASC RES, V71, P185, DOI 10.1016/j.mvr.2006.02.005
   Dal Pra I, 2003, TISSUE ENG, V9, P1113, DOI 10.1089/10763270360728026
   Dal Pra I, 2005, BIOMATERIALS, V26, P1987, DOI 10.1016/j.biomaterials.2004.06.036
   Elvin CM, 2005, NATURE, V437, P999, DOI 10.1038/nature04085
   Fahnestock S.R., 2003, BIOPOLYMERS POLYAMID
   FAHNESTOCK SR, 2003, BIOPOLYMERS POLYAMID, V1
   Fini M, 2005, BIOMATERIALS, V26, P3527, DOI 10.1016/j.biomaterials.2004.09.040
   Foo CWP, 2006, P NATL ACAD SCI USA, V103, P9428, DOI 10.1073/pnas.0601096103
   Friess W, 2003, ADV DRUG DELIVER REV, V55, P1529, DOI 10.1016/j.addr.2003.08.001
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   Haider M, 2004, J CONTROL RELEASE, V95, P1, DOI 10.1016/j.jconrel.2003.11.011
   Hofmann S, 2006, J CONTROL RELEASE, V111, P219, DOI 10.1016/j.jconrel.205.12.009
   Horan RL, 2006, J BIOMECH, V39, P2232, DOI 10.1016/j.jbiomech.2005.07.007
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   HUANG J, 2006, IN PRESS BIOMATERIAL
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Jin HJ, 2005, ADV FUNCT MATER, V15, P1241, DOI 10.1002/adfm.200400405
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Kohn WD, 1998, TRENDS BIOTECHNOL, V16, P379, DOI 10.1016/S0167-7799(98)01212-8
   Langer R, 2006, MRS BULL, V31, P477, DOI 10.1557/mrs2006.122
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lee J, 2001, BIOMACROMOLECULES, V2, P170, DOI 10.1021/bm0000900
   Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022
   Li CM, 2005, J MATER RES, V20, P3374, DOI 10.1557/JMR.2005.0425
   Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/S0968-0004(96)10052-9
   Ma ZW, 2005, BIOMATERIALS, V26, P1253, DOI 10.1016/j.biomaterials.2004.04.031
   Maskarinec SA, 2005, CURR OPIN BIOTECH, V16, P422, DOI 10.1016/j.copbio.2005.06.009
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   MCGRATH K, 1998, PROTEIN BASED MAT
   Megeed Z, 2002, ADV DRUG DELIVER REV, V54, P1075, DOI 10.1016/S0169-409X(02)00063-7
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Merle C, 2002, FEBS LETT, V515, P114, DOI 10.1016/S0014-5793(02)02452-3
   Meyer DE, 2002, BIOMACROMOLECULES, V3, P357, DOI 10.1021/bm015630n
   Meyer DE, 2001, CANCER RES, V61, P1548
   Mi LX, 2006, BIOMACROMOLECULES, V7, P38, DOI 10.1021/bm050157p
   Miao M, 2003, J BIOL CHEM, V278, P48553, DOI 10.1074/jbc.M308465200
   Mock ML, 2006, CHEMBIOCHEM, V7, P83, DOI 10.1002/cbic.200500201
   Moreau JE, 2005, TISSUE ENG, V11, P1887, DOI 10.1089/ten.2005.11.1887
   Motta A, 2004, J BIOMAT SCI-POLYM E, V15, P851, DOI 10.1163/1568562041271075
   Naik RR, 2003, CHEM COMMUN, P238, DOI 10.1039/b210635c
   Patwardhan SV, 2005, CHEM COMMUN, P1113, DOI 10.1039/b416926c
   Perret S, 2001, J BIOL CHEM, V276, P43693, DOI 10.1074/jbc.M105507200
   Petka WA, 1998, SCIENCE, V281, P389, DOI 10.1126/science.281.5375.389
   Petrini P, 2001, J MATER SCI-MATER M, V12, P849, DOI 10.1023/A:1012847301850
   Phillips DM, 2004, J AM CHEM SOC, V126, P14350, DOI 10.1021/ja046079f
   Ruggiero F, 2000, FEBS LETT, V469, P132, DOI 10.1016/S0014-5793(00)01259-X
   Scheibel T, 2005, CURR OPIN BIOTECH, V16, P427, DOI 10.1016/j.copbio.2005.05.005
   Scheller J, 2004, TRANSGENIC RES, V13, P51, DOI 10.1023/B:TRAG.0000017175.78809.7a
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Serizawa T, 1999, J POLYM SCI POL CHEM, V37, P1903
   Sharma D, 2006, ANGEW CHEM INT EDIT, V45, P5633, DOI 10.1002/anie.200600382
   Shewry P. R., 2003, ELASTOMERIC PROTEINS
   Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771
   Trabbic-Carlson K, 2003, BIOMACROMOLECULES, V4, P572, DOI 10.1021/bm025671z
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Urry DW, 1999, TRENDS BIOTECHNOL, V17, P249, DOI 10.1016/S0167-7799(99)01306-2
   Urry DW, 1997, J PHYS CHEM B, V101, P11007, DOI 10.1021/jp972167t
   Vepari CP, 2006, BIOTECHNOL BIOENG, V93, P1130, DOI 10.1002/bit.20833
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Wang L, 2006, ANNU REV BIOPH BIOM, V35, P225, DOI 10.1146/annurev.biophys.35.101105.121507
   Wang XY, 2005, LANGMUIR, V21, P11335, DOI 10.1021/la051862m
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   WANG YZ, 2006, IN PRESS BIOMATERIAL
   Wilson DL, 2001, P NATL ACAD SCI USA, V98, P13660, DOI 10.1073/pnas.241323198
   WONG PFC, 2006, APPL PHYS A, V82, P223
   Yu YB, 2002, ADV DRUG DELIVER REV, V54, P1113, DOI 10.1016/S0169-409X(02)00058-3
   Zhou CC, 2006, BIOMACROMOLECULES, V7, P2415, DOI 10.1021/bm060199t
NR 86
TC 27
Z9 27
U1 4
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1369-7021
EI 1873-4103
J9 MATER TODAY
JI Mater. Today
PD DEC
PY 2006
VL 9
IS 12
BP 44
EP 53
DI 10.1016/S1369-7021(06)71742-4
PG 10
WC Materials Science, Multidisciplinary
SC Materials Science
GA 113TS
UT WOS:000242621000024
OA Other Gold
DA 2018-10-19
ER

PT J
AU Park, IS
   Woo, TG
   Lee, MH
   Ahn, SG
   Park, MS
   Bae, TS
   Seol, KW
AF Park, Il Song
   Woo, Tae Gyu
   Lee, Min Ho
   Ahn, Seung Geun
   Park, Myung Sik
   Bae, Tae Sung
   Seol, Kyeong Won
TI Effects of anodizing voltage on the anodized and hydrothermally treated
   titanium surface
SO METALS AND MATERIALS INTERNATIONAL
LA English
DT Article
DE titanium; biomaterials; surface modification; anodic spark oxidation;
   hydroxyapatite
ID OXIDE-FILMS; PURE TITANIUM; IMPLANTS; BONE; HYDROXYAPATITE; INTERFACE;
   CA; COATINGS; ALLOY
AB Anodic oxidation is the process of creating a titanium oxide layer with various defects more dense and stable. In this study, a dense, stable and porous oxide layer was formed using anodic spark oxidation on pure titanium surface and hydroxyapatite crystals were formed on its surface via a hydrothermal treatment. A mixture of 0.02M-GP (Glycerolphosphate disodium salt) and 0.2M-CA (Calcium acetate) was used as an electrolyte. By increasing the anodizing voltage to 220, 260, 300, and 360 V, the effects of the anodizing voltage were examined by evaluating the film properties after anodization and a hydrothermal treatment. Breakdown occurred around 230 V. As the voltage increased after breakdown, the pore size increased. After the hydrothermal treatment, the amount of HA crystal precipitation was also increased as the voltage increased. The mean surface roughness (Ra) of the anodizing surface was also increased as the voltage increased. The Ra value was larger in the hydrothermally treated group compared with the group treated with anodization as a result of the HA crystals present on the surface after the hydrothermal treatment. Corrosion resistance of the surface modified by anodization was significantly increased in a saline solution compared to that for the non-treated group; this increased further after the hydrothermal treatment. These increases were most likely due to a thick stable oxide layer formed through anodization. Thus, it is believed that titanium with its surface modified through anodic spark oxidation would be a suitable biomaterial due to its corrosion resistance and biocompatibility.
C1 Chonbuk Natl Univ, Sch Dent, Dept Dent Biomat, Jeonju 561756, South Korea.
   Chonbuk Natl Univ, Sch Dent, Inst Oral Biosci, Jeonju 561756, South Korea.
   Chonbuk Natl Univ, Coll Engn, Div Adv Mat Enfn, Jeonju, South Korea.
   Chonbuk Natl Univ, Coll Engn, Res Ctr Ind Technol, Jeonju, South Korea.
   Chonbuk Natl Univ, Sch Dent, Dept Prosthodont, Jeonju, South Korea.
   Chonbuk Natl Univ, Sch Dent, Inst Oral Biosci, Jeonju, South Korea.
   Chonbuk Natl Univ, Sch Dent, Dept Orthoped Surg, Jeonju, South Korea.
RP Bae, TS (reprint author), Chonbuk Natl Univ, Sch Dent, Dept Dent Biomat, Jeonju 561756, South Korea.
EM bts@chonbuk.ac.kr
CR ALBREKTSSON T, 1983, ANN BIOMED ENG, V11, P1, DOI 10.1007/BF02363944
   Hamada K, 2002, BIOMATERIALS, V23, P2265, DOI 10.1016/S0142-9612(01)00361-1
   Hanawa T, 1997, J BIOMED MATER RES, V34, P273
   HAYASHI K, 1993, J BIOMED MATER RES, V27, P557, DOI 10.1002/jbm.820270502
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P65, DOI 10.1002/jbm.820290110
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1071, DOI 10.1002/jbm.820290907
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1459, DOI 10.1002/jbm.820291118
   Kim HH, 2004, BIOCONTROL SCI TECHN, V14, P171, DOI 10.1080/09583150310001655693
   KLEIN CPAT, 1991, J BIOMED MATER RES, V25, P53, DOI 10.1002/jbm.820250105
   Larsson C, 1996, BIOMATERIALS, V17, P605, DOI 10.1016/0142-9612(96)88711-4
   Lee MH, 2003, MET MATER-INT, V9, P35, DOI 10.1007/BF03027227
   Lee TM, 2000, J BIOMED MATER RES, V50, P499, DOI 10.1002/(SICI)1097-4636(20000615)50:4<499::AID-JBM5>3.0.CO;2-U
   Suh JY, 2003, BIOMATERIALS, V24, P347, DOI 10.1016/S0142-9612(02)00325-3
   Sul YT, 2002, BIOMATERIALS, V23, P491, DOI 10.1016/S0142-9612(01)00131-4
   Sul YT, 2002, BIOMATERIALS, V23, P1809, DOI 10.1016/S0142-9612(01)00307-6
   Sul YT, 2001, MED ENG PHYS, V23, P329, DOI 10.1016/S1350-4533(01)00050-9
   WHITEHEAD RY, 1993, J BIOMED MATER RES, V27, P1501, DOI 10.1002/jbm.820271206
   Yan WQ, 1997, J BIOMED MATER RES, V37, P267, DOI 10.1002/(SICI)1097-4636(199711)37:2<267::AID-JBM17>3.0.CO;2-B
   ZYMAN Z, 1993, BIOMATERIALS, V14, P225, DOI 10.1016/0142-9612(93)90027-Y
NR 19
TC 12
Z9 12
U1 0
U2 3
PU KOREAN INST METALS MATERIALS
PI SEOUL
PA POSCO CENTER, 4TH FL (EAST WING), 892 DAECHI-4-DONG, KANGNAM-KU, SEOUL
   135-777, SOUTH KOREA
SN 1598-9623
J9 MET MATER-INT
JI Met. Mater.-Int.
PD DEC
PY 2006
VL 12
IS 6
BP 505
EP 511
DI 10.1007/BF03027751
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 121DD
UT WOS:000243137400008
DA 2018-10-19
ER

PT J
AU Taniguchi, I
   Kuhlman, WA
   Mayes, AM
   Griffith, LG
AF Taniguchi, Ikuo
   Kuhlman, William A.
   Mayes, Anne M.
   Griffith, Linda G.
TI Functional modification of biodegradable polyesters through a
   chemoselective approach: application to biomaterial surfaces
SO POLYMER INTERNATIONAL
LA English
DT Review
DE biodegradable; chemoselective coupling; polyester; poly(ethylene oxide);
   ring-opening polymerization
ID RING-OPENING POLYMERIZATION; PENDANT HYDROXYL-GROUPS; POLY(ETHYLENE
   GLYCOL); POLY(BETA-MALIC ACID); MALIC-ACID; POLY(4-HYDROXY-L-PROLINE
   ESTER); ALIPHATIC POLYESTERS; EPSILON-CAPROLACTONE; POLY(L-LACTIC ACID);
   MOLECULAR-WEIGHT
AB This paper presents an overview of functional modifications of synthetic aliphatic polyesters and a new synthetic route to graft functional moieties onto the polyester backbone by a chemoselective approach. Aminooxy groups react efficiently and selectively with ketones or aldehydes to form oxime linkages under mild reaction conditions without catalysts, even in the presence of other functional groups. Chemoselective coupling of aminooxy-terminated poly(ethylene oxide) (PEO) onto ketone-bearing poly(e-caprolactone) (PCL) was exploited to prepare comb-shaped copolymers that exhibit cell resistance when the PEO content is above 30 wt%. The free hydroxyl groups of PEO chain ends allowed further incorporation of cell signaling peptides including the sequence RGD. The results show chemoselective coupling to be a promising general route for introducing functional pendant groups onto most polyesters obtained by ring-opening polymerization without backbone degradation. (C) 2006 Society of Chemical Industry.
C1 MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
   MIT, Dept Mech Engn, Biol Engn Div, Cambridge, MA 02139 USA.
   MIT, Ctr Biotechnol Proc Engn, Cambridge, MA 02139 USA.
RP Taniguchi, I (reprint author), MIT, Dept Mat Sci & Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM ikuot@mit.edu
CR Albertsson A. C., 1994, Chemistry and technology of biodegradable polymers., P7
   ALBERTSSON AC, 2000, DEGRADABILITY RENEWA
   Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
   ARNOLD SC, 1986, MAKROMOL CHEM-M SYMP, V6, P285, DOI 10.1002/masy.19860060128
   BAHARI K, 2005, ANGEW MAKROMOL CHEM, V250, P31
   Barbaud C, 1999, POLYM BULL, V43, P297, DOI 10.1007/s002890050614
   BARRERA DA, 1995, MACROMOLECULES, V28, P425, DOI 10.1021/ma00106a004
   BIN H, 2005, MACROMOLECULES, V38, P8227
   BOUTAULT K, 1995, MACROMOLECULES, V28, P3516, DOI 10.1021/ma00114a004
   BRAUD C, 1985, POLYM BULL, V13, P293
   Bure C, 2000, RAPID COMMUN MASS SP, V14, P2158, DOI 10.1002/1097-0231(20001215)14:23<2158::AID-RCM147>3.0.CO;2-C
   Cammas S, 1996, POLYMER, V37, P4215, DOI 10.1016/0032-3861(96)00204-2
   CAMMAS S, 1993, TETRAHEDRON-ASYMMETR, V4, P1925, DOI 10.1016/S0957-4166(00)80433-4
   CAMMAS S, 1994, POLYM B, V33, P148
   Chan W. C., 2000, FMOC SOLID PHASE PEP
   Chiellini E., 2003, BIODEGRADABLE POLYM
   Cho KY, 1999, MACROMOL RAPID COMM, V20, P598, DOI 10.1002/(SICI)1521-3927(19991101)20:11<598::AID-MARC598>3.0.CO;2-1
   DOI Y, 2002, BIOPOLYM BIOL CHEM B, V3
   DOI Y, 2002, BIOPOLYMERS BIOL CHE, V3
   DOI Y, 2002, BIOPOLYMERS BIOL CHE, V4
   FIETIER I, 1990, POLYM BULL, V24, P349, DOI 10.1007/BF00294086
   Forget D, 2001, CHEM-EUR J, V7, P3976, DOI 10.1002/1521-3765(20010917)7:18<3976::AID-CHEM3976>3.0.CO;2-X
   FRAZZA E J, 1971, Journal of Biomedical Materials Research Biomedical Materials Symposium, V1, P43
   Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f
   GEBLIN ME, 1992, J AM CHEM SOC, V114, P3962
   Gimenez S, 2001, J BIOACT COMPAT POL, V16, P32, DOI 10.1106/MF92-TCJC-KC2X-J0FB
   Gruber P, 2002, BIOPOLYMERS, V4, P235
   GUERIN P, 1987, POLYM COMMUN, V28, P11
   Hamma T, 2003, BIOCONJUGATE CHEM, V14, P320, DOI 10.1021/bc025638+
   He B, 2004, BIOMATERIALS, V25, P5239, DOI 10.1016/j.biomaterials.2003.12.030
   He B, 2003, POLYMER, V44, P989, DOI 10.1016/S0032-3861(02)00831-5
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   IKEDA I, 1994, J APPL POLYM SCI, V54, P1123, DOI 10.1002/app.1994.070540815
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P545, DOI 10.1021/bm015510f
   JARM V, 1977, J POLYM SCI POL CHEM, V15, P1061, DOI 10.1002/pol.1977.170150504
   Kajiyama T, 2004, BIOMACROMOLECULES, V5, P169, DOI 10.1021/bm0342990
   Kaufman M., 1969, HIST PVC CHEM IND PR
   Kawashima N., 2002, BIOPOLYMERS, P251
   KIMURA Y, 1988, MACROMOLECULES, V21, P3338, DOI 10.1021/ma00189a037
   KIMURA Y, 1993, POLYMER, V34, P1741, DOI 10.1016/0032-3861(93)90335-8
   Kline BJ, 1998, J AM CHEM SOC, V120, P9475, DOI 10.1021/ja9808907
   LAMATY G, 1976, RECL TRAV CHIM PAY B, V95, P54
   LEMOIGNE M, 1926, B SOC CHIM BIOL, V8, P770
   LENZ RW, 1986, ACS POLYM PREPR, V27, P175
   Lim YB, 1999, J AM CHEM SOC, V121, P5633, DOI 10.1021/ja984012k
   Mayes AM, 1998, MATER RES SOC SYMP P, V530, P73, DOI 10.1557/PROC-530-73
   Mecerreyes D., 1998, ADV POLYM SCI, V147, P1
   Mitomo H, 2005, POLYMER, V46, P4695, DOI 10.1016/j.polymer.2005.03.088
   Moine L, 1997, POLYMER, V38, P3121, DOI 10.1016/S0032-3861(96)01097-X
   Ni Q, 1998, J AM CHEM SOC, V120, P1645, DOI 10.1021/ja9738790
   Nugroho P, 2001, POLYM DEGRAD STABIL, V72, P337, DOI 10.1016/S0141-3910(01)00030-1
   OHYA Y, 1991, REACT POLYM, V15, P153, DOI 10.1016/0923-1137(91)90159-L
   OUCHI T, 1989, MAKROMOL CHEM, V190, P1523
   Ouchi T, 2002, BIOMACROMOLECULES, V3, P885, DOI 10.1021/bm0200231
   PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294
   Ponsart S, 2000, BIOMACROMOLECULES, V1, P275, DOI 10.1021/bm005521t
   Ponsart S, 2002, J BIOACT COMPAT POL, V17, P417, DOI 10.1177/088391102030911
   Putnam D, 1999, MACROMOLECULES, V32, P3658, DOI 10.1021/ma982004i
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Renard E, 2005, BIOMACROMOLECULES, V6, P891, DOI 10.1021/bm049337+
   RENARD I, 1996, ACS POLYM PREPRINTS, V37, P137
   Rossignol H, 1999, INT J BIOL MACROMOL, V25, P255, DOI 10.1016/S0141-8130(99)00040-9
   Salo H, 1999, BIOCONJUGATE CHEM, V10, P815, DOI 10.1021/bc990021m
   Saulnier B, 2004, MACROMOL BIOSCI, V4, P232, DOI 10.1002/mabi.200300087
   SEPPALA JV, 2002, BIOPOLYMERS BIOL CHE, V4, P327
   Shalaby S. W., 2004, ABSORBABLE BIODEGRAD
   SHIMADA K, 1969, BIOCHEM BIOPH RES CO, V35, P619, DOI 10.1016/0006-291X(69)90449-5
   Stassin F, 2000, MACROMOL SYMP, V153, P27, DOI 10.1002/1521-3900(200003)153:1<27::AID-MASY27>3.0.CO;2-N
   STEINBUCHEL A, 1995, FEMS MICROBIOL LETT, V128, P219, DOI 10.1016/0378-1097(95)00125-O
   Steinbuchel A, 2001, MACROMOL BIOSCI, V1, P1
   Stigers DJ, 2003, BIOMACROMOLECULES, V4, P193, DOI 10.1021/bm025728h
   Taniguchi I, 2005, MACROMOLECULES, V38, P216, DOI 10.1021/ma0487554
   Tian D, 1997, MACROMOLECULES, V30, P1947, DOI 10.1021/ma961614k
   Tian D, 1997, MACROMOLECULES, V30, P406, DOI 10.1021/ma961631+
   Tian D, 1997, MACROMOLECULES, V30, P2575, DOI 10.1021/ma961567w
   Tsuji H., 2002, BIOPOLYMERS, VIII, P129
   Uyama H, 2000, CHEM LETT, P800, DOI 10.1246/cl.2000.800
   Vert M, 2005, BIOMACROMOLECULES, V6, P538, DOI 10.1021/bm0494702
   Vert M., 1979, ACS POLYM PREPT, V20, P608
   Vert M., 2002, BIOPOLYMERS, P179
   VERT M, 1985, POLYM B, V14, P187
   Vicent MJ, 2005, ANGEW CHEM INT EDIT, V44, P4061, DOI 10.1002/anie.200462960
   Won CY, 1996, MACROMOL RAPID COMM, V17, P653, DOI 10.1002/marc.1996.030170907
   Won CY, 1998, POLYMER, V39, P6677, DOI 10.1016/S0032-3861(98)00032-9
   Yao FL, 2003, J POLYM SCI POL CHEM, V41, P2073, DOI 10.1002/pola.10756
   Zhang SP, 2003, BIOMACROMOLECULES, V4, P437, DOI 10.1021/bm0201183
   ZHOU QX, 1990, MACROMOLECULES, V23, P3399, DOI 10.1021/ma00216a002
NR 89
TC 37
Z9 37
U1 2
U2 53
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0959-8103
J9 POLYM INT
JI Polym. Int.
PD DEC
PY 2006
VL 55
IS 12
BP 1385
EP 1397
DI 10.1002/pi.2139
PG 13
WC Polymer Science
SC Polymer Science
GA 112CP
UT WOS:000242503100005
DA 2018-10-19
ER

PT J
AU Wang, H
   Chen, CZ
   Wang, DG
AF Wang, Hui
   Chen, Chuanzhong
   Wang, Diangang
TI Development of hydroxyapatite coating prepared by sol-gel technique
SO SURFACE REVIEW AND LETTERS
LA English
DT Article
DE hydroxyapatite; coating; sol-gel; development
ID IN-VITRO; TITANIUM SUBSTRATE; CALCIUM-PHOSPHATE; FILMS; DEPOSITION;
   IMPLANTS; HYDROXYLAPATITE; TI-6AL-4V; CERAMICS; STRENGTH
AB Metallic biomaterial, as a kind of composite materials, has been applied extensively in medical field clue to its mechanical advantages and biological affinity. The sol-gel technique, as a new method to prepare the hydroxyapatite (HA) coating, has a lot of advantages. Therefore, the principle, characteristic and the researchment status of sol-gel technique are introduced. And the structure, characteristic and bioactivity of the HA coatings prepared by this introduced, as well a the influence of various parameters are discussed. Finally, the applied prospects of sol-gel technique in medical field are discussed.
C1 Shandong Univ, Sch Mat Sci & Engn, Shandong 250061, Jinan, Peoples R China.
RP Chen, CZ (reprint author), Shandong Univ, Sch Mat Sci & Engn, Shandong 250061, Jinan, Peoples R China.
EM czchen@sdu.edu.cn
RI Wang, Hui/O-6288-2014
OI Chen, Chuanzhong/0000-0003-4044-6915
CR Berndt C. C., 1990, Materials Forum, V14, P161
   Cerroni L, 2002, BIOMOL ENG, V19, P119, DOI 10.1016/S1389-0344(02)00027-8
   Chai CS, 1998, BIOMATERIALS, V19, P2291, DOI 10.1016/S0142-9612(98)90138-7
   Cheng K, 2001, MATER LETT, V51, P37, DOI 10.1016/S0167-577X(01)00261-0
   COTELL CM, 1992, J APPL BIOMATER, V3, P87, DOI 10.1002/jab.770030204
   DEGROOT K, 1987, J BIOMED MATER RES, V21, P1375, DOI 10.1002/jbm.820211203
   DUCHEYNE P, 1986, BIOMATERIALS, V7, P97, DOI 10.1016/0142-9612(86)90063-3
   EBELMAN M, 1846, ANN CHIM PHYS, V57, P319
   Hayashi K, 1999, BIOMATERIALS, V20, P111, DOI 10.1016/S0142-9612(98)00011-8
   Hsieh MF, 2002, MATER CHEM PHYS, V74, P245, DOI 10.1016/S0254-0584(01)00474-6
   Hwang K, 1999, SURF COAT TECH, V115, P172, DOI 10.1016/S0257-8972(99)00174-7
   Hwang K, 2000, SURF COAT TECH, V123, P252, DOI 10.1016/S0257-8972(99)00512-5
   Kaciulis S, 1999, APPL SURF SCI, V151, P1, DOI 10.1016/S0169-4332(99)00267-6
   Kaciulis S, 1998, J ELECTRON SPECTROSC, V95, P61, DOI 10.1016/S0368-2048(98)00202-3
   Kim HW, 2004, BIOMATERIALS, V25, P3351, DOI 10.1016/j.biomaterials.2003.09.104
   Kim HW, 2004, BIOMATERIALS, V25, P2533, DOI 10.1016/j.biomaterials.2003.09.041
   Lacefield W R, 1988, Ann N Y Acad Sci, V523, P72, DOI 10.1111/j.1749-6632.1988.tb38501.x
   Liu D, 2003, ARTERIOSCL THROM VAS, V23, P2002, DOI 10.1161/01.ATV.0000098644.03153.6F
   Liu DM, 2002, BIOMATERIALS, V23, P1679, DOI 10.1016/S0142-9612(01)00295-2
   Metikos-Hukovic M, 2003, SURF COAT TECH, V165, P40, DOI 10.1016/S0257-8972(02)00732-6
   OGUCHI H, 1995, BIOMATERIALS, V16, P33, DOI 10.1016/0142-9612(95)91093-E
   ONG JL, 1992, BIOMATERIALS, V13, P249, DOI 10.1016/0142-9612(92)90192-Q
   Overgaard S, 1998, J BIOMED MATER RES, V39, P141, DOI 10.1002/(SICI)1097-4636(199801)39:1<141::AID-JBM16>3.0.CO;2-I
   Piveteau LD, 2000, BIOMATERIALS, V21, P2193, DOI 10.1016/S0142-9612(00)00160-5
   Ramires PA, 2001, BIOMATERIALS, V22, P1467, DOI 10.1016/S0142-9612(00)00269-6
   Sato M, 2005, BIOMATERIALS, V26, P1349, DOI 10.1016/j.biomaterials.2004.04.044
   Tancred DC, 1998, BIOMATERIALS, V19, P1735, DOI 10.1016/S0142-9612(98)00082-9
   Weng WJ, 2003, SURF COAT TECH, V167, P292, DOI 10.1016/S0257-8972(02)00922-2
   Yang YC, 2001, BIOMATERIALS, V22, P1827, DOI 10.1016/S0142-9612(00)00364-1
   YUAN H, 1999, BIOMATERIALS, V200, P1799
   Zhitomirsky I, 1997, J MATER SCI-MATER M, V8, P213, DOI 10.1023/A:1018587623231
NR 31
TC 1
Z9 1
U1 1
U2 9
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 0218-625X
J9 SURF REV LETT
JI Surf. Rev. Lett.
PD DEC
PY 2006
VL 13
IS 6
BP 737
EP 745
DI 10.1142/S0218625X06008773
PG 9
WC Chemistry, Physical; Physics, Condensed Matter
SC Chemistry; Physics
GA 161FH
UT WOS:000245999400002
DA 2018-10-19
ER

PT J
AU Mikos, AG
   Herring, SW
   Ochareon, P
   Elisseeff, J
   Lu, HH
   Kandel, R
   Schoen, FJ
   Toner, M
   Mooney, D
   Atala, A
   Van Dyke, ME
   Kaplan, D
   Vunjak-Novakovic, G
AF Mikos, Antonios G.
   Herring, Susan W.
   Ochareon, Pannee
   Elisseeff, Jennifer
   Lu, Helen H.
   Kandel, Rita
   Schoen, Frederick J.
   Toner, Mehmet
   Mooney, David
   Atala, Anthony
   Van Dyke, Mark E.
   Kaplan, David
   Vunjak-Novakovic, Gordana
TI Engineering complex tissues
SO TISSUE ENGINEERING
LA English
DT Article; Proceedings Paper
CT Workshop on Tissue Engineering - The Next Generation
CY MAY 02-04, 2005
CL Boston, MA
ID MESENCHYMAL STEM-CELLS; ANTERIOR CRUCIATE LIGAMENT; ARTICULAR-CARTILAGE
   REPAIR; ENDOTHELIAL GROWTH-FACTOR; CALCIUM POLYPHOSPHATE SCAFFOLDS; BONE
   SUBSTITUTE APPLICATIONS; MEDIAL COLLATERAL LIGAMENT; BIOPROSTHETIC
   HEART-VALVE; TOTAL HIP-ARTHROPLASTY; FORMED IN-VITRO
AB This article summarizes the views expressed at the third session of the workshop "Tissue Engineering - The Next Generation,'' which was devoted to the engineering of complex tissue structures. Antonios Mikos described the engineering of complex oral and craniofacial tissues as a "guided interplay'' between biomaterial scaffolds, growth factors, and local cell populations toward the restoration of the original architecture and function of complex tissues. Susan Herring, reviewing osteogenesis and vasculogenesis, explained that the vascular arrangement precedes and dictates the architecture of the new bone, and proposed that engineering of osseous tissues might benefit from preconstruction of an appropriate vasculature. Jennifer Elisseeff explored the formation of complex tissue structures based on the example of stratified cartilage engineered using stem cells and hydrogels. Helen Lu discussed engineering of tissue interfaces, a problem critical for biological fixation of tendons and ligaments, and the development of a new generation of fixation devices. Rita Kandel discussed the challenges related to the re-creation of the cartilage-bone interface, in the context of tissue engineered joint repair. Frederick Schoen emphasized, in the context of heart valve engineering, the need for including the requirements derived from "adult biology'' of tissue remodeling and establishing reliable early predictors of success or failure of tissue engineered implants. Mehmet Toner presented a review of biopreservation techniques and stressed that a new breakthrough in this field may be necessary to meet all the needs of tissue engineering. David Mooney described systems providing temporal and spatial regulation of growth factor availability, which may find utility in virtually all tissue engineering and regeneration applications, including directed in vitro and in vivo vascularization of tissues. Anthony Atala offered a clinician's perspective for functional tissue regeneration, and discussed new biomaterials that can be used to develop new regenerative technologies.
C1 Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA.
   Columbia Univ, Coll Dent Med, New York, NY 10027 USA.
   Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA.
   Univ Washington, Dept Orthodont, Seattle, WA 98195 USA.
   Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
   Univ Toronto, Dept Pathol & Lab Med, Toronto, ON, Canada.
   Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA.
   Harvard Univ, Sch Med, Massachusetts Gen Hosp, Boston, MA USA.
   Harvard Univ, Sch Med, Boston, MA USA.
   Shriners Hosp Children, Boston, MA USA.
   Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA.
   Wake Forest Univ, Sch Med, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA.
   Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Vunjak-Novakovic, G (reprint author), Columbia Univ, Dept Biomed Engn, 363G Engn Terrace,Mail Code 8904,1210 Amsterdam A, New York, NY 10027 USA.
EM gv2131@columbia.edu
RI Kandel, Rita/E-2149-2017
OI Kandel, Rita/0000-0003-4047-3913; Atala, Anthony/0000-0001-8186-2160;
   Vunjak-Novakovic, Gordana/0000-0002-9382-1574
FU NIBIB NIH HHS [P41 EB002520]; NIAMS NIH HHS [AR052402, R21 AR052402];
   NIDCR NIH HHS [R01 DE008513, DE08513, R01 DE015164, R01 DE008513-18, R01
   DE15164]
CR Acker JP, 1999, CRYOBIOLOGY, V38, P363, DOI 10.1006/cryo.1999.2179
   Acker JP, 2000, CRYOBIOLOGY, V40, P54, DOI 10.1006/cryo.1999.2221
   Acker JP, 2003, CRYOBIOLOGY, V46, P197, DOI 10.1016/S0011-2240(03)00025-7
   ACKER JP, 2002, CELL PRESERV TECHNOL, V1, P129
   Aikawa E, 2006, CIRCULATION, V113, P1344, DOI 10.1161/CIRCULATIONAHA.105.591768
   Akiyama S K, 1996, Hum Cell, V9, P181
   Alhadlaq A, 2005, J BONE JOINT SURG AM, V87A, P936, DOI 10.2106/JBJS.D.02104
   Alhadlaq A, 2004, ANN BIOMED ENG, V32, P911, DOI 10.1023/B:ABME.0000032454.53116.ee
   ALLAN KS, IN PRESS TISSUE ENG
   Almarza AJ, 2004, ANN BIOMED ENG, V32, P2, DOI 10.1023/B:ABME.0000007786.37957.65
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   *AM AC ORTH SURG, 1997, ARTH TOT JOINT REPL
   Andrews PW, 2005, CURR OPIN BIOTECH, V16, P485, DOI 10.1016/j.copbio.2005.09.002
   Armstrong EJ, 2004, CIRC RES, V95, P459, DOI 10.1161/01.RES.0000141146.95728.da
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Badylak Stephen F., 2005, Anatomical Record Part B:The New Anatomist, V287, P36, DOI 10.1002/ar.b.20081
   Baharvand H, 2005, J MOL CELL CARDIOL, V38, P495, DOI 10.1016/j.yjmcc.2004.12.011
   Barry FP, 2004, INT J BIOCHEM CELL B, V36, P568, DOI 10.1016/j.biocel.2003.11.001
   Bartsch G, 2005, STEM CELLS DEV, V14, P337, DOI 10.1089/scd.2005.14.337
   BASHKIN P, 1989, BIOCHEMISTRY-US, V28, P1737, DOI 10.1021/bi00430a047
   BENJAMIN M, 1991, J ANAT, V177, P127
   BENJAMIN M, 1986, J ANAT, V149, P89
   Berend KR, 2005, J ARTHROPLASTY, V20, P93, DOI 10.1016/j.arth.2005.06.001
   Berenji K, 2005, AM J PHYSIOL-HEART C, V289, pH8, DOI 10.1152/ajpheart.01303.2004
   BERRY DJ, 1995, CLIN ORTHOP RELAT R, V319, P168
   Beynnon BD, 2002, J BONE JOINT SURG AM, V84A, P1503, DOI 10.2106/00004623-200209000-00001
   Bhowmick S, 2003, BIOL REPROD, V68, P1779, DOI 10.1095/biolreprod.102.009407
   Blickenstaff KR, 1997, AM J SPORT MED, V25, P554, DOI 10.1177/036354659702500420
   Blom IE, 2001, J CLIN PATHOL-MOL PA, V54, P192
   Boecker W, 2004, MOL IMAGING, V3, P69, DOI 10.1162/1535350041464847
   Bottaro DP, 2002, ANN NY ACAD SCI, V961, P143, DOI 10.1111/j.1749-6632.2002.tb03068.x
   Breuer CK, 2004, TISSUE ENG, V10, P1725, DOI 10.1089/ten.2004.10.1725
   BUCK CA, 1987, ANNU REV CELL BIOL, V3, P179, DOI 10.1146/annurev.cb.03.110187.001143
   Burr DB, 2004, OSTEOARTHR CARTILAGE, V12, pS20, DOI DOI 10.1016/J.J0CA.2003.09.016
   Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906
   Cancedda R, 2003, MATRIX BIOL, V22, P81, DOI 10.1016/S0945-053X(03)00012-X
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0
   Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478
   Carvalho RS, 2004, BONE, V34, P849, DOI 10.1016/j.bone.2003.12.027
   Caterson EJ, 2002, ANN NY ACAD SCI, V961, P134, DOI 10.1111/j.1749-6632.2002.tb03066.x
   Chang CH, 2004, J BIOMED MATER RES B, V71B, P313, DOI 10.1002/jbm.b.30090
   Chen JQ, 2002, CIRCULATION, V105, P2766, DOI 10.1161/01.CIR.0000017860.20619.23
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   Conway EM, 2001, CARDIOVASC RES, V49, P507, DOI 10.1016/S0008-6363(00)00281-9
   COOPER RR, 1970, J BONE JOINT SURG AM, VA 52, P1
   Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479
   CRANE GM, 1995, NAT MED, V1, P1322, DOI 10.1038/nm1295-1322
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   De Ugarte DA, 2003, ANN PLAS SURG, V50, P215, DOI 10.1097/01.SAP.0000029661.38066.15
   Deb A, 2005, J HEART VALVE DIS, V14, P674
   Della Rocca F, 2000, ANN THORAC SURG, V70, P1594, DOI 10.1016/S0003-4975(00)01979-2
   Dimmeler S, 2005, J CLIN INVEST, V115, P572, DOI 10.1172/JCI200524283
   DUNN MG, 1995, J BIOMED MATER RES, V29, P1363, DOI 10.1002/jbm.820291107
   EISENBERG LM, 1995, CIRC RES, V77, P1, DOI 10.1161/01.RES.77.1.1
   Elisseeff J, 2000, J BIOMED MATER RES, V51, P164, DOI 10.1002/(SICI)1097-4636(200008)51:2<164::AID-JBM4>3.0.CO;2-W
   Elisseeff J, 2006, STEM CELLS DEV, V15, P295, DOI 10.1089/scd.2006.15.295
   Elisseeff J, 2005, Orthod Craniofac Res, V8, P150, DOI 10.1111/j.1601-6343.2005.00335.x
   Elisseeff J, 2004, EXPERT OPIN BIOL TH, V4, P1849, DOI 10.1517/14712598.4.12.1849
   Elisseeff J, 1999, P NATL ACAD SCI USA, V96, P3104, DOI 10.1073/pnas.96.6.3104
   Elisseeff JH, 2004, TRENDS BIOTECHNOL, V22, P155, DOI 10.1016/j.tibtech.2004.02.006
   Elkins RC, 2001, ANN THORAC SURG, V71, pS428, DOI 10.1016/S0003-4975(01)02503-6
   Ennett AB, 2002, EXPERT OPIN BIOL TH, V2, P805, DOI 10.1517/14712598.2.8.805
   Ennett AB, 2006, J BIOMED MATER RES A, V79A, P176, DOI 10.1002/jbm.a.30771
   Eschenhagen T, 2005, CIRC RES, V97, P1220, DOI 10.1161/01.RES.0000196562.73231.7d
   Fahy GM, 1997, CRYOBIOLOGY, V35, P114, DOI 10.1006/cryo.1997.2026
   Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Fowler AJ, 1998, ANN NY ACAD SCI, V858, P245, DOI 10.1111/j.1749-6632.1998.tb10158.x
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   Frenkel SR, 2004, ANN BIOMED ENG, V32, P26, DOI 10.1023/B:ABME.0000007788.41804.0d
   FRIEDMAN MJ, 1985, CLIN ORTHOP RELAT R, V186, P9
   Fujioka H, 1998, CONNECT TISSUE RES, V37, P205, DOI 10.3109/03008209809002440
   Fukuda D, 2006, AM J CARDIOL, V97, P175, DOI 10.1016/j.amjcard.2005.08.020
   Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433
   Gao JZ, 2001, TISSUE ENG, V7, P363, DOI 10.1089/10763270152436427
   Gao RZ, 2002, TISSUE ENG, V8, P827, DOI 10.1089/10763270260424187
   Gearhart J, 1998, SCIENCE, V282, P1061, DOI 10.1126/science.282.5391.1061
   Gencbay M, 1998, J HEART VALVE DIS, V7, P601
   Gerber HP, 1999, NAT MED, V5, P623
   Gerstenfeld LC, 2002, J BONE MINER RES, V17, P221, DOI 10.1359/jbmr.2002.17.2.221
   GLASS J, 1994, ANN NY ACAD SCI, V745, P177
   Goetz A, 1938, J APPL PHYS, V9, P718, DOI 10.1063/1.1710381
   GOODRICH RP, 1992, P NATL ACAD SCI USA, V89, P967, DOI 10.1073/pnas.89.3.967
   GRANA WA, 1994, AM J SPORT MED, V22, P344, DOI 10.1177/036354659402200309
   Greenberg DA, 2005, NATURE, V438, P954, DOI 10.1038/nature04481
   GROSSMAN W, 1975, J CLIN INVEST, V56, P56, DOI 10.1172/JCI108079
   Grynpas MD, 2002, BIOMATERIALS, V23, P2063, DOI 10.1016/S0142-9612(01)00336-2
   Guo XM, 2004, TISSUE ENG, V10, P1830, DOI 10.1089/ten.2004.10.1830
   HAMILTON WJ, 1962, HUMAN EMBRYOLOGY
   Hammermeister K, 2000, J AM COLL CARDIOL, V36, P1152, DOI 10.1016/S0735-1097(00)00834-2
   Hill JM, 2003, CIRCULATION, V108, P1009, DOI 10.1161/01.CIR.0000084537.66419.7A
   Hoerstrup SP, 2000, CIRCULATION, V102, P44
   Huang YC, 2005, J BONE MINER RES, V20, P848, DOI 10.1359/JBMR.041226
   Huang YC, 2005, HUM GENE THER, V16, P609, DOI 10.1089/hum.2005.16.609
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   Hung CT, 2003, J BIOMECH, V36, P1853, DOI 10.1016/S0021-9290(03)00213-6
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   INOUE N, 2001, J BIOMECH, V34, pS81
   Irimia D, 2002, BIOPHYS J, V82, P1858, DOI 10.1016/S0006-3495(02)75536-7
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776
   Iwai S, 2004, J THORAC CARDIOV SUR, V128, P472, DOI 10.1016/j.jtcvs.2004.04.013
   JACKSON DW, 1994, ARTHROSCOPY, V10, P442, DOI 10.1016/S0749-8063(05)80197-5
   JACOBSSON SA, 1996, CLIN ORTHOP S, V329, P60
   Jaffer FA, 2005, JAMA-J AM MED ASSOC, V293, P855, DOI 10.1001/jama.293.7.855
   Jaffer FA, 2002, ARTERIOSCL THROM VAS, V22, P1929, DOI 10.1161/01.ATV.0000033089.56970.2D
   Jaffer FA, 2004, CIRC RES, V94, P433, DOI 10.1161/01.RES.0000119321.18573.5A
   Jiang J, 2005, BIOCHEM BIOPH RES CO, V338, P762, DOI 10.1016/j.bbrc.2005.10.025
   Johari GP, 1996, SCIENCE, V273, P90, DOI 10.1126/science.273.5271.90
   JOHNSON RJ, 1982, INT J SPORTS MED, V3, P71, DOI 10.1055/s-2008-1026066
   Jones GT, 2003, J VASC SURG, V38, P1363, DOI 10.1016/S0741-5214(03)01027-9
   Kaiser J, 2002, SCIENCE, V295, P1015, DOI 10.1126/science.295.5557.1015
   Kandel R, 1999, TISSUE ENG, V5, P25, DOI 10.1089/ten.1999.5.25
   Kandel R A, 1997, In Vitro Cell Dev Biol Anim, V33, P174
   Karlsson JOM, 1996, HUM REPROD, V11, P1296
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Kim MS, 2005, STEM CELLS, V23, P113, DOI 10.1634/stemcells.2004-0110
   Kinner B, 2005, ADV BIOCHEM ENG BIOT, V94, P91, DOI 10.1007/b100001
   Kleinman HK, 2003, CURR OPIN BIOTECH, V14, P526, DOI 10.1016/j.copbio.2003.08.002
   Kobayashi M, 2005, AM J SPORT MED, V33, P1892, DOI 10.1177/0363546505277140
   Kong HJ, 2005, NAT MATER, V4, P460, DOI 10.1038/nmat1392
   KOUCHOUKOS NT, 1994, NEW ENGL J MED, V330, P1, DOI 10.1056/NEJM199401063300101
   Kreklau B, 1999, BIOMATERIALS, V20, P1743, DOI 10.1016/S0142-9612(99)00061-7
   KROMPECHER S, 1934, ANAT ANZEIGER, P34
   KUROSAKA M, 1987, AM J SPORT MED, V15, P225, DOI 10.1177/036354658701500306
   LACROIX P, 1951, ORG BONES
   Laham RJ, 1999, DRUG METAB DISPOS, V27, P821
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer R, 1998, NATURE, V392, P5
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Lazarous DF, 1996, CIRCULATION, V94, P1074, DOI 10.1161/01.CIR.94.5.1074
   Leach JK, 2004, EXPERT OPIN BIOL TH, V4, P1015, DOI 10.1517/14712598.4.7.1015
   Lee KY, 2000, NATURE, V408, P998
   Leor J, 2004, ANN NY ACAD SCI, V1015, P312, DOI 10.1196/annals.1302.026
   Li F, 2004, ENDOTHELIUM-J ENDOTH, V11, P199, DOI 10.1080/10623320490512390
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   LIN HB, 1992, BIOMATERIALS, V13, P905, DOI 10.1016/0142-9612(92)90113-3
   LOVELOCK JE, 1953, BIOCHIM BIOPHYS ACTA, V11, P28, DOI 10.1016/0006-3002(53)90005-5
   Lu HH, 2003, J BIOMED MATER RES A, V64A, P465, DOI 10.1002/jbm.a.10399
   Lu HH, 2005, BIOMATERIALS, V26, P4805, DOI 10.1016/j.biomaterials.2004.11.050
   Lu HH, 2005, BIOCERAMICS, V17, P607
   Mahmoudifar N, 2005, BIOMATERIALS, V26, P7012, DOI 10.1016/j.biomaterials.2005.04.062
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   Masuda K, 2003, J ORTHOPAED RES, V21, P139, DOI 10.1016/S0736-0266(02)00109-2
   Matheny RG, 2000, J HEART VALVE DIS, V9, P769
   MATYAS JR, 1995, J BIOMECH, V28, P147, DOI 10.1016/0021-9290(94)00058-C
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   MAZUR P, 1984, AM J PHYSIOL, V247, pC125
   MAZUR P, 1990, CELL BIOPHYS, V17, P53, DOI 10.1007/BF02989804
   MAZUR P, 1989, CRYOBIOLOGY, V26, P1, DOI 10.1016/0011-2240(89)90030-8
   McBrearty BA, 1998, P NATL ACAD SCI USA, V95, P11792, DOI 10.1073/pnas.95.20.11792
   MCDONALD JA, 1991, RECEPTORS EXTRACELLU
   Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3
   Mendelson K, 2006, ANN BIOMED ENG, V34, P1799, DOI 10.1007/s10439-006-9163-z
   MENTE PL, 1994, J ORTHOPAED RES, V12, P637, DOI 10.1002/jor.1100120506
   Merryman WD, 2006, AM J PHYSIOL-HEART C, V290, pH224, DOI 10.1152/ajpheart.00521.2005
   MERRYMAN WD, 2006, P BIO2006 ASME SUMM
   MERYMAN H, 2004, LIFE FROZEN STATE
   MJAATVEDT CH, 1999, HEART DEV
   MOFFAT KL, 2005, P ASME SUMM BIOENG C
   Mooney DJ, 1999, SCI AM, V280, P60, DOI 10.1038/scientificamerican0499-60
   MOULD AP, 1991, J BIOL CHEM, V266, P3579
   Murphy WL, 2004, J DENT RES, V83, P204, DOI 10.1177/154405910408300304
   Newby AC, 2005, PHYSIOL REV, V85, P1, DOI 10.1152/physrev.00048.2003
   Niederauer GG, 2000, BIOMATERIALS, V21, P2561, DOI 10.1016/S0142-9612(00)00124-1
   Niyibizi C, 1995, MATRIX BIOL, V14, P743, DOI 10.1016/S0945-053X(05)80017-4
   Niyibizi C, 1996, BIOCHEM BIOPH RES CO, V222, P584, DOI 10.1006/bbrc.1996.0787
   Nor JE, 1999, AM J PATHOL, V154, P375, DOI 10.1016/S0002-9440(10)65284-4
   Nugent HM, 2003, CIRC RES, V92, P1068, DOI 10.1161/01.RES.0000073844.41372.38
   O'Brien M F, 1999, Semin Thorac Cardiovasc Surg, V11, P194
   OCHAREON P, 2004, THESIS U WASHINGTON
   OEGEMA TR, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P319
   Ogata T, 2005, J VASC SURG, V41, P1036, DOI 10.1016/j.jvs.2005.02.020
   Paranya G, 2001, AM J PATHOL, V159, P1335, DOI 10.1016/S0002-9440(10)62520-5
   PEGG DE, 1984, CRYOBIOLOGY, V21, P491, DOI 10.1016/0011-2240(84)90047-6
   Peters MC, 2002, J BIOMED MATER RES, V60, P668, DOI 10.1002/jbm.10134
   Petersen W, 1999, ANAT EMBRYOL, V200, P325, DOI 10.1007/s004290050283
   Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa
   Philip D, 2005, STEM CELLS, V23, P288, DOI 10.1634/stemcells.2002.0109
   PIERSCHBACHER MD, 1994, J CELL BIOCHEM, V56, P150, DOI 10.1002/jcb.240560205
   PIERSCHBACHER MD, 1982, J BIOL CHEM, V257, P9593
   Pilliar RM, 2001, BIOMATERIALS, V22, P963, DOI 10.1016/S0142-9612(00)00261-1
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Pries AR, 2005, HYPERTENSION, V46, P725, DOI 10.1161/01.HYP.0000184428.16429.be
   Rabkin E, 2002, CARDIOVASC PATHOL, V11, P305, DOI 10.1016/S1054-8807(02)00130-8
   Rabkin E, 2002, J HEART VALVE DIS, V11, P308
   Rabkin E, 2001, CIRCULATION, V104, P2525, DOI 10.1161/hc4601.099489
   Rabkin-Aikawa E, 2004, J THORAC CARDIOV SUR, V128, P552, DOI 10.1016/j.jtcvs.2004.04.016
   Rabkin-Aikawa E, 2005, ADV BIOCHEM ENG BIOT, V94, P141, DOI 10.1007/b100003
   Rafferty KL, 2000, J EXP BIOL, V203, P2093
   Rafii S, 1995, ANN THORAC SURG, V60, P1627, DOI 10.1016/0003-4975(95)00807-1
   Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702
   RAGHOW R, 1994, FASEB J, V8, P823
   Rahimtoola SH, 2003, J AM COLL CARDIOL, V42, P1720, DOI 10.1016/j.jacc.2003.07.008
   RALL WF, 1980, NATURE, V286, P511, DOI 10.1038/286511a0
   Redman S N, 2005, Eur Cell Mater, V9, P23
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Riley SL, 2001, J MATER SCI-MATER M, V12, P983, DOI 10.1023/A:1012817317296
   Ripamonti U, 2004, J CELL MOL MED, V8, P169, DOI 10.1111/j.1582-4934.2004.tb00272.x
   ROBERTSON DB, 1986, AM J SPORT MED, V14, P398, DOI 10.1177/036354658601400512
   RODEO SA, 1993, J BONE JOINT SURG AM, V75A, P1795, DOI 10.2106/00004623-199312000-00009
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   ROWE JH, 2004, LIFE FROZEN STATE, P581
   Sacks MS, 2002, J BIOMED MATER RES, V62, P359, DOI 10.1002/jbm.10293
   Schaefer D, 2000, BIOMATERIALS, V21, P2599, DOI 10.1016/S0142-9612(00)00127-7
   Schaefer D, 2002, ARTHRITIS RHEUM, V46, P2524, DOI 10.1002/art.10493
   Schek RM, 2004, TISSUE ENG, V10, P1376, DOI 10.1089/ten.2004.10.1376
   SCHMITTGRAFF A, 1994, VIRCHOWS ARCH, V425, P3, DOI 10.1007/BF00193944
   Schnabel M, 2002, OSTEOARTHR CARTILAGE, V10, P62, DOI 10.1053/joca.2001.0482
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   SCHOEN FJ, 1986, AM J PATHOL, V123, P134
   Schoen FJ, 1997, J HEART VALVE DIS, V6, P1
   SCHOEN FJ, 1985, LAB INVEST, V52, P523
   Schoen FJ, 1999, J HEART VALVE DIS, V8, P350
   SCHOEN FJ, 2001, CARDIIOVASCULAR PATH
   Schroeder JA, 2003, J MOL MED-JMM, V81, P392, DOI 10.1007/s00109-003-0456-5
   Schurch W, 1998, AM J SURG PATHOL, V22, P141, DOI 10.1097/00000478-199802000-00001
   SCOTT M, 1995, ANN THORAC SURG, V60, pS391, DOI 10.1016/0003-4975(95)00263-K
   SHAN M, 2004, ANN M BIOM ENG SOC
   Sharma B, 2004, ANN BIOMED ENG, V32, P148, DOI 10.1023/B:ABME.0000007799.60142.78
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Sheridan MH, 2000, J CONTROL RELEASE, V64, P91, DOI 10.1016/S0168-3659(99)00138-8
   Sherwood JK, 2002, BIOMATERIALS, V23, P4739, DOI 10.1016/S0142-9612(02)00223-5
   Shi Q, 1998, BLOOD, V92, P362
   Simon P, 2003, EUR J CARDIO-THORAC, V23, P1002, DOI 10.1016/S1010-7940(03)00094-0
   Simons M, 2005, CIRCULATION, V111, P1556, DOI 10.1161/01.CIR.0000159345.00591.8F
   SIMPSON AHRW, 1985, J ANAT, V140, P697
   SKALAK R, 1998, UCLA S MOL CELL BIOL, P107
   Smith GD, 2005, J BONE JOINT SURG BR, V87B, P445, DOI 10.1302/0301-620X.87B4
   Smith MK, 2004, TISSUE ENG, V10, P63, DOI 10.1089/107632704322791709
   Soderman P, 2001, ACTA ORTHOP SCAND, V72, P113, DOI 10.1080/000164701317323345
   SONG YC, 1995, CRYOBIOLOGY, V32, P405, DOI 10.1006/cryo.1995.1040
   Spalazzi J. P., 2004, T ORTHOPAEDIC RES SO
   Spalazzi JP, 2006, TISSUE ENG, V12, P3497, DOI 10.1089/ten.2006.12.3497
   Spalazzi JP, 2006, J ORTHOP RES, V24, P2001, DOI 10.1002/jor.20260
   Spalazzi JP, 2003, IEEE ENG MED BIOL, V22, P27, DOI 10.1109/MEMB.2003.1256269
   SPALAZZI JP, 2006, T INT S LIG TEND
   Staros EB, 2005, AM J CLIN PATHOL, V123, P305, DOI 10.1309/N0C70VCU3EHL57WK
   Steinhoff G, 2000, CIRCULATION, V102, P50
   Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099
   Streuli C, 1999, CURR OPIN CELL BIOL, V11, P634, DOI 10.1016/S0955-0674(99)00026-5
   Sun QH, 2005, PHARM RES, V22, P1110, DOI 10.1007/s11095-005-5644-2
   Tamura K, 2000, J HEART VALVE DIS, V9, P53
   Tanaka T, 2005, TISSUE ENG, V11, P331, DOI 10.1089/ten.2005.11.331
   Taylor MJ, 2004, LIFE IN THE FROZEN STATE, P603, DOI 10.1201/9780203647073.ch22
   Taylor PA, 2003, INT J BIOCHEM CELL B, V35, P113, DOI 10.1016/S1357-2725(02)00100-0
   Taylor PM, 2000, J HEART VALVE DIS, V9, P150
   Thirumala S, 2005, J BIOMECH ENG-T ASME, V127, P295, DOI 10.1115/1.1865213
   Thomopoulos S, 2003, J ORTHOPAED RES, V21, P413, DOI 10.1016/S0736-0266(03)00057-3
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614
   Tuli R, 2004, TISSUE ENG, V10, P1169, DOI 10.1089/ten.2004.10.1169
   van Susante JLC, 1998, BIOMATERIALS, V19, P2367, DOI 10.1016/S0142-9612(98)00158-6
   Vesely I, 2005, CIRC RES, V97, P743, DOI 10.1161/01.RES.0000185326.04010.9f
   VILLANUEVA JE, 1990, J BONE MINER RES, V5, P733
   Visconti RP, 2006, CIRC RES, V98, P690, DOI 10.1161/01.RES.0000207384.81818.d4
   VOGEL KG, 1989, INT REV CYTOL, V115, P267
   Waldman SD, 2003, J BONE JOINT SURG AM, V85A, P101, DOI 10.2106/00004623-200300002-00013
   Waldman SD, 2002, J BIOMED MATER RES, V62, P323, DOI 10.1002/jbm.10235
   Walker GA, 2004, CIRC RES, V95, P253, DOI 10.1161/01.RES.0000136520.07995.aa
   Wang INE, 2006, J ORTHOP RES, V24, P1745, DOI 10.1002/jor.20149
   WANG IE, 2006, UNPUB BIOCH BIOPHYS
   WANG IE, 2005, T ORTHOPAEDIC RES SO
   Wang XH, 2004, BIOMATERIALS, V25, P3681, DOI 10.1016/j.biomaterials.2003.10.102
   Wei XC, 1996, ANAT EMBRYOL, V193, P53
   Weiler A, 2002, ARTHROSCOPY, V18, P124, DOI 10.1053/jars.2002.30657
   Weinshilboum R, 2003, NEW ENGL J MED, V348, P529, DOI 10.1056/NEJMra020021
   Williams CG, 2003, TISSUE ENG, V9, P679, DOI 10.1089/107632703768247377
   Wolff J., 1892, GESETZ TRANSFORMATIO
   Woo S L, 1983, J Orthop Res, V1, P22, DOI 10.1002/jor.1100010104
   WOO SL, 1999, CLIN ORTHOP S, V367, P312
   WOO SLY, 1988, J ORTHOP RES, V6, P907, DOI 10.1002/jor.1100060615
   Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215
   Yaszemski MJ, 1996, BIOMATERIALS, V17, P175, DOI 10.1016/0142-9612(96)85762-0
   Ye S, 2000, MATRIX BIOL, V19, P623, DOI 10.1016/S0945-053X(00)00102-5
   Yoshikawa Hideki, 2005, J Artif Organs, V8, P131, DOI 10.1007/s10047-005-0292-1
   Yu HS, 1997, BIOMATERIALS, V18, P1425, DOI 10.1016/S0142-9612(97)00071-9
   Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129
   Zhang Y, 2003, WORLD J GASTROENTERO, V9, P201, DOI 10.3748/wjg.v9.i2.201
   Zisch AH, 2003, CARDIOVASC PATHOL, V12, P295, DOI 10.1016/S1054-8807(03)00089-9
   Zund G, 1997, EUR J CARDIO-THORAC, V11, P493, DOI 10.1016/S1010-7940(96)01005-6
   1990, TISSUE ENG SE, V14, P227
NR 285
TC 338
Z9 354
U1 6
U2 149
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4947
J9 TISSUE ENG
JI Tissue Eng.
PD DEC
PY 2006
VL 12
IS 12
BP 3307
EP 3339
DI 10.1089/ten.2006.12.3307
PG 33
WC Cell & Tissue Engineering
SC Cell Biology
GA 122CB
UT WOS:000243202200005
PM 17518671
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Uebersax, L
   Hagenmueller, H
   Hofmann, S
   Gruenblatt, E
   Mueller, R
   Vunjak-Novakovic, G
   Kaplan, DL
   Merkle, HP
   Meinel, L
AF Uebersax, Lorenz
   Hagenmueller, Henri
   Hofmann, Sandra
   Gruenblatt, Emanuel
   Mueller, Ralph
   Vunjak-Novakovic, Gordana
   Kaplan, David L.
   Merkle, H. P.
   Meinel, Lorenz
TI Effect of scaffold design on bone morphology in vitro
SO TISSUE ENGINEERING
LA English
DT Article; Proceedings Paper
CT Workshop on Tissue Engineering - The Next Generation
CY MAY 02-04, 2005
CL Boston, MA
ID MESENCHYMAL STEM-CELLS; POLY(L-LACTIC ACID) SCAFFOLDS; SILK-BASED
   BIOMATERIALS; DERMAL SHEEP COLLAGENS; GROWTH-FACTOR DELIVERY; POLYMER
   SCAFFOLDS; PROTEIN SCAFFOLDS; TRABECULAR BONE; STROMAL CELLS; TISSUE
AB Silk fibroin is an important polymer for scaffold designs, forming biocompatible and mechanically robust biomaterials for bone, cartilage, and ligament tissue engineering. In the present work, 3D biomaterial matrices were fabricated from silk fibroin with controlled pore diameter and pore interconnectivity, and utilized to engineer bone starting from human mesenchymal stem cells (hMSC). Osteogenic differentiation of hMSC seeded on these scaffolds resulted in extensive mineralization, alkaline phosphatase activity, and the formation of interconnected trabecular- or cortical-like mineralized networks as a function of the scaffold design utilized; allowing mineralized features of the tissue engineered bone to be dictated by the scaffold features used initially in the cell culture process. This approach to scaffold predictors of tissue structure expands the window of applications for silk fibroin - based biomaterials into the realm of directing the formation of complex tissue architecture. As a result of slow degradation inherent to silk fibroin, scaffolds preserved their initial morphology and provided a stable template during the mineralization phase of stem cells progressing through osteogenic differentiation and new extracellular matrix formation. The slow degradation feature also facilitated transport throughout the 3D scaffolds to foster improved homogeneity of new tissue, avoiding regions with decreased cellular density. The ability to direct bone morphology via scaffold design suggests new options in the use of biodegradable scaffolds to control in vitro engineered bone tissue outcomes.
C1 ETH, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland.
   Univ Zurich, Inst Biomed Engn, Zurich, Switzerland.
   Columbia Univ, Dept Biomed Engn, New York, NY USA.
   Harvard Mit Div Hlth Sci & Technol, Cambridge, MA USA.
   Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RP Meinel, L (reprint author), ETH, Inst Pharmaceut Sci, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.
EM lorenz.meinel@pharma.ethz.ch
RI Merkle, Hans/A-4381-2014; Hofmann, Sandra/F-2832-2010; Meinel,
   Lorenz/D-9997-2015; Muller, Ralph/A-1198-2008
OI Hofmann, Sandra/0000-0002-2568-8388; Meinel, Lorenz/0000-0002-7549-7627;
   Muller, Ralph/0000-0002-5811-7725; Vunjak-Novakovic,
   Gordana/0000-0002-9382-1574
FU NIBIB NIH HHS [P41-EB002520, P41 EB002520]
CR Akay G, 2004, BIOMATERIALS, V25, P3991, DOI 10.1016/j.biomaterials.2003.10.086
   Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Barry FP, 1999, BIOCHEM BIOPH RES CO, V265, P134, DOI 10.1006/bbrc.1999.1620
   BHAT NV, 1980, J APPL POLYM SCI, V25, P921, DOI 10.1002/app.1980.070250518
   Bigi A, 1997, J INORG BIOCHEM, V68, P45, DOI 10.1016/S0162-0134(97)00007-X
   Chen VJ, 2004, BIOMATERIALS, V25, P2065, DOI 10.1016/j.biomaterials.2003.08.058
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   DeLisser H M, 1993, Curr Top Microbiol Immunol, V184, P37
   DELUSTRO F, 1990, CLIN ORTHOP RELAT R, P263
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167
   Hile DD, 2000, J CONTROL RELEASE, V66, P177, DOI 10.1016/S0168-3659(99)00268-0
   Holland TA, 2005, J CONTROL RELEASE, V101, P111, DOI 10.1016/j.jconrel.2004.07.004
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   *ICH, Q3C R3 GUID RES SOLV
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   JUDD W, 1980, J EXP MED, V152, P1430, DOI 10.1084/jem.152.5.1430
   Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002
   Kim HJ, 2005, BIOMATERIALS, V26, P4442, DOI 10.1016/j.biomaterials.2004.11.013
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   KUHN LC, 1984, CELL, V37, P95, DOI 10.1016/0092-8674(84)90304-0
   Lange F, 1903, VERH DTSCH ORTHOP GE, V2, P10
   LANGE F, 1907, MUNCH MED WOCHENSCHR, V834
   Lee SJ, 2000, YONSEI MED J, V41, P704, DOI 10.3349/ymj.2000.41.6.704
   LEHUEC JC, 1995, BIOMATERIALS, V16, P113, DOI 10.1016/0142-9612(95)98272-G
   Lin ASP, 2003, BIOMATERIALS, V24, P481, DOI 10.1016/S0142-9612(02)00361-7
   Ma ZW, 2003, J BIOMED MATER RES B, V67B, P610, DOI 10.1002/jbm.b.10049
   MAGOSHI J, 1977, J APPL POLYM SCI, V21, P2405, DOI 10.1002/app.1977.070210909
   Majumdar MK, 2000, J CELL PHYSIOL, V185, P98
   Martin I, 2001, J BIOMED MATER RES, V55, P229, DOI 10.1002/1097-4636(200105)55:2<229::AID-JBM1009>3.3.CO;2-H
   Martin R. B, 1998, SKELETAL TISSUE MECH
   Meaney D F, 1995, Clin Podiatr Med Surg, V12, P363
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Meinel L, 2001, J CONTROL RELEASE, V70, P193, DOI 10.1016/S0168-3659(00)00352-7
   MINGZHONG L, 1999, J APPL POLYM SCI, V79, P2185
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   Moroni L, 2006, BIOMATERIALS, V27, P974, DOI 10.1016/j.biomaterials.2005.07.023
   MULLER R, 1994, PHYS MED BIOL, V39, P145, DOI 10.1088/0031-9155/39/1/009
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Negrin RS, 2000, BIOL BLOOD MARROW TR, V6, P262, DOI 10.1016/S1083-8791(00)70008-5
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Ruegsegger P, 1996, CALCIFIED TISSUE INT, V58, P24, DOI 10.1007/s002239900006
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810
   SRIVASTAVA S, 1990, BIOMATERIALS, V11, P155, DOI 10.1016/0142-9612(90)90148-J
   Suh H, 1998, YONSEI MED J, V39, P87, DOI 10.3349/ymj.1998.39.2.87
   TSUKADA M, 1994, J APPL POLYM SCI, V54, P507, DOI 10.1002/app.1994.070540411
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   *US PHARM CONV, 2006, USP, V29, pCH467
   Valluzzi R, 2002, PHILOS T ROY SOC B, V357, P165, DOI 10.1098/rstb.2001.1032
   Valluzzi R, 1999, INT J BIOL MACROMOL, V24, P237, DOI 10.1016/S0141-8130(99)00002-1
   VANLUYN MJA, 1992, J BIOMED MATER RES, V26, P1091, DOI 10.1002/jbm.820260810
   VANLUYN MJA, 1992, BIOMATERIALS, V13, P1017, DOI 10.1016/0142-9612(92)90153-F
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   Whitaker MJ, 2001, J PHARM PHARMACOL, V53, P1427, DOI 10.1211/0022357011777963
NR 63
TC 92
Z9 98
U1 1
U2 23
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD DEC
PY 2006
VL 12
IS 12
BP 3417
EP 3429
DI 10.1089/ten.2006.12.3417
PG 13
WC Cell & Tissue Engineering
SC Cell Biology
GA 122CB
UT WOS:000243202200012
PM 17518678
DA 2018-10-19
ER

PT J
AU Reddy, ST
   Swartz, MA
   Hubbell, JA
AF Reddy, Sai T.
   Swartz, Melody A.
   Hubbell, Jeffrey A.
TI Targeting dendritic cells with biomaterials: developing the next
   generation of vaccines
SO TRENDS IN IMMUNOLOGY
LA English
DT Review
ID POLY(D,L-LACTIC-CO-GLYCOLIC ACID) MICROSPHERES; EPIDERMAL-GROWTH-FACTOR;
   IN-VIVO; ANTIGEN PRESENTATION; IMMUNE-RESPONSES; DNA VACCINES; CATIONIC
   MICROPARTICLES; INFLAMMATORY RESPONSES; NANOPARTICULATE SYSTEM;
   ANTITUMOR IMMUNITY
AB Current vaccine and immunotherapy technology faces ongoing challenges in both efficacy and practicality: many chronic diseases cannot yet be addressed by vaccination, and several vaccines that do function well require multiple injections, which is a substantial limitation in various parts of the world. A possible key to developing the next generation of vaccines is the ability to deliver antigen to dendritic cells (DCs) more specifically and induce the subsequent activation of T-cell immunity. However, antigen delivery to, and activation of, DCs is a complex problem, involving antigen transport to DC-rich areas, DC binding and antigen uptake, and antigen processing and presentation. Addressing these challenges requires novel and multidisciplinary approaches, for example, the application of biomaterials to immunotechnology. Here, we review the latest advances in biomaterial drug vehicles, such as polymer microparticles and nanoparticles, and liposomes, that are being used to target DCs in new strategies for vaccination.
C1 Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland.
   Ecole Polytech Fed Lausanne, Inst Chem Sci & Engn, CH-1015 Lausanne, Switzerland.
RP Swartz, MA (reprint author), Ecole Polytech Fed Lausanne, Inst Bioengn, CH-1015 Lausanne, Switzerland.
EM melody.swartz@epfl.ch; jeffrey.hubbell@epfl.ch
RI Swartz, Melody/F-9563-2011; Reddy, Sai/B-4190-2012; Swartz,
   Melody/B-7633-2009; Hubbell, Jeffrey/A-9266-2008
OI Reddy, Sai/0000-0002-9177-0857; Hubbell, Jeffrey/0000-0003-0276-5456
CR Avrameas A, 1996, EUR J IMMUNOL, V26, P394, DOI 10.1002/eji.1830260219
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Banchereau J, 2005, NAT REV IMMUNOL, V5, P296, DOI 10.1038/nri1592
   Barrick JE, 2002, PROTEIN SCI, V11, P2688, DOI 10.1110/ps.0208902
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220
   Copland MJ, 2003, VACCINE, V21, P883, DOI 10.1016/S0264-410X(02)00536-4
   Davis NL, 2002, IUBMB LIFE, V53, P209, DOI 10.1080/15216540290098945
   Denis-Mize KS, 2000, GENE THER, V7, P2105, DOI 10.1038/sj.gt.3301347
   Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972
   Elamanchili P, 2004, VACCINE, V22, P2406, DOI 10.1016/j.vaccine.2003.12.032
   Espuelas S, 2005, MOL IMMUNOL, V42, P721, DOI 10.1016/j.molimm.2004.09.022
   Gatza E, 2002, J IMMUNOL, V169, P5227, DOI 10.4049/jimmunol.169.9.5227
   GUPTA RK, 1995, VACCINE, V13, P1263, DOI 10.1016/0264-410X(95)00011-O
   Gupta RK, 1998, ADV DRUG DELIVER REV, V32, P155, DOI 10.1016/S0169-409X(98)00008-8
   Hauser H, 2004, GENE THER, V11, P924, DOI 10.1038/sj.gt.3302160
   Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x
   Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620
   Hu WJ, 2001, BLOOD, V98, P1231, DOI 10.1182/blood.V98.4.1231
   HUNTER R, 1981, J IMMUNOL, V127, P1244
   Hunter RL, 2002, VACCINE, V20, pS7, DOI 10.1016/S0264-410X(02)00164-0
   Jiang WL, 2005, ADV DRUG DELIVER REV, V57, P391, DOI 10.1016/j.addr.2004.09.003
   Kasturi SP, 2006, J CONTROL RELEASE, V113, P261, DOI 10.1016/j.jcornel.2006.04.006
   KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629
   Kwon YJ, 2005, P NATL ACAD SCI USA, V102, P18264, DOI 10.1073/pnas.0509541102
   LANGER R, 1976, NATURE, V263, P797, DOI 10.1038/263797a0
   Lanzavecchia A, 1996, CURR OPIN IMMUNOL, V8, P348, DOI 10.1016/S0952-7915(96)80124-5
   Lee H, 2003, PHARMACEUT RES, V20, P818, DOI 10.1023/A:1023402123119
   Lee H, 2002, PHARMACEUT RES, V19, P845, DOI 10.1023/A:1016113117851
   Little SR, 2004, P NATL ACAD SCI USA, V101, P9534, DOI 10.1079/pnas.0403549101
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Lutsiak MEC, 2002, PHARM RES-DORDR, V19, P1480, DOI 10.1023/A:1020452531828
   Mahnke K, 2005, CANCER RES, V65, P7007, DOI 10.1158/0008-5472.CAN-05-0938
   Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7
   McKeever U, 2002, VACCINE, V20, P1524, DOI 10.1016/S0264-410X(01)00509-6
   Murthy N, 2003, BIOCONJUGATE CHEM, V14, P412, DOI 10.1021/bc020056d
   Napoli A, 2004, NAT MATER, V3, P183, DOI 10.1038/nmat1081
   Nestle FO, 2001, NAT MED, V7, P761, DOI 10.1038/89863
   Newman KD, 2002, J BIOMED MATER RES, V60, P480, DOI 10.1002/jbm.10019
   Newman KD, 1998, J CONTROL RELEASE, V54, P49, DOI 10.1016/S0168-3659(97)00142-9
   Nishioka Y, 2001, ADV DRUG DELIVER REV, V47, P55, DOI 10.1016/S0169-409X(00)00121-6
   Norbury CC, 1995, IMMUNITY, V3, P783, DOI 10.1016/1074-7613(95)90067-5
   O'Hagan DT, 2003, NAT REV DRUG DISCOV, V2, P727, DOI 10.1038/nrd1176
   Oussoren C, 2001, ADV DRUG DELIVER REV, V50, P143, DOI 10.1016/S0169-409X(01)00154-5
   Oussoren C, 1997, BBA-BIOMEMBRANES, V1328, P261, DOI 10.1016/S0005-2736(97)00122-3
   Pack DW, 2004, NAT MATER, V3, P133, DOI 10.1038/nmat1084
   PEPPAS NA, 1994, SCIENCE, V263, P1715, DOI 10.1126/science.8134835
   Persing D.H., 2002, TRENDS MICROBIOL, V10, P32
   PREIS I, 1979, J IMMUNOL METHODS, V28, P193, DOI 10.1016/0022-1759(79)90341-7
   Probst HC, 2003, IMMUNITY, V18, P713, DOI 10.1016/S1074-7613(03)00120-1
   Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670
   Reddy ST, 2006, J APPL PHYSIOL, V101, P1162, DOI 10.1152/japplphysiol.00389.2006
   Reddy ST, 2006, J CONTROL RELEASE, V112, P26, DOI 10.1016/j.jconrel.2006.01.006
   Rehor A, 2005, LANGMUIR, V21, P411, DOI 10.1021/la0478043
   Roberts MJ, 2002, ADV DRUG DELIVER REV, V54, P459, DOI 10.1016/S0169-409X(02)00022-4
   Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x
   ROCK KL, 1990, SCIENCE, V249, P918, DOI 10.1126/science.2392683
   Roth A, 2004, BIOCONJUGATE CHEM, V15, P541, DOI 10.1021/bc034184t
   SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389
   Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372
   Singh M, 1999, NAT BIOTECHNOL, V17, P1075, DOI 10.1038/15058
   Singh M, 2000, P NATL ACAD SCI USA, V97, P811, DOI 10.1073/pnas.97.2.811
   Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013
   Swartz MA, 2001, ADV DRUG DELIVER REV, V50, P3, DOI 10.1016/S0169-409X(01)00150-8
   Tang LP, 1996, J CLIN INVEST, V97, P1329, DOI 10.1172/JCI118549
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   Thiele L, 2003, PHARM RES-DORDR, V20, P221, DOI 10.1023/A:1022271020390
   Timmerman JM, 2002, BLOOD, V99, P1517, DOI 10.1182/blood.V99.5.1517
   Todd CW, 1998, ADV DRUG DELIV REV, V32, P199
   van Broekhoven CL, 2004, CANCER RES, V64, P4357, DOI 10.1158/0008-5472.CAN-04-0138
   Villadangos JA, 2005, IMMUNOL REV, V207, P191, DOI 10.1111/j.0105-2896.2005.00317.x
   Walter E, 2001, J CONTROL RELEASE, V76, P149, DOI 10.1016/S0168-3659(01)00413-8
   Wang C, 2004, NAT MATER, V3, P190, DOI 10.1038/nmat1075
   Wang DQ, 1999, J CONTROL RELEASE, V57, P9, DOI 10.1016/S0168-3659(98)00099-6
   Wang RF, 2002, NAT BIOTECHNOL, V20, P149, DOI 10.1038/nbt0202-149
   Wilson NS, 2004, BLOOD, V103, P2187, DOI 10.1182/blood-2003-08-2729
   Wilson NS, 2004, IMMUNOL CELL BIOL, V82, P91, DOI 10.1111/j.1440-1711.2004.01216.x
   Wilson NS, 2003, BLOOD, V102, P2187, DOI 10.1182/blood-2003-02-0513
   Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
NR 80
TC 265
Z9 270
U1 4
U2 93
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4906
J9 TRENDS IMMUNOL
JI Trends Immunol.
PD DEC
PY 2006
VL 27
IS 12
BP 573
EP 579
DI 10.1016/j.it.2006.10.005
PG 7
WC Immunology
SC Immunology
GA 114QO
UT WOS:000242680900006
PM 17049307
DA 2018-10-19
ER

PT J
AU Zheng, JM
   Chin, WC
   Khijniak, E
   Khijniak, E
   Pollack, GH
AF Zheng, Jian-ming
   Chin, Wei-Chun
   Khijniak, Eugene
   Khijniak, Eugene, Jr.
   Pollack, Gerald H.
TI Surfaces and interfacial water: Evidence that hydrophilic surfaces have
   long-range impact
SO ADVANCES IN COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE water; gel; colloid; hydrophilic surface; interface
ID COLLOIDAL DISPERSIONS; VOID STRUCTURE; THIN-FILMS; CONDENSATION;
   ATTRACTION; LIQUID; SHEAR
AB It is generally thought that the impact of surfaces on the contiguous aqueous phase extends to a distance of no more than a few water-molecule layers. Older studies, on the other hand, suggest a more extensive impact. We report here that colloidal and molecular solutes suspended in aqueous solution are profoundly and extensively excluded from the vicinity of various hydrophilic surfaces. The width of the solute-free zone is typically several hundred microns. Such large exclusion zones were observed in the vicinity of many types of surface including artificial and natural hydrogels, biological tissues, hydrophilic polymers, monolayers, and ion-exchange beads, as well as with a variety of solutes. Using microscopic observations, as well as measurements of electrical potential and UV-Vis absorption-spectra, infrared imaging, and NMR imaging, we find that the solute-free zone is a physically distinct and less mobile phase of water that can co-exist indefinitely with the contiguous solute-containing phase. The extensiveness of this modified zone is impressive, and carries broad implication for surface-molecule interactions in many realms, including cellular recognition, biomaterial-surface antifouling, bioseparation technologies, and other areas of biology, physics and chemistry. (c) 2006 Published by Elsevier B.V
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   Univ Calif, Sch Engn, Merced, CA 95344 USA.
   Inst Theoret & Expt Biophys, Pushchino, Russia.
RP Pollack, GH (reprint author), Univ Washington, Dept Bioengn, Box 355061, Seattle, WA 98195 USA.
EM ghp@u.washington.edu
RI Chin, Wei-Chun/A-6068-2008
OI Chin, Wei-Chun/0000-0003-4881-9085
FU NCCIH NIH HHS [5R21AT002362-02, 5R21AT002635- 01A1]
CR Albertsson P. A., 1960, PARTITION CELL PARTI
   ASAKURA S, 1958, J POLYM SCI, V33, P183, DOI 10.1002/pol.1958.1203312618
   Clegg J. S., 1991, BIOCH MOL BIOL FISHE
   CLEGG JS, 1984, AM J PHYSIOL, V246, pR133
   CLEGG JS, 1998, MICROCOMPARTMENTATIO
   Crocker JC, 1999, PHYS REV LETT, V82, P4352, DOI 10.1103/PhysRevLett.82.4352
   DIESTLER DJ, 1993, SCIENCE, V262, P545, DOI 10.1126/science.262.5133.545
   FISHER LR, 1981, NATURE, V290, P575, DOI 10.1038/290575a0
   GEE ML, 1990, J CHEM PHYS, V93, P1895, DOI 10.1063/1.459067
   HeitnerWirguin C, 1996, J MEMBRANE SCI, V120, P1, DOI 10.1016/0376-7388(96)00155-X
   HENNIKER JC, 1949, REV MOD PHYS, V21, P322, DOI 10.1103/RevModPhys.21.322
   Ise N, 1999, LANGMUIR, V15, P4176, DOI 10.1021/la981088l
   ISE N, 1990, FARADAY DISCUSS, V90, P153, DOI 10.1039/dc9909000153
   Israelachvili JN, 1992, INTERMOLECULAR SURFA
   ITO K, 1994, SCIENCE, V263, P66, DOI 10.1126/science.263.5143.66
   ITO K, 1988, J AM CHEM SOC, V110, P6955, DOI 10.1021/ja00229a004
   KAPLAN PD, 1994, PHYS REV LETT, V72, P582, DOI 10.1103/PhysRevLett.72.582
   Ling Gilbert N., 2003, Physiological Chemistry and Physics and Medical NMR, V35, P91
   LING GN, 1984, SEARCH PHYS BASIS LI
   NEGENDANK W, 1982, BIOCHIM BIOPHYS ACTA, V694, P123, DOI 10.1016/0304-4157(82)90022-3
   PASHLEY RM, 1979, J COLLOID INTERF SCI, V71, P49
   POLLACK GH, 2001, CELLS GELS ENGINES L
   ROY R, 2005, MATER RES INNOV, V9, P1066
   SZENTGYORGYI A, 1957, BIOENERGETICS
   THOMPSON PA, 1990, SCIENCE, V250, P792, DOI 10.1126/science.250.4982.792
   WIGGINS PM, 1990, MICROBIOL REV, V54, P432
   YOSHIDA H, 1995, J CHEM PHYS, V103, P10146, DOI 10.1063/1.469916
   YOSHIZAWA H, 1993, J PHYS CHEM-US, V97, P11300, DOI 10.1021/j100145a031
   Zheng J., 2003, PHYS REV E, V68, P1
NR 29
TC 194
Z9 202
U1 1
U2 95
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-8686
J9 ADV COLLOID INTERFAC
JI Adv. Colloid Interface Sci.
PD NOV 23
PY 2006
VL 127
IS 1
BP 19
EP 27
DI 10.1016/j.cis.2006.07.002
PG 9
WC Chemistry, Physical
SC Chemistry
GA 124AW
UT WOS:000243340300003
PM 16952332
DA 2018-10-19
ER

PT J
AU Grosskinsky, U
AF Grosskinsky, Ulrich
TI Biomaterial regulations for tissue engineering
SO DESALINATION
LA English
DT Article; Proceedings Paper
CT Conference of the European-Membrane-Society (EUROMEMBRANE 2006)
CY SEP 24-28, 2006
CL Giardini Naxos, ITALY
SP Inst Membrane Technol, Natl Res Council Italy, Univ Calabria, Ctr Excellence CEMIF CAL, ITM-CNR
C1 LSMW GMBH Total Life Sci Solut, Reg Off, D-10179 Berlin, Germany.
RP Grosskinsky, U (reprint author), LSMW GMBH Total Life Sci Solut, Reg Off, Alte Jakobstr 79-80, D-10179 Berlin, Germany.
EM ulrich.grosskinsky@lsmw.com
CR *ASME, 2002, PART SD DES STER CLE, P10
   *ASME, 2005, PART PM POLYM BAS MA
   *ASTM, D123998 ASTM
   *ASTM, F215002E1 ASTM
   *EN DIN, 1995, 10088 EN DIN
   *ISO EN AAMI DIN, 10993 ISO EN AAMI DI
   *ISO EN DIN, 2000, 9001 ISO EN DIN
   *ISO EN DIN, 2003, 13485 ISO EN DIN
   *NIST, POLYM DIV BIOM GROUP
   *US STATS PHARM, 2005, USP 28
   2002, MAT CONTAINERS CONTA
   2005, USP 28
NR 12
TC 2
Z9 3
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0011-9164
J9 DESALINATION
JI Desalination
PD NOV 20
PY 2006
VL 199
IS 1-3
BP 265
EP 267
DI 10.1016/j.desal.2006.03.172
PG 3
WC Engineering, Chemical; Water Resources
SC Engineering; Water Resources
GA 108YU
UT WOS:000242275900100
DA 2018-10-19
ER

PT J
AU Saralidze, K
   Knetsch, MLW
   van Hooy-Corstjens, CSJ
   Koole, LH
AF Saralidze, Ketie
   Knetsch, Menno L. W.
   van Hooy-Corstjens, Catharina S. J.
   Koole, Leo H.
TI Radio-opaque and surface-functionalized polymer microparticles:
   Potentially safer biomaterials for different injection therapies
SO BIOMACROMOLECULES
LA English
DT Article
ID STRESS URINARY-INCONTINENCE; SOFT-TISSUE AUGMENTATION; PERIURETHRAL
   COLLAGEN INJECTION; BULKING AGENT; HYDROGEL MICROSPHERES; VOLUME
   AUGMENTATION; FILLER SUBSTANCES; ADVERSE-REACTIONS; FOLLOW-UP;
   COMPLICATIONS
AB Injectable polymer particles with a diameter in the range of 30-300 mu m find applications as a biomaterial in different clinical fields, such as cosmetic surgery, reconstructive surgery, and urology. However, clinical effects tend to disappear after several months, either due to migration of the particles away from the injection site (caused by weak adherence with the surrounding soft tissues) or due to fibrosis (caused by excessive encapsulation of the particles by fibrous tissue). Little is known about the fate of injected microparticles, due to the fact that they are extremely difficult to trace in a noninvasive manner. Design, synthesis, and characterization of new polymeric microspheres with two additional features that can enhance safety and can help to overcome drawbacks of existing products are reported. First, the new microparticles feature clear radio-opacity (X-ray visibility) as they are prepared on the basis of a reactive methacrylic monomer that contains covalently bound iodine. Model experiments reveal that the level of X-ray contrast is sufficient for clinical monitoring; they can be visualized both during the injection and afterward. The particles feature excellent cytocompatibility in vitro and in vivo. Second, a method is explored to functionalize the surface of the particles, for example, through immobilization of collagen. Other extracellular matrix proteins can also be immobilized, and this provides a mechanism to control anchoring of the particles in soft tissue. The results are briefly discussed in the context of improved biomaterials, contemporary X-ray imaging, and control over biomaterial-soft tissue interactions in vivo.
C1 Univ Limburg, Ctr Biomat Res, NL-6200 MD Maastricht, Netherlands.
   Eindhoven Univ Technol, Fac Biomed Engn, Eindhoven, Netherlands.
RP Koole, LH (reprint author), Univ Limburg, Ctr Biomat Res, POB 616, NL-6200 MD Maastricht, Netherlands.
EM l.koole@bioch.unimaas.nl
CR Aldenhoff YBJ, 2002, BIOMATERIALS, V23, P881, DOI 10.1016/S0142-9612(01)00197-1
   Bent AE, 2001, J UROLOGY, V166, P1354, DOI 10.1016/S0022-5347(05)65768-0
   Benzina A, 1996, J BIOMED MATER RES, V32, P459, DOI 10.1002/(SICI)1097-4636(199611)32:3<459::AID-JBM20>3.0.CO;2-A
   Boelen EJH, 2005, BIOMATERIALS, V26, P6674, DOI 10.1016/j.biomaterials.2005.04.020
   BOS SD, 1995, BRIT J UROL, V76, P275
   BUTTAFOCO L, 2005, J BIOMED MAT RES B
   Byrne Patrick J, 2004, Facial Plast Surg, V20, P31, DOI 10.1055/s-2004-822956
   Carruthers A, 2005, DERMATOL SURG, V31, P1561, DOI 10.2310/6350.2005.31242
   Christensen L, 2005, AESTHET PLAST SURG, V29, P34, DOI 10.1007/s00266-004-0113-6
   CLAES H, 1989, J UROLOGY, V142, P821
   Corcos J, 1999, UROLOGY, V54, P815, DOI 10.1016/S0090-4295(99)00269-1
   Currie I, 1997, Int Urogynecol J Pelvic Floor Dysfunct, V8, P377, DOI 10.1007/BF02765599
   Dewez JL, 1998, BIOMATERIALS, V19, P1441, DOI 10.1016/S0142-9612(98)00055-6
   Echols KT, 2002, INT UROGYNECOL J PEL, V13, P52, DOI 10.1007/s001920200012
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   Guys JM, 2006, J UROLOGY, V175, P1106, DOI 10.1016/S0022-5347(05)00404-0
   Halachmi S, 2004, J UROLOGY, V171, P1287, DOI 10.1097/01.ju.0000111221.43756.a3
   Haneke E, 2004, SEMIN CUTAN MED SURG, V23, P227, DOI 10.1016/j.sder.2004.08.002
   Herschorn Sender, 2006, Can J Urol, V13 Suppl 1, P5
   Homicz Mark R, 2004, Facial Plast Surg, V20, P21, DOI 10.1055/s-2004-822955
   JAYAKRISHNAN A, 1989, B MATER SCI, V12, P17, DOI 10.1007/BF02744590
   Jordan DR, 2003, CAN J OPHTHALMOL, V38, P285, DOI 10.1016/S0008-4182(03)80093-5
   Kanchwala SK, 2005, ANN PLAS SURG, V55, P30, DOI 10.1097/01.sap.0000168292.69753.73
   KIILHOLMA PJ, 1993, NEUROUROL URODYNAM, V12, P131, DOI 10.1002/nau.1930120206
   Lemperle G, 2004, PLAST RECONSTR SURG, V113, P1380, DOI 10.1097/01.PRS.0000112764.22839.7A
   Lemperle G, 2003, AESTHET PLAST SURG, V27, P354, DOI 10.1007/s00266-003-3022-1
   Lemperle G, 2003, DERMATOL SURG, V29, P573, DOI 10.1046/j.1524-4725.2003.29140.x
   LEWANDOWSKI K, 1998, J CHEM MAT, V10, P385
   Lightner D, 2001, UROLOGY, V58, P12, DOI 10.1016/S0090-4295(01)01148-7
   Lightner Deborah J, 2002, Curr Urol Rep, V3, P408, DOI 10.1007/s11934-002-0086-4
   Lightner Deborah J, 2002, Curr Opin Urol, V12, P333, DOI 10.1097/00042307-200207000-00012
   Madjar S, 2003, J UROLOGY, V170, P2327, DOI 10.1097/01.ju.0000090968.85279.84
   MALIZIA AA, 1984, JAMA-J AM MED ASSOC, V251, P3277, DOI 10.1001/jama.251.24.3277
   Mayer R, 2001, UROLOGY, V57, P434, DOI 10.1016/S0090-4295(00)01098-0
   McCarthy JB, 1996, BIOPOLYMERS, V40, P371, DOI 10.1002/(SICI)1097-0282(1996)40:4<371::AID-BIP3>3.0.CO;2-T
   McLennan MT, 1998, OBSTET GYNECOL, V92, P650, DOI 10.1016/S0029-7844(98)00129-X
   MONGA AK, 1995, BRIT J UROL, V76, P156, DOI 10.1111/j.1464-410X.1995.tb07664.x
   Morhenn VB, 2002, DERMATOL SURG, V28, P484, DOI 10.1046/j.1524-4725.2002.01273.x
   Palma PCR, 1997, J ENDOUROL, V11, P67, DOI 10.1089/end.1997.11.67
   Pannek J, 2001, J UROLOGY, V166, P1350, DOI 10.1016/S0022-5347(05)65767-9
   Perenack J, 2005, J ORAL MAXIL SURG, V63, P1634, DOI 10.1016/j.joms.2005.05.160
   Puleo DA, 2002, BIOMATERIALS, V23, P2079, DOI 10.1016/S0142-9612(01)00339-8
   Requena C, 2001, AM J DERMATOPATH, V23, P197, DOI 10.1097/00000372-200106000-00006
   Rubin JP, 1997, PLAST RECONSTR SURG, V100, P1336, DOI 10.1097/00006534-199710000-00043
   Saralidze K, 2003, BIOMACROMOLECULES, V4, P793, DOI 10.1021/bm030002m
   Sclafani A P, 2000, Facial Plast Surg, V16, P29, DOI 10.1055/s-2000-7323
   Sheriff MKM, 1997, EUR UROL, V32, P284
   Sivakumar M, 2002, J APPL POLYM SCI, V83, P3045, DOI 10.1002/app.10310
   Stenberg AM, 2003, INT UROGYNECOL J PEL, V14, P335, DOI 10.1007/s00192-003-1075-y
   Sweat SD, 1999, J UROLOGY, V161, P93, DOI 10.1016/S0022-5347(01)62074-3
   ter Meulen P, 2004, EXPERT REV MED DEVIC, V1, P205, DOI 10.1586/14734440.1.2.205
   Thaunat O, 2004, PLAST RECONSTR SURG, V113, P2235, DOI 10.1097/01.PRS.0000123627.33690.9E
   van Hooy-Corstjens CSJ, 2004, J MATER CHEM, V14, P3008, DOI 10.1039/b407228f
   van Hooy-Corstjens CSJ, 2004, BIOMATERIALS, V25, P2657, DOI 10.1016/j.biomaterials.2003.09.038
   Van Kerrebroeck P, 2004, UROLOGY, V64, P276, DOI 10.1016/j.urology.2004.03.017
   Wall SJ, 2002, OTOLARYNG CLIN N AM, V35, P87, DOI 10.1016/S0030-6665(03)00096-3
   Zullo MA, 2005, J UROLOGY, V173, P898, DOI 10.1097/01.ju.0000152568.40199.a8
NR 57
TC 16
Z9 17
U1 0
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV 13
PY 2006
VL 7
IS 11
BP 2991
EP 2996
DI 10.1021/bm0603903
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 104FI
UT WOS:000241941600010
PM 17096523
DA 2018-10-19
ER

PT J
AU Bini, E
   Foo, CWP
   Huang, J
   Karageorgiou, V
   Kitchel, B
   Kaplan, DL
AF Bini, Elisabetta
   Foo, Cheryl Wong Po
   Huang, Jia
   Karageorgiou, Vassilis
   Kitchel, Brandon
   Kaplan, David L.
TI RGD-functionalized bioengineered spider dragline silk biomaterial
SO BIOMACROMOLECULES
LA English
DT Article
ID GENETICALLY-ENGINEERED SILK; MESENCHYMAL STEM-CELLS; MARROW STROMAL
   CELL; BOMBYX-MORI SILK; ESCHERICHIA-COLI; PROTEIN; FIBROIN; EXPRESSION;
   SEQUENCE; BETA
AB Spider silk fibers have remarkable mechanical properties that suggest the component proteins could be useful biopolymers for fabricating biomaterial scaffolds for tissue formation. Two bioengineered protein variants from the consensus sequence of the major component of dragline silk from Nephila clavipes were cloned and expressed to include RGD cell-binding domains. The engineered silks were characterized by CD and FTIR and showed structural transitions from random coil to insoluble, beta-sheet upon treatment with methanol. The recombinant proteins were processed into films and fibers and successfully used as biomaterial matrixes to culture human bone marrow stromal cells induced to differentiate into bone-like tissue upon addition of osteogenic stimulants. The recombinant spider silk and the recombinant spider silk with RGD encoded into the protein both supported enhanced the differentiation of human bone marrow derived mesenchymal stem cells ( hMSCs) to osteogenic outcomes when compared to tissue culture plastic. The recombinant spider silk protein without the RGD displayed enhanced bone related outcomes, measured by calcium deposition, when compared to the same protein with RGD. Based on comparisons to our prior studies with silkworm silks and RGD modifications, the current results illustrate the potential to bioengineer spider silk proteins into new biomaterial matrixes, while also highlighting the importance of subtle differences in silk sources and modes of presentation of RGD to cells in terms of tissue-specific outcomes.
C1 Tufts Univ, Dept Biomed Engn, Dept Chem, Bioengn & Biotechnol Ctr, Medford, MA 02155 USA.
   Rutgers State Univ, Dept Biochem & Microbiol, New Brunswick, NJ 08901 USA.
RP Kaplan, DL (reprint author), Tufts Univ, Dept Biomed Engn, Dept Chem, Bioengn & Biotechnol Ctr, 4 Colby St, Medford, MA 02155 USA.
EM david.kaplan@tufts.edu
OI Karageorgiou, Vassilis/0000-0002-0892-510X
FU NIBIB NIH HHS [EB002520, EB003210]
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2001, FASEB J, V15, P270, DOI 10.1096/fj.01-0656fje
   Arcidiacono S, 1998, APPL MICROBIOL BIOT, V49, P31, DOI 10.1007/s002530051133
   Asakura T, 2004, BIOMATERIALS, V25, P617, DOI 10.1016/S0142-9612(03)00570-2
   BEER JH, 1992, BLOOD, V79, P117
   Chen JS, 2003, J BIOMED MATER RES A, V67A, P559, DOI 10.1002/jbm.a.10120
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P23, DOI 10.1007/s002530050883
   Fahnestock SR, 1997, APPL MICROBIOL BIOT, V47, P33, DOI 10.1007/s002530050884
   FAHNETOCK SR, 2000, BIOTECHNOL, V74, P105
   Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131
   Fukushima Y, 1998, BIOPOLYMERS, V45, P269, DOI 10.1002/(SICI)1097-0282(19980405)45:4<269::AID-BIP1>3.0.CO;2-J
   Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561
   Gosline JM, 1999, J EXP BIOL, V202, P3295
   GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Higuchi A, 2003, J BIOMED MATER RES A, V65A, P369, DOI 10.1002/jbm.a.10428
   Hinman MB, 2000, TRENDS BIOTECHNOL, V18, P374, DOI 10.1016/S0167-7799(00)01481-5
   Huang J, 2003, J BIOL CHEM, V278, P46117, DOI 10.1074/jbc.M307792200
   Jin HJ, 2004, BIOMATERIALS, V25, P1039, DOI 10.1016/S0142-9612(03)00609-4
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Kenney JM, 2002, EUR J BIOCHEM, V269, P4159, DOI 10.1046/j.1432-1033.2002.03112.x
   Lazaris A, 2002, SCIENCE, V295, P472, DOI 10.1126/science.1065780
   Lewis RV, 1996, PROTEIN EXPRES PURIF, V7, P400, DOI 10.1006/prep.1996.0060
   Mao W., 2001, INT J ENG SIMULATION, V2, P17
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   Panitch A, 1997, MACROMOLECULES, V30, P42, DOI 10.1021/ma961059m
   Peri S, 2001, TRENDS GENET, V17, P685, DOI 10.1016/S0168-9525(01)02493-3
   PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0
   PRINCE JT, 1995, BIOCHEMISTRY-US, V34, P10879, DOI 10.1021/bi00034a022
   Rougier F, 1998, CYTOKINE, V10, P93, DOI 10.1006/cyto.1997.0262
   Scheller J, 2001, NAT BIOTECHNOL, V19, P573, DOI 10.1038/89335
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Sukigara S, 2003, POLYMER, V44, P5721, DOI 10.1016/S0032-3861(03)00532-9
   Szela S, 2000, BIOMACROMOLECULES, V1, P534, DOI 10.1021/bm0055697
   Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000
   Vollrath F, 2001, P ROY SOC B-BIOL SCI, V268, P2339, DOI 10.1098/rspb.2001.1590
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P12739, DOI 10.1021/bi001335w
   Winkler S, 2000, BIOCHEMISTRY-US, V39, P14002, DOI 10.1021/bi005119z
   XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120
   Yan SZ, 2001, J BIOL CHEM, V276, P8500, DOI 10.1074/jbc.M010361200
   Zhou CZ, 2001, PROTEINS, V44, P119, DOI 10.1002/prot.1078
   Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009
   Zou W, 2002, J BONE MINER RES, V17, P1211, DOI 10.1359/jbmr.2002.17.7.1211
NR 45
TC 128
Z9 137
U1 3
U2 42
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
EI 1526-4602
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV 13
PY 2006
VL 7
IS 11
BP 3139
EP 3145
DI 10.1021/bm0607877
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 104FI
UT WOS:000241941600030
PM 17096543
DA 2018-10-19
ER

PT J
AU Zelikin, AN
   Zawaneh, PN
   Putnam, D
AF Zelikin, Alexander N.
   Zawaneh, Peter N.
   Putnam, David
TI A functionalizable biomaterial based on dihydroxyacetone, an
   intermediate of glucose metabolism
SO BIOMACROMOLECULES
LA English
DT Article
ID SURFACES; POLYMERS; ADHESION; PHOSPHATE; BEHAVIOR; LIGANDS; BONE
AB A biomaterial and its potential degradation products should be biocompatible, nontoxic, and removed by the body upon expiration of its functional lifetime. One historically successful approach is to create new materials from biomolecules that naturally occur in the human body. Herein, we report the synthesis and characterization of a polycarbonate based on dihydroxyacetone, a 3-carbon ketose, and an intermediate in the glucose metabolic pathway. The polymer was synthesized in a range of molecular weights (similar to 8000 to similar to 37500) by ring-opening polymerization. The C2 carbonyl of dihydroxyacetone is reactive to amines, and this reactivity was used to functionalize the polymer's surface in a one-step reaction by reductive amination. Additionally, contact angle measurements show the surface of poly(2-oxypropylene carbonate) is hydrophilic even though it is insoluble in water. Mechanical analysis of the polymer revealed it is exceptionally strong for an aliphatic polycarbonate. Specifically, poly(2-oxypropylene carbonate), M-w 37500, yielded a Young's modulus of 0.5 GPa and a compressive yield stress of 50 MPa. These values equal or exceed those of cancellous bone with similar dimensions.
C1 Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.
   Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.
RP Putnam, D (reprint author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.
EM dap43@cornell.edu
RI Zelikin, Alexander/J-3659-2012
OI Zelikin, Alexander/0000-0002-9864-321X; Putnam,
   David/0000-0002-0794-4915
CR AKAR A, 1989, MAKROMOL CHEM-RAPID, V10, P127
   BALLOU CE, 1956, J AM CHEM SOC, V78, P1659, DOI 10.1021/ja01589a045
   CARTER DR, 1977, J BONE JOINT SURG AM, V59, P954, DOI 10.2106/00004623-197759070-00021
   Dahmen C, 2004, ANGEW CHEM INT EDIT, V43, P6649, DOI 10.1002/anie.200460770
   DAVIS L, 1973, BIOORG CHEM, V2, P197, DOI 10.1016/0045-2068(73)90023-0
   ESMANN V, 1968, ACTA CHEM SCAND, V22, P2281, DOI 10.3891/acta.chem.scand.22-2281
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Ferguson GS, 1992, MODERN APPROACHES WE
   Ferroni EL, 1999, J ORG CHEM, V64, P4943, DOI 10.1021/jo9823902
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   Kallrot M, 2006, BIOMATERIALS, V27, P1788, DOI 10.1016/j.biomaterials.2005.10.010
   Kantlehner M, 1999, ANGEW CHEM INT EDIT, V38, P560, DOI 10.1002/(SICI)1521-3773(19990215)38:4<560::AID-ANIE560>3.0.CO;2-F
   KATO N, 1986, APPL MICROBIOL BIOT, V23, P180
   Keegan ME, 2006, J CONTROL RELEASE, V110, P574, DOI 10.1016/j.jconrel.2005.11.004
   Langer R, 2003, SCI AM, V288, P50, DOI 10.1038/scientificamerican0403-50
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LINDE F, 1992, J BIOMECH, V25, P359, DOI 10.1016/0021-9290(92)90255-Y
   Liu ZL, 2003, J POLYM SCI POL CHEM, V41, P4001, DOI 10.1002/pola.11001
   Metzke M, 2003, J AM CHEM SOC, V125, P7760, DOI 10.1021/ja0349507
   Nguyen BC, 2003, J INVEST DERMATOL, V120, P655, DOI 10.1046/j.1523-1747.2003.12089.x
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Patel S, 2006, BIOMATERIALS, V27, P2890, DOI 10.1016/j.biomaterials.2005.12.009
   Putnam D, 2006, NAT MATER, V5, P439, DOI 10.1038/nmat1645
   RAY WC, 2005, MACROMOLECULES, V36, P3557
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   SOLER C, 1993, BIOCHEM J, V294, P865, DOI 10.1042/bj2940865
   Strain HH, 1934, J AM CHEM SOC, V56, P2649, DOI 10.1021/ja01327a034
   Vargha-Butler EI, 2001, COLLOID POLYM SCI, V279, P1160, DOI 10.1007/s003960100549
   Wang LS, 2004, MACROMOL RAPID COMM, V25, P959, DOI 10.1002/marc.200300319
   YAMADA S, 1979, J FERMENT TECHNOL, V57, P215
   Yang J, 2004, BIOMACROMOLECULES, V5, P209, DOI 10.1021/bm0343242
   Zawaneh PN, 2006, BIOMACROMOLECULES, V7, P3245, DOI 10.1021/bm0605457
   Zelikin AN, 2005, MACROMOLECULES, V38, P5532, DOI 10.1021/ma050049v
   ZHU KJ, 1991, MACROMOLECULES, V24, P1736, DOI 10.1021/ma00008a008
NR 34
TC 37
Z9 39
U1 1
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD NOV 13
PY 2006
VL 7
IS 11
BP 3239
EP 3244
DI 10.1021/bm060544e
PG 6
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 104FI
UT WOS:000241941600043
PM 17096556
DA 2018-10-19
ER

PT J
AU Pyzalla, AR
   Sander, PM
   Hansen, A
   Ferreyro, R
   Yi, SB
   Stempniewicz, M
   Brokmeier, HG
AF Pyzalla, A. R.
   Sander, P. M.
   Hansen, A.
   Ferreyro, R.
   Yi, S. -B.
   Stempniewicz, M.
   Brokmeier, H. -G.
TI Texture analyses of Sauropod dinosaur bones from Tendaguru
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article; Proceedings Paper
CT TMS Annual Meeting and Exhibition
CY FEB 13-16, 2005
CL San Francisco, CA
SP TMS
DE biomaterial; texture; bone; Sauropod; neutrons
ID ORGANIC MATRIX; APATITE; ADAPTATION; CRYSTALS; TENDON
AB The apatite texture of fossil Brachiosaurus brancai and Barosaurus africanus sauropod bones from the excavation site at Tendaguru, Tanzania, was characterized by neutron diffraction pole figures. The results obtained reveal predominantly (0 0 0 1) -fibre textures of the apatite; the fibre direction coincides with the longitudinal direction of the long bones of the skeletons. Neutron pole figures further indicate that other texture types may also be present. Texture strength is similar to dinosaur tendons and contemporary turkey tendon studied by others. Variations of texture strength across the bone wall cross-sections are not significantly large. (c) 2006 Elsevier B.V. All rights reserved.
C1 MPI Eisenforsch GmbH, D-40237 Dusseldorf, Germany.
   TU Wien, Inst Mat Sci & Technol, A-1040 Vienna, Austria.
   Univ Bonn, Inst Paleontol, D-53115 Bonn, Germany.
   Tech Univ Clausthal, Inst Mat Sci & Engn, D-21502 Geesthacht, Germany.
   GKSS Res Ctr Geesthacht GmbH, Geesthacht, Germany.
RP Pyzalla, AR (reprint author), MPI Eisenforsch GmbH, Max Planck Str 1, D-40237 Dusseldorf, Germany.
EM pyzalla@mpie.de
RI Walczak, Magdalena/F-9259-2013; Yi, Sangbong/I-5113-2013
CR ANDERSON JF, 1985, J ZOOL, V207, P53, DOI 10.1111/j.1469-7998.1985.tb04915.x
   BACON GE, 1977, J APPL CRYSTALLOGR, V19, P124
   Burness GP, 2001, P NATL ACAD SCI USA, V98, P14518, DOI 10.1073/pnas.251548698
   CHIPERA SJ, 1991, ADV X RAY ANAL, V34, P473
   CURREY JD, 1968, J THEOR BIOL, V20, P91, DOI 10.1016/0022-5193(68)90094-5
   DAHMS M, 1989, J APPL CRYSTALLOGR, V22, P439, DOI 10.1107/S0021889889005261
   DODSON P, 2004, DINOSAURIA, P402
   Francillon-Vieillot H., 1990, SKELETAL BIOMINERALI, V1, P471
   GLIMCHER MJ, 1984, PHILOS T R SOC B, V304, P479, DOI 10.1098/rstb.1984.0041
   GUNGA HC, 1999, GEOWISSENSCHAFTLICHE, V2, P25
   Heinrich Wolf-Dieter, 1999, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Geowissenschaftliche Reihe, V2, P25
   Hubert JF, 1996, J SEDIMENT RES, V66, P531
   Janensch W, 1950, PALAEONTOGRAPHICA S7, V3, P95
   LANDIS WJ, 1995, BONE, V16, P533, DOI 10.1016/8756-3282(95)00076-P
   Lonardelli I, 2005, J SYNCHROTRON RADIAT, V12, P354, DOI 10.1107/S090904950500138X
   Meneghini C, 2003, BIOPHYS J, V84, P2021, DOI 10.1016/S0006-3495(03)75010-3
   Reid R.E.H., 1997, P403
   Reid REH, 1997, ENCY DINOSAURS, P329
   Ricqles Ad, 1991, BONE, V3, P1, DOI DOI 10.1111/J.0021-8782.2004.00275.X
   Samoilov VS, 2000, NEUES JB MINER MONAT, P129
   Sander PM, 2000, PALEOBIOLOGY, V26, P466, DOI 10.1666/0094-8373(2000)026<0466:LHOTTS>2.0.CO;2
   Sander PM., 1999, GEOWISSENSCHAFTLICHE, V2, P103
   Sasaki N, 1997, CALCIFIED TISSUE INT, V60, P361, DOI 10.1007/s002239900244
   Seebacher F, 2001, J VERTEBR PALEONTOL, V21, P51, DOI 10.1671/0272-4634(2001)021[0051:ANMTCA]2.0.CO;2
   Tanck E, 2001, BONE, V28, P650, DOI 10.1016/S8756-3282(01)00464-1
   Upchurch P, 1998, ZOOL J LINN SOC-LOND, V124, P43, DOI 10.1111/j.1096-3642.1998.tb00569.x
   Wenk HR, 1999, BONE, V24, P361, DOI 10.1016/S8756-3282(98)00192-6
   Wilson JA, 2002, ZOOL J LINN SOC-LOND, V136, P217
   Wolff J., 1892, GESETZ TRANSFORMATIO
   ZOCCO TG, 1994, PALAEONTOLOGY, V37, P493
NR 30
TC 6
Z9 7
U1 0
U2 4
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD NOV 10
PY 2006
VL 437
IS 1
SI SI
BP 2
EP 9
DI 10.1016/j.msea.2006.04.047
PG 8
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 103PG
UT WOS:000241898600002
DA 2018-10-19
ER

PT J
AU Gao, J
   Kim, YM
   Coe, H
   Zern, B
   Sheppard, B
   Wang, YD
AF Gao, Jin
   Kim, Yu Mi
   Coe, Herna
   Zern, Blaine
   Sheppard, Barbara
   Wang, Yadong
TI A neuroinductive biomaterial based on dopamine
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE neurotransmitter; regenerative medicine
ID CELLS PC12 CELLS; NEURITE OUTGROWTH; CONDUCTING POLYMER; GROWTH-FACTOR;
   NEURONS; NEUROTRANSMITTERS; RELEASE; DIFFERENTIATION; REGENERATION;
   STIMULATION
AB Chemical messengers such as neurotransmitters play an important role in cell communication, differentiation, and survival. We have designed and synthesized a bioactive biomaterial that derived its biological activity from dopamine. The resultant biodegradable polymer, PCD, has pendent groups bearing dopamine functionalities. Image analysis demonstrated that nerve growth factor-primed rat pheochromocytoma cells (PC12) and explanted rat dorsal root ganglions attached well and displayed substantial neurite outgrowth on the polymer surface. Furthermore, PCD promoted more vigorous neurite outgrowth in PC12 cells than tissue culture polystyrene, laminin, and poly(D-lysine). The histogram of neurite length of PC12 cells showed distinctive patterns on PCD that were absent on the controls. A subset of PC12 cells displayed high filopodium density on PCD. The addition of dopamine in culture medium had little effect on the differentiation of PC12 cells on tissue culture polystyrene. Tyrosine, the precursor of dopamine, did not exhibit this ability to impart specific bioactivity to an analogous polymer. Thus, the dopamine functional group is likely the origin of the inductive effect. PCD did not cause nerve degeneration or fibrous encapsulation when implanted immediately adjacent to the rat sciatic nerves. This work is a step toward creating a diverse family of bioactive materials using small chemical messengers as monomers.
C1 Georgia Inst Technol, Dept Biomed Engn, Sch Chem & Biochem, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   Kyungpook Natl Univ, Dept Biol & Med Engn, Taegu 702701, South Korea.
   Univ Florida, Coll Vet Med, Gainesville, FL 32611 USA.
RP Wang, YD (reprint author), Georgia Inst Technol, Dept Biomed Engn, Sch Chem & Biochem, Atlanta, GA 30332 USA.
EM ywang@gatech.edu
OI Gao, Jin/0000-0002-6200-4141; Wang, Yadong/0000-0003-2067-382X
CR Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Angelastro JM, 2000, P NATL ACAD SCI USA, V97, P10424, DOI 10.1073/pnas.97.19.10424
   Asanuma M, 2003, NEUROTOX RES, V5, P165, DOI 10.1007/BF03033137
   CANNON JG, 1978, J MED CHEM, V21, P248, DOI 10.1021/jm00201a002
   Casper CL, 2005, BIOMACROMOLECULES, V6, P1998, DOI 10.1021/bm050007e
   Dalsin JL, 2003, J AM CHEM SOC, V125, P4253, DOI 10.1021/ja0284963
   Evans GRD, 2000, SEMIN SURG ONCOL, V19, P312, DOI 10.1002/1098-2388(200010/11)19:3<312::AID-SSU13>3.0.CO;2-M
   Filogamo G, 1971, Neurosci Res (N Y), V4, P29
   GINOS JZ, 1979, J MED CHEM, V22, P1323, DOI 10.1021/jm00197a009
   GRIGORIADIS N, 2004, DEV BRAIN RES, V153, P79
   Han SI, 2005, ADV FUNCT MATER, V15, P367, DOI 10.1002/adfm.200400079
   Hedberg EL, 2005, BIOMATERIALS, V26, P4616, DOI 10.1016/j.biomaterials.2004.11.039
   HOKFELT T, 1994, TRENDS NEUROSCI, V17, P22, DOI 10.1016/0166-2236(94)90031-0
   Kawakami Hiroyoshi, 2004, J Artif Organs, V7, P83
   Koshimura K, 2000, J NEUROSCI RES, V62, P112, DOI 10.1002/1097-4547(20001001)62:1<112::AID-JNR12>3.3.CO;2-Y
   Kotch FW, 2006, P NATL ACAD SCI USA, V103, P3028, DOI 10.1073/pnas.0508783103
   Kuhl PR, 1996, NAT MED, V2, P1022, DOI 10.1038/nm0996-1022
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Luo Y, 2004, NAT MATER, V3, P249, DOI 10.1038/nmat1092
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   MATTSON MP, 1988, BRAIN RES REV, V13, P179, DOI 10.1016/0165-0173(88)90020-3
   MEREDITH GE, 1995, J NEUROSCI, V15, P3808
   Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3
   Park YH, 2003, J NEUROCHEM, V87, P1546, DOI 10.1046/j.1471-4159.2003.02127.x
   Park YH, 2002, BRAIN RES, V951, P43, DOI 10.1016/S0006-8993(02)03103-7
   RANIERI JP, 1995, J BIOMED MATER RES, V29, P779, DOI 10.1002/jbm.820290614
   Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V65, P389, DOI 10.1016/S0168-3659(99)00221-7
   Sanghvi AB, 2005, NAT MATER, V4, P496, DOI 10.1038/nmat1397
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   Si FQ, 1998, EXP BRAIN RES, V123, P263, DOI 10.1007/s002210050568
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Snyder SH, 2006, CELL, V125, P13, DOI 10.1016/j.cell.2006.03.023
   Sombers LA, 2002, ANN NY ACAD SCI, V971, P86, DOI 10.1111/j.1749-6632.2002.tb04439.x
   Songyang Zhou, 1997, Proceedings of the National Academy of Sciences of the United States of America, V94, P11345, DOI 10.1073/pnas.94.21.11345
   Stevens CF, 2003, NEURON, V40, P381, DOI 10.1016/S0896-6273(03)00643-3
   Stokes AH, 1999, J NEUROSCI RES, V55, P659, DOI 10.1002/(SICI)1097-4547(19990315)55:6<659::AID-JNR1>3.0.CO;2-C
   Theocharous P, 1997, J HEMATOTHER, V6, P21, DOI 10.1089/scd.1.1997.6.21
   THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464
   van Hest JCM, 2001, CHEM COMMUN, P1897, DOI 10.1039/b105185g
   van Kesteren RE, 2003, REV NEUROSCIENCE, V14, P217
   Wang XY, 2002, ANAL SCI, V18, P931, DOI 10.2116/analsci.18.931
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
   Zachor DA, 2000, BRAIN RES, V869, P85, DOI 10.1016/S0006-8993(00)02355-6
   Zigmond RE, 1997, ANN NY ACAD SCI, V814, P181, DOI 10.1111/j.1749-6632.1997.tb46157.x
NR 47
TC 32
Z9 32
U1 0
U2 14
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD NOV 7
PY 2006
VL 103
IS 45
BP 16681
EP 16686
DI 10.1073/pnas.0606237103
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 104PB
UT WOS:000241969500013
PM 17075054
OA Bronze, Green Published
DA 2018-10-19
ER

PT J
AU Christman, KL
   Enriquez-Rios, VD
   Maynard, HD
AF Christman, Karen L.
   Enriquez-Rios, Vanessa D.
   Maynard, Heather D.
TI Nanopatterning proteins and peptides
SO SOFT MATTER
LA English
DT Review
ID DIP-PEN NANOLITHOGRAPHY; ELECTRON-BEAM LITHOGRAPHY; SELF-ASSEMBLED
   MONOLAYERS; ATOMIC-FORCE MICROSCOPY; CELL-ADHESION; FOCAL ADHESIONS;
   MOLECULAR RECOGNITION; INTEGRIN FUNCTION; OXIDE SURFACES; COMB POLYMERS
AB A variety of techniques have been developed to site-specifically immobilize biomolecules onto surfaces with resolutions below one micron. The ability to pattern proteins and peptides in particular has great potential for applications in biosensors, biomaterials, and tissue engineering. For example, immobilizing proteins at the nanoscale could lead to the development of diagnostic protein nanoarrays, while patterning peptides could lead to greater control over the cell/biomaterial interface. This review discusses the methods that have been reported for patterning proteins and peptides with submicron and nanometer resolutions.
C1 Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA.
RP Christman, KL (reprint author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.
EM maynard@chem.ucla.edu
CR Agarwal G, 2003, J AM CHEM SOC, V125, P7408, DOI 10.1021/ja029856p
   Agarwal G, 2003, J AM CHEM SOC, V125, P580, DOI 10.1021/ja020471g
   Agheli H, 2006, NANO LETT, V6, P1165, DOI 10.1021/nl060403i
   Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014
   Banerjee IA, 2004, NANO LETT, V4, P2437, DOI 10.1021/nl0484503
   Batra D, 2005, LANGMUIR, V21, P10301, DOI 10.1021/la051948f
   Bergman AA, 1998, LANGMUIR, V14, P6785, DOI 10.1021/la980642o
   Borini S, 2005, LAB CHIP, V5, P1048, DOI 10.1039/b505089h
   Broers AN, 1996, MICROELECTRON ENG, V32, P131, DOI 10.1016/0167-9317(95)00368-1
   Bruckbauer A, 2004, J AM CHEM SOC, V126, P6508, DOI 10.1021/ja0317426
   Bruckbauer A, 2003, J AM CHEM SOC, V125, P9834, DOI 10.1021/ja035755v
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   Cai YG, 2005, LANGMUIR, V21, P9274, DOI 10.1021/la051656e
   Case MA, 2003, NANO LETT, V3, P425, DOI 10.1021/nl025795h
   Christman KL, 2006, LANGMUIR, V22, P7444, DOI 10.1021/la0608213
   Christman KL, 2005, LANGMUIR, V21, P8389, DOI 10.1021/la050646a
   Csucs G, 2003, LANGMUIR, V19, P6104, DOI 10.1021/la0342823
   Denis FA, 2005, SMALL, V1, P984, DOI 10.1002/smll.200500116
   Falconnet D, 2004, NANO LETT, V4, P1909, DOI 10.1021/nl0489438
   Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6
   Ginger DS, 2004, ANGEW CHEM INT EDIT, V43, P30, DOI 10.1002/anie.200300608
   Groll J, 2005, CHEMBIOCHEM, V6, P1782, DOI 10.1002/cbic.200500041
   Gu JH, 2004, J AM CHEM SOC, V126, P8098, DOI 10.1021/ja048405x
   Harnett CK, 2001, LANGMUIR, V17, P178, DOI 10.1021/la0009543
   Hoff JD, 2004, NANO LETT, V4, P853, DOI 10.1021/nl049758x
   Hong SH, 1999, SCIENCE, V286, P523, DOI 10.1126/science.286.5439.523
   Hong Y, 2004, LANGMUIR, V20, P11123, DOI 10.1021/la048651m
   Hu Y, 2005, LANGMUIR, V21, P9103, DOI 10.1021/la046857h
   HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S
   Hyun J, 2004, J AM CHEM SOC, V126, P7330, DOI 10.1021/ja049721e
   Hyun J, 2002, NANO LETT, V2, P1203, DOI 10.1021/n10257364
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P85, DOI 10.1021/bm005584b
   Irvine DJ, 2001, BIOMACROMOLECULES, V2, P545, DOI 10.1021/bm015510f
   Kenseth JR, 2001, LANGMUIR, V17, P4105, DOI 10.1021/la0100744
   Koo LY, 2002, J CELL SCI, V115, P1423
   Kumagai S, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2189566
   Kumagai S, 2005, J PHOTOPOLYM SCI TEC, V18, P495, DOI 10.2494/photopolymer.18.495
   KUMAR A, 1993, APPL PHYS LETT, V63, P2002, DOI 10.1063/1.110628
   Kunzi PA, 2005, MICROELECTRON ENG, V78-79, P582, DOI 10.1016/j.mee.2004.12.073
   Kwak SK, 2004, MAT SCI ENG C-BIO S, V24, P151, DOI 10.1016/j.msec.2003.09.015
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   Lee KB, 2004, NANO LETT, V4, P1869, DOI 10.1021/nl049002y
   Lee KB, 2003, J AM CHEM SOC, V125, P5588, DOI 10.1021/ja034236p
   Lee KY, 2004, NANO LETT, V4, P1501, DOI 10.1021/nl0493592
   Lee M, 2006, PROTEOMICS, V6, P1094, DOI 10.1002/pmic.200500392
   Lee SW, 2006, ADV MATER, V18, P1133, DOI 10.1002/adma.200600070
   Li B, 2005, ULTRAMICROSCOPY, V105, P312, DOI 10.1016/j.ultramic.2005.06.056
   Li HW, 2003, LANGMUIR, V19, P1963, DOI 10.1021/la0269098
   Lim JH, 2003, ANGEW CHEM INT EDIT, V42, P2309, DOI 10.1002/anie.200351256
   Liu GY, 2002, P NATL ACAD SCI USA, V99, P5165, DOI 10.1073/pnas.072695699
   Love JC, 2005, CHEM REV, V105, P1103, DOI 10.1021/cr0300789
   Lussi JW, 2005, NANOTECHNOLOGY, V16, P1781, DOI 10.1088/0957-4484/16/9/062
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791
   Nam JM, 2004, ANGEW CHEM INT EDIT, V43, P1246, DOI 10.1002/anie.200353203
   Naujoks N, 2004, COLLOID SURFACE A, V249, P69, DOI 10.1016/j.colsurfa.2004.08.053
   Noy A, 2002, NANO LETT, V2, P109, DOI 10.1021/nl010081c
   Nuraje N, 2004, J AM CHEM SOC, V126, P8088, DOI 10.1021/ja048617u
   Pallandre A, 2005, J AM CHEM SOC, V127, P4320, DOI 10.1021/ja043656r
   Pallandre A, 2004, NANO LETT, V4, P365, DOI 10.1021/nl035045n
   Park SH, 2005, NANO LETT, V5, P729, DOI 10.1021/nl050175c
   Parviz BA, 2003, IEEE T ADV PACKAGING, V26, P233, DOI 10.1109/TADVP.2003.817971
   Patolsky F, 2004, P NATL ACAD SCI USA, V101, P14017, DOI 10.1073/pnas.0406159101
   Pavlovic E, 2003, NANO LETT, V3, P779, DOI 10.1021/nl034191q
   Pena DJ, 2003, LANGMUIR, V19, P9028, DOI 10.1021/la034787t
   Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1
   Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661
   Powell T, 2006, BIOTECHNOL PROGR, V22, P106, DOI 10.1021/bp0501726
   Renault JP, 2003, J PHYS CHEM B, V107, P703, DOI 10.1021/jp0263424
   Rocken C, 2004, PATHOL RES PRACT, V200, P69, DOI 10.1016/j.prp.2004.03.002
   Rundqvist J, 2006, LANGMUIR, V22, P5100, DOI 10.1021/la052306v
   Senaratne W, 2006, J AM CHEM SOC, V128, P5594, DOI 10.1021/ja058701p
   SHAW LM, 1990, J CELL BIOL, V110, P2167, DOI 10.1083/jcb.110.6.2167
   Silzel JW, 1998, CLIN CHEM, V44, P2036
   Smith JC, 2003, NANO LETT, V3, P883, DOI 10.1021/nl025956h
   Sohda Y, 2003, MICROELECTRON ENG, V67-8, P78, DOI 10.1016/S0167-9317(03)00062-5
   Taha H, 2003, APPL PHYS LETT, V83, P1041, DOI 10.1063/1.1594844
   Valiokas R, 2006, LANGMUIR, V22, P3456, DOI 10.1021/la053367w
   Valsesia A, 2006, LANGMUIR, V22, P1763, DOI 10.1021/la0526333
   Vega RA, 2005, ANGEW CHEM INT EDIT, V44, P6013, DOI 10.1002/anie.200501978
   Wadu-Mesthrige K, 1999, LANGMUIR, V15, P8580, DOI 10.1021/la991196n
   Wadu-Mesthrige K, 2001, BIOPHYS J, V80, P1891, DOI 10.1016/S0006-3495(01)76158-9
   Walter G, 2002, TRENDS MOL MED, V8, P250, DOI 10.1016/S1471-4914(02)02352-3
   Walter N, 2006, NANO LETT, V6, P398, DOI 10.1021/nl052168u
   Welle AM, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2149985
   Wilson DL, 2001, P NATL ACAD SCI USA, V98, P13660, DOI 10.1073/pnas.241323198
   Wilson DS, 2003, ANGEW CHEM INT EDIT, V42, P494, DOI 10.1002/anie.200390150
   Xia Y.N., 1998, ANGEW CHEM INT EDIT, V37, P551, DOI DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G
   Xia YN, 1999, CHEM REV, V99, P1823, DOI 10.1021/cr980002q
   Yamabe M, 2005, J MICROLITH MICROFAB, V4, DOI 10.1117/1.1862648
   Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389
   Yoshinobu T, 2003, ELECTROCHIM ACTA, V48, P3131, DOI 10.1016/S0013-4686(03)00342-6
   Zhang H, 2003, NANOTECHNOLOGY, V14, P1113, DOI 10.1088/0957-4484/14/10/308
   Zhao ZY, 2005, J AM CHEM SOC, V127, P8930, DOI 10.1021/ja051053p
   Zhou DJ, 2003, LANGMUIR, V19, P10557, DOI 10.1021/la035491q
   Zhu XY, 2005, NAT MATER, V4, P403, DOI 10.1038/nmat1365
NR 97
TC 170
Z9 171
U1 2
U2 77
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
J9 SOFT MATTER
JI Soft Matter
PD NOV 7
PY 2006
VL 2
IS 11
BP 928
EP 939
DI 10.1039/b611000b
PG 12
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 104IX
UT WOS:000241953200003
DA 2018-10-19
ER

PT J
AU Matsumoto, A
   Chen, J
   Collette, AL
   Kim, UJ
   Altman, GH
   Cebe, P
   Kaplan, DL
AF Matsumoto, Akira
   Chen, Jingsong
   Collette, Adam L.
   Kim, Ung-Jin
   Altman, Gregory H.
   Cebe, Peggy
   Kaplan, David L.
TI Mechanisms of silk fibroin sol-gel transitions
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID VOLUME-PHASE-TRANSITION; BOMBYX-MORI SILK; N-ISOPROPYLACRYLAMIDE;
   CONFORMATIONAL TRANSITIONS; INFRARED-SPECTROSCOPY; POLY(ETHYLENE OXIDE);
   PH; BIOMATERIAL; TEMPERATURE; PROTEINS
AB Silk fibroin sol-gel transitions were studied by monitoring the process under various physicochemical conditions with optical spectroscopy at 550 nm. The secondary structural change of the fibroin from a disordered state in solution to a beta-sheet-rich conformation in the gel state was assessed by FTIR and CD over a range of fibroin concentrations, temperatures, and pH values. The structural changes were correlated to the degree of gelation based on changes in optical density at 550 nm. No detectable changes in the protein secondary structure (FTIR, CD) were found up to about 15% gelation (at 550 nm), indicating that these early stages of gelation are not accompanied by the formation of beta-sheets. Above 15%, the fraction of beta-sheet linearly increased with the degree of gelation. A pH dependency of gelation time was found with correlation to the predominant acidic side chains in the silk. Electrostatic interactions were related to the rate of gelation above neutral pH. The overall independencies of processing parameters including concentration, temperature, and pH on gel formation and protein structure can be related to primary sequence-specific features in the molecular organization of the fibroin protein. These findings clarify aspects of the self-assembly of this unique family of proteins as a route to gain control of material properties, as well as for new insight into the design of synthetic silk-biomimetic polymers with predictable solution and assembly properties.
C1 Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   Tufts Univ, Dept Biol & Chem Engn, Medford, MA 02155 USA.
   Tufts Univ, Bioengn & Biotechnol Ctr, Medford, MA 02155 USA.
   Tufts Univ, Dept Phys, Medford, MA 02155 USA.
   Tufts Univ, Dept Astron, Medford, MA 02155 USA.
   Tissue Regenerat Inc, Somerville, MA 02143 USA.
RP Matsumoto, A (reprint author), Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
RI Matsumoto, Akira/B-6935-2011
OI Cebe, Peggy/0000-0002-8721-644X
FU NIBIB NIH HHS [P41 EB002520]
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Altman GH, 2002, J BIOMECH ENG-T ASME, V124, P742, DOI 10.1115/1.1519280
   ARRONDO JLR, 1993, PROG BIOPHYS MOL BIO, V59, P23, DOI 10.1016/0079-6107(93)90006-6
   ASAKURA T, 1985, MACROMOLECULES, V18, P1841, DOI 10.1021/ma00152a009
   Asakura T., 1994, ENCY AGR SCI, V4, P1
   AYUB ZH, 1993, BIOSCI BIOTECH BIOCH, V57, P1910, DOI 10.1271/bbb.57.1910
   BYLER DM, 1986, BIOPOLYMERS, V25, P469, DOI 10.1002/bip.360250307
   Chen X, 2001, POLYMER, V42, P9969, DOI 10.1016/S0032-3861(01)00541-9
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   DECKO C, 2004, BIOCHEMISTRY-US, V43, P14080
   DECKO C, 2004, BIOMACROMOLECULES, V5, P758
   DONG A, 1990, BIOCHEMISTRY-US, V29, P3303, DOI 10.1021/bi00465a022
   EDSALL JT, 1983, ADV BIOPHYS, V16, P53
   FEIL H, 1993, MACROMOLECULES, V26, P2496, DOI 10.1021/ma00062a016
   FOO CWP, 2005, APPL PHYS A
   HANAWA T, 1995, CHEM PHARM BULL, V43, P284
   Horan RL, 2005, BIOMATERIALS, V26, P3385, DOI 10.1016/j.biomaterials.2004.09.020
   Jin HJ, 2004, BIOMACROMOLECULES, V5, P711, DOI 10.1021/bm0343287
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   JIN HJ, IN PRESS ADV FUNCT M
   Jones MS, 1999, EUR POLYM J, V35, P795, DOI 10.1016/S0014-3057(98)00066-4
   KAMATH KR, 1993, ADV DRUG DELIVER REV, V11, P59, DOI 10.1016/0169-409X(93)90027-2
   Kang GD, 2000, MACROMOL RAPID COMM, V21, P788, DOI 10.1002/1521-3927(20000701)21:11<788::AID-MARC788>3.3.CO;2-O
   KAPLAN D, 1994, ACS SYM SER, V544, P2
   KAPLAN DL, 1998, PROTEIN BASED MAT, P103
   Kawasaki H, 1997, J PHYS CHEM B, V101, P5089, DOI 10.1021/jp962809x
   Kawashima T, 2005, J PHYS CHEM B, V109, P1055, DOI 10.1021/jp046236x
   Kenney JM, 2002, EUR J BIOCHEM, V269, P4159, DOI 10.1046/j.1432-1033.2002.03112.x
   Kim UJ, 2005, BIOMATERIALS, V26, P2775, DOI 10.1016/j.biomaterials.2004.07.044
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   Koga S, 2001, J PHYS CHEM B, V105, P4105, DOI 10.1021/jp0024625
   LUAN CH, 1990, BIOPOLYMERS, V29, P1699, DOI 10.1002/bip.360291403
   MAGOSHI J, 1996, POLYM MAT ENCY, V119, P669
   Magoshi J., 1996, POLYM MAT ENCY, V1, P667
   Mautner MMN, 1999, J AM CHEM SOC, V121, P7625
   MEINEL L, 2004, BIOMATERIALS, V26, P147
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   NAGERSEKAR A, 2002, J BIOMED MATER RES, V62, P195
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Smith DA, 2000, J PHYS CHEM B, V104, P8862, DOI 10.1021/jp0023056
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   SPEARE JO, 1990, BIOPOLYMERS, V72, P193
   Tanaka K, 1999, BBA-PROTEIN STRUCT M, V1432, P92, DOI 10.1016/S0167-4838(99)00088-6
   Terry AE, 2004, BIOMACROMOLECULES, V5, P768, DOI 10.1021/bm034381v
   Tretinnikov ON, 2001, LANGMUIR, V17, P7406, DOI 10.1021/la010791y
   URRY DW, 1993, ANGEW CHEM INT EDIT, V32, P819, DOI 10.1002/anie.199308191
   Urry DW, 1997, J PHYS CHEM B, V101, P11007, DOI 10.1021/jp972167t
   URRY DW, 1997, J AM CHEM SOC, V19, P11161
   Valluzzi R, 1999, J PHYS CHEM B, V103, P11382, DOI 10.1021/jp991363s
   Wang M, 2004, MACROMOLECULES, V37, P6856, DOI 10.1021/ma048988v
   Wilson D, 2000, BIOPHYS J, V78, P2690, DOI 10.1016/S0006-3495(00)76813-5
   Yamamoto K, 2001, MACROMOLECULES, V34, P8014, DOI 10.1021/ma0102969
   Zhou CZ, 2000, NUCLEIC ACIDS RES, V28, P2413, DOI 10.1093/nar/28.12.2413
   Zhou L, 2005, J PHYS CHEM B, V109, P16937, DOI 10.1021/jp050883m
   Zhou P, 2004, BIOCHEMISTRY-US, V43, P11302, DOI 10.1021/bi049344i
NR 58
TC 233
Z9 238
U1 14
U2 144
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD NOV 2
PY 2006
VL 110
IS 43
BP 21630
EP 21638
DI 10.1021/jp056350v
PG 9
WC Chemistry, Physical
SC Chemistry
GA 098WL
UT WOS:000241553500037
PM 17064118
DA 2018-10-19
ER

PT J
AU Charles, M
   Veesler, S
   Bonnete, F
AF Charles, Mathieu
   Veesler, Stephane
   Bonnete, Francoise
TI MPCD: a new interactive on-line crystallization data bank for screening
   strategies
SO ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
LA English
DT Article
ID PROTEIN DATA-BANK; X-RAY-SCATTERING; BIOLOGICAL MACROMOLECULES; RELATIVE
   EFFECTIVENESS; CRYSTAL-GROWTH; BPTI MOLECULES; APROTININ BPTI;
   SOLUBILITY; LYSOZYME; TEMPERATURE
AB The Marseille Protein Crystallization Database (MPCD) is a new crystallization database, freely accessible via http://www.crmcn.univ-mrs.fr/ mpcd/, populated with information found in the BMCD and CYCLOP. This new online database includes details about macromolecules (such as name, pI, molecular weight, number of subunits), crystallization conditions, methods and additives used in an easy-to-compare table form. It allows users to choose their own crystallization parameters, to create tables for further analysis and also to enter new proteins and crystallization conditions in order to supplement this database. As an essential tool in structural biology, this crystallization database will be highly relevant to crystal growers, when connected to the Protein Data Bank, for the crystallogenesis of a variety of structurally distinct molecules and assemblies, and to macromolecular and biomaterial researchers designing structures.
C1 CRMCN, CNRS UPR 7251, F-13288 Marseille 09, France.
RP Bonnete, F (reprint author), CRMCN, CNRS UPR 7251, Campus Luminy,Case 913, F-13288 Marseille 09, France.
EM bonnete@crmcn.univ-mrs.fr
RI bonnete, francoise/Q-2143-2015
OI bonnete, francoise/0000-0002-1690-1757; Veesler,
   Stephane/0000-0001-8362-2531
CR Anand K, 2002, ACTA CRYSTALLOGR D, V58, P1722, DOI 10.1107/S0907444902014610
   ARAKAWA T, 1985, METHOD ENZYMOL, V114, P49
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   BOISTELLE R, 1988, J CRYST GROWTH, V90, P14, DOI 10.1016/0022-0248(88)90294-1
   BOISTELLE R, 1992, J CRYST GROWTH, V123, P109, DOI 10.1016/0022-0248(92)90015-B
   Boistelle R, 1986, Adv Nephrol Necker Hosp, V15, P173
   Bonnete F, 1999, J CRYST GROWTH, V196, P403, DOI 10.1016/S0022-0248(98)00826-4
   Boyer M, 1999, J CRYST GROWTH, V196, P185, DOI 10.1016/S0022-0248(98)00838-0
   CARBONNAUX C, 1995, PROTEIN SCI, V4, P2123, DOI 10.1002/pro.5560041018
   CARTER CW, 1979, J BIOL CHEM, V254, P2219
   Costenaro L, 2001, J CRYST GROWTH, V232, P102, DOI 10.1016/S0022-0248(01)01150-2
   Ducruix A, 1996, J CRYST GROWTH, V168, P28, DOI 10.1016/0022-0248(96)00359-4
   Farnum M, 1999, BIOPHYS J, V76, P2716, DOI 10.1016/S0006-3495(99)77424-2
   Finet S, 2003, METHOD ENZYMOL, V368, P105, DOI 10.1016/S0076-6879(03)68007-9
   GEORGE A, 1994, ACTA CRYSTALLOGR D, V50, P361, DOI 10.1107/S0907444994001216
   GILLILAND GL, 1994, ACTA CRYSTALLOGR D, V50, P408, DOI 10.1107/S0907444994002003
   GILLILAND GL, 1988, J CRYST GROWTH, V90, P51, DOI 10.1016/0022-0248(88)90298-9
   Hennessy D, 2000, ACTA CRYSTALLOGR D, V56, P817, DOI 10.1107/S0907444900004261
   Hennessy D, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P179
   Hofmeister F., 1888, ARCH EXP PATHOL PH, V24, P247, DOI DOI 10.1007/BF01918191
   JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430
   Jones WF, 2001, J CRYST GROWTH, V232, P221, DOI 10.1016/S0022-0248(01)01064-8
   Kantardjieff KA, 2004, BIOINFORMATICS, V20, P2162, DOI 10.1093/bioinformatics/bth066
   LAFONT S, 1994, J CRYST GROWTH, V143, P249, DOI 10.1016/0022-0248(94)90064-7
   Lafont S, 1997, J CRYST GROWTH, V173, P132, DOI 10.1016/S0022-0248(96)00834-2
   LORBER B, 1992, J CRYST GROWTH, V122, P168, DOI 10.1016/0022-0248(92)90240-J
   MCPHERSON A, 1982, PREPARATION ANAL PR
   Muschol M, 1995, J CHEM PHYS, V103, P10424, DOI 10.1063/1.469891
   Peat TS, 2005, ACTA CRYSTALLOGR D, V61, P1662, DOI 10.1107/S0907444905033202
   Piazza R., 2000, J PHYS-CONDENS MAT, V12, P443
   Ries-Kautt M., 1992, CRYSTALLIZATION NUCL, P195
   RIESKAUTT MM, 1989, J BIOL CHEM, V264, P745
   SAMUDZI CT, 1992, J CRYST GROWTH, V123, P47, DOI 10.1016/0022-0248(92)90009-8
   Tardieu A, 2002, ACTA CRYSTALLOGR D, V58, P1549, DOI 10.1107/S0907444902014439
   Trakhanov S, 1998, PROTEIN SCI, V7, P600
   Veesler S, 2004, CRYST GROWTH DES, V4, P1137, DOI 10.1021/cg0498195
   Vivares D, 2002, ACTA CRYSTALLOGR D, V58, P472, DOI 10.1107/S0907444902000124
NR 37
TC 21
Z9 22
U1 1
U2 3
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0907-4449
J9 ACTA CRYSTALLOGR D
JI Acta Crystallogr. Sect. D-Biol. Crystallogr.
PD NOV
PY 2006
VL 62
BP 1311
EP 1318
DI 10.1107/S0907444906027594
PN 11
PG 8
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 096ML
UT WOS:000241381100004
PM 17057333
DA 2018-10-19
ER

PT J
AU Kim, S
   Kim, Y
   Kim, P
   Ha, JM
   Kim, K
   Sohn, M
   Yoo, JS
   Lee, J
   Kwon, JA
   Lee, KN
AF Kim, Soyoun
   Kim, Youngdeuk
   Kim, Philseok
   Ha, Jeongmin
   Kim, Kyunyoung
   Sohn, Mijin
   Yoo, Jin-San
   Lee, Jungeun
   Kwon, Jung-ah
   Lee, Kap No
TI Improved sensitivity and physical properties of sol-gel protein chips
   using large-scale material screening and selection
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID PORE-SIZE; MICROARRAYS; SILICA; ARRAYS; MEMBRANE; POLYMERS;
   QUANTIFICATION; BIOLOGICALS; TECHNOLOGY; PROTEOMICS
AB Protein chips are a powerful emerging technology with extensive biomedical applications. However, the development of optimal, economical surface materials capable of maintaining the activity of embedded proteins is a challenge. Here, we introduce a new optimized, low-cost, sol-gel biomaterial for use in protein chips with femtogram-level sensitivity. A novel protein chip material with significantly improved physical properties and sensitivity was produced using unique screening and selection methods. Using this platform, the sensitive, specific detection of the interactions between an HIV antigen and its antibody and between a cyclin-kinase protein pair was observed. This study is the first to demonstrate the detection of protein-protein interactions on sol-gel microarrays and describes an important improvement in the physical properties of sol-gel-derived protein chip materials for biomedical research.
C1 Dongguk Univ, Dept Chem, Seoul, South Korea.
   LG Chem Ltd, Taejon, South Korea.
   LG Life Sci, Taejon, South Korea.
   Kuro Korea Univ Hosp, Diag Div, Seoul, South Korea.
   Minist Sci & Technol, Natl Res Lab, NanoBio Technol Lab, Seoul, South Korea.
RP Kim, S (reprint author), Dongguk Univ, Dept Chem, Seoul, South Korea.
EM skim@dongguk.edu
CR Angenendt P, 2003, J CHROMATOGR A, V1009, P97, DOI 10.1016/S0021-9673(03)00769-6
   Arenkov P, 2000, ANAL BIOCHEM, V278, P123, DOI 10.1006/abio.1999.4363
   Besanger TR, 2004, ANAL CHEM, V76, P6470, DOI 10.1021/ac0488210
   Boury B, 2000, ADV MATER, V12, P989, DOI 10.1002/1521-4095(200006)12:13<989::AID-ADMA989>3.0.CO;2-K
   Cahill DJ, 2001, J IMMUNOL METHODS, V250, P81, DOI 10.1016/S0022-1759(01)00325-8
   Cho EJ, 2002, ANAL CHEM, V74, P1462, DOI 10.1021/ac010907v
   Copeland S, 2004, J IMMUNOL METHODS, V284, P99, DOI 10.1016/j.jim.2003.10.011
   Fujii T, 2001, J MEMBRANE SCI, V187, P171, DOI 10.1016/S0376-7388(01)00338-6
   Gill I, 2000, TRENDS BIOTECHNOL, V18, P282, DOI 10.1016/S0167-7799(00)01457-8
   Gill I, 1998, J AM CHEM SOC, V120, P8587, DOI 10.1021/ja9814568
   Gill I, 2001, CHEM MATER, V13, P3404, DOI 10.1021/cm0102483
   Gogotsi Y, 2003, NAT MATER, V2, P591, DOI 10.1038/nmat957
   Haab BB, 2001, GENOME BIOL, V2
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kim YD, 2001, BIOTECHNOL BIOENG, V73, P331, DOI 10.1002/bit.1066
   Kusakabe K, 1999, SEP PURIF TECHNOL, V16, P139, DOI 10.1016/S1383-5866(98)00120-8
   LIVAGE J, 2001, J PHYS-CONDENS MAT, V13, P673
   MacBeath G, 2002, NAT GENET, V32, P526, DOI 10.1038/ng1037
   MacBeath G, 2001, NAT BIOTECHNOL, V19, P828, DOI 10.1038/nbt0901-828
   MacBeath G, 2000, SCIENCE, V289, P1760
   MACBEATH G, 2001, GENOME BIOL, V2
   Park CB, 2002, BIOTECHNOL BIOENG, V78, P229, DOI 10.1002/bit.10238
   Price CP, 2001, CLIN CHEM, V47, P1345
   Price DH, 2000, MOL CELL BIOL, V20, P2629, DOI 10.1128/MCB.20.8.2629-2634.2000
   RichaletSecordel PM, 1996, CLIN DIAGN VIROL, V5, P111, DOI 10.1016/0928-0197(96)00212-7
   Rupcich N, 2003, CHEM MATER, V15, P1803, DOI 10.1021/cm030028k
   Suh CW, 2004, J BIOTECHNOL, V112, P267, DOI 10.1016/j.jbiotec.2004.05.005
   Wiese R, 2001, CLIN CHEM, V47, P1451
   Zhu H, 2000, NAT GENET, V26, P283
   Zhu H, 2003, CURR OPIN CHEM BIOL, V7, P55, DOI 10.1016/S1367-5931(02)00005-4
NR 30
TC 34
Z9 35
U1 0
U2 16
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
J9 ANAL CHEM
JI Anal. Chem.
PD NOV 1
PY 2006
VL 78
IS 21
BP 7392
EP 7396
DI 10.1021/ac0520487
PG 5
WC Chemistry, Analytical
SC Chemistry
GA 100LG
UT WOS:000241670000019
PM 17073404
DA 2018-10-19
ER

PT J
AU Feng, ZG
   Ishibashi, M
   Nomura, Y
   Kitajima, T
   Nakamura, T
AF Feng, Zhonggang
   Ishibashi, Makiko
   Nomura, Yasutomo
   Kitajima, Tastuo
   Nakamura, Takao
TI Constraint stress, microstructural characteristics, and enhanced
   mechanical properties of a special fibroblast-embedded collagen
   construct
SO ARTIFICIAL ORGANS
LA English
DT Article
DE collagen structure; mechanical properties; constraint stress;
   microstructure; fibril orientation
ID EXTRACELLULAR-MATRIX; I COLLAGEN; CONTRACTION; EXPRESSION; TISSUE;
   CELLS; GELS; VITRO
AB Cell-contracted collagen gels could provide rejection-free biomaterials for tissue engineering, but their application is limited by relatively low mechanical strength. We developed a special type I collagen construct (based on embedded fibroblasts) that was formed into a gel thread by using two anchors to constrain gel contraction in one direction. Each gel thread contained 2 mg of type I collagen and 1.0 x 10(6) fibroblasts, and had an initial volume of 3 mL. After 9 days in culture, this preparation was transformed into a thread-like construct measuring 26 x 2.3 x 0.21 mm. Investigation of the microstructure showed that the collagen fibrils longitudinally between two cells had most aligned with the direction of the constraint stress and had assumed higher density than those in the freely contracted controls. During culturing, the constraint stress first increased then decreased, with implications for the nature of the interaction between the embedded cells and collagen matrix. Under uniaxial tensile testing, the ultimate stress and material modulus increased by factors of 6 and 16, respectively, compared with controls, while the maximal strain decreased by 590%. Compared with the similar constructs in the literature, the thread gel was fabricated by means of a novel mold configuration so that it contracted to thread shape much faster, and more importantly, the constraint force was firstly reported in this article. The improved mechanical properties show that the gel thread could be an effective biomaterial for such tissue engineering applications as the fabrication of blood vessels, ligaments, and tendon grafts.
C1 Yamagata Univ, Dept Biosyst Engn, Yonezawa, Yamagata 9928510, Japan.
   Yamagata Univ, Dept Environm Life Sci, Yonezawa, Yamagata 9928510, Japan.
RP Feng, ZG (reprint author), Yamagata Univ, Dept Biosyst Engn, JohNan 4-3-16, Yonezawa, Yamagata 9928510, Japan.
EM zhgfeng@yz.yamagata-u.ac.jp
CR Brown RA, 2002, EXP CELL RES, V274, P310, DOI 10.1006/excr.2002.5471
   Brown RA, 1996, J CELL PHYSIOL, V169, P439, DOI 10.1002/(SICI)1097-4652(199612)169:3<439::AID-JCP4>3.0.CO;2-P
   BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415
   Eschenhagen Thomas, 2002, Basic Research in Cardiology, V97
   Feng Z, 2003, ARTIF ORGANS, V27, P84, DOI 10.1046/j.1525-1594.2003.07187.x
   Feng Zhonggang, 2003, J Artif Organs, V6, P192, DOI 10.1007/s10047-003-0230-z
   Gentleman E, 2004, TISSUE ENG, V10, P421, DOI 10.1089/107632704323061780
   Gildner CD, 2004, AM J PHYSIOL-HEART C, V287, pH46, DOI 10.1152/ajpheart.00859.2003
   HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0
   Ker RF, 1999, J EXP BIOL, V202, P3315
   Kuboki Y, 1998, EUR J ORAL SCI, V106, P197, DOI 10.1111/j.1600-0722.1998.tb02176.x
   Lambert CA, 2001, MATRIX BIOL, V20, P397, DOI 10.1016/S0945-053X(01)00156-1
   Liu XD, 1998, AM J PHYSIOL-LUNG C, V274, pL58, DOI 10.1152/ajplung.1998.274.1.L58
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Shi YL, 2003, TISSUE ENG, V9, P1233, DOI 10.1089/10763270360728143
   STEINBERG BM, 1980, J CELL BIOL, V87, P304, DOI 10.1083/jcb.87.1.304
   Takahashi I, 2003, EUR J CELL BIOL, V82, P182, DOI 10.1078/0171-9335-00307
   Vernon RB, 1996, J CELL BIOCHEM, V60, P185, DOI 10.1002/(SICI)1097-4644(19960201)60:2<185::AID-JCB3>3.0.CO;2-T
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   Yamato M, 1998, EXTRACELLULAR MATRIX-CELL INTERACTION, P123
NR 20
TC 15
Z9 15
U1 0
U2 2
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD NOV
PY 2006
VL 30
IS 11
BP 870
EP 877
DI 10.1111/j.1525-1594.2006.00314.x
PG 8
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 098GY
UT WOS:000241510200004
PM 17062110
DA 2018-10-19
ER

PT J
AU Petrie, TA
   Capadona, JR
   Reyes, CD
   Garcia, AJ
AF Petrie, Timothy A.
   Capadona, Jeffrey R.
   Reyes, Catherine D.
   Garcia, Andres J.
TI Integrin specificity and enhanced cellular activities associated with
   surfaces presenting a recombinant fibronectin fragment compared to RGD
   supports
SO BIOMATERIALS
LA English
DT Article
DE biomimetic; integrins; cell adhesion; focal adhesion; FAK;
   self-assembled monolayers
ID EXTRACELLULAR-MATRIX PROTEINS; OSTEOBLAST DIFFERENTIATION; BIOMATERIAL
   SURFACES; ADHESIVE SURFACES; MIMETIC PEPTIDE; BONE-FORMATION; SYNERGY
   SITE; IN-VIVO; BINDING; DOMAINS
AB Biomimetic strategies focusing on presenting short bioadhesive oligopeptides, including the arginine-glycine-aspartic acid (RGD) motif present in numerous adhesive proteins, on a non-fouling support have emerged as promising approaches to improve cellular activities and healing responses. Nevertheless, these bio-inspired strategies are limited by low activity of the oligopeptides compared to the native ligand due to the absence of complementary or modulatory domains. In the present analysis, we generated well-defined biointerfaces presenting RGD-based ligands of increasing complexity to directly compare their biological activities in terms of cell adhesion strength, integrin binding and signaling. Mixed self-assembled monolayers of alkanethiols on gold were optimized to engineer robust supports that present anchoring groups for ligand tethering within a non-fouling, protein adsorption-resistant background. Controlled bioadhesive interfaces were generated by tethering adhesive ligands via standard peptide chemistry. On a molar basis, biointerfaces functionalized with the FNIII7-10 recombinant fragment presenting the RGD and PHSRN adhesive motifs in the correct structural context exhibited significantly higher adhesion strength, FAK activation, and cell proliferation rate than supports presenting RGD ligand or RGD-PHSRN, an oligopeptide presenting these two sites separated by a polyglycine linker. Moreover, FNIII7-10 functionalized surfaces displayed specificity for alpha(5)beta(1) integrin, while cell adhesion to supports presenting RGD or RGD-PHSRN was primarily mediated by alpha(v)beta(3) integrin. These results are significant to the rational engineering of bioactive materials that convey integrin binding specificity for directed cellular and tissue responses in biomedical and biotechnological applications. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
   Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.
RP Garcia, AJ (reprint author), Georgia Inst Technol, George W Woodruff Sch Mech Engn, 315 Ferst Dr,2314 IBB, Atlanta, GA 30332 USA.
EM gtg415p@mail.gatech.edu; capadona@fes.case.edu; CDReyes@aol.com;
   andres.garcia@me.gatech.edu
RI Sanguansri, Luz/B-6630-2011; Capadona, Jeffrey/G-4772-2010
OI Sanguansri, Luz/0000-0003-1908-7604; 
FU NIBIB NIH HHS [R01 EB-004496]
CR Alsberg E, 2002, P NATL ACAD SCI USA, V99, P12025, DOI 10.1073/pnas.192291499
   Altroff H, 2004, J BIOL CHEM, V279, P55995, DOI 10.1074/jbc.M406976200
   AOTA S, 1994, J BIOL CHEM, V269, P24756
   Benoit DSW, 2005, BIOMATERIALS, V26, P5209, DOI 10.1016/j.biomaterials.2005.01.045
   Capadona JR, 2005, ADV MATER, V17, P2604, DOI 10.1002/adma.200500959
   Capadona JR, 2003, LANGMUIR, V19, P1847, DOI 10.1021/la026244
   Cheng SL, 2001, J BONE MINER RES, V16, P277, DOI 10.1359/jbmr.2001.16.2.277
   Cowles EA, 2000, J BIOMED MATER RES, V52, P725, DOI 10.1002/1097-4636(20001215)52:4<725::AID-JBM18>3.3.CO;2-F
   Cutler SM, 2003, BIOMATERIALS, V24, P1759, DOI 10.1016/S0142-9612(02)00570-7
   De Arcangelis A, 2000, TRENDS GENET, V16, P389, DOI 10.1016/S0168-9525(00)02074-6
   Dillow AK, 2001, BIOMATERIALS, V22, P1493, DOI 10.1016/S0142-9612(00)00304-5
   Elmengaard B, 2005, BIOMATERIALS, V26, P3521, DOI 10.1016/j.biomaterials.2004.09.039
   Emsley J, 2000, CELL, V101, P47, DOI 10.1016/S0092-8674(00)80622-4
   Feng YZ, 2004, BIOCHEMISTRY-US, V43, P15811, DOI 10.1021/bi049174+
   Ferris DM, 1999, BIOMATERIALS, V20, P2323, DOI 10.1016/S0142-9612(99)00161-1
   Garcia AJ, 2002, BIOCHEMISTRY-US, V41, P9063, DOI 10.1021/bi025752f
   Garcia AJ, 2005, J DENT RES, V84, P407, DOI 10.1177/154405910508400502
   HANKS SK, 2003, FRONT BIOSCI, V8, P982
   Heilshorn SC, 2003, BIOMATERIALS, V24, P4245, DOI 10.1016/S0142-9612(03)00294-1
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Humphries JD, 2000, J BIOL CHEM, V275, P20337, DOI 10.1074/jbc.M000568200
   Kao WJ, 2001, J BIOMED MATER RES, V55, P79, DOI 10.1002/1097-4636(200104)55:1<79::AID-JBM110>3.3.CO;2-Q
   Keselowsky BG, 2005, BIOMATERIALS, V26, P413, DOI 10.1016/j.biomaterials.2004.02.050
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Krammer A, 2002, MATRIX BIOL, V21, P139, DOI 10.1016/S0945-053X(01)00197-4
   Lahiri J, 1999, ANAL CHEM, V71, P777, DOI 10.1021/ac980959t
   Lan MA, 2005, BIOMATERIALS, V26, P4523, DOI 10.1016/j.biomaterials.2004.11.028
   Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8
   Li FF, 2003, P NATL ACAD SCI USA, V100, P15346, DOI 10.1073/pnas.2536767100
   Liu JC, 2004, BIOMACROMOLECULES, V5, P497, DOI 10.1021/bm034340z
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Maheshwari G, 2000, J CELL SCI, V113, P1677
   Mardilovich A, 2006, LANGMUIR, V22, P3259, DOI 10.1021/la052756n
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Mi J, 2005, BIOCHEM BIOPH RES CO, V338, P956, DOI 10.1016/j.bbrc.2005.10.043
   Moursi AM, 1997, J CELL SCI, V110, P2187
   Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521
   Reichardt L. F., 1999, GUIDEBOOK EXTRACELLU, P335
   Reyes CD, 2003, J BIOMED MATER RES A, V67A, P328, DOI 10.1002/jbm.a.10122
   Reyes CD, 2003, J BIOMED MATER RES A, V65A, P511, DOI 10.1002/jbm.a.10550
   Reyes CD, 2004, J BIOMED MATER RES A, V69A, P591, DOI 10.1002/jbm.a.30034
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Rowley JA, 2002, J BIOMED MATER RES, V60, P217, DOI 10.1002/jbm.1287
   Schense JC, 2000, J BIOL CHEM, V275, P6813, DOI 10.1074/jbc.275.10.6813
   Schense JC, 2000, NAT BIOTECHNOL, V18, P415
   SCHOEN RC, 1982, HYBRIDOMA, V1, P99, DOI 10.1089/hyb.1.1982.1.99
   Shin H, 2002, J BIOMED MATER RES, V61, P169, DOI 10.1002/jbm.10193
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007
   Yu XJ, 2003, TISSUE ENG, V9, P421, DOI 10.1089/107632703322066606
NR 52
TC 176
Z9 181
U1 3
U2 48
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2006
VL 27
IS 31
BP 5459
EP 5470
DI 10.1016/j.biomaterials.2006.06.027
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 085NO
UT WOS:000240611000013
PM 16846640
DA 2018-10-19
ER

PT J
AU Chen, W
   Liu, Y
   Courtney, HS
   Bettenga, M
   Agrawal, CM
   Bumgardner, JD
   Ong, JL
AF Chen, W.
   Liu, Y.
   Courtney, H. S.
   Bettenga, M.
   Agrawal, C. M.
   Bumgardner, J. D.
   Ong, J. L.
TI In vitro anti-bacterial and biological properties of magnetron
   co-sputtered silver-containing hydroxyapatite coating
SO BIOMATERIALS
LA English
DT Article
DE hydroxyapatite coating; cytotoxicity; bacterial adhesion; silver
ID CALCIUM-PHOSPHATE COATINGS; CENTRAL VENOUS CATHETERS; TOTAL KNEE
   REPLACEMENT; BONE-CEMENT; TOTAL HIP; ANTIMICROBIAL ACTIVITY;
   MECHANICAL-PROPERTIES; BACTERIAL ADHERENCE; JOINT ARTHROPLASTY;
   BIOACTIVE GLASS
AB Bacterial infection after implant placement is a significant rising complication. In order to reduce the incidence of implant-associated infections, several biomaterial surface treatments have been proposed. In this study, the effect of in vitro antibacterial activity and in vitro cytotoxicity of co-sputtered silver (Ag)-containing hydroxyapatite (HA) coating was evaluated. Deposition was achieved by a concurrent supply of 10 W to the Ag target and 300 W to the HA target. Heat treatment at 400 degrees C for 4 It was performed after 3 h deposition. X-ray diffraction, contact angles measurements, and surface roughness were used to characterize the coating surfaces. The RP12 strain of Staphylococcus epidermidis (ATCC 35984) and the Cowan I strain of Staphylococcus aureus were used to evaluate the antibacterial activity of the Ag-HA coatings, whereas human embryonic palatal mesenchyme cells, an osteoblast precursor cell line, were used to evaluate the in vitro cytotoxicity of the coatings. X-ray diffraction analysis performed in this study indicated peaks corresponding to Ag and HA on the co-sputtered Ag-HA surfaces. The contact angles for HA and Ag-HA surfaces were observed to be significantly lower when compared to Ti surfaces, whereas no significant difference in surface roughness was observed for all groups. In vitro bacterial adhesion study indicated a significantly reduced number of S. epidermidis and S. aureus on Ag-HA surface when compared to titanium (Ti) and HA surfaces. In addition, no significant difference in the in vitro cytotoxicty was observed between HA and Ag-HA surfaces. Overall, it was concluded that the creation of a multifunctional surface can be achieved by co-sputtering the osteoconductive HA with antibacterial Ag. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Tennessee, Ctr Hlth Sci, Dept Biomed Engn, Memphis, TN 38163 USA.
   Fujian Med Univ, Union Hosp, Dept Oral Surg, Fujian 350001, Peoples R China.
   Univ Texas, Dept Biomed Engn, San Antonio, TX 78249 USA.
   Vet Affairs Med Ctr, Memphis, TN 38103 USA.
   Univ Memphis, Dept Biomed Engn, Memphis, TN 38152 USA.
RP Ong, JL (reprint author), Univ Tennessee, Ctr Hlth Sci, Dept Biomed Engn, 920 Madison Ave,Suite 1005, Memphis, TN 38163 USA.
EM jong@utmem.edu
FU NCRR NIH HHS [1S10RR016879-01]; NIAMS NIH HHS [1R01AR46581]
CR Alt V, 2004, BIOMATERIALS, V25, P4383, DOI 10.1016/j.biomaterials.2003.10.078
   ANTTIPOIKA I, 1990, ACTA ORTHOP SCAND, V61, P163, DOI 10.3109/17453679009006513
   Bechert T, 2000, NAT MED, V6, P1053, DOI 10.1038/79568
   Bechert T, 1999, INFECTION, V27, pS24, DOI 10.1007/BF02561613
   Bellantone M, 2002, ANTIMICROB AGENTS CH, V46, P1940, DOI 10.1128/AAC.46.6.1940-1945.2002
   Bellantone M, 2000, J BIOMED MATER RES, V51, P484, DOI 10.1002/1097-4636(20000905)51:3<484::AID-JBM24>3.0.CO;2-4
   BISHOP JB, 1992, J VASC SURG, V16, P251, DOI 10.1016/0741-5214(92)90115-O
   Blaker JJ, 2004, BIOMATERIALS, V25, P1319, DOI 10.1016/j.biomaterials.2003.08.007
   Bosetti M, 2002, BIOMATERIALS, V23, P887, DOI 10.1016/S0142-9612(01)00198-3
   Buczynski BW, 2003, COLLOID SURFACE B, V30, P167, DOI 10.1016/S0927-7765(03)00068-7
   Cen L, 2004, J BIOMED MATER RES A, V71A, P70, DOI 10.1002/jbm.a.30125
   CHU CS, 1988, J TRAUMA, V28, P1488, DOI 10.1097/00005373-198810000-00016
   Cleries L, 2000, BIOMATERIALS, V21, P967, DOI 10.1016/S0142-9612(99)00240-9
   Clupper DC, 2001, J MATER SCI-MATER M, V12, P917, DOI 10.1023/A:1012836426866
   COSTERTON JW, 1994, ANTIMICROB AGENTS CH, V38, P2803, DOI 10.1128/AAC.38.12.2803
   CRISTINA AG, 1987, SCIENCE, V237, P1588
   D'Antonio JA, 2001, CLIN ORTHOP RELAT R, P101
   Darouiche RO, 1999, CLIN INFECT DIS, V29, P1371, DOI 10.1086/313561
   de Sena LA, 2002, J BIOMED MATER RES, V60, P1
   DEITCH EA, 1987, J TRAUMA, V27, P301
   Del Re M, 2002, SURF COAT TECH, V151, P86, DOI 10.1016/S0257-8972(01)01592-4
   DUELAND R, 1982, CLIN ORTHOP RELAT R, P264
   Dunn K, 2004, BURNS, V30, pS1, DOI 10.1016/j.burns.2004.06.000
   Ewald A, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-22
   Fitzgerald RH, 1995, J AM ACAD ORTHOP SUR, V3, P249
   Geesink RGT, 2002, CLIN ORTHOP RELAT R, P53, DOI 10.1097/00003086-200202000-00007
   GHANDOUR W, 1988, APPL MICROBIOL BIOT, V28, P559, DOI 10.1007/BF00250412
   GREENFELD JI, 1995, CRIT CARE MED, V23, P894, DOI 10.1097/00003246-199505000-00018
   GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014
   Hanssen A D, 1997, Instr Course Lect, V46, P555
   HARRIS WH, 1990, NEW ENGL J MED, V323, P801, DOI 10.1056/NEJM199009203231206
   Havelin LI, 2000, ACTA ORTHOP SCAND, V71, P337, DOI 10.1080/000164700317393321
   Hendriks JGE, 2004, BIOMATERIALS, V25, P545, DOI 10.1016/S0142-9612(03)00554-4
   Hidalgo E, 1998, TOXICOL LETT, V98, P169, DOI 10.1016/S0378-4274(98)00114-3
   Jansen B, 1994, J Biomater Appl, V9, P55, DOI 10.1177/088532829400900103
   Joyce-Wohrmann RM, 1999, INFECTION, V27, pS46, DOI 10.1007/BF02561618
   KRAMER SJ, 1981, CLIN ORTHOP RELAT R, P154
   LACEFIELD WR, 1988, BIOCERAMICS MAT CHAR, P72
   Lansdown A B G, 2002, J Wound Care, V11, P173
   Lansdown A B G, 2002, J Wound Care, V11, P125
   Lansdown ABG, 1997, BRIT J DERMATOL, V137, P728
   Li PLS, 1999, J BONE JOINT SURG BR, V81B, P647, DOI 10.1302/0301-620X.81B4.9262
   LUCAS LC, 1993, COLLOID SURFACE A, V77, P141, DOI 10.1016/0927-7757(93)80110-Z
   MARGRAF HW, 1977, ARCH SURG-CHICAGO, V112, P699
   MCLEAN RJC, 1993, CAN J MICROBIOL, V39, P895, DOI 10.1139/m93-134
   NASSER S, 1992, ORTHOP CLIN N AM, V23, P265
   NOHR RS, 1994, J BIOMAT SCI-POLYM E, V5, P607, DOI 10.1163/156856294X00239
   Ong JL, 2002, J BIOMED MATER RES, V59, P184, DOI 10.1002/jbm.1232
   PETERING HG, 1976, PHARMACOL THER PT A, V1, P127, DOI 10.1016/0362-5478(76)90002-4
   PRAEMER A, 1992, MUSCULOSKELETAL COND, P27
   Saint S, 1998, AM J MED, V105, P236, DOI 10.1016/S0002-9343(98)00240-X
   Schmidmaier G, 2006, INJURY, V37, P105, DOI 10.1016/j.injury.2006.04.016
   SCHREURS WJA, 1982, J BACTERIOL, V152, P7
   Shi ZL, 2006, BIOMATERIALS, V27, P2440, DOI 10.1016/j.biomaterials.2005.11.036
   STOODLEY P, 2005, CLIN ORTHOP RELAT R, V437, P31
   Strathmann M, 2004, INT J ANTIMICROB AG, V24, P234, DOI 10.1016/j.ijantimicag.2003.03.001
   Tiller JC, 2001, P NATL ACAD SCI USA, V98, P5981, DOI 10.1073/pnas.111143098
   Tyagi M, 1997, Biomed Sci Instrum, V33, P240
   van de Belt H, 2001, ACTA ORTHOP SCAND, V72, P557
   VIK H, 1985, LANCET, V1, P872
   WYATT D, 1990, J TRAUMA, V30, P857, DOI 10.1097/00005373-199007000-00016
   Yang Y, 2004, BIOMATERIALS ORTHOPE, P401
   Yang YZ, 2005, BIOMATERIALS, V26, P327, DOI 10.1016/j.biomaterials.2004.02.029
   Yorganci K, 2002, EUR J CLIN MICROBIOL, V21, P379, DOI 10.1007/s10096-002-0719-z
NR 64
TC 341
Z9 354
U1 7
U2 193
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2006
VL 27
IS 32
BP 5512
EP 5517
DI 10.1016/j.biomaterials.2006.07.003
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 088ER
UT WOS:000240794900005
PM 16872671
DA 2018-10-19
ER

PT J
AU Chatterjee, K
   Vogler, EA
   Siedlecki, CA
AF Chatterjee, Kaushik
   Vogler, Erwin A.
   Siedlecki, Christopher A.
TI Procoagulant activity of surface-immobilized Hageman factor
SO BIOMATERIALS
LA English
DT Article
DE coagulation; blood compatibility; plasma proteins
ID MOLECULAR-WEIGHT KININOGEN; BLOOD-PLASMA COAGULATION; FACTOR-XII;
   CONTACT ACTIVATION; PROTEIN ADSORPTION; HYDROPHOBIC SURFACES; BINDING;
   PREKALLIKREIN; AUTOACTIVATION; COMPATIBILITY
AB Procoagulant activity of surface-immobilized coagulation factor XIIa (activated Hageman factor) is reported. Activity of FXIIa immobilized onto the surfaces of three silanized-glass procoagulants spanning a wide range of wettability was assayed in normal and FXII-deficient plasmas. Previously published mathematical models were used to characterize the procoagulant activity of protein-immobilized materials and soluble enzymes. Results show that FXIIa activity is unrelated to underlying procoagulant surface chemistry and is similar to soluble FXIIa activity. The uninfluential role of the surface on FXIIa suggests that the solid surface activates FXII in biomaterial-induced blood coagulation but is not otherwise involved in FXIIa activity as described by the classical mechanism. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Penn State Univ, Milton S Hershey Med Ctr, Inst Biomed Engn, Dept Surg,Coll Med, Hershey, PA 17033 USA.
   Penn State Univ, Coll Med, Dept Bioengn, University Pk, PA 16802 USA.
   Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA.
RP Siedlecki, CA (reprint author), Penn State Univ, Milton S Hershey Med Ctr, Inst Biomed Engn, Dept Surg,Coll Med, H151,500 Univ Dr, Hershey, PA 17033 USA.
EM csiedlecki@psu.edu
OI Chatterjee, Kaushik/0000-0002-7204-2926
FU NHLBI NIH HHS [R01 HL69965]
CR ANDRADE JD, 1981, T AM SOC ART INT ORG, V27, P659
   COLMAN RW, 2001, HEMOSTASIS THROMBOSI, P103
   Davie E W, 1979, Adv Enzymol Relat Areas Mol Biol, V48, P277
   GALLOWAY AC, 1999, PRINCIPLES SURG, P845
   Goncalves IC, 2005, BIOMATERIALS, V26, P3891, DOI 10.1016/j.biomaterials.2004.10.006
   GRIFFIN JH, 1978, P NATL ACAD SCI USA, V75, P1998, DOI 10.1073/pnas.75.4.1998
   GRIFFIN JH, 1976, P NATL ACAD SCI USA, V73, P2554, DOI 10.1073/pnas.73.8.2554
   GRIFFIN JH, 1979, SEMIN THROMB HEMOST, V5, P254
   Guo Z, 2006, BIOMATERIALS, V27, P796, DOI 10.1016/j.biomaterials.2005.06.021
   Hermanson G. T., 1992, IMMOBILIZED AFFINITY
   Horbett TA, 1993, CARDIOVASC PATHOL, V2, P137, DOI DOI 10.1016/1054-8807(93)90054-6)
   Jones LJ, 2003, BIOTECHNIQUES, V34, P850, DOI 10.2144/03344pt03
   Kaplan A P, 1978, Prog Hemost Thromb, V4, P127
   KIRBY EP, 1983, BLOOD, V61, P652
   Lysaght MJ, 2000, ASAIO J, V46, P515, DOI 10.1097/00002480-200009000-00001
   McBride LR, 1999, ANN THORAC SURG, V67, P1233, DOI 10.1016/S0003-4975(99)00246-5
   MEIER HL, 1977, J CLIN INVEST, V60, P18, DOI 10.1172/JCI108754
   RATNER BD, 1993, J BIOMED MATER RES, V27, P283, DOI 10.1002/jbm.820270302
   Ratner BD, 2000, J BIOMAT SCI-POLYM E, V11, P1107, DOI 10.1163/156856200744219
   RATNOFF OD, 1958, AM J MED, V25, P160, DOI 10.1016/0002-9343(58)90023-8
   RATNOFF OD, 1966, PROGR HEMATOL, V2, P204
   Renner L, 2005, LANGMUIR, V21, P4571, DOI 10.1021/la046801n
   REVAK SD, 1977, J CLIN INVEST, V59, P1167, DOI 10.1172/JCI108741
   Roach P, 2005, J AM CHEM SOC, V127, P8168, DOI 10.1021/ja042898o
   SAMUEL M, 1992, J BIOL CHEM, V267, P19691
   SCOTT CF, 1984, J CLIN INVEST, V73, P954, DOI 10.1172/JCI111319
   Sethuraman A, 2004, LANGMUIR, V20, P7779, DOI 10.1021/la049454q
   TELLER DC, 1976, NATURE, V260, P729, DOI 10.1038/260729a0
   VOGLER EA, 1995, J BIOMED MATER RES, V29, P1005, DOI 10.1002/jbm.820290813
   VROMAN L, 1964, THROMB DIATH HAEMOST, V10, P455, DOI 10.1055/s-0038-1654798
   Wagner MS, 2003, J BIOMED MATER RES A, V64A, P1, DOI 10.1002/jbm.a.10263
   WIGGINS RC, 1977, P NATL ACAD SCI USA, V74, P4636, DOI 10.1073/pnas.74.10.4636
   WIGGINS RC, 1983, J BIOL CHEM, V258, P8963
   WILLIAMS DF, 1987, HEMOSTASIS THROMBOSI, P5
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Zhuo R, 2005, BIOMATERIALS, V26, P2965, DOI 10.1016/j.biomaterials.2004.08.008
   Zhuo R, 2006, BIOMATERIALS, V27, P4325, DOI 10.1016/j.biomaterials.2006.04.001
NR 37
TC 13
Z9 13
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2006
VL 27
IS 33
BP 5643
EP 5650
DI 10.1016/j.biomaterials.2006.07.025
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 092XR
UT WOS:000241131500003
PM 16905185
DA 2018-10-19
ER

PT J
AU Du, YN
   Chia, SM
   Han, RB
   Chang, S
   Tang, HH
   Yu, H
AF Du, Yanan
   Chia, Ser-mien
   Han, Rongbin
   Chang, Shi
   Tang, Huihuan
   Yu, Hanry
TI 3D hepatocyte monolayer on hybrid RGD/galactose substratum
SO BIOMATERIALS
LA English
DT Article
DE surface modification; RGD peptide; galactosylation; hybrid biomaterial;
   hepatocyte; hepatotoxicity
ID CULTURED RAT HEPATOCYTES; ACETAMINOPHEN HEPATOTOXICITY;
   EXTRACELLULAR-MATRIX; ASIALOGLYCOPROTEIN RECEPTOR; CELL-ADHESION;
   ACRYLIC-ACID; RGD; SURFACES; SYSTEMS; CONFIGURATION
AB Hepatocyte-based applications such as xenobiotics metabolism and toxicity studies usually require hepatocytes anchoring onto flat substrata that support their functional maintenance. Conventional cell culture plates coated with natural matrices or synthetic ligands allow hepatocytes to adhere tightly as two-dimensional (2D) monolayer but these tightly anchored hepatocytes rapidly lose their differentiated functions. On galactosylated substrata, hepatocytes adhere loosely; and readily form three-dimensional (3D) spheroids that can maintain high levels of cellular functions. These spheroids detach easily from the substrata and exhibit poor mass transport properties unsuitable for many applications. Here, we have developed a hybrid RGD/galactose substratum based on polyethylene terephthalate film conjugated with both RGD peptide and galactose ligand to enhance cell adhesion and functions synergistically. Primary hepatocytes adhere effectively onto the transparent hybrid substratum in 96-well plates as monolayer while exhibiting high levels of liver-specific functions, morphology and cell-cell interactions typically seen in the 3D hepatocyte spheroids. The hepatocytes cultured onto the hybrid substratum also exhibit high levels of sensitivity to a model drug acetaminophen similar to the 3D hepatocyte spheroids. The monolayer of hepatocytes exhibiting the 3D cell behaviors on this flat hybrid substratum can be useful for various applications requiring both effective mass transfer and cellular support. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore.
   Natl Univ Singapore, Sch Integrat Sci & Engn, Grad Program Bioengn, Singapore 117597, Singapore.
   Cent S Univ, Dept Gen Surg, Xiang Ya Hosp, Changsha 410008, Peoples R China.
   Inst Bioengn & Nanotechnol, Singapore 138669, Singapore.
RP Yu, H (reprint author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, 2 Med Dr,MD9 03-03, Singapore 117597, Singapore.
EM phsyuh@nus.edu.sg
RI Han, Rongbin/E-4049-2012; Yu, Hanry/C-1031-2013
OI Yu, Hanry/0000-0002-0339-3685
CR Allen JW, 2001, HEPATOLOGY, V34, P447, DOI 10.1053/jhep.2001.26753
   Bhadriraju K, 2002, DRUG DISCOV TODAY, V7, P612, DOI 10.1016/S1359-6446(02)02273-0
   BLACK M, 1984, ANNU REV MED, V35, P577, DOI 10.1146/annurev.med.35.1.577
   BLACK SD, 1992, FASEB J, V6, P680
   BRUNK CF, 1979, ANAL BIOCHEM, V92, P497, DOI 10.1016/0003-2697(79)90690-0
   Busse B, 1999, ANN NY ACAD SCI, V875, P326, DOI 10.1111/j.1749-6632.1999.tb08515.x
   Carlisle ES, 2000, TISSUE ENG, V6, P45, DOI 10.1089/107632700320883
   Chia SM, 2000, TISSUE ENG, V6, P481, DOI 10.1089/107632700750022134
   Cho CS, 2006, BIOMATERIALS, V27, P576, DOI 10.1016/j.biomaterials.2005.06.008
   Coecke S, 1999, ATLA-ALTERN LAB ANIM, V27, P579
   DUNN JCY, 1989, FASEB J, V3, P174
   EZZELL RM, 1993, EXP CELL RES, V208, P442, DOI 10.1006/excr.1993.1266
   FINDEIS MA, 1994, INT J PEPT PROT RES, V43, P477
   Fittkau MH, 2005, BIOMATERIALS, V26, P167, DOI 10.1016/j.biomaterials.2004.02.012
   Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736
   Gebhardt R, 2003, DRUG METAB REV, V35, P145, DOI 10.1081/DMR-120023684
   Glicklis R, 2004, BIOTECHNOL BIOENG, V86, P672, DOI 10.1002/bit.20085
   GULLBERG D, 1990, EXP CELL RES, V190, P254, DOI 10.1016/0014-4827(90)90194-F
   Gupta B, 2002, BIOMATERIALS, V23, P863, DOI 10.1016/S0142-9612(01)00195-8
   Hamilton GA, 2001, CELL TISSUE RES, V306, P85
   Hasirci V, 2001, TISSUE ENG, V7, P385, DOI 10.1089/10763270152436445
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Jiang JL, 2004, TISSUE ENG, V10, P1577, DOI 10.1089/ten.2004.10.1577
   Kikkawa Rie, 2005, Journal of Toxicological Sciences, V30, P61, DOI 10.2131/jts.30.61
   Kim SH, 2003, FEBS LETT, V553, P433, DOI 10.1016/S0014-5793(03)01047-0
   KOIDE N, 1990, EXP CELL RES, V186, P227, DOI 10.1016/0014-4827(90)90300-Y
   Kostrubsky SE, 2005, TOXICOL SCI, V87, P146, DOI 10.1093/toxsci/kfi211
   Kostrubsky VE, 1997, TOXICOL APPL PHARM, V142, P79, DOI 10.1006/taap.1996.8023
   Kostrubsky VE, 1997, TOXICOL APPL PHARM, V143, P315, DOI 10.1006/taap.1996.8081
   LeCluyse E L, 1996, Pharm Biotechnol, V8, P121
   LODISH HF, 1991, TRENDS BIOCHEM SCI, V16, P374, DOI 10.1016/0968-0004(91)90154-N
   Lu HF, 2003, BIOMATERIALS, V24, P4893, DOI 10.1016/S0142-9612(03)00404-6
   MASSIA SP, 1991, J CELL BIOL, V114, P1089, DOI 10.1083/jcb.114.5.1089
   Nakagiri R, 2003, BIOSCI BIOTECH BIOCH, V67, P1629, DOI 10.1271/bbb.67.1629
   Park JK, 2005, J BIOSCI BIOENG, V99, P311, DOI 10.1263/jbb.99.311
   Powers MJ, 1998, MICROSC RES TECHNIQ, V43, P379, DOI 10.1002/(SICI)1097-0029(19981201)43:5<379::AID-JEMT4>3.3.CO;2-S
   Rezania A, 1999, BIOTECHNOL PROGR, V15, P19, DOI 10.1021/bp980083b
   Richardson A, 1996, NATURE, V380, P538, DOI 10.1038/380538a0
   SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680
   Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
   Takei R, 2005, BIOTECHNOL LETT, V27, P1149, DOI 10.1007/s10529-005-8652-8
   TASHIRO K, 1991, J CELL PHYSIOL, V146, P451, DOI 10.1002/jcp.1041460316
   Tzanakakis ES, 2001, CELL MOTIL CYTOSKEL, V48, P175, DOI 10.1002/1097-0169(200103)48:3<175::AID-CM1007>3.0.CO;2-2
   UCHIDA E, 1993, LANGMUIR, V9, P1121, DOI 10.1021/la00028a040
   Walker TM, 2000, TOXICOL IN VITRO, V14, P475, DOI 10.1016/S0887-2333(00)00036-9
   WEIGEL PH, 1979, CARBOHYD RES, V70, P83, DOI 10.1016/S0008-6215(00)83272-3
   YASUYUKI S, 1996, CYTOTECHNOLOGY, V21, P243
   Ying L, 2003, BIOMACROMOLECULES, V4, P157, DOI 10.1021/bm025676w
   Zhang QX, 2004, BASIC CLIN PHARMACOL, V94, P191
   2004, 8 INT C DRUG DRUG IN
NR 50
TC 69
Z9 71
U1 1
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2006
VL 27
IS 33
BP 5669
EP 5680
DI 10.1016/j.biomaterials.2006.07.018
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 092XR
UT WOS:000241131500006
PM 16904177
DA 2018-10-19
ER

PT J
AU Bashur, CA
   Dahlgren, LA
   Goldstein, AS
AF Bashur, Chris A.
   Dahlgren, Linda A.
   Goldstein, Aaron S.
TI Effect of fiber diameter and orientation on fibroblast morphology and
   proliferation on electrospun poly(D,L-lactic-co-glycolic acid) meshes
SO BIOMATERIALS
LA English
DT Article
DE ligament; fibroblast; electrospin; cell adhesion; cell proliferation;
   cell morphology
ID ANTERIOR CRUCIATE LIGAMENT; PATELLAR TENDON; IN-VITRO;
   MECHANICAL-PROPERTIES; TISSUE CONSTRUCTS; CONTACT GUIDANCE; CELL-SHAPE;
   SCAFFOLDS; COLLAGEN; NANOFIBERS
AB Engineered ligament tissues are promising materials for the repair of tears and ruptures, but require the development of biomaterial scaffolds that not only support physiologically relevant loads, but also possess architectures capable of orienting cell adhesion and extracellular matrix deposition. Based on evidence that micron-scale topographic features induce cell orientation through a contact guidance phenomenon, we postulate that oriented micron-scale fiber meshes-formed by the electrospinning process-can regulate cell morphology. To test this, fused fiber meshes of poly(D,L-lactic-co-glycolic acid) (PLGA) were electrospun onto rigid supports under conditions that produced mean fiber diameters of 0.14-3.6 mu m, and angular standard deviations of 31-60 degrees. Analysis of the morphology of adherent NIH 3T3 fibroblasts indicated that projected cell area and aspect ratio increased systematically with both increasing fiber diameter and degree of fiber orientation. Importantly, cell morphology on 3.6 mu m fibers was similar to that on spincoated PLGA films, Finally, cell densities on electrospun meshes were not significantly different from spincoated PLGA, indicating that cell proliferation is not sensitive to fiber diameter or orientation. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA.
   Virginia Polytech Inst & State Univ, Sch Biomed Engn & Sci, Blacksburg, VA 24061 USA.
   Virginia Maryland Reg Coll Vet Med, Dept Large Anim Clin Sci, Blacksburg, VA 24061 USA.
RP Goldstein, AS (reprint author), Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA.
EM goldst@vt.edu
OI Bashur, Chris/0000-0002-2637-9149
CR Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Badami AS, 2006, BIOMATERIALS, V27, P596, DOI 10.1016/j.biomaterials.2005.05.084
   Boland ED, 2004, J BIOMED MATER RES B, V71B, P144, DOI 10.1002/jbm.b.30105
   Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m
   Cooper JA, 2005, BIOMATERIALS, V26, P1523, DOI 10.1016/j.biomaterials.2004.05.014
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   den Braber ET, 1998, J BIOMED MATER RES, V40, P291, DOI 10.1002/(SICI)1097-4636(199805)40:2<291::AID-JBM14>3.3.CO;2-8
   Engelmayr GC, 2006, J BIOMECH, V39, P1819, DOI 10.1016/j.jbiomech.2005.05.020
   Fisher NI, 1993, STAT ANAL CIRCULAR D
   Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3
   FRANK C, 1983, AM J SPORT MED, V11, P379, DOI 10.1177/036354658301100602
   Glass-Brudzinski JT, 2002, J BIOMED MATER RES, V61, P608, DOI 10.1002/jbm.10243
   Goldblatt JP, 2005, ARTHROSCOPY, V21, P791, DOI 10.1016/j.arthro.2005.04.107
   GOLDSTEIN AS, 2006, BIOMEDICAL ENG HDB T
   Guidoin MF, 2000, BIOMATERIALS, V21, P2461, DOI 10.1016/S0142-9612(00)00114-9
   Gupta P, 2005, POLYMER, V46, P4799, DOI 10.1016/j.polymer.2005.04.021
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   JACKSON DW, 1993, AM J SPORT MED, V21, P176, DOI 10.1177/036354659302100203
   Jeong SI, 2004, J BIOMAT SCI-POLYM E, V15, P645, DOI 10.1163/156856204323046906
   Johansson F, 2006, BIOMATERIALS, V27, P1251, DOI [10.1016/j.biomaterials.2005.07.047, 10.1016/j.niomaterials.2005.07.047]
   Kim SG, 2002, CELL STRUCT FUNCT, V27, P139, DOI 10.1247/csf.27.139
   Kwon IK, 2005, BIOMATERIALS, V26, P3929, DOI 10.1016/j.biomaterials.2004.10.007
   Lee CK, 2005, SYNTHETIC MET, V154, P209, DOI 10.1016/j.synthmet.2005.07.053
   Li D, 2003, NANO LETT, V3, P1167, DOI 10.1021/nl0344256
   Lu HH, 2005, BIOMATERIALS, V26, P4805, DOI 10.1016/j.biomaterials.2004.11.050
   Moreau JE, 2005, TISSUE ENG, V11, P1887, DOI 10.1089/ten.2005.11.1887
   Moreau JE, 2005, J ORTHOP RES, V23, P164, DOI 10.1016/j.orthres.2004.05.004
   Murray MM, 2005, SPORTS MED ARTHROSC, V13, P151, DOI 10.1097/01.jsa.0000173243.92319.da
   Nair LS, 2004, BIOMACROMOLECULES, V5, P2212, DOI 10.1021/bm049759j
   Rahaman MN, 2005, BIOTECHNOL BIOENG, V91, P261, DOI 10.1002/bit.20292
   Riboldi SA, 2005, BIOMATERIALS, V26, P4606, DOI 10.1016/j.biomaterials.2004.11.035
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   SINGHVI R, 1994, SCIENCE, V264, P696, DOI 10.1126/science.8171320
   Stankus JJ, 2004, J BIOMED MATER RES A, V70A, P603, DOI 10.1002/jbm.a.30122
   Teixeira AI, 2003, J CELL SCI, V116, P1881, DOI 10.1242/jcs.00383
   Vunjak-Novakovic G, 2004, ANNU REV BIOMED ENG, V6, P131, DOI 10.1146/annurev.bioeng.6.040803.140037
   Walboomers XF, 1999, J BIOMED MATER RES, V47, P204, DOI 10.1002/(SICI)1097-4636(199911)47:2<204::AID-JBM10>3.0.CO;2-H
   Wang JHC, 2003, J BIOMECH, V36, P97, DOI 10.1016/S0021-9290(02)00233-6
   Williamson MR, 2004, BIOMATERIALS, V25, P459, DOI 10.1016/S0142-9612(03)00536-2
   Xu CY, 2004, BIOMATERIALS, V25, P877, DOI 10.1016/S0142-9612(03)00593-3
   Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051
   Yang GG, 2004, J BIOMECH, V37, P1543, DOI 10.1016/j.jbiomech.2004.01.005
   Zhu BS, 2005, TISSUE ENG, V11, P825, DOI 10.1089/ten.2005.11.825
   Zong XH, 2005, BIOMATERIALS, V26, P5330, DOI 10.1016/j.biomaterials.2005.01.052
NR 44
TC 248
Z9 255
U1 6
U2 133
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2006
VL 27
IS 33
BP 5681
EP 5688
DI 10.1016/j.biomaterials.2006.07.005
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 092XR
UT WOS:000241131500007
PM 16914196
DA 2018-10-19
ER

PT J
AU Hino, R
   Tomita, M
   Yoshizato, K
AF Hino, Rika
   Tomita, Masahiro
   Yoshizato, Katsutoshi
TI The generation of germline transgenic silkworms for the production of
   biologically active recombinant fusion proteins of fibroin and human
   basic fibroblast growth factor
SO BIOMATERIALS
LA English
DT Article
DE silk; transgenic silkworms; human fibroblast growth factor; bioactive
   fibroin; scaffold; human umbilical vein endothelial cells
ID GENETICALLY DIABETIC MICE; SILK FIBROIN; BOMBYX-MORI; CELLS; ATTACHMENT;
   SCAFFOLDS; ACCELERATION; BIOMATERIALS; MICROSPHERES; REGENERATION
AB We generated germline transgenic silkworms bearing a fibroin light chain (FL) promoter-driven FL gene whose 3'-end was flanked with human basic fibroblast growth factor (bFGF) gene, FL/bFGF gene. The cocoons from transgenic worms were trypsinized to remove sericin layers, and treated with solution containing CaCl2, ethanol, and water at a molar ratio of 1:2:8 (CaCl2/ethanol/water) to solubilize fibroin layers. Western blot analysis showed that the recombinant protein, r(FL/bFGF), was solubilized with CaCl2/ethanol/water, but not with trypsin, indicating that r(FL/bFGF) was in fibroin layers. Thus, it was concluded that the worms spun cocoons whose fibroin layers were composed of the inherent gene-derived natural fibroin (nF) and r(FL/bFGF). The mixture of nF and r(FL/bFGF) was dubbed r(FL/bFGF)nF. The solubilized r(FL/bFGF)nF was refolded using the glutathione redox system. Human umbilical vein endothelial cells (HUVECs) grew in the refolded r(FL/bFGF)nF-containing culture media, showing that bFGF in r(FL/bFGF) was biologically active. r(FL/bFGF)nF immobilized on a culture dish also supported the growth of HUVECs in bFGF-free media, suggesting the usefulness of r(FL/bFGF)nF as a new biomaterial for tissue engineering. The currently developed transgenic silkworms will be suitable for mass production of fibroins bearing a variety of biological activities. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, Dev Biol Lab, Higashihiroshima, Hiroshima 7398526, Japan.
   Hiroshima Prefect Inst Ind Sci & Technol, Yoshizato Project, Cooperat Link Unique Sci & Technol Econ Revitaliz, Higashihiroshima, Hiroshima 7390046, Japan.
RP Yoshizato, K (reprint author), Hiroshima Univ, Grad Sch Sci, Dept Biol Sci, Dev Biol Lab, 1-3-1 Kagamiyama, Higashihiroshima, Hiroshima 7398526, Japan.
EM kyoshiz@hiroshima-u.ac.jp
CR AEBISCHER P, 1989, J NEUROSCI RES, V23, P282, DOI 10.1002/jnr.490230306
   Ahrendt G, 1998, TISSUE ENG, V4, P117, DOI 10.1089/ten.1998.4.117
   Ajisawa A, 1998, J SERIC SCI JPN, V67, P91
   ALBERTSON S, 1993, SURGERY, V114, P368
   Andrades JA, 2001, GROWTH FACTORS, V18, P261, DOI 10.3109/08977190109029115
   Aoki H, 2003, BIO-MED MATER ENG, V13, P309
   DEBOIS C, 1994, BIOMATERIALS, V15, P655
   FIDDES JC, 1991, ANN NY ACAD SCI, V638, P316
   Fujisato T, 1996, BIOMATERIALS, V17, P155, DOI 10.1016/0142-9612(96)85760-7
   Gotoh Y, 1998, J BIOMED MATER RES, V39, P351, DOI 10.1002/(SICI)1097-4636(19980305)39:3<351::AID-JBM2>3.0.CO;2-I
   GREENHALGH DG, 1990, AM J PATHOL, V136, P1235
   HANAWA T, 1995, CHEM PHARM BULL, V43, P284
   HEATH WF, 1991, BIOCHEMISTRY-US, V30, P5608, DOI 10.1021/bi00236a039
   Inoue S, 2005, INSECT BIOCHEM MOLEC, V35, P51, DOI 10.1016/j.jibm.2004.10.002
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   ISHIYAMA M, 1993, CHEM PHARM BULL, V41, P1118
   KAJIO T, 1992, J PHARMACOL TOXICOL, V28, P9
   KANDA T, 1991, B SERIC ENTOMOL, V2, P32
   Karageorgiou V, 2004, J BIOMED MATER RES A, V71A, P528, DOI 10.1002/jbm.a.30186
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   KLINGBEIL CK, 1990, CLIN EXPT APPROACHES, P443
   KNOERZER W, 1989, GENE, V75, P21, DOI 10.1016/0378-1119(89)90379-X
   Li MZ, 2003, BIOMATERIALS, V24, P357, DOI 10.1016/S0142-9612(02)00326-5
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   MINAGAWA M, 1960, SENI GAKKAISHI JPN, V16, P507
   MINOURA N, 1995, J BIOMED MATER RES, V29, P1215, DOI 10.1002/jbm.820291008
   MINOURA N, 1995, BIOCHEM BIOPH RES CO, V208, P511, DOI 10.1006/bbrc.1995.1368
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Mizuno K, 2003, J BIOMED MATER RES A, V64A, P177, DOI 10.1002/jbm.a.10396
   Motta A, 2004, J BIOMAT SCI-POLYM E, V15, P851, DOI 10.1163/1568562041271075
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   O'Reilly DR, BACULOVIRUS EXPRESSI
   Okumura M, 1996, ARZNEIMITTEL-FORSCH, V46, P1021
   Okumura M, 1996, BIOL PHARM BULL, V19, P530
   Okumura M, 1996, ARZNEIMITTEL-FORSCH, V46, P547
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   PIERCE GF, 1992, AM J PATHOL, V140, P1375
   RINAS U, 1992, BIO-TECHNOL, V10, P435, DOI 10.1038/nbt0492-435
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   Tabata Y, 1999, J BIOMAT SCI-POLYM E, V10, P79, DOI 10.1163/156856299X00298
   Tamura T, 2000, NAT BIOTECHNOL, V18, P81
   Tanaka E, 1996, BIOL PHARM BULL, V19, P1141
   Tomita M, 2003, NAT BIOTECHNOL, V21, P52, DOI 10.1038/nbt771
   TSUBOI R, 1990, J EXP MED, V172, P245, DOI 10.1084/jem.172.1.245
   Tsubouchi Kozo, 2003, Journal of Insect Biotechnology and Sericology, V72, P65
   Wong C, 2003, THROMB HAEMOSTASIS, V89, P573
   Yamada H, 2004, BIOMATERIALS, V25, P467, DOI 10.1016/S0142-9612(03)00540-4
NR 47
TC 57
Z9 70
U1 1
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD NOV
PY 2006
VL 27
IS 33
BP 5715
EP 5724
DI 10.1016/j.biomaterials.2006.07.028
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 092XR
UT WOS:000241131500011
PM 16905183
DA 2018-10-19
ER

PT J
AU Ishii, SI
   Unno, H
   Miyata, S
   Hori, K
AF Ishii, Shun'ichi
   Unno, Hajime
   Miyata, Shunsuke
   Hori, Katsutoshi
TI Effect of cell appendages on the adhesion properties of a highly
   adhesive bacterium, Acinetobacter sp Tol 5
SO BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY
LA English
DT Article
DE microbial adhesion; Acinetobacter; cell appendage;
   Derjaguin-Landau-Verwey-Overbeek (DLVO) theory
ID GRAM-NEGATIVE BACTERIA; IONIC-STRENGTH; ESCHERICHIA-COLI; SURFACE
   HYDROPHOBICITY; BIOMATERIAL SURFACES; GLASS; MECHANISMS; ATTACHMENT;
   TRANSPORT; PH
AB A toluene-degrading bacterium, Acinetobacter sp. Tol 5, shows noteworthy adhesiveness mediated by two types of cell appendages. In this study, we obtained a less-adhesive mutant, T1, which lost both types of appendages, and investigated how the cell appendages affect the adhesion properties of this useful bacterium for environmental technology. Wild-type cells attained irreversible adhesion to polyurethane carriers within 30 s, while adhesion of T1 cells was still reversible at that time. While T1 showed decreased adhesion with decreasing ionic strength and did not adhere at all at 0.015 mM, adhesion of the wild type was fully independent of ionic strength. Acinetobacter sp. Tol 5 was also found to be not motile. Our results suggest that through the long distant interaction mediated by the appendages between the cells and surfaces, Tol 5 cells can attain irreversible adhesion very quickly without approaching the vicinity of the substratum.
C1 Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan.
   Nagoya Inst Technol, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan.
RP Hori, K (reprint author), Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, 4259-B-29 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.
EM hori.katsutosh@nitech.ac.jp
RI Hori, Katsutoshi/K-5289-2012
OI Hori, Katsutoshi/0000-0003-1994-3124; Ishii,
   Shun'ichi/0000-0002-0203-8569
CR Abu-Lail NI, 2003, BIOMACROMOLECULES, V4, P1000, DOI 10.1021/bm034055f
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Bolster CH, 2001, J CONTAM HYDROL, V50, P287, DOI 10.1016/S0169-7722(01)00106-1
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   BUNT CR, 1995, INT J PHARM, V113, P257, DOI 10.1016/0378-5173(94)00205-J
   Hiemenz P.C., 1997, PRINCIPLES COLLOID S
   Hori K, 2001, J CHEM ENG JPN, V34, P1120, DOI 10.1252/jcej.34.1120
   Ishii S, 2004, APPL ENVIRON MICROB, V70, P5026, DOI 10.1128/AEM.70.8.5026-5029.2004
   JEWETT DG, 1995, WATER RES, V29, P1673, DOI 10.1016/0043-1354(94)00338-8
   JONES GW, 1983, CRC CR REV MICROBIOL, V10, P229
   Jucker BA, 1998, COLLOID SURFACE B, V11, P33, DOI 10.1016/S0927-7765(98)00029-0
   Kogure K, 1998, J BACTERIOL, V180, P932
   Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000
   Li Q, 1999, WATER RES, V33, P1090, DOI 10.1016/S0043-1354(98)00291-7
   MARSHALL KC, 1971, J GEN MICROBIOL, V68, P337, DOI 10.1099/00221287-68-3-337
   MARSHALL KC, 1973, ARCH MIKROBIOL, V91, P29, DOI 10.1007/BF00409536
   Morisaki H, 1999, MICROBIOL-SGM, V145, P2797, DOI 10.1099/00221287-145-10-2797
   NORDE W, 1989, COLLOID SURFACE, V38, P1, DOI 10.1016/0166-6622(89)80138-6
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   Otto K, 1999, J BACTERIOL, V181, P5210
   QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x
   RUTTER P R, 1984, P21
   SIMON R, 1989, GENE, V80, P161, DOI 10.1016/0378-1119(89)90262-X
   Tsang PH, 2006, P NATL ACAD SCI USA, V103, P5764, DOI 10.1073/pnas.0601705103
   VANLOOSDRECHT MCM, 1989, MICROBIAL ECOL, V17, P1, DOI 10.1007/BF02025589
   VANLOOSDRECHT MCM, 1987, APPL ENVIRON MICROB, V53, P1898
   VANLOOSDRECHT MCM, 1990, EXPERIENTIA, V46, P817
   Vigeant MAS, 1997, APPL ENVIRON MICROB, V63, P3474
   ZITA A, 1994, APPL ENVIRON MICROB, V60, P3041
NR 29
TC 22
Z9 22
U1 1
U2 3
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0916-8451
EI 1347-6947
J9 BIOSCI BIOTECH BIOCH
JI Biosci. Biotechnol. Biochem.
PD NOV
PY 2006
VL 70
IS 11
BP 2635
EP 2640
DI 10.1271/bbb.602336
PG 6
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry, Applied; Food Science & Technology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry; Food Science & Technology
GA 111MI
UT WOS:000242455800007
PM 17090933
DA 2018-10-19
ER

PT J
AU Remminghorst, U
   Rehm, BHA
AF Remminghorst, Uwe
   Rehm, Bernd H. A.
TI Bacterial alginates: from biosynthesis to applications
SO BIOTECHNOLOGY LETTERS
LA English
DT Review
DE alginate; alginate polymerisation; alginate secretion; Azotobacter;
   biomaterial; biopolymer; guluronic acid; mannuronic acid; Pseudomonas
ID PSEUDOMONAS-AERUGINOSA ALGINATE; GDP-MANNOSE DEHYDROGENASE; MANNURONAN
   C-5 EPIMERASES; CYSTIC-FIBROSIS PATIENTS; OUTER-MEMBRANE PROTEIN;
   AZOTOBACTER-VINELANDII; GENE-CLUSTER; O-ACETYLATION; POLYMER FORMATION;
   ESCHERICHIA-COLI
AB Alginate is a polysaccharide belonging to the family of linear (unbranched), non-repeating copolymers, consisting of variable amounts of beta-D-mannuronic acid and its C5-epimer alpha-L-guluronic acid linked via beta-1,4-glycosidic bonds. Like DNA, alginate is a negatively charged polymer, imparting material properties ranging from viscous solutions to gel-like structures in the presence of divalent cations. Bacterial alginates are synthesized by only two bacterial genera, Pseudomonas and Azotobacter, and have been extensively studied over the last 40 years. While primarily synthesized in form of polymannuronic acid, alginate undergoes chemical modifications comprising acetylation and epimerization, which occurs during periplasmic transfer and before final export through the outer membrane. Alginate with its unique material properties and characteristics has been increasingly considered as biomaterial for medical applications. The genetic modification of alginate producing microorganisms could enable biotechnological production of new alginates with unique, tailor-made properties, suitable for medical and industrial applications.
C1 Massey Univ, Inst Mol BioSci, Palmerston North, New Zealand.
RP Rehm, BHA (reprint author), Massey Univ, Inst Mol BioSci, Private Bag 11222, Palmerston North, New Zealand.
EM B.Rehm@massey.ac.nz
RI Rehm, Bernd/B-3675-2011
CR Aarons SJ, 1997, MICROBIOL-SGM, V143, P641, DOI 10.1099/00221287-143-2-641
   Akama H, 2004, J BIOL CHEM, V279, P25939, DOI 10.1074/jbc.C400164200
   Albrecht MT, 2005, J BACTERIOL, V187, P3869, DOI 10.1128/JB.187.11.3569-3872.2005
   Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739
   Bakkevig K, 2005, J BACTERIOL, V187, P8375, DOI 10.1128/JB.187.24.8375-8384.2005
   Bjerkan TM, 2004, BIOCHEM J, V381, P813, DOI 10.1042/BJ20031580
   BOYD A, 1993, GENE, V131, P1, DOI 10.1016/0378-1119(93)90662-M
   Campos ME, 1996, J BACTERIOL, V178, P1793, DOI 10.1128/jb.178.7.1793-1799.1996
   CHITNIS CE, 1990, J BACTERIOL, V172, P2894, DOI 10.1128/jb.172.6.2894-2900.1990
   CHITNIS CE, 1993, MOL MICROBIOL, V8, P583, DOI 10.1111/j.1365-2958.1993.tb01602.x
   Costerton JW, 2001, TRENDS MICROBIOL, V9, P50, DOI 10.1016/S0966-842X(00)01918-1
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Ertesvag H, 1999, METAB ENG, V1, P262, DOI 10.1006/mben.1999.0130
   Favre-Bonte S, 2002, MICROB PATHOGENESIS, V32, P143, DOI 10.1006/mpat.2001.0487
   Firoved AM, 2003, J BACTERIOL, V185, P1071, DOI 10.1128/JB.185.3.1071-1081.2003
   FRANKLIN MJ, 1993, J BACTERIOL, V175, P5057
   Franklin MJ, 2004, J BACTERIOL, V186, P4759, DOI 10.1128/JB.186.14.4759-4773.2004
   FRANKLIN MJ, 1994, J BACTERIOL, V176, P1821, DOI 10.1128/jb.176.7.1821-1830.1994
   Franklin MJ, 2002, J BACTERIOL, V184, P3000, DOI 10.1128/JB.184.11.3000-3007.2002
   Franklin MJ, 1996, J BACTERIOL, V178, P2186, DOI 10.1128/jb.178.8.2186-2195.1996
   Gacesa P, 1990, PSEUDOMONAS INFECTIO, P29
   Gimmestad M, 2003, J BACTERIOL, V185, P3515, DOI 10.1128/JB.185.12.3515-3523.2003
   GOLDBERG JB, 1993, J BACTERIOL, V175, P1605
   GRABERT E, 1990, FEMS MICROBIOL LETT, V68, P83
   Gutsche J, 2006, BIOCHIMIE, V88, P245, DOI 10.1016/j.biochi.2005.06.003
   Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821
   Hoidal HK, 2000, ENVIRON MICROBIOL, V2, P27, DOI 10.1046/j.1462-2920.2000.00074.x
   Jain S, 2005, INFECT IMMUN, V73, P6429, DOI 10.1128/IAI.73.10.6429-6436.2005
   Jain S, 2003, MOL MICROBIOL, V47, P1123, DOI 10.1046/j.1365-2958.2003.03361.x
   Jain S, 1998, J BACTERIOL, V180, P634
   King A, 2003, J BIOMED MATER RES A, V64A, P533, DOI 10.1002/jbm.a.10276
   Kulseng B, 1999, TRANSPLANTATION, V67, P978, DOI 10.1097/00007890-199904150-00008
   Leid JG, 2005, J IMMUNOL, V175, P7512, DOI 10.4049/jimmunol.175.11.7512
   LIN TY, 1966, J BIOL CHEM, V241, P5284
   Lloret L, 1996, MOL MICROBIOL, V21, P449, DOI 10.1111/j.1365-2958.1996.tb02554.x
   Mathee K, 1999, MICROBIOL-SGM, V145, P1349, DOI 10.1099/13500872-145-6-1349
   MAY TB, 1994, J BIOL CHEM, V269, P4872
   Mirshafiey A, 2005, IMMUNOPHARM IMMUNOT, V27, P255, DOI 10.1081/IPH-200067751
   Monday SR, 1996, J BACTERIOL, V178, P625, DOI 10.1128/jb.178.3.625-632.1996
   Moreno S, 1998, J BACTERIOL, V180, P2766
   NARBAD A, 1988, MICROBIOS, V54, P171
   Nivens DE, 2001, J BACTERIOL, V183, P1047, DOI 10.1128/JB.183.3.1047-1057.2001
   Nyvall P, 2003, PLANT PHYSIOL, V133, P726, DOI 10.1104/pp.103.025981
   Olvera C, 1999, FEMS MICROBIOL LETT, V179, P85, DOI 10.1016/S0378-1097(99)00381-X
   Pandey R, 2004, J ANTIMICROB CHEMOTH, V53, P635, DOI 10.1093/jac/dkh139
   Rehm BH, 1996, J BACTERIOL, V178, P5884, DOI 10.1128/jb.178.20.5884-5889.1996
   REHM BHA, 1994, MICROB PATHOGENESIS, V16, P43, DOI 10.1006/mpat.1994.1004
   Rehm BHA, 1996, MICROBIOL-UK, V142, P873, DOI 10.1099/00221287-142-4-873
   REHM BHA, 1994, J BACTERIOL, V176, P5639
   Rehm BHA, 1997, APPL MICROBIOL BIOT, V48, P281, DOI 10.1007/s002530051051
   REHM BHA, 2005, ENCY BIOMATERIALS BI, V1, P1
   Remminghorst U, 2006, APPL ENVIRON MICROB, V72, P298, DOI 10.1128/AEM.72.1.298-305.2006
   REMMINGHORST U, 2006, IN PRESS FEBS LETT
   Richard A, 2004, BIOTECHNOL BIOENG, V87, P501, DOI 10.1002/bit.20156
   Robles-Price A, 2004, J BACTERIOL, V186, P7369, DOI 10.1128/JB.186.21.7369-7377.2004
   Rokstad AM, 2001, ANN NY ACAD SCI, V944, P216
   Romling U, 2006, CURR OPIN MICROBIOL, V9, P218, DOI 10.1016/j.mib.2006.02.010
   SALZIG M, 2006, MICROBIAL BIONANOTEC, P125
   Saxena IM, 2000, CURR OPIN PLANT BIOL, V3, P523, DOI 10.1016/S1369-5266(00)00125-4
   SAXENA IM, 1995, J BACTERIOL, V177, P1419, DOI 10.1128/jb.177.6.1419-1424.1995
   Saxena IM, 2001, PHYTOCHEMISTRY, V57, P1135, DOI 10.1016/S0031-9422(01)00048-6
   SCHILLER NL, 1993, J BACTERIOL, V175, P4780
   SchmittAndrieu L, 1996, CR ACAD SCI III-VIE, V319, P153
   Shankar S, 1995, Adv Enzymol Relat Areas Mol Biol, V70, P221
   SHINABARGER D, 1993, MOL MICROBIOL, V9, P1027, DOI 10.1111/j.1365-2958.1993.tb01232.x
   TATNELL PJ, 1994, MICROBIOL-SGM, V140, P1745, DOI 10.1099/13500872-140-7-1745
   Thomas S, 2000, J Wound Care, V9, P56
   Trujillo-Roldan MA, 2004, APPL MICROBIOL BIOT, V63, P742, DOI 10.1007/s00253-003-1419-z
   Trujillo-Roldan MA, 2003, APPL MICROBIOL BIOT, V60, P733, DOI 10.1007/s00253-002-1173-7
   Valla S, 2001, BIOCHIMIE, V83, P819, DOI 10.1016/S0300-9084(01)01313-X
   Vazquez A, 1999, GENE, V232, P217, DOI 10.1016/S0378-1119(99)00119-5
   Wood LF, 2006, J BACTERIOL, V188, P3134, DOI 10.1128/JB.188.8.3134-3137.2006
   Wu WH, 2004, J BACTERIOL, V186, P7575, DOI 10.1128/JB.186.22.7575-7585.2004
NR 73
TC 147
Z9 157
U1 2
U2 58
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-5492
EI 1573-6776
J9 BIOTECHNOL LETT
JI Biotechnol. Lett.
PD NOV
PY 2006
VL 28
IS 21
BP 1701
EP 1712
DI 10.1007/s10529-006-9156-x
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 088JO
UT WOS:000240808200001
PM 16912921
DA 2018-10-19
ER

PT J
AU Ries, MD
   Cabalo, A
   Bozic, KJ
   Anderson, M
AF Ries, Michael D.
   Cabalo, Adam
   Bozic, Kevin J.
   Anderson, Martin
TI Porous tantalum patellar augmentation - The importance of residual bone
   stock
SO CLINICAL ORTHOPAEDICS AND RELATED RESEARCH
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the Knee-Society
CY 2006
CL San Diego, CA
SP Knee Soc
ID TOTAL KNEE ARTHROPLASTY; COMPONENT RESECTION; SURFACED IMPLANTS;
   REVISION; INGROWTH; RECONSTRUCTION; BIOMATERIAL; INTERFACE; OPTIONS
AB Trabecular metal augmentation of bone defects has been associated with favorable bone ingrowth. Animal studies also suggest fibrous tissue attachment to trabecular metal can be achieved. We treated 16 patients with total knee arthroplasty (18 knees) with severe patellar bone loss using trabecular metal patellar reconstruction. The patients were divided into two groups based on the amount of residual patellar bone stock present at the time of surgery: Group 1 (six patients, seven knees) with no patellar bone stock and Group 2 (10 patients, 11 knees) in whom at least 50% of the patellar component surface was covered by host bone. All seven patellar components in Group 1 loosened within 1 year. Two of these developed necrosis of the extensor mechanism leading to extensor mechanism discontinuity. One component in Group 2 became infected and loosened, whereas the remaining 10 components remained stable at minimum 12-month followup. Our results suggest stable fixation of a trabecular metal patellar component can be achieved when residual bone is present for implant fixation, but early loosening is likely to occur when soft tissue is used for fixation to the implant.
C1 Univ Calif San Francisco, Dept Orthopaed Surg, San Francisco, CA 94143 USA.
   Tahoe Fracture Clin, Carson City, NV USA.
RP Ries, MD (reprint author), Univ Calif San Francisco, Dept Orthopaed Surg, 500 Parnassus Ave MU 320-W, San Francisco, CA 94143 USA.
EM riesm@orthosurg.ucsf.edu
CR Barrack RL, 2001, ORTHOPEDICS, V24, P899
   Barrack RL, 1998, CLIN ORTHOP RELAT R, P139
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   BOZIC K, 2005, TECHNIQUES KNEE SURG, V4, P55
   EMERSON RH, 1994, CLIN ORTHOP RELAT R, P79
   ENGH CA, 1992, CLIN ORTHOP RELAT R, P13
   Engh G A, 1999, Instr Course Lect, V48, P167
   Graham J, 2003, J BONE JOINT SURG AM, V85A, P1901, DOI 10.2106/00004623-200310000-00006
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   Hanssen AD, 2001, J BONE JOINT SURG AM, V83A, P171, DOI 10.2106/00004623-200102000-00003
   Hanssen Arlen D, 2004, Instr Course Lect, V53, P201
   Hitt K, 2003, J BONE JOINT SURG AM, V85A, P115, DOI 10.2106/00004623-200300004-00015
   Jasty M, 1997, J BONE JOINT SURG AM, V79A, P707, DOI 10.2106/00004623-199705000-00010
   LEWALLEN DG, 2006, CLIN ORTHOP RELAT RE, V452
   Nasser S, 2004, J ARTHROPLASTY, V19, P562, DOI 10.1016/j.arth.2004.02.025
   Nazarian DG, 1999, CLIN ORTHOP RELAT R, P123
   Nelson CL, 2003, J ARTHROPLASTY, V18, P37, DOI 10.1054/S0883-5403(03)00290-0
   Pagnano MW, 1998, CLIN ORTHOP RELAT R, P134
   Parvizi J, 2002, CLIN ORTHOP RELAT R, P356
   PILLIAR RM, 1986, CLIN ORTHOP RELAT R, P108
   Rorabeck CH, 2003, CLIN ORTHOP RELAT R, P84, DOI 10.1097/01.blo.0000092982.12414.a0
   SEEL MJ, 1986, ORTHOP T, V19, P338
   van Loon C J, 1999, Acta Orthop Belg, V65, P154
   VINCE KG, 2000, J ARTHROPLASTY, V15, P254
NR 25
TC 26
Z9 26
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0009-921X
J9 CLIN ORTHOP RELAT R
JI Clin. Orthop. Rel. Res.
PD NOV
PY 2006
IS 452
BP 166
EP 170
DI 10.1097/01.blo.0000229359.27491.9f
PG 5
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 119OK
UT WOS:000243021400032
PM 16906118
DA 2018-10-19
ER

PT J
AU Jolly, G
   Dupont, L
   Aplincourt, M
   Lambert, J
AF Jolly, G.
   Dupont, L.
   Aplincourt, M.
   Lambert, J.
TI Improved Cu and Zn sorption on oxidized wheat lignocellulose
SO ENVIRONMENTAL CHEMISTRY LETTERS
LA English
DT Article
DE lignocellulosic substrate; wheat bran; sorption; copper; zinc; oxidizing
   agents
ID NICA-DONNAN APPROACH; AQUEOUS-SOLUTIONS; IONS; ADSORPTION; REMOVAL;
   BINDING; COPPER; BRAN
AB We studied the effect an oxidizing treatment of a lignocellulosic substrate, extracted from wheat bran, on the sorption of Cu and Zn. Oxidizing agents, such as potassium permanganate (KMnO4) or sodium periodate (NaIO4), creates oxygenated functions, e.g. alcohol and carboxylic acid, which increase the density of functional sites and the binding capacity of lignocellulose towards copper and zinc. We found that the treatment with KMnO4 is the most efficient, with an increase of about 30-40% metal ion binding, compared to 15-25% using NaIO4. The investigation of the oxidation process shows that the efficiency of KMnO4 can be attributed to its affinity towards insaturated double bonds of lignin entities. Oxidized lignocellulose is thus a promising, efficient, and cheap biomaterial for the decontamination of wastewater.
C1 Univ Reims, GRECI, F-51687 Reims 2, France.
   Univ Nancy 1, LCPME, CNRS, F-54600 Villers Les Nancy, France.
RP Dupont, L (reprint author), Univ Reims, GRECI, BP 1039, F-51687 Reims 2, France.
EM laurent.dupont@univ-reims.fr
CR Bouanda J, 2002, ANAL BIOANAL CHEM, V373, P174, DOI 10.1007/s00216-002-1305-z
   Cay S, 2004, SEP PURIF TECHNOL, V38, P273, DOI 10.1016/j.seppur.2003.12.003
   Chubar N, 2004, COLLOID SURFACE A, V238, P51, DOI 10.1016/j.colsurfa.2004.01.039
   Dupont L, 2003, J COLLOID INTERF SCI, V263, P35, DOI 10.1016/S0021-9797(03)00241-8
   Gauthier A, 2002, ANAL BIOANAL CHEM, V373, P830, DOI 10.1007/s00216-002-1371-2
   Lee A, 1999, INT J COAL GEOL, V39, P329, DOI 10.1016/S0166-5162(98)00050-0
   LICHTFOUSE E, 2005, ENV CHEM GREEN CHEM, V5
   LICHTFOUSE E, 2005, ENV CHEM GREEN CHEM, V1
   LICHTFOUSE E, 2005, ENV CHEM GREEN CHEM, V2
   LICHTFOUSE E, 2005, ENV CHEM GREEN CHEM, V7
   LICHTFOUSE E, 2005, ENV CHEM GREEN CHEM, V6
   LICHTFOUSE E, 2005, ENV CHEM GREEN CHEM, V3
   LICHTFOUSE E, 2005, ENV CHEM GREEN CHEM, V4
   Taty-Costodes VC, 2003, J HAZARD MATER, V105, P121, DOI 10.1016/j.jhazmat.2003.07.009
   Veglio F, 2003, WATER RES, V37, P4895, DOI 10.1016/S0043-1354(03)00414-7
   Villaescusa I, 2004, WATER RES, V38, P992, DOI 10.1016/j.watres.2003.10.040
   YUHSHAN H, 2003, WATER RES, V37, P2323
NR 17
TC 12
Z9 14
U1 0
U2 7
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1610-3653
J9 ENVIRON CHEM LETT
JI Environ. Chem. Lett.
PD NOV
PY 2006
VL 4
IS 4
BP 219
EP 223
DI 10.1007/s10311-006-0051-4
PG 5
WC Chemistry, Multidisciplinary; Engineering, Environmental; Environmental
   Sciences
SC Chemistry; Engineering; Environmental Sciences & Ecology
GA 115HT
UT WOS:000242726100007
DA 2018-10-19
ER

PT J
AU Asberg, AE
   Videm, V
AF Asberg, Ann E.
   Videm, Vibeke
TI Neutrophil dysfunction after biomaterial contact in an in vitro model of
   cardiopulmonary bypass
SO EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
LA English
DT Article
DE neutrophil; endothelial cells; adhesion; polyvinylchloride; inflammation
ID MULTIPLE ORGAN FAILURE; SURGEONS NATIONAL DATABASE; FUTURE-DIRECTIONS;
   ADHESION; ACTIVATION; LEUKOCYTES; SELECTIN; MYELOPEROXIDASE;
   GRANULOCYTES; RELEASE
AB Objective: Cardiopulmonary bypass (CPB) induces neutrophil degranulation and superoxide anion production in vivo. We hypothesized that CPB-associated neutrophil dysregulation alters neutrophil adhesion to vascular endothelial cells and the extracellular matrix. Methods: We, therefore, recirculated neutrophils in polyvinyl chloride (PVC) tubing using a roller pump model and thereafter measured adhesion to cultured microvascular endothelial cells and gelatin-coated surfaces. Recirculation-induced neutrophil priming or exhaustion was tested by boosting with phorbol myristate-acetate (PMA) or N-formyl-methiolyl-leucyl-phenylalanine (FMLP) before quantification of adhesion. Results and conclusion: After recirculation, neutrophils retained their adhesive capability to vascular endothelial cells, whereas adhesion to gelatin increased. This increase was not seen when the neutrophils were recirculated with a rotator instead of a roller pump, indicating that not only the pump mode but also foreign surf ace contact was of significance. The neutrophil PMA response after recirculation was not altered compared to resting neutrophils prestimulated with PMA. Recirculated neutrophils adhered less to cultured vascular endothetial cells after FMLP activation and more to gelatin compared to resting neutrophils prestimutated with FMLP. It is conceivable that dysregulation of neutrophil adhesive capability may play a part in the development of tissue damage after CPB. (c) 2006 Published by Elsevier B.V.
C1 Univ Trondheim Hosp, Dept Immunol & Transfus Med, St Olavs Hosp, N-7006 Trondheim, Norway.
   Norwegian Univ Sci & Technol, Dept Lab Med, N-7034 Trondheim, Norway.
RP Asberg, AE (reprint author), Univ Trondheim Hosp, Dept Immunol & Transfus Med, St Olavs Hosp, N-7006 Trondheim, Norway.
EM ann.asberg@ntnu.no
CR Asberg AE, 2005, ARTIF ORGANS, V29, P927, DOI 10.1111/j.1525-1594.2005.00162.x
   Asimakopoulos G, 1998, ANN THORAC SURG, V66, P2135, DOI 10.1016/S0003-4975(98)00727-9
   Biffl WL, 1999, SURGERY, V126, P198, DOI 10.1016/S0039-6060(99)70155-8
   Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P9
   Conover W. J., 1999, PRACTICAL NONPARAMET
   Davenpeck KL, 2000, J IMMUNOL, V165, P2764, DOI 10.4049/jimmunol.165.5.2764
   Evangelista V, 1999, BLOOD, V93, P876
   Gorbet MB, 2004, BIOMATERIALS, V25, P5681, DOI 10.1016/j.biomaterials.2004.01.023
   Gourlay T, 2001, PERFUSION-UK, V16, P381, DOI 10.1177/026765910101600508
   Grover FL, 1999, ANN THORAC SURG, V68, P367, DOI 10.1016/S0003-4975(99)00599-8
   Grover FW, 1999, ANN THORAC SURG, V68, P374
   Hattori H, 2005, EPILEPSIA, V46, P4
   Laffey JG, 2002, ANESTHESIOLOGY, V97, P215
   Levy JH, 2003, ANN THORAC SURG, V75, P715
   LEY K, 1989, BLOOD, V73, P1324
   Mandell KJ, 2005, ADV DRUG DELIVER REV, V57, P857, DOI 10.1016/j.addr.2005.01.005
   Murphy GJ, 2004, J CARDIAC SURG, V19, P481, DOI 10.1111/j.0886-0440.2004.04101.x
   Paparella D, 2002, EUR J CARDIO-THORAC, V21, P232, DOI 10.1016/S1010-7940(01)01099-5
   Partrick DA, 1999, J SURG RES, V86, P42, DOI 10.1006/jsre.1999.5702
   Partrick DA, 1999, AM J SURG, V178, P564, DOI 10.1016/S0002-9610(99)00240-8
   Smalley DM, 2005, J CELL MOL MED, V9, P255, DOI 10.1111/j.1582-4934.2005.tb00354.x
   SUZUKI K, 1983, ANAL BIOCHEM, V132, P345, DOI 10.1016/0003-2697(83)90019-2
   Videm V, 1996, SCAND J IMMUNOL, V43, P385, DOI 10.1046/j.1365-3083.1996.d01-57.x
NR 23
TC 6
Z9 7
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1010-7940
J9 EUR J CARDIO-THORAC
JI Eur. J. Cardio-Thorac. Surg.
PD NOV
PY 2006
VL 30
IS 5
BP 744
EP 748
DI 10.1016/j.ejcts.2006.08.019
PG 5
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 118MJ
UT WOS:000242946100010
PM 17029835
OA Bronze
DA 2018-10-19
ER

PT J
AU Sacks, MS
   Mirnajafi, A
   Sun, W
   Schmidt, P
AF Sacks, Michael S.
   Mirnajafi, Ali
   Sun, Wei
   Schmidt, Paul
TI Bioprosthetic heart valve heterograft biomaterials: structure,
   mechanical behavior and computational simulation
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Review
DE bioprostheses; heart valve; implantable devices
ID BEAM COMPUTED-TOMOGRAPHY; TISSUE ENGINEERING SCAFFOLDS; COLLAGEN FIBER
   ARCHITECTURE; BOVINE PERICARDIUM; VISCOELASTIC PROPERTIES;
   STRESS-STRAIN; INTERSTITIAL-CELLS; CONSTITUTIVE MODEL; SELECTION SITES;
   PULMONARY VALVE
AB The present review surveys significant developments in the biomechanical characterization and computational simulation of biologically derived chemically cross-linked soft tissues, or 'heterograft' biomaterials, used in replacement bioprosthetic heart valve (BHV). A survey of mechanical characterization techniques, relevant mechanical properties and computational simulation approaches is presented for both the source tissues and cross-linked biomaterials. Since durability remains the critical problem with current bioprostheses, changes with the mechanical behavior with fatigue are also presented. Moreover, given the complex nature of the mechanical properties of heterograft biomaterials it is not surprising that most constitutive (stress-strain) models, historically used to characterize their behavior, were oversimplified. Simulations of BHV function utilizing these models have inevitably been inaccurate. Thus, more recent finite element simulations utilizing nonlinear constitutive models, which achieve greater model fidelity, are reviewed. An important conclusion of this review is the need for accurate constitutive models, rigorously validated with appropriate experimental data, in order that the design benefits of computational models can be realized. Finally, for at least the coming 20 years, BHVs fabricated from heterograft biomaterials will continue to be extensively used, and will probably remain as the dominant valve design. We should thus recognize that rational, scientifically based approaches to BHV biomaterial development and design can lead to significantly improved BHV, over the coming decades, which can potentially impact millions of patients worldwide with heart valve disease.
C1 Univ Pittsburgh, Engineered Tissue Mech Lab, Dept Bioengn, Pittsburgh, PA 15261 USA.
   Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15261 USA.
   Edwards Lifesci, Heart Valve Therapy R&D, Irvine, CA 92614 USA.
RP Sacks, MS (reprint author), Univ Pittsburgh, Engineered Tissue Mech Lab, Dept Bioengn, Pittsburgh, PA 15261 USA.
EM nuacks@pitt.edu
FU NHLBI NIH HHS [HL74731, HL071814, HL063026]
CR Alferiev I, 2001, BIOMATERIALS, V22, P2683, DOI 10.1016/S0142-9612(01)00010-2
   Alferiev I, 2003, J BIOMED MATER RES A, V66A, P385, DOI 10.1002/jbm.a.10896
   Billiar KL, 2000, J BIOMECH ENG-T ASME, V122, P327, DOI 10.1115/1.1287158
   Billiar KL, 2005, J BIOMED MATER RES A, V73A, P182, DOI 10.1002/jbm.a.30282
   Billiar KL, 2000, J BIOMECH ENG-T ASME, V122, P23, DOI 10.1115/1.429624
   BLACK MM, 1991, J BIOMECH, V24, P793, DOI 10.1016/0021-9290(91)90304-6
   BROOM ND, 1978, J THORAC CARDIOV SUR, V76, P202
   BROOM ND, 1980, BIOMATERIALS, V1, P3, DOI 10.1016/0142-9612(80)90049-6
   BROOM ND, 1977, J BIOMECH, V10, P707, DOI 10.1016/0021-9290(77)90086-0
   Brossollet LJ, 1996, J BIOMECH ENG-T ASME, V118, P433, DOI 10.1115/1.2796028
   Burriesci G, 1999, J MED ENG TECHNOL, V23, P203
   Cacciola G, 2000, J BIOMECH, V33, P653, DOI 10.1016/S0021-9290(00)00003-8
   Cacciola G, 2000, J BIOMECH, V33, P521, DOI 10.1016/S0021-9290(99)00222-5
   Carew EO, 2004, ANN BIOMED ENG, V32, P563, DOI 10.1023/B:ABME.0000019176.49650.19
   CATALOGLU A, 1977, J BIOMECH, V10, P153, DOI 10.1016/0021-9290(77)90053-7
   CHEW PH, 1986, J MOL CELL CARDIOL, V18, P567, DOI 10.1016/S0022-2828(86)80965-8
   CHRISTIE GW, 1995, ANN THORAC SURG, V60, pS195, DOI 10.1016/0003-4975(95)00279-T
   CHRISTIE GW, 1995, ANN THORAC SURG, V60, pS156, DOI 10.1016/0003-4975(95)00219-B
   Connolly JM, 2005, AM J PATHOL, V166, P1, DOI 10.1016/S0002-9440(10)62227-4
   COURTMAN DW, 1995, J BIOMED MATER RES, V29, P1507, DOI 10.1002/jbm.820291207
   Courtney T, 2006, BIOMATERIALS, V27, P3631, DOI 10.1016/j.biomaterials.2006.02.024
   CROFTS CE, 1989, BIOMATERIALS, V10, P230, DOI 10.1016/0142-9612(89)90098-7
   *DOC RESP NEUR DEV, 1993, REPL HEART VALV GUID
   Driessen NJB, 2005, J BIOMECH ENG-T ASME, V127, P329, DOI 10.1115/1.1865187
   Driessen NJB, 2003, J BIOMECH ENG-T ASME, V125, P549, DOI 10.1115/1.1590361
   Duncan AC, 1996, BIOMATERIALS, V17, P1849, DOI 10.1016/0142-9612(96)00006-3
   Einstein DR, 2005, J BIOMECH ENG-T ASME, V127, P134, DOI 10.1115/1.1835359
   Einstein DR, 2004, MED BIOL ENG COMPUT, V42, P832, DOI 10.1007/BF02345218
   Engelmayr GC, 2005, BIOMATERIALS, V26, P175, DOI 10.1016/j.biomaterials.2004.02.035
   Engelmayr GC, 2003, BIOMATERIALS, V24, P2523, DOI 10.1016/S0142-9612(03)00051-6
   Engelmayr GC, 2006, BIOMATERIALS, V27, P6083, DOI 10.1016/j.biomaterials.2006.07.045
   Engelmayr GC, 2006, J BIOMECH ENG-T ASME, V128, P610, DOI 10.1115/1.2205371
   FILIP DA, 1986, CIRC RES, V59, P310, DOI 10.1161/01.RES.59.3.310
   FRISCHFAY R, 1962, FLEXIBLE BARS, P220
   Fung Y.-C., 1993, BIOMECHANICS MECH PR, P568, DOI [10.1007/978-1-4757-2257-4, DOI 10.1007/978-1-4757-2257-4]
   GABBAY S, 1984, J THORAC CARDIOV SUR, V88, P758
   Gaudiani VA, 2004, HEART SURG FORUM, V7, pE170, DOI 10.1532/HSF98.20041005
   GLOECKNER D, 1998, 3 WORLD C BIOM HOK J
   Gloeckner DC, 1999, ASAIO J, V45, P59, DOI 10.1097/00002480-199901000-00014
   Gould P. L., 1973, Computers and Structures, V3, P377, DOI 10.1016/0045-7949(73)90024-2
   HAMID MS, 1986, J BIOMECH, V19, P759, DOI 10.1016/0021-9290(86)90199-5
   Harada Y, 1989, Kyobu Geka, V42, P457
   Hiester ED, 1998, J BIOMED MATER RES, V39, P215, DOI 10.1002/(SICI)1097-4636(199802)39:2<215::AID-JBM7>3.0.CO;2-S
   Hiester ED, 1998, J BIOMED MATER RES, V39, P207, DOI 10.1002/(SICI)1097-4636(199802)39:2<207::AID-JBM6>3.0.CO;2-T
   HILBERT SL, 1986, J BIOMED MATER RES, V20, P1411, DOI 10.1002/jbm.820200914
   HUANG X, 1990, J BIOMECH, V23, P753, DOI 10.1016/0021-9290(90)90022-U
   HUMPHREY JD, 1992, J BIOMECH ENG-T ASME, V114, P461, DOI 10.1115/1.2894095
   HUMPHREY JD, 1986, ANN BIOMED ENG, V14, P451, DOI 10.1007/BF02367365
   Iyengar AKS, 2001, ANN BIOMED ENG, V29, P963, DOI 10.1114/1.1415523
   KIM H, 2006, ANN BIOMED ENG
   Kim H, 2006, J BIOMECH ENG-T ASME, V128, P717, DOI 10.1115/1.2244578
   Korossis SA, 2002, J HEART VALVE DIS, V11, P463
   KRONICK PL, 1994, J BIOMECH ENG-T ASME, V116, P140, DOI 10.1115/1.2895712
   KRUCINSKI S, 1993, J BIOMECH, V26, P929, DOI 10.1016/0021-9290(93)90055-J
   LEAT ME, 1993, J BIOMED ENG, V15, P516, DOI 10.1016/0141-5425(93)90068-A
   LEE JM, 1984, J BIOMED MATER RES, V18, P79, DOI 10.1002/jbm.820180109
   Li J, 2001, J BIOMECH, V34, P1279, DOI 10.1016/S0021-9290(01)00092-6
   Lovekamp JJ, 2006, BIOMATERIALS, V27, P1507, DOI 10.1016/j.biomaterials.2005.08.003
   Mako WJ, 1999, J BIOMED MATER RES, V45, P209, DOI 10.1002/(SICI)1097-4636(19990605)45:3<209::AID-JBM8>3.0.CO;2-N
   MAYNE ASD, 1989, J THORAC CARDIOV SUR, V98, P170
   Merryman WD, 2006, J BIOMECH, V39, P88, DOI 10.1016/j.jbiomech.2004.11.008
   MESSIER RH, 1994, J SURG RES, V57, P1, DOI 10.1006/jsre.1994.1102
   Messika-Zeitoun D, 2004, CIRCULATION, V110, P356, DOI 10.1161/01.CIR.0000135469.82545.D0
   Mirnajafi A, 2005, BIOMATERIALS, V26, P795, DOI 10.1016/j.biomaterials.2004.03.004
   Mirnajafi A, 2006, J BIOMECH, V39, P2966, DOI 10.1016/j.jbiomech.2005.10.026
   Moczar M, 2000, J HEART VALVE DIS, V9, P88
   Moore MA, 1998, ANN THORAC SURG, V66, pS245, DOI 10.1016/S0003-4975(98)01118-7
   Mulholland DL, 1996, CAN J CARDIOL, V12, P231
   Patterson EA, 1996, J MED ENG TECHNOL, V20, P95, DOI 10.3109/03091909609008387
   PEREIRA CA, 1990, J BIOMED MATER RES, V24, P345, DOI 10.1002/jbm.820240307
   Pohle K, 2004, MAYO CLIN PROC, V79, P1242, DOI 10.4065/79.10.1242
   Pohle K, 2004, INVEST RADIOL, V39, P230, DOI 10.1097/01.rli.0000115749.08234.6a
   PURINYA B, 1994, J BIOMECH, V27, P1, DOI 10.1016/0021-9290(94)90027-2
   Sacks M.S., 2003, ANN REV BIOMED ENG
   Sacks MS, 2002, J BIOMED MATER RES, V62, P359, DOI 10.1002/jbm.10293
   Sacks MS, 1998, ANN BIOMED ENG, V26, P892, DOI 10.1114/1.135
   Sacks MS, 1999, J BIOMECH ENG-T ASME, V121, P551, DOI 10.1115/1.2835086
   Sacks MS, 2000, J ELASTICITY, V61, P199, DOI 10.1023/A:1010917028671
   Sacks MS, 2003, J BIOMECH ENG-T ASME, V125, P280, DOI 10.1115/1.1544508
   SACKS MS, 2003, FUNCTIONAL TISSUE EN
   Sacks MS, 1997, ADV ANTICALCIFIC ANT
   Schoen FJ, 2005, ANN THORAC SURG, V79, P1072, DOI 10.1016/j.athoracsur.2004.06.033
   Schoen FJ, 1997, J HEART VALVE DIS, V6, P1
   Schoen FJ, 2001, J HEART VALVE DIS, V10, P458
   SELLARO TL, 2006, J BIOMED MATER RES, V80, P194
   Stradins P, 2004, EUR J CARDIO-THORAC, V26, P634, DOI 10.1016/j.ejcts.2004.05.043
   Sun W, 2004, J BIOMED MATER RES A, V69A, P658, DOI 10.1002/jbm.a.30031
   Sun W, 2003, J BIOMECH ENG-T ASME, V125, P372, DOI 10.1115/1.1572518
   Sun W, 2005, J BIOMECH ENG-T ASME, V127, P905, DOI 10.1115/1.2049337
   Sun W., 2005, BIOMECH MODEL MECHAN
   Talman EA, 2001, ANN THORAC SURG, V71, pS375, DOI 10.1016/S0003-4975(01)02546-2
   Taylor PA, 2003, INT J BIOCHEM CELL B, V35, P113, DOI 10.1016/S1357-2725(02)00100-0
   THUBRIKAR MJ, 1982, J BIOMED MATER RES, V16, P811, DOI 10.1002/jbm.820160607
   THUBRIKAR MJ, 1983, J THORAC CARDIOV SUR, V86, P115
   TONG P, 1976, J BIOMECH, V9, P649, DOI 10.1016/0021-9290(76)90107-X
   TROWBRIDGE EA, 1987, J BIOMED ENG, V9, P345, DOI 10.1016/0141-5425(87)90084-7
   Vesely I, 2003, CARDIOVASC PATHOL, V12, P277, DOI 10.1016/S1054-8807(03)00075-9
   Vesely I, 2001, J HEART VALVE DIS, V10, P471
   Vesely I, 1998, J BIOMECH, V31, P115
   VESELY I, 1990, J THORAC CARDIOV SUR, V99, P119
   VESELY I, 1989, J BIOMECH, V22, P655, DOI 10.1016/0021-9290(89)90016-X
   Vyavahare N, 1999, J BIOMED MATER RES, V46, P44
   Walsh CR, 2004, AM J CARDIOL, V93, P421, DOI 10.1016/j.amjcard.2003.10.035
   Wells SM, 2005, BIOMATERIALS, V26, P2611, DOI 10.1016/j.biomaterials.2004.06.046
   Wells SM, 2002, BIOMATERIALS, V23, P2389, DOI 10.1016/S0142-9612(01)00375-1
   WINEMAN AS, 1976, T SOC RHEOL, V20, P203, DOI 10.1122/1.549410
   ZIOUPOS P, 1994, J BIOMED MATER RES, V28, P49, DOI 10.1002/jbm.820280107
   ZIOUPOS P, 1992, MED BIOL ENG COMPUT, V30, P76, DOI 10.1007/BF02446197
NR 108
TC 22
Z9 23
U1 2
U2 15
PU FUTURE DRUGS LTD
PI LONDON
PA UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB,
   ENGLAND
SN 1743-4440
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD NOV
PY 2006
VL 3
IS 6
BP 817
EP 834
DI 10.1586/17434440.3.6.817
PG 18
WC Engineering, Biomedical
SC Engineering
GA 124DT
UT WOS:000243348400022
PM 17280546
DA 2018-10-19
ER

PT J
AU Li, XF
   Wang, C
   Xiang, HB
   Zhang, GX
AF Li, Xingfei
   Wang, Chi
   Xiang, Hongbiao
   Zhang, Guoxiong
TI Finite element simulation of ultrasonic guided waves generated by a
   pulsed laser in human skin
SO INSTRUMENTATION SCIENCE & TECHNOLOGY
LA English
DT Article
DE FEM; temperature field; surface acoustic wave; human skin; laser
   ultrasonic
AB A high-power, short laser, pulse incident on human skin generates a transient temperature field. As a rapid and localized thermal expansion occurs, energy is released in the form of propagating ultrasound in all directions. Laser-generated ultrasound is non-contact, broadband, and multiple propagation modes, and so, has been studied widely in the non-destructive testing of structural materials. However, its application in human skin is still new. Considering human skin properties, the transient temperature distribution in human skin is simulated using the finite element method (FEM). A finite element model, a 2-layer elastic, isotropic biomaterial model, is developed to simulate the laser thermo-elastic generation and propagation of the laser ultrasound. Taking into consideration the fundamental understanding of the laser/material interface, the simulation comprises a set of boundary conditions that approximate a heat flux point source with Gaussian spatial variation located on top of the surface of the material. We obtained the temporal characteristics of the ultrasonic guided waves generated by the pulsed laser with different beam radius and the various rise times. The numerical results indicate the significant influence of pulsed laser beam radius and pulse-width on laser-generated ultrasound propagation features, and that the heat-affected zone is very localized; such a distribution of the transient temperature is considered as a body source in the generation of ultrasound. Obviously, these results and the method discussed in this paper establish a qualitative basis for the thermo-elastic mechanism in non-destructive evaluation of the human skin properties, which is of great significance and applicability.
C1 Tianjin Univ, State Key Lab Precise Measurement Technol & Instr, Tianjin 300072, Peoples R China.
RP Li, XF (reprint author), Tianjin Univ, State Key Lab Precise Measurement Technol & Instr, Tianjin 300072, Peoples R China.
EM lixf@tju.edu.cn
CR CHENG JC, 1995, APPL PHYS A-MATER, V61, P311, DOI 10.1007/BF01538196
   Cook RD, 1989, CONCEPTS APPL FINITE
   [高会栋 Gao Huidong], 2002, [应用声学, Applied Acoustics], V21, P19
   [何跃娟 He Yuejuan], 2004, [激光杂志, Laser Journal], V25, P73
   HUTCHINS DA, 1988, PHYS ACOUSTICS, V18, P21
   NIEDERHAUSER JJ, 2004, THESIS SWISS FED I T
   Qian Menghu, 1995, Acta Acustica, V20, P1
   Reddy J.N, 1993, INTRO FINITE ELEMENT
   ROSE LRF, 1984, J ACOUST SOC AM, V75, P723, DOI 10.1121/1.390583
   Scruby CB, 1990, LASER ULTRASONICS TE
   SHEN Z, 2004, CHINESE J LASERS, V31, P621
   Shen Zhonghua, 2002, Acta Acustica, V27, P203
   Zhang Z. G., 1992, Journal of Huazhong Agricultural University, V11, P1
NR 13
TC 2
Z9 5
U1 0
U2 8
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 1073-9149
J9 INSTRUM SCI TECHNOL
JI Instrum. Sci. Technol.
PD NOV-DEC
PY 2006
VL 34
IS 6
BP 711
EP 725
DI 10.1080/10739140600964127
PG 15
WC Chemistry, Analytical; Instruments & Instrumentation
SC Chemistry; Instruments & Instrumentation
GA 090FO
UT WOS:000240936300007
DA 2018-10-19
ER

PT J
AU Tachaboonyakiat, W
   Ogomi, D
   Serizawa, T
   Akashi, M
AF Tachaboonyakiat, Wanpen
   Ogomi, Daisuke
   Serizawa, Takeshi
   Akashi, Mitsuru
TI Evaluation of cell adhesion and proliferation on a novel tissue
   engineering scaffold containing chitosan and hydroxyapatite
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE porous; chitosan-hydroxyapatite; enzymatic hydrolysis; biocompatibility
ID BIOMATERIAL; SURFACES; DEGRADATION; IMPLANTS; TITANIUM
AB Porous chitosan-hxdroxyapatite hybrids were developed by partial enzymatic degradation [14] of the chitin/chitosan surface using chitosanase and lysozyme. This article evaluates the influence of chitosan and hydroxyapatite components, substrate roughness, stability, as well as surface porosity produced by enzymatic hydrolysis to cell adhesion and proliferation. L929 mouse fibroblastic lung cells were cultured on enzymatic degraded porous chitosan-hydroxyapatite hybrids. The presence of hydroxyapatite and porosity produced by partial lysozyme hydrolysis enhance cell proliferation. Besides,,cell adhesion and proliferation are primarily dependent on substrate roughness and stability.
C1 Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan.
   Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan.
   Nitto Denko Corp, Hiroshima 7220212, Japan.
   Chulalongkorn Univ, Fac Sci, Dept Mat Sci, Bangkok 10330, Thailand.
RP Akashi, M (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, Yamada Oka, Suita, Osaka 5650871, Japan.
EM akashi@chem.eng.osaka-u.ac.jp
RI Serizawa, Takeshi/S-7133-2018
OI Serizawa, Takeshi/0000-0002-4867-8625
CR AEBISCHER P, 1988, BIOMATERIALS, V9, P80, DOI 10.1016/0142-9612(88)90075-0
   Beppu Marisa M., 2002, Mat. Res., V5, P47, DOI 10.1590/S1516-14392002000100008
   Craig RG, 1999, J BIOMED MATER RES, V47, P585, DOI 10.1002/(SICI)1097-4636(19991215)47:4<585::AID-JBM16>3.0.CO;2-O
   Deible CR, 1999, BIOMATERIALS, V20, P101, DOI 10.1016/S0142-9612(98)00001-5
   DESAI N P, 1989, Journal of Biomaterials Science Polymer Edition, V1, P123, DOI 10.1163/156856289X00118
   DION I, 1993, BIOMATERIALS, V14, P712, DOI 10.1016/0142-9612(93)90070-I
   FEUERSTEIN IA, 1990, BIOMATERIALS, V11, P127, DOI 10.1016/0142-9612(90)90128-D
   GHANNAM AE, 1997, J BIOMED MATER RES, V36, P167
   Gloeckner DC, 2000, J BIOMED MATER RES, V52, P365, DOI 10.1002/1097-4636(200011)52:2<365::AID-JBM17>3.0.CO;2-3
   Hu QL, 2004, BIOMATERIALS, V25, P779, DOI 10.1016/S0142-9612(03)00582-9
   IIO K, 1994, J BIOMED MATER RES, V28, P459, DOI 10.1002/jbm.820280408
   IZUME M, 1989, CHITIN CHITOSAN, P653
   Langer R, 1999, J CONTROL RELEASE, V62, P7, DOI 10.1016/S0168-3659(99)00057-7
   Layman DL, 1998, J BIOMED MATER RES, V40, P282, DOI 10.1002/(SICI)1097-4636(199805)40:2<282::AID-JBM13>3.0.CO;2-O
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   Lo WJ, 2000, J BIOMED MATER RES, V50, P536, DOI 10.1002/(SICI)1097-4636(20000615)50:4<536::AID-JBM9>3.3.CO;2-L
   Narita T, 2000, BIOMACROMOLECULES, V1, P162, DOI 10.1021/bm9900085
   Saad B, 1998, J BIOMED MATER RES, V39, P594, DOI 10.1002/(SICI)1097-4636(19980315)39:4<594::AID-JBM14>3.0.CO;2-7
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Tachaboonyakiat W, 2002, J BIOMAT SCI-POLYM E, V13, P1021, DOI 10.1163/156856202760319162
   Tachaboonyakiat W, 2001, POLYM J, V33, P177, DOI 10.1295/polymj.33.177
   Thomson R. C., 1995, ADV POLYM SCI, V122, P247
   Vogt S., 2002, European Cells & Materials, V4, P30
   Zhang RY, 1999, J BIOMED MATER RES, V44, P446
NR 24
TC 9
Z9 11
U1 1
U2 9
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD NOV
PY 2006
VL 21
IS 6
BP 579
EP 589
DI 10.1177/0883911506070441
PG 11
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 099XQ
UT WOS:000241631500007
DA 2018-10-19
ER

PT J
AU Rocha, LB
   Adam, RL
   Leite, NJ
   Metze, K
   Rossi, MA
AF Rocha, Lenaldo B.
   Adam, Randall L.
   Leite, Neucimar J.
   Metze, Konradin
   Rossi, Marcos A.
TI Biomineralization of polyanionic collagen-elastin matrices during
   cavarial bone repair
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article; Proceedings Paper
CT 22nd Annual Meeting of the Brazillian-Society-for-Dental-Research
CY SEP   05, 2005
CL Aguas de Lindoia, BRAZIL
SP Brazillian Soc Dent Res
DE bone regeneration; bioabsorption; collagen; electroactive polymer;
   osteoconduction
ID ANIONIC COLLAGEN; TISSUE-RESPONSE; CELL-ADHESION; IN-VITRO;
   CALCIFICATION; REGENERATION; SCAFFOLDS; PHOSPHATE; DEFECTS; GEL
AB The polyanionic collagen-elastin matrices (PCEMs) are osteoconductive scaffolds that present high biocompatibility and efficacy in the regeneration of bone defects. In this study, the objective was to determine if these matrices are directly mineralized during the osteogenesis process and their influence in the organization of the new bone extracellular matrix. Samples of three PCEMs, differing in their charge density, were implanted into critical-sized calvarial bone defects created in rats and evaluated from 3 days up to 1 year after implantation. The implanted PCEMs were directly biomineralized by osteoblasts as shown by ultrastructural, histoenzymologic, and morphologic analysis. The removal of the implants occurred during the bone remodeling process. The organization of the new bone matrix was evaluated by image texture analysis determining the Shannon's entropy and the fractal dimension of digital images. The bone matrix complexity decreased as the osteogenesis progressed approaching the values obtained for the original bone structure. These results show that the PCEMs allow faster formation of new bone by direct biomineralization of its structure and skipping the biomaterial resorption phase. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pathol, BR-14049900 Ribeirao Preto, SP, Brazil.
   Univ Estadual Campinas, Dept Pathol, Fac Med, BR-13081970 Campinas, Brazil.
   Univ Estadual Campinas, Dept Informat Syst, Inst Comp, BR-13084970 Campinas, SP, Brazil.
RP Rocha, LB (reprint author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Pathol, Av Bandeirantes 3900, BR-14049900 Ribeirao Preto, SP, Brazil.
EM lenaldo@rpa.fmrp.usp.br
RI Metze, Konradin/A-8703-2008; Rocha, Lenaldo/D-2382-2011; Leite,
   Neucimar/H-7299-2012; Retter, Clementine/S-3383-2016
OI Rocha, Lenaldo/0000-0002-4345-6994; Leite, Neucimar/0000-0001-5015-2131;
   Metze, Konradin/0000-0003-0742-8846
CR Alsberg E, 2003, J DENT RES, V82, P903, DOI 10.1177/154405910308201111
   Bet MR, 2003, BIOMATERIALS, V24, P131, DOI 10.1016/S0142-9612(02)00270-3
   Bet MR, 2001, BIOMACROMOLECULES, V2, P1074, DOI 10.1021/bm0001188
   Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217
   CHAPMAN JA, 1990, ELECTRON MICROSC REV, V3, P143, DOI 10.1016/0892-0354(90)90018-N
   Cirelli JA, 1997, BIOMATERIALS, V18, P1227, DOI 10.1016/S0142-9612(97)00053-7
   Daamen WF, 2005, BIOMATERIALS, V26, P81, DOI 10.1016/j.biomaterials.2004.02.011
   DELBALSO AM, 1976, ORAL SURG ORAL MED O, V42, P562, DOI 10.1016/0030-4220(76)90205-X
   Fuerst G, 2004, J CLIN PERIODONTOL, V31, P784, DOI 10.1111/j.1600-051X.2004.00561.x
   Goes JC, 2002, J PHYS CHEM SOLIDS, V63, P465, DOI 10.1016/S0022-3697(01)00161-5
   Goissis G, 2003, ARTIF ORGANS, V27, P437, DOI 10.1046/j.1525-1594.2003.07252.x
   Goissis G, 1998, ARTIF ORGANS, V22, P203, DOI 10.1046/j.1525-1594.1998.06109.x
   Gungormus M, 2002, J ORAL MAXIL SURG, V60, P541, DOI 10.1053/joms.2002.31852
   Hill P A, 1998, Br J Orthod, V25, P101
   Kamakura S, 2002, J BIOMED MATER RES, V59, P29, DOI 10.1002/jbm.1213.abs
   Lindsey WH, 1996, ARCH OTOLARYNGOL, V122, P37
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077
   MEIKLE MC, 1992, J CELL SCI, V103, P1093
   Metze Konradin, 2005, Cellular Oncology, V27, P137
   Miao DS, 2002, J HISTOCHEM CYTOCHEM, V50, P333, DOI 10.1177/002215540205000305
   Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0
   Mistry AS, 2005, ADV BIOCHEM ENG BIOT, V94, P1, DOI 10.1007/b99997
   Moreira PL, 2004, J BIOMED MATER RES B, V71B, P229, DOI 10.1002/jbm.b.30026
   MORI S, 1988, J HISTOCHEM CYTOCHEM, V36, P111, DOI 10.1177/36.1.3275709
   MOSKOW BS, 1976, J PERIODONTOL, V47, P596
   Nakagawa T, 2000, ORAL DIS, V6, P172
   NIMNI ME, 1988, CALCIFIED TISSUE INT, V42, P313, DOI 10.1007/BF02556366
   Ohgaki M, 2001, J BIOMED MATER RES, V57, P366, DOI 10.1002/1097-4636(20011205)57:3<366::AID-JBM1179>3.0.CO;2-X
   Pollok J M, 1996, Semin Pediatr Surg, V5, P191
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
   Rocha LB, 2004, J BIOMED MATER RES B, V71B, P355, DOI 10.1002/jbm.b.30102
   Rocha LB, 2002, BIOMATERIALS, V23, P449, DOI 10.1016/S0142-9612(01)00126-0
   Rosa FP, 2003, BIOMATERIALS, V24, P207, DOI 10.1016/S0142-9612(02)00292-2
   Rosso F, 2005, J CELL PHYSIOL, V203, P465, DOI 10.1002/jcp.20270
   Sarkar MR, 2001, J BIOMED MATER RES, V58, P329, DOI 10.1002/1097-4636(2001)58:3<329::AID-JBM1025>3.3.CO;2-0
   Schlegel KA, 2004, BIOMATERIALS, V25, P5387, DOI 10.1016/j.biomaterials.2003.12.043
   SHANNON CE, 1948, AT&T TECH J, V27, P379
   Toung JS, 1999, LARYNGOSCOPE, V109, P1580, DOI 10.1097/00005537-199910000-00006
   Vardaxis NJ, 1996, BIOMATERIALS, V17, P1489, DOI 10.1016/0142-9612(96)89773-0
NR 40
TC 18
Z9 18
U1 0
U2 4
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV
PY 2006
VL 79A
IS 2
BP 237
EP 245
DI 10.1002/jbm.a.30782
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 092YB
UT WOS:000241132500003
PM 16817211
DA 2018-10-19
ER

PT J
AU Yoshida, M
   Babensee, JE
AF Yoshida, Mutsumi
   Babensee, Julia E.
TI Differential effects of agarose and poly(lactic-co-glycolic acid) on
   dendritic cell maturation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE combination products; biomaterial; adjuvant; dendritic cells
ID NF-KAPPA-B; MHC CLASS-II; IN-VITRO; IMMUNE-RESPONSE; HUMAN BLOOD;
   POLYMERIC MICROSPHERES; CONTROLLED-RELEASE; VACCINE ADJUVANTS;
   PROTEIN-KINASE; BONE-FORMATION
AB Application of biomaterials in combination products in which the biomaterial is presented to the host with a biological component prompts the need for understanding the biomaterial-associated adjuvant effect in the immune response against antigens associated with such a product. We have previously demonstrated that a polymer commonly used in tissue engineering and vaccine delivery, poly(lactic-co-glycolic acid) (PLGA), exerts an adjuvant effect in vivo, which was supported by PLGA-induced dendritic cell (DC) maturation in vitro. In this study, the effects of agarose and PLGA on DC maturation were compared in vitro to establish differential biomaterial effects. Human monocyte-derived DCs were treated with agarose or PLGA microparticles or films, and their maturation effect was measured as expression of costimulatory and MHC class II molecules, allostimulatory capacity, and proinflammatory cytokine secretion. Direct comparison of DC maturation phenotype indicated that PLGA was a stronger stimulus of DC maturation than agarose, and this maturation was not affected by microparticle phagocytosis. However, agarose-treated DCs showed higher activation of nuclear factor kappa B (NF kappa B) 24 h after the initial stimulation of DCs. Taken together, these results demonstrate differential biomaterial effects on DC maturation, substantiating the maturation effect of PLGA, and provide screening methods for biomaterial adjuvant effect for applications in combination products. (c) 2006 Wiley Periodicals, Inc.
C1 Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.
   Emory Univ, Atlanta, GA 30332 USA.
RP Babensee, JE (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, 313 Ferst Dr, Atlanta, GA 30332 USA.
EM julia.babensee@bme.gatech.edu
FU NIBIB NIH HHS [1R01EB004633-01A1]
CR Arrighi JF, 2001, J IMMUNOL, V166, P3837, DOI 10.4049/jimmunol.166.6.3837
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Babensee JE, 2005, J BIOMED MATER RES A, V74A, P503, DOI 10.1002/jbm.a.30429
   BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.iy.12.040194.001041
   Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   Bouissou C, 2004, J CONTROL RELEASE, V95, P557, DOI 10.1016/j.conrel.2003.12.016
   Cadic-Amadeuf C M, 1992, ASAIO J, V38, pM386, DOI 10.1097/00002480-199207000-00061
   Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030
   Croll TI, 2004, BIOMACROMOLECULES, V5, P463, DOI 10.1021/bm0343040
   Ertl HCJ, 1996, VACCINE, V14, P879, DOI 10.1016/0264-410X(96)00005-9
   Feng SS, 2001, J CONTROL RELEASE, V71, P53, DOI 10.1016/S0168-3659(00)00364-3
   Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200
   Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Jotwani R, 2003, EUR J IMMUNOL, V33, P2980, DOI 10.1002/eji.200324392
   Karp JM, 2003, J BIOMED MATER RES A, V64A, P388, DOI 10.1002/jbm.a.10420
   Kishida A, 2001, BIOMATERIALS, V22, P541, DOI 10.1016/S0142-9612(00)00210-6
   Koch F, 1996, J EXP MED, V184, P741, DOI 10.1084/jem.184.2.741
   Liu FI, 2003, INT J PHARM, V257, P23, DOI 10.1016/S0378-5173(03)00110-8
   Lutsiak MEC, 2002, PHARM RES-DORDR, V19, P1480, DOI 10.1023/A:1020452531828
   Matzelle MM, 2004, BIOMATERIALS, V25, P295, DOI 10.1016/S0142-9612(03)00531-3
   MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.immunol.12.1.991
   Meese TM, 2002, J BIOMAT SCI-POLYM E, V13, P141, DOI 10.1163/156856202317414339
   Menger FM, 2004, J AM CHEM SOC, V126, P5987, DOI 10.1021/ja040066k
   Mikos AG, 1998, ADV DRUG DELIV REV, V33, P111
   Newman KD, 2002, J BIOMED MATER RES, V60, P480, DOI 10.1002/jbm.10019
   Newman KD, 1998, J CONTROL RELEASE, V54, P49, DOI 10.1016/S0168-3659(97)00142-9
   Ouaz F, 2002, IMMUNITY, V16, P257
   Raghuvanshi RJ, 2001, J MICROENCAPSUL, V18, P723
   Rahfoth B, 1998, OSTEOARTHR CARTILAGE, V6, P50, DOI 10.1053/joca.1997.0092
   Ratner B D, 1996, BIOMATERIAL SCI INTR
   Rescigno M, 1998, J EXP MED, V188, P2175, DOI 10.1084/jem.188.11.2175
   Rescigno M, 1999, IMMUNOL TODAY, V20, P200, DOI 10.1016/S0167-5699(98)01427-3
   Rihova B, 2000, ADV DRUG DELIVER REV, V42, P65
   ROLLWAGEN FM, 1993, J IMMUNOL METHODS, V166, P223, DOI 10.1016/0022-1759(93)90363-C
   Romani N, 1996, J IMMUNOL METHODS, V196, P137, DOI 10.1016/0022-1759(96)00078-6
   Sahoo SK, 2002, J CONTROL RELEASE, V82, P105, DOI 10.1016/S0168-3659(02)00127-X
   SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109
   Shoichet MS, 1996, BIOTECHNOL BIOENG, V50, P374, DOI 10.1002/(SICI)1097-0290(19960520)50:4<374::AID-BIT4>3.0.CO;2-I
   Singh M, 1999, NAT BIOTECHNOL, V17, P1075, DOI 10.1038/15058
   SPARGO BJ, 1994, BIOMATERIALS, V15, P853, DOI 10.1016/0142-9612(94)90042-6
   STARKE JR, 1987, PEDIATR RES, V22, P698, DOI 10.1203/00006450-198712000-00017
   Sun HF, 2003, VACCINE, V21, P849, DOI 10.1016/S0264-410X(02)00531-5
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   van Heeckeren AM, 2000, AM J RESP CRIT CARE, V161, P271, DOI 10.1164/ajrccm.161.1.9903019
   Waeckerle-Men Y, 2004, J IMMUNOL METHODS, V287, P109, DOI 10.1016/j.jim.2004.01.010
   Wake MC, 1998, BIOMATERIALS, V19, P1255
   Walker KB, 1998, DEV BIOL STAND, V92, P259
   Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317
   Yang R, 2002, SCAND J IMMUNOL, V55, P2, DOI 10.1046/j.0300-9475.2001.01033.x
   Yoshida M, 2004, J BIOMED MATER RES A, V71A, P45, DOI 10.1002/jbm.a.30131
   Yoshida M, 2006, J BIOMAT SCI-POLYM E, V17, P893, DOI 10.1163/156856206777996844
   Zeyda M, 2005, J BIOL CHEM, V280, P14293, DOI 10.1074/jbc.M410000200
   ZHOU LJ, 1995, J IMMUNOL, V154, P3821
NR 56
TC 54
Z9 55
U1 0
U2 10
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV
PY 2006
VL 79A
IS 2
BP 393
EP 408
DI 10.1002/jbm.a.30798
PG 16
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 092YB
UT WOS:000241132500019
PM 16886225
DA 2018-10-19
ER

PT J
AU Willenberg, BJ
   Hamazaki, T
   Meng, FW
   Terada, N
   Batich, C
AF Willenberg, Bradley J.
   Hamazaki, Takashi
   Meng, Fan-Wei
   Terada, Naohiro
   Batich, Christopher
TI Self-assembled copper-capillary alginate gel scaffolds with
   oligochitosan support embryonic stem cell growth
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE anisotropic; alginate; biomaterial scaffold; tissue engineering;
   embryonic stem cells
ID POLYMER SCAFFOLDS; IONOTROPIC GELS; SODIUM ALGINATE; SPINAL-CORD;
   ARCHITECTURE; MEMBRANES; CHITOSAN; CONDUIT; COMPLEX
AB Biomaterial scaffolds are fundamental components of strategies aimed at engineering a wide range of tissues. Scaffolds possessing uniform, oriented microtubular architectures could be ideal for multiple tissues, but are challenging to produce. Therefore, we developed hydrogel scaffolds possessing regular, tubular microstructures from self-assembled copper-capillary alginate gel (CCAG). To abrogate the rapid dissolution of CCAG in cell culture media, we treated it with oligochitosan and created a stable oligochitosan-CCAG (OCCAG) polyelectrolyte complex. Fourier transform infrared spectroscopy confirmed polyelectrolyte complexation between alginate and oligochitosan. OCCAG retained capillary morphology, shrank anisotropically in bulk, lost Cu2+ ions, and maintained (71.9 +/- 5.65)% of its mass in cell culture media. Next, we seeded mouse embryonic stem (ES) cells within OCCAG scaffolds, and examined cell morphology and quantified cell growth and viability over four days. ES cells were guided to form cylindrical structures of staggered cells within scaffold capillaries. Analysis of the total cells recovered from the scaffolds revealed exponential cell growth (normalized to day 0) that was statistically similar to gelatinized-plate controls. OCCAG-cultured ES cell viability was also not significantly different from controls at day 4. CCAG-derived scaffolds can therefore serve as a unique platform for stem cell-based tissue engineering. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Florida, Coll Engn, Dept Mat Sci & Engn, Gainesville, FL 32611 USA.
   Univ Florida, Coll Engn, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32611 USA.
   Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32610 USA.
   Univ Florida, Coll Med, Shands Canc Ctr, Gainesville, FL 32610 USA.
RP Batich, C (reprint author), Univ Florida, Coll Engn, Dept Mat Sci & Engn, Gainesville, FL 32611 USA.
EM cbati@mse.ufl.edu
RI Batich, Chris/H-3966-2017
FU NCI NIH HHS [T32 CA09126]
CR Bartkowiak A, 2001, ANN NY ACAD SCI, V944, P120
   BATICH C, 2005, Patent No. 20050196423
   Despang F, 2005, MATERIALWISS WERKST, V36, P761, DOI 10.1002/mawe.200500961
   Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8
   Hadlock T, 1998, ARCH OTOLARYNGOL, V124, P1081, DOI 10.1001/archotol.124.10.1081
   Hadlock T, 2000, TISSUE ENG, V6, P119, DOI 10.1089/107632700320748
   HASSAN RM, 1988, EUR POLYM J, V24, P1173, DOI 10.1016/0014-3057(88)90106-1
   HASSAN RM, 1991, J POLYM SCI POL CHEM, V29, P1645, DOI 10.1002/pola.1991.080291115
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Levenberg S, 2003, P NATL ACAD SCI USA, V100, P12741, DOI 10.1073/pnas.1735463100
   Ma PX, 2004, MATER TODAY, V7, P30, DOI 10.1016/S1369-7021(04)00233-0
   Ma PX, 2001, J BIOMED MATER RES, V56, P469, DOI 10.1002/1097-4636(20010915)56:4<469::AID-JBM1118>3.0.CO;2-H
   Mitrevej A, 2001, PHARM DEV TECHNOL, V6, P385, DOI 10.1081/PDT-100002247
   Prang P, 2006, BIOMATERIALS, V27, P3560, DOI 10.1016/j.biomaterials.2006.01.053
   SCHUBERTH RJ, 1992, THESIS U REGENSBURG
   Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0
   Smitha B, 2005, EUR POLYM J, V41, P1859, DOI 10.1016/j.eurpolymj.2005.02.018
   Sundback C, 2003, BIOMATERIALS, V24, P819, DOI 10.1016/S0142-9612(02)00409-X
   Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899
   Thiele H, 1957, KOLLOID Z, V151, P1
   THIELE H, 1967, THESIS AKAD VERLAGSG, P1
   Thumbs J, 1996, CHEM PHYS, V208, P9, DOI 10.1016/0301-0104(96)00031-6
   Treml H, 2003, CHEM PHYS, V293, P341, DOI 10.1016/S0301-0104(03)00336-7
   Treml H, 2000, CHEM PHYS, V252, P199, DOI 10.1016/S0301-0104(99)00361-4
   Wang LH, 2001, J PHARM SCI-US, V90, P1134, DOI 10.1002/jps.1067
   WILLENBERG BJ, 2005, THESIS U FLORIDA GAI
   Woelki S, 2003, CHEM PHYS, V293, P323, DOI 10.1016/S0301-0104(03)00338-0
   Yeong WY, 2004, TRENDS BIOTECHNOL, V22, P643, DOI 10.1016/j.tibtech.2004.10.004
   Zhang RY, 2000, J BIOMED MATER RES, V52, P430, DOI 10.1002/1097-4636(200011)52:2<430::AID-JBM25>3.0.CO;2-L
   Zmora S, 2002, BIOMATERIALS, V23, P4087, DOI 10.1016/S0142-9612(02)00146-1
NR 30
TC 23
Z9 24
U1 0
U2 18
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD NOV
PY 2006
VL 79A
IS 2
BP 440
EP 450
DI 10.1002/jbm.a.30942
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 092YB
UT WOS:000241132500023
PM 16941595
DA 2018-10-19
ER

PT J
AU Paez, JMG
   Carrera, A
   Jorge, E
   Millan, I
   Cordon, A
   Maestro, MA
   Rocha, A
   Morales, S
   Castillo-Olivares, JL
AF Paez, Jose Maria Garcia
   Carrera, Antonio
   Jorge, Eduardo
   Millan, Isabel
   Cordon, Angeles
   Maestro, Maria A.
   Rocha, Aurora
   Morales, S.
   Castillo-Olivares, Jose Luis
TI Determination of the force necessary for the propagation of tears in
   ostrich and calf pericardium
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE force; tearing; cardiac bioprostheses; calf pericardium; ostrich
   pericardium
ID HEART-VALVE BIOPROSTHESES; BOVINE PERICARDIUM; CALCIFICATION; SELECTION;
   SITES; CUSPS
AB The durability of prosthetic heart valve leaflets made of biological materials is limited. A tear in the biomaterial accelerates their early failure, but microtearing of the collagen fibers may be responsible for their medium-term failure. We studied the force necessary to propagate tearing in two biomaterials: ostrich and calf pericardium. One hundred twenty samples of each tissue were tested in an Elmendorf pendulum capable of measuring the force required to tear a tissue in which a predefined slit had been made. The forces required to produce tears, ranging between 2.5 and 0.25 cm in length, were determined. For ostrich pericardium, this force ranged between 67.67 and 4.80 newton, while that required to tear the same lengths of calf pericardium ranged between 70.67 and 4.70 newton. The function that relates the tearing force to the length of the tear was expressed as follows: y = 20.62x + 1.77x(2) (R-2 = 0.923) for ostrich pericardium and y = 45.57x - 7.21x(2) (R-2 = 0.936) for calf pericardium, where y is the force in newton and x is the length in centimeter. Calf pericardium was found to have a greater resistance to tearing. However, these results should be interpreted with caution owing to the fact that the thickness of the majority of the samples of ostrich pericardium was significantly less than that of calf pericardium. A more careful selection and utilization of adult ostrich pericardium would probably improve these results. (c) 2006 Wiley Periodicals, Inc.
C1 Clin Puerta Hierro, Serv Cirurg Expt, Madrid, Spain.
   Escuela Super Ingn Ind, Dept Mecan Estruct & Resistencia Mat, Madrid, Spain.
   Clin Puerta Hierro, Serv Bioestadist, Madrid, Spain.
RP Paez, JMG (reprint author), Clin Puerta Hierro, Serv Cirurg Expt, Madrid, Spain.
EM jmgpaez@telefonica.net
RI Jorge Herrero, EDUARDO/F-7240-2010
CR Barratt-Boyes BG, 1998, J THORAC CARDIOV SUR, V116, P1005, DOI 10.1016/S0022-5223(98)70053-4
   Braile DM, 1998, J HEART VALVE DIS, V7, P202
   BUTANY J, 2001, J LONG-TERM EFF MED, V1, P115
   Butterfield M, 2001, J HEART VALVE DIS, V10, P105
   Carrera San Martin A, 1998, J Biomed Mater Res, V39, P568
   Ellsmere JC, 1999, BIOMATERIALS, V20, P1143, DOI 10.1016/S0142-9612(99)00013-7
   Fann JI, 1996, ANN THORAC SURG, V62, P1301, DOI 10.1016/0003-4975(96)00629-7
   HARIZA F, 1996, J HEART VALVE DIS, V5, P35
   Hiester ED, 1998, J BIOMED MATER RES, V39, P215, DOI 10.1002/(SICI)1097-4636(199802)39:2<215::AID-JBM7>3.0.CO;2-S
   ISHIHARA T, 1981, AM J CARDIOL, V48, P665, DOI 10.1016/0002-9149(81)90145-4
   KENT PD, 1998, CARDIOVASC PATHOL, V17, P9
   PAEZ JMG, 1990, J THORAC CARDIOV SUR, V100, P580
   Paez JMG, 2004, J BIOMED MATER RES B, V69B, P125, DOI 10.1002/jbm.b.20014
   Paez JMG, 2001, BIOMATERIALS, V22, P2731
   PAEZ JMG, 1994, BIOMATERIALS, V5, P172
   ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806
   SABBAH HN, 1986, ANN THORAC SURG, V42, P93, DOI 10.1016/S0003-4975(10)61845-0
   Sacks M S, 1994, ASAIO J, V40, pM632, DOI 10.1097/00002480-199407000-00075
   Sacks MS, 2002, J BIOMED MATER RES, V62, P359, DOI 10.1002/jbm.10293
   SCHOEN FJ, 1987, CIRCULATION, V76, P618, DOI 10.1161/01.CIR.76.3.618
   Talman EA, 1996, J HEART VALVE DIS, V5, P152
   TIMOSHENKO S, 1970, ESPASA CALPE, V2, P431
   TROWBRIDGE EA, 1989, CRIT REV BIOCOMPAT, V5, P102
   TYERS GFO, 1995, ANN THORAC SURG, V60, pS464
   VONFRAUNHOFER JA, 1992, BIOMATERIALS, V13, P715, DOI 10.1016/0142-9612(92)90133-9
   Vongpatanasin W, 1996, NEW ENGL J MED, V335, P407, DOI 10.1056/NEJM199608083350607
NR 26
TC 1
Z9 1
U1 0
U2 4
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV
PY 2006
VL 79B
IS 2
BP 229
EP 235
DI 10.1002/jbm.b.30533
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 098GK
UT WOS:000241508800004
PM 16637030
DA 2018-10-19
ER

PT J
AU Murugesan, S
   Mousa, S
   Vijayaraghavan, A
   Ajayan, PM
   Linhardt, RJ
AF Murugesan, Saravanababu
   Mousa, Shaker
   Vijayaraghavan, Aravind
   Ajayan, Pulickel M.
   Linhardt, Robert J.
TI Ionic liquid-derived blood-compatible composite membranes for kidney
   dialysis
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE biomaterials; heparin; renal dialysis; ionic liquids; cellulose
ID HEPARIN CONJUGATE; BIOCOMPATIBILITY; ADSORPTION; CELLULOSE; CHITOSAN;
   RELEASE
AB A novel heparin- and cellulose-based biocomposite is fabricated by exploiting the enhanced dissolution of polysaccharides in room temperature ionic liquids (RTILs). This represents the first reported example of using a new class of solvents, RTILs, to fabricate blood-compatible biomaterials. Using this approach, it is possible to fabricate the biomaterials in any form, such as films or membranes, fibers (nanometer- or micron-sized), spheres (nanometer- or micron-sized), or any shape using templates. In this work, we have evaluated a membrane film of this composite. Surface morphological studies on this biocomposite film showed the uniformly distributed presence of heparin throughout the cellulose matrix. Activated partial thromboplastin time and thromboelastography demonstrate that this composite is superior to other existing heparinized biomaterials in preventing clot formation in human blood plasma and in human whole blood. Membranes made of these composites allow the passage of urea while retaining albumin, representing a promising blood-compatible biomaterial for renal dialysis, with a possibility of eliminating the systemic administration of heparin to the patients undergoing renal dialysis. (c) 2006 Wiley Periodicals, Inc.
C1 Rensselaer Polytech Inst, Dept Biol & Chem Engn, Troy, NY 12180 USA.
   Albany Coll Pharm, Pharmaceut Res Inst, Albany, NY 12208 USA.
   Rensselaer Polytech Inst, Dept Mat Sci & Engn, Troy, NY 12180 USA.
   Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA.
RP Linhardt, RJ (reprint author), Rensselaer Polytech Inst, Dept Biol & Chem Engn, Troy, NY 12180 USA.
EM linhar@rpi.edu
RI Vijayaraghavan, Aravind/E-1087-2011
OI Vijayaraghavan, Aravind/0000-0001-8289-2337
FU NHLBI NIH HHS [R01 HL062244-07, R01 HL052622, HL 62244, R01 HL052622-05,
   HL 52622, R01 HL062244]; NIGMS NIH HHS [GM 38060, R01 GM038060]
CR Amass W, 1998, POLYM INT, V47, P89, DOI 10.1002/(SICI)1097-0126(1998100)47:2<89::AID-PI86>3.0.CO;2-F
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   Breiterman-White R, 1995, ANNA J, V22, P491
   Chanard J, 2003, NEPHROL DIAL TRANSPL, V18, P252, DOI 10.1093/ndt/18.2.252
   Denizli A, 1999, J APPL POLYM SCI, V74, P655, DOI 10.1002/(SICI)1097-4628(19991017)74:3<655::AID-APP19>3.0.CO;2-N
   Duncan AC, 2001, EUR POLYM J, V37, P1821, DOI 10.1016/S0014-3057(01)00015-5
   Huang X, 2001, J CONTROL RELEASE, V73, P121, DOI 10.1016/S0168-3659(01)00248-6
   Kang IK, 1996, BIOMATERIALS, V17, P841, DOI 10.1016/0142-9612(96)81422-0
   KEUREN JFW, 2004, ARTERIOSCLER THROMB, P613
   LANGER R, 1982, SCIENCE, V217, P261, DOI 10.1126/science.7089564
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lin WC, 2004, BIOMATERIALS, V25, P1947, DOI 10.1016/j.biomaterials.2003.08.027
   Marconi W, 1997, BIOMATERIALS, V18, P885, DOI 10.1016/S0142-9612(97)00015-X
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   Modi GK, 2001, SEMIN DIALYSIS, V14, P318, DOI 10.1046/j.1525-139X.2001.00078.x
   Monte S, 2004, INT J OBSTET ANESTH, V13, P91, DOI 10.1016/j.ijoa.2003.10.009
   Murugesan S, 2006, CARBOHYD POLYM, V63, P268, DOI 10.1016/j.carbpol.2005.09.022
   Murugesan S, 2005, CURR ORG SYNTH, V2, P437, DOI 10.2174/157017905774322640
   Murugesan S, 2003, SYNLETT, P1283
   Narasimhan B, 1997, J CONTROL RELEASE, V47, P13, DOI 10.1016/S0168-3659(96)01611-2
   O'Shea SI, 2003, SEMIN DIALYSIS, V16, P61, DOI 10.1046/j.1525-139X.2003.03014.x
   Risbud MV, 2001, J BIOMED MATER RES, V54, P436, DOI 10.1002/1097-4636(20010305)54:3<436::AID-JBM180>3.3.CO;2-#
   Rydberg EJ, 1999, AM FAM PHYSICIAN, V59, P1607
   Sanchez J, 1998, THROMB RES, V89, P41, DOI 10.1016/S0049-3848(97)00310-1
   Seddon K. R., 2002, TCE-THE CHEM ENG, V730, P33
   Sheldon R, 2001, CHEM COMMUN, P2399, DOI 10.1039/b107270f
   Shenoy S, 1999, CURR PHARM DESIGN, V5, P965
   SWATLOSKI RP, 2004, J AM CHEM SOC, V8, P4974
   VANCE NG, 2002, ANESTH ANALG, V95, P1503
   Yang MC, 2002, J POLYM RES-TAIWAN, V9, P201, DOI 10.1023/A:1021347810130
NR 30
TC 23
Z9 25
U1 2
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV
PY 2006
VL 79B
IS 2
BP 298
EP 304
DI 10.1002/jbm.b.30542
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 098GK
UT WOS:000241508800013
PM 16637031
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Rondelli, G
   Torricelli, P
   Fini, M
   Rimondini, L
   Giardino, R
AF Rondelli, G.
   Torricelli, P.
   Fini, M.
   Rimondini, L.
   Giardino, R.
TI In vitro corrosion study by EIS of an equiatomic NiTi alloy and an
   implant quality AISI 316 stainless steel
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE shape memory alloy; stainless steel; corrosion; in vitro test;
   electrochemistry
ID ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; NICKEL; BIOMATERIAL; TITANIUM
AB The electrochemical impedance spectroscopy (EIS) technique was used for the study of the electrochemical behavior of an equiatomic NiTi alloy and an implant quality AISI 316 stainless steel type ASTM F138. Experiments were carried out using four different different test solutions: phosphate buffered saline (PBS), Dulbecco minimum essential medium (MEM), MEM + fetal calf serum (FCS), and MEM + fetal calf serum + fibroblast cell (CELL). Specimens were finished to 600-grit SiC paper and were tested in conditions that did not provoke abrupt mechanical damage of the passive film. Bode-phase spectra showed the presence of two maxima and were fitted with an equivalent circuit characterized by two parallel combinations (R, resistance; CPE, constant phase element). The R, and CPE, branch was assigned to the inner compact passive film and the R, and CPE, branch to the external porous film. The resistance of the inner film R, roughly corresponding to the polarization resistance (R-P), which is inversely proportional to the material's corrosion rate, increased with the immersion time and was generally greater in PBS than in other media. With the exception of FCS solution, R, for NiTi alloy is better or similar to that of ASTM F138. (c) 2006 Wiley Periodicals, Inc.
C1 Rizzoli Orthopaed Inst, Res Inst Codivilla Putti, Dept Expt Surg, Bologna, Italy.
   CNR, IENI, Milan, Italy.
RP Rondelli, G (reprint author), CNR, IENI, Milan, Italy.
EM rondelli@ieni.cnr.it
RI TORRICELLI, PAOLA/J-5298-2016; Fini, Milena/J-4808-2016
OI TORRICELLI, PAOLA/0000-0001-7494-9970; Fini, Milena/0000-0002-3732-3570
CR *ASTM, 1984, ANN BOOK ASTM STAND, P32
   CLAYTON CR, 1995, CORROSION MECH THEOR, P175
   Contu F, 2002, J BIOMED MATER RES, V62, P412, DOI 10.1002/jbm.10329
   Disegi J A, 2000, Injury, V31 Suppl 4, P2
   Es-Souni M, 2005, ANAL BIOANAL CHEM, V381, P557, DOI 10.1007/s00216-004-2888-3
   Hiromoto S, 2002, CORROS SCI, V44, P955, DOI 10.1016/S0010-938X(01)00110-X
   Kanerva L, 2001, CONTACT DERMATITIS, V44, P103, DOI 10.1034/j.1600-0536.2001.4402096.x
   KOCIJAN A, 2003, J MATER SCI-MATER M, V14, P68
   KOVACS P, 1992, NAT ASS CORR ENG NAC
   Pan J, 1996, ELECTROCHIM ACTA, V41, P1143, DOI 10.1016/0013-4686(95)00465-3
   Pan J, 1997, J BIOMED MATER RES, V35, P309, DOI 10.1002/(SICI)1097-4636(19970605)35:3<309::AID-JBM5>3.3.CO;2-N
   Rondelli G, 2005, BIOMATERIALS, V26, P739, DOI 10.1016/j.biomaterials.2004.03.012
   Shabalovskaya SA, 2001, INT MATER REV, V46, P233, DOI 10.1179/095066001771048745
   Souto RM, 2000, CORROS SCI, V42, P2201, DOI 10.1016/S0010-938X(00)00057-3
   TORGERSEN S, 1993, INT J ORAL MAX SURG, V22, P246, DOI 10.1016/S0901-5027(05)80647-2
   YEUM B, 2002, ZSIMPWIN 3 10
NR 16
TC 20
Z9 23
U1 2
U2 11
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV
PY 2006
VL 79B
IS 2
BP 320
EP 324
DI 10.1002/jbm.b.30545
PG 5
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 098GK
UT WOS:000241508800016
PM 16850480
DA 2018-10-19
ER

PT J
AU McLemore, R
   Preul, MC
   Vernon, BL
AF McLemore, Ryan
   Preul, Mark C.
   Vernon, Brent L.
TI Controlling delivery properties of a waterborne, in-situ-forming
   biomaterial
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE in situ polymer; embolization; arteriovenous malformation; endovascular
   technique
ID ARTERIOVENOUS-MALFORMATION; DRUG-DELIVERY; EMBOLIZATION; COPOLYMER;
   ALGINATE; SYSTEMS; MODEL; BIOCOMPATIBILITY; GELATION; SWINE
AB This study details efforts to transition an in-situ-gelling polymer for endovascular embolization from the bench-top to preclinical cerebral arteriovenous malformation animal model studies. The in-situ-forming gel is based on waterborne, reverse emulsion materials. For controlled embolization of vascular defects, it is crucial to understand the delivery properties of an in-situ-forming gel. Directing a liquid into a small cavity requires both precise control of the fluid flow, and depends upon minimal variability in the materials behavior. A 2 3 factorial experiment performed in the laboratory revealed that temperature, mixing time, and buffer strength are all significant factors affecting the gelation time of the specific system studied. All three factors were also seen to reduce the standard deviation on the gel times. Changing the temperature from 21.3 to 37.0 degrees C reduced the cross population variability from 6.0 +/- 3.3 min to 3.4 +/- 1.6 min. At 30-s premixing, the protocol produced an average gel time of 5.3 +/- 3.0 min, which was reduced to 3.3 +/- 1.2 min with 90 s. Finally, a 50 MM buffer solution provided a gel time of 6.5 +/- 3.2 min, which was reduced to 2.95 +/- 0.6 min at 100 mM. Viscosity data was analyzed to suggest a model for injection volume and viscosity. (c) 2006 Wiley Periodicals, Inc.
C1 Arizona State Univ, Harrington Dept Bioengn, Tempe, AZ 85287 USA.
   St Josephs Hosp, Barrow Neurol Inst, Div Neurol Surg, Neurosurg Res Lab, Phoenix, AZ USA.
RP Vernon, BL (reprint author), Arizona State Univ, Harrington Dept Bioengn, Tempe, AZ 85287 USA.
EM brent.vernon@asu.edu
RI Vernon, Brent/F-2859-2010
CR Akin ED, 2003, J NEUROSURG, V98, P366, DOI 10.3171/jns.2003.98.2.0366
   Alexandre E, 2004, MACROMOL BIOSCI, V4, P639, DOI 10.1002/mabi.200400034
   Andrews GP, 2005, BIOMATERIALS, V26, P571, DOI 10.1016/j.biomaterials.2004.02.062
   BAKKER D, 1990, J BIOMED MATER RES, V24, P489, DOI 10.1002/jbm.820240407
   Becker TA, 2002, NEUROSURGERY, V51, P453, DOI 10.1227/01.NEU.0000020083.33150.81
   Birdno M, 2005, ANN BIOMED ENG, V33, P191, DOI 10.1007/s10439-005-8977-4
   Bu HT, 2004, BIOMACROMOLECULES, V5, P1470, DOI 10.1021/bm049947+
   Emerich DF, 2000, PHARMACEUT RES, V17, P767, DOI 10.1023/A:1007576405039
   GEORGE J, 1996, STROKE, V27, P1072
   Gutowska A, 2001, ANAT RECORD, V263, P342, DOI 10.1002/ar.1115
   Hatefi A, 2002, J CONTROL RELEASE, V80, P9, DOI 10.1016/S0168-3659(02)00008-1
   He SL, 2000, BIOMATERIALS, V21, P2389, DOI 10.1016/S0142-9612(00)00106-X
   Jeong B, 2000, J BIOMED MATER RES, V50, P171, DOI 10.1002/(SICI)1097-4636(200005)50:2<171::AID-JBM11>3.0.CO;2-F
   Jeong B, 1997, NATURE, V388, P860, DOI 10.1038/42218
   Jones DS, 2003, J PHARM SCI, V92, P995, DOI 10.1002/jps.10357
   Lin HR, 2004, BIOMACROMOLECULES, V5, P2358, DOI 10.1021/bm0496965
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.10.092, 10.1016/j.biomaterials.2003.08.014]
   Montgomery D. C., 2001, DESIGN ANAL ENG EXPT
   *NIH NAT I NEUR DI, 2000, ART MALF OTH VASC LE, P23
   Norrie B, 2004, ADV EXP MED BIOL, V553, P19
   Sims CD, 1996, PLAST RECONSTR SURG, V98, P843, DOI 10.1097/00006534-199610000-00015
   Soga Y, 2004, NEUROSURGERY, V55, P1401, DOI 10.1227/01.NEU.0000143616.22174.67
   Temenoff JS, 2000, BIOMATERIALS, V21, P2405, DOI 10.1016/S0142-9612(00)00108-3
   Vernon B, 2003, J BIOMED MATER RES A, V64A, P447, DOI 10.1002/jbm.a.10369
   Yu SCH, 2004, AM J NEURORADIOL, V25, P1139
NR 25
TC 13
Z9 13
U1 0
U2 3
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV
PY 2006
VL 79B
IS 2
BP 398
EP 410
DI 10.1002/jbm.b.30554
PG 13
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 098GK
UT WOS:000241508800025
PM 16649173
DA 2018-10-19
ER

PT J
AU Wang, HJ
   Liu, XM
   Ji, LW
   Ma, DL
   Ren, QS
   Wang, JY
AF Wang, Hua-Jie
   Liu, Xin-Ming
   Ji, Li-Wen
   Ma, Dong-Lan
   Ren, Qiushi
   Wang, Jin-Ye
TI Film from peroxidation of an amino phospholipid and its biocompatibility
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE biocompatibility; endothelial cell; fluorescence; oxidation;
   phospholipid; scanning electron microscope
ID HUMAN ENDOTHELIAL-CELLS; PROTEIN ADSORPTION; PLATELET-ADHESION;
   PHOSPHORYLCHOLINE POLYMER; SEGMENTED POLYURETHANE; FIBRINOGEN
   ADSORPTION; BLOOD COMPATIBILITY; SURFACE; GROWTH; HEMOCOMPATIBILITY
AB A new kind of phospholipid product with fluorescence was derived from autoxidation of an aminophospholipid, L-a-phosphatidylethanolamine dilinolcoyl in solid film state. Atomic force microscopy showed that the film product was composed of round and elliptical vesicles with diameters of about 20-45 nm. The product was difficult to dissolve in water and most organic solvents. Fourier transform infrared spectroscopy, solid-state C-13 NMR, and solid-state P-31 NMR indicated that the unsaturated double carbon bond decreased with the reaction, and polymerization within/between phospholipid molecules occurred. Endothelial cells from human vein seeded onto the film showed the highest proliferating activity compared with seeding onto Corning culture plate, glass plate, or phospholipid film with phosphoryl-choline head group, as evaluated by 3-(4,5-timethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide assay (p < 0.001). The hemocompatibility of the film was also assessed by platelet adhesion and protein adsorption. The results suggest that the product has potential applications as a new biomaterial coating. (c) 2006 Wiley Periodicals, Inc.
C1 Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China.
   Chinese Acad Sci, Shanghai Inst Organ Chem, Shanghai 200032, Peoples R China.
   Henan Normal Univ, Dept Chem, Henan 453002, Peoples R China.
RP Ren, QS (reprint author), Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, 800 Dong Chuan Rd, Shanghai 200240, Peoples R China.
EM renqsh@sjtu.edu.cn; jywang@mail.sioc.ac.cn
RI Ren, Qiushi/D-1451-2012; Wang, Jin-Ye/H-1450-2011
CR Abraham GA, 2002, BIOMATERIALS, V23, P1625, DOI 10.1016/S0142-9612(01)00289-7
   ASAHARA T, 1995, CIRCULATION, V91, P2793, DOI 10.1161/01.CIR.91.11.2793
   BELLAVITE P, 1994, ANAL BIOCHEM, V216, P444, DOI 10.1006/abio.1994.1066
   Chung TW, 2003, BIOMATERIALS, V24, P4655, DOI 10.1016/S0142-9612(03)00361-1
   FISCHMAN DL, 1994, NEW ENGL J MED, V331, P496, DOI 10.1056/NEJM199408253310802
   Garguilo JM, 2004, DIAM RELAT MATER, V13, P595, DOI 10.1016/j.diamond.2003.10.008
   Gessner A, 2002, EUR J PHARM BIOPHARM, V54, P165, DOI 10.1016/S0939-6411(02)00081-4
   HAYWARD JA, 1984, BIOMATERIALS, V5, P135, DOI 10.1016/0142-9612(84)90047-4
   HEIDEN AP, 1997, J BIOMED MATER RES, V37, P282
   HERRING M, 1978, SURGERY, V84, P498
   Hwang JJ, 2002, P NATL ACAD SCI USA, V99, P9662, DOI 10.1073/pnas.152667399
   Imbert E, 1998, BIOMATERIALS, V19, P2285, DOI 10.1016/S0142-9612(98)00137-9
   Ishihara K, 1999, J BIOMAT SCI-POLYM E, V10, P1047, DOI 10.1163/156856299X00676
   Ishihara K, 1999, BIOMATERIALS, V20, P1553, DOI 10.1016/S0142-9612(98)00206-3
   Iwasaki Y, 2003, BIOMATERIALS, V24, P3599, DOI 10.1016/S0142-9612(03)00212-6
   Kohler AS, 1996, J BIOMED MATER RES, V32, P237, DOI 10.1002/(SICI)1097-4636(199610)32:2<237::AID-JBM13>3.0.CO;2-G
   Konno T, 2001, BIOMATERIALS, V22, P1883, DOI 10.1016/S0142-9612(00)00373-2
   Lee JH, 2000, J COLLOID INTERF SCI, V230, P84, DOI 10.1006/jcis.2000.7080
   Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X
   Morimoto N, 2002, BIOMATERIALS, V23, P4881, DOI 10.1016/S0142-9612(02)00246-6
   Riedel M, 2001, BIOMATERIALS, V22, P2307, DOI 10.1016/S0142-9612(01)00011-4
   SIEGEL DP, 1987, CELL FUSION, P181
   Sklodowaka A., 1999, BIOL P ONLINE, V1, P114, DOI DOI 10.1251/BP014.PMID:12734596
   Sun SD, 2003, J MEMBRANE SCI, V222, P3, DOI 10.1016/S0376-7388(03)00313-2
   Tanaka M, 2000, BIOMATERIALS, V21, P1471, DOI 10.1016/S0142-9612(00)00031-4
   Tangpasuthadol V, 2003, CARBOHYD RES, V338, P937, DOI 10.1016/S0008-6215(03)00038-7
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871
   van Kooten TG, 2004, BIOMATERIALS, V25, P1735, DOI 10.1016/j.biomaterials.2003.08.071
   VANWACHEM PB, 1986, THROMB HAEMOSTASIS, V56, P189
   Wang HJ, 2005, J CONTROL RELEASE, V105, P120, DOI 10.1016/j.jconrel.2005.03.014
   WANG JY, 1995, BBA-BIOMEMBRANES, V1236, P228, DOI 10.1016/0005-2736(95)00052-5
   XU JP, 2004, EUR POLYM J, V20, P291
   Yoneyama T, 2002, BIOMATERIALS, V23, P1455, DOI 10.1016/S0142-9612(01)00268-X
   Zhu YB, 2004, COLLOID SURFACE B, V36, P49, DOI 10.1016/j.colsurfb.2004.04.008
NR 35
TC 8
Z9 8
U1 1
U2 3
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD NOV
PY 2006
VL 79B
IS 2
BP 411
EP 419
DI 10.1002/jbm.b.30555
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 098GK
UT WOS:000241508800026
PM 16649174
DA 2018-10-19
ER

PT J
AU Veillette, CJH
   Mehdian, H
   Schemitsch, EH
   McKee, MD
AF Veillette, Christian J. H.
   Mehdian, Hossein
   Schemitsch, Emil H.
   McKee, Michael D.
TI Survivorship analysis and radiographic outcome following tantalum rod
   insertion for osteonecrosis of the femoral head
SO JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME
LA English
DT Article; Proceedings Paper
CT 13th International Symposium on Bone Circulation
CY SEP 15-17, 2005
CL Imperial Coll, London, ENGLAND
SP Assoc Res Circulat Osseous
HO Imperial Coll
ID SYSTEMIC-LUPUS-ERYTHEMATOSUS; DONOR-SITE MORBIDITY; CORE DECOMPRESSION;
   AVASCULAR NECROSIS; MANAGEMENT; BIOMATERIAL; GRAFTS; HIPS
AB Background: For early stages of osteonecrosis, preservation of the femoral head is the primary objective; however, there has not been a consensus on how best to achieve this goal. Core decompression alone is associated with a lack of structural support with inconsistent outcomes, whereas vascularized fibular grafting requires an extensive surgical procedure with high donor-site morbidity and prolonged rehabilitation. The adjunctive use of a porous tantalum implant offers the advantages of core decompression, structural support, minimally invasive surgery, and no donor-site morbidity. The purpose of this study was to assess the survivorship and to evaluate the clinical results and radiographic outcomes of hips in which osteonecrosis of the femoral head was treated with core decompression and a porous tantalum implant.
   Methods: We evaluated fifty-four patients (sixty consecutive hips) in whom osteonecrosis of the femoral head was treated with core decompression and insertion of a porous tantalum implant. Fifty-two patients (fifty-eight hips) were available for follow-up at a mean of twenty-four months. All patients were sixty-five years of age or younger (mean age, thirty-five years). According to the classification system of Steinberg et al., one hip (2%) had staged disease, forty-nine hips (84%) had stage-II disease, and eight hips (14%) had stage-III disease. Outcome measures that were used included a limb-specific score (Harris hip score), -radiographic outcome measures, and survivorship analysis with revision to total hip arthroplasty as the end point.
   Results: Overall, nine hips (15.5%) were converted to total hip arthroplasty, including six with stage-II disease and three with stage-III disease. The overall survival rates were 91.8% (95% confidence interval, 87.8% to 95.8%) at twelve months, 81.7% (95% confidence interval, 75.8% to 87.6%) at twenty-four months, and 68.1% (95% confidence interval, 54.7% to 81.5%) at forty-eight months. The absence of chronic systemic diseases resulted in a survival rate of 92% at forty-eight months (95% confidence interval, 87.4% to 96.4%).
   Conclusions: Treatment of early stage osteonecrosis of the femoral head with core decompression and a porous tantalum implant can be accomplished with a minimally invasive technique and no donor-site morbidity. The early clinical results show encouraging survival rates in patients who do not have chronic systemic disease, especially in association with early stage disease.
   Level of Evidence: Therapeutic Level IV. See Instructions to Authors on jbjs.org for a complete description of levels of evidence.
C1 Univ Toronto, St Michaels Hosp, Dept Surg, Div Orthopaed Surg, Toronto, ON M5C 1R6, Canada.
RP McKee, MD (reprint author), Univ Toronto, St Michaels Hosp, Dept Surg, Div Orthopaed Surg, 55 Queen St E,Suite 800, Toronto, ON M5C 1R6, Canada.
EM mckeem@smh.toronto.on.ca
CR Aaron RK, 1998, ADULT HIP, P451
   Aldridge J Mack 3rd, 2004, Am J Orthop (Belle Mead NJ), V33, P327
   Allison GT, 2003, AIDS, V17, P1, DOI 10.1097/01.aids.0000042940.55529.93
   Aluisio FV, 1998, CLIN ORTHOP RELAT R, P192
   Berend KR, 2003, J BONE JOINT SURG AM, V85A, P987, DOI 10.2106/00004623-200306000-00001
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   BOZIC KJ, 1999, J BONE JOINT SURG AM, V81, P209
   Colwell CW, 1996, ORTHOPEDICS, V19, P941
   Cornell CN, 1998, CLIN ORTHOP RELAT R, pS267
   FAIRBANK AC, 1995, J BONE JOINT SURG BR, V77B, P42
   Garberina MJ, 2004, ORTHOP CLIN N AM, V35, P353, DOI 10.1016/j.ocl.2004.04.002
   KALLA AA, 1986, ANN RHEUM DIS, V45, P649, DOI 10.1136/ard.45.8.649
   KOO KH, 1995, J BONE JOINT SURG BR, V77B, P870
   Lieberman Jay R, 2003, Instr Course Lect, V52, P337
   Louie BE, 1999, CAN J SURG, V42, P274
   Mont MA, 1998, J BONE JOINT SURG BR, V80B, P56, DOI 10.1302/0301-620X.80B1.7989
   Mont MA, 1997, J RHEUMATOL, V24, P654
   Mont MA, 2000, RHEUM DIS CLIN N AM, V26, P279, DOI 10.1016/S0889-857X(05)70139-3
   Mont MA, 1997, CLIN ORTHOP RELAT R, P91
   Mont MA, 1996, CLIN ORTHOP RELAT R, P169
   ROSENWASSER MP, 1994, CLIN ORTHOP RELAT R, P17
   SCHEMITSCH EH, 1996, P CAN ORTH ASS M 199
   Scully SP, 1998, J BONE JOINT SURG AM, V80A, P1270, DOI 10.2106/00004623-199809000-00004
   SMITH SW, 1995, J BONE JOINT SURG AM, V77A, P674, DOI 10.2106/00004623-199505000-00003
   Steinberg M E, 1999, Acta Orthop Belg, V65 Suppl 1, P45
   Steinberg M E, 1995, Can J Surg, V38 Suppl 1, pS18
   Steinberg ME, 2001, CLIN ORTHOP RELAT R, P71
   STEINBERG ME, 1994, AAOS INSTR COURS LEC, V43, P513
   STEINBERG ME, 1995, J BONE JOINT SURG BR, V77B, P34
   Steinberg ME, 2004, ORTHOP CLIN N AM, V35, P273, DOI 10.1016/j.ocl.2004.02.005
   STULBERG BN, 1991, CLIN ORTHOP RELAT R, P140
   Tang CL, 1998, MICROSURG, V18, P383, DOI 10.1002/(SICI)1098-2752(1998)18:6<383::AID-MICR8>3.0.CO;2-5
   Tanzer M, 2005, CLIN ORTHOP RELAT R, P30, DOI 10.1097/01.blo.0000194728.62996.2d
   Tsao AK, 2005, J BONE JOINT SURG AM, V87A, P22, DOI 10.2106/JBJS.E.00490
   URBANIAK JR, 1995, J BONE JOINT SURG AM, V77A, P681, DOI 10.2106/00004623-199505000-00004
   Vail TP, 1996, J BONE JOINT SURG AM, V78A, P204, DOI 10.2106/00004623-199602000-00006
NR 37
TC 71
Z9 95
U1 1
U2 9
PU JOURNAL BONE JOINT SURGERY INC
PI NEEDHAM
PA 20 PICKERING ST, NEEDHAM, MA 02192 USA
SN 0021-9355
J9 J BONE JOINT SURG AM
JI J. Bone Joint Surg.-Am. Vol.
PD NOV
PY 2006
VL 88A
SU 3
BP 48
EP 55
DI 10.2106/JBJS.F.00538
PG 8
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 102XX
UT WOS:000241848000008
PM 17079367
DA 2018-10-19
ER

PT J
AU Fathima, NN
   Bose, MC
   Rao, JR
   Nair, BU
AF Fathima, Nishtar Nishad
   Bose, Murugan Chandra
   Rao, Jonnalagadda Raghava
   Nair, Balachandran Unni
TI Stabilization of type I collagen against collagenases (type I) and
   thermal degradation using iron complex
SO JOURNAL OF INORGANIC BIOCHEMISTRY
LA English
DT Article
DE iron complex; rat tail tendon; collagen; collagenase; circular
   dichroism; differential scanning calorimetry
ID RAT TAIL TENDON; DIMENSIONAL STABILITY; BETA-CAROTENE; FIBER; SKIN;
   HYDROXYPROLINE; TISSUE
AB The widespread application of collagen as a biomaterial warrants research in understanding the stabilization of the same. In this study, interaction of iron-tetrakis (hydroxymethyl) phosphonium (THP) complex with type I collagen has been investigated. DSC and hydrothermal measurement studies reveal that the shrinkage temperature of iron THP treated rat tail tendon (RTT) collagen is 33 degrees C higher than that of native RTT collagen. Fe-THP complex also brings about high degree of enzymatic stability to type I collagen. The effect of Fe THP on the conformation of collagen was studied using circular dichroism and it was found that no major alterations in the triple helical structure of collagen occur on treatment with Fe-THP. It is observed from viscosity experiment results that though Fe-THP complex is able to bring about long range ordering of collagen, as evident from the thermal and enzymatic stability imparted to collagen, this ordering does not lead to any aggregation of collagen. Since THPS is reducing in nature, it is expected to keep iron in the +2 state and if THP chelates to Fe(II), the hydrolytic behavior of iron can also be controlled. (c) 2006 Elsevier Inc. All rights reserved.
C1 Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
RP Rao, JR (reprint author), Cent Leather Res Inst, Chem Lab, Madras 600020, Tamil Nadu, India.
EM clrichem@mailcity.com; bcunchem@rediffmail.com
RI Rao, Jonnalagadda/B-8486-2009; Fathima, Nishad/B-7919-2009; Nair,
   Balachandran/D-1508-2010
CR Boccafoschi F, 2005, BIOMATERIALS, V26, P7410, DOI 10.1016/j.biomaterials.2005.05.052
   Borasky R., 1949, J AM LEATHER CHEM AS, V44, P830
   Brodsky B, 1997, MATRIX BIOL, V15, P545, DOI 10.1016/S0945-053X(97)90030-5
   CHANDRAKASAN G, 1976, J BIOL CHEM, V251, P6062
   Eglin D, 2005, BIO-MED MATER ENG, V15, P43
   Fassbach M, 2005, Z KARDIOL, V94, P328, DOI 10.1007/s00392-005-0214-5
   Fathima NN, 2004, INT J BIOL MACROMOL, V34, P241, DOI 10.1016/j.ijbiomac.2004.05.004
   Fathima NN, 2003, J INORG BIOCHEM, V95, P47, DOI 10.1016/S0162-0134(03)00071-0
   Fathima NN, 2002, BIOMACROMOLECULES, V3, P899, DOI 10.1021/bm025541q
   FLANDIN F, 1984, BIOCHIM BIOPHYS ACTA, V791, P205, DOI 10.1016/0167-4838(84)90010-4
   Gaidau C, 1998, J SOC LEATH TECH CH, V82, P143
   Gayatri R, 1999, P INDIAN AS-CHEM SCI, V111, P133
   HORMANN H, 1974, MET IONS BIOL SYST, V3, P90
   Kaminska A, 1999, POLYM DEGRAD STABIL, V65, P87, DOI 10.1016/S0141-3910(98)00221-3
   KASTELIC J, 1980, MECHANICAL PROPERTIE, P397
   KOPP J, 1990, MATRIX, V9, P443, DOI 10.1016/S0934-8832(11)80013-2
   LECROISEY A, 1979, BIOCHEM J, V179, P53, DOI 10.1042/bj1790053
   Madhan B, 2005, INT J BIOL MACROMOL, V37, P47, DOI 10.1016/j.ijbiomac.2005.08.005
   NIMNI ME, 1988, COLLAGEN, V1, P1
   Persikov AV, 2003, J AM CHEM SOC, V125, P11500, DOI 10.1021/ja036673+
   RAMACHANDRA GN, 1967, TREATISE COLLAGEN
   RYAN JN, 1971, BIOCHEM BIOPH RES CO, V44, P144, DOI 10.1016/S0006-291X(71)80170-5
   Shrivastava HY, 2001, BIOCHEM BIOPH RES CO, V285, P915, DOI 10.1006/bbrc.2001.5258
   Sionkowska A, 1999, INT J BIOL MACROMOL, V24, P337, DOI 10.1016/S0141-8130(99)00047-1
   Sionkowska A, 2004, SURF SCI, V566, P608, DOI 10.1016/j.susc.2004.05.114
   Sionkowska A, 1999, J PHOTOCH PHOTOBIO A, V120, P207, DOI 10.1016/S1010-6030(98)00427-4
   Sreeram KJ, 2004, BBA-GEN SUBJECTS, V1670, P121, DOI 10.1016/j.bbagen.2003.11.001
   TAKAHASHI S, 1987, BIOCHEM J, V241, P49, DOI 10.1042/bj2410049
   Usha R, 2002, J APPL POLYM SCI, V84, P975, DOI 10.1002/app.10262
   Usha R, 2000, J APPL POLYM SCI, V75, P1577
   Usha R, 2000, THERMOCHIM ACTA, V356, P59, DOI 10.1016/S0040-6031(00)00518-9
   VATER CA, 1979, BIOCHEM J, V181, P639, DOI 10.1042/bj1810639
   WOESSNER JF, 1961, ARCH BIOCHEM BIOPHYS, V93, P440, DOI 10.1016/0003-9861(61)90291-0
NR 33
TC 43
Z9 46
U1 1
U2 20
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0162-0134
EI 1873-3344
J9 J INORG BIOCHEM
JI J. Inorg. Biochem.
PD NOV
PY 2006
VL 100
IS 11
BP 1774
EP 1780
DI 10.1016/j.jinorgbio.2006.06.014
PG 7
WC Biochemistry & Molecular Biology; Chemistry, Inorganic & Nuclear
SC Biochemistry & Molecular Biology; Chemistry
GA 108YJ
UT WOS:000242274800008
PM 16908069
DA 2018-10-19
ER

PT J
AU Holand, W
   Rheinberger, V
   Apel, E
   van't Hoen, C
   Hoeland, M
   Dommann, A
   Obrecht, M
   Mauth, C
   Graf-Husner, U
AF Hoeland, Wolfram
   Rheinberger, Volker
   Apel, Elke
   van't Hoen, Christian
   Hoeland, Marlies
   Dommann, Alex
   Obrecht, Marcel
   Mauth, Corinna
   Graf-Husner, Ursula
TI Clinical applications of glass-ceramics in dentistry
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article; Proceedings Paper
CT 1985 ANNUAL CONVENTION OF THE AMERICAN PSYCHOLOGICAL ASSOC
CY 1985
CL LOS ANGELES, CA
SP AMER PSYCHOL ASSOC
ID RHENANITE; LEUCITE
AB Glass-ceramics featuring special properties can be used as a basis to develop biomaterials. It is generally differentiated between highly durable biomaterials for restorative dental applications and bioactive glass-ceramics for medical use, for example, bone replacements. In detail, this paper presents one biomaterial from each of these two groups of materials.
   In respect to the restorative dental biomaterials, the authors give an overview of the most important glass-ceramics for clinical applications. Leucite, leucite-apatite, lithium disilicate and apatite containing glass-ceramics represent biomaterials for these applications. In detail, the authors report on nucleation and crystallization mechanisms and properties of leucite-apatite glass-ceramics. The mechanism of apatite nucleation is characterized by a heterogeneous process. Primary crystal phases of alpha - and beta -NaCaPO4 were determined.
   Rhenanite glass-ceramics represent biomaterials with high surface reactivity in simulated body fluid, SBF, and exhibit reactive behaviour in tests with bone cells. Cell adhesion phenomena and cell growth were observed. Suitable colonization and proliferation and differentiation of cells as a preliminary stage in the development of a material for bone regeneration applications was established. The authors conclude that the processes of heterogeneous nucleation and crystallization are important for controlling the required reactions in both biomaterial groups.
C1 Ivoclar Vivadent AG, Schaan, Liechtenstein.
   Univ Appl Sci & Technol, Buchs, Switzerland.
   Zurcher Hsch Winterthur, Winterthur, Switzerland.
RP Holand, W (reprint author), Ivoclar Vivadent AG, Schaan, Liechtenstein.
EM wolfram.hoeland@ivoclarvivadent.com
CR ANDO J, 1968, B CHEM SOC JPN, V41, P342, DOI 10.1246/bcsj.41.342
   Apel E, 2004, GLASS SCI TECHNOL, V77, P199
   BARR L, 1989, CRIT REV NEUROBIOL, V4, P325
   Busch S, 2001, CHEM MATER, V13, P3260, DOI 10.1021/cm0110728
   EDELHOFF D, 1999, QUINTESSENZ, V50, P177
   ELLIOT JC, 1994, STUDIES INORGANIC CH, V18, P64
   GROSSMAN DG, 1991, INTERNATIONAL SYMPOSIUM ON COMPUTER RESTORATIONS, P103
   HATTAR S, 2002, EUR CELL MAT, V31, P61
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Holand M, 2005, GLASS SCI TECHNOL, V78, P153
   Holand W, 2004, GLASS SCI TECHNOL, V77, P114
   HOLAND W, 1995, J NON-CRYST SOLIDS, V180, P292, DOI 10.1016/0022-3093(94)00464-1
   Holand W, 2002, GLASS CERAMIC TECHNO
   Juhasz JA, 2003, J MATER SCI-MATER M, V14, P489, DOI 10.1023/A:1023499728588
   Kasuga T, 2004, T MAT RES SOC JAPAN, V29, P2933
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   KREJCI I, 1993, J PROSTHET DENT, V69, P425, DOI 10.1016/0022-3913(93)90192-Q
   MCLEAN JW, 1972, DENT MATER, P77
   OBRIAN WJ, 1978, OUTLINE DENT MAT THE, P180
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   RAMSELAAR MMA, 1993, J MATER SCI-MATER M, V4, P311, DOI 10.1007/BF00122287
   RHEINBERGER V, 2005, ZAHNARZT WOCHE DZW, V37, P14
   Sorensen JA, 1999, QUINTESSENCE DENT TE, V22, P153
   SORENSEN JA, 1998, QUNIT DENT TECHNOL, V21, P81
   Suchanek W, 1998, J EUR CERAM SOC, V18, P1923, DOI 10.1016/S0955-2219(98)00131-9
   van't Hoen C, 2004, GLASS SCI TECHNOL, V77, P382
   Wohlwend A, 1990, QUINTESSENZ ZAHNTECH, V16, P966
NR 29
TC 75
Z9 79
U1 0
U2 37
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2006
VL 17
IS 11
BP 1037
EP 1042
DI 10.1007/s10856-006-0441-y
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 109GM
UT WOS:000242295900012
PM 17122916
DA 2018-10-19
ER

PT J
AU Brovarone, CV
   Verne, E
   Appendino, P
AF Brovarone, C. Vitale
   Verne, E.
   Appendino, P.
TI Macroporous bioactive glass-ceramic scaffolds for tissue engineering
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
CT 1985 ANNUAL CONVENTION OF THE AMERICAN PSYCHOLOGICAL ASSOC
CY 1985
CL LOS ANGELES, CA
SP AMER PSYCHOL ASSOC
ID IN-VIVO EVALUATION; CREST BONE-GRAFT; POROUS HYDROXYAPATITE;
   MECHANICAL-PROPERTIES; STARCH CONSOLIDATION; PORE-SIZE; INGROWTH;
   SURFACE; FOAMS; PROLIFERATION
AB Highly bioactive scaffolds for tissue engineering were synthesized using a glass belonging to the SiO(2)-CaO-K(2)O (SCK) system. The glass SCK was prepared by a traditional melting-quenching route and its bioactivity was assessed by in vitro tests in a simulated body fluid (SBF). The glass was ground and sieved to obtain powders of specific size that were subsequently mixed with polyethylene particles of two different dimensions. The powders were then uniaxially pressed to obtain a crack free green compact that was thermally treated to remove the organic component and to sinter the inorganic phase. The obtained biomaterial was characterised by means of X-ray Diffraction, SEM equipped with EDS, mercury intrusion porosimetry, density measurements, image analysis, mechanical tests and in vitro evaluations. A glass-ceramic macroporous scaffold with a homogenously distributed and highly interconnected porosity was obtained. The amount and size of the introduced porosity could be tailored using various amounts of polyethylene powders of different size.
C1 Politecn Torino, Dept Mat Sci & Chem Engn, I-10129 Turin, Italy.
RP Verne, E (reprint author), Politecn Torino, Dept Mat Sci & Chem Engn, Cso Duca Abruzzi 24, I-10129 Turin, Italy.
EM enrica.verne@polito.it
RI Vitale Brovarone, Chiara/G-9630-2012
OI Vitale Brovarone, Chiara/0000-0003-2413-5594; Verne,
   Enrica/0000-0002-8649-4739
CR Andrade JCT, 2002, J BIOMED MATER RES, V62, P30, DOI 10.1002/jbm.10242
   BANWART JC, 1995, SPINE, V20, P1055, DOI 10.1097/00007632-199505000-00012
   Bose S, 2003, MAT SCI ENG C-BIO S, V23, P479, DOI 10.1016/S0928-4931(02)00129-7
   Callcut S, 2002, J MATER SCI-MATER M, V13, P485, DOI 10.1023/A:1014718722710
   Charriere E, 2003, BIOMATERIALS, V24, P809, DOI 10.1016/S0142-9612(02)00406-4
   Cong Zhang, 2001, Journal of Biomedical Materials Research, V55, P28, DOI 10.1002/1097-4636(200104)55:1<28::AID-JBM40>3.3.CO;2-Y
   De Aza PN, 2003, BIOMATERIALS, V24, P1437, DOI 10.1016/S0142-9612(02)00530-6
   Fujibayashi S, 2003, BIOMATERIALS, V24, P1349, DOI 10.1016/S0142-9612(02)00511-2
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   Goulet JA, 1997, CLIN ORTHOP RELAT R, P76
   HELM GA, 2001, NEUROSURG FOCUS, V10
   Hench LL, 1998, J BIOMED MATER RES, V41, P511, DOI 10.1002/(SICI)1097-4636(19980915)41:4<511::AID-JBM1>3.0.CO;2-F
   Hench LL, 1997, CURR OPIN SOLID ST M, V2, P604, DOI 10.1016/S1359-0286(97)80053-8
   Jones JR, 2003, CURR OPIN SOLID ST M, V7, P301, DOI 10.1016/j.cossms.2003.09.012
   Kaufmann EABE, 2000, J BIOMED MATER RES, V52, P783
   Kim CY, 2003, J EUR CERAM SOC, V23, P1803, DOI 10.1016/S0955-2219(02)00444-2
   Kim HW, 2003, BIOMATERIALS, V24, P3277, DOI 10.1016/S0142-9612(03)00162-5
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Komlev VS, 2002, J MATER SCI-MATER M, V13, P295, DOI 10.1023/A:1014015002331
   Lee YM, 2001, J BIOMED MATER RES, V54, P216, DOI 10.1002/1097-4636(200102)54:2<216::AID-JBM8>3.0.CO;2-C
   Lemos AF, 2000, MAT SCI ENG C-BIO S, V11, P35, DOI 10.1016/S0928-4931(00)00134-X
   Livingston T, 2002, J BIOMED MATER RES, V62, P1, DOI 10.1002/jbm.10157
   Lyckfeldt O, 1998, J EUR CERAM SOC, V18, P131, DOI 10.1016/S0955-2219(97)00101-5
   MASIELLO SA, 2001, COMMUNICATION
   McAfee PC, 2003, SPINE, V28, P332, DOI 10.1097/00007632-200302150-00004
   OHTSUKI C, 1995, J CERAM SOC JPN, V103, P449, DOI 10.2109/jcersj.103.449
   Ortega FS, 2001, AM CERAM SOC BULL, V80, P37
   Peitl O, 2001, J NON-CRYST SOLIDS, V292, P115, DOI 10.1016/S0022-3093(01)00822-5
   PEREIRA MM, 1994, J BIOMED MATER RES, V28, P693, DOI 10.1002/jbm.820280606
   PILITSIS J, 2002, NEUROSURG FOCUS, V13
   Ramay HR, 2003, BIOMATERIALS, V24, P3293, DOI 10.1016/S0142-9612(03)00171-6
   SCHWARTZ Z, 1994, J CELL BIOCHEM, V56, P340, DOI 10.1002/jcb.240560310
   Sepulveda P, 1999, J EUR CERAM SOC, V19, P2059, DOI 10.1016/S0955-2219(99)00024-2
   Sepulveda P, 2000, J BIOMED MATER RES, V50, P27, DOI 10.1002/(SICI)1097-4636(200004)50:1<27::AID-JBM5>3.0.CO;2-6
   Sepulveda P, 2002, J BIOMED MATER RES, V62, P587, DOI 10.1002/jbm.10173
   Sepulveda P, 2002, J BIOMED MATER RES, V59, P340, DOI 10.1002/jbm.1250
   Vallet-Regi M, 2003, J BIOMED MATER RES A, V66A, P580, DOI 10.1002/jbm.a.10576
   Vitale-Brovarone C, 2004, J MATER SCI-MATER M, V15, P209, DOI 10.1023/B:JMSM.0000015480.49061.e1
   VITALEBROVARONE C, IN PRESS J MAT SCI M
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2000, J BIOMED MATER RES, V155, P151
   Yuan HP, 2001, J BIOMED MATER RES, V58, P270, DOI 10.1002/1097-4636(2001)58:3<270::AID-JBM1016>3.0.CO;2-2
   Zhang C, 2001, J BIOMED MATER RES, V54, P407, DOI 10.1002/1097-4636(20010305)54:3<407::AID-JBM140>3.3.CO;2-3
NR 44
TC 52
Z9 53
U1 0
U2 8
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD NOV
PY 2006
VL 17
IS 11
BP 1069
EP 1078
DI 10.1007/s10856-006-0533-8
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 109GM
UT WOS:000242295900017
PM 17122921
DA 2018-10-19
ER

PT J
AU Sunil, I
   Bond, SJ
   Nagaraj, HS
AF Sunil, Indira
   Bond, Sheldon J.
   Nagaraj, Hirikati S.
TI Primitive neuroectodermal tumor of the sternum in a child: resection and
   reconstruction
SO JOURNAL OF PEDIATRIC SURGERY
LA English
DT Article
ID CHEST-WALL TUMORS; TITANIUM; SURGERY
AB Pediatric primary malignancies of the sternum are rare. They represent less than 1% of all bone tumors. Primitive neuroectodermal tumor of the chest wall or Askin's tumor is more often seen in the ribs than in the sternum. Surgical treatment involves resection of the tumor followed by primary reconstruction. We report the case of a 16-year-old adolescent boy who was diagnosed to have primitive neuroectodermal tumor of the sternum and underwent resection with primary reconstruction of the anterior chest wall. We describe for the first time the use of a 2-mm Gore-Tex Dualmesh plus biomaterial (W.L. Gore and Associates, Flagstaff, Ariz) and locking mandibular multiperforated titanium plates with screws (Stryker-Leibinger, Freiburg, Germany) for primary sternal reconstruction in a child. Despite having a wide resection, he did not require postoperative ventilation and had an uncomplicated recovery. The reconstructed chest wall has a normal contour with normal pulmonary physiology. (c) 2006 Elsevier Inc. All rights reserved.
C1 Univ Louisville, Div Pediat Surg, Dept Surg, Louisville, KY 40202 USA.
RP Nagaraj, HS (reprint author), Univ Louisville, Div Pediat Surg, Dept Surg, Louisville, KY 40202 USA.
EM hsnaga01@louisville.edu
CR Arnold PG, 1996, PLAST RECONSTR SURG, V98, P804, DOI 10.1097/00006534-199610000-00008
   Briccoli A, 2002, EUR J SURG, V168, P494, DOI 10.1080/110241502321116523
   CLAUDE D, 1999, J THORAC CARDIOVASC, V117, P558
   Dang NC, 1999, J PEDIATR SURG, V34, P1773, DOI 10.1016/S0022-3468(99)90310-X
   Gosain AK, 1998, PLAST RECONSTR SURG, V101, P582, DOI 10.1097/00006534-199803000-00004
   GROSFELD JL, 1998, J PEDIATR SURG, V23, P667
   Kimber C, 1998, J PEDIATR SURG, V33, P39, DOI 10.1016/S0022-3468(98)90357-8
   Kokubo T, 2004, Med J Malaysia, V59 Suppl B, P91
   Kotoulas Christophoros, 2003, Interact Cardiovasc Thorac Surg, V2, P565, DOI 10.1016/S1569-9293(03)00145-2
   LEROUX BT, 1983, CURR PROB SURG, P346
   MCCORMACK P, 1981, ANN THORAC SURG, V31, P45, DOI 10.1016/S0003-4975(10)61315-X
   Ohno K, 1998, ANN THORAC SURG, V66, P1805, DOI 10.1016/S0003-4975(98)00922-9
   SABANATHAN S, 1985, ANN THORAC SURG, V39, P4, DOI 10.1016/S0003-4975(10)62515-5
   Serbetci K, 2000, TURK J MED SCI, V30, P543
   Shamberger R C, 1994, Semin Pediatr Surg, V3, P267
   Shamberger RC, 2003, ANN SURG, V238, P563, DOI 10.1097/01.sla.0000089857.45191.52
NR 16
TC 7
Z9 8
U1 0
U2 0
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0022-3468
EI 1531-5037
J9 J PEDIATR SURG
JI J. Pediatr. Surg.
PD NOV
PY 2006
VL 41
IS 11
AR E5
DI 10.1016/j.jpedsurg.2006.07.013
PG 4
WC Pediatrics; Surgery
SC Pediatrics; Surgery
GA 110RB
UT WOS:000242395200039
PM 17101344
DA 2018-10-19
ER

PT J
AU Ouchi, T
   Kontani, T
   Aoki, R
   Saito, T
   Ohya, Y
AF Ouchi, Tatsuro
   Kontani, Tomohiro
   Aoki, Rie
   Saito, Toshifumi
   Ohya, Yuichi
TI Characteristic properties of film prepared from poly(L-lactide)-grafted
   dextran of a relatively high sugar unit content as a degradable
   biomaterial
SO JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY
LA English
DT Article
DE biodegradable; biomaterials; degradability; films; graft copolymers;
   polylactide-grafted dextran; water absorption ability; wettable surface
ID POLYLACTIDE-GRAFTED DEXTRAN; TRIMETHYLSILYL PROTECTION METHOD; DELIVERY
   SYSTEMS; BLOCK-COPOLYMER; DRUG-DELIVERY; L-LACTIDE; IN-VITRO;
   SUPPRESSION; PULLULAN; ADHESION
AB To develop novel biomedical soft materials with degradability, amphiphilic poly(L-lactide)-grafted dextrans (Dex-g-PLLAs) of relatively high sugar unit contents were synthesized with the trimethylsilyl protection method. The characteristic properties of solution-cast films prepared from the obtained Dex-g-PLLAs were investigated. The water absorption and degradation rate of the Dex-g-PLLA films increased with increasing sugar unit content. The morphology of the bulk phase and top surface of the Dex-g-PLLA films was evaluated with transmission electron microscopy and atomic force microscopy, respectively. The bulk phase of the Dex-g-PLLA films with a sugar unit content of 16-25 wt % was found by transmission electron microscopy to form a lamellar type of phase-separated structure composed of approximately 80-100-nm-wide nanodomains because of their amphiphilic and branched structures. The hydrophobic top surface for a Dex-g-PLLA film with a sugar unit content of 25 wt % covered with PLLA segments was confirmed by atomic force microscopy phase images to be easily converted to a wettable top surface covered with hydrophilic dextran aggregates showing an 8-10-nm-wide honeycomb pattern by means of annealing in water. (c) 2006 Wiley Periodicals, Inc.
C1 Kansai Univ, Fac Engn, Dept Appl Chem, Suita, Osaka 5648680, Japan.
   Kansai Univ, High Technol Res Ctr, Dept Appl Chem, Suita, Osaka 5648680, Japan.
RP Ouchi, T (reprint author), Kansai Univ, Fac Engn, Dept Appl Chem, Suita, Osaka 5648680, Japan.
EM touchi@ipcku.kansai-u.ac.jp; yohya@ipcku.kansai-u.ac.jp
CR CELLI A, 1992, POLYMER, V33, P2699, DOI 10.1016/0032-3861(92)90440-8
   CHABOT F, 1983, POLYMER, V24, P53, DOI 10.1016/0032-3861(83)90080-0
   Choi EJ, 1999, MACROMOLECULES, V32, P7402, DOI 10.1021/ma981453f
   Donabedian DH, 1998, MACROMOLECULES, V31, P1032, DOI 10.1021/ma961741g
   Erdodi G, 2005, J POLYM SCI POL CHEM, V43, P4953, DOI 10.1002/pola.20978
   Gudipati CS, 2004, J POLYM SCI POL CHEM, V42, P6193, DOI 10.1002/pola.20466
   Harada A, 1998, MACROMOLECULES, V31, P288, DOI 10.1021/ma971277v
   Heller J, 1984, Crit Rev Ther Drug Carrier Syst, V1, P39
   HOLLAND S J, 1986, Journal of Controlled Release, V4, P155, DOI 10.1016/0168-3659(86)90001-5
   JEOUNG SY, 1986, ARCH PHARM RES, V9, P63
   Jong S. J., 2000, MACROMOLECULES, V33, P3680
   Kissel T, 1996, J CONTROL RELEASE, V39, P315, DOI 10.1016/0168-3659(95)00163-8
   Kricheldorf HR, 1996, MACROMOL SYMP, V103, P85
   Langer R, 2000, ACCOUNTS CHEM RES, V33, P94, DOI 10.1021/ar9800993
   Li YX, 1997, POLYMER, V38, P6197, DOI 10.1016/S0032-3861(97)00178-X
   Nagahama K, 2006, MACROMOL BIOSCI, V6, P412, DOI 10.1002/mabi.200500249
   Ohya Y, 1998, MACROMOL CHEM PHYSIC, V199, P2017, DOI 10.1002/(SICI)1521-3935(19980901)199:9<2017::AID-MACP2017>3.0.CO;2-9
   Ohya Y, 1998, MACROMOLECULES, V31, P4662, DOI 10.1021/ma980377d
   Otsuka H, 2000, BIOMACROMOLECULES, V1, P39, DOI 10.1021/bm990005s
   Ouchi T, 2006, POLYMER, V47, P429, DOI 10.1016/j.polymer.2005.11.039
   Ouchi T, 2005, J BIOMAT SCI-POLYM E, V16, P1035, DOI 10.1163/1568562054414649
   Ouchi T, 2003, J POLYM SCI POL CHEM, V41, P2462, DOI 10.1002/pola.10783
   Ouchi T, 2003, POLYMER, V44, P3927, DOI 10.1016/S0032-3861(03)000308-2
   Tasaka F, 1999, MACROMOLECULES, V32, P6386, DOI 10.1021/ma990766n
   WOOD DA, 1980, INT J PHARM, V7, P1, DOI 10.1016/0378-5173(80)90094-0
   Yamaoka T, 2001, J BIOMED MATER RES, V54, P470, DOI 10.1002/1097-4636(20010315)54:4<470::AID-JBM20>3.3.CO;2-O
   Ydens I, 2000, MACROMOLECULES, V33, P6713, DOI 10.1021/ma0002803
NR 27
TC 13
Z9 13
U1 1
U2 11
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0887-624X
J9 J POLYM SCI POL CHEM
JI J. Polym. Sci. Pol. Chem.
PD NOV 1
PY 2006
VL 44
IS 21
BP 6402
EP 6409
DI 10.1002/pola.21750
PG 8
WC Polymer Science
SC Polymer Science
GA 096HR
UT WOS:000241368700021
DA 2018-10-19
ER

PT J
AU Ponto, JA
AF Ponto, James A.
TI Dispensing and administration of Radiopharmaceuticals for
   dacryoscintigraphy
SO JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
LA English
DT Article
AB Dacryoscintigraphy was first introduced in 1972 as a method to detect and localize obstructions of lacrimal drainage under physiologic conditions. 1 It has since become commonly used in the evaluation of epiphora. (2-7) Briefly, about 50-100 mu Ci of Technetium Tc-99m sodium pertechnetate or Tc-99m sulfur colloid in a volume of about 10-15 L is placed on the surface of the eye. 3,5 The transport of the radioactive tracer from the conjunctiva into the lacrimal drainage system and flow through the drainage duct to the nasal cavity can then be followed through images obtained using a gamma camera. This radiopharmaceutical dose has customarily been administered onto the surface of the eye using a micropipette. (2-6,8-12) Although feasible for administration, dispensing of the radioactive dose in this manner is problematic, especially related to issues of sterility and radioactive contamination. Using a micropipette necessarily requires withdrawal of the radiopharmaceutical solution from an open container into an unsealed pipette tip, which makes sterility difficult to maintain. Leakage of radiopharmaceutical solution from the unsealed pipette tip, resulting in radioactive contamination of the immediate surroundings, may be difficult to avoid. Because these sterility and radioactive contamination issues preclude transportation of the loaded micropipette, it must be filled with the radiopharmaceutical at the immediate location of use. Hence, dispensing ( and administration) of the radiopharmaceutical dose in a closed, sterile apparatus taken from a sealed, sterile source would be desirable. The purpose of this study was to evaluate alternative devices for dispensing and administration of radiopharmaceuticals for dacryoscintigraphy.
   Methods
   The following devices were evaluated as potentially useful for dispensing and administration of radiopharmaceuticals for dacryoscintigraphy:
   Plastic eye dropper bottle (Steri-dropper, EPS The Medi-Dose Group, Warwick, Pa.) 1 mL syringe with 25-gauge steel needle (PrecisionGlide, Becton Dickinson, Franklin Lakes, N.J.) 1 mL syringe with 22- or 24-gauge flexible biomaterial intravenous catheter (Insyte Vialon IV catheter, BD Medical Systems, Sandy, Utah)
   The drop volume expressed from each device was determined by individually weighing 20 drops of 0.9% sodium chloride solution on a tared analytical balance (Model A-160, Denver Instrument Co., Arvada, Colo.). Other characteristics of each apparatus were assessed by observation and hands-on experience.
   Results The drop volume obtained from each device is shown in Table 1. Based on the drop volume, the required concentration of the radiopharmaceutical at the time of administration was calculated. Observation and hands-on experience revealed that all devices were appropriate for maintenance of sterility and avoidance of radioactive contamination, but the risk of eye injury varied.
   Discussion The drop volume is an important variable in the administration of radiopharmaceuticals for dacryoscintigraphy. Although some physicians have used drop volumes of up to 35-50 mu L, (13,14) most have used about 10-20 mu L. (1,2,4,6-12,15-17) The precorneal tear film is about 7 L, so the maximum volume instilled on the eye should be no more than twice this volume, or about 10-15 L. (5) Volumes larger than this are more likely to overflow from the eye. Overflow of a radiopharmaceutical from the eye results in radioactive contamination of the face and surrounding environment and may interfere with diagnostic interpretation of the resulting images. As shown in Table 1, the plastic eye dropper bottle delivers an undesirably large drop volume, whereas the needle and catheters deliver optimal drop volumes. Variable amounts of radioactivity have been used for dacryoscintigraphy procedures, ranging from 50 mu Ci(4,10,13) to 500 mu Ci.(14,18,19) A dose of 50-100 mu Ci is recommended. (1,5) The concentration of the radiopharmaceutical at the time of administration needed to deliver this recommended dose in one drop was calculated and is shown in Table 1. Several chemical forms of Tc-99m radiopharmaceuticals have been used for dacryoscintigraphy. Although Tc-99m sodium pertechnetate has been most common, (1,3,5,9,11-15,17-19) Tc-99m colloids such as sulfur colloid, (2,6,8,16) albumin colloid, 7 and tin colloid (4,10) have also been used. Each of these is equally successful in producing high-quality diagnostic images of transit through the lacrimal duct. A disadvantage for Tc-99m sodium pertechnetate is that,following transit into the nasal cavity, it is swallowed, absorbed from the gastrointestinal tract, and distributed by the blood to various internal organs, including the thyroid gland. At least one group has recommended that the patient be pretreated with potassium perchlorate to block thyroidal uptake of absorbed pertechnetate. 12 On the other hand, an insoluble colloid offers the advantage of no absorption from the gastrointestinal tract, so it delivers a lower radiation dose to the thyroid and other internal organs. Standard syringe needles, 21-25 gauge, have been used by some physicians for administration of Tc-99m radiopharmaceuticals onto the surface of the eye. (11,13,19) Although the drop volume expressed from a 25-gauge needle is appropriate in size, the risk of eye injury from the sharp tip of the needle is worrisome. The choice of administration device for dacryoscintigraphy has largely been at the discretion of the responsible physician. Over the years at my institution, individual physicians have opted for administration using standard syringe needles or using plastic eye dropper bottles, apparently considering the relative virtues of drop volume versus risk of eye injury in their own judgments. Physicians at this institution have now accepted flexible intravenous catheters as the device of choice, appreciating that the catheters possess advantageous characteristics for both drop volume and risk of eye injury.
   Conclusion
   Flexible biomaterial intravenous catheters are suggested as the administration device of choice for dacryoscintigraphy. The radiopharmaceutical, Tc-99m sulfur colloid (preferred) or Tc-99m sodium pertechnetate, can be dispensed at an appropriate concentration in a 1 mL syringe to which is then attached a 22- or 24-gauge flexible intravenous catheter. This method provides maintenance of sterility, lack of radioactive contamination, appropriate drop volume, and low risk of eye injury.
C1 Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA.
   Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA.
RP Ponto, JA (reprint author), Univ Iowa Hosp & Clin, 200 Hawkins Dr, Iowa City, IA 52242 USA.
EM james-ponto@uiowa.edu
CR AMANAT LA, 1983, BRIT J OPHTHALMOL, V67, P720, DOI 10.1136/bjo.67.11.720
   AMANAT LA, 1979, BRIT J OPHTHALMOL, V63, P511, DOI 10.1136/bjo.63.7.511
   BLANKSMA LJ, 1977, DOC OPHTHALMOL, V42, P381, DOI 10.1007/BF02742252
   BRIZEL HE, 1975, RADIOLOGY, V116, P373, DOI 10.1148/116.2.373
   BROWN M, 1981, SEMIN NUCL MED, V11, P250, DOI 10.1016/S0001-2998(81)80022-0
   CARLTON WH, 1973, J NUCL MED, V14, P89
   CHAUDHURI TK, 1975, J NUCL MED, V16, P605
   CHAUDHURI TK, 1976, CLIN NUCL MED, V1, P83
   CHAVIS RM, 1978, ARCH OPHTHALMOL-CHIC, V96, P2066
   Foster JA, 1996, OPHTHALMIC PLAST REC, V12, P32, DOI 10.1097/00002341-199603000-00005
   Guzek JP, 1997, OPHTHALMOLOGY, V104, P1875, DOI 10.1016/S0161-6420(97)30013-X
   HILDITCH TE, 1983, BRIT J OPHTHALMOL, V67, P713, DOI 10.1136/bjo.67.11.713
   HURWITZ JJ, 1975, BRIT J OPHTHALMOL, V59, P308, DOI 10.1136/bjo.59.6.308
   ROSE JDG, 1985, BRIT J RADIOL, V58, P1183, DOI 10.1259/0007-1285-58-696-1183
   ROSSOMONDO RM, 1972, ARCH OPHTHALMOL-CHIC, V88, P523
   SAPAROFF GR, 1976, OPHTHALMIC SEMIN, V1, P135
   SORENSEN T, 1980, ACTA OPHTHALMOL, V58, P597
   VONDENFFER H, 1984, SEMIN NUCL MED, V14, P8
   Ziccardi VB, 1995, ORAL SURG ORAL MED O, V80, P645, DOI 10.1016/S1079-2104(05)80244-6
NR 19
TC 0
Z9 0
U1 0
U2 2
PU AMER PHARMACEUTICAL ASSOC
PI WASHINGTON
PA 2215 CONSTITUTION AVE NW, WASHINGTON, DC 20037 USA
SN 1544-3191
J9 J AM PHARM ASSOC
JI J. Am. Pharm. Assoc.
PD NOV-DEC
PY 2006
VL 46
IS 6
BP 749
EP 750
DI 10.1331/1544-3191.46.6.749.Ponto
PG 2
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA V43ZC
UT WOS:000202972000014
PM 17176691
DA 2018-10-19
ER

PT J
AU Vogel, JP
   Szalay, K
   Geiger, F
   Kramer, M
   Richter, W
   Kasten, P
AF Vogel, Julia P.
   Szalay, Krisztian
   Geiger, Florian
   Kramer, Martin
   Richter, Wiltrud
   Kasten, Philip
TI Platelet-rich plasma improves expansion of human mesenchymal stem cells
   and retains differentiation capacity and in vivo bone formation in
   calcium phosphate ceramics
SO PLATELETS
LA English
DT Article
DE bone tissue engineering; ceramics; mesenchymal stem cells; platelet-rich
   plasma; xenogene media supplements
ID STROMAL CELLS; MARROW; PROLIFERATION
AB Introduction: Mesenchymal stem cells (MSC) applied to bone substitution materials can improve bone healing. Bone formation in biocomposites is highly dependent on the kind of biomaterial, its pre-treatment and the applied cells. Potentially immunogenic or infectious supplements such as fetal calf serum (FCS) should be avoided in cell expansion media. Therefore, we developed an expansion protocol free of xenogenic supplements. Cells expanded with two different media were tested on distinct biomaterials for their bone formation capacity after ectopic implantation in vivo, as well as for their growth rate and differentiation capacity in vitro.
   Methods: MSC of six donors were expanded with cell expansion medium containing FCS (2%) or platelet-rich plasma (PRP, 3%). Their growth rate and osteogenic, adipogenic and chondrogenic differentiation capacity were compared in vitro. For the in vivo bone formation assay, expanded cells (2 x 10(5) or 2 x 10(6)) were seeded on calcium-deficient hydroxyapatite (CDHA; n = 12) and on beta-tricalcium phosphate (beta-TCP; n = 12) blocks, which had been coated with either fibronectin or human serum. They were then implanted subcutaneously in severe combined immunodeficient mice (SCID), harvested after 8 weeks and analysed by histology. Bone formation was assessed by a semi-quantitative bone score, after toluidine blue and alizarin red staining. Human cells were detected by an in situ hybridisation for human-specific alu sequences.
   Results: PRP-supplemented expansion medium yielded two-fold higher cell numbers compared to medium with FCS (P = 0.046) after 3 weeks (four passages) and retained a similar capacity to differentiate towards the osteogenic, chondrogenic and adipogenic lineage. In vivo bone formation was equal for cells expanded with PRP and FCS and depended on the specific surface area of the carrier. CDHA (specific surface area (SSA) 48m(2)/g) showed a significantly better bone formation in deep layers (P = 0.005) than beta-TCP (SSA 0.5 m(2)/g). Fibronectin-coating of the ceramics was slightly superior to coating with human serum (P = 0.045).
   Conclusions: The replacement of FCS by PRP eliminated risks connected with the use of xenogeneic supplements. It improved expansion of MSC and retained their differentiation and in vivo bone formation capacity in a setting adaptable to autogenous use.
C1 Univ Heidelberg, Dept Orthopaed Surg, D-69118 Heidelberg, Germany.
   Univ Giessen, Dept Surg, Clin Small Anim, Giessen, Germany.
RP Kasten, P (reprint author), Univ Heidelberg, Dept Orthopaed Surg, Schlierbacher Landstr 200A, D-69118 Heidelberg, Germany.
EM Philip.Kasten@gmx.de
RI Richter, Wiltrud/V-3217-2017
OI Richter, Wiltrud/0000-0003-4694-2768
CR Aguzzi A, 1997, B WORLD HEALTH ORGAN, V75, P505
   Bohner M, 2000, Injury, V31 Suppl 4, P37
   Dennis J E, 1992, Cell Transplant, V1, P23
   Gruber R, 2004, PLATELETS, V15, P29, DOI 10.1080/09537100310001643999
   Kasten P, 2005, BIOMATERIALS, V26, P5879, DOI 10.1016/j.biomaterials.2005.03.001
   KIEVITS F, 1988, J IMMUNOL, V140, P4253
   Krebsbach PH, 1997, TRANSPLANTATION, V63, P1059, DOI 10.1097/00007890-199704270-00003
   Kuznetsov SA, 2000, TRANSPLANTATION, V70, P1780, DOI 10.1097/00007890-200012270-00018
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Lucarelli E, 2003, BIOMATERIALS, V24, P3095, DOI 10.1016/S0142-9612(03)00114-5
   MacDermott R P, 1983, Behring Inst Mitt, P122
   Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615
   STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420
   Walker JA, 2003, ANAL BIOCHEM, V315, P122, DOI 10.1016/S0003-2697(03)00081-2
   Weibrich G, 2002, Mund Kiefer Gesichtschir, V6, P168
   Weibrich G, 2003, CLIN ORAL IMPLAN RES, V14, P357, DOI 10.1034/j.1600-0501.2003.00810.x
   Winter A, 2003, ARTHRITIS RHEUM, V48, P418, DOI 10.1002/art.10767
NR 17
TC 117
Z9 121
U1 0
U2 12
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0953-7104
J9 PLATELETS
JI Platelets
PD NOV
PY 2006
VL 17
IS 7
BP 462
EP 469
DI 10.1080/09537100600758867
PG 8
WC Cell Biology; Hematology
SC Cell Biology; Hematology
GA 100IM
UT WOS:000241661700005
PM 17074722
DA 2018-10-19
ER

PT J
AU Toth, A
   Mohai, M
   Ujvari, T
   Bertoti, I
AF Toth, A.
   Mohai, M.
   Ujvari, T.
   Bertoti, I.
TI Advanced surface modification of ultra-high molecular weight
   poly(ethylene) by helium plasma immersion ion implantation
SO POLYMERS FOR ADVANCED TECHNOLOGIES
LA English
DT Article; Proceedings Paper
CT 8th International Symposium on Polymers for Advanced Technologies
CY SEP 13-16, 2005
CL Budapest, HUNGARY
SP IUPAC, European Polymer Federat, Soc Polymer Sci Japan, Chem Soc Japan, Amer Chem Soc, Polymer & PMSE Div, Hungarian Acad Sci, Budapest Univ Technol & Econ
DE poly(ethylene) (PE); surfaces; modification; ESCA/XPS; mechanical
   properties
ID GAS SEPARATION MEMBRANES; BEAM TREATMENT; POLYETHYLENE; MACROPHAGES;
   RESISTANCE; UHMWPE
AB Plasma immersion ion implantation is an emerging, versatile, relatively simple and cost-effective surface modification technique, alternative to conventional ion implantation. With this method even irregularly shaped objects can be uniformly treated, enhancing thus their surface properties. Ultrahigh molecular weight polyethylene is a principal biomaterial currently used in total joint arthroplasty, the wear of which and in particular the wear debris induced osteolysis is the main cause of the premature failure of the hip joint prostheses.
   In order to improve the wear resistance of ultra-high molecular weight polyethylene, in this work it was surface treated by plasma immersion ion implantation in helium. Process parameters like acceleration voltage, fluence and fluence rate were varied systematically. X-ray photoelectron spectroscopy was applied to monitor the surface chemical changes. Alterations induced in the surface mechanical and wear properties like hardness, reduced modulus and volume loss were determined by nanoindentation and multipass wear test measurements. The results demonstrate that the applied treatment can significantly modify the surface chemical and nanomechanical properties and increase the wear resistance of ultra-high molecular weight polyethylene. Copyright (c) 2006 John Wiley & Sons, Ltd.
C1 Hungarian Acad Sci, Inst Mat & Environm Chem, Chem Res Ctr, Budapest, Hungary.
RP Toth, A (reprint author), Hungarian Acad Sci, Inst Mat & Environm Chem, Chem Res Ctr, POB 17, Budapest, Hungary.
EM totha@chemres.hu
OI Mohai, Miklos/0000-0002-5162-1590; Bertoti, Imre/0000-0002-6062-1277
CR BLAZSO M, 1995, J ANAL APPL PYROL, V35, P221, DOI 10.1016/0165-2370(95)00910-7
   CALCAGNO L, 1985, APPL PHYS LETT, V47, P363, DOI 10.1063/1.96165
   Dong H, 2000, J MATER SCI LETT, V19, P1147, DOI 10.1023/A:1006755008958
   Dong H, 2004, T NONFERR METAL SOC, V14, P36
   Ingham E, 2005, BIOMATERIALS, V26, P1271, DOI 10.1016/j.biomaterials.2004.04.035
   Kohdyurin A., 2002, VACUUM, V64, P105
   Kondyurin A, 2003, VACUUM, V68, P341
   Koshimizu M, 2003, RADIAT PHYS CHEM, V66, P35, DOI 10.1016/S0969-806X(02)00281-5
   Kostov KG, 2004, SURF COAT TECH, V186, P287, DOI 10.1016/j.surfcoat.2004.03.033
   Marcondes AR, 2004, BRAZ J PHYS, V34, P1667, DOI 10.1590/S0103-97332004000800029
   MARLETTA G, 1992, MACROMOLECULES, V25, P3190, DOI 10.1021/ma00038a027
   Marletta G, 1998, NUCL INSTRUM METH B, V141, P684, DOI 10.1016/S0168-583X(98)00109-8
   MURRAY DW, 1990, J BONE JOINT SURG BR, V72, P988
   Oral E, 2006, BIOMATERIALS, V27, P917, DOI 10.1016/j.bomaterials.2005.06.025
   Shi W, 2001, WEAR, V250, P544, DOI 10.1016/S0043-1648(01)00636-6
   Toth A, 2004, SURF INTERFACE ANAL, V36, P1041, DOI 10.1002/sia.1832
   Toth A, 1997, NUCL INSTRUM METH B, V122, P547, DOI 10.1016/S0168-583X(96)00760-4
   Toth A, 1996, J APPL POLYM SCI, V60, P1883
   Toth A, 2000, SURF INTERFACE ANAL, V30, P434
   Toth A, 1999, NUCL INSTRUM METH B, V148, P1131, DOI 10.1016/S0168-583X(98)00833-7
   Ujvari T, 2001, SOLID STATE IONICS, V141, P225, DOI 10.1016/S0167-2738(01)00750-0
NR 21
TC 5
Z9 5
U1 0
U2 10
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1042-7147
J9 POLYM ADVAN TECHNOL
JI Polym. Adv. Technol.
PD NOV-DEC
PY 2006
VL 17
IS 11-12
BP 898
EP 901
DI 10.1002/pat.788
PG 4
WC Polymer Science
SC Polymer Science
GA 123OH
UT WOS:000243304700012
DA 2018-10-19
ER

PT J
AU Vinu, A
   Mori, T
   Ariga, K
AF Vinu, Ajayan
   Mori, Toshiyuki
   Ariga, Katsuhiko
TI New families of mesoporous materials
SO SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS
LA English
DT Review
DE mesoporous material; template synthesis; replica synthesis; elemental
   substitution; biomaterial
ID CARBON MOLECULAR-SIEVES; AIR-WATER-INTERFACE; TRIPEPTIDE-CONTAINING
   AMPHIPHILES; FLAVIN ADENINE-DINUCLEOTIDE; MIXED INSOLUBLE MONOLAYERS;
   LANGMUIR-BLODGETT FILMS; CELL-SURFACE RECEPTORS; BETA-SHEET ASSEMBLAGE;
   BY-LAYER ADSORPTION; SOL-GEL SYNTHESIS
AB Mesoporous materials have been paid much attention in both scientific researches and practical applications. In this review, we focus on recent developments on preparation and functionalization of new families of mesoporous materials, especially non-siliceous mesoporous materials invented in our research group. Replica synthesis is known as the method to synthesize mesoporous materials composed of various elements using originally prepared mesoporous replica. This strategy has been applied for the syntheses of novel mesoporous materials such as carbon nanocage and mesoporous carbon nitride. Carbon nanocage has a cage-type structure with huge surface area and pore volume, which exhibits superior capabilities for biomolecular adsorption. Mesoporous carbon nitride was synthesized, for first time, by using mixed material source of carbon and nitrogen simultaneously. As a totally new strategy for synthesis of mesoporous materials, the elemental substitution method has been recently proposed by us. Direct substitution of component elements in original mesoporous materials, with maintaining structural regularity, provided novel mesoporous materials. According to this synthetic strategy, mesoporous boron nitride and mesoporous boron carbon nitride have been successfully prepared, for first time. In addition to these material inventions, hybridization of high functional materials, such as biomaterials, to mesoporous structure has been also developed. Especially, immobilization of proteins in mesopores was systematically researched, and preparation of peptide-hybridized mesoporous silica was demonstrated. These new families of mesoporous materials introduced in this review would have high potentials in future practical applications in wide ranges from electronics and photonics to environmental and medical uses. (c) 2006 NIMS and Elsevier Ltd. All rights reserved.
C1 NIMS, Supermol Grp, Tsukuba, Ibaraki 3050044, Japan.
EM vinu.ajayan@nims.go.jp; ariga.katsuhiko@nims.go.jp
RI Vinu, Ajayan/H-9814-2012; ARIGA, Katsuhiko/H-2695-2011; MORI,
   Toshiyuki/H-2920-2011
OI Vinu, Ajayan/0000-0002-7508-251X; MORI, Toshiyuki/0000-0003-3199-2498
CR Aida T, 2001, ANGEW CHEM INT EDIT, V40, P3803, DOI 10.1002/1521-3773(20011015)40:20<3803::AID-ANIE3803>3.0.CO;2-T
   ANTONELLI DM, 1995, ANGEW CHEM INT EDIT, V34, P2014, DOI 10.1002/anie.199520141
   Antonelli DM, 1996, CHEM MATER, V8, P874, DOI 10.1021/cm9504697
   Antonelli DM, 1996, INORG CHEM, V35, P3126, DOI 10.1021/ic951533p
   Antonelli DM, 1996, ANGEW CHEM INT EDIT, V35, P426, DOI 10.1002/anie.199604261
   Ariga K, 2000, POLYM ADVAN TECHNOL, V11, P856, DOI 10.1002/1099-1581(200008/12)11:8/12<856::AID-PAT33>3.0.CO;2-3
   Ariga K, 2005, J AM CHEM SOC, V127, P12074, DOI 10.1021/ja053226g
   Ariga K, 2000, LANGMUIR, V16, P4929, DOI 10.1021/la000249u
   Ariga K, 2005, LANGMUIR, V21, P4578, DOI 10.1021/la0467887
   Ariga K, 1999, CHEM LETT, P787, DOI 10.1246/cl.1999.787
   Ariga K, 1998, CHEM LETT, P493, DOI 10.1246/cl.1998.493
   ARIGA K, 1992, J ORG CHEM, V57, P417, DOI 10.1021/jo00028a001
   Ariga K, 2004, J NANOSCI NANOTECHNO, V4, P23, DOI 10.1166/jnn.2004.048
   Ariga K, 2004, CHEM REC, V3, P297, DOI 10.1002/tcr.10071
   Ariga K, 2003, STUD SURF SCI CATAL, V146, P427
   Ariga K, 1999, LANGMUIR, V15, P3875, DOI 10.1021/la981047p
   Ariga K, 2001, PHYS CHEM CHEM PHYS, V3, P3442, DOI 10.1039/b100974p
   Ariga K, 2001, DEFECT DIFFUS FORUM, V191, P35, DOI 10.4028/www.scientific.net/DDF.191.35
   Ariga K, 1997, J MATER CHEM, V7, P1155, DOI 10.1039/a700081b
   Ariga K, 1998, CHEM LETT, P1007, DOI 10.1246/cl.1998.1007
   Ariga K, 1997, CHEM LETT, P25, DOI 10.1246/cl.1997.25
   Ariga K, 2000, CHEM LETT, P82
   Ariga K, 2000, COLLOID SURFACE A, V169, P47, DOI 10.1016/S0927-7757(00)00416-7
   Ariga K, 2006, CURR NANOSCI, V2, P197
   Ariga K, 2002, INT J NANOSCI SER, V1, P521, DOI 10.1142/S0219581X02000607
   Asefa T, 1999, NATURE, V402, P867
   Bach U, 1998, NATURE, V395, P583, DOI 10.1038/26936
   BAGSHAW SA, 1995, SCIENCE, V269, P1242, DOI 10.1126/science.269.5228.1242
   Bagshaw SA, 1996, ANGEW CHEM INT EDIT, V35, P1102, DOI 10.1002/anie.199611021
   BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   BRESLOW R, 1980, ACCOUNTS CHEM RES, V13, P170, DOI 10.1021/ar50150a002
   Caruso F, 1998, LANGMUIR, V14, P4559, DOI 10.1021/la971288h
   Cha X, 1996, B CHEM SOC JPN, V69, P163, DOI 10.1246/bcsj.69.163
   Cha X, 1996, CHEM LETT, P73, DOI 10.1246/cl.1996.73
   Cha X, 1996, J AM CHEM SOC, V118, P9545, DOI 10.1021/ja961526f
   CHA XA, 1995, J AM CHEM SOC, V117, P11833, DOI 10.1021/ja00153a003
   Chakraborty B, 1997, CHEM COMMUN, P911, DOI 10.1039/a701195d
   Chandrasekar G, 2005, STUD SURF SCI CATAL, V158, P1169
   Che S, 2004, NATURE, V429, P281, DOI 10.1038/nature02529
   Che S, 2006, J NANOSCI NANOTECHNO, V6, P1557, DOI 10.1166/jnn.2006.252
   Chong ASM, 2004, APPL SURF SCI, V237, P398, DOI 10.1016/j.apsusc.2004.06.080
   Ciesla U, 1999, MICROPOR MESOPOR MAT, V27, P131, DOI 10.1016/S1387-1811(98)00249-2
   Corma A, 1997, CHEM REV, V97, P2373, DOI 10.1021/cr960406n
   Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785
   Deere J, 2003, CATAL LETT, V85, P19, DOI 10.1023/A:1022156405117
   Deere J, 2002, J PHYS CHEM B, V106, P7340, DOI 10.1021/jp0139484
   Deere J, 2001, CHEM COMMUN, P465, DOI 10.1039/b009478l
   Diaz JF, 1996, J MOL CATAL B-ENZYM, V2, P115, DOI 10.1016/S1381-1177(96)00017-3
   DUBOIS M, 1993, LANGMUIR, V9, P673, DOI 10.1021/la00027a011
   EBARA Y, 1994, LANGMUIR, V10, P2267, DOI 10.1021/la00019a040
   Fukuda K, 2001, J MOL CATAL B-ENZYM, V11, P971, DOI 10.1016/S1381-1177(00)00012-6
   Ginger DS, 2004, ANGEW CHEM INT EDIT, V43, P30, DOI 10.1002/anie.200300608
   Golberg D, 1999, CHEM PHYS LETT, V308, P337, DOI 10.1016/S0009-2614(99)00591-6
   Golberg D, 2000, CHEM PHYS LETT, V323, P185, DOI 10.1016/S0009-2614(00)00480-2
   Golberg D, 2003, APPL PHYS LETT, V82, P1275, DOI 10.1063/1.1555713
   Goradia D, 2005, J MOL CATAL B-ENZYM, V32, P231, DOI 10.1016/j.molcatb.2004.12.007
   Gust D, 2001, ACCOUNTS CHEM RES, V34, P40, DOI 10.1021/ar9801301
   Han SJ, 2003, MICROPOR MESOPOR MAT, V58, P131, DOI 10.1016/S1387-1811(02)00611-X
   Han Y, 2006, CHEM MATER, V18, P643, DOI 10.1021/cm0520618
   Han YJ, 2002, J MOL CATAL B-ENZYM, V17, P1, DOI 10.1016/S1381-1177(01)00072-8
   Hartmann M, 2005, CHEM MATER, V17, P4577, DOI 10.1021/cm0485658
   Hartmann M, 2005, CHEM MATER, V17, P829, DOI 10.1021/cm048564f
   Hartmann M, 2002, LANGMUIR, V18, P8010, DOI 10.1021/la025782j
   Hartmann M, 2002, CHEM COMMUN, P1238, DOI 10.1039/b202662g
   Hayward RC, 2005, ADV MATER, V17, P2591, DOI 10.1002/adma.200500334
   Holland BT, 1997, J AM CHEM SOC, V119, P6796, DOI 10.1021/ja970823x
   Ikegame M, 2003, ANGEW CHEM INT EDIT, V42, P2154, DOI 10.1002/anie.200250800
   Inagaki M, 2004, CARBON, V42, P1401, DOI 10.1016/j.carbon.2004.02.032
   Inagaki S, 2002, NATURE, V416, P304, DOI 10.1038/416304a
   INAGAKI S, 1993, J CHEM SOC CHEM COMM, P680, DOI 10.1039/c39930000680
   Inagaki S, 1999, J AM CHEM SOC, V121, P9611, DOI 10.1021/ja9916658
   Jin HY, 2006, ADV MATER, V18, P593, DOI 10.1002/adma.200502038
   Joo SH, 2001, NATURE, V412, P169, DOI 10.1038/35084046
   Jun S, 2000, J AM CHEM SOC, V122, P10712, DOI 10.1021/ja002261e
   Kartini I, 2004, J NANOSCI NANOTECHNO, V4, P270, DOI 10.1166/jnn.2004.037
   Katagiri K, 2002, LANGMUIR, V18, P6709, DOI 10.1021/la025772i
   Katagiri K, 2002, J AM CHEM SOC, V124, P7892, DOI 10.1021/ja0259281
   Khushalani D, 2001, J NANOSCI NANOTECHNO, V1, P129, DOI 10.1166/jnn.2001.030
   Kikuchi J, 2001, J MOL CATAL B-ENZYM, V11, P977, DOI 10.1016/S1381-1177(00)00019-9
   Kikuchi J, 1999, CHEM LETT, P253
   Kikuchi J, 1999, CHEM COMMUN, P547, DOI 10.1039/a900083f
   Kimura M, 2001, J AM CHEM SOC, V123, P2438, DOI 10.1021/ja004034i
   Kimura T, 1999, CHEM MATER, V11, P508, DOI 10.1021/cm981036h
   Kleitz F, 2003, J PHYS CHEM B, V107, P14296, DOI 10.1021/jp036136b
   KNEELAND DM, 1993, J AM CHEM SOC, V115, P10042, DOI 10.1021/ja00075a021
   Kondo JN, 2000, B CHEM SOC JPN, V73, P1123, DOI 10.1246/bcsj.73.1123
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Krithiga T, 2005, J MOL CATAL A-CHEM, V237, P238, DOI 10.1016/j.molcata.2005.05.008
   Kyotani T, 1997, CHEM MATER, V9, P609, DOI 10.1021/cm960430h
   Kyotani T, 2000, CARBON, V38, P269, DOI 10.1016/S0008-6223(99)00142-6
   Lee J, 2000, ADV MATER, V12, P359, DOI 10.1002/(SICI)1521-4095(200003)12:5<359::AID-ADMA359>3.0.CO;2-1
   Lee J, 1999, CHEM COMMUN, P2177, DOI 10.1039/a906872d
   Leite ER, 2002, J NANOSCI NANOTECHNO, V2, P89, DOI 10.1166/jnn.2002.070
   Li GT, 2003, ANGEW CHEM INT EDIT, V42, P3818, DOI 10.1002/anie.200351158
   Liu P, 1997, CHEM MATER, V9, P2513, DOI 10.1021/cm970067u
   Lu YF, 2001, NATURE, V410, P913, DOI 10.1038/35073544
   LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026
   LVOV Y, 1995, J CHEM SOC CHEM COMM, P2313, DOI 10.1039/c39950002313
   LVOV Y, 1994, CHEM LETT, P2323, DOI 10.1246/cl.1994.2323
   Lvov Y, 1998, J BIOMAT SCI-POLYM E, V9, P345, DOI 10.1080/09205063.1998.9753060
   LVOV Y, 1996, THIN SOLID FILMS, V285, P797
   Mehdi A, 2006, J NANOSCI NANOTECHNO, V6, P377, DOI 10.1166/jnn.2006.011
   Melde BJ, 1999, CHEM MATER, V11, P3302, DOI 10.1021/cm9903935
   Miyahara M, 2006, THIN SOLID FILMS, V499, P13, DOI 10.1016/j.tsf.2005.07.046
   Miyahara M, 2004, KOBUNSHI RONBUNSHU, V61, P623, DOI 10.1295/koron.61.623
   Miyahara M, 2006, J NANOSCI NANOTECHNO, V6, P1765, DOI 10.1166/jnn.2006.221
   Moller K, 1998, CHEM MATER, V10, P2950, DOI 10.1021/cm980243e
   Morey MS, 1998, J POROUS MAT, V5, P195, DOI 10.1023/A:1009626103498
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   Murakami M, 2006, CHEM LETT, V35, P986, DOI 10.1246/cl.2006.986
   OGAWA M, 1994, J AM CHEM SOC, V116, P7941, DOI 10.1021/ja00096a079
   Oishi Y, 1997, LANGMUIR, V13, P519, DOI 10.1021/la960112x
   Oishi Y, 1996, CHEM LETT, P411, DOI 10.1246/cl.1996.411
   Okabe A, 2004, J AM CHEM SOC, V126, P9013, DOI 10.1021/ja0478532
   Okabe A, 2003, STUD SURF SCI CATAL, V146, P73
   Okabe A, 2002, ANGEW CHEM INT EDIT, V41, P3414, DOI 10.1002/1521-3773(20020916)41:18<3414::AID-ANIE3414>3.0.CO;2-T
   OKAHATA Y, 1988, LANGMUIR, V4, P1373, DOI 10.1021/la00084a030
   OKAHATA Y, 1989, THIN SOLID FILMS, V180, P65, DOI 10.1016/0040-6090(89)90055-2
   Onda M, 1999, J BIOSCI BIOENG, V87, P69, DOI 10.1016/S1389-1723(99)80010-3
   Onda M, 1996, J FERMENT BIOENG, V82, P502, DOI 10.1016/S0922-338X(97)86992-9
   Onda M, 1996, J AM CHEM SOC, V118, P8524, DOI 10.1021/ja960991+
   Onda M, 1996, BIOTECHNOL BIOENG, V51, P163, DOI 10.1002/(SICI)1097-0290(19960720)51:2<163::AID-BIT5>3.0.CO;2-H
   Onda M, 1997, JPN J APPL PHYS 2, V36, pL1608, DOI 10.1143/JJAP.36.L1608
   OTANI W, IN PRESS CHEM EUR J
   Polarz S, 2002, J NANOSCI NANOTECHNO, V2, P581, DOI 10.1166/jnn.2002.151
   Raman NK, 1996, CHEM MATER, V8, P1682, DOI 10.1021/cm960138+
   Ravikovitch PI, 2002, LANGMUIR, V18, P1550, DOI 10.1021/la0107594
   Ruiz-Hitzky E, 2002, ADV MATER, V14, P439, DOI 10.1002/1521-4095(20020318)14:6<439::AID-ADMA439>3.0.CO;2-8
   Ryoo R, 2001, ADV MATER, V13, P677, DOI 10.1002/1521-4095(200105)13:9<677::AID-ADMA677>3.3.CO;2-3
   Ryoo R, 1999, J PHYS CHEM B, V103, P7743, DOI 10.1021/jp991673a
   Sanchez C, 2001, CHEM MATER, V13, P3061, DOI 10.1021/cm01106le
   Sasaki T, 2001, APPL ENVIRON MICROB, V67, P2208, DOI 10.1128/AEM.67.5.2208-2212.2001
   Sawant DP, 2005, J CATAL, V235, P341, DOI 10.1016/j.jcat.2005.08.010
   Sayari A, 1996, CHEM MATER, V8, P1840, DOI 10.1021/cm950585+
   Schmidt-Winkel P, 1999, J AM CHEM SOC, V121, P254, DOI 10.1021/ja983218i
   Seeman NC, 1997, ACCOUNTS CHEM RES, V30, P357, DOI 10.1021/ar9601407
   Seeman NC, 1998, ANGEW CHEM INT EDIT, V37, P3220, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3220::AID-ANIE3220>3.0.CO;2-C
   Shibata H, 2005, J AM CHEM SOC, V127, P16396, DOI 10.1021/ja0552601
   SHIMOJIMA A, 2003, ANGEW CHEM INT EDIT, V42, P40570
   SMITH J, 1993, J AM CHEM SOC, V115, P362, DOI 10.1021/ja00054a062
   Solovyov LA, 2002, J PHYS CHEM B, V106, P12198, DOI 10.1021/jp0257653
   Stein A, 2000, ADV MATER, V12, P1403, DOI 10.1002/1521-4095(200010)12:19<1403::AID-ADMA1403>3.0.CO;2-X
   Subramanian V, 2004, J NANOSCI NANOTECHNO, V4, P125, DOI 10.1166/jnn.2004.045
   Taguchi A, 2005, MICROPOR MESOPOR MAT, V77, P1, DOI 10.1016/j.micromeso.2004.06.030
   TAGUCHI K, 1995, CHEM LETT, P701, DOI 10.1246/cl.1995.701
   Takahashi H, 2000, CHEM MATER, V12, P3301, DOI 10.1021/cm000487a
   Takahashi H, 2001, MICROPOR MESOPOR MAT, V44, P755, DOI 10.1016/S1387-1811(01)00257-8
   TANEV PT, 1995, SCIENCE, V267, P865, DOI 10.1126/science.267.5199.865
   TANEVA S, 1989, LANGMUIR, V5, P111, DOI 10.1021/la00085a020
   TANEVA S, 1989, J COLLOID INTERF SCI, V131, P561, DOI 10.1016/0021-9797(89)90198-7
   Umamaheswari V, 2006, MICROPOR MESOPOR MAT, V89, P47, DOI 10.1016/j.micromeso.2005.05.045
   VARTULI JC, 1994, CHEM MATER, V6, P2317, DOI 10.1021/cm00048a018
   Vinu A, 2005, STUD SURF SCI CATAL, V158, P971
   Vinu A, 2006, CARBON, V44, P530, DOI 10.1016/j.carbon.2005.08.004
   Vinu A, 2006, J PHYS CHEM B, V110, P801, DOI 10.1021/jp055851d
   Vinu A, 2005, STUD SURF SCI CATAL, V156, P631
   Vinu A, 2005, STUD SURF SCI CATAL, V156, P637
   Vinu A, 2005, J MATER CHEM, V15, P5122, DOI 10.1039/b507456h
   Vinu A, 2005, CHEM MATER, V17, P5887, DOI 10.1021/cm051780j
   Vinu A, 2005, CHEM MATER, V17, P5339, DOI 10.1021/cm050883z
   Vinu A, 2005, ADV MATER, V17, P1648, DOI 10.1002/adma.200401643
   Vinu A, 2005, J MOL CATAL A-CHEM, V235, P57, DOI 10.1016/j.molcata.2005.03.014
   Vinu A, 2005, CHEM LETT, V34, P674, DOI 10.1246/cl.2005.674
   Vinu A, 2005, MICROPOR MESOPOR MAT, V80, P195, DOI 10.1016/j.micromeso.2004.12.012
   Vinu A, 2005, J NANOSCI NANOTECHNO, V5, P347, DOI 10.1166/jnn.2005.089
   Vinu A, 2005, J PHYS CHEM B, V109, P6436, DOI 10.1021/jp050454o
   Vinu A, 2005, APPL CATAL A-GEN, V281, P207, DOI 10.1016/j.apcata.2004.11.031
   Vinu A, 2005, J MOL CATAL A-CHEM, V230, P151, DOI 10.1016/j.molcata.2004.12.018
   Vinu A, 2004, ADV MATER, V16, P1817, DOI 10.1002/adma.200400229
   Vinu A, 2004, MICROPOR MESOPOR MAT, V76, P91, DOI 10.1016/j.micromeso.2004.07.036
   Vinu A, 2004, J PHYS CHEM B, V108, P11496, DOI 10.1021/jp048411f
   Vinu A, 2004, CHEM MATER, V16, P3056, DOI 10.1021/cm049718u
   Vinu A, 2004, J PHYS CHEM B, V108, P7323, DOI 10.1021/jp037303a
   Vinu A, 2004, CHEM LETT, V33, P588, DOI 10.1246/cl.2004.588
   Vinu A, 2005, CATAL TODAY, V102, P189, DOI 10.1016/j.cattod.2005.02.028
   Vinu A, 2003, CHEM MATER, V15, P1385, DOI 10.1021/cm0213523
   Vinu A, 2003, J PHYS CHEM B, V107, P8297, DOI 10.1021/jp035246f
   Vinu A, 2002, CHEM MATER, V14, P2433, DOI 10.1021/cm025544+
   Vinu A, 2006, J PHYS CHEM B, V110, P11924, DOI 10.1021/jp061523h
   Vinu A, 2006, J POROUS MAT, V13, P379, DOI 10.1007/s10934-006-8034-1
   Vinu A, 2006, J NANOSCI NANOTECHNO, V6, P1510, DOI 10.1166/jnn.2006.253
   Wang YJ, 2005, CHEM MATER, V17, P953, DOI 10.1021/cm0483137
   Washmon-Kriel L, 2000, J MOL CATAL B-ENZYM, V10, P453, DOI 10.1016/S1381-1177(99)00123-X
   Wei Y, 2001, J NANOSCI NANOTECHNO, V1, P83, DOI 10.1166/jnn.2001.014
   Wong MS, 1998, CHEM MATER, V10, P2067, DOI 10.1021/cm970525z
   Wu S, 2004, CHEM MATER, V16, P486, DOI 10.1021/cm0343857
   Yamada N, 2000, COLLOID SURFACE A, V169, P271, DOI 10.1016/S0927-7757(00)00442-8
   Yamada N, 2000, SYNLETT, P575
   Yamada N, 1998, J AM CHEM SOC, V120, P12192, DOI 10.1021/ja981363q
   YANAGISAWA T, 1990, B CHEM SOC JPN, V63, P988, DOI 10.1246/bcsj.63.988
   Yang H, 1996, NATURE, V379, P703, DOI 10.1038/379703a0
   Yang HF, 2005, J MATER CHEM, V15, P1217, DOI 10.1039/b414402c
   Yang NYC, 2003, J NANOSCI NANOTECHNO, V3, P386, DOI 10.1166/jnn.2003.216
   Ying JY, 1999, ANGEW CHEM INT EDIT, V38, P56, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<56::AID-ANIE56>3.0.CO;2-E
   Yiu HHP, 2001, MICROPOR MESOPOR MAT, V44, P763, DOI 10.1016/S1387-1811(01)00258-X
   Yiu HHP, 2001, PHYS CHEM CHEM PHYS, V3, P2983, DOI 10.1039/b104729a
   Zhang Q, 2003, STUD SURF SCI CATAL, V146, P465
   Zhang QM, 2004, J AM CHEM SOC, V126, P988, DOI 10.1021/ja0395l5r
   Zhao D, 1998, ADV MATER, V10, P1380, DOI 10.1002/(SICI)1521-4095(199811)10:16<1380::AID-ADMA1380>3.0.CO;2-8
   Zhao DY, 1997, CHEM COMMUN, P1009, DOI 10.1039/a700965h
   Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548
   Zhao DY, 1998, J AM CHEM SOC, V120, P6024, DOI 10.1021/ja974025i
NR 203
TC 144
Z9 151
U1 4
U2 192
PU NATL INST MATERIALS SCIENCE
PI IBARAKI
PA NATL INST MATERIALS SCIENCE, 1-2-1 SENGEN, TSUKUBA-CITY, IBARAKI,
   305-0047, JAPAN
SN 1468-6996
J9 SCI TECHNOL ADV MAT
JI Sci. Technol. Adv. Mater.
PD NOV
PY 2006
VL 7
IS 8
BP 753
EP 771
DI 10.1016/j.stam.2006.10.007
PG 19
WC Materials Science, Multidisciplinary
SC Materials Science
GA 151NH
UT WOS:000245296800001
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Dong, Q
   Su, HL
   Zhang, D
   Zhu, N
   Guo, XQ
AF Dong, Qun
   Su, Huilan
   Zhang, Di
   Zhu, Na
   Guo, Xinqiu
TI Biotemplate-directed assembly of porous SnO2 nanoparticles into tubular
   hierarchical structures
SO SCRIPTA MATERIALIA
LA English
DT Article
DE biomorphic; porous materials; tubular fibers; binary oxides; liquid
   infiltration
ID CALCIUM-CARBONATE; OXIDES; NANOCLUSTERS; FABRICATION; TEMPLATES;
   CERAMICS; FIBERS; SCALES
AB A simple, green and versatile route has been developed for the fabrication of hierarchical SnO2 via a soaking technique combined with a calcination treatment. The biomaterial eggshell membrane (ESM) is used as the template, and Sn(NO3)(4) solution acts as the impregnant. As-prepared SnO2 nanoparticles assemble into tubular fibers, and further array into porous hierarchical meshworks to faithfully retain the morphology of the natural ESM. The sintering temperature has a significant effect on the morphology and surface pore-size distribution of the target material. (c) 2006 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Shanghai 200030, Peoples R China.
   Shanghai Jiao Tong Univ, Instrumental Anal Ctr, Shanghai 200030, Peoples R China.
RP Su, HL (reprint author), Shanghai Jiao Tong Univ, State Key Lab Met Matrix Composites, Shanghai 200030, Peoples R China.
EM hlsu@sjtu.edu.cn
CR BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020
   Clavier GM, 2000, J MATER CHEM, V10, P1725, DOI 10.1039/b000525h
   Dabbs DM, 2000, ANNU REV PHYS CHEM, V51, P601, DOI 10.1146/annurev.physchem.51.1.601
   Dieguez A, 1999, SENSOR ACTUAT B-CHEM, V60, P125, DOI 10.1016/S0925-4005(99)00258-0
   Dong Q, 2005, J PHYS CHEM B, V109, P17429, DOI 10.1021/jp052826z
   Ferrere S, 1997, J PHYS CHEM B, V101, P4490, DOI 10.1021/jp970683d
   GIBSON CP, 1995, SCIENCE, V267, P1338, DOI 10.1126/science.267.5202.1338
   Ginley DS, 2000, MRS BULL, V25, P15, DOI 10.1557/mrs2000.256
   Hincke MT, 2000, MATRIX BIOL, V19, P443, DOI 10.1016/S0945-053X(00)00095-0
   Imai H, 2000, J MATER CHEM, V10, P2005, DOI 10.1039/b004543h
   Kato T, 2002, ADV MATER, V14, P869, DOI 10.1002/1521-4095(20020618)14:12<869::AID-ADMA869>3.0.CO;2-E
   Kim DK, 2001, SCRIPTA MATER, V44, P1713, DOI 10.1016/S1359-6462(01)00870-3
   Lee SW, 2004, NANO LETT, V4, P387, DOI 10.1021/nl034911t
   Lowenstam HA, 1989, BIOMINERALIZATION
   Mann S, 1996, NATURE, V382, P313, DOI 10.1038/382313a0
   Mann S., 2001, BIOMINERALIZATION PR
   Mann S., 1996, BIOMIMETIC MAT CHEM
   Meldrum FC, 2003, INT MATER REV, V48, P187, DOI 10.1179/095066003225005836
   Niemeyer CM, 2001, ANGEW CHEM INT EDIT, V40, P4128, DOI 10.1002/1521-3773(20011119)40:22<4128::AID-ANIE4128>3.0.CO;2-S
   Pan ZW, 2001, SCIENCE, V291, P1947, DOI 10.1126/science.1058120
   Pileni MP, 1999, ADV MATER, V11, P1358, DOI 10.1002/(SICI)1521-4095(199911)11:16<1358::AID-ADMA1358>3.3.CO;2-R
   Presas M, 2005, SCRIPTA MATER, V53, P1175, DOI 10.1016/j.scriptamat.2005.07.033
   Scott RWJ, 2001, ADV MATER, V13, P1468, DOI 10.1002/1521-4095(200110)13:19<1468::AID-ADMA1468>3.0.CO;2-O
   Seshadri R, 2000, ADV MATER, V12, P1149, DOI 10.1002/1521-4095(200008)12:15<1149::AID-ADMA1149>3.3.CO;2-Y
   Shin YS, 2001, ADV MATER, V13, P728, DOI 10.1002/1521-4095(200105)13:10<728::AID-ADMA728>3.0.CO;2-J
   Yang D, 2002, ADV MATER, V14, P1543, DOI 10.1002/1521-4095(20021104)14:21<1543::AID-ADMA1543>3.0.CO;2-B
   Yang PD, 1998, NATURE, V396, P152
   Yu SH, 2004, J MATER CHEM, V14, P2124, DOI 10.1039/b401420k
   Zhang W, 2006, NANOTECHNOLOGY, V17, P840, DOI 10.1088/0957-4484/17/3/038
NR 29
TC 33
Z9 41
U1 0
U2 32
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-6462
J9 SCRIPTA MATER
JI Scr. Mater.
PD NOV
PY 2006
VL 55
IS 9
BP 799
EP 802
DI 10.1016/j.scriptamat.2006.07.012
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 086SQ
UT WOS:000240693700012
DA 2018-10-19
ER

PT J
AU Wright, CJ
   Armstrong, I
AF Wright, Chris J.
   Armstrong, Ian
TI The application of atomic force microscopy force measurements to the
   characterisation of microbial surfaces
SO SURFACE AND INTERFACE ANALYSIS
LA English
DT Review
DE adhesion; aggregation; atomic force microscopy; AFM; cell surface; force
   measurements; microbiology; molecular interactions; nanomechanics
ID NIGER SPORE ADHESION; LIVING CELLS; DIRECT QUANTIFICATION; BIOMATERIAL
   SURFACES; BIOLOGICAL-MATERIALS; BACTERIAL ADHESION; SPECTROSCOPY;
   ELASTICITY; CALIBRATION; TOPOGRAPHY
AB The interaction of microbes and subsequent development of biofilms at surfaces has far-reaching consequences in bioprocess engineering, agriculture, medicine and dentistry. Thus, the microbial surface has been the focus of wide scientific investigation. However, only recently has technology permitted quantitative study of the molecular interactions that govern the interactions of microbes. One such technology is atomic force microscopy (AFM) that not only permits the high resolution imaging of microbial surfaces but also the direct measurement of molecular forces and physical properties found at the microbial surface. This review highlights the current development of AFM force measurements and how these may be applied to microbial cell surfaces. The refinement of the AFM force measurement technique for characterising microbial surfaces will be discussed with reference to selected studies from the author's laboratory and key results from other research teams. The review will demonstrate how the application of the AFM techniques of single-molecule force spectroscopy, functionalised tips, cell probes and lateral force measurement to microbial surfaces has provided exciting and unique insights into the microbial surface and its interactions. Copyright (C) 2006 John Wiley & Sons, Ltd.
C1 Univ Wales Swansea, Multidisciplinary Nanotechnol Ctr, Swansea, W Glam, Wales.
RP Wright, CJ (reprint author), Univ Wales Swansea, Multidisciplinary Nanotechnol Ctr, Singleton Pk, Swansea, W Glam, Wales.
EM c.wright@swansea.ac.uk
OI Wright, Chris/0000-0003-2375-8159
CR A-Hassan E, 1998, BIOPHYS J, V74, P1564, DOI 10.1016/S0006-3495(98)77868-3
   Abu-Lail NI, 2002, LANGMUIR, V18, P4071, DOI 10.1021/la015695b
   Afrin R, 2004, ULTRAMICROSCOPY, V100, P187, DOI 10.1016/j.ultramic.2004.01.013
   Ahimou F, 2002, LANGMUIR, V18, P9937, DOI 10.1021/la026273k
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Antonik MD, 1997, IEEE ENG MED BIOL, V16, P66, DOI 10.1109/51.582178
   Arnoldi M, 2000, PHYS REV E, V62, P1034, DOI 10.1103/PhysRevE.62.1034
   BELLONFONTAINE MN, 1990, CELL BIOPHYS, V17, P93, DOI 10.1007/BF02989805
   Benoit M, 2000, NAT CELL BIOL, V2, P313, DOI 10.1038/35014000
   Benoit M, 2002, CELLS TISSUES ORGANS, V172, P174, DOI 10.1159/000066964
   Benoit M, 2002, METHOD CELL BIOL, V68, P91
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Bowen WR, 2000, COLLOID SURFACE A, V173, P205, DOI 10.1016/S0927-7757(00)00566-5
   Bowen WR, 2000, J COLLOID INTERF SCI, V228, P428, DOI 10.1006/jcis.2000.6969
   Bowen WR, 1998, J COLLOID INTERF SCI, V197, P348, DOI 10.1006/jcis.1997.5247
   Bowen WR, 1999, J MEMBRANE SCI, V154, P205
   Bowen WR, 2000, BIOTECHNOL LETT, V22, P893, DOI 10.1023/A:1005604028444
   Bowen WR, 1998, COLLOID SURFACE A, V136, P231, DOI 10.1016/S0927-7757(97)00243-4
   Bowen WR, 2002, BIOTECHNOL BIOENG, V79, P170, DOI 10.1002/bit.10321
   Bowen WR, 2001, J COLLOID INTERF SCI, V237, P54, DOI 10.1006/jcis.2001.7437
   Bower CK, 1999, INT J FOOD MICROBIOL, V50, P33, DOI 10.1016/S0168-1605(99)00075-6
   Boyd RD, 2002, LANGMUIR, V18, P2343, DOI 10.1021/la011142p
   BUSSCHER HJ, 1995, METHOD ENZYMOL, V253, P455
   Calleja GB, 1987, YEASTS, V2, P165
   Chang KC, 1996, LANGMUIR, V12, P2271, DOI 10.1021/la950690y
   Clausen-Schaumann H, 2000, CURR OPIN CHEM BIOL, V4, P524, DOI 10.1016/S1367-5931(00)00126-5
   CLEVELAND JP, 1993, REV SCI INSTRUM, V64, P403, DOI 10.1063/1.1144209
   DCOSTA NP, 1995, REV SCI INSTRUM, V66, P5096, DOI 10.1063/1.1146135
   DUCKER WA, 1991, NATURE, V353, P239, DOI 10.1038/353239a0
   Dufrene YF, 1999, J BACTERIOL, V181, P5350
   Dupres V, 2005, NAT METHODS, V2, P515, DOI 10.1038/NMETH769
   Gaboriaud F, 2005, J BACTERIOL, V187, P3864, DOI 10.1128/JB.187.11.3864-3868.2005
   Heinz WF, 1999, TRENDS BIOTECHNOL, V17, P143, DOI 10.1016/S0167-7799(99)01304-9
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   Hertz H., 1882, J REINE ANGEW MATH, V92, P156, DOI DOI 10.1515/CRLL.1882.92.156
   Hinterdorfer P, 2002, METHOD CELL BIOL, V68, P115
   HUTTER JL, 1993, REV SCI INSTRUM, V64, P1868, DOI 10.1063/1.1143970
   Lanero T, 2006, J BIOTECHNOL, V124, P723, DOI DOI 10.1016/J.JBIOTEC.2006.02.016
   Lower SK, 2001, SCIENCE, V292, P1360, DOI 10.1126/science.1059567
   Ming F, 1998, ENZYME MICROB TECH, V22, P94, DOI 10.1016/S0141-0229(97)00136-1
   Muller DJ, 1999, P NATL ACAD SCI USA, V96, P13170, DOI 10.1073/pnas.96.23.13170
   MULLER DJ, 2002, METHODS CELL BIOL AT, V68, P258
   Ong YL, 1999, LANGMUIR, V15, P2719, DOI 10.1021/la981104e
   PARAPURA V, 1993, J VAC SCI TECHNOL A, V11, P773
   Postollec F, 2006, J DENT RES, V85, P231, DOI 10.1177/154405910608500305
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   SADER JE, 1995, REV SCI INSTRUM, V66, P3789, DOI 10.1063/1.1145439
   Sagvolden G, 1999, P NATL ACAD SCI USA, V96, P471, DOI 10.1073/pnas.96.2.471
   Schaer-Zammaretti P, 2003, ULTRAMICROSCOPY, V97, P199, DOI 10.1016/S0304-3991(03)00044-5
   Sneddon IN, 1965, INT J ENG SCI, V3, P47, DOI DOI 10.1016/0020-7225(65)90019-4
   Sosa-Gomez DR, 1998, J INVERTEBR PATHOL, V71, P115, DOI 10.1006/jipa.1997.4716
   Tanaka T, 1999, ELECTROCHIM ACTA, V44, P3827, DOI 10.1016/S0013-4686(99)00089-4
   Toikka G, 1996, J COLLOID INTERF SCI, V180, P329, DOI 10.1006/jcis.1996.0311
   Touhami A, 2006, J BACTERIOL, V188, P370, DOI 10.1128/JB.188.2.370-377.2006
   Touhami A, 2003, MICROBIOL-SGM, V149, P2873, DOI 10.1099/mic.0.26431-0
   Touhami A, 2003, LANGMUIR, V19, P4539, DOI 10.1021/la034136x
   Vadillo-Rodrigues V, 2004, APPL ENVIRON MICROB, V70, P5441, DOI 10.1128/AEM.70.9.5441-5446.2004
   Vadillo-Rodriguez V, 2004, J BACTERIOL, V186, P6647, DOI 10.1128/JB.186.19.6647-6650.2004
   van der Aa BC, 2001, LANGMUIR, V17, P3116, DOI 10.1021/la001573s
   Vinckier A, 1998, FEBS LETT, V430, P12, DOI 10.1016/S0014-5793(98)00592-4
   Whitehead KA, 2006, COLLOID SURFACE B, V51, P44, DOI 10.1016/j.colsurfb.2006.05.003
   Zhao LM, 2005, APPL ENVIRON MICROB, V71, P955, DOI 10.1128/AEM.71.2.955-960.2005
   Zhao LM, 2005, BIOTECHNOL PROGR, V21, P292, DOI 10.1021/bp0497233
   Zlatanova J, 2000, PROG BIOPHYS MOL BIO, V74, P37, DOI 10.1016/S0079-6107(00)00014-6
NR 64
TC 51
Z9 55
U1 2
U2 47
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0142-2421
J9 SURF INTERFACE ANAL
JI Surf. Interface Anal.
PD NOV
PY 2006
VL 38
IS 11
BP 1419
EP 1428
DI 10.1002/sia.2506
PG 10
WC Chemistry, Physical
SC Chemistry
GA 108YZ
UT WOS:000242276400007
DA 2018-10-19
ER

PT J
AU Desai, KM
   Diaz, S
   Dorward, IG
   Winslow, ER
   La Regina, MC
   Halpin, V
   Soper, NJ
AF Desai, K. M.
   Diaz, S.
   Dorward, I. G.
   Winslow, E. R.
   La Regina, M. C.
   Halpin, V.
   Soper, N. J.
TI Histologic results 1 year after bioprosthetic repair of paraesophageal
   hernia in a canine model
SO SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
LA English
DT Article; Proceedings Paper
CT Annual Meeting of the
   Society-of-American-Gastrointestinal-and-Endoscopic-Surgeons (SAGES)
CY MAR 31-APR 03, 2004
CL Denver, CO
SP Soc Amer Gastrointestinal & Endoscop Surg
DE laparoscopy; paraesophageal hernia; small intestinal submucosa
ID SMALL-INTESTINAL SUBMUCOSA; LARGE HIATAL-HERNIA; BODY-WALL REPAIR;
   LAPAROSCOPIC REPAIR; MESH; CRUROPLASTY; POLYTETRAFLUOROETHYLENE;
   BIOMATERIAL
AB Background: The use of prosthetic materials for the repair of paraesophageal hiatal hernia (PEH) may lead to esophageal stricture and perforation. High recurrence rates after primary repair have led surgeons to explore other options, including various bioprostheses. However, the long-term effects of these newer materials when placed at the esophageal hiatus are unknown. This study assessed the anatomic and histologic characteristics 1 year after PEH repair using a U-shaped configuration of commercially available small intestinal submucosa (SIS) mesh in a canine model.
   Methods: Six dogs underwent laparoscopic PEH repair with SIS mesh 4 weeks after thoracoscopic creation of PEH. When the six dogs were sacrificed 12 months later, endoscopy and barium x-ray were performed, and biopsies of the esophagus and crura were obtained.
   Results: The mean weight of the dogs 1 year after surgery was identical to their entry weight. No dog had gross dysphagia, evidence of esophageal stricture, or reherniation. At sacrifice, the biomaterial was not identifiable grossly. Biopsies of the hiatal region showed fibrosis as well as muscle fiber proliferation and regeneration. No dog had erosion of the mesh into the esophagus.
   Conclusions: This reproducible canine model of PEH formation and repair did not result in erosion of SIS mesh into the esophagus or in stricture formation. Native muscle ingrowth was noted 1 year after placement of the biomaterial. According to the findings, SIS may provide a scaffold for ingrowth of crural muscle and a durable repair of PEH over the long term.
C1 Washington Univ, Sch Med, Dept Surg, St Louis, MO 63130 USA.
   Washington Univ, Sch Med, Inst Minimally Invas Surg, St Louis, MO 63130 USA.
   Northwestern Univ, Dept Surg, Chicago, IL 60208 USA.
RP Soper, NJ (reprint author), Washington Univ, Sch Med, Dept Surg, St Louis, MO 63130 USA.
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   Badylak S, 2002, J SURG RES, V103, P190, DOI 10.1006/jsre.2001.6349
   Badylak S, 2001, J SURG RES, V99, P282, DOI 10.1006/jsre.2001.6176
   Champion JK, 2003, SURG ENDOSC, V17, P551, DOI 10.1007/s00464-002-8817-7
   Clarke KM, 1996, J SURG RES, V60, P107, DOI 10.1006/jsre.1996.0018
   Diaz S, 2003, J GASTROINTEST SURG, V7, P59, DOI 10.1016/S1091-255X(02)00151-8
   EDELMAN DS, 1995, SURG LAPAROSC ENDOSC, V5, P32
   ELLIS FH, 1986, ARCH SURG-CHICAGO, V121, P416
   Frantzides CT, 1999, SURG ENDOSC-ULTRAS, V13, P906, DOI 10.1007/s004649901131
   Frantzides CT, 1997, SURG ENDOSC-ULTRAS, V11, P769, DOI 10.1007/s004649900447
   Frantzides CT, 2002, ARCH SURG-CHICAGO, V137, P649, DOI 10.1001/archsurg.137.6.649
   Gloeckner DC, 2000, J BIOMED MATER RES, V52, P365, DOI 10.1002/1097-4636(200011)52:2<365::AID-JBM17>3.0.CO;2-3
   HALPIN V, 2002, SURG ENDOSC S, V16, pS977
   Hashemi M, 2000, J AM COLL SURGEONS, V190, P553, DOI 10.1016/S1072-7515(00)00260-X
   Keidar A, 2003, SURG LAPARO ENDO PER, V13, P149, DOI 10.1097/00129689-200306000-00002
   Kurzer M, 2003, SURG CLIN N AM, V83, P1099, DOI 10.1016/S0039-6109(03)00134-8
   Oelschlager BK, 2003, AM J SURG, V186, P4, DOI 10.1016/S0002-9610(03)00114-4
   PITCHER DE, 1995, ARCH SURG-CHICAGO, V130, P590
   PREVEL CD, 1995, ANN PLAS SURG, V35, P374, DOI 10.1097/00000637-199510000-00008
   SANTORA TA, 1993, SURG CLIN N AM, V73, P557
   SCHNEIDER R, 1979, AM SURGEON, V45, P337
   Willekes CL, 1997, ANN SURG, V225, P31, DOI 10.1097/00000658-199701000-00004
   WILLIAMSON WA, 1993, ANN THORAC SURG, V56, P447, DOI 10.1016/0003-4975(93)90878-L
   Wu JS, 1999, SURG ENDOSC-ULTRAS, V13, P497, DOI 10.1007/s004649901021
NR 24
TC 26
Z9 27
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING STREET, NEW YORK, NY 10013 USA
SN 0930-2794
J9 SURG ENDOSC
JI Surg. Endosc.
PD NOV
PY 2006
VL 20
IS 11
BP 1693
EP 1697
DI 10.1007/s00464-006-0680-5
PG 5
WC Surgery
SC Surgery
GA 110LC
UT WOS:000242379400012
PM 17031737
DA 2018-10-19
ER

PT J
AU Mullen, MJ
   Hildick-Smith, D
   De Giovanni, JV
   Duke, C
   Hillis, WS
   Morrison, WL
   Jux, C
AF Mullen, Michael J.
   Hildick-Smith, David
   De Giovanni, Joseph V.
   Duke, Christopher
   Hillis, W. Stewart
   Morrison, W. Lindsay
   Jux, Christian
TI BioSTAR evaluation STudy (BEST) - A prospective, multicenter, phase I
   clinical trial to evaluate the feasibility, efficacy, and safety of the
   BioSTAR bioabsorbable septal repair implant for the closure of
   atrial-level shunts
SO CIRCULATION
LA English
DT Article
DE heart septal defects; heart defects, congenital; pediatrics; stroke
ID PATENT FORAMEN OVALE; TRANSCATHETER CLOSURE; INTESTINAL SUBMUCOSA;
   EXTRACELLULAR-MATRIX; CARDIAC PERFORATION; OCCLUDER DEVICE; DEFECT
   CLOSURE; SINGLE-CENTER; ABNORMALITIES; BIOMATERIAL
AB Background - The use of permanent synthetic implants to close atrial septal defects ( ASD) and patent foramen ovale ( PFO) has a number of limitations, including late complications and the limiting of transeptal access to the left heart should it be required for the later treatment of acquired heart disease. BioSTAR is a novel, bioabsorbable, atrial septal repair implant. This phase I pilot study evaluates the feasibility, safety, and effectiveness of BioSTAR for the first time in humans.
   Methods and Results - We conducted a prospective, open-label, multicenter clinical study in 58 patients aged 28 to 68 years who had a clinically significant ASD or PFO. Percutaneous shunt closure was undertaken with the BioSTAR septal repair implant. Successful device implantation was achieved in 57 ( 98%) of 58 patients. Closure at 30 days and 6 months, assessed by contrast transthoracic echocardiography, was 48 ( 92%) of 52 and 54 ( 96%) of 56, respectively. There was no evidence of a clinically significant response to the device. Transient atrial arrhythmia occurred in 5 patients after implantation. No major safety issues were observed.
   Conclusions - This study demonstrates the feasibility, safety, and effectiveness of BioSTAR for the closure of ASD and PFO in humans with a high rate of early and complete shunt closure. BioSTAR is a novel septal repair implant designed to provide biological closure of atrial-level defects using the patient's natural healing response. Because 90% to 95% of the implant is absorbed and replaced with healthy native tissue, future access to the left atrium may be achieved.
C1 Royal Brompton Hosp, London SW3 6NP, England.
   Royal Sussex Cty Hosp, Brighton BN2 5BE, E Sussex, England.
   Univ Hosp, Birmingham, W Midlands, England.
   Glenfield Gen Hosp, Leicester LE3 9QP, Leics, England.
   Univ Glasgow, Western Infirm, Glasgow G11 6NT, Lanark, Scotland.
   Ctr Cardiothorac, Liverpool, Merseyside, England.
   Univ Gottingen, D-3400 Gottingen, Germany.
RP Mullen, MJ (reprint author), Royal Brompton Hosp, Sydney St, London SW3 6NP, England.
EM m.mullen@rbht.nhs.uk
CR Abraham GA, 2000, J BIOMED MATER RES, V51, P442, DOI 10.1002/1097-4636(20000905)51:3<442::AID-JBM19>3.3.CO;2-W
   Alaeddini Jamshid, 2006, J Invasive Cardiol, V18, P365
   Amin Z, 2004, CATHETER CARDIO INTE, V63, P496, DOI 10.1002/ccd.20211
   BADYLAK SF, 1995, J BIOMED MATER RES, V29, P977, DOI 10.1002/jbm.820290809
   Badylak SF, 2004, TRANSPL IMMUNOL, V12, P367, DOI 10.1016/j.trim.2003.12.016
   Berthet K, 2000, STROKE, V31, P398, DOI 10.1161/01.STR.31.2.398
   Billiar K, 2001, J BIOMED MATER RES, V56, P101, DOI 10.1002/1097-4636(200107)56:1<101::AID-JBM1074>3.0.CO;2-6
   BILLINGER K, 1960, EUROINTERVENTION, V1, P465
   Buscheck Franziska, 2006, J Interv Cardiol, V19, P328, DOI 10.1111/j.1540-8183.2006.00154.x
   Carminati M, 2001, J Interv Cardiol, V14, P319, DOI 10.1111/j.1540-8183.2001.tb00339.x
   Chintala K, 2003, CATHETER CARDIO INTE, V60, P101, DOI 10.1002/ccd.10603
   Divekar A, 2005, J AM COLL CARDIOL, V45, P1213, DOI 10.1016/j.jacc.2004.12.072
   Franklin M E Jr, 2004, Hernia, V8, P186
   Fyler DC, 1992, NADAS PEDIAT CARDIOL
   HardinYoung J, 1996, BIOTECHNOL BIOENG, V49, P675, DOI 10.1002/(SICI)1097-0290(19960320)49:6<675::AID-BIT9>3.0.CO;2-L
   Hausdorf G, 1999, AM J CARDIOL, V84, P1113, DOI 10.1016/S0002-9149(99)00515-9
   Hausdorf G, 2001, J Interv Cardiol, V14, P69, DOI 10.1111/j.1540-8183.2001.tb00715.x
   Hill SL, 2000, J INTERV CARD ELECTR, V4, P469, DOI 10.1023/A:1009852312907
   Huynh T, 1999, NAT BIOTECHNOL, V17, P1083
   Jux C, 2006, J AM COLL CARDIOL, V48, P161, DOI 10.1016/j.jacc.2006.02.057
   Jux Christian, 2003, J Interv Cardiol, V16, P149, DOI 10.1046/j.1540-8183.2003.08027.x
   Kiblawi FM, 2006, CATHETER CARDIO INTE, V68, P136, DOI 10.1002/ccd.20722
   Lai DW, 2005, CATHETER CARDIO INTE, V66, P424, DOI 10.1002/ccd.20497
   MEIER JM, 2005, EUROINTERVENTION, V1, P22
   Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042
   Nugent AW, 2006, J AM COLL CARDIOL, V48, P538, DOI 10.1016/j.jacc.2006.03.049
   PERLOFF JK, 1991, CONGENITAL HEART DIS
   Post MC, 2005, ACTA CARDIOL, V60, P515, DOI 10.2143/AC.60.5.2004973
   Preventza O, 2004, ANN THORAC SURG, V77, P1435, DOI 10.1016/50003-4975(03)00901-9
   Purcell IF, 2004, CLIN CARDIOL, V27, P509, DOI 10.1002/clc.4960270907
   Rose S, 2005, WAR HIST, V12, P231, DOI 10.1177/096834450501200208
   Ruiz CE, 2001, CATHETER CARDIO INTE, V53, P369, DOI 10.1002/ccd.1183
   Sherman JM, 2004, CATHETER CARDIO INTE, V63, P486, DOI 10.1002/ccd.20220
   Sigler M, 2007, HEART, V93, P444, DOI 10.1136/hrt.2006.098103
   Solomon Stephen B, 2004, Int J Cardiovasc Intervent, V6, P101
   Wertman B, 2006, J AM COLL CARDIOL, V47, P1226, DOI 10.1016/j.jacc.2005.12.017
NR 36
TC 77
Z9 86
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0009-7322
EI 1524-4539
J9 CIRCULATION
JI Circulation
PD OCT 31
PY 2006
VL 114
IS 18
BP 1962
EP 1967
DI 10.1161/CIRCULATIONAHA.106.664672
PG 6
WC Cardiac & Cardiovascular Systems; Peripheral Vascular Disease
SC Cardiovascular System & Cardiology
GA 100KE
UT WOS:000241666800013
PM 17062781
OA Bronze
DA 2018-10-19
ER

PT J
AU Guhathakurta, S
   Varghese, S
   Balasubramanian, V
   Agarwal, R
   Murthy, BS
   Veerappan, S
   Padmaja, P
   Cherian, KM
AF Guhathakurta, S.
   Varghese, S.
   Balasubramanian, V.
   Agarwal, R.
   Murthy, B. S.
   Veerappan, S.
   Padmaja, P.
   Cherian, K. M.
TI Technique to process xenogenic tissues for cardiovascular implantation -
   A preliminary report
SO CURRENT SCIENCE
LA English
DT Article
DE anti-calcium treatment; calcific degeneration; decellularization;
   xenograft
ID ALLOGRAFTS
AB Processing of xenograft, a biomaterial in clinical cardiovascular surgery can influence implantation life and efficiency in desired function. Existing xenografts have a limited service time as they undergo degenerative changes. Degradation of xenografts occurs due to several deficiencies in processing and also due to in vivo enzymatic digestion and immune response. The objective of this study is to deceflularize xenograft tissues and preserve their architecture using an efficient method. This method can produce decellularized tissues that are durable and sturdy to withstand physiological stresses due to circulation during cardiovascular surgeries. Porcine valves (40 pulmonary and eight aortic), bovine jugular veins (57 with and 41 without valves) and 29 bovine pericardia were treated chemically with different methods of decellularization. Anti-calcium treatment was performed to reduce mineralization and further processing of tissues was performed to prevent blood-protein seepage in the biological tissues during blood circulation. The most effective decellularization process was determined by a microscopic examination of the decellularized tissues. One per cent DCA and enzymatic treatment for 50 and 15 h respectively, decellularized the xenografts in an efficient manner. This decellularization along with enzymatic treatment was found to produce good results in comparison with other detergents. This can make them a suitable xenograft tissue for clinical use. Animal experiments can provide evidence of autologous cell seeding in the same processed tissues after implantation has taken place. These experiments can prove the ability of the tissue to grow cells in individuals inside whom the grafts are to be implanted.
C1 Indian Inst Technol, Rehabil Bioengn Grp, Dept Biotechnol, Madras 600036, Tamil Nadu, India.
   Frontier Life Line Private Ltd, Int Ctr Cardiothorac & Vasc Dis, Madras 600101, Tamil Nadu, India.
RP Balasubramanian, V (reprint author), Indian Inst Technol, Rehabil Bioengn Grp, Dept Biotechnol, Madras 600036, Tamil Nadu, India.
EM chanakya@iitm.ac.in
CR AUGUSTINUS B, 1998, EUR J CARDIO-THORAC, V14, P279
   CARY WA, 1998, ANN THORAC SURG, V65, P1545
   Christine ES, 2000, BIOMATERIALS, V21, P2215
   CHRISTINE ES, 2000, BIOMATERIALS, V21, P2115
   COLOMB G, 1987, AM J PATHOL, V127, P122
   COURTMAN DW, 1994, J BIOMED MATER RES, V28, P655, DOI 10.1002/jbm.820280602
   COURTMAN DW, 1999, P SOC BIOM 25 ANN M, P20
   Elkins R C, 2001, Semin Thorac Cardiovasc Surg, V13, P82
   Elkins RC, 2001, ANN THORAC SURG, V71, P428
   ERWIN R, 2004, J THORAC CARDIOVASC, V127, P399
   FRANCISCO DA, 2005, EUR J CARDIO-THORAC, V27, P572
   FREDERICK JS, 2005, ANN THORAC SURG, V79, P1072
   Hawkins JA, 2003, J THORAC CARDIOV SUR, V126, P247, DOI 10.1016/S0022-5223(03)00116-8
   Ichikawa Y, 1994, ASAIO J, V40, pM714, DOI 10.1097/00002480-199407000-00091
   JASON H, 2002, BIOTECHNOL BIOENG, V79, P211
   JOCELYN NC, 2005, ANN THORAC SURG, V79, P897
   Lalka S G, 1989, Ann Vasc Surg, V3, P108, DOI 10.1016/S0890-5096(06)62002-5
   LEVY RJ, 1991, J BIOMED MATER RES, V25, P905, DOI 10.1002/jbm.820250802
   MALONE JM, 1984, J VASC SURG, V1, P181, DOI 10.1067/mva.1984.avs0010181
   NARENDRA V, 1997, CIRCULATION, V95, P479
   Okoshi T, 1990, ASAIO Trans, V36, pM411
   PASCAL MD, 2001, SEM THORAC CARDIOVAS, V13, P93
   PETER Z, 2005, ANN THORAC SURG, V79, P905
   RYGG IH, P 3 INT S YORK MED B
   TETSYA K, 2001, J MED INVEST, V48, P123
   Welters MJP, 2002, HUM IMMUNOL, V63, P1019, DOI 10.1016/S0198-8859(02)00441-X
   Wilson G J, 1990, ASAIO Trans, V36, pM340
   YUKIO I, 1997, J THORAC CARDIOVASC, V114, P224
NR 28
TC 9
Z9 9
U1 0
U2 1
PU INDIAN ACAD SCIENCES
PI BANGALORE
PA C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA
SN 0011-3891
J9 CURR SCI INDIA
JI Curr. Sci.
PD OCT 25
PY 2006
VL 91
IS 8
BP 1068
EP 1073
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 102YG
UT WOS:000241849000021
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Jin, YL
   Chen, JY
   Xu, L
   Wang, PN
AF Jin, Y. L.
   Chen, J. Y.
   Xu, L.
   Wang, P. N.
TI Refractive index measurement for biomaterial samples by total internal
   reflection
SO PHYSICS IN MEDICINE AND BIOLOGY
LA English
DT Article
ID SINGLE; CELLS
AB The refractive index of biological tissue is a fundamental parameter in applications of optical diagnosis and laser treatments. In the present work, the refractive indices and thermo-optic coefficients of some basic biomaterials, such as blood plasma, haemoglobin solution and lipid membrane, were studied by the method of total internal reflection at the wavelengths of 532 and 632.8 nm that are the most frequently used laser wavelengths in the biomedical field. The effects of the sample concentration and the temperature on refractive index were measured, and empirical relationships were summarized, accompanied by a theoretical explanation based on molecular polarization theory. The results provide some fundamental data for the refractive indices of these biomaterials under variant conditions, and also demonstrate that the total internal reflection method is a feasible and reliable way to measure the refractive indices of biological samples.
C1 Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China.
   Fudan Univ, State Key Lab Adv Photon Mat & Devices, Shanghai 200433, Peoples R China.
RP Jin, YL (reprint author), Fudan Univ, Dept Phys, Shanghai 200433, Peoples R China.
EM jychen@fudan.edu.cn
CR ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0
   Barton JK, 2001, IEEE J SEL TOP QUANT, V7, P936, DOI 10.1109/2944.983297
   Beuthan J, 1996, PHYS MED BIOL, V41, P369, DOI 10.1088/0031-9155/41/3/002
   Beuthan J., 1990, LASER MED SURG, V6, P72
   BOLIN FP, 1989, APPL OPTICS, V28, P2297, DOI 10.1364/AO.28.002297
   Dougherty TJ, 1998, JNCI-J NATL CANCER I, V90, P889, DOI 10.1093/jnci/90.12.889
   Ferrari M., 1993, MED OPT TOMOGR, P576
   Friebel M, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2138027
   Friebel M, 2006, APPL OPTICS, V45, P2838, DOI 10.1364/AO.45.002838
   GEWIESE B, 1994, INVEST RADIOL, V29, P345, DOI 10.1097/00004424-199403000-00015
   *IAPWS, 1997, 55 IAPWS
   Li H, 1996, APPL OPTICS, V35, P1793, DOI 10.1364/AO.35.001793
   LI XZ, 1998, CHIN J PHYS THER, V21, P17
   Lorentz H. A., 1880, ANN PHYS, V245, P641, DOI DOI 10.1002/ANDP.18802450406
   Lorenz L., 1880, ANN PHYS, V247, P70, DOI DOI 10.1002/ANDP.18802470905
   Muller G., 1993, INTERNAL REFLECTION, V333-363
   MULLER GJ, 1991, OPTIK, V88, P83
   Nebel S, 1997, BIOCHEMISTRY-US, V36, P2853, DOI 10.1021/bi961839n
   Swatland HJ, 2002, MEAT SCI, V62, P225, DOI 10.1016/S0309-1740(01)00250-9
NR 19
TC 45
Z9 46
U1 1
U2 16
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 0031-9155
J9 PHYS MED BIOL
JI Phys. Med. Biol.
PD OCT 21
PY 2006
VL 51
IS 20
BP N371
EP N379
DI 10.1088/0031-9155/51/20/N02
PG 9
WC Engineering, Biomedical; Radiology, Nuclear Medicine & Medical Imaging
SC Engineering; Radiology, Nuclear Medicine & Medical Imaging
GA 092GE
UT WOS:000241084200022
PM 17019025
DA 2018-10-19
ER

PT J
AU Cho, J
   Grant, J
   Piquette-Miller, M
   Allen, C
AF Cho, Jaepyoung
   Grant, Justin
   Piquette-Miller, Micheline
   Allen, Christine
TI Synthesis and physicochemical and dynamic mechanical properties of a
   water-soluble chitosan derivative as a biomaterial
SO BIOMACROMOLECULES
LA English
DT Article
ID MOLECULAR-WEIGHT DISTRIBUTION; RELAXATION-TIME SPECTRUM; GENE DELIVERY
   VECTORS; INTRINSIC-VISCOSITY; POLYMER-SOLUTIONS; QUATERNARY AMMONIUM;
   VISCOELASTIC PROPERTIES; REGULARIZATION METHOD; POLYELECTROLYTES;
   BEHAVIOR
AB The physicochemical and rheological properties of a water-soluble chitosan (WSC) derivative were characterized in order to facilitate its use as a novel material for biomedical applications. The WSC was prepared by conjugating glycidyltrimethylammonium chloride (GTMAC) onto chitosan chains. Varying the molar ratio of GTMAC to chitosan from 3: 1 to 6: 1 produced WSCs with a degree of substitution (DS) that ranged from 56% to 74%. The WSC with the highest DS was soluble in water up to concentrations of 25g/dL at room temperature. An increase in the polymer concentration gradually increased both the pH and conductivity of the WSC solutions. The rheological properties of the WSC solutions were found to be dependent on the salt and polymer concentrations as well as the DS value. In the absence of salt, the rheological behavior of the WSC was found to be typical of that for a polyelectrolyte in the dilute solution regime. However, the addition of salt decreased the viscosity of the polymer solution due to the reduction of electrostatic repulsions by the positively charged trimethylated ammonium groups of the WSC. In the concentrated regime, the viscosity of the WSCs was found to follow a power-law expression. The lowest DS WSC had the more favorable viscoelastic properties that were attributed to its high molecular weight, as confirmed by the stress relaxation spectra and intrinsic viscosity measurements. The effect of DS on the degree of interaction between WSC and the lipid egg phosphatidylcholine was investigated by FTIR analysis. Overall, the lower DS WSC had enhanced rheological properties and was capable of engaging in stronger intermolecular physical interactions.
C1 Univ Toronto, Dept Pharmaceut Sci, Leslie Dan Fac Pharm, Toronto, ON M5S 2S2, Canada.
   Univ Toronto, Dept Chem, Toronto, ON M5S 2S2, Canada.
RP Allen, C (reprint author), Univ Toronto, Dept Pharmaceut Sci, Leslie Dan Fac Pharm, 19 Russell St, Toronto, ON M5S 2S2, Canada.
EM cj.allen@utoronto.ca
CR Alberty R. A., 1997, PHYS CHEM
   Allan G., 1984, CHITIN CHITOSAN RELA
   AMIJI MM, 1995, CARBOHYD POLYM, V26, P211, DOI 10.1016/0144-8617(94)00095-B
   Antonietti M, 1996, J CHEM PHYS, V105, P7795, DOI 10.1063/1.472605
   Antonietti M, 1997, MACROMOLECULES, V30, P2700, DOI 10.1021/ma9617025
   ARAI K, 1968, B TOKAI REGIONAL FIS, V56, P89
   Brugnerotto J, 2001, MACROMOL SYMP, V168, P1, DOI 10.1002/1521-3900(200103)168:1<1::AID-MASY1>3.0.CO;2-W
   Carreau P. J., 1997, RHEOLOGY POLYM SYSTE
   Chen RH, 1998, INT J BIOL MACROMOL, V23, P135, DOI 10.1016/S0141-8130(98)00036-1
   Chen WR, 2002, CANCER RES, V62, P4295
   Chenite A, 2001, CARBOHYD POLYM, V46, P39, DOI 10.1016/S0144-8617(00)00281-2
   Cho JY, 2006, J FOOD ENG, V74, P500, DOI 10.1016/j.jfoodeng.2005.01.047
   COLBY RH, 1991, MACROMOLECULES, V24, P3873, DOI 10.1021/ma00013a021
   Connors K.A., 1979, CHEM STABILITY PHARM
   Coury L., 1999, CURR SEP, V18, p[3, 91]
   COX WP, 1958, J POLYM SCI, V28, P619, DOI 10.1002/pol.1958.1202811812
   Desbrieres J, 2002, BIOMACROMOLECULES, V3, P342, DOI 10.1021/bm010151+
   DOBRYNIN AV, 1995, MACROMOLECULES, V28, P1859, DOI 10.1021/ma00110a021
   DOMARD A, 1987, INT J BIOL MACROMOL, V9, P98, DOI 10.1016/0141-8130(87)90033-X
   FUOSS RM, 1949, J POLYM SCI, V4, P96, DOI 10.1002/pol.1949.120040111
   FUOSS RM, 1948, J POLYM SCI, V3, P603, DOI 10.1002/pol.1948.120030414
   Gastaud JM, 1998, CR ACAD SCI III-VIE, V321, P5, DOI 10.1016/S0764-4469(97)89619-9
   Grant J, 2006, ACS SYM SER, V934, P201
   Grant J, 2005, J PHARM SCI-US, V94, P1512, DOI 10.1002/jps.20379
   Heo Y, 2005, J RHEOL, V49, P1117, DOI 10.1122/1.1993595
   HONERKAMP J, 1993, RHEOL ACTA, V32, P65, DOI 10.1007/BF00396678
   Hwang J. K., 2000, KOREA-AUST RHEOL J, V12, P175
   Jayakumar R, 2005, CARBOHYD POLYM, V62, P142, DOI 10.1016/j.carbpol.2005.07.017
   Jumaa M, 2002, EUR J PHARM BIOPHARM, V53, P115, DOI 10.1016/S0939-6411(01)00191-6
   Kasaai MR, 2000, J POLYM SCI POL PHYS, V38, P2591, DOI 10.1002/1099-0488(20001001)38:19<2591::AID-POLB110>3.0.CO;2-6
   Kean T, 2005, J CONTROL RELEASE, V103, P643, DOI 10.1016/j.jconrel.2004.01.001
   Khan TA, 2000, J PHARM PHARM SCI, V3, P303
   KIENZLESTERZER C, 1982, J APPL POLYM SCI, V27, P4467, DOI 10.1002/app.1982.070271133
   Kim SK, 2005, CARBOHYD POLYM, V62, P357, DOI 10.1016/j.carbpol.2005.08.012
   Kulicke W.-M., 2004, VISCOSIMETRY POLYM P
   Kumar MNVR, 2000, REACT FUNCT POLYM, V46, P1
   Liaw DJ, 1997, J APPL POLYM SCI, V63, P175, DOI 10.1002/(SICI)1097-4628(19970110)63:2<175::AID-APP5>3.3.CO;2-6
   Lide D. R., 2004, CRC HDB CHEM PHYS
   Lim SH, 2004, CARBOHYD RES, V339, P313, DOI 10.1016/j.carres.2003.10.024
   Macosko CW, 1994, RHEOLOGY PRINCIPLES
   Maeda Y, 2004, J NUTR, V134, P945
   MIYA M, 1980, INT J BIOL MACROMOL, V2, P323, DOI 10.1016/0141-8130(80)90056-2
   MIYAMOTO S, 1981, MACROMOL CHEM PHYS, V182, P483
   Morel FMM, 1993, PRINCIPLES APPL AQUA
   Nam CW, 2001, J APPL POLYM SCI, V82, P1620, DOI 10.1002/app.2001.abs
   Painter PC, 1997, FUNDAMENTALS POLYM S
   Park JH, 2003, BIOMACROMOLECULES, V4, P1087, DOI 10.1021/bm034094r
   Qin CQ, 2004, INT J BIOL MACROMOL, V34, P121, DOI 10.1016/j.ijbiomac.2004.03.009
   Qin CQ, 2002, INT J BIOL MACROMOL, V31, P111, DOI 10.1016/S0141-8130(02)00064-8
   REMYHEINTZ N, 1993, CR ACAD SCI III-VIE, V316, P1363
   Roberts G, 1992, CHITIN CHEM
   Roths T, 2000, RHEOL ACTA, V39, P163, DOI 10.1007/s003970050016
   Sandford P.A., 1987, IND POLYSACCHARIDES
   SANFORD PA, 1989, CHITIN CHITOSAN
   Sashiwa H, 2003, CARBOHYD RES, V338, P557, DOI 10.1016/S0008-6215(02)00492-5
   Savarmand S, 2003, J RHEOL, V47, P1133, DOI 10.1122/1.1603237
   Seong HS, 2000, J APPL POLYM SCI, V76, P2009, DOI 10.1002/(SICI)1097-4628(20000628)76:14<2009::AID-APP3>3.0.CO;2-W
   Sieval AB, 1998, CARBOHYD POLYM, V36, P157, DOI 10.1016/S0144-8617(98)00009-5
   Singla AK, 2001, J PHARM PHARMACOL, V53, P1047, DOI 10.1211/0022357011776441
   Stepanek P, 1998, MACROMOLECULES, V31, P1889, DOI 10.1021/ma970458u
   TAKAHASHI A, 1967, J PHYS CHEM-US, V71, P2001, DOI 10.1021/j100866a600
   Thanou M, 2002, BIOMATERIALS, V23, P153, DOI 10.1016/S0142-9612(01)00090-4
   Thimm W, 1999, J RHEOL, V43, P1663, DOI 10.1122/1.551066
   Tsaih ML, 1999, J APPL POLYM SCI, V71, P1905, DOI 10.1002/(SICI)1097-4628(19990314)71:11<1905::AID-APP21>3.0.CO;2-J
   Vega JF, 2004, J RHEOL, V48, P663, DOI 10.1122/1.1718367
   Wood-Adams PM, 1996, J RHEOL, V40, P761, DOI 10.1122/1.550763
   Wood-Adams PM, 2001, ABSTR PAP AM CHEM S, V221, pU396
   Xu F, 1999, MED PHYS, V26, P1371, DOI 10.1118/1.598633
   Yang HY, 2005, EUR POLYM J, V41, P329, DOI 10.1016/j.eurpolymj.2004.10.002
   Young R.J., 1991, INTRO POLYM
NR 70
TC 68
Z9 70
U1 2
U2 35
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1525-7797
J9 BIOMACROMOLECULES
JI Biomacromolecules
PD OCT 9
PY 2006
VL 7
IS 10
BP 2845
EP 2855
DI 10.1021/bm060436s
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Organic; Polymer Science
SC Biochemistry & Molecular Biology; Chemistry; Polymer Science
GA 092OG
UT WOS:000241106600021
PM 17025361
DA 2018-10-19
ER

PT J
AU Bonomini, M
   Pavone, B
   Sirolli, V
   Del Buono, F
   Di Cesare, M
   Del Boccio, P
   Amoroso, L
   Di Ilio, C
   Sacchetta, P
   Federici, G
   Urbani, A
AF Bonomini, Mario
   Pavone, Barbara
   Sirolli, Vittorio
   Del Buono, Francesca
   Di Cesare, Moreno
   Del Boccio, Piero
   Amoroso, Luigi
   Di Ilio, Carmine
   Sacchetta, Paolo
   Federici, Giorgio
   Urbani, Andrea
TI Proteomics characterization of protein adsorption onto hemodialysis
   membranes
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE protein adsorption; hemodialysis; membrane material; minidialyzer;
   proteomics; mass spectrometry
ID MALDI MASS-SPECTROMETRY; DIALYSIS MEMBRANE; BIOMATERIAL SURFACES;
   BIOCOMPATIBILITY; ACTIVATION; PLASMA; IDENTIFICATION; POLYMERS; BLOOD;
   ELECTROPHORESIS
AB Protein-adsorptive properties are a key feature of membranes used for hemodialysis treatment. Protein adsorption is vital to the biocompatibility of a membrane material and influences membrane's performance. The object of the present study is to investigate membrane biocompatibility by correlating the adsorbed proteome repertoire with structural feature of the membrane surfaces. Minidialyzers of identical structural characteristics composed of either cellulose diacetate or ethylenevinyl alcohol materials were employed to develop an ex vivo apparatus to investigate protein adsorption. Adsorbed proteins were eluted by a strong chaotropic buffer condition and investigated by 2-DE coupled to both MALDI-TOF mass spectrometry (MS) mass fingerprinting and fragmentation analysis on a nanoLC-MS/MS hybrid instrument. Membrane surface characterization included evaluation of roughness (atomic force microscopy), elemental chemical composition (X-ray-photoelectron-spectroscopy), and hydrophilicity (pulsed nuclear magnetic resonance). The present study identifies a number of different proteins as common or characteristic of filter material interaction, showing that proteomic techniques are a promising approach for the investigation of proteins surface-adsorbed onto hemodialysis membrane. Proteomic analysis enables the characterization of protein layers of unknown composition.
C1 Univ G dAnnunzio, Ctr Invest Aging, Ctr Studi Invecchiamento, CeSI,Ist Clin Nefrol,Dipartimento, I-66100 Chieti, Italy.
   Univ G dAnnunzio, Dipartimento Sci Biocmed, Pescara, Italy.
   Univ Roma Tor Vergata, Policlin Tor Vergata, Dipartimento Med Lab, Rome, Italy.
   Univ Roma Tor Vergata, Dipartimento Med Interna, Rome, Italy.
   IRCCS, Fdn Santa Lucia, Rome, Italy.
RP Bonomini, M (reprint author), Univ G dAnnunzio, Ctr Invest Aging, Ctr Studi Invecchiamento, CeSI,Ist Clin Nefrol,Dipartimento, Via Cole Ara,Chieti Scalo, I-66100 Chieti, Italy.
EM m.bonomini@nephro.unich.it; a.urbani@unich.it
CR ANDERSON JM, 1990, INT J ARTIF ORGANS, V13, P375
   Anderson NL, 1998, ELECTROPHORESIS, V19, P1853, DOI 10.1002/elps.1150191103
   Aoyagi S, 2004, J MEMBRANE SCI, V236, P91, DOI 10.1016/j.memsci.2004.02.010
   Banks RE, 2000, LANCET, V356, P1749, DOI 10.1016/S0140-6736(00)03214-1
   BASILE C, 1989, NEPHRON, V52, P113, DOI 10.1159/000185612
   BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1357, DOI 10.1002/elps.11501401209
   BONOMINI V, 1991, NEPHROL DIAL TRANSPL, V6, P1
   Bouman CSC, 1998, BLOOD PURIFICAT, V16, P261, DOI 10.1159/000014343
   Chanard J, 2003, NEPHROL DIAL TRANSPL, V18, P252, DOI 10.1093/ndt/18.2.252
   CHEUNG AK, 1990, KIDNEY INT, V37, P1055, DOI 10.1038/ki.1990.85
   CHEUNG AK, 1991, BLOOD PURIFICAT, V9, P153, DOI 10.1159/000170012
   Cornelius RM, 2002, BIOMATERIALS, V23, P3583, DOI 10.1016/S0142-9612(02)00083-2
   CORNELIUS RM, 1993, J BIOMAT SCI-POLYM E, V4, P291, DOI 10.1163/156856293X00573
   Frank RD, 2001, KIDNEY INT, V60, P1972, DOI 10.1046/j.1523-1755.2001.00009.x
   Goldman M, 1987, Nephrol Dial Transplant, V2, P576
   GORG A, 1988, ELECTROPHORESIS, V9, P531, DOI 10.1002/elps.1150090913
   Griesser HJ, 2004, BIOMATERIALS, V25, P4861, DOI 10.1016/j.biomaterials.2004.01.049
   HAKIM RM, 1993, KIDNEY INT, V44, P484, DOI 10.1038/ki.1993.272
   HAYCOX CL, 1993, J BIOMED MATER RES, V27, P1181, DOI 10.1002/jbm.820270909
   Ishii Y, 1996, NEPHRON, V73, P407
   JOHNSON RJ, 1994, NEPHROL DIAL TRANSPL, V9, P36
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEVITSKI T, 2004, J AM SOC NEPHROL, V15, pA364
   LONNEMANN G, 1988, J LAB CLIN MED, V112, P76
   Magnani A, 2004, ELECTROPHORESIS, V25, P2413, DOI 10.1002/elps.200305826
   MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296
   MIYATA T, 1993, J CLIN INVEST, V92, P1243, DOI 10.1172/JCI116696
   MONDECCHINI M, 1995, BLOOD PURIFICAT, V13, P322
   Mortz E, 2001, PROTEOMICS, V1, P1359, DOI 10.1002/1615-9861(200111)1:11<1359::AID-PROT1359>3.0.CO;2-Q
   MUJAIS SK, 1995, CONTRIB NEPHROL, V113, P101
   MULZER SR, 1989, J BIOMED MATER RES, V23, P1483, DOI 10.1002/jbm.820231210
   Oleschuk RD, 2000, BIOMATERIALS, V21, P1701, DOI 10.1016/S0142-9612(00)00054-5
   PASCAL M, 1996, KIDNEY INT, V43, P903
   Pascual M, 1996, KIDNEY INT, V49, P309, DOI 10.1038/ki.1996.47
   Rumpf K W, 1977, Proc Eur Dial Transplant Assoc, V14, P607
   Sirolli V, 2002, INT J ARTIF ORGANS, V25, P529
   THONYBOONKEND V, 2004, CONTRIBUTION NEPHROL, V141, P1
   Urbani A, 2005, PROTEOMICS, V5, P796, DOI 10.1002/pmic.200401147
   Valette P, 1999, BIOMATERIALS, V20, P1621, DOI 10.1016/S0142-9612(99)00070-8
   Vienken J, 2002, INT J ARTIF ORGANS, V25, P470
   Walker AK, 1999, ANAL CHEM, V71, P268, DOI 10.1021/ac980750f
   Walker AK, 2000, J AM SOC MASS SPECTR, V11, P62, DOI 10.1016/S1044-0305(99)00117-8
   Ward RA, 2004, CONTRIB NEPHROL, V141, P280
   Weissinger EM, 2004, NEPHROL DIAL TRANSPL, V19, P3068, DOI 10.1093/ndt/gfh509
   Werner C, 1999, INT J ARTIF ORGANS, V22, P160
NR 45
TC 37
Z9 38
U1 0
U2 14
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD OCT 6
PY 2006
VL 5
IS 10
BP 2666
EP 2674
DI 10.1021/pr060150u
PG 9
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 091UF
UT WOS:000241053100018
PM 17022637
DA 2018-10-19
ER

PT J
AU Di Bonaventura, G
   Pompilio, A
   Picciani, C
   Iezzi, M
   D'Antonio, D
   Piccolomini, R
AF Di Bonaventura, Giovanni
   Pompilio, Arianna
   Picciani, Carla
   Iezzi, Manuela
   D'Antonio, Domenico
   Piccolomini, Raffaele
TI Biofilm formation by the emerging fungal pathogen Trichosporon asahii:
   Development, architecture, and antifungal resistance
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID CANDIDA-ALBICANS; IN-VITRO; INFECTION; AGENTS; CUTANEUM
AB Dichosporon asahii is the most common cause of fatal disseminated trichosporonosis, frequently associated with indwelling medical devices. Despite the use of antifungal drugs to treat trichosporonosis, infection is often persistent and is associated with high mortality. This drove our interest in evaluating the capability of T. asahii to form a biofilm on biomaterial-representative polystyrene surfaces through the development and optimization of a reproducible T. asahii-associated biofilm model. Time course analyses of viable counts and a formazan salt reduction assay, as well as microscopy studies, revealed that biofilm formation by T. asahii occurred in an organized fashion through four distinct developmental phases: initial adherence of yeast cells (0 to 2 h), germination and microcolony formation (2 to 4 h), filamentation (4 to 6 h), and proliferation and maturation (24 to 72 h). Scanning electron microscopy and confocal scanning laser microscopy revealed that mature T. asahii biofilms (72-h) displayed a complex, heterogeneous three-dimensional structure, consisting of a dense network of metabolically active yeast cells and hyphal elements completely embedded within exopolymeric material. Antifungal susceptibility testing demonstrated a remarkable rise in the MICs of sessile T. asahii cells against clinically used amphotericin B, caspofungin, voriconazole, and fluconazole compared to their planktonic counterparts. In particular, T. asahii biotilms were up to 16,000 times more resistant to voriconazole, the most active agent against planktonic cells (MIC, 0.06 mu g/ml). Our results suggest that the ability of T. asahii to form a biofilm may be a major factor in determining persistence of the infection in spite of in vitro susceptibility of clinical isolates.
C1 Univ G dAnnunzio, Dept Biomed Sci G Annunzio, Lab Clin Microbiol, Chieti, Italy.
   Gabriele Annunzio Univ Fdn, Aging Res Ctr, CeSI, Chieti, Italy.
   Santo Spirito Hosp, Clin Microbiol Serv, Dept Hematol & Oncol, Pescara, Italy.
RP Di Bonaventura, G (reprint author), CeSI, Lab Clin Microbiol, Via Colle Ara, I-66013 Chieti, Italy.
EM giovannidibo@hotmail.com
OI Iezzi, Manuela/0000-0002-6296-6498; Di Bonaventura,
   Giovanni/0000-0001-5850-2810
CR Abdala E, 2005, TRANSPL INFECT DIS, V7, P162, DOI 10.1111/j.1399-3062.2005.00104.x
   Armitage Gary C, 2004, Ann R Australas Coll Dent Surg, V17, P30
   Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001
   Chandra J, 2005, CURR DRUG TARGETS, V6, P887, DOI 10.2174/138945005774912762
   Chowdhary A, 2004, Indian J Med Microbiol, V22, P16
   Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000
   Di Bonaventura G, 2004, ANTIMICROB AGENTS CH, V48, P151, DOI 10.1128/AAC.48.1.151-160.2004
   Groll AH, 2001, CLIN MICROBIOL INFEC, V7, P8, DOI 10.1111/j.1469-0691.2001.tb00005.x
   GUEHO E, 1992, ANTON LEEUW INT J G, V61, P289, DOI 10.1007/BF00713938
   HAWSER SP, 1995, ANTIMICROB AGENTS CH, V39, P2128, DOI 10.1128/AAC.39.9.2128
   Hawser SP, 1998, J CLIN MICROBIOL, V36, P1450
   Herbrecht R., 1993, Journal de Mycologie Medicale, V3, P129
   HOSPENTHAL DR, 2000, PRINCIPALS PRACTICE, P2778
   KREMERY V, 1997, SUPPORT CARE CANCER, V7, P39
   Krzossok S, 2004, CLIN NEPHROL, V62, P66
   Kuhn DM, 2002, INFECT IMMUN, V70, P878, DOI 10.1128/IAI.70.2.878-888.2002
   Kwon-Chung K.J., 1992, MED MYCOL, P768
   Lo Passo C, 2001, MYCOSES, V44, P13, DOI 10.1046/j.1439-0507.2001.00614.x
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   McGinnis MR, 1998, MED MYCOL, V36, P239, DOI 10.1080/02681219880000361
   Mooty MY, 2001, EUR J CLIN MICROBIOL, V20, P139, DOI 10.1007/PL00011245
   Moretti-Branchini ML, 2001, DIAGN MICR INFEC DIS, V39, P161, DOI 10.1016/S0732-8893(01)00215-2
   Mukherjee PK, 2004, DRUG RESIST UPDATE, V7, P301, DOI 10.1016/j.drup.2004.09.002
   *NAT COMM CLIN LAB, 2002, M27A2 NAT COMM CLIN, V22
   Paphitou NI, 2002, ANTIMICROB AGENTS CH, V46, P1144, DOI 10.1128/AAC.46.4.1144-1146.2002
   Pini G, 2005, MYCOSES, V48, P45, DOI 10.1111/j.1439-0507.2004.01062.x
   Ramage G, 2001, J CLIN MICROBIOL, V39, P3234, DOI 10.1128/JCM.39.9.3234-3240.2001
   Silva Victor, 2003, Revista Iberoamericana de Micologia, V20, P21
   Sugita T, 1998, J CLIN MICROBIOL, V36, P2742
   SUGITA T, 1994, J GEN APPL MICROBIOL, V40, P397, DOI 10.2323/jgam.40.397
   SUGITA T, 1995, J CLIN MICROBIOL, V33, P1368
   TASHIRO T, 1994, EUR J CLIN MICROBIOL, V13, P218, DOI 10.1007/BF01974540
   WALSH TJ, 1986, MEDICINE, V65, P268, DOI 10.1097/00005792-198607000-00005
   Walsh TJ, 2004, CLIN MICROBIOL INFEC, V10, P48, DOI 10.1111/j.1470-9465.2004.00839.x
NR 34
TC 81
Z9 83
U1 1
U2 11
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD OCT
PY 2006
VL 50
IS 10
BP 3269
EP 3276
DI 10.1128/AAC.00556-06
PG 8
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA 091IX
UT WOS:000241021700006
PM 17005804
OA Green Published, Bronze
DA 2018-10-19
ER

PT J
AU Kirkpatrick, CJ
   Fuchs, S
   Peters, K
   Brochhausen, C
   Hermanns, MI
   Unger, RE
AF Kirkpatrick, C. James
   Fuchs, Sabine
   Peters, Kirsten
   Brochhausen, Christoph
   Hermanns, M. Iris
   Unger, Ronald E.
TI Visions for regenerative medicine: Interface between scientific fact and
   science fiction
SO ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 43rd Tutzing Symposium on Regenerative Medicine - Membranes and
   Scaffolds
CY NOV 20-23, 2005
CL Tutzing, GERMANY
SP DECHEMA
DE regenerative medicine; materials sciences; life sciences; intelligent
   materials-stem cells; drug delivery; gene therapy
ID SILK FIBROIN NET; IN-VITRO; ENDOTHELIAL-CELLS; STEM-CELL; SYSTEMS;
   MODELS; BIOCOMPATIBILITY; DIFFERENTIATION; ANGIOGENESIS; COCULTURE
AB This article gives a brief overview of the authors' views on the future development of tissue engineering with respect to the challenges both to the materials and life sciences. Emphasis will be placed on the advantages of three-dimensional bioresorbable polymers in combination with relevant molecular cues and the application of autologous stem or progenitor cells. There is a requirement for much more diversity in the synthesis of so-called "intelligent" materials, which respond to external stimuli, as well as the development of novel drug and gene delivery systems. In addition, much more basic research is necessary in developmental biology and the application of modern cell and molecular biology to biomaterial questions.
C1 Univ Mainz, Inst Pathol, REPAIR Lab, D-55101 Mainz, Germany.
RP Kirkpatrick, CJ (reprint author), Univ Mainz, Inst Pathol, REPAIR Lab, Langenbeck Str 1, D-55101 Mainz, Germany.
EM kirkpatrick@repair-lab.org
RI Peters, Kirsten/S-3484-2016
CR Birgersdotter A, 2005, SEMIN CANCER BIOL, V15, P405, DOI 10.1016/j.semcancer.2005.06.009
   Black AF, 1999, CELL BIOL TOXICOL, V15, P81, DOI 10.1023/A:1007541713398
   Deutsch M, 1999, SURGERY, V126, P847, DOI 10.1067/msy.2099.99852
   Dorsett-Martin WA, 2004, WOUND REPAIR REGEN, V12, P591, DOI 10.1111/j.1067-1927.2004.12601.x
   Estes BT, 2004, CURR TOP DEV BIOL, V60, P91
   Fausto N, 1999, AM J PHYSIOL-GASTR L, V277, pG917, DOI 10.1152/ajpgi.1999.277.5.G917
   Fittkau MH, 2005, BIOMATERIALS, V26, P167, DOI 10.1016/j.biomaterials.2004.02.012
   Gatti AM, 2004, BIOMATERIALS, V25, P385, DOI 10.1016/S0142-9612(03)00537-4
   Hermanns MI, 2004, LAB INVEST, V84, P736, DOI 10.1038/labinvest.3700081
   Hirose M, 2000, YONSEI MED J, V41, P803, DOI 10.3349/ymj.2000.41.6.803
   HOFFMAN AS, 1988, ARTIF ORGANS, V12, P504, DOI 10.1111/j.1525-1594.1988.tb02813.x
   Josserand V, 2006, J PHARMACOL EXP THER, V316, P79, DOI 10.1124/jpet.105.089102
   Kaito T, 2005, BIOMATERIALS, V26, P73, DOI 10.1016/j.biomaterials.2004.02.010
   Kirkpatrick CJ, 2003, J MATER SCI-MATER M, V14, P677, DOI 10.1023/A:1024903514335
   Kirkpatrick CJ, 2002, BIOMOL ENG, V19, P211, DOI 10.1016/S1389-0344(02)00019-9
   Lai CH, 2005, BRAIN RES REV, V50, P258, DOI 10.1016/j.brainreserv.2005.07.004
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397
   Park KH, 2003, J BIOL CHEM, V278, P50212, DOI 10.1074/jbc.M310216200
   Peters K, 2002, BIOMATERIALS, V23, P3413, DOI 10.1016/S0142-9612(02)00042-X
   Riha GM, 2005, ANN BIOMED ENG, V33, P772, DOI 10.1007/s10439-005-3310-9
   Rolland JP, 2005, J AM CHEM SOC, V127, P10096, DOI 10.1021/ja051977c
   SCHOFIELD R, 1978, BLOOD CELLS, V4, P7
   Seliktar D, 2004, J BIOMED MATER RES A, V68A, P704, DOI 10.1002/jbm.a.20091
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Sorkin AM, 2004, AM J PHYSIOL-CELL PH, V287, pC1527, DOI 10.1152/ajpcell.00059.2004
   Stayton Patrick S., 2004, V283, P37
   Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x
   Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200462.9446.d7
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Unger RE, 2004, BIOMATERIALS, V25, P1069, DOI [10.1016/S0142-9612(03)00619-7, 10.1016/S0142-9612(03)00630-6]
   Uprichard SL, 2005, FEBS LETT, V579, P5996, DOI 10.1016/j.febslet.2005.08.004
   Wang M, 2002, J MATER SCI-MATER M, V13, P607, DOI 10.1023/A:1015139213211
   Welss T, 2004, TOXICOL IN VITRO, V18, P231, DOI 10.1016/j.tiv.2003.09.009
   Williams BR, 2005, NEW ENGL J MED, V353, P1410, DOI 10.1056/NEJMcibr052492
NR 36
TC 23
Z9 23
U1 2
U2 4
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0160-564X
J9 ARTIF ORGANS
JI Artif. Organs
PD OCT
PY 2006
VL 30
IS 10
BP 822
EP 827
DI 10.1111/j.1525-1594.2006.00306.x
PG 6
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 090ZT
UT WOS:000240995800013
PM 17026583
DA 2018-10-19
ER

PT J
AU De Laporte, L
   Rea, JC
   Shea, LD
AF De Laporte, L
   Rea, JC
   Shea, LD
TI Design of modular non-viral gene therapy vectors
SO BIOMATERIALS
LA English
DT Article
DE gene therapy; vector; lipoplex; polyplex; cell trafficking
ID CARBOHYDRATE-CONTAINING POLYCATIONS; NUCLEAR-LOCALIZATION SEQUENCE;
   LIPID-DNA COMPLEXES; IN-VIVO; DELIVERY VEHICLES; PLASMID DELIVERY;
   CATIONIC LIPIDS; EXPRESSION; PEPTIDE; RELEASE
AB Gene delivery has numerous potential applications both clinically and for basic science research. Non-viral vectors represent the long-term future of gene therapy and biomaterials are a critical component for the development of efficient delivery systems. Biomaterial development combined with fundamental studies of virus function and cellular processes will enable the molecular level design of modular vectors. Vectors are being developed based on cationic polymers or lipids that contain functional groups to mediate appropriate interactions with the extracellular environment or to interface with specific cellular processes. This review describes recent progress on the development of biomaterials for non-viral vectors and highlights opportunities for future development. Ultimately, efficient vectors will expand the traditional applications of gene therapy within the clinic and may enable numerous other opportunities within diagnostics, biotechnology, and basic science research. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.
RP Shea, LD (reprint author), Northwestern Univ, Dept Chem & Biol Engn, 2145 Sheridan Rd E156, Evanston, IL 60208 USA.
EM l-shea@northwestern.edu
RI De Laporte, Laura/B-9980-2014; Shea, Lonnie/B-7615-2009
OI De Laporte, Laura/0000-0002-9438-0977; Rea, Jennifer/0000-0002-7405-6790
FU NIGMS NIH HHS [R01 GM066830, R01 GM066830-01A1]; NIBIB NIH HHS [R01
   EB003806-01, R01 EB003806]
CR Agarwal A, 2005, J CONTROL RELEASE, V103, P245, DOI 10.1016/j.jconrel.2004.11.022
   Akinc A, 2003, J AM CHEM SOC, V125, P5316, DOI 10.1021/ja034429c
   Anderson DG, 2003, ANGEW CHEM INT EDIT, V42, P3153, DOI 10.1002/anie.200351244
   Anderson DG, 2005, MOL THER, V11, P426, DOI 10.1016/j.ymthe.2004.11.015
   Bajaj B, 2001, BIOTECHNOL PROGR, V17, P587, DOI 10.1021/bp010039n
   Baru M, 1998, J DRUG TARGET, V6, P191, DOI 10.3109/10611869808997893
   Blessing T, 2001, BIOCONJUGATE CHEM, V12, P529, DOI 10.1021/bc0001488
   Boulanger C, 2004, BIOCONJUGATE CHEM, V15, P901, DOI 10.1021/bc049942+
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Braun CS, 2005, J PHARM SCI-US, V94, P423, DOI 10.1002/jps.20251
   Bremner KH, 2004, BIOCONJUGATE CHEM, V15, P152, DOI 10.1021/bc034140k
   Check E, 2003, NATURE, V423, P573, DOI 10.1038/423573a
   Chen Y, 2001, GENE THER, V8, P1024, DOI 10.1038/sj.gt.3301482
   Dean DA, 2005, GENE THER, V12, P881, DOI 10.1038/sj.gt.3302534
   Ewert KK, 2005, EXPERT OPIN BIOL TH, V5, P33, DOI 10.1517/14712598.5.1.33
   Gruneich JA, 2004, GENE THER, V11, P668, DOI 10.1038/sj.gt.3302214
   Gupta M, 2004, J CONTROL RELEASE, V99, P157, DOI 10.1016/j.jconrel.2004.06.016
   Huang YC, 2005, HUM GENE THER, V16, P609, DOI 10.1089/hum.2005.16.609
   Jang JH, 2005, MOL THER, V12, P475, DOI 10.1016/j.ymrhe.2005.03.036
   Kelkar SA, 2004, J VIROL, V78, P10122, DOI 10.1128/JVI.78.18.10122-10132.2004
   Kichler A, 2004, J GENE MED, V6, pS3, DOI 10.1002/jgm.507
   Kichler Antoine, 1997, Bioconjugate Chemistry, V8, P213, DOI 10.1021/bc970009z
   Kim SH, 2005, J CONTROL RELEASE, V103, P625, DOI 10.1016/j.jconrel.2004.01.006
   Kircheis R, 1997, GENE THER, V4, P409, DOI 10.1038/sj.gt.3300418
   KONG HJ, 2005, NAT MAT
   Kunath K, 2003, J GENE MED, V5, P588, DOI 10.1002/jgm.382
   Leong KW, 1998, J CONTROL RELEASE, V53, P183, DOI 10.1016/S0168-3659(97)00252-6
   Li S, 1999, AM J PHYSIOL-LUNG C, V276, pL796, DOI 10.1152/ajplung.1999.276.5.L796
   Liu YM, 2005, J AM CHEM SOC, V127, P3004, DOI 10.1021/ja0436446
   Liu YM, 2004, J AM CHEM SOC, V126, P7422, DOI 10.1021/ja049831l
   Martin-Herranz A, 2004, BIOPHYS J, V86, P1160, DOI 10.1016/S0006-3495(04)74190-9
   Morris MC, 2000, CURR OPIN BIOTECH, V11, P461, DOI 10.1016/S0958-1669(00)00128-2
   Neu M, 2005, J GENE MED, V7, P992, DOI 10.1002/jgm.773
   Ogris M, 1999, GENE THER, V6, P595, DOI 10.1038/sj.gt.3300900
   Pannier AK, 2005, ACTA BIOMATER, V1, P511, DOI 10.1016/j.actbio.2005.05.004
   Pannier AK, 2004, MOL THER, V10, P19, DOI 10.1016/j.ymthe.2004.03.020
   Popielarski SR, 2003, BIOCONJUGATE CHEM, V14, P672, DOI 10.1021/bc034010b
   Reineke TM, 2003, BIOCONJUGATE CHEM, V14, P247, DOI 10.1021/bc025592k
   Ritter W, 2003, J MOL MED-JMM, V81, P708, DOI 10.1007/s00109-003-0483-2
   Roth CM, 2004, ANNU REV BIOMED ENG, V6, P397, DOI 10.1146/annurev.bioeng.6.040803.140203
   Schaffer DV, 2000, BIOTECHNOL BIOENG, V67, P598, DOI 10.1002/(SICI)1097-0290(20000305)67:5<598::AID-BIT10>3.0.CO;2-G
   Scherer F, 2002, J GENE MED, V4, P634, DOI 10.1002/jgm.298
   Segura T, 2005, BIOMATERIALS, V26, P1575, DOI 10.1016/j.biomaterials.2004.05.007
   Segura T, 2003, J CONTROL RELEASE, V93, P69, DOI 10.1016/j.jconrel.2003.08.003
   Segura T, 2001, ANNU REV MATER RES, V31, P25, DOI 10.1146/annurev.matsci.31.1.25
   Tranchant I, 2004, J GENE MED, V6, pS24, DOI 10.1002/jgm.509
   URNOV FD, 2005, NATURE
   VARGA CM, 2005, GENE THER
   Wang J, 2002, GENE THER, V9, P1254, DOI 10.1038/sj.gt.3301794
   Wyman TB, 1997, BIOCHEMISTRY-US, V36, P3008, DOI 10.1021/bi9618474
   Zhang JT, 2004, LANGMUIR, V20, P8015, DOI 10.1021/la048888i
   Zhang XH, 2003, J GENE MED, V5, P209, DOI 10.1002/jgm.340
   Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114
NR 53
TC 124
Z9 130
U1 3
U2 38
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2006
VL 27
IS 7
BP 947
EP 954
DI 10.1016/j.biomaterials.2005.09.036
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 996BB
UT WOS:000234148300001
PM 16243391
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Hollander, DA
   von Walter, M
   Wirtz, T
   Sellei, R
   Schmidt-Rohlfing, B
   Paar, O
   Erli, HJ
AF Hollander, DA
   von Walter, M
   Wirtz, T
   Sellei, R
   Schmidt-Rohlfing, B
   Paar, O
   Erli, HJ
TI Structural, mechanical and in vitro characterization of individually
   structured Ti-6Al-4V produced by direct laser forming
SO BIOMATERIALS
LA English
DT Article
DE titanium alloy; rapid prototyping; structure; mechanical properties;
   osteoblast; cell spreading
ID SCAFFOLDS
AB Direct laser forming (DLF) is a rapid prototyping technique which enables prompt modelling of metal parts with high bulk density on the base of individual three-dimensional data, including computer tomography models of anatomical structures. In our project, we tested DLF-produced material on the basis of the titanium alloy Ti-6Al-4V for its applicability as hard tissue biomaterial. To this end, we investigated mechanical and structural properties of DLF-Ti-6Al-4V. While the tensile and yield strengths of untreated DLF alloy ranged beyond 1000 MPa, a breaking elongation of 6.5 +/- 0.6% was determined for this material. After an additional post-DLF annealing treatment, this parameter was increased two-fold to 13.0 +/- 0.6%, while tensile and yield strengths were reduced by approx. 8%. A Young's modulus of 118.000 +/- 2.300 MPa was determined for post-DLF annealed Ti-6Al-4V. All data gained from tensile testing of post-DLF annealed Ti-6Al-4V matched American Society of Testing and Materials (ASTM) specifications for the usage of this alloy as medical material. Rotating bending tests revealed that the fatigue profile of post-DLF annealed Ti-6Al-4V was comparable to casted/hot isostatic pressed alloy. We characterized the structure of non-finished DLF-Ti-6Al-4V by scanning electron microscopy and observed a surface-associated layer of particles, which was removable by sandblasting as a finishing step. We manufactured porous specimens with nominal pore diameters of 500, 700 and 1000 mu m. The diameters were reduced by the used DLF processing by approx. 300 mu m. In an in vitro investigation, we cultured human osteoblasts on non-porous and porous blasted DLF-Ti-6Al-4V specimens to study morphology, vitality, proliferation and differentiation of the cells. The cells spreaded and proliferated on DLF-Ti-6Al-4V over a culture time of 14 days. On porous specimens, osteoblasts grew along the rims of the pores and formed circle-shaped structures, as Visualized by live/dead staining as well as scanning electron microscopy. Overall, the DLF-Ti-6Al-4V approach proved to be efficient and could be further advanced in the field of hard tissue biomaterials. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Hosp Aachen, Dept Trauma Surg, D-52074 Aachen, Germany.
   Fraunhofer Inst Lasertech, D-5100 Aachen, Germany.
RP von Walter, M (reprint author), Univ Hosp Aachen, Dept Trauma Surg, Pauwelsstr 30, D-52074 Aachen, Germany.
EM UC-labor@ukaachen.de
CR Antonov EN, 2005, ADV MATER, V17, P327, DOI 10.1002/adma.200400838
   Berry E, 1997, MED ENG PHYS, V19, P90, DOI 10.1016/S1350-4533(96)00039-2
   HUGHES J, 1997, METHODS BONE BIOL, P1
   HULBERT S F, 1970, Journal of Biomedical Materials Research, V4, P433, DOI 10.1002/jbm.820040309
   Ku CH, 2002, BIOMATERIALS, V23, P1447, DOI 10.1016/S0142-9612(01)00266-6
   Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9
   MEINERS W, 1999, P SOL FREEF FABR S A
   PULEO DA, 1991, J BIOMED MATER RES, V25, P711, DOI 10.1002/jbm.820250603
   SCHLIEPHAKE H, 1991, INT J ORAL MAX SURG, V20, P52, DOI 10.1016/S0901-5027(05)80698-8
   SODEK J, 1987, METHOD ENZYMOL, V145, P303
   Tan KH, 2005, BIO-MED MATER ENG, V15, P113
   WILLIAMS DF, 1981, TITANIUM TITANIUM AL
   Zong G., 1992, P SOL FREEF FABR S U, P72
   2004, ANN BOOK ASTM STAND
NR 14
TC 215
Z9 228
U1 6
U2 84
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2006
VL 27
IS 7
BP 955
EP 963
DI 10.1016/j.biomaterials.2005.07.041
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 996BB
UT WOS:000234148300002
PM 16115681
DA 2018-10-19
ER

PT J
AU Woodfield, TBF
   Miot, S
   Martin, I
   van Blitterswijk, CA
   Riesle, J
AF Woodfield, TBF
   Miot, S
   Martin, I
   van Blitterswijk, CA
   Riesle, J
TI The regulation of expanded human nasal chondrocyte re-differentiation
   capacity by substrate composition and gas plasma surface modification
SO BIOMATERIALS
LA English
DT Article
DE chondrocyte; gene expression; surface modification; PCR; fibronectin;
   vitronectin; cartilage tissue engineering
ID HUMAN ARTICULAR CHONDROCYTES; BIODEGRADABLE POLYMERS; CELL-ADHESION;
   CARTILAGE; CULTURE; FIBRONECTIN; DEPOSITION; PHENOTYPE; SCAFFOLDS; VITRO
AB Optimizing re-differentiation of clinically relevant cell sources on biomaterial substrates in serum containing (S+) and serum-free (SF) media is a key consideration in scaffold-based articular cartilage repair strategies. We investigated whether the adhesion and post-expansion re-differentiation of human chondrocytes could be regulated by controlled changes in substrate surface chemistry and composition in S+ and SF media following gas plasma (GP) treatment. Expanded human nasal chondrocytes were plated on gas plasma treated (GP+) or untreated (GP-) poly(ethylene glycol)-terephthalate-poly(butylene terephthalate) (PEGT/PBT) block co-polymer films with two compositions (low or high PEG content). Total cellularity, cell morphology and immunofluorescent staining of vitronectin (VN) and fibronectin (FN) integrin receptors were evaluated, while post-expansion chondrogenic phenotype was assessed by collagen types I and II mRNA expression.
   We observed a direct relationship between cellularity, cell morphology and re-differentiation potential. Substrates supporting high cell adhesion and a spread morphology (i.e. GP+ and low PEG content films), resulted in a significantly greater number of cells expressing alpha(5)beta(1) FN to alpha(V)beta(3) VN integrin receptors, concomitant with reduced collagen type II/I mRNA gene expression. Substrates supporting low cell adhesion and a spherical morphology (GP- and high PEG content films) promoted chondrocyte redifferentiation indicated by high collagen type II/I gene expression and a low percentage of alpha(5)beta(1) FN integrin expressing cells.
   This study demonstrates that cell-substrate interactions via alpha(5)beta(1) FN integrin mediated receptors negatively impacts expanded human nasal chondrocyte re-differentiation capacity. GP treatment promotes cell adhesion in S + media but reverses the ability of low PEG content PEGT/PBT substrates to maintain chondrocyte phenotype. We suggest alternative cell immobilization techniques to GP are necessary for clinical application in articular cartilage repair. (c) 2005 Elsevier Ltd. All rights reserved.
C1 Univ Canterbury, Ctr Bioengn, Christchurch 8020, New Zealand.
   Univ Twente, Inst Biomed Technol, Bilthoven Res Grp, NL-3723 MB Bilthoven, Netherlands.
   Univ Basel, Dept Surg, CH-4031 Basel, Switzerland.
   Univ Basel, Dept Res, CH-4031 Basel, Switzerland.
   Cell Co Tec BV, NL-3723 MB Bilthoven, Netherlands.
RP Woodfield, TBF (reprint author), Univ Canterbury, Ctr Bioengn, Private Bag 4800, Christchurch 8020, New Zealand.
EM tim.woodfield@canterbury.ac.nz
RI Woodfield, Tim/A-2705-2009
OI Woodfield, Tim/0000-0002-5428-7575; van Blitterswijk,
   Clemens/0000-0003-2371-4615
CR Altankov G, 2000, J BIOMED MATER RES, V52, P219, DOI 10.1002/1097-4636(200010)52:1<219::AID-JBM28>3.0.CO;2-F
   Barbero A, 2003, ARTHRITIS RHEUM, V48, P1315, DOI 10.1002/art.10950
   Basser PJ, 1998, ARCH BIOCHEM BIOPHYS, V351, P207, DOI 10.1006/abbi.1997.0507
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   BEUMER GJ, 1993, BIOMATERIALS, V14, P598, DOI 10.1016/0142-9612(93)90178-5
   CHAWLA A, 1986, POLYM BIOMATERIALS, P221
   Chim H, 2003, J BIOMED MATER RES A, V65A, P327, DOI 10.1002/jbm.a.10478
   Claase MB, 2003, BIOMACROMOLECULES, V4, P57, DOI 10.1021/bm0256045
   Deschamps AA, 2002, J CONTROL RELEASE, V78, P175, DOI 10.1016/S0168-3659(01)00497-7
   Goessler UR, 2005, IN VIVO, V19, P501
   Hern DL, 1998, J BIOMED MATER RES, V39, P266, DOI 10.1002/(SICI)1097-4636(199802)39:2<266::AID-JBM14>3.0.CO;2-B
   Hjelle K, 2002, ARTHROSCOPY, V18, P730, DOI 10.1053/jars.2002.32839
   HOLTZER H, 1960, P NATL ACAD SCI USA, V46, P1533, DOI 10.1073/pnas.46.12.1533
   ISHAUG SL, 1994, J BIOMED MATER RES, V28, P1445, DOI 10.1002/jbm.820281210
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   ITO Y, 1991, J BIOMED MATER RES, V25, P1325, DOI 10.1002/jbm.820251102
   Jakobsen JA, 2003, ACTA RADIOL, V44, P3
   Kafienah W, 2002, TISSUE ENG, V8, P817, DOI 10.1089/10763270260424178
   Khang G, 1997, BIO-MED MATER ENG, V7, P357
   Knudson W, 2002, CELL MOL LIFE SCI, V59, P36, DOI 10.1007/s00018-002-8403-0
   LIVECCHI AB, 1994, J BIOMED MATER RES, V28, P839, DOI 10.1002/jbm.820280802
   LYDON MJ, 1985, CELL BIOL INT REP, V9, P911, DOI 10.1016/S0309-1651(85)90112-2
   LYDON MJ, 1985, BIOMATERIALS, V6, P396, DOI 10.1016/0142-9612(85)90100-0
   Mahmood TA, 2004, EXP CELL RES, V301, P179, DOI 10.1016/j.yexcr.2004.07.027
   MAHMOOD TA, 2005, UNPUB CELL TISSUE EN
   MAROUDAS NG, 1973, NATURE, V244, P353, DOI 10.1038/244353a0
   Miot S, 2005, BIOMATERIALS, V26, P2479, DOI 10.1016/j.biomaterials.2004.06.048
   Nakao A, 1987, J Biomater Appl, V2, P219, DOI 10.1177/088532828700200203
   Papadaki M, 2001, J BIOMED MATER RES, V54, P47, DOI 10.1002/1097-4636(200101)54:1<47::AID-JBM6>3.0.CO;2-3
   PENNYPACKER JP, 1979, EXP CELL RES, V121, P411, DOI 10.1016/0014-4827(79)90022-3
   Rahman MS, 2001, TISSUE ENG, V7, P781, DOI 10.1089/107632701753337726
   Riekerink MBO, 2003, J BIOMED MATER RES A, V65A, P417, DOI 10.1002/jbm.a.10520
   STEELE JG, 1994, J BIOMAT SCI-POLYM E, V6, P511, DOI 10.1163/156856294X00473
   TAKIGAWA M, 1987, BONE MINER, V2, P449
   Tay AG, 2004, TISSUE ENG, V10, P762, DOI 10.1089/1076327041348572
   TERLINGEN JGA, 1993, J BIOMAT SCI-POLYM E, V4, P165, DOI 10.1163/156856293X00500
   VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0
   WATT FM, 1988, J CELL SCI, V89, P373
   WEST CM, 1979, CELL, V17, P491
   Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056
   Woodfield TBF, 2002, CRIT REV EUKAR GENE, V12, P209, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i3.40
   WOODFIELD TBF, 2002, T ORTHOP RES SOC, V27, P473
   Wyre R. M., 2002, Biomaterials, V23, P357, DOI 10.1016/S0142-9612(01)00113-2
NR 43
TC 68
Z9 68
U1 0
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2006
VL 27
IS 7
BP 1043
EP 1053
DI 10.1016/j.biomaterials.2005.07.032
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 996BB
UT WOS:000234148300012
PM 16125219
DA 2018-10-19
ER

PT J
AU Zhuo, R
   Vogler, EA
AF Zhuo, Rui
   Vogler, Erwin A.
TI Practical application of a chromogenic FXIIa assay
SO BIOMATERIALS
LA English
DT Article
DE blood coagulation; factor XII; Hageman factor; autoactivation;
   autohydrolysis
ID PLASMA COAGULATION CASCADE; XII HAGEMAN-FACTOR; CONTACT ACTIVATION;
   AUTOACTIVATION; ADSORPTION; SURFACES; TIME
AB Autohydrolysis of blood factor XII (FXII + FXIIa -> 2FXIIa) is found to be a facile reaction in neat-buffer buffer solutions of FXII but an insignificant reaction in the presence of plasma proteins. Autohydrolysis causes a chromogenic assay for FXIIa in buffer solution to strongly deviate from the traditional plasma-coagulation assay. Autohydrolysis can be accommodated by performing chromogenic detection of FXIIa as a rate assay in swamping concentrations of FXII. Rate-assay results performed in this way are shown to be in analytical agreement with the plasma-coagulation assay. Autohydrolysis can be used as a means of amplifying FXIIa produced by contacting neat-buffer solutions of FXII with biomaterials, suggesting a route to highly sensitive measurement of biomaterial hemocompatibility. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA.
   Dept Bioengn, University Pk, PA 16802 USA.
RP Vogler, EA (reprint author), Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA.
EM eav3@psu.edu
FU NHLBI NIH HHS [5 R01 HL 69965-04]
CR Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200
   Asmis LM, 2002, THROMB RES, V105, P463, DOI 10.1016/S0049-3848(02)00045-2
   Brown B., 1980, HEMATOLOGY PRINCIPLE
   Colman RW, 1997, BLOOD, V90, P3819
   FRIBERGER P, 1983, SEMIN THROMB HEMOST, V9, P281
   Groth T, 1997, J BIOMAT SCI-POLYM E, V8, P797, DOI 10.1163/156856297X00326
   Grunkemeier JM, 1998, J BIOMED MATER RES, V41, P657, DOI 10.1002/(SICI)1097-4636(19980915)41:4<657::AID-JBM18>3.0.CO;2-B
   Guo Z, 2006, BIOMATERIALS, V27, P796, DOI 10.1016/j.biomaterials.2005.06.021
   Hanson S. R., 1996, BIOMATERIALS SCI INT, P193
   LAVINE M, 2002, SCIENCE, V295, P995
   MARATA BM, 1996, J BIOMED MATER RES, V31, P63
   Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175
   SAITO H, 1976, J LAB CLIN MED, V88, P506
   SAMUEL M, 1992, J BIOL CHEM, V267, P19691
   TANS G, 1983, J BIOL CHEM, V258, P8215
   TANS G, 1987, SEMIN THROMB HEMOST, V13, P1987
   TRIPODI A, 1984, CLIN CHEM, V30, P1392
   VANDERKAMP KWHJ, 1995, J BIOMED MATER RES, V29, P1303, DOI 10.1002/jbm.820291018
   VOGLER EA, 1995, J BIOMED MATER RES, V29, P1005, DOI 10.1002/jbm.820290813
   VOGLER EA, 1995, J BIOMED MATER RES, V29, P1017, DOI 10.1002/jbm.820290814
   VOGLER EA, 1997, J BIOMED MATER RES, V40, P92
   Zhuo R, 2005, ACTA BIOMATER, V1, P583, DOI 10.1016/j.actbio.2005.05.005
   Zhuo R, 2005, BIOMATERIALS, V26, P2965, DOI 10.1016/j.biomaterials.2004.08.008
   Zhuo R, 2006, BIOMATERIALS, V27, P4325, DOI 10.1016/j.biomaterials.2006.04.001
   ZIATS NP, 1990, J LAB CLIN MED, V116, P687
NR 25
TC 11
Z9 12
U1 0
U2 18
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2006
VL 27
IS 28
BP 4840
EP 4845
DI 10.1016/j.biomaterials.2006.05.008
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 071QU
UT WOS:000239617500002
PM 16765435
DA 2018-10-19
ER

PT J
AU Lord, MS
   Cousins, BG
   Doherty, PJ
   Whitelock, JM
   Simmons, A
   Williams, RL
   Milthorpe, BK
AF Lord, M. S.
   Cousins, B. G.
   Doherty, P. J.
   Whitelock, J. M.
   Simmons, A.
   Williams, R. L.
   Milthorpe, B. K.
TI The effect of silica nanoparticulate coatings on serum protein
   adsorption and cellular response
SO BIOMATERIALS
LA English
DT Article
DE surface topography; nanostructures; protein adsorption; cellular
   response
ID QUARTZ-CRYSTAL MICROBALANCE; NANO-STRUCTURED SURFACES; POLYMER-FILMS;
   MONOCLONAL-ANTIBODIES; FIBRINOGEN ADSORPTION; BIOLOGICAL-ACTIVITY;
   HUMAN-PLASMA; ADHESION; FIBRONECTIN; TOPOGRAPHY
AB Serum protein adsorption on colloidal silica surfaces was investigated using a quartz crystal microbalance with dissipation (QCM-D) monitoring. The amount of serum proteins adsorbed on colloidal silica-coated surfaces was not significantly different from the control silica surfaces, with the exception of 21 nm colloidal silica which experienced significantly less (P < 0.05) fibrinogen adsorption compared with control silica. The adhesion and proliferation of human endothelial cells (C11STH) on nano-scale colloidal silica surfaces were significantly reduced compared with control silica surfaces, suggesting that the conformation of adsorbed proteins on the colloidal silica surfaces plays a role in modulating the amount of cell binding. Fibronectin is one of the main extracellular matrix proteins involved in endothelial cell attachment to biomaterial surfaces. There was reduced binding of a monoclonal anti-fibronectin antibody, that reacted specifically with the cell-binding fragment, to fibronectin-coated colloidal silica surfaces compared with control silica surfaces. This suggests that the fibronectin adsorbed on the colloidal silica-coated surfaces was conformationally changed compared with control silica reducing the availability of the cell-binding domain of fibronectin. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
   Univ Liverpool, Sch Clin Sci, Liverpool L69 3GA, Merseyside, England.
RP Milthorpe, BK (reprint author), Univ New S Wales, Grad Sch Biomed Engn, Sydney, NSW 2052, Australia.
EM b.milthorpe@unsw.edu.au
RI Lord, Megan/D-4673-2013; Milthorpe, Bruce/A-7014-2008
OI Lord, Megan/0000-0002-0506-9811; Williams, Rachel/0000-0002-1954-0256
CR Assender H, 2002, SCIENCE, V297, P973, DOI 10.1126/science.1074955
   Bandey HL, 1997, FARADAY DISCUSS, V107, P105, DOI 10.1039/a704278g
   Barbucci R, 2003, J MATER SCI-MATER M, V14, P721, DOI 10.1023/A:1024919917969
   BRUNETTE DM, 1986, EXP CELL RES, V167, P203, DOI 10.1016/0014-4827(86)90217-X
   Conti M, 2002, J BIOMED MATER RES, V61, P370, DOI 10.1002/jbm.10168
   Cousins BG, 2004, J MATER SCI-MATER M, V15, P355, DOI 10.1023/B:JMSM.0000021101.64938.b3
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Dalby MJ, 2004, J BIOMED MATER RES A, V69A, P314, DOI 10.1002/jbm.a.20138
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   den Braber ET, 1998, J BIOMED MATER RES, V40, P291, DOI 10.1002/(SICI)1097-4636(199805)40:2<291::AID-JBM14>3.3.CO;2-8
   Denis FA, 2002, LANGMUIR, V18, P819, DOI 10.1021/la011011o
   Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   Galli C, 2002, COLLOID SURFACE B, V26, P255, DOI 10.1016/S0927-7765(02)00015-2
   GRINNELL F, 1982, J BIOL CHEM, V257, P4888
   GRINNELL F, 1981, J BIOMED MATER RES, V15, P363, DOI 10.1002/jbm.820150308
   HAAS TA, 1994, CURR OPIN CELL BIOL, V6, P656, DOI 10.1016/0955-0674(94)90091-4
   Hook F, 1998, LANGMUIR, V14, P729, DOI 10.1021/la970815u
   HOOK F, 1999, 1999 JOINT M EETF IE
   HORBETT TA, 1994, COLLOID SURFACE B, V2, P225, DOI 10.1016/0927-7765(94)80037-5
   Johannsmann D, 1999, MACROMOL CHEM PHYS, V200, P501
   Katz BZ, 2000, MOL BIOL CELL, V11, P1047, DOI 10.1091/mbc.11.3.1047
   Kondo A, 1996, J COLLOID INTERF SCI, V177, P214, DOI 10.1006/jcis.1996.0023
   Lampin M, 1997, J BIOMED MATER RES, V36, P99, DOI 10.1002/(SICI)1097-4636(199707)36:1<99::AID-JBM12>3.0.CO;2-E
   LEWANDOWSKA K, 1989, J CELL PHYSIOL, V141, P334, DOI 10.1002/jcp.1041410215
   MARTIN SJ, 1997, FARADAY DISCUSS, V107, P462
   Martins MCL, 2003, BIOMATERIALS, V24, P2067, DOI 10.1016/S0142-9612(03)00002-4
   Marx KA, 2003, BIOMACROMOLECULES, V4, P1099, DOI 10.1021/bm020116i
   McHale G, 2004, J APPL PHYS, V95, P373, DOI 10.1063/1.1630373
   Nath N, 2004, SURF SCI, V570, P98, DOI 10.1016/j.susc.2004.06.182
   NYGEN H, 1992, PROG COLLOID POLYM S, V88, P96
   RODAHL M, 1995, REV SCI INSTRUM, V66, P3924, DOI 10.1063/1.1145396
   Sottile J, 2000, J CELL SCI, V113, P4287
   Sutherland DS, 2001, MACROMOL BIOSCI, V1, P270, DOI 10.1002/1616-5195(20010801)1:6<270::AID-MABI270>3.3.CO;2-V
   Theisen LA, 2004, ANAL CHEM, V76, P796, DOI 10.1021/ac034777x
   Tsai WB, 1999, J BIOMED MATER RES, V44, P130, DOI 10.1002/(SICI)1097-4636(199902)44:2<130::AID-JBM2>3.0.CO;2-9
   UNDERWOOD PA, 1991, J IMMUNOL METHODS, V142, P83, DOI 10.1016/0022-1759(91)90295-Q
   UNDERWOOD PA, 1993, J CELL SCI, V104, P793
   UNDERWOOD PA, 1990, J IMMUNOL METHODS, V127, P91, DOI 10.1016/0022-1759(90)90344-U
   UNDERWOOD PA, 1993, J IMMUNOL METHODS, V164, P119, DOI 10.1016/0022-1759(93)90282-C
   UNDERWOOD PA, 1992, J CELL SCI, V102, P833
   Voinova MV, 1999, PHYS SCRIPTA, V59, P391, DOI 10.1238/Physica.Regular.059a00391
   VUENTO M, 1979, BIOCHEM J, V183, P331, DOI 10.1042/bj1830331
   Wieland M, 2001, INT J ORAL MAX IMPL, V16, P163
   WILLIAMS RL, 1995, J BIOMED MATER RES, V29, P1545, DOI 10.1002/jbm.820291211
NR 45
TC 77
Z9 77
U1 3
U2 51
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2006
VL 27
IS 28
BP 4856
EP 4862
DI 10.1016/j.biomaterials.2006.05.037
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 071QU
UT WOS:000239617500004
PM 16757021
DA 2018-10-19
ER

PT J
AU Rucker, M
   Laschke, MW
   Junker, D
   Carvalho, C
   Schramm, A
   Mulhaupt, R
   Gellrich, NC
   Menger, MD
AF Ruecker, Martin
   Laschke, Matthias W.
   Junker, Dominik
   Carvalho, Carlos
   Schramm, Alexander
   Muelhaupt, Rolf
   Gellrich, Nils-Claudius
   Menger, Michael D.
TI Angiogenic and inflammatory response to biodegradable scaffolds in
   dorsal skinfold chambers of mice
SO BIOMATERIALS
LA English
DT Article
DE tissue engineering; scaffold; biocompatibility; microcirculation;
   inflammation; angiogenesis
ID ENDOTHELIAL GROWTH-FACTOR; COMPARATIVE IN-VIVO; INTRAVITAL MICROSCOPY;
   QUANTITATIVE-ANALYSIS; STAINLESS-STEEL; NEOVASCULARIZATION; FABRICATION;
   IMPLANTS; RELEASE; FOAMS
AB For tissue engineering, scaffolds should be biocompatible and promote neovascularization. Because little is known on those specific properties, we herein studied in vivo the host angiogenic and inflammatory response after implantation of commonly used scaffold materials. Porous Poly(L-lactide-co-glycolide) (PLGA) and collagen-chitosan-hydroxyapatite hydrogel scaffolds were implanted into dorsal skinfold chambers of balb/c mice. Additional animals received cortical bone as an isogeneic, biological implant, while chambers of animals without implants served as controls. Angiogenesis and neovascularization as well as leukocyte-endothelial cell interaction and microvascular permeability were analyzed over 14 day using intravital fluorescence microscopy. PLGA scaffolds showed a slight increase in leukocyte recruitment compared to controls. This was associated with an elevation of microvascular permeability, which was comparable to that observed in isogeneic bone tissue. Of interest, PLGA induced a marked angiogenic response, revealing a density of newly formed capillaries almost similar to that observed in bone implants. Histology showed infiltration of macrophages, probably indicating resorption of the biomaterial. In contrast, hydrogel scaffolds induced a severe inflammation, as indicated by an similar to 15-fold increase of leukocyte-endothelial cell interaction and a marked elevation of microvascular permeability. This was associated by induction of apoptotic cell death within the surrounding tissue and a complete lack of ingrowth of newly formed microvessels. Histology confirmed adequate engraftment of PLGA and isogeneic bone but not hydrogel within the host tissue. PLGA scaffolds show a better biocompatibility than hydrogel scaffolds and promote vascular ingrowth, guaranteeing adequate engraftment within the host tissue. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Hannover Med Sch, Dept Oral & Maxillofacial Surg, D-30625 Hannover, Germany.
   Univ Saarland, Inst Clin & Expt Surg, D-66421 Homburg, Germany.
   Univ Freiburg, Freiburger Mat Forschungszentrum, D-79104 Freiburg, Germany.
   Univ Freiburg, Inst Makromol Chem, D-79104 Freiburg, Germany.
RP Rucker, M (reprint author), Hannover Med Sch, Dept Oral & Maxillofacial Surg, D-30625 Hannover, Germany.
EM ruecker.martin@mh-hannover.de
CR Ahsan T, 2005, Orthod Craniofac Res, V8, P134, DOI 10.1111/j.1601-6343.2005.00326.x
   BAKER M, 1974, MICROVASC RES, V7, P131, DOI 10.1016/0026-2862(74)90043-0
   Bingle L, 2006, BRIT J CANCER, V94, P101, DOI 10.1038/sj.bjc.6602901
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   CARMICHAEL J, 1987, CANCER RES, V47, P943
   Carvalho C, 2005, Virtual Modeling and Rapid Manufacturing, P97
   Druecke D, 2004, J BIOMED MATER RES A, V68A, P10, DOI 10.1002/jbm.a..20016
   Karayiannakis AJ, 2003, EUR SURG RES, V35, P492, DOI 10.1159/000073388
   Klosterhalfen B, 2003, EUR SURG, V35, P16
   Kraft CN, 2001, J BIOMED MATER RES, V57, P404, DOI 10.1002/1097-4636(20011205)57:3<404::AID-JBM1183>3.0.CO;2-W
   Kraft CN, 2000, J BIOMED MATER RES, V49, P192, DOI 10.1002/(SICI)1097-4636(200002)49:2<192::AID-JBM6>3.0.CO;2-C
   Landers R, 2002, BIOMATERIALS, V23, P4437, DOI 10.1016/S0142-9612(02)00139-4
   Laschke MW, 2005, J BIOMED MATER RES A, V74A, P696, DOI 10.1002/jbm.a.30371
   LEHR HA, 1993, AM J PATHOL, V143, P1055
   Lo H, 1996, J BIOMED MATER RES, V30, P475, DOI 10.1002/(SICI)1097-4636(199604)30:4<475::AID-JBM5>3.0.CO;2-M
   MENGER MD, 1990, EUR J CARDIO-THORAC, V4, P191, DOI 10.1016/1010-7940(90)90003-I
   MENGER MD, 1993, IMMUNOL TODAY, V14, P519, DOI 10.1016/0167-5699(93)90179-O
   MENGER MD, 1992, AM J PHYSIOL, V263, pH1901
   MENGER MD, 1992, AM J PHYSIOL, V263, pH1892
   MENGER MD, 1990, THORAC CARDIOV SURG, V38, P139, DOI 10.1055/s-2007-1014008
   MENGER MD, 1992, THORAC CARDIOV SURG, V40, P19, DOI 10.1055/s-2007-1020105
   MIKOS AG, 1993, J BIOMED MATER RES, V27, P183, DOI 10.1002/jbm.820270207
   Mohle R, 1997, P NATL ACAD SCI USA, V94, P663, DOI 10.1073/pnas.94.2.663
   Nam YS, 2000, J BIOMED MATER RES, V53, P1, DOI 10.1002/(SICI)1097-4636(2000)53:1<1::AID-JBM1>3.0.CO;2-R
   Rucker M, 2001, SURGERY, V129, P292, DOI 10.1067/msy.2001.111079
   Schliephake H, 2002, INT J ORAL MAX SURG, V31, P469, DOI 10.1054/ijom.2002.0244
   Shaw JP, 2003, J SURG RES, V109, P37, DOI 10.1006/jsre.2002.6559
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Wake MC, 1996, CELL TRANSPLANT, V5, P465, DOI 10.1016/0963-6897(96)00025-5
   WAKE MC, 1994, CELL TRANSPLANT, V3, P339, DOI 10.1177/096368979400300411
   Yarlagadda PKDV, 2005, BIO-MED MATER ENG, V15, P159
NR 31
TC 134
Z9 139
U1 1
U2 56
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2006
VL 27
IS 29
BP 5027
EP 5038
DI 10.1016/j.biomaterials.2006.05.033
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 079HW
UT WOS:000240167500003
PM 16769111
DA 2018-10-19
ER

PT J
AU Ni, GX
   Lu, WW
   Xu, B
   Chiu, KY
   Yang, C
   Li, ZY
   Lam, WM
   Luk, KDK
AF Ni, G. X.
   Lu, W. W.
   Xu, B.
   Chiu, K. Y.
   Yang, C.
   Li, Z. Y.
   Lam, W. M.
   Luk, K. D. K.
TI Interfacial behaviour of strontium-containing hydroxyapatite cement with
   cancellous and cortical bone
SO BIOMATERIALS
LA English
DT Article
DE strontium-containing hydroxyapatite bone cement; bone-bonding behaviors;
   interface; mechanism; chemical composition
ID TRANSMISSION ELECTRON-MICROSCOPY; BETA-TRICALCIUM PHOSPHATE; IN-VIVO;
   SUBSTITUTED HYDROXYAPATITE; IMPLANT INTERFACE; APATITE; REPLACEMENT;
   CERAMICS; COATINGS; SURFACE
AB The bone-bonding behaviors of various biomaterials have been extensively investigated. However, the precise mechanisms of bone bonding have not yet been clarified, and the differences in interfacial behaviors of biomaterial bonding with cancellous bone and cortical bone have not yet been understood. In this study, strontium-containing hydroxyapatite (Sr-HA) cement, in which 10% calcium ions were substituted by strontium, was performed in a rabbit hip replacement model. Six months later, the morphology and chemical composition of interfaces between Sr-HA cement with cancellous bone and cortical bone were evaluated by field emission scanning electron microscopy (FESEM) and time-of-flight secondary ion mass spectrometry (ToF-SIMS). Remarkable differences between these two interfaces were suggested both in morphology and chemical compositions. An apatite layer was found between Sr-HA cement and cancellous bone with a thickness of about 70 mu m. However, only a very thin interface (about mu m) was formed with cortical bone. As for the cancellous bone/cement interface, high ions intensity of Ca, P, Sr, Na, and O were confirmed by FESEM-EDX and ToF-SIMS. Differences in morphology and chemical component between these two interfaces provided convincing evidences for the proposed dissolution-precipitation coupling mechanism in the formation of biological apatite. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.
   Hong Kong Univ Sci & Technol, Dept Chem, Hong Kong, Hong Kong, Peoples R China.
RP Lu, WW (reprint author), Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong, Hong Kong, Peoples R China.
EM wwlu@hkusua.hku.hk
RI XU, Bing/A-7828-2008; Chiu, Peter/C-4246-2009
OI XU, Bing/0000-0002-4639-387X; 
CR Apkarian RP, 1997, SCANNING, V19, P361, DOI 10.1002/sca.4950190503
   Black J., 1998, HDB BIOMATERIAL PROP, P3
   Chen QZ, 2004, BIOMATERIALS, V25, P4243, DOI 10.1016/j.biomaterials.2003.11.017
   Christoffersen J, 1997, BONE, V20, P47, DOI 10.1016/S8756-3282(96)00316-X
   DACULSI G, 1990, CALCIFIED TISSUE INT, V46, P20, DOI 10.1007/BF02555820
   Dalby MJ, 2001, BIOMATERIALS, V22, P1739, DOI 10.1016/S0142-9612(00)00334-3
   Davies JE, 1997, J BIOMED MATER RES, V36, P429, DOI 10.1002/(SICI)1097-4636(19970915)36:4<429::AID-JBM1>3.0.CO;2-G
   Fujita H, 2000, J BIOMED MATER RES, V49, P273, DOI 10.1002/(SICI)1097-4636(200002)49:2<273::AID-JBM17>3.0.CO;2-Y
   Fujita H, 1998, J BIOMED MATER RES, V40, P145, DOI 10.1002/(SICI)1097-4636(199804)40:1<145::AID-JBM17>3.3.CO;2-F
   Fujita R, 2003, TISSUE CELL, V35, P427, DOI 10.1016/S0040-8166(03)00067-3
   FUJITA Y, 1991, J BIOMED MATER RES, V25, P991, DOI 10.1002/jbm.820250806
   HENCH LL, 1982, BIOPHYSICS BIOENGINE, V4, P62
   KOTANI S, 1991, J BIOMED MATER RES, V25, P1303, DOI 10.1002/jbm.820251010
   Li YW, 2000, J BIOMED MATER RES, V52, P164, DOI 10.1002/1097-4636(200010)52:1<164::AID-JBM21>3.0.CO;2-R
   Lu JX, 1998, J BIOMED MATER RES, V42, P357, DOI 10.1002/(SICI)1097-4636(19981205)42:3<357::AID-JBM3>3.0.CO;2-I
   Lu WW, 2001, SPINE, V26, P2684, DOI 10.1097/00007632-200112150-00010
   Lu X, 2004, J MATER SCI, V39, P6809, DOI 10.1023/B:JMSC.0000045608.64178.55
   Matsuda Y, 1997, CLIN ORTHOP RELAT R, P263
   NEO M, 1992, J BIOMED MATER RES, V26, P1419, DOI 10.1002/jbm.820261103
   NEO M, 1993, J BIOMED MATER RES, V27, P999, DOI 10.1002/jbm.820270805
   NEO M, 1992, J BIOMED MATER RES, V26, P255, DOI 10.1002/jbm.820260210
   Ni GX, 2006, J BIOMED MATER RES B, V77B, P409, DOI 10.1002/jbm.b.30417
   Ni GX, 2006, BIOMATERIALS, V27, P1963, DOI 10.1016/j.biomaterials.2005.09.044
   Okada Y, 2001, J BIOMED MATER RES, V57, P101, DOI 10.1002/1097-4636(200110)57:1<101::AID-JBM1147>3.0.CO;2-G
   OKAYAMA S, 1991, Bio-Medical Materials and Engineering, V1, P11
   ORLY I, 1989, CALCIFIED TISSUE INT, V45, P20, DOI 10.1007/BF02556656
   Porter AE, 2004, J BIOMED MATER RES A, V69A, P670, DOI 10.1002/jbm.a.30035
   Porter AE, 2004, BIOMATERIALS, V25, P3303, DOI 10.1016/j.biomaterials.2003.10.006
   SANTANNA C, 2005, HISTOCHEM CELL BIOL, V12, P89
   Senaha Y, 1996, J BONE JOINT SURG BR, V78B, P26
   TAMURA J, 1995, BIOCERAMICS, V8, P219
   Wen J, 2000, BIOMATERIALS, V21, P1339, DOI 10.1016/S0142-9612(99)00273-2
   Weng J, 1997, BIOMATERIALS, V18, P1027, DOI 10.1016/S0142-9612(97)00022-7
   Yan LL, 2003, BIOMATERIALS, V24, P2585, DOI 10.1016/S0142-9612(03)00061-9
NR 34
TC 64
Z9 66
U1 1
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2006
VL 27
IS 29
BP 5127
EP 5133
DI 10.1016/j.biomaterials.2006.05.030
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 079HW
UT WOS:000240167500013
PM 16781769
DA 2018-10-19
ER

PT J
AU Butcher, JT
   Barrett, BC
   Nerem, RM
AF Butcher, Jonathan T.
   Barrett, Brian C.
   Nerem, Robert M.
TI Equibiaxial strain stimulates fibroblastic phenotype shift in smooth
   muscle cells in an engineered tissue model of the aortic wall
SO BIOMATERIALS
LA English
DT Article
DE soft tissue biomechanics; adhesion; tissue engineering; bioreactor
ID IN-VITRO; SHEAR-STRESS; 3-DIMENSIONAL CULTURE; ENDOTHELIAL-CELLS;
   BIAXIAL STRAIN; ATHEROSCLEROSIS; OSTEOBLASTS; EXPRESSION; ADHESIVE;
   PROTEIN
AB Many cells in the body reside in a complex three-dimensional (3D) environment stimulated by mechanical force. In vitro bioreactor systems have greatly improved our understanding of the mechanisms behind cell mechanotransduction. Current systems to impose strain in vitro are limited either by the lack of uniform strain profile or inability to strain 3D engineered tissues. In this study, we present a system capable of generating cyclic equibiaxial strain to an engineered vascular wall model. Type I collagen hydrogels populated with rat aortic smooth muscle cells (RASMCs) were created either as a compacting disk or constrained hemisphere. Both models were adhered to silicone membranes precoated with collagen I, fibronectin, or Cell-Tak and assayed for adhesion characteristics. The best performing model was then exposed to 48 h of 10% strain at 1 Hz to simulate wall strain profiles found in vascular aneurysms, with static cultures serving as controls. The finite strain profile at the level of the membrane and the free surface of the construct was quantified using microbeads. The results indicate that the hemisphere model adhered with Cell-Tak had the most stable adhesion, followed by fibronectin and collagen I. Disk models did not adhere well under any coating condition. Uniform strain propagation was possible up to a maximum area strain of 20% with this system. RASMC responded to 10% equibiaxial strain by becoming less elongated, and immunohistochemistry suggested that stretched RASMC shifted to a more synthetic phenotype in comparison to static controls. These results suggest that equibiaxial strain may induce smooth muscle cell differentiation. We conclude that this system is effective in stimulating cells with cyclic equibiaxial strain in 3D cultures, and can be applied to a variety of biomaterial and tissue engineering applications. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
   Penn State Univ, Dept Bioengn, State Coll, PA 16804 USA.
   Georgia Inst Technol, Woodruff Sch Mech Engn, Atlanta, GA 30332 USA.
RP Nerem, RM (reprint author), Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA.
EM robert.nerem@ibb.gatech.edu
RI Butcher, Jonathan/D-2280-2012
OI Butcher, Jonathan/0000-0002-9309-6296
CR Auerbach ID, 2003, EXP MOL PATHOL, V74, P148, DOI 10.1016/S0014-4800(03)00013-3
   AWOLESI MA, 1995, J CLIN INVEST, V96, P1449, DOI 10.1172/JCI118181
   Bai TR, 2005, CLIN SCI, V108, P463, DOI 10.1042/CS20040342
   Benthien JP, 2004, ANN ANAT, V186, P561, DOI 10.1016/S0940-9602(04)80108-0
   Brown TD, 2000, J BIOMECH, V33, P3, DOI 10.1016/S0021-9290(99)00177-3
   Brown TD, 1998, AM J MED SCI, V316, P162, DOI 10.1097/00000441-199809000-00003
   BUCKLEY MJ, 1990, J ORAL MAXIL SURG, V48, P276, DOI 10.1016/0278-2391(90)90393-G
   Butcher JT, 2004, J HEART VALVE DIS, V13, P478
   Chaqour B, 2002, J CELL BIOCHEM, V84, P264, DOI 10.1002/jcb.10013
   Clerin V, 2003, TISSUE ENG, V9, P461, DOI 10.1089/107632703322066642
   Dai GH, 2004, P NATL ACAD SCI USA, V101, P14871, DOI 10.1073/pnas.0406073101
   Endlich N, 2002, FASEB J, V16, P1850, DOI 10.1096/fj.02-0125fje
   Engelmayr GC, 2003, BIOMATERIALS, V24, P2523, DOI 10.1016/S0142-9612(03)00051-6
   Fujigaki Y, 2002, NEPHRON, V92, P203, DOI 10.1159/000064469
   Fung Y. C., 1977, 1 COURSE CONTINUUM M
   Gong Y, 2003, J SURG RES, V114, P202, DOI 10.1016/S0022-4804(03)00333-0
   Grinnell F, 1999, J BIOL CHEM, V274, P918, DOI 10.1074/jbc.274.2.918
   Hoshina K, 2003, J VASC SURG, V37, P1067, DOI 10.1067/mva.2003.169
   HULINSKY I, 1995, PANCREAS, V11, P309, DOI 10.1097/00006676-199510000-00015
   Kessler D, 2001, J BIOL CHEM, V276, P36575, DOI 10.1074/jbc.M101602200
   Kladakis SM, 2004, ENDOTHELIUM-J ENDOTH, V11, P29, DOI 10.1080/10623320490432461
   Lee AA, 1999, J MOL CELL CARDIOL, V31, P1833, DOI 10.1006/jmcc.1999.1017
   LEVESQUE MJ, 1985, J BIOMECH ENG-T ASME, V107, P341, DOI 10.1115/1.3138567
   Lu SH, 2005, BIOMATERIALS, V26, P443, DOI 10.1016/j.biomaterials.2004.05.006
   NOTTER MFD, 1988, EXP CELL RES, V177, P237, DOI 10.1016/0014-4827(88)90458-2
   SACKS MS, 1993, J BIOMECH, V26, P1341, DOI 10.1016/0021-9290(93)90357-K
   Sakamoto H, 2001, CIRCULATION, V104, P109, DOI 10.1161/hc2701.091070
   Seliktar D, 2000, ANN BIOMED ENG, V28, P351, DOI 10.1114/1.275
   Smith PG, 1997, AM J PHYSIOL-LUNG C, V272, pL20
   Sotoudeh M, 1998, ANN BIOMED ENG, V26, P181, DOI 10.1114/1.88
   Stegemann JP, 2003, EXP CELL RES, V283, P146, DOI 10.1016/S0014-4827(02)00041-1
NR 31
TC 38
Z9 39
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2006
VL 27
IS 30
BP 5252
EP 5258
DI 10.1016/j.biomaterials.2006.05.040
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 084BK
UT WOS:000240506400011
PM 16806457
DA 2018-10-19
ER

PT J
AU Lacroix, D
   Chateau, A
   Ginebra, MP
   Planell, JA
AF Lacroix, Damien
   Chateau, Arnaud
   Ginebra, Maria-Pau
   Planell, Josep A.
TI Micro-finite element models of bone tissue-engineering scaffolds
SO BIOMATERIALS
LA English
DT Article
DE finite element analysis; tissue engineering; scaffold; porosity; ceramic
ID MECHANO-REGULATION; BIOPHYSICAL STIMULI; DIFFERENTIATION; CONSTRUCTS;
   CELLS; ARCHITECTURE; POROSITY; DESIGN
AB Tissue engineering is an emerging area in bioengineering at the frontiers between biomaterials, biology and biomechanics. The basic knowledge of the interactions between mechanical stimuli, cells and biomaterials is growing but the quantitative effect of mechanical stimuli on cells attached to biomaterials is still unknown. The objective of this study was to develop finite element models of various bone scaffolds based on calcium phosphate in order to calculate the load transfer from the biomaterial structure to the biological entities. Samples of porous calcium phosphate bone cement and biodegradable glass were scanned using micro-CT to determine the overall macroporosity, architecture and to develop finite element models of such materials. Compressive loads were applied on the models to simulate the in vitro environment of a bioreactor and stress and strain distributions were calculated. It was found that the effective Young's modulus was linearly related to the sample macroporosity. Results suggest that a 0.5% overall compressive strain can produce internal strain of the same order of magnitude as found in previous in vitro mechanically cell-strained studies or in mechanoregulation studies. Stress and strain concentrations due to the porous structures are possible candidate for favouring cell differentiation. Although strain distributions were similar between bone cement and porous glass, the stress distribution is clearly different. Future in vitro results could correlate the results obtained with such finite element study to explain the influence of mechanical stimuli on cell behaviour. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Politecn Catalunya, Inst Bioengn Catalunya, Dept Mat Sci, Glassboro, NJ 08028 USA.
RP Lacroix, D (reprint author), Univ Politecn Catalunya, Inst Bioengn Catalunya, Dept Mat Sci, Avda Diagonal 647, Glassboro, NJ 08028 USA.
EM damien.lacroix@upc.edu
RI Ginebra, Maria-Pau/J-8149-2017; Lacroix, Damien/G-3230-2010
OI Ginebra, Maria-Pau/0000-0002-4700-5621; Lacroix,
   Damien/0000-0002-5482-6006
CR Almirall A, 2004, KEY ENG MAT, V254-2, P253, DOI 10.4028/www.scientific.net/KEM.254-256.253
   Avila G, 2005, P INT C POR CER MAT
   Boerboom RA, 2003, ANN BIOMED ENG, V31, P1040, DOI 10.1114/1.1603749
   Boyd SK, 2006, J BIOMECH, V39, P1287, DOI 10.1016/j.jbiomech.2005.03.006
   Breuls RGM, 2002, J BIOMECH ENG-T ASME, V124, P198, DOI 10.1115/1.1449492
   BROWN TD, 2004, J BIOMECH, V33, P3
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Connelly JT, 2004, BIORHEOLOGY, V41, P377
   Ignatius A, 2005, BIOMATERIALS, V26, P311, DOI 10.1016/j.biomaterials.2004.02.045
   Isaksson H, 2006, J BIOMECH, V39, P1507, DOI 10.1016/j.jbiomech.2005.01.037
   Jaecques SVN, 2004, BIOMATERIALS, V25, P1683, DOI 10.1016/S0142-9612(03)00516-7
   Karande TS, 2004, ANN BIOMED ENG, V32, P1728, DOI 10.1007/s10439-004-7825-2
   Kelly DJ, 2005, J BIOMECH, V38, P1413, DOI 10.1016/j.jbiomech.2004.06.026
   Kelly DJ, 2004, MED BIOL ENG COMPUT, V42, P9, DOI 10.1007/BF02351005
   Lacroix D, 2002, J BIOMECH, V35, P1163, DOI 10.1016/S0021-9290(02)00086-6
   Lima EG, 2004, BIORHEOLOGY, V41, P577
   Lin CY, 2004, J BIOMECH, V37, P623, DOI 10.1016/j.jbiomech.2003.09.029
   Martin I, 2004, TRENDS BIOTECHNOL, V22, P80, DOI 10.1016/j.tibtech.2003.12.001
   Prendergast PJ, 1997, J BIOMECH, V30, P539, DOI 10.1016/S0021-9290(96)00140-6
   Schriefer JL, 2005, J BIOMECH, V38, P1838, DOI 10.1016/j.jbiomech.2004.08.017
   Sun W, 2005, COMPUT AIDED DESIGN, V37, P1097, DOI 10.1016/j.cad.2005.02.002
   Williams JM, 2005, BIOMATERIALS, V26, P4817, DOI 10.1016/j.biomaterials.2004.11.057
NR 22
TC 90
Z9 92
U1 3
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD OCT
PY 2006
VL 27
IS 30
BP 5326
EP 5334
DI 10.1016/j.biomaterials.2006.06.009
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 084BK
UT WOS:000240506400020
PM 16824593
DA 2018-10-19
ER

PT J
AU Meinel, L
   Betz, O
   Fajardo, R
   Hofmann, S
   Nazarian, A
   Cory, E
   Hilbe, M
   McCool, J
   Langer, R
   Vunjak-Novakovic, G
   Merkle, HP
   Rechenberg, B
   Kaplan, DL
   Kirker-Head, C
AF Meinel, L.
   Betz, O.
   Fajardo, R.
   Hofmann, S.
   Nazarian, A.
   Cory, E.
   Hilbe, M.
   McCool, J.
   Langer, R.
   Vunjak-Novakovic, G.
   Merkle, H. P.
   Rechenberg, B.
   Kaplan, D. L.
   Kirker-Head, C.
TI Silk based biomaterials to heal critical sized femur defects
SO BONE
LA English
DT Article
DE human mesenchymal stem cells; silk implant; tissue engineering; long
   bone defect; mechanical characterization; micro-computed tomography
ID MESENCHYMAL STEM-CELLS; ITERATIVE SELECTION METHOD; IN-VITRO;
   THRESHOLDING ALGORITHMS; BONE REGENERATION; IMMUNE-RESPONSES; CANCELLOUS
   BONE; BOMBYX-MORI; TISSUE; SCAFFOLDS
AB Bone auto- and allografts have inherent drawbacks, therefore the treatment of non-unions and critical size defects in load bearing long bones would benefit from the use of osteopromotive biodegradable, biocompatible and mechanically durable matrices to enhance migration or delivery of cell populations and/or morphogens/cytokines. Silk fibroin biomaterial scaffolds were evaluated as osteopromotive matrices in critical sized mid-femoral segmental defects in nude rats. Four treatment groups were assessed over 8 weeks in vivo: silk scaffolds (SS) with human mesenchymal stem cells (hMSCs) that had previously been differentiated along an ostcoblastic lineage in vitro (group I; pdHMSC/SS); SS with undifferentiated hMSCs (group II; udHMSC/SS); SS alone (group III; SS); and empty defects (group IV). When hMSCs were cultured in vitro in osteogenic medium for 5 weeks, bone formation was characterized with bimodal peak activities for alkaline phosphatase at 2 and 4 weeks. Calcium deposition started after 1 week and progressively increased to peak at 4 weeks, reaching cumulative levels of deposited calcium at 16 mu g per mg scaffold wet weight. In vivo osteogenesis was characterized by almost bridged defects with newly formed bone after 8 weeks in group I. Significantly (P < 0.01) greater bone volumes were observed with the pdHMSC/SS (group I) implants than with groups II, III or IV These three groups failed to induce substantial new bone formation and resulted in the ingrowth of cells with fibroblast-like morphology into the defect zone. The implantation of pdHMSC/SS resulted in significantly (P < 0.05) greater maximal load and torque when compared to the other treatment regimens. The pdHMSC/SS implants demonstrated osteogenic ability in vitro and capacity to thrive towards the healing of critical size femoral segmental defects in vivo. Thus, these new constructs provide an alternative protein-based biomaterial for load bearing applications. (c) 2006 Elsevier Inc. All rights reserved.
C1 ETH, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland.
   Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   MIT, Div Hlth Sci & Technol, Cambridge, MA 02142 USA.
   Harvard Univ, Ctr Mol Orthopaed, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA.
   Harvard Univ, Orthopaed Biomech Lab, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02115 USA.
   Univ Zurich, Inst Vet Pathol, Vetsuisse Fac, Zurich, Switzerland.
   Tufts Univ, Cummings Sch Vet Med, North Grafton, MA 01536 USA.
   Columbia Univ, Dept Bioengn, New York, NY 10032 USA.
   Univ Zurich, Fac Vet Med, Musculoskeletal Res Unit, Zurich, Switzerland.
RP Meinel, L (reprint author), ETH, Dept Chem & Appl Biosci, HCI J 390-1,Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.
EM lorenz.meinel@pharma.ethz.ch
RI Meinel, Lorenz/D-9997-2015; Merkle, Hans/A-4381-2014; Hofmann,
   Sandra/F-2832-2010
OI Meinel, Lorenz/0000-0002-7549-7627; Hofmann, Sandra/0000-0002-2568-8388;
   Vunjak-Novakovic, Gordana/0000-0002-9382-1574
FU NIDCR NIH HHS [DE13405-04]; NIBIB NIH HHS [EB002520, P41 EB002520]
CR Albrektsson T, 2001, EUR SPINE J, V10, pS96, DOI 10.1007/s005860100282
   Altman GH, 2002, BIOMATERIALS, V23, P4131, DOI 10.1016/S0142-9612(02)00156-4
   Asakura T., 1994, ENCY AGR SCI, V4, P1
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   Aubin J E, 1998, J Cell Biochem Suppl, V30-31, P73
   BOS GD, 1983, J BONE JOINT SURG AM, V65, P239, DOI 10.2106/00004623-198365020-00015
   BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303
   CHOONG PFM, 1993, J ORTHOPAED RES, V11, P638, DOI 10.1002/jor.1100110505
   Cornell CN, 1998, CLIN ORTHOP RELAT R, pS267
   Craig CL, 1999, INT J BIOL MACROMOL, V24, P109, DOI 10.1016/S0141-8130(99)00006-9
   CUNNIFF PM, 1994, POLYM ADVAN TECHNOL, V5, P401
   DELUSTRO F, 1990, CLIN ORTHOP RELAT R, P263
   Dennis J E, 1992, Cell Transplant, V1, P23
   DEWAIR M, 1985, J ALLERGY CLIN IMMUN, V76, P537, DOI 10.1016/0091-6749(85)90772-9
   DRIESSEN AA, 1982, BIOMATERIALS, V3, P113
   Einhorn T A, 2001, J Am Acad Orthop Surg, V9, P157
   EINHORN TA, 1984, J BONE JOINT SURG AM, V66A, P274, DOI 10.2106/00004623-198466020-00015
   EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016
   Eiselt P, 1998, BIOTECHNOL PROGR, V14, P134, DOI 10.1021/bp970135h
   FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x
   GLASBEY CA, 1993, CVGIP-GRAPH MODEL IM, V55, P532, DOI 10.1006/cgip.1993.1040
   HALSTED W, 1892, ANN SURG, V16, P505
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311
   Hildebrand T, 1999, J BONE MINER RES, V14, P1167, DOI 10.1359/jbmr.1999.14.7.1167
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   Hollinger JO, 1996, BIOMATERIALS, V17, P187, DOI 10.1016/0142-9612(96)85763-2
   HOROWITZ MC, 1987, ORTHOP CLIN N AM, V18, P227
   Inoue S, 2000, J BIOL CHEM, V275, P40517, DOI 10.1074/jbc.M006897200
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Jin HJ, 2003, NATURE, V424, P1057, DOI 10.1038/nature01809
   JOHNSON EE, 1988, CLIN ORTHOP RELAT R, P249
   Kim UJ, 2004, BIOMACROMOLECULES, V5, P786, DOI 10.1021/bm0345460
   KLEIN CPAT, 1984, BIOMATERIALS, V5, P157, DOI 10.1016/0142-9612(84)90051-6
   Kokubo T, 2004, J MATER SCI-MATER M, V15, P99, DOI 10.1023/B:JMSM.0000011809.36275.0c
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Leung CK, 1996, PATTERN RECOGN, V29, P1523, DOI 10.1016/0031-3203(96)00009-X
   Luginbuehl V, 2004, EUR J PHARM BIOPHARM, V58, P197, DOI 10.1016/j.ejpb.2004.03.004
   Lysaght MJ, 2001, TISSUE ENG, V7, P485, DOI 10.1089/107632701753213110
   McAndrew M P, 1988, J Orthop Trauma, V2, P333, DOI 10.1097/00005131-198802040-00011
   Meinel L, 2005, BONE, V37, P688, DOI 10.1016/j.bone.2005.06.010
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   MEINEL L, UNPUB BONE ENG HUMAN
   NADE S, 1977, J BONE JOINT SURG BR, V59, P189
   Nazarov R, 2004, BIOMACROMOLECULES, V5, P718, DOI 10.1021/bm034327e
   NIMNI ME, 1987, J BIOMED MATER RES, V21, P741, DOI 10.1002/jbm.820210606
   OHGUSHI H, 1992, CRC HDB BIOACTIVE CE, V2, P235
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Reginster JY, 2002, RHEUMATOLOGY, V41, P1, DOI 10.1093/rheumatology/41.suppl_1.1
   RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630
   ROSSITCH E, 1987, CHILD NERV SYST, V3, P375, DOI 10.1007/BF00270712
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Service RF, 2000, SCIENCE, V289, P1498, DOI 10.1126/science.289.5484.1498
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   SRIVASTAVA S, 1990, BIOMATERIALS, V11, P155, DOI 10.1016/0142-9612(90)90148-J
   Suh H, 1998, YONSEI MED J, V39, P87, DOI 10.3349/ymj.1998.39.2.87
   Tanaka K, 1999, INSECT BIOCHEM MOLEC, V29, P269, DOI 10.1016/S0965-1748(98)00135-0
   TRUSSELL HJ, 1979, IEEE T SYST MAN CYB, V9, P311, DOI 10.1109/TSMC.1979.4310204
   Vunjak-Novakovic G, 2005, Orthod Craniofac Res, V8, P209, DOI 10.1111/j.1601-6343.2005.00334.x
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   Vunjak-Novakovic G, 1998, BIOTECHNOL PROGR, V14, P193, DOI 10.1021/bp970120j
NR 65
TC 146
Z9 160
U1 3
U2 56
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 8756-3282
J9 BONE
JI Bone
PD OCT
PY 2006
VL 39
IS 4
BP 922
EP 931
DI 10.1016/j.bone.2006.04.019
PG 10
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 088DW
UT WOS:000240792700028
PM 16757219
DA 2018-10-19
ER

PT J
AU Teughels, W
   Van Assche, N
   Sliepen, I
   Quirynen, M
AF Teughels, Wim
   Van Assche, Nele
   Sliepen, Isabelle
   Quirynen, Marc
TI Effect of material characteristics and/or surface topography on biofilm
   development
SO CLINICAL ORAL IMPLANTS RESEARCH
LA English
DT Article; Proceedings Paper
CT 1st Consensus Conference of the
   European-Association-for-Osseointegration
CY FEB 16-19, 2006
CL Con, Pfaffikon, SWITZERLAND
HO Con
DE biofilm; implants; peri-implantitis; periodontal disease; plaque growth;
   surface; characteristics; surface free energy; surface roughness
ID EARLY PLAQUE-FORMATION; PARTIALLY EDENTULOUS PATIENTS; OSSEOINTEGRATED
   TITANIUM IMPLANTS; SALIVA-COATED HYDROXYAPATITE; BACTERIAL ADHESION;
   IN-VIVO; FREE-ENERGY; DENTAL IMPLANTS; COMPOSITE RESIN; HUMAN-ENAMEL
AB Background: From an ecological viewpoint, the oral cavity, in fact the oro-pharynx, is an 'open growth system'. It undergoes an uninterrupted introduction and removal of both microorganisms and nutrients. In order to survive within the oro-pharyngeal area, bacteria need to adhere either to the soft or hard tissues in order to resist shear forces. The fast turnover of the oral lining epithelia (shedding 3 x /day) is an efficient defence mechanism as it prevents the accumulation of large masses of microorganisms. Teeth, dentures, or endosseous implants, however, providing non-shedding surfaces, allow the formation of thick biofilms. in general, the established biofilm maintains an equilibrium with the host. An uncontrolled accumulation and/or metabolism of bacteria on the hard surfaces forms, however, the primary cause of dental caries, gingivitis, periodontitis, peri-implantitis, and stomatitis.
   Objectives: This systematic review aimed to evaluate critically the impact of surface characteristics (free energy, roughness, chemistry) on the de novo biofilm formation, especially in the supragingival and to a lesser extent in the subgingival areas.
   Methods: An electronic Medline search (from 1966 until July 2005) was conducted applying the following search items: 'biofilm formation and dental/oral implants/surface characteristics', 'surface characteristics and implants', 'biofilm formation and oral', 'plaque/biofilm and roughness', 'plaque/biofilm and surface free energy', and 'plaque formation and implants'. Only clinical studies within the oro-pharyngeal area were included.
   Results: From a series of split-mouth studies, it could be concluded that both an increase in surface roughness above the R-a threshold of 0.2 mu m and/or of the surface-free energy facilitates biofilm formation on restorative materials. When both surface characteristics interact with each other, surface roughness was found to be predominant. The biofilm formation is also influenced by the type (chemical composition) of biomaterial or the type of coating. Direct comparisons in biofilm formation on different transmucosal implant surfaces are scars.
   Conclusions: Extrapolation of data from studies on different restorative materials seems to indicate that transmucosal implant surfaces with a higher surface roughness/surface free energy facilitate biofilm formation.
C1 Catholic Univ Louvain, Dept Periodontol, Fac Med, Res Grp Microbial Adhes,Sch Dent Oral Pathol & Ma, B-3000 Louvain, Belgium.
RP Quirynen, M (reprint author), Catholic Univ Louvain, Dept Periodontol, Fac Med, Res Grp Microbial Adhes,Sch Dent Oral Pathol & Ma, Kapucijnenvoer 33, B-3000 Louvain, Belgium.
EM marc.quirynen@med.kuleuven.be
RI Teughels, Wim/F-4337-2014
OI Teughels, Wim/0000-0001-7675-5643
CR ABSOLOM DR, 1987, J BIOMED MATER RES, V21, P161, DOI 10.1002/jbm.820210202
   ABSOLOM DR, 1983, APPL ENVIRON MICROB, V46, P90
   APSE P, 1989, J PERIODONTAL RES, V24, P96, DOI 10.1111/j.1600-0765.1989.tb00863.x
   BAIER RE, 1978, ACTA ODONTOL SCAND, V36, P289, DOI 10.3109/00016357809029079
   Bakker DP, 2004, APPL ENVIRON MICROB, V70, P3758, DOI 10.1128/AEM.70.6.3758-3760.2004
   Barton AJ, 1996, J BIOMED MATER RES, V32, P271, DOI 10.1002/(SICI)1097-4636(199610)32:2<271::AID-JBM17>3.0.CO;2-M
   Barton AJ, 1996, J BIOMED MATER RES, V30, P403, DOI 10.1002/(SICI)1097-4636(199603)30:3<403::AID-JBM15>3.0.CO;2-K
   BELLONFONTAINE MN, 1990, CELL BIOPHYS, V17, P93, DOI 10.1007/BF02989805
   Binon P P, 1992, Int J Oral Maxillofac Implants, V7, P168
   BLANK LW, 1979, J PROSTHET DENT, V42, P626, DOI 10.1016/0022-3913(79)90192-6
   Boles BR, 2004, P NATL ACAD SCI USA, V101, P16630, DOI 10.1073/pnas.0407460101
   Bollen CML, 1996, CLIN ORAL IMPLAN RES, V7, P201, DOI 10.1034/j.1600-0501.1996.070302.x
   Bollen CML, 1997, DENT MATER, V13, P258, DOI 10.1016/S0109-5641(97)80038-3
   Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2
   Bradshaw DJ, 1998, INFECT IMMUN, V66, P4729
   BUDTZJORGENSEN E, 1986, SCAND J DENT RES, V94, P569
   BUNDY KJ, 1980, J BIOMED MATER RES, V14, P653, DOI 10.1002/jbm.820140511
   BUSSCHER HJ, 1984, COLLOID SURFACE, V9, P319, DOI 10.1016/0166-6622(84)80175-4
   BUSSCHER HJ, 1995, FEMS MICROBIOL LETT, V128, P229, DOI 10.1016/0378-1097(95)00103-C
   BUSSCHER HJ, 1987, FEMS MICROBIOL LETT, V46, P165, DOI 10.1016/0378-1097(87)90062-0
   BUSSCHER HJ, 1990, MICROBIAL CELL SURFA, P335
   Caldwell DE, 1997, ADV MICROB ECOL, V15, P105
   CHRISTERSSON CE, 1989, SCAND J DENT RES, V97, P247
   CRISP DJ, 1985, J COLLOID INTERF SCI, V104, P40, DOI 10.1016/0021-9797(85)90007-4
   Dalton HM, 1998, CURR OPIN BIOTECH, V9, P252, DOI 10.1016/S0958-1669(98)80055-4
   DANSER MM, 1994, J CLIN PERIODONTOL, V21, P484, DOI 10.1111/j.1600-051X.1994.tb00412.x
   De Boever AL, 2006, CLIN ORAL IMPLAN RES, V17, P8, DOI 10.1111/j.1600-0501.2005.01175.x
   DEJONG HP, 1984, CARIES RES, V18, P505, DOI 10.1159/000260812
   DEWET FA, 1980, J PROSTHET DENT, V44, P300, DOI 10.1016/0022-3913(80)90016-5
   ELAGLI K, 1992, BIOMATERIALS, V13, P25, DOI 10.1016/0142-9612(92)90090-B
   ERICSSON I, 1995, J CLIN PERIODONTOL, V22, P255
   Everaert EPJM, 1999, ARCH OTOLARYNGOL, V125, P1329, DOI 10.1001/archotol.125.12.1329
   FACHONKALWEIT S, 1985, INFECT IMMUN, V48, P617
   FINE DH, 1984, INFECT IMMUN, V44, P332
   FIVESTAYLOR PM, 1985, INFECT IMMUN, V47, P752
   FLETCHER M, 1985, J COLLOID INTERF SCI, V104, P5, DOI 10.1016/0021-9797(85)90004-9
   FLETCHER RL, 1984, MAR BIOL LETT, V5, P251
   Gatewood R R, 1993, Clin Oral Implants Res, V4, P53, DOI 10.1034/j.1600-0501.1993.040201.x
   GIBBONS RJ, 1988, INFECT IMMUN, V56, P2990
   GIBBONS RJ, 1988, INFECT IMMUN, V56, P439
   Gildenhuys R R, 1975, Dent Surv, V51, P56
   GLANTZ PO, 1969, ODONTOL REVY, V2, P1
   Gouvoussis J, 1997, INT J ORAL MAX IMPL, V12, P666
   Groenen PMW, 2004, EUR J OBSTET GYN R B, V112, P16, DOI 10.1016/S0301-2115(03)00279-3
   Gross M, 1999, INT J ORAL MAX IMPL, V14, P94
   Hannig M, 1999, EUR J ORAL SCI, V107, P55, DOI 10.1046/j.0909-8836.1999.eos107109.x
   HARKES G, 1992, J BIOMAT SCI-POLYM E, V3, P403, DOI 10.1163/156856292X00213
   HAWTHORN L, 1990, J BIOMED MATER RES, V24, P1325, DOI 10.1002/jbm.820241005
   HSU SD, 1994, MICROB ECOL HEALTH D, V7, P125, DOI 10.3109/08910609409141342
   Hultin M, 2002, CLIN ORAL IMPLAN RES, V13, P349, DOI 10.1034/j.1600-0501.2002.130402.x
   Hultin M, 2000, J CLIN PERIODONTOL, V27, P128, DOI 10.1034/j.1600-051x.2000.027002128.x
   Jansen VK, 1997, INT J ORAL MAX IMPL, V12, P527
   JOSHI RI, 1988, J MED MICROBIOL, V27, P105, DOI 10.1099/00222615-27-2-105
   KEENAN MP, 1980, J PROSTHET DENT, V43, P168, DOI 10.1016/0022-3913(80)90182-1
   Keith SE, 1999, INT J ORAL MAX IMPL, V14, P369
   Kohavi D, 1994, INT J ORAL MAXILLOF, V9, P673
   KOKA S, 1993, J PROSTHET DENT, V70, P141, DOI 10.1016/0022-3913(93)90009-D
   KOLENBRANDER PE, 1993, FASEB J, V7, P406
   KOLENBRANDER PE, 1989, CRIT REV MICROBIOL, V17, P137, DOI 10.3109/10408418909105746
   KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247, DOI 10.1128/jb.175.11.3247-3252.1993
   KOLENBRANDER PE, 1995, INFECT IMMUN, V63, P4684
   LARATO DC, 1972, J PROSTHET DENT, V28, P402, DOI 10.1016/0022-3913(72)90241-7
   LEE RG, 1974, THROMB RES, V4, P485, DOI 10.1016/0049-3848(74)90083-8
   LEKHOLM U, 1986, J CLIN PERIODONTOL, V13, P558, DOI 10.1111/j.1600-051X.1986.tb00847.x
   LEONHARDT A, 1993, CLIN ORAL IMPLAN RES, V4, P113, DOI 10.1034/j.1600-0501.1993.040301.x
   LEONHARDT A, 1995, EUR J ORAL SCI, V103, P382, DOI 10.1111/j.1600-0722.1995.tb01861.x
   Liu Y, 2005, BIOPHYS CHEM, V117, P39, DOI 10.1016/j.bpc.2005.04.015
   Mabboux F, 2004, COLLOID SURFACE B, V39, P199, DOI 10.1016/j.colsurfb.2004.08.002
   Marsh P. D., 1999, DENT PLAQUE REVISITE, P237
   Marsh PD, 2004, CARIES RES, V38, P204, DOI 10.1159/000077756
   Marsh PD, 2005, J CLIN PERIODONTOL, V32, P7, DOI 10.1111/j.1600-051X.2005.00790.x
   MARSH PD, 2000, COMMUNITY STRUCTURE, P167
   Mengel R, 1996, J PERIODONTOL, V67, P782, DOI 10.1902/jop.1996.67.8.782
   MERGENHAGEN SE, 1987, REV INFECT DIS, V9, P467
   MOMBELLI A, 1988, ORAL MICROBIOL IMMUN, V3, P113, DOI 10.1111/j.1399-302X.1988.tb00095.x
   MOMBELLI A, 1995, J CLIN PERIODONTOL, V22, P124
   MORMANN W, 1974, J CLIN PERIODONTOL, V1, P120, DOI 10.1111/j.1600-051X.1974.tb01247.x
   Morra M, 1997, J BIOMAT SCI-POLYM E, V9, P55, DOI 10.1163/156856297X00263
   NAKAZATO G, 1989, International Journal of Oral and Maxillofacial Implants, V4, P321
   OLSSON J, 1992, CARIES RES, V26, P428, DOI 10.1159/000261482
   Papaioannou W, 1996, CLIN ORAL IMPLAN RES, V7, P405, DOI 10.1034/j.1600-0501.1996.070415.x
   Parvizi J, 2004, CLIN ORTHOP RELAT R, P33, DOI 10.1097/01.blo.0000150116.65231.45
   Peumans M, 1998, J PERIODONTOL, V69, P422, DOI 10.1902/jop.1998.69.4.422
   PRATTTERPSTRA IH, 1989, J DENT RES, V68, P463, DOI 10.1177/00220345890680030501
   PRATTTERPSTRA IH, 1991, J BIOMATERIALS SCI P, V3, P239
   QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x
   Quirynen M, 2006, CLIN ORAL IMPLAN RES, V17, P25, DOI 10.1111/j.1600-0501.2005.01194.x
   QUIRYNEN M, 1989, J DENT RES, V68, P796, DOI 10.1177/00220345890680050801
   Quirynen M, 1996, Int J Oral Maxillofac Implants, V11, P169
   QUIRYNEN M, 1994, CLIN ORAL IMPLAN RES, V5, P239, DOI 10.1034/j.1600-0501.1994.050407.x
   QUIRYNEN M, 1993, CLIN ORAL IMPLAN RES, V4, P158, DOI 10.1034/j.1600-0501.1993.040307.x
   QUIRYNEN M, 1990, J CLIN PERIODONTOL, V17, P138, DOI 10.1111/j.1600-051X.1990.tb01077.x
   QUIRYNEN M, 1993, J DENT RES, V72, P1304, DOI 10.1177/00220345930720090801
   Quirynen M, 2002, CLIN ORAL IMPLAN RES, V13, P1, DOI 10.1034/j.1600-0501.2002.130101.x
   QUIRYNEN M, 1990, CLIN ORAL IMPLAN RES, V4, P8
   QUIRYNEN M, 1986, THESIS LEUVEN
   Rakhorst G, 1999, INT J ARTIF ORGANS, V22, P35
   Rasperini G, 1998, CLIN ORAL IMPLAN RES, V9, P357, DOI 10.1034/j.1600-0501.1996.090601.x
   Rimondini L, 1997, J PERIODONTOL, V68, P556, DOI 10.1902/jop.1997.68.6.556
   Rimondini L, 2002, INT J ORAL MAX IMPL, V17, P793
   Rolla G., 1991, BIOFOULING, V3, P175
   RUAN MS, 1986, ARCH ORAL BIOL, V31, P597, DOI 10.1016/0003-9969(86)90083-X
   RUTTER P R, 1984, P21
   RYKKE M, 1991, SCAND J DENT RES, V99, P463
   Sbordone L, 1999, J PERIODONTOL, V70, P1322, DOI 10.1902/jop.1999.70.11.1322
   SCANNAPIECO FA, 1995, J DENT RES, V74, P1360, DOI 10.1177/00220345950740070701
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   Scarano Antonio, 2003, J Oral Implantol, V29, P80, DOI 10.1563/1548-1336(2003)029<0080:BAOTNA>2.3.CO;2
   Scheie A A, 1994, Adv Dent Res, V8, P246
   SCHEUTZEL P, 1989, ZWR (Heidelberg), V98, P857
   SCHMITT DD, 1986, J VASC SURG, V3, P732, DOI 10.1067/mva.1986.avs0030732
   SHAFAGH I, 1986, J PROSTHET DENT, V55, P339, DOI 10.1016/0022-3913(86)90116-2
   Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81
   Siegrist BE, 1991, CLIN ORAL IMPLAN RES, V2, P38, DOI 10.1034/j.1600-0501.1991.020105.x
   SIOCHI EJ, 1987, J COLLOID INTERF SCI, V115, P346, DOI 10.1016/0021-9797(87)90049-X
   Sipahi C, 2001, J DENT, V29, P197, DOI 10.1016/S0300-5712(01)00011-2
   SMALES RJ, 1981, J DENT, V9, P133, DOI 10.1016/0300-5712(81)90087-7
   STENSTROM TA, 1989, APPL ENVIRON MICROB, V55, P142
   Suketa N, 2005, CLIN IMPLANT DENT R, V7, P105, DOI 10.1111/j.1708-8208.2005.tb00053.x
   Tanner J, 2005, CLIN ORAL INVEST, V9, P154, DOI 10.1007/s00784-005-0317-4
   TRIVEDI SC, 1973, J PROSTHET DENT, V29, P73, DOI 10.1016/0022-3913(73)90142-X
   van Loosdrecht M C, 1990, J Biomater Appl, V5, P91, DOI 10.1177/088532829000500202
   VANDIJK J, 1987, J CLIN PERIODONTOL, V14, P300
   VANDIJKEN JWV, 1987, J CLIN PERIODONTOL, V14, P185
   VANDIJKEN JWV, 1987, J CLIN PERIODONTOL, V14, P257
   VANLOOSDRECHT MCM, 1990, MICROBIOL REV, V54, P75
   VANLOOSDRECHT MCM, 1990, EXPERIENTIA, V46, P817
   VANOSS CJ, 1986, J CHROMATOGR, V376, P111, DOI 10.1016/S0378-4347(00)80828-2
   VANPELT AWJ, 1983, J BIOMED MATER RES, V17, P637, DOI 10.1002/jbm.820170408
   Wahl G, 1992, Schweiz Monatsschr Zahnmed, V102, P1321
   WEERKAMP AH, 1988, J DENT RES, V67, P1483, DOI 10.1177/00220345880670120801
   WEERKAMP AH, 1989, MICROBIAL ECOLOGY HL, V2, P11
   WEITMAN RT, 1975, J AM DENT ASSOC, V91, P101, DOI 10.14219/jada.archive.1975.0294
   Wennerberg A, 2003, J CLIN PERIODONTOL, V30, P88, DOI 10.1034/j.1600-051X.2003.10026.x
   Whittaker CJ, 1996, ANNU REV MICROBIOL, V50, P513, DOI 10.1146/annurev.micro.50.1.513
   Yoshinari M, 2001, BIOMATERIALS, V22, P2043, DOI 10.1016/S0142-9612(00)00392-6
NR 136
TC 435
Z9 447
U1 8
U2 120
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0905-7161
J9 CLIN ORAL IMPLAN RES
JI Clin. Oral Implant. Res.
PD OCT
PY 2006
VL 17
SU 2
BP 68
EP 81
DI 10.1111/j.1600-0501.2006.01353.x
PG 14
WC Dentistry, Oral Surgery & Medicine; Engineering, Biomedical
SC Dentistry, Oral Surgery & Medicine; Engineering
GA 088IG
UT WOS:000240804800008
PM 16968383
OA Bronze
DA 2018-10-19
ER

PT J
AU Mendez-Vilas, A
   Donoso, MG
   Gonzalez-Carrasco, JL
   Gonzalez-Martin, ML
AF Mendez-Vilas, A.
   Donoso, M. G.
   Gonzalez-Carrasco, J. L.
   Gonzalez-Martin, M. L.
TI Looking at the micro-topography of polished and blasted Ti-based
   biomaterials using atomic force microscopy and contact angle goniometry
SO COLLOIDS AND SURFACES B-BIOINTERFACES
LA English
DT Article; Proceedings Paper
CT 1st International Conference on Environmental Industrial and Applied
   Microbiology
CY MAR 15-18, 2005
CL Badajoz, SPAIN
DE surface roughness; micro-roughness; atomic force microscopy (AFM);
   biomaterial; adhesion; titanium; biocompatibility; Biofilm; surfaces;
   contact angle
ID SURFACE-ROUGHNESS; PURE TITANIUM; ADHESION; CELLS; ATTACHMENT; ENERGY
AB Surface topography of polished and blasted samples of a Ti6Al4V biomaterial has been studied using an atomic force microscope. Surface RMS roughness and surface area have been measured at different scales, from 1 to 50 mu m, while at distances below 10 mu m the surface RMS roughness in both kinds of samples is not very different, this difference becomes significant at larger scanning sizes. This means that the surface roughness scale that could have a main role in cell adhesion varies depending on the size, shape and flexibility of participating cells. This consideration suggests that in cell-material interaction studies, surface roughness should not be considered as an absolute and independent property of the material, but should be measured at scales in the order of the cell sizes, at least if a microscopic interpretation of the influence of roughness on the adhesion is intended. The microscopic information is contrasted with that coming from a macroscopic approach obtained by contact angle measurements for polar and non-polar liquids whose surface tension is comprised in a broad range. Despite the very large differences of contact angles among liquids for each surface condition, a similar increase for the blasted surface with respect to the polished has been found. Interpretation of these results are in accordance with the microscopic analysis done through the use of a functional roughness parameter, namely the valley fluid retention index, evaluated from the AFM images, which has been shown not to correlate with the RMS roughness, one of the most commonly used roughness parameter. (C) 2006 Elsevier B.V. All rights reserved.
C1 Univ Extremadura, Dept Fis, E-06071 Badajoz, Spain.
   CSIC, CENIM, Ctr Nacl Invest Met, E-28040 Madrid, Spain.
RP Mendez-Vilas, A (reprint author), Univ Extremadura, Dept Fis, Avda Elvas S-N, E-06071 Badajoz, Spain.
EM amvilas@formatex.org
RI Gonzalez Martin, Maria Luisa/L-3476-2014; Gonzalez Carrasco, Jose
   Luis/A-7971-2008
OI Gonzalez Martin, Maria Luisa/0000-0002-9207-444X; Gonzalez-Carrasco,
   Jose Luis/0000-0003-2004-4505
CR Abrahamsson I, 2002, J CLIN PERIODONTOL, V29, P448, DOI 10.1034/j.1600-051X.2002.290510.x
   Alcamo E., 1995, MICROBIOLOGY COLORIN
   Anselme K, 2005, ACTA BIOMATER, V1, P211, DOI 10.1016/j.actbio.2004.11.009
   Bathomarco RV, 2004, APPL SURF SCI, V233, P29, DOI 10.1016/j.apsusc.2004.04.007
   Bico J, 2002, COLLOID SURFACE A, V206, P41, DOI 10.1016/S0927-7757(02)00061-4
   Bigerelle M, 2002, BIOMOL ENG, V19, P79, DOI 10.1016/S1389-0344(02)00048-5
   BIGERELLE M, 2004, J BIOMED MATER RES A, V72, P36
   BREN L, 2004, 7 WORLD BIOM C AUSTR, P1121
   CASSIE ABD, 1948, DISCUSS FARADAY SOC, V3, P11, DOI 10.1039/df9480300011
   DONOSO MG, IN PRESS INT BIODETE
   FREITAS RA, 1999, NANOMEDICINE, V1
   Genov DA, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.056611
   Good R. J., 1993, CONTACT ANGLE WETTAB
   Gough JE, 2004, J BIOMED MATER RES A, V68A, P640, DOI 10.1002/jbm.a.20075
   Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297
   Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033
   He B, 2003, LANGMUIR, V19, P4999, DOI 10.1021/la0268348
   HUANG HH, 2003, P 81 GEN SESS INT AS
   JANSEN B, 1995, J IND MICROBIOL, V15, P391, DOI 10.1007/BF01569996
   Katsaros D, 2004, IEEE INTERNET COMPUT, V8, P37, DOI 10.1109/MIC.2004.1297272
   Korovessis PG, 2002, J SPINAL DISORD TECH, V15, P175, DOI 10.1097/00024720-200204000-00015
   KURTZMAN CP, 2005, YEASTS TAXONOMIC STU
   LI D, 1996, THERMODYNAMIC STATUS
   Linez-Bataillon P, 2002, BIOMOL ENG, V19, P133, DOI 10.1016/S1389-0344(02)00024-2
   LUKATSKY B, 2003, PHYS REV E, V67, DOI UNSP 062402
   Mendez-Vilas A, 2004, APPL SURF SCI, V238, P51, DOI 10.1016/j.apsusc.2004.05.212
   Mendez-Vilas A, 2002, MATER SCI FORUM, V408-4, P245, DOI 10.4028/www.scientific.net/MSF.408-412.245
   Muller B, 2001, J VAC SCI TECHNOL B, V19, P1715, DOI 10.1116/1.1392402
   Nicholls J. G., 1992, NEURON BRAIN
   Otto A, 2001, PHYS STATUS SOLIDI A, V188, P1455, DOI 10.1002/1521-396X(200112)188:4<1455::AID-PSSA1455>3.0.CO;2-4
   Patankar NA, 2003, LANGMUIR, V19, P1249, DOI 10.1021/la026612+
   PHAM MT, 2002, E MRS SPRING M STRAS, pR11
   QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x
   Russell TP, 1999, SCIENCE, V285, P1219, DOI 10.1126/science.285.5431.1219
   Scarano A, 2004, J PERIODONTOL, V75, P292, DOI 10.1902/jop.2004.75.2.292
   Senechal A., 2005, J BIOMAT SCI-POLYM E, V16, P112
   STOUT EJ, 1994, PUBLICATION EUR
   Streek M, 2004, J BIOTECHNOL, V112, P79, DOI 10.1016/j.jbiotec.2004.04.021
   WENZEL RN, 1949, J PHYS COLLOID CHEM, V53, P1466, DOI 10.1021/j150474a015
   Young T, 1805, PHILOS T R SOC LONDO, V95, P65, DOI DOI 10.1098/RSTL.1805.0005
   Zinger O, 2004, BIOMATERIALS, V25, P2695, DOI 10.1016/j.biomaterials.2003.09.111
NR 41
TC 16
Z9 16
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0927-7765
J9 COLLOID SURFACE B
JI Colloid Surf. B-Biointerfaces
PD OCT 1
PY 2006
VL 52
IS 2
BP 157
EP 166
DI 10.1016/j.colsurfb.2006.05.002
PG 10
WC Biophysics; Chemistry, Physical; Materials Science, Biomaterials
SC Biophysics; Chemistry; Materials Science
GA 097KD
UT WOS:000241445200010
PM 16782313
DA 2018-10-19
ER

PT J
AU Luo, DW
   Yu, C
   He, LQ
   Lu, CC
   Gao, DY
AF Luo, Dawei
   Yu, Chun
   He, Liqun
   Lu, Caicheng
   Gao, Dayong
TI Development of a single mode electromagnetic resonant cavity for
   rewarming of cryopreserved biomaterials
SO CRYOBIOLOGY
LA English
DT Article
DE cryopreservation; electromagnetic warming
ID DIELECTRIC-PROPERTIES; DIMETHYL-SULFOXIDE; KIDNEYS
AB An electromagnetic (EM) heating system is developed to achieve the rapid and uniform warming of cryopreserved biomaterials. Using the heating system, a rectangular resonant cavity is excited in TE 101 mode at frequencies near 434 MHz. In experiments, a spherical phantom of biomaterial with a diameter of 36mm is placed at the center of the cavity. The phantom is first cooled down to about -80 degrees C within the cavity and then thawed by EM absorption. Results show that EM warming can produce much higher warming rate than conventional water-bath warming method. The spatial temperature distribution in the phantom during EM warming is also more uniform than that during the water-bath warming. (c) 2006 Elsevier Inc. All rights reserved.
C1 Univ Kentucky, Dept Mech Engn, Lexington, KY 40506 USA.
   Univ Kentucky, Dept Elect & Comp Engn, Lexington, KY 40506 USA.
   Univ Sci & Technol China, Dept Thermal Sci & Energy Engn, Hefei 230026, Peoples R China.
RP Gao, DY (reprint author), Univ Washington, MEB 254, Seattle, WA 98195 USA.
EM dayong@u.washington.edu
CR GUTTMAN FM, 1977, CRYOBIOLOGY, V14, P559, DOI 10.1016/0011-2240(77)90166-3
   JACOBSEN IA, 1984, CRYOBIOLOGY, V21, P637, DOI 10.1016/0011-2240(84)90223-2
   KETTERER FD, 1971, CRYOBIOLOGY, V8, P395, DOI 10.1016/0011-2240(71)90197-0
   MAZUR P, 1984, AM J PHYSIOL, V247, pE125
   Michelson SC, 1996, PHYS MED BIOL, V41, P2053, DOI 10.1088/0031-9155/41/10/014
   PEGG DE, 1978, CRYOBIOLOGY, V15, P618, DOI 10.1016/0011-2240(78)90086-X
   RACHMAN MJ, 1992, J BIOMED ENG, V14, P397, DOI 10.1016/0141-5425(92)90085-Y
   Robinson MP, 1999, IEEE T BIO-MED ENG, V46, P1413, DOI 10.1109/10.804569
   RUGGERA PS, 1990, CRYOBIOLOGY, V27, P465, DOI 10.1016/0011-2240(90)90035-3
   Wusteman MC, 2002, CRYOBIOLOGY, V44, P24, DOI 10.1016/S0011-2240(02)00002-0
NR 10
TC 10
Z9 11
U1 0
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0011-2240
J9 CRYOBIOLOGY
JI Cryobiology
PD OCT
PY 2006
VL 53
IS 2
BP 288
EP 293
DI 10.1016/j.cryobiol.2006.07.001
PG 6
WC Biology; Physiology
SC Life Sciences & Biomedicine - Other Topics; Physiology
GA 093CQ
UT WOS:000241145300016
PM 16930581
DA 2018-10-19
ER

PT J
AU Okroj, W
   Kaminska, M
   Klimek, L
   Szymanski, W
   Walkowiak, B
AF Okroj, W.
   Kaminska, M.
   Klimek, L.
   Szymanski, W.
   Walkowiak, B.
TI Blood platelets in contact with nanocrystalline diamond surfaces
SO DIAMOND AND RELATED MATERIALS
LA English
DT Article
DE platelet adhesion; surface modifications; stainless steel;
   nanocrystalline diamond-NCD
ID ADSORBED FIBRINOGEN; PROTEIN ADSORPTION; TITANIUM; HEMOCOMPATIBILITY;
   COATINGS; FILMS; TIN; BIOMATERIAL; ACTIVATION; DLC
AB The stainless steel (AISI 316L) and nanocrystalline diamond (NCD) deposited on stainless steel substrates by Radio Frequency Plasma Chemical Vapour Deposition (RF PCVD), predicted for use as coatings for medical applications, were studied by a meaning of blood platelet adhesion. After 12 h contact with platelet poor plasma (PPP) and additional 1 h with citrated whole human blood, platelets present at the surface were found to spread on the stainless steel but not on nanocrystalliane diamond surfaces. The only exception made damaged fragments of NCD surfaces, where we have found adhered blood platelets and other blood cells. The results indicate favorable properties of NCD surface in contact with human blood. (c) 2006 Elsevier B.V. All rights reserved.
C1 Tech Univ Lodz, Ctr Excellence NANODIAM, Inst Mat Sci & Engn, PL-90924 Lodz, Poland.
   Med Univ Lodz, Dept Mol & Med Biophys, PL-92215 Lodz, Poland.
RP Okroj, W (reprint author), Tech Univ Lodz, Ctr Excellence NANODIAM, Inst Mat Sci & Engn, Stefanowskiego 1, PL-90924 Lodz, Poland.
EM okroj@p.lodz.pl
RI Kaminska, Marta/T-1949-2018; Szymanski, Witold/S-1240-2018; Klimek,
   Leszek/K-5958-2015
OI Kaminska, Marta/0000-0002-3427-0944; Szymanski,
   Witold/0000-0002-4738-5847; Klimek, Leszek/0000-0003-3617-8225;
   Walkowiak, Bogdan/0000-0003-4867-5456
CR CHANDRA L, 1995, DIAM RELAT MATER, V4, P853
   Chen JY, 2002, BIOMATERIALS, V23, P2545, DOI 10.1016/S0142-9612(01)00389-1
   DION I, 1993, BIOMATERIALS, V14, P169, DOI 10.1016/0142-9612(93)90019-X
   Grunkemeier JM, 2000, BIOMATERIALS, V21, P2243, DOI 10.1016/S0142-9612(00)00150-2
   HAYCOX CL, 1993, J BIOMED MATER RES, V27, P1181, DOI 10.1002/jbm.820270909
   Hong J, 1999, BIOMATERIALS, V20, P603, DOI 10.1016/S0142-9612(98)00210-5
   Hong J, 1999, THROMB HAEMOSTASIS, V82, P58
   Jones MI, 1999, DIAM RELAT MATER, V8, P457, DOI 10.1016/S0925-9635(98)00426-9
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Mitamura Y, 1989, J Biomater Appl, V4, P33, DOI 10.1177/088532828900400103
   Mitura S, 1999, CHAOS SOLITON FRACT, V10, P2165, DOI 10.1016/S0960-0779(98)00251-3
   Mitura S, 1996, DIAM RELAT MATER, V5, P1185, DOI 10.1016/0925-9635(95)00525-0
   Park JY, 2001, BIOMATERIALS, V22, P2671, DOI 10.1016/S0142-9612(01)00009-6
   Schlegel KA, 2002, BIOMATERIALS, V23, P2939, DOI 10.1016/S0142-9612(01)00423-9
   SOGA T, 2004, FIZIKA TWIERDOWO TIE, V46, P702
   TANG L, 1995, BIOMATERIALS, V16, P483, DOI 10.1016/0142-9612(95)98822-V
   Thull R, 2002, BIOMOL ENG, V19, P43, DOI 10.1016/S1389-0344(02)00009-6
   Walkowiak B., 2002, Journal of Wide Bandgap Materials, V9, P231, DOI 10.1106/152451102024426
   Wang T, 2004, DIAM RELAT MATER, V13, P6, DOI 10.1016/j.diamond.2003.08.014
   Wu YG, 2005, J BIOMED MATER RES A, V74A, P722, DOI 10.1002/jbm.a.30381
   Yang TS, 2002, J APPL PHYS, V92, P2133, DOI 10.1063/1.1492864
NR 21
TC 36
Z9 37
U1 0
U2 20
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0925-9635
J9 DIAM RELAT MATER
JI Diam. Relat. Mat.
PD OCT
PY 2006
VL 15
IS 10
BP 1535
EP 1539
DI 10.1016/j.diamond.2005.12.033
PG 5
WC Materials Science, Multidisciplinary; Materials Science, Coatings &
   Films; Physics, Applied; Physics, Condensed Matter
SC Materials Science; Physics
GA 094FD
UT WOS:000241224000006
DA 2018-10-19
ER

PT J
AU Lepidi, S
   Grego, F
   Vindigni, V
   Zavan, B
   Tonello, C
   Deriu, GP
   Abatangelo, G
   Cortivo, R
AF Lepidi, S.
   Grego, F.
   Vindigni, V.
   Zavan, B.
   Tonello, C.
   Deriu, G. P.
   Abatangelo, G.
   Cortivo, R.
TI Hyaluronan biodegradable scaffold for small-caliber artery grafting:
   Preliminary results in an animal model
SO EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
LA English
DT Article
DE Biomaterials; vascular graft; peripheral vascular disease
ID ENGINEERED VASCULAR GRAFTS; IN-VITRO; ENDOTHELIAL-CELLS; BLOOD-VESSEL;
   ACID; MATRIX; BONE
AB Objective. To evaluate a new Hyaluronan-based graft.
   Material and methods. Hyaluronan-based grafts (HYAFF 11(TM) tube, diameter 2 mm, length 1.5 cm) were implanted in an end-to-end fashion in the abdominal aorta of 15 rats. Histology, immunohistochemistry and electron microscopy were used to evaluate the results at 7, 21, and 90 days.
   Results. At day 7, new tissue was observed in the graft coming from both the proximal and distal ends of the aorta. The luminal surface of the regenerating tissue was covered by endothelial cells (CD34(+), VEGFR-2(+), vWF(+)). At day 21, regenerating tissue joined at the centre of the tube. The neo-vessel was formed by smooth muscle cells (Myosin Light Chain Kinase) as well as elastic, and collagen fibres. At day 90 a stable artery segment was formed and the biomaterial was almost completely degraded. Infiltration of neutrophils and lymphocytes was not observed. All animals survived the observation period and there were no signs of stenoses or aneurysms.
   Conclusion. The hyaluronan-based graft allowed complete regeneration of a newly formed vascular tube in which all the cellular and extracellular components are present and organized in a well defined architecture similar to native artery.
C1 Univ Padua, Dept Vasc Surg, I-35100 Padua, Italy.
   Univ Padua, Dept Histol Microbiol & Med Biotechnol, Padua, Italy.
   Univ Padua, Unit Plast Surg, Padua, Italy.
RP Grego, F (reprint author), Univ Padua, Dept Vasc Surg, 1 Piano Monoblocco Osped,Via Giustiniani 2, I-35100 Padua, Italy.
EM franco.grego@unipd.it
OI Vindigni, Vincenzo/0000-0001-6638-9010
CR Caravaggi C, 2003, DIABETES CARE, V26, P2853, DOI 10.2337/diacare.26.10.2853
   DEREEDER EG, 1988, AM J PATHOL, V132, P574
   GREISLER HP, 1991, SURGERY, V110, P645
   Isenberg BC, 2006, CIRC RES, V98, P25, DOI 10.1161/01.RES.0000196867.12470.84
   L'Heureux N, 1998, FASEB J, V12, P47
   Lepidi S, 1996, EUR J VASC ENDOVASC, V11, P36, DOI 10.1016/S1078-5884(96)80132-8
   LEVESQUE H, 1994, ATHEROSCLEROSIS, V105, P51, DOI 10.1016/0021-9150(94)90007-8
   Lisignoli G, 2002, BIOMATERIALS, V23, P1043, DOI 10.1016/S0142-9612(01)00216-2
   Mitchell SL, 2003, CARDIOVASC PATHOL, V12, P59, DOI 10.1016/S1054-8807(02)00183-7
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Remuzzi A, 2004, TISSUE ENG, V10, P699, DOI 10.1089/1076327041348347
   Riessen R, 1996, CIRCULATION, V93, P1141, DOI 10.1161/01.CIR.93.6.1141
   SCHMITZRIXEN T, 1988, J VASC SURG, V7, P82, DOI 10.1067/mva.1988.avs0070082
   Solchaga LA, 1999, J ORTHOPAED RES, V17, P205, DOI 10.1002/jor.1100170209
   Tonello C, 2003, BIOMATERIALS, V24, P1205, DOI 10.1016/S0142-9612(02)00450-7
   Turner NJ, 2004, BIOMATERIALS, V25, P5955, DOI 10.1016/j.biomaterials.2004.02.002
   VESCOVO G, 1996, BASIC APPL MYOL, V6, P183
   Wang H, 2005, ARTERIOSCL THROM VAS, V25, P1817, DOI 10.1161/01.ATV.0000175840.90510.a8
   WEINBERG CB, 1986, SCIENCE, V231, P397, DOI 10.1126/science.2934816
   WIGHT TN, 1989, ARTERIOSCLEROSIS, V9, P1, DOI 10.1161/01.ATV.9.1.1
   WILSON GJ, 1995, ANN THORAC SURG, V60, pS353, DOI 10.1016/0003-4975(95)98967-Y
   Zilla P, 1999, Semin Vasc Surg, V12, P52
NR 22
TC 40
Z9 42
U1 0
U2 8
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 1078-5884
J9 EUR J VASC ENDOVASC
JI Eur. J. Vasc. Endovasc. Surg.
PD OCT
PY 2006
VL 32
IS 4
BP 411
EP 417
DI 10.1016/j.ejvs.2006.02.012
PG 7
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA 096WU
UT WOS:000241408300015
PM 16678455
OA Bronze
DA 2018-10-19
ER

PT J
AU Ogino, A
   Kral, M
   Narushima, K
   Yamashita, M
   Nagatsu, M
AF Ogino, Akihisa
   Kral, Martin
   Narushima, Kazuo
   Yamashita, Mitsuji
   Nagatsu, Masaaki
TI Surface amination of biopolymer using surface-wave excited ammonia
   plasma
SO JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS BRIEF
   COMMUNICATIONS & REVIEW PAPERS
LA English
DT Article; Proceedings Paper
CT 6th International Conference on Reactive Plasma/23rd Symposium on Plasma
   Processing (ICRP-6/SPP-23)
CY JAN 24-27, 2006
CL Matsushima, JAPAN
SP Japan Soc Appl Phys
DE microwave; ammonia plasma; chitosan; surface modification; amino group
ID GLOW-DISCHARGE; IMMOBILIZED POLYURETHANES; POLYETHYLENE
AB Surface-wave plasma has been used to modify polymer surfaces. The density and selectivity of the functionalizations are very important for biomaterial applications. Low-temperature plasma treatment has been successfully applied to many types of polymers to generate functional surfaces. In this study, we focus on the surface modification of amino groups on chitosan surfaces by ammonia plasma treatment. Chitosan is a nontoxic, biocompatible and biodegradable polymer, which promotes the scarless healing of skin through embolization. The experimental results of X-ray photoelectron spectroscopy measurements showed that the ammonia plasma exposure to the chitosan surface increased the nitrogen incorporation on the surface from 4.67 to 9.92%. The selectivity of amino group functionalizations (-NH2/N) increased from 53.7 to 78.4% after the plasma irradiation.
C1 Shizuoka Univ, Fac Engn, Hamamatsu, Shizuoka 4328561, Japan.
RP Ogino, A (reprint author), Shizuoka Univ, Fac Engn, 3-5-1 Johoku, Hamamatsu, Shizuoka 4328561, Japan.
EM taogino@ipc.shizuoka.ac.jp
CR Bae JS, 1999, BIOMATERIALS, V20, P529, DOI 10.1016/S0142-9612(98)00204-X
   Chan-Park MB, 2002, J ADHES SCI TECHNOL, V16, P1883, DOI 10.1163/15685610260427665
   GENGENBACH TR, 1994, J ADHES SCI TECHNOL, V8, P305, DOI 10.1163/156856194X00267
   HAYAT U, 1992, BIOMATERIALS, V13, P801, DOI 10.1016/0142-9612(92)90022-G
   Inagaki N, 2004, J POLYM SCI POL PHYS, V42, P3727, DOI 10.1002/polb.20234
   Kang IK, 1996, BIOMATERIALS, V17, P841, DOI 10.1016/0142-9612(96)81422-0
   Kim EJ, 1998, BIOMATERIALS, V19, P239, DOI 10.1016/S0142-9612(98)00203-8
   Kumagai H, 2004, J VAC SCI TECHNOL A, V22, P1, DOI 10.1116/1.1624286
   Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75
   MATIENZO LJ, 2002, MACROMOL MATER ENG, V12, P287
   Meyer-Plath AA, 2003, VACUUM, V71, P391, DOI 10.1016/S0042-207X(02)00766-2
   Nagatsu M, 2000, JPN J APPL PHYS 2, V39, pL929, DOI 10.1143/JJAP.39.L929
   Nagatsu M, 1997, PLASMA SOURCES SCI T, V6, P427, DOI 10.1088/0963-0252/6/3/020
   Ohl A, 1999, SURF COAT TECH, V116, P820, DOI 10.1016/S0257-8972(99)00150-4
   SIPEHIA R, 1986, BIOMATERIALS, V7, P471, DOI 10.1016/0142-9612(86)90038-4
   Sprang N, 1998, SURF COAT TECH, V98, P865, DOI 10.1016/S0257-8972(97)00362-9
   SUZUKI M, 1986, MACROMOLECULES, V19, P1804, DOI 10.1021/ma00161a005
   Wang LJ, 2005, J APPL POLYM SCI, V97, P2418, DOI 10.1002/app.21948
   YAO YG, 1993, J ADHES SCI TECHNOL, V7, P63
   Zhu X, 2005, J BIOMED MATER RES A, V73A, P264, DOI 10.1002/jbm.a.30211
NR 20
TC 15
Z9 15
U1 0
U2 4
PU JAPAN SOC APPLIED PHYSICS
PI TOKYO
PA KUDAN-KITA BUILDING 5TH FLOOR, 1-12-3 KUDAN-KITA, CHIYODA-KU, TOKYO,
   102-0073, JAPAN
SN 0021-4922
J9 JPN J APPL PHYS 1
JI Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Brief Commun. Rev. Pap.
PD OCT
PY 2006
VL 45
IS 10B
BP 8494
EP 8497
DI 10.1143/JJAP.45.8494
PG 4
WC Physics, Applied
SC Physics
GA 103QX
UT WOS:000241902900097
DA 2018-10-19
ER

PT J
AU Beckstead, BL
   Santosa, DM
   Giachelli, CM
AF Beckstead, Benjamin L.
   Santosa, Daniel M.
   Giachelli, Cecilia M.
TI Mimicking cell-cell interactions at the biomaterial-cell interface for
   control of stem cell differentiation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE notch; biomaterials; Jagged-1; epithelial cells; stem cells
ID TRANSIT-AMPLIFYING CELLS; ESOPHAGEAL EPITHELIUM; INTRACELLULAR DOMAIN;
   IN-VITRO; NOTCH; KERATINOCYTES; ACTIVATION; TISSUE; EXPRESSION; RELEASE
AB The ability to regulate stem cell proliferation and differentiation has relevance in numerous medical applications, including medical devices, tissue engineering, and regenerative medicine. To control cellular behavior at the biomaterial or scaffold interface, many studies have employed surface modifications that mimic the extracellular matrix. Strikingly absent is the immobilization of cell-surface ligands to the biomaterial surface. One cell-to-cell signaling pathway that has been shown to regulate tissue development and stem cell fate is the Notch pathway. Recently, the Notch signaling pathway was identified as a key regulator of epithelial differentiation. Utilizing this knowledge, we applied an affinity immobilization scheme designed to attach and orient the Notch ligand, Jagged-1, in an active conformation on a biomaterial surface. When epithelial stem cells were plated on the bound ligand, the Notch/CBF-1 signaling pathway was stimulated and the cells upregulated both intermediate- and late-stage differentiation markers. In addition, the ligand promoted tight clustering and extensive stratification. Soluble Jagged-1 showed no Notch/CBF-1 signaling and very little, if any, cell differentiating activity. The high potency of bound Jagged-1 suggests that modification of a surface with a Notch ligand presents a powerful method to control stem cell differentiation at the cell-biomaterial interface. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
   Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.
RP Giachelli, CM (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
EM ceci@u.washington.edu
FU NIBIB NIH HHS [EB-002027]
CR Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770
   Beckstead BL, 2005, BIOMATERIALS, V26, P6217, DOI 10.1016/j.biomaterials.2005.04.010
   Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573
   DALE BA, 1983, J INVEST DERMATOL, V81, pS90, DOI 10.1111/1523-1747.ep12540769
   De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083
   Eckert RL, 1997, PHYSIOL REV, V77, P397
   Hicks C, 2002, J NEUROSCI RES, V68, P655, DOI 10.1002/jnr.10263
   HOFFMAN AS, 2004, BIOMATERIALS SCI INT, P225
   JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K
   Kang JS, 2001, LANGMUIR, V17, P4352, DOI 10.1021/la001310y
   Keselowsky BG, 2005, P NATL ACAD SCI USA, V102, P5953, DOI 10.1073/pnas.0407356102
   Krisanaprakornkit S, 1998, INFECT IMMUN, V66, P4222
   Linden KG, 1999, AM J MED, V107, P595, DOI 10.1016/S0002-9343(99)00284-3
   Lowell S, 2000, CURR BIOL, V10, P491, DOI 10.1016/S0960-9822(00)00451-6
   Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055
   Martin SM, 2004, J BIOMED MATER RES A, V70A, P10, DOI 10.1002/jbm.a.30052
   Martin SM, 2003, J BIOMED MATER RES A, V67A, P334, DOI 10.1002/jbm.a.10060
   Nickoloff BJ, 2002, CELL DEATH DIFFER, V9, P842, DOI 10.1038/sj.cdd.4401036
   Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9
   Oishi K, 2004, DEV BIOL, V276, P172, DOI 10.1016/j.ydbio.2004.08.039
   Okuyama R, 2004, DEV CELL, V6, P551, DOI 10.1016/S1534-5807(04)00098-X
   Peppas NA, 2004, BIOMATERIALS SCI INT, P100
   Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427
   RATNER BD, 2004, BIOMATERIALS SCI INT, P201
   Raya A, 2003, P NATL ACAD SCI USA, V100, P11889, DOI 10.1073/pnas.1834204100
   Roh C, 2005, J INVEST DERMATOL, V125, P1099, DOI 10.1111/j.0022-202X.2005.23958.x
   Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756
   SCHWEISGUTH F, 2004, CURR BIOL, V14, P129
   Seery JP, 2002, J CELL SCI, V115, P1783
   Seery JP, 2000, CURR BIOL, V10, P1447, DOI 10.1016/S0960-9822(00)00803-4
   Small D, 2001, J BIOL CHEM, V276, P32022, DOI 10.1074/jbc.M100933200
   Squier C A, 2001, J Natl Cancer Inst Monogr, P7
   Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390
   Varnum-Finney B, 2000, J CELL SCI, V113, P4313
   VONRECUM AF, 1984, J BIOMED MATER RES, V18, P323, DOI 10.1002/jbm.820180403
   Watt FM, 2001, CURR OPIN GENET DEV, V11, P410, DOI 10.1016/S0959-437X(00)00211-2
   Wong CSM, 2003, BRIT MED J, V327, P794, DOI 10.1136/bmj.327.7418.794
   Yang H, 2004, KIDNEY INT, V66, P2293, DOI 10.1111/j.1523-1755.2004.66015.x
   ZAGOURAS P, 1995, P NATL ACAD SCI USA, V92, P6414, DOI 10.1073/pnas.92.14.6414
NR 39
TC 52
Z9 56
U1 0
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD OCT
PY 2006
VL 79A
IS 1
BP 94
EP 103
DI 10.1002/jbm.a.30760
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 084CL
UT WOS:000240509300012
PM 16758464
DA 2018-10-19
ER

PT J
AU Andrade, AL
   Andrade, SP
   Domingues, RZ
AF Andrade, Angela Leao
   Andrade, Silvia Passos
   Domingues, Rosana Zacarias
TI In vivo performance of a sol-gel glass-coated collagen
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE angiogenesis; scaffold; collagen; in vivo test; bioactive glass
ID TRANSFORM INFRARED-SPECTROSCOPY; RESORBABLE CERAMICS;
   COMPOSITE-MATERIALS; CALCIUM-PHOSPHATE; GROWTH-FACTOR; BONE DEFECTS;
   SILICA-GEL; HYDROXYAPATITE; HYDROXYLAPATITE; VITRO
AB Synthetic bioactive materials offer possibilities to repair large tissue defects. It is well known that bioactivity, angiogenesis, and inflammation are key events in implant incorporation. Using glass-coated and glass-free collagen as potential bone graft substitutes, we carried out in vitro bioactivity and an in vivo angiogenesis and inflammation studies. The in vitro study showed bioactivity when the glass-coated samples were left in SBF for 5 days. This was confirmed by FTIR results, which presented P-O vibration bands characteristic of hydroxyapatite close to 1060 cm(-1) and 600 cm(-1). The in vivo response was evaluated following subcutaneous implantation of the biomaterial in the mouse dorsa. Angiogenesis, as determined by hemoglobin content extracted from implants 7 and 14 days after implantation, increased progressively in both glass-coated and glass-free collagen implants. However, vascularization was higher in the glass-coated collagen implants 14 days after implantation (mu g Hb per mg wet tissue 6.0 +/- 0.3) compared with the glass-free group (1.6 +/- 0.1). The inflammatory process, determined by the levels of myeloperoxidase and N-acetylglucosaminidase, was similar for both implants. This study shows that glass-coated collagen implants hold osteogenic and angiogenic potential and may be used in clinical conditions requiring improvement of these biological processes. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Fed Minas Gerais, Dept Chem, ICEX, BR-31270901 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Dept Physiol & Biophys, ICB, BR-31270901 Belo Horizonte, MG, Brazil.
RP Domingues, RZ (reprint author), Univ Fed Minas Gerais, Dept Chem, ICEX, CP 702, BR-31270901 Belo Horizonte, MG, Brazil.
EM rosanazd@ufmg.br
RI Domingues, Rosana/C-3174-2013; Domingues, Rosana/P-2017-2014; Andrade,
   Angela/O-2985-2015
OI Domingues, Rosana/0000-0001-5667-2031; Domingues,
   Rosana/0000-0001-5667-2031; 
CR Baley P, 1988, METHOD ENZYMOL, V162, P327
   BERTOLUZZA A, 1982, J NON-CRYST SOLIDS, V48, P117, DOI 10.1016/0022-3093(82)90250-2
   Boccaccini A. R., 2002, Ceramic Engineering and Science Proceedings, V23, P805
   Boyce T, 1999, ORTHOP CLIN N AM, V30, P571, DOI 10.1016/S0030-5898(05)70110-3
   Carollo M, 2001, BRIT J PHARMACOL, V134, P1166, DOI 10.1038/sj.bjp.0704371
   Chapman MW, 1993, OPERATIVE ORTHOPAEDI, P139
   Durucan C, 2001, ADV ENG MATER, V3, P227, DOI 10.1002/1527-2648(200104)3:4<227::AID-ADEM227>3.3.CO;2-T
   Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4
   Gadaleta SJ, 1996, CALCIFIED TISSUE INT, V58, P9, DOI 10.1007/s002239900004
   GATTI AM, 1991, BIOMATERIALS, V12, P497, DOI 10.1016/0142-9612(91)90149-5
   Gauthier O, 1998, BIOMATERIALS, V19, P133, DOI 10.1016/S0142-9612(97)00180-4
   GOLDBERG VM, 1987, CLIN ORTHOP RELAT R, P7
   GROSS U, 1988, CRIT REV BIOCOMPAT, V4, P155
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Ignatius AA, 2001, J BIOMED MATER RES, V57, P126, DOI 10.1002/1097-4636(200110)57:1<126::AID-JBM1151>3.0.CO;2-M
   ISHIKAWA T, 1989, LANGMUIR, V5, P140, DOI 10.1021/la00085a025
   Jiang GW, 1999, J BIOMED MATER RES, V48, P117, DOI 10.1002/(SICI)1097-4636(1999)48:2<117::AID-JBM4>3.0.CO;2-B
   KUKOBO T, 1990, J BIOMED MATER RES, V24, P721
   Lage AP, 2000, MICROVASC RES, V59, P278, DOI 10.1006/mvre.1999.2217
   LANE JM, 1999, CLIN ORTHOP S, V367, P107
   Ma PX, 2001, J BIOMED MATER RES, V54, P284, DOI 10.1002/1097-4636(200102)54:2<284::AID-JBM16>3.0.CO;2-W
   MATOS MC, 1992, J NON-CRYST SOLIDS, V147, P232, DOI 10.1016/S0022-3093(05)80622-2
   Oonishi H, 1997, CLIN ORTHOP RELAT R, P316
   Paschalis EP, 1997, CALCIFIED TISSUE INT, V61, P480, DOI 10.1007/s002239900371
   PASSANITI A, 1992, LAB INVEST, V67, P519
   PAYNE KJ, 1988, BIOPOLYMERS, V27, P1749, DOI 10.1002/bip.360271105
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   Rizzi SC, 2001, J BIOMED MATER RES, V55, P475, DOI 10.1002/1097-4636(20010615)55:4<475::AID-JBM1039>3.0.CO;2-Q
   Roether JA, 2002, BIOMATERIALS, V23, P3871, DOI 10.1016/S0142-9612(02)00131-X
   Schepers EJG, 1997, J ORAL REHABIL, V24, P171
   Schliephake H, 2001, J BIOMED MATER RES, V56, P128, DOI 10.1002/1097-4636(200107)56:1<128::AID-JBM1077>3.0.CO;2-L
   Shi DL, 2000, J BIOMED MATER RES, V53, P457
   Shors EC, 1999, ORTHOP CLIN N AM, V30, P599, DOI 10.1016/S0030-5898(05)70113-9
   Souza DG, 2000, BRIT J PHARMACOL, V131, P1800, DOI 10.1038/sj.bjp.0703756
   Tomford WW, 1999, ORTHOP CLIN N AM, V30, P565, DOI 10.1016/S0030-5898(05)70109-7
   VERHEYEN CCPM, 1993, J BIOMED MATER RES, V27, P433, DOI 10.1002/jbm.820270404
   YOSHINO H, 1990, J NON-CRYST SOLIDS, V126, P68, DOI 10.1016/0022-3093(90)91024-L
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 39
TC 18
Z9 20
U1 1
U2 10
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD OCT
PY 2006
VL 79B
IS 1
BP 122
EP 128
DI 10.1002/jbm.b.30521
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 087EA
UT WOS:000240724300017
PM 16615070
DA 2018-10-19
ER

PT J
AU Ruhe, PQ
   Boerman, OC
   Russel, FGM
   Mikos, AG
   Spauwen, PHM
   Jansen, JA
AF Ruhe, P. Q.
   Boerman, O. C.
   Russel, F. G. M.
   Mikos, A. G.
   Spauwen, P. H. M.
   Jansen, J. A.
TI In vivo release of rhBMP-2 loaded porous calcium phosphate cement
   pretreated with albumin
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID RECOMBINANT HUMAN BONE; HUMAN OSTEOGENIC PROTEIN-1; RAT ECTOPIC MODEL;
   MORPHOGENETIC PROTEIN; HYDROXYAPATITE IMPLANTS; BIOMATERIAL CARRIERS;
   INDUCTIVE PROPERTIES; SPINE ARTHRODESIS; SERUM-ALBUMIN; ADSORPTION
AB In this study, the release of rhBMP-2 loaded porous Ca-P cement was studied in vitro and in vivo. We hypothesized that adsorption sites of Ca-P ceramic with high affinity for rhBMP-2 can be blocked by pretreatment of the ceramic with albumin prior to rhBMP-2 loading, which would result in weaker rhBMP-2 binding and enhanced release of rhBMP-2. Preset porous Ca-P cement discs with a diameter of 6.35 mm (volume: 75 mm(3)) were pretreated by incubation in a solution of 10% rat serum albumin for 24 h or in ddH(2)O (control group) prior to administration of 5 mu g radiolabeled I-131-rhBMP-2. Release was assessed in vitro in phosphate buffered saline (PBS) and fetal calf serum and in vivo by longitudinal scintigraphic imaging of radiolabeled I-131-rhBMP-2 and gamma counting of dissected implants.
   In vitro release from pretreated discs was higher during the first day. For both formulations, release in PBS was limited compared to release in serum. In vivo release considerably exceeded in vitro release. In vivo release kinetics showed no significant difference of half-lives between pretreated and control discs. Both formulations showed sustained release during at least 4 weeks. Ex vivo gamma counting of retrieved samples confirmed scintigraphic results and showed that the capsule and surrounding tissues only contained a minor fraction rhBMP-2. We conclude that 1. scintigraphy of I-131-labeled rhBMP-2 provides a reliable method for longitudinal measurement of rhBMP-2 release kinetics in vivo. 2. albumin pretreatment of porous Ca-P cement does not results in relevant increase of initial release of rhBMP-2 in vivo, and 3. preset rhBMP-2 loaded porous Ca-P cement discs exhibit one phase exponential release kinetics in the rat ectopic model, characterized by a retention of 20-30% after 4 weeks.
C1 Radboud Univ Nijmegen Med Ctr, Dept Periodontol & Biomat, NL-6500 HB Nijmegen, Netherlands.
   Radboud Univ Nijmegen Med Ctr, Dept Nucl Med, NL-6500 HB Nijmegen, Netherlands.
   Radboud Univ Nijmegen Med Ctr, Dept Pharmacol & Toxicol, NL-6500 HB Nijmegen, Netherlands.
   Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
   Radboud Univ Nijmegen Med Ctr, Dept Plast & Reconstruct Surg, NL-6500 HB Nijmegen, Netherlands.
RP Jansen, JA (reprint author), Radboud Univ Nijmegen Med Ctr, Dept Periodontol & Biomat, POB 9101, NL-6500 HB Nijmegen, Netherlands.
EM j.jansen@dent.umcn.nl
RI Boerman, Otto/A-8112-2014; Russel, Frans/B-3184-2014; Jansen,
   John/H-8055-2014
OI Boerman, Otto/0000-0001-6832-101X; Russel, Frans/0000-0002-7959-2314; 
CR Baker ME, 2002, J ENDOCRINOL, V175, P121, DOI 10.1677/joe.0.1750121
   Boden SD, 1999, SPINE, V24, P1179, DOI 10.1097/00007632-199906150-00002
   Chander S., 1984, ADSORPTION SURFACE C, P29
   Clarke SA, 2004, J BONE JOINT SURG BR, V86B, P126, DOI 10.1302/0301-620X.85B1.14175
   Combes C, 2002, BIOMATERIALS, V23, P2817, DOI 10.1016/S0142-9612(02)00073-X
   CUNNINGHAM NS, 1992, P NATL ACAD SCI USA, V89, P11740, DOI 10.1073/pnas.89.24.11740
   del Real RP, 2002, BIOMATERIALS, V23, P3673, DOI 10.1016/S0142-9612(02)00101-1
   Feng B, 2002, BIOMATERIALS, V23, P2499, DOI 10.1016/S0142-9612(01)00384-2
   FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0
   Koempel JA, 1998, J BIOMED MATER RES, V41, P359, DOI 10.1002/(SICI)1097-4636(19980905)41:3<359::AID-JBM3>3.0.CO;2-B
   Kroese-Deutman HC, 2005, BIOMATERIALS, V26, P1131, DOI 10.1016/j.biomaterials.2004.04.021
   Kuboki Y., 2001, J BONE JOINT SURG AM, V83, P105
   Laffargue P, 2000, J BIOMED MATER RES, V49, P415, DOI 10.1002/(SICI)1097-4636(20000305)49:3<415::AID-JBM15>3.3.CO;2-Q
   Li RH, 2003, J ORTHOP RES, V21, P997, DOI 10.1016/S0736-0266(03)00082-2
   Lind M, 1996, J ORTHOPAED RES, V14, P343, DOI 10.1002/jor.1100140303
   Louis-Ugbo J, 2002, J ORTHOPAED RES, V20, P1050, DOI 10.1016/S0736-0266(02)00011-6
   Meraw SJ, 2000, J PERIODONTOL, V71, P8, DOI 10.1902/jop.2000.71.1.8
   MISHRA RK, 1980, COLLOID SURFACE, V1, P105, DOI 10.1016/0166-6622(80)80040-0
   Murata M, 1998, INT J ORAL MAX SURG, V27, P391, DOI 10.1016/S0901-5027(98)80071-4
   Ono I, 1999, J BIOMED MATER RES, V45, P337
   Radin S, 1998, J BIOMED MATER RES, V39, P234, DOI 10.1002/(SICI)1097-4636(199802)39:2<234::AID-JBM10>3.0.CO;2-D
   REDDI AH, 1993, J BONE MINER RES, V8, P499
   Ripamonti U, 2001, PLAST RECONSTR SURG, V107, P977, DOI 10.1097/00006534-200104010-00012
   Rosengren A, 2002, BIOMATERIALS, V23, P1237, DOI 10.1016/S0142-9612(01)00244-7
   Ruhe PQ, 2004, BIOMATERIALS, V25, P2123, DOI 10.1016/j.biomaterials.2003.09.007
   Serro AP, 2004, J BIOMED MATER RES A, V70A, P420, DOI 10.1002/jbm.a.30096
   Sharpe JR, 1997, BIOMATERIALS, V18, P471, DOI 10.1016/S0142-9612(96)00157-3
   Sumner DR, 2004, J ORTHOP RES, V22, P58, DOI 10.1016/S0736-0266(03)00127-X
   Terheyden H, 2001, INT J ORAL MAX SURG, V30, P373, DOI 10.1054/ijom.2001.0032
   Tung M S, 2001, Monogr Oral Sci, V18, P112
   TUNG MS, 1985, CARIES RES, V19, P72, DOI 10.1159/000260831
   Uludag H, 2000, J BIOMED MATER RES, V50, P227, DOI 10.1002/(SICI)1097-4636(200005)50:2<227::AID-JBM18>3.0.CO;2-2
   Uludag H, 1999, J BIOMED MATER RES, V46, P193, DOI 10.1002/(SICI)1097-4636(199908)46:2<193::AID-JBM8>3.0.CO;2-1
   Uludag H, 2001, J BONE JOINT SURG AM, V83, P128
NR 34
TC 87
Z9 88
U1 0
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD OCT
PY 2006
VL 17
IS 10
BP 919
EP 927
DI 10.1007/s10856-006-0181-z
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 084SB
UT WOS:000240553600006
PM 16977389
DA 2018-10-19
ER

PT J
AU Artzi, Z
   Weinreb, M
   Tal, H
   Nemcovsky, CE
   Rohrer, MD
   Prasad, HS
   Kozlovsky, A
AF Artzi, Zvi
   Weinreb, Miron
   Tal, Haim
   Nemcovsky, Carlos E.
   Rohrer, Michael D.
   Prasad, Hari S.
   Kozlovsky, Avital
TI Experimental intrabony and periodontal defects treated with natural
   mineral combined with a synthetic cell-binding peptide in the canine:
   Morphometric evaluations
SO JOURNAL OF PERIODONTOLOGY
LA English
DT Article
DE animals; bone; bovine; peptide
ID EXPERIMENTAL BONE DEFECTS; BOVINE BONE; OSSEOUS DEFECTS; QUANTITATIVE
   EXPRESSION; FENESTRATION DEFECTS; IN-VITRO; COLLAGEN; P-15; MATRIX;
   REGENERATION
AB Background: A synthetic peptide (P-15) analog of collagen added to anorganic bovine bone mineral (ABM) has recently been used as an enhanced bone graft material (ABM/P-15). The objective of this study was to test the contribution of ABM/P-15 in a new putty form (PEP) in two experimental membrane-protected defects: periodontal and intrabony. Its efficacy as filler biomaterial in guided tissue regeneration (GTR) and guided bone regeneration (GBR) procedures was evaluated histologically and morphometrically.
   Methods: In the maxillary canines, a facial mucoperiosteal flap was raised bilaterally in nine dogs. Two circular defects, 5 mm in diameter and 2 mm in depth, were made on each side: a fenestrated periodontal on the canine root and an intrabony in the alveolar diastema, anteriorly. PEP particles filled both defects on one side; the contralateral side was blood filled (control). All surgical sites were covered with a bioabsorbable membrane. Histologically, at 4 months, tissue blocks were made using the cutting/grinding non-decalcification method followed by morphometric analysis. In the periodontal fenestration root surface, the linear percentage of new cementum (%CEM), area percentage of new bone (%NB), and residual biomaterial particles (%PEP) were calculated. These same measurements were calculated at the intrabony sites, except cementum. The amount of direct NB to PEP contact was measured to assess the osteoconductivity level (OSC). The Pearson correlation test was used to evaluate any significant relationship between the different measured parameters.
   Results: In the grafted and non-grafted fenestration root surface defects, %CEM averaged 59.5% and 73.9% (P < 0.02), respectively; %NB averaged 36.1% and 31.4%, respectively; and %PEP averaged 20.6%. The mean percentage of OSC was 52.4%. In the intrabony grafted and non-grafted sites, %NB averaged 50.7% and 60.1 %, respectively (P < 0.02). Residual %PEP averaged 26.1 %, and OSC averaged 35.6%. At the intrabony sites, higher %NB and lower %OSC were found compared to the fenestration sites (P < 0.001 and P < 0.03, respectively). Correlation analysis showed a negative correlation between %NB and %PEP at the fenestration defects. In between the two defect types, %OSC was significantly correlated (P < 0.05).
   Conclusions: ABM/P-15 putty showed osteoconductive and biocompatible qualities. However, at 4 months in this model, no enhanced regeneration was present compared to a higher CEM and NB growth detected at non-grafted membrane-protected sites.
C1 Tel Aviv Univ, Sch Dent Med, Dept Periodontol, IL-69978 Tel Aviv, Israel.
   Tel Aviv Univ, Sch Dent Med, Dept Oral Biol, IL-69978 Tel Aviv, Israel.
   Univ Minnesota, Sch Dent, Div Oral & Maxillofacial Pathol, Minneapolis, MN 55455 USA.
   Univ Minnesota, Sch Dent, Hard Tissue Res Lab, Minneapolis, MN 55455 USA.
RP Artzi, Z (reprint author), Tel Aviv Univ, Sch Dent Med, Dept Periodontol, IL-69978 Tel Aviv, Israel.
EM zviartzi@post.tau.ac.il
CR Acil Y, 2002, J CELL BIOCHEM, V86, P90, DOI 10.1002/jcb.10197
   Artzi Z, 2005, J CLIN PERIODONTOL, V32, P193, DOI 10.1111/j.1600-051X.2005.00656.x
   Artzi Z, 2004, INT J ORAL MAX IMPL, V19, P357
   Artzi Z, 2003, J PERIODONTOL, V74, P1143, DOI 10.1902/jop.2003.74.8.1143
   Artzi Z, 2003, J PERIODONTOL, V74, P1153, DOI 10.1902/jop.2003.74.8.1153
   Artzi Z, 2001, J PERIODONTOL, V72, P911, DOI 10.1902/jop.2001.72.7.911
   Artzi Z, 2001, J PERIODONTOL, V72, P152, DOI 10.1902/jop.2001.72.2.152
   Barboza EP, 2002, J PERIODONTOL, V73, P1153, DOI 10.1902/jop.2002.73.10.1153
   Bhatnagar RS, 1997, J BIOMOL STRUCT DYN, V14, P547, DOI 10.1080/07391102.1997.10508155
   Bhatnagar RS, 1999, TISSUE ENG, V5, P53, DOI 10.1089/ten.1999.5.53
   Buser D, 1998, CLIN ORAL IMPLAN RES, V9, P137, DOI 10.1034/j.1600-0501.1998.090301.x
   COHEN RE, 1994, J PERIODONTOL, V65, P1008, DOI 10.1902/jop.1994.65.11.1008
   Degidi Marco, 2004, J Oral Implantol, V30, P376, DOI 10.1563/0720.1
   DONATH K, 1982, J ORAL PATHOL MED, V11, P318, DOI 10.1111/j.1600-0714.1982.tb00172.x
   Gelbart Michael, 2005, Implant Dent, V14, P185, DOI 10.1097/01.id.0000165029.86196.27
   Hahn Jack, 2004, Implant Dent, V13, P228, DOI 10.1097/01.id.0000136916.28634.d3
   Hahn Jack, 2003, Implant Dent, V12, P170
   Hammerle CHF, 1997, CLIN ORAL IMPLAN RES, V8, P198, DOI 10.1034/j.1600-0501.1997.080306.x
   Hole BB, 2005, J BIOMED MATER RES A, V74A, P712, DOI 10.1002/jbm.a.30331
   KARNOVSKY MJ, 1965, J CELL BIOL, V27, P137
   Krauser J T, 2000, Implant Dent, V9, P298, DOI 10.1097/00008505-200009040-00004
   Kubler Alexander, 2004, Implant Dent, V13, P171
   Lallier TE, 2001, J PERIODONTOL, V72, P990, DOI 10.1902/jop.2001.72.8.990
   Nguyen H, 2003, BIOCHEM BIOPH RES CO, V311, P179, DOI 10.1016/j.bbrc.2003.09.192
   Philippart P, 2005, INT J ORAL MAX IMPL, V20, P274
   POUMARAT G, 1993, BIOMATERIALS, V14, P337, DOI 10.1016/0142-9612(93)90051-3
   Qian JJ, 1996, J BIOMED MATER RES, V31, P545, DOI 10.1002/(SICI)1097-4636(199608)31:4<545::AID-JBM15>3.0.CO;2-F
   Radhakrishnan Sujatha, 2004, J Int Acad Periodontol, V6, P101
   Spector M, 1999, TISSUE ENGINEERING, P3
   Stephan EB, 1999, J PERIODONTOL, V70, P364, DOI 10.1902/jop.1999.70.4.364
   Tal H, 2005, INT J PERIODONT REST, V25, P509
   Tal H, 1996, J CLIN PERIODONTOL, V23, P1, DOI 10.1111/j.1600-051X.1996.tb00496.x
   Tehemar Sherif, 2003, Clin Implant Dent Relat Res, V5, P193, DOI 10.1111/j.1708-8208.2003.tb00202.x
   Trasatti C, 2004, J ENDODONT, V30, P213, DOI 10.1097/00004770-200404000-00007
   Turhani D, 2005, INT J ORAL MAX SURG, V34, P543, DOI 10.1016/j.ijom.2004.10.023
   Vastardis S, 2005, J PERIODONTOL, V76, P1690, DOI 10.1902/jop.2005.76.10.1690
   Walters SP, 2003, J PERIODONTOL, V74, P1161, DOI 10.1902/jop.2003.74.8.1161
   Yang XBB, 2004, TISSUE ENG, V10, P1148, DOI 10.1089/1076327041887871
   Yeung Richie W K, 2005, Implant Dent, V14, P237, DOI 10.1097/01.id.0000173331.14116.7f
   Yukna RA, 1998, J PERIODONTOL, V69, P655, DOI 10.1902/jop.1998.69.6.655
   Yukna RA, 2002, J PERIODONTOL, V73, P123, DOI 10.1902/jop.2002.73.1.123
   Yukna RA, 2000, J PERIODONTOL, V71, P1671, DOI 10.1902/jop.2000.71.11.1671
   Yukna Raymonda, 2002, Int J Periodontics Restorative Dent, V22, P146
NR 43
TC 12
Z9 13
U1 0
U2 2
PU AMER ACAD PERIODONTOLOGY
PI CHICAGO
PA 737 NORTH MICHIGAN AVENUE, SUITE 800, CHICAGO, IL 60611-2690 USA
SN 0022-3492
J9 J PERIODONTOL
JI J. Periodont.
PD OCT
PY 2006
VL 77
IS 10
BP 1658
EP 1664
DI 10.1902/jop.2006.060041
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 103IU
UT WOS:000241879700006
PM 17032107
DA 2018-10-19
ER

PT J
AU Bellon, JM
   Lopez-Hervas, P
   Rodriguez, M
   Garcia-Honduvilla, N
   Pascual, G
   Bujan, J
AF Bellon, Juan M.
   Lopez-Hervas, Pedro
   Rodriguez, Marta
   Garcia-Honduvilla, Natalio
   Pascual, Gemma
   Bujan, Julia
TI Midline abdominal wall closure: A new prophylactic mesh concept
SO JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
LA English
DT Article
ID LINEA ALBA; POSTOPERATIVE HERNIA; POLYPROPYLENE MESH; INCISIONAL HERNIA;
   SUTURE TECHNIQUE; COLLAGEN-FIBERS; RECTUS SHEATHS; PREVENTION; SURGERY;
   REPAIR
AB BACKGROUND: Despite intense research efforts, incisional hernias continue to be a problem in patients who undergo laparotomy. This study was designed to reinforce the midline laparotomy closure by including a new prosthetic design between the edges of the surgical wound.
   STUDY DESIGN: A midline incision was made in New Zealand white rabbits and closed by inserting a polypropylene strip, T-shaped in cross-section, between the incisional borders. The T was placed upside down such that the horizontal arm of the T, whose surface is coated with extra-low pore size expanded polytetrafluoroethylene, made contact with the visceral peritoneum. The mesh was secured by a mass polypropylene 3/0 running suture. Surgery outcomes in these animals were compared with those in which the surgical wound was closed by simple suture and with control, nonoperated animals.
   RESULTS: The T-mesh induced an increased amount of scar tissue at the midline, where neoformed recipient tissue appeared around the polypropylene mesh filaments. The expanded polytetrafluoroethylene lamina became appropriately mesothelialized. Compared with the simple suture, the T-mesh provided a significant gain in biomechanical strength at postoperative week 6 (43.99 +/- 4.17 Newtons and 56.96 +/- 10.94 Newtons, respectively, p < 0.05). At 6 months, the strength of the reinforced wound even surpassed, although not significantly, that of the control intact abdominal wall (82.25 +/- 7.60 Newtons versus 79.55 +/- 11.46 Newtons). Data were expressed as mean +/- standard deviation.
   CONCLUSIONS: The use of a nonabsorbable biomaterial for midline laparotomy closure significantly improves its biomechanical resistance. Used in high-risk patients or even prophylactically, this technique could reduce the incidence of incisional hernia.
C1 Alcala Univ, Fac Med, Dept Surg, Madrid 28871, Spain.
   Alcala Univ, Fac Med, Dept Med Specialties, Madrid, Spain.
RP Bellon, JM (reprint author), Alcala Univ, Fac Med, Dept Surg, Ctra Madrid Barcelona,Km 33600, Madrid 28871, Spain.
OI Garcia Honduvilla, Natalio/0000-0003-0904-6198; bujan,
   Julia/0000-0003-2419-2476; PASCUAL, GEMMA/0000-0002-1623-4384; BELLON,
   JUAN M./0000-0002-6071-5011
CR ASKAR OM, 1977, ANN ROY COLL SURG, V59, P313
   Axer H, 2001, J SURG RES, V96, P239, DOI 10.1006/jsre.2000.6071
   Axer H, 2001, J SURG RES, V96, P127, DOI 10.1006/jsre.2000.6070
   Bellon JM, 1996, J AM COLL SURGEONS, V183, P11
   Grantcharov TP, 2001, EUR J SURG, V167, P260
   Grassel D, 2005, J SURG RES, V124, P118, DOI 10.1016/j.jss.2004.10.010
   Gutierrez de la Pena C, 2003, Hernia, V7, P134
   Hoer J, 2000, EUR SURG RES, V32, P359, DOI 10.1159/000052218
   Israelsson LA, 2000, EUR J SURG, V166, P642
   Israelsson LA, 1999, EUR J SURG, V165, P3, DOI 10.1080/110241599750007432
   Janes A, 2004, BRIT J SURG, V91, P280, DOI 10.1002/bjs.4417
   JENKINS TPN, 1976, BRIT J SURG, V63, P873, DOI 10.1002/bjs.1800631110
   LORD RSA, 1994, J VASC SURG, V20, P27, DOI 10.1016/0741-5214(94)90172-4
   Pans A, 1998, WORLD J SURG, V22, P479, DOI 10.1007/s002689900420
   Rath AM, 1996, SURG RADIOL ANAT, V18, P281, DOI 10.1007/BF01627606
   Riet M, 2002, BRIT J SURG, V89, P1350
   Rogers M, 2003, EUR J VASC ENDOVASC, V26, P519, DOI 10.1016/S1078-5884(03)00383-6
   Rucinski J, 2001, AM SURGEON, V67, P421
   Strzelczyk J, 2005, ANN SURG, V241, P196
   Strzelczyk J, 2002, LANGENBECK ARCH SURG, V387, P294, DOI 10.1007/s00423-002-0325-7
   Weiland DE, 1998, AM J SURG, V176, P666, DOI 10.1016/S0002-9610(98)00277-3
NR 21
TC 24
Z9 24
U1 3
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1072-7515
J9 J AM COLL SURGEONS
JI J. Am. Coll. Surg.
PD OCT
PY 2006
VL 203
IS 4
BP 490
EP 497
DI 10.1016/j.jamcollsurg.2006.06.023
PG 8
WC Surgery
SC Surgery
GA 094YR
UT WOS:000241275800010
PM 17000392
DA 2018-10-19
ER

PT J
AU Rodrikuez-Cabello, JC
   Prieto, S
   Arias, FJ
   Reguera, J
   Ribeiro, A
AF Carlos Rodrikuez-Cabello, J.
   Prieto, S.
   Arias, F. J.
   Reguera, J.
   Ribeiro, A.
TI Nanobiotechnological approach to engineered biomaterial design: the
   example of elastin-like polymers
SO NANOMEDICINE
LA English
DT Review
DE cell adhesion; drug delivery; elastin-like polymers; hydrogels;
   nanobiotechnology; nanotechnology; protein polymer; tissue engineering
ID INVERSE TEMPERATURE TRANSITION; EXTRACELLULAR-MATRIX PROTEINS;
   ELASTOMERIC POLYPENTAPEPTIDES; HYDROPHOBIC HYDRATION;
   MECHANICAL-PROPERTIES; DRUG-DELIVERY; CELL; POLYPEPTIDES; ADHESION;
   BIOPOLYMERS
AB Today, the development of advanced biomaterials is still lacking an appropriate tailored engineering approach. Most of the biomaterials currently used have their origin in materials developed for other technological applications. This lack of adequate biomaterial design is probably due to the peculiar environment where those materials must operate. On the one hand, this environment is dominated by the immune rejection system. On the other hand, the functionality of natural biomolecules is based on complex topological physical-chemical function distributions at the nanometer level. This review presents arguments concerning the role of biotechnology and nanotechnology in the future development of new advanced biomaterials and the potential of these biomaterials as a way to achieve highly biofunctional and truly biocompatible biomaterials for hot such as regenerative medicine and controlled release. Recombinant areas, protein-polymers will be presented as an example of candidates for this new paradigm in biomaterial design and production.
C1 Univ Valladolid, Dept Fis Mat Condensada, ETSII, Bioforge Grp, E-47011 Valladolid, Spain.
RP Rodrikuez-Cabello, JC (reprint author), Univ Valladolid, Dept Fis Mat Condensada, ETSII, Bioforge Grp, Cauce S-N, E-47011 Valladolid, Spain.
EM cabello@eis.uva.es
RI Ribeiro, Artur/L-1128-2014; Arias, Francisco Javier/A-2640-2012;
   Reguera, Javier/E-5289-2010; Rodriguez-Cabello, Jose Carlos/G-6555-2017
OI Ribeiro, Artur/0000-0003-3298-5564; Arias, Francisco
   Javier/0000-0001-8584-3768; Reguera, Javier/0000-0001-5110-5361;
   Rodriguez-Cabello, Jose Carlos/0000-0002-3438-858X
CR Alix Alain J. P., 2001, Journal de la Societe de Biologie, V195, P181
   Alonso M, 2001, MACROMOLECULES, V34, P8072, DOI 10.1021/ma010455o
   Alonso M, 2000, MACROMOLECULES, V33, P9480, DOI 10.1021/ma001348h
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P1093, DOI 10.1016/S0169-409X(02)00060-1
   Di Zio K, 2003, MACROMOLECULES, V36, P1553, DOI 10.1021/ma0256587
   Dreher MR, 2003, J CONTROL RELEASE, V91, P31, DOI 10.1016/S0168-3659(03)00216-5
   Flamia R, 2004, BIOMACROMOLECULES, V5, P1511, DOI 10.1021/bm049930r
   Girotti A, 2004, J MATER SCI-MATER M, V15, P479, DOI 10.1023/B:JMSM.0000021124.58688.7a
   Girotti A, 2004, MACROMOLECULES, V37, P3396, DOI 10.1021/ma035603k
   Heilshorn SC, 2005, BIOMACROMOLECULES, V6, P318, DOI 10.1021/bm049627q
   Herrero-Vanrell R, 2005, J CONTROL RELEASE, V102, P113, DOI 10.1016/j.jconrel.2004.10.001
   Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6
   Lee J, 2001, MACROMOLECULES, V34, P5968, DOI 10.1021/ma0017844
   Lee J, 2001, BIOMACROMOLECULES, V2, P170, DOI 10.1021/bm0000900
   Lee TAT, 2000, ADV MATER, V12, P1105, DOI 10.1002/1521-4095(200008)12:15<1105::AID-ADMA1105>3.0.CO;2-1
   Li B, 2001, J AM CHEM SOC, V123, P11991, DOI 10.1021/ja010363e
   Li B, 2001, J MOL BIOL, V305, P581, DOI 10.1006/jmbi.2000.4306
   Liu JC, 2004, BIOMACROMOLECULES, V5, P497, DOI 10.1021/bm034340z
   Martino M, 2002, MACROMOL BIOSCI, V2, P319, DOI 10.1002/1616-5195(200209)2:7<319::AID-MABI319>3.0.CO;2-L
   McMillan RA, 1999, MACROMOLECULES, V32, P9067, DOI 10.1021/ma991119z
   Miao M, 2003, J BIOL CHEM, V278, P48553, DOI 10.1074/jbc.M308465200
   Nicol A., 1994, BIOTECHNOLOGY BIOACT
   Panitch A, 1999, MACROMOLECULES, V32, P1701, DOI 10.1021/ma980875m
   Reguera J, 2004, J AM CHEM SOC, V126, P13212, DOI 10.1021/ja047417f
   Richman GP, 2005, J CONTROL RELEASE, V101, P3, DOI 10.1016/j.jconrel.2004.07.034
   Rodriguez-Cabello JC, 2002, ADV MATER, V14, P1151, DOI 10.1002/1521-4095(20020816)14:16<1151::AID-ADMA1151>3.0.CO;2-Y
   Rodriguez-Cabello JC, 2005, PROG POLYM SCI, V30, P1119, DOI 10.1016/j.progpolymsci.2005.07.004
   Rodriguez-Cabello JC, 2000, BIOPOLYMERS, V54, P282, DOI 10.1002/1097-0282(20001005)54:4<282::AID-BIP50>3.0.CO;2-F
   Shao ZZ, 2002, NATURE, V418, P741, DOI 10.1038/418741a
   Trabbic-Carlson K, 2003, BIOMACROMOLECULES, V4, P572, DOI 10.1021/bm025671z
   Urry D. W., 2005, WHAT SUSTAINS LIFE C
   URRY DW, 1991, J BIOACT COMPAT POL, V6, P263, DOI 10.1177/088391159100600306
   URRY DW, 1990, ABSTR PAP AM CHEM S, V200, P74
   Urry DW, 1993, BIOTECHNOLOGICAL POL, P82
   Welsh ER, 2000, BIOMACROMOLECULES, V1, P23, DOI 10.1021/bm0002914
   Woodhouse KA, 2004, BIOMATERIALS, V25, P4543, DOI 10.1016/j.biomaterials.2003.11.013
   Wright ER, 2002, ADV DRUG DELIVER REV, V54, P1057, DOI 10.1016/S0169-409X(02)00059-5
   Xiong JP, 2003, BLOOD, V102, P1155, DOI 10.1182/blood-2003-01-0334
NR 38
TC 19
Z9 20
U1 1
U2 17
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1743-5889
J9 NANOMEDICINE-UK
JI Nanomedicine
PD OCT
PY 2006
VL 1
IS 3
BP 267
EP 280
DI 10.2217/17435889.1.3.267
PG 14
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA 130YM
UT WOS:000243834900011
PM 17716158
DA 2018-10-19
ER

PT J
AU Chiari, C
   Koller, U
   Dorotka, R
   Eder, C
   Plasenzotti, R
   Lang, S
   Ambrosio, L
   Tognana, E
   Kon, E
   Salter, D
   Nehrer, S
AF Chiari, C.
   Koller, U.
   Dorotka, R.
   Eder, C.
   Plasenzotti, R.
   Lang, S.
   Ambrosio, L.
   Tognana, E.
   Kon, E.
   Salter, D.
   Nehrer, S.
TI A tissue engineering approach to meniscus regeneration in a sheep model
SO OSTEOARTHRITIS AND CARTILAGE
LA English
DT Article
DE meniscus; regeneration; biomaterial; animal model; hyaluronan; HYAFF;
   tissue engineering
ID ALLOGRAFT TRANSPLANTATION; ARTICULAR-CARTILAGE; COLLAGEN MENISCUS;
   MEDIAL MENISCUS; CANINE MODEL; REPLACEMENT; DEGRADATION; IMPLANTS;
   PROSTHESIS; SCAFFOLD
AB Objective: Regeneration of the meniscal tissue occurs to a limited extent, and the loss of meniscal tissue leads to osteoarthritis. A new biomaterial consisting of hyaluronic acid and polycaprolactone was used as a meniscus substitute in sheep to evaluate the properties of the implant material with regard to size, biomechanical stability, tissue ingrowth, and integration.
   Methods: Eight sheep (right stifle joints) were treated with three total and three partial meniscus replacements while two meniscectomies served as empty controls. The animals were euthanized after 6 weeks. The specimens were assessed by gross inspection and histology, and compared with the nonoperated left joints.,
   Results: The surgical technique was found to be feasible. The implants remained in position, did not tear, and showed excellent tissue ingrowth to the capsule. Tissue integration was also observed between the original meniscus and the implant. However, graft compression and extrusion occurred. The histological investigation revealed tissue formation, cellular infiltration and vascularization. Cartilage degeneration was more severe in the operated joints.
   Conclusion: The present study shows promising results concerning the qualities of this biomaterial with regard to implantation technique, stability and tissue ingrowth. (C) 2006 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
C1 Med Univ Vienna, Dept Orthopaed, A-1090 Vienna, Austria.
   Med Univ Vienna, Core Unit Biomed Res, Vienna, Austria.
   Med Univ Vienna, Dept Pathol, Vienna, Austria.
   CNR, IMCB, I-80125 Naples, Italy.
   Univ Naples Federico II, Interdisciplinary Res Ctr Biomat, Naples, Italy.
   Fidia Adv Biopolymers SRL, Abano Terme, PD, Italy.
   Ist Ortoped Rizzoli, Bologna, Italy.
   Univ Edinburgh, Sch Med, Dept Pathol, Edinburgh, Midlothian, Scotland.
RP Nehrer, S (reprint author), Med Univ Vienna, Dept Orthopaed, Waehringer Guertel 18-20, A-1090 Vienna, Austria.
EM stefan.nehrer@meduniwien.ac.at
OI Plasenzotti, Roberto/0000-0001-7652-1249; AMBROSIO,
   LUIGI/0000-0002-8367-2405
CR Aagaard H, 2003, CLIN ORTHOP RELAT R, P218, DOI 10.1097/01.blo.0000030066.92399.7f
   Aagaard H, 1999, KNEE SURG SPORT TR A, V7, P184, DOI 10.1007/s001670050145
   ARNOCZKY SP, 1983, AM J SPORT MED, V11, P131, DOI 10.1177/036354658301100305
   ARNOCZKY SP, 1988, J BONE JOINT SURG AM, V70A, P1209, DOI 10.2106/00004623-198870080-00012
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   COOK JL, 2005, AM J SPORTS MED
   deGroot JH, 1997, BIOMATERIALS, V18, P613, DOI 10.1016/S0142-9612(96)00169-X
   DOROTKA R, 2005, OSTEOARTHRITIS CARTI
   Elliott DM, 2002, KNEE SURG SPORT TR A, V10, P109, DOI 10.1007/s001670100227
   FAIRBANK TJ, 1948, J BONE JOINT SURG BR, V30, P664
   Goto H, 2000, OSTEOARTHR CARTILAGE, V8, P266, DOI 10.1053/joca.1999.0300
   JACKSON DW, 1992, AM J SPORT MED, V20, P644, DOI 10.1177/036354659202000605
   Klompmaker J, 1996, BIOMATERIALS, V17, P1169, DOI 10.1016/0142-9612(96)84937-4
   Kobayashi M, 2003, BIOMATERIALS, V24, P639, DOI 10.1016/S0142-9612(02)00378-2
   Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8
   MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009
   Martinek V., 2005, ARCH ORTHOP TRAUMA S, P1
   Martini L, 2001, COMPARATIVE MED, V51, P292
   Messner K, 1999, SCAND J MED SCI SPOR, V9, P181
   MILLER MD, 1994, KNEE SURG
   PITT CG, 1981, BIOMATERIALS, V2, P215
   Rijk PC, 2004, ARTHROSCOPY, V20, P911, DOI 10.1016/j.arthro.2004.06.036
   Rijk PC, 2004, ARTHROSCOPY, V20, P728, DOI 10.1016/j.arthro.2004.06.015
   Rodkey WG, 1999, CLIN ORTHOP RELAT R, pS281
   SOMMERLATH K, 1992, AM J SPORT MED, V20, P73, DOI 10.1177/036354659202000117
   Steadman JR, 2005, ARTHROSCOPY, V21, P515, DOI 10.1016/j.arthro.2005.01.006
   Stone KR, 1997, J BONE JOINT SURG AM, V79A, P1770, DOI 10.2106/00004623-199712000-00002
   STONE KR, 1990, CLIN ORTHOP RELAT R, P129
   STONE KR, 1992, AM J SPORT MED, V20, P104, DOI 10.1177/036354659202000202
   Sung HJ, 2004, BIOMATERIALS, V25, P5735, DOI 10.1016/j.biomaterials.2004.01.066
   Szomor ZL, 2000, J BONE JOINT SURG AM, V82A, P80, DOI 10.2106/00004623-200001000-00010
   TOYONAGA T, 1983, CLIN ORTHOP RELAT R, P291
   van Tienen TG, 2002, BIOMATERIALS, V23, P1731, DOI 10.1016/S0142-9612(01)00280-0
   VETH RPH, 1986, CLIN ORTHOP RELAT R, P286
   WOOD DJ, 1990, BIOMATERIALS, V11, P13, DOI 10.1016/0142-9612(90)90045-R
   Wyland DJ, 2002, J ORTHOP RES, V20, P996, DOI 10.1016/S0736-0266(02)00022-0
   ZHANG ZN, 1995, AM J SPORT MED, V23, P35
NR 37
TC 92
Z9 97
U1 2
U2 16
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 1063-4584
J9 OSTEOARTHR CARTILAGE
JI Osteoarthritis Cartilage
PD OCT
PY 2006
VL 14
IS 10
BP 1056
EP 1065
DI 10.1016/j.joca.2006.04.007
PG 10
WC Orthopedics; Rheumatology
SC Orthopedics; Rheumatology
GA 090LT
UT WOS:000240953500012
PM 16731009
OA Bronze
DA 2018-10-19
ER

PT J
AU Yoshida, M
   Langer, R
   Lendlein, A
   Lahann, J
AF Yoshida, Mutsumi
   Langer, Robert
   Lendlein, Andreas
   Lahann, Joerg
TI From advanced biomedical coatings to multi-functionalized biomaterials
SO POLYMER REVIEWS
LA English
DT Review
DE biointerface; shape-memory polymer; multifunctionalization; responsive
   materials
ID CHEMICAL-VAPOR-DEPOSITION; SELF-ASSEMBLED MONOLAYERS; ENDOTHELIAL-CELL
   SHEETS; SHAPE-MEMORY POLYMERS; RESPONSIVE CULTURE DISHES; ELASTIN-LIKE
   POLYPEPTIDE; DRUG-DELIVERY-SYSTEMS; N-ISOPROPYLACRYLAMIDE; THIN-FILMS;
   OLIGO(EPSILON-CAPROLACTONE) SEGMENTS
AB In this review, current activities in the development of active biomaterials related to bio-interfacial design as well as novel concepts for smart polymer systems are highlighted. For instance, advanced biomedical coatings, including vapor-based polymer coatings for the controlled attachment of biomolecules, and temperature-responsive coatings for tissue engineering are outlined. Moreover, recent trends with the fabrication of "smart," switchable surfaces, such as conformationally switching monolayers, will be reviewed. Specific focus will further be given to multi- functionalized biomaterials including shape-memory polymers that undergo specific changes in shape in response to stimuli like heat or light. This novel class of intelligent materials highlights a recent trend in biomaterial development targeting is the extension of this concept to multi-functionalization. In particular, the combination of biodegradability and shape-memory effects opens a range of opportunities for biomedical applications including intelligent sutures or stents.
C1 Univ Michigan, Dept Chem Engn Mat Sci & Engn, Ann Arbor, MI 48109 USA.
   Univ Michigan, Dept Macromol Sci & Engn, Ann Arbor, MI 48109 USA.
   MIT, Dept Chem Engn, Cambridge, MA USA.
   GKSS Forschungszentrum Geesthacht GmbH, Inst Polymer Res, Teltow, Germany.
RP Lahann, J (reprint author), Univ Michigan, Dept Chem Engn Mat Sci & Engn, 2300 Hayward St, Ann Arbor, MI 48109 USA.
EM lahann@umich.edu
RI Lendlein, Andreas/K-9553-2013; Lahann, Joerg/J-7663-2013
OI Lendlein, Andreas/0000-0003-4126-4670; 
CR ABBOTT NL, 1994, LANGMUIR, V10, P1493, DOI 10.1021/la00017a029
   ABBOTT NL, 1995, LANGMUIR, V11, P16, DOI 10.1021/la00001a005
   Abbott S, 1999, LANGMUIR, V15, P8923, DOI 10.1021/la990558o
   Akiyama Y, 2004, LANGMUIR, V20, P5506, DOI 10.1021/la036139f
   Alteheld A, 2005, ANGEW CHEM INT EDIT, V44, P1188, DOI 10.1002/anie.200461360
   Aoyagi T, 2000, J BIOMAT SCI-POLYM E, V11, P101, DOI 10.1163/156856200743526
   Ayaro E, 2005, J CHROMATOGR A, V1069, P281, DOI 10.1016/j.chroma.2005.01.100
   Biercuk MJ, 2002, APPL PHYS LETT, V80, P2767, DOI 10.1063/1.1469696
   Blossey R, 2003, NAT MATER, V2, P301, DOI 10.1038/nmat856
   Bunker BC, 2003, NANO LETT, V3, P1723, DOI 10.1021/nl034759v
   Canavan HE, 2005, J BIOMED MATER RES A, V75A, P1, DOI 10.1002/jbm.a.30297
   Castner DG, 2002, SURF SCI, V500, P28, DOI 10.1016/S0039-6028(01)01587-4
   Chen HY, 2006, J AM CHEM SOC, V128, P374, DOI 10.1021/ja057082h
   Chen HY, 2005, ANAL CHEM, V77, P6909, DOI 10.1021/ac050964e
   CHEN JP, 1990, BIOMATERIALS, V11, P631, DOI 10.1016/0142-9612(90)90020-Q
   Cheng XH, 2004, J BIOMED MATER RES A, V70A, P159, DOI 10.1002/jbm.a.30053
   Chilkoti A, 2002, ADV DRUG DELIVER REV, V54, P613, DOI 10.1016/S0169-409X(02)00041-8
   Chilkoti A, 2005, MRS BULL, V30, P175, DOI 10.1557/mrs2005.48
   Chrisey DB, 2003, CHEM REV, V103, P553, DOI 10.1021/cr010428w
   *CORD CORP, 2003, INSTR US CYPH SIR EL
   DEGENNES PG, 1985, REV MOD PHYS, V57, P827, DOI 10.1103/RevModPhys.57.827
   Desponds A, 2005, BIOTECHNOL BIOENG, V91, P583, DOI 10.1002/bit.20479
   Ding ZL, 2001, NATURE, V411, P59, DOI 10.1038/35075028
   Ding ZL, 1998, J BIOMED MATER RES, V39, P498, DOI 10.1002/(SICI)1097-4636(19980305)39:3<498::AID-JBM22>3.0.CO;2-5
   Ebara M, 2004, TISSUE ENG, V10, P1125, DOI 10.1089/1076327041887691
   Ebara M, 2004, BIOMACROMOLECULES, V5, P505, DOI 10.1021/bm0343601
   Ebara M, 2003, BIOMACROMOLECULES, V4, P344, DOI 10.1021/bm025692t
   Eberhart RC, 2003, J BIOMAT SCI-POLYM E, V14, P299, DOI 10.1163/156856203321478838
   Fare S, 2005, J BIOMED MATER RES A, V73A, P1, DOI 10.1002/jbm.a.30193
   Fong RB, 2002, BIOTECHNOL BIOENG, V79, P271, DOI 10.1002/bit.10315
   Fu DG, 2002, ADV MATER, V14, P339, DOI 10.1002/1521-4095(20020304)14:5<339::AID-ADMA339>3.0.CO;2-Q
   Fu Q, 2004, J AM CHEM SOC, V126, P8904, DOI 10.1021/ja047895q
   Gall K, 2005, J BIOMED MATER RES A, V73A, P339, DOI 10.1002/jbm.a.30296
   Gao D, 2006, J AM CHEM SOC, V128, P676, DOI 10.1021/ja056364e
   GEWEHR M, 1992, MAKROMOL CHEM, V193, P249
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Harimoto M, 2002, J BIOMED MATER RES, V62, P464, DOI 10.1002/jbm.10228
   Herrera-Alonso M, 2004, LANGMUIR, V20, P9184, DOI 10.1021/la049025s
   HOSOYA K, 1994, MACROMOLECULES, V27, P3973, DOI 10.1021/ma00092a042
   Huang WM, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1880448
   Huber DL, 2003, SCIENCE, V301, P352, DOI 10.1126/science.1080759
   Hyun J, 2004, J AM CHEM SOC, V126, P7330, DOI 10.1021/ja049721e
   Ibusuki S, 2003, TISSUE ENG, V9, P1133, DOI 10.1089/10763270360728044
   Ibusuki S, 2003, TISSUE ENG, V9, P371, DOI 10.1089/107632703764664846
   Ichimura K, 2000, SCIENCE, V288, P1624, DOI 10.1126/science.288.5471.1624
   Ide T, 2006, BIOMATERIALS, V27, P607, DOI 10.1016/j.biomaterials.2005.06.005
   Iguchi N, 1997, PACE, V20, P372, DOI 10.1111/j.1540-8159.1997.tb06188.x
   Jiang HY, 2006, ADV MATER, V18, P1471, DOI 10.1002/adma.200502266
   Jiang WH, 2005, CHEM COMMUN, P3550, DOI 10.1039/b504479k
   Kanazawa H, 1997, J PHARMACEUT BIOMED, V15, P1545, DOI 10.1016/S0731-7085(96)02004-3
   Kanazawa H, 2002, ANAL SCI, V18, P45, DOI 10.2116/analsci.18.45
   Kanazawa H, 1996, ANAL CHEM, V68, P100, DOI 10.1021/ac950359j
   Kanazawa H, 1997, ANAL CHEM, V69, P823, DOI 10.1021/ac961024k
   Kanazawa H, 2000, ANAL CHEM, V72, P5961, DOI 10.1021/ac0004658
   Katz E, 2004, J AM CHEM SOC, V126, P15520, DOI 10.1021/ja045465u
   Kavanagh CA, 2004, PHARMACOL THERAPEUT, V102, P1, DOI 10.1016/j.pharmthera.2003.01.001
   Kikuchi A, 2002, ADV DRUG DELIVER REV, V54, P53, DOI 10.1016/S0169-409X(01)00243-5
   Kim BK, 1996, POLYMER, V37, P5781, DOI 10.1016/S0032-3861(96)00442-9
   Kim JY, 2005, BIOTECHNOL BIOENG, V90, P373, DOI 10.1002/bit.20451
   Koerner H, 2004, NAT MATER, V3, P115, DOI 10.1038/nmat1059
   Kost J, 2001, ADV DRUG DELIVER REV, V46, P125, DOI 10.1016/S0169-409X(00)00136-8
   Kushida A, 1999, J BIOMED MATER RES, V45, P355, DOI 10.1002/(SICI)1097-4636(19990615)45:4<355::AID-JBM10>3.0.CO;2-7
   Lahann J, 2005, MRS BULL, V30, P185, DOI 10.1557/mrs2005.50
   Lahann J, 2003, SCIENCE, V299, P371, DOI 10.1126/science.1078933
   Lahann J, 2001, J MATER SCI-MATER M, V12, P807, DOI 10.1023/A:1013929103147
   Lahann J, 2001, BIOMATERIALS, V22, P817, DOI 10.1016/S0142-9612(00)00244-1
   Lahann J, 1999, J MATER SCI-MATER M, V10, P443, DOI 10.1023/A:1008939400812
   LAHANN J, 2006, POLYM INT       0606
   Lahann J, 2006, CHEM ENG COMMUN, V193, P1457, DOI 10.1080/00986440500511619
   Lake N, 2005, LANGMUIR, V21, P11922, DOI 10.1021/la051457v
   Lakhiari H, 1998, BBA-GEN SUBJECTS, V1379, P303, DOI 10.1016/S0304-4165(97)00110-4
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   LaVan DA, 2003, NAT BIOTECHNOL, V21, P1184, DOI 10.1038/nbt876
   Lendlein A, 2002, SCIENCE, V296, P1673, DOI 10.1126/science.1066102
   Lendlein A, 2002, ANGEW CHEM INT EDIT, V41, P2034, DOI 10.1002/1521-3773(20020617)41:12<2034::AID-ANIE2034>3.0.CO;2-M
   Lendlein A, 2005, MATER SCI FORUM, V492-493, P219, DOI 10.4028/www.scientific.net/MSF.492-493.219
   Lendlein A, 2001, P NATL ACAD SCI USA, V98, P842, DOI 10.1073/pnas.031571398
   Lendlein A, 2005, NATURE, V434, P879, DOI 10.1038/nature03496
   Li FK, 2000, J APPL POLYM SCI, V75, P68, DOI 10.1002/(SICI)1097-4628(20000103)75:1<68::AID-APP8>3.0.CO;2-I
   Li J, 2005, LANGMUIR, V21, P9562, DOI 10.1021/la051109t
   LIU C, 2003, ANN TECHN C SOC PLAS, V61, P1962
   Liu Y, 2004, CHEM COMMUN, P1194, DOI 10.1039/b400776j
   Luzinov I, 2004, PROG POLYM SCI, V29, P635, DOI 10.1016/j.progpolymsci.2004.03.001
   Maitland DJ, 2002, LASER SURG MED, V30, P1
   Malmstadt N, 2004, LAB CHIP, V4, P412, DOI 10.1039/b315394k
   Malmstadt N, 2003, ANAL CHEM, V75, P2943, DOI 10.1021/ac034274r
   Mao Y, 2004, LANGMUIR, V20, P2484, DOI 10.1021/la0359427
   Marmur A, 2004, LANGMUIR, V20, P3517, DOI 10.1021/la036369u
   Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100
   Min CC, 2005, POLYM ADVAN TECHNOL, V16, P608, DOI 10.1002/pat.624
   Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev
   Mrksich M, 2005, MRS BULL, V30, P180, DOI 10.1557/mrs2005.49
   Murthy SK, 2002, MACROMOLECULES, V35, P1967, DOI 10.1021/ma011286a
   Murthy SK, 2004, J APPL POLYM SCI, V91, P2176, DOI 10.1002/app.13342
   Naito H, 2004, ASAIO J, V50, P344, DOI 10.1097/01.MAT.0000132656.42232.E3
   Nandivada H, 2005, MACROMOL RAPID COMM, V26, P1794, DOI 10.1002/marc.200500449
   Nath N, 2004, SURF SCI, V570, P98, DOI 10.1016/j.susc.2004.06.182
   Nath N, 2003, ANAL CHEM, V75, P709, DOI 10.1021/ac0261855
   Nath N, 2001, J AM CHEM SOC, V123, P8197, DOI 10.1021/ja015585r
   Nishida K, 2004, TRANSPLANTATION, V77, P379, DOI 10.1097/01.TP.0000110320.45678.30
   Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455
   NOWLIN TE, 1980, J APPL POLYM SCI, V25, P1619, DOI 10.1002/app.1980.070250809
   Okajima S, 2005, BIOTECHNOL BIOENG, V91, P237, DOI 10.1002/bit.20512
   Okajima S, 2005, LANGMUIR, V21, P4043, DOI 10.1021/la046994e
   Okamura A, 2005, BIOMATERIALS, V26, P1287, DOI 10.1016/j.biomaterials.2004.04.028
   OKANO T, 1995, BIOMATERIALS, V16, P297, DOI 10.1016/0142-9612(95)93257-E
   OSADA Y, 1995, NATURE, V376, P219, DOI 10.1038/376219a0
   Park KH, 2004, J BIOSCI BIOENG, V97, P374, DOI 10.1263/jbb.97.374
   Ping P, 2005, BIOMACROMOLECULES, V6, P587, DOI 10.1021/bm049477j
   Rickert D, 2003, J BIOMED MATER RES B, V67B, P722, DOI 10.1002/jbm.b.10069
   Riskin M, 2006, J AM CHEM SOC, V128, P1253, DOI 10.1021/ja0561183
   Rousseau IA, 2003, J AM CHEM SOC, V125, P15300, DOI 10.1021/ja039001s
   Sakiyama-Elbert SE, 2001, ANN REV MATER RES, V31, P183, DOI 10.1146/annurev.matsci.31.1.183
   Saltzman WM, 2000, PRINCIPLES TISSUE EN
   Schultz ZD, 2005, ANAL CHEM, V77, P7373, DOI 10.1021/ac0511593
   Senaratne W, 2005, BIOMACROMOLECULES, V6, P2427, DOI 10.1021/bm050180a
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   Shimizu T, 2003, BIOMATERIALS, V24, P2309, DOI 10.1016/S0142-9612(03)00110-8
   Shimoboji T, 2002, BIOCONJUGATE CHEM, V13, P915, DOI 10.1021/bc010057q
   Shimoboji T, 2001, BIOCONJUGATE CHEM, V12, P314, DOI 10.1021/bc000107b
   Shin JY, 1999, LANGMUIR, V15, P4404, DOI 10.1021/la981477f
   Smith JP, 2005, ANAL CHEM, V77, p412A
   SONDAGHUETHORST JAM, 1994, LANGMUIR, V10, P4380, DOI 10.1021/la00023a074
   Soppimath KS, 2002, DRUG DEV IND PHARM, V28, P957, DOI 10.1081/DDC-120006428
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   Stile RA, 2001, BIOMACROMOLECULES, V2, P185, DOI 10.1021/bm0000945
   Suh KY, 2004, ADV MATER, V16, P1401, DOI 10.1002/adma.200400101
   Sun TL, 2004, ANGEW CHEM INT EDIT, V43, P357, DOI 10.1002/anie.200352565
   Takahashi T, 1996, J APPL POLYM SCI, V60, P1061
   Trabbic-Carlson K, 2004, PROTEIN ENG DES SEL, V17, P57, DOI 10.1093/protein/gzh006
   Tsuda Y, 2005, BIOMATERIALS, V26, P1885, DOI 10.1016/j.biomaterials.2004.06.005
   URRY DW, 1991, J AM CHEM SOC, V113, P4346, DOI 10.1021/ja00011a057
   Urry DW, 1997, J PHYS CHEM B, V101, P11007, DOI 10.1021/jp972167t
   Wache HM, 2003, J MATER SCI-MATER M, V14, P109, DOI 10.1023/A:1022007510352
   Wang XM, 2003, ELECTROCHEM COMMUN, V5, P814, DOI 10.1016/j.elecom.2003.07.002
   Wang XM, 2003, CHEM COMMUN, P1542, DOI 10.1039/b303845a
   Yamaguchi S, 2004, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2004/07/047
   Yamato M, 2003, J BIOMED MATER RES A, V67A, P1065, DOI 10.1002/jbm.a.10078
   Yamato M, 1999, J BIOMED MATER RES, V44, P44, DOI 10.1002/(SICI)1097-4636(199901)44:1<44::AID-JBM5>3.0.CO;2-X
   Yamato M, 2002, BIOMATERIALS, V23, P561, DOI 10.1016/S0142-9612(01)00138-7
   Yamato M, 2001, J BIOMED MATER RES, V55, P137, DOI 10.1002/1097-4636(200104)55:1<137::AID-JBM180>3.0.CO;2-L
   Yang B, 2006, POLYMER, V47, P1348, DOI 10.1016/j.polymer.2005.12.051
   Yang H, 2004, ANAL CHEM, V76, P1537, DOI 10.1021/ac035270p
   Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061
   Yasutake M, 2003, MACROMOLECULES, V36, P5974, DOI 10.1021/ma021795s
   Yousaf MN, 2001, P NATL ACAD SCI USA, V98, P5992, DOI 10.1073/pnas.101112898
   Yu YL, 2005, MACROMOL CHEM PHYS, V206, P1705, DOI 10.1002/macp.200500318
   Zeng J, 2005, BIOMACROMOLECULES, V6, P1484, DOI 10.1021/bm0492576
NR 148
TC 89
Z9 90
U1 6
U2 115
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1558-3724
EI 1558-3716
J9 POLYM REV
JI Polym. Rev.
PD OCT-DEC
PY 2006
VL 46
IS 4
BP 347
EP 375
DI 10.1080/15583720600945394
PG 29
WC Polymer Science
SC Polymer Science
GA 108AS
UT WOS:000242212700003
DA 2018-10-19
ER

PT J
AU de Moura, MR
   Aouada, FA
   Guilherme, MR
   Radovanovic, E
   Rubira, AF
   Muniz, EC
AF de Moura, Marcia R.
   Aouada, Fauze A.
   Guilherme, Marcos R.
   Radovanovic, Eduardo
   Rubira, Adley F.
   Muniz, Edvani C.
TI Thermo-sensitive IPN hydrogels composed of PNIPAAm gels supported on
   alginate-Ca2+ with LCST tailored close to human body temperature
SO POLYMER TESTING
LA English
DT Article
DE IPN hydrogels; alginate; PNIPAAm; LCST displacement
ID MEMBRANES; WATER; POLY(N-ISOPROPYLACRYLAMIDE); MICROSPHERES; PAAM
AB Transition temperature of interpenetrating polymer networks (lPN) hydrogels, composed of PNIPAAm gels supported on alginate-Ca2+, was investigated. Plots of partition coefficient, k, vs. temperature of Orange II converge to a maximum k value, attributed to the hydrophilic-to-hydrophobic transition in lPN hydrogels. This was associated with the lower critical solution temperature (LCST) of PNIPAAm in these IPN hydrogels. Shifts in the LCST values were related to the PNIPAAm and alginate-Ca2+ contents in the hydrogel, which affects the movements of water molecules outward and PNIPAAm chains inward at the point in time of the shrinking process. Bound and free water contents in the lPN hydrogels were investigated by differential scanning calorimetry (DSC). The higher the PNIPAAm, and alginate-Ca2+ contents in the lPN hydrogel, the lower is the relative amount of free water and the higher is the relative amount of bound water. The resultant tighter polymer structure of the hydrogels was evaluated by average molar mass between two adjacent cross-links (M-c). The LCST of these hydrogels may be tailored to close to human body temperature by controlling the amount of PNIPAAm and alginate-Ca2+ during synthesis. This characteristic makes lPN hydrogels of alginate-Ca2+/PNIPAAm attractive for potential uses in biomaterial applications. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Estadual Maringa, Dept Quim, GMPC, BR-87020900 Maringa, Parana, Brazil.
RP Muniz, EC (reprint author), Univ Estadual Maringa, Dept Quim, GMPC, BR-87020900 Maringa, Parana, Brazil.
EM ecmuniz@uem.br
RI Radovanovic, Eduardo/G-3831-2012; Guilherme, Marcos/J-6008-2012; Aouada,
   Fauze/C-3989-2012; Aouada, Marcia/F-6231-2014
OI Radovanovic, Eduardo/0000-0001-7859-955X; Aouada,
   Fauze/0000-0002-6870-6961; Guilherme, Marcos/0000-0002-4260-5660; Muniz,
   Edvani/0000-0001-6685-1519; Moura Aouada, Marcia Regina
   de/0000-0002-2534-5553
CR Aouada FA, 2006, POLYM TEST, V25, P158, DOI 10.1016/j.polymertesting.2005.11.005
   Becker TA, 2002, J BIOMED MATER RES, V61, P533, DOI 10.1002/jbm.10202
   Bell CL, 1995, ADV POLYM SCI, V122, P125
   Chan LW, 2002, BIOMATERIALS, V23, P1319, DOI 10.1016/S0142-9612(01)00250-2
   Crispim EG, 2006, POLYM TEST, V25, P377, DOI 10.1016/j.polymertesting.2005.12.003
   Crispim EG, 1999, POLYMER, V40, P5129, DOI 10.1016/S0032-3861(98)00653-3
   Draget KI, 1997, INT J BIOL MACROMOL, V21, P47, DOI 10.1016/S0141-8130(97)00040-8
   Fatin-Rouge N, 2006, WATER RES, V40, P1303, DOI 10.1016/j.watres.2006.01.026
   Flory P. J, 1953, PRINCIPLES POLYM CHE
   Flory PJ, 1943, J CHEM PHYS, V11, P521, DOI 10.1063/1.1723792
   FREITAS RFS, 1987, CHEM ENG SCI, V42, P97, DOI 10.1016/0009-2509(87)80213-0
   Guilherme MR, 2003, POLYMER, V44, P4213, DOI 10.1016/S0032-3861(03)00370-7
   Guilherme MR, 2002, J MEMBRANE SCI, V210, P129, DOI 10.1016/S0376-7388(02)00382-4
   HEINES PJ, 1995, THERMAL METHODS ANAL
   Hoffman AS, 2002, ADV DRUG DELIVER REV, V54, P3, DOI 10.1016/S0169-409X(01)00239-3
   Huang X, 2005, BIOMACROMOLECULES, V6, P2131, DOI 10.1021/bm050116t
   Ju HK, 2002, J APPL POLYM SCI, V83, P1128, DOI 10.1002/app.10137
   Kim JH, 2002, POLYMER, V43, P7549, DOI 10.1016/S0032-3861(02)00675-4
   Kong HJ, 2003, BIOMATERIALS, V24, P4023, DOI 10.1016/S0142-9612(03)00295-3
   Kwon OH, 2000, J BIOMED MATER RES, V50, P82, DOI 10.1002/(SICI)1097-4636(200004)50:1<82::AID-JBM12>3.3.CO;2-Z
   Muniz EC, 2001, MACROMOLECULES, V34, P4480, DOI 10.1021/ma001192l
   Ribeiro CC, 2004, BIOMATERIALS, V25, P4363, DOI 10.1016/j.biomaterials.2003.11.028
   SCHILD HG, 1992, PROG POLYM SCI, V17, P163, DOI 10.1016/0079-6700(92)90023-R
   TANAKA T, 1979, J CHEM PHYS, V70, P1214, DOI 10.1063/1.437602
NR 24
TC 35
Z9 35
U1 3
U2 26
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9418
J9 POLYM TEST
JI Polym. Test
PD OCT
PY 2006
VL 25
IS 7
BP 961
EP 969
DI 10.1016/j.polymertesting.2006.06.002
PG 9
WC Materials Science, Characterization & Testing; Polymer Science
SC Materials Science; Polymer Science
GA 098ON
UT WOS:000241532600013
DA 2018-10-19
ER

PT J
AU Mochizuki, S
   Kano, A
   Yamayoshi, A
   Maruyama, A
AF Mochizuki, S.
   Kano, A.
   Yamayoshi, A.
   Maruyama, A.
TI Hyaluronan conjugation of antigenic protein to modify immunogenic
   information
SO SCIENCE AND TECHNOLOGY OF ADVANCED MATERIALS
LA English
DT Article
DE protein modification; hyaluronic acid; ovalbumin; reductive amination;
   antigenicity
ID MODIFIED ADENOSINE-DEAMINASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; VIRUS TYPE-1
   INFECTION; CHRONIC HEPATITIS-C; POLYETHYLENE-GLYCOL; MODIFIED ALLERGENS;
   ACID; SUPPRESSION; ANTIBODIES; TOLERANCE
AB Hyaluronan is an anionic polysaccharide and a major component of extracellular matrices. The major physiological roll of hyaluronan (hyaluronic acid.. HA) is thought to be a space filling material and HA is an attractive biomaterial due to its biocompatibility and biodegradability. We chemically modified ovalbumin (OVA), a well defined protein antigen, with HA to reduce its immunogenicity. HA was enzymatically fragmented by a hyaluronidase and different sizes of fragments (M-n = 3000 and 9000) were obtained. The enzyme-digested HA fragments have a reducing end, which was used for coupling with OVA through reductive amination reaction. Colorimetric assay for free amino groups in OVA indicated that the conjugated number of HA fragments was maximally 10 and 6 per OVA, for the smaller (M-n = 3000) and larger (M-n = 9000) HA fragments, respectively. The HA contents of the conjugates were calculated as 40 and 55 wt%. respectively. We also obtained HA conjugates that have different length but almost the same number of HA fragments on OVA. The mice injected with the HA-conjugated OVA showed considerably lower OVA-specific IgE production than those with native OVA, implying reduced immunogenicity of OVA by the HA-modification. The data suggest that HA is a useful biomaterial for modification of immunological information in antigenic proteins. (c) 2006 NIMS and Elsevier Ltd. All rights reserved.
C1 Kyushu Univ, Inst Mat Chem & Engn, Higashi Ku, Fukuoka 8128581, Japan.
   CREST, Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan.
RP Maruyama, A (reprint author), Kyushu Univ, Inst Mat Chem & Engn, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.
EM maruyama@ms.ifoc.kyushu-u.ac.jp
RI Yamayoshi, Asako/Q-2486-2016; Maruyama, Atsushi/C-9186-2015
OI Maruyama, Atsushi/0000-0002-7495-2974
CR Abshire TC, 2000, BLOOD, V96, P1709
   ABUCHOWSKI A, 1977, J BIOL CHEM, V252, P3578
   Asayama S, 1998, BIOCONJUGATE CHEM, V9, P476, DOI 10.1021/bc970213m
   Avramis VI, 2002, BLOOD, V99, P1986, DOI 10.1182/blood.V99.6.1986
   COWMAN MK, 1984, BIOCHEM J, V221, P707, DOI 10.1042/bj2210707
   CRAMER JA, 1994, BBA-GEN SUBJECTS, V1200, P315, DOI 10.1016/0304-4165(94)90173-2
   Elton D, 1999, J VIROL, V73, P7357
   GOLAN DT, 1971, J EXP MED, V134, P1046, DOI 10.1084/jem.134.4.1046
   HERSHFIELD MS, 1987, NEW ENGL J MED, V316, P589, DOI 10.1056/NEJM198703053161005
   Joddar B, 2006, BIOMATERIALS, V27, P2994, DOI 10.1016/j.biomaterials.2006.01.020
   LEE WY, 1977, NATURE, V267, P618, DOI 10.1038/267618a0
   Lindsay KL, 2001, HEPATOLOGY, V34, P395, DOI 10.1053/jhep.2001.26371
   LIU FT, 1979, P NATL ACAD SCI USA, V76, P1430, DOI 10.1073/pnas.76.3.1430
   MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1
   NISBET AD, 1981, EUR J BIOCHEM, V115, P335, DOI 10.1111/j.1432-1033.1981.tb05243.x
   Russo M, 2001, AM J RESP CELL MOL, V24, P518, DOI 10.1165/ajrcmb.24.5.4320
   SAKAMOTO M, 1984, J IMMUNOL, V132, P2614
   SEHON AH, 1979, J ALLERGY CLIN IMMUN, V64, P242, DOI 10.1016/0091-6749(79)90139-8
   SWANN DA, 1982, BIOCHEM J, V207, P409, DOI 10.1042/bj2070409
   Takei Y, 2004, FASEB J, V18, P699, DOI 10.1096/fj.03-0494fje
   TEPPLER H, 1993, J INFECT DIS, V167, P291, DOI 10.1093/infdis/167.2.291
   TEPPLER H, 1993, J EXP MED, V177, P483, DOI 10.1084/jem.177.2.483
   TURNER RE, 1985, ARCH BIOCHEM BIOPHYS, V237, P253, DOI 10.1016/0003-9861(85)90276-0
   URANECK CA, 1960, J POLYM SCI, V46, P535, DOI 10.1002/pol.1960.1204614825
   WEI BY, 1986, J ALLERGY CLIN IMMUN, V78, P1066, DOI 10.1016/0091-6749(86)90307-6
   WEINBERG K, 1993, J CLIN INVEST, V92, P596, DOI 10.1172/JCI116626
   WEISSMANN B, 1954, J AM CHEM SOC, V76, P1753, DOI 10.1021/ja01636a010
   Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301
NR 28
TC 2
Z9 2
U1 0
U2 5
PU NATL INST MATERIALS SCIENCE
PI IBARAKI
PA NATL INST MATERIALS SCIENCE, 1-2-1 SENGEN, TSUKUBA-CITY, IBARAKI,
   305-0047, JAPAN
SN 1468-6996
J9 SCI TECHNOL ADV MAT
JI Sci. Technol. Adv. Mater.
PD OCT
PY 2006
VL 7
IS 7
BP 685
EP 691
DI 10.1016/j.stam.2006.05.010
PG 7
WC Materials Science, Multidisciplinary
SC Materials Science
GA 123ZF
UT WOS:000243335700014
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Inabo, HI
AF Inabo, H. I.
TI The significance of Candida infections of medical implants
SO SCIENTIFIC RESEARCH AND ESSAYS
LA English
DT Review
DE Candida albicans; medical implants; biofilm; biomaterial manufacture
AB Infection of medical implants is acquired at the time of instrumentation or surgery. It is an early complication of this intrusive procedure. Biofilm formation on implanted implants such as dentures, catheters or a prosthetic heart valve may lead to Candida infections. Factors affecting the biofilm formation and the risk factors associated with the implantation of the various medical devices are highlighted in this paper. The modification of biomaterial surface with anti-infective agents to enhance biocompatibility of the indwelling medical devices is discussed.
C1 Ahmadu Bello Univ, Fac Sci, Dept Microbiol, Samaru, Nigeria.
RP Inabo, HI (reprint author), Ahmadu Bello Univ, Fac Sci, Dept Microbiol, Samaru, Nigeria.
EM heleninabo@yahoo.co.uk
CR Chandra J, 2001, J BACTERIOL, V183, P5385, DOI 10.1128/JB.183.18.5385-5394.2001
   Colombo A L, 2000, Braz J Infect Dis, V4, P113
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000
   Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002
   Douglas LJ, 2003, TRENDS MICROBIOL, V11, P30, DOI 10.1016/S0966-842X(02)00002-1
   Ista LK, 1996, FEMS MICROBIOL LETT, V142, P59
   JAQUES M, 1986, AM J OBSTET GYNECOL, V154, P648
   Kauffman CA, 2000, CLIN INFECT DIS, V30, P14, DOI 10.1086/313583
   KAYE D, 1994, INFECTIONS ASS INDWE
   Kojic EM, 2004, CLIN MICROBIOL REV, V17, P255, DOI 10.1128/CMR.17.2.255-267.2004
   Montero A, 2000, ACTA NEUROCHIR, V142, P67, DOI 10.1007/s007010050009
   Nucci M, 2002, CLIN INFECT DIS, V34, P591, DOI 10.1086/338714
   Potera C, 1999, SCIENCE, V283, P1837, DOI 10.1126/science.283.5409.1837
   Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795
   ROMAMDAN N, 2001, J INFECTION, V42, P74
   Shintani H., 2004, TRENDS BIOMATER ARTI, V18, P1
   STOCKS G, 2000, ASAIO J, V46, P541
   van der Mei HC, 2000, J MED MICROBIOL, V49, P713, DOI 10.1099/0022-1317-49-8-713
   Zimmerli W, 2003, INFECTION, V31, P99, DOI 10.1007/s15010-002-3079-9
NR 20
TC 3
Z9 4
U1 0
U2 1
PU ACADEMIC JOURNALS
PI VICTORIA ISLAND
PA P O BOX 5170-00200 NAIROBI, VICTORIA ISLAND, LAGOS 73023, NIGERIA
SN 1992-2248
J9 SCI RES ESSAYS
JI Sci. Res. Essays
PD OCT
PY 2006
VL 1
IS 1
BP 8
EP 10
PG 3
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V59KG
UT WOS:000204015000002
DA 2018-10-19
ER

PT J
AU Giordani, EJ
   Jorge, AM
   Balancin, O
AF Giordani, E. J.
   Jorge, A. M., Jr.
   Balancin, O.
TI Proportion of recovery and recrystallization during interpass times at
   high temperatures on a Nb- and N-bearing austenitic stainless steel
   biomaterial
SO SCRIPTA MATERIALIA
LA English
DT Article
DE softening; recovery; recrystallization; biomaterial
AB Softening between deformations was determined by double torsion tests, metallographic examination and electron backscattered diffraction. High levels of softening of as much as 60% can be promoted by recovery during interpass times, before and at the beginning of recrystallization. The restoration promoted by recovery during recrystallization was analyzed through the evolution of low angle grain boundary fractions. (c) 2006 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Univ Fed Sao Carlos, Dept Mat Engn, BR-13565905 Sao Carlos, SP, Brazil.
RP Giordani, EJ (reprint author), Univ Fed Sao Carlos, Dept Mat Engn, Rod Washington Luiz,Km 235, BR-13565905 Sao Carlos, SP, Brazil.
EM enricogiordani@uol.com.br
RI Jorge Junior, Alberto/B-2566-2012
OI Jorge Junior, Alberto/0000-0002-8121-9834
CR ANDRADE HL, 1983, METALL TRANS A, V14, P1967, DOI 10.1007/BF02662364
   Fernandez AI, 1999, SCRIPTA MATER, V40, P543, DOI 10.1016/S1359-6462(98)00452-7
   Giordani EJ, 2005, MATER SCI FORUM, V500-501, P179, DOI 10.4028/www.scientific.net/MSF.500-501.179
   Giordani EJ, 2004, INT J FATIGUE, V26, P1129, DOI 10.1016/j.ijfatigue.2004.03.002
   JACK DH, 1972, J IRON STEEL I, V210, P790
   Jazaeri H, 2004, J MICROSC-OXFORD, V213, P241, DOI 10.1111/j.0022-2720.2004.01296.x
   Mataya MC, 1996, METALL MATER TRANS A, V27, P1251, DOI 10.1007/BF02649862
   Ornhagen C, 1996, J BIOMED MATER RES, V31, P97, DOI 10.1002/(SICI)1097-4636(199605)31:1<97::AID-JBM12>3.0.CO;2-J
   SCHRAMM RE, 1975, METALL TRANS A, V6, P1345, DOI 10.1007/BF02641927
   SUN WP, 1995, ISIJ INT, V35, P908, DOI 10.2355/isijinternational.35.908
NR 10
TC 12
Z9 15
U1 1
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1359-6462
J9 SCRIPTA MATER
JI Scr. Mater.
PD OCT
PY 2006
VL 55
IS 8
BP 743
EP 746
DI 10.1016/j.scriptamat.2006.05.015
PG 4
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 079OD
UT WOS:000240185600021
DA 2018-10-19
ER

PT J
AU Fathi, MH
   Salehi, M
   Mortazavi, V
   Mousavi, SB
   Parsapour, A
AF Fathi, M. H.
   Salehi, M.
   Mortazavi, V.
   Mousavi, S. B.
   Parsapour, A.
TI Novel hydroxyapatite/niobium surface coating for endodontic dental
   implant
SO SURFACE ENGINEERING
LA English
DT Article
DE endodontic dental implant; hydroxyapatite coating; HA/Nb coating
ID SCANNING ELECTRON-MICROSCOPE; ENDOSSEOUS IMPLANTS; TITANIUM; BEHAVIOR;
   STABILIZERS; BIOCERAMICS; IMPROVEMENT; MICROPROBE; CORROSION; ALLOYS
AB Endodontic dental implants have been used for many years. Many materials have been advocated for use as endodontic implants but a few of them have shown biocompatibility and have been acceptable. The aim of this study was to design and produce a novel biomaterial by producing a new surface coating on metallic substrate in order to achieve two goals, namely, an improvement in the corrosion behaviour of metallic endodontic dental implant and the bone osteointegration simultaneously. Stainless steel (SS) 316L was used as the metallic substrate and a novel double layer hydroxyapatite/niobium (HA/Nb) composite coating was prepared on it. X-ray diffraction (XRD) and scanning electron microscopy (SEM) techniques were utilised to characterise the coating. Electrochemical tests were performed in physiological solutions in order to determine the corrosion behaviour of the coated and uncoated specimens. Two types of endodontic implants were used, including SS with and without novel HA/Nb coating, which were prepared and subsequently implanted in the mandibular canine of 22 cats after completion of root canal treatment and osseous preparation. After a healing period of 4 months, osteointegration evaluation and histopathological interpretation were carried out using SEM and optical microscopy. In vitro tests indicated that the novel HA/Nb composite coating could improve the corrosion resistance and therefore the biocompatibility of SS endodontic dental implant. The clinical evaluation results showed that the average bone osteointegration of coated implants was more than for uncoated implants. The histopathological results and bone tissue response to the coated endodontic dental implants were acceptable. It can be concluded that HA/Nb composite coated SS could be used as an endodontic dental implant material.
C1 Isfahan Univ Technol, Dept Mat Engn, Esfahan 84154, Iran.
   Isfahan Univ Med Sci, Fac Dent, Esfahan 81744, Iran.
RP Fathi, MH (reprint author), Isfahan Univ Technol, Dept Mat Engn, Esfahan 84154, Iran.
EM fathi@cc.iut.ac.ir
CR BARBOSA MA, 1998, HDB BIOMATERIAL PROP, P420
   BATTAGE I, 2000, J BIOMED MATER RES, V53, P76
   CASWELL CW, 1983, J PROSTHET DENT, V50, P530, DOI 10.1016/0022-3913(83)90576-0
   *COUNC DENT MAT, 1986, JADA, V113, P949
   CRANIN AN, 1977, J AM DENT ASSOC, V94, P315, DOI 10.14219/jada.archive.1977.0288
   Ding SJ, 2003, BIOMATERIALS, V24, P4233, DOI 10.1016/S0142-9612(03)00315-6
   DUCHEYNE P, 1988, J BIOMED MATER RES, V22, P1137, DOI 10.1002/jbm.820221207
   Fathi MH, 2003, DENT MATER, V19, P188, DOI 10.1016/S0109-5641(02)00029-5
   Fathi MH, 2001, SURF ENG, V17, P459, DOI 10.1179/026708401322911365
   FATHI MH, 2001, IUT J ENG, V20, P189
   FRANK AL, 1967, J AM DENT ASSOC, V74, P451, DOI 10.14219/jada.archive.1967.0083
   Garcia C, 2004, J NON-CRYST SOLIDS, V348, P218, DOI 10.1016/j.jnoncrysol.2004.08.172
   Gross KA, 1998, INT J ORAL MAX IMPL, V13, P601
   Gunzel R, 1999, SURF COAT TECH, V116, P1107, DOI 10.1016/S0257-8972(99)00321-7
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hench LL, 1993, INTRO BIOCERAMICS, P223
   LARSEN RM, 1989, J ENDODONT, V15, P496, DOI 10.1016/S0099-2399(89)80033-0
   MADISON S, 1988, J PROSTHET DENT, V59, P603, DOI 10.1016/0022-3913(88)90079-0
   Maeda Y, 1984, J Osaka Univ Dent Sch, V24, P131
   Metikos-Hukovic M, 2003, BIOMATERIALS, V24, P3765, DOI 10.1016/S0142-9612(03)00252-7
   Miao X, 2003, MATER LETT, V57, P1848, DOI 10.1016/S0167-577X(02)01080-7
   Nie X, 2000, SURF COAT TECH, V125, P407, DOI 10.1016/S0257-8972(99)00612-X
   ORLAY HG, 1960, BRIT DENT J, V108, P118
   Parreira FR, 1996, J ENDODONT, V22, P161, DOI 10.1016/S0099-2399(96)80092-6
   SELTZER S, 1973, ORAL SURG ORAL MED O, V35, P828, DOI 10.1016/0030-4220(73)90121-7
   SILVERBRAND H, 1978, J ORAL SURG, V45, P920
   STROCK AE, 1943, J ORAL SURG, V1, P252
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Ward LP, 1996, J MATER PROCESS TECH, V56, P364, DOI 10.1016/0924-0136(95)01850-6
   WEINE FS, 1993, J ENDODONT, V19, P524, DOI 10.1016/S0099-2399(06)81496-2
   ZMENER O, 1983, J ENDODONT, V9, P486, DOI 10.1016/S0099-2399(83)80164-2
NR 32
TC 13
Z9 13
U1 0
U2 8
PU MANEY PUBLISHING
PI LEEDS
PA STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND
SN 0267-0844
J9 SURF ENG
JI Surf. Eng.
PD OCT
PY 2006
VL 22
IS 5
BP 353
EP 358
DI 10.1179/174329406X126708
PG 6
WC Materials Science, Coatings & Films
SC Materials Science
GA 100LR
UT WOS:000241671100006
DA 2018-10-19
ER

PT J
AU Bachle, M
   Hubner, U
   Kohal, RJ
   Han, JS
   Wiedmann-Al-Ahmad, M
AF Baechle, M.
   Huebner, U.
   Kohal, R. J.
   Han, J. S.
   Wiedmann-Al-Ahmad, M.
TI Structure and in vitro cytocompatibility of the gastropod shell of Helix
   pomatia
SO TISSUE & CELL
LA English
DT Article
DE gastropod shell; XRD; SEM; osteoblast-like cells; cell proliferation;
   cell viability
ID OSTEOBLASTS MAINTAINED INVITRO; BONE REGENERATION; NACRE;
   HYDROXYAPATITE; IMPLANTS; CORAL; SHEEP
AB Distinguishing features of biological constructions are high stability and adaptation to their environment. Beside biocompatibility, nontoxicity and degradability these characteristics are demanded for new biomaterials in the field of tissue engineering. This study investigated the chemical composition, the organization and the in vitro osteoconductive potential of the terrestrial gastropod shell (Helix pomatia) on CAL72 and human osteoblast-like cells. Chemical composition of the biomaterial was examined by X-ray diffraction (XRD) and scanning electron microscopy (SEM) was performed to analyze the architecture of the snail shell and the morphology of the seeded cells. A double staining procedure (FDA/PI) and a proliferation test (EZ4U) assessed the viability of the cells. Microscopical images showed the multilayered architecture of the aragonite shell with hexagonal crystals on the inner side. The cells spread well on the biomaterial and the highest proliferation rate could be measured with CAL72 cells on the inner shell surface. The osteoconductive effects of this natural biomaterial could encourage further experiments in the field of tissue engineering. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Hosp Freiburg, Sch Dent, Dept Prosthodont, D-79106 Freiburg, Germany.
   Univ Hosp Freiburg, Sch Dent, Dept Oral & Maxillofacial Surg, D-79106 Freiburg, Germany.
   Seoul Natl Univ, Coll Dent, Dept Prosthodont, Seoul 110749, South Korea.
   Seoul Natl Univ, Dent Res Inst, Seoul 110749, South Korea.
RP Bachle, M (reprint author), Univ Hosp Freiburg, Sch Dent, Dept Prosthodont, Hugstetter Str 55, D-79106 Freiburg, Germany.
EM maria.baechle-haas@uniklinik-freiburg.de
RI Han, Jung-Suk/D-5783-2012
OI Kohal, Ralf/0000-0001-7095-4190
CR ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531
   Atlan G, 1997, CR ACAD SCI III-VIE, V320, P253, DOI 10.1016/S0764-4469(97)86933-8
   Atlan G, 1999, BIOMATERIALS, V20, P1017, DOI 10.1016/S0142-9612(98)90212-5
   BENGTSON S, 1992, ORIGIN EARLY EVOLUTI, P447
   CAMPRASSE S, 1990, Clinical Materials, V5, P235, DOI 10.1016/0267-6605(90)90022-N
   Carter J. G, 1990, SKELETAL BIOMINERALI
   COMPERE EL, 1973, LIMNOL OCEANOGR, V18, P326, DOI 10.4319/lo.1973.18.2.0326
   DELATTRE O, 1997, EUR J ORTHOP SURG TR, V7, P1
   GODAN D, 1979, SCHADSCHNECKEN IHRE, P40
   Hedegaard C, 1997, J MOLLUS STUD, V63, P369, DOI 10.1093/mollus/63.3.369
   HEDEGAARD C, 1990, THESIS U AARHUS
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HEUER AH, 1992, SCIENCE, V255, P1098, DOI 10.1126/science.1546311
   HOLMES RE, 1979, PLAST RECONSTR SURG, V63, P626, DOI 10.1097/00006534-197905000-00004
   JAMMET P, 1994, J CRANIO MAXILL SURG, V22, P103, DOI 10.1016/S1010-5182(05)80019-8
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   KNIPRATH E, 1972, CALC TISS RES, V9, P260, DOI 10.1007/BF02061966
   Liao HH, 2000, BIOMATERIALS, V21, P457, DOI 10.1016/S0142-9612(99)00184-2
   LINDBERG DR, 1988, MALACOLOGICAL REV S, V4, P35
   LINDE A, 1989, CALCIFIED TISSUE INT, V44, P286, DOI 10.1007/BF02553763
   Lloyd SJ, 2003, PHILOS T ROY SOC A, V361, P2931, DOI 10.1098/rsta.2003.1276
   LOPEZ E, 1992, TISSUE CELL, V24, P667, DOI 10.1016/0040-8166(92)90037-8
   Lowenstam H.A., 1989, ON BIOMINERALISATION
   MACCLINTOCK C, 1967, YALE U B, V22, P1
   Manoli F, 2000, J CRYST GROWTH, V217, P416, DOI 10.1016/S0022-0248(00)00514-5
   Mouries LP, 2002, COMP BIOCHEM PHYS B, V132, P217
   Ni M, 2003, BIOMATERIALS, V24, P4323, DOI 10.1016/S0142-9612(03)00236-9
   Osborn J F, 1979, SSO Schweiz Monatsschr Zahnheilkd, V89, P1138
   PATEL A, 1980, Calcified Tissue International, V31, P108
   Rocca M, 2002, BIOMATERIALS, V23, P1017, DOI 10.1016/S0142-9612(01)00213-7
   Rubner M, 2003, NATURE, V423, P925, DOI 10.1038/423925a
   RUNNEGAR B, 1975, LETHAIA, V8, P181, DOI 10.1111/j.1502-3931.1975.tb01311.x
   Siewert W., 1972, STUTTGARTER BEITRA B, V1, P1
   SILVE C, 1992, CALCIFIED TISSUE INT, V51, P363, DOI 10.1007/BF00316881
   SOUYRIS F, 1985, J MAXILLOFAC SURG, V13, P64, DOI 10.1016/S0301-0503(85)80018-7
   TAYLOR J D, 1973, Bulletin of the British Museum (Natural History) Zoology, V22, P253
   TAYLOR JD, 1969, B BRIT MUSEUM NATU S, V3, P1
   Wang XX, 2005, BIOMATERIALS, V26, P6229, DOI 10.1016/j.biomaterials.2005.03.029
   Westbroek P, 1998, NATURE, V392, P861, DOI 10.1038/31798
NR 39
TC 4
Z9 4
U1 0
U2 10
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0040-8166
J9 TISSUE CELL
JI Tissue Cell
PD OCT
PY 2006
VL 38
IS 5
BP 337
EP 344
DI 10.1016/j.tice.2006.08.004
PG 8
WC Anatomy & Morphology; Cell Biology
SC Anatomy & Morphology; Cell Biology
GA 109EL
UT WOS:000242290600007
PM 17010402
DA 2018-10-19
ER

PT J
AU Hofmann, S
   Knecht, S
   Langer, R
   Kaplan, DL
   Vunjak-Novakovic, G
   Merkle, HP
   Meinel, L
AF Hofmann, Sandra
   Knecht, Sven
   Langer, Robert
   Kaplan, David L.
   Vunjak-Novakovic, Gordana
   Merkle, Hans P.
   Meinel, Lorenz
TI Cartilage-like tissue engineering using silk scaffolds and mesenchymal
   stem cells
SO TISSUE ENGINEERING
LA English
DT Article
ID BONE-MARROW; IN-VITRO; CHONDROGENIC DIFFERENTIATION; BIOMATERIALS;
   RESPONSES; COLLAGEN; INVITRO
AB Silk fibroin scaffolds were studied as a new biomaterial option for tissue-engineered cartilage-like tissue. Human bone marrow-derived mesenchymal stem cells (MSCs) were seeded on silk, collagen, and crosslinked collagen scaffolds and cultured for 21 days in serum-free chondrogenic medium. Cells proliferated more rapidly on the silk fibroin scaffolds than on the collagen matrices. The total content of glycosaminoglycan deposition was three times higher on silk as compared to collagen scaffolds. Glycosaminoglycan deposition coincided with overexpression of collagen type II and aggrecan genes. Cartilage-like tissue was homogeneously distributed throughout the entire silk scaffolds, while on the collagen and crosslinked collagen systems tissue formation was restricted to the outer rim, leaving a doughnut appearance. Round or angular-shaped cells resided in deep lacunae in the silk systems and stained positively for collagen type II. The aggregate modulus of the tissue-engineered cartilage constructs was more than 2-fold higher than that of the unseeded silk scaffold controls. These results suggest that silk fibroin scaffolds are suitable biomaterial substrates for autologous cartilage tissue engineering in serum-free medium and enable mechanical improvements along with compositional features suitable for durable implants to generate or regenerate cartilage.
C1 ETH, Inst Pharmaceut Sci, Zurich, Switzerland.
   Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA.
   ETH, Biomech Lab, Zurich, Switzerland.
   MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   Columbia Univ, Dept Bioengn, New York, NY USA.
RP Meinel, L (reprint author), ETH, Inst Pharmaceut Sci, Zurich, Switzerland.
EM Lorenz.Meinel@pharma.ethz.ch
RI Hofmann, Sandra/F-2832-2010; Merkle, Hans/A-4381-2014; Meinel,
   Lorenz/D-9997-2015
OI Hofmann, Sandra/0000-0002-2568-8388; Meinel, Lorenz/0000-0002-7549-7627
FU NIBIB NIH HHS [P41 EB002520]
CR Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8
   Altman GH, 2002, J BIOMECH ENG-T ASME, V124, P742, DOI 10.1115/1.1519280
   Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   ATHANASIOU KA, 1991, J ORTHOP RES, V9, P330, DOI 10.1002/jor.1100090304
   Barry F, 2001, EXP CELL RES, V268, P189, DOI 10.1006/excr.2001.5278
   Barry Frank P, 2003, Novartis Found Symp, V249, P86
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brundtland GH, 2003, WHO TECH REP SER, V919, P1
   CAPLAN AI, 1994, CLIN PLAST SURG, V21, P429
   Caterson EJ, 2001, J BIOMED MATER RES, V57, P394, DOI 10.1002/1097-4636(20011205)57:3<394::AID-JBM1182>3.0.CO;2-9
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FRIEDENSTEIN AJ, 1987, CELL TISSUE KINET, V20, P263, DOI 10.1111/j.1365-2184.1987.tb01309.x
   FRIEDENSTEIN AJ, 1976, INT REV CYTOL, V47, P327, DOI 10.1016/S0074-7696(08)60092-3
   Harris LD, 1998, J BIOMED MATER RES, V42, P396, DOI 10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
   Heng BC, 2004, CARDIOVASC RES, V62, P34, DOI 10.1016/j.cardiores.2003.12.022
   Hollinger JO, 1996, CLIN ORTHOP RELAT R, P55
   Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415
   Martin I, 2001, J BIOMED MATER RES, V55, P229, DOI 10.1002/1097-4636(200105)55:2<229::AID-JBM1009>3.3.CO;2-H
   MCCARROLL JR, 1983, CLIN ORTHOP RELAT R, P130
   Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047
   Meinel L, 2004, ANN BIOMED ENG, V32, P112, DOI 10.1023/B:ABME.0000007796.48329.b4
   Meinel L, 2004, BIOTECHNOL BIOENG, V88, P379, DOI 10.1002/bit.20252
   Meinel L, 2004, J BIOMED MATER RES A, V71A, P25, DOI 10.1002/jbm.a.30117
   MEINEL L, 2006, BIOMATERIALS, V28, P4993
   Menche DS, 1996, ARTHROSCOPY, V12, P280, DOI 10.1016/S0749-8063(96)90059-6
   Panilaitis B, 2003, BIOMATERIALS, V24, P3079, DOI 10.1016/S0142-9612(03)00158-3
   POOLE AR, 2001, CLIN ORTHOP S, V391, P26
   PRIDIE KH, 1959, J BONE JOINT SURG BR, V41, P618
   Qi WN, 1998, EXP CELL RES, V241, P142, DOI 10.1006/excr.1998.4032
   Qi WN, 1997, J ORTHOPAED RES, V15, P483, DOI 10.1002/jor.1100150402
   Santin M, 1999, J BIOMED MATER RES, V46, P382, DOI 10.1002/(SICI)1097-4636(19990905)46:3<382::AID-JBM11>3.0.CO;2-R
   Sofia S, 2001, J BIOMED MATER RES, V54, P139, DOI 10.1002/1097-4636(200101)54:1<139::AID-JBM17>3.0.CO;2-7
   SOONG HK, 1984, OPHTHALMOLOGY, V91, P479
   Suh H, 1998, YONSEI MED J, V39, P87, DOI 10.3349/ymj.1998.39.2.87
   WAKITANI S, 1994, J BONE JOINT SURG AM, V76A, P579, DOI 10.2106/00004623-199404000-00013
   WONG MY, 1993, IN VITRO CELL DEV-AN, V29A, P917
NR 37
TC 129
Z9 139
U1 0
U2 30
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD OCT
PY 2006
VL 12
IS 10
BP 2729
EP 2738
DI 10.1089/ten.2006.12.2729
PG 10
WC Cell & Tissue Engineering
SC Cell Biology
GA 105PU
UT WOS:000242045600003
PM 17518642
DA 2018-10-19
ER

PT J
AU Novotny, JE
   Turka, CM
   Jeong, C
   Wheaton, AJ
   Li, CZ
   Presedo, A
   Richardson, DW
   Reddy, R
   Dodge, GR
AF Novotny, John E.
   Turka, Christina M.
   Jeong, Changhoon
   Wheaton, Andrew J.
   Li, Chuanzhao
   Presedo, Ana
   Richardson, Dean W.
   Reddy, Ravinder
   Dodge, George R.
TI Biomechanical and magnetic resonance characteristics of a cartilage-like
   equivalent generated in a suspension culture
SO TISSUE ENGINEERING
LA English
DT Article
ID BOVINE ARTICULAR-CARTILAGE; FULL-THICKNESS DEFECTS; FIXED
   CHARGE-DENSITY; IN-VIVO; ENGINEERED CARTILAGE; PERIOSTEAL GRAFTS; NA-23
   MRI; REPAIR; KNEE; OSTEOARTHRITIS
AB Objective: To generate a cartilage biomaterial using a suspension culture with biophysical properties similar to native articular cartilage. Design: A novel cartilage tissue equivalent (CTE) using a no-scaffold, high-density suspension culture of neonatal porcine chondrocytes was formed on poly 2-hydroxyethyl methacrylate-treated plates for up to 16 weeks. Equilibrium aggregate modulus and hydraulic permeability were measured at 8 and 16 weeks using confined compression stress relaxation experiments. The CTE proteoglycan composition was characterized using sodium and T-1 rho magnetic resonance imaging methods after 8 weeks. Results: The resultant CTE produces a biomaterial consistent with a hyaline cartilage phenotype in appearance and expression of type II collagen and aggrecan. The equilibrium aggregate modulus and permeability for the 8-week specimens were 41.6 ( standard deviation (SD) 4.3) kPa and 2.85(-13) (SD 2.45(-13)) m(4)/Ns, respectively, and, for the 16-week specimens, 35.2 ( SD 7.6) kPa and 2.67(-13) ( SD 1.06(-13)) m(4)/Ns, respectively. Average sodium concentration of the 8- week CTE ranged from 260 to 278 mM and average T-1 rho relaxation times from 105 to 107 ms, indicating proteoglycan content similar to that of native articular cartilage. Conclusion: The high-density culture method produced a CTE with characteristics that approach those of native articular cartilage. The CTE mechanical properties are similar to those of the native cartilage. The CTE developed in this study represents a promising methodological advancement in cartilage tissue engineering and cartilage repair.
C1 Alfred I DuPont Hosp Children, Bone & Cartilage Res Lab, Dept Orthopaed, Wilmington, DE 19803 USA.
   Univ Delaware, Dept Engn Mech, Biomed Engn Res Ctr, Newark, DE USA.
   Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA.
   Univ Penn, Sch Vet Med, New Bolton Ctr, Dept Clin Sci, Kennett Sq, PA USA.
RP Dodge, GR (reprint author), Alfred I DuPont Hosp Children, Bone & Cartilage Res Lab, Dept Orthopaed, 1600 Rockland Rd, Wilmington, DE 19803 USA.
EM gdodge@nemours.org
OI Reddy, Ravinder/0000-0003-4580-2392
FU NIAMS NIH HHS [AR045242, AR5P20RR016458]; NCRR NIH HHS [P20RR020173]
CR Akella SVS, 2001, MAGNET RESON MED, V46, P419, DOI 10.1002/mrm.1208
   Almarza AJ, 2004, ANN BIOMED ENG, V32, P2, DOI 10.1023/B:ABME.0000007786.37957.65
   Altman Roy D, 2003, Curr Rheumatol Rep, V5, P7, DOI 10.1007/s11926-003-0077-6
   Ateshian GA, 1997, J BIOMECH, V30, P1157, DOI 10.1016/S0021-9290(97)85606-0
   BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401
   Brittberg M, 1999, CLIN ORTHOP RELAT R, pS147
   BRITTBERG M, 2001, CLIN ORTHOP S, V391, P337
   Buckwalter JA, 1999, CLIN ORTHOP RELAT R, pS224
   BULSTRA SK, 1990, J ORTHOP RES, V8, P328, DOI 10.1002/jor.1100080304
   Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251
   Dodge GR, 1998, ARTHRITIS RHEUM, V41, P274
   Duvvuri U, 1997, MAGN RESON MED, V38, P863, DOI 10.1002/mrm.1910380602
   Duvvuri U, 2001, RADIOLOGY, V220, P822, DOI 10.1148/radiol.2203001662
   Estrada LE, 2001, OSTEOARTHR CARTILAGE, V9, P169, DOI 10.1053/joca.2000.0373
   Frenkel SR, 2004, ANN BIOMED ENG, V32, P26, DOI 10.1023/B:ABME.0000007788.41804.0d
   FURUKAWA T, 1980, J BONE JOINT SURG AM, V62, P79, DOI 10.2106/00004623-198062010-00012
   Ghosh P, 2002, SEMIN ARTHRITIS RHEU, V32, P10, DOI 10.1053/sarh.2002.32549
   Hangody L, 2003, J BONE JOINT SURG AM, V85A, P25, DOI 10.2106/00004623-200300002-00004
   HANGODY L, 2001, CLIN ORTHOP S, V391, P328
   HOLMES MH, 1990, J BIOMECH, V23, P1145, DOI 10.1016/0021-9290(90)90007-P
   HOMMINGA GN, 1990, J BONE JOINT SURG BR, V72, P1003
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   INSALL J, 1974, CLIN ORTHOP RELAT R, P61
   JOHNSON L L, 1986, Arthroscopy, V2, P54, DOI 10.1016/S0749-8063(86)80012-3
   Klein TJ, 2003, OSTEOARTHR CARTILAGE, V11, P595, DOI 10.1016/S1063-4584(03)00090-6
   Ma PX, 1999, J BIOMED MATER RES, V44, P217
   MANKIN HJ, 1982, J BONE JOINT SURG AM, V64, P460, DOI 10.2106/00004623-198264030-00022
   Mauck RL, 2002, ANN BIOMED ENG, V30, P1046, DOI 10.1114/1.1512676
   Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656
   MOW VC, 1980, J BIOMECH ENG-T ASME, V102, P73, DOI 10.1115/1.3138202
   Niemann H, 2003, REPROD DOMEST ANIM, V38, P82, DOI 10.1046/j.1439-0531.2003.00409.x
   Nottle MB, 2002, XENOTRANSPLANTATION, V9, P305, DOI 10.1034/j.1399-3089.2002.t01-1-02036.x
   ODRISCOLL SW, 1988, J BONE JOINT SURG AM, V70A, P595, DOI 10.2106/00004623-198870040-00017
   ODRISCOLL SW, 2001, CLIN ORTHOP S, V391, pS397
   Regatte RR, 2003, J MAGN RESON IMAGING, V18, P336, DOI 10.1002/jmri.10358
   REGINATO AM, 1994, ARTHRITIS RHEUM, V37, P1338, DOI 10.1002/art.1780370912
   RUBAK JM, 1982, ACTA ORTHOP SCAND, V53, P181, DOI 10.3109/17453678208992198
   Sandrin MS, 2001, J CARDIAC SURG, V16, P448, DOI 10.1111/j.1540-8191.2001.tb00549.x
   Shapiro EM, 2000, J MAGN RESON, V142, P24, DOI 10.1006/jmre.1999.1932
   Shapiro EM, 2002, MAGNET RESON MED, V47, P284, DOI 10.1002/mrm.10054
   Trippel SB, 2004, GENE THER, V11, P351, DOI 10.1038/sj.gt.3302201
   Vunjak-Novakovic G, 1999, J ORTHOPAED RES, V17, P130, DOI 10.1002/jor.1100170119
   Wheaton AJ, 2004, J MAGN RESON IMAGING, V20, P519, DOI 10.1002/jmri.20148
   Wheaton AJ, 2004, ACAD RADIOL, V11, P21, DOI 10.1016/S1076-6332(03)00574-9
NR 44
TC 28
Z9 30
U1 0
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4947
J9 TISSUE ENG
JI Tissue Eng.
PD OCT
PY 2006
VL 12
IS 10
BP 2755
EP 2764
DI 10.1089/ten.2006.12.2755
PG 10
WC Cell & Tissue Engineering
SC Cell Biology
GA 105PU
UT WOS:000242045600006
PM 17518645
DA 2018-10-19
ER

PT J
AU Hook, AL
   Thissen, H
   Voelcker, NH
AF Hook, Andrew L.
   Thissen, Helmut
   Voelcker, Nicolas H.
TI Surface manilpulation of biomolecules for cell microarray applications
SO TRENDS IN BIOTECHNOLOGY
LA English
DT Review
ID GENE DELIVERY; TRANSFECTION MICROARRAY; POLYMER SURFACES; FUNCTION
   SCREENS; MAMMALIAN-CELLS; DNA MICROARRAY; ARRAYS; CHIP; FABRICATION;
   TECHNOLOGY
AB Many biological events, such as cellular communication, antigen recognition, tissue repair and DNA linear transfer, are intimately associated with biomolecule interactions at the solid-liquid interface. To facilitate the study and use of these biological events for biodevice and biomaterial applications, a sound understanding of how biomolecules behave at interfaces and a concomitant ability to manipulate biomolecules spatially and temporally at surfaces is required. This is particularly true for cell microarray applications, where a range of biological processes must be duly controlled to maximize the efficiency and throughput of these devices. Of particular interest are transfected-cell microarrays (TCMs), which significantly widen the scope of microarray genomic analysis by enabling the high-throughput analysis of gene function within living cells. This article reviews this current research focus, discussing fundamental and applied research into the spatial and temporal surface manipulation of DNA, proteins and other biomolecules and the implications of this work for TCMs.
C1 Flinders Univ S Australia, Sch Chem Phys & Earth Sci, Adelaide, SA 5001, Australia.
   CSIRO, Mol & Hlth Technol, Clayton, Vic 3168, Australia.
RP Voelcker, NH (reprint author), Flinders Univ S Australia, Sch Chem Phys & Earth Sci, Adelaide, SA 5001, Australia.
EM nico.voelcker@flinders.edu.au
RI Voelcker, Nicolas/D-6199-2012; Thissen, Helmut/D-3835-2011; Hook,
   Andrew/K-6924-2012
OI Voelcker, Nicolas/0000-0002-1536-7804; Hook, Andrew/0000-0001-7756-8444
CR Angres B, 2005, EXPERT REV MOL DIAGN, V5, P769, DOI 10.1586/14737159.5-5.769
   Baac HW, 2004, MAT SCI ENG C-BIO S, V24, P209, DOI 10.1016/j.msec.2003.09.009
   Baghdoyan S, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh074
   Bailey SN, 2002, DRUG DISCOV TODAY, V7, pS113, DOI 10.1016/S1359-6446(02)02386-3
   Bailey SN, 2006, NAT METHODS, V3, P117, DOI 10.1038/NMETH848
   Carre A, 2003, J COLLOID INTERF SCI, V260, P49, DOI 10.1016/S0021-9797(02)00147-9
   Chang FH, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh029
   Conrad C, 2004, GENOME RES, V14, P1130, DOI 10.1101/gr.2383804
   Delehanty JB, 2004, ANAL CHEM, V76, P7323, DOI 10.1021/ac049259g
   Delehanty JB, 2004, BIOSENS BIOELECTRON, V20, P773, DOI 10.1016/j.bios.2004.04.016
   Dufva M, 2005, BIOMOL ENG, V22, P173, DOI 10.1016/j.bioeng.2005.09.003
   Erfle H, 2004, BIOTECHNIQUES, V37, P454, DOI 10.2144/04373RT01
   Falconnet D, 2006, BIOMATERIALS, V27, P3044, DOI 10.1016/j.biomaterials.2005.12.024
   Falconnet D, 2004, ADV FUNCT MATER, V14, P749, DOI 10.1002/adfm.200305182
   FODOR SPA, 1991, SCIENCE, V251, P767, DOI 10.1126/science.1990438
   Forster T, 2003, J ENDOCRINOL, V178, P195, DOI 10.1677/joe.0.1780195
   Fujita M, 2002, ULTRAMICROSCOPY, V91, P281, DOI 10.1016/S0304-3991(02)00110-9
   Gutmann O, 2004, BIOMED MICRODEVICES, V6, P131, DOI 10.1023/B:BMMD.0000031750.37323.dd
   Heller MJ, 2002, ANNU REV BIOMED ENG, V4, P129, DOI 10.1146/annurev.bioeng.4.020702.153438
   Heller MJ, 2000, ELECTROPHORESIS, V21, P157, DOI 10.1002/(SICI)1522-2683(20000101)21:1<157::AID-ELPS157>3.0.CO;2-E
   HOOK AL, 2005, BIOSENS BIOELECTRON, V21, P2137
   Hu YH, 2005, BIOCHEM SOC T, V33, P1407, DOI 10.1042/BST0331407
   Huang Y, 2002, ANAL CHEM, V74, P3362, DOI 10.1021/ac011273v
   Hyun J, 2001, LANGMUIR, V17, P6358, DOI 10.1021/la010695x
   Kasemo B, 2002, SURF SCI, V500, P656, DOI 10.1016/S0039-6028(01)01809-X
   Kato K, 2004, BIOTECHNIQUES, V37, P444, DOI 10.2144/04373RR02
   Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9
   Koh WG, 2003, ANAL CHEM, V75, P5783, DOI 10.1021/ac034773s
   Kopatz I, 2004, J GENE MED, V6, P769, DOI 10.1002/jgm.558
   Kulkarni GV, 2000, ARCH ORAL BIOL, V45, P475, DOI 10.1016/S0003-9969(00)00010-8
   Kumar G, 2003, LANGMUIR, V19, P10550, DOI 10.1021/la035309l
   Kumar R, 2003, GENOME RES, V13, P2333, DOI 10.1101/gr.1575003
   Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202
   Levicky R, 2005, TRENDS BIOTECHNOL, V23, P143, DOI 10.1016/j.tibtech.2005.01.004
   McFarland CD, 2000, J BIOMED MATER RES, V49, P200, DOI 10.1002/(SICI)1097-4636(200002)49:2<200::AID-JBM7>3.3.CO;2-C
   Melzak KA, 1996, J COLLOID INTERF SCI, V181, P635, DOI 10.1006/jcis.1996.0421
   Messai I, 2003, COLLOID SURFACE B, V32, P293, DOI 10.1016/S0927-7765(03)00182-6
   Mishina YM, 2004, J BIOMOL SCREEN, V9, P196, DOI 10.1177/1087057103261880
   Mousses S, 2003, GENOME RES, V13, P2341, DOI 10.1101/gr.1478703
   Mousses S, 2002, CURR OPIN CHEM BIOL, V6, P97, DOI 10.1016/S1367-5931(01)00283-6
   Otsuka H, 2004, CHEMBIOCHEM, V5, P850, DOI 10.1002/cbic.200300822
   Patel N, 1998, FASEB J, V12, P1447
   Redmond TM, 2004, MOL CELL PROTEOMICS, V3, P770, DOI 10.1074/mcp.M400018-MCP200
   Reimer U, 2002, CURR OPIN BIOTECH, V13, P315, DOI 10.1016/S0958-1669(02)00339-7
   Safinya CR, 2001, CURR OPIN STRUC BIOL, V11, P440, DOI 10.1016/S0959-440X(00)00230-X
   Scheideler L, 2003, MAT SCI ENG C-BIO S, V23, P455, DOI 10.1016/S0928-4931(02)00321-1
   Segura T, 2002, BIOCONJUGATE CHEM, V13, P621, DOI 10.1021/bc015575f
   Silva JM, 2004, P NATL ACAD SCI USA, V101, P6548, DOI 10.1073/pnas.0400165101
   SINGHVI R, 1994, BIOTECHNOL BIOENG, V43, P764, DOI 10.1002/bit.260430811
   Szili E, 2004, BIOSENS BIOELECTRON, V19, P1395, DOI 10.1016/j.bios.2003.12.019
   Templin MF, 2002, TRENDS BIOTECHNOL, V20, P160, DOI 10.1016/S0167-7799(01)01910-2
   Thissen H, 2002, SMART MATER STRUCT, V11, P792, DOI 10.1088/0964-1726/11/5/326
   Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996
   Uchimura E, 2005, NEUROSCI LETT, V378, P40, DOI 10.1016/j.neulet.2004.12.018
   Vanhecke D, 2004, ONCOGENE, V23, P8353, DOI 10.1038/sj.onc.1208027
   Walboomers XF, 1998, BIOMATERIALS, V19, P1861, DOI 10.1016/S0142-9612(98)00093-3
   Wang J, 1999, ELECTROCHEM COMMUN, V1, P197, DOI 10.1016/S1388-2481(99)00044-2
   Wang J, 2000, BIOELECTROCHEMISTRY, V52, P111, DOI 10.1016/S0302-4598(00)00081-7
   WANG J, 2000, ELECTROANAL, V13, P635
   Webb BL, 2003, J BIOMOL SCREEN, V8, P620, DOI 10.1177/1087057103259324
   Wheeler DB, 2005, NAT GENET, V37, pS25, DOI 10.1038/ng1560
   Wheeler DB, 2004, NAT METHODS, V1, P127, DOI 10.1038/NMETH711
   Wu RZ, 2002, TRENDS CELL BIOL, V12, P485, DOI 10.1016/S0962-8924(02)02354-1
   Xu CW, 2002, GENOME RES, V12, P482, DOI 10.1101/gr.213002
   Yamamura S, 2005, ANAL CHEM, V77, P8050, DOI 10.1021/ac051632
   Yamato M, 2002, BIOMATERIALS, V23, P561, DOI 10.1016/S0142-9612(01)00138-7
   Yamato M, 2001, J BIOMED MATER RES, V55, P137, DOI 10.1002/1097-4636(200104)55:1<137::AID-JBM180>3.0.CO;2-L
   Yamauchi F, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh176
   Yamauchi F, 2004, BBA-GEN SUBJECTS, V1672, P138, DOI 10.1016/j.bbagen.2004.03.008
   Yoshikawa T, 2004, J CONTROL RELEASE, V96, P227, DOI 10.1016/j.jconrel.2004.01.024
   Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9
   Zhao YD, 1999, ANAL CHIM ACTA, V388, P93, DOI 10.1016/S0003-2670(99)00065-3
   Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114
NR 73
TC 64
Z9 65
U1 0
U2 16
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0167-7799
J9 TRENDS BIOTECHNOL
JI Trends Biotechnol.
PD OCT
PY 2006
VL 24
IS 10
BP 471
EP 477
DI 10.1016/j.tibtech.2006.08.001
PG 7
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 094QZ
UT WOS:000241255400007
PM 16919345
DA 2018-10-19
ER

PT J
AU Elias, LM
   Schneider, SG
   Schneider, S
   Silva, HM
   Malvisi, E
AF Elias, L. M.
   Schneider, S. G.
   Schneider, S.
   Silva, H. M.
   Malvisi, E.
TI Microstructural and mechanical characterization of biomedical
   Ti-Nb-Zr(-Ta) alloys
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE biomaterial; Ti-Nb-Zr(-Ta) alloys; mechanical properties
ID TI-TA ALLOYS; TITANIUM-ALLOYS; BEHAVIOR; ELEMENTS
AB In recent years there has been a significant development of novel implant alloys based on beta-Ti such as Ti-Nb-Zr and Ti-Nb-Zr-Ta alloys systems. The purpose of this work is to provide characterization of Ti-35.3Nb-5.1Ta-7.1Zr and Ti-41.lNb-7.1Zr alloys, in which Nb will substitute the atomic amount of Ta, with emphasis in the property-microstructure-composition relationships. These alloys are produced from commercially pure materials (Ti, Nb, Zr and Ta) by an arc melting method. All ingots were submitted to sequences of heat treatment (1000 degrees C/2 h - WQ), cold working by swaging procedures and other heat treatment (1000 degrees C/2 h - WQ). Specimens, in as cast and heat-treated condition, were examined by light and scanning electron microscopy (SEM). These results suggested the presence of beta- and omega-phases. Mechanical properties were based on tensile and hardness tests. These alloys exhibit a lower modulus than that of conventional Ti alloys and the other mechanical properties are suitable for biomedical applications. (c) 2006 Elsevier B.V. All rights reserved.
C1 FAENQUIL DEMAR, Fac Engn Quim, BR-12600970 Lorena, SP, Brazil.
   ITA, BR-12228904 Sao Jose Dos Campos, Brazil.
RP Schneider, SG (reprint author), FAENQUIL DEMAR, Fac Engn Quim, Gleba A1-6,CP 116, BR-12600970 Lorena, SP, Brazil.
EM sandra@demar.faenquil.br
RI Schneider, Sandra/E-6087-2015
CR Geetha M, 2004, CORROS SCI, V46, P877, DOI 10.1016/S0010-938X(03)00186-0
   Gordin DM, 2005, MATER LETT, V59, P2936, DOI 10.1016/j.matlet.2004.09.063
   Hill B. N., 1944, 927 NACA
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   Niinomi M, 1998, MAT SCI ENG A-STRUCT, V243, P231, DOI 10.1016/S0921-5093(97)00806-X
   OKAZAKI Y, 1993, MATER T JIM, V34, P1217, DOI 10.2320/matertrans1989.34.1217
   Rasmussen KJR, 2003, J CONSTR STEEL RES, V59, P47, DOI 10.1016/S0143-974X(02)00018-4
   Schneider Sergio, 2005, Mat. Res., V8, P435, DOI 10.1590/S1516-14392005000400013
   Tang X, 2000, J MATER SCI, V35, P1805, DOI 10.1023/A:1004792922155
   van den Berg GJ, 2000, J CONSTR STEEL RES, V54, P135, DOI 10.1016/S0143-974X(99)00053-X
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V384, P92, DOI 10.1016/j.msea.2004.05.084
   Zhou YL, 2004, MAT SCI ENG A-STRUCT, V371, P283, DOI 10.1016/j.msea.2003.12.011
NR 12
TC 97
Z9 102
U1 0
U2 40
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD SEP 25
PY 2006
VL 432
IS 1-2
BP 108
EP 112
DI 10.1016/j.msea.2006.06.013
PG 5
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 087CV
UT WOS:000240721000015
DA 2018-10-19
ER

PT J
AU Park, D
   Park, JM
   Yun, YS
AF Park, Donghee
   Park, Jong Moon
   Yun, Yeoung-Sang
TI Mechanisms of the removal of hexavalent chromium by biomaterials or
   biomaterial-based activated carbons
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Letter
DE hexavalent chromium; biosorption; reduction; biomaterial; activated
   carbon
ID LENTINUS-SAJOR-CAJU; DEAD FUNGAL BIOMASS; AQUEOUS-SOLUTIONS;
   AEROMONAS-CAVIAE; TREATED BIOMASS; CR(VI) REMOVAL; BROWN SEAWEED;
   ECKLONIA SP; BIOSORPTION; ADSORPTION
AB Three papers published during recent 2 years in Journal of Hazardous Materials made a mistake in analyzing chromium species in aqueous solution, resulting in incorrect elucidation of Cr(VI) biosorption; the Cr(VI) was removed from aqueous solution systems by 'anionic adsorption'. However, it has been proved that Cr(VI) is easily reduced to Cr(Ill) by contact with organic materials under acidic conditions because of its high redox potential value (above +1.3 V at standard condition). Therefore, it is strongly possible that the mechanism of Cr(VI) removal by biomaterials or biomaterial-based activated carbons is not "anionic adsorption" but "adsorption-coupled reduction". Thus, for researches of Cr(VI) biosorption, researchers have to analyze not only Cr(VI) but also total Cr in aqueous solution and to check the oxidation state of chromium bound on the biomaterials or activated carbons. (c) 2006 Elsevier B.V. All rights reserved.
C1 Pohang Univ Sci & Technol, Sch Environm Sci & Engn, Adv Environm Biotechnol Res Ctr, Dept Chem Engn, Pohang 790784, South Korea.
   Chonbuk Natl Univ, Ind Technol Res Inst, Div Environm & Chem Engn, Chonju 561756, South Korea.
RP Park, JM (reprint author), Pohang Univ Sci & Technol, Sch Environm Sci & Engn, Adv Environm Biotechnol Res Ctr, Dept Chem Engn, San 31,Hyoja Dong, Pohang 790784, South Korea.
EM jmpark@postech.ac.kr
RI Yun, Yeoung-Sang/F-8340-2011
OI Yun, Yeoung-Sang/0000-0002-2583-8278
CR Acar FN, 2004, BIORESOURCE TECHNOL, V94, P13, DOI [10.1016/j.biortech.2003.10.032, 10.1016/j.biotech.2003.10.032]
   Agarwal GS, 2006, BIORESOURCE TECHNOL, V97, P949, DOI 10.1016/j.biortech.2005.04.030
   Altundogan HS, 2005, PROCESS BIOCHEM, V40, P1443, DOI 10.1016/j.procbio.2004.06.027
   Aoyama M, 2004, SEPAR SCI TECHNOL, V39, P1149, DOI 10.1081/SS-120028576
   Arica MY, 2005, PROCESS BIOCHEM, V40, P2351, DOI 10.1016/j.procbio.2004.09.008
   Arica MY, 2005, COLLOID SURFACE A, V253, P203, DOI 10.1016/j.colsurfa.2004.11.012
   Babel S, 2004, CHEMOSPHERE, V54, P951, DOI 10.1016/j.chemosphere.2003.10.001
   Bajpai J, 2004, COLLOID SURFACE A, V236, P81, DOI 10.1016/j.colsurfa.2004.01.021
   Bayramoglu G, 2005, J HAZARD MATER, V119, P219, DOI 10.1016/j.jhazmat.2004.12.022
   Bingol A, 2004, BIORESOURCE TECHNOL, V94, P245, DOI [10.1016/j.biortech.2004.01.018, 10.1016/j.biotech.2004.01.018]
   Bishnoi NR, 2004, BIORESOURCE TECHNOL, V91, P305, DOI 10.1016/S0960-8524(03)00204-9
   CARMONA MER, 2005, PROCESS BIOCHEM, V40, P3485
   Chun Li, 2004, Process Biochemistry, V39, P541, DOI 10.1016/S0032-9592(03)00087-6
   Dambies L, 2001, COLLOID SURFACE A, V177, P203, DOI 10.1016/S0927-7757(00)00678-6
   Gardea-Torresday JL, 2000, J HAZARD MATER, V80, P175, DOI 10.1016/S0304-3894(00)00301-0
   Garg VK, 2004, BIORESOURCE TECHNOL, V92, P79, DOI 10.1016/j.biortech.2003.07.004
   Karthikeyan T, 2005, J HAZARD MATER, V124, P192, DOI 10.1016/j.hazmat.2005.05.003
   Khezami L, 2005, J HAZARD MATER, V123, P223, DOI 10.1016/j.jhazmat.2005.04.012
   Kobya M, 2004, BIORESOURCE TECHNOL, V91, P317, DOI 10.1016/j.biortech.2003.07.001
   Loukidou MX, 2004, COLLOID SURFACE A, V242, P93, DOI 10.1016/j.colsurfa.2004.03.030
   Loukidou MX, 2004, IND ENG CHEM RES, V43, P1748, DOI 10.1021/ie034132n
   Lytle CM, 1998, ENVIRON SCI TECHNOL, V32, P3087, DOI 10.1021/es980089x
   Marshall WE, 2004, J CHEM TECHNOL BIOT, V79, P1286, DOI 10.1002/jctb.1126
   Melo JS, 2004, BIORESOURCE TECHNOL, V92, P151, DOI 10.1016/j.biortech.2003.08.015
   Mohan D, 2005, IND ENG CHEM RES, V44, P1027, DOI 10.1021/ie0400898
   Mohanty K, 2005, CHEM ENG SCI, V60, P3049, DOI 10.1016/j.ces.2004.12.049
   Nakajima A, 2004, WATER RES, V38, P2859, DOI 10.1016/j.watres.2004.04.005
   Oguz E, 2005, COLLOID SURFACE A, V252, P121, DOI 10.1016/j.colsurfa.2004.10.004
   Oliveira EA, 2005, PROCESS BIOCHEM, V40, P3485, DOI 10.1016/j.procbio.2005.02.026
   Ozdemir G, 2004, CHEM ENG J, V102, P249, DOI 10.1016/j.cej.2004.01.032
   Ozdemir G, 2004, APPL MICROBIOL BIOT, V64, P599, DOI 10.1007/s00253-003-1479-0
   Park D, 2005, J MICROBIOL BIOTECHN, V15, P780
   Park D, 2005, CHEMOSPHERE, V60, P1356, DOI 10.1016/j.chemosphere.2005.02.020
   Park D, 2005, WATER RES, V39, P533, DOI 10.1016/j.watres.2004.11.002
   Park D, 2005, PROCESS BIOCHEM, V40, P2559, DOI 10.1016/j.procbio.2004.12.002
   Park D, 2004, IND ENG CHEM RES, V43, P8226, DOI 10.1021/ie049323k
   Park D, 2004, ENVIRON SCI TECHNOL, V38, P4860, DOI 10.1021/es035329
   Rojas G, 2005, SEP PURIF TECHNOL, V44, P31, DOI 10.1016/j.seppur.2004.11.013
   ROMEROGONZALEZ J, 2005, J CHEM THERMODYN, V37, P347
   Sahin Y, 2005, PROCESS BIOCHEM, V40, P1895, DOI 10.1016/j.procbio.2004.07.002
   Sarin V, 2006, BIORESOURCE TECHNOL, V97, P15, DOI 10.1016/j.biortech.2005.02.010
   Seki H, 2005, J COLLOID INTERF SCI, V281, P261, DOI 10.1016/j.jcis.2004.08.167
   Sumathi KMS, 2005, BIORESOURCE TECHNOL, V96, P309, DOI 10.1016/j.biortech.2004.04.015
   Tewari N, 2005, BIOCHEM ENG J, V23, P185, DOI 10.1016/j.bej.2005.01.011
   Tunali S, 2005, MINER ENG, V18, P681, DOI 10.1016/j.mineng.2004.11.002
   Unnithan MR, 2004, IND ENG CHEM RES, V43, P2247, DOI 10.1021/ie0302084
   Zouboulis AI, 2004, PROCESS BIOCHEM, V39, P909, DOI 10.1016/S0032-9592(03)00200-0
NR 47
TC 57
Z9 64
U1 1
U2 43
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD SEP 21
PY 2006
VL 137
IS 2
BP 1254
EP 1257
DI 10.1016/j.jhazmat.2006.04.007
PG 4
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 092YZ
UT WOS:000241135200073
PM 16713082
DA 2018-10-19
ER

PT J
AU Weisser, JT
   Nilges, MJ
   Sever, MJ
   Wilker, JJ
AF Weisser, Jaime T.
   Nilges, Mark J.
   Sever, Mary J.
   Wilker, Jonathan J.
TI EPR investigation and spectral simulations of iron-catecholate complexes
   and iron-peptide models of marine adhesive cross-links
SO INORGANIC CHEMISTRY
LA English
DT Article
ID ELECTRON-PARAMAGNETIC-RESONANCE; TRANSITION-METAL COMPLEXES; AQUEOUS
   ACID SOLUTION; MYTILUS-EDULIS; COORDINATION CHEMISTRY; SPIN-RESONANCE;
   PROTOCATECHUATE 3,4-DIOXYGENASE; SOYBEAN LIPOXYGENASE-1; TRANSPORT
   COMPOUNDS; FUNCTIONAL MODELS
AB Electron paramagnetic resonance (EPR) spectra are presented for iron complexes of catecholate, tironate, and a 3,4-dihydroxyphenylalanine (DOPA)-containing peptide of sequence Ac-Ala-DOPA-Thr-Pro-CONH2 ("AdopaTP"). This peptide was prepared to model potential metal - protein cross-links in the adhesive used by marine mussels, Mytilus edulis, for affixing themselves to surfaces. Spectra are shown for iron bound to each ligand in mono, bis, and tris coordination environments. For example, the catecholate complexes {Fe(cat)}, {Fe(cat)(2)}, and [Fe(cat)(3)](3-) are provided. Detailed simulations are presented to describe the origin of spectra for the iron - catecholate and iron - peptide species, which show that the spectral features can be accounted for only with the inclusion of D- and E-strain. The spectroscopy of each compound is shown under both anaerobic and aerobic conditions. When exposed to air, the high-spin Fe3+ signal of [Fe(AdopaTP)(3)](3-) decreases and an organic radical is formed. No other sample exhibited an appreciable radical signal. These data are discussed in light of the biomaterial synthesis carried out by marine mussels.
C1 Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.
   Illinois EPR Res Ctr, Urbana, IL 61801 USA.
RP Nilges, MJ (reprint author), Purdue Univ, Dept Chem, 560 0val Dr, W Lafayette, IN 47907 USA.
EM wilker@purdue.edu
CR AASA R, 1970, J CHEM PHYS, V52, P3919, DOI 10.1063/1.1673591
   AVDEEF A, 1978, J AM CHEM SOC, V100, P5362, DOI 10.1021/ja00485a018
   BERGER R, 1995, J NON-CRYST SOLIDS, V180, P151, DOI 10.1016/0022-3093(94)00480-3
   Biaso F, 2005, EUR J INORG CHEM, P467, DOI 10.1002/ejic.200400414
   CHEN CH, 2002, J CHEM SOC DA
   COLLISON D, 1990, INORG CHEM, V29, P4735, DOI 10.1021/ic00348a030
   COOMBS TL, 1981, AQUAT TOXICOL, V1, P291, DOI 10.1016/0166-445X(81)90023-0
   COX DD, 1988, J AM CHEM SOC, V110, P8085, DOI 10.1021/ja00232a021
   COX DD, 1988, J AM CHEM SOC, V110, P2026, DOI 10.1021/ja00215a002
   Deming TJ, 1999, CURR OPIN CHEM BIOL, V3, P100, DOI 10.1016/S1367-5931(99)80018-0
   DONAT JR, 1997, TRACE ELEMENTS NATUR, P247
   FELIX AM, 1974, J MED CHEM, V17, P422, DOI 10.1021/jm00250a011
   FELIX CC, 1981, J AM CHEM SOC, V103, P2831, DOI 10.1021/ja00400a056
   Frank BP, 2002, BIOTECHNOL PROGR, V18, P580, DOI 10.1021/bp010140s
   GALPIN JR, 1976, FEBS LETT, V69, P179, DOI 10.1016/0014-5793(76)80681-3
   GEORGE SG, 1976, J EXP MAR BIOL ECOL, V23, P71, DOI 10.1016/0022-0981(76)90086-1
   GOLDING RM, 1978, J PHYS C SOLID STATE, V11, P5041, DOI 10.1088/0022-3719/11/24/032
   HAN S, 1995, SCIENCE, V270, P976, DOI 10.1126/science.270.5238.976
   Herebian D, 2001, J AM CHEM SOC, V123, P10012, DOI 10.1021/ja011155p
   JO DH, 2001, INORG CHEM, V40
   KENT TA, 1987, INORG CHEM, V26, P1402, DOI 10.1021/ic00256a014
   KITA H, 1969, J BIOCHEM-TOKYO, V66, P45, DOI 10.1093/oxfordjournals.jbchem.a129118
   Liu Y, 2004, PIGM CELL RES, V17, P262, DOI 10.1111/j.1600-0749.2004.00140.x
   MAGERS KD, 1980, INORG CHEM, V19, P492, DOI 10.1021/ic50204a042
   MATTSON K, 1991, THESIS U ILLINOIS UR
   MENTASTI E, 1973, J CHEM SOC DALTON, P2609, DOI 10.1039/dt9730002609
   MENTASTI E, 1973, J CHEM SOC DALTON, P2605, DOI 10.1039/dt9730002605
   Merdy P, 2003, NEW J CHEM, V27, P577, DOI 10.1039/b209665j
   Monahan J, 2004, LANGMUIR, V20, P3724, DOI 10.1021/la0362728
   Monahan J, 2003, CHEM COMMUN, P1672, DOI 10.1039/b301052j
   NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723
   NELSON MJ, 1988, BIOCHEMISTRY-US, V27, P4273, DOI 10.1021/bi00412a011
   NILGES MJ, 1998, 40 ROCK MOUNT C AN C
   NILGES MJ, 2002, SIMPIM
   NILGES MJ, 1979, THESIS U ILLINOIS UR
   OHLENDORF DH, 1988, NATURE, V336, P403, DOI 10.1038/336403a0
   PALMER G, 1985, BIOCHEM SOC T, V13, P548, DOI 10.1042/bst0130548
   Palmer G., 2000, PHYS METHODS BIOINOR
   PAPOV VV, 1995, J BIOL CHEM, V270, P20183, DOI 10.1074/jbc.270.34.20183
   PIERPONT CG, 1994, PROG INORG CHEM, V41, P331, DOI 10.1002/9780470166420.ch5
   PIERPONT CG, 1981, COORDIN CHEM REV, V38, P45, DOI 10.1016/S0010-8545(00)80499-3
   POWELL HKJ, 1982, AUST J CHEM, V35, P739, DOI 10.1071/CH9820739
   PULAY P, 1980, CHEM PHYS LETT, V73, P393, DOI 10.1016/0009-2614(80)80396-4
   Qian YH, 2002, CHEMOSPHERE, V48, P21, DOI 10.1016/S0045-6535(02)00044-9
   QUE L, 1987, J AM CHEM SOC, V109, P5373, DOI 10.1021/ja00252a012
   QUE L, 1987, J AM CHEM SOC, V109, P5381, DOI 10.1021/ja00252a013
   Rahimi-Moghaddam P, 2003, APPL MAGN RESON, V24, P113, DOI 10.1007/BF03166683
   RAYMOND KN, 1984, TOP CURR CHEM, V123, P49
   Rzepecki L.M., 1991, Bioorganic Marine Chemistry, V4, P119
   Rzepecki L. M., 1991, Molecular Marine Biology and Biotechnology, V1, P78
   SAKURAI H, 1988, INORG CHEM, V27, P3877
   Sever M. J., 2006, J DALTON T, P813
   Sever MJ, 2004, ANGEW CHEM INT EDIT, V43, P448, DOI 10.1002/anie.200352759
   Sever MJ, 2001, TETRAHEDRON, V57, P6139, DOI 10.1016/S0040-4020(01)00601-9
   SEVER MJ, 2001, J DALTON T, P1061
   Simaan AJ, 2001, INORG CHEM, V40, P6538, DOI 10.1021/ic010635e
   SLAPPENDEL S, 1981, BIOCHIM BIOPHYS ACTA, V667, P77, DOI 10.1016/0005-2795(81)90068-4
   Smith JJ, 1997, EUR J BIOCHEM, V244, P325, DOI 10.1111/j.1432-1033.1997.00325.x
   Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875
   TAYLOR SW, 1994, INORG CHEM, V33, P5819, DOI 10.1021/ic00103a032
   TAYLOR SW, 1994, J AM CHEM SOC, V116, P10803, DOI 10.1021/ja00102a063
   Taylor SW, 1996, INORG CHEM, V35, P7572, DOI 10.1021/ic960514s
   TAYLOR SW, 1995, INORG CHEM, V35, P1487
   Vaillancourt FH, 2002, J AM CHEM SOC, V124, P2485, DOI 10.1021/ja0174682
   Vetting MW, 2000, BIOCHEMISTRY-US, V39, P7943, DOI 10.1021/bi000151e
   Vreeland V, 1998, J PHYCOL, V34, P1, DOI 10.1046/j.1529-8817.1998.340001.x
   WAITE JH, 1990, INT J BIOL MACROMOL, V12, P139, DOI 10.1016/0141-8130(90)90065-I
   WAITE JH, 1990, COMP BIOCHEM PHYS B, V97, P19, DOI 10.1016/0305-0491(90)90172-P
   Waite JH, 2005, J ADHESION, V81, P297, DOI 10.1080/00218460590944602
   Warner SC, 1999, MAR BIOL, V134, P729, DOI 10.1007/s002270050589
   WICKMAN HH, 1965, J CHEM PHYS, V42, P2113, DOI 10.1063/1.1696253
   YAHIAOUI EM, 1994, J PHYS-CONDENS MAT, V6, P9415, DOI 10.1088/0953-8984/6/44/020
   ZECCA L, 1994, J NEUROCHEM, V62, P1097
   Zhilinskaya EA, 2003, LANGMUIR, V19, P3596, DOI 10.1021/la026137f
NR 74
TC 38
Z9 38
U1 2
U2 35
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0020-1669
J9 INORG CHEM
JI Inorg. Chem.
PD SEP 18
PY 2006
VL 45
IS 19
BP 7736
EP 7747
DI 10.1021/ic060685p
PG 12
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA 082QY
UT WOS:000240403500031
PM 16961365
DA 2018-10-19
ER

PT J
AU Shan, B
   Yan, H
   Shen, J
   Lin, SC
AF Shan, Bing
   Yan, Han
   Shen, Jian
   Lin, Sicong
TI Ozone-induced grafting of a sulfoammonium zwitterionic polymer onto
   low-density polyethylene film for improving hemocompatibility
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE adhesion; polyethylene (PE); film
ID SURFACE MODIFICATION; PLATELET-ADHESION; COPOLYMERIZATION; DISCHARGE;
   MONOMER; ACID
AB Ozone-induced grafting was developed to improve the hemocompatibility of biomaterials based on low-density polyethylene (LDPE). An LDPE film was activated with ozone and graft-polymerized with N,N'-dimethyl(methacryloylethyl)ammonium propane sulfonate (DMAPS). The existence of sulfobetaine structures on the grafted film was confirmed by X-ray photoelectron spectroscopy and attenuated total reflection/Fourier transform infrared (ATR-FTIR). More DMAPS was grafted onto the LDPE film as the DMAPS concentration increased, as determined by ATR-FTIR. Static contact-angle measurements indicated that the DMAPS-grafted LDPE film had a significant increase in hydrophilicity. The blood compatibility of the grafted film was preliminarily evaluated with a platelet-rich-plasma (PRP) adhesion study. No platelet adhesion was observed on the grafted film incubated with PRP at 37 degrees C for 180 min. This new sulfoammonium zwitterionic-structure-grafted biomaterial might have potential for biomedical applications. (c) 2006 Wiley Periodicals, Inc.
C1 Nanjing Univ, Ctr Res Surface & Interface Chem Engn & Technol, Nanjing 210093, Peoples R China.
RP Lin, SC (reprint author), Nanjing Univ, Ctr Res Surface & Interface Chem Engn & Technol, Nanjing 210093, Peoples R China.
EM sicong_lin@yahoo.com
RI Shan, Bing/G-5460-2011
CR Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043
   FUJIMOTO K, 1993, J POLYM SCI POL CHEM, V31, P1035, DOI 10.1002/pola.1993.080310426
   GRASEL TG, 1989, J BIOMED MATER RES, V23, P311, DOI 10.1002/jbm.820230304
   KOKATMUR VK, 1943, J AM CHEM SOC, V63, P1432
   Lee JH, 2000, BIOMATERIALS, V21, P683, DOI 10.1016/S0142-9612(99)00197-0
   Lei JX, 2001, ACTA CHIM SINICA, V59, P685
   Lin JC, 2000, J BIOMAT SCI-POLYM E, V11, P701, DOI 10.1163/156856200743968
   Lin S.C., 1997, POLYM B, V1, P1
   LIN SC, 1997, POLYM B, V2, P76
   Lin SC, 1998, POLYM B, V1, P1
   OKKEMA AZ, 1991, J BIOMED MATER RES, V25, P1371, DOI 10.1002/jbm.820251106
   ONEILL T, 1972, J POLYM SCI A1, V10, P569, DOI 10.1002/pol.1972.150100221
   Shi JL, 1998, EUR POLYM J, V34, P1429, DOI 10.1016/S0014-3057(97)00283-8
   SUZUKI M, 1986, MACROMOLECULES, V19, P1804, DOI 10.1021/ma00161a005
   THOMPSON AR, 1983, MANUAL HEMOSTASIS TH
   vanderHeiden AP, 1997, J BIOMED MATER RES, V37, P282, DOI 10.1002/(SICI)1097-4636(199711)37:2<282::AID-JBM19>3.0.CO;2-G
   WANG CH, 1997, ACTA POLYM SIN, V1, P114
   Wang P, 2000, J BIOMAT SCI-POLYM E, V11, P169, DOI 10.1163/156856200743634
   Yuan YL, 2002, J BIOMAT SCI-POLYM E, V13, P1081, DOI 10.1163/156856202320813800
   Zhang J, 2003, COLLOID SURFACE B, V28, P1
   Zhou J, 2002, CHEM J CHINESE U, V23, P2393
NR 21
TC 19
Z9 22
U1 1
U2 13
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD SEP 15
PY 2006
VL 101
IS 6
BP 3697
EP 3703
DI 10.1002/app.20860
PG 7
WC Polymer Science
SC Polymer Science
GA 069KQ
UT WOS:000239445500017
DA 2018-10-19
ER

PT J
AU Spiteri, CG
   Pilliar, RM
   Kandel, RA
AF Spiteri, C. G.
   Pilliar, R. M.
   Kandel, R. A.
TI Substrate porosity enhances chondrocyte attachment, spreading, and
   cartilage tissue formation in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cartilage tissue engineering; cell adhesion; cell morphology; titanium
   alloy; substrate porosity
ID BOVINE ARTICULAR CHONDROCYTES; CELL-ADHESION; PORE-SIZE; SURFACES;
   PROLIFERATION; TRANSPORT; REPAIR; ACID
AB Tissue engineering is being explored as a new approach to treat damaged cartilage. As the biomaterial used may influence tissue formation, the effects of substrate geometry on chondrocyte behavior in vitro were examined. Articular chondrocytes were isolated and cultured on the surface of smooth, rough, porous-coated, and fully porous Ti-6Al-4V substrates. The percentage of chondrocytes that attached to each substrate at 24 h was determined. After 24 and 72 h, chondrocytes were visualized by scanning electron microscopy and cell areas were measured. Collagen and proteoglycan accumulation within the first 24 h was determined by incorporation with [H-3]-proline and [S-35]-SO4, respectively. Chondrocyte attachment as well as matrix accumulation was enhanced as substrate surface area increased. Cell areas on the fully porous substrate were over four times greater than on any other substrate by 72 h in culture. After 8 weeks in culture, a continuous layer of cartilaginous tissue formed only on the surface of the fully porous substrate. This suggests that fully porous Ti-6Al-4V substrates provide the conditions that favor cartilage tissue formation by influencing cell attachment and extent of cell spreading. Understanding how substrate porosity influences chondrocyte behavior may help identify methods to further enhance cartilage tissue formation in vitro. (c) 2006 Wiley Periodicals, Inc.
C1 Mt Sinai Hosp, Bioengn Skeletal Tissues Team, Toronto, ON M5G 1X5, Canada.
   Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
RP Kandel, RA (reprint author), Mt Sinai Hosp, Bioengn Skeletal Tissues Team, 600 Univ Ave,Suite 600-9, Toronto, ON M5G 1X5, Canada.
EM rkandel@mtsinai.on.ca
RI Kandel, Rita/E-2149-2017
OI Kandel, Rita/0000-0003-4047-3913
CR BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Bhardwaj T, 2001, J BIOMED MATER RES, V57, P190, DOI 10.1002/1097-4636(200111)57:2<190::AID-JBM1158>3.0.CO;2-J
   BOYLE J, 1995, OSTEOARTHR CARTILAGE, V3, P117, DOI 10.1016/S1063-4584(05)80044-5
   BROWN PD, 1988, J CELL BIOL, V106, P171, DOI 10.1083/jcb.106.1.171
   Formby B, 2003, BIOCHEM BIOPH RES CO, V305, P203, DOI 10.1016/S0006-291X(03)00723-X
   Genes NG, 2004, ARCH BIOCHEM BIOPHYS, V422, P161, DOI 10.1016/j.abb.2003.11.023
   Huan W, 2003, J ORTHOPAED RES, V21, P88, DOI 10.1016/S0736-0266(02)00130-4
   Hunziker EB, 1999, OSTEOARTHR CARTILAGE, V7, P15, DOI 10.1053/joca.1998.0159
   Hunziker EB, 2002, OSTEOARTHR CARTILAGE, V10, P432, DOI 10.1053/joca.2002.0801
   Ishaug-Riley SL, 1999, BIOMATERIALS, V20, P2245, DOI 10.1016/S0142-9612(99)00155-6
   Jayaraman M, 2004, BIOMATERIALS, V25, P625, DOI 10.1016/S0142-9612(03)00571-4
   KIM YJ, 1988, ANAL BIOCHEM, V174, P168, DOI 10.1016/0003-2697(88)90532-5
   Kinner B, 2005, ADV BIOCHEM ENG BIOT, V94, P91, DOI 10.1007/b100001
   Lauer G, 2001, BIOMATERIALS, V22, P2799, DOI 10.1016/S0142-9612(01)00024-2
   Lee SJ, 2004, J APPL POLYM SCI, V92, P2784, DOI 10.1002/app.20281
   Loeser RF, 2002, BIORHEOLOGY, V39, P119
   Mankin HJ, 1994, ORTHOPAEDIC BASIC SC, P1
   Meredith D, 2002, CELL PHYSIOL BIOCHEM, V12, P227, DOI 10.1159/000066282
   Nehrer S, 1997, BIOMATERIALS, V18, P769, DOI 10.1016/S0142-9612(97)00001-X
   NEWMAN P, 1988, EXP CELL RES, V178, P199, DOI 10.1016/0014-4827(88)90391-6
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   OTTE P, 1991, Z RHEUMATOL, V50, P304
   PILLIAR RM, 1987, J BIOMED MATER RES-A, V21, P1
   Redman S N, 2005, Eur Cell Mater, V9, P23
   Schwartz Z, 1996, J BIOMED MATER RES, V30, P145
   Vunjak-Novakovic Gordana, 2003, Novartis Found Symp, V249, P34
   Waldman SD, 2002, J BIOMED MATER RES, V62, P323, DOI 10.1002/jbm.10235
   Wang HJ, 2004, OSTEOARTHR CARTILAGE, V12, P56, DOI 10.1016/j.joca.2003.08.007
   Windhaber RAJ, 2003, PFLUG ARCH EUR J PHY, V446, P572, DOI 10.1007/s00424-003-1080-5
   Wyre R. M., 2002, Biomaterials, V23, P357, DOI 10.1016/S0142-9612(01)00113-2
   Zhan M, 2004, HISTOL HISTOPATHOL, V19, P973, DOI 10.14670/HH-19.973
NR 31
TC 41
Z9 41
U1 0
U2 4
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2006
VL 78A
IS 4
BP 676
EP 683
DI 10.1002/jbm.a.30746
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 076BU
UT WOS:000239932800004
PM 16739175
DA 2018-10-19
ER

PT J
AU Wang, XF
   Ohlin, CA
   Lu, QH
   Hu, J
AF Wang, Xuefeng
   Ohlin, C. Andre
   Lu, Qinghua
   Hu, Jun
TI Influence of physicochemical properties of laser-modified polystyrene on
   bovine serum albumin adsorption and rat C6 glioma cell behavior
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE cell alignment; laser; nanostructures; polystyrene; rat C6 glioma cells
ID PLASMA TREATMENT; SOLID-SURFACES; IN-VITRO; NANOTOPOGRAPHY; FEATURES;
   PROLIFERATION; BIOTECHNOLOGY; LAMELLIPODIA; MORPHOLOGY; FILOPODIA
AB Biomaterial surface modification is an efficient way of improving cell-material interactions. In this study, sub-micrometer laser-induced periodic surface structures (LIPSS) were produced on polystyrene by laser irradiation. FT-IR analysis confirmed that this treatment also led to surface oxidation and anisotropic orientation of the produced carbonyl groups. As a consequence, the surface energy of the laser-treated polystyrene was 1.45 times that of the untreated polystyrene, as measured by contact-angle goniometry. Protein adsorption and rat C6 glioma cell behavior on the two substrates were investigated, showing that the changed physicochemical properties of laser-modified polystyrene surface led to an increase in the quantity of adsorbed bovine serum albumin and significantly affected the behavior of rat C6 glioma cells. In the early stages of cell spreading, cells explored their microenvironment using filopodium as the main sensor. Moreover, cells actively aligned themselves along the direction of LIPSS gradually and cell attachment and proliferation were significantly enhanced. (c) 2006 Wiley Periodicals, Inc.
C1 Shanghai Jiao Tong Univ, Sch Chem & Chem Technol, Shanghai 200240, Peoples R China.
   Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai 200240, Peoples R China.
RP Lu, QH (reprint author), Shanghai Jiao Tong Univ, Sch Chem & Chem Technol, Shanghai 200240, Peoples R China.
EM qhlu@sjtu.edu.cn
RI Ohlin, C. Andre/B-3567-2008; wang, xuefeng/J-2365-2014; wang,
   xuefeng/D-4319-2013
OI Ohlin, C. Andre/0000-0002-3804-6421; 
CR Andersson AS, 2003, BIOMATERIALS, V24, P3427, DOI 10.1016/S0142-9612(03)00208-4
   BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311
   BUSSCHER HJ, 1984, COLLOID SURFACE, V9, P319, DOI 10.1016/0166-6622(84)80175-4
   CLARK P, 1990, DEVELOPMENT, V108, P635
   Clark P, 2002, INT J BIOCHEM CELL B, V34, P816, DOI 10.1016/S1357-2725(01)00180-7
   Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5
   Curtis ASG, 2004, IEEE T NANOBIOSCI, V3, P61, DOI 10.1109/TNB.2004.824276
   Cyster LA, 2004, BIOMATERIALS, V25, P97, DOI 10.1016/S0142-9612(03)00480-0
   Dalby MJ, 2004, CELL BIOL INT, V28, P229, DOI 10.1016/j.cellbi.2003.12.004
   Dalby MJ, 2003, J BIOMED MATER RES A, V67A, P1025, DOI 10.1002/jbm.a.10139
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   FENG B, 2003, MATER CHARACT, V49, P129, DOI DOI 10.1016/S1044-5803(02)00341-8
   Gray JJ, 2004, CURR OPIN STRUC BIOL, V14, P110, DOI 10.1016/j.sbi.2003.12.001
   Hao L, 2005, J BIOMED MATER RES B, V73B, P148, DOI 10.1002/jbm.b.30194
   JACKMAN RJ, 1995, SCIENCE, V269, P664, DOI 10.1126/science.7624795
   KAELBLE DH, 1970, J ADHESION, V2, P66, DOI 10.1080/0021846708544582
   KIM KH, 2001, NUCL INSTRUM METH B, V177, P542
   Lenhert S, 2005, BIOMATERIALS, V26, P563, DOI 10.1016/j.biomaterials.2004.02.068
   Lopez-Gejo J, 2005, PHOTOCHEM PHOTOBIOL, V81, P777, DOI 10.1562/2004-11-30-RA-387R.1
   Mackay DJG, 1998, J BIOL CHEM, V273, P20685, DOI 10.1074/jbc.273.33.20685
   Morra M, 2002, PLASMAS POLYM, V7, P89, DOI 10.1023/A:1016250718123
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4
   OWENS DK, 1969, J APPL POLYM SCI, V13, P1741, DOI 10.1002/app.1969.070130815
   Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com
   Puskas JE, 2004, BIOMACROMOLECULES, V5, P1412, DOI 10.1021/bm034497r
   Rabel W., 1977, Physikalische Blaetter, V33, P151
   Redey SA, 2000, J BIOMED MATER RES, V50, P353, DOI 10.1002/(SICI)1097-4636(20000605)50:3<353::AID-JBM9>3.0.CO;2-C
   Schindler M, 2005, BIOMATERIALS, V26, P5624, DOI 10.1016/j.biomaterials.2005.02.014
   Sgarbi N, 2004, BIOMATERIALS, V25, P1349, DOI 10.1016/j.biomaterials.2003.08.017
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Thom VH, 2000, LANGMUIR, V16, P2756, DOI 10.1021/la990303a
   Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024
   Yang J, 2002, POLYM ADVAN TECHNOL, V13, P220, DOI 10.1002/pat.177
   Yim EKF, 2005, BIOMATERIALS, V26, P5405, DOI 10.1016/j.biomaterials.2005.01.058
   Yoon JY, 1999, COLLOID SURFACE A, V153, P413, DOI 10.1016/S0927-7757(98)00533-0
NR 36
TC 10
Z9 11
U1 1
U2 4
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2006
VL 78A
IS 4
BP 746
EP 754
DI 10.1002/jbm.a.30764
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 076BU
UT WOS:000239932800012
PM 16739177
DA 2018-10-19
ER

PT J
AU MacKintosh, EE
   Patel, JD
   Marchant, RE
   Anderson, JM
AF MacKintosh, Erin E.
   Patel, Jasmine D.
   Marchant, Roger E.
   Anderson, James M.
TI Effects of biomaterial surface chemistry on the adhesion and biofilm
   formation of Staphylococcus epidermidis in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE infection; biomaterials; biofilm; S. epidermidis; adhesion
ID BACTERIAL; BINDING; FIBRONECTIN; INFECTIONS; PROTEIN; POLYETHYLENE;
   ADSORPTION; EXPRESSION; CLUSTERIN; POLYMERS
AB The formation of biofilm, a structured community of bacteria enclosed in slime, is a significant virulence factor in medical-device-centered infection. The development of cardiovascular device infection can be separated into two phases: initial bacterial adhesion and aggregation, followed by proliferation and production of slime. It is possible to modulate the adhesion and biofilm formation of Staphylococcus epidermidis, a commensal skin bacterium commonly found on infected medical devices, through biomaterial surface chemistry. This study examines bacterial adhesion and biofilm formation on surface-modified polyethylene terephthalate (PET), including surfaces with varying hydrophilic, hydrophobic, and ionic character. Bacterial adhesion and biofilm formation were observed over 48 hours in phosphate-buffered saline (PBS) and 20% pooled human serum. The hydrophilic surface (PAAm) had significantly less non-specific adhesion of bacteria than that in the control (PET) and other surfaces, when cultured in PBS (P < 0.0001). Charged surfaces, both anionic and cationic, had increased adhesion and aggregation of bacteria in comparison with the control (PET) in the presence of serum proteins over 24 hours (P < 0.0001). Bacteria cultured in serum on the charged surfaces did not have significantly different amounts of biofilm formation compared with that of the control (PET) surface after 48 hours. This study showed that biomaterial surface chemistry characteristics impact initial adhesion and aggregation of S. epidermidis on biomaterials. (c) 2006 Wiley Periodicals, Inc.
C1 Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
   Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA.
RP Anderson, JM (reprint author), Case Western Reserve Univ, Dept Biomed Engn, Cleveland, OH 44106 USA.
EM jma6@po.cwru.edu
FU NIBIB NIH HHS [EB 00279]; NCI NIH HHS [P30 CA43703]
CR Arciola CR, 2004, BIOMATERIALS, V25, P4825, DOI 10.1016/j.biomaterials.2003.11.056
   Baugh L, 2004, J BIOMED MATER RES A, V69A, P525, DOI 10.1002/jbm.a.30026
   Bergkvist M, 2003, J BIOMED MATER RES A, V64A, P349, DOI 10.1002/jbm.a.10423
   Brodbeck WG, 2002, P NATL ACAD SCI USA, V99, P10287, DOI 10.1073/pnas.162124199
   Brodbeck WG, 2002, CYTOKINE, V18, P311, DOI 10.1006/cyto.2002.1048
   BRODBECK WG, 2003, J BIOMED MATER RES A, V6, P320
   Costerton JW, 1999, INT J ANTIMICROB AG, V11, P217, DOI 10.1016/S0924-8579(99)00018-7
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Garrett Q, 1998, BIOMATERIALS, V19, P2175, DOI 10.1016/S0142-9612(98)00125-2
   Gottenbos B, 2001, J ANTIMICROB CHEMOTH, V48, P7, DOI 10.1093/jac/48.1.7
   HAAS R, 1984, FEBS LETT, V174, P279, DOI 10.1016/0014-5793(84)81173-4
   Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x
   Higashi JM, 1998, J BIOMED MATER RES, V39, P341, DOI 10.1002/(SICI)1097-4636(19980305)39:3<341::AID-JBM1>3.0.CO;2-J
   Kaper HJ, 2003, J BIOMAT SCI-POLYM E, V14, P313, DOI 10.1163/156856203321478847
   Keselowsky BG, 2003, J BIOMED MATER RES A, V66A, P247, DOI 10.1002/jbm.a.10537
   Li DQ, 2001, J MATER SCI-MATER M, V12, P979, DOI 10.1023/A:1012865200458
   Li DQ, 2001, FEMS IMMUNOL MED MIC, V31, P197
   LI DQ, 2001, CURR MICROBIOL, V24, P361
   Ljungh A, 1996, FEMS IMMUNOL MED MIC, V16, P117, DOI 10.1016/S0928-8244(96)00073-9
   Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996
   Nilsson M, 1998, INFECT IMMUN, V66, P2666
   Palmer RR, 2004, BIOMATERIALS, V25, P4785, DOI 10.1016/j.biomaterials.2003.12.034
   Patel JD, 2003, J BIOMAT SCI-POLYM E, V14, P279, DOI 10.1163/156856203763572725
   Piehler J, 1999, COLLOID SURFACE B, V13, P325, DOI 10.1016/S0927-7765(99)00046-6
   Rose SF, 2004, BIOMATERIALS, V25, P5125, DOI 10.1016/j.biomaterials.2003.12.016
   SAPATNEKAR S, 1995, J BIOMED MATER RES, V29, P247, DOI 10.1002/jbm.820290216
   Shi L, 2000, COLLOID SURFACE B, V17, P229, DOI 10.1016/S0927-7765(99)00121-6
   Soltys-Robitaille CE, 2001, BIOMATERIALS, V22, P3257, DOI 10.1016/S0142-9612(01)00163-6
   Vacheethasanee K, 2000, J BIOMED MATER RES, V50, P302, DOI 10.1002/(SICI)1097-4636(20000605)50:3<302::AID-JBM3>3.0.CO;2-1
   Vacheethasanee K, 1998, J BIOMED MATER RES, V42, P425, DOI 10.1002/(SICI)1097-4636(19981205)42:3<425::AID-JBM12>3.0.CO;2-F
   Vandecasteele SJ, 2003, J INFECT DIS, V188, P730, DOI 10.1086/377452
   Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1111/j.1462-5822.2004.00367.x
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Yongoli C, 1999, J COLLOID INTERF SCI, V214, P38, DOI DOI 10.1006/JCIS.1999.6159
NR 34
TC 65
Z9 68
U1 2
U2 20
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 15
PY 2006
VL 78A
IS 4
BP 836
EP 842
DI 10.1002/jbm.a.30905
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 076BU
UT WOS:000239932800021
PM 16817192
DA 2018-10-19
ER

PT J
AU Silva, CC
   Graca, MPF
   Valente, MA
   Goes, JC
   Sombra, ASB
AF Silva, C. C.
   Graca, M. P. F.
   Valente, M. A.
   Goes, J. C.
   Sombra, A. S. B.
TI Microwave preparation, structure and electrical properties of
   calcium-sodium-phosphate biosystem
SO JOURNAL OF NON-CRYSTALLINE SOLIDS
LA English
DT Article; Proceedings Paper
CT 7th Brazilian Symposium on Glasses and Related Materials/3rd
   International Symposium on Non-Crystalline Solids in Brazil
CY NOV 13-16, 2005
CL Maringa, BRAZIL
SP Natl Council Sci & Technol Dev, CNPq, Brazilian Innvovat Agcy, FINEP, CAPES Fdn, Parana Fdn, Fund Araucar
DE biomaterials; glass ceramics; X-ray diffraction; dielectric properties;
   relaxation, electric modulus; microwave; scanning electron microscopy;
   optical properties
ID HYDROXYAPATITE; INTERFACE; COATINGS; TITANIUM; FILMS
AB The hydroxyapatite biomaterial (Ca-10(PO4)(6)(OH)(2) - HAP) is the main mineral constituent of teeth and bones, with excellent biocompatibility with hard and muscle tissues. These materials exhibit several problems of handling and fabrication, which can be overcome by mixing them with a suitable binder. In this study, a microwave process was used to produce hydroxyapatite using the starting materials CaCl2 and Na2HPO4 with previous precipitation. The mixture was exposed to microwave radiation for 5, 10, 15 and 20 min through domestic microwave ovens with an output power of I kW and frequency oscillation of 2.45 GHz. The samples were analyzed by Xray powder diffraction, scanning electron microscopy, energy dispersive X-ray, dc conductivity and impedance spectroscopy. X-ray powder diffraction revealed the formation of HAP after 5 min of exposure, The presence of a low crystallinity state and the transition, with the rise of radiation exposure time, to a crystalline phase was related to the Ca/P mass and Ca/P atomic ratio. The presence of this low crystalline phase, detected by X-ray powder diffraction and scanning electron microscopy, seems to have a direct influence on electrical and dielectrical characteristics. (c) 2006 Elsevier B.V. All rights reserved.
C1 Univ Fed Ceara, Met & Mat Engn Dept, BR-60455760 Fortaleza, Ceara, Brazil.
   Univ Aveiro, Dept Phys, P-3810193 Aveiro, Portugal.
   Univ Fed Ceara, Dept Phys, Telecommun & Mat Sci & Engn Lab, BR-60455760 Fortaleza, Ceara, Brazil.
RP Silva, CC (reprint author), Univ Fed Ceara, Met & Mat Engn Dept, Campus Pici 714 Block, BR-60455760 Fortaleza, Ceara, Brazil.
EM ccsilva@fisica.ufc.br
RI Graca, Manuel Pedro/E-6065-2013; Universidade Aveiro, Departamento
   Fisica/E-4128-2013; UFC, DF/E-1564-2017; Valente, Manuel/H-9137-2013;
   Universidade Federal do Ceara, Physics Department/J-4630-2016; Sombra,
   Antonio/B-2963-2013
OI Graca, Manuel Pedro/0000-0002-6858-9507; Valente,
   Manuel/0000-0001-9039-2199; Universidade Federal do Ceara, Physics
   Department/0000-0002-9247-6780; Goes, Julio Cesar/0000-0002-6324-7647
CR de Figueiredo RS, 1998, J MATER SCI LETT, V17, P449, DOI 10.1023/A:1006563924005
   Ducheyne P, 1992, Clin Orthop Relat Res, P102
   ELLIOT JC, 1994, STRUCTURE CHEM APAIT
   Elliott J.C., 1994, STUDIES INORGANIC CH, V18, P137
   Graca MPF, 2003, J NON-CRYST SOLIDS, V325, P267, DOI 10.1016/S0022-3093(03)00314-4
   HEIMKE G, 1983, BIOCERAMICS CALCIUM, P79
   Hench L. L., 1993, ADV SERIES CERAMICS, V1, P1
   Hontsu S, 1997, THIN SOLID FILMS, V295, P214, DOI 10.1016/S0040-6090(96)09146-8
   *JCPDS, 86074O HAPREF
   Katakam S, 2003, MATER LETT, V57, P2716, DOI 10.1016/S0167-577X(02)01364-2
   Kim SR, 2003, BIOMATERIALS, V24, P1389, DOI 10.1016/S0142-9612(02)00523-9
   MARQUES JMV, 1997, THESIS U AVEIRO PORT, P21
   Murugan R, 2004, MATER LETT, V58, P230, DOI 10.1016/S0167-577X(03)00451-8
   NELSON DGA, 1981, J DENT RES, V60, P1621, DOI 10.1177/002203458106000312011
   PAGE DG, 1987, J ORAL MAXIL SURG, V45, P356, DOI 10.1016/0278-2391(87)90360-0
   PAJAMAKI KJJ, 1995, J MATER SCI-MATER M, V6, P14, DOI 10.1007/BF00121240
   SARIG S, 2002, J CRYST GROWTH, V55, P237
   Sharma AK, 2002, J EUR CERAM SOC, V22, P2849, DOI 10.1016/S0955-2219(02)00051-1
   Silva CC, 2005, J NON-CRYST SOLIDS, V351, P2945, DOI 10.1016/j.jnoncrysol.2005.04.082
   Silva CC, 2005, MATER CHEM PHYS, V92, P260, DOI 10.1016/j.matchemphys.2005.01.028
   Silva CC, 2004, SOLID STATE SCI, V6, P1365, DOI 10.1016/j.solidstatesciences.2004.07.009
   Silva CC, 2002, J PHYS CHEM SOLIDS, V63, P1745, DOI 10.1016/S0022-3697(01)00262-1
   SILVA CC, 2003, THESIS FORTALEZA CEA
   STEA S, 1995, J MATER SCI-MATER M, V6, P455, DOI 10.1007/BF00123370
   Sugimoto T, 1996, J COLLOID INTERF SCI, V182, P444, DOI 10.1006/jcis.1996.0486
   Vallet-Regi M, 2004, PROG SOLID STATE CH, V32, P1, DOI 10.1016/j.progsolidstchem.2004.07.001
   Vijayan S, 2002, MATER LETT, V56, P827, DOI 10.1016/S0167-577X(02)00622-5
   VOGEL W, 1987, ANGEW CHEM INT EDIT, V26, P527, DOI 10.1002/anie.198705271
   WEEBER AW, 1988, PHYSICA B, V153, P93, DOI 10.1016/0921-4526(88)90038-5
   Xiu ZL, 2004, INORG CHEM COMMUN, V7, P604, DOI 10.1016/j.inoche.2004.02.031
   Yang YZ, 2002, J MATER SCI LETT, V21, P67, DOI 10.1023/A:1014250813564
   Zeng HT, 2000, BIOMATERIALS, V21, P23, DOI 10.1016/S0142-9612(99)00128-3
NR 32
TC 14
Z9 14
U1 0
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-3093
EI 1873-4812
J9 J NON-CRYST SOLIDS
JI J. Non-Cryst. Solids
PD SEP 15
PY 2006
VL 352
IS 32-35
BP 3512
EP 3517
DI 10.1016/j.jnoncrysol.2006.02.011
PG 6
WC Materials Science, Ceramics; Materials Science, Multidisciplinary
SC Materials Science
GA 086XI
UT WOS:000240706000024
DA 2018-10-19
ER

PT J
AU Stanek, LG
   Heilmann, SM
   Gleason, WB
AF Stanek, Lee G.
   Heilmann, Steven M.
   Gleason, William B.
TI Preparation and copolymerization of a novel carbohydrate containing
   monomer
SO CARBOHYDRATE POLYMERS
LA English
DT Article
DE vinyl saccharide; polymerization; MMA; contact angle; deprotection
ID FREE-RADICAL COPOLYMERIZATION; CATIONIC POLYMERIZATION; DRUG-DELIVERY;
   SURFACES; SUGAR; DERIVATIVES; METHACRYLATE; HYDROGELS; ADHESION; BOND
AB A novel carbohydrate containing monomer was prepared by simple reaction of 2-vinyl-4,4'-dimethylazlactone (VDMA) and 1,2;5,6-diisopropylidene-alpha-D-glucofuranose (DAG). The monomer was easily homopolymerized as well as copolymerized with methyl methacrylate (MMA) to give high molecular weight polymers using free radical conditions. Upon removal of the isopropylidene groups from the polymer, water contact angles decreased for polymeric films of the material, indicating a more hydrophilic surface. The addition of a carbohydrate moiety to MMA copolymers increases its hydrophilicity and allows for potential use of the new polymer as a biomaterial in a variety of applications. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA.
   3M Co, Organ Mat Technol Ctr, St Paul, MN 55144 USA.
   Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.
RP Gleason, WB (reprint author), Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA.
EM stan0309@umn.edu
CR BERTOZZI C, 2000, BIOMIMETIC HYDROGEL, V6, P107
   Bulpitt P, 1999, J BIOMED MATER RES, V47, P152
   FUKUDA T, 1991, MACROMOLECULES, V24, P370, DOI 10.1021/ma00002a005
   Gabius HJ, 1998, PHARM RES-DORDR, V15, P23, DOI 10.1023/A:1011936300845
   Garcia-Martin MG, 2000, POLYMER, V41, P821, DOI 10.1016/S0032-3861(99)00266-9
   Heuts JPA, 1997, MACROMOLECULES, V30, P726, DOI 10.1021/ma960704m
   Klein J, 1995, CAN J CHEM, V73, P1941, DOI 10.1139/v95-239
   Koch U, 2003, J POLYM SCI POL CHEM, V41, P788, DOI 10.1002/pola.10625
   Kunath K, 2003, J CONTROL RELEASE, V88, P159, DOI 10.1016/S0168-3659(02)00458-3
   Kwok DY, 1998, J COLLOID INTERF SCI, V206, P44, DOI 10.1006/jcis.1998.5610
   Morra M, 1997, J BIOMAT SCI-POLYM E, V9, P55, DOI 10.1163/156856297X00263
   Morra M, 1999, J BIOMAT SCI-POLYM E, V10, P1107, DOI 10.1163/156856299X00711
   Ojala WH, 1996, ACTA CRYSTALLOGR C, V52, P155, DOI 10.1107/S0108270195009991
   Ratner B. D., 1996, BIOMATERIALS SCI INT
   Ren T, 2001, BIOORGAN MED CHEM, V9, P2969, DOI 10.1016/S0968-0896(01)00203-6
   Shantha KL, 2002, J APPL POLYM SCI, V84, P2597, DOI 10.1002/app.10378
   Stanek LG, 2003, J POLYM SCI POL CHEM, V41, P3027, DOI 10.1002/pola.10897
   URYU T, 1978, MAKROMOL CHEM, V179, P1773
   WANG P, 1992, J AM CHEM SOC, V114, P378, DOI 10.1021/ja00027a068
   WEISZ OA, 1991, J CELL BIOL, V115, P485, DOI 10.1083/jcb.115.2.485
   Wulff G, 1997, MACROMOL CHEM PHYSIC, V198, P763, DOI 10.1002/macp.1997.021980308
   Wulff G, 1998, MACROMOL CHEM PHYSIC, V199, P141, DOI 10.1002/(SICI)1521-3935(19980101)199:1<141::AID-MACP141>3.3.CO;2-U
   Wulff G, 1999, MACROMOL CHEM PHYSIC, V200, P774
   Yamada K, 2001, J POLYM SCI POL CHEM, V39, P459, DOI 10.1002/1099-0518(20010215)39:4<459::AID-POLA1014>3.0.CO;2-E
NR 24
TC 10
Z9 10
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0144-8617
J9 CARBOHYD POLYM
JI Carbohydr. Polym.
PD SEP 13
PY 2006
VL 65
IS 4
BP 552
EP 556
DI 10.1016/j.carbpol.2006.01.021
PG 5
WC Chemistry, Applied; Chemistry, Organic; Polymer Science
SC Chemistry; Polymer Science
GA 088DP
UT WOS:000240792000022
DA 2018-10-19
ER

PT J
AU Strehl, G
   Gonzalez-Carrasco, JL
   Peris, JL
   Montealegre, MA
   Garcia, S
   Atienza, C
   Borchardt, G
AF Strehl, G.
   Gonzalez-Carrasco, J. L.
   Peris, J. L.
   Montealegre, M. A.
   Garcia, S.
   Atienza, C.
   Borchardt, G.
TI Application of thermal oxidation to the development of PM 2000 as
   potential biomaterial for medical devices
SO SURFACE & COATINGS TECHNOLOGY
LA English
DT Article
DE thermal oxidation; alumina layer; roughness; wear; biomaterials
ID TOTAL HIP; IMPLANT APPLICATIONS; METAL IMPLANTS; ALUMINA; SUPERALLOY;
   ALLOYS; GROWTH; MA-956; REPLACEMENT; TEMPERATURE
AB PM 2000 is a FeCrAl alloy suitable to be coated with a dense alpha-alumina layer by thermal oxidation, combining the inherent mechanical properties of the substrate with a good biocompatibility in vitro. The associated elevated residual stresses in the coating account for the capability to deform without cracking and also enhances the fatigue limit. Such residual stresses could also be beneficial for the wear behaviour. However, oxide nodules developed at the outer part of the scale provide the material with a high roughness that precludes their use for articulating surfaces. The aim of this investigation is to find out the optimal conditions for the defined thermal oxidation treatment in order to form a dense, adherent but smooth alumina scale. The effect of a short vacuum heating stage prior to oxidation on the kinetics, surface scale composition and roughness has been investigated. The development of the surface roughness follows an approximate parabolic law, which is in accordance with the oxide growth. Regarding the roughness, the maximum permissible value of 50 nm for an articulating surface is reached before 1 h exposure, irrespective of the oxidation process. A final manual polishing, however, was found to provide a smaller roughness value. To check the influence of the scale formation on the wear rate of UHMWPE, a set of femoral heads of standards dimensions, with and without alumina layer, were prepared. For comparative purposes, femoral heads of CoCr and 316 LVM stainless steel, currently used, were also tested for 10 million cycles in a four-station simplified joint wear simulator with bi-directional motion. Above 3.7 million cycles, preoxidised and polished PM 2000, with a roughness of about 40 nm, clearly causes the smaller polyethylene wear rate. Results confirm that the higher material roughness the higher wear rate. (c) 2005 Elsevier B.V. All rights reserved.
C1 Tech Univ Clausthal, Inst Met, D-38678 Clausthal Zellerfeld, Germany.
   CSIC, CENIM, Ctr Nacl Invest Met, E-28040 Madrid, Spain.
   Univ Politecn Valencia, IBV, E-46022 Valencia, Spain.
   Surgival, E-46980 Paterna, Valencia, Spain.
RP Gonzalez-Carrasco, JL (reprint author), Tech Univ Clausthal, Inst Met, D-38678 Clausthal Zellerfeld, Germany.
EM jlg@cenim.csic.es
RI Gonzalez Carrasco, Jose Luis/A-7971-2008
OI Gonzalez-Carrasco, Jose Luis/0000-0003-2004-4505; Peris, Jose
   L/0000-0003-3780-2659
CR BARIN I, 1989, THERMOMECHANICAL DAT
   Birks N., 1983, INTRO HIGH TEMPERATU
   Bull SJ, 1996, SURF COAT TECH, V82, P218, DOI 10.1016/0257-8972(95)02641-X
   Christensen RJ, 1997, ACTA MATER, V45, P1761, DOI 10.1016/S1359-6454(96)00258-3
   Ciapetti G, 2005, BIOMATERIALS, V26, P849, DOI 10.1016/j.biomaterials.2004.03.032
   CZYRSKAFILEMONO.A, 1993, P 2 INT C MICR OX SE, P288
   DAVIDSON JA, 1994, BIO-MED MATER ENG, V4, P231
   DOYCHAK J, 1989, OXID MET, V31, P431, DOI 10.1007/BF00666466
   ESCUDERO ML, 1994, BIOMATERIALS, V15, P1175, DOI 10.1016/0142-9612(94)90239-9
   Florentine SK, 2004, LAND DEGRAD DEV, V15, P1, DOI 10.1002/ldr.586
   FRAISSINET P, 1994, J MATER SCI-MATER M, V5, P491
   Garcia-Alonso MC, 2001, J MATER SCI-MATER M, V12, P589, DOI 10.1023/A:1011281425321
   GIAPETTI G, 2004, 2 IB C BIOM BIOS EV, P7
   Gobel M., 1997, P 3 INT C MICR OX 16, P191
   Gonzalez-Carrasco JL, 2001, OXID MET, V55, P209, DOI 10.1023/A:1010351909187
   Gonzalez-Carrasco JL, 2001, MATER CORROS, V52, P860
   Gonzalez-Carrasco JL, 1998, MATER MANUF PROCESS, V13, P431, DOI 10.1080/10426919808935260
   Gonzalez-Carrasco JL, 2005, BIOMATERIALS, V26, P3861, DOI 10.1016/j.biomaterials.2004.09.058
   Guttmann V, 2000, HIGH TEMPERATURE SURFACE ENGINEERING, P43
   GUTTMANN V, 1999, EFC PUBLICATIONS, V27, P17
   HAANAPPEL VAC, 2000, SMT 14 SURFACE MODIF
   HAYASHI K, 1989, J BIOMED MATER RES, V23, P1247, DOI 10.1002/jbm.820231103
   HAZAN R, 1993, BIOMATERIALS, V14, P570, DOI 10.1016/0142-9612(93)90172-X
   Hilpert K, 1996, J ELECTROCHEM SOC, V143, P3642, DOI 10.1149/1.1837264
   Ingham E, 2005, BIOMATERIALS, V26, P1271, DOI 10.1016/j.biomaterials.2004.04.035
   JAGER M, 1981, S BIOMATER, P114
   KONTTINEN YT, 1997, CURR ORTHOPAED, V11, P40
   Oonishi H, 1988, Ann N Y Acad Sci, V523, P38, DOI 10.1111/j.1749-6632.1988.tb38499.x
   Perez P, 2001, SURF COAT TECH, V139, P207, DOI 10.1016/S0257-8972(00)01169-5
   Prasanna KMN, 1996, OXID MET, V46, P465, DOI 10.1007/BF01048641
   QUADAKKERS WJ, 1990, WERKST KORROS, V41, P659
   Schmalzried TP, 1999, J BONE JOINT SURG AM, V81A, P115, DOI 10.2106/00004623-199901000-00016
   SCHMIDIG G, 2000, 46 ANN M ORTH RES SO
   Zywitzki O, 1996, SURF COAT TECH, V82, P169, DOI 10.1016/0257-8972(95)00270-7
   GRD1199910659
NR 35
TC 11
Z9 11
U1 3
U2 12
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0257-8972
J9 SURF COAT TECH
JI Surf. Coat. Technol.
PD SEP 12
PY 2006
VL 201
IS 1-2
BP 148
EP 156
DI 10.1016/j.surfcoat.2005.11.073
PG 9
WC Materials Science, Coatings & Films; Physics, Applied
SC Materials Science; Physics
GA 085PS
UT WOS:000240616600020
DA 2018-10-19
ER

PT J
AU Zhu, Y
   Chen, Y
   Zhang, LM
   Zheng, H
AF Zhu, Yan
   Chen, Yu
   Zhang, Lian-Meng
   Zheng, Hua
TI PMSE 504-Combinatorial characterization of micropatterned polyurethane
   cell-biomaterial interfaces
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Zhu, Yan; Chen, Yu; Zheng, Hua] Wuhan Univ Technol, Sch Chem Engn & Technol, Wuhan 430070, Peoples R China.
   [Zhang, Lian-Meng] Wuhan Univ Technol, State Key Lab Adv Technol Mat Synth Proc, Wuhan 430070, Peoples R China.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD SEP 10
PY 2006
VL 232
MA 345-PMSE
BP 590
EP 590
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA V15DC
UT WOS:000207781700581
DA 2018-10-19
ER

PT J
AU Su, J
   Meredith, JC
AF Su, Jing
   Meredith, J. Carson
TI CINF 90-Cell-Surface Informatics (CSI): A platform for quantifying
   effects of biomaterial surface features on cells
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Meredith, J. Carson] Georgia Inst Technol, Sch Chem & Biomol Engn, Atlanta, GA 30332 USA.
   [Su, Jing] Emory Univ, Georgia Inst Technol, Coulter Sch Biomed Engn, Atlanta, GA 30332 USA.
RI Meredith, Carson/B-3323-2009
OI Meredith, Carson/0000-0003-2519-5003
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD SEP 10
PY 2006
VL 232
MA 90-CINF
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA V15DB
UT WOS:000207781603096
DA 2018-10-19
ER

PT J
AU Taniguchi, I
   Kuhlman, WA
   Griffith, L
   Mayes, AM
AF Taniguchi, Ikuo
   Kuhlman, William A.
   Griffith, Linda
   Mayes, Anne M.
TI POLY 59-Functional modification of biodegradable polyester for
   cell-specific biomaterial surfaces
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
C1 [Taniguchi, Ikuo; Kuhlman, William A.; Mayes, Anne M.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA.
   [Griffith, Linda] MIT, Dept Chem Engn, Ctr Biotechnol Proc Engn, Div Biol Engn, Cambridge, MA 02139 USA.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD SEP 10
PY 2006
VL 232
MA 59-POLY
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA V15DC
UT WOS:000207781701672
DA 2018-10-19
ER

PT J
AU Li, DL
   Shen, Q
   Ding, HG
   Gu, QF
   Wang, ZX
AF Li, De-Lan
   Shen, Qing
   Ding, Hong-Gui
   Gu, Qing-Feng
   Wang, Zhi-Xin
TI Fabrication and characterization of a persimmon leaves
   (PL)/poly(acrylonitrile) (PAN) blend bio-fiber
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE persimmon leaves; poly(acrylonitrile); blend fiber; wet spinning;
   structure; properties
ID SURFACE-PROPERTIES; LEAF EXTRACT; DERMATITIS; NC/NGA; MICE
AB Adopting persimmon leaves, PL, as a biomaterial to blend with poly(acrylonitrile) (PAN) via the wet spinning method, a PL/PAN blend biofiber was fabricated. On the basis of mechanical measurements, X-ray diffraction, and DSC characterization, it was found that this biofiber has acceptable mechanical properties for further applying to different cases. Results also showed that though the crystal structure, especially the crystal size, is changed indeed for blend fiber, it seems to be of less influence on the thermal properties, especially the crystallization temperature, T-c. (c) 2006 Wiley Periodicals, Inc.
C1 Donghua Univ, Dept Polymer Mat & Engn, Shanghai 200051, Peoples R China.
   Donghua Univ, State Key Lab Modificat Chem Fibers & Polymer Mat, Shanghai 200051, Peoples R China.
RP Shen, Q (reprint author), Donghua Univ, Dept Polymer Mat & Engn, Shanghai 200051, Peoples R China.
EM sqing@dhu.edu.cn
CR ALEXANDER LE, 1969, XRAY DIFFRACTION MET, P137
   BILLMEYER FW, 2000, TXB POLYM SCI
   FOCHER B, 1994, J APPL POLYM SCI, V51, P583, DOI 10.1002/app.1994.070510401
   FUNAYAMA S, 1979, CHEM PHARM BULL, V27, P2865
   Hu J. F., 2002, J INNER MONGOLIA POL, V21, P272
   KAMEDA K, 1987, J NAT PROD, V50, P680, DOI 10.1021/np50052a017
   Kotani M, 2000, J ALLERGY CLIN IMMUN, V106, P159, DOI 10.1067/mai.2000.107194
   Kotani M., 1999, J JPN SOC NUTR FOOD, V52, P147
   Matsumoto M, 2002, BRIT J DERMATOL, V146, P221, DOI 10.1046/j.1365-2133.2002.04557.x
   Shen Q, 2004, COLLOID SURFACE B, V37, P133, DOI 10.1016/j.colsurfb.2004.07.006
   Shen Q, 2003, J COLLOID INTERF SCI, V267, P333, DOI 10.1016/S0021-9797(03)00651-9
   Tanaka T., 2003, Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, V2, P57, DOI 10.2174/1568014033355790
   Wang ZX, 2004, CARBOHYD POLYM, V57, P415, DOI 10.1016/j.carbpol.2004.05.017
NR 13
TC 5
Z9 5
U1 0
U2 0
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD SEP 5
PY 2006
VL 101
IS 5
BP 2810
EP 2813
DI 10.1002/app.22612
PG 4
WC Polymer Science
SC Polymer Science
GA 064ZC
UT WOS:000239128200012
DA 2018-10-19
ER

PT J
AU Christman, KL
   Lee, RJ
AF Christman, Karen L.
   Lee, Randall J.
TI Biomaterials for the treatment of myocardial infarction
SO JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
LA English
DT Article
ID LEFT-VENTRICULAR GEOMETRY; ASSEMBLING PEPTIDE NANOFIBERS; BIOENGINEERED
   CARDIAC GRAFTS; HEART-FAILURE; CELLULAR CARDIOMYOPLASTY; NEOVASCULATURE
   FORMATION; ISCHEMIC-MYOCARDIUM; SKELETAL MYOBLASTS; ENDOTHELIAL-CELLS;
   CULTURED-CELLS
AB For nearly a decade, researchers have investigated the possibility of cell transplantation for cardiac repair. More recently, the emerging fields of tissue engineering and biomaterials have begun to provide potential treatments. Tissue engineering approaches are designed to repair lost or damaged tissue through the use of growth factors, cellular transplantation, and biomaterial scaffolds. There are currently 3 biomaterial approaches for the treatment of myocardial infarction (MI). The first involves polymeric left ventricular restraints in the prevention of heart failure. The second utilizes in vitro engineered cardiac tissue, which is subsequently implanted in vivo. The final approach entails injecting cells and/or a scaffold into the myocardium to create in situ engineered cardiac tissue. This review gives an overview of the current progress in the growing field of biomaterials for the treatment of MI.
C1 Univ Calif Berkeley, Berkeley, CA 94720 USA.
   San Francisco Joint Bioengn Grad Grp, San Francisco, CA USA.
   Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94143 USA.
RP Lee, RJ (reprint author), MU E Tower,Box 1354,500 Parnassus Ave, San Francisco, CA 94143 USA.
EM lee@medicine.ucsf.edu
CR Akhyari P, 2002, CIRCULATION, V106, P1137
   Anderson James M., 1996, P165
   Blom AS, 2005, CIRCULATION, V112, P1274, DOI 10.1161/CIRCULATIONAHA.104.499202
   Bonadio J, 2000, J MOL MED-JMM, V78, P303, DOI 10.1007/s001090000118
   Bowen FW, 2001, ANN THORAC SURG, V72, P1950, DOI 10.1016/S0003-4975(01)03282-9
   Bursac N, 1999, AM J PHYSIOL-HEART C, V277, pH433, DOI 10.1152/ajpheart.1999.277.2.H433
   Carrier RL, 1999, BIOTECHNOL BIOENG, V64, P580, DOI 10.1002/(SICI)1097-0290(19990905)64:5<580::AID-BIT8>3.0.CO;2-X
   Carrier RL, 2002, TISSUE ENG, V8, P175, DOI 10.1089/107632702753724950
   Chaudhry PA, 2000, ANN THORAC SURG, V70, P1275, DOI 10.1016/S0003-4975(00)01755-0
   Chekanov V, 2003, PACE, V26, P496, DOI 10.1046/j.1460-9592.2003.00080.x
   Christman KL, 2003, CIRCULATION, V108, P246
   Christman KL, 2005, BIOMATERIALS, V26, P1139, DOI 10.1016/j.biomaterials.2004.04.025
   Christman KL, 2004, J AM COLL CARDIOL, V44, P654, DOI 10.1016/j.jacc.2004.04.040
   Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762
   Dai WD, 2005, J AM COLL CARDIOL, V46, P714, DOI 10.1016/j.jacc.2005.04.056
   Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80
   Enomoto Y, 2005, ANN THORAC SURG, V79, P881, DOI 10.1016/j.athorascur.2004.05.072
   Franco-Cereceda A, 2004, SCAND CARDIOVASC J, V38, P159, DOI 10.1080/14017430410031155
   Hsieh PCH, 2006, J CLIN INVEST, V116, P237, DOI 10.1172/JCI25878
   Huang NF, 2005, TISSUE ENG, V11, P1860, DOI 10.1089/ten.2005.11.1860
   Iwakura A, 2003, HEART VESSELS, V18, P93, DOI 10.1007/s10380-002-0686-5
   Kellar RS, 2005, TISSUE ENG, V11, P1678, DOI 10.1089/ten.2005.11.1678
   Kelley ST, 1999, CIRCULATION, V99, P135, DOI 10.1161/01.CIR.99.1.135
   Kofidis T, 2005, J HEART LUNG TRANSPL, V24, P737, DOI 10.1016/j.healun.2004.03.023
   Kofidis T, 2004, J THORAC CARDIOV SUR, V128, P571, DOI 10.1016/j.jtcvs.2004.05.021
   Kofidis T., 2005, CIRCULATION, V112, pI173
   Konertz W, 2001, CIRCULATION, V104, P1270
   Krupnick AS, 2002, J HEART LUNG TRANSPL, V21, P233, DOI 10.1016/S1053-2498(01)00349-7
   Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117
   Leor J, 2000, CIRCULATION, V102, P56
   Leor J, 2005, PHARMACOL THERAPEUT, V105, P151, DOI 10.1016/j.pharmthera.2004.10.003
   Li RK, 1999, CIRCULATION, V100, P63
   Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999
   Menasche P, 2003, J AM COLL CARDIOL, V41, P1078, DOI 10.1016/S0735-1097(03)00092-5
   Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391
   Moainie SL, 2002, ANN THORAC SURG, V74, P444, DOI 10.1016/S0003-4975(02)03747-5
   Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491
   OKANO T, 1993, J BIOMED MATER RES, V27, P1243, DOI 10.1002/jbm.820271005
   Olsson A, 2005, EUR J CARDIO-THORAC, V28, P448, DOI 10.1016/j.ejcts.2005.05.027
   Papadaki M, 2001, AM J PHYSIOL-HEART C, V280, pH168
   Park H, 2005, IN VITRO CELL DEV-AN, V41, P188
   Pilla JJ, 2003, J THORAC CARDIOV SUR, V126, P1467, DOI 10.1016/S0022-5223(03)00739-6
   Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101
   Radisic M, 2004, AM J PHYSIOL-HEART C, V286, pH507, DOI 10.1152/ajpheart.00171.2003
   Radisic M, 2003, BIOTECHNOL BIOENG, V82, P403, DOI 10.1002/bit.10594
   Reffelmann T, 2003, CARDIOVASC RES, V58, P358, DOI 10.1016/S0008-6363(02)00739-3
   Reinecke H, 2002, J MOL CELL CARDIOL, V34, P251, DOI 10.1006/jmcc.2001.1494
   Reinecke H, 2000, CARDIOVASC PATHOL, V9, P337, DOI 10.1016/S1054-8807(00)00055-7
   Ryu JH, 2005, BIOMATERIALS, V26, P319, DOI 10.1016/j.biomaterials.2004.02.058
   Saavedra WF, 2002, J AM COLL CARDIOL, V39, P2069, DOI 10.1016/S0735-1097(02)01890-9
   Sabbah HN, 2003, CIRC RES, V93, P1095, DOI 10.1161/01.RES.0000101932.70443.FE
   Shimizu T, 2002, CIRC RES, V90, pE40, DOI 10.1161/hh0302.105722
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Sun Y, 2000, CARDIOVASC RES, V46, P250, DOI 10.1016/S0008-6363(00)00032-8
   Thompson CA, 2003, J AM COLL CARDIOL, V41, P1964, DOI 10.1016/S0735-1097(03)00397-8
   van Luyn MJA, 2002, BIOMATERIALS, V23, P4793, DOI 10.1016/S0142-9612(02)00230-2
   Vunjak-Novakovic G., 1998, ADV DRUG DELIV REV, V33, P15
   YAMADA N, 1990, MAKROMOL CHEM-RAPID, V11, P571
   Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367
   Zhang PC, 2006, ARTIF ORGANS, V30, P86, DOI 10.1111/j.1525-1594.2006.00186.x
   Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394
   Zimmermann WH, 2003, HEART FAIL REV, V8, P259, DOI 10.1023/A:1024725818835
   ZIMMERMANN WH, 2002, CIRCULATION, V106, P151
NR 63
TC 249
Z9 262
U1 1
U2 40
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0735-1097
J9 J AM COLL CARDIOL
JI J. Am. Coll. Cardiol.
PD SEP 5
PY 2006
VL 48
IS 5
BP 907
EP 913
DI 10.1016/j.jacc.2006.06.005
PG 7
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA 081NO
UT WOS:000240324500001
PM 16949479
OA Bronze
DA 2018-10-19
ER

PT J
AU Liu, H
   Li, H
   Cheng, WJ
   Yang, Y
   Zhu, MY
   Zhou, CR
AF Liu, Hua
   Li, Hong
   Cheng, Wenjun
   Yang, Yuan
   Zhu, Minying
   Zhou, Changren
TI Novel injectable calcium phosphate/chitosan composites for bone
   substitute materials
SO ACTA BIOMATERIALIA
LA English
DT Article
DE calcium phosphate; chitosan; citric acid; bone substitute material;
   bioactivity
ID SIMULATED BODY-FLUID; BETA-TRICALCIUM PHOSPHATE; IN-VITRO PROPERTIES;
   APATITE FORMATION; BIOACTIVE GLASS; SETTING REACTION; FILLING PASTE;
   SILICA-GEL; CEMENT; CHITOSAN
AB In this study, a novel injectable bone substitute material was developed which consists of chitosan, citric acid and glucose solution as the liquid phase, and tricalcium phosphate powder as the solid phase. This material was moldable because of its paste consistency after mixing. We used four groups of cement to investigate the mechanical properties and biocompatibility of the new biomaterial in vitro, which were named group A (10% citric acid), B (15% citric acid), C (20% citric acid) and D (25% citric acid). The setting times of the cements were 5-30 min. X-ray diffraction analysis showed that the products were hydroxyapatite (HA) and dicalcium phosphate anhydrous. When the concentration of citric acid was increased, the compressive strength of specimen increased. Through the simulated body fluid test, we observed the material was bioactive. Group D could induce Ca and P ions to deposit the surface group D quickly. These results indicated that the concentration of citric acid in the liquid component affected the mechanical properties and bioactivity of cements. The cell cultivation test showed that the cytocompatibility of the new biomaterial was good. The method for preparing the novel bone substitute material is simple. The starting material is more readily available and cheaper than HA, poly(methyl methacrylate), and so on. The cement could have good prospects for medical application. (C) 2006 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Jinan Univ, Dept Mat Sci & Engn, Guangzhou 510632, Peoples R China.
   South Hosp, Dept Orthoped & Traumatol, Guangzhou 510515, Peoples R China.
RP Zhou, CR (reprint author), Jinan Univ, Dept Mat Sci & Engn, Guangzhou 510632, Peoples R China.
EM tcrz9@jnu.edu.cn
CR Brown WE, 1986, CEMENTS RES PROGR, P351
   Brown WE, 1986, United States patent, Patent No. [4612053, EP 4612053]
   CHOHAYEB AA, 1987, J ENDODONT, V13, P384, DOI 10.1016/S0099-2399(87)80198-X
   CHOW LC, 1994, HYDROXYAPATITE AND RELATED MATERIALS, P127
   CHOW LC, 1991, NIPPON SERAM KYO GAK, V99, P954
   CHOW LC, 1989, SPECIALTY CEMENTS AD
   CHOW LC, 1998, CEMENT RES PROGR, V20, P4215
   Constantz BR, 1998, J BIOMED MATER RES, V43, P451, DOI 10.1002/(SICI)1097-4636(199824)43:4<451::AID-JBM13>3.0.CO;2-Q
   COSTANTINO PD, 1991, ARCH OTOLARYNGOL, V117, P379
   CUROTTO E, 1993, ANAL BIOCHEM, V211, P240, DOI 10.1006/abio.1993.1263
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   DRIESSENS FCM, 1993, J MATER SCI-MATER M, V4, P503, DOI 10.1007/BF00120130
   Fernandez E, 1996, J BIOMED MATER RES, V32, P367, DOI 10.1002/(SICI)1097-4636(199611)32:3<367::AID-JBM9>3.0.CO;2-Q
   Frayssinet P, 1998, BIOMATERIALS, V19, P971, DOI 10.1016/S0142-9612(97)00163-4
   Friedmann T, 2003, MOL THER, V8, P5, DOI 10.1016/mthe.2003.1022
   Fujibayashi S, 2003, BIOMATERIALS, V24, P1349, DOI 10.1016/S0142-9612(02)00511-2
   FUKASE Y, 1990, J DENT RES, V69, P1852, DOI 10.1177/00220345900690121201
   Ginebra MP, 1997, J DENT RES, V76, P905, DOI 10.1177/00220345970760041201
   Grover LM, 2003, BIOMATERIALS, V24, P4133, DOI 10.1016/S0142-9612(03)00293-X
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   ISHIKAWA K, 1995, J BIOMED MATER RES, V29, P1537, DOI 10.1002/jbm.820291210
   ISHIKAWA K, 1994, DENT MATER, V10, P26, DOI 10.1016/0109-5641(94)90018-3
   *ISO, 2003, 99171 ISO 1
   Ito M, 1996, J BIOMED MATER RES, V32, P95, DOI 10.1002/(SICI)1097-4636(199609)32:1<95::AID-JBM11>3.3.CO;2-L
   Ito Michio, 1994, Bio-Medical Materials and Engineering, V4, P439
   Kaneko H, 2002, KEY ENG MAT, V218-2, P649, DOI 10.4028/www.scientific.net/KEM.218-220.649
   Karesh J W, 1998, Curr Opin Ophthalmol, V9, P66, DOI 10.1097/00055735-199810000-00013
   Khairoun I, 1999, BIOMATERIALS, V20, P393, DOI 10.1016/S0142-9612(98)00202-6
   KOKUBO T, 1992, J MATER SCI-MATER M, V3, P79, DOI 10.1007/BF00705272
   Kokubo T, 1998, ACTA MATER, V46, P2519, DOI 10.1016/S1359-6454(98)80036-0
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P331, DOI 10.1002/jbm.820240306
   Kopylov P, 1996, J HAND SURG-BRIT EUR, V21B, P768, DOI 10.1016/S0266-7681(96)80184-7
   Kruyt MC, 2004, J ORTHOPAED RES, V22, P544, DOI 10.1016/j.orthres.2003.10.010
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   LI P, 1993, J MATER SCI-MATER M, V4, P127, DOI 10.1007/BF00120381
   LI P, 1993, J APPL BIOMATER, V4, P221, DOI 10.1002/jab.770040303
   Lu X, 2005, BIOMATERIALS, V26, P1097, DOI 10.1016/j.biomaterials.2004.05.034
   Machida Y, 1986, Drug Des Deliv, V1, P119
   Maruyama M, 1996, J BIOMED MATER RES, V32, P527, DOI 10.1002/(SICI)1097-4636(199612)32:4<527::AID-JBM5>3.0.CO;2-T
   MIRTCHI AA, 1989, BIOMATERIALS, V10, P475, DOI 10.1016/0142-9612(89)90089-6
   MITA Y, 1987, FOOD CHEM, V1
   Miyamoto Y, 1998, BIOMATERIALS, V19, P707, DOI 10.1016/S0142-9612(97)00186-5
   Miyamoto Y, 1999, J BIOMED MATER RES, V48, P36, DOI 10.1002/(SICI)1097-4636(1999)48:1<36::AID-JBM8>3.0.CO;2-I
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   MUZZARELLI RAA, 1993, BIOMATERIALS, V14, P39, DOI 10.1016/0142-9612(93)90073-B
   Muzzarelli RAA, 1989, CHITIN CHITOSAN, P87
   Nguyen H, 2003, BIOCHEM BIOPH RES CO, V311, P179, DOI 10.1016/j.bbrc.2003.09.192
   Penel G, 1999, BONE, V25, p81S, DOI 10.1016/S8756-3282(99)00139-8
   Peter SJ, 1997, TISSUE ENG, V3, P207, DOI 10.1089/ten.1997.3.207
   POSNER AS, 1985, CLIN ORTHOP RELAT R, V200, P87
   Siriphannon P, 2002, J BIOMED MATER RES, V60, P175, DOI 10.1002/jbm.10056
   Sugawara A, 1992, Dent Mater J, V11, P11
   Takechi M, 1998, BIOMATERIALS, V19, P2057, DOI 10.1016/S0142-9612(98)00114-8
   THOMAS KA, 1987, J BIOMED MATER RES, V21, P1395, DOI 10.1002/jbm.820211205
   WEI W, 1991, INT J BIOL MACROMOL, V13, P281, DOI 10.1016/0141-8130(91)90027-R
   Yokoyama A, 2002, BIOMATERIALS, V23, P1091, DOI 10.1016/S0142-9612(01)00221-6
   Zhang Y, 2001, J BIOMED MATER RES, V55, P304, DOI 10.1002/1097-4636(20010605)55:3<304::AID-JBM1018>3.0.CO;2-J
NR 58
TC 107
Z9 115
U1 0
U2 41
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
EI 1878-7568
J9 ACTA BIOMATER
JI Acta Biomater.
PD SEP
PY 2006
VL 2
IS 5
BP 557
EP 565
DI 10.1016/j.actbio.2006.03.007
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 080OO
UT WOS:000240257600010
PM 16774852
DA 2018-10-19
ER

PT J
AU Low, SP
   Williams, KA
   Canham, LT
   Voelcker, NH
AF Low, Suet Peng
   Williams, Keryn A.
   Canham, Leigh T.
   Voelcker, Nicolas H.
TI Evaluation of mammalian cell adhesion on surface-modified porous silicon
SO BIOMATERIALS
LA English
DT Article
DE porous silicon; surface modification; cell adhesion; biodegradable
   materials; vitality assays
ID NERVE GROWTH-FACTOR; MONOCYTE/MACROPHAGE ADHESION; ALAMAR BLUE;
   DISSOLUTION; FABRICATION; SUBSTRATUM; OUTGROWTH; PROTEINS; NEURONS; LINE
AB Porous silicon is a promising biomaterial that is non-toxic and biodegradable. Surface modification can offer control over the degradation rate and can also impart properties that promote cell adhesion. In this study, we modified the surface of porous silicon surface by ozone oxidation, silanisation or coating with collagen or serum. For each surface, topography was characterised using atomic force microscopy, wettability by water contact angle measurements, degradation in aqueous buffer by interferometric reflectance spectroscopy and surface chemistry by Fourier-transform infrared spectroscopy. The adhesion of rat pheochromocytoma (PC12) and human lens epithelial cells to these surfaces was investigated. Cells were incubated on the surfaces for 4 and 24 h, and adhesion characteristics were determined by using a fluorescent vital stain and cell counts. Collagen coated and amino silanised porous silicon promoted cell attachment for both cell lines whereas cells attached poorly to ozone oxidised and polyethylene glycol silanised surfaces. We showed that the two cell lines had different adhesion characteristics on the various surfaces at different time points. The use of the vitality assays Alamar Blue (redox based assay) and neutral red (active cellular uptake assay) with porous silicon was also investigated. We reveal incompatibilities between certain resazurin (Alamar Blue), lysosomal incorporation assays (neutral red) and porous silicon. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Flinders Univ S Australia, Sch Chem, Bedford Pk, SA 5042, Australia.
   Flinders Univ S Australia, Sch Med, Dept Ophthalmol, Bedford Pk, SA 5042, Australia.
   PSi Med Ltd, Malvern, Worcs, England.
RP Voelcker, NH (reprint author), Flinders Univ S Australia, Sch Chem, Sturt Rd, Bedford Pk, SA 5042, Australia.
EM Nico.voelcker@flinders.edu.au
RI Voelcker, Nicolas/D-6199-2012
OI Voelcker, Nicolas/0000-0002-1536-7804
CR Alcantar NA, 2000, J BIOMED MATER RES, V51, P343, DOI 10.1002/1097-4636(20000905)51:3<343::AID-JBM7>3.0.CO;2-D
   ALLONGUE P, 1993, J ELECTROCHEM SOC, V140, P1018, DOI 10.1149/1.2056190
   Altankov G, 1996, J BIOMED MATER RES, V30, P385, DOI 10.1002/(SICI)1097-4636(199603)30:3<385::AID-JBM13>3.0.CO;2-J
   Anderson SHC, 2003, PHYS STATUS SOLIDI A, V197, P331, DOI [10.1002/pssa.200306519, 10.1002/7pssa.200306519]
   Bayliss S, 1997, THIN SOLID FILMS, V297, P308, DOI 10.1016/S0040-6090(96)09416-3
   Bayliss SC, 1999, ADV MATER, V11, P318, DOI 10.1002/(SICI)1521-4095(199903)11:4<318::AID-ADMA318>3.0.CO;2-Z
   Buriak JM, 1998, J AM CHEM SOC, V120, P1339, DOI 10.1021/ja9740125
   CANHAM LT, 1990, APPL PHYS LETT, V57, P1046, DOI 10.1063/1.103561
   Canham LT, 1995, ADV MATER, V7, P1033, DOI 10.1002/adma.19950071215
   Canham LT, 1999, ADV MATER, V11, P1505, DOI 10.1002/(SICI)1521-4095(199912)11:18<1505::AID-ADMA1505>3.3.CO;2-3
   Chin V, 2001, ADV MATER, V13, P1877, DOI 10.1002/1521-4095(200112)13:24<1877::AID-ADMA1877>3.0.CO;2-4
   Coffer JL, 2005, PHYS STATUS SOLIDI A, V202, P1451, DOI 10.1002/pssa.200461134
   Coulthard I, 2000, PHYS STATUS SOLIDI A, V182, P157, DOI 10.1002/1521-396X(200011)182:1<157::AID-PSSA157>3.0.CO;2-O
   Dancil KPS, 1999, J AM CHEM SOC, V121, P7925, DOI 10.1021/ja991421n
   de Leon SB, 2004, APPL PHYS LETT, V84, P4361, DOI 10.1063/1.1741032
   Dewez JL, 1999, BIOMATERIALS, V20, P547, DOI 10.1016/S0142-9612(98)00207-5
   Faucheux N, 2004, BIOMATERIALS, V25, P2721, DOI 10.1016/j.biomaterials.2003.09.069
   FUJII DK, 1982, J NEUROSCI, V2, P1157
   Gonzalez RJ, 2001, TOXICOL IN VITRO, V15, P257, DOI 10.1016/S0887-2333(01)00014-5
   GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424
   Ibaraki N, 1998, EXP EYE RES, V67, P577, DOI 10.1006/exer.1998.0551
   Janshoff A, 1998, J AM CHEM SOC, V120, P12108, DOI 10.1021/ja9826237
   Jenney CR, 1998, J BIOMED MATER RES, V41, P171, DOI 10.1002/(SICI)1097-4636(199808)41:2<171::AID-JBM1>3.0.CO;2-F
   KLEINFELD D, 1988, J NEUROSCI, V8, P4098
   Li HL, 2002, LANGMUIR, V18, P3198, DOI 10.1021/la015664g
   Mayne AH, 2000, PHYS STATUS SOLIDI A, V182, P505, DOI 10.1002/1521-396X(200011)182:1<505::AID-PSSA505>3.0.CO;2-#
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x
   Oharazawa H, 1999, EXP EYE RES, V69, P603, DOI 10.1006/exer.1999.0723
   Reffitt DM, 1999, J INORG BIOCHEM, V76, P141, DOI 10.1016/S0162-0134(99)00126-9
   Saneinejad S, 1998, J BIOMED MATER RES, V42, P13, DOI 10.1002/(SICI)1097-4636(199810)42:1<13::AID-JBM3>3.0.CO;2-R
   Sapelkin AV, 2006, BIOMATERIALS, V27, P842, DOI 10.1016/j.biomaterials.2005.06.023
   Shen MC, 2001, J BIOMED MATER RES, V57, P336, DOI 10.1002/1097-4636(20011205)57:3<336::AID-JBM1176>3.0.CO;2-E
   Sheth SR, 1997, P NATL ACAD SCI USA, V94, P8399, DOI 10.1073/pnas.94.16.8399
   Steinem C, 2004, TETRAHEDRON, V60, P11259, DOI 10.1016/j.tet.2004.06.130
   Tinsley-Bown AM, 2000, PHYS STATUS SOLIDI A, V182, P547, DOI 10.1002/1521-396X(200011)182:1<547::AID-PSSA547>3.0.CO;2-C
   Xu DS, 2003, NEW J CHEM, V27, P300, DOI 10.1039/b204359a
   Yashiki S, 2001, J BIOSCI BIOENG, V92, P385, DOI 10.1263/jbb.92.385
NR 38
TC 196
Z9 196
U1 5
U2 60
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2006
VL 27
IS 26
BP 4538
EP 4546
DI 10.1016/j.biomaterials.2006.04.015
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 063CV
UT WOS:000238994500003
PM 16707158
DA 2018-10-19
ER

PT J
AU Hutchens, SA
   Benson, RS
   Evans, BR
   O'Neill, HM
   Rawn, CJ
AF Hutchens, Stacy A.
   Benson, Roberto S.
   Evans, Barbara R.
   O'Neill, Hugh M.
   Rawn, Claudia J.
TI Biomimetic synthesis of calcium-deficient hydroxyapatite in a natural
   hydrogel
SO BIOMATERIALS
LA English
DT Article
DE bacterial cellulose; hydrogel; hydroxyapatite composites; biomimetic
   material
ID PHOSPHATE CERAMIC PARTICLES; BACTERIAL CELLULOSE; MECHANICAL-PROPERTIES;
   IN-VIVO; APATITE; MINERALIZATION; BIOCOMPATIBILITY; BIOMATERIALS;
   DIFFRACTION; INVITRO
AB A novel composite material consisting of calcium-deficient hydroxyapatite (CdHAP) biomimetically deposited in a bacterial cellulose hydrogel was synthesized and characterized. Cellulose produced by Gluconacetobacter hansenii was purified and sequentially incubated in solutions of calcium chloride followed by sodium phosphate dibasic. A substantial amount of apatite (50-90% of total dry weight) was homogeneously incorporated throughout the hydrogel after this treatment. X-ray diffractometry (XRD) showed that CdHAP crystallites had formed in the cellulose. XRD further demonstrated that the CdHAP was comprised of 10-50 nm anisotropic crystallites elongated in the c-axis, similar to natural bone apatite. Fourier transform infrared (FTIR) spectroscopy demonstrated that hydroxyl IR bands of the cellulose shifted to lower wave numbers indicating that a coordinate bond had possibly formed between the CdHAP and the cellulose hydroxyl groups. FTIR also suggested that the CdHAP had formed from an octacalcium phosphate precursor similar to physiological bone. Scanning electron microscopy (SEM) images confirmed that uniform similar to 1 mu m spherical CdHAP particles comprised of nanosized crystallites with a lamellar morphology had formed in the cellulose. The synthesis of the composite mimics the natural biomineralization of bone indicating that bacterial cellulose can be used as a template for biomimetic apatite formation. This composite may have potential use as an orthopedic biomaterial. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
   Univ Tennessee, Dept Mech Aerosp & Biomed Engn, Knoxville, TN 37996 USA.
   Oak Ridge Natl Lab, Div Chem Sci, Oak Ridge, TN 37831 USA.
   Oak Ridge Natl Lab, Div Met & Ceram, Oak Ridge, TN 37831 USA.
RP Hutchens, SA (reprint author), Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA.
EM shutchen@utk.edu; rbenson1@utk.edu
RI Xu, Qingguo/C-1962-2014
OI Xu, Qingguo/0000-0003-3191-0771; O'Neill, Hugh/0000-0003-2966-5527
CR Alexander H, 1996, BIOMATERIAL SCI, P94
   ANDERSON HC, 1993, PHYSL PHARM BONE
   Bellamy L. J., INFRARED SPECTRA COM
   BIELECKI ES, 2001, BIOPOLYMERS, V5, P37
   Bourgeois B, 2003, J BIOMED MATER RES A, V65A, P402, DOI 10.1002/jbm.a.10518
   Danilchenko SN, 2004, CRYST RES TECHNOL, V39, P71, DOI 10.1002/crat.200310151
   DOBBINS RJ, 1973, IND GUMS POLYSACCHAR
   Ducheyne P, 1999, BIOMATERIALS, V20, P2287, DOI 10.1016/S0142-9612(99)00181-7
   Dumitru S., 1996, POLYSACCHARIDES MED, P87
   Dupraz A, 1999, BIOMATERIALS, V20, P663, DOI 10.1016/S0142-9612(98)00222-1
   Evans BR, 2003, BIOSENS BIOELECTRON, V18, P917, DOI 10.1016/S0956-5663(02)00212-9
   Granja PL, 2001, J MATER SCI, V36, P2163, DOI 10.1023/A:1017587815583
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Helenius G, 2006, J BIOMED MATER RES A, V76A, P431, DOI 10.1002/jbm.a.30570
   Hong L, 2006, MATER LETT, V60, P1710, DOI 10.1016/j.matlet.2005.12.004
   HUTCHENS SA, Patent No. 20040096509
   KLEIN CPAT, 1990, BIOMATERIALS, V11, P509, DOI 10.1016/0142-9612(90)90067-Z
   Klemm D, 2001, PROG POLYM SCI, V26, P1561, DOI 10.1016/S0079-6700(01)00021-1
   Klemm D., 2005, ANGEW CHEM INT EDIT, V44, P2
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Lin JHC, 2001, J MATER SCI-MATER M, V12, P731, DOI 10.1023/A:1011280828663
   Martens W, 2003, AM MINERAL, V88, P37
   Mavropoulos E, 2003, MATER CHARACT, V50, P203, DOI 10.1016/S1044-5803(03)00093-7
   Mello LR, 1997, J NEUROSURG, V86, P143, DOI 10.3171/jns.1997.86.1.0143
   MIYAMOTO T, 1989, J BIOMED MATER RES, V23, P125, DOI 10.1002/jbm.820230110
   Murugan R, 2004, BIOMATERIALS, V25, P3829, DOI 10.1016/j.biomaterials.2003.10.016
   NISHI Y, 1990, J MATER SCI, V25, P2997, DOI 10.1007/BF00584917
   NOVAES AB, 1991, BRAZ DENT J, V4, P65
   Oyane A, 2003, BIOMATERIALS, V24, P1729, DOI 10.1016/S0142-9612(02)00581-1
   Park JB, 1984, BIOMATERIALS SCI ENG
   Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546
   Rhee SH, 2000, J MATER SCI-MATER M, V11, P449, DOI 10.1023/A:1008992009826
   SAUER GR, 1988, J BIOL CHEM, V263, P13718
   SCHRAMM M, 1954, J GEN MICROBIOL, V11, P123, DOI 10.1099/00221287-11-1-123
   Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242
   SUGIYAMA J, 1991, MACROMOLECULES, V24, P2461, DOI 10.1021/ma00009a050
   Svensson A, 2005, BIOMATERIALS, V26, P419, DOI 10.1016/j.biomaterials.2004.02.049
   Vallet-Regi M, 1997, SOLID STATE IONICS, V101, P1279, DOI 10.1016/S0167-2738(97)00213-0
   Walton A. G., 1973, BIOPOLYMERS
   White DG, 1989, CELLULOSE WOOD CHEM, P573
   Wilson RM, 2005, BIOMATERIALS, V26, P1317, DOI 10.1016/j.biomaterials.2004.04.038
   Won CY, 2000, BIOMATERIALS BIOENGI, P355
   Yang PY, 1996, J APPL POLYM SCI, V60, P1137, DOI 10.1002/(SICI)1097-4628(19960523)60:8<1137::AID-APP6>3.0.CO;2-M
   Yannas I. V., 1996, BIOMATERIALS SCI INT, V1, P84
NR 44
TC 195
Z9 209
U1 10
U2 141
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2006
VL 27
IS 26
BP 4661
EP 4670
DI 10.1016/j.biomaterials.2006.04.032
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 063CV
UT WOS:000238994500017
PM 16713623
DA 2018-10-19
ER

PT J
AU Levine, BR
   Sporer, S
   Poggie, RA
   Della Valle, CJ
   Jacobs, JJ
AF Levine, Brett Russell
   Sporer, Scott
   Poggie, Robert A.
   Della Valle, Craig J.
   Jacobs, Joshua J.
TI Experimental and clinical performance of porous tantalum in orthopedic
   surgery
SO BIOMATERIALS
LA English
DT Article
DE tantalum; orthopaedics
ID MONOBLOCK ACETABULAR COMPONENT; TOTAL KNEE ARTHROPLASTY; TOTAL
   HIP-ARTHROPLASTY; METAL IMPLANTS; MECHANICAL-PROPERTIES; TRABECULAR
   METAL; BONE INGROWTH; TISSUE INGROWTH; FIBROUS TISSUE; PORE-SIZE
AB Porous tantalum, a new low modulus metal with a characteristic appearance similar to cancellous bone, is currently available for use in several orthopedic applications (hip and knee arthroplasty, spine surgery, and bone graft substitute). The open-cell structure of repeating dodecahedrons is produced via carbon vapor deposition/infiltration of commercially pure tantalum onto a vitreous carbon scaffolding. This transition metal maintains several interesting biomaterial properties, including: a high volumetric porosity (70-80%), low modulus of elasticity (3 MPa), and high frictional characteristics. Tantalum has excellent biocompatibility and is safe to use in vivo as evidenced by its historical and current use in pacemaker electrodes, cranioplasty plates and as radiopaque markers. The bioactivity and biocompatibility of porous tantalum stems from its ability to form a self-passivating surface oxide layer. This surface layer leads to the formation of a bone-like apatite coating in vivo and affords excellent bone and fibrous in-growth properties allowing for rapid and substantial bone and soft tissue attachment. Tantalum-chondrocyte composites have yielded successful early results in vitro and may. afford an option for joint resurfacing in the future. The development of porous tantalum is in its early stages of evolution and the following represents a review of its biomaterial properties and applications in orthopedic surgery. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Rush Univ, Med Ctr, Chicago, IL 60612 USA.
   Zimmer Trabecular Met Technol Inc, Global Brand Management, Parsippany, NJ 07054 USA.
RP Levine, BR (reprint author), Rush Univ, Med Ctr, 1725 E Harrison St,Suite 1063, Chicago, IL 60612 USA.
EM brettlevinemd@gmail.com; bob.poggie@zimmer.com; craigdv@yahoo.com;
   jacobs.jacobs@rushortho.com
OI Jacobs, Joshua/0000-0003-3902-7334
CR Adams JE, 2005, J HAND SURG-AM, V30A, P1128, DOI 10.1016/j.jhsa.2005.08.008
   Andreykiv A, 2005, J BIOMECH, V38, P1023, DOI 10.1016/j.jbiomech.2004.05.044
   BARGIOTAS K, 2005, 7I AAOS ANN M WASH D
   Barrere F, 2003, J BIOMED MATER RES B, V67B, P655, DOI 10.1002/jbm.b.10057
   Barrere F, 2003, J BIOMED MATER RES A, V66A, P779, DOI 10.1002/jbm.a.10454
   Bermudez MD, 2005, WEAR, V258, P693, DOI 10.1016/j.wear.2004.09.023
   Black Jonathan, 1994, Clinical Materials, V16, P167, DOI 10.1016/0267-6605(94)90113-9
   BLEOBAUM RD, 1994, CLIN ORTHOP RELAT R, V298, P19
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   BOBYN JD, 1982, J BIOMED MATER RES, V16, P571, DOI 10.1002/jbm.820160505
   CARDONNE SM, 1995, INT J REFRACT MET H, V13, P187, DOI 10.1016/0263-4368(95)94023-R
   Chalkin B, 2005, J ARTHROPLASTY, V20, P127, DOI 10.1016/j.arth.2004.09.029
   Christie Michael J, 2002, Am J Orthop (Belle Mead NJ), V31, P219
   Cohen Robert, 2002, Am J Orthop (Belle Mead NJ), V31, P216
   Findlay DM, 2004, BIOMATERIALS, V25, P2215, DOI 10.1016/j.biomaterials.2003.09.005
   GARBUZ DS, 2004, OPER TECH ORTHOP, V14, P117
   Gordon WJ, 2005, J BIOMED MATER RES B, V75B, P229, DOI 10.1002/jbm.b.30242
   Gross AE, 2005, J ARTHROPLASTY, V20, P91, DOI 10.1016/j.arth.2005.03.020
   Gruen TA, 2005, J ARTHROPLASTY, V20, P369, DOI 10.1016/j.arth.2004.12.049
   Hacking SA, 2000, J BIOMED MATER RES, V52, P631
   Heiner AD, 2001, T ORTHOP RES SOC, V26, P480
   Hirakawa K, 2004, CLIN ORTHOP RELAT R, P10
   Hui PW, 1996, J BIOMECH, V29, P123, DOI 10.1016/0021-9290(95)00010-0
   JASTY M, 1993, J BIOMED MATER RES, V27, P639, DOI 10.1002/jbm.820270511
   JOHANSSON CB, 1990, BIOMATERIALS, V11, P277, DOI 10.1016/0142-9612(90)90010-N
   Kato H, 2000, J BIOMED MATER RES, V53, P28, DOI 10.1002/(SICI)1097-4636(2000)53:1<28::AID-JBM4>3.3.CO;2-6
   Kim HM, 1996, J BIOMED MATER RES, V32, P409, DOI 10.1002/(SICI)1097-4636(199611)32:3<409::AID-JBM14>3.0.CO;2-B
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   KOKUBO T, 1991, BIOMATERIALS, V12, P155, DOI 10.1016/0142-9612(91)90194-F
   Kokubo T, 2004, Med J Malaysia, V59 Suppl B, P91
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   LABERGE M, 1990, J BIOMED MATER RES, V24, P959, DOI 10.1002/jbm.820240712
   LEVINE BR, IN PRESS J KNEE SURG
   LEVINE BR, IN PRESS J AM ACAD O
   LEWIS RJ, 2003, ANN M AM AC ORTH SUR
   Macheras GA, 2006, J BONE JOINT SURG BR, V88B, P304, DOI 10.1302/0301-620X.88B3.16940
   MALKANI AL, 2005, 72 AAOS ANN M WASH D
   Mardones RM, 2005, TISSUE ENG, V11, P1368, DOI 10.1089/ten.2005.11.1368
   MARDONES RM, 2005, 72 AAOS ANN M WASH D
   Matsuno H, 2001, BIOMATERIALS, V22, P1253, DOI 10.1016/S0142-9612(00)00275-1
   Miyazaki T, 2000, J BIOMED MATER RES, V50, P35, DOI 10.1002/(SICI)1097-4636(200004)50:1<35::AID-JBM6>3.0.CO;2-8
   Miyazaki T, 2002, BIOMATERIALS, V23, P827, DOI 10.1016/S0142-9612(01)00188-0
   Nasser S, 2004, J ARTHROPLASTY, V19, P562, DOI 10.1016/j.arth.2004.02.025
   Nehme A, 2004, CLIN ORTHOP RELAT R, P201, DOI 10.1097/01.blo.0000150133.88271
   Nelson CL, 2003, J ARTHROPLASTY, V18, P37, DOI 10.1054/S0883-5403(03)00290-0
   NEO M, 1992, J BIOMED MATER RES, V26, P255, DOI 10.1002/jbm.820260210
   ODRISCOLL SW, 1995, OSTEOARTHR CARTILAGE, V3, P197, DOI 10.1016/S1063-4584(05)80054-8
   Rahbek O, 2005, INT ORTHOP, P1
   Schoettle T, 2005, P ANN M CSRS SAN DIE
   Sculco TP, 2002, J ARTHROPLASTY, V17, P118, DOI 10.1054/arth.2002.32690
   Shimko DA, 2005, J BIOMED MATER RES B, V73B, P315, DOI 10.1002/jbm.b.30229
   SHIRAZIADL A, 1993, J BIOMED MATER RES, V27, P167, DOI 10.1002/jbm.820270205
   Sidhu K S, 2001, Spine J, V1, P331, DOI 10.1016/S1529-9430(01)00113-9
   SIFFRI PC, 2006, 73 AAOS ANN M CHIC
   Sporer SM, 2005, J ARTHROPLASTY, V20, P79, DOI 10.1016/j.arth.2005.03.006
   SPORER SM, 2005, AAHKS 15 ANN M DALL
   Springer BD, 2005, J BONE JOINT SURG AM, V87A, P2626, DOI 10.2106/JBJS.E.00088
   Steinberg ME, 2004, ORTHOP CLIN N AM, V35, P273, DOI 10.1016/j.ocl.2004.02.005
   Stulberg SD, 2003, J ARTHROPLASTY, V18, P48, DOI 10.1054/arth.2003.50106
   STULBERG SD, 2004, 71 AAOS ANN M SAN FR
   STULBERG SD, 2004, J ARTHROPLASTY, V169, P257
   STULBERG SD, 2004, J BONE JOINT SURG S4, V86, P417
   Tsao AK, 2005, J BONE JOINT SURG AM, V87A, P22, DOI 10.2106/JBJS.E.00490
   Unger AS, 2005, J ARTHROPLASTY, V20, P1002, DOI 10.1016/j.arth.2005.01.023
   Wigfield C, 2003, BRIT J NEUROSURG, V17, P418, DOI 10.1080/02688690310001611206
   Zardiackas LD, 2001, J BIOMED MATER RES, V58, P180, DOI 10.1002/1097-4636(2001)58:2<180::AID-JBM1005>3.0.CO;2-5
   Zhang Y., 1999, Journal of Musculoskeletal Research, V3, P245, DOI 10.1142/S0218957799000269
   Zou XN, 2005, SPINE, V30, pE392, DOI 10.1097/01.brs.0000170588.80377.3f
   Zou Xuenong, 2004, Spine J, V4, P99, DOI 10.1016/S1529-9430(03)00407-8
NR 72
TC 255
Z9 268
U1 10
U2 94
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2006
VL 27
IS 27
BP 4671
EP 4681
DI 10.1016/j.biomaterials.2006.04.041
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 067HA
UT WOS:000239291300001
PM 16737737
DA 2018-10-19
ER

PT J
AU Wu, ACK
   Grondahl, L
   Jack, KS
   Foo, MX
   Trau, M
   Hume, DA
   Cassady, AI
AF Wu, Andy C. K.
   Grondahl, Lisbeth
   Jack, Kevin S.
   Foo, Michelle X.
   Trau, Matt
   Hume, David A.
   Cassady, Alan I.
TI Reduction of the in vitro pro-inflammatory response by macrophages to
   poly(3-hydroxybutyrate-co-3-hydroxyvalerate)
SO BIOMATERIALS
LA English
DT Article
DE biocompatibility; endotoxin; inflammation; macrophage
ID TISSUE-RESPONSE; COMPOSITE SCAFFOLDS; SIGNAL-TRANSDUCTION; ANTIBIOTIC
   RELEASE; BACTERIAL-DNA; DEGRADATION; POLY(3-HYDROXYBUTYRATE);
   POLYHYDROXYALKANOATES; IMPLANTATION; FABRICATION
AB This study evaluates the pro-inflammatory response to the thermoplastic biopolymer poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) through the analysis of cellular responses in vitro. The murine macrophage RAW264.7 cell line was cultured on solvent cast PHBV films, which was found to induce pro-inflammatory activity that required direct contact between the material and the macrophages. The identity of the pro-inflammatory stimulus was determined by culturing bone marrow-derived macrophages from bacterial lipopolysaccharide (LPS) hyporesponsive C3H/HeJ mice and CpG non-responsive TLR9-/- mice on PHBV. The lack of a pro-inflammatory response by the C3H/HeJ cells indicates that the pro-inflammatory agent present within PHBV is predominately LPS while the TLR9-/- macrophages confirmed that CpG-containing bacterial DNA is unlikely to contribute to the activity. A series of purification procedures was evaluated and one procedure was developed that utilized hydrogen peroxide treatment in solution. The optimized purification was found to substantially reduce the pro-inflammatory response to PHBV without adversely affecting either the molecular structure or molecular weight of the material thereby rendering it more amenable for use as a biomaterial in vivo. Crown Copyright (c) 2006 Published by Elsevier Ltd. All rights reserved.
C1 Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.
   Univ Queensland, Cooperat Res Ctr Inflammatory Dis, St Lucia, Qld 4072, Australia.
   Univ Queensland, Sch Mol & Microbial Sci, St Lucia, Qld 4072, Australia.
   Univ Queensland, Ctr Nanotechnol & Biomat, St Lucia, Qld 4072, Australia.
   Univ Queensland, Australian Inst Bioengn & Nanotechnol, St Lucia, Qld 4072, Australia.
RP Cassady, AI (reprint author), Univ Queensland, Inst Mol Biosci, St Lucia, Qld 4072, Australia.
EM I.Cassady@imb.uq.edu.au
RI Trau, Matt/E-3944-2015; Jack, Kevin/I-5636-2014; Hume, David/C-7695-2013
OI Trau, Matt/0000-0001-5516-1280; Jack, Kevin/0000-0002-9536-8048;
   Grondahl, Lisbeth/0000-0001-6012-9808; Hume, David/0000-0002-2615-1478;
   Cassady, Alan/0000-0001-8585-5427
CR Betz RR, 2002, ORTHOPEDICS, V25, pS561
   CASSADY AI, 1991, NUCLEIC ACIDS RES, V19, P6839, DOI 10.1093/nar/19.24.6839
   Chen GQ, 2005, BIOMATERIALS, V26, P6565, DOI 10.1016/j.biomaterials.2005.04.036
   Dragoi AM, 2005, EMBO J, V24, P779, DOI 10.1038/sj.emboj.7600539
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X
   Gursel I, 2002, J MICROENCAPSUL, V19, P153, DOI 10.1080/02652040110065413
   Hankermeyer C R, 1999, Rev Environ Contam Toxicol, V159, P1
   Hemmi H, 2000, NATURE, V408, P740
   Hume D A, 2001, BMC Immunol, V2, P11, DOI 10.1186/1471-2172-2-11
   Hume DA, 2002, J LEUKOCYTE BIOL, V72, P621
   Kose GT, 2004, TISSUE ENG, V10, P1234, DOI 10.1089/ten.2004.10.1234
   Kose GT, 2003, BIOMATERIALS, V24, P4999, DOI 10.1016/S0142-9612(03)00417-4
   Lee SY, 1999, APPL ENVIRON MICROB, V65, P2762
   Li HY, 2005, J BIOMATER APPL, V20, P137, DOI 10.1177/0885328205049472
   Li HY, 2004, BIOMATERIALS, V25, P5473, DOI 10.1016/j.biomaterials.2003.12.052
   LUZIER WD, 1992, P NATL ACAD SCI USA, V89, P839, DOI 10.1073/pnas.89.3.839
   Miller YI, 2005, ARTERIOSCL THROM VAS, V25, P1213, DOI 10.1161/01.ATV.0000159891.73193.31
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Nitschke M, 2002, J BIOMED MATER RES, V59, P632, DOI 10.1002/jbm.1274.abs
   Pasare C, 2004, MICROBES INFECT, V6, P1382, DOI 10.1016/j.micinf.2004.08.018
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0
   Rossi S, 2004, J ANTIMICROB CHEMOTH, V54, P1013, DOI 10.1093/jac/dkh477
   Rouxhet L, 1998, MACROMOL SYMP, V130, P347, DOI 10.1002/masy.19981300130
   Sevastianov VI, 2003, J BIOMAT SCI-POLYM E, V14, P1029, DOI 10.1163/156856203769231547
   Shishatskaya EI, 2004, J MATER SCI-MATER M, V15, P915, DOI 10.1023/B:JMSM.0000036280.98763.c1
   Shishatskaya EI, 2004, J MATER SCI-MATER M, V15, P719, DOI 10.1023/B:JMSM.0000030215.49991.0d
   Slater S, 1999, NAT BIOTECHNOL, V17, P1011, DOI 10.1038/13711
   Stacey KJ, 1996, J IMMUNOL, V157, P2116
   Stacey KJ, 2003, J IMMUNOL, V170, P3614, DOI 10.4049/jimmunol.170.7.3614
   Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8
   TANG LP, 1995, AM J CLIN PATHOL, V103, P466
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   Turesin F, 2001, J BIOMAT SCI-POLYM E, V12, P195, DOI 10.1163/156856201750180924
   Ulmer AJ, 2002, TRENDS GLYCOSCI GLYC, V14, P53, DOI 10.4052/tigg.14.53
   vanderGiessen WJ, 1996, CIRCULATION, V94, P1690, DOI 10.1161/01.CIR.94.7.1690
   WEARY M, 1988, BIOPHARM, V1, P22
   Williams David, 2003, Med Device Technol, V14, P8
   WILLIAMS KR, 1987, BIOMATERIALS, V8, P254, DOI 10.1016/0142-9612(87)90112-8
   Williams SF, 1999, INT J BIOL MACROMOL, V25, P111, DOI 10.1016/S0141-8130(99)00022-7
NR 41
TC 21
Z9 21
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD SEP
PY 2006
VL 27
IS 27
BP 4715
EP 4725
DI 10.1016/j.biomaterials.2006.05.010
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 067HA
UT WOS:000239291300006
PM 16750849
DA 2018-10-19
ER

PT J
AU Subramani, K
   Birch, MA
AF Subramani, K.
   Birch, M. A.
TI Fabrication of poly(ethylene glycol) hydrogel micropatterns with
   osteoinductive growth factors and evaluation of the effects on
   osteoblast activity and function
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID CELL-MIGRATION; SURFACES; ADHESION; PHOTOLITHOGRAPHY; DIFFERENTIATION;
   BIOMATERIALS; ENHANCEMENT; DENSITY
AB The aims of this study were to fabricate poly(ethylene glycol) (PEG) hydrogel micropatterns on a biomaterial surface to guide osteoblast behaviour and to study how incorporating vascular endothelial growth factor (VEGF) within the adhered hydrogel influenced cell morphology. Standard photolithographic procedures or photopolymerization through a poly(dimethyl siloxane) (PDMS) mould were used to fabricate patterned PEG hydrogels on the surface of silanized silicon wafers. Hydrogel patterns were evaluated by light microscopy and surface profilometry. Rat osteoblasts were cultured on these surfaces and cell morphology investigated by fluorescence microscopy, scanning electron microscopy (SEM) and atomic force microscopy (AFM). Release of protein trapped in the polymerized PEG was evaluated and VEGF-PEG surfaces were characterized for their ability to support cell growth. These studies show that photopolymerized PEG can be used to create anti-adhesive structures on the surface of silicon that completely control where cell interaction with the substrate takes place. Using conventional lithography, structures down to 50 mu m were routinely fabricated with the boundaries exhibiting sloping sides. Using the PDMS mould approach, structures were fabricated as small as 10 mu m and boundaries were very sharp and vertical. Osteoblasts exhibiting typical morphology only grew on the silicon wafer surface that was not coated with PEG. Adding BSA to the monomer solution showed that protein could be released from the hydrogel for up to 7 days in vitro. Incorporating VEGF in the hydrogel produced micropatterns that dramatically altered osteoblast behaviour. At boundaries with the VEGF-PEG hydrogel, there was striking formation of cellular processes and membrane ruffling indicative of a change in cell morphology. This study has explored the morphogenetic properties of VEGF and the applications of nano/microfabrication techniques for guided tissue (bone) regeneration in dental and orthopaedic applications using osteoinductive PEG hydrogel micropatterns.
C1 Univ Newcastle Upon Tyne, INSAT, Inst Nanoscale Sci & Technol, Newcastle Upon Tyne NE1 7AR, Tyne & Wear, England.
   Univ Newcastle Upon Tyne, Sch Med, Sch Surg & Reprod Sci Orthopaed, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.
RP Subramani, K (reprint author), Univ Newcastle Upon Tyne, INSAT, Inst Nanoscale Sci & Technol, Newcastle Upon Tyne NE1 7AR, Tyne & Wear, England.
EM Karthikeyan.Subramani@ncl.ac.uk; M.A.Birch@ncl.ac.uk
RI SUBRAMANI, KARTHIKEYAN/N-8156-2017; SUBRAMANI, KARTHIKEYAN/D-1565-2009;
   Birch, Mark/B-7051-2009
OI SUBRAMANI, KARTHIKEYAN/0000-0003-4284-0457; 
CR Agrawal CM, 1998, JOM-J MIN MET MAT S, V50, P31, DOI 10.1007/s11837-998-0064-5
   An YJ, 2000, J CONTROL RELEASE, V64, P205, DOI 10.1016/S0168-3659(99)00143-1
   Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   BHAT SV, 2005, BIOMATERIALS
   Bokhari MA, 2005, BIOMATERIALS, V26, P5198, DOI 10.1016/j.biomaterials.2005.01.040
   Hasenbein ME, 2002, BIOMATERIALS, V23, P3937, DOI 10.1016/S0142-9612(02)00129-1
   Horwitz AR, 1999, SCIENCE, V286, P1102, DOI 10.1126/science.286.5442.1102
   Ito Y, 1999, BIOMATERIALS, V20, P2333, DOI 10.1016/S0142-9612(99)00162-3
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   Liu VA, 2002, BIOMED MICRODEVICES, V4, P257, DOI 10.1023/A:1020932105236
   Lu SX, 2000, J PHARM SCI, V89, P45, DOI 10.1002/(SICI)1520-6017(200001)89:1<45::AID-JPS5>3.0.CO;2-8
   Mann BK, 1999, BIOMATERIALS, V20, P2281, DOI 10.1016/S0142-9612(99)00158-1
   Matsuzaka K, 2003, BIOMATERIALS, V24, P2711, DOI 10.1016/S0142-9612(03)00085-1
   Mayr-Wohlfart U, 2002, BONE, V30, P472, DOI 10.1016/S8756-3282(01)00690-1
   Nagayama M, 2001, CELL MOTIL CYTOSKEL, V50, P173, DOI 10.1002/cm.10008
   NETTI PA, 1993, BIOMATERIALS, V14, P1098, DOI 10.1016/0142-9612(93)90211-J
   PATHAK CP, 1992, J AM CHEM SOC, V114, P8311, DOI 10.1021/ja00047a065
   Porte-Durrieu MC, 2004, BIOMATERIALS, V25, P4837, DOI 10.1016/j.biomaterials.2003.11.037
   QUINN CP, 1995, BIOMATERIALS, V16, P389, DOI 10.1016/0142-9612(95)98856-9
   Revzin A, 2001, LANGMUIR, V17, P5440, DOI 10.1021/la010075w
   Revzin A, 2004, LANGMUIR, V20, P2999, DOI 10.1021/la035827w
   Revzin A, 2003, LANGMUIR, V19, P9855, DOI 10.1021/la035129b
   Rezania A, 1999, J ORTHOPAED RES, V17, P615, DOI 10.1002/jor.1100170423
   Rezania A, 2000, J BIOMED MATER RES, V52, P595, DOI 10.1002/1097-4636(20001215)52:4<595::AID-JBM3>3.0.CO;2-3
   Russell RJ, 1999, ANAL CHEM, V71, P3126, DOI 10.1021/ac990060r
   Suggs LJ, 1999, CELL TRANSPLANT, V8, P345, DOI 10.1177/096368979900800402
   Tosatti S, 2004, J BIOMED MATER RES A, V68A, P458, DOI 10.1002/jbm.a.20082
   Woo RK, 2005, NANOSCALE TECHNOLOGY IN BIOLOGICAL SYSTEMS, P1
NR 28
TC 20
Z9 20
U1 1
U2 20
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD SEP
PY 2006
VL 1
IS 3
BP 144
EP 154
DI 10.1088/1748-6041/1/3/009
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 212LE
UT WOS:000249597000011
PM 18458396
DA 2018-10-19
ER

PT J
AU Medrado, GCB
   Machado, CB
   Valerio, P
   Sanches, MD
   Goes, AM
AF Medrado, G. C. B.
   Machado, C. B.
   Valerio, P.
   Sanches, M. D.
   Goes, A. M.
TI The effect of a chitosan-gelatin matrix and dexamethasone on the
   behavior of rabbit mesenchymal stem cells
SO BIOMEDICAL MATERIALS
LA English
DT Article
ID CARTILAGE DEFECTS; SILK SCAFFOLDS; TISSUE; CHONDROCYTES; PROLIFERATION;
   HYPERTROPHY; GLUCOCORTICOIDS; DIFFERENTIATION; TRANSPLANTATION;
   THYROXINE
AB Cartilage tissue has poor capability of self-repair, especially in the case of severe cartilage damage due to trauma or age-related degeneration. Cell-based tissue engineering using scaffolds has provided an option for the repair of defects in adult cartilage tissue. Mesenchymal stem cells (MSC) and chondrocytes are the two major cell sources for cartilage tissue engineering. The present study combined culture conditions of MSC in a chitosan-gelatin matrix in chondrogenic media to evaluate their effects on MSC viability and chondrogenesis for cartilage tissue engineering. MSC were harvested from rabbit bone marrows and cultured in chondrogenic media supplemented, or not, with dexamethasone in a chitosan-gelatin film (C-GF). The association of C-GF and dexamethasone promoted significant increase in cell adhesivity, viability and proliferation when compared to MCS cultured in media without dexamethasone or C-GF. In addition, dexamethasone promoted increase in the collagen concentration of MSC cultures. A reduction of alkaline phosphatase activity after three weeks of culture in chondrogenic media was verified. No influence of the C-GF or of dexamethasone was observed in this matter. Therefore, it is reasonable to suggest that biomaterial-based chitosan-gelatin and chondrogenic media supplemented with dexamethasone may stimulate the proliferation and differentiation of MSC according to the complex environmental conditions. The information presented here should be useful for the development of biomaterials to regulate the chondrogenesis of MSC suitable for cartilage tissue engineering.
C1 Univ Fed Minas Gerais, Sch Med, BR-31270901 Belo Horizonte, MG, Brazil.
   Univ Fed Minas Gerais, Biochem & Immumol Dept, Inst Biol Sci, BR-31270901 Belo Horizonte, MG, Brazil.
RP Goes, AM (reprint author), Univ Fed Minas Gerais, Sch Med, Mailbox 486, BR-31270901 Belo Horizonte, MG, Brazil.
EM goes@mono.icb.ufmg.br
OI Barcellos Machado, Carolina/0000-0003-4420-6097
CR BALLOCK RT, 1994, J CELL BIOL, V126, P1311, DOI 10.1083/jcb.126.5.1311
   BOHME K, 1992, J CELL BIOL, V116, P1035, DOI 10.1083/jcb.116.4.1035
   CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504
   Chang CH, 2003, BIOMATERIALS, V24, P4853, DOI 10.1016/S0142-9612(03)00383-1
   Chang PL, 2006, CONNECT TISSUE RES, V47, P67, DOI 10.1080/03008200600584074
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Di Martino A, 2005, BIOMATERIALS, V26, P5983, DOI 10.1016/j.biomaterials.2005.03.016
   Donati I, 2005, BIOMATERIALS, V26, P987, DOI 10.1016/j.biomaterials.2004.04.015
   Enomoto-Iwamoto M, 1998, J CELL BIOL, V140, P409, DOI 10.1083/jcb.140.2.409
   Grigolo B, 2001, BIOMATERIALS, V22, P2417, DOI 10.1016/S0142-9612(00)00429-4
   GRIGORIADIS AE, 1989, ENDOCRINOLOGY, V125, P2103, DOI 10.1210/endo-125-4-2103
   Huang Y, 2005, BIOMATERIALS, V26, P7616, DOI 10.1016/j.biomaterials.2005.05.036
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Madihally SV, 1999, BIOMATERIALS, V20, P1133, DOI 10.1016/S0142-9612(99)00011-3
   Malafaya PB, 2005, J MATER SCI-MATER M, V16, P1077, DOI 10.1007/s10856-005-4709-4
   Mao JS, 2004, BIOMATERIALS, V25, P3973, DOI 10.1016/j.biomaterials.2003.10.080
   MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4
   Noth U, 2002, TISSUE ENG, V8, P131, DOI 10.1089/107632702753503126
   QUARTO R, 1992, J CELL BIOL, V119, P989, DOI 10.1083/jcb.119.4.989
   Suh JKF, 2000, BIOMATERIALS, V21, P2589
   Tian J, 2001, J IMMUNOL, V167, P1081, DOI 10.4049/jimmunol.167.2.1081
   Valerio P, 2004, BIOMATERIALS, V25, P2941, DOI 10.1016/j.biomaterials.2003.09.086
   Wakitani S, 2002, OSTEOARTHR CARTILAGE, V10, P199, DOI 10.1053/joca.2001.0504
   Wang YZ, 2006, BIOMATERIALS, V27, P4434, DOI 10.1016/j.biomaterials.2006.03.050
   Wang YZ, 2005, BIOMATERIALS, V26, P7082, DOI 10.1016/j.biomaterials.2005.05.022
   Xia WY, 2004, J BIOMED MATER RES B, V71B, P373, DOI 10.1002/jbm.b.30087
   Yin L, 2006, CHINESE MED J-PEKING, V119, P581
   Zhao HR, 2002, BIOMATERIALS, V23, P4459, DOI 10.1016/S0142-9612(02)00162-X
NR 28
TC 27
Z9 28
U1 0
U2 7
PU IOP PUBLISHING LTD
PI BRISTOL
PA DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND
SN 1748-6041
J9 BIOMED MATER
JI Biomed. Mater.
PD SEP
PY 2006
VL 1
IS 3
BP 155
EP 161
DI 10.1088/1748-6041/1/3/010
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 212LE
UT WOS:000249597000012
PM 18458397
DA 2018-10-19
ER

PT J
AU Rogers, RG
   Abed, H
   Fenner, DE
AF Rogers, Rebecca G.
   Abed, Husam
   Fenner, Dee E.
TI Current diagnosis and treatment algorithms for anal incontinence
SO BJU INTERNATIONAL
LA English
DT Article
DE fecal incontinence; anal sphincter; quality of life
ID SACRAL NERVE-STIMULATION; QUALITY-OF-LIFE; INJECTABLE SILICONE
   BIOMATERIAL; RANDOMIZED CLINICAL-TRIAL; FECAL INCONTINENCE; SPHINCTER
   REPAIR; VAGINAL DELIVERY; ELECTRICAL-STIMULATION; URINARY-INCONTINENCE;
   RISK-FACTORS
C1 Univ New Mexico, Dept Obstet & Gynecol, Div Femal Pelv Med & Reconstruct Surg, Albuquerque, NM 87131 USA.
   Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA.
RP Rogers, RG (reprint author), Univ New Mexico, Dept Obstet & Gynecol, Div Femal Pelv Med & Reconstruct Surg, Albuquerque, NM 87131 USA.
EM rrogers@salud.unm.edu
CR Azpiroz F, 2002, AM J GASTROENTEROL, V97, P232
   BAETEN CGMI, 1991, LANCET, V338, P1163, DOI 10.1016/0140-6736(91)92030-6
   Baeten GMI, 2000, DIS COLON RECTUM, V43, P743, DOI 10.1007/BF02238008
   Barber MD, 2005, AM J OBSTET GYNECOL, V193, P103, DOI 10.1016/j.ajog.2004.12.025
   Barisic GI, 2006, INT J COLORECTAL DIS, V21, P52, DOI 10.1007/s00384-004-0737-7
   Baxter NN, 2003, DIS COLON RECTUM, V46, P1591, DOI 10.1097/013DCR.0000098906.61097.1C
   Beets-Tan RGH, 2001, RADIOLOGY, V220, P81, DOI 10.1148/radiology.220.1.r01jn1481
   Berghmans LCM, 1998, BRIT J UROL, V82, P181
   Boreham MK, 2005, AM J OBSTET GYNECOL, V192, P1637, DOI 10.1016/j.ajog.2004.11.030
   BRINK CA, 1994, NURS RES, V43, P352
   Bug G J, 2001, BJOG, V108, P1057
   BURNETT SJD, 1991, BRIT J SURG, V78, P448, DOI 10.1002/bjs.1800780419
   Casal E, 2004, Colorectal Dis, V6, P180, DOI 10.1111/j.1463-1318.2004.00609.x
   Cheetham M, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002116
   Chen ASH, 1998, DIS COLON RECTUM, V41, P1005, DOI 10.1007/BF02237391
   Christiansen J, 1999, ANN SURG, V230, P45, DOI 10.1097/00000658-199907000-00007
   Davies R, 2005, BRAIN INJURY, V19, P941, DOI 10.1080/02699050400000565
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   DEEN KI, 1993, ANN SURG, V218, P201, DOI 10.1097/00000658-199308000-00013
   Delancey JOL, 1997, OBSTET GYNECOL, V90, P924, DOI 10.1016/S0029-7844(97)00472-9
   Deutekom M, 2005, SCAND J GASTROENTERO, V40, P552, DOI 10.1080/00365520510012172
   DEUTEKOM M, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD05086.PUB2
   Devesa JM, 2002, DIS COLON RECTUM, V45, P1154, DOI 10.1007/s10350-004-6382-y
   Dietz HP, 2005, OBSTET GYNECOL, V106, P707, DOI 10.1097/01.AOG.0000178779.62181.01
   Dietz HP, 2005, ULTRASOUND OBST GYN, V25, P580, DOI 10.1002/uog.1899
   Dobben AC, 2005, AM J ROENTGENOL, V185, P1166, DOI 10.2214/AJR.04.1387
   Dobben AC, 2006, INT J COLORECTAL DIS, V21, P515, DOI 10.1007/s00384-005-0049-6
   Donnelly V, 1997, BRIT J OBSTET GYNAEC, V104, P311, DOI 10.1111/j.1471-0528.1997.tb11459.x
   Eason E, 2002, CAN MED ASSOC J, V166, P326
   Efron Jonathan E, 2004, Surg Technol Int, V13, P107
   FALK PM, 1994, DIS COLON RECTUM, V37, P468, DOI 10.1007/BF02076193
   Fenner DE, 2003, AM J OBSTET GYNECOL, V189, P1543, DOI 10.1016/j.ajog.2003.09.030
   Fitzpatrick M, 2000, AM J OBSTET GYNECOL, V183, P1220, DOI 10.1067/mob.2000.108880
   Fynes MM, 1999, DIS COLON RECTUM, V42, P753, DOI 10.1007/BF02236930
   Garcia V, 2005, AM J OBSTET GYNECOL, V192, P1697, DOI 10.1016/j.ajog.2004.11.045
   GRANT A, 1989, BRIT J OBSTET GYNAEC, V96, P1281, DOI 10.1111/j.1471-0528.1989.tb03225.x
   Guenaga KF, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001544.pub2
   Gutierrez AB, 2004, DIS COLON RECTUM, V47, P727, DOI 10.1007/s10350-003-0114-6
   HALLAN RI, 1989, BRIT J SURG, V76, P973, DOI 10.1002/bjs.1800760934
   Halverson AL, 2002, DIS COLON RECTUM, V45, P345, DOI 10.1007/s10350-004-6180-6
   Handa VL, 2001, OBSTET GYNECOL, V98, P225, DOI 10.1016/S0029-7844(01)01445-4
   HOSKER G, 2000, COCHRANE DB SYST REV, V2
   Hsu Y, 2005, OBSTET GYNECOL, V106, P1259, DOI 10.1097/01.AOG.0000189084.82449.fc
   Jarrett MED, 2004, BRIT J SURG, V91, P755, DOI 10.1002/bjs.4545
   Kammerer-Doak DN, 1999, AM J OBSTET GYNECOL, V181, P1317, DOI 10.1016/S0002-9378(99)70370-4
   Karoui S, 2000, DIS COLON RECTUM, V43, P813, DOI 10.1007/BF02238020
   Keating JP, 1997, DIS COLON RECTUM, V40, P896, DOI 10.1007/BF02051195
   Kenefick N J, 2004, Colorectal Dis, V6, P75, DOI 10.1111/j.1462-8910.2004.00610.x
   Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
   Kleinubing H, 2000, DIS COLON RECTUM, V43, P1572, DOI 10.1007/BF02236741
   Koch SM, 2004, DIS COLON RECTUM, V47, P1711, DOI 10.1007/s10350-004-0683-z
   Kwon S, 2005, DIS COLON RECTUM, V48, P323, DOI 10.1007/s10350-004-0899-y
   Lal M, 2003, OBSTET GYNECOL, V101, P305, DOI 10.1016/S0029-7844(02)02716-3
   LEIGH RJ, 1982, LANCET, V1, P1349
   Leroi AM, 2005, ANN SURG, V242, P662, DOI 10.1097/01.sla.0000186281.09475.db
   Mackrodt C, 1998, BRIT J OBSTET GYNAEC, V105, P441, DOI 10.1111/j.1471-0528.1998.tb10131.x
   MAHOMED K, 1989, BRIT J OBSTET GYNAEC, V96, P1272, DOI 10.1111/j.1471-0528.1989.tb03224.x
   Mahony RT, 2004, AM J OBSTET GYNECOL, V191, P885, DOI 10.1016/j.ajog.2004.07.006
   Malouf AJ, 2000, LANCET, V355, P260, DOI 10.1016/S0140-6736(99)05218-6
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   Martinez-Puente MD, 2004, INT J COLORECTAL DIS, V19, P210, DOI 10.1007/s00384-004-0537-5
   MATZEL KE, 1995, LANCET, V346, P1124, DOI 10.1016/S0140-6736(95)91799-3
   Matzel KE, 2004, DIS COLON RECTUM, V47, P1720, DOI 10.1007/s10350-004-0636-6
   Meyenberger C, 1996, ENDOSCOPY, V28, P217, DOI 10.1055/s-2007-1005431
   MINOR PB, 2004, GASTROENTEROLOGY, V126, pS14
   Muller C, 2005, LANGENBECK ARCH SURG, V390, P544, DOI 10.1007/s00423-005-0566-3
   Mundy L, 2004, BRIT J SURG, V91, P665, DOI 10.1002/bjs.4587
   Nelson R, 1998, DIS COLON RECTUM, V41, P1226, DOI 10.1007/BF02258218
   Nessim A, 1999, DIS COLON RECTUM, V42, P16, DOI 10.1007/BF02235177
   Norton C, 2006, DIS COLON RECTUM, V49, P190, DOI 10.1007/s10350-005-0251-1
   Norton C, 2005, DIS COLON RECTUM, V48, P1062, DOI 10.1007/s10350-004-0868-5
   Norton C, 2003, GASTROENTEROLOGY, V125, P1320, DOI 10.1053/S0016-5085(03)01368-4
   NORTON C, 2002, INCONTINENCE
   NORTON C, 2000, COCHRANE DB SYST REV, V2, P2111, DOI DOI 10.1002/14651858
   Ozturk R, 2004, ALIMENT PHARM THERAP, V20, P667, DOI 10.1111/j.1365-2036.2004.02125.x
   PARKS AG, 1975, P ROY SOC MED, V68, P681
   PESCATORI M, 1992, DIS COLON RECTUM, V35, P482, DOI 10.1007/BF02049407
   Pfrommer W, 2000, EUR J PEDIATR SURG, V10, P186, DOI 10.1055/s-2008-1072354
   Pollack J, 2004, OBSTET GYNECOL, V104, P1397, DOI 10.1097/01.AOG.0000147597.45349.e8
   Rao SSC, 2002, NEUROGASTROENT MOTIL, V14, P553, DOI 10.1046/j.1365-2982.2002.00352.x
   Rociu E, 1999, RADIOLOGY, V212, P453, DOI 10.1148/radiology.212.2.r99au10453
   Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236
   Rockwood TH, 1999, DIS COLON RECTUM, V42, P1525, DOI 10.1007/BF02236199
   Rotholtz NA, 2001, GASTROENTEROL CLIN N, V30, P131, DOI 10.1016/S0889-8553(05)70171-0
   SHAFIK A, 1993, INT SURG, V78, P159
   Solomon MJ, 2003, DIS COLON RECTUM, V46, P703, DOI 10.1097/01.DCR.0000070034.58255.06
   SULTAN AH, 1993, NEW ENGL J MED, V329, P1905, DOI 10.1056/NEJM199312233292601
   SULTAN AH, 1994, BRIT MED J, V308, P887, DOI 10.1136/bmj.308.6933.887
   Takahashi T, 2003, DIS COLON RECTUM, V46, P711, DOI 10.1097/01.DCR.0000070342.56449.4A
   Tan M, 2001, DIS COLON RECTUM, V44, P1624, DOI 10.1007/BF02234382
   Tjandra JJ, 2004, ANZ J SURG, V74, P1098, DOI 10.1111/j.1445-1433.2004.03259.x
   Tjandra JJ, 2004, DIS COLON RECTUM, V47, P2138, DOI 10.1007/s10350-004-0760-3
   Tjandra JJ, 2003, DIS COLON RECTUM, V46, P937, DOI 10.1097/01.DCR.0000074687.97942.92
   Vaizey CJ, 1999, GUT, V44, P77, DOI 10.1136/gut.44.1.77
   van Brummen HJ, 2006, INT UROGYNECOL J, V17, P224, DOI 10.1007/s00192-005-1351-0
   Varma A, 1999, DIS COLON RECTUM, V42, P1537, DOI 10.1007/BF02236202
   WILLIAMS NS, 1991, LANCET, V338, P1166
   Zetterstrom J, 1999, OBSTET GYNECOL, V94, P21, DOI 10.1016/S0029-7844(99)00248-3
NR 98
TC 10
Z9 10
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1464-4096
EI 1464-410X
J9 BJU INT
JI BJU Int.
PD SEP
PY 2006
VL 98
SU 1
BP 97
EP 106
DI 10.1111/j.1464-410X.2006.06307.x
PG 10
WC Urology & Nephrology
SC Urology & Nephrology
GA 070XQ
UT WOS:000239560400023
PM 16911614
OA Bronze
DA 2018-10-19
ER

PT J
AU Morra, M
   Cassinelli, C
AF Morra, M.
   Cassinelli, C.
TI Biomaterials surface characterization and modification
SO INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
LA English
DT Article; Proceedings Paper
CT 4th Conference on Engineering with Membranes - Medical and Biological
   Applications
CY MAY 15-18, 2005
CL Camogli, ITALY
DE surface analysis; surface modification; biomaterials surfaces; surface
   engineering
ID TITANIUM IMPLANTS; CELL-ADHESION; BALLOON ANGIOPLASTY; IN-VIVO;
   COLLAGEN; RESTENOSIS; PROTEIN; STENTS; SPECTROSCOPY; HYALURONAN
AB This paper presents several examples of recent work in the field of surface modification and characterization of biomaterials. Due to the explosion of techniques and approaches in this area, a complete review would be unmanageable in a single paper. Rather selected examples taken from such different areas as bone-contacting devices, drug eluting stents, and immobilization of novel biomolecules are presented. The aim is to place the existing and quickly developing background of analytical and synthetic biomaterial surface science into the current perspective of this rapidly evolving discipline.
C1 Nobil Bio Ric Srl, I-14018 Villafranca Asti, Italy.
RP Morra, M (reprint author), Nobil Bio Ric Srl, Str 8 Rocco 36, I-14018 Villafranca Asti, Italy.
EM mmorra@nobilbio.it
CR ADELL R, 1981, INT J ORAL MAXILLOF, V10, P387, DOI 10.1016/S0300-9785(81)80077-4
   ALBREKTSSON T, 1985, Critical Reviews in Biocompatibility, V1, P53
   Bohn PW, 2003, SURF SCI SERIES, V111, P163
   BRIGGS D, 1990, PRACTICAL SURFACE AN, V1
   Brunette D. M., 2001, TITANIUM MED
   Butt HJ, 1999, LANGMUIR, V15, P2559, DOI 10.1021/la981503+
   *CE FOUND STREP PR, NAN COAT MED DEV PEC
   Chajara A, 1998, PATHOL BIOL, V46, P561
   DAVIES JE, 2000, BONE ENG
   DAVIES JE, 1991, BONE BIOMATERIAL INT
   DILKS A, 1981, ELECTRON SPECTROSCOP, V4, P277
   Edelman ER, 1996, CIRCULATION, V94, P1199, DOI 10.1161/01.CIR.94.6.1199
   Garbassi F., 1998, POLYM SURFACES PHYS
   Gemmell CH, 2000, BONE ENG, P108
   GRILL A., 1994, COLD PLASMA MAT FABR
   Gungormus M, 2002, J ORAL MAXIL SURG, V60, P541, DOI 10.1053/joms.2002.31852
   HAMMERLE C, 2005, INT J ORAL MAXILLOF, V20, P311
   HANSSON HA, 1983, J PROSTHET DENT, V50, P108, DOI 10.1016/0022-3913(83)90175-0
   Heemskerk JWM, 1997, BLOOD, V90, P2615
   KASEMO B, 1988, J BIOMED MATER RES-A, V22, P145, DOI 10.1002/jbm.820221307
   Lebaron RG, 2000, TISSUE ENG, V6, P85, DOI 10.1089/107632700320720
   Li LH, 2004, BIOMATERIALS, V25, P2867, DOI 10.1016/j.biomaterials.2003.09.048
   Merrett K, 2002, J BIOMAT SCI-POLYM E, V13, P593, DOI 10.1163/156856202320269111
   Mikulec LJ, 1996, J BIOMED MATER RES, V32, P203, DOI 10.1002/(SICI)1097-4636(199610)32:2<203::AID-JBM8>3.0.CO;2-X
   MILLER DR, 1986, J MACROMOL SCI R M C, VC26, P33
   Morra M, 2005, BIOMACROMOLECULES, V6, P1205, DOI 10.1021/bm049346i
   Morra M, 2006, J BIOMED MATER RES A, V78A, P449, DOI 10.1002/jbm.a.30783
   Morra M, 2005, INT J ORAL MAX IMPL, V20, P23
   Morra M, 2004, BIOMACROMOLECULES, V5, P2094, DOI 10.1021/bm049834q
   Morra M, 2003, BIOMATERIALS, V24, P4639, DOI 10.1016/S0142-9612(03)00360-0
   MORRA M, 2006, P 20 EUR C BIOM NANT
   Morra M, 2001, WATER BIOMATERIALS S
   MORRA M, 2005, EUR CELL MAT S3, V10, P6
   Nangia-Makker P, 2002, TRENDS MOL MED, V8, P187, DOI 10.1016/S1471-4914(02)02295-5
   POPMA JJ, 1991, CIRCULATION, V84, P1426, DOI 10.1161/01.CIR.84.3.1426
   Puleo DA, 2002, BIOMATERIALS, V23, P2079, DOI 10.1016/S0142-9612(01)00339-8
   Puleo DA, 1999, BIOMATERIALS, V20, P2311, DOI 10.1016/S0142-9612(99)00160-X
   Rao KP, 1995, J BIOMAT SCI-POLYM E, V7, P623
   RATNER BD, 1986, SPECTROSC-BIOMED APP, P107
   Salam AM, 2006, CURR PROB CARDIOLOGY, V31, P8, DOI 10.1016/j.cpcardiol.2005.09.002
   Savani RC, 1995, INT J TISSUE REACT, V17, P141
   Sayag J, 1996, J Wound Care, V5, P357
   Scholl HJ, 2003, PECTINS THEIR MANIPU, P1
   SERRUYS PW, 1994, NEW ENGL J MED, V331, P489, DOI 10.1056/NEJM199408253310801
   Sul YT, 2002, BIOMATERIALS, V23, P491, DOI 10.1016/S0142-9612(01)00131-4
   Sul YT, 2003, BIOMATERIALS, V24, P3893, DOI 10.1016/S0142-9612(03)00261-8
   Thierry B, 2003, BIOMACROMOLECULES, V4, P1564, DOI 10.1021/bm0341834
   vanderGiessen WJ, 1996, CIRCULATION, V94, P1690, DOI 10.1161/01.CIR.94.7.1690
   Vickerman J. C., 1989, SECONDARY ION MASS S
   Vogler EA, 1996, J ELECTRON SPECTROSC, V81, P237, DOI 10.1016/0368-2048(96)02526-1
   Wagner H, 2000, PR PHYT SOC, V44, P1
   WIGHT TN, 2002, HYALURONAN, V2, P173
   Yamada H, 2000, PR PHYT SOC, V44, P15
   Yasuda H., 1985, PLASMA POLYM
NR 54
TC 11
Z9 12
U1 1
U2 9
PU WICHTIG EDITORE
PI MILAN
PA 72/74 VIA FRIULI, 20135 MILAN, ITALY
SN 0391-3988
J9 INT J ARTIF ORGANS
JI Int. J. Artif. Organs
PD SEP
PY 2006
VL 29
IS 9
BP 824
EP 833
PG 10
WC Engineering, Biomedical; Transplantation
SC Engineering; Transplantation
GA 098KS
UT WOS:000241520000003
PM 17033989
DA 2018-10-19
ER

PT J
AU Brown, MA
   Park, TS
   Rosakis, A
   Ustundag, E
   Huang, Y
   Tamura, N
   Valek, B
AF Brown, Michall A.
   Park, Tae-Soon
   Rosakis, Ares
   Ustundag, Ersan
   Huang, Young
   Tamura, Nobumichi
   Valek, Bryan
TI A comparison of X-ray microdiffraction and coherent gradient sensing in
   measuring discontinuous curvatures in thin film: Substrate systems
SO JOURNAL OF APPLIED MECHANICS-TRANSACTIONS OF THE ASME
LA English
DT Article; Proceedings Paper
CT Symposium on Current Trends in Mechanics
CY NOV 15-16, 2004
CL Calif Inst Technol, Grad Aeronaut Lab, Pasadena, CA
HO Calif Inst Technol, Grad Aeronaut Lab
ID EVOLUTION
AB The coherent gradient sensor (CGS) is a shearing interferometer which has been. proposed for the rapid, full-field measurement of deformation states (slopes and curvatures) in thin film-wafer substrate systems, and for the subsequent inference of stresses in the thin films. This approach needs to be verified using a more well-established but time-consuming grain orientation and stress measurement tool, X-ray microdiffraction (XRD). Both CGS and XRD are used to measure the deformation state of the same W film/Si wafer at room temperature. CGS provides a global, wafer-level measurement of slopes while XRD provides a local micromeasurement of lattice rotations. An extreme case of a circular Si wafer with a circular W film island in its center is used because of the presence of discontinuous system curvatures across the wafer The results are also compared with a theoretical model based on elastic plate analysis of the axisymmetric biomaterial film-substrate system. Slope and curvature measurements by XRD and by CGS compare very well with each other and with theory. The favorable comparison demonstrates that wafer-level CGS metrology provides a quick and accurate alternative to other measurements. It also demonstrates the accuracy of plate theory in modeling thin film-substrate systems, even in the presence of curvature discontinuities.
C1 CALTECH, Dept Mat Sci, Pasadena, CA 91125 USA.
   Orax Diagnost, Fremont, CA 94539 USA.
   CALTECH, Grad Aeronaut Labs, Pasadena, CA 91125 USA.
   Iowa State Univ, Dept Mat Sci & Engn, Ames, IA 50011 USA.
   Univ Illinois, Dept Mech Engn, Urbana, IL 61801 USA.
   Univ Calif Berkeley, Lawrence Berkeley Lab, Adv Light Source, Berkeley, CA 94720 USA.
RP Brown, MA (reprint author), CALTECH, Dept Mat Sci, M-C 205-45, Pasadena, CA 91125 USA.
EM mabrown@Caltech.edu
RI Ustundag, Ersan/C-1258-2009; Huang, Yonggang/B-6998-2009
OI Ustundag, Ersan/0000-0002-0812-7028; Tamura,
   Nobumichi/0000-0002-3698-2611
CR Freund L.B., 2003, THIN FILM MAT STRESS
   Gouldstone A, 1998, J MATER RES, V13, P1956, DOI 10.1557/JMR.1998.0275
   Lee H, 2001, J APPL PHYS, V89, P6116, DOI 10.1063/1.1364650
   Noyan I. C., 1987, RESIDUAL STRESS MEAS
   Park TS, 2000, ACTA MATER, V48, P3169, DOI 10.1016/S1359-6454(00)00114-2
   Park TS, 2003, J MECH PHYS SOLIDS, V51, P2191, DOI 10.1016/j.jmps.2003.09.031
   PARK TS, 2005, UNPUB J ELECT MATER
   Rosakis AJ, 1998, THIN SOLID FILMS, V325, P42, DOI 10.1016/S0040-6090(98)00432-5
   ROSAKIS AJ, 2005, UNPUB THIN SOLID FIL
   ROSAKIS AJ, 2005, UNPUB THERMOELASTIC
   Stoney GG, 1909, P R SOC LOND A-CONTA, V82, P172, DOI 10.1098/rspa.1909.0021
   Tamura N, 2003, J SYNCHROTRON RADIAT, V10, P137, DOI 10.1107/S0909049502021362
NR 12
TC 10
Z9 10
U1 0
U2 6
PU ASME-AMER SOC MECHANICAL ENG
PI NEW YORK
PA THREE PARK AVE, NEW YORK, NY 10016-5990 USA
SN 0021-8936
J9 J APPL MECH-T ASME
JI J. Appl. Mech.-Trans. ASME
PD SEP
PY 2006
VL 73
IS 5
BP 723
EP 729
DI 10.1115/1.2150500
PG 7
WC Mechanics
SC Mechanics
GA 077ED
UT WOS:000240009700003
OA Green Published
DA 2018-10-19
ER

PT J
AU Boukari, A
   Francius, G
   Hemmerle, J
AF Boukari, Abdessamad
   Francius, Gregory
   Hemmerle, Joseph
TI AFM force spectroscopy of the fibrinogen adsorption process onto dental
   implants
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE atomic force microscopy; force spectroscopy; fibrinogen; adsorption;
   dental implant
ID TITANIUM-ALLOY; SURFACE; HYDROXYAPATITE; BIOMATERIALS; MICROSCOPE;
   TOPOGRAPHY; ATTACHMENT; RESPONSES; PROTEINS; ADHESION
AB Protein binding to implants is governed by the physicochemical properties of the biomaterial surface. The adhesion of a protein onto a solid surface is nonspecific. The aim of this study was to assess the adsorption process of fibrinogen at two different dental implants. The first biomaterial has a sand-blasted titanium surface, whereas the second one is covered by a calcium phosphate coating. After scanning electron microscopy and atomic force microscopy characterization of the implant surfaces, force spectroscopy has been used to determine the unbinding force of fibrinogen adsorbed at the two different substrates. Force-measurement findings indicate that the detachment force of fibrinogen adsorbed onto both surfaces varies as a function of the interaction time. The mean strength of the unbinding forces increases with the interaction time (100 and 1000 ms, respectively). However, experimental data suggest that fibrinogen fixes to the two studied biomaterials by different mechanisms. Moreover, it appears that, after an interaction time of 1000 ms, the detachment force of the adsorbed protein is quite larger for the titanium surface than for the calcium phosphate coating. (c) 2006 Wiley Periodicals, Inc.
C1 INSERM, Unite 595, F-67085 Strasbourg, France.
   Univ Strasbourg 1, Fac Chirurg Dent, F-67000 Strasbourg, France.
RP Hemmerle, J (reprint author), INSERM, Unite 595, 11 Rue Humann, F-67085 Strasbourg, France.
EM Joseph.Hemmerle@medecine.u-strasbg.fr
RI Francius, Gregory/A-4246-2015
OI Francius, Gregory/0000-0001-8533-9449
CR Cacciafesta P, 2001, SURF SCI, V491, P405, DOI 10.1016/S0039-6028(01)01303-6
   Cacciafesta P, 2000, LANGMUIR, V16, P8167, DOI 10.1021/la000362k
   De Paris R, 2000, SINGLE MOL, V1, P285, DOI DOI 10.1002/1438-5171(200012)1:4<285::AID-SIMO285>3.0.CO;2-3
   Diener A, 2005, BIOMATERIALS, V26, P383, DOI [10.1016/j.biomaterials.2004.02.038, 10.1016/j.biomaterials.2004.02.019]
   Gergely C, 2001, ULTRAMICROSCOPY, V87, P67, DOI 10.1016/S0304-3991(00)00063-2
   Gotz HE, 2004, BIOMATERIALS, V25, P4057, DOI 10.1016/j.biomaterials.2003.11.002
   Habibovic P, 2005, BIOMATERIALS, V26, P23, DOI 10.1016/j.biomaterials.2004.02.026
   Hemmerle J, 1999, P NATL ACAD SCI USA, V96, P6705, DOI 10.1073/pnas.96.12.6705
   Hemmerle J, 1996, BIOMATERIALS, V17, P1913, DOI 10.1016/0142-9612(95)00244-8
   Hemmerle J, 1997, J BIOMED MATER RES, V36, P418, DOI 10.1002/(SICI)1097-4636(19970905)36:3<418::AID-JBM17>3.3.CO;2-N
   Hemmerle J, 1997, J DENT RES, V76, P682, DOI 10.1177/00220345970760020901
   Jenney CR, 2000, J BIOMED MATER RES, V49, P435
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   Kaufmann EABE, 2000, J BIOMED MATER RES, V52, P825, DOI 10.1002/1097-4636(20001215)52:4<825::AID-JBM28>3.0.CO;2-M
   Leize EM, 2000, CLIN ORAL IMPLAN RES, V11, P279, DOI 10.1034/j.1600-0501.2000.011004279.x
   Levy R, 2002, NANOTECHNOLOGY, V13, P33, DOI 10.1088/0957-4484/13/1/307
   Lincks J, 1998, BIOMATERIALS, V19, P2219, DOI 10.1016/S0142-9612(98)00144-6
   MacDonald DE, 1998, J BIOMED MATER RES, V41, P120
   Mustafa K, 2005, BIOMATERIALS, V26, P373, DOI 10.1016/j.biomaterials.2004.02.037
   Porter AE, 2004, BIOMATERIALS, V25, P5199, DOI 10.1016/j.biomaterials.2003.12.018
   Siebers MC, 2005, BIOMATERIALS, V26, P137, DOI 10.1016/j.biomaterials.2004.02.021
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   Wang MS, 2004, LANGMUIR, V20, P7753, DOI 10.1021/la049849+
   Zhu XL, 2004, BIOMATERIALS, V25, P4087, DOI 10.1016/j.biomaterials.2003.11.011
NR 24
TC 20
Z9 21
U1 0
U2 12
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2006
VL 78A
IS 3
BP 466
EP 472
DI 10.1002/jbm.a.30778
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 071PJ
UT WOS:000239613800005
PM 16721792
DA 2018-10-19
ER

PT J
AU Blouin, S
   Moreau, MF
   Weiss, P
   Daculsi, G
   Basle, MF
   Chappard, D
AF Blouin, S.
   Moreau, M. F.
   Weiss, P.
   Daculsi, G.
   Basle, M. F.
   Chappard, D.
TI Evaluation of an injectable bone substitute (beta
   TCP/hydroxyapatite/hydroxy-propyl-methyl-cellulose) in severely
   osteopenic and aged rats
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE microCT; osteoporosis-treatment; injectable material; castration;
   calcium-phosphate
ID CALCIUM-PHOSPHATE CERAMICS; IN-VITRO; PERCUTANEOUS VERTEBROPLASTY;
   SYNTHETIC HYDROXYAPATITE; OSTEOCLASTIC RESORPTION; TISSUE-REACTIONS;
   RABBIT BONE; BIOMATERIALS; CELLS; MICROARCHITECTURE
AB The use of injectable biomaterials is of interest in osteoporotic patients to locally restore bone mass in sites at risk of fracture. An injectable bone substitute (IBS1 made of beta TCP/hydroxyapatite as a calcium phosphate substitute and hydroxy-propyl-methyl-cellulose as a polymer carrier) was used in a severely osteopenic rat model obtained by combining orchidectomy (ORX) and disuse (paralysis induced by botulinum toxin - BTX). Fifty-six aged male rats were randomized into three groups: 18 were SHAM operated; 38 were ORX and BTX injected in the right hindlimb; they constituted the OP (osteoporotic) group. One month after ORX-BTX surgery, 20 of these OP rats received a IBS1 injection in the right femur (OP-IBS1 rats). Animals were studied at the time of IBS1 injection 1 month post ORX-BTX (M1), 1 month (M2) and 2 months (M3) after IBS1 injection. Bone mass (BV/TV) and microarchitectural parameters were measured by microCT. BV/TV was decreased after ORX-BTX; ORX and BTX had cumulative effects on bone loss (differences maximized on the right femur). BV/TV (combining the volume of both bone and material in OP-IBS1 rats) was elevated at M1 but decreased at M2. Marked bone formation was found onto the biomaterial granules but bone had a woven texture. A marked increase in the number of nonosteoclastic TRAcP+ cells was found in the implanted area. IBS1 induced new bone formation shortly after implantation but both IBS1 and woven bone were resorbed without inducing lamellar bone. Biomaterial trials must be conducted with long-term implantation periods, in aged osteoporotic animals. (c) 2006 Wiley Periodicals, Inc.
C1 Fac Med, INSERM, EMI 0335, LHEA, F-49045 Angers, France.
   Fac Chirurg Dent, INSERM, EMI 9903, F-44042 Nantes, France.
RP Chappard, D (reprint author), Fac Med, INSERM, EMI 0335, LHEA, F-49045 Angers, France.
EM daniel.chappard@univ-angers.fr
RI Weiss, Pierre/P-1372-2014; Daculsi, Guy/P-1320-2014; Xu,
   Qingguo/C-1962-2014
OI Weiss, Pierre/0000-0002-6159-8590; Daculsi, Guy/0000-0003-1030-3446; Xu,
   Qingguo/0000-0003-3191-0771; Blouin, Stephane/0000-0001-6575-8443
CR Audran M, 2001, CALCIFIED TISSUE INT, V69, P214, DOI 10.1007/s00223-001-1058-2
   Ayers RA, 1999, J BIOMED MATER RES, V47, P54, DOI 10.1002/(SICI)1097-4636(199910)47:1<54::AID-JBM7>3.3.CO;2-G
   BASLE MF, 1993, CALCIFIED TISSUE INT, V53, P348, DOI 10.1007/BF01351842
   CHAPPARD D, 1983, BASIC APPL HISTOCHEM, V27, P75
   Chappard D, 1999, INT J ORAL MAX IMPL, V14, P189
   Chappard D, 2001, BONE, V28, P72, DOI 10.1016/S8756-3282(00)00438-5
   Cotten A, 1998, RADIOGRAPHICS, V18, P311, DOI 10.1148/radiographics.18.2.9536480
   Currey JD, 2003, J BIOMECH, V36, P1487, DOI 10.1016/S0021-9290(03)00124-6
   DACULSI G, 1989, J BIOMED MATER RES, V23, P883, DOI 10.1002/jbm.820230806
   Daculsi G, 1998, BIOMATERIALS, V19, P1473, DOI 10.1016/S0142-9612(98)00061-1
   DERSOT JM, 1995, ANAT REC, V242, P166, DOI 10.1002/ar.1092420205
   Dong JA, 2002, BIOMATERIALS, V23, P4493, DOI 10.1016/S0142-9612(02)00193-X
   Dupraz A, 1998, J BIOMED MATER RES, V42, P368, DOI 10.1002/(SICI)1097-4636(19981205)42:3<368::AID-JBM4>3.3.CO;2-V
   Eid K, 2001, J ORTHOPAED RES, V19, P962, DOI 10.1016/S0736-0266(00)00080-2
   Fini M, 1997, INT J ARTIF ORGANS, V20, P291
   Frost H M, 1983, Henry Ford Hosp Med J, V31, P3
   Gauthier O, 1999, J BIOMED MATER RES, V47, P28, DOI 10.1002/(SICI)1097-4636(199910)47:1<28::AID-JBM4>3.0.CO;2-P
   Gauthier O, 2005, BIOMATERIALS, V26, P5444, DOI 10.1016/j.biomaterials.2005.01.072
   Gauthier O, 2001, J MATER SCI-MATER M, V12, P385, DOI 10.1023/A:1011284517429
   GAUTHIER O, 1999, BONE, V25, P71
   Gisep A, 2002, INJURY, V33, P88, DOI 10.1016/S0020-1383(02)00138-9
   GOMI K, 1993, BIOMATERIALS, V14, P91, DOI 10.1016/0142-9612(93)90216-O
   Grimandi G, 1998, J BIOMED MATER RES, V39, P660, DOI 10.1002/(SICI)1097-4636(19980315)39:4<660::AID-JBM22>3.0.CO;2-9
   HAHN M, 1992, BONE, V13, P327, DOI 10.1016/8756-3282(92)90078-B
   Heini P.F., 2001, EUR SPINE J, V10, P205
   Hide IG, 2004, CLIN RADIOL, V59, P461, DOI 10.1016/j.crad.2004.01.001
   Iwamoto J, 2002, BONE, V30, P360, DOI 10.1016/S8756-3282(01)00687-1
   Iwamoto J, 2003, J BONE MINER RES, V18, P776, DOI 10.1359/jbmr.2003.18.4.776
   JARCHO M, 1981, CLIN ORTHOP RELAT R, P259
   Jee W.S.S., 1999, Morphologie, V83, P25
   Jinnai H, 2002, BONE, V30, P191, DOI 10.1016/S8756-3282(01)00672-X
   Johnson KD, 1996, J ORTHOPAED RES, V14, P351, DOI 10.1002/jor.1100140304
   Kamakura S, 1997, J ELECTRON MICROSC, V46, P397, DOI 10.1093/oxfordjournals.jmicro.a023535
   Khairoun I, 2002, J BIOMED MATER RES, V60, P633, DOI 10.1002/jbm.10132
   LIN BY, 1994, BONE MINER, V25, P199, DOI 10.1016/S0169-6009(08)80239-5
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Lu JX, 1998, J BIOMED MATER RES, V42, P357, DOI 10.1002/(SICI)1097-4636(19981205)42:3<357::AID-JBM3>3.0.CO;2-I
   MINAIRE P, 1974, CALC TISS RES, V17, P57, DOI 10.1007/BF02547214
   Monchau F, 2002, BIOMOL ENG, V19, P143, DOI 10.1016/S1389-0344(02)00023-0
   Noshi T, 2000, J BIOMED MATER RES, V52, P621
   OKUMURA H, 1991, CELL MATER, P125
   Ooms EM, 2002, J BIOMED MATER RES, V61, P9, DOI 10.1002/jbm.10029
   PANUSH RS, 1993, AM J MED, V95, P1, DOI 10.1016/0002-9343(93)90225-E
   Saito T, 2002, BIOMATERIALS, V23, P2711, DOI 10.1016/S0142-9612(02)00003-0
   SEEMAN E, 2003, OSTEOPOROS INT S5, V14, P3
   TAKESHITA N, 1992, J ELECTRON MICROSC, V41, P141
   Tanaka Akiyoshi, 2002, J Orthop Sci, V7, P370, DOI 10.1007/s007760200062
   VANDERSCHUEREN D, 1992, ENDOCRINOLOGY, V130, P2906, DOI 10.1210/en.130.5.2906
   Weiss P, 2003, BIOMATERIALS, V24, P4591, DOI 10.1016/S0142-9612(03)00335-1
   Yamada S, 1997, J BIOMED MATER RES, V37, P346, DOI 10.1002/(SICI)1097-4636(19971205)37:3<346::AID-JBM5>3.0.CO;2-L
   Yoshikawa T, 1996, J BIOMED MATER RES, V32, P481
NR 51
TC 22
Z9 26
U1 2
U2 13
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD SEP 1
PY 2006
VL 78A
IS 3
BP 570
EP 580
DI 10.1002/jbm.a.30721
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 071PJ
UT WOS:000239613800017
PM 16739169
DA 2018-10-19
ER

PT J
AU Pendegrass, CJ
   Oddy, MJ
   Sundar, S
   Cannon, SR
   Goodship, AE
   Blunn, GW
AF Pendegrass, C. J.
   Oddy, M. J.
   Sundar, S.
   Cannon, S. R.
   Goodship, A. E.
   Blunn, G. W.
TI The novel use of resorbable Vicryl mesh for in vivo tendon
   reconstruction to a metal prosthesis
SO JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME
LA English
DT Article
ID EXTENSOR MECHANISM RECONSTRUCTION; AUTOGENOUS CANCELLOUS BONE; PROXIMAL
   TIBIA; CANINE MODEL; LIGAMENT AUGMENTATION; REPLACEMENT; IMPLANT;
   FIXATION; SURGERY; FIBERS
AB We examined the mechanical properties of Vicryl (polyglactin 910) mesh in vitro and assessed its use in vivo as a novel biomaterial to attach tendon to a hydroxyapatite-coated metal implant, the interface of which was augmented with autogenous bone and marrow graft. This was compared with tendon re-attachment using a compressive clamp device in an identical animal model. Two- and four-ply sleeves of Vicryl mesh tested to failure under tension reached 5.13% and 28.35% of the normal ovine patellar tendon, respectively. Four-ply sleeves supported gait in an ovine model with 67.05% weight-bearing through the operated limb at 12 weeks, without evidence of mechanical failure.
   Mesh fibres were visible at six weeks but had been completely resorbed by 12 weeks, with no evidence of chronic inflammation. The tendon-implant neoenthesis was predominantly an indirect type, with tendon attached to the bone-hydroxyapatite surface by perforating collagen fibres.
C1 Inst Orthopaed & Musculoskeletal Sci, Stanmore HA7 4LP, Middx, England.
RP Pendegrass, CJ (reprint author), Royal Natl Orthopaed Hosp, Ctr Biomed Engn, Brockley Hill, Stanmore HA7 4LP, Middx, England.
EM c.pendegrass@ucl.ac.uk
CR Athanasiou KA, 1996, BIOMATERIALS, V17, P93, DOI 10.1016/0142-9612(96)85754-1
   BALSHI T J, 1991, International Journal of Oral and Maxillofacial Implants, V6, P87
   BENJAMIN M, 1986, J ANAT, V149, P89
   Bickels J, 2001, J ARTHROPLASTY, V16, P856, DOI 10.1054/arth.2001.25502
   BUCHSBAUM HJ, 1985, ARCH SURG-CHICAGO, V120, P1389
   Cannon SR, 1997, J BONE JOINT SURG BR, V79B, P497, DOI 10.1302/0301-620X.79B3.14191
   Cao YL, 2002, PLAST RECONSTR SURG, V110, P1280, DOI 10.1097/01.PRS.0000025290.49889.4D
   CHAO EY, 1997, T ORTHOP RES SOC S1, V22, P1
   Durselen L, 2001, J BIOMED MATER RES, V58, P666, DOI 10.1002/jbm.1067
   ECKARDT JJ, 1991, ORTHOP CLIN N AM, V22, P149
   EHRLICHMAN RJ, 1991, SURG CLIN N AM, V71, P1323
   GIANNINI S, 1994, FOOT ANKLE INT, V15, P372
   Gosheger G, 2001, CLIN ORTHOP RELAT R, P264
   GOTTSAUNERWOLF F, 1994, J ORTHOPAED RES, V12, P814, DOI 10.1002/jor.1100120609
   Guyton GP, 2001, J BONE JOINT SURG AM, V83A, P1084, DOI 10.2106/00004623-200107000-00017
   Higuera CA, 2005, J ORTHOP RES, V23, P1091, DOI 10.1016/j.orthres.2005.01.017
   HUNT TK, 1972, SURG GYNECOL OBSTETR, V135, P561
   Inoue N, 2002, J ORTHOPAED RES, V20, P957, DOI 10.1016/S0736-0266(02)00037-2
   Kdolsky RK, 1997, J ORTHOP RES, V15, P1, DOI 10.1002/jor.1100150102
   Korvick DL, 1996, J BIOMECH, V29, P557, DOI 10.1016/0021-9290(95)00036-4
   LAITINEN O, 1992, BIOMATERIALS, V13, P1012, DOI 10.1016/0142-9612(92)90152-E
   MALAWER MM, 1989, CLIN ORTHOP RELAT R, P231
   Oddy MJ, 2005, J BONE JOINT SURG BR, V87B, P873, DOI 10.1302/0301-620X.87B6.15363
   Oguma H, 2001, J ORTHOPAED RES, V19, P873, DOI 10.1016/S0736-0266(01)00021-3
   OZAKI J, 1989, CLIN ORTHOP RELAT R, P204
   Ozaki T, 1999, ACTA ORTHOP SCAND, V70, P527, DOI 10.3109/17453679909000997
   Pendegrass CJ, 2004, J ORTHOP RES, V22, P1316, DOI 10.1016/j.orthes.2004.03.022
   Qin TW, 2005, BIOMATERIALS, V26, P6635, DOI 10.1016/j.biomaterials.2005.04.023
   Rempel D, 2001, J ORTHOPAED RES, V19, P143, DOI 10.1016/S0736-0266(00)00005-X
   ROBERTS JM, 1983, CLIN ORTHOP RELAT R, P244
   Sato M, 2000, J Orthop Sci, V5, P256, DOI 10.1007/s007760050161
   Shinhar D, 1998, PEDIATR SURG INT, V13, P84, DOI 10.1007/s003830050254
   Tobias AM, 2003, PLAST RECONSTR SURG, V112, P766, DOI 10.1097/01.PRS.0000070175.10990.51
   WOO SLY, 1987, J BONE JOINT SURG AM, V69A, P1200, DOI 10.2106/00004623-198769080-00014
   Yang J, 2005, BIOMATERIALS, V26, P6415, DOI 10.1016/j.biomaterials.2005.04.061
NR 35
TC 11
Z9 11
U1 0
U2 4
PU BRITISH EDITORIAL SOC BONE JOINT SURGERY
PI LONDON
PA 22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND
SN 0301-620X
J9 J BONE JOINT SURG BR
JI J. Bone Joint Surg.-Br. Vol.
PD SEP
PY 2006
VL 88B
IS 9
BP 1245
EP 1251
DI 10.1302/0301-620X.88B9.17748
PG 7
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 089CA
UT WOS:000240856500023
PM 16943481
OA Bronze
DA 2018-10-19
ER

PT J
AU Niemela, SM
   Lansman, S
   Ikaheimo, I
   Koskela, M
   Veiranto, M
   Suokas, E
   Tormala, P
   Syrjala, H
   Ashammakhi, N
AF Niemela, Sanna-Mari
   Lansman, Satu
   Ikaheimo, Irma
   Koskela, Markku
   Veiranto, Minna
   Suokas, Esa
   Tormala, Pertti
   Syrjala, Hannu
   Ashammakhi, Nureddin
TI Self-reinforced ciprofloxacin-releasing polylactide-co-glycolide 80/20
   inhibits attachment and biofilm formation by Staphylococcus epidermidis:
   An in vitro study
SO JOURNAL OF CRANIOFACIAL SURGERY
LA English
DT Article
DE antibiotic; bioabsorbable; biofilm; ciprofloxacin;
   polylactide-co-glycolide
ID BIOABSORBABLE OSTEOFIXATION DEVICES; PEDIATRIC CRANIOFACIAL SURGERY;
   DELIVERY SYSTEM; FRACTURES; FIXATION; OSTEOMYELITIS; SCREWS; INFECTIONS;
   POLYMER; BONE
AB We have observed the efficiency of antibiotic-releasing polylactide-co-glycolide (PLGA) 80/20 in preventing Staphylococcus epidermidis attachment and biofilm formation in vitro. The aim of the present study was to evaluate the effect of self-reinforced (SR) implants with enhanced antibiotic release on bacterial attachment and biofilm formation rates, and also on growth inhibition of Staphylococcus epidermidis. Cylindrical SR-PLGA+AB specimens (length 30 mm, diameter 3 mm) were examined by scanning electron microscopy (SEM) for attachment of S. epidermidis ATCC 35989 on biomaterial surface and formation of biofiim, after incubating with bacterial suspension of ca. 10(5) cfu/mL for 1, 3, 7,14 and 21 days. SR-PLGA and SR-PLGA+AB implants were tested on agar plates by measuring the inhibition distance around implants. On the surface of SR-PLGA+AB, at days 1, 3,7,14 and 21, the percentage of areas with not a single bacteria attached, was 88.66%. 71.1%, 73.7%, 73.7%, and 68.4%, respectively. On the areas where bacteria were detected, the number of bacterial cells remained low during whole study period, and no significant increase by time was seen. There was no biofilm observed on 97-99% of the examined areas during the whole study period on SR-PLGA+AB. In agar plates, the SR-PLGA+AB showed inhibition of bacterial growth, with (mean) 53.2 mm diameter of inhibition area with peeled implants and 50.5 mm with nonpeeled implants. There was no inhibition seen around implants without ciprofloxacin. Bioabsorbable ciprofloxacin-releasing self-reinforced PLGA (SR-PLGA+AB) was superior to plain SR-PLGA in preventing bacterial attachment, biofilm formation, and also the growth of Staphylococcus epidermidis.
C1 Tampere Univ Technol, Inst Biomat, FIN-33101 Tampere, Finland.
   Oulu Univ Hosp, Dept Surg, Oulu, Finland.
   Oulu Univ Hosp, Dept Ophthalmol, Oulu, Finland.
   Oulu Univ Hosp, Clin Microbiol Lab, Oulu, Finland.
   Linvatec Biomat Ltd, Tampere, Finland.
   Oulu Univ Hosp, Dept Infect Control, Oulu, Finland.
RP Ashammakhi, N (reprint author), Tampere Univ Technol, Inst Biomat, POB 589,Hermiankatu 12B, FIN-33101 Tampere, Finland.
EM nureddin.ashammakhi@tut.fi
CR Andreopoulos AG, 1996, J BIOMATER APPL, V10, P338, DOI 10.1177/088532829601000404
   Ashammakhi N, 2003, J CRANIOFAC SURG, V14, P247, DOI 10.1097/00001665-200303000-00021
   Ashammakhi N, 2004, J CRANIOFAC SURG, V15, P692, DOI 10.1097/00001665-200407000-00031
   Ashammakhi N, 2001, PLAST RECONSTR SURG, V108, P167, DOI 10.1097/00006534-200107000-00027
   Ashammakhi N, 2004, EUR J PLAST SURG, V26, P383
   Calhoun JH, 1997, CLIN ORTHOP RELAT R, P206
   CHRISTENSEN GD, 1982, INFECT IMMUN, V37, P318
   CRAIG WA, 2002, ANTIMICROBIAL PHARMA, P1
   Darouiche RO, 2001, CLIN INFECT DIS, V33, P1567, DOI 10.1086/323130
   DAVIS H, 1989, ANN INTERN MED, V111, P1041, DOI 10.7326/0003-4819-111-12-1041
   Davis N, 1999, J BONE JOINT SURG BR, V81B, P886, DOI 10.1302/0301-620X.81B5.9545
   Enislidis G, 1998, INT J ORAL MAX SURG, V27, P352, DOI 10.1016/S0901-5027(98)80063-5
   Eppley BL, 1998, J CRANIOFAC SURG, V9, P317, DOI 10.1097/00001665-199807000-00005
   Eppley BL, 1997, J CRANIOFAC SURG, V8, P103, DOI 10.1097/00001665-199703000-00008
   Fish DN, 2001, PHARMACOTHERAPY, V21, p253S, DOI 10.1592/phco.21.16.253S.33993
   Grayson ACR, 2004, J BIOMAT SCI-POLYM E, V15, P1281, DOI 10.1163/1568562041959991
   Gumusderelioglu M, 2000, J BIOMAT SCI-POLYM E, V11, P1039, DOI 10.1163/156856200743562
   Henry S L, 1991, Orthop Rev, V20, P242
   HUOLMAN R, IN PRESS J CRANIOFAC
   JACOB E, 1991, CLIN ORTHOP RELAT R, P237
   KANGAS J, 2005, MICROSCOPICAL CHARAC
   KITCHELL JP, 1985, METHOD ENZYMOL, V112, P436
   Kujala S, 2004, J HAND SURG-AM, V29A, P68, DOI 10.1016/j.jhsa.2003.09.009
   Kumar AV, 1997, J CRANIOFAC SURG, V8, P97, DOI 10.1097/00001665-199703000-00006
   Lachenbruch PA, 2002, STAT METHODS MED RES, V11, P297, DOI 10.1191/0962280202sm289ra
   Lansman SM, 2005, RETINA-J RET VIT DIS, V25, P581
   Leinonen S, 2002, J CRANIOFAC SURG, V13, P212, DOI 10.1097/00001665-200203000-00005
   Lipsky BA, 1999, CLIN INFECT DIS, V28, P352, DOI 10.1086/515104
   Liu SJ, 2002, J BIOMED MATER RES, V63, P807, DOI 10.1002/jbm.10406
   Montag ME, 1997, J CRANIOFAC SURG, V8, P100, DOI 10.1097/00001665-199703000-00007
   Nie L, 1998, J ORTHOPAED RES, V16, P76, DOI 10.1002/jor.1100160113
   Niemela SM, 2006, J BIOMED MATER RES B, V76B, P8, DOI 10.1002/jbm.b.30414
   OSTERMANN PAW, 1993, CLIN ORTHOP RELAT R, P102
   OVERBECK JP, 1995, J INVEST SURG, V8, P155, DOI 10.3109/08941939509023138
   Seligson D, 1992, J Orthop Trauma, V6, P401, DOI 10.1097/00005131-199212000-00001
   SHINTO Y, 1992, J BONE JOINT SURG BR, V74, P600
   TEUPE C, 1992, ARCH ORTHOP TRAUM SU, V112, P33, DOI 10.1007/BF00431041
   Tiainen J, 2002, J CRANIOFAC SURG, V13, P427, DOI 10.1097/00001665-200205000-00013
   TIAINEN J, 2005, 3 INT S ADV BIOM BIO
   TORMALA P, 1992, Clinical Materials, V10, P29, DOI 10.1016/0267-6605(92)90081-4
   Veiranto M, 2002, J MATER SCI-MATER M, V13, P1259, DOI 10.1023/A:1021187331458
   VIITANEN P, 2005, 3 WORLD C REG MED TI, P117
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   Waris E, 2004, J HAND SURG-AM, V29A, P452, DOI 10.1016/j.jhsa.2004.01.013
   Waris E, 2004, J HAND SURG-BRIT EUR, V29B, P590, DOI 10.1016/j.jhsb.2004.02.005
   WEI GX, 1991, J BONE JOINT SURG BR, V73, P246
   Ylikontiola L, 2004, ORAL SURG ORAL MED O, V97, P312, DOI 10.1016/j.tripleo.2003.10.030
NR 47
TC 3
Z9 3
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1049-2275
J9 J CRANIOFAC SURG
JI J. Craniofac. Surg.
PD SEP
PY 2006
VL 17
IS 5
BP 950
EP 956
DI 10.1097/01.scs.0000231621.02888.46
PG 7
WC Surgery
SC Surgery
GA 091CC
UT WOS:000241002600022
PM 17003625
DA 2018-10-19
ER

PT J
AU Hatton, PV
   Hurrell-Gillingham, K
   Brook, IM
AF Hatton, P. V.
   Hurrell-Gillingham, K.
   Brook, I. M.
TI Biocompatibility of glass-ionomer bone cements
SO JOURNAL OF DENTISTRY
LA English
DT Article; Proceedings Paper
CT 2nd European Conference on Glass Ionomer Cements (GIC)
CY MAY, 2004
CL Univ Warwick, Coventry, ENGLAND
HO Univ Warwick
DE glass-ionomer cements; biocompatibility; bone
ID ALUMINUM ENCEPHALOPATHY; REVISION ARTHROPLASTY; OTONEUROSURGERY;
   SUBSTITUTE; CERAMICS; SURGERY; IMPLANT
AB Glass-ionomer cements (GIC) have been extensively used in dentistry for over 30 years. Due to their excellent biocompatibility in dental applications GIC have been formulated for medical applications. The past decade has seen some impressive advances in the development of medical GICs, however these advances have been matched by serious critical problems. This review examines the properties of GICs, which can influence their behaviour in a biological environment. The progress made and the problems encountered in the development of these bone cements will also be addressed. The review will conclude with the research currently being employed to optimise the biocompatibility of these important biomaterials. There is little doubt that GICs compare favourably with alternative bone cements for specific applications, based on in vitro and in vivo studies. There is however, a degree of risk inherent in the use of any medical device or biomaterial. GICs must therefore be used carefully and in accordance with the instructions that are based on a significant body of research data. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Univ Sheffield, Sch Clin Dent, Ctr Biomat & Tissue Engn, Sheffield S10 2TA, S Yorkshire, England.
   Univ Sheffield, Dept Mat Engn, Sheffield S1 3JD, S Yorkshire, England.
RP Hatton, PV (reprint author), Univ Sheffield, Sch Clin Dent, Ctr Biomat & Tissue Engn, Claremont Crescent, Sheffield S10 2TA, S Yorkshire, England.
EM p.v.hatton@sheffield.ac.uk
OI Hatton, Paul/0000-0001-5234-1104
FU Engineering and Physical Sciences Research Council [GR/S78254/01]
CR BROOK I M, 1991, Clinical Materials, V7, P295, DOI 10.1016/0267-6605(91)90073-O
   BROOK IM, 1992, BIOMATERIALS, V13, P721, DOI 10.1016/0142-9612(92)90134-A
   BROOK IM, 1991, BIOMATERIALS, V12, P179, DOI 10.1016/0142-9612(91)90197-I
   Brook IM, 1998, BIOMATERIALS, V19, P565, DOI 10.1016/S0142-9612(98)00138-0
   Eldridge JDJ, 2003, BIOMATERIALS, V24, P499, DOI 10.1016/S0142-9612(02)00363-0
   Engelbrecht E, 2000, J BONE JOINT SURG BR, V82B, P192, DOI 10.1302/0301-620X.82B2 .9342
   Geyer G, 1997, HNO, V45, P442, DOI 10.1007/s001060050121
   Gross U, 1988, Ann N Y Acad Sci, V523, P211, DOI 10.1111/j.1749-6632.1988.tb38514.x
   GROSS U, 1988, CRIT REV BIOCOMPAT, V4, P155
   HANTSON P, 1994, LANCET, V344, P1647, DOI 10.1016/S0140-6736(94)90446-4
   HELMS J, 1994, J LARYNGOL OTOL, V108, P202
   Hurrell-Gillingham K, 2003, BIOMATERIALS, V24, P3153, DOI 10.1016/S0142-9612(03)00124-8
   HURRELLGILLINGH.KE, IN PRESS J DENT
   JONCK L M, 1990, Clinical Materials, V6, P323, DOI 10.1016/0267-6605(90)90052-W
   JONCK L M, 1992, Clinical Materials, V9, P85, DOI 10.1016/0267-6605(92)90053-V
   JONCK LM, 1989, CLIN MAT, V4, P201, DOI DOI 10.1016/0267-6605(89)90030-9
   Kenny SM, 2003, J MATER SCI-MATER M, V14, P923, DOI 10.1023/A:1026394530192
   RENARD JL, 1994, LANCET, V344, P63, DOI 10.1016/S0140-6736(94)91089-8
   Reusche E, 2001, HUM PATHOL, V32, P1136, DOI 10.1053/hupa.2001.28251
   Wallace KE, 1999, J MATER SCI-MATER M, V10, P697, DOI 10.1023/A:1008910718446
NR 20
TC 40
Z9 41
U1 0
U2 19
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0300-5712
J9 J DENT
JI J. Dent.
PD SEP
PY 2006
VL 34
IS 8
SI SI
BP 598
EP 601
DI 10.1016/j.jdent.2004.10.027
PG 4
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 088DM
UT WOS:000240791700011
PM 16545900
DA 2018-10-19
ER

PT J
AU Iucci, G
   Rossi, L
   Rosato, N
   Savini, I
   Duranti, G
   Polzonetti, G
AF Iucci, G.
   Rossi, L.
   Rosato, N.
   Savini, I.
   Duranti, G.
   Polzonetti, G.
TI The interaction of the polyphenylacetylene surface with biological
   environments studied by XPS, RAIRS and biological tests
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID RAY PHOTOELECTRON-SPECTROSCOPY; ALBUMIN ADSORPTION; SERUM-ALBUMIN;
   POLYSTYRENE SURFACES; PROTEIN ADSORPTION; FILMS; FIBRONECTIN; ADHESION;
   H2O
AB A pi-conjugated polymer, polyphenylacetylene or PPA, has been tested for its possible applications as biosensor or biomaterial. Protein adsorption was investigated by incubating PPA films in solutions of bovine serum albumin (BSA) dissolved in phosphate buffer (PBS) having increasing protein concentration. Investigations on the PPA films were carried out by means of two surface analysis techniques, X-ray photoelectron spectroscopy (XPS) and reflection-absorption infrared spectroscopy (RAIRS). Desorption of BSA from the PPA surface was also investigated.
   Finally, the cytototoxicity of the PPA surface was checked by measuring viability and proliferation of lymphoma macrophages and SAOS osteoblasts grown in the presence of the polymer.
C1 Univ Roma Tre, Dipartimento Fis E Amaldi, Unita INFM, INST, I-00146 Rome, Italy.
   CISDiC, I-00146 Rome, Italy.
   Univ Roma Tor Vergata, Dipartimento Med Sperimentale & Sci Biochim, I-00133 Rome, Italy.
RP Iucci, G (reprint author), Univ Roma Tre, Dipartimento Fis E Amaldi, Unita INFM, INST, Via Vasca Navale 84, I-00146 Rome, Italy.
EM iucci@uniroma3.it
OI Duranti, Guglielmo/0000-0002-1664-9387
CR BEARZOTTI A, 1996, MATER SCI ENG, V340, P1
   BENDEDOUCH D, 1983, J PHYS CHEM-US, V87, P1473, DOI 10.1021/j100232a003
   BONERT JL, 1986, J COLLOID INTERF SCI, V111, P363
   CALLEN BW, 1993, J BIOMED MATER RES, V27, P851, DOI 10.1002/jbm.820270703
   CARTER DC, 1994, ADV PROTEIN CHEM, V45, P153
   Deligianni DD, 2001, BIOMATERIALS, V22, P1241, DOI 10.1016/S0142-9612(00)00274-X
   DELNERO J, 2002, OPT MATER, V21, P461
   FENG L, 1988, J COLLOID INTERF SCI, V126, P650, DOI 10.1016/0021-9797(88)90169-5
   FOSTER JF, 1977, ALBUMIN STRUCTURE FU, P53, DOI DOI 10.1016/B978-0-08-019603-9.50010-7
   FURLANI A, 1989, J POLYM SCI POL CHEM, V27, P75, DOI 10.1002/pola.1989.080270107
   FURLANI A, 1992, SENSOR ACTUAT B-CHEM, V8, P123, DOI 10.1016/0925-4005(92)85018-R
   Gaspar S, 2001, SENSOR ACTUAT B-CHEM, V72, P63, DOI 10.1016/S0925-4005(00)00633-X
   Griffith A, 1996, BIOSENS BIOELECTRON, V11, P625, DOI 10.1016/0956-5663(96)83297-0
   Henry M, 2004, SURF INTERFACE ANAL, V36, P729, DOI 10.1002/sia.1748
   Iucci G, 2004, SURF INTERFACE ANAL, V36, P724, DOI 10.1002/sia.1747
   Kowalczynska HM, 2002, J BIOMED MATER RES, V61, P260, DOI 10.1002/jbm.10151
   LEBUGLE A, 1995, BBA-PROTEIN STRUCT M, V1248, P107, DOI 10.1016/0167-4838(95)00009-J
   Lhoest JB, 1998, J BIOMED MATER RES, V41, P95, DOI 10.1002/(SICI)1097-4636(199807)41:1<95::AID-JBM12>3.0.CO;2-G
   Moulder J. F., 1995, HDB XRAY PHOTOELECTR
   MU SL, 1991, J ELECTROANAL CHEM, V34, P7
   POLZONETTI G, 1992, J ELECTRON SPECTROSC, V60, pR7, DOI 10.1016/0368-2048(92)80035-7
   POLZONETTI G, 1991, CHEM PHYS LETT, V185, P105, DOI 10.1016/0009-2614(91)80148-Q
   Satriano C, 2000, NUCL INSTRUM METH B, V166, P782, DOI 10.1016/S0168-583X(99)00865-4
   SCOFIELD JH, 1976, J ELECTRON SPECTROSC, V8, P129, DOI 10.1016/0368-2048(76)80015-1
   SEAH P, 1979, SURF INTERFACE ANAL, V1, P30
   Teare DOH, 2000, LANGMUIR, V16, P2818, DOI 10.1021/la9907533
   Tidwell CD, 2001, SURF INTERFACE ANAL, V31, P724, DOI 10.1002/sia.1101
   TROJANOWICZ M, 1995, SENSOR ACTUAT B-CHEM, V28, P191, DOI 10.1016/0925-4005(95)01724-0
   Zhang F, 2002, BIOMATERIALS, V23, P787, DOI 10.1016/S0142-9612(01)00184-3
NR 29
TC 4
Z9 4
U1 0
U2 9
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD SEP
PY 2006
VL 17
IS 9
BP 779
EP 787
DI 10.1007/s10856-006-9835-0
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 077UC
UT WOS:000240055100002
PM 16932858
DA 2018-10-19
ER

PT J
AU Dunehoo, AL
   Anderson, M
   Majumdar, S
   Kobayashi, N
   Berkland, C
   Siahaan, TJ
AF Dunehoo, Alison L.
   Anderson, Meagan
   Majumdar, Sumit
   Kobayashi, Naoki
   Berkland, Cory
   Siahaan, Teruna J.
TI Cell adhesion molecules for targeted drug delivery
SO JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Review
DE cell adhesion; RGD; ICAM-1; LFA-1; targeted delivery; peptide;
   biomaterial; diagnostic; integrin
ID ARG-GLY-ASP; FUNCTION-ASSOCIATED ANTIGEN-1; GLYCOPROTEIN-IIB/IIIA
   RECEPTOR; PHENYLPROPIONIC ACID LINKER; PEPTIDOMIMETIC RGD ANALOGS;
   MOUTH-DISEASE VIRUS; INTEGRIN ALPHA(V)BETA(3); T-CELLS; CYCLIC PRODRUGS;
   LIGAND-BINDING
AB Rapid advancement of the understanding of the structure and function of cell adhesion molecules (i.e., integrins, cadherins) has impacted the design and development of drugs (i.e., peptide, proteins) with the potential to treat cancer and heart and autoimmune diseases. For example, RGD peptides/peptidomimetics have been marketed as anti-thrombic agents and are being investigated for inhibiting tumor angiogenesis. Other cell adhesion peptides derived from ICAM-1 and LFA-1 sequences were found to block T-cell adhesion to vascular endothelial cells and epithelial cells; these peptides are being investigated for treating autoimmune diseases. Recent findings suggest that cell adhesion receptors such as integrins can internalize their peptide ligands into the intracellular space. Thus, many cell adhesion peptides (i.e., RGD peptide) were used to target drugs, particles, and diagnostic agents to a specific cell that has increased expression of cell adhesion receptors. This review is focused on the utilization of cell adhesion peptides and receptors in specific targeted drug delivery, diagnostics, and tissue engineering. In the future, more information on the mechanism of internalization and intracellular trafficking of cell adhesion molecules will be exploited for delivering drug molecules to a specific type of cell or for diagnosis of cancer and heart and autoimmune diseases. (c) 2006 Wiley-Liss, Inc.
C1 Univ Kansas, Simons Res Labs, Dept Pharmaceut Chem, Lawrence, KS 66047 USA.
RP Siahaan, TJ (reprint author), Univ Kansas, Simons Res Labs, Dept Pharmaceut Chem, 2095 Constant Ave, Lawrence, KS 66047 USA.
RI Majumdar, Sumit/B-2900-2010
FU NIBIB NIH HHS [EB-00226]; NIAID NIH HHS [AI-063002]
CR Akula SM, 2002, CELL, V108, P407, DOI 10.1016/S0092-8674(02)00628-1
   Anderson ME, 2004, BIOORG MED CHEM LETT, V14, P1399, DOI 10.1016/j.bmcl.2003.09.100
   Anderson ME, 2003, PHARMACEUT RES, V20, P1523, DOI 10.1023/A:1026188212126
   Anderson ME, 2003, PEPTIDES, V24, P487, DOI 10.1016/S0196-9781(03)00083-4
   Andrews RK, 2004, THROMB RES, V114, P447, DOI 10.1016/j.thromres.2004.07.020
   Andronati SA, 2004, CURR MED CHEM, V11, P1183, DOI 10.2174/0929867043365314
   Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377
   Arnberg N, 2000, J VIROL, V74, P7691, DOI 10.1128/JVI.74.16.7691-7693.2000
   AUMAILLEY M, 1991, FEBS LETT, V291, P50, DOI 10.1016/0014-5793(91)81101-D
   BEER JH, 1992, BLOOD, V79, P117
   Bella J, 1998, P NATL ACAD SCI USA, V95, P4140, DOI 10.1073/pnas.95.8.4140
   BERINSTEIN A, 1995, J VIROL, V69, P2664
   Bibby DC, 2005, INT J PHARM, V293, P281, DOI 10.1016/j.ijpharm.2004.12.021
   Bosshardt DD, 2005, J DENT RES, V84, P9, DOI 10.1177/154405910508400102
   Boyd ND, 2002, BIOCHEMISTRY-US, V41, P7232, DOI 10.1021/bi011501f
   BRETSCHER MS, 1989, EMBO J, V8, P1341, DOI 10.1002/j.1460-2075.1989.tb03514.x
   BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x
   Bromley SK, 2002, IMMUNOLOGY, V106, P289, DOI 10.1046/j.1365-2567.2002.01441.x
   BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751
   Brown EJ, 2001, TRENDS CELL BIOL, V11, P130, DOI 10.1016/S0962-8924(00)01906-1
   Burdick JA, 2002, BIOMATERIALS, V23, P4315, DOI 10.1016/S0142-9612(02)00176-X
   Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463
   Camenisch GP, 1998, PHARMACEUT RES, V15, P1174, DOI 10.1023/A:1011975404789
   Casasnovas JM, 1998, P NATL ACAD SCI USA, V95, P4134, DOI 10.1073/pnas.95.8.4134
   CHEN WJ, 1990, J BIOL CHEM, V265, P3116
   Chen XY, 2005, J MED CHEM, V48, P1098, DOI 10.1021/jm049165z
   Chen XY, 2004, BIOCONJUGATE CHEM, V15, P41, DOI 10.1021/bc0300403
   Chew DP, 2002, INTERN MED J, V32, P338, DOI 10.1046/j.1445-5994.2002.00226.x
   Chiu CY, 1999, J VIROL, V73, P6759
   Christofori G, 2003, EMBO J, V22, P2318, DOI 10.1093/emboj/cdg228
   Coulson BS, 1997, P NATL ACAD SCI USA, V94, P5389, DOI 10.1073/pnas.94.10.5389
   de Curtis I, 2001, EMBO REP, V2, P277, DOI 10.1093/embo-reports/kve072
   Dechantsreiter MA, 1999, J MED CHEM, V42, P3033, DOI 10.1021/jm970832g
   Dmitriev I, 1998, J VIROL, V72, P9706
   Dustin ML, 2002, J CLIN INVEST, V109, P155
   Felsenfeld DP, 1996, NATURE, V383, P438, DOI 10.1038/383438a0
   Fortin JF, 1997, J VIROL, V71, P3588
   Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028
   Gibbins JM, 2004, J CELL SCI, V117, P3415, DOI 10.1242/jcs.01325
   GOEBEL S, 2005, IN PRESS AM J PHYSL
   Gottlieb AB, 2002, ARCH DERMATOL, V138, P591, DOI 10.1001/archderm.138.5.591
   Graham KL, 2003, J VIROL, V77, P9969, DOI 10.1128/JVI.77.18.9969-9978.2003
   Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221
   Guerrero CA, 2000, P NATL ACAD SCI USA, V97, P14644, DOI 10.1073/pnas.250299897
   Gursoy RN, 1999, J PEPT RES, V53, P422, DOI 10.1034/j.1399-3011.1999.00080.x
   Gursoy RN, 1999, J PEPT RES, V53, P414, DOI 10.1034/j.1399-3011.1999.00079.x
   Gustavsson A, 2002, J CELL SCI, V115, P2669
   Haass NK, 2005, PIGM CELL RES, V18, P150, DOI 10.1111/j.1600-0749.2005.00235.x
   Harihara Y, 1996, TRANSPLANT P, V28, P1794
   Harvie P, 2003, J LIPOSOME RES, V13, P231, DOI 10.1081/LPR-120026389
   Haubner R, 2005, PLOS MED, V2, P244, DOI 10.1371/journal.pmed.0020070
   Haubner R, 1996, J AM CHEM SOC, V118, P7461, DOI 10.1021/ja9603721
   HAYMAN EG, 1985, J CELL BIOL, V100, P1948, DOI 10.1083/jcb.100.6.1948
   He HT, 2003, J PEPT RES, V61, P331, DOI 10.1034/j.1399-3011.2003.00062.x
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Hewish MJ, 2000, J VIROL, V74, P228, DOI 10.1128/JVI.74.1.228-236.2000
   Holig P, 2004, PROTEIN ENG DES SEL, V17, P433, DOI 10.1093/protein/gzh055
   Hood JD, 2002, SCIENCE, V296, P2404, DOI 10.1126/science.1070200
   Hu YH, 2003, J BIOMED MATER RES A, V64A, P583, DOI 10.1002/jbm.a.10438
   HUANG CC, 1995, J BIOL CHEM, V270, P19008, DOI 10.1074/jbc.270.32.19008
   Huang M, 2005, AM J PHYSIOL-GASTR L, V288, pG67, DOI 10.1152/ajpgi.00267.2004
   Huang S, 1996, J VIROL, V70, P4502
   Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89
   Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918
   Isberg Ralph R., 1994, Trends in Microbiology, V2, P10, DOI 10.1016/0966-842X(94)90338-7
   ISBERG RR, 1990, CELL, V60, P861, DOI 10.1016/0092-8674(90)90099-Z
   ISOBE M, 1992, SCIENCE, V255, P1125, DOI 10.1126/science.1347662
   Janssen APCA, 2003, INT J PHARM, V254, P55, DOI 10.1016/S0378-5173(02)00682-8
   Ji J, 2004, BIOMATERIALS, V25, P1859, DOI 10.1016/j.biometerials.2003.08.031
   Jin M, 2004, STRUCTURE, V12, P2137, DOI 10.1016/j.str.2004.10.005
   Jois DSS, 1997, J PEPT RES, V49, P517
   Jois SDS, 1996, J BIOMOL STRUCT DYN, V14, P1
   Jun CD, 2001, J BIOL CHEM, V276, P29019, DOI 10.1074/jbc.M103394200
   Kavanaugh AF, 1996, J RHEUMATOL, V23, P1338
   Kok RJ, 2002, BIOCONJUGATE CHEM, V13, P128, DOI 10.1021/bc015561+
   KOPPLE KD, 1992, J AM CHEM SOC, V114, P9615, DOI 10.1021/ja00050a049
   Krasnykh V, 1998, J VIROL, V72, P1844
   Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5
   LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0
   Lepor Norman E, 2002, Rev Cardiovasc Med, V3 Suppl 1, pS3
   Lestini BJ, 2002, J CONTROL RELEASE, V78, P235, DOI 10.1016/S0168-3659(01)00505-3
   Li EG, 1998, J VIROL, V72, P2055
   Lieb E, 2005, BIOMATERIALS, V26, P2333, DOI 10.1016/j.biomaterials.2004.07.010
   Lu CF, 2001, J IMMUNOL, V166, P5629, DOI 10.4049/jimmunol.166.9.5629
   Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102
   Ma Q, 2002, J BIOL CHEM, V277, P10638, DOI 10.1074/jbc.M112417200
   Maaser K, 1999, MOL BIOL CELL, V10, P3067, DOI 10.1091/mbc.10.10.3067
   Marinelli L, 2005, J MED CHEM, V48, P4204, DOI 10.1021/jm040224i
   Marinelli L, 2004, J MED CHEM, V47, P4166, DOI 10.1021/jm030635j
   Marinelli L, 2003, J MED CHEM, V46, P4393, DOI 10.1021/jm020577m
   Masuko T, 2005, BIOMATERIALS, V26, P5339, DOI 10.1016/j.biomaterials.2005.01.062
   Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575
   Mitra A, 2005, J CONTROL RELEASE, V102, P191, DOI 10.1016/j.jconrel.2004.09.023
   Moriyama H, 1996, J IMMUNOL, V157, P3737
   MULLER G, 1994, J COMPUT AID MOL DES, V8, P709, DOI 10.1007/BF00124017
   MULLER G, 1993, PROTEINS, V15, P235, DOI 10.1002/prot.340150303
   Neff S, 2000, J VIROL, V74, P7298, DOI 10.1128/JVI.74.16.7298-7306.2000
   Nemerow GR, 1999, MICROBIOL MOL BIOL R, V63, P725
   Pancioli AM, 2004, CNS DRUGS, V18, P981, DOI 10.2165/00023210-200418140-00003
   Papp K, 2001, J AM ACAD DERMATOL, V45, P665, DOI 10.1067/mjd.2001.117850
   PAVALKO FM, 1994, P SOC EXP BIOL MED, V205, P282
   PEISHOFF CE, 1992, J MED CHEM, V35, P3962, DOI 10.1021/jm00099a026
   PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294
   PIERSCHBACHER MD, 1984, P NATL ACAD SCI-BIOL, V81, P5985, DOI 10.1073/pnas.81.19.5985
   PIERSCHBACHER MD, 1994, J CELL BIOCHEM, V56, P150, DOI 10.1002/jcb.240560205
   Podar K, 2002, J BIOL CHEM, V277, P7875, DOI 10.1074/jbc.M109068200
   PYTELA R, 1985, P NATL ACAD SCI USA, V82, P5766, DOI 10.1073/pnas.82.17.5766
   RABB H, 1993, J IMMUNOL, V151, P990
   ROOT RK, 1989, T AM CLIN CLIMAT ASS, V101, P207
   Rossi ML, 2004, MINI-REV MED CHEM, V4, P703
   RUOSLAHTI E, 1986, CELL, V44, P517, DOI 10.1016/0092-8674(86)90259-X
   Ruoslahti E, 2004, BIOCHEM SOC T, V32, P397, DOI 10.1042/BST0320397
   Ruoslahti E, 2002, NAT REV CANCER, V2, P83, DOI 10.1038/nrc724
   Ruoslahti E, 1999, ADV CANCER RES, V76, P1, DOI 10.1016/S0065-230X(08)60772-1
   Schiffelers RM, 2003, J CONTROL RELEASE, V91, P115, DOI 10.1016/S0168-3659(03)00240-2
   Schiffelers RM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh140
   Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cb.11.110195.003001
   Sen Gupta A, 2005, THROMB HAEMOSTASIS, V93, P106, DOI 10.1160/TH04-06-0340
   Shimaoka M, 2004, CURR TOP MED CHEM, V4, P1485, DOI 10.2174/1568026043387575
   SIAHAAN TJ, 1992, BIOCHEM BIOPH RES CO, V187, P1042, DOI 10.1016/0006-291X(92)91302-7
   SIAHAAN TJ, 1994, INT J PEPT PROT RES, V44, P427
   Song XP, 2002, BIOORG CHEM, V30, P285, DOI 10.1016/S0045-2068(02)00013-5
   Song XP, 2002, BIOORG MED CHEM LETT, V12, P3439, DOI 10.1016/S0960-894X(02)00750-3
   Song XP, 2002, ORG LETT, V4, P549, DOI 10.1021/ol010282n
   Spinler Sarah A, 2004, J Am Pharm Assoc (2003), V44, pS14, DOI 10.1331/154434504322904578
   Springer TA, 2004, ADV PROTEIN CHEM, V68, P29
   SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0
   Stupack DG, 2004, CURR TOP DEV BIOL, V64, P207, DOI 10.1016/S0070-2153(04)64009-9
   Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569
   Thibault G, 2001, J PHARMACOL EXP THER, V296, P690
   Tibbetts SA, 1999, TRANSPLANTATION, V68, P685, DOI 10.1097/00007890-199909150-00015
   Tibbetts SA, 2000, PEPTIDES, V21, P1161, DOI 10.1016/S0196-9781(00)00255-2
   Triantafilou K, 2001, CRIT REV IMMUNOL, V21, P311
   Triantafilou K, 2000, J VIROL, V74, P5856, DOI 10.1128/JVI.74.13.5856-5862.2000
   Tucker Gordon C, 2003, Curr Opin Investig Drugs, V4, P722
   Turowski P, 2005, CELL MOL NEUROBIOL, V25, P153, DOI 10.1007/s10571-004-1380-0
   Vicente-Manzanares M, 2002, INT REV CYTOL, V216, P233
   Wang BH, 1999, CHEM PHARM BULL, V47, P90
   Wang FZ, 2003, J VIROL, V77, P3131, DOI 10.1128/JVI.77.5.3131-3147.2003
   Wang W, 2000, J CONTROL RELEASE, V65, P245, DOI 10.1016/S0168-3659(99)00241-2
   Wang W, 2000, CURR MED CHEM, V7, P437, DOI 10.2174/0929867003375074
   Woerly S, 2001, BIOMATERIALS, V22, P1095, DOI 10.1016/S0142-9612(00)00354-9
   Yusuf-Makagiansar H, 2002, MED RES REV, V22, P146, DOI 10.1002/med.10001
   Yusuf-Makagiansar H, 2001, PEPTIDES, V22, P1955, DOI 10.1016/S0196-9781(01)00546-0
   Yusuf-Makagiansar H, 2001, PHARMACEUT RES, V18, P329, DOI 10.1023/A:1011007014510
   Yusuf-Makagiansar H, 2001, INFLAMMATION, V25, P203, DOI 10.1023/A:1011044616170
NR 146
TC 87
Z9 96
U1 0
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3549
EI 1520-6017
J9 J PHARM SCI-US
JI J. Pharm. Sci.
PD SEP
PY 2006
VL 95
IS 9
BP 1856
EP 1872
DI 10.1002/jps.20676
PG 17
WC Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology &
   Pharmacy
SC Pharmacology & Pharmacy; Chemistry
GA 081NE
UT WOS:000240323500001
PM 16850395
DA 2018-10-19
ER

PT J
AU Matsumoto, T
   Tamine, K
   Kagawa, R
   Hamada, Y
   Okazaki, M
   Takahashi, J
AF Matsumoto, Takuya
   Tamine, Ken-ichi
   Kagawa, Ryosuke
   Hamada, Yoshinosuke
   Okazaki, Masayuki
   Takahashi, Junzo
TI Different behavior of implanted hydroxyapatite depending on morphology,
   size and crystallinity
SO JOURNAL OF THE CERAMIC SOCIETY OF JAPAN
LA English
DT Article
DE hydroxyapatite; biomaterial; bioabsorption; osteoconductivity; bone
   remodeling
ID CONTROLLED-RELEASE; BONE; OSTEOCALCIN; APATITE
AB Hydroxyapatite (HAp) materials with different morphology, size and crystallinity were prepared and were implanted into a male rat tibia. Each of the HAp materials showed a high biocompatiblity and osteoconductivity. The morphology and size of the implanted HAp affected the intrusion of bone marrow derived cells among HAp materials, and this cell intrusion was important for regulating the newly formed bone mass. High crystalline sintered HAp was stable and remained in its initial shape for long periods. However, low crystalline HAp was absorbed and disappeared during bone remodeling. This study indicates that choosing suitable HAp materials in morphology, size and crystallinity is important for a treatment plan (e.g. reconstruction or regeneration; large region or small region etc.) and for achieving a desired prognosis.
C1 Osaka Univ, Grad Sch Dent, Suita, Osaka 5650871, Japan.
   Hiroshima Univ, Grad Sch Biomed Sci, Minami Ku, Hiroshima 7348553, Japan.
RP Matsumoto, T (reprint author), Osaka Univ, Grad Sch Dent, 1-8 Yamada Oka, Suita, Osaka 5650871, Japan.
CR Barralet JE, 2005, J BIOMED MATER RES B, V73B, P238, DOI 10.1002/jbm.b.30197
   DEBRUIJN JD, 1995, J BIOMED MATER RES, V29, P89, DOI 10.1002/jbm.820290113
   Fanovich MA, 1998, J MATER SCI-MATER M, V9, P53, DOI 10.1023/A:1008834712212
   Fu QN, 2004, J MATER SCI-MATER M, V15, P1333, DOI 10.1007/s10856-004-5742-4
   Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079
   Lu WW, 2003, J MATER SCI-MATER M, V14, P1039, DOI 10.1023/B:JMSM.0000004000.56814.9e
   Mathur Kevin K, 2003, Arch Facial Plast Surg, V5, P379, DOI 10.1001/archfaci.5.5.379
   Matsumoto T, 2004, BIOMATERIALS, V25, P3807, DOI 10.1016/j.biomaterials.2003.10.081
   Matsumoto T, 2002, J BIOMED MATER RES, V60, P651, DOI 10.1002/jbm.10133
   Matsumoto T, 2002, BIOMATERIALS, V23, P2241, DOI 10.1016/S0142-9612(01)00358-1
   Milan AM, 2004, CALCIFIED TISSUE INT, V75, P197, DOI 10.1007/s00223-004-0273-z
   Nishihara Katsunari, 1994, Bio-Medical Materials and Engineering, V4, P61
   Raman R, 2005, J BONE JOINT SURG BR, V87B, P1061, DOI 10.1302/0301-620X.87B8.16161
   Rammelt S, 2005, J BIOMED MATER RES A, V73A, P284, DOI 10.1002/jbm.a.30263
   YAMAMOTO H, 2005, J BIOMED MATER RES B, V78, P211
NR 15
TC 14
Z9 14
U1 0
U2 2
PU CERAMIC SOC JAPAN-NIPPON SERAMIKKUSU KYOKAI
PI TOKYO
PA 22-17, HYAKUNIN-CHO 2-CHOME, SHINJUKU-KU, TOKYO, 169-0073, JAPAN
SN 1882-0743
EI 1348-6535
J9 J CERAM SOC JPN
JI J. Ceram. Soc. Jpn.
PD SEP
PY 2006
VL 114
IS 1333
BP 760
EP 762
DI 10.2109/jcersj.114.760
PG 3
WC Materials Science, Ceramics
SC Materials Science
GA 086AE
UT WOS:000240644700006
OA Bronze
DA 2018-10-19
ER

PT J
AU Gao, WY
   Wang, YW
   Dong, LM
   Yu, ZW
AF Gao, W. Y.
   Wang, Y. W.
   Dong, L. M.
   Yu, Z. W.
TI Thermokinetic analysis of the hydration process of calcium phosphate
   cement
SO JOURNAL OF THERMAL ANALYSIS AND CALORIMETRY
LA English
DT Article; Proceedings Paper
CT 4th International/6th China-Japan Joint Symposium on Calorimetry and
   Thermal Analysis (CATS-2005)
CY OCT 06-08, 2005
CL Fukuoka, JAPAN
SP Japanese Soc Calorimetry & Thermal Anal, Chinese Chem Soc, Comm Chem Thermodynam & Thermal Analysis
DE calcium phosphate cement; hydration process; rebuilding thermogenetic
   curve; thermokinetics
ID THERMAL-ANALYSIS; BEHAVIOR
AB A microcalorimeter (Setaram c-80) was used to study the thermokinetics of the hydration process of calcium phosphate cement (CPC), a biocompatible biomaterial used in bone repair. The hydration enthalpy was determined to be 35.8 J g(-1) at 37.0 degrees C when up to 80 mg CPC was dissolved in 2 mL of citric buffer. In the present study, parameters related to time constants of the calorimeter were obtained by fitting the recorded thermal curves with the function theta=Ae(-omega 1t)(1-e(-omega 2t-2)). The real thermogenetic curves were then retrieved with Tian function and the transformation rate of the hydration process of CPC was found to follow the equation alpha=1-[1-(0.0075t)(3)](3). The microstructures of the hydrated CPC were examined by scanning electron microscopy. The nano-scale flake microstructures are due to crystallization of calcium phosphate and they could contribute to the good biocompatibility and high bioactivity.
C1 Tsing Hua Univ, Dept Chem, Minist Educ, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China.
   Tsing Hua Univ, Inst Nucl & New Energy Technol, Beijing 100084, Peoples R China.
RP Yu, ZW (reprint author), Tsing Hua Univ, Dept Chem, Minist Educ, Key Lab Bioorgan Phosphorus Chem & Chem Biol, Beijing 100084, Peoples R China.
EM yuzhw@tsinghua.edu.cn
CR BARES P, 1991, STRUCTURE FUNCTION C, P252
   Calvet E., 1963, RECENT PROGR MICROCA
   Chen L, 2002, J MACROMOL SCI PHYS, VB41, P137, DOI 10.1081/MB-120002351
   Chen L, 2001, BIOPHYS CHEM, V89, P231, DOI 10.1016/S0301-4622(00)00232-5
   Chow LC, 1994, FORMATION HYDROXYAPA, P127
   Chowdhury B, 2005, J THERM ANAL CALORIM, V81, P179, DOI 10.1007/s10973-005-0764-9
   Ginebra MP, 1997, J DENT RES, V76, P905, DOI 10.1177/00220345970760041201
   Hemminger W., 1984, CALORIMETRY FUNDAMEN
   Kirchner R, 1998, THERMOCHIM ACTA, V310, P19, DOI 10.1016/S0040-6031(97)00380-8
   KVETON JF, 1995, LARYNGOSCOPE, V105, P156, DOI 10.1288/00005537-199502000-00008
   Li CD, 2004, J MATER SCI-MATER M, V15, P85, DOI 10.1023/B:JMSM.0000010101.45352.d1
   Nocun-Wczelik W, 2001, J THERM ANAL CALORIM, V65, P613, DOI 10.1023/A:1017970228316
   NOCUNWCZELIK W, 2004, J THERM ANAL CALORIM, V77, P1388
   Pacewska B, 2000, J THERM ANAL CALORIM, V60, P71, DOI 10.1023/A:1010120518062
   Roszczynialski W, 2002, J THERM ANAL CALORIM, V70, P387, DOI 10.1023/A:1021660020674
   Usherov-Marshak A, 2002, J THERM ANAL CALORIM, V68, P223, DOI 10.1023/A:1014917601533
   Vyazovkin S, 2002, ANAL CHEM, V74, P2749, DOI 10.1021/ac020219r
   Wadso I, 2001, J THERM ANAL CALORIM, V64, P75
   ZENG XC, 1996, J CHEM CHINESE U, V17, P607
NR 19
TC 11
Z9 13
U1 2
U2 16
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1388-6150
J9 J THERM ANAL CALORIM
JI J. Therm. Anal. Calorim.
PD SEP
PY 2006
VL 85
IS 3
BP 785
EP 789
DI 10.1007/s10973-005-7433-x
PG 5
WC Thermodynamics; Chemistry, Analytical; Chemistry, Physical
SC Thermodynamics; Chemistry
GA 084SK
UT WOS:000240554500044
DA 2018-10-19
ER

PT J
AU Park, MH
   Han, MS
   Ahn, CY
   Kim, HS
   Yoon, BD
   Oh, HM
AF Park, M. -H.
   Han, M. -S.
   Ahn, C. -Y.
   Kim, H. -S.
   Yoon, B. -D.
   Oh, H. -M.
TI Growth inhibition of bloom-forming cyanobacterium Microcystis aeruginosa
   by rice straw extract
SO LETTERS IN APPLIED MICROBIOLOGY
LA English
DT Article
DE allelopathy; cyanobacteria; inhibition; Microcystis; rice straw;
   salicylic acid
ID BLUE-GREEN-ALGAE; BARLEY STRAW; SALICYLIC-ACID; PHYTOPLANKTON
AB Aims: To inhibit the growth of the bloom-forming cyanobacterium Microcystis aeruginosa using a rice straw extract.
   Methods and Results: The cell numbers of the algal strain M. aeruginosa UTEX 2388 significantly decreased after treatment with different concentrations (0.01, 0.1, 1 and 10 mg l(-1)) of a rice straw extract for an 8-day cultivation period. Among seven tested allelochemicals from rice straw, salicylic acid at 0.1 mg l(-1) exhibited the highest allelopathic activity (26%) on day 8. A synergistic effect on algal growth inhibition was found when adding two or three phenolic compounds from the rice straw.
   Conclusions: The growth of M. aeruginosa was inhibited by rice straw extract concentrations ranging from 0.01 to 10 mg l(-1). This activity was due to the synergistic effects of various phenolic compounds in the rice straw.
   Significance and Impact of the Study: The identification of rice straw as an effective material for the growth inhibition of M. aeruginosa implies it may have the potential to be used as an environment-friendly biomaterial for controlling the algal bloom of M. aeruginosa in eutrophic water.
C1 Korea Res Inst Biosci & Biotechnol, Environm Biotechnol Lab, Taejon 305333, South Korea.
   Hanyang Univ, Dept Environm Sci, Seoul 133791, South Korea.
RP Oh, HM (reprint author), Korea Res Inst Biosci & Biotechnol, Environm Biotechnol Lab, Taejon 305333, South Korea.
EM heemock@kribb.re.kr
OI Ahn, Chi-Yong/0000-0002-9626-2755; Oh, Hee-Mock/0000-0002-2151-3687
CR Ahn JK, 2000, AGRON J, V92, P1162, DOI 10.2134/agronj2000.9261162x
   ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x
   Ball AS, 2001, BIORESOURCE TECHNOL, V77, P177, DOI 10.1016/S0960-8524(00)00148-6
   Barrett PRF, 1996, HYDROBIOLOGIA, V340, P307, DOI 10.1007/BF00012773
   Chung IM, 2001, CROP PROT, V20, P921, DOI 10.1016/S0261-2194(01)00046-1
   Codd G. A., 1988, Biochemistry of the Algae and Cyanobacteria . Proceedings of The Phytochemical Society of Europe, No 28., P283
   DEDONDER A, 1971, Z PFLANZENPHYSIOL, V65, P70
   Ebana K, 2001, AGRON J, V93, P12, DOI 10.2134/agronj2001.93112x
   GIBSON M T, 1990, Journal of Applied Phycology, V2, P241, DOI 10.1007/BF02179781
   Inderjit Dakshini KMM, 1995, ACS S SERIES
   Karan V, 1998, ECOTOX ENVIRON SAFE, V40, P49, DOI 10.1006/eesa.1998.1641
   LAM AKY, 1995, WATER RES, V29, P1845, DOI 10.1016/0043-1354(94)00348-B
   Legrand C, 2003, PHYCOLOGIA, V42, P406, DOI 10.2216/i0031-8884-42-4-406.1
   Nakai S, 2000, WATER RES, V34, P3026, DOI 10.1016/S0043-1354(00)00039-7
   Oh HM, 2000, APPL ENVIRON MICROB, V66, P176, DOI 10.1128/AEM.66.1.176-179.2000
   PENALOZA R, 1990, FRESHWATER BIOL, V24, P233, DOI 10.1111/j.1365-2427.1990.tb00705.x
   RICE EL, 1980, BOT BULL ACAD SINICA, V21, P111
   Rice EL, 1984, ALLELOPATHY
   Ridge I, 1996, HYDROBIOLOGIA, V340, P301, DOI 10.1007/BF00012772
   SCHARFF TG, 1976, P SOC EXP BIOL MED, V151, P72
   Suzuki Y, 1998, J EXP MAR BIOL ECOL, V225, P69, DOI 10.1016/S0022-0981(97)00208-6
   TILLBERG JE, 1970, PHYSIOL PLANTARUM, V23, P647, DOI 10.1111/j.1399-3054.1970.tb06457.x
   Watanabe MF, 1989, J APPL PHYCOL, V1, P161, DOI 10.1007/BF00003879
   WELCH I M, 1990, Journal of Applied Phycology, V2, P231, DOI 10.1007/BF02179780
   YASUNO M, 2000, ADV MICROALGAL PROTO, P43
NR 25
TC 43
Z9 55
U1 1
U2 31
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0266-8254
J9 LETT APPL MICROBIOL
JI Lett. Appl. Microbiol.
PD SEP
PY 2006
VL 43
IS 3
BP 307
EP 312
DI 10.1111/j.1472-765X.2006.01951.x
PG 6
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 072VX
UT WOS:000239702200013
PM 16910937
OA Bronze
DA 2018-10-19
ER

PT J
AU Liu, Y
   Sheng, XX
   Dan, XH
   Xiang, QJ
AF Liu, Yong
   Sheng, Xiaoxian
   Dan, Xiaohong
   Xiang, Qijun
TI Preparation of mica/apatite glass-ceramics biomaterials
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT 1st Symposium on Biological Materials Science held at the 2005 TMA
   Annual Meeting
CY FEB 13-17, 2005
CL San Francisco, CA
SP TMS
DE glass-ceramics; mica; apatite; mechanical property; bioactivity
ID CRYSTALLIZATION PROCESS
AB Glass-ceramics have become more and more important biomaterials. In this work mica glass/apatite composites with various compositions were prepared by casting and subsequent heat treatments. The effects of composition, phase constitution and crystallinity on mechanical properties, including elastic modulus and transverse rupture strength (TRS), were investigated by using X-ray diffraction analyses (XRD), scanning electron microscopy (SEM) and mechanical tests. Results show that addition of apatite composition in mica glass accelerates the crystallization process and induces the formation of fluoroapatite phase, and the nucleation of apatite crystals occurs before that of mica crystals. The fuoroapatite in this work is needle-like, which is almost the same to that in human bone. The transverse rupture strength increases with the content of fluoroapatite and the crystallinity increasing, except that at a low apatite content the mechanical properties are lower than those of mica glass under the same processing conditions. The transverse rupture strength and elastic modulus obtained in this work fall in the range of those of human bone. SBF immersion test demonstrates good bioactivity of this biomaterial. (c) 2005 Elsevier B.V. All rights reserved.
C1 Cent S Univ, State Key Lab Powder Met, Changsha 410083, Peoples R China.
RP Liu, Y (reprint author), Cent S Univ, State Key Lab Powder Met, Changsha 410083, Peoples R China.
EM yonliu@mail.csu.edu.cn
CR BLENCKE BA, 1978, J BIOMED MATER RES, V12, P307, DOI 10.1002/jbm.820120305
   Chen CC, 2004, ELECTROCHIM ACTA, V50, P1023, DOI 10.1016/j.electacta.2004.08.001
   Clupper DC, 2002, BIOMATERIALS, V23, P2599, DOI 10.1016/S0142-9612(01)00398-2
   Habelitz S, 1999, ACTA MATER, V47, P2831, DOI 10.1016/S1359-6454(99)00135-4
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   HOELAND W, 1983, Patent No. 3306648
   Holand W, 2000, J MATER SCI-MATER M, V11, P11, DOI 10.1023/A:1008977416834
   Hulbert S. F., 1982, Ceramics International, V8, P131, DOI 10.1016/0272-8842(82)90003-7
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   KOKUBO T, 1986, INDIAN CERAM SOC, V2, P408
   Lopes MA, 1999, BIOMATERIALS, V20, P2085, DOI 10.1016/S0142-9612(99)00112-X
   Peitl O, 2001, J NON-CRYST SOLIDS, V292, P115, DOI 10.1016/S0022-3093(01)00822-5
   SHERIEF M, 2002, MATER CHEM PHYS, V77, P846
   Taruta S, 2003, J NON-CRYST SOLIDS, V321, P96, DOI 10.1016/S0022-3093(03)00105-4
   Taruta S, 2001, J NON-CRYST SOLIDS, V296, P201, DOI 10.1016/S0022-3093(01)00909-7
   UNO T, 1993, J AM CERAM SOC, V76, P539, DOI 10.1111/j.1151-2916.1993.tb03821.x
   VOGEL W, 1990, J NON-CRYST SOLIDS, V123, P349, DOI 10.1016/0022-3093(90)90807-X
   VOGEL W, 1985, J NON-CRYST SOLIDS, V73, P593, DOI 10.1016/0022-3093(85)90378-3
   YU B, 2002, CERAM SOC, V30, P77
NR 20
TC 19
Z9 21
U1 2
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD SEP
PY 2006
VL 26
IS 8
SI SI
BP 1390
EP 1394
DI 10.1016/j.msec.2005.08.017
PG 5
WC Materials Science, Multidisciplinary
SC Materials Science
GA 077NS
UT WOS:000240037100023
DA 2018-10-19
ER

PT J
AU Wen, CE
   Yamada, Y
   Hodgson, PD
AF Wen, C. E.
   Yamada, Y.
   Hodgson, P. D.
TI Fabrication of novel TiZr alloy foams for biomedical applications
SO MATERIALS SCIENCE & ENGINEERING C-BIOMIMETIC AND SUPRAMOLECULAR SYSTEMS
LA English
DT Article; Proceedings Paper
CT 1st Symposium on Biological Materials Science held at the 2005 TMA
   Annual Meeting
CY FEB 13-17, 2005
CL San Francisco, CA
SP TMS
DE porous metals; biomaterials; mechanical properties; porosity; powder
   metallurgy
ID POROUS HYDROXYAPATITE; MECHANICAL-PROPERTIES; PORE-SIZE; SCAFFOLDS;
   BONE; METAL; BIOMATERIALS; OSTEOGENESIS; IMPLANTS
AB Bone injuries and failures often require the inception of implant biomaterial. Research in this area has received increasing attention recently. In particular, porous metals are attractive due to its unique physical, mechanical, and new bone tissue ingrowth properties. In the present study, TiZr alloy powders were prepared using mechanical alloying. Novel TiZr alloy foams with relative densities of approximately 0.3 were fabricated by a powder metallurgical process. The TiZr alloy foams displayed an interconnected porous structure resembling bone and the pore size ranged from 200 to 500 mu m. The compressive plateau stress and the Young's modulus of the TiZr foam were 78.4 MPa and 15.3 GPa, respectively. Both the porous structure and the mechanical properties of the TiZr foam were very close to those of natural bone. (c) 2005 Elsevier B.V. All rights reserved.
C1 Deakin Univ, Fac Sci & Technol, Geelong, Vic 3217, Australia.
   AIST, Mat Res Inst Sustainable Dev, Nagoya, Aichi 4638560, Japan.
RP Wen, CE (reprint author), Deakin Univ, Fac Sci & Technol, Geelong, Vic 3217, Australia.
EM cwen@deakin.edu.au
OI Wen, Cuie/0000-0001-8008-3536
CR Athanasiou KA, 1998, ARTHROSCOPY, V14, P726, DOI 10.1016/S0749-8063(98)70099-4
   CLEMOW AJT, 1981, J BIOMED MATER RES, V15, P73, DOI 10.1002/jbm.820150111
   Dong J, 2001, J BIOMED MATER RES, V57, P208, DOI 10.1002/1097-4636(200111)57:2<208::AID-JBM1160>3.0.CO;2-N
   Evans F G, 1969, Artif Limbs, V13, P37
   Fujibayashi S, 2004, BIOMATERIALS, V25, P443, DOI 10.1016/S0142-9612(03)0051-9
   Gibson L. J., 1997, CELLULAR SOLIDS STRU, P1
   Gogolewski S, 2000, INJURY, V31, pS28
   Gomes ME, 2001, BIOMATERIALS, V22, P883, DOI 10.1016/S0142-9612(00)00211-8
   Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5
   Hutmacher DW, 2000, BIOMATERIALS, V21, P2529, DOI 10.1016/S0142-9612(00)00121-6
   Inoue A, 2000, ACTA MATER, V48, P279, DOI 10.1016/S1359-6454(99)00300-6
   Kasuga T, 2003, BIOMATERIALS, V24, P283, DOI 10.1016/S0142-9612(02)00316-2
   Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9
   Lawless M.W., 2000, J MUSCULOSKELET RES, V4, P129
   Ma E, 2003, SCRIPTA MATER, V49, P941, DOI 10.1016/S1359-6462(03)00477-9
   Murphy WL, 2000, J BIOMED MATER RES, V50, P50, DOI 10.1002/(SICI)1097-4636(200004)50:1<50::AID-JBM8>3.0.CO;2-F
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Okazaki Y, 1998, MAT SCI ENG A-STRUCT, V243, P250, DOI 10.1016/S0921-5093(97)00809-5
   Okazaki Y, 2002, BIOMATERIALS, V23, P2071, DOI 10.1016/S0142-9612(01)00337-4
   Ramay HRR, 2004, BIOMATERIALS, V25, P5171, DOI 10.1016/j.biomaterials.2003.12.023
   Ripamonti U, 1997, CRIT REV ORAL BIOL M, V8, P154, DOI 10.1177/10454411970080020401
   Sikavitsas VI, 2001, BIOMATERIALS, V22, P2581, DOI 10.1016/S0142-9612(01)00002-3
   Steinemann S. G., 1980, EVALUATION BIOMATERI, P1
   Tsuruga E, 1997, J BIOCHEM-TOKYO, V121, P317
   Uchida M, 2002, BIOMATERIALS, V23, P313, DOI 10.1016/S0142-9612(01)00110-7
   Wen CE, 2002, J MATER RES, V17, P2633, DOI 10.1557/JMR.2002.0382
   Wen CE, 2002, J MATER SCI-MATER M, V13, P397, DOI 10.1023/A:1014344819558
   Wen CE, 2004, MATER LETT, V58, P357, DOI [10.1016/S0167-577X(03)00500-7, 10.1016/S0167-577X(03)004500-7]
   Wen CE, 2001, SCRIPTA MATER, V45, P1147, DOI 10.1016/S1359-6462(01)01132-0
   Wen CE, 2000, J MATER SCI, V35, P2099, DOI 10.1023/A:1004763713031
   WILLIAMS DF, 2001, TITANIUM MED, P13
NR 31
TC 51
Z9 53
U1 1
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0928-4931
J9 MAT SCI ENG C-BIO S
JI Mater. Sci. Eng. C-Biomimetic Supramol. Syst.
PD SEP
PY 2006
VL 26
IS 8
SI SI
BP 1439
EP 1444
DI 10.1016/j.msec.2005.08.006
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA 077NS
UT WOS:000240037100031
DA 2018-10-19
ER

PT J
AU Nakano, T
   Kan, T
   Ishimoto, T
   Ohashi, Y
   Fujitani, W
   Umakoshi, Y
   Hattori, T
   Higuchi, Y
   Tane, M
   Nakajima, H
AF Nakano, Takayoshi
   Kan, Tomoko
   Ishimoto, Takuya
   Ohashi, Yoshio
   Fujitani, Wataru
   Umakoshi, Yukichi
   Hattori, Tomokazu
   Higuchi, Yuichi
   Tane, Masakazu
   Nakajima, Hideo
TI Evaluation of bone quality near metallic implants with and without
   lotus-type pores for optimal biomaterial design
SO MATERIALS TRANSACTIONS
LA English
DT Article; Proceedings Paper
CT 4th International Conference on Porous Metals and Metal Foaming
   Technology (MetFoam 2005)
CY SEP 21-23, 2005
CL Kyoto, JAPAN
DE hard tissue; metallic implant; lotus-type porous implant; biological
   apatite; bone mineral density; texture; microbeam X-ray diffraction;
   bone quality; stress shielding; elongated pore
ID BIOLOGICAL APATITE; PREFERENTIAL ALIGNMENT; LONG BONES; TISSUES;
   FABRICATION; ORIENTATION; ADAPTATION; STIFFNESS; FIXATION; CRYSTALS
AB The stress shielding effect often degrades the quality and quantity of bones near implants. Thus, the shape and structure of metallic biomaterials should be optimally designed. A dominant inorganic substance in bones is a biological apatite (BAp) nanocrystal, which basically crystallizes in an anisotropic hexagonal lattice. The BAp c-axis is parallel to elongated collagen fibers. Because the BAp orientation of bones is a possible parameter of bone quality near implants, we used a microbeam X-ray diffractometer system with a beam spot, which had a diameter of 50 or 100 mu m phi, to evaluate the BAp orientation of bones.
   Two animal models were prepared: (1) a nail model (phi: 3.0 mm, SUS316L), which was used to understand the stress shielding effect in a rabbit tibial marrow cavity, and (2) a model of a lotus-type porous implant (phi: 3.4 mm, mean pore diameter: 170 mu m, SUS304L), which was used to understand the effect of the unidirectional-elongated pore direction in an anisotropic bone tissue of a beagle mandible. The porous implants were implanted so that the pore direction was parallel or perpendicular to the mesiodistal axis of mandible.
   For the porous implant model, new bone formation strongly depended on the elongated pore direction and the time after implantation. For example, four weeks after implantation, new bone formed in pores of the implants, but the BAp orientation degree in the new bone was more similar to that in the original bone in the elongated pores parallel to the mesiodistal direction than that in the perpendicular pores. These differences in bone formation inside the parallel and perpendicular pores may be closely related to the anisotropy of original bone tissues such as the orientations of collagen fiber, BAp, and blood vessels. The orientation degree of BAp also changed in the nail model. The stress shielding effect decreased the orientation degree of the BAp c-axis in the tibia along the longitudinal axis.
   Thus, optimal design of metallic biomaterials such as implant shape, pore size, elongated pore direction, etc., should be based on the anisotropy of the bone microstructure.
C1 Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan.
   Osaka Dent Univ Hosp, Osaka 5400008, Japan.
   Meijo Univ, Fac Engn, Dept Mat Sci & Engn, Nagoya, Aichi 4688502, Japan.
   Osaka Univ, Inst Sci & Ind Res, Ibaraki 5670047, Japan.
RP Nakano, T (reprint author), Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
RI Tane, Masakazu/D-2772-2011; NAKANO, Takayoshi/F-8140-2011
OI Tane, Masakazu/0000-0002-1478-6820; 
CR BACON GE, 1980, J BIOMECH, V13, P725, DOI 10.1016/0021-9290(80)90358-9
   BOBYN JD, 1980, CLIN ORTHOP RELAT R, P263
   BONFIELD W, 1977, NATURE, V270, P453, DOI 10.1038/270453a0
   GOSS S, 2001, J BIOMECH, V34, P995
   Guldberg RE, 1997, J BIOMECH, V30, P147, DOI 10.1016/S0021-9290(96)00106-6
   HATTORI Y, 2002, J JPN SOC CLIN BIOME, V23, P299
   HAYASHI K, 2003, BIOMECHANICS REMODEL, P1
   Ikeda T, 2005, METALL MATER TRANS A, V36A, P77, DOI 10.1007/s11661-005-0140-1
   Ishimoto T, 2006, MATER SCI FORUM, V512, P261, DOI 10.4028/www.scientific.net/MSF.512.261
   Ishimoto T, 2004, PHOSPH RES B, V17, P77
   LANDIS WJ, 1995, BONE, V16, P533, DOI 10.1016/8756-3282(95)00076-P
   Lee JW, 2006, MATER SCI FORUM, V512, P265, DOI 10.4028/www.scientific.net/MSF.512.265
   LEWIS JL, 1984, J BONE JOINT SURG AM, V66A, P280, DOI 10.2106/00004623-198466020-00016
   Nakajima H, 2004, ADV ENG MATER, V6, P377, DOI 10.1002/adem.200405149
   Nakano T, 2006, MATER SCI FORUM, V512, P255, DOI 10.4028/www.scientific.net/MSF.512.255
   Nakano T, 2002, BONE, V31, P479, DOI 10.1016/S8756-3282(02)00850-5
   Nakano T, 2004, MATER SCI FORUM, V449-4, P1289, DOI 10.4028/www.scientific.net/MSF.449-452.1289
   Nakano T, 2005, ENCY MAT SCI TECHNOL, P1
   Niinomi M, 2003, BIOMATERIALS, V24, P2673, DOI 10.1016/S0142-9612(03)00069-3
   Okazaki Y, 2004, BIOMATERIALS, V25, P5913, DOI 10.1016/j.biomaterials.2004.01.064
   Prendergast PJ, 1997, CLIN BIOMECH, V12, P343, DOI 10.1016/S0268-0033(97)00018-1
   Sumner DR, 1998, J BIOMECH, V31, P909, DOI 10.1016/S0021-9290(98)00096-7
   Tsubota K, 2003, ANN BIOMED ENG, V31, P733, DOI 10.1114/1.1574028
NR 23
TC 21
Z9 21
U1 0
U2 6
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD SEP
PY 2006
VL 47
IS 9
BP 2233
EP 2239
DI 10.2320/matertrans.47.2233
PG 7
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 103QA
UT WOS:000241900600023
OA Bronze
DA 2018-10-19
ER

PT J
AU Choong, CSN
   Hutmacher, DW
   Triffitt, JT
AF Choong, Cleo S. N.
   Hutmacher, Dietmar W.
   Triffitt, James T.
TI Co-culture of bone marrow fibroblasts and endothelial cells on modified
   polycaprolactone substrates for enhanced potentials in bone tissue
   engineering
SO TISSUE ENGINEERING
LA English
DT Article
ID SURFACE MODIFICATION; VASCULAR PROSTHESES; GROWTH-FACTORS;
   BLOOD-VESSELS; ANGIOGENESIS; POLYMERS; ADHESION; BIOMATERIALS;
   OSTEOBLASTS; DEPOSITION
AB The creation of a vascularized bed makes the survival of seeded cells on 3-dimensional scaffolds much more likely. However, relying purely on random capillary ingrowth into the porous scaffolds from the host may compromise vascularization of a scaffold. One solution is to transplant cells capable of differentiating into new blood vessels into the scaffolds to accelerate the creation of a vascularized scaffold. Because endothelial cells are the key cells involved in blood vessel formation, the present study was designed to investigate the development of a biomaterial surface that supports endothelial cell attachment and proliferation. The subsequent effects of the material surface modifications on the differentiation and proliferation of human bone marrow-derived fibroblasts (HBMFs) when grown in co-culture with a human bone marrow endothelial cell line (HBMEC-60) were studied. Endothelialization studies showed that the gelatin-coated and hydroxyapatite-coated substrates were superior for HBMEC-60 attachment and proliferation to hydrolyzed-only or untreated polycaprolactone substrates. Co-culture studies showed that the presence of the HBMEC-60 specifically enhanced HBMF cell proliferation and differentiation and that this effect was not observed with co-culture with skin fibroblasts. It is concluded that the co-culture of endothelial cells with HBMFs could be a promising culture system for bone tissue engineering applications.
C1 Univ Oxford, Inst Musculoskeletal Sci, Botnar Res Ctr, Oxford OX3 7LD, England.
   Natl Univ Singapore, Fac Engn, Div Bioengn, Singapore 117548, Singapore.
RP Choong, CSN (reprint author), Univ Oxford, Inst Musculoskeletal Sci, Botnar Res Ctr, Oxford OX3 7LD, England.
EM cleo.choong@gmail.com
RI Choong, Cleo/A-2240-2011
OI Hutmacher, Dietmar Werner/0000-0001-5678-2134
CR Anselme K, 2000, BIOMATERIALS, V21, P667, DOI 10.1016/S0142-9612(99)00242-2
   AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8
   Ball SG, 2004, INT J BIOCHEM CELL B, V36, P714, DOI 10.1016/j.biocel.2003.10.015
   Bishop E T, 1999, Angiogenesis, V3, P335, DOI 10.1023/A:1026546219962
   Bowlin GL, 1997, CELL TRANSPLANT, V6, P623, DOI 10.1016/S0963-6897(97)00096-1
   Boyan B. D., 2000, BONE ENG, P232
   Choong C, 2004, FOOD BIOPROD PROCESS, V82, P117, DOI 10.1205/0960308041614864
   CHOONG C, 2004, WORLD BIOM C SYDN AU
   COLLINOSDOBY P, 1994, J CELL BIOCHEM, V55, P304, DOI 10.1002/jcb.240550306
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   Corden TJ, 2000, BIOMATERIALS, V21, P713, DOI 10.1016/S0142-9612(99)00236-7
   Darland DC, 2001, CURR TOP DEV BIOL, V52, P107, DOI 10.1016/S0070-2153(01)52010-4
   DARNEY PD, 1989, AM J OBSTET GYNECOL, V160, P1292, DOI 10.1016/S0002-9378(89)80015-8
   DECKER B, 1995, ANAT REC, V242, P310, DOI 10.1002/ar.1092420304
   DONAVAN D, 2001, ANGIOGENESIS, V4, P113
   Drake CJ, 1998, ANN NY ACAD SCI, V857, P155, DOI 10.1111/j.1749-6632.1998.tb10115.x
   Drotleff S, 2004, EUR J PHARM BIOPHARM, V58, P385, DOI 10.1016/j.ejpb.2004.03.018
   ENGELBERG I, 1991, BIOMATERIALS, V12, P292, DOI 10.1016/0142-9612(91)90037-B
   FONTAINE M, 1995, J PEDIATR SURG, V30, P50
   Guillotin B, 2004, CELL PHYSIOL BIOCHEM, V14, P325, DOI 10.1159/000080342
   Hattori K, 2000, J Orthop Sci, V5, P57, DOI 10.1007/s007760050009
   HERMANSON GT, 1996, BIOCONJUGATE TECHNOL
   Holder WD, 1997, TISSUE ENG, V3, P149, DOI 10.1089/ten.1997.3.149
   Hutmacher DW, 2001, J BIOMED MATER RES, V55, P203, DOI 10.1002/1097-4636(200105)55:2<203::AID-JBM1007>3.3.CO;2-Z
   KELLY PJ, 1968, J BONE JOINT SURG AM, VA 50, P766, DOI 10.2106/00004623-196850040-00015
   Khang G., 2002, METHODS TISSUE ENG, P771
   LANZA R, 1993, SCIENCE, V260, P920
   Mark C., 1990, BIODEGRADABLE POLYM, P71
   MASSIA SP, 1991, J BIOMED MATER RES, V25, P223, DOI 10.1002/jbm.820250209
   MCAUSLAN BR, 1987, J BIOMED MATER RES, V21, P921, DOI 10.1002/jbm.820210708
   MCCARTHY ID, 1909, SCI BASIC ORTHOPAEDI, P15
   MIKOS AG, 1993, BIOTECHNOL BIOENG, V42, P716, DOI 10.1002/bit.260420606
   MOODIE GD, 1998, MATER RES SOC S P, V550, P207
   MOONEY DJ, 1994, TRANSPLANT P, V26, P3425
   Mooney DJ, 1997, J BIOMED MATER RES, V37, P413, DOI 10.1002/(SICI)1097-4636(19971205)37:3<413::AID-JBM12>3.0.CO;2-C
   Murphy WL, 2000, BIOMATERIALS, V21, P2521, DOI 10.1016/S0142-9612(00)00120-4
   Nomi M, 2002, MOL ASPECTS MED, V23, P463, DOI 10.1016/S0098-2997(02)00008-0
   Oyane A, 2005, BIOMATERIALS, V26, P2407, DOI 10.1016/j.biomaterials.2004.07.048
   Peters MC, 2002, J BIOMED MATER RES, V60, P668, DOI 10.1002/jbm.10134
   PEZZATINI S, 2004, P 7 WORLD BIOM C SYD, P1724
   Ramires PA, 2000, J BIOMED MATER RES, V51, P535, DOI 10.1002/1097-4636(20000905)51:3<535::AID-JBM31>3.0.CO;2-P
   REECE GP, 1998, FRONTIERS TISSUE ENG, P289
   Rood PML, 2000, EUR J CLIN INVEST, V30, P618
   Shin V, 2004, J VASC RES, V41, P193, DOI 10.1159/000077394
   Sieminski AL, 2000, BIOMATERIALS, V21, P2233, DOI 10.1016/S0142-9612(00)00149-6
   Stahl A, 2004, BIOCHEM BIOPH RES CO, V322, P684, DOI 10.1016/j.bbrc.2004.07.175
   Temenoff JS, 2000, BONE ENG, P454
   TRUETA J, 1963, J BONE JOINT SURG BR, V45, P402
   Unger RE, 2004, BIOMATERIALS, V25, P5137, DOI 10.1016/j.biomaterials.2003.12.040
   Vailhe B, 2001, LAB INVEST, V81, P439, DOI 10.1038/labinvest.3780252
   VANWACHEM PB, 1987, BIOMATERIALS, V8, P323, DOI 10.1016/0142-9612(87)90001-9
   VANWACHEM PB, 1985, BIOMATERIALS, V6, P403, DOI 10.1016/0142-9612(85)90101-2
   VILLANUEVA JE, 1990, J BONE MINER RES, V5, P733
   Villars F, 2000, J CELL BIOCHEM, V79, P672, DOI 10.1002/1097-4644(20001215)79:4<672::AID-JCB150>3.0.CO;2-2
   Wang DS, 1997, ENDOCRINOLOGY, V138, P2953, DOI 10.1210/en.138.7.2953
   Wenger A, 2004, TISSUE ENG, V10, P1536, DOI 10.1089/1076327042500283
   Wilting J, 1996, NATURWISSENSCHAFTEN, V83, P153, DOI 10.1007/s001140050265
   Yancopoulos GD, 1998, CELL, V93, P661, DOI 10.1016/S0092-8674(00)81426-9
   Zein I, 2002, BIOMATERIALS, V23, P1169, DOI 10.1016/S0142-9612(01)00232-0
   Zhang Z, 2004, BIOMATERIALS, V25, P177, DOI 10.1016/S0142-9612(03)00478-2
NR 60
TC 91
Z9 99
U1 2
U2 19
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD SEP
PY 2006
VL 12
IS 9
BP 2521
EP 2531
DI 10.1089/ten.2006.12.2521
PG 11
WC Cell & Tissue Engineering
SC Cell Biology
GA 087ZI
UT WOS:000240780900012
PM 16995785
DA 2018-10-19
ER

PT J
AU Werner, L
   Chew, J
   Mamalis, N
AF Werner, Liliana
   Chew, Jesse
   Mamalis, Nick
TI Experimental evaluation of ophthalmic devices and solutions using rabbit
   models
SO VETERINARY OPHTHALMOLOGY
LA English
DT Article
DE biomaterial; cataract surgery; intraocular lens; rabbit; ultrasound
ID POSTERIOR CAPSULE OPACIFICATION; ACRYLIC INTRAOCULAR LENSES; ZEALAND
   ALBINO RABBITS; CORNEAL ENDOTHELIUM; REGENERATION; TOXICITY; EYES;
   VISCOANESTHESIA; IMPLANTATION; ULTRASOUND
AB Objective To analyze and compare the geometry of the anterior segment of rabbit and human eyes, with relevance for the evaluation of intraocular lenses, and to review rabbit models used in our laboratory for the evaluation of different ophthalmic devices and solutions.
   Procedures Fifteen rabbit and 15 human eyes (10 phakic and 5 pseudophakic/group) obtained postmortem were used. Anterior-posterior length, equatorial diameter, and white-to-white (corneal diameter) were measured with calipers. The eyes were then analyzed with a very high-frequency ultrasound (Artemis, Ultralink) for measurements of the anterior chamber depth, and anterior chamber and ciliary sulcus diameters. The capsular bag diameter was measured with calipers from a posterior view, and the diameter and thickness of the crystalline lenses were measured after their excision from the phakic eyes.
   Results Although the size of the rabbit eye is overall smaller than the size of the human eye, the dimensions of the anterior segment of rabbit eyes are generally larger. The differences between rabbit and human eyes were statistically significant (Wilcoxon rank sum test) in terms of anterior-posterior length, equatorial diameter, white-to-white measurements (P < 0.0001), anterior chamber diameter (P = 0.0004), ciliary sulcus diameter (P = 0.0012), and crystalline lens diameter and thickness (P = 0.0003).
   Conclusions Experimental evaluation of design features of new phakic intraocular lenses in rabbit eyes may be inconclusive without adaptation of their size/design, contrary to the evaluation of new pseudophakic lenses by implantation in the capsular bag. The rabbit is a very valuable model for the experimental evaluation of different ophthalmic devices and solutions.
C1 Univ Utah, John A Moran Eye Ctr, Salt Lake City, UT 84112 USA.
RP Werner, L (reprint author), Univ Utah, John A Moran Eye Ctr, Salt Lake City, UT 84112 USA.
EM liliana.werner@hsc.utah.edu
CR AUFFARTH GU, 1994, J CATARACT REFR SURG, V20, P188, DOI 10.1016/S0886-3350(13)80164-2
   BEFANIS PJ, 1981, AM J VET RES, V42, P590
   BITO LZ, 1984, EXP EYE RES, V39, P807, DOI 10.1016/0014-4835(84)90079-4
   CHEW J, 2005, IN PRESS CLIN EXPT O
   GWON A, 1993, J CATARACT REFR SURG, V19, P735, DOI 10.1016/S0886-3350(13)80343-4
   GWON A, 1993, INVEST OPHTH VIS SCI, V34, P2124
   GWON AE, 1990, INVEST OPHTH VIS SCI, V31, P540
   GWON AE, 1992, INVEST OPHTH VIS SCI, V33, P2279
   Hayashi S, 2002, J MORPHOL, V254, P247, DOI 10.1002/jmor.10030
   Hicks CR, 1997, SURV OPHTHALMOL, V42, P175, DOI 10.1016/S0039-6257(97)00024-6
   KAUFMAN HE, 1966, AM J OPHTHALMOL, V61, P835, DOI 10.1016/0002-9394(66)90921-4
   Legeais JM, 1998, J CATARACT REFR SURG, V24, P371, DOI 10.1016/S0886-3350(98)80326-X
   Lheureux D, 2000, ULTRASONICS, V38, P391, DOI 10.1016/S0041-624X(99)00136-5
   Macky TA, 2003, J CATARACT REFR SURG, V29, P556, DOI 10.1016/S0886-3350(02)01603-6
   Mamalis N, 1996, J CATARACT REFR SURG, V22, P1291, DOI 10.1016/S0886-3350(96)80087-3
   Pandey SK, 2002, J CATARACT REFR SURG, V28, P139, DOI 10.1016/S0886-3350(01)01069-0
   Reinstein DZ, 2000, J REFRACT SURG, V16, P414
   SPENCE DJ, 1976, INVEST OPHTH VISUAL, V15, P1000
   Trivedi RH, 2003, J CATARACT REFR SURG, V29, P550, DOI 10.1016/S0886-3350(02)01601-2
   VANHORN DL, 1977, INVEST OPHTHALMOL, V16, P697
   Vargas LG, 2003, J CATARACT REFR SURG, V29, P1613, DOI 10.1016/S0886-3350(03)00215-3
   Wallentin N, 2002, OPHTHALMIC RES, V34, P14, DOI 10.1159/000048320
   Werner L, 2005, J CATARACT REFR SURG, V31, P1414, DOI 10.1016/j.jcr.2004.10.071
   Werner L, 2005, J CATARACT REFR SURG, V31, P805, DOI 10.1016/j.jcrs.2004.06.088
   Werner L, 2004, J CATARACT REFR SURG, V30, P2403, DOI 10.1016/j.jcrs.2004.02.085
   Werner L, 2004, J CATARACT REFR SURG, V30, P1114, DOI 10.1016/j.jcrs.2003.09.044
   WERNER L, 2006, J CATARACT REFR SURG, V32, P656
   Werner LP, 1998, J CATARACT REFR SURG, V24, P1371, DOI 10.1016/S0886-3350(98)80231-9
   Werner LP, 1997, J CATARACT REFR SURG, V23, P1013, DOI 10.1016/S0886-3350(97)80073-9
NR 29
TC 25
Z9 25
U1 0
U2 2
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1463-5216
J9 VET OPHTHALMOL
JI Vet. Ophthalmol.
PD SEP-OCT
PY 2006
VL 9
IS 5
BP 281
EP 291
DI 10.1111/j.1463-5224.2006.00495.x
PG 11
WC Veterinary Sciences
SC Veterinary Sciences
GA 077KB
UT WOS:000240027100003
PM 16939455
DA 2018-10-19
ER

PT J
AU Yanase, M
   Takaha, T
   Kuriki, T
AF Yanase, Michiyo
   Takaha, Takeshi
   Kuriki, Takashi
TI alpha-Glucan phosphorylase and its use in carbohydrate engineering
SO JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
LA English
DT Article; Proceedings Paper
CT 4th European Symposium of Enzymes in Grain Processing (ESEGP-4)
CY JUN 06-08, 2005
CL Nantes, FRANCE
SP INRA Res Unit, Biopolymers, Interact, Assemblies
DE alpha-glucan phosphorylase; amylose; glucose polymer; carbohydrate
   engineering
ID PURIFICATION; AMYLOSE; ENZYMES; EVOLUTION; POTATO
AB Amylose is expected to be a functional biomaterial for various industries but is not produced on an industrial scale, since the purification of natural amylose from starch is difficult. The authors have recently established a system to produce synthetic amylose from either sucrose or cellobiose using the combined action of alpha-glucan phosphorylase (EC 2.4.1.1) together with sucrose phosphorylase (EC 2.4.1.7) or cellobiose phosphorylase (EC 2.4.1.20). In these combined enzymic systems, alpha-glucan phosphorylase is a key enzyme. This paper summarises the authors' work to engineer practical alpha-glucan phosphorylase for industrial processes and its use in the enzymatic synthesis of essentially linear amylose and other glucose polymers. (c) 2006 Society of Chemical Industry
C1 Ezaki Glico Co Ltd, Biochem Res Lab, Nishiyodogawa Ku, Osaka 5558502, Japan.
RP Yanase, M (reprint author), Ezaki Glico Co Ltd, Biochem Res Lab, Nishiyodogawa Ku, 4-6-5 Utajima, Osaka 5558502, Japan.
EM yanase-michiyo@glico.co.jp
CR Boeck B, 1996, EUR J BIOCHEM, V239, P150, DOI 10.1111/j.1432-1033.1996.0150u.x
   Coutinho P. M., CARBOHYDRATE ACTIVE
   Fujii K., 2006, Journal of Applied Glycoscience, V53, P91
   Fujii K, 2003, BIOCATAL BIOTRANSFOR, V21, P167, DOI 10.1080/1024240310001614379
   FUKUI T, 1982, MOL CELL BIOCHEM, V42, P129, DOI 10.1007/BF00238507
   GIDLEY MJ, 1989, MACROMOLECULES, V22, P341, DOI 10.1021/ma00191a062
   HIZUKURI S, 1981, CARBOHYD RES, V94, P205, DOI 10.1016/S0008-6215(00)80718-1
   Hizukuri S, 1996, CARBOHYDRATES FOOD, P347
   HUDSON JW, 1993, J MOL BIOL, V234, P700, DOI 10.1006/jmbi.1993.1621
   Kim JH, 1997, J MICROBIOL BIOTECHN, V7, P132
   Kitamura S, 2000, CYCLIC POLYMERS, SECOND EDITION, P125
   KITAMURA S, 1996, POLYM MAT ENCY, P7915
   MANNERS DJ, 1991, CARBOHYD POLYM, V16, P37, DOI 10.1016/0144-8617(91)90071-J
   Niemann C., 1991, ACS SYM SER, P189
   OHDAN K, 2006, IN PRESS BIOCATAL BI
   PALM D, 1985, NATURE, V313, P500, DOI 10.1038/313500a0
   Shannon J. C., 1984, STARCH CHEM TECHNOLO, P25
   SHINZEL R, 1999, FEMS MICROBIOL LETT, V171, P73
   Takaha T., 2001, J APPL GLYCOSCI, V48, P71
   Takata H., 2003, Journal of Applied Glycoscience, V50, P15
   Takata H, 1998, J FERMENT BIOENG, V85, P156, DOI 10.1016/S0922-338X(97)86760-8
   WALDMANN H, 1986, CARBOHYD RES, V157, pC4, DOI 10.1016/0008-6215(86)85078-9
   Xavier KB, 1999, J BACTERIOL, V181, P3358
   Yanase M, 2005, APPL ENVIRON MICROB, V71, P5433, DOI 10.1128/AEM.71.9.5433-5439.2005
   PAM 17 0 7868 FAMILI
NR 25
TC 57
Z9 59
U1 1
U2 8
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0022-5142
J9 J SCI FOOD AGR
JI J. Sci. Food Agric.
PD AUG 30
PY 2006
VL 86
IS 11
BP 1631
EP 1635
DI 10.1002/jsfa.2513
PG 5
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
SC Agriculture; Chemistry; Food Science & Technology
GA 075CR
UT WOS:000239860700009
DA 2018-10-19
ER

PT J
AU Blomeier, H
   Zhang, XM
   Rives, C
   Brissova, M
   Hughes, E
   Baker, M
   Powers, AC
   Kaufman, DB
   Shea, LD
   Lowe, WL
AF Blomeier, Herman
   Zhang, Xiaomin
   Rives, Christopher
   Brissova, Marcela
   Hughes, Elizabeth
   Baker, Marshall
   Powers, Alvin C.
   Kaufman, Dixon B.
   Shea, Lonnie D.
   Lowe, William L., Jr.
TI Polymer scaffolds as synthetic microenvironments for extrahepatic islet
   transplantation
SO TRANSPLANTATION
LA English
DT Article
DE islet transplantation; biomaterial; diabetes
ID TISSUE-ENGINEERING SCAFFOLDS; PANCREATIC-ISLETS; ENDOTHELIAL-CELLS;
   GRAFT-SURVIVAL; GROWTH-FACTOR; DELIVERY; REVASCULARIZATION; MATRICES;
   SITE; DNA
AB Background. Problems associated with the hepatic transplantation of islets may preclude the broad application of islet transplantation. Thus, we sought to develop an approach to the extrahepatic transplantation of islets using a synthetic biodegradable polymer scaffold.
   Methods. Microporous polymer scaffolds that allow vascular ingrowth and nutrient diffusion from host tissues were fabricated from copolymers of lactide and glycolide. Murine islets were transplanted without or with a scaffold onto intraperitoneal fat of syngeneic diabetic recipients. Bioluminescence imaging using a cooled charge-coupled device camera, immunohistochemistry, and glycemia were used to assess islet engraftment and function posttransplant.
   Results. By bioluminescence imaging, islets transplanted on a polymer scaffold remain localized to the transplant site and survive for an extended period of time. Islets transplanted on scaffolds retained the architecture of native islets and developed a functional islet vasculature. Transplantation of marginal masses of islets on the polymer scaffold demonstrated improved islet function compared to transplantation without a scaffold as assessed by the effectiveness of diabetes reversal, including mean time required to achieve euglycemia, weight gain, and glucose levels during an intraperitoneal glucose tolerance test.
   Conclusion. These findings indicate that a synthetic polymer scaffold can serve as a platform for islet transplantation and improves the function of extrahepatically transplanted islets compared to islets transplanted without a scaffold. The scaffold may also be useful to deliver bioactive molecules to modify the microenvironment surrounding the transplanted islets and, thus, enhance islet survival and function.
C1 Northwestern Univ, Feinberg Sch Med, Ctr Endocrinol Metab & Mol Med, Div Endocrinol Metab & Mol Med,Dept Med, Chicago, IL 60611 USA.
   Northwestern Univ, Feinberg Sch Med, Dept Surg, Div Transplant Surg, Chicago, IL 60611 USA.
   Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL USA.
   Vanderbilt Univ, Med Ctr, Dept Med, Div Endocrinol Diabet & Metab, Nashville, TN USA.
   VA Tennessee Valley Healthcare Syst, Nashville, TN USA.
RP Lowe, WL (reprint author), Northwestern Univ, Feinberg Sch Med, Ctr Endocrinol Metab & Mol Med, Div Endocrinol Metab & Mol Med,Dept Med, Tarry 15-703,303 E Chicago Ave, Chicago, IL 60611 USA.
EM wlowe@northwestern.edu
RI Shea, Lonnie/B-7615-2009
FU NIDDK NIH HHS [R21 DK067833, R01 DK063439, R01 DK52919, R21 DK063439,
   R01 DK062641, R21 DK062641]; NIBIB NIH HHS [R01 EB003806, R01
   EB003806-02]
CR Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649
   Boontheekul T, 2003, CURR OPIN BIOTECH, V14, P559, DOI 10.1016/j.copbio.2003.08.004
   Bottino R, 1998, DIABETES, V47, P316, DOI 10.2337/diabetes.47.3.316
   Brissova M, 2004, DIABETES, V53, P1318, DOI 10.2337/diabetes.53.5.1318
   Chaikof EL, 1999, ANNU REV BIOMED ENG, V1, P103, DOI 10.1146/annurev.bioeng.1.1.103
   de Vos P, 2002, DIABETOLOGIA, V45, P159, DOI 10.1007/s00125-001-0729-x
   Dombrowski F, 1997, AM J PATHOL, V150, P1071
   Dufour JM, 2005, TISSUE ENG, V11, P1323, DOI 10.1089/ten.2005.11.1323
   Gupta V, 1997, DIABETES, V46, P28, DOI 10.2337/diabetes.46.1.28
   Hara M, 2004, TRANSPLANTATION, V78, P615, DOI 10.1097/01.TP.0000128838.54074.74
   Hyon SH, 1998, TRANSPLANT P, V30, P409, DOI 10.1016/S0041-1345(97)01330-4
   Jang JH, 2005, MOL THER, V12, P475, DOI 10.1016/j.ymrhe.2005.03.036
   Jansson L, 2002, DIABETOLOGIA, V45, P749, DOI 10.1007/s00125-002-0827-4
   Juang JH, 1996, TRANSPLANTATION, V61, P1557, DOI 10.1097/00007890-199606150-00001
   KAUFMAN DB, 1994, DIABETES, V43, P778, DOI 10.2337/diabetes.43.6.778
   KAUFMAN DB, 2003, CURR DIABETES REP, V3, P344
   KIM WS, 1994, PLAST RECONSTR SURG, V94, P233, DOI 10.1097/00006534-199408000-00001
   Kin T, 2003, AM J TRANSPLANT, V3, P281, DOI 10.1034/j.1600-6143.2003.00049.x
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Linn T, 2003, CELL TRANSPLANT, V12, P769, DOI 10.3727/000000003108747244
   Markmann JF, 2003, DIABETES, V52, P1591, DOI 10.2337/diabetes.52.7.1591
   McDonald DM, 2003, NAT MED, V9, P713, DOI 10.1038/nm0603-713
   McKinnon CM, 2001, DIABETOLOGIA, V44, P1203, DOI 10.1007/s001250100628
   Melloul D, 2002, DIABETOLOGIA, V45, P309, DOI 10.1007/s00125-001-0728-y
   MIKOS AG, 1993, BIOMATERIALS, V14, P323, DOI 10.1016/0142-9612(93)90049-8
   MOONEY DJ, 1994, CELL TRANSPLANT, V3, P203, DOI 10.1177/096368979400300209
   Murphy WL, 2002, TISSUE ENG, V8, P43, DOI 10.1089/107632702753503045
   Nof M, 2002, J BIOMED MATER RES, V59, P349, DOI 10.1002/jbm.1251
   Nyqvist D, 2005, DIABETES, V54, P2287, DOI 10.2337/diabetes.54.8.2287
   Putnam AJ, 1996, NAT MED, V2, P824, DOI 10.1038/nm0796-824
   Richardson TP, 2001, CRIT REV EUKAR GENE, V11, P47
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Robertson RP, 2004, NEW ENGL J MED, V350, P694, DOI 10.1056/NEJMra032425
   Robertson RP, 2002, J CLIN ENDOCR METAB, V87, P5416, DOI 10.1210/jc.2002-021612
   Ryan EA, 2002, DIABETES, V51, P2148, DOI 10.2337/diabetes.51.7.2148
   Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060
   Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   VAJKOCZY P, 1995, AM J PATHOL, V146, P1397
   Yang Y, 2005, J CONTROL RELEASE, V104, P433, DOI 10.1016/j.jconrel.2005.02.022
NR 40
TC 71
Z9 73
U1 2
U2 14
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0041-1337
EI 1534-6080
J9 TRANSPLANTATION
JI Transplantation
PD AUG 27
PY 2006
VL 82
IS 4
BP 452
EP 459
DI 10.1097/01.tp.0000231708.19937.21
PG 8
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA 078TD
UT WOS:000240125600003
PM 16926587
OA Green Accepted
DA 2018-10-19
ER

PT J
AU Hung, CH
   Young, TH
AF Hung, Chih-Huang
   Young, Tai-Horng
TI NGF IMPROVES NEURITE FASCICULATION OF EMBRYONIC RAT CEREBRAL CORTICAL
   NEURAL STEM CELLS ON EVAL SUBSTRATES UNDER SERUM FREE CONDITIONS
SO BIOMEDICAL ENGINEERING-APPLICATIONS BASIS COMMUNICATIONS
LA English
DT Article
DE poly (ethylene-co vinyl alcohol) (EVAL); nerve growth factor (NGF);
   neural stem cells
AB The behaviors of multipotential neural stem cells are regulated by several factors, including culture substrates, soluble factors, and cell-cell interactions. The purpose of this study was to explore the effects of cell-cell and cell-substrate interactions on developmental potential of neural stem cells from embryonic rat cerebral cortex at neurosphere level in the presence of nerve growth factors (NGF). The results suggested that, in combination with NGF, EVAL substrates could induce neurite fasciculation of differentiated forming-neurosphere cells under serum free conditions. Quantitative analysis of process growth reveals that, under serum free conditions, when NGF was present the process breadth was significantly larger than that of neurospheres cultured without NGF. In contrast, when serum were added in the medium, regardless of the addition of NGF or not, the neurospheres were induced into typically an extensive cellular substratum of protoplasmic cells upon which process-bearing cells spread. It indicated that, when serum was present, the differentiated GFAP-positive astrocytes layer could serve as a supported architectural for growth and survival of process-bearing cells. At this time, neurites were failed to fasciculate. Here, we proposed that the mediation of cell-biomaterial interaction by cell-cell interaction should be taken into account for regulation of neurites fasciculation. Moreover, the pattern of neural stem cell growth on EVAL subtrates with or without NGF in the absence or presence of serum in this studies suggested that neurons are more adherent to glail cells than to other neurons but are more adherent to other neurons than to EVAL substrates.
C1 [Hung, Chih-Huang; Young, Tai-Horng] Natl Taiwan Univ, Coll Med & Engn, Inst Biomed Engn, Taipei 100, Taiwan.
RP Young, TH (reprint author), Natl Taiwan Univ, Coll Med & Engn, Inst Biomed Engn, Taipei 100, Taiwan.
EM thyoung@ha.mc.ntu.edu.tw
FU National Taiwan University Hospital; National Science Council of the
   Republic of China
FX The authors thank National Taiwan University Hospital and National
   Science Council of the Republic of China for their financial support of
   this research.
CR Arsenijevic Y, 2001, J NEUROSCI, V21, P7194, DOI 10.1523/JNEUROSCI.21-18-07194.2001
   BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8
   BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514
   Cameron HA, 1998, J NEUROBIOL, V36, P287, DOI 10.1002/(SICI)1097-4695(199808)36:2<287::AID-NEU13>3.3.CO;2-E
   Chiang YH, 1996, CELL TRANSPLANT, V5, P179, DOI 10.1016/0963-6897(95)02043-8
   Ciccolini F, 1998, J NEUROSCI, V18, P7869
   Draberova E, 1998, HISTOCHEM CELL BIOL, V109, P231
   Gritti A, 1996, J NEUROSCI, V16, P1091
   Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129
   NOBLE M, 1984, J NEUROSCI, V4, P1892
   REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558
   Schmidt CE, 2003, ANNU REV BIOMED ENG, V5, P293, DOI 10.1146/annurev.bioeng.5.011303.120731
   Shimazaki T, 2001, J NEUROSCI, V21, P7642
   Tsai RYL, 2000, J NEUROSCI, V20, P3725
   WECLEWICZ K, 1993, J NEUROSCI RES, V36, P173, DOI 10.1002/jnr.490360207
   Wong G, 2004, EXP NEUROL, V187, P171, DOI 10.1016/j.expneurol.2004.01.009
   Young TH, 1998, BIOMATERIALS, V19, P717, DOI 10.1016/S0142-9612(98)00187-2
   Young TH, 2005, BIOMATERIALS, V26, P4291, DOI 10.1016/j.biomaterials.2004.10.043
NR 18
TC 0
Z9 0
U1 1
U2 2
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 1016-2372
EI 1793-7132
J9 BIOMED ENG-APP BAS C
JI Biomed. Eng.-Appl. Basis Commun.
PD AUG 25
PY 2006
VL 18
IS 4
DI 10.4015/S1016237206000336
PG 7
WC Engineering, Biomedical
SC Engineering
GA V98ID
UT WOS:000213392200008
OA Bronze
DA 2018-10-19
ER

PT J
AU Lee, IC
   Young, TH
AF Lee, I-Chi
   Young, Tai-Horng
TI PREPARATION OF PLLA MEMBRANES WITH DIFFERENT MORPHOLOGIES FOR CULTURE OF
   LIGAMENT CELLS
SO BIOMEDICAL ENGINEERING-APPLICATIONS BASIS COMMUNICATIONS
LA English
DT Article
DE poly-L-lactide (PLLA); medial collateral ligament cells (MCLs); collagen
   type I; fibronectin
AB Poly (lactic acid) is a biodegradable biomedical material that has been used for connective tissue reconstruction. In this work, poly-L-lactide (PLLA) membranes with different morphologies were prepared by phase separation method. Otherwise, biomaterials coated with various extracellular matrix (ECM) have been shown to promote cell adhesion, proliferation, and differentiation. In addition, the in vitro interaction of medial collateral ligament cells (MCLs) and PLLA membranes with dense, porous and particulate morphologies and with ECM coating was investigated. It was found that the cell compatibility of three types of PLLA membranes almost the same before coating ECM. The results also revealed that collagen type I could improve ligament cells adhesion and fibronectin could improve ligament cells growth, and this effect was most obvious in particulate membrane. Therefore, because the PLLA materials with particulate structure could adsorb more ECM which in turn influenced the cell adhesion and cell growth. The PLLA membrane with the particulate morphology satisfies the biomaterial requirement necessary for temporary scaffold to transplanted ligament cells and provides a means for the architectural design of more complex tissue-engineered systems.
C1 [Lee, I-Chi; Young, Tai-Horng] Natl Taiwan Univ, Inst Biomed Engn, Coll Med & Engn, Taipei 100, Taiwan.
RP Young, TH (reprint author), Natl Taiwan Univ, Inst Biomed Engn, Coll Med & Engn, Taipei 100, Taiwan.
EM thyoung@ha.mc.ntu.edu.tw
FU National Taiwan University Hospital; National Science Council of the
   Republic of China
FX The authors thank the National Taiwan University Hospital and the
   National Science Council of the Republic of China for their financial
   support.
CR AMIEL D, 1990, MATRIX, V9, P421, DOI 10.1016/S0934-8832(11)80010-7
   Bhati RS, 2001, J BIOMED MATER RES, V56, P74, DOI 10.1002/1097-4636(200107)56:1<74::AID-JBM1070>3.0.CO;2-M
   Carlstedt C. A., 1989, BASIC BIOMECHANICS M, P59
   CONNOR NS, 1983, J CELL SCI, V63, P233
   Garcia AJ, 1999, MOL BIOL CELL, V10, P785, DOI 10.1091/mbc.10.3.785
   Goulet F, 1997, PRINCIPLES TISSUE EN, P633
   Hubbell JA, 1999, CURR OPIN BIOTECH, V10, P123, DOI 10.1016/S0958-1669(99)80021-4
   HUBBLE J, 1995, BIOCHEM J, V311, P917, DOI 10.1042/bj3110917
   JACKSON DW, 1994, ARTHROSCOPY, V10, P442, DOI 10.1016/S0749-8063(05)80197-5
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Liu HC, 2004, BIOMATERIALS, V25, P4047, DOI 10.1016/j.biomaterials.2003.10.098
   Ma ZW, 2003, J BIOMAT SCI-POLYM E, V14, P13, DOI 10.1163/15685620360511119
   MAKISALO SE, 1989, INJURY, V20, P72, DOI 10.1016/0020-1383(89)90143-5
   Ohya Y, 2003, J BIOMED MATER RES A, V65A, P79, DOI 10.1002/jbm.a.10446
   Wan YQ, 2003, BIOMATERIALS, V24, P3757, DOI [10.1016/S0142-9612(03)00251-5, 10.1016/S0142-9612(03)00251-2]
NR 15
TC 4
Z9 4
U1 0
U2 0
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 1016-2372
EI 1793-7132
J9 BIOMED ENG-APP BAS C
JI Biomed. Eng.-Appl. Basis Commun.
PD AUG 25
PY 2006
VL 18
IS 4
DI 10.4015/S1016237206000294
PG 5
WC Engineering, Biomedical
SC Engineering
GA V98ID
UT WOS:000213392200004
OA Bronze
DA 2018-10-19
ER

PT J
AU Nancharaiah, YV
   Joshi, HM
   Mohan, TVK
   Venugopalan, VP
   Narasimhan, SV
AF Nancharaiah, Y. V.
   Joshi, H. M.
   Mohan, T. V. K.
   Venugopalan, V. P.
   Narasimhan, S. V.
TI Aerobic granular biomass: a novel biomaterial for efficient uranium
   removal
SO CURRENT SCIENCE
LA English
DT Article
DE aerobic granular sludge; biosorption; microbial granules; radionuclide;
   uranium
ID WASTE-WATER TREATMENT; MICROBIAL BIOFILMS; COBALT SORPTION; SLUDGE;
   BIOSORPTION; NICKEL; PRECIPITATION; BIOSORBENT; REACTOR; GREEN
AB Aerobic microbial granules, self-immobilized microbial consortia cultured in aerobically operated bioreactors, primarily consist of mixed species of bacteria ensconced in an extracellular polymeric matrix of their own creation. Such aerobically grown microbial granules have attracted considerable research interest in environmental biotechnology. In recent times, it has been demonstrated that the granules could be used for efficient degradation of recalcitrant organic compounds and for the treatment of a growing number of wastes. The objective of this study was to investigate whether aerobic granules could be used as novel biomass material for biosorption of uranium from aqueous solutions. The granular biomass for biosorption experiments was cultivated in a laboratory-scale sequencing batch reactor by feeding with synthetic wastewater. Biosorption of uranium [U(VI)] was studied at different initial pH values (1 to 8) and different initial uranium concentrations (6 to 750 mg l(-1)). Biosorption was observed to be rapid (< 1 h) in acidic pH range (1 to 6) compared to that at. pH 7.0 or above. Almost complete removal of uranium was observed in the range 6-100 mg l(-1) in less than 1 h. Redlich-Peterson model gave the best fit when the experimental data were analysed using different adsorption isotherm equations. The maximum biosorption capacity of U(VI) was determined to be 218 2 mg g(-1) dry granular biomass. Further, it was observed that cations such as Na+, K+, Mg+, and Ca+ Were simultaneously released into the bulk solution during U(VI) biosorption, indicating the involvement of ion exchange mechanism in radionuclide uptake. Live and dead biomass did not show significant difference in U removal, indicating the involvement of a passive sorption process.. The study suggests that aerobic granular biomass has the potential to be employed as an effective biosorbent material for recovering/removing uranium (and probably other radionuclides) from dilute nuclear wastes.
C1 BARC Facil, Water & Steam Chem Div, Kalpakkam 603102, Tamil Nadu, India.
RP Venugopalan, VP (reprint author), BARC Facil, Water & Steam Chem Div, Kalpakkam 603102, Tamil Nadu, India.
EM vpv@igcar.gov.in
OI Venugopalan, Vayalam P/0000-0002-2837-6339; Joshi,
   Hiren/0000-0002-2774-7695
CR Beun JJ, 2002, WATER RES, V36, P702, DOI 10.1016/S0043-1354(01)00250-0
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   Etterer T, 2001, WATER SCI TECHNOL, V43, P19
   Gadd GM, 2000, CURR OPIN BIOTECH, V11, P271, DOI 10.1016/S0958-1669(00)00095-1
   Gadd GM, 2004, GEODERMA, V122, P109, DOI 10.1016/j.goederma.2004.01.002
   Genc O, 2003, INT J MINER PROCESS, V68, P93, DOI 10.1016/S0301-7516(02)00062-5
   GORBY YA, 1992, ENVIRON SCI TECHNOL, V26, P205, DOI 10.1021/es00025a026
   Hawari AH, 2006, BIORESOURCE TECHNOL, V97, P692, DOI 10.1016/j.biortech.2005.03.033
   HOSTEN E, 1997, ANAL CHIM ACTA, P95
   HU Z, 2005, APPL ENVIRON MICROB, V71, P4021
   LAWRENCE JR, 1991, J BACTERIOL, V173, P6558, DOI 10.1128/jb.173.20.6558-6567.1991
   LIOYD JR, 2004, CURR OPIN BIOTECH, V16, P254
   Liu Y, 2002, WATER RES, V36, P1653, DOI 10.1016/S0043-1354(01)00379-7
   Liu Y, 2004, BIOTECHNOL ADV, V22, P533, DOI 10.1016/j.biotechadv.2004.05.001
   Liu Y, 2003, J BIOTECHNOL, V102, P233, DOI 10.1016/S0168-1656(03)00030-0
   Liu Y, 2002, LETT APPL MICROBIOL, V35, P548, DOI 10.1046/j.1472-765X.2002.01227.x
   Lloyd JR, 2000, ENVIRONMENTAL MICROBE-METAL INTERACTIONS, P277
   Merroun M, 2003, RADIOCHIM ACTA, V91, P583, DOI 10.1524/ract.91.10.583.22477
   Morgenroth E, 1997, WATER RES, V31, P3191, DOI 10.1016/S0043-1354(97)00216-9
   Nancharaiah YV, 2005, J MICROBIOL METH, V60, P179, DOI 10.1016/j.mimet.2004.09.016
   NANCHARAIAH YV, IN PRESS WATER RES
   Nicolella C, 2000, J BIOTECHNOL, V80, P1, DOI 10.1016/S0168-1656(00)00229-7
   POLLMANN K, 2005, BIOTECHNOL ADV, V24, P58
   Renninger N, 2004, APPL ENVIRON MICROB, V70, P7404, DOI 10.1128/AEM.70.12.7404-7412.2004
   Renshaw JC, 2005, ENVIRON SCI TECHNOL, V39, P5657, DOI 10.1021/es048232b
   Sar P, 2004, INT BIODETER BIODEGR, V54, P193, DOI 10.1016/j.ibiod.2004.05.004
   van Hullebusch ED, 2006, J BIOTECHNOL, V121, P227, DOI 10.1016/j.jbiotec.2005.07.011
   van Hullebusch ED, 2005, CHEMOSPHERE, V58, P493, DOI 10.1016/j.chemosphere.2004.09.017
   van Hullebusch ED, 2004, J CHEM TECHNOL BIOT, V79, P1219, DOI 10.1002/jctb.1116
   van Hullebusch Eric D., 2003, Reviews in Environmental Science and Bio/Technology, V2, P9, DOI 10.1023/B:RESB.0000022995.48330.55
   Venugopalan VP, 2005, APPL ENVIRON MICROB, V71, P2677, DOI 10.1128/AEM.71.5.2677-2686.2005
   VENUGOPALAN VP, 2005, BARC NEWSL, V254, P1
   Wuertz S, 2000, J IND MICROBIOL BIOT, V24, P116, DOI 10.1038/sj.jim.2900784
   Xu H, 2006, BIORESOURCE TECHNOL, V97, P359, DOI 10.1016/j.biortech.2005.03.011
NR 34
TC 52
Z9 61
U1 0
U2 36
PU CURRENT SCIENCE ASSN
PI BANGALORE
PA C V RAMAN AVENUE, PO BOX 8005, BANGALORE 560 080, INDIA
SN 0011-3891
J9 CURR SCI INDIA
JI Curr. Sci.
PD AUG 25
PY 2006
VL 91
IS 4
BP 503
EP 509
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 080RR
UT WOS:000240266200025
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Sarra-Bournet, C
   Turgeon, S
   Mantovani, D
   Laroche, G
AF Sarra-Bournet, C.
   Turgeon, S.
   Mantovani, D.
   Laroche, G.
TI A study of atmospheric pressure plasma discharges for surface
   functionalization of PTFE used in biomedical applications
SO JOURNAL OF PHYSICS D-APPLIED PHYSICS
LA English
DT Article
ID DIELECTRIC BARRIER DISCHARGE; GLOW-DISCHARGE; CHEMICAL DERIVATIZATION;
   TREATED POLYPROPYLENE; NITROGEN; POLYETHYLENE; CHEMISTRY; AMMONIA;
   PHYSICS; CORONA
AB Plasma polymer surface modification is widely used in the biomedical field to tailor the surface properties of materials to improve their biocompatibility. Most of these treatments are performed using low pressure plasma systems but recently, filamentary dielectric barrier discharge (FDBD) and atmospheric pressure glow discharge (APGD) have appeared as interesting alternatives. The aim of this paper is to evaluate the potential of surface modifications realized with FDBD and APGD in different atmospheres (N(2)+ H(2) and N(2)+ NH(3) mixtures) on poly(tetrafluoroethylene) to determine the relative influence of both the discharge regime and the gas nature on the surface transformations. From XPS analysis, it is shown that the discharge regime can have a significant effect on the surface transformation; FDBDs operating in H(2)/N(2) lead to a high concentration of amino-groups with high specificity but also important damaging on the surface. Glow discharges in both H(2)/N(2) and NH(3)/N(2) lead to lower concentrations of amino-groups with lower specificity but lower surface damaging. Therefore, this simple surface treatment seems to be an effective, low cost method for the production of uniform surface modification with amino-groups that can subsequently be used to graft various chemical functionalities used for biomaterial compatibility.
C1 Univ Laval, Dept Min Met & Mat Engn, Surface Engn Lab, Ste Foy, PQ G1K 7P4, Canada.
   St Francis Assisi Hosp, Univ Hosp Res Ctr, Quebec City, PQ G1L 3L5, Canada.
   Univ Laval, Dept Min Met & Mat Engn, Lab Biomat & Bioengn, Ste Foy, PQ G1K 7P4, Canada.
RP Sarra-Bournet, C (reprint author), Univ Laval, Dept Min Met & Mat Engn, Surface Engn Lab, Ste Foy, PQ G1K 7P4, Canada.
EM Gaetan.Laroche@gmn.ulaval.ca
OI Mantovani, Diego/0000-0001-9672-895X
CR ANDERSON JM, 1986, NATO ASI SER E, V106, P29
   Arefi-Khonsari F, 1997, NATO ADV SCI I E-APP, V346, P165
   Badey JP, 1996, POLYMER, V37, P1377, DOI 10.1016/0032-3861(96)81135-9
   Beamson G., 1992, HIGH RESOLUTION XPS
   Chan C.-M., 1996, Surface Science Reports, V24, P1, DOI 10.1016/0167-5729(96)80003-3
   Chevallier P, 2001, J PHYS CHEM B, V105, P12490, DOI 10.1021/jp011607k
   CROQUESEL E, 2001, 15 INT S PLASM CHEM
   d'Agostino R, 1997, PLASMA PROCESSING PO, V346
   Dorai R, 2003, J PHYS D APPL PHYS, V36, P666, DOI 10.1088/0022-3727/36/6/309
   Dumitrascu N., 2002, Entropie, V38, P168
   ELIASSON B, 1991, IEEE T PLASMA SCI, V19, P309, DOI 10.1109/27.106829
   Favia P, 1996, PLASMAS POLYM, V1, P91, DOI DOI 10.1007/BF02532821
   Fridman A, 2005, J PHYS D APPL PHYS, V38, pR1, DOI 10.1088/0022-3727/38/2/R01
   Gauvreau V, 2004, BIOCONJUGATE CHEM, V15, P1146, DOI 10.1021/bc049858u
   GEGENBACH TR, 1994, J ADHES SCI TECHNOL, V8, P305
   Gerenser L.J., 1994, PLASMA SURFACE MODIF, P43
   Gerenser LJ, 2000, SURF INTERFACE ANAL, V29, P12, DOI 10.1002/(SICI)1096-9918(200001)29:1<12::AID-SIA687>3.3.CO;2-Z
   Gessner C, 2004, THIN SOLID FILMS, V459, P118, DOI 10.1016/j.tsf.2003.12.112
   GHERARDI N, 2003, 16 INT S PLASM CHEM
   Girard-Lauriault PL, 2005, PLASMA PROCESS POLYM, V2, P263, DOI 10.1002/ppap.200400092
   Griesser H. J., 1990, Materials Forum, V14, P192
   Guimond S, 2002, PLASMAS POLYM, V7, P71, DOI 10.1023/A:1015274118642
   HOFFMAN AS, 1988, J APPL POLYM SCI APP, V42, P251
   Ishikawa S, 2000, SURF COAT TECH, V130, P52, DOI 10.1016/S0257-8972(00)00688-5
   Klages CP, 1999, MATERIALWISS WERKST, V30, P767, DOI 10.1002/(SICI)1521-4052(199912)30:12<767::AID-MAWE767>3.0.CO;2-S
   KLEMBERGSAPIEHA JE, 1991, J VAC SCI TECHNOL A, V9, P2975, DOI 10.1116/1.577158
   Kogelschatz U, 2003, PLASMA CHEM PLASMA P, V23, P1, DOI 10.1023/A:1022470901385
   Kozlov KV, 2005, J PHYS D APPL PHYS, V38, P518, DOI 10.1088/0022-3727/38/4/003
   Markkula TK, 2002, SURF INTERFACE ANAL, V34, P583, DOI 10.1002/sia.1365
   Massines F, 2005, PLASMA PHYS CONTR F, V47, pB577, DOI 10.1088/0741-3335/47/12B/S42
   Massines F, 1998, J PHYS D APPL PHYS, V31, P3411, DOI 10.1088/0022-3727/31/24/003
   Massines F, 2003, SURF COAT TECH, V174, P8, DOI 10.1016/S0257-8972(03)00540-1
   Massines F., 2001, Plasmas and Polymers, V6, P35, DOI 10.1023/A:1011365306501
   Massines F., 1998, Plasmas and Polymers, V3, P43, DOI 10.1023/A:1022582017499
   Medard N, 2002, LANGMUIR, V18, P2246, DOI 10.1021/la011481i
   Miralai S F, 2000, PLASMAS POLYM, V5, P63
   O'Hare LA, 2002, SURF INTERFACE ANAL, V33, P335, DOI 10.1002/sia.1217
   Oehr C, 2003, NUCL INSTRUM METH B, V208, P40, DOI 10.1016/S0168-583X(03)00650-5
   OKAZAKI S, 1993, J PHYS D APPL PHYS, V26, P889, DOI 10.1088/0022-3727/26/5/025
   Pringle SD, 1996, SURF INTERFACE ANAL, V24, P821, DOI 10.1002/(SICI)1096-9918(199611)24:12<821::AID-SIA189>3.0.CO;2-B
   RATNER BD, 1983, ANN BIOMED ENG, V11, P313, DOI 10.1007/BF02363290
   Ratner BD, 1990, PLASMA DEPOSITION TR, P463
   Roth JR, 2005, J PHYS D APPL PHYS, V38, P555, DOI 10.1088/0022-3727/38/4/007
   RYAN ME, 1995, MACROMOLECULES, V28, P1377, DOI 10.1021/ma00109a008
   SARRABOURNET C, 2006, IN PRESS PLASMA PROC
   SEEBOCK R, 2000, PLASMAS POLYM, V5, P103
   Simon C, 2000, J LONG-TERM EFF MED, V10, P127
   Sira M, 2005, J PHYS D APPL PHYS, V38, P621, DOI 10.1088/0022-3727/38/4/015
   STROBEL M, 1989, J ADHES SCI TECHNOL, V3, P321, DOI 10.1163/156856189X00245
   Tanaka K, 2003, INT J ADHES ADHES, V23, P515, DOI 10.1016/S0143-7496(03)00094-0
   VARGO TG, 1991, J POLYM SCI POL CHEM, V29, P555, DOI 10.1002/pola.1991.080290412
   Zhang Q, 2002, J BIOMED MATER RES, V60, P502, DOI 10.1002/jbm.1294
NR 52
TC 70
Z9 76
U1 7
U2 23
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0022-3727
J9 J PHYS D APPL PHYS
JI J. Phys. D-Appl. Phys.
PD AUG 21
PY 2006
VL 39
IS 16
BP 3461
EP 3469
DI 10.1088/0022-3727/39/16/S03
PG 9
WC Physics, Applied
SC Physics
GA 071PI
UT WOS:000239613700004
DA 2018-10-19
ER

PT J
AU Alexis, F
   Lo, SL
   Wang, S
AF Alexis, Frank
   Lo, Seong-Loong
   Wang, Shu
TI Covalent attachment of low molecular weight poly(ethylene imine)
   improves tat peptide mediated gene delivery
SO ADVANCED MATERIALS
LA English
DT Article
ID POLYETHYLENIMINE; VECTOR; TRANSFECTION; CYTOTOXICITY; DERIVATIVES
AB A polymer-peptide hybrid biomaterial synthesized by coupling poly(ethylene imine) directly to resin-supported Tat peptide takes advantage of the unique features associated with the two original cationic materials and functions as a novel gene-delivery vector with good biocompatibility. The figure shows cells transfected with green fluorescent protein (GFP) using complexes of the polymer-peptide hybrid and GFP (scale bar: 100 mu m).
C1 Inst Bioengn & Nanotechnol, Gene Delivery Grp, Singapore 138669, Singapore.
   Natl Univ Singapore, Gene Delivery Grp, Inst Bioengn & Nanotechnol, Dept Sci Biol, Singapore 117543, Singapore.
RP Wang, S (reprint author), Inst Bioengn & Nanotechnol, Gene Delivery Grp, 31 Biopolis Way, Singapore 138669, Singapore.
EM swang@ibn.a-star.edu.sg
RI wang, shu/H-6744-2012
CR Akinc A, 2005, J GENE MED, V7, P657, DOI 10.1002/jgm.696
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001
   Fischer D, 1999, PHARMACEUT RES, V16, P1273, DOI 10.1023/A:1014861900478
   Gupta B, 2005, ADV DRUG DELIVER REV, V57, P637, DOI 10.1016/j.addr.2004.10.007
   Hyndman L, 2004, J CONTROL RELEASE, V99, P435, DOI 10.1016/j.jconrel.2004.07.023
   Moghimi SM, 2005, MOL THER, V11, P990, DOI 10.1016/j.mythe.2005.02.010
   Neu M, 2005, J GENE MED, V7, P992, DOI 10.1002/jgm.773
   Sloots A, 2005, FEBS J, V272, P4221, DOI 10.1111/j.1742-4658.2005.04834.x
   SOUNDARA MD, 2005, J CONTROL RELEASE, V102, P293
   YANG CY, GENE THER
NR 11
TC 44
Z9 44
U1 2
U2 21
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0935-9648
J9 ADV MATER
JI Adv. Mater.
PD AUG 18
PY 2006
VL 18
IS 16
BP 2174
EP +
DI 10.1002/adma.200502173
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 082SX
UT WOS:000240408600019
DA 2018-10-19
ER

PT J
AU Chu, CL
   Xue, XY
   Zhu, JC
   Yin, Z
AF Chu, Chenglin
   Xue, Xiaoyan
   Zhu, Jingchuan
   Yin, Zhongda
TI In vivo study on biocompatibility and bonding strength of Ti/Ti-20 vol.%
   HA/Ti-4 vol.% HA functionally graded biomaterial with bone tissues in
   the rabbit
SO MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES
   MICROSTRUCTURE AND PROCESSING
LA English
DT Article
DE hydroxyapatite; titanium; functionally graded biomaterial;
   biocompatibility; osseointegration
ID SPRAYED HYDROXYAPATITE COATINGS; CONTROLLED POROSITY; FABRICATION;
   BIOCERAMICS; DESIGN
AB Ti/Ti-20 vol.% HA/Ti-40 vol.% HA functionally graded biomaterial (FGM) was fabricated by a hot-pressing technique. Then the comprehensive biocompatibility and bonding strength of the FGM with bone tissues in the rabbit were systematically investigated by in vivo studies in comparison with those of Ti metal. The microstructure of sintered FGM varied gradually from Ti side to Ti-40 vol.% HA side with a graded distribution of each element. There are some fibrous tissues existing at the interface between Ti implant and newborn bones at 4 weeks in vivo. Contrarily new bone tissues can contact directly with Ti-40 vol. % HA graded layer in the FGM at or after 4 weeks in vivo. At 8 weeks, the bonding interfaces between Ti-40 vol. % HA graded layer in the FGM and new bones cannot already be distinguished and the FGM was osseointegrated fully with bone tissues into one bony body. During all implanting periods, the increasing rate of bonding strength for the FGM is higher than that of pure Ti. At 3 months in vivo, the shear fracture for Ti-40 vol.% HA graded layer in the FGM implants occurred in new bone tissues zones near the interface between the FGM implants and bones tissues. The bonding strength of the FGM implants could even exceed the shear strength of new bone tissues (4.73 MPa). Obviously the FGM has better biocompatibility and osseointegration abilities than Ti metal, especially during the early stage after the implantation, which can be due to the existence of the graded layers mixed by HA and Ti. Therefore, it is a promising biomaterial for hard tissue replacement. (c) 2006 Elsevier B.V. All rights reserved.
C1 SE Univ, Sch Mat Sci & Engn, Nanjing 210096, Peoples R China.
   SE Univ, Zhong Da Hosp, Gen Med Ctr, Nanjing 210009, Peoples R China.
   Harbin Inst Technol, Sch Mat Sci & Engn, Harbin 150001, Peoples R China.
RP Chu, CL (reprint author), SE Univ, Sch Mat Sci & Engn, Nanjing 210096, Peoples R China.
EM clchu@seu.edu.cn
RI Zhu, Jingchuan/B-3573-2018
OI Zhu, Jingchuan/0000-0002-6075-2373
CR AOKI H, 1991, SCI MED APPL HYDROXY
   ARITA IH, 1995, J MATER SCI-MATER M, V6, P19, DOI 10.1007/BF00121241
   BISHOP A, 1993, J MATER SCI LETT, V12, P1516
   BONFIELD W, 1988, BIOCERAMICS MATERIAL, V523, P173
   Chu CL, 2003, MAT SCI ENG A-STRUCT, V348, P244, DOI 10.1016/S0921-5093(02)00738-4
   Chu CL, 2001, MAT SCI ENG A-STRUCT, V316, P205, DOI 10.1016/S0921-5093(01)01239-4
   DEWITH G, 1981, J MATER SCI, V16, P1592
   FRAYSSINET P, 1994, J MATER SCI-MATER M, V5, P11, DOI 10.1007/BF00121147
   Ha SW, 1998, J AM CERAM SOC, V81, P81
   HENCH LL, 1991, J AM CERAM SOC, V74, P1487, DOI 10.1111/j.1151-2916.1991.tb07132.x
   Kimura H, 1996, POWDER METALL, V39, P59, DOI 10.1179/pom.1996.39.1.59
   Kirihara S, 1997, MATER T JIM, V38, P650, DOI 10.2320/matertrans1989.38.650
   Liu DM, 1997, J MATER SCI-MATER M, V8, P227, DOI 10.1023/A:1018591724140
   Raynaud S, 1998, J MATER SCI-MATER M, V9, P221, DOI 10.1023/A:1008840308094
   RUYS AJ, 1995, J MATER SCI-MATER M, V6, P297, DOI 10.1007/BF00120274
   Suchanek W, 1998, J MATER RES, V13, P94, DOI 10.1557/JMR.1998.0015
   Tampieri A, 1997, J MATER SCI-MATER M, V8, P29, DOI 10.1023/A:1018538212328
   Van N. R., 1987, J MATER RES, V22, P3801
   WANG BC, 1993, SURF COAT TECH, V58, P107, DOI 10.1016/0257-8972(93)90181-M
   Wang K, 1996, MAT SCI ENG A-STRUCT, V213, P134, DOI 10.1016/0921-5093(96)10243-4
   WILLIAMS DF, 1987, MATER SCI TECH SER, V3, P797, DOI 10.1179/mst.1987.3.10.797
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
NR 22
TC 24
Z9 26
U1 0
U2 11
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 0921-5093
J9 MAT SCI ENG A-STRUCT
JI Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.
PD AUG 15
PY 2006
VL 429
IS 1-2
BP 18
EP 24
DI 10.1016/j.msea.2006.03.099
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Metallurgy & Metallurgical Engineering
SC Science & Technology - Other Topics; Materials Science; Metallurgy &
   Metallurgical Engineering
GA 072PS
UT WOS:000239685900003
DA 2018-10-19
ER

PT J
AU Jones, KS
   Sefton, MV
   Gorczynski, RM
AF Jones, Kim S.
   Sefton, Michael V.
   Gorczynski, Reginald M.
TI Suppressed splenocyte proliferation following a xenogeneic skin graft
   due to implanted biomaterials
SO TRANSPLANTATION
LA English
DT Article
DE rodent; Th1/Th2 cells; antibodies; transplantation; inflammation;
   biomaterials
ID IMMUNE-SYSTEM; T-CELLS; XENOGRAFT REJECTION; ISLET XENOGRAFTS; MICE;
   TRANSPLANTATION; ENCAPSULATION; RECOGNITION; DESTRUCTION; MACROPHAGES
AB Background. Immune system responses to antigens in the context of biomaterials are poorly understood. Biomaterial implantation results in an inflammatory reaction, which is anticipated to alter the adaptive immune response, in the case presented here, to a skin xenograft. Our earlier work showed unexpectedly low splenocyte proliferation following a xenogeneic cell implant in tandem with a biomaterial in the form of a microcapsule. Here we explore whether that effect was due to the cells or the biomaterial, and attempt to dissect the mechanism of immune deviation.
   Methods. We assessed the immune response of Balb/c mice to hamster skin grafts accompanied by one of three implants: encapsulated xenogeneic cells; free cells accompanied by the same encapsulation biomaterials; and the encapsulation biomaterials without cells. Cells were encapsulated in a hydroxyethyl methacrylate-methyl methacrylate copolymer then embedded in an agarose gel. Splenocyte proliferation upon re-challenge in vitro, antibody titer in serum, and Th 1/2 polarization (by cytokines in splenocyte challenge supernatants and antibody isotypes in serum) were measured.
   Results. All skin grafts with encapsulation materials (even without cells) suppressed subsequent splenocyte proliferation at 10 days postimplant, athough this effect disappeared by two months. In contrast, the antibody response was equal to or greater than that for a skin graft alone. Th 1/2 polarization could not explain these observations because it did not correlate with the suppression of splenocyte proliferation.
   Conclusions. Implanted biomaterials caused nonspecific, transient suppression of splenocyte responses to hamster cells following hamster skin grafts, which is potentially important in the context of tissue engineering.
C1 Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.
   Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada.
   Toronto Hosp, Transplant Res Div, Toronto, ON M5T 2S8, Canada.
RP Jones, KS (reprint author), McMaster Univ, Dept Chem Engn, 1280 Main St W, Hamilton, ON L8S 4L7, Canada.
EM kjones@mcmaster.ca
CR ANDERSON JM, 1993, CARDIOVASC PATHOL S, V2, P33
   Babensee JE, 1998, BIOMATERIALS, V19, P839, DOI 10.1016/S0142-9612(97)00242-1
   Barchet W, 2006, BLOOD, V107, P1497, DOI 10.1182/blood-2005-07-2951
   Bennewitz NL, 2005, BIOMATERIALS, V26, P2991, DOI 10.1016/j.biomaterials.2004.08.023
   Brayden DJ, 2001, VACCINE, V19, P4185, DOI 10.1016/S0264-410X(01)00162-1
   Feng XM, 1999, TRANSPLANTATION, V68, P1775, DOI 10.1097/00007890-199912150-00023
   Fox A, 2000, IMMUNOL REV, V173, P141, DOI 10.1034/j.1600-065X.2000.917313.x
   Fox A, 2001, J IMMUNOL, V166, P2133, DOI 10.4049/jimmunol.166.3.2133
   Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6
   Gray DWR, 2001, ANN NY ACAD SCI, V944, P226
   HAKIM RM, 1993, CARDIOVASC PATHOL, V2, pS187
   HOFFMAN RA, 1993, TRANSPLANTATION, V55, P591, DOI 10.1097/00007890-199303000-00024
   Itescu S, 2003, ANN THORAC SURG, V75, pS58, DOI 10.1016/S0003-4975(03)00480-6
   Jenkins ME, 1996, J INVEST SURG, V9, P1, DOI 10.3109/08941939609012455
   Jones KS, 2004, TRANSPLANTATION, V78, P1454, DOI 10.1097/01.TP.0000142094.63083.FB
   Kemper C., 2002, International Immunopharmacology, V2, P1232
   KUPCIECWEGLINSK.JW, 1993, J IMMUNOL, V151, P5053
   LAHOOTI S, 1999, TISSUE ENG METHODS P, P331
   Le Moine A, 2002, TRANSPLANTATION, V73, P1373, DOI 10.1097/00007890-200205150-00001
   Loudovaris T, 1996, TRANSPLANTATION, V61, P1678, DOI 10.1097/00007890-199606270-00003
   Metcalfe SM, 2005, TRANSPLANTATION, V79, P726, DOI 10.1097/01.TP.0000149324.42994.38
   Miyatake T, 1998, J IMMUNOL, V160, P4114
   Morikawa N, 1996, J BIOMAT SCI-POLYM E, V8, P225
   Naim JO, 1997, J BIOMED MATER RES, V37, P534, DOI 10.1002/(SICI)1097-4636(19971215)37:4<534::AID-JBM12>3.0.CO;2-8
   Newman MJ, 1998, CRIT REV THER DRUG, V15, P89, DOI 10.1615/CritRevTherDrugCarrierSyst.v15.i2.10
   Simeonovic CJ, 2002, XENOTRANSPLANTATION, V9, P169, DOI 10.1034/j.1399-3089.2002.01024.x
   Soares MP, 2001, IMMUNOL REV, V184, P275, DOI 10.1034/j.1600-065x.2001.1840124.x
   Sohn JH, 2003, NAT MED, V9, P206, DOI 10.1038/nm814
   van der Veen RC, 2000, CELL IMMUNOL, V199, P43, DOI 10.1006/cimm.1999.1597
   WEBER CJ, 1990, TRANSPLANTATION, V49, P396, DOI 10.1097/00007890-199002000-00034
   Yi SN, 2003, J IMMUNOL, V170, P2750, DOI 10.4049/jimmunol.170.5.2750
NR 31
TC 4
Z9 4
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0041-1337
J9 TRANSPLANTATION
JI Transplantation
PD AUG 15
PY 2006
VL 82
IS 3
BP 415
EP 421
DI 10.1097/01.tp.0000228917.57323.ec
PG 7
WC Immunology; Surgery; Transplantation
SC Immunology; Surgery; Transplantation
GA 075KV
UT WOS:000239884800020
PM 16906042
OA Bronze
DA 2018-10-19
ER

PT J
AU Taglienti, A
   Cellesi, F
   Crescenzi, V
   Sequi, P
   Valentini, M
   Tirelli, N
AF Taglienti, Anna
   Cellesi, Francesco
   Crescenzi, Vittorio
   Sequi, Paolo
   Valentini, Massimiliano
   Tirelli, Nicola
TI Investigating the interactions of hyaluronan derivatives with
   biomolecules. The use of diffusional NMR techniques
SO MACROMOLECULAR BIOSCIENCE
LA English
DT Article
DE colloidal carriers; hyaluronan; PFG NMR; protein adsorption; "stealth"
   character
ID ECHO PGSE DIFFUSION; ORGANOMETALLIC CHEMISTRY; PROTEIN ADSORPTION;
   BLOCK-COPOLYMERS; SELF-DIFFUSION; SERUM ALBUMIN; DRUG CARRIERS;
   IN-VITRO; ACID; NANOPARTICLES
AB The interactions between a biomaterial and biomolecules present in body fluids often determine the fate of the biomaterial. This paper presents a study on hyaluronan (HA)-containing materials (in soluble or colloidal form) that focuses on their interactions with lipids and proteins and for the first time uses PFG NMR as an analytical technique for probing these events. The interactions of HA-base polymers with phospholipids (DPPC and DPPG liposomes) are shown to depend both on charge and hydrophobicity factors. Despite the difference in behaviour between albumin (substantially non-adhesive) and fibrinogen (adhesive), the interactions of the polymers with proteins, do not seem to be based on hydrophobic effects but on surface polar interactions.
C1 Univ Roma La Sapienza, Dept Chem, I-00185 Rome, Italy.
   Univ Manchester, Sch Pharm, Manchester M13 9PL, Lancs, England.
   Univ Manchester, Ctr Mol Mat, Manchester M13 9PL, Lancs, England.
   Agr Res Council, Expt Inst Plant Nutr, I-00184 Rome, Italy.
RP Valentini, M (reprint author), Univ Roma La Sapienza, Dept Chem, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
EM massimiliano.valentini@entecra.it
RI Tirelli, Nicola/P-3604-2018; Tirelli, Nicola/P-7210-2014
OI Tirelli, Nicola/0000-0002-4879-3949; Tirelli,
   Nicola/0000-0002-4879-3949; CELLESI, FRANCESCO/0000-0001-6106-9317
FU Engineering and Physical Sciences Research Council [EP/C543564/1,
   EP/C543572/1]
CR DeFife KM, 1999, J BIOMED MATER RES, V44, P298, DOI 10.1002/(SICI)1097-4636(19990305)44:3<298::AID-JBM8>3.0.CO;2-N
   Elisseeff J, 2004, EXPERT OPIN BIOL TH, V4, P1849, DOI 10.1517/14712598.4.12.1849
   Engelhardt M, 2003, DEUT Z SPORTMED, V54, P205
   Eugene M, 2004, CELL MOL BIOL, V50, P209
   Garbuzenko O, 2005, LANGMUIR, V21, P2560, DOI 10.1021/la0479105
   GOA KL, 1994, DRUGS, V47, P536, DOI 10.2165/00003495-199447030-00009
   Goreish HH, 2004, J BIOMED MATER RES A, V68A, P1, DOI 10.1002/jbm.a.10141
   Griffiths P, 2002, CURR OPIN COLLOID IN, V7, P249, DOI 10.1016/S1359-0294(02)00042-0
   Grymonpre KR, 2001, BIOMACROMOLECULES, V2, P422, DOI 10.1021/bm005656z
   Halter M, 2005, J CONTROL RELEASE, V101, P209, DOI 10.1016/j.jconrel.2004.07.002
   Horch RE, 2005, J CELL MOL MED, V9, P592, DOI 10.1111/j.1582-4934.2005.tb00491.x
   Jones MN, 1996, CURR OPIN COLLOID IN, V1, P91, DOI 10.1016/S1359-0294(96)80049-5
   Kamiguchi K, 2005, POLYMER, V46, P11470, DOI 10.1016/j.polymer.2005.10.045
   Kayitmazer AB, 2003, J PHYS CHEM B, V107, P8158, DOI 10.1021/jp034065a
   Kidane AG, 2004, BIOMACROMOLECULES, V5, P798, DOI 10.1021/bm0344553
   Kirker KR, 2004, J POLYM SCI POL PHYS, V42, P4344, DOI 10.1002/polb.20299
   Kocsis JF, 2000, J LONG-TERM EFF MED, V10, P19
   LEBOEUF RD, 1986, J BIOL CHEM, V261, P2586
   Lee JY, 2000, CURR OPIN CELL BIOL, V12, P581, DOI 10.1016/S0955-0674(00)00135-6
   LI JT, 1996, ADV CHEM SER, V248, P61
   Liu EH, 2003, LANGMUIR, V19, P7249, DOI 10.1021/la034616o
   Lu YP, 2004, BIOMATERIALS, V25, P4393, DOI [10.1016/j.biomaterials.2003.10.092, 10.1016/j.biomaterials.2003.08.014]
   Lutolf MP, 2003, ADV MATER, V15, P888, DOI 10.1002/adma.200304621
   Marshall KW, 2000, CURR OPIN RHEUMATOL, V12, P468, DOI 10.1097/00002281-200009000-00022
   Moghimi SM, 2001, CRIT REV THER DRUG, V18, P527
   Mohamed EETEA, 2005, PHYS MEDICA, V21, P69, DOI 10.1016/S1120-1797(05)80022-5
   Mori M, 2004, ACTA HISTOCHEM CYTOC, V37, P1, DOI 10.1267/ahc.37.1
   Nelson SR, 2000, CARDIOVASC INTER RAD, V23, P252, DOI 10.1007/s002700010064
   NIEDERMEIER W, 1968, CARBOHYD RES, V8, P317, DOI 10.1016/S0008-6215(00)82238-7
   Oates KMN, 2006, J R SOC INTERFACE, V3, P167, DOI 10.1098/rsif.2005.0086
   Ogawara K, 2002, CRIT REV THER DRUG, V19, P277, DOI 10.1615/CritRevTherDrugCarrierSyst.v19.i45.10
   Owens DE, 2006, INT J PHARM, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010
   Pechar M, 1997, MACROMOL CHEM PHYSIC, V198, P1009, DOI 10.1002/macp.1997.021980408
   Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004
   Pregosin PS, 2005, CHEM REV, V105, P2977, DOI 10.1021/cr0406716
   Price RD, 2005, AM J CLIN DERMATOL, V6, P393, DOI 10.2165/00128071-200506060-00006
   Price WS, 2002, MAGN RESON CHEM, V40, P391, DOI 10.1002/mrc.1029
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Satoh T, 2004, POLYM ADVAN TECHNOL, V15, P720, DOI 10.1002/pat.486
   Shen MC, 2002, J BIOMAT SCI-POLYM E, V13, P367, DOI 10.1163/156856202320253910
   Sofia SJ, 1997, ACS SYM SER, V680, P342
   Taglienti A, 2005, BIOMACROMOLECULES, V6, P1648, DOI 10.1021/bm049221d
   Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200
   Valentini M, 2000, ORGANOMETALLICS, V19, P2551, DOI 10.1021/om000104i
   Valentini M, 2004, J AM CHEM SOC, V126, P2142, DOI 10.1021/ja037247r
   Valentini M, 2001, HELV CHIM ACTA, V84, P2833, DOI 10.1002/1522-2675(20011017)84:10<2833::AID-HLCA2833>3.0.CO;2-O
   vanOss CJ, 1997, CURR OPIN COLLOID IN, V2, P503, DOI 10.1016/S1359-0294(97)80099-4
NR 47
TC 17
Z9 17
U1 1
U2 19
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-5187
J9 MACROMOL BIOSCI
JI Macromol. Biosci.
PD AUG 7
PY 2006
VL 6
IS 8
BP 611
EP 622
DI 10.1002/mabi.200600041
PG 12
WC Biochemistry & Molecular Biology; Materials Science, Biomaterials;
   Polymer Science
SC Biochemistry & Molecular Biology; Materials Science; Polymer Science
GA 074YC
UT WOS:000239847400004
PM 16881041
DA 2018-10-19
ER

PT J
AU Kim, HW
   Kim, HE
   Knowles, JC
AF Kim, Hae-Won
   Kim, Hyoun-Ee
   Knowles, Jonathan C.
TI Production and potential of bioactive glass nanofibers as a
   next-generation biomaterial
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID IN-VITRO; FIBERS
AB Over the past decades, bioactive glass has played a central role in the bone regeneration field, due to its excellent bioactivity, osteoconductivity, and even osteoinductivity. Herein, exploitation of bioactive glass as a one-dimensional nanoscale fiber by employing an electrospinning process based on a sol-gel precursor is reported for the first time. Under controlled processing conditions, continuous nanofibers have been generated successfully with variable diameters. The excellent bioactivity of the nanofiber is confirmed in vitro within a simulated body fluid by the rapid induction of bonelike minerals onto the nanofiber surface. The bone-marrow-derived cells are observed to attach and proliferate actively on the nanofiber mesh, and differentiate into osteoblastic cells with excellent osteogenic potential. The bioactive nanofibers have been further exploited in various forms, such as bundled filament, nanofibrous membrane, 3D macroporous scaffold, and nanocomposite with biopolymer, suggesting their versatility and potential applications in bone-tissue engineering. Based on this study, the bioactive nanofibrous matrix is regarded as a promising next-generation biomaterial in the bone-regeneration field.
C1 Dankuk Univ, Sch Dent, Dept Dent Biomat, Cheonan 330714, South Korea.
   Seoul Natl Univ, Sch Mat Sci & Engn, Seoul 151742, South Korea.
   UCL Eastman Dent Inst, Div Biomat & Tissue Engn, London WC1X 8LD, England.
RP Kim, HW (reprint author), Dankuk Univ, Sch Dent, Dept Dent Biomat, Cheonan 330714, South Korea.
EM kimhw@dku.edu
RI Knowles, Jonathan Campbell/B-9019-2008
OI Knowles, Jonathan Campbell/0000-0003-3917-3446
CR Bognitzki M, 2001, ADV MATER, V13, P70, DOI 10.1002/1521-4095(200101)13:1<70::AID-ADMA70>3.3.CO;2-8
   DANIEN CJ, 1991, J APPL BIOMATER, V2, P187
   De Diego MA, 2000, J BIOMED MATER RES, V53, P199, DOI 10.1002/(SICI)1097-4636(2000)53:3<199::AID-JBM2>3.0.CO;2-J
   Dzenis Y, 2004, SCIENCE, V304, P1917, DOI 10.1126/science.1099074
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   HENCH LL, 1998, J AM CERAM SOC, V81, P1785
   Kim HW, 2004, J BIOMED MATER RES B, V71B, P66, DOI 10.1002/jbm.b.30064
   Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388
   Larsen G, 2003, J AM CHEM SOC, V125, P1154, DOI 10.1021/ja028983i
   Laurencin CT, 1999, ANNU REV BIOMED ENG, V1, P19, DOI 10.1146/annurev.bioeng.1.1.19
   Li D, 2004, ADV MATER, V16, P1151, DOI 10.1002/adma.200400719
   LI D, 2003, NANO LETT, V3, P635
   LI R, 1991, J APPL BIOMATER, V2, P231, DOI 10.1002/jab.770020403
   MANN S, 1988, NATURE, V332, P119, DOI 10.1038/332119a0
   Maquet V, 2004, BIOMATERIALS, V25, P4185, DOI 10.1016/j.biomaterials.2003.10.082
   Rey C, 1995, CELL MATER, V5, P345
   Salinas AJ, 2002, J BIOMED MATER RES, V61, P524, DOI 10.1002/jbm.10229
   Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587
   WILSON J, 1993, INTRO BIOCERAMICS, P63
   Zhong JP, 2000, J BIOMED MATER RES, V53, P694, DOI 10.1002/1097-4636(2000)53:6<694::AID-JBM12>3.0.CO;2-6
NR 20
TC 158
Z9 161
U1 6
U2 74
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 1616-301X
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD AUG 4
PY 2006
VL 16
IS 12
BP 1529
EP 1535
DI 10.1002/adfm.200500750
PG 7
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 076JE
UT WOS:000239952400001
DA 2018-10-19
ER

PT J
AU Jaworski, J
   Klapperich, CM
AF Jaworski, J
   Klapperich, CM
TI Fibroblast remodeling activity at two- and three-dimensional
   collagen-glycosaminoglycan interfaces
SO BIOMATERIALS
LA English
DT Article
DE collagen; biocompatibility; PCR (polymerase chain reaction); mRNA;
   metalloproteinases; glycosaminoglycan
ID MATRIX METALLOPROTEINASE-19; ARTIFICIAL SKIN; RECONSTRUCTIVE SURGERY;
   TISSUE INHIBITORS; HEME OXYGENASE; EXPRESSION; CELLS; NORMALIZATION;
   ANGIOGENESIS; SUBSTITUTES
AB Previously we demonstrated that high throughput gene expression experiments can yield novel information about how cells respond to a collagen-glycosaminoglycan (GAG) three-dimensional culture environment. The goal of the current study was to determine which of these differences result from culture in a three-dimensional construct versus those caused simply by the presence of the collagen-GAG biomaterial. To make this distinction, cells were cultured both in collagen-GAG scaffolds fabricated using a phase separation method and on thin two-dimensional coatings of the same material. Control cells were grown on standard tissue culture polystyrene (TCPS). Cell response was measured using histology and microarray analysis and select results were verified with real time polymerase chain reaction (RT-PCR) assays. Genes involved in matrix remodeling (matrix components, matrix metalloproteinases and growth factors) and angiogenesis (VEGF, HGF and HMOX) were shown to be differentially expressed between the treatment conditions. Several matrix metalloproteinases (MMPs) were up regulated in mesh grown cell while some of their inhibitors (TIMPs) were down regulated. These results suggest that the three-dimensional presentation of the collagen-GAG material to the cells is required to stimulate the observed increase in fibroblast remodeling behavior. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Boston Univ, Dept Mfg Engn, Boston, MA 02215 USA.
   Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA.
RP Klapperich, CM (reprint author), Boston Univ, Dept Mfg Engn, 44 Cummington St, Boston, MA 02215 USA.
EM catherin@bu.edu
RI Klapperich, Catherine/D-5533-2011
OI Klapperich, Catherine/0000-0001-6103-849X
CR Bard J, 2003, BIOESSAYS, V25, P501, DOI 10.1002/bies.10260
   Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   Braydich-Stolle L, 2005, TOXICOL SCI, V88, P412, DOI 10.1093/toxsci/kfi256
   Chakraborti S, 2003, MOL CELL BIOCHEM, V253, P1, DOI 10.1023/A:1026025113423
   Dang CM, 2003, PLAST RECONSTR SURG, V111, P2273, DOI 10.1097/01.PRS.0000060102.57809.DA
   Dantzer E, 2001, BRIT J PLAST SURG, V54, P659, DOI 10.1054/bjps.2001.3684
   Finch PW, 2004, ADV CANCER RES, V91, P69, DOI 10.1016/S0065-230X(04)91003-2
   Floss T, 1997, GENE DEV, V11, P2040, DOI 10.1101/gad.11.16.2040
   Handsley MM, 2005, INT J CANCER, V115, P849, DOI 10.1002/ijc.20945
   Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002
   Hieta N, 2003, J INVEST DERMATOL, V121, P997, DOI 10.1046/j.1523-1747.2003.12533.x
   Impola U, 2003, INT J CANCER, V103, P709, DOI 10.1002/ijc.10902
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Jones I, 2002, BRIT J PLAST SURG, V55, P185, DOI 10.1054/bjps.2002.3800
   KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99
   King P, 2000, BURNS, V26, P501, DOI 10.1016/S0305-4179(99)00186-2
   Klapperich CM, 2004, BIOMATERIALS, V25, P5631, DOI 10.1016/j.biomaterials.2004.01.025
   Kolb C, 1999, EXP CELL RES, V250, P122, DOI 10.1006/excr.1999.4493
   Kremer M, 2000, BRIT J PLAST SURG, V53, P459, DOI 10.1054/bjps.2000.3368
   KUBERKA M, 2002, BIOMED TECH BER 1 S1, V47, P484
   Lee CH, 2001, INT J PHARM, V221, P1, DOI 10.1016/S0378-5173(01)00691-3
   Lu XR, 2001, EXP BRAIN RES, V137, P424, DOI 10.1007/s002210000616
   Mauch C, 2003, J INVEST DERMATOL, V121, pXIX, DOI 10.1046/j.1523-1747.2003.12582.x
   Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Orgill DP, 1999, ANN NY ACAD SCI, V888, P233, DOI 10.1111/j.1749-6632.1999.tb07959.x
   Redekop WK, 2003, PHARMACOECONOMICS, V21, P1171, DOI 10.2165/00019053-200321160-00003
   Ruszczak Z, 2003, ADV DRUG DELIVER REV, V55, P1595, DOI 10.1016/j.addr.2003.08.003
   Sheridan RL, 1999, BURNS, V25, P97, DOI 10.1016/S0305-4179(98)00176-4
   Toyoda M, 2001, FEBS LETT, V509, P95, DOI 10.1016/S0014-5793(01)03126-X
   Vaalamo M, 1999, HUM PATHOL, V30, P795, DOI 10.1016/S0046-8177(99)90140-5
   Van Belle E, 1998, CIRCULATION, V97, P381
   van der Laan WH, 2003, GENE THER, V10, P234, DOI 10.1038/sj.gt.3301871
   Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D
   Wagener FADTG, 2003, BLOOD, V102, P521, DOI 10.1182/blood-2002-07-2248
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P65, DOI 10.1002/jbm.820140108
   YANNAS IV, 1980, J BIOMED MATER RES, V14, P107, DOI 10.1002/jbm.820140203
NR 37
TC 17
Z9 17
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2006
VL 27
IS 23
BP 4212
EP 4220
DI 10.1016/j.biomaterials.2006.03.026
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 050UL
UT WOS:000238114100004
PM 16620959
DA 2018-10-19
ER

PT J
AU Zhuo, R
   Siedlecki, CA
   Vogler, EA
AF Zhuo, Rui
   Siedlecki, Christopher A.
   Vogler, Erwin A.
TI Autoactivation of blood factor XII at hydrophilic and hydrophobic
   surfaces
SO BIOMATERIALS
LA English
DT Article
DE blood coagulation; FXII; Hageman factor; contact activation;
   autoactivation
ID PLASMA COAGULATION CASCADE; CONTACT ACTIVATION; ELECTRONEGATIVE SURFACE;
   BIOMATERIAL SURFACES; PREKALLIKREIN; WATER
AB Contact activation of blood factor XII (FXII, Hageman factor) in neat-buffer solution is shown not to be specific for anionic hydrophilic procoagulants as proposed by the accepted biochemistry of surface activation. Rather, FXII activation in the presence of plasma proteins leads to an apparent specificity for hydrophilic surfaces that is actually due to a relative diminution of the FXII -> FXIIa reaction at hydrophobic surfaces. FXII activation in neat-buffer solution was effectively instantaneous upon contact with either hydrophilic (fully water-wettable clean glass) or hydrophobic (poorly water-wettable silanized glass) procoagulant particles, with greater FXIIa yield obtained by activation with hydrophobic procoagulants. In sharp contrast, both activation rate and yield was found to be significantly attenuated at hydrophobic surfaces in the presence of plasma proteins. Putative FXIIa produced by surface activation with both hydrophilic and hydrophobic procoagulants was shown to hydrolyze blood factor XI (FXI) to the activated form FXIa (FXIIa (FXIIa)(->) FXIa) that causes FXI-deficient plasma to rapidly coagulate. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Dept Bioengn, University Pk, PA 16802 USA.
   Penn State Univ, Dept Mat Sci & Engn, University Pk, PA 16802 USA.
   Penn State Univ, Dept Surg, Coll Med, Inst Biomed Engn, Hershey, PA 17033 USA.
EM eav3@psu.edu
FU NHLBI NIH HHS [5 R01 HL 69965-03]
CR Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200
   CADENA RAD, 1994, HEMOSTASIS THROMBOSI
   Clery D, 2002, SCIENCE, V297, P961, DOI 10.1126/science.297.5583.961
   COLMAN RW, 1987, ANN NY ACAD SCI, V516, P253, DOI 10.1111/j.1749-6632.1987.tb33046.x
   Colman RW, 1997, BLOOD, V90, P3819
   COLMAN RW, 2000, HEMOSTASIS THROMBOSI, P103
   FRIBERGER P, 1983, SEMIN THROMB HEMOST, V9, P281
   FUJIKAWA K, 1995, MOL BASIS THROMBOSIS, P257
   GREGORY K, 1994, ANN BIOMED ENG, V22, P184, DOI 10.1007/BF02390376
   Guo Z, 2006, BIOMATERIALS, V27, P796, DOI 10.1016/j.biomaterials.2005.06.021
   Hanson S. R., 1996, BIOMATERIALS SCI INT, P193
   HOFFMAN AS, 1986, J BIOMED MATER RES, V20, pR9, DOI 10.1002/jbm.820200903
   LEVINE SN, 1966, SCIENCE, V152, P651, DOI 10.1126/science.152.3722.651
   Marder V., 1994, HEMOSTASIS THROMBOSI, P3
   Miller R, 2006, BIOMATERIALS, V27, P208, DOI 10.1016/j.biomaterials.2005.05.087
   Mitropoulos KA, 1999, THROMB RES, V94, P117, DOI 10.1016/S0049-3848(98)00207-2
   Mitropoulos KA, 1999, THROMB HAEMOSTASIS, V82, P1033
   Pokhilko AV, 1998, J THEOR BIOL, V191, P213, DOI 10.1006/jtbi.1997.0584
   Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175
   SAITO H, 1976, J LAB CLIN MED, V88, P506
   SAMUEL M, 1992, J BIOL CHEM, V267, P19691
   Vogler E.A., 2001, WATER BIOMATERIALS S, P150
   VOGLER EA, 1995, J BIOMED MATER RES, V29, P1005, DOI 10.1002/jbm.820290813
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   Vogler EA, 1998, J BIOMED MATER RES, V40, P92, DOI 10.1002/(SICI)1097-4636(199804)40:1<92::AID-JBM11>3.3.CO;2-W
   VOGLER EA, 1995, J BIOMED MATER RES, V29, P1017, DOI 10.1002/jbm.820290814
   Vogler EA, 1999, J BIOMAT SCI-POLYM E, V10, P1015, DOI 10.1163/156856299X00667
   Zhuo R, 2005, ACTA BIOMATER, V1, P583, DOI 10.1016/j.actbio.2005.05.005
   Zhuo R, 2005, BIOMATERIALS, V26, P2965, DOI 10.1016/j.biomaterials.2004.08.008
NR 29
TC 56
Z9 57
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
EI 1878-5905
J9 BIOMATERIALS
JI Biomaterials
PD AUG
PY 2006
VL 27
IS 24
BP 4325
EP 4332
DI 10.1016/j.biomaterials.2006.04.001
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 052NT
UT WOS:000238241100006
PM 16644008
DA 2018-10-19
ER

PT J
AU Ariga, K
   Vinu, A
   Miyahara, M
AF Ariga, Katsuhiko
   Vinu, Ajayan
   Miyahara, Masahiko
TI Recent progresses in bio-inorganic nanohybrids
SO CURRENT NANOSCIENCE
LA English
DT Review
DE hybrid; biomolecules; inorganic materials; layer-by-layer assembly;
   mesoporous material
ID LANGMUIR-BLODGETT-FILMS; MESOPOROUS MOLECULAR-SIEVES; ORGANIC-INORGANIC
   NANOCOMPOSITES; QUARTZ-CRYSTAL MICROBALANCE; AIR-WATER-INTERFACE;
   POROUS-GLASS PLATE; SOL-GEL SYNTHESIS; GLUCOSE-OXIDASE; CYTOCHROME-C;
   POLYELECTROLYTE MICROCAPSULES
AB This review presents a comprehensive overview of the recent advances in the field of bio-inorganic nanohybrids. In the first part of this review, examples on hybridization of biomembrane mimics with inorganic backbone are described. Silane-bearing amphiphile was used for the preparation of Langmuir-Blodgett films that are mechanically stable and capable of permeation controls and electrode modification with vitamin function. The similar amphiphiles were utilized to form organic-inorganic hybrid vesicle "Cerasome", which can be assembled in layer-by-layer manner to construct multi-cellular mimic. Furthermore, the potential applications of the above materials are reviewed and proposed. The second part of this review provides the methodology of immobilizing various biomolecules into nanosized inorganic structures including clay minerals and layer-by-layer (LBL) assemblies. Films and hollow capsules prepared through the LBL techniques offer sophisticated designs of the bio-inorganic nanohybrids that can be applied to biomaterial entrapment and bio-reactors. Examples on hybridization of biomolecules with mesoporous inorganic structure are also introduced in the last part. A controlled release or biochemical drugs and immobilization of bio-assemblics on the materials with well-defined pore structures in nanometer ranges are briefly examined, discussed and summarized.
C1 Natl Inst Mat Sci, Supermol Grp, Tsukuba, Ibaraki 3050044, Japan.
   Natl Inst Mat Sci, Nano Ion Mat Grp, Tsukuba, Ibaraki 3050044, Japan.
RP Ariga, K (reprint author), Natl Inst Mat Sci, Supermol Grp, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.
EM ARIGA.Katsuhiko@nims.go.jp
RI ARIGA, Katsuhiko/H-2695-2011; Vinu, Ajayan/H-9814-2012
OI Vinu, Ajayan/0000-0002-7508-251X
CR Ariga K, 1998, ACCOUNTS CHEM RES, V31, P371, DOI 10.1021/ar970014i
   Ariga K, 2000, J AM CHEM SOC, V122, P7835, DOI 10.1021/ja000924m
   Ariga K, 2000, LANGMUIR, V16, P4929, DOI 10.1021/la000249u
   ARIGA K, 1994, LANGMUIR, V10, P3255, DOI 10.1021/la00021a058
   Ariga K, 2005, LANGMUIR, V21, P976, DOI 10.1021/la0477845
   Ariga K, 2004, J NANOSCI NANOTECHNO, V4, P23, DOI 10.1166/jnn.2004.048
   Ariga K, 2004, CHEM REC, V3, P297, DOI 10.1002/tcr.10071
   Ariga K, 2001, PHYS CHEM CHEM PHYS, V3, P3442, DOI 10.1039/b100974p
   ARIGA K, 1989, J AM CHEM SOC, V111, P5618, DOI 10.1021/ja00197a018
   Ariga K, 2002, INT J NANOSCI SER, V1, P521, DOI 10.1142/S0219581X02000607
   Asefa T, 1999, NATURE, V402, P867
   Caruso F, 2000, CHEM-EUR J, V6, P413, DOI 10.1002/(SICI)1521-3765(20000204)6:3<413::AID-CHEM413>3.0.CO;2-9
   Caruso F, 2000, LANGMUIR, V16, P9595, DOI 10.1021/la000942h
   Caruso F, 1998, LANGMUIR, V14, P4559, DOI 10.1021/la971288h
   Caruso F, 2003, TOP CURR CHEM, V227, P145, DOI 10.1007/b10837
   Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111
   Caruso F, 2000, LANGMUIR, V16, P1485, DOI 10.1021/la991161n
   Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038
   Cha X, 1996, J AM CHEM SOC, V118, P9545, DOI 10.1021/ja961526f
   CHA XA, 1995, J AM CHEM SOC, V117, P11833, DOI 10.1021/ja00153a003
   Che S, 2004, NATURE, V429, P281, DOI 10.1038/nature02529
   Colfen H, 2003, ANGEW CHEM INT EDIT, V42, P2350, DOI 10.1002/anie.200200562
   Corma A, 2003, CHEM REV, V103, P4307, DOI 10.1021/cr030680z
   Darder M, 2003, CHEM MATER, V15, P3774, DOI 10.1021/cm0343047
   Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785
   Deere J, 2001, CHEM COMMUN, P465, DOI 10.1039/b009478l
   Dennany L, 2004, J AM CHEM SOC, V126, P8835, DOI 10.1021/ja048615+
   Diaz JF, 1996, J MOL CATAL B-ENZYM, V2, P115, DOI 10.1016/S1381-1177(96)00017-3
   Estroff LA, 2001, CHEM MATER, V13, P3227, DOI 10.1021/cm010110k
   Fang M, 2002, LANGMUIR, V18, P6338, DOI 10.1021/la025731m
   FUHRHOP JH, 1993, CHEM REV, V93, P1565, DOI 10.1021/cr00020a008
   Furukawa H, 2005, LANGMUIR, V21, P3992, DOI 10.1021/la047845z
   Furukawa H, 2001, CHEM COMMUN, P2002, DOI 10.1039/b104959n
   Gust D, 2001, ACCOUNTS CHEM RES, V34, P40, DOI 10.1021/ar9801301
   Han YJ, 1999, J AM CHEM SOC, V121, P9897, DOI 10.1021/ja992138r
   Inagaki S, 2002, NATURE, V416, P304, DOI 10.1038/416304a
   Itoh T, 2002, J MATER CHEM, V12, P3275, DOI 10.1039/b203923k
   Itoh T, 2002, J AM CHEM SOC, V124, P13437, DOI 10.1021/ja0203059
   Jung JH, 2003, CHEM-EUR J, V9, P5307, DOI 10.1002/chem.200305008
   Jung JH, 2001, J AM CHEM SOC, V123, P8785, DOI 10.1021/ja010508h
   Katagiri K, 2004, J SOL-GEL SCI TECHN, V31, P59, DOI 10.1023/B:JSST.0000047960.00667.20
   Katagiri K, 1999, CHEM LETT, P661, DOI 10.1246/cl.1999.661
   Katagiri K, 2005, ADV MATER, V17, P738, DOI 10.1002/adma.200401441
   Katagiri K, 2003, J SOL-GEL SCI TECHN, V26, P393, DOI 10.1023/A:1020781400998
   Katagiri K, 2002, LANGMUIR, V18, P6709, DOI 10.1021/la025772i
   Katagiri K, 2002, J AM CHEM SOC, V124, P7892, DOI 10.1021/ja0259281
   Khopade AJ, 2003, LANGMUIR, V19, P6219, DOI 10.1021/la030016d
   Kikuchi J, 1999, CHEM LETT, P253
   Kikuchi J, 1999, CHEM COMMUN, P547, DOI 10.1039/a900083f
   Kim SS, 1998, SCIENCE, V282, P1302, DOI 10.1126/science.282.5392.1302
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Lai CY, 2003, J AM CHEM SOC, V125, P4451, DOI 10.1021/ja028650l
   Langley PJ, 1999, CHEM SOC REV, V28, P279, DOI 10.1039/a704290f
   Liu HY, 2004, LANGMUIR, V20, P10700, DOI 10.1021/la0488598
   Lu ZH, 2005, LANGMUIR, V21, P2042, DOI 10.1021/la047629q
   LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026
   LVOV Y, 1995, J CHEM SOC CHEM COMM, P2313, DOI 10.1039/c39950002313
   LVOV Y, 1994, CHEM LETT, P2323, DOI 10.1246/cl.1994.2323
   Lvov Y, 2001, NANO LETT, V1, P125, DOI 10.1021/nl0100015
   Lvov YM, 1998, J AM CHEM SOC, V120, P4073, DOI 10.1021/ja9737984
   Mal NK, 2003, CHEM MATER, V15, P3385, DOI 10.1021/cm0343296
   Mal NK, 2003, NATURE, V421, P350, DOI 10.1038/nature01362
   MANN S, 1993, NATURE, V365, P499, DOI 10.1038/365499a0
   Mann S, 2000, ADV MATER, V12, P147, DOI 10.1002/(SICI)1521-4095(200001)12:2<147::AID-ADMA147>3.0.CO;2-U
   McCullough DH, 2004, CHEM COMMUN, P2787, DOI 10.1039/b410027c
   Meegan JE, 2004, ADV FUNCT MATER, V14, P31, DOI 10.1002/adfm.200304477
   Miyahara M, 2004, KOBUNSHI RONBUNSHU, V61, P623, DOI 10.1295/koron.61.623
   NAKASHIMA N, 1985, J AM CHEM SOC, V107, P509, DOI 10.1021/ja00288a043
   Ogawa M, 1997, B CHEM SOC JPN, V70, P2593, DOI 10.1246/bcsj.70.2593
   Ogoshi T, 2005, COMPOS INTERFACE, V11, P539, DOI 10.1163/1568554053148735
   Okabe A, 2004, J AM CHEM SOC, V126, P9013, DOI 10.1021/ja0478532
   Okabe A, 2002, ANGEW CHEM INT EDIT, V41, P3414, DOI 10.1002/1521-3773(20020916)41:18<3414::AID-ANIE3414>3.0.CO;2-T
   OKAHATA Y, 1989, J AM CHEM SOC, V111, P9190, DOI 10.1021/ja00208a009
   OKAHATA Y, 1986, J CHEM SOC CHEM COMM, P1069, DOI 10.1039/c39860001069
   OKAHATA Y, 1988, LANGMUIR, V4, P1373, DOI 10.1021/la00084a030
   OKAHATA Y, 1989, THIN SOLID FILMS, V180, P65, DOI 10.1016/0040-6090(89)90055-2
   Onda M, 1999, J BIOSCI BIOENG, V87, P69, DOI 10.1016/S1389-1723(99)80010-3
   Onda M, 1996, J FERMENT BIOENG, V82, P502, DOI 10.1016/S0922-338X(97)86992-9
   Onda M, 1996, BIOTECHNOL BIOENG, V51, P163, DOI 10.1002/(SICI)1097-0290(19960720)51:2<163::AID-BIT5>3.0.CO;2-H
   Panchagnula V, 2002, J AM CHEM SOC, V124, P12515, DOI 10.1021/ja020683d
   Patwardhan SV, 2005, CHEM COMMUN, P1113, DOI 10.1039/b416926c
   Perry CC, 2000, J BIOL INORG CHEM, V5, P537, DOI 10.1007/s007750000130
   Qiu XP, 2001, LANGMUIR, V17, P5375, DOI 10.1021/la010201w
   Radt B, 2004, ADV MATER, V16, P2184, DOI 10.1002/adma.200400920
   Radu DR, 2004, J AM CHEM SOC, V126, P1640, DOI 10.1021/ja038222v
   RINGSDORF H, 1988, ANGEW CHEM INT EDIT, V27, P113, DOI 10.1002/anie.198801131
   Roth KM, 2005, J AM CHEM SOC, V127, P325, DOI 10.1021/ja045308v
   Ruiz-Hitzky E, 2003, CHEM REC, V3, P88, DOI 10.1002/tcr.10054
   Ruiz-Hitzky E, 2002, ADV MATER, V14, P439, DOI 10.1002/1521-4095(20020318)14:6<439::AID-ADMA439>3.0.CO;2-8
   Ryoo R, 1999, J PHYS CHEM B, V103, P7743, DOI 10.1021/jp991673a
   Sanchez C, 2003, ADV MATER, V15, P1969, DOI 10.1002/adma.200300389
   Sanchez C, 2001, CHEM MATER, V13, P3061, DOI 10.1021/cm01106le
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Sayari A, 2001, CHEM MATER, V13, P3151, DOI [10.1021/cm011039l, 10.1021/cm0110391]
   Sayari A, 1996, CHEM MATER, V8, P1840, DOI 10.1021/cm950585+
   Scott BJ, 2001, CHEM MATER, V13, P3140, DOI 10.1021/cm0110730
   Shchukin DG, 2004, CHEM MATER, V16, P3446, DOI 10.1021/cm049506x
   Shchukin DG, 2004, J AM CHEM SOC, V126, P3374, DOI 10.1021/ja036952x
   Shenton W, 1999, ADV MATER, V11, P449, DOI 10.1002/(SICI)1521-4095(199904)11:6<449::AID-ADMA449>3.0.CO;2-A
   Shenton W, 1999, ADV MATER, V11, P253, DOI 10.1002/(SICI)1521-4095(199903)11:3<253::AID-ADMA253>3.0.CO;2-7
   Shimizu K, 1998, P NATL ACAD SCI USA, V95, P6234, DOI 10.1073/pnas.95.11.6234
   Shimizu T, 2005, CHEM REV, V105, P1401, DOI 10.1021/cr030072j
   Stein A, 2000, ADV MATER, V12, P1403, DOI 10.1002/1521-4095(200010)12:19<1403::AID-ADMA1403>3.0.CO;2-X
   Stein A, 2003, ADV MATER, V15, P763, DOI 10.1002/adma.200300007
   Tahir MN, 2004, CHEM COMMUN, P2848, DOI 10.1039/b410283e
   Takahashi H, 2000, CHEM MATER, V12, P3301, DOI 10.1021/cm000487a
   Vallet-Regi M, 2001, CHEM MATER, V13, P308, DOI 10.1021/cm0011559
   Vinu A, 2005, J MOL CATAL A-CHEM, V235, P57, DOI 10.1016/j.molcata.2005.03.014
   Vinu A, 2005, J NANOSCI NANOTECHNO, V5, P542, DOI 10.1166/jnn.2005.073
   Vinu A, 2005, MICROPOR MESOPOR MAT, V80, P195, DOI 10.1016/j.micromeso.2004.12.012
   Vinu A, 2005, J NANOSCI NANOTECHNO, V5, P347, DOI 10.1166/jnn.2005.089
   Vinu A, 2005, J PHYS CHEM B, V109, P6436, DOI 10.1021/jp050454o
   Vinu A, 2005, J MOL CATAL A-CHEM, V230, P151, DOI 10.1016/j.molcata.2004.12.018
   Vinu A, 2004, ADV MATER, V16, P1817, DOI 10.1002/adma.200400229
   Vinu A, 2004, MICROPOR MESOPOR MAT, V76, P91, DOI 10.1016/j.micromeso.2004.07.036
   Vinu A, 2004, CHEM MATER, V16, P3056, DOI 10.1021/cm049718u
   Vinu A, 2004, J PHYS CHEM B, V108, P7323, DOI 10.1021/jp037303a
   Vinu A, 2003, J PHYS CHEM B, V107, P8297, DOI 10.1021/jp035246f
   Wallace JM, 2003, NANO LETT, V3, P1463, DOI 10.1021/nl034646b
   Wang YJ, 2005, CHEM MATER, V17, P953, DOI 10.1021/cm0483137
   Yamada N, 1998, J AM CHEM SOC, V120, P12192, DOI 10.1021/ja981363q
   Yamamoto E, 2002, GERONTOLOGIST, V42, P398
   YANAGISAWA T, 1990, B CHEM SOC JPN, V63, P988, DOI 10.1246/bcsj.63.988
   Yang PD, 2000, SCIENCE, V287, P465, DOI 10.1126/science.287.5452.465
   Ying JY, 1999, ANGEW CHEM INT EDIT, V38, P56, DOI 10.1002/(SICI)1521-3773(19990115)38:1/2<56::AID-ANIE56>3.0.CO;2-E
   Yiu HHP, 2001, PHYS CHEM CHEM PHYS, V3, P2983, DOI 10.1039/b104729a
   Yu AM, 2003, ANAL CHEM, V75, P3031, DOI 10.1021/ac0340049
   ZASADZINSKI JA, 1994, SCIENCE, V263, P1726, DOI 10.1126/science.8134836
   Zhang Q, 2003, STUD SURF SCI CATAL, V146, P465
   Zhang QM, 2004, J AM CHEM SOC, V126, P988, DOI 10.1021/ja0395l5r
   Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548
NR 131
TC 30
Z9 31
U1 4
U2 63
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1573-4137
J9 CURR NANOSCI
JI Curr. Nanosci.
PD AUG
PY 2006
VL 2
IS 3
BP 197
EP 210
PG 14
WC Biotechnology & Applied Microbiology; Nanoscience & Nanotechnology;
   Materials Science, Multidisciplinary
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics; Materials Science
GA 063LW
UT WOS:000239020700005
DA 2018-10-19
ER

PT J
AU Boyd, LM
   Carter, AJ
AF Boyd, Lawrence M.
   Carter, Andrew J.
TI Injectable biomaterials and vertebral endplate treatment for repair and
   regeneration of the intervertebral disc
SO EUROPEAN SPINE JOURNAL
LA English
DT Review
DE intervertebral disc repair; disc prosthesis; injectable biomaterial;
   vertebral endplate; minimally invasive surgery
ID INTEGRATIVE CARTILAGE REPAIR; LUMBAR DISKS; IN-VITRO; NUCLEUS PULPOSUS;
   GENE-THERAPY; DEGENERATION; MATRIX; HERNIATION; DISKECTOMY; DIFFUSION
AB The objectives of augmentation of the nucleus pulposus following disc removal are to prevent disc height loss and the associated biomechanical and biochemical changes. Flowable materials may be injected via a small incision, allowing minimally invasive access to the disc space. Fluids can interdigitate with the irregular surgical defects and may even physically bond to the adjacent tissue. Injectable biomaterials allow for incorporation and uniform dispersion of cells and/or therapeutic agents. Injectable biomaterials have been developed that may act as a substitute for the disc nucleus pulposus. Our work has focused on the evaluation of a recombinant protein copolymer consisting of amino acid sequence blocks derived from silk and elastin structural proteins as an injectable biomaterial for augmentation of the nucleus pulposus. This implant, NuCore(TM) Injectable Nucleus is being developed by Spine Wave (Shelton, CT). The NuCore(TM) material is comprised of a solution of the protein polymer and a polyfunctional cross-linking agent. The material closely mimics the protein content, water content, pH and complex modulus of the natural nucleus pulposus. Extensive mechanical testing, biocompatibility and toxicology testing have been performed on the material. Characterization studies indicate that the NuCore(TM) Injectable Nucleus is able to restore the biomechanics of the disc following a microdiscectomy. Extensive biomaterial characterization shows the material to be non-toxic and biocompatible. The mechanical properties of the material mimic those of the natural nucleus pulposus. Thus NuCore TM Injectable Nucleus is suitable to replace the natural nucleus pulposus following a discectomy procedure. Human clinical evaluation is underway in a multi center clinical study on the use of the material as an adjunct to microdiscectomy. Further clinical studies of the use of NuCore TM Injectable Nucleus for treatment of early stage degenerative disc disease are planned in the near future. On-going efforts are characterizing the use of the material as a cell delivery vehicle for disc repair and reconstruction. Related development efforts are exploring methods for repair and regeneration of the cartilage endplate that are implemented to enhance the host-implant interface. Prior to the introduction of the above-mentioned biomaterial, our work proposes to utilize a process for the treatment of the vertebral endplates. The goal of this process is to restore the endplates as closely as possible to their natural state prior to disease or degeneration. The nature of the treatment will depend upon the form of the endplate degeneration and on the type of scaffolding that is intended to be introduced in the nuclear cavity. Endplate therapy is a potential means of enhancing biomaterial integration and cell survival, but remains a long-term and currently untested methodology.
C1 Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA.
   Spine Wave Inc, Shelton, CT 06484 USA.
RP Boyd, LM (reprint author), Duke Univ, Dept Biomed Engn, Room 136,Hudson Hall,POB 90281, Durham, NC 27708 USA.
EM Lawrence.boyd@duke.edu
CR ADAMS MA, 1983, SPINE, V8, P665, DOI 10.1097/00007632-198309000-00013
   ADAMS MA, 2002, BIOMECHANICS BACK PA, P197
   BAO QBH, 2001, Patent No. 6224630
   BENNEKER LM, 2005, SPINE, V7, P97
   BERNICK S, 1982, SPINE, V7, P97, DOI 10.1097/00007632-198203000-00002
   Bibby SRS, 2005, SPINE, V30, P487, DOI 10.1097/01.brs.0000154619.38122.47
   Boos N, 2002, SPINE, V27, P2631, DOI 10.1097/00007632-200212010-00002
   Bos PK, 2002, ARTHRITIS RHEUM, V46, P976, DOI 10.1002/art.10208
   BRINCKMANN P, 1991, SPINE, V16, P641, DOI 10.1097/00007632-199106000-00008
   BRODIN H, 1955, Acta Orthop Scand, V24, P177
   BUSCHMANN MD, 1995, J CELL SCI, V108, P1497
   CAPLAN AI, 1997, CLIN ORTHOP RELAT R, V342, P254
   CAPPELLO J, 1996, HDB DEGRADABLE POLYM, P387
   CAPPELLO J, 1994, PLASTICS MICROBES, P35
   CAPPELLO JE, 2002, Patent No. 6380154
   Carragee EJ, 1999, SPINE, V24, P2346, DOI 10.1097/00007632-199911150-00010
   Chandraraj S, 1998, CLIN ANAT, V11, P171, DOI 10.1002/(SICI)1098-2353(1998)11:3<171::AID-CA4>3.3.CO;2-I
   Chen J, 2004, MATRIX BIOL, V22, P573, DOI 10.1016/j.matbio.2003.11.008
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   CROCK HV, 1984, SPINE, V9, P702, DOI 10.1097/00007632-198410000-00009
   DONISCH EW, 1971, ANAT RECORD, V169, P705, DOI 10.1002/ar.1091690409
   FELT JC, 2001, Patent No. 6306177
   FERRARI FA, 2002, Patent No. 6355776
   FRYMOYER JW, 1979, SPINE, V4, P435, DOI 10.1097/00007632-197909000-00008
   GOTFRIED Y, 1986, SPINE, V11, P944, DOI 10.1097/00007632-198611000-00016
   GRAVENBOER JV, 2005, ARTHRITIS RES THERAP, V6, P469
   HASSLER O, 1969, ACTA ORTHOP SCAND, V40, P765, DOI 10.3109/17453676908989540
   Hermantin FU, 1999, J BONE JOINT SURG AM, V81A, P958, DOI 10.2106/00004623-199907000-00008
   HUBBELL JA, 1997, Patent No. 5626863
   HUBBELL JA, 2002, Patent No. 20020177680
   Iatridis JC, 1999, SPINE, V24, P996, DOI 10.1097/00007632-199905150-00013
   Iatridis JC, 1996, SPINE, V21, P1174, DOI 10.1097/00007632-199605150-00009
   KITANO T, 1993, CLIN ORTHOP RELAT R, P372
   Kokkonen SM, 2002, SPINE, V27, P2274, DOI 10.1097/01.BRS.0000029248.13169.51
   Lotz JC, 1998, SPINE, V23, P2493, DOI 10.1097/00007632-199812010-00004
   MAHAR AT, 2002, WORLD C BIOM CALG CA, P356
   MAROUDAS A, 1975, Journal of Anatomy, V120, P113
   Milner R. S., 2001, [No title captured], Patent No. [6187048, US6187048B1]
   Mochida J, 2001, J BONE JOINT SURG BR, V83B, P501, DOI 10.1302/0301-620X.83B4.11508
   MODIC MT, 1988, RADIOLOGY, V166, P193, DOI 10.1148/radiology.166.1.3336678
   NACHEMSON A, 1970, ACTA ORTHOP SCAND, V41, P589, DOI 10.3109/17453677008991550
   NACHEMSON A, 1962, Bull Hosp Joint Dis, V23, P130
   NATARAJAN RN, 1994, SPINE, V19, P259, DOI 10.1097/00007632-199402000-00001
   Nishida K, 2000, SPINE, V25, P1308, DOI 10.1097/00007632-200005150-00021
   OHSHIMA H, 1995, J ORTHOPAED RES, V13, P22, DOI 10.1002/jor.1100130106
   Oki S, 1996, SPINE, V21, P174, DOI 10.1097/00007632-199601150-00003
   PAAJANEN H, 1994, J ORTHOPAED RES, V12, P509, DOI 10.1002/jor.1100120407
   PANJABI MM, 1984, SPINE, V9, P707, DOI 10.1097/00007632-198410000-00010
   PRITZKER KPH, 1977, ORTHOP CLIN N AM, V8, P65
   Quinn TM, 2002, TISSUE ENG, V8, P799, DOI 10.1089/10763270260424150
   RHEE WM, 2001, Patent No. 6323278
   SCHNEIDER PG, 1974, Z ORTHOP GRENZGEB, V112, P791
   SCHNEIDER PG, 1974, Z ORTHOP GRENZGEB, V112, P1078
   SCOVILLE WB, 1973, J NEUROSURG, V39, P265, DOI 10.3171/jns.1973.39.2.0265
   STEDRONSKY E, 2002, Patent No. 6423333
   TIBREWAL SB, 1985, SPINE, V10, P452, DOI 10.1097/00007632-198506000-00009
   Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52
   URBAN JPG, 1979, BIOCHIM BIOPHYS ACTA, V586, P166, DOI 10.1016/0304-4165(79)90415-X
   URBAN JPG, 1978, BIORHEOLOGY, V15, P203
   URRY DW, 1991, Patent No. 5064430
   VERNONRO.B, 1973, ANN RHEUM DIS, V32, P406, DOI 10.1136/ard.32.5.406
   WALKENHORST J, 2004, 11 INT M ADV SPIN TE
   WALLACE AL, 1994, SPINE, V19, P1324, DOI 10.1097/00007632-199406000-00004
   WHALEN JL, 1985, J PEDIATR ORTHOPED, V5, P403, DOI 10.1097/01241398-198507000-00003
   Yoon ST, 2004, ORTHOP CLIN N AM, V35, P95, DOI 10.1016/S0030-5898(03)00097-X
   Yorimitsu E, 2001, SPINE, V26, P652, DOI 10.1097/00007632-200103150-00019
   YUKSEL KU, 2005, Patent No. 6921412
NR 67
TC 64
Z9 70
U1 6
U2 42
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0940-6719
EI 1432-0932
J9 EUR SPINE J
JI Eur. Spine J.
PD AUG
PY 2006
VL 15
SU 3
BP S414
EP S421
DI 10.1007/s00586-006-0172-2
PG 8
WC Clinical Neurology; Orthopedics
SC Neurosciences & Neurology; Orthopedics
GA 095PX
UT WOS:000241321100016
PM 16868785
OA Green Published
DA 2018-10-19
ER

PT J
AU Tachibana, K
AF Tachibana, Kunihide
TI Current status of microplasma research
SO IEEJ TRANSACTIONS ON ELECTRICAL AND ELECTRONIC ENGINEERING
LA English
DT Review
DE microplasma; microdischarge; plasma diagnostics; material processing;
   chemical analyses; photonic devices; plasma photonic crystals
ID PLASMA DISPLAY PANELS; MICROHOLLOW CATHODE-DISCHARGE;
   ATMOSPHERIC-PRESSURE; MICROSTRIP TECHNOLOGY; EMISSION-SPECTROMETRY;
   COUPLED MICROPLASMA; GAS-CHROMATOGRAPHY; RF MICROPLASMA; JET SOURCE;
   SILICON
AB Microscale plasmas of micrometer to millimeter range have been attracting much attention in recent years. Those microplasmas generally operate at high-pressure regions, including atmospheric pressure, and exhibit characteristics that differ from traditional plasmas at lower pressure regions in their plasma parameters and other parameters originating from their small dimensions. When those characteristics are well combined with the inherent properties of plasmas as reactive, light-emissive and conductive/dielectric media, there appear a variety of potential applications for nano-material syntheses, micromachining tools, microchemical analyses, photonic devices and biomaterial processing. In this article, the current status and perspective of microplasma research are reviewed from the viewpoints of plasma generation, diagnostics/simulations and new applications. (c) 2006 Institute of Electrical Engineers of Japan. Published by John Wiley & Sons, Inc.
C1 Kyoto Univ, Dept Elect Sci & Engn, Nishikyo Ku, Kyoto 6158510, Japan.
RP Tachibana, K (reprint author), Kyoto Univ, Dept Elect Sci & Engn, Nishikyo Ku, Kyoto 6158510, Japan.
EM tatibana@kuee.kyoto-u.ac.jp
CR Amemiya H., 2005, J PLASMA FUSION RES, V81, P482
   Bilgic AM, 2000, PLASMA SOURCES SCI T, V9, P1, DOI 10.1088/0963-0252/9/1/301
   Boeuf JP, 2003, J PHYS D APPL PHYS, V36, pR53, DOI 10.1088/0022-3727/36/6/201
   Brok WJM, 2005, J APPL PHYS, V98, DOI 10.1063/1.1944218
   Cenian A, 2005, J APPL PHYS, V97, DOI 10.1063/1.1938275
   Choi EH, 2002, IEEE T PLASMA SCI, V30, P2160, DOI 10.1109/TPS.2002.806640
   Cziesla K, 2001, FRESEN J ANAL CHEM, V371, P1043, DOI 10.1007/s002160101054
   Duan YX, 2003, REV SCI INSTRUM, V74, P2811, DOI 10.1063/1.1569401
   Eden JG, 2003, J PHYS D APPL PHYS, V36, P2869, DOI 10.1088/0022-3727/36/23/001
   El-Habachi A, 2000, J APPL PHYS, V88, P3220, DOI 10.1063/1.1288699
   Guchardi R, 2004, J CHROMATOGR A, V1033, P333, DOI 10.1016/j.chroma.2004.01.044
   HAMAGUCHI S, 2005, ANN PROGR REPORT SCI, P142
   Heeren T, 2005, IEEE T PLASMA SCI, V33, P1205, DOI 10.1109/TPS.2005.852433
   IBUKA S, 2003, P 14 IEEE INT PULS P, V2, P931
   Ichiki T, 2004, J APPL PHYS, V95, P35, DOI 10.1063/1.1630375
   Ichiki T, 2003, PLASMA SOURCES SCI T, V12, pS16, DOI 10.1088/0963-0252/12/4/315
   Ito T, 2004, J PHYS D APPL PHYS, V37, P445, DOI 10.1088/0022-3727/37/3/023
   Ito T, 2002, APPL PHYS LETT, V80, P2648, DOI 10.1063/1.1468898
   Ito T, 2002, APPL PHYS LETT, V80, P2854, DOI 10.1063/1.1470695
   Iza F, 2005, PLASMA SOURCES SCI T, V14, P397, DOI 10.1088/0963-0252/14/2/023
   Iza F, 2004, IEEE T PLASMA SCI, V32, P498, DOI 10.1109/TPS.2004.826145
   Jenkins G, 2002, J MICROMECH MICROENG, V12, pN19, DOI 10.1088/0960-1317/12/5/401
   Jeong DC, 2005, J APPL PHYS, V97, DOI 10.1063/1.1821637
   Karanassios V, 2004, SPECTROCHIM ACTA B, V59, P909, DOI 10.1016/j.sab.2004.04.005
   Kedzierski J, 2005, SOL ST PHEN, V107, P119
   Kim J, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1926411
   Kono A, 2004, JPN J APPL PHYS 2, V43, pL1010, DOI 10.1143/JJAP.43.L1010
   Kothnur PS, 2005, J APPL PHYS, V97, DOI 10.1063/1.1849816
   Kunze K, 2003, SPECTROCHIM ACTA B, V58, P1435, DOI 10.1016/S0584-8547(03)00104-6
   Kurosawa S, 2005, J PHOTOPOLYM SCI TEC, V18, P273, DOI 10.2494/photopolymer.18.273
   Kushner MJ, 2005, J PHYS D APPL PHYS, V38, P1633, DOI 10.1088/0022-3727/38/11/001
   Matsunaga Y, 2003, J APPL PHYS, V93, P5043, DOI 10.1063/1.1567034
   Miclea M, 2005, J PHYS D APPL PHYS, V38, P1709, DOI 10.1088/0022-3727/38/11/011
   Moselhy M, 2003, J PHYS D APPL PHYS, V36, P2922, DOI 10.1088/0022-3727/36/23/009
   Motoyama Y, 2001, IEEE T ELECTRON DEV, V48, P1568, DOI 10.1109/16.936562
   Motoyama Y, 2005, PROCEEDINGS OF THE TWENTY-FIFTH INTERNATIONAL DISPLAY RESEARCH CONFERENCE - EURODISPLAY 2005, P205
   Okumura T, 2004, JPN J APPL PHYS 1, V43, P3959, DOI 10.1143/JJAP.43.3959
   Park SJ, 2004, APPL PHYS LETT, V84, P4481, DOI 10.1063/1.1755845
   Renaudin P, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.075002
   Sakai O, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2147709
   Sakai O, 2005, PLASMA PHYS CONTR F, V47, pB617, DOI 10.1088/0741-3335/47/12B/S45
   Sakai O, 2005, J PHYS D APPL PHYS, V38, P431, DOI 10.1088/0022-3727/38/3/012
   Sakurai T, 2002, J APPL PHYS, V91, P4806, DOI 10.1063/1456961
   Sakurai Y, 2005, JPN J APPL PHYS 2, V44, pL749, DOI 10.1143/JJAP.44.L749
   Sankaran RM, 2005, NANO LETT, V5, P537, DOI 10.1021/nl0480060
   Schoenbach KH, 1997, PLASMA SOURCES SCI T, V6, P468, DOI 10.1088/0963-0252/6/4/003
   Shimizu Y, 2003, J PHYS D APPL PHYS, V36, P2940, DOI 10.1088/0022-3727/36/23/011
   Shirai H, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2084342
   SHIRAI N, 2004, PST0429 IEEJ, P97
   Sladek REJ, 2005, J PHYS D APPL PHYS, V38, P1716, DOI 10.1088/0022-3727/38/11/012
   Stark RH, 1999, J APPL PHYS, V85, P2075, DOI 10.1063/1.369505
   SUGAHARA K, 2004, I PHYS C SERIES, V182, P409
   Tachibana K, 2000, J APPL PHYS, V88, P4967, DOI 10.1063/1.1314312
   Tachibana K, 2005, J PHYS D APPL PHYS, V38, P1739, DOI 10.1088/0022-3727/38/11/015
   Tachibana K, 2003, IEEE T PLASMA SCI, V31, P68, DOI 10.1109/TPS.2003.808882
   TACHIBANA K, 2006, MONTHLY PUBLICATION, V75, P399
   TACHIBANA K, 2004, J PLASMA FUSION RES, V80, P825
   Takao Y, 2006, PLASMA SOURCES SCI T, V15, P211, DOI 10.1088/0963-0252/15/2/006
   Tan HML, 2005, J PHOTOPOLYM SCI TEC, V18, P237, DOI 10.2494/photopolymer.18.237
   TESCHKE M, 2005, 48 ANN TECHN C P
   UCHINO K, 2005, ANN PROGR REPORT SCI, V2, P152
   von Engel A, 1965, IONIZED GASES
   Yin Y, 1999, IEEE T PLASMA SCI, V27, P1516, DOI 10.1109/27.799834
   Yoshiki H, 2003, JPN J APPL PHYS 1, V42, P4000, DOI 10.1143/JJAP.42.4000
   Zhang CH, 2005, JPN J APPL PHYS 1, V44, P5544, DOI 10.1143/JJAP.44.5544
NR 65
TC 118
Z9 120
U1 4
U2 104
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1931-4973
EI 1931-4981
J9 IEEJ T ELECTR ELECTR
JI IEEJ Trans. Electr. Electron. Eng.
PD AUG
PY 2006
VL 1
IS 2
BP 145
EP 155
DI 10.1002/tee.20031
PG 11
WC Engineering, Electrical & Electronic
SC Engineering
GA 190EM
UT WOS:000248040800006
OA Bronze
DA 2018-10-19
ER

PT J
AU Canullo, L
   Trisi, P
   Simion, M
AF Canullo, Luigi
   Trisi, Paolo
   Simion, Massimo
TI Vertical ridge augmentation around implants using e-PTFE
   titanium-reinforced membrane and deproteinized bovine bone mineral
   (Bio-Oss): A case report
SO INTERNATIONAL JOURNAL OF PERIODONTICS & RESTORATIVE DENTISTRY
LA English
DT Article
ID SINUS AUGMENTATION; HUMANS; REGENERATION; BIOMATERIAL; PLACEMENT
AB with an expanded polytetrafluoroethylene, titanium-reinforced membrane to restore a vertical bone defect. Bio-Oss served as a filler material. After the membrane was removed, screw-type implants were placed. During this phase, cylindric bone samples were retrieved from the augmented area for histologic examination. on. The biopsy samples were composed of low-density trabecular bone with numerous interspersed graft particles. Clinical and histologic results demonstrated that this surgical technique could be a successful and predictable procedure for rebuilding a resorbed ridge to place implants.
C1 Univ Milan, Sch Dent, Dept Periodontol, Clin Odontoiatr & Stomatol, I-20129 Milan, Italy.
RP Simion, M (reprint author), Univ Milan, Sch Dent, Dept Periodontol, Clin Odontoiatr & Stomatol, Via Commenda 10, I-20129 Milan, Italy.
CR Araujo MG, 2002, J CLIN PERIODONTOL, V29, P1122, DOI 10.1034/j.1600-051X.2002.291213.x
   Dahlin C, 1998, CLIN ORAL IMPLAN RES, V9, P100, DOI 10.1034/j.1600-0501.1998.090205.x
   Dies F, 1996, CLIN ORAL IMPLAN RES, V7, P277, DOI 10.1034/j.1600-0501.1996.070310.x
   Fugazzotto PA, 2003, INT J PERIODONT REST, V23, P361
   Hammerle CHF, 1996, CLIN ORAL IMPLAN RES, V7, P38, DOI 10.1034/j.1600-0501.1996.070105.x
   Jensen O T, 1995, Int J Oral Maxillofac Implants, V10, P335
   Jovanovic S A, 1995, Int J Oral Maxillofac Implants, V10, P23
   Piattelli M, 1999, INT J ORAL MAX IMPL, V14, P835
   Renvert S, 1996, CLIN ORAL IMPLAN RES, V7, P360, DOI 10.1034/j.1600-0501.1996.070409.x
   Schlegel KA, 2003, INT J ORAL MAX IMPL, V18, P53
   Simion M, 1998, Int J Periodontics Restorative Dent, V18, P8
   Simion M, 2001, CLIN ORAL IMPLAN RES, V12, P35, DOI 10.1034/j.1600-0501.2001.012001035.x
   Simion M, 1999, CLIN ORAL IMPLAN RES, V10, P73, DOI 10.1034/j.1600-0501.1999.100201.x
   SIMION M, 1994, INT J PERIODONT REST, V14, P497
   Skoglund A, 1997, INT J ORAL MAX IMPL, V12, P194
   Tinti C, 1996, INT J PERIODONT REST, V16, P221
   TINTI C, 1998, INT J PERIODONT REST, V18, P445
   Valentini P, 2000, INT J PERIODONT REST, V20, P245
   ZITZMANN N, 2001, INT J ORAL MAXILLOF, V16, P289
NR 19
TC 28
Z9 29
U1 0
U2 3
PU QUINTESSENCE PUBLISHING CO INC
PI HANOVER PARK
PA 4350 CHANDLER DRIVE, HANOVER PARK, IL 60133 USA
SN 0198-7569
J9 INT J PERIODONT REST
JI Int. J. Periodontics Restor. Dent.
PD AUG
PY 2006
VL 26
IS 4
BP 355
EP 361
PG 7
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA 075IV
UT WOS:000239879100007
PM 16939017
DA 2018-10-19
ER

PT J
AU Priebe, M
   Muller-Hulsbeck, S
   Jahnke, T
   Charalambous, N
   Hedderich, J
   Heller, M
   Paulsen, FP
AF Priebe, Markus
   Mueller-Huelsbeck, Stefan
   Jahnke, Thomas
   Charalambous, Nikolas
   Hedderich, Juergen
   Heller, Martin
   Paulsen, Friedrich Paul
TI Influence of various cell-detachment solutions on endothelial cells
   after catheter abrasion for prosthesis colonization prior to
   implantation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE endothelial cell; stent endothelialization; catheter abrasion; stent
   coating
ID CULTURE; GRAFTS; GROWTH; STENTS; ANTIBODY; BLOOD
AB We (1) evaluated the effectiveness of different media on the detachment of endothelial cells (ECs) from a catheter brush (Cragg thrombolytic catheter system) that was previously used for endothelial cell abrasion in 10 cm human umbilical vein (HUV) segments; (2) tested the practicability of endovascular catheter brush abrasion followed by EC detachment from the catheter brush, in vitro culture of harvested ECs, and finally endothelialization of a prosthesis; and (3) analyzed the defect created by the catheter brush in HUV segments after endovascular catheter abrasion. Best results in detachment of ECs from the catheter brush were obtained with a mixture of phosphate-buffered saline + 1% human albumin. EC vitality was time-dependent in the collected HUV segments postdelivery. Harvested EC viability decreased from (26.28 +/- 5.76)% (0-3 h postdelivery) to (17.29 +/- 4.56)% (after 4-8 h). ECs were easily cultured ex vivo within 2-3 weeks; seeded on nitinol stents, they grew to confluency and formed a monolayer on the stent surface (determined. by scanning electron microscopy - SEM). Histological and SEM analysis of HUV segments that had undergone previous catheter brush abrasion revealed slight disruption of the intima but intact subintimal layers. Our findings indicate an advantageous method of capturing and culturing primary ECs for gene therapy or for the analysis and diagnosis of certain blood vessel diseases, especially in cases in which endovascular intervention is performed anyway. Moreover, and of high relevance to the biomaterial field, theoretically the procedure could be used to endothelialze a prosthesis ex vivo for implantation into the patient from whom the ECs were harvested, to reduce the inherent thrombogenicity of the prosthesis. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Kiel, Dept Diagnost Radiol, D-24098 Kiel, Germany.
   Univ Munich, Dept Nucl Med, Munich, Germany.
   Univ Kiel, Dept Biostat & Med Informat, D-24098 Kiel, Germany.
   Univ Halle Wittenberg, Dept Anat & Cell Biol, D-4010 Halle, Germany.
RP Muller-Hulsbeck, S (reprint author), Univ Kiel, Dept Diagnost Radiol, D-24098 Kiel, Germany.
EM muehue@rad.uni-kiel.de
RI Heller, Martin/D-1837-2010
CR AHLSWEDE KM, 1994, ARTERIOSCLER THROMB, V14, P25, DOI 10.1161/01.ATV.14.1.25
   Aoki J, 2005, J AM COLL CARDIOL, V45, P1574, DOI 10.1016/j.jacc.2005.01.048
   BELLON JM, 1995, ANN VASC SURG, V9, P266, DOI 10.1007/BF02135286
   BERGER K, 1972, ANN SURG, V175, P118, DOI 10.1097/00000658-197201000-00018
   Boyer M, 2000, J VASC SURG, V31, P181, DOI 10.1016/S0741-5214(00)70080-2
   CAMPBELL JB, 1985, J AM SOC ARTIF INTER, V113, P113
   DAVISON PM, 1980, J INVEST DERMATOL, V75, P316, DOI 10.1111/1523-1747.ep12530941
   Deutsch M, 1999, SURGERY, V126, P847, DOI 10.1067/msy.2099.99852
   Dunzendorfer S, 1999, CELL BIOL INT, V23, P89, DOI 10.1006/cbir.1998.0313
   Feng L, 1999, RADIOLOGY, V212, P655, DOI 10.1148/radiology.212.3.r99au28655
   GEORGE F, 1992, THROMB HAEMOSTASIS, V67, P147
   GIMBRONE MA, 1974, J CELL BIOL, V60, P673, DOI 10.1083/jcb.60.3.673
   JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470
   LINDL T, 1989, CELL TISSUE CULTURE, P29
   Marin V, 2001, J IMMUNOL METHODS, V254, P183, DOI 10.1016/S0022-1759(01)00408-2
   MOUSSY F, 1990, ASAIO T, V36, P568
   Muller-Hulsbeck S, 2005, RADIOLOGY, V235, P454, DOI 10.1148/radiol.2352031968
   MULLERHULSBECK S, 2000, INVEST RADIOL, V37, P314
   ORTENWALL P, 1987, J VASC SURG, V6, P17
   Priebe M, 2001, ROFO-FORTSCHR RONTG, V173, P955, DOI 10.1055/s-2001-17586
   SCOTT NA, 1995, AM HEART J, V129, P860, DOI 10.1016/0002-8703(95)90104-3
   SHINDO S, 1987, J VASC SURG, V6, P325, DOI 10.1067/mva.1987.avs0060325
   Sipehia R, 1996, ARTIF CELL BLOOD SUB, V24, P51, DOI 10.3109/10731199609117431
   Swanson Neil, 2003, J Invasive Cardiol, V15, P688
   VanBelle E, 1997, J AM COLL CARDIOL, V29, P1371, DOI 10.1016/S0735-1097(97)00049-1
   VanBelle E, 1997, CIRCULATION, V95, P438
NR 26
TC 4
Z9 4
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2006
VL 78A
IS 2
BP 399
EP 406
DI 10.1002/jbm.a.30779
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 062ET
UT WOS:000238928100021
PM 16705650
DA 2018-10-19
ER

PT J
AU Karamichos, D
   Brown, RA
   Mudera, V
AF Karamichos, D.
   Brown, R. A.
   Mudera, V.
TI Complex dependence of substrate stiffness and serum concentration on
   cell-force generation
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE collagen gel; stiffness; mechanical loads; viscoelastic; tissue
   engineering
ID EXTRACELLULAR-MATRIX; COLLAGEN GELS; IN-VITRO; DERMAL FIBROBLASTS;
   MECHANICAL FORCES; SKIN FIBROBLASTS; SKELETAL-MUSCLE; CONTRACTION;
   CYTOSKELETON; FIBRONECTIN
AB Collagen is a widely used biomaterial in tissue engineering. Mechanical stimulation of cell-seeded collagen constructs and its effects on cell orientation, intracellular signaling, and molecular responses have been reported. Our aim was to study the transfer of applied mechanical load to resident cells in 3D collagen constructs. Stainless steel markers were embedded in constructs as reporters of micromovement and uniaxial (0-15%) strain was applied. Cell-seeded collagen constructs were also subjected to (0-15%) uniaxial strain and material responses recorded. The viscoelastic properties of collagen resulted in comparatively small movement of the marker bars relative to gel deformation. Cell seeding density of 1 million/mL had no significant effect on the viscoelastic properties of collagen for the range of strain tested. Our findings indicate that viscoelastic properties of collagen result in minimal force transfer of applied loads as recorded by movement of stainless steel markers. At higher strain rates as collagen got stiffer the movement decreased. These findings indicate that as cell-seeded collagen constructs mature in a bioreactor and become stiffer due to ECM production/deposition, mechanical stimulation will have to be tailored over time to account for increased stiffness of constructs in vitro to elicit predictable and consistent cellular responses. (c) 2006 Wiley Periodicals, Inc.
C1 UCL, Tissue Repair & Engn Ctr, Inst Orthopaed & Musculoskeletal Sci, Stanmore HA7 4LP, Middx, England.
RP Mudera, V (reprint author), UCL, Tissue Repair & Engn Ctr, Inst Orthopaed & Musculoskeletal Sci, Stanmore HA7 4LP, Middx, England.
EM v.mudera@ucl.ac.uk
RI Mudera, Vivek/C-9383-2009; karamichos, dimitrios/D-9651-2015
CR Auluck A, 2005, EUR J ORAL SCI, V113, P218, DOI 10.1111/j.1600-0722.2005.00215.x
   Bischofs IB, 2003, P NATL ACAD SCI USA, V100, P9274, DOI 10.1073/pnas.1233544100
   Brown RA, 1998, J CELL PHYSIOL, V175, P323, DOI 10.1002/(SICI)1097-4652(199806)175:3<323::AID-JCP10>3.0.CO;2-6
   Brown RA, 1996, J CELL PHYSIOL, V169, P439, DOI 10.1002/(SICI)1097-4652(199612)169:3<439::AID-JCP4>3.0.CO;2-P
   BROWN RA, 2005, ADV FUNC MAT
   BURT AM, 1992, ANIMAL CELL BIOTECHN, V5, P151
   Cheema U, 2005, J CELL PHYSIOL, V202, P67, DOI 10.1002/jcp.20107
   Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5
   Cullinane DM, 2003, J EXP BIOL, V206, P2459, DOI 10.1242/jeb.00453
   DELVOYE P, 1991, J INVEST DERMATOL, V97, P898, DOI 10.1111/1523-1747.ep12491651
   EASTWOOD M, 1994, BBA-GEN SUBJECTS, V1201, P186, DOI 10.1016/0304-4165(94)90040-X
   Gentleman E, 2003, BIOMATERIALS, V24, P3805, DOI 10.1016/S0142-9612(03)00206-0
   HALLIDAY NL, 1995, EXP CELL RES, V217, P109, DOI 10.1006/excr.1995.1069
   Kostyuk O, 2004, BIOPHYS J, V87, P648, DOI 10.1529/biophysj.103.038976
   Krishnan L, 2004, TISSUE ENG, V10, P241, DOI 10.1089/107632704322791880
   Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5
   Mudera VC, 2000, CELL MOTIL CYTOSKEL, V45, P1, DOI 10.1002/(SICI)1097-0169(200001)45:1<1::AID-CM1>3.0.CO;2-J
   Talas G, 1997, INT J BIOCHEM CELL B, V29, P261, DOI 10.1016/S1357-2725(96)00132-X
   TOMASEK JJ, 1984, J CELL BIOL, V99, P536, DOI 10.1083/jcb.99.2.536
   Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809
   Wakatsuki T, 2003, BIOPHYS CHEM, V100, P593, DOI 10.1016/S0301-4622(02)00308-3
   WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161
   Yamamoto T, 2001, BIOCHEM BIOPH RES CO, V281, P200, DOI 10.1006/bbrc.2001.4321
   ZHELEV DV, 1995, BIOPHYS J, V68, P2004, DOI 10.1016/S0006-3495(95)80377-2
NR 24
TC 28
Z9 28
U1 0
U2 8
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD AUG
PY 2006
VL 78A
IS 2
BP 407
EP 415
DI 10.1002/jbm.a.30814
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 062ET
UT WOS:000238928100022
PM 16715519
DA 2018-10-19
ER

PT J
AU Jones, DS
   Garvin, CP
   Dowling, D
   Donnelly, K
   Gorman, SP
AF Jones, David S.
   Garvin, Clare P.
   Dowling, Denis
   Donnelly, Kevin
   Gorman, Sean P.
TI Examination of surface properties and in vitro biological performance of
   amorphous diamond-like carbon-coated polyurethane
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE diamond-like carbon; polyurethane; encrustation; microbial adherence;
   contact angle
ID VENTILATOR-ASSOCIATED PNEUMONIA; TUBE POLY(VINYL CHLORIDE); BIOMATERIAL
   ENCRUSTATION; COATINGS; CATHETER; RESISTANCE; ADHERENCE; BIOFILM; FILMS;
   DLC
AB Despite the emerging use of diamond-like carbon (DLC) as a coating for medical devices, few studies have examined the resistance of DLC coatings onto medical polymers to both microbial adherence and encrustation. In this study, amorphous DLC of a range of refractive indexes (1.7-1.9) and thicknesses (100-600 nm) was deposited onto polyurethane, a model polymer, and the resistance to microbial adherence (Escherichia coli; clinical isolate) and encrustation examined using in vitro models. In comparison to the native polymer, the advancing and receding contact angles of DLC-coated polyurethane were lower, indicating greater hydrophilic properties. No relationship was observed between refractive index, thickness, and advancing contact angle, as determined using multiple correlation analysis. The resistances of the various DLC-coated polyurethane films to encrustation and microbial adherence were significantly greater than that to polyurethane; however, there were individual differences between the resistances of the various DLC coatings. In general, increasing the refractive index of the coatings (100 nm thickness) decreased the resistance of the films to both hydroxyapatite and struvite encrustation and to microbial adherence. Films of lower thicknesses (100 and 200 nm; of defined refractive index, 1.8), exhibited the greatest resistance to encrustation and to microbial adherence. In conclusion, this study has uniquely illustrated both the microbial antiadherence properties and resistance to urinary encrustation of DLC-coated polyurethane. The resistances to encrustation and microbial adherence were substantial, and in light of this, it is suggested that DLC coatings of low thickness and refractive index show particular promise as coatings of polymeric medical devices. (c) 2006 Wiley Periodicals, Inc.
C1 Queens Univ Belfast, Ctr Med Biol, Sch Pharm, Med Devices Grp, Belfast BT9 7BL, Antrim, North Ireland.
   Univ Coll Dublin, Dept Mech Engn, Dublin 4, Ireland.
   Enterprise Ireland, Dublin 9, Ireland.
RP Jones, DS (reprint author), Queens Univ Belfast, Ctr Med Biol, Sch Pharm, Med Devices Grp, Belfast BT9 7BL, Antrim, North Ireland.
EM d.jones@qub.ac.uk
CR Adair CG, 1999, INTENS CARE MED, V25, P1072, DOI 10.1007/s001340051014
   BRIDGETT MJ, 1993, BIOMATERIALS, V14, P184, DOI 10.1016/0142-9612(93)90021-S
   BULL SJ, 1995, JOM-J MIN MET MAT S, V47, P16
   BULL SJ, 1995, DIAM RELAT MATER, V4, P827, DOI 10.1016/0925-9635(94)05325-1
   Donnelly K, 2001, THIN SOLID FILMS, V394, P102
   DONNELLY K, 1993, P MAT PROC TECHN 93, P769
   Dowling DP, 1996, DIAM RELAT MATER, V5, P492, DOI 10.1016/0925-9635(96)80066-5
   Dowling DP, 1998, DIAM RELAT MATER, V7, P432, DOI 10.1016/S0925-9635(97)00233-1
   Gabriel MM, 1996, CURR MICROBIOL, V33, P1, DOI 10.1007/s002849900064
   Gorman SP, 2001, BIOMATERIALS, V22, P2741, DOI 10.1016/S0142-9612(01)00017-5
   GORMAN SP, 1993, J MED MICROBIOL, V38, P411, DOI 10.1099/00222615-38-6-411
   Gorman SP, 2003, MED IMPLICATIONS BIO, P136
   Grill A., 1994, SYNTHETIC DIAMOND EM, P91
   Jones D. S., 2002, PHARM STAT
   Jones DS, 1997, BIOMATERIALS, V18, P503, DOI 10.1016/S0142-9612(96)00170-6
   Jones DS, 2002, BIOMATERIALS, V23, P4449, DOI 10.1016/S0142-9612(02)00158-8
   Jones DS, 2004, BIOMATERIALS, V25, P1421, DOI 10.1016/j.biomaterials.2003.08.01
   Jones DS, 2003, J PHARM PHARMACOL, V55, P43, DOI 10.1211/002235702496
   Jones DS, 2002, PHARMACEUT RES, V19, P818, DOI 10.1023/A:1016104516034
   Jones DS, 2001, J MATER SCI-MATER M, V12, P399, DOI 10.1023/A:1011240818338
   Jones MI, 2000, J BIOMED MATER RES, V52, P413, DOI 10.1002/1097-4636(200011)52:2<413::AID-JBM23>3.0.CO;2-U
   KEANE PF, 1994, BRIT J UROL, V73, P687, DOI 10.1111/j.1464-410X.1994.tb07557.x
   LETTINGTON AH, 1993, PHILOS T ROY SOC A, V342, P287, DOI 10.1098/rsta.1993.0022
   Li DJ, 2002, B MATER SCI, V25, P7, DOI 10.1007/BF02704587
   Matthew A., 2001, J BIOMED MATER RES, V58, P319
   McCrory R, 2003, J PHARM PHARMACOL, V55, P411, DOI 10.1211/0022357021035
   MONAGHAN DP, 1993, MATER WORLD, V1, P347
   Raad I, 1997, CLIN INFECT DIS, V25, P149, DOI 10.1086/514518
   Raad II, 1998, CRIT CARE MED, V26, P219, DOI 10.1097/00003246-199802000-00015
   Raad II, 1997, INFECT CONT HOSP EP, V18, P227
   THOMSON LA, 1991, BIOMATERIALS, V12, P37
   Tunney MM, 1996, BIOMATERIALS, V17, P1541, DOI 10.1016/0142-9612(96)89780-8
   Tunney MM, 1996, BIOMATERIALS, V17, P1025, DOI 10.1016/0142-9612(96)84679-5
   TUNNEY MM, 1998, METHODS ENZYMOLOGY B, P558
NR 34
TC 25
Z9 28
U1 1
U2 14
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2006
VL 78B
IS 2
BP 230
EP 236
DI 10.1002/jbm.b.30474
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 067KF
UT WOS:000239300000003
PM 16615067
DA 2018-10-19
ER

PT J
AU Miguel, FB
   Cardoso, AKMV
   Barbosa, AA
   Marcantonio, E
   Goissis, G
   Rosa, FP
AF Miguel, Fulvio B.
   Cardoso, Ana Karina M. V.
   Barbosa, Aryon A., Jr.
   Marcantonio, Elcio, Jr.
   Goissis, Gilberto
   Rosa, Fabiana P.
TI Morphological assessment of the behavior of three-dimensional anionic
   collagen matrices in bone regeneration in rats
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE tissue bioengineering; anionic collagen; three-dimensional matrix; bone
   regeneration; critical size defect
ID CROSS-LINKING; POLYANIONIC COLLAGEN; DEFECTS; SIZE; BIOCOMPATIBILITY;
   MEMBRANES; REPAIR; FILMS
AB The osteogenic behavior of three-dimensional collagenic and anionic matrices (M3DGA) implanted in critical bone defects of 8 mm diameter was morphologically assessed. The defects were performed in the calvaria of 48 adult male (Wistar) rats, and observed at days 15, 30, and 60. The animals were distributed in four groups of equal number: GA1 (M3DGA with 60 min of cross-linking in glutaraldehyde [GA]); GA2 (M3DGA with 30 min of cross-linking in GA); GA3 (M3DGA with 15 min of cross-linking in GA); and G4 (control group, without any implanted biomaterial). The M3DGAs were biocompatible, with mild and regressive chronic granulomatous inflammation, associated with the degradation of their fibers. Furthermore, tissue neovascularization and neomineralization was noted, with statistically significant differences in these amounts among the groups (GA1, GA2, and GA3) and G4. In G4 neoformation was limited to the edges of the defect as well as interstitial fibrosis. Under the experimental conditions and for the parameters analyzed, the M3DGAs had osteogenic behavior, which was more evident in M3DGA 15 min. (c) 2006 Wiley Periodicals. Inc.
C1 Univ Fed Bahia, Hlth Sci Inst, Salvador, BA, Brazil.
   Univ Fed Bahia, Fac Dent, Salvador, BA, Brazil.
   Oswaldo Cruz Fdn, Goncalo Moniz Res Ctr, Salvador, BA, Brazil.
   State Paulista Univ, Fac Dent, Araraquara, SP, Brazil.
   Univ Sao Paulo, Dept Chem, Sao Paulo, Brazil.
RP Rosa, FP (reprint author), Univ Fed Bahia, Hlth Sci Inst, Salvador, BA, Brazil.
EM fabianapaim@cpqgm.fiocruz.br
RI Marcantonio, Elcio/A-4784-2008
OI Marcantonio, Elcio/0000-0003-1294-2305
CR Bet MR, 2001, BIOMACROMOLECULES, V2, P1074, DOI 10.1021/bm0001188
   BOSCH C, 1995, CLEFT PALATE-CRAN J, V32, P311, DOI 10.1597/1545-1569(1995)032<0311:GBRICB>2.3.CO;2
   Bosch C, 1998, J CRANIOFAC SURG, V9, P310, DOI 10.1097/00001665-199807000-00004
   Brunel G, 1996, J PERIODONTOL, V67, P1342, DOI 10.1902/jop.1996.67.12.1342
   Chesmel KD, 1998, J ORAL MAXIL SURG, V56, P857, DOI 10.1016/S0278-2391(98)90015-5
   Goes JC, 2002, J PHYS CHEM SOLIDS, V63, P465, DOI 10.1016/S0022-3697(01)00161-5
   Goissis G, 2003, ARTIF ORGANS, V27, P437, DOI 10.1046/j.1525-1594.2003.07252.x
   Goissis G, 1999, BIOMATERIALS, V20, P27, DOI 10.1016/S0142-9612(97)00198-1
   Goissis G, 1998, ARTIF ORGANS, V22, P203, DOI 10.1046/j.1525-1594.1998.06109.x
   Jorge-Herrero E, 1999, BIOMATERIALS, V20, P539, DOI 10.1016/S0142-9612(98)90205-8
   Khor E, 1997, BIOMATERIALS, V18, P95, DOI 10.1016/S0142-9612(96)00106-8
   O'Brien FJ, 2005, BIOMATERIALS, V26, P433, DOI 10.1016/j.biomaterials.2004.02.052
   Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1
   Rocha LB, 2002, BIOMATERIALS, V23, P449, DOI 10.1016/S0142-9612(01)00126-0
   Rosa FP, 2003, BIOMATERIALS, V24, P207, DOI 10.1016/S0142-9612(02)00292-2
   ROSA FP, 2001, THESIS U ESTADUAL PA
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   SWEENEY TM, 1995, J NEUROSURG, V83, P710, DOI 10.3171/jns.1995.83.4.0710
   TAKAGI K, 1982, ANN SURG, V196, P100, DOI 10.1097/00000658-198207000-00020
   Tiller JC, 2001, BIOTECHNOL BIOENG, V73, P246, DOI 10.1002/bit.1057
NR 20
TC 6
Z9 7
U1 0
U2 1
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2006
VL 78B
IS 2
BP 334
EP 339
DI 10.1002/jbm.b.30492
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 067KF
UT WOS:000239300000017
PM 16470816
DA 2018-10-19
ER

PT J
AU Bellon, JM
   Garcia-Honduvilla, N
   Rodriguez, M
   Pascual, G
   Gomez-Gil, V
   Bujan, J
AF Bellon, J. M.
   Garcia-Honduvilla, N.
   Rodriguez, M.
   Pascual, G.
   Gomez-Gil, V.
   Bujan, J.
TI Influence of the structure of new generation prostheses on shrinkage
   after implant in the abdominal wall
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE prostheses; PTFE; wound healing; composite
ID MESH; REPAIR; MYOFIBROBLASTS; BIOMATERIALS; SCAR
AB When a biomaterial is used to repair an abdominal wall defect, wound contraction can cause the prosthesis to shrink, and the tension generated can provoke recurrence of the defect. This study was designed to determine whether the structure of a prosthesis can directly influence prosthetic shrinkage. Abdominal wall defects (7 X 5 cm) in rabbits were repaired using the laminar prosthesis DualMesh (R) (DM), the composites Sepramesh (R) (Se) and Vypro II (R) (Vy), and the reticular prosthesis Surgipro (R) (PP). The animals were sacrificed 14 and 90 days after surgery, at which time implant specimens were morphologically and immunohistochemically examined to establish the presence of myofibroblasts and macrophages. The size of each prosthesis was measured at the end of the study through image analysis. Morphometric measurements revealed greatest prosthesis shrinkage for Se, PP, and Vy (16.05 % +/- 5.08 %; 13.75 % +/- 4.22 %; 16.16 % +/- 6.34%), while the DNI prostheses only showed a 7.57% +/- 0.62% decrease in size (P < 0.05). In the DNI implants, the macrophage response and myofibroblast labeling were reduced. Both biomaterial structure and the macrophage reaction induced at the implant site modulate prosthetic shrinkage, laminar prostheses of the ePTFE type undergoing less shrinkage than reticular meshes. Reduced DNI shrinkage was linked to decreased myofibroblast numbers 2 weeks postimplant. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Alcala de Henares, Dept Surg, Fac Med, Alcala De Henares 28871, Spain.
   Univ Alcala de Henares, Dept Med Special, Fac Med, Alcala De Henares 28871, Spain.
RP Bellon, JM (reprint author), Univ Alcala de Henares, Dept Surg, Fac Med, Ctra N-11,Km 33-600, Alcala De Henares 28871, Spain.
EM juanm.bellon@uah.es
OI bujan, Julia/0000-0003-2419-2476; Garcia Honduvilla,
   Natalio/0000-0003-0904-6198; Gomez-Gil, Veronica/0000-0002-6642-5912;
   PASCUAL, GEMMA/0000-0002-1623-4384; BELLON, JUAN M./0000-0002-6071-5011
CR Amid PK, 2002, AM J SURG, V184, P259, DOI 10.1016/S0002-9610(02)00936-4
   Amid PK, 1997, HERNIA, V1, P15, DOI DOI 10.1007/BF02426382
   AMID PK, 2004, MESHES BENEFITS RISK, P199
   Bellon JM, 1996, J AM COLL SURGEONS, V183, P11
   BELLON JM, 1995, BIOMATERIALS, V16, P381, DOI 10.1016/0142-9612(95)98855-8
   Bellon JM, 2002, AM J SURG, V184, P154, DOI 10.1016/S0002-9610(02)00907-8
   Berry DP, 1998, PLAST RECONSTR SURG, V102, P124, DOI 10.1097/00006534-199807000-00019
   Cobb William S, 2005, Surg Innov, V12, P63, DOI 10.1177/155335060501200109
   DARBY I, 1990, LAB INVEST, V63, P21
   DESMOULIERE A, 1995, AM J PATHOL, V146, P56
   GABIANI G, 2003, J PATHOL, V200, P500
   Junge K, 2002, WORLD J SURG, V26, P1472, DOI 10.1007/s00268-002-6444-z
   Klinge U, 1998, EUR J SURG, V164, P965
   Schachtrupp A, 2003, BRIT J SURG, V90, P114, DOI 10.1002/bjs.4023
   SCHUMPELICK V, 1998, CHIRURG, V69, P489
NR 15
TC 10
Z9 10
U1 0
U2 2
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2006
VL 78B
IS 2
BP 340
EP 346
DI 10.1002/jbm.b.30493
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 067KF
UT WOS:000239300000018
PM 16544301
DA 2018-10-19
ER

PT J
AU Long, L
   Liu, ZB
   Wang, T
   Deng, XP
   Yang, KG
   Li, LJ
   Zhao, CS
AF Long, Li
   Liu, Zongbin
   Wang, Ting
   Deng, Xiaopei
   Yang, Kaiguang
   Li, Longjiang
   Zhao, Changsheng
TI Polyethersulfone dead-end tube as a scaffold for artificial lacrimal
   glands in vitro
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Article
DE polyethersulfone; dead-end tube; scaffold; lacrimal gland; cell culture
ID HOLLOW-FIBER MEMBRANES; DRY EYE; ACINAR-CELLS; HEMODIALYSIS;
   POLYSULFONE; GROWTH
AB Polyethersulfone (PES) dead-end tubes were fabricated by means of a phase inversion technique, and then were used as scaffolds for artificial lacrimal glands. The wall of the dead-end tubes could allow nutrients such as ascorbic acid, L-tryptophan, and glucose to pass through, but prevents rat IgG from passing through. Lacrimal acinar epithelial cells of Sprague-Dawley rats were cultured in vitro, and cell-associated secretory component was detected with an immunofluorescence technique to identify the acinar cells. The second passage of the cells showed high degree of cellular differentiation, and was used to seed on the PES tubes. The results showed that the PES tube could support the attachment, the growth, and the proliferation of the rat lacrimal acinar cells. Thus, PES is a substrate for the growth of lacrimal acinar cells and may be a useful scaffolding biomaterial for tissue engineering, such as a scaffold for artificial lacrimal glands. (c) 2006 Wiley Periodicals, Inc.
C1 Sichuan Univ, Dept Biomed Polymer Mat, State Key Lab Polymer Mat Engn, Coll Polymer Sci & Engn, Chengdu 610065, Peoples R China.
   Tianjin Stomatol Hosp, Tianjin 300041, Peoples R China.
   Sichuan Univ, W China Coll Stomatol, Chengdu 610065, Peoples R China.
RP Zhao, CS (reprint author), Sichuan Univ, Dept Biomed Polymer Mat, State Key Lab Polymer Mat Engn, Coll Polymer Sci & Engn, Chengdu 610065, Peoples R China.
EM zhaochsh70@163.com
RI Yang, Kaiguang/C-7259-2009; Deng, Xiaopei/E-3546-2014
OI Yang, Kaiguang/0000-0001-9544-2714; Deng, Xiaopei/0000-0002-5668-024X
CR Baudouin C, 2001, SURV OPHTHALMOL, V45, pS211, DOI 10.1016/S0039-6257(00)00200-9
   Calonge M, 2001, SURV OPHTHALMOL, V45, pS227, DOI 10.1016/S0039-6257(00)00205-8
   David S, 2003, CONTRIB NEPHROL, V138, P43
   Figliuzzi M, 2005, BIOMATERIALS, V26, P5640, DOI 10.1016/j.biomaterials.2005.02.019
   Gores F, 2002, BIOMATERIALS, V23, P3131, DOI 10.1016/S0142-9612(02)00057-1
   Haishima Y, 2001, J BIOMED MATER RES, V58, P209, DOI 10.1002/1097-4636(2001)58:2<209::AID-JBM1009>3.0.CO;2-7
   HANN LE, 1991, INVEST OPHTH VIS SCI, V32, P2610
   Hasegawa T, 2002, J BIOMED MATER RES, V63, P333, DOI 10.1002/jbm.10210
   Moce-Llivina L, 2003, J VIROL METHODS, V109, P99, DOI 10.1016/S0166-0934(03)00046-6
   Nguyen DH, 1999, IN VITRO CELL DEV-AN, V35, P198
   OLIVER C, 1980, IN VITRO CELL DEV B, V16, P297
   PAUL D, 2002, BIOMATERIALS, P179
   SITU Z, 2004, CELL CULTURE, P19
   Sottile J, 2000, J CELL SCI, V113, P4287
   Stern ME, 2004, EXP EYE RES, V78, P409, DOI 10.1016/j.exer.2003.09.003
   Unger RE, 2005, BIOMATERIALS, V26, P1877, DOI 10.1016/j.biomaterials.2004.05.032
   Unger RE, 2005, BIOMATERIALS, V26, P3461, DOI 10.1016/j.biomaterials.2004.09.047
   Zhao CS, 2001, ARTIF ORGANS, V25, P60
NR 18
TC 15
Z9 17
U1 0
U2 7
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD AUG
PY 2006
VL 78B
IS 2
BP 409
EP 416
DI 10.1002/jbm.b.30502
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 067KF
UT WOS:000239300000027
PM 16544306
DA 2018-10-19
ER

PT J
AU Lombardo, M
   De Santo, MP
   Lombardo, G
   Barberi, R
   Serrao, S
AF Lombardo, Marco
   De Santo, Maria P.
   Lombardo, Giuseppe
   Barberi, Riccardo
   Serrao, Sebastiano
TI Analysis of intraocular lens surface properties with atomic force
   microscopy
SO JOURNAL OF CATARACT AND REFRACTIVE SURGERY
LA English
DT Article
ID POSTERIOR CAPSULE OPACIFICATION; EPITHELIAL-CELL MIGRATION; POLY(METHYL
   METHACRYLATE); OPTIC EDGE; SILICONE; ADHESION; SHARP; BIOCOMPATIBILITY;
   IMPLANTATION; INHIBITION
AB PURPOSE: To analyze the surface optics of 4 currently available intraocular lenses (IOLs) with atomic force microscopy.
   SETTING: Licryl Laboratory, University of Calabria, Rende, Italy.
   METHODS: The surface roughness and topography of poly(methyl methacrylate) (PMMA), silicone, hydrophobic, and hydrophilic acrylic IOLs were evaluated with atomic force microscopy in contact mode. The analysis was performed in a liquid environment using cantilevers with a 0.01 Newtonw/ meter nominal elastic constant. Measurements were made over areas of 10 mu m(2) on different locations of the posterior optic surface of the IOL.
   RESULTS: Atomic force microscopy permitted high-resolution imaging of IOL optic surface characteristics. Surface topography showed different features with respect to the lens biomaterial. The root-mean-square roughness of the IOL optic surface was significantly different between lenses of various materials (P<.001). The hydrophobic acrylic and silicone IOLs had the lowest mean surface roughness, 3.8 nm +/- 0.2 (SD) and 4.0 +/- 0.5 nm, respectively, and the 2 PMMA IOLs had the highest mean surface roughness, 6.6 +/- 0.3 nm and 7.0 +/- 0.6 nm.
   CONCLUSIONS: Atomic force microscopy was effective and accurate in analyzing IOL optics. The surface topography of IOLs may vary with different manufacturing processes.
C1 Univ Magna Graecia, Dept Expt & Clin Med, Catanzaro, Italy.
   Vis Engn, Calabria, Italy.
   Univ Calabria, Dept Phys, CNR INFM Lab, I-87036 Arcavacata Di Rende, Italy.
   Serraolaser, Rome, Italy.
RP Lombardo, M (reprint author), Via Adda 7, I-00198 Rome, Italy.
EM mflombardo@libero.it
RI Lombardo, Giuseppe/B-2656-2012; Barberi, Riccardo/D-9219-2012
OI Lombardo, Giuseppe/0000-0002-9416-967X; Barberi,
   Riccardo/0000-0001-9713-1696; Lombardo, Marco/0000-0001-8842-7102; De
   Santo, Maria Penelope/0000-0001-6556-3611
CR Abela-Formanek C, 2002, J CATARACT REFR SURG, V28, P50, DOI 10.1016/S0886-3350(01)01122-1
   Alonso JL, 2003, LIFE SCI, V72, P2553, DOI 10.1016/S0024-3205(03)00165-6
   Apple DJ, 2001, OPHTHALMOLOGY, V108, P505, DOI 10.1016/S0161-6420(00)00589-3
   Bhatia Sameer, 1997, CLAO Journal, V23, P264
   Buehl W, 2002, J CATARACT REFR SURG, V28, P1105, DOI 10.1016/S0886-3350(02)01371-8
   Davison JA, 2004, J CATARACT REFR SURG, V30, P1492, DOI 10.1016/j.jcrs.2003.011.042
   Dogru M, 2000, J CATARACT REFR SURG, V26, P571, DOI 10.1016/S0886-3350(99)00342-9
   Escobar-Gomez M, 2003, J CATARACT REFR SURG, V29, P164, DOI 10.1016/S0886-3350(02)01435-9
   Findl O, 2005, OPHTHALMOLOGY, V112, P67, DOI 10.1016/j.ophtha.2004.07.032
   Hayashi K, 2001, J CATARACT REFR SURG, V27, P817, DOI 10.1016/S0886-3350(01)00787-8
   Hollick EJ, 1999, OPHTHALMOLOGY, V106, P49, DOI 10.1016/S0161-6420(99)90047-7
   Hollick EJ, 1998, BRIT J OPHTHALMOL, V82, P1182, DOI 10.1136/bjo.82.10.1182
   ISRAELACHVILI J, 1992, INTERMOLECULAR SURFA, P128
   Kruger AJ, 2000, J CATARACT REFR SURG, V26, P566, DOI 10.1016/S0886-3350(00)00323-0
   Kurosaka D, 2002, OPHTHALMIC RES, V34, P29, DOI 10.1159/000048322
   Kurosaka D, 2001, J CATARACT REFR SURG, V27, P1591, DOI 10.1016/S0886-3350(01)00870-7
   Linnola RJ, 1997, J CATARACT REFR SURG, V23, P1539, DOI 10.1016/S0886-3350(97)80026-0
   Lloyd AW, 2001, BIOMATERIALS, V22, P769, DOI 10.1016/S0142-9612(00)00237-4
   Lombardo M, 2005, J REFRACT SURG, V21, P469
   LOMBARDO M, 2005, J BIOMECHANICS  1004
   Majima K, 2001, J CATARACT REFR SURG, V27, P745, DOI 10.1016/S0886-3350(00)00685-4
   Mullner-Eidenbock A, 2001, J CATARACT REFR SURG, V27, P734, DOI 10.1016/S0886-3350(01)00846-X
   Nagamoto T, 2003, J CATARACT REFR SURG, V29, P1605, DOI 10.1016/S0886-3350(03)00050-6
   Nishi O, 2000, J CATARACT REFR SURG, V26, P1543, DOI 10.1016/S0886-3350(00)00426-0
   Nishi O, 1998, OPHTHALMIC SURG LAS, V29, P587
   Nishi O, 2004, J CATARACT REFR SURG, V30, P2170, DOI 10.1016/j.jcrs.2004.05.022
   Nishi O, 2003, J CATARACT REFR SURG, V29, P348, DOI 10.1016/S0886-3350(02)01530-4
   Nishi O, 2002, J CATARACT REFR SURG, V28, P431, DOI 10.1016/S0886-3350(01)01094-X
   Ohnishi Y, 2001, J CATARACT REFR SURG, V27, P2036, DOI 10.1016/S0886-3350(01)00961-0
   Oshika T, 1998, BRIT J OPHTHALMOL, V82, P549, DOI 10.1136/bjo.82.5.549
   Sacu S, 2004, J CATARACT REFR SURG, V30, P2322, DOI 10.1016/j.jcrs.2004.03.042
   Saika S, 2004, PROG RETIN EYE RES, V23, P283, DOI 10.1016/j.preteyeres.2004.02.004
   Sanchez-Sevilla A, 2002, ULTRAMICROSCOPY, V92, P151, DOI 10.1016/S0304-3991(02)00128-6
   SANKAR V, 2004, TRENDS BIOMATER ARTI, V17, P24
   Schauersberger J, 2001, J CATARACT REFR SURG, V27, P850, DOI 10.1016/S0886-3350(00)00861-0
   SHAH SM, 1995, J CATARACT REFR SURG, V21, P579, DOI 10.1016/S0886-3350(13)80221-0
   Tanaka T, 2005, J CATARACT REFR SURG, V31, P1648, DOI 10.1016/j.jcrs.2004.11.050
   Tognetto D, 2002, J CATARACT REFR SURG, V28, P644, DOI 10.1016/S0886-3350(01)01158-0
   Versura P, 1999, J CATARACT REFR SURG, V25, P527
   Wejde G, 2003, J CATARACT REFR SURG, V29, P1556, DOI 10.1016/S0886-3350(03)00342-0
   Yamakawa N, 2003, J CATARACT REFR SURG, V29, P367, DOI 10.1016/S0886-3350(02)01459-1
NR 41
TC 19
Z9 19
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0886-3350
J9 J CATARACT REFR SURG
JI J. Cataract. Refract. Surg.
PD AUG
PY 2006
VL 32
IS 8
BP 1378
EP 1384
DI 10.1016/j.jcrs.2006.02.068
PG 7
WC Ophthalmology; Surgery
SC Ophthalmology; Surgery
GA 071FG
UT WOS:000239583300033
PM 16863979
DA 2018-10-19
ER

PT J
AU Mooney, RG
   Costales, CA
   Freeman, EG
   Curtin, JM
   Corrin, AA
   Lee, JT
   Reynolds, S
   Tawil, B
   Shaw, MC
AF Mooney, R. G.
   Costales, C. A.
   Freeman, E. G.
   Curtin, J. M.
   Corrin, A. A.
   Lee, J. T.
   Reynolds, S.
   Tawil, B.
   Shaw, M. C.
TI Indentation micromechanics of three-dimensional fibrin/collagen
   biomaterial scaffolds
SO JOURNAL OF MATERIALS RESEARCH
LA English
DT Article
ID MECHANICAL-PROPERTIES; FIBRIN; TISSUE; BONE; NANOINDENTATION; BEHAVIOR;
   MODEL; SKIN
AB The underlying relationships between the microstructure and time-dependent mechanical properties of hydrated fibrin, collagen, and fibrin/collagen composite materials have been explored using an adaptation of the classical rigid, cylindrical, flat punch loaded normally to a planar specimen surface. A suite of quasi-static elastic and viscoelastic indentation experiments have been conducted with uniformly mixed fibrin, collagen, and fibrin/collagen composites, in addition to macrolayered collagen materials. Coupled with insights obtained from optical and confocal fluorescence microscopy, a simple micromechanics model has been developed for the effect of local microstructural variables on the macroscopic mechanical stiffness. These results demonstrate the efficacy of this technique to efficiently and reproducibly probe hydrated engineered tissue replacement materials for local variations in viscoelastic material behavior without the need for extensive specimen preparation or grips, as well as being suitable for performing directly comparable measurements with explants of human skin.
C1 Calif Lutheran Univ, Thousand Oaks, CA 91360 USA.
RP Shaw, MC (reprint author), Calif Lutheran Univ, Thousand Oaks, CA 91360 USA.
EM mcshaw@clunet.edu
OI Mooney, Rachael/0000-0002-9069-0206
CR ATALA A, 2002, METHODS TISSUE ENG 2
   Bonne M, 2003, WEAR, V254, P55, DOI 10.1016/S0043-1648(02)00304-6
   Clark RAF, 1996, MOL CELLULAR BIOL WO
   Clyne T. W., 1993, INTRO METAL MATRIX C
   CORRIN AA, UNPUB
   Cox S, 2004, TISSUE ENG, V10, P942, DOI 10.1089/1076327041348392
   Currie LJ, 2001, PLAST RECONSTR SURG, V108, P1713, DOI 10.1097/00006534-200111000-00045
   Danielsson M, 2004, MECH MATER, V36, P347, DOI 10.1016/S0167-6636(03)00064-4
   DISCHER DE, 2005, SCIENCE, V310, P18
   Fan Z, 2002, J ORTHOPAED RES, V20, P806, DOI 10.1016/S0736-0266(01)00186-3
   FERRY JD, 1947, J AM CHEM SOC, V388
   Fung YC, 1993, BIOMECHANICS MECH PR
   GAMBAROTTA L, 2003, J PLAST RECONSTRUCT, V1
   GAMBAROTTA L, 2003, P INT MECH ENG C EXP
   Han LH, 2003, ULTRASOUND MED BIOL, V29, P813, DOI 10.1016/S0301-5629(02)00776-7
   HELGERSON S, 2004, ENCY BIOMATERIALS BI
   Henry F, 2004, BIOPHYS CHEM, V112, P181, DOI 10.1016/j.bpc.2004.07.030
   HILL R, 1954, THEORY PLASTICITY
   JANMEY P, 1999, J BIOCHEM BIOPH METH, V22, P41
   Kadler KE, 1996, BIOCHEM J, V316, P1
   Korhonen RK, 2002, MED ENG PHYS, V24, P99, DOI 10.1016/S1350-4533(01)00123-0
   LAKES RS, 2004, REV SCI INSTRUM, V75, P4
   Lamethe JF, 2003, WEAR, V255, P758, DOI 10.1016/S0043-1648(03)00169-8
   LOUBET J, 1984, ASTM STP, V889
   MEREDITH JE, 1993, MOL BIOL CELL, V4, P953
   Mooney RG, 2005, MATER RES SOC SYMP P, V874, P205
   OLIVER WC, 1984, ASTM STP, V889
   Qin QH, 2004, BIOMATERIALS, V25, P5081, DOI 10.1016/j.biomaterials.2003.12.042
   Rho JY, 2002, J BIOMECH, V35, P189, DOI 10.1016/S0021-9290(01)00199-3
   ROBERTSON DW, 1974, COSTERUS, V1, P1
   Shergold OA, 2004, P ROY SOC A-MATH PHY, V460, P3037, DOI 10.1098/rspa.2004.1315
   Shigley JE, 1983, MECH ENG DESIGN
   Silva MJ, 2004, J BIOMECH, V37, P1639, DOI 10.1016/j.jbiomech.2004.02.018
   Sneddon IN, 1965, INT J ENG SCI, V3, P47, DOI DOI 10.1016/0020-7225(65)90019-4
   TAWIL B, 2006, IN PRESS INTRO BIOMA
   TAWIL B, 2003, WOUND REPAIR RE 1102
   Weisel JW, 2004, BIOPHYS CHEM, V112, P267, DOI 10.1016/j.bpc.2004.07.029
NR 37
TC 5
Z9 5
U1 0
U2 7
PU MATERIALS RESEARCH SOCIETY
PI WARRENDALE
PA 506 KEYSTONE DR, WARRENDALE, PA 15086 USA
SN 0884-2914
J9 J MATER RES
JI J. Mater. Res.
PD AUG
PY 2006
VL 21
IS 8
BP 2023
EP 2034
DI 10.1557/JMR.2006.0258
PG 12
WC Materials Science, Multidisciplinary
SC Materials Science
GA 072LL
UT WOS:000239674800019
DA 2018-10-19
ER

PT J
AU Katsikogianni, M
   Spiliopoulou, I
   Dowling, DP
   Missirlis, YF
AF Katsikogianni, M.
   Spiliopoulou, I.
   Dowling, D. P.
   Missirlis, Y. F.
TI Adhesion of slime producing Staphylococcus epidermidis strains to PVC
   and diamond-like carbon/silver/fluorinated coatings
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID COAGULASE-NEGATIVE STAPHYLOCOCCI; BACTERIAL ADHESION; BIOMATERIAL
   SURFACES; CARBON-FILMS; INFECTIONS; DEPOSITION; BIOFILMS; SHEAR; CELL
AB Staphylococcus epidermidis has emerged as a pathogen associated with infections of implanted medical devices. Bacterial adhesion is a crucial step in infection on biomaterial surfaces. To quantitatively determine the relationship between poly (vinyl chloride) (PVC) surface properties and bacterial adhesion, we have compared attachment of slime-producing S. epidermidis strains on PVC and various coatings under flow conditions. Bacterial adhesion and colonization was quantified by counting the viable organisms on the adherent surface as well as by scanning electron microscopy, epifluorescence microscopy and atomic force microscopy. Fluorination of the PVC surface encourages S. epidermidis adhesion whereas; diamond-like carbon (DLC) and especially silver (Ag) coatings seem to inhibit its adhesion. In most materials, the number of adherent bacteria decreased with the increase of shear rate. These results indicate that bacterial adhesion is influenced by the chemical properties of the polymeric surfaces, the surface roughness and the associated flow conditions.
C1 Univ Patras, Dept Mech Engn, Lab Biomech & Biomed Engn, Patras, Greece.
   Univ Patras, Sch Med, Dept Microbiol, GR-26110 Patras, Greece.
   UCD, Sch Elect Elect & Mech Engn, Dublin 4, Ireland.
RP Missirlis, YF (reprint author), Univ Patras, Dept Mech Engn, Lab Biomech & Biomed Engn, Patras, Greece.
EM misirlis@mech.upatras.gr
OI Katsikogianni, Maria/0000-0002-1560-3993
CR AMANN RI, 1990, J BACTERIOL, V172, P762, DOI 10.1128/jb.172.2.762-770.1990
   An YH, 1997, J MICROBIOL METH, V30, P141, DOI 10.1016/S0167-7012(97)00058-4
   An YH, 1998, J BIOMED MATER RES, V43, P338, DOI 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B
   Balazs DJ, 2003, SURF INTERFACE ANAL, V35, P301, DOI 10.1002/sia.1533
   Beech IB, 2002, COLLOID SURFACE B, V23, P231, DOI 10.1016/S0927-7765(01)00233-8
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   DICKINSON RB, 1995, AICHE J, V41, P2160, DOI 10.1002/aic.690410915
   Dowling DP, 1997, DIAM RELAT MATER, V6, P390, DOI 10.1016/S0925-9635(96)00687-5
   Dowling DP, 2001, THIN SOLID FILMS, V398, P602, DOI 10.1016/S0040-6090(01)01326-8
   Dowling DP, 1998, DIAM RELAT MATER, V7, P432, DOI 10.1016/S0925-9635(97)00233-1
   DUGUID IG, 1992, J ANTIMICROB CHEMOTH, V30, P803, DOI 10.1093/jac/30.6.803
   FRANKS J, 1989, J VAC SCI TECHNOL A, V7, P2307, DOI 10.1116/1.575933
   GOLDSMITH HL, 1986, THROMB HAEMOSTASIS, V55, P415
   GRAY ED, 1984, LANCET, V1, P365
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Hermansson M, 1999, COLLOID SURFACE B, V14, P105, DOI 10.1016/S0927-7765(99)00029-6
   ISHAK MA, 1985, J CLIN MICROBIOL, V22, P1025
   Liu Y, 2004, J BIOTECHNOL, V110, P251, DOI 10.1016/j.jbiotec.2004.02.012
   Mohamed N, 2000, BIOTECHNOL BIOENG, V68, P628, DOI 10.1002/(SICI)1097-0290(20000620)68:6<628::AID-BIT5>3.3.CO;2-4
   Morra M, 1997, J BIOMAT SCI-POLYM E, V9, P55, DOI 10.1163/156856297X00263
   NIRMALA R, 2003, BIOMATERIALS, V24, P2205
   PIZZOFERRATO A, 1995, BIOMATERIALS, V16, P361, DOI 10.1016/0142-9612(95)93853-6
   Sarangi D, 2000, VACUUM, V58, P609, DOI 10.1016/S0042-207X(00)00366-3
   Scheuerman TR, 1998, J COLLOID INTERF SCI, V208, P23, DOI 10.1006/jcis.1998.5717
   Spiliopoulou I, 2003, MICROB DRUG RESIST, V9, P273, DOI 10.1089/107662903322286481
   van der Mei HC, 1998, COLLOID SURFACE B, V11, P213, DOI 10.1016/S0927-7765(98)00037-X
   Vincent JL, 2003, LANCET, V361, P2068, DOI 10.1016/S0140-6736(03)13644-6
   von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3
   Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0
   Wang J, 2004, SURF COAT TECH, V186, P299, DOI 10.1016/j.surfcoat.2004.02.046
NR 30
TC 49
Z9 50
U1 0
U2 14
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD AUG
PY 2006
VL 17
IS 8
BP 679
EP 689
DI 10.1007/s10856-006-9678-8
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 069VE
UT WOS:000239476000001
PM 16897160
DA 2018-10-19
ER

PT J
AU Cook, RJ
   Thompson, ID
   Robinson, PD
   Watson, TF
AF Cook, R. J.
   Thompson, I. D.
   Robinson, P. D.
   Watson, T. F.
TI A novel real-time confocal imaging technique for examining host-implant
   interfacial shear failure patterns
SO JOURNAL OF MICROSCOPY-OXFORD
LA English
DT Article
DE bioactive; confocal imaging; implant; interface; real-time; shear
ID SCANNING-ELECTRON-MICROSCOPY; TENSILE BOND STRENGTH; REFLECTED
   LIGHT-MICROSCOPY; TOOTH-CUTTING INTERACTIONS; PUSH-OUT TEST; HUMAN
   OSTEOBLASTS; IONIC PRODUCTS; IN-VITRO; DENTIN; FRACTURE
AB In clinical practice, implant failure usually occurs at the biomaterial-host tissue interface, typically involving both biomechanical and biochemical mechanisms. By definition, any new 'bioactive' material will bond to living bone but, prior to clinical use, interface formation, performance, longevity and failure pattern characterizations are necessary. The common missing link in many biomaterial interface investigations is imaging at the point of presumed loaded failure. The novel real-time confocal technique described here allows bond strength, formation rate, longevity and bone-material interface failure pattern characterization for a wide range of biomaterials capable of forming tissue interfaces, in one real-time imaged microshear stress process, conducted using imaging frame matched load/displacement data acquisition under relatively normal near in vivo environmental conditions. The technique, validated by post-failure scanning electron microscopy imaging, revealed that more slowly reacting melt-derived 45S5 glass materials produced stronger and more stable long-term interfaces than faster reacting microporous bioactive sol-gel glasses.
C1 Kings Coll London, London Dent Inst, Guys Hosp, Dept Biomat Microscopy Imaging, London SE1 9RT, England.
   Kings Coll London, London Dent Inst, Guys Hosp, Dept Oral Surg, London SE1 9RT, England.
RP Cook, RJ (reprint author), Kings Coll London, London Dent Inst, Guys Hosp, Dept Biomat Microscopy Imaging, Floor 17,St Thomas St, London SE1 9RT, England.
EM richard_james.cook@kcl.ac.uk
RI Watson, Timothy/C-6815-2013
OI Watson, Timothy/0000-0001-6039-3780
CR Banerjee A, 1998, CARIES RES, V32, P219, DOI 10.1159/000016456
   BOYDE A, 1990, J MICROSC-OXFORD, V158, P261, DOI 10.1111/j.1365-2818.1990.tb02999.x
   BOYDE A, 1986, BONE, V7, P148, DOI 10.1016/8756-3282(86)90699-X
   BOYDE A, 1990, J MICROSC-OXFORD, V157, P39, DOI 10.1111/j.1365-2818.1990.tb02945.x
   BOYDE A, 1978, Scanning, V1, P157
   BRANEMARK P I, 1969, Scandinavian Journal of Plastic and Reconstructive Surgery, V3, P81
   BROWNE MA, 1992, SCANNING, V14, P145, DOI 10.1002/sca.4950140304
   CALLISTER WD, 1991, MAT SCI ENG INTRO, P113
   Cook RJ, 2001, J MICROSC-OXFORD, V203, P199, DOI 10.1046/j.1365-2818.2001.00934.x
   COOK RJ, 2003, THESIS U LONDON
   DAVIDSON JA, 1980, J POLYM SCI POL PHYS, V18, P51, DOI 10.1002/pol.1980.180180105
   DEHOFF PH, 1995, DENT MATER, V11, P126, DOI 10.1016/0109-5641(95)80047-6
   Donald AM, 2003, ANN BOT-LONDON, V92, P73, DOI 10.1093/aob/mcg115
   Donald AM, 2003, NAT MATER, V2, P511, DOI 10.1038/nmat898
   Dusevich VM, 2002, SCANNING, V24, P101
   ELIADES G, 1994, J DENT, V22, P73, DOI 10.1016/0300-5712(94)90004-3
   FROST H. M., 1961, JOUR NEW DRUGS, V1, P206, DOI 10.1177/009127006100100503
   GREENSPAN DC, 1998, BIOCERAMICS, V11, P345
   GREENSPAN DC, 1997, BIOCERAMICS, V10, P391
   Griffiths BM, 2000, AM J DENT, V13, P271
   Hayakawa S, 2002, KEY ENG MAT, V218-2, P71, DOI 10.4028/www.scientific.net/KEM.218-220.71
   He C, 1997, J MATER SCI, V32, P5661, DOI 10.1023/A:1018649213373
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   HENCH LL, 1990, CHEM REV, V90, P33, DOI 10.1021/cr00099a003
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   HENCH LL, 1993, INTRO BIOCERAMICS
   Hench LL, 1971, J BIOMED MATER RES S, V2, P117, DOI DOI 10.1002/JBM.820050611
   Inglis C. E, 1913, T I NAVAL ARCHITEC 1, V55, P219
   KANEKO S, 2001, BIOCERAMICS, V12, P295
   KATONA TR, 1994, AM J ORTHOD DENTOFAC, V106, P395, DOI 10.1016/S0889-5406(94)70061-3
   KELLY JR, 1995, DENT MATER, V11, P103, DOI 10.1016/0109-5641(95)80043-3
   LI PJ, 1993, J BIOMED MATER RES, V27, P1495, DOI 10.1002/jbm.820271205
   Liu D, 2000, J MATER SCI-MATER M, V11, P49, DOI 10.1023/A:1008989719560
   Manero JM, 2003, MICROSC RES TECHNIQ, V61, P469, DOI 10.1002/jemt.10358
   Molin MK, 1996, DENT MATER, V12, P245, DOI 10.1016/S0109-5641(96)80030-3
   Moroni A, 1997, J ORTHOP TRAUMA, V11, P154, DOI 10.1097/00005131-199704000-00003
   Mott L, 1996, WOOD FIBER SCI, V28, P429
   MOTT L, 1995, TAPPI J, V78, P143
   Nakajima M, 1995, J DENT RES, V74, P1679, DOI 10.1177/00220345950740100901
   NIKI M, 1991, BONE-BIOMATERIAL INTERFACE, P350
   Oilo G, 1993, Int Dent J, V43, P492
   OSAKA A, 2001, KEY ENG MATER, V192, P263
   PASHLEY DH, 1995, DENT MATER, V11, P117, DOI 10.1016/0109-5641(95)80046-8
   Porter AE, 2004, BIOMATERIALS, V25, P3303, DOI 10.1016/j.biomaterials.2003.10.006
   SANO H, 1994, DENT MATER, V10, P236, DOI 10.1016/0109-5641(94)90067-1
   SHAPIRO IM, 1984, METAB BONE DIS RELAT, V5, P317, DOI 10.1016/0221-8747(84)90019-5
   SHIRAZIADL A, 1992, J BIOMECH ENG-T ASME, V114, P111, DOI 10.1115/1.2895434
   Sidhu SK, 1999, J DENT, V27, P373, DOI 10.1016/S0300-5712(98)00057-8
   Sinhoreti MAC, 2001, J MATER SCI-MATER M, V12, P39, DOI 10.1023/A:1013848901553
   Skripitz R, 1999, BIOMATERIALS, V20, P351, DOI 10.1016/S0142-9612(98)00175-6
   SODERHOLM KJM, 1991, DENT MATER, V7, P74, DOI 10.1016/0109-5641(91)90049-5
   STRANG R, 1996, LIT REV J DENT, V26, P191
   Thiel BL, 2000, J TEXTURE STUD, V31, P437, DOI 10.1111/j.1745-4603.2000.tb00301.x
   Thiel BL, 1998, ANN BOT-LONDON, V82, P727, DOI 10.1006/anbo.1998.0732
   Thomas V, 1998, REV SCI INSTRUM, V69, P463, DOI 10.1063/1.1148720
   Thompson JI, 1999, J MATER SCI-MATER M, V10, P863, DOI 10.1023/A:1008929201918
   VANNOORT R, 1991, J DENT RES, V70, P889, DOI 10.1177/00220345910700050501
   VANNOORT R, 1989, J DENT, V17, P61, DOI 10.1016/0300-5712(89)90131-0
   Versluis A, 1997, J DENT RES, V76, P1298, DOI 10.1177/00220345970760061001
   WATSON TF, 1990, J MICROSC-OXFORD, V157, P51, DOI 10.1111/j.1365-2818.1990.tb02946.x
   Watson TF, 1995, J DENT RES, V74, P1749, DOI 10.1177/00220345950740110601
   WATSON TF, 1994, SCANNING, V16, P168
   Watson TF, 2000, BRIT DENT J, V188, P680, DOI 10.1038/sj.bdj.4800576a
   WATSON TF, 1987, SCANNING MICROSCOPY, V1, P1971
   WATSON TF, 2001, J DENT RES, V80, P693
   Xynos ID, 2000, CALCIFIED TISSUE INT, V67, P321, DOI 10.1007/s002230001134
   Xynos ID, 2000, BIOCHEM BIOPH RES CO, V276, P461, DOI 10.1006/bbrc.2000.3503
   Xynos ID, 2001, J BIOMED MATER RES, V55, P151, DOI 10.1002/1097-4636(200105)55:2<151::AID-JBM1001>3.3.CO;2-4
NR 68
TC 1
Z9 1
U1 1
U2 6
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0022-2720
J9 J MICROSC-OXFORD
JI J. Microsc.-Oxf.
PD AUG
PY 2006
VL 223
BP 96
EP 106
DI 10.1111/j.1365-2818.2006.01602.x
PN 2
PG 11
WC Microscopy
SC Microscopy
GA 072WC
UT WOS:000239702700003
PM 16911070
OA Bronze
DA 2018-10-19
ER

PT J
AU Ariga, K
   Nakanishi, T
   Michinobu, T
AF Ariga, Katsuhiko
   Nakanishi, Takashi
   Michinobu, Tsuyoshi
TI Immobilization of biomaterials to nano-assembled films (self-assembled
   monolayers, Langmuir-Blodgett films, and layer-by-layer assemblies) and
   their related functions
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Review
DE self-assembled monolayer (SAM); Langmuir-Blodgett (LB) film;
   layer-by-layer (LBL) assembly; protein; DNA; molecular recognition;
   sensor; reactor
ID AIR-WATER-INTERFACE; QUARTZ-CRYSTAL-MICROBALANCE; FLAVIN
   ADENINE-DINUCLEOTIDE; ULTRATHIN MULTILAYER FILMS; ORGANIC-INORGANIC
   HYBRID; DIP-PEN NANOLITHOGRAPHY; POROUS-GLASS PLATE;
   TRIPEPTIDE-CONTAINING AMPHIPHILES; DIRECTED PROTEIN IMMOBILIZATION;
   FORCE MICROSCOPIC OBSERVATION
AB For utilization of highly sophisticated functions of biomaterials in nano-scale functional systems, immobilization of biomaterials on artificial devices such as electrodes via thin film technology is one of the most powerful strategies. In this review, we focus on three major organic ultrathin films, self-assembled monolayers (SAM), Langmuir-Blodgett (LB) films, and layer-by-layer (LBL) assemblies, and from the viewpoints of biomaterial immobilization, typical examples and recent progresses in these film technologies are described. The SAM method allows facile contact between biomaterials and man-made devices, and well used for bio-related sensors. In addition, recent micro-fabrication techniques such as micro-contact printing and dip-pen nanolithography were successfully applied to preparation of biomaterial patterning. A monolayer at the air-water interface, which is a unit structure of LB films, provides a unique environment for recognition of aqueous biomaterials. Recognition and immobilization of various biomaterials including nucleotides, nucleic acid bases, amino acids, sugars, and peptides were widely investigated. The LB film can be also used for immobilization of enzymes in an ultrathin film on an electrode, resulting in sensor application. The LBL assembling method is available for wide range of biomaterials and provides great freedom in designs of layered structures. These advantages are reflected in preparation of thin-film bio-reactors where multiple kinds of enzymes sequentially operate. LBL assemblies were also utilized for sensors and drug delivery systems. This kind of assembling structures can be prepared on micro-size particle and very useful for preparation of hollow capsules with biological functions.
C1 Natl Inst Mat Sci, Supermol Grp, Tsukuba, Ibaraki 3050044, Japan.
RP Ariga, K (reprint author), Natl Inst Mat Sci, Supermol Grp, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.
RI Nakanishi, Takashi/B-7276-2011; Michinobu, Tsuyoshi/B-9460-2015; ARIGA,
   Katsuhiko/H-2695-2011
OI Nakanishi, Takashi/0000-0002-8744-782X; Michinobu,
   Tsuyoshi/0000-0001-6948-1189; 
CR Abad JM, 2002, J AM CHEM SOC, V124, P12845, DOI 10.1021/ja026658p
   AMES BN, 1995, P NATL ACAD SCI USA, V92, P5258, DOI 10.1073/pnas.92.12.5258
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   ANDO E, 1989, THIN SOLID FILMS, V180, P287, DOI 10.1016/0040-6090(89)90085-0
   Anslyn EV, 1993, SUPRAMOL CHEM, V1, P201, DOI 10.1080/10610279308035163
   Anzai J, 1997, J CHEM SOC PERK T 2, P1887, DOI 10.1039/a704744d
   Anzai J, 1998, ANAL CHEM, V70, P811, DOI 10.1021/ac970536b
   Anzai J, 1997, ANAL SCI, V13, P859, DOI 10.2116/analsci.13.859
   Ariga K, 1998, ACCOUNTS CHEM RES, V31, P371, DOI 10.1021/ar970014i
   Ariga K, 2000, POLYM ADVAN TECHNOL, V11, P856, DOI 10.1002/1099-1581(200008/12)11:8/12<856::AID-PAT33>3.0.CO;2-3
   Ariga K, 2000, LANGMUIR, V16, P9147, DOI 10.1021/la000901l
   Ariga K, 2003, SUPRAMOL CHEM, V15, P87, DOI 10.1080/1061027031000065567
   ARIGA K, 1994, LANGMUIR, V10, P2272, DOI 10.1021/la00019a041
   Ariga K, 2000, J AM CHEM SOC, V122, P7835, DOI 10.1021/ja000924m
   ARIGA K, 1994, J COLLOID INTERF SCI, V167, P275, DOI 10.1006/jcis.1994.1361
   Ariga K, 1996, J CHEM SOC PERK T 2, P667, DOI 10.1039/p29960000667
   Ariga K, 2005, SOFT MATTER, V1, P132, DOI 10.1039/b501945a
   Ariga K, 2000, LANGMUIR, V16, P4929, DOI 10.1021/la000249u
   Ariga K, 2005, LANGMUIR, V21, P4578, DOI 10.1021/la0467887
   ARIGA K, 1994, LANGMUIR, V10, P3255, DOI 10.1021/la00021a058
   Ariga K, 1999, CHEM LETT, P787, DOI 10.1246/cl.1999.787
   Ariga K, 1998, CHEM LETT, P493, DOI 10.1246/cl.1998.493
   Ariga K, 2005, LANGMUIR, V21, P976, DOI 10.1021/la0477845
   Ariga K, 2000, KOBUNSHI RONBUNSHU, V57, P251, DOI 10.1295/koron.57.251
   ARIGA K, 1992, J ORG CHEM, V57, P417, DOI 10.1021/jo00028a001
   Ariga K, 2004, LANGMUIR, V20, P6762, DOI 10.1021/la0490238
   Ariga K, 2004, J NANOSCI NANOTECHNO, V4, P23, DOI 10.1166/jnn.2004.048
   Ariga K, 2004, CHEM REC, V3, P297, DOI 10.1002/tcr.10071
   Ariga K, 2003, STUD SURF SCI CATAL, V146, P427
   Ariga K, 2002, J NANOSCI NANOTECHNO, V2, P669, DOI 10.1166/jnn.2002.147
   Ariga K, 1999, LANGMUIR, V15, P3875, DOI 10.1021/la981047p
   Ariga K, 2001, MOL CRYST LIQ CRYST, V371, P21, DOI 10.1080/10587250108024678
   Ariga K, 2001, MOL CRYST LIQ CRYST, V370, P343, DOI 10.1080/10587250108030102
   Ariga K, 2002, J NANOSCI NANOTECHNO, V2, P41, DOI 10.1166/jnn.2002.068
   Ariga K, 1999, APPL CLAY SCI, V15, P137, DOI 10.1016/S0169-1317(99)00012-5
   Ariga K, 2001, THIN SOLID FILMS, V393, P291, DOI 10.1016/S0040-6090(01)01092-6
   Ariga K, 2001, KOBUNSHI RONBUNSHU, V58, P363, DOI 10.1295/koron.58.363
   Ariga K, 2001, PHYS CHEM CHEM PHYS, V3, P3442, DOI 10.1039/b100974p
   Ariga K, 1997, J MATER CHEM, V7, P1155, DOI 10.1039/a700081b
   Ariga K, 1998, CHEM LETT, P1007, DOI 10.1246/cl.1998.1007
   ARIGA K, 1989, J AM CHEM SOC, V111, P5618, DOI 10.1021/ja00197a018
   Ariga K, 1997, CHEM LETT, P125, DOI 10.1246/cl.1997.125
   Ariga K, 1997, CHEM LETT, P25, DOI 10.1246/cl.1997.25
   Ariga K, 1997, J AM CHEM SOC, V119, P2224, DOI 10.1021/ja963442c
   Ariga K, 2000, CHEM LETT, P82
   Ariga K, 2000, COLLOID SURFACE A, V169, P47, DOI 10.1016/S0927-7757(00)00416-7
   ARIGA K, 1995, J COLLOID INTERF SCI, V170, P440, DOI 10.1006/jcis.1995.1123
   ARIGA K, 2002, HDB POLYELECTROLYTES, V1, P99
   ARIGA K, 2001, STUD SURF SCI CATAL, V132, P443
   Ariga K, 2002, INT J NANOSCI SER, V1, P521, DOI 10.1142/S0219581X02000607
   Arunkumar E, 2005, J AM CHEM SOC, V127, P3156, DOI 10.1021/ja045760e
   AVNIR D, 1994, CHEM MATER, V6, P1605, DOI 10.1021/cm00046a008
   BAIN CD, 1989, J AM CHEM SOC, V111, P321, DOI 10.1021/ja00183a049
   Balabushevitch NG, 2001, BIOTECHNOL BIOENG, V76, P207, DOI 10.1002/bit.1184
   Bardea A, 1998, CHEM COMMUN, P839, DOI 10.1039/a800215k
   BARTLETT PN, 1987, J ELECTROANAL CHEM, V224, P37, DOI 10.1016/0022-0728(87)85082-9
   BARTLETT PN, 1993, J ELECTROANAL CHEM, V362, P1
   Beckman KB, 1997, J BIOL CHEM, V272, P19633, DOI 10.1074/jbc.272.32.19633
   BERNDT P, 1992, LANGMUIR, V8, P2486, DOI 10.1021/la00046a022
   Bertrand P, 2000, MACROMOL RAPID COMM, V21, P319, DOI 10.1002/(SICI)1521-3927(20000401)21:7<319::AID-MARC319>3.0.CO;2-7
   Bissel P, 1999, LANGMUIR, V15, P1791, DOI 10.1021/la981043k
   Blawas AS, 1998, BIOMATERIALS, V19, P595, DOI 10.1016/S0142-9612(97)00218-4
   BOHANON TM, 1995, ANGEW CHEM INT EDIT, V34, P58, DOI 10.1002/anie.199500581
   Bong DT, 2001, ANGEW CHEM INT EDIT, V40, P988, DOI 10.1002/1521-3773(20010316)40:6<988::AID-ANIE9880>3.3.CO;2-E
   Boozer C, 2004, ANAL CHEM, V76, P6967, DOI 10.1021/ac048908l
   Borato CE, 2004, INSTRUM SCI TECHNOL, V32, P21, DOI 10.1081/CI-120027344
   BRESLOW R, 1982, SCIENCE, V218, P532, DOI 10.1126/science.7123255
   Breslow R, 1998, CHEM REV, V98, P1997, DOI 10.1021/cr970011j
   BRESLOW R, 1991, ACCOUNTS CHEM RES, V24, P159, DOI 10.1021/ar00006a001
   BRESLOW R, 1995, ACCOUNTS CHEM RES, V28, P146, DOI 10.1021/ar00051a008
   BRYCE MR, 1995, NATURE, V374, P771, DOI 10.1038/374771a0
   Cao TB, 2003, LANGMUIR, V19, P8127, DOI 10.1021/la034561n
   Caruso F, 2000, CHEM-EUR J, V6, P413, DOI 10.1002/(SICI)1521-3765(20000204)6:3<413::AID-CHEM413>3.0.CO;2-9
   Caruso F, 2001, ADV MATER, V13, P11, DOI 10.1002/1521-4095(200101)13:1<11::AID-ADMA11>3.0.CO;2-N
   Caruso F, 2000, LANGMUIR, V16, P9595, DOI 10.1021/la000942h
   Caruso F, 1998, LANGMUIR, V14, P4559, DOI 10.1021/la971288h
   Caruso F, 1998, J AM CHEM SOC, V120, P8523, DOI 10.1021/ja9815024
   Caruso F, 1998, SCIENCE, V282, P1111, DOI 10.1126/science.282.5391.1111
   Caruso F, 2000, LANGMUIR, V16, P1485, DOI 10.1021/la991161n
   Cassier T, 1998, SUPRAMOL SCI, V5, P309, DOI 10.1016/S0968-5677(98)00024-8
   Cha JN, 2000, NATURE, V403, P289, DOI 10.1038/35002038
   Cha X, 1996, B CHEM SOC JPN, V69, P163, DOI 10.1246/bcsj.69.163
   Cha X, 1996, CHEM LETT, P73, DOI 10.1246/cl.1996.73
   Cha X, 1996, J AM CHEM SOC, V118, P9545, DOI 10.1021/ja961526f
   CHA XA, 1995, J AM CHEM SOC, V117, P11833, DOI 10.1021/ja00153a003
   Constantine CA, 2003, J AM CHEM SOC, V125, P1805, DOI 10.1021/ja028691h
   COOPER TM, 1995, LANGMUIR, V11, P2713, DOI 10.1021/la00007a061
   Cosnier S, 1999, BIOSENS BIOELECTRON, V14, P443, DOI 10.1016/S0956-5663(99)00024-X
   Cutler P, 2003, PROTEOMICS, V3, P3, DOI 10.1002/pmic.200390007
   DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A
   Decher G, 1997, SCIENCE, V277, P1232, DOI 10.1126/science.277.5330.1232
   DECHER G, 1991, MAKROMOL CHEM-M SYMP, V46, P321, DOI 10.1002/masy.19910460145
   Deere J, 2001, CHEM COMMUN, P465, DOI 10.1039/b009478l
   Dennany L, 2004, J AM CHEM SOC, V126, P8835, DOI 10.1021/ja048615+
   Dhathathreyan A, 2002, LANGMUIR, V18, P10039, DOI 10.1021/la026069x
   dos Santos DS, 2003, MACROMOL BIOSCI, V3, P591, DOI 10.1002/mabi.200350027
   Dubas ST, 2001, J AM CHEM SOC, V123, P5368, DOI 10.1021/ja015774+
   Dynarowicz-Latka P, 2001, ADV COLLOID INTERFAC, V91, P221, DOI 10.1016/S0001-8686(99)00034-2
   EBARA Y, 1994, LANGMUIR, V10, P2267, DOI 10.1021/la00019a040
   Evans SD, 1998, LANGMUIR, V14, P6436, DOI 10.1021/la980450t
   Fang M, 2002, LANGMUIR, V18, P6338, DOI 10.1021/la025731m
   Fendler JH, 1996, CHEM MATER, V8, P1616, DOI 10.1021/cm960116n
   Ferreira M, 2004, BIOSENS BIOELECTRON, V19, P1611, DOI 10.1016/j.bios.2003.12.025
   Ferreira M, 2004, THIN SOLID FILMS, V446, P301, DOI 10.1016/j.tsf.2003.10.006
   Ferreira M, 2003, POLYMER, V44, P4205, DOI 10.1016/S0032-3861(03)00388-4
   Fiorito PA, 2005, CHEM COMMUN, P366, DOI 10.1039/b412583e
   Fou AC, 1996, J APPL PHYS, V79, P7501, DOI 10.1063/1.362421
   FOULDS NC, 1986, J CHEM SOC FARAD T 1, V82, P1259, DOI 10.1039/f19868201259
   FUJIHIRA M, 1985, THIN SOLID FILMS, V132, P77, DOI 10.1016/0040-6090(85)90459-6
   Fujita K, 2004, J AM CHEM SOC, V126, P13954, DOI 10.1021/ja047875o
   Fukuda K, 2001, J MOL CATAL B-ENZYM, V11, P971, DOI 10.1016/S1381-1177(00)00012-6
   Fung YS, 2001, ANAL CHEM, V73, P5302, DOI 10.1021/ac010655y
   Gao Q, 2004, CHEM COMMUN, P30, DOI 10.1039/b311535f
   GHADIRI MR, 1993, NATURE, V366, P324, DOI 10.1038/366324a0
   Ginger DS, 2004, ANGEW CHEM INT EDIT, V43, P30, DOI 10.1002/anie.200300608
   GUISAN JM, 1988, ENZYME MICROB TECH, V10, P375, DOI 10.1016/0141-0229(88)90018-X
   Guo YZ, 1997, CHEM COMMUN, P1437, DOI 10.1039/a703254d
   Hammond PT, 2004, ADV MATER, V16, P1271, DOI 10.1002/adma.200400760
   He JA, 1999, ADV MATER, V11, P435, DOI 10.1002/(SICI)1521-4095(199904)11:6<435::AID-ADMA435>3.3.CO;2-L
   Hecht S, 2001, ANGEW CHEM INT EDIT, V40, P74, DOI 10.1002/1521-3773(20010105)40:1<74::AID-ANIE74>3.0.CO;2-C
   Higashi N, 2001, J NANOSCI NANOTECHNO, V1, P309, DOI 10.1166/jnn 2001.038
   Higuchi M, 2001, J AM CHEM SOC, V123, P4414, DOI 10.1021/ja004239r
   Hodak J, 1997, LANGMUIR, V13, P2708, DOI 10.1021/la962014h
   HONG HG, 1991, CHEM MATER, V3, P521, DOI 10.1021/cm00015a030
   Hoshi T, 2002, LANGMUIR, V18, P7024, DOI 10.1021/la0203685
   Hou SF, 2005, NANO LETT, V5, P231, DOI 10.1021/nl048305p
   Huang E, 2001, LANGMUIR, V17, P1215, DOI 10.1021/la001019i
   Huang RP, 2003, FRONT BIOSCI, V8, pD559, DOI 10.2741/1017
   Huang X, 2004, J AM CHEM SOC, V126, P1322, DOI 10.1021/ja036878i
   Huguenin F, 2004, ADV FUNCT MATER, V14, P985, DOI 10.1002/adfm.200305077
   Huo Q, 2001, CHEM-EUR J, V7, P4796
   Huo Q, 1998, LANGMUIR, V14, P2174, DOI 10.1021/la971329+
   Hyun J, 2002, NANO LETT, V2, P1203, DOI 10.1021/n10257364
   Ichinose I, 1998, LANGMUIR, V14, P187, DOI 10.1021/la970797g
   Ichinose I, 1996, CHEM LETT, P257, DOI 10.1246/cl.1996.257
   Ikeda A, 1997, CHEM REV, V97, P1713, DOI 10.1021/cr960385x
   Ikeda A, 2001, J AM CHEM SOC, V123, P4855, DOI 10.1021/ja015596k
   IKEURA Y, 1990, CHEM LETT, P169, DOI 10.1246/cl.1990.169
   IKEURA Y, 1991, J AM CHEM SOC, V113, P7342, DOI 10.1021/ja00019a035
   ILER RK, 1966, J COLLOID INTERF SCI, V21, P569, DOI 10.1016/0095-8522(66)90018-3
   INGHAM KC, 1981, BIOCHIM BIOPHYS ACTA, V670, P181, DOI 10.1016/0005-2795(81)90007-6
   JACKMAN RJ, 1995, SCIENCE, V269, P664, DOI 10.1126/science.7624795
   Jaffar S, 2004, NANO LETT, V4, P1421, DOI 10.1021/nl0493287
   James TD, 2002, TOP CURR CHEM, V218, P159
   James TD, 1996, ANGEW CHEM INT EDIT, V35, P1910, DOI 10.1002/anie.199619101
   JAMES TD, 1995, NATURE, V374, P345, DOI 10.1038/374345a0
   JANATA J, 1998, ANAL CHEM, V70, P179
   Jenison R, 2001, NAT BIOTECHNOL, V19, P62, DOI 10.1038/83530
   Jiang SG, 2004, CHEM MATER, V16, P3985, DOI 10.1021/cm0491476
   Kamat PV, 2002, J PHYS CHEM B, V106, P7729, DOI 10.1021/jp0209289
   KAMINO A, 1995, COLLOID SURFACE A, V103, P183, DOI 10.1016/0927-7757(95)03244-8
   Kamino A, 1996, B CHEM SOC JPN, V69, P3619, DOI 10.1246/bcsj.69.3619
   KASAGI T, 2001, STUD SURF SCI CATAL, V132, P537
   Katagiri K, 2004, J SOL-GEL SCI TECHN, V31, P59, DOI 10.1023/B:JSST.0000047960.00667.20
   Katagiri K, 1999, CHEM LETT, P661, DOI 10.1246/cl.1999.661
   Katagiri K, 2003, J SOL-GEL SCI TECHN, V26, P393, DOI 10.1023/A:1020781400998
   Katagiri K, 2002, LANGMUIR, V18, P6709, DOI 10.1021/la025772i
   Katagiri K, 2002, J AM CHEM SOC, V124, P7892, DOI 10.1021/ja0259281
   KATAGIRI K, 2001, STUDIES SURFACE SCI, V132, P599
   KAWAHARA T, 1992, CHEM LETT, P1839, DOI 10.1246/cl.1992.1839
   Khan AR, 1998, CHEM REV, V98, P1977, DOI 10.1021/cr970012b
   Khoshtariya DE, 2003, J AM CHEM SOC, V125, P7704, DOI 10.1021/ja034719t
   Kikuchi J, 2001, J MOL CATAL B-ENZYM, V11, P977, DOI 10.1016/S1381-1177(00)00019-9
   Kikuchi J, 1999, CHEM LETT, P253
   Kikuchi J, 1999, CHEM COMMUN, P547, DOI 10.1039/a900083f
   Kim E, 2003, ANAL CHEM, V75, P5665, DOI 10.1021/ac034253x
   KITANO H, 1985, B CHEM SOC JPN, V58, P2826, DOI 10.1246/bcsj.58.2826
   KNEELAND DM, 1993, J AM CHEM SOC, V115, P10042, DOI 10.1021/ja00075a021
   Kodadek T, 2001, CHEM BIOL, V8, P105, DOI 10.1016/S1074-5521(00)90067-X
   KOMIYAMA M, 1995, J BIOCHEM-TOKYO, V118, P665, DOI 10.1093/oxfordjournals.jbchem.a124961
   KOTOV NA, 1995, J PHYS CHEM-US, V99, P13065, DOI 10.1021/j100035a005
   Kotov NA, 1997, J AM CHEM SOC, V119, P6821, DOI 10.1021/ja964409t
   Koyano H, 1996, CHEM COMMUN, P1769, DOI 10.1039/cc9960001769
   Koyano H, 1997, LANGMUIR, V13, P5426, DOI 10.1021/la970014r
   Koyano H, 1997, CHEM-EUR J, V3, P1077, DOI 10.1002/chem.19970030715
   Kramer S, 2003, CHEM REV, V103, P4367, DOI 10.1021/cr020704m
   Kunitake T, 1996, THIN SOLID FILMS, V284, P9, DOI 10.1016/S0040-6090(96)08831-1
   KURIHARA K, 1992, LANGMUIR, V8, P2087, DOI 10.1021/la00045a003
   KURIHARA K, 1991, J AM CHEM SOC, V113, P5077, DOI 10.1021/ja00013a063
   Kurihara K, 1997, COLLOID SURFACE A, V123, P425, DOI 10.1016/S0927-7757(96)03831-9
   Kuzmenko I, 2001, CHEM REV, V101, P1659, DOI 10.1021/cr990038y
   Ladd J, 2004, LANGMUIR, V20, P8090, DOI 10.1021/la049867r
   LANDAU EM, 1989, J AM CHEM SOC, V111, P1436, DOI 10.1021/ja00186a044
   LEE H, 1988, J PHYS CHEM-US, V92, P2597, DOI 10.1021/j100320a040
   Lee KB, 2002, SCIENCE, V295, P1702, DOI 10.1126/science.1067172
   LEHN JM, 1990, ANGEW CHEM INT EDIT, V29, P1304, DOI 10.1002/anie.199013041
   Lenihan JS, 2004, J NANOSCI NANOTECHNO, V4, P600, DOI 10.1166/jnn.2004.150
   Li C, 2000, LANGMUIR, V16, P7701, DOI 10.1021/la000181i
   Li CQ, 2004, LANGMUIR, V20, P8641, DOI 10.1021/la0490339
   Li XM, 2004, J MATER CHEM, V14, P2954, DOI 10.1039/b406037g
   Liu JQ, 2004, J PHYS CHEM B, V108, P8460, DOI 10.1021/jp037494h
   LUDWIG R, 1993, CHEM LETT, P1413, DOI 10.1246/cl.1993.1413
   LVOV Y, 1993, LANGMUIR, V9, P481, DOI 10.1021/la00026a020
   LVOV Y, 1993, MACROMOLECULES, V26, P5396, DOI 10.1021/ma00072a016
   LVOV Y, 1993, J PHYS CHEM-US, V97, P13773, DOI 10.1021/j100153a055
   LVOV Y, 1995, J AM CHEM SOC, V117, P6117, DOI 10.1021/ja00127a026
   LVOV Y, 1995, J CHEM SOC CHEM COMM, P2313, DOI 10.1039/c39950002313
   Lvov Y, 2001, ANAL CHEM, V73, P4212, DOI 10.1021/ac010118d
   Lvov Y, 1999, COLLOID SURFACE A, V146, P337, DOI 10.1016/S0927-7757(98)00789-4
   Lvov Y, 1996, LANGMUIR, V12, P3038, DOI 10.1021/la951002d
   LVOV Y, 1994, LANGMUIR, V10, P4232, DOI 10.1021/la00023a052
   LVOV Y, 1994, CHEM LETT, P2323, DOI 10.1246/cl.1994.2323
   Lvov Y, 1998, J BIOMAT SCI-POLYM E, V9, P345, DOI 10.1080/09205063.1998.9753060
   Lvov Y, 1997, LANGMUIR, V13, P6195, DOI 10.1021/la970517x
   Lvov Y, 2001, NANO LETT, V1, P125, DOI 10.1021/nl0100015
   Lvov Y, 1996, THIN SOLID FILMS, V284, P797, DOI 10.1016/S0040-6090(95)08449-5
   Lvov YM, 1998, J AM CHEM SOC, V120, P4073, DOI 10.1021/ja9737984
   MANN S, 1993, NATURE, V365, P499, DOI 10.1038/365499a0
   MAO GZ, 1995, LANGMUIR, V11, P942, DOI 10.1021/la00003a043
   Marchi-Artzner V, 1998, LANGMUIR, V14, P5164, DOI 10.1021/la971192n
   Mark SS, 2004, LANGMUIR, V20, P6808, DOI 10.1021/la0495276
   Mateo C, 2000, BIOMACROMOLECULES, V1, P739, DOI 10.1021/bm000071q
   Mateos-Timoneda MA, 2004, CHEM SOC REV, V33, P363, DOI 10.1039/b305550g
   Matsui H, 2001, NANO LETT, V1, P461, DOI 10.1021/nl015564v
   MATTOSO LHC, 1994, THIN SOLID FILMS, V244, P714, DOI 10.1016/0040-6090(94)90556-8
   McCullough DH, 2004, CHEM COMMUN, P2787, DOI 10.1039/b410027c
   Meyer EA, 2003, ANGEW CHEM INT EDIT, V42, P1210, DOI 10.1002/anie.200390319
   Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0
   Miyahara M, 2006, THIN SOLID FILMS, V499, P13, DOI 10.1016/j.tsf.2005.07.046
   Miyahara M, 2004, KOBUNSHI RONBUNSHU, V61, P623, DOI 10.1295/koron.61.623
   Moraes ML, 2005, COLLOID SURFACE B, V41, P15, DOI 10.1016/j.colsurfb.2004.10.026
   MORGAN H, 1991, BIOCHIM BIOPHYS ACTA, V1062, P149, DOI 10.1016/0005-2736(91)90386-M
   Mrksich M, 1996, ANNU REV BIOPH BIOM, V25, P55, DOI 10.1146/annurev.bb.25.060196.000415
   MUEHLDORF AV, 1988, J AM CHEM SOC, V110, P6561, DOI 10.1021/ja00227a045
   Murakami Y, 1996, CHEM REV, V96, P721, DOI 10.1021/cr9403704
   Murgida DH, 2001, J AM CHEM SOC, V123, P4062, DOI 10.1021/ja004165j
   Nakamura F, 2003, LANGMUIR, V19, P5823, DOI 10.1021/la020952d
   Nelson BP, 2001, ANAL CHEM, V73, P1, DOI 10.1021/ac0010431
   Nicolini C, 2001, LANGMUIR, V17, P3719, DOI 10.1021/la001418d
   Niemeyer CM, 2002, TRENDS BIOTECHNOL, V20, P395, DOI 10.1016/S0167-7799(02)02022-X
   Niwa M, 1998, LANGMUIR, V14, P3916, DOI 10.1021/la971261y
   Nonglaton G, 2004, J AM CHEM SOC, V126, P1497, DOI 10.1021/ja039072r
   NUZZO RG, 1983, J AM CHEM SOC, V105, P4481, DOI 10.1021/ja00351a063
   OHNISHI M, 1976, J BIOCHEM-TOKYO, V79, P1007, DOI 10.1093/oxfordjournals.jbchem.a131140
   Oishi Y, 1997, LANGMUIR, V13, P519, DOI 10.1021/la960112x
   Oishi Y, 1996, CHEM LETT, P411, DOI 10.1246/cl.1996.411
   Oishi Y, 1997, CHEM COMMUN, P1357, DOI 10.1039/a702880f
   Oishi Y, 1996, CHEM LETT, P857, DOI 10.1246/cl.1996.857
   OKAHATA Y, 1990, LANGMUIR, V6, P1148, DOI 10.1021/la00096a022
   OKAHATA Y, 1989, LANGMUIR, V5, P1261, DOI 10.1021/la00089a026
   OKAHATA Y, 1992, THIN SOLID FILMS, V210, P702, DOI 10.1016/0040-6090(92)90379-P
   OKAHATA Y, 1989, J AM CHEM SOC, V111, P9190, DOI 10.1021/ja00208a009
   OKAHATA Y, 1986, J AM CHEM SOC, V108, P2863, DOI 10.1021/ja00271a013
   OKAHATA Y, 1988, J AM CHEM SOC, V110, P2495, DOI 10.1021/ja00216a024
   OKAHATA Y, 1986, J CHEM SOC CHEM COMM, P1069, DOI 10.1039/c39860001069
   OKAHATA Y, 1988, LANGMUIR, V4, P1373, DOI 10.1021/la00084a030
   OKAHATA Y, 1989, THIN SOLID FILMS, V180, P65, DOI 10.1016/0040-6090(89)90055-2
   OKAHATA Y, 1986, LANGMUIR, V2, P538, DOI 10.1021/la00070a028
   OKAHATA Y, 1989, THIN SOLID FILMS, V178, P465, DOI 10.1016/0040-6090(89)90339-8
   OKAHATA Y, 1987, J CHEM SOC CHEM COMM, P1535, DOI 10.1039/c39870001535
   Onda M, 1999, J BIOSCI BIOENG, V87, P69, DOI 10.1016/S1389-1723(99)80010-3
   Onda M, 1996, J FERMENT BIOENG, V82, P502, DOI 10.1016/S0922-338X(97)86992-9
   Onda M, 1996, J AM CHEM SOC, V118, P8524, DOI 10.1021/ja960991+
   Onda M, 1996, BIOTECHNOL BIOENG, V51, P163, DOI 10.1002/(SICI)1097-0290(19960720)51:2<163::AID-BIT5>3.0.CO;2-H
   Onda M, 1997, JPN J APPL PHYS 2, V36, pL1608, DOI 10.1143/JJAP.36.L1608
   ONOUE Y, 1987, JPN J APPL PHYS 2, V26, pL1897, DOI 10.1143/JJAP.26.L1897
   OSHANNESSY DJ, 1987, J IMMUNOL METHODS, V99, P153, DOI 10.1016/0022-1759(87)90120-7
   Ostuni E, 2001, LANGMUIR, V17, P5605, DOI 10.1021/la010384m
   OZIN GA, 1992, ADV MATER, V4, P612, DOI 10.1002/adma.19920041003
   Ozsoz M, 2003, ANAL CHEM, V75, P2181, DOI 10.1021/ac026212r
   Paleos CM, 1997, ADV MATER, V9, P695, DOI 10.1002/adma.19970090904
   Panchagnula V, 2002, J AM CHEM SOC, V124, P12515, DOI 10.1021/ja020683d
   Paternolli C, 2004, LANGMUIR, V20, P11706, DOI 10.1021/la048081q
   Peelen D, 2005, LANGMUIR, V21, P266, DOI 10.1021/la048166r
   Peterson AW, 2002, J AM CHEM SOC, V124, P14601, DOI 10.1021/ja0279996
   Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661
   Pontes RS, 1999, PHYS STATUS SOLIDI A, V173, P41, DOI 10.1002/(SICI)1521-396X(199905)173:1<41::AID-PSSA41>3.0.CO;2-Q
   Ramakrishnan V, 2002, LANGMUIR, V18, P6307, DOI 10.1021/la025755t
   Ramsay G, 1998, NAT BIOTECHNOL, V16, P40, DOI 10.1038/nbt0198-40
   Rekharsky MV, 1998, CHEM REV, V98, P1875, DOI 10.1021/cr970015o
   Riul A, 2004, SENSOR ACTUAT B-CHEM, V98, P77, DOI 10.1016/j.snb.2003.09.025
   Riul A, 2002, LANGMUIR, V18, P239, DOI 10.1021/la011017d
   RIUL A, 1995, SYNTHETIC MET, V71, P2067, DOI 10.1016/0379-6779(94)03169-7
   ROBERTS GG, 1985, ADV PHYS, V34, P475, DOI 10.1080/00018738500101801
   Roth KM, 2002, LANGMUIR, V18, P4030, DOI 10.1021/la025525e
   Sackmann E, 2000, TRENDS BIOTECHNOL, V18, P58, DOI 10.1016/S0167-7799(99)01412-2
   SAGIV J, 1980, J AM CHEM SOC, V102, P92, DOI 10.1021/ja00521a016
   SAKURAI M, 1995, CHEM LETT, P1001, DOI 10.1246/cl.1995.1001
   Sakurai M, 1997, J PHYS CHEM B, V101, P4810, DOI 10.1021/jp9700591
   Santos JP, 2001, LANGMUIR, V17, P5361, DOI 10.1021/la0102556
   SASAKI DY, 1991, J AM CHEM SOC, V113, P9685, DOI 10.1021/ja00025a051
   SASAKI DY, 1992, J AM CHEM SOC, V114, P10994, DOI 10.1021/ja00053a065
   SASAKI DY, 1992, THIN SOLID FILMS, V210, P776
   Satjapipat M, 2001, LANGMUIR, V17, P7637, DOI 10.1021/la010989i
   Schmitt J, 1997, ADV MATER, V9, P61, DOI 10.1002/adma.19970090114
   SCHNEIDER HJ, 1991, ANGEW CHEM INT EDIT, V30, P1417, DOI 10.1002/anie.199114171
   Schuler C, 2001, BIOMACROMOLECULES, V2, P921, DOI 10.1021/bm010052w
   SEEL C, 1992, ANGEW CHEM INT EDIT, V31, P528, DOI 10.1002/anie.199205281
   Serizawa T, 2000, LANGMUIR, V16, P7112, DOI 10.1021/la000241k
   Serizawa T, 2004, NATURE, V429, P52, DOI 10.1038/nature02525
   Serizawa T, 2000, J AM CHEM SOC, V122, P1891, DOI 10.1021/ja9913535
   Service RF, 1998, SCIENCE, V282, P396, DOI 10.1126/science.282.5388.396
   SHA S, 1989, THIN SOLID FILMS, V179, P277, DOI 10.1016/0040-6090(89)90194-6
   Shchukin DG, 2004, CHEM MATER, V16, P3446, DOI 10.1021/cm049506x
   SHIEGENAGA MK, 1994, P NATL ACAD SCI USA, V91, P10771
   Shimakoshi H, 2003, DALTON T, P2308, DOI 10.1039/b212863b
   Shimazaki Y, 1998, LANGMUIR, V14, P2768, DOI 10.1021/la9713457
   Shimazaki Y, 1997, LANGMUIR, V13, P1385, DOI 10.1021/la9609579
   Shimizu T, 2005, CHEM REV, V105, P1401, DOI 10.1021/cr030072j
   Shimomura M, 2001, CURR OPIN COLLOID IN, V6, P11, DOI 10.1016/S1359-0294(00)00081-9
   SHINKAI S, 1991, J CHEM SOC CHEM COMM, P1039, DOI 10.1039/c39910001039
   Shiratori SS, 2000, MACROMOLECULES, V33, P4213, DOI 10.1021/ma991645q
   Shumaker-Parry JS, 2004, ANAL CHEM, V76, P918, DOI 10.1021/ac034964v
   SMITH J, 1993, J AM CHEM SOC, V115, P362, DOI 10.1021/ja00054a062
   Smith RK, 2004, PROG SURF SCI, V75, P1, DOI 10.1016/j.progsurf.2003.12.001
   Sortino S, 2003, LANGMUIR, V19, P536, DOI 10.1021/la0264365
   Southern E, 1999, NAT GENET, V21, P5, DOI 10.1038/4429
   SPRINGS B, 1977, BIOORG CHEM, V6, P181, DOI 10.1016/0045-2068(77)90019-0
   Stockton WB, 1997, MACROMOLECULES, V30, P2717, DOI 10.1021/ma9700486
   Sukhishvili SA, 2000, J AM CHEM SOC, V122, P9550, DOI 10.1021/ja002410t
   Sukhishvili SA, 2002, MACROMOLECULES, V35, P301, DOI 10.1021/ma011346c
   TABUSHI I, 1984, TETRAHEDRON, V40, P269, DOI 10.1016/S0040-4020(01)91173-1
   TACHIBANA H, 1989, J AM CHEM SOC, V111, P3080, DOI 10.1021/ja00190a061
   TAGUCHI K, 1995, CHEM LETT, P701, DOI 10.1246/cl.1995.701
   Takenaka S, 2000, ANAL CHEM, V72, P1334, DOI 10.1021/ac991031j
   Tamagawa H, 1997, J PHYS CHEM B, V101, P4817, DOI 10.1021/jp9700600
   Tan JL, 2002, LANGMUIR, V18, P519, DOI 10.1021/la011351+
   TANAKA M, 1994, THIN SOLID FILMS, V244, P832, DOI 10.1016/0040-6090(94)90581-9
   TANEVA S, 1989, LANGMUIR, V5, P111, DOI 10.1021/la00085a020
   TANEVA S, 1989, J COLLOID INTERF SCI, V131, P561, DOI 10.1016/0021-9797(89)90198-7
   TAYLOR DM, 1989, CHEM PHYS LETT, V161, P147, DOI 10.1016/0009-2614(89)85047-X
   TIEKE B, 1991, ADV MATER, V3, P532, DOI 10.1002/adma.19910031103
   Tiourina OP, 2001, MACROMOL BIOSCI, V1, P209, DOI 10.1002/1616-5195(20010701)1:5<209::AID-MABI209>3.0.CO;2-Y
   Trau D, 2002, ANAL CHEM, V74, P5480, DOI 10.1021/ac0200522
   TSANG VCW, 1984, J IMMUNOL METHODS, V70, P91, DOI 10.1016/0022-1759(84)90393-4
   Vareiro MLM, 2005, ANAL CHEM, V77, P2426, DOI 10.1021/ac0482460
   Vinu A, 2005, J NANOSCI NANOTECHNO, V5, P347, DOI 10.1166/jnn.2005.089
   Vinu A, 2005, J PHYS CHEM B, V109, P6436, DOI 10.1021/jp050454o
   WALTON AG, 1981, POLYPEPTIDES PROTEIN, P36
   Wang J, 2000, NUCLEIC ACIDS RES, V28, P3011, DOI 10.1093/nar/28.16.3011
   Wang J, 1999, CHEM-EUR J, V5, P1681, DOI 10.1002/(SICI)1521-3765(19990604)5:6<1681::AID-CHEM1681>3.0.CO;2-U
   Wang YJ, 2004, ADV FUNCT MATER, V14, P1012, DOI 10.1002/adfm.200400144
   Wang YJ, 2005, CHEM MATER, V17, P953, DOI 10.1021/cm0483137
   Washmon-Kriel L, 2000, J MOL CATAL B-ENZYM, V10, P453, DOI 10.1016/S1381-1177(99)00123-X
   WEBB TH, 1993, CHEM SOC REV, V22, P383, DOI 10.1039/cs9932200383
   Wei JJ, 2004, J PHYS CHEM B, V108, P16912, DOI 10.1021/jp048148i
   Wei Y, 2001, J NANOSCI NANOTECHNO, V1, P83, DOI 10.1166/jnn.2001.014
   Weng S, 2002, PROTEOMICS, V2, P48, DOI 10.1002/1615-9861(200201)2:1<48::AID-PROT48>3.0.CO;2-I
   Werts MHV, 2002, NANO LETT, V2, P43, DOI 10.1021/nl015629u
   WILLIAMS DG, 1984, J IMMUNOL METHODS, V72, P261, DOI 10.1016/0022-1759(84)90454-X
   WILLNER I, 1994, ANAL CHEM, V66, P1535, DOI 10.1021/ac00081a028
   Wood KC, 2005, LANGMUIR, V21, P1603, DOI 10.1021/la0476480
   Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153
   Yamada N, 2000, COLLOID SURFACE A, V169, P271, DOI 10.1016/S0927-7757(00)00442-8
   Yamada N, 2000, SYNLETT, P575
   Yamada N, 1998, J AM CHEM SOC, V120, P12192, DOI 10.1021/ja981363q
   YAMAZAKI I, 1995, PURE APPL CHEM, V67, P209, DOI 10.1351/pac199567010209
   YAMAZAKI I, 1987, J PHYS CHEM-US, V91, P3572, DOI 10.1021/j100297a021
   YAMAZAKI I, 1988, J PHYS CHEM-US, V92, P5035, DOI 10.1021/j100328a041
   Yang GZ, 2004, J NANOSCI NANOTECHNO, V4, P561, DOI 10.1166/jnn.2004.008
   Yoo D, 1998, MACROMOLECULES, V31, P4309, DOI 10.1021/ma9800360
   Zhang JT, 2004, LANGMUIR, V20, P8015, DOI 10.1021/la048888i
   Zhang Q, 2003, STUD SURF SCI CATAL, V146, P465
   Zhang QM, 2004, J AM CHEM SOC, V126, P988, DOI 10.1021/ja0395l5r
   Zhang XX, 1997, CHEM REV, V97, P3313, DOI 10.1021/cr960144p
   Zhou LP, 2003, J AM CHEM SOC, V125, P1431, DOI 10.1021/ja0290274
   Zhou XC, 2004, LANGMUIR, V20, P8877, DOI 10.1021/la048950b
   Zhou YL, 2002, LANGMUIR, V18, P211, DOI 10.1021/la010834a
NR 358
TC 108
Z9 110
U1 4
U2 154
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD AUG
PY 2006
VL 6
IS 8
BP 2278
EP 2301
DI 10.1166/jnn.2006.503
PG 24
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 073ZD
UT WOS:000239780500005
PM 17037834
DA 2018-10-19
ER

PT J
AU De Bartolo, L
   Morelli, S
   Rende, M
   Salerno, S
   Giorno, L
   Lopez, LC
   Favia, P
   d'Agostino, R
   Drioli, E
AF De Bartolo, Loredana
   Morelli, Sabrina
   Rende, Maria
   Salerno, Simona
   Giorno, Lidietta
   Lopez, Linda C.
   Favia, Pietro
   d'Agostino, Riccardo
   Drioli, Enrico
TI Galactose derivative immobilized glow discharge processed
   polyethersulfone membranes maintain the liver cell metabolic activity
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE membrane; plasma modification; galactose derivative immobilization;
   human hepatocytes; liver specific functions; drug biotransformation
ID RAT HEPATOCYTES; MODIFIED POLYMERS; PLASMA; CULTURE; ADHESION;
   EXPRESSION; SURFACES; COATINGS; FIBRONECTIN; BIOREACTORS
AB New strategies aimed to surface modification of polymeric membranes are crucial to optimise cell-biomaterial interactions in vivo and in vitro biohybrid systems. In this paper, we investigated the surface modification of Polyethersulfone (PES) membranes by plasma polymerisation of acrylic acid monomers (PES-pdAA) and by immobilization of galactonic acid through a hydrophilic "spacer arm" molecule (PES-pdAA-SA-GAL). The modification steps were characterised by high resolution X-ray photoelectron spectroscopy. The performance of modified and unmodified membranes was evaluated by assessing the expression of liver specific biotransformation functions of pig and human hepatocytes. Human liver cells cultured on PES-pdAA-SA-GAL membranes displayed an enhanced albumin production, urea synthesis and protein secretion for 24 days of culture. The immobilisation of galactose derivative units on the membrane allowed specific interactions with hepatocytes biomimicking the cellular microenvironment and produced an improvement of the long-term maintenance and differentiation of human hepatocytes.
C1 Univ Calabria, CNR, ITM, I-87030 Arcavacata Di Rende, CS, Italy.
   Univ Calabria, Dept Pharmacobiol, I-87030 Arcavacata Di Rende, CS, Italy.
   Univ Bari, Dept Chem, I-70126 Bari, Italy.
RP De Bartolo, L (reprint author), Univ Calabria, CNR, ITM, Via P Bucci Cubo 17-C, I-87030 Arcavacata Di Rende, CS, Italy.
RI Salerno, Simona/F-1230-2016; De Bartolo, Loredana/E-5074-2015; Giorno,
   Lidietta/I-7824-2013
OI Salerno, Simona/0000-0001-8178-8837; De Bartolo,
   Loredana/0000-0003-3774-9114; Giorno, Lidietta/0000-0002-4408-5849;
   MORELLI, SABRINA/0000-0001-7551-8427; Drioli, Enrico/0000-0003-1092-5368
CR Bader A, 2000, J BIOTECHNOL, V81, P95, DOI 10.1016/S0168-1656(00)00233-9
   BENZEEV A, 1988, P NATL ACAD SCI USA, V85, P2161, DOI 10.1073/pnas.85.7.2161
   BISSELL DM, 1986, EUR J CELL BIOL, V40, P72
   d'Agostino R, 2005, PLASMA PROCESS POLYM, V2, P7, DOI 10.1002/ppap.200400074
   Dai LM, 2000, SURF INTERFACE ANAL, V29, P46, DOI 10.1002/(SICI)1096-9918(200001)29:1<46::AID-SIA692>3.0.CO;2-6
   De Bartolo L, 2005, BIOMATERIALS, V26, P4432, DOI 10.1016/j.biomaterials.2004.11.009
   De Bartolo L, 2004, BIOMATERIALS, V25, P3621, DOI 10.1016/j.biomaterials.2003.10.042
   De Bartolo L, 1999, J BIOMAT SCI-POLYM E, V10, P641, DOI 10.1163/156856299X00856
   De Bartolo L, 2000, BIOTECHNOL PROGR, V16, P102, DOI 10.1021/bp990128o
   De Bartolo L, 2002, BIOMATERIALS, V23, P2485, DOI 10.1016/S0142-9612(01)00383-0
   Detomaso L, 2005, BIOMATERIALS, V26, P3831, DOI 10.1016/j.biomaterials.2004.10.011
   Favia P, 2002, J PHOTOPOLYM SCI TEC, V15, P341
   Gancarz I, 2003, EUR POLYM J, V39, P2217, DOI 10.1016/S0014-3057(03)00160-5
   GERLACH J, 1989, INT J ARTIF ORGANS, V12, P788
   GUILLOUZO A, 1990, TOXICOL IN VITRO, V4, P415, DOI 10.1016/0887-2333(90)90092-8
   Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   Kang E. T., 2002, ENCY SURFACE COLLOID, P2320
   Kern A, 1997, BIOCHEM PHARMACOL, V54, P761, DOI 10.1016/S0006-2952(97)00204-9
   LeCluyse EL, 1996, ADV DRUG DELIVER REV, V22, P133, DOI 10.1016/S0169-409X(96)00418-8
   Lopez LC, 2005, SURF COAT TECH, V200, P1000, DOI 10.1016/j.surfcoat.2005.02.003
   Lopina ST, 1996, BIOMATERIALS, V17, P559, DOI 10.1016/0142-9612(96)88706-0
   LU HF, 2003, BIOMATERIALS, V24, P93
   Moore S, 1940, J BIOL CHEM, V133, P293
   Quirk RA, 2003, BIOTECHNOL BIOENG, V81, P625, DOI 10.1002/bit.10502
   Sanchez A, 2000, J HEPATOL, V32, P242, DOI 10.1016/S0168-8278(00)80069-0
   Swaminathan CP, 2000, J BIOL CHEM, V275, P28483, DOI 10.1074/jbc.M004685200
   Tseng WW, 2002, J GASTROINTEST SURG, V6, P838, DOI 10.1016/S1091-255X(02)00061-6
   Woolf E, 1999, J CHROMATOGR B, V730, P221, DOI 10.1016/S0378-4347(99)00215-7
   Yang J, 2002, BIOMATERIALS, V23, P2607, DOI 10.1016/S0142-9612(01)00400-8
   Yin C, 2003, J BIOMED MATER RES A, V67A, P1093, DOI 10.1002/jbm.a.10033
   Ying L, 2003, BIOMACROMOLECULES, V4, P157, DOI 10.1021/bm025676w
NR 32
TC 17
Z9 18
U1 0
U2 6
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD AUG
PY 2006
VL 6
IS 8
BP 2344
EP 2353
DI 10.1166/jnn.2006.514
PG 10
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 073ZD
UT WOS:000239780500011
PM 17037840
DA 2018-10-19
ER

PT J
AU Andersson, J
   Johannessen, E
   Areva, S
   Jarn, M
   Linden, M
AF Andersson, Jenny
   Johannessen, Espen
   Areva, Sami
   Jarn, Mikael
   Linden, Mika
TI Wet powder processing of sol-gel derived mesoporous
   silica-hydroxyapatite hybrid powders
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Article
DE porous silica; sol-gel method; hybrid materials
ID DISSOLUTION; SURFACE; SIZE
AB This paper describes a method by which a porous silica coating layer can be obtained on different apatite particles through a simple sol-gel synthesis route. Sol-gel derived powders of hydroxyapatite (HAP) and beta tricalciumphosphate (beta-TCP) were coated with a mesoporous silica using C(16)TAB (hexadecyltrimethylammonium bromide) as a template in order to induce mesophase formation. Further calcination of the material removes the template from the mesophase and leaves a highly ordered hexagonal arranged mesoporous silica structure with a core of HAP/beta-TCP. The phase purity of the SiO2/apatite composites has been thoroughly investigated by the means of FT-IR, XRD, and solid state P-31 MAS NMR. The phase purity of these materials is shown to be dependent on the solubility properties of the used apatites. The hybrid materials are suitable as a multifunctional biomaterial where osteoconductive properties can be combined with drug delivery.
C1 Abo Akad Univ, Dept Phys Chem, FIN-20500 Turku, Finland.
RP Linden, M (reprint author), Abo Akad Univ, Dept Phys Chem, Porthansgatan 3-5, FIN-20500 Turku, Finland.
CR Andersson J, 2005, BIOMATERIALS, V26, P6827, DOI 10.1016/j.biomaterials.2005.05.002
   Andersson J, 2004, CHEM MATER, V16, P4160, DOI 10.1021/cm0401490
   BECK JS, 1992, J AM CHEM SOC, V114, P10834, DOI 10.1021/ja00053a020
   Borum L, 2003, BIOMATERIALS, V24, P3681, DOI 10.1016/S0142-9612(03)00240-0
   Cazalbou S, 2004, J MATER CHEM, V14, P2148, DOI 10.1039/b401318b
   Conz Marcio Baltazar, 2005, J. Appl. Oral Sci., V13, P136, DOI 10.1590/S1678-77572005000200008
   DAVIS ME, 1993, NATURE, V364, P391, DOI 10.1038/364391a0
   Gallardo J, 2002, BIOMATERIALS, V23, P4277, DOI 10.1016/S0142-9612(02)00190-4
   Grun M, 1997, ADV MATER, V9, P254, DOI 10.1002/adma.19970090317
   HENCH LL, 1973, J BIOMED MATER RES, V7, P25, DOI 10.1002/jbm.820070304
   KRESGE CT, 1992, NATURE, V359, P710, DOI 10.1038/359710a0
   Landau MV, 1999, MICROPOR MESOPOR MAT, V33, P149, DOI 10.1016/S1387-1811(99)00133-X
   LI PJ, 1992, J AM CERAM SOC, V75, P2094, DOI 10.1111/j.1151-2916.1992.tb04470.x
   Lind A, 2002, LANGMUIR, V18, P1380, DOI 10.1021/la011240a
   LIND A, 2001, COLLOID SURFACE A, V415, P183
   Ozin GA, 1997, ADV MATER, V9, P662, DOI 10.1002/adma.19970090817
   Patarin J, 2002, CURR OPIN COLLOID IN, V7, P107, DOI 10.1016/S1359-0294(02)00012-2
   PEREIRA MM, 1995, J AM CERAM SOC, V78, P2463, DOI 10.1111/j.1151-2916.1995.tb08686.x
   Roelofs F, 2004, J PHYS CHEM B, V108, P11308, DOI 10.1021/jp048767r
   Schuth F, 2002, ADV MATER, V14, P629, DOI 10.1002/1521-4095(20020503)14:9<629::AID-ADMA629>3.0.CO;2-B
   Soler-Illia GJDA, 2003, CURR OPIN COLLOID IN, V8, P109, DOI 10.1016/S1359-0294(03)00002-5
   Tang RK, 2004, J MATER CHEM, V14, P2341, DOI 10.1039/b401097c
   Tas AC, 2000, BIOMATERIALS, V21, P1429
NR 23
TC 6
Z9 6
U1 2
U2 19
PU AMER SCIENTIFIC PUBLISHERS
PI STEVENSON RANCH
PA 25650 NORTH LEWIS WAY, STEVENSON RANCH, CA 91381-1439 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD AUG
PY 2006
VL 6
IS 8
BP 2438
EP 2444
DI 10.1166/jnn.2006.515
PG 7
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 073ZD
UT WOS:000239780500024
PM 17037853
DA 2018-10-19
ER

PT J
AU Skrabal, CA
   Choi, YH
   Kaminski, A
   Steiner, M
   Kundt, G
   Steinhoff, G
   Liebold, A
AF Skrabal, Christian A.
   Choi, Yeong H.
   Kaminski, Alexander
   Steiner, Michael
   Kundt, Guenther
   Steinhoff, Gustav
   Liebold, Andreas
TI Circulating endothelial cells demonstrate an attenuation of endothelial
   damage by minimizing the extracorporeal circulation
SO JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
LA English
DT Article
ID SYSTEMIC INFLAMMATORY RESPONSE; SURGEONS NATIONAL DATABASE;
   CARDIOPULMONARY BYPASS; PLATELET ACTIVATION; CARDIOTOMY SUCTION;
   FUTURE-DIRECTIONS; CARDIAC-SURGERY; ROLLER-PUMP; BIOMATERIAL;
   CENTRIFUGAL
AB Objective: Detachment of endothelial cells may represent serious injury of the endothelium after cardiopulmonary bypass. We investigated whether the extent of endothelial injury is related to the type of cardiopulmonary bypass system used ( conventional or minimized) and determined circulating endothelial cells as well as von Willebrand factor and soluble thrombomodulin.
   Methods: Twenty patients scheduled for elective coronary bypass grafting were randomly assigned to either the minimal extracorporeal circulation system or the standard cardiopulmonary bypass. Ten healthy volunteers served as controls. Circulating endothelial cells per milliliter of full blood were perioperatively determined by immunomagnetic cell separation technique. Endothelial plasma markers were measured by enzyme-linked immunosorbent assay.
   Results: Preoperative circulating endothelial cell numbers did not differ between the experimental groups, but were significantly higher than in the healthy controls (18.6 +/- 5.6 vs 7.2 +/- 3.8, P <.001). At 6 hours, circulating endothelial cell numbers increased significantly compared with baseline in both experimental groups and peaked at 12 hours after cardiopulmonary bypass initiation, each time with significantly lower values in the minimal extracorporeal circulation group ( 6 hours: 44.0 +/- 9.9 vs 29.6 +/- 9.8, P =.007; 12 hours: 48.1 +/- 6.8 vs 31.8 +/- 7.1, P <.001). Likewise, von Willebrand factor and soluble thrombomodulin postoperatively increased in both groups with a tendency toward lower levels in the minimal extracorporeal circulation group. Although circulating endothelial cells gradually declined, continually with lower numbers in the minimal extracorporeal circulation group, the endothelial plasma markers remained elevated during observation time.
   Conclusions: Circulating endothelial cells represent a novel marker of the intrinsic endothelial damage caused by cardiopulmonary bypass. Its analysis facilitates the evaluation of cardiopulmonary bypass modifications as the minimal extracorporeal circulation system could be proven to be less injurious to endothelium and myocardium.
C1 Univ Rostock, Dept Cardiac Surg, Inst Clin Chem & Lab Med, D-18057 Rostock, Germany.
   Univ Rostock, Inst Med Informat & Biometry, Rostock, Germany.
RP Skrabal, CA (reprint author), Univ Rostock, Dept Cardiac Surg, Inst Clin Chem & Lab Med, Schillingallee 35, D-18057 Rostock, Germany.
EM cskrabal@fastmail.fm
CR Aldea GS, 2002, J THORAC CARDIOV SUR, V123, P742, DOI 10.1067/mtc.2002.120347
   Andersen KS, 2003, SCAND CARDIOVASC J, V37, P356, DOI 10.1080/14017430310015523
   Ascione R, 2000, ANN THORAC SURG, V69, P1198, DOI 10.1016/S0003-4975(00)01152-8
   Asimakopoulos G, 1999, PERFUSION-UK, V14, P269, DOI 10.1177/026765919901400406
   Bardin N, 1996, TISSUE ANTIGENS, V48, P531, DOI 10.1111/j.1399-0039.1996.tb02666.x
   Chong AY, 2004, CIRCULATION, V110, P1794, DOI 10.1161/01.CIR.0000143073.60937.50
   Conway DSG, 2003, CIRCULATION, V107, P3141, DOI 10.1161/01.CIR.0000077912.12202.FC
   Dignat-George F, 2000, EUR J HAEMATOL, V65, P215, DOI 10.1034/j.1600-0609.2000.065004215.x
   Fromes Y, 2002, EUR J CARDIO-THORAC, V22, P527, DOI 10.1016/S1010-7940(02)00372-X
   Gong J, 1996, J CLIN IMMUNOL, V16, P222, DOI 10.1007/BF01541228
   Gourlay T, 2003, PERFUSION-UK, V18, P87, DOI 10.1191/0267659103pf648oa
   Grover FL, 1999, ANN THORAC SURG, V68, P367, DOI 10.1016/S0003-4975(99)00599-8
   Grover FW, 1999, ANN THORAC SURG, V68, P374
   Haubitz M, 2004, INTERNAL MED, V43, P660, DOI 10.2169/internalmedicine.43.660
   KIRKLIN JK, 1983, J THORAC CARDIOV SUR, V86, P845
   Linneweber J, 2002, INT J ARTIF ORGANS, V25, P549
   McClung JA, 2005, DIABETOLOGIA, V48, P345, DOI 10.1007/s00125-004-1647-5
   Mutin M, 1999, BLOOD, V93, P2951
   Paparella D, 2002, EUR J CARDIO-THORAC, V21, P232, DOI 10.1016/S1010-7940(01)01099-5
   Parolari A, 2000, EUR J CARDIO-THORAC, V18, P575, DOI 10.1016/S1010-7940(00)00552-2
   Salomaa V, 1999, LANCET, V353, P1729, DOI 10.1016/S0140-6736(98)09057-6
   Scholz M, 2004, J INVEST SURG, V17, P143, DOI 10.1080/08941930490446928
   Solovey A, 1997, NEW ENGL J MED, V337, P1584, DOI 10.1056/NEJM199711273372203
   Westerberg M, 2004, ANN THORAC SURG, V78, P54, DOI 10.1016/j.athoracsur.2003.12.029
   Wierzbowska A, 2005, EUR J HAEMATOL, V75, P492, DOI 10.1111/j.1600-0609.2005.00549.x
   Wiesenack C, 2004, ARTIF ORGANS, V28, P1082, DOI 10.1111/j.1525-1594.2004.00030.x
   Woywodt A, 2004, ANN HEMATOL, V83, P491, DOI 10.1007/s00277-004-0878-3
   Woywodt A, 2003, TRANSPLANTATION, V76, P1, DOI 10.1097/01.TP.0000074569.65127.26
   Woywodt A, 2003, LANCET, V361, P206, DOI 10.1016/S0140-6736(03)12269-6
   Woywodt A, 2002, NEPHROL DIAL TRANSPL, V17, P1728, DOI 10.1093/ndt/17.10.1728
NR 30
TC 23
Z9 25
U1 0
U2 0
PU MOSBY, INC
PI ST LOUIS
PA 11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA
SN 0022-5223
J9 J THORAC CARDIOV SUR
JI J. Thorac. Cardiovasc. Surg.
PD AUG
PY 2006
VL 132
IS 2
BP 291
EP 296
DI 10.1016/j.jtcvs.2006.03.017
PG 6
WC Cardiac & Cardiovascular Systems; Respiratory System; Surgery
SC Cardiovascular System & Cardiology; Respiratory System; Surgery
GA 070UF
UT WOS:000239549700017
PM 16872952
OA Bronze
DA 2018-10-19
ER

PT J
AU O'Shaughnessy, WS
   Gao, ML
   Gleason, KK
AF O'Shaughnessy, W. Shannan
   Gao, Meiling
   Gleason, Karen K.
TI Initiated chemical vapor deposition of trivinyltrimethylcyclotrisiloxane
   for biomaterial coatings
SO LANGMUIR
LA English
DT Article
ID METHACRYLATE) THIN-FILMS; PLASMA; POLYMERS; HEXAMETHYLCYCLOTRISILOXANE;
   POLYMERIZATION; METHYLSILANE; PLATELETS; PARYLENE; CVD
AB Organosilicon polymers show great utility as both biocompatible and electrically insulating materials. In this work, thin films of a novel organosilicon polymer are synthesized by initiated chemical vapor deposition utilizing trivinyltrimethylcyclotrisiloxane as a monomer and tert-butyl peroxide as a free-radical-generating initiator. Use of an initiator allows for the formation of polymer films at filament temperatures as low as 250 degrees C, significantly lower than those required to thermally polymerize the monomer species. The mild reaction conditions allow for the retention of all siloxane ring moieties within the resulting polymer. Films deposited at filament temperatures of 600 degrees C or higher exhibit damage to this moiety. The all-dry deposition process generates a highly cross-linked matrix material in which over 95% of the vinyl moieties present on the monomer units have been reacted out to form linear polymerized hydrocarbon chains. While each hydrocarbon backbone chain averages 8.9 monomer units in length, as evaluated by X-ray photoelectron spectroscopy analysis, each monomer unit is involved in three independent chains, resulting in polymer films of such high molecular weight that they are completely insoluble. Kinetic analysis of the deposition process indicates that the film formation rate is limited by the adsorption of reactive species to the deposition substrate, with an apparent activation energy of -23.2 kJ/mol with respect to the substrate temperature. These results are consistent with a surface growth mechanism, ideal for the coating of nonuniform or high aspect ratio substrates.
C1 MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
RP Gleason, KK (reprint author), MIT, Dept Chem Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM kkg@mit.edu
RI Gleason, Karen/G-1471-2013
OI Gleason, Karen/0000-0001-6127-1056
FU NINDS NIH HHS [N01 NS 22347]
CR Belanger MC, 2001, J BIOMED MATER RES, V58, P467, DOI 10.1002/jbm.1043
   Casserly TB, 2005, PLASMA PROCESS POLYM, V2, P679, DOI 10.1002/ppap.200500055
   Chan K, 2005, CHEM VAPOR DEPOS, V11, P437, DOI 10.1002/cvde.200506381
   Chan K, 2005, LANGMUIR, V21, P8930, DOI 10.1021/la051004q
   CHAWLA AS, 1981, BIOMATERIALS, V2, P83, DOI 10.1016/0142-9612(81)90004-1
   Chu PK, 2002, MAT SCI ENG R, V36, P143, DOI 10.1016/S0927-796X(02)00004-9
   *COBL SOC, 2005, NIST CHEM WEBB
   Favia P, 1998, SURF COAT TECH, V98, P1102, DOI 10.1016/S0257-8972(97)00285-5
   Fogler H. S., 1999, ELEMENTS CHEM REACTI
   Furusawa T, 2001, J ELECTROCHEM SOC, V148, pF175, DOI 10.1149/1.1386916
   Ganguli S, 1997, J VAC SCI TECHNOL A, V15, P3138, DOI 10.1116/1.580858
   HENCH LL, 1982, BIOMATERIALS INTERFA
   ISHIKAWA Y, 1985, MAKROMOL CHEM-RAPID, V6, P495
   Lau KKS, 2000, J FLUORINE CHEM, V104, P119, DOI 10.1016/S0022-1139(00)00234-7
   LAU KKS, IN PRESS MACROMOLECU
   Lewis HGP, 2000, CHEM MATER, V12, P3488
   LEWIS HGP, 2001, J ELECTROCHEM SOC, V148, pF242
   Limb SJ, 1997, J VAC SCI TECHNOL A, V15, P1814, DOI 10.1116/1.580796
   Lin-Vien D., 1991, HDB INFRARED RAMAN C
   MA R, 1992, INORG CHEM, V31, P1925, DOI 10.1021/ic00036a037
   Mao Y, 2004, LANGMUIR, V20, P2484, DOI 10.1021/la0359427
   Mekarbane PG, 1999, MACROMOLECULES, V32, P3620, DOI 10.1021/ma981917+
   Murthy SK, 2002, LANGMUIR, V18, P6424, DOI 10.1021/la025815v
   ODIAN G, 1991, PRINCIPLES POLYM
   Pierson H. O., 1999, HDB CHEM VAPOR DEPOS
   RATNR BD, 1987, J BIOMED MATER RES-A, V21, P59
   Rogojevic S, 1999, J VAC SCI TECHNOL A, V17, P266, DOI 10.1116/1.581544
   Wu QG, 2003, J VAC SCI TECHNOL A, V21, P388, DOI 10.1116/1.1539086
   Wu QG, 2003, PLASMAS POLYM, V8, P31, DOI 10.1023/A:1022813808367
   YASUDA H, 1977, J POLYM SCI POL CHEM, V15, P81, DOI 10.1002/pol.1977.170150109
   Yasuda H., 1985, PLASMA POLYM
NR 31
TC 48
Z9 49
U1 7
U2 33
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD AUG 1
PY 2006
VL 22
IS 16
BP 7021
EP 7026
DI 10.1021/la0607858
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 066OB
UT WOS:000239238100048
PM 16863255
DA 2018-10-19
ER

PT J
AU Kurosu, S
   Nomura, N
   Chiba, A
AF Kurosu, Shingo
   Nomura, Naoyuki
   Chiba, Akihiko
TI Effect of sigma phase in Co-29Cr-6Mo alloy on corrosion behavior in
   saline solution
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE cobalt-chromium-molybdenum alloy; biomaterial; metal ion release;
   corrosion; sigma phase (sigma); isothermal aging treatment
ID FORGED LOW-NI; CR-MO ALLOYS; MECHANICAL-PROPERTIES; LOCALIZED CORROSION;
   IMPLANT ALLOY; MICROSTRUCTURE
AB Effect of the sigma (or) phase in Co-29Cr-6Mo alloy on corrosion behavior in saline solution has been investigated. The area fraction of the a phase contained in Co-29Cr-6Mo alloy varies depending on the aging time at 1023 K. The a phase is mainly observed at grain boundaries. The area fraction of the or phase increases with increasing aging time and reaches 0.6% after aging at 1023 K for 21.6 ks. The Co-29Cr-6Mo alloys aged at 1023 K for various aging times were immersed in saline solution at 3 10 K for I week and metal ions released from the alloys were examined by inductively coupled plasma atomic emission spectrometer (ICP-AES). The quantity of a released Co ion does not depend on the aging time and shows almost the same value regardless of the different area fraction of the or phase, while that of released Cr, Mo and Ni ions increases with increasing area fraction of the a phase. Results of polarization test in saline solution at 3 10 K revealed that passive current density and breakdown potential of Co-29Cr-6Mo alloys aged at 1023 K for various aging times exhibit almost the same values, although the alloys have different area fraction of the or phase. These results suggest that a small amount of the a phase (< 0.6%) hardly affect the formation and breakdown of passive film in the Co-29Cr-6Mo alloy aged at 1023 K.
C1 Iwate Univ, Grad Sch Engn, Dept Mat Sci, Morioka, Iwate 0208551, Japan.
   Iwate Univ, Fac Engn, Dept Welf Engn, Morioka, Iwate 0208551, Japan.
RP Kurosu, S (reprint author), Iwate Univ, Grad Sch Engn, Dept Mat Sci, Morioka, Iwate 0208551, Japan.
RI NOMURA, Naoyuki/L-7149-2017; Chiba, Akihiko/D-1326-2011
CR AGUILAR MAD, IN PRESS CORROS SCI
   Angelini E, 2004, CORROS SCI, V46, P1351, DOI 10.1016/j.corsci.2003.09.024
   Borgenstam A, 2000, ACTA MATER, V48, P2765, DOI 10.1016/S1359-6454(00)00102-6
   Chiba A, 2005, MATER SCI FORUM, V475-479, P2317, DOI 10.4028/www.scientific.net/MSF.475-479.2317
   GARCIA AJS, 2005, J BIOMED MATER RES A, V74, P269
   Hiromoto S, 2005, BIOMATERIALS, V26, P4912, DOI 10.1016/j.biomaterials.2005.01.028
   HOLLEK H, 1995, HDB TERNARY ALLOY PH, V6
   Kurosu S, 2005, J JPN I MET, V69, P886, DOI 10.2320/jinstmet.69.886
   Lee SH, 2006, MATER TRANS, V47, P287, DOI 10.2320/matertrans.47.287
   Lee SH, 2005, MATER TRANS, V46, P1790, DOI 10.2320/matertrans.46.1790
   Park CJ, 2006, MAT SCI ENG A-STRUCT, V418, P211, DOI 10.1016/j.msea.2005.11.053
   Silverman R., 1957, T ASM, V49, P805
NR 12
TC 12
Z9 12
U1 0
U2 7
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD AUG
PY 2006
VL 47
IS 8
BP 1961
EP 1964
DI 10.2320/matertrans.47.1961
PG 4
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 093FG
UT WOS:000241152800023
OA Bronze
DA 2018-10-19
ER

PT J
AU Kwon, OS
   Park, HH
   Lee, OY
   Lee, MH
AF Kwon, Oh-Seong
   Park, Hyeoung-Ho
   Lee, Oh-Yon
   Lee, Min-Ho
TI Evaluation of cell toxicity and surface properties of surface modified
   Ti and Ti alloys
SO MATERIALS TRANSACTIONS
LA English
DT Article
DE biomaterial; anodizing; hydrothermal treatment; cell toxicity
ID BIOACTIVE TITANIUM METAL; APATITE FORMATION; SHEAR-STRENGTH;
   HYDROXYAPATITE; IMPLANTS; BONE; LAYERS
AB This study was per-formed to investigate the surface properties and cell toxicity of the anodized and hydrothermally treated Ti, Ti-6Al-4V alloy and Ti-6Al-7Nb alloy. Bioactivity was evaluated from the surface activation layers formed on the surface of specimens in simulated body fluid (SBF) for a period of 30 days. Cell toxicity was evaluated based on the optical density of the survival cell. The porous oxide films were formed on all of the specimens by anodic oxidation. The oxide films of Ti were composed of strong anatase peaks without rutile peaks, Ti-6Al-4V alloy was composed of weak anatase peaks and weak rutile peaks and Ti-6Al-7Nb alloy was composed of strong anatase peaks and weak rutile peaks. The oxide films of all of the specimens exhibited an increase in the intensity of anatase peaks after hydrothermal treatment. The surface activation layers were formed only on the oxide films of Ti-6Al-7Nb alloy, also this alloy presented a significantly higher optical density than Ti and Ti-6Al-4V alloy on the MTT assay for cell toxicity evaluation.
C1 Chonbuk Natl Univ, Sch Adv Mat Engn, Jeonju 561756, South Korea.
   Chonbuk Natl Univ, Sch Dent, Dept Dent Biomat, Jeonju 561756, South Korea.
RP Kwon, OS (reprint author), Chonbuk Natl Univ, Sch Adv Mat Engn, Jeonju 561756, South Korea.
CR Ban S, 1996, Dent Mater J, V15, P31
   BRYAN MC, 1976, NATURE, V260, P727
   HANAWA T, 1995, MATER T JIM, V36, P438, DOI 10.2320/matertrans1989.36.438
   HAYASHI K, 1993, J BIOMED MATER RES, V27, P557, DOI 10.1002/jbm.820270502
   Hirata T, 2001, J ORAL REHABIL, V28, P773, DOI 10.1046/j.1365-2842.2001.00737.x
   Iijima D, 2003, BIOMATERIALS, V24, P1519, DOI 10.1016/S0142-9612(02)00533-1
   ISHIZAWA H, 1995, J BIOMED MATER RES, V29, P1071, DOI 10.1002/jbm.820290907
   Kuroiwa A., 1998, J JPN PROSTHODONT SO, V42, P547
   LI PJ, 1994, J BIOMED MATER RES, V28, P7, DOI 10.1002/jbm.820280103
   Long M, 1998, BIOMATERIALS, V19, P1621, DOI 10.1016/S0142-9612(97)00146-4
   MOSSMANN T, 1983, J IMMUNOL METHODS, V65, P55
   Takadama H, 2001, J BIOMED MATER RES, V55, P185, DOI 10.1002/1097-4636(200105)55:2<185::AID-JBM1005>3.3.CO;2-G
   Takadama H, 2001, J BIOMED MATER RES, V57, P441, DOI 10.1002/1097-4636(20011205)57:3<441::AID-JBM1187>3.0.CO;2-B
   WANG BC, 1993, J BIOMED MATER RES, V27, P1315, DOI 10.1002/jbm.820271012
   Yan WQ, 1997, J BIOMED MATER RES, V37, P267, DOI 10.1002/(SICI)1097-4636(199711)37:2<267::AID-JBM17>3.0.CO;2-B
NR 15
TC 1
Z9 1
U1 1
U2 6
PU JAPAN INST METALS
PI SENDAI
PA 1-14-32, ICHIBANCHO, AOBA-KU, SENDAI, 980-8544, JAPAN
SN 1345-9678
EI 1347-5320
J9 MATER TRANS
JI Mater. Trans.
PD AUG
PY 2006
VL 47
IS 8
BP 2033
EP 2037
DI 10.2320/matertrans.47.2033
PG 5
WC Materials Science, Multidisciplinary; Metallurgy & Metallurgical
   Engineering
SC Materials Science; Metallurgy & Metallurgical Engineering
GA 093FG
UT WOS:000241152800034
OA Bronze
DA 2018-10-19
ER

PT J
AU Rodriguez-Martinez, JM
   Pascual, A
AF Rodriguez-Martinez, Jose M.
   Pascual, Alvaro
TI Antimicrobial resistance in bacterial biofilms
SO REVIEWS IN MEDICAL MICROBIOLOGY
LA English
DT Article
DE antimicrobial; biofilms; infection; biomaterials; resistance
ID QUORUM-SENSING INHIBITORS; PSEUDOMONAS-AERUGINOSA BIOFILMS; LATEX
   URINARY CATHETERS; FORMING STAPHYLOCOCCUS-EPIDERMIDIS;
   COAGULASE-NEGATIVE STAPHYLOCOCCI; GROWTH-RATE; IN-VITRO; PLASTIC
   CATHETERS; POLYMORPHONUCLEAR LEUKOCYTES; INTERCELLULAR-ADHESION
AB Bacteria can grow by forming a matrix-enclosed biofilm which adheres to a surface, providing some major advantages over the planktonicform of theorganism. The ability to colonize different surfaces is utilized by somebacterial species, leading to significant infections. These range from minor skin complaints to life-threatening systemic infections. Bacteria adhering to implanted medical devices may be the cause of recurrent infection; bacterial persistence and the increasing use of indwelling medical devices has led to a steady increase in device-related bacterial infections. These bacteria are very resistant to antimicrobial therapy and the concentration of drugs required to achieve bactericidal activity may be at a higher order of magnitude than for planktonic bacteria. Different control strategies have been designed to inhibit biofilm formation on medical devices; however, it seems that biornaterial composition may play a role in the development of antimicrobial resistance, depending on the composition of the biomaterial, the bacterial species and the drugs. In this review, we discuss the most important mechanisms related to biofilm resistance to antimicrobial agents and bacterial interaction with medical devices, and their consequences for treatment failure. (c) 2006 Lippincott Williams & Wilkins.
C1 Univ Seville, Dept Microbiol, E-41009 Seville, Spain.
RP Pascual, A (reprint author), Univ Seville, Dept Microbiol, E-41009 Seville, Spain.
EM apascual@us.es
OI Pascual Hernandez, Alvaro/0000-0002-8672-5891
CR Abdi-Ali A, 2006, INT J ANTIMICROB AG, V27, P196, DOI 10.1016/j.ijantimicag.2005.10.007
   Anderl JN, 2003, ANTIMICROB AGENTS CH, V47, P1251, DOI 10.1128/AAC.47.4.1251-1256.2003
   ANWAR H, 1992, CAN J MICROBIOL, V38, P618, DOI 10.1139/m92-102
   Bagge N, 2000, APMIS, V108, P589, DOI 10.1034/j.1600-0463.2000.d01-102.x
   Ballesta S, 2006, J ANTIMICROB CHEMOTH, V57, P1010, DOI 10.1093/jac/dk1072
   BALLESTA S, 2006, 16 EUR C CLIN MICR I
   Bjarnsholt T, 2005, MICROBIOL-SGM, V151, P373, DOI 10.1099/mic.0.27463-0
   Ceri H, 1999, J CLIN MICROBIOL, V37, P1771
   Christensen BB, 1998, APPL ENVIRON MICROB, V64, P2247
   Conejo MC, 2005, INT J ANTIMICROB AG, V26, P96, DOI 10.1016/j.ijantimicag.2005.04.009
   Conejo MC, 2003, INT J ANTIMICROB AG, V22, P122, DOI 10.1016/S0924-8579(03)00119-5
   Conejo MC, 2003, ANTIMICROB AGENTS CH, V47, P2313, DOI 10.1128/AAC.47.7.2313-2315.2003
   Conlon KM, 2002, J BACTERIOL, V184, P4400, DOI 10.1128/JB.184.16.4400-4408.2002
   Coquet L, 1998, J ANTIMICROB CHEMOTH, V42, P755, DOI 10.1093/jac/42.6.755
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   COSTERTON JW, 1987, ANNU REV MICROBIOL, V41, P435, DOI 10.1146/annurev.mi.41.100187.002251
   Cramton SE, 1999, INFECT IMMUN, V67, P5427
   DARVEAU RP, 2000, PERIODONTOL, V1997, P12
   Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295
   DUBAR V, 1990, J ANTIMICROB CHEMOTH, V26, P791, DOI 10.1093/jac/26.6.791
   EVANS DJ, 1990, J ANTIMICROB CHEMOTH, V26, P473, DOI 10.1093/jac/26.4.473
   Field TR, 2005, EUR J CLIN MICROBIOL, V24, P677, DOI 10.1007/s10096-005-0031-9
   Fonseca AP, 2004, J MED MICROBIOL, V53, P903, DOI 10.1099/jmm.0.45637-0
   Fux CA, 2005, TRENDS MICROBIOL, V13, P58, DOI 10.1016/j.tim.2004.11.001
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010
   Ghigo JM, 2001, NATURE, V412, P442, DOI 10.1038/35086581
   Gillis RJ, 2005, ANTIMICROB AGENTS CH, V49, P3858, DOI 10.1128/AAC.49.9.3858-3867.2005
   Gotz F, 2000, INFECT ASS INDWELLIN, P55
   Hatch RA, 1998, ANTIMICROB AGENTS CH, V42, P974, DOI 10.1128/AAC.42.4.974
   Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x
   Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366
   Hyde JAJ, 1998, J HEART VALVE DIS, V7, P316
   Isiklar ZU, 1996, CLIN ORTHOP RELAT R, P184
   Jefferson KK, 2004, J BACTERIOL, V186, P2449, DOI 10.1128/JB.186.8.2449-2456.2004
   Jorgensen J. H., 1999, MANUAL CLIN MICROBIO, P1526
   Jucker BA, 1996, J BACTERIOL, V178, P5472, DOI 10.1128/jb.178.18.5472-5479.1996
   Kaye Donald, 1994, P291
   Lee JY, 2006, J ANTIMICROB CHEMOTH, V57, P1110, DOI 10.1093/jac/dk1098
   Leung JW, 1998, GASTROINTEST ENDOSC, V48, P250, DOI 10.1016/S0016-5107(98)70186-5
   Lim Y, 2004, J BACTERIOL, V186, P722, DOI 10.1128/JB.186.3.722-729.2004
   LOPEZLOPEZ G, 1990, EUR J CLIN MICROBIOL, V9, P324
   Luo HL, 2005, APPL ENVIRON MICROB, V71, P2970, DOI 10.1128/AEM.71.6.2970-2978.2005
   Mah TF, 2003, NATURE, V426, P306, DOI 10.1038/nature02122
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   Martinez-Martinez L, 1991, Enferm Infecc Microbiol Clin, V9, P543
   Martinez-Martinez L, 1999, ANTIMICROB AGENTS CH, V43, P397, DOI 10.1128/AAC.43.2.397
   MARTINEZMARTINEZ L, 1990, J HOSP INFECT, V16, P311, DOI 10.1016/0195-6701(90)90003-7
   McKenney D, 1999, SCIENCE, V284, P1523, DOI 10.1126/science.284.5419.1523
   Molin S, 2003, CURR OPIN BIOTECH, V14, P255, DOI 10.1016/S0958-1669(03)00036-3
   Morris NS, 1999, WORLD J UROL, V17, P345, DOI 10.1007/s003450050159
   Otto M, 2004, FEMS MICROBIOL LETT, V241, P135, DOI 10.1016/j.femsle.2004.11.016
   PASCUAL A, 1988, EUR J CLIN MICROBIOL, V7, P161, DOI 10.1007/BF01963070
   PASCUAL A, 1994, EUR J CLIN MICROBIOL, V13, P515, DOI 10.1007/BF01974647
   PASSERINI L, 1992, CRIT CARE MED, V20, P665, DOI 10.1097/00003246-199205000-00020
   Perron K, 2004, J BIOL CHEM, V279, P8761, DOI 10.1074/jbc.M312080200
   Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000
   Rasmussen TB, 2006, INT J MED MICROBIOL, V296, P149, DOI 10.1016/j.ijmm.2006.02.005
   Rasmussen TB, 2005, J BACTERIOL, V187, P1799, DOI 10.1128/JB.187.5.1799-1814.2005
   Rasmussen TB, 2005, MICROBIOL-SGM, V151, P1325, DOI 10.1099/mic.0.27715-0
   Reisner A, 2006, J BACTERIOL, V188, P3582, DOI 10.1128/JB.188.10.3582-3588.2006
   Rioufol C, 1999, J HOSP INFECT, V43, P203, DOI 10.1053/jhin.1999.0629
   Schuster M, 2006, INT J MED MICROBIOL, V296, P73, DOI 10.1016/j.ijmm.2006.01.036
   Sedor J, 1999, UROL CLIN N AM, V26, P821, DOI 10.1016/S0094-0143(05)70222-6
   Shigeta M, 1997, CHEMOTHERAPY, V43, P137, DOI 10.1159/000239548
   Shih PC, 2002, J ANTIMICROB CHEMOTH, V49, P309, DOI 10.1093/jac/49.2.309
   Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627
   Sorensen SJ, 2005, NAT REV MICROBIOL, V3, P700, DOI 10.1038/nrmicro1232
   Souli M, 1998, ANTIMICROB AGENTS CH, V42, P939, DOI 10.1128/AAC.42.4.939
   Tanaka G, 1999, CHEMOTHERAPY, V45, P28, DOI 10.1159/000007162
   TUOMANEN E, 1986, ANTIMICROB AGENTS CH, V30, P521, DOI 10.1128/AAC.30.4.521
   Turner SL, 2002, FEMS MICROBIOL ECOL, V42, P177, DOI 10.1111/j.1574-6941.2002.tb01007.x
   *VAUD P FPLDWFA, 2000, INF ASS INDW MED DEV
   Wentland EJ, 1996, BIOTECHNOL PROGR, V12, P316, DOI 10.1021/bp9600243
NR 74
TC 24
Z9 26
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0954-139X
J9 REV MED MICROBIOL
JI Rev. Med. Microbiol.
PD AUG
PY 2006
VL 17
IS 3
BP 65
EP 75
PG 11
WC Microbiology
SC Microbiology
GA 142AV
UT WOS:000244621700001
DA 2018-10-19
ER

PT J
AU Person, B
   Kaidar-Person, O
   Wexner, SD
AF Person, Benjamin
   Kaidar-Person, Orit
   Wexner, Steven D.
TI Novel approaches in the treatment of fecal incontinence
SO SURGICAL CLINICS OF NORTH AMERICA
LA English
DT Article
ID RADIOFREQUENCY ENERGY DELIVERY; INJECTABLE SILICONE BIOMATERIAL;
   GLUTEUS-MAXIMUS TRANSPOSITION; VOLUMETRIC TISSUE REDUCTION; ARTIFICIAL
   BOWEL SPHINCTER; SACRAL NERVE-STIMULATION; DYNAMIC GRACILOPLASTY;
   ANAL-SPHINCTER; URINARY-INCONTINENCE; STRESS-INCONTINENCE
AB Patients who have severe fecal incontinence that is not responsive to conservative treatment may be divided broadly into two major categories of surgical approach. Overlapping sphincteroplasty, which is the most prevalent surgical procedure, may offer some benefit to patients who have anatomically identifiable anal sphincter defects, although recent data show that long-term results are moderate to poor. A second group includes incontinent patients who do not have a single, potentially correctable defect. These patients were traditionally treated by construction of a permanent stoma. Fortunately, recent advances in surgical technology have led to several techniques and several surgical alternatives to permanent stoma. This article reviews several of these newer, innovative treatment modalities for fecal incontinence.
C1 Cleveland Clin Florida, Dept Colorectal Surg, Weston, FL 33331 USA.
   Cleveland Clin Fdn, Ohio State Univ Hlth Sci Ctr, Cleveland, OH 44195 USA.
   Univ S Florida, Coll Med, Tampa, FL 33612 USA.
   Florida Atlantic Univ, Charles E Schmidt Coll Med, Dept Biomed Sci, Boca Raton, FL 33431 USA.
RP Wexner, SD (reprint author), Cleveland Clin Florida, Dept Colorectal Surg, 2950 Cleveland Clin Blvd, Weston, FL 33331 USA.
EM wexners@ccf.org
CR BAETEN CGMI, 1991, LANCET, V338, P1163, DOI 10.1016/0140-6736(91)92030-6
   Baeten GMI, 2000, DIS COLON RECTUM, V43, P743, DOI 10.1007/BF02238008
   Chapman AE, 2002, BRIT J SURG, V89, P138, DOI 10.1046/j.1365-2168.2002.02018.x
   CHETWOOD CH, 1902, MED REC, V61, P529
   CHRISTIANSEN J, 1987, LANCET, V2, P244
   Davis K, 2003, ALIMENT PHARM THERAP, V18, P237, DOI 10.1046/j.0269-2813.2003.01668.x
   Dawkins GPC, 1997, BRIT J UROL, V79, P910, DOI 10.1046/j.1464-410X.1997.00184.x
   Deutekom M, 2005, COLORECTAL DIS, V7, P263, DOI 10.1111/j.1463-1318.2005.00772.x
   DEVESA JM, 1992, DIS COLON RECTUM, V35, P339, DOI 10.1007/BF02048111
   Efron JE, 2003, DIS COLON RECTUM, V46, P1606, DOI 10.1097/01.DCR.0000098927.47914.D0
   Ganio E, 2001, DIS COLON RECTUM, V44, P1261, DOI 10.1007/BF02234782
   GUSTAVSON KH, 1964, FED PROC, V23, P613
   Haab F, 1997, J UROLOGY, V157, P1283, DOI 10.1016/S0022-5347(01)64951-6
   Hecht P, 1999, AM J SPORT MED, V27, P761, DOI 10.1177/03635465990270061301
   Jarrett MED, 2004, BRIT J SURG, V91, P1559, DOI 10.1002/bjs.4796
   Kenefick NJ, 2002, GUT, V51, P225, DOI 10.1136/gut.51.2.225
   Kenefick NJ, 2003, BRIT J SURG, V90, P1256, DOI 10.1002/bjs.4196
   KONSTEN J, 1994, BRIT J SURG, V81, P466, DOI 10.1002/bjs.1800810350
   KONSTEN J, 1993, DIS COLON RECTUM, V36, P559, DOI 10.1007/BF02049862
   Kumar D, 1998, BRIT J SURG, V85, P978
   Lightner D, 2001, UROLOGY, V58, P12, DOI 10.1016/S0090-4295(01)01148-7
   Macmillan AK, 2004, DIS COLON RECTUM, V47, P1341, DOI 10.1007/s10350-004-0593-0
   MADOFF RD, 1992, NEW ENGL J MED, V326, P1002
   Madoff RD, 2004, LANCET, V364, P621, DOI 10.1016/S0140-6736(04)16856-6
   Malouf AJ, 2001, DIS COLON RECTUM, V44, P595, DOI 10.1007/BF02234337
   MARCIO J, 1993, DIS COLON RECTUM, V36, P77
   MATZEL KE, 1995, LANCET, V346, P1124, DOI 10.1016/S0140-6736(95)91799-3
   Mavrantonis C, 1998, J CLIN GASTROENTEROL, V27, P108, DOI 10.1097/00004836-199809000-00003
   Mellgren A, 1999, DIS COLON RECTUM, V42, P857, DOI 10.1007/BF02237089
   Miner PB, 2004, GASTROENTEROLOGY, V126, pS8, DOI 10.1053/j.gastro.2003.10.056
   MONGA AK, 1995, BRIT J UROL, V76, P156, DOI 10.1111/j.1464-410X.1995.tb07664.x
   Mundy L, 2004, BRIT J SURG, V91, P665, DOI 10.1002/bjs.4587
   NELSON R, 1995, JAMA-J AM MED ASSOC, V274, P559, DOI 10.1001/jama.274.7.559
   Ortiz H, 2003, INT J COLORECTAL DIS, V18, P349, DOI 10.1007/s00384-002-0472-x
   PEARL RK, 1991, DIS COLON RECTUM, V34, P478, DOI 10.1007/BF02049933
   PETTE D, 1992, REV PHYSIOL BIOCH P, V120, P115, DOI 10.1007/BFb0036123
   PICKRELL KL, 1952, ANN SURG, V135, P853, DOI 10.1097/00000658-195206000-00010
   Powell NB, 1998, CHEST, V113, P1163, DOI 10.1378/chest.113.5.1163
   Richards W O, 2001, J Laparoendosc Adv Surg Tech A, V11, P267, DOI 10.1089/109264201317054546
   Rothbarth J, 2001, DIS COLON RECTUM, V44, P67, DOI 10.1007/BF02234823
   Said B, 2003, ANN OTO RHINOL LARYN, V112, P276, DOI 10.1177/000348940311200315
   Scott F B, 1973, Urology, V1, P252
   SHAFIK A, 1993, INT SURG, V78, P159
   SHAFIK A, 1995, DIS COLON RECTUM, V38, P583, DOI 10.1007/BF02054115
   Steward DL, 2004, LARYNGOSCOPE, V114, P2073, DOI 10.1097/01.mlg.0000149438.35855.af
   Takahashi T, 2003, DIS COLON RECTUM, V46, P711, DOI 10.1097/01.DCR.0000070342.56449.4A
   Takahashi T, 2002, DIS COLON RECTUM, V45, P915, DOI 10.1007/s10350-004-6328-4
   Triadafilopoulos G, 2002, GASTROINTEST ENDOSC, V55, P149, DOI 10.1067/mge.2002.121227
   Triadafilopoulos G, 2001, GASTROINTEST ENDOSC, V53, P407, DOI 10.1067/mge.2001.112843
   Weiss KM, 2002, PERSPECT BIOL MED, V45, P46, DOI 10.1353/pbm.2002.0020
   Wexner SD, 2002, DIS COLON RECTUM, V45, P809, DOI 10.1097/01.DCR.0000017604.54619.64
   Whitehead W E, 2001, Dis Colon Rectum, V44, P131, DOI 10.1007/BF02234835
   WILLIAMS NS, 1991, LANCET, V338, P1166
   Wong WD, 2002, DIS COLON RECTUM, V45, P1139, DOI 10.1097/01.DCR.0000027038.03012.E3
NR 54
TC 1
Z9 1
U1 0
U2 2
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0039-6109
EI 1558-3171
J9 SURG CLIN N AM
JI Surg. Clin.-North Am.
PD AUG
PY 2006
VL 86
IS 4
BP 969
EP +
DI 10.1016/j.suc.2006.06.010
PG 19
WC Surgery
SC Surgery
GA 086CE
UT WOS:000240649900011
PM 16905419
DA 2018-10-19
ER

PT J
AU Laschke, MW
   Harder, Y
   Amon, M
   Martin, I
   Farhadi, J
   Ring, A
   Torio-Padron, N
   Schramm, R
   Rucker, M
   Junker, D
   Haufel, JM
   Carvalho, C
   Heberer, M
   Germann, G
   Vollmar, B
   Menger, MD
AF Laschke, Matthias W.
   Harder, Yves
   Amon, Michaela
   Martin, Ivan
   Farhadi, Jian
   Ring, Andrej
   Torio-Padron, Nestor
   Schramm, Rene
   Ruecker, Martin
   Junker, Dominic
   Haeufel, Joerg M.
   Carvalho, Carlos
   Heberer, Michael
   Germann, Gunter
   Vollmar, Brigitte
   Menger, Michael D.
TI Angiogenesis in tissue engineering: Breathing life into constructed
   tissue substitutes
SO TISSUE ENGINEERING
LA English
DT Review
ID ENDOTHELIAL GROWTH-FACTOR; COMPARATIVE IN-VIVO; CHICKEN CHORIOALLANTOIC
   MEMBRANE; MUSCLE MICROVASCULAR RESPONSE; DORSAL SKINFOLD CHAMBER;
   EXTRACELLULAR-MATRIX; INTRAVITAL MICROSCOPY; QUANTITATIVE-ANALYSIS; VEIN
   GRAFTS; POLYMERIC SCAFFOLDS
AB Long-term function of three-dimensional (3D) tissue constructs depends on adequate vascularization after implantation. Accordingly, research in tissue engineering has focused on the analysis of angiogenesis. For this purpose, 2 sophisticated in vivo models (the chorioallantoic membrane and the dorsal skinfold chamber) have recently been introduced in tissue engineering research, allowing a more detailed analysis of angiogenic dysfunction and engraftment failure. To achieve vascularization of tissue constructs, several approaches are currently under investigation. These include the modification of biomaterial properties of scaffolds and the stimulation of blood vessel development and maturation by different growth factors using slow-release devices through pre-encapsulated microspheres. Moreover, new microvascular networks in tissue substitutes can be engineered by using endothelial cells and stem cells or by creating arteriovenous shunt loops. Nonetheless, the currently used techniques are not sufficient to induce the rapid vascularization necessary for an adequate cellular oxygen supply. Thus, future directions of research should focus on the creation of microvascular networks within 3D tissue constructs in vitro before implantation or by co-stimulation of angiogenesis and parenchymal cell proliferation to engineer the vascularized tissue substitute in situ.
C1 Univ Saarland, Inst Clin & Expt Surg, D-66421 Homburg, Germany.
   Univ Bern, Dept Plast & Reconstruct Surg, Bern, Switzerland.
   Univ Basel, Inst Surg Res, Basel, Switzerland.
   Univ Basel, Dept Plast & Reconstruct Surg, Basel, Switzerland.
   Ruhr Univ Bochum, Dept Plast & Hand Surg, Burn Ctr, D-4630 Bochum, Germany.
   Univ Freiburg, Dept Plast & Hand Surg, Freiburg, Germany.
   Hannover Med Sch, Dept Oral & Maxillofacial Surg, Hannover, Germany.
   FMF, Freiburg, Germany.
   Univ Heidelberg, Dept Plast Reconstruct & Hand Surg, Burn Ctr, Ludwigshafen, Germany.
   Univ Rostock, Dept Expt Surg, Rostock, Germany.
RP Laschke, MW (reprint author), Univ Saarland, Inst Clin & Expt Surg, D-66421 Homburg, Germany.
EM matthias.laschke@uniklinik-saarland.de
CR Agrawal CM, 2001, J BIOMED MATER RES, V55, P141, DOI 10.1002/1097-4636(200105)55:2<141::AID-JBM1000>3.0.CO;2-J
   Algire GH, 1943, J NATL CANCER I, V4, P1
   Anderson CR, 2004, J HISTOCHEM CYTOCHEM, V52, P1063, DOI 10.1369/jhc.4a6250.2004j
   Asahara T, 2004, AM J PHYSIOL-CELL PH, V287, pC572, DOI 10.1152/ajpcell.00330.2003
   ASAISHI K, 1981, CANCER RES, V41, P1898
   AUSPRUNK DH, 1986, AM J ANAT, V177, P313, DOI 10.1002/aja.1001770304
   AUSPRUNK DH, 1974, DEV BIOL, V38, P237, DOI 10.1016/0012-1606(74)90004-9
   Badylak SE, 2002, SEMIN CELL DEV BIOL, V13, P377, DOI 10.1016/S1084-9521(02)00094-0
   Black AF, 1999, CELL BIOL TOXICOL, V15, P81, DOI 10.1023/A:1007541713398
   Bonadio J, 1999, NAT MED, V5, P753, DOI 10.1038/10473
   Borges J, 2003, TISSUE ENG, V9, P1263, DOI 10.1089/10763270360728170
   Borges J, 2003, TISSUE ENG, V9, P441, DOI 10.1089/107632703322066624
   Burg KJL, 2000, J BIOMED MATER RES, V51, P642, DOI 10.1002/1097-4636(20000915)51:4<642::AID-JBM12>3.0.CO;2-L
   CARDON S Z, 1970, Microvascular Research, V2, P67, DOI 10.1016/0026-2862(70)90052-X
   Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651
   Chaplin JM, 1999, NEUROSURGERY, V45, P320, DOI 10.1097/00006123-199908000-00025
   Cho SW, 2005, ANN SURG, V241, P506, DOI 10.1097/01.sla.0000154268.12239.ed
   COLTON CK, 1995, CELL TRANSPLANT, V4, P415, DOI 10.1016/0963-6897(95)00025-S
   Deasy BM, 2004, CURR OPIN BIOTECH, V15, P419, DOI 10.1016/j.copbio.2004.08.004
   DOLDERER JH, 2004, LANGENBECK ARCH SURG, V389, P453
   Druecke D, 2004, J BIOMED MATER RES A, V68A, P10, DOI 10.1002/jbm.a..20016
   ENDRICH B, 1980, RES EXP MED, V177, P125, DOI 10.1007/BF01851841
   EROL OO, 1979, SURG FORUM, V30, P530
   FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745
   Frerich B, 2001, INT J ORAL MAX SURG, V30, P414, DOI 10.1054/ijom.2001.0130
   FUNK W, 1986, RES EXP MED, V186, P259, DOI 10.1007/BF01852303
   GORDON JR, 1986, INT J CANCER, V38, P437, DOI 10.1002/ijc.2910380321
   Hibino N, 2005, J THORAC CARDIOV SUR, V129, P1064, DOI 10.1016/j.jtcvs.2004.10.030
   HIRASE Y, 1989, BRIT J PLAST SURG, V42, P216, DOI 10.1016/0007-1226(89)90207-5
   Hodde J, 2002, TISSUE ENG, V8, P295, DOI 10.1089/107632702753725058
   Hodde JP, 2001, ENDOTHELIUM-NEW YORK, V8, P11, DOI 10.3109/10623320109063154
   Holder WD, 1997, TISSUE ENG, V3, P149, DOI 10.1089/ten.1997.3.149
   Jiang JL, 2004, TISSUE ENG, V10, P1577, DOI 10.1089/ten.2004.10.1577
   Kaigler D, 2005, FASEB J, V19, P665, DOI 10.1096/fj.04-2529fje
   Kasahara H, 2003, J AM COLL CARDIOL, V41, P1056, DOI 10.1016/S0735-1097(02)03007-3
   Kaushal S, 2001, NAT MED, V7, P1035, DOI 10.1038/nm0901-1035
   Kirkpatrick CJ, 2003, J MATER SCI-MATER M, V14, P677, DOI 10.1023/A:1024903514335
   Kirkpatrick CJ, 1999, J MATER SCI-MATER M, V10, P589, DOI 10.1023/A:1008946615663
   KNIGHTON D, 1977, BRIT J CANCER, V35, P347, DOI 10.1038/bjc.1977.49
   Kraft CN, 2002, Z ORTHOP GRENZGEB, V140, P672, DOI 10.1055/s-2002-36035
   Kraft CN, 2001, J BIOMED MATER RES, V57, P404, DOI 10.1002/1097-4636(20011205)57:3<404::AID-JBM1183>3.0.CO;2-W
   Kraft CN, 2000, J BIOMED MATER RES, V49, P192, DOI 10.1002/(SICI)1097-4636(200002)49:2<192::AID-JBM6>3.0.CO;2-C
   Kremer M, 2000, BRIT J PLAST SURG, V53, P459, DOI 10.1054/bjps.2000.3368
   KURZ H, 1995, DEV DYNAM, V203, P174, DOI 10.1002/aja.1002030206
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Langer S, 2002, ANN PLAS SURG, V48, P53, DOI 10.1097/00000637-200201000-00008
   Laschke MW, 2002, J ENDOCRINOL, V172, P535, DOI 10.1677/joe.0.1720535
   LEHR HA, 1993, AM J PATHOL, V143, P1055
   LEUNIG M, 1992, CANCER RES, V52, P6553
   Lundborg G, 2004, Handchir Mikrochir Plast Chir, V36, P1
   Maas JWM, 2001, HUM REPROD, V16, P1557, DOI 10.1093/humrep/16.8.1557
   MARAGOUDAKIS ME, 1988, TISSUE CELL, V20, P531, DOI 10.1016/0040-8166(88)90055-9
   Masuda T, 2004, TISSUE ENG, V10, P1672, DOI 10.1089/ten.2004.10.1672
   McPherson TB, 1998, TISSUE ENG, V4, P75, DOI 10.1089/ten.1998.4.75
   Meinert M, 2001, AM J OBSTET GYNECOL, V184, P679, DOI 10.1067/mob.2001.110294
   MENGER MD, 1990, EUR J CARDIO-THORAC, V4, P191, DOI 10.1016/1010-7940(90)90003-I
   MENGER MD, 1989, DIABETES, V38, P199, DOI 10.2337/diab.38.1.S199
   MENGER MD, 1993, IMMUNOL TODAY, V14, P519, DOI 10.1016/0167-5699(93)90179-O
   MENGER MD, 1990, THORAC CARDIOV SURG, V38, P139, DOI 10.1055/s-2007-1014008
   MENGER MD, 1992, THORAC CARDIOV SURG, V40, P19, DOI 10.1055/s-2007-1020105
   Mian RA, 2001, TISSUE ENG, V7, P73, DOI 10.1089/107632700300003305
   Mian RW, 2000, TISSUE ENG, V6, P595, DOI 10.1089/10763270050199541
   Mooney DJ, 1999, SCI AM, V280, P60, DOI 10.1038/scientificamerican0499-60
   Norrby K, 1997, APMIS, V105, P417, DOI 10.1111/j.1699-0463.1997.tb00590.x
   Ohashi K, 2005, HEPATOLOGY, V41, P132, DOI 10.1002/hep.20484
   Pandit AS, 1998, J BIOMATER APPL, V12, P222, DOI 10.1177/088532829801200303
   Pandit AS, 1998, GROWTH FACTORS, V15, P113, DOI 10.3109/08977199809117187
   PAPENFUSS HD, 1979, MICROVASC RES, V18, P311, DOI 10.1016/0026-2862(79)90039-6
   Patan S, 2004, CANC TREAT, V117, P3
   Patrick CW, 2004, ANNU REV BIOMED ENG, V6, P109, DOI 10.1146/annurev.bioeng.6.040803.140032
   Perets A, 2003, J BIOMED MATER RES A, V65A, P489, DOI 10.1002/jbm.a.10542
   Peters K, 2002, BIOMATERIALS, V23, P3413, DOI 10.1016/S0142-9612(02)00042-X
   Peters K, 2001, J MATER SCI-MATER M, V12, P955, DOI 10.1023/A:1012852814570
   Pieper JS, 2000, BIOMATERIALS, V21, P1689, DOI 10.1016/S0142-9612(00)00052-1
   Pinney E, 2000, J CELL PHYSIOL, V183, P74, DOI 10.1002/(SICI)1097-4652(200004)183:1<74::AID-JCP9>3.0.CO;2-G
   RIABIKHIN AW, 2000, CELLS TISSUES ORGANS, V166, P16
   Ribatti D, 2001, ANAT REC, V264, P317, DOI 10.1002/ar.10021
   Richardson TP, 2001, NAT BIOTECHNOL, V19, P1029, DOI 10.1038/nbt1101-1029
   Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0
   ROMANOFF AL, 1952, ANN NY ACAD SCI, V155, P288
   Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026
   Schwarz ER, 2000, J AM COLL CARDIOL, V35, P1323, DOI 10.1016/S0735-1097(00)00522-2
   Shea LD, 1999, NAT BIOTECHNOL, V17, P551
   Simons M, 2000, CIRCULATION, V102, P73
   Tabata Y, 1999, J BIOMAT SCI-POLYM E, V10, P957, DOI 10.1163/156856299X00559
   TAKATO T, 1991, BRIT J PLAST SURG, V44, P593, DOI 10.1016/0007-1226(91)90096-3
   Taniyama Y, 2001, CIRCULATION, V104, P2344, DOI 10.1161/hc4401.098470
   Tremblay PL, 2005, AM J TRANSPLANT, V5, P1002, DOI 10.1111/j.1600-6143.2005.00790.x
   VACANTI CA, 1994, CLIN PLAST SURG, V21, P445
   Vajkoczy P, 2000, NEOPLASIA, V2, P53, DOI 10.1038/sj.neo.7900062
   Vogel V, 2003, ANNU REV BIOMED ENG, V5, P441, DOI 10.1146/annurev.bioeng.5.040202.121615
   Vollmar B, 2001, AM J PATHOL, V159, P1661, DOI 10.1016/S0002-9440(10)63013-1
   Wendt D, 2003, BIOTECHNOL BIOENG, V84, P205, DOI 10.1002/bit.10759
   WILSON YT, 1994, MICROSURG, V15, P717, DOI 10.1002/micr.1920151010
   WILTING J, 1993, CELL TISSUE RES, V274, P163, DOI 10.1007/BF00327997
   WILTING J, 1993, ACTA ANAT, V147, P207
   WILTING J, 1991, ANAT EMBRYOL, V183, P259
   Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568
   Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215
   YANG EY, 1990, J CELL BIOL, V111, P731, DOI 10.1083/jcb.111.2.731
   Zwaginga JJ, 2003, CLIN EXP PHARMACOL P, V30, P900, DOI 10.1046/j.1440-1681.2003.03931.x
NR 101
TC 341
Z9 349
U1 6
U2 88
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD AUG
PY 2006
VL 12
IS 8
BP 2093
EP 2104
DI 10.1089/ten.2006.12.2093
PG 12
WC Cell & Tissue Engineering
SC Cell Biology
GA 081VS
UT WOS:000240345800005
PM 16968151
DA 2018-10-19
ER

PT J
AU Allison, DD
   Grande-Allen, KJ
AF Allison, David D.
   Grande-Allen, K. Jane
TI Review. Hyaluronan: A powerful tissue engineering tool
SO TISSUE ENGINEERING
LA English
DT Review
ID SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-BETA; VALVULAR INTERSTITIAL-CELLS;
   SYNOVIAL LINING CELLS; ACID HYDROGELS; DRUG-DELIVERY; TGF-BETA;
   IN-VITRO; TRANSFORMING GROWTH-FACTOR-BETA-1; INTRACELLULAR HYALURONAN
AB Hyaluronan (HA) is a versatile molecular tool with considerable potential for tissue engineering applications. The inclusion of HA has created biocompatible biomaterials and engineered tissues that can be crosslinked or degraded controllably and can facilitate angiogenesis, osteointegration, and cell phenotype preservation. The utility of HA in tissue engineering has been broadened further by the recently identified HA synthases, which can be manipulated to stimulate the endogenous production of HA by cells seeded within biomaterial scaffolds. Overall, HA shows great promise in the development of engineered tissues and biomaterials for a variety of biomedical needs including orthopedic, cardiovascular, pharmacologic, and oncologic applications.
C1 Rice Univ, Dept Bioengn, Houston, TX 77251 USA.
RP Grande-Allen, KJ (reprint author), Rice Univ, Dept Bioengn, MS 142,POB 1892, Houston, TX 77251 USA.
EM grande@rice.edu
RI Grande-Allen, Kathryn/P-4042-2014
OI Grande-Allen, Kathryn/0000-0003-1533-3767
CR Aigner J, 1998, J BIOMED MATER RES, V42, P172, DOI 10.1002/(SICI)1097-4636(199811)42:2<172::AID-JBM2>3.0.CO;2-M
   AMARNATH LP, 2005, BIOMATERIALS
   Burdick JA, 2005, BIOMACROMOLECULES, V6, P386, DOI 10.1021/bm049508a
   Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272
   Camenisch TD, 2000, AM J RESP CELL MOL, V23, P431, DOI 10.1165/ajrcmb.23.4.f201
   Campoccia D, 1998, BIOMATERIALS, V19, P2101, DOI 10.1016/S0142-9612(98)00042-8
   Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b
   Chajara A, 2003, ATHEROSCLEROSIS, V171, P15, DOI 10.1016/S0021-9150(03)00303-4
   Chen L, 2004, BIOMACROMOLECULES, V5, P238, DOI 10.1021/bm0344102
   Chong BF, 2005, APPL MICROBIOL BIOT, V66, P341, DOI 10.1007/s00253-004-1774-4
   Collier JH, 2000, J BIOMED MATER RES, V50, P574, DOI 10.1002/(SICI)1097-4636(20000615)50:4<574::AID-JBM13>3.0.CO;2-I
   DELMAGE JM, 1986, ANN CLIN LAB SCI, V16, P303
   Delpech B, 1997, J INTERN MED, V242, P41, DOI 10.1046/j.1365-2796.1997.00172.x
   Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004
   Evanko SP, 1998, AM J PATHOL, V152, P533
   FOSCHI D, 1990, INT J TISSUE REACT, V12, P333
   Gao JZ, 2001, TISSUE ENG, V7, P363, DOI 10.1089/10763270152436427
   GIRARD LJ, 1994, ARCH OPHTHALMOL-CHIC, V112, P577, DOI 10.1001/archopht.1994.01090170021004
   Goldberg VM, 2005, OSTEOARTHR CARTILAGE, V13, P216, DOI 10.1016/j.joca.2004.11.010
   Grigolo B, 2002, BIOMATERIALS, V23, P1187, DOI 10.1016/S0142-9612(01)00236-8
   Hahn SK, 2004, J BIOMAT SCI-POLYM E, V15, P1111, DOI 10.1163/1568562041753115
   Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013
   HASCALL VC, 1997, HYALUORNAN TODAY
   HAUBECK HD, 1995, ARTHRITIS RHEUM-US, V38, P669, DOI 10.1002/art.1780380515
   Hedberg EL, 2004, J CONTROL RELEASE, V100, P257, DOI 10.1016/j.jconrel.2004.08.020
   HodgeDufour J, 1997, J IMMUNOL, V159, P2492
   Ishida O, 1997, J BONE MINER RES, V12, P1657, DOI 10.1359/jbmr.1997.12.10.1657
   Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085
   Itano N, 2002, P NATL ACAD SCI USA, V99, P3609, DOI 10.1073/pnas.052026799
   Ito T, 2004, J BIOL CHEM, V279, P25326, DOI 10.1074/jbc.M403135200
   Ito T, 2004, AM J PATHOL, V164, P1979, DOI 10.1016/S0002-9440(10)63758-3
   Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029
   Karvinen S, 2003, BRIT J DERMATOL, V148, P86, DOI 10.1046/j.1365-2133.2003.05028.x
   Kawakami M, 1998, ANN RHEUM DIS, V57, P602, DOI 10.1136/ard.57.10.602
   Kawasaki K, 1999, J CELL PHYSIOL, V179, P142, DOI 10.1002/(SICI)1097-4652(199905)179:2<142::AID-JCP4>3.0.CO;2-Q
   LAURENT T, 2004, XENOTRANSPLANTATION, V11, P269
   LAURENT TC, 1992, FASEB J, V6, P2397
   LAURENT TC, 1964, ACTA CHEM SCAND, V18, P274, DOI 10.3891/acta.chem.scand.18-0274
   Laurich C, 2004, J SURG RES, V122, P70, DOI 10.1016/j.jss.2004.05.018
   Leach JB, 2003, BIOTECHNOL BIOENG, V82, P578, DOI 10.1002/bit.10605
   Leach JB, 2005, BIOMATERIALS, V26, P125, DOI 10.1016/j.biomaterials.2004.02.018
   Lee JE, 2002, ARTIF ORGANS, V26, P636, DOI 10.1046/j.1525-1594.2002.06847.x
   LEES VC, 1995, LAB INVEST, V73, P259
   Lesley J, 2000, J BIOL CHEM, V275, P26967
   Liu GK, 2005, SPRINGER SERIES MATE, V83, P1, DOI 10.1007/3-540-28209-2_1
   Liu YC, 2005, BIOMATERIALS, V26, P4737, DOI 10.1016/j.biomaterials.2005.01.003
   Luo Y, 2000, J CONTROL RELEASE, V69, P169, DOI 10.1016/S0168-3659(00)00300-X
   Luo Y, 2002, PHARMACEUT RES, V19, P396, DOI 10.1023/A:1015170907274
   Masters KS, 2005, BIOMATERIALS, V26, P2517, DOI 10.1016/j.biomaterials.2004.07.018
   Masters KS, 2004, J BIOMED MATER RES A, V71A, P172, DOI 10.1002/jbm.a.30149
   McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054
   Meyer K, 1934, J BIOL CHEM, V107, P629
   Mrosek E, 2003, CELLS TISSUES ORGANS, V173, P93, DOI 10.1159/000068944
   Nishida Y, 2005, EXP CELL RES, V307, P194, DOI 10.1016/j.yexcr.2005.03.026
   Ohri R, 2004, J BIOMED MATER RES A, V70A, P328, DOI 10.1002/jbm.a.30088
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Pasonen-Seppanen S, 2003, J INVEST DERMATOL, V120, P1038, DOI 10.1046/j.1523-1747.2003.12249.x
   Pavesio Alessandra, 2003, Novartis Found Symp, V249, P203
   Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200
   Radice M, 2000, J BIOMED MATER RES, V50, P101, DOI 10.1002/(SICI)1097-4636(200005)50:2<101::AID-JBM2>3.0.CO;2-M
   Ramamurthi A, 2005, BIOMATERIALS, V26, P999, DOI 10.1016/j.biomaterials.2004.04.016
   Ramamurthi A, 2003, J BIOMED MATER RES A, V66A, P317, DOI 10.1002/jbm.a.10588
   Remuzzi A, 2004, TISSUE ENG, V10, P699, DOI 10.1089/1076327041348347
   RICHTER AW, 1979, INT ARCH ALLER A IMM, V59, P45, DOI 10.1159/000232238
   Riessen R, 1996, CIRCULATION, V93, P1141, DOI 10.1161/01.CIR.93.6.1141
   Savani RC, 2001, J BIOL CHEM, V276, P36770, DOI 10.1074/jbc.M102273200
   Schmitz H, 1997, PHILOS RUNDSCH, V44, P90
   Schoenfelder M, 2003, BIOL REPROD, V69, P269, DOI 10.1095/biolreprod.102.011577
   Segura T, 2005, BIOMATERIALS, V26, P1575, DOI 10.1016/j.biomaterials.2004.05.007
   Segura T, 2005, BIOMATERIALS, V26, P359, DOI 10.1016/j.biomaterials.2004.02.067
   Simpson MA, 2002, AM J PATHOL, V161, P849, DOI 10.1016/S0002-9440(10)64245-9
   Solchaga LA, 2005, OSTEOARTHR CARTILAGE, V13, P297, DOI 10.1016/j.joca.2004.12.016
   Stern R, 2003, GLYCOBIOLOGY, V13, p105R, DOI 10.1093/glycob/cwg112
   Stuhlmeier KM, 2004, J BIOL CHEM, V279, P8753, DOI 10.1074/jbc.M303945200
   Suzuki K, 2003, JPN J OPHTHALMOL, V47, P557, DOI 10.1016/j.jjo.2003.09.001
   Tanimoto K, 2004, J DENT RES, V83, P40, DOI 10.1177/154405910408300108
   Tempel C, 2000, BIOL REPROD, V63, P134, DOI 10.1095/biolreprod63.1.134
   Tomihata K, 1997, J BIOMED MATER RES, V37, P243
   Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244
   Toole BP, 2000, J CLIN INVEST, V106, P335, DOI 10.1172/JCI10706
   Toole BP, 2002, AM J PATHOL, V161, P745, DOI 10.1016/S0002-9440(10)64232-0
   Toole BP, 2002, GLYCOBIOLOGY, V12, p37R, DOI 10.1093/glycob/12.3.37R
   Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200
   Travis JA, 2001, CIRC RES, V88, P77, DOI 10.1161/01.RES.88.1.77
   Trochon V, 1996, INT J CANCER, V66, P664, DOI 10.1002/(SICI)1097-0215(19960529)66:5<664::AID-IJC14>3.0.CO;2-4
   Turner NJ, 2004, BIOMATERIALS, V25, P5955, DOI 10.1016/j.biomaterials.2004.02.002
   Vercruysse KP, 1997, BIOCONJUGATE CHEM, V8, P686, DOI 10.1021/bc9701095
   Vercruysse KP, 1998, CRIT REV THER DRUG, V15, P513
   Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997
   WEISSMANN B, 1954, J AM CHEM SOC, V76, P1753, DOI 10.1021/ja01636a010
   WEST DC, 1989, CIBA F SYMP, V143, P187
   WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340
   WIGHT TN, 1991, CELL BIOL EXTRACELLU
   WILKINSON TS, 2005, J CELL PHYSL
   Yamane S, 2005, BIOMATERIALS, V26, P611, DOI 10.1016/j.biomaterials.2004.03.013
   Yoo HS, 2005, BIOMATERIALS, V26, P1925, DOI 10.1016/j.biomaterials.2004.06.021
   Zavan B, 2005, BIOMATERIALS, V26, P7038, DOI 10.1016/j.biomaterials.2005.04.067
   ZAVAN B, 2006, BIOMATERIALS, V26, P2994
NR 98
TC 192
Z9 199
U1 4
U2 63
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2152-4947
J9 TISSUE ENG
JI Tissue Eng.
PD AUG
PY 2006
VL 12
IS 8
BP 2131
EP 2140
DI 10.1089/ten.2006.12.2131
PG 10
WC Cell & Tissue Engineering
SC Cell Biology
GA 081VS
UT WOS:000240345800008
PM 16968154
DA 2018-10-19
ER

PT J
AU Garreta, E
   Genove, E
   Borros, S
   Semino, CE
AF Garreta, Elena
   Genove, Elsa
   Borros, Salvador
   Semino, Carlos E.
TI Osteogenic differentiation of mouse embryonic stem cells and mouse
   embryonic fibroblasts in a three-dimensional self-assembling peptide
   scaffold
SO TISSUE ENGINEERING
LA English
DT Article
ID IN-VITRO DIFFERENTIATION; BONE-FORMATION; OSTEOBLASTS; PHENOTYPE;
   CULTURE; PROLIFERATION; ADIPOGENESIS; MODEL; PROTEOLYSIS; RECRUITMENT
AB In the present work, we studied the differentiation capacity of mouse embryonic stem cells (mESCs) and mouse embryonic fibroblasts (MEFs) to differentiate into osteoblast-like cells in a 3-dimensional (3D) self-assembling peptide scaffold, a synthetic nanofiber biomaterial with potential applications in regenerative medicine. We demonstrated that 2D and 3D systems promoted differentiation of mESCs into cells with an osteoblast-like phenotype consisting of osteopontin and collagen I marker expression, as well as high alkaline phosphatase (ALP) activity and calcium phosphate deposits. In 3D cultures the frequency of appearance of embryonic stem cell-like colonies was substantially greater, suggesting that the 3D microenvironment promoted the generation a stem cell-like niche that allows undifferentiated stem cell maintenance. On the other hand, after MEFs were cultures in the 3D system with their regular growth medium, but not in the 2D system, they expressed osteopontin, up-regulated metalloproteinase activities, and they acquired a distinct phenotype consisting of small, elongated cells with remaining mitotic-activity. Furthermore, only 3D MEF cultures underwent osteoblast differentiation after osteogenic induction, based on matrix mineralization, collagen I synthesis, ALP activity, and expression of the osteoblast transcription factor Runx2, suggesting that the 3D environment promotes differentiation of MEFs into osteoblast-like cells. We propose that the 3D system provides a unique microenvironment that promotes differentiation of mESCs and MEFs into osteoblast-like cells.
C1 MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA.
   Univ Ramon Llull, Inst Quim Sarria, Barcelona Bioengn Ctr, Barcelona, Spain.
RP Semino, CE (reprint author), MIT, Ctr Biomed Engn, NE47-383,77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM semino@mit.edu
RI Borros, Salvador/A-3950-2016
OI Borros, Salvador/0000-0002-4003-0381
FU NIBIB NIH HHS [1-R01-EB00385-01A]
CR Alexander DL, 1998, J CELL SCI, V111, P3311
   Armant DR, 2005, DEV BIOL, V280, P260, DOI 10.1016/j.ydbio.2005.02.009
   ARMSTRONG JR, 1995, DEV BIOL, V169, P242, DOI 10.1006/dbio.1995.1141
   Bielby RC, 2004, TISSUE ENG, V10, P1518, DOI 10.1089/ten.2004.10.1518
   BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0
   Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754
   Buttery LDK, 2001, TISSUE ENG, V7, P89, DOI 10.1089/107632700300003323
   Cao T, 2005, TISSUE CELL, V37, P325, DOI 10.1016/j.tice.2005.03.008
   Clark RN., 1999, MANUAL REMOTE SENSIN, P3
   Dani C, 1997, J CELL SCI, V110, P1279
   Drab M, 1997, FASEB J, V11, P905
   DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007
   EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0
   Ferrera D, 2002, BONE, V30, P718, DOI 10.1016/S8756-3282(02)00691-9
   Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066
   Genove E, 2005, BIOMATERIALS, V26, P3341, DOI 10.1016/j.biomaterials.2004.08.012
   Gourevitch D, 2003, DEV DYNAM, V226, P377, DOI 10.1002/dvdy.10243
   HAMAGUCHI M, 1995, ONCOGENE, V10, P1037
   HOPKINSONWOOLLEY J, 1994, J CELL SCI, V107, P1159
   Imai S, 1998, J CELL BIOL, V143, P1113, DOI 10.1083/jcb.143.4.1113
   Jaiswal N, 1997, J CELL BIOCHEM, V64, P295, DOI 10.1002/(SICI)1097-4644(199702)64:2<295::AID-JCB12>3.0.CO;2-I
   Johnson S, 1999, AM J PHYSIOL-LUNG C, V277, pL1109, DOI 10.1152/ajplung.1999.277.6.L1109
   Kale S, 2000, NAT BIOTECHNOL, V18, P954
   Kramer J, 2000, MECH DEVELOP, V92, P193, DOI 10.1016/S0925-4773(99)00339-1
   Landsberg RL, 2003, P NATL ACAD SCI USA, V100, P2456, DOI 10.1073/pnas.0138064100
   Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536
   Lengner CJ, 2004, J CELL PHYSIOL, V200, P327, DOI 10.1002/jcp.20118
   Liaw L, 1998, J CLIN INVEST, V101, P1468
   LINDBLAD WJ, 1991, HEPATOLOGY, V13, P282, DOI 10.1002/hep.1840130213
   Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866
   Maroto M, 2005, INT J DEV BIOL, V49, P309, DOI 10.1087/ijdb.041958mm
   MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634
   MCGEERUSSELL SM, 1958, J HISTOCHEM CYTOCHEM, V6, P22, DOI 10.1177/6.1.22
   Murphy G, 1999, CURR OPIN CELL BIOL, V11, P614, DOI 10.1016/S0955-0674(99)00022-8
   Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143
   Rangaswami H, 2004, J BIOL CHEM, V279, P38921, DOI 10.1074/jbc.M404674200
   Ross Jason W, 2003, Reprod Biol Endocrinol, V1, P23, DOI 10.1186/1477-7827-1-23
   SCHMITT MR, 1991, GENE DEV, V5, P728
   Semino CE, 2004, TISSUE ENG, V10, P643, DOI 10.1089/107632704323061997
   Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x
   Shui CX, 2002, J CELL PHYSIOL, V193, P164, DOI 10.1002/jcp.10157
   SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0
   Stains JP, 2005, BIOCHEM BIOPH RES CO, V328, P721, DOI 10.1016/j.bbrc.2004.11.078
   STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424
   Tai GP, 2004, TISSUE ENG, V10, P1456, DOI 10.1089/1076327042500300
   Viswanathan S, 2003, BIOTECHNOL BIOENG, V84, P505, DOI 10.1002/bit.10799
   Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8
   Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8
   WILES MV, 1991, DEVELOPMENT, V111, P259
   WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0
   Wobus Anna M., 2001, Molecular Aspects of Medicine, V22, P149, DOI 10.1016/S0098-2997(01)00006-1
   Wu LNY, 1997, J BIOL CHEM, V272, P4404, DOI 10.1074/jbc.272.7.4404
   Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568
   Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4
   zur Nieden NI, 2003, DIFFERENTIATION, V71, P18, DOI 10.1046/j.1432-0436.2003.700602.x
   zur Nieden NI, 2001, TOXICOL IN VITRO, V15, P455, DOI 10.1016/S0887-2333(01)00071-6
NR 56
TC 118
Z9 125
U1 0
U2 20
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD AUG
PY 2006
VL 12
IS 8
BP 2215
EP 2227
DI 10.1089/ten.2006.12.2215
PG 13
WC Cell & Tissue Engineering
SC Cell Biology
GA 081VS
UT WOS:000240345800016
PM 16968162
DA 2018-10-19
ER

PT J
AU Chen, GQ
   Zeng, GM
   Tu, X
   Niu, CG
   Huang, GH
   Jiang, W
AF Chen, Gui-Qiu
   Zeng, Guang-Ming
   Tu, Xianc
   Niu, Chen-Gang
   Huang, Guo-He
   Jiang, Wen
TI Application of a by-product of Lentinus edodes to the bioremediation of
   chromate contaminated water
SO JOURNAL OF HAZARDOUS MATERIALS
LA English
DT Article
DE bioremediation; waste water; chromium; agricultural by-product
ID SPENT MUSHROOM COMPOST; HEAVY-METALS; HEXAVALENT CHROMIUM;
   AQUEOUS-SOLUTIONS; CADMIUM REMOVAL; CONE BIOMASS; WASTE-WATER;
   BIOSORPTION; ADSORPTION; BIOSORBENT
AB The agricultural by-product of Lentinus edodes was used as a novel biosorbent for bioremediation of chromate contaminated waste water in the simulated experimental conditions. The contact time, particle size. biosorbent dosage and optimum pH range were investigated to optimize the sorption condition. The biosorption by the biomass was strongly affected by pH. At pH 1.0-2.5, all hexavalent chromium was diminished, either removed by the biosorbent or reduced to less toxic trivalent chromium even in very high concentration of 1000 mg/L. The adsorbed hexavalent chromium and reduced trivalent chromium were both linearly dependent on the initial chromium concentration. Most uptake of Cr occurred at pH around 4. The maximum uptake of chromium was 21.5 mg/g when simulated with Langmuir model. which showed the potential biosorption capacity of this biomaterial. The change of oxidation-reduction potential (ORP) during biosorption process revealed strong reduction ability of this biosorbent. Comparing analysis from Fourier transform infrared spectrums indicated that nitrogen oxide and carboxyl groups were increased after biosorption. The energy-dispersive X-ray microanalyzer revealed the mechanism of cation exchange during biosorption. (c) 2005 Elsevier B.V. All rights reserved.
C1 Hunan Univ, Coll Environm Sci & Engn, Changsha 410082, Peoples R China.
   Univ Regina, Fac Engn, Regina, SK S4S 0A2, Canada.
RP Zeng, GM (reprint author), Hunan Univ, Coll Environm Sci & Engn, Changsha 410082, Peoples R China.
EM zgming@hnu.cn
RI Huang, Guohe/H-5306-2011
OI Huang, Guohe/0000-0003-4974-3019
CR Alvarez AH, 1999, J BACTERIOL, V181, P7398
   Aravindhan R, 2004, ENVIRON SCI TECHNOL, V38, P300, DOI 10.1021/es034427s
   Arica MY, 2001, BIORESOURCE TECHNOL, V80, P121, DOI 10.1016/S0960-8524(01)00084-0
   Bai RS, 2003, BIORESOURCE TECHNOL, V87, P17
   Bailey SE, 1999, WATER RES, V33, P2469, DOI 10.1016/S0043-1354(98)00475-8
   Benguella B, 2002, WATER RES, V36, P2463, DOI 10.1016/S0043-1354(01)00459-6
   Bingol A, 2004, BIORESOURCE TECHNOL, V94, P245, DOI [10.1016/j.biortech.2004.01.018, 10.1016/j.biotech.2004.01.018]
   Boddu VM, 2003, ENVIRON SCI TECHNOL, V37, P4449, DOI 10.1021/es021013a
   Cabatingan LK, 2001, IND ENG CHEM RES, V40, P2302, DOI 10.1021/ie0008575
   Chen GQ, 2005, J ENVIRON SCI-CHINA, V17, P756
   Dupont L, 2003, ENVIRON SCI TECHNOL, V37, P4235, DOI 10.1021/es0342345
   Kellner R., 1998, ANAL CHEM
   Klimmek S, 2001, ENVIRON SCI TECHNOL, V35, P4283, DOI 10.1021/es010063x
   Law WM, 2003, CHEMOSPHERE, V52, P1531, DOI 10.1016/S0045-6535(03)00492-2
   McLean J, 2001, APPL ENVIRON MICROB, V67, P1076, DOI 10.1128/AEM.67.3.1076-1084.2001
   Mustafa MM, 2002, J PROCESS CONTR, V12, P405, DOI 10.1016/S0959-1524(01)00039-7
   Nuhoglu Y, 2003, PROCESS BIOCHEM, V38, P1627, DOI 10.1016/S0032-9592(03)00055-4
   Sag Y, 1998, PROCESS BIOCHEM, V33, P273, DOI 10.1016/S0032-9592(97)00060-5
   Schneegurt MA, 2001, ENVIRON SCI TECHNOL, V35, P3786, DOI 10.1021/es010766e
   Semple KT, 2001, ENVIRON POLLUT, V112, P269, DOI 10.1016/S0269-7491(00)00099-3
   Sharma A, 2005, J HAZARD MATER, V125, P102, DOI 10.1016/j.jhazmat.2005.05.012
   Srinath T, 2002, CHEMOSPHERE, V48, P427, DOI 10.1016/S0045-6535(02)00089-9
   Tarley CRT, 2004, CHEMOSPHERE, V54, P987, DOI 10.1016/j.chemosphere.2003.09.001
   Ucun H, 2002, BIORESOURCE TECHNOL, V85, P155, DOI 10.1016/S0960-8524(02)00086-X
   Yun YS, 2001, ENVIRON SCI TECHNOL, V35, P4353, DOI 10.1021/es010866k
   Zhou D, 2004, WATER RES, V38, P2643, DOI 10.1016/j.watres.2004.03.026
NR 26
TC 37
Z9 45
U1 0
U2 18
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0304-3894
J9 J HAZARD MATER
JI J. Hazard. Mater.
PD JUL 31
PY 2006
VL 135
IS 1-3
BP 249
EP 255
DI 10.1016/j.jhazmat.2005.11.060
PG 7
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA 065BE
UT WOS:000239133600035
PM 16386843
DA 2018-10-19
ER

PT J
AU Honda, Y
   Anada, T
   Kamakura, S
   Nakamura, M
   Sugawara, S
   Suzuki, O
AF Honda, Y
   Anada, T
   Kamakura, S
   Nakamura, M
   Sugawara, S
   Suzuki, O
TI Elevated extracellular calcium stimulates secretion of bone
   morphogenetic protein 2 by a macrophage cell line
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE resorbable calcium phosphate; octacalciuni phosphate; biomaterial;
   BMP-2; macrophages; calcium; bone
ID IMPLANTED OCTACALCIUM PHOSPHATE; HYDROXYAPATITE; BIOMATERIALS;
   EXPRESSION; MECHANISM; RECEPTOR; CEMENT; DIFFERENTIATION; APOPTOSIS;
   MARROW
AB It has been suggested that macrophages and multinucleated giant cells are responsible for phagocytosis of resorbable calcium phosphate (CaP) compounds implanted in bone defects. However, function of macrophages around the CaP, if continuously exposed to various concentration of extracellular calcium ions ([Ca2+](0)), is still unknown. The present study showed that when resorbable octacalcium phosphate was implanted in mouse calvaria, macrophage-like cells were observed around the implant during bone formation. Then, experiments were designed to investigate whether secretion of bone morphogenetic protein 2 (BMP-2) is enhanced by extracellular calcium ions in a macrophage cell line (J774A.1) in vitro. The mRNA expression and the secretion of BMP-2 in J774A.1 cells were significantly increased when incubated in the medium with [Ca2+](0) up to 14 mM. The promotion of mRNA expression was maintained even when incubated with a small amount of minute CaP crystals. The present results suggest that [Ca2+](0), above physiological concentration may stimulate macrophages to induce osteogenic cytokine, such as BMP-2, for bone formation by osteoblasts. (c) 2006 Elsevier Inc. All rights reserved.
C1 Tohoku Univ, Grad Sch Dent, Div Craniofacial Funct Engn, Aoba Ku, Sendai, Miyagi 9808575, Japan.
   Tohoku Univ, Sch Med,Ctr Translat & Adv Anim Res, Div Clin Cell Therapy,Dept Translat Res, Aoba Ku, Sendai, Miyagi 9808574, Japan.
   Showa Univ, Sch Dent, Dept Oral Anat & Dev Biol, Shinagawa Ku, Tokyo 142, Japan.
   Tohoku Univ, Grad Sch Dent, Dept Oral Immunol, Aoba Ku, Sendai, Miyagi 9808575, Japan.
RP Suzuki, O (reprint author), Tohoku Univ, Grad Sch Dent, Div Craniofacial Funct Engn, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.
EM suzuki-o@mail.tains.tohoku.ac.jp
RI Kamakura, Shinji/A-5385-2013
CR Apelt D, 2004, BIOMATERIALS, V25, P1439, DOI 10.1016/j.biomaterials.2003.08.073
   BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0
   Brown EM, 2001, PHYSIOL REV, V81, P239
   Champagne CM, 2002, BONE, V30, P26, DOI 10.1016/S8756-3282(01)00638-X
   CHENG PT, 1983, CALCIFIED TISSUE INT, V35, P596, DOI 10.1007/BF02405100
   CHOW LC, 2001, OCTACALCIUM PHOSPHAT, P148
   Chowdhury EH, 2004, GENE, V341, P77, DOI 10.1016/j.gene.2004.07.015
   Constantz BR, 1998, J BIOMED MATER RES, V43, P451, DOI 10.1002/(SICI)1097-4636(199824)43:4<451::AID-JBM13>3.0.CO;2-Q
   CRANE NJ, 2006, IN PRESS BONE
   Dvorak MM, 2004, P NATL ACAD SCI USA, V101, P5140, DOI 10.1073/pnas.0306141101
   Fiedler J, 2002, J CELL BIOCHEM, V87, P305, DOI 10.1002/jcb.10309
   FUREDIMILHOFER H, 1971, CALC TISS RES, V8, P142, DOI 10.1007/BF02010131
   Grover LM, 2003, BIOMATERIALS, V24, P4133, DOI 10.1016/S0142-9612(03)00293-X
   Imaizumi H, 2006, CALCIFIED TISSUE INT, V78, P45, DOI 10.1007/s00223-005-0170-0
   Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001
   Kamakura S, 1997, J ELECTRON MICROSC, V46, P397, DOI 10.1093/oxfordjournals.jmicro.a023535
   Kamakura S, 2002, J BIOMED MATER RES, V59, P29, DOI 10.1002/jbm.1213.abs
   LEGEROS RZ, 1985, CALCIFIED TISSUE INT, V37, P194, DOI 10.1007/BF02554841
   LeGeros RZ, 2002, CLIN ORTHOP RELAT R, P81
   Lorget F, 2000, BIOCHEM BIOPH RES CO, V268, P899, DOI 10.1006/bbrc.2000.2229
   Lories RJU, 2003, ARTHRITIS RHEUM, V48, P2807, DOI 10.1002/art.11389
   Lu JX, 2002, J BIOMED MATER RES, V63, P408, DOI 10.1002/jbm.10259
   Maeno S, 2005, BIOMATERIALS, V26, P4847, DOI 10.1016/j.biomaterials.2005.01.006
   Nadra I, 2005, CIRC RES, V96, P1248, DOI 10.1161/01.RES.0000171451.88616.c2
   Nakade O, 2001, J BONE MINER METAB, V19, P13, DOI 10.1007/s007740170055
   Ooms EM, 2002, J BIOMED MATER RES, V61, P9, DOI 10.1002/jbm.10029
   Quarles LD, 1997, J BONE MINER RES, V12, P393, DOI 10.1359/jbmr.1997.12.3.393
   SUZUKI O, 1993, BONE MINER, V20, P151, DOI 10.1016/S0169-6009(08)80024-4
   Suzuki O, 2006, BIOMATERIALS, V27, P2671, DOI 10.1016/j.boimaterials.2005.12.004
   SUZUKI O, 1991, TOHOKU J EXP MED, V164, P37, DOI 10.1620/tjem.164.37
   Takebe J, 2003, J BIOMED MATER RES A, V64A, P207, DOI 10.1002/jbm.a.10275
   Theiss F, 2005, BIOMATERIALS, V26, P4383, DOI 10.1016/j.biomaterials.2004.11.056
   THIES RS, 1992, ENDOCRINOLOGY, V130, P1318, DOI 10.1210/en.130.3.1318
   Yamaguchi T, 1998, J BONE MINER RES, V13, P1390, DOI 10.1359/jbmr.1998.13.9.1390
   Zaffe D, 2005, MICRON, V36, P583, DOI 10.1016/j.micron.2005.05.008
   ZAIDI M, 1989, BIOCHEM BIOPH RES CO, V163, P1461, DOI 10.1016/0006-291X(89)91143-1
NR 36
TC 48
Z9 51
U1 1
U2 9
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD JUL 7
PY 2006
VL 345
IS 3
BP 1155
EP 1160
DI 10.1016/j.bbrc.2006.05.013
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 054AA
UT WOS:000238346500036
PM 16716259
DA 2018-10-19
ER

PT J
AU Mallika, P
   Himabindu, A
   Shailaja, D
AF Mallika, P
   Himabindu, A
   Shailaja, D
TI Modification of chitosan towards a biomaterial with improved
   physico-chemical properties
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE chitosan; polyvinylpyrrolidone; graft copolymers; swelling ratio;
   mechanical properties
ID GRAFT-COPOLYMERIZATION; GLASS-TRANSITION; BEHAVIOR; CHITIN; BLENDS;
   FILMS; ION
AB Modification of chitosan (CTN), a natural biomaterial, leading to improved physical and chemical properties makes the polymer overcome the limitations on its application in biomedical fields. We have modified CTN using polyvinylpyrrolidone (PVP) in three ways, i.e., by blending (CTN: PVP), by graft copolymerization [poly(CTN-g-PVP)], and by free radical induced crosslinking [poly(CTN-cl-PVP)], varying the CTN to PVP ratio. The properties of all the modified and unmodified CTN studied included structural, thermal, mechanical, and water uptake capacity. Modification by blending imparted enhanced strength, toughness, glass transition temperatures, and thermal stability to the dry membranes. The equilibrium water content (EWC) of the membrane gels was investigated as a function of pH and ionic strength. Swelling ratio of the chemically modified membranes were found to be less sensitive to pH, with higher % EWC maintaining the gel integrity in both acidic and neutral media unlike the plain CTN. The hydrogen bonding and free volume of the films were found to play a major role in determining the properties of the type of modification. CTN membranes with enhanced water uptake capacities clubbed with optimum mechanical properties shall be a suitable choice for biomedical and controlled release applications. (c) 2006 Wiley Periodicals, Inc.
C1 Indian Inst Chem Technol, Organ Coatings & Polymers Div, Hyderabad 500007, Andhra Pradesh, India.
RP Shailaja, D (reprint author), Indian Inst Chem Technol, Organ Coatings & Polymers Div, Hyderabad 500007, Andhra Pradesh, India.
EM sdonempudi@iictnet.org
CR Ikejima T, 2000, CARBOHYD POLYM, V41, P351, DOI 10.1016/S0144-8617(99)00105-8
   Kim SY, 2000, J APPL POLYM SCI, V78, P1381, DOI 10.1002/1097-4628(20001114)78:7<1381::AID-APP90>3.0.CO;2-M
   KURITA K, 1991, J APPL POLYM SCI, V42, P2885, DOI 10.1002/app.1991.070421104
   Kweon DK, 1999, J APPL POLYM SCI, V74, P458, DOI 10.1002/(SICI)1097-4628(19991010)74:2<458::AID-APP29>3.0.CO;2-6
   Lazaridou A, 2002, CARBOHYD POLYM, V48, P179, DOI 10.1016/S0144-8617(01)00261-2
   Paula HCB, 2002, CARBOHYD POLYM, V48, P313, DOI 10.1016/S0144-8617(01)00264-8
   Pawlak A, 2003, THERMOCHIM ACTA, V396, P153, DOI 10.1016/S0040-6031(02)00523-3
   Sakurai K, 2000, POLYMER, V41, P7051, DOI 10.1016/S0032-3861(00)00067-7
   Shantha KL, 2000, INT J PHARM, V207, P65, DOI 10.1016/S0378-5173(00)00533-0
   Sonntag C. V., 2003, RADIAT PHYS CHEM, V67, P353
   Sun T, 2003, EUR POLYM J, V39, P189, DOI 10.1016/S0014-3057(02)00174-X
   Yang JM, 1999, J MEMBRANE SCI, V153, P175, DOI 10.1016/S0376-7388(98)00261-0
   Yang JM, 2004, J MEMBRANE SCI, V236, P39, DOI 10.1016/j.memsci.2004.02.005
   YazdaniPedram M, 1997, J APPL POLYM SCI, V63, P1321, DOI 10.1002/(SICI)1097-4628(19970307)63:10<1321::AID-APP11>3.0.CO;2-7
   Zhang J, 2003, EUR POLYM J, V39, P847, DOI 10.1016/S0014-3057(02)00286-0
NR 15
TC 10
Z9 11
U1 0
U2 11
PU JOHN WILEY & SONS INC
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0021-8995
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUL 5
PY 2006
VL 101
IS 1
BP 63
EP 69
DI 10.1002/app.22893
PG 7
WC Polymer Science
SC Polymer Science
GA 044NT
UT WOS:000237680000009
DA 2018-10-19
ER

PT J
AU Mikolajczyk, T
   Rabiej, S
   Bogun, M
AF Mikolajczyk, Teresa
   Rabiej, Stanislaw
   Bogun, Maciej
TI Analysis of the structural parameters of polyacrylonitrile fibers
   containing nanohydroxyapatite
SO JOURNAL OF APPLIED POLYMER SCIENCE
LA English
DT Article
DE fibers; orientation; crystal structures; nanoparticles; hydroxyapatite
ID SEMICRYSTALLINE POLYMERS; CARBON; RECONSTRUCTION; CRYSTALLINITY
AB The structural parameters and strength properties of a new generation of polyacrylonitrile fibers have been analyzed. These fibers, after being carbonized, can be used in biomaterial engineering. They are characterized by a high tensile strength of 31-43 cN/tex. An advantageous influence of nanoparticles added to the fiber matter on the degree of crystallinity has been found. When nano-particles of hydroxyapatite are incorporated into these fibers, their degree of crystallinity increases by about 5%. (c) 2006 Wiley Periodicals, Inc.
C1 Tech Univ Lodz, Fac Text Engn & Mkt, Dept Man Made Fibers, PL-90924 Lodz, Poland.
   Univ Bielsko Biala, Fac Text Engn & Environm Protect, Inst Polymer Mat & Text Engn, Bielsko Biala, Poland.
RP Mikolajczyk, T (reprint author), Tech Univ Lodz, Fac Text Engn & Mkt, Dept Man Made Fibers, PL-90924 Lodz, Poland.
EM mikolter@mail.p.lodz.pl
CR BLAZEWICZ S, 2005, Patent No. 377921
   Brandrup J., 1999, POLYM HDB
   CAMPBELL AC, 1995, ANN ROY COLL SURG, V77, P349
   DEGROOT K, 1993, CERAM INT, V19, P363, DOI 10.1016/0272-8842(93)90050-2
   GORECKI A, 1990, CHIR NARZ RUCHU ORTO, V2, P131
   Hehl G, 1997, CHIRURG, V68, P1119, DOI 10.1007/s001040050331
   HINRICHSEN G, 1971, KOLLOID Z Z POLYM, V247, P844, DOI 10.1007/BF01500258
   KITAJGORODSKIJ AJ, 1959, DOKL AKAD NAUK, V4, P861
   KLEMENT JJ, 1968, J POLYM SCI A2, V6, P1381, DOI 10.1002/pol.1968.160060714
   Mikolajczyk T, 2006, J APPL POLYM SCI, V100, P2881, DOI 10.1002/app.23464
   MIKOLAJCZYK T, 1989, TEXT RES J, V59, P557, DOI 10.1177/004051758905901001
   MIKOLAJCZYK T, 2005, FIBRES TEXT EAST EUR, V3, P30
   MIKOLAJCZYK T, 1995, FIBRES TEXT EAST EUR, V3, P44
   MIKOLAJCZYK T, 2005, FIBRES TEXT EAST EUR, V1, P28
   MIKOLAJZYK T, 1997, SCI B TU LODZ, P781
   NATTA J, 1960, ATTI, V25, P3
   PAPKOW SP, 1981, CHIM WOLOK, V4, P13
   PATEL GN, 1970, J POLYM SCI A2, V6, P1381
   Rabiej M, 2003, POLIMERY-W, V48, P288
   Rabiej M, 2002, POLIMERY-W, V47, P423
   STEFANI R, 1960, CR HEBD ACAD SCI, V251, P2174
   STOCH A, 2004, INZ BIOMATER, V38, P164
   SZAFRAN M, 2004, INZ BIOMATER, V38, P150
   URBANCZYK G, 1962, SCI B TU LODZ, V45, P79
NR 24
TC 17
Z9 17
U1 2
U2 7
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-8995
EI 1097-4628
J9 J APPL POLYM SCI
JI J. Appl. Polym. Sci.
PD JUL 5
PY 2006
VL 101
IS 1
BP 760
EP 765
DI 10.1002/app.23978
PG 6
WC Polymer Science
SC Polymer Science
GA 044NT
UT WOS:000237680000105
DA 2018-10-19
ER

PT J
AU Rana, S
   Rawat, J
   Sorensson, MM
   Misra, RDK
AF Rana, S
   Rawat, J
   Sorensson, MM
   Misra, RDK
TI Antimicrobial function of Nd3+-doped anatase titania-coated nickel
   ferrite composite nanoparticles: A biomaterial system
SO ACTA BIOMATERIALIA
LA English
DT Article
DE antimicrobial function; photocatalysis titania; doping; composite
   nanoparticles
ID REVERSE MICELLE TECHNIQUE; SEMICONDUCTOR PHOTOCATALYSIS; TIO2
   NANOPARTICLES; DINITROGEN PHOTOREDUCTION; MAGNETIC CORE; WATER;
   OXIDATION; DIOXIDE; POWDERS; STERILIZATION
AB The present study describes and makes a relative comparison of the antimicrobial function of undoped and neodymium-doped titania coated-nickel ferrite composite nanoparticles processed by uniquely combining the reverse micelle and chemical hydrolysis approaches. This methodology facilitates the formation of undoped and doped photocatalytic titania shells and a magnetic ferrite core. The ferrite core is needed to help in the removal of particles from the sprayed surface using a small magnetic field. Doping of the titania shell with neodymium significantly enhances the photocatalytic and anti-microbial function of the core-shell composite nanoparticles without influencing the magnetic characteristics of the nickel ferrite core. The increased performance is believed to be related to the inhibition of electron-hole recombination and a decrease in the band gap energy of titania. The retention of magnetic strength ensures controlled movement of the composite nanoparticles by the magnetic field, facilitating their application as removable anti-microbial photocatalyst nanoparticles. The consistent behavior of the composite nanoparticles points to the viability of the synthesis process adopted. (c) 2006 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
C1 Univ SW Louisiana, Ctr Struct & Funct Mat, Lafayette, LA 70504 USA.
   Univ SW Louisiana, Dept Chem Engn, Lafayette, LA 70504 USA.
   Univ SW Louisiana, Dept Chem, Lafayette, LA 70504 USA.
RP Misra, RDK (reprint author), Univ SW Louisiana, Ctr Struct & Funct Mat, POB 44130, Lafayette, LA 70504 USA.
EM dmisra@louisiana.edu
RI Dom, Rekha/B-7113-2012
CR ADACHI M, 2003, J ELECTROCHEM SOC, V150, P488
   BORGARELLO E, 1982, J AM CHEM SOC, V104, P2996, DOI 10.1021/ja00375a010
   FOX MA, 1993, CHEM REV, V93, P341, DOI 10.1021/cr00017a016
   FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0
   GRATZEL M, 1990, J PHYS CHEM-US, V94, P2566
   Gubbala S, 2004, PHYSICA B, V348, P317, DOI 10.1016/j.physb.2003.12.017
   HARRIS GD, 1987, WATER RES, V21, P687, DOI 10.1016/0043-1354(87)90080-7
   Heller A, 1995, ACCOUNTS CHEM RES, V28, P503, DOI 10.1021/ar00060a006
   HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004
   HUANG Z, 2000, J PHOTOCH PHOTOBIO A, V130, P163, DOI DOI 10.1016/S1010-6030(99)00205-1
   Lachheb H, 2002, APPL CATAL B-ENVIRON, V39, P75, DOI 10.1016/S0926-3373(02)00078-4
   Li W, 2003, APPL PHYS LETT, V83, P4143, DOI 10.1063/1.1627962
   LUO ZH, 1992, J PHOTOCH PHOTOBIO A, V63, P367, DOI 10.1016/1010-6030(92)85202-6
   Maness PC, 1999, APPL ENVIRON MICROB, V65, P4094
   Marci G, 2003, ANN CHIM-ROME, V93, P639
   Martinez B, 1998, PHYS REV LETT, V80, P181, DOI 10.1103/PhysRevLett.80.181
   MATSUNAGA T, 1985, FEMS MICROBIOL LETT, V29, P211
   MATSUNAGA T, 1988, APPL ENVIRON MICROB, V54, P1330
   MATSUNAGA T, 1995, ENVIRON SCI TECHNOL, V29, P501, DOI 10.1021/es00002a028
   Mills A, 1997, J PHOTOCH PHOTOBIO A, V108, P1, DOI 10.1016/S1010-6030(97)00118-4
   MILLS A, 1993, CHEM SOC REV, V22, P417, DOI 10.1039/cs9932200417
   Misra RDK, 2004, MAT SCI ENG B-SOLID, V111, P164, DOI 10.1016/j.mseb.2004.04.014
   MU W, 1989, CATAL LETT, V3, P73, DOI 10.1007/BF00765057
   NAVIO JA, 1991, J PHOTOCH PHOTOBIO A, V55, P319, DOI 10.1016/1010-6030(91)87033-R
   Ollis D.F., 1993, PHOTOCATALYTIC PURIF
   PALMISANO L, 1988, J PHYS CHEM-US, V92, P6710, DOI 10.1021/j100334a044
   Rana S, 2005, ACTA BIOMATER, V1, P691, DOI 10.1016/j.actbio.2005.07.007
   Rana S, 2005, MAT SCI ENG B-SOLID, V119, P144, DOI 10.1016/j.mseb.2005.02.043
   Rincon AG, 2001, J PHOTOCH PHOTOBIO A, V139, P233, DOI 10.1016/S1010-6030(01)00374-4
   Shah SI, 2002, P NATL ACAD SCI USA, V99, P6482, DOI 10.1073/pnas.052518299
   SORIA J, 1991, J PHYS CHEM-US, V95, P274, DOI 10.1021/j100154a052
   Sunada K, 2003, J PHOTOCH PHOTOBIO A, V156, P227, DOI 10.1016/S1010-6030(02)00434-3
   Wang YQ, 2000, J MOL CATAL A-CHEM, V151, P205, DOI 10.1016/S1381-1169(99)00245-9
   Yun CY, 2004, WATER SCI TECHNOL, V49, P177
   XRAY POWDER JCPDS DI
NR 35
TC 140
Z9 142
U1 2
U2 35
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1742-7061
J9 ACTA BIOMATER
JI Acta Biomater.
PD JUL
PY 2006
VL 2
IS 4
BP 421
EP 432
DI 10.1016/j.actbio.2006.03.005
PG 12
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 059OT
UT WOS:000238742800006
PM 16765882
DA 2018-10-19
ER

PT J
AU Bellamkonda, RV
AF Bellamkonda, RV
TI Peripheral nerve regeneration: An opinion on channels, scaffolds and
   anisotropy
SO BIOMATERIALS
LA English
DT Article
DE neutral tissue engineering; hydrogels; nanofibers
ID CHONDROITIN SULFATE PROTEOGLYCAN; MOUSE SCIATIC-NERVE; GROWTH CONES;
   LAMININ; REPAIR; FIBRONECTIN; GRADIENT; INJURY
AB Peripheral nerve regeneration presents a significant clinical challenge and the Current state of the art using autografts to repair long peripheral nerve gaps is unsatisfactory. In this manuscript, the analytical framework that determines the fate of grafts (autografts or biomaterial-based grafts) is discussed. Also outlined are parameters and variables that might be manipulated to enhance the efficacy of scaffolds designed for peripheral nerve regeneration. The importance Of using appropriate animal models and outcome measures in evaluating biomaterials-based scaffolds or other engineered constructs suitability for bridging peripheral nerve gaps is highlighted. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Lab Neuroengn, Atlanta, GA 30332 USA.
RP Bellamkonda, RV (reprint author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Lab Neuroengn, 313 Ferst Dr,Suite 3108, Atlanta, GA 30332 USA.
EM ravi@gatech.edu
FU NINDS NIH HHS [NS44409]
CR Adams DN, 2005, J NEUROBIOL, V62, P134, DOI 10.1002/neu.20075
   AEBISCHER P, 1987, BRAIN RES, V436, P165, DOI 10.1016/0006-8993(87)91570-8
   ARCHIBALD SJ, 1991, J COMP NEUROL, V306, P685, DOI 10.1002/cne.903060410
   Cao X, 2003, NEUROSCIENCE, V122, P381, DOI 10.1016/j.neuroscience.2003.08.018
   Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X
   Dobkin BH, 2004, ANN NY ACAD SCI, V1038, P148, DOI 10.1196/annals.1315.024
   DODLA M, IN PRESS J BIOMED MA
   Evans GRD, 2001, ANAT RECORD, V263, P396, DOI 10.1002/ar.1120
   GOMEZ TM, 1994, J NEUROSCI, V14, P5959
   Hudson TW, 1999, CLIN PLAST SURG, V26, P617
   Kihara K, 1996, AM J PHYSIOL-REG I, V271, pR1481
   MOLANDER H, 1982, MUSCLE NERVE, V5, P54, DOI 10.1002/mus.880050110
   Nichols CM, 2004, EXP NEUROL, V190, P347, DOI 10.1016/j.expneurol.2004.08.003
   NYILAS E, 1983, T AM SOC ART INT ORG, V29, P307
   Snow DM, 1996, INT J DEV NEUROSCI, V14, P331, DOI 10.1016/0736-5748(96)00017-2
   UZMAN BG, 1983, J NEUROSCI RES, V9, P325, DOI 10.1002/jnr.490090309
   VALENTINI RF, 1989, BRAIN RES, V480, P300, DOI 10.1016/0006-8993(89)90196-0
   Zuo J, 1998, J NEUROBIOL, V34, P41, DOI 10.1002/(SICI)1097-4695(199801)34:1<41::AID-NEU4>3.0.CO;2-C
NR 18
TC 229
Z9 247
U1 2
U2 59
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2006
VL 27
IS 19
BP 3515
EP 3518
DI 10.1016/j.biomaterials.2006.02.030
PG 4
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 037CW
UT WOS:000237125300001
PM 16533522
DA 2018-10-19
ER

PT J
AU Liu, XY
   Huang, AP
   Ding, CX
   Chu, PK
AF Liu, XY
   Huang, AP
   Ding, CX
   Chu, PK
TI Bioactivity and cytocompatibility of zirconia (ZrO2) films fabricated by
   cathodic arc deposition
SO BIOMATERIALS
LA English
DT Article
DE ZrO2; thin film; cathodic arc deposition; bioactivity; apatite
ID SIMULATED BODY-FLUID; APATITE FORMATION; GLASS; BONE; HYDROXYAPATITE;
   BIOMATERIAL; ADSORPTION; PARTICLES; COATINGS; CELLS
AB Zirconium oxide thin films were fabricated on silicon wafers using a filtered cathodic arc system in concert with oxygen plasma. The Structure and phase composition of the zirconium oxide thin films were characterized by atomic force microscopy (AFM), X-ray diffraction (XRD), Rutherford backscattering spectrometry (RBS), and transmission electron microscopy (TEM). The bioactivity was assessed by investigating the formation of apatite on the film surface after soaking in simulated body fluids. Bone marrow mesenchymal stem cells (BMMSC) were used to further evaluate the cytocompatibility of the materials. The results indicate that the films are composed of stoichiometric ZrO2 and the composition is quite uniform throughout the thickness. Bone-like apatite can be formed on the surface of the ZrO2 thin film in Our SBF immersion experiments, suggesting that the surface is bioactive. The outermost layer of the ZrO2 thin film comprises nano-sized particles that can be identified by AFM images taken on the thin film surface and TEM micrographs obtained from the interface between the ZrO2 thin film and apatite layer. The nanostructured surface is believed to be the key factor that apatite is induced to precipitate on the surface. Bone marrow mesenchymal stem cells are observed to grow and proliferate in good states on the film surface. Our results Show that ZrO2 thin films fabricated by cathodic arc deposition exhibit favorable bioactivity and cytocompatibility. (c) 2006 Elsevier Ltd. All rights reserved.
C1 City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon, Hong Kong, Peoples R China.
   Chinese Acad Sci, Shanghai Inst Ceram, Shanghai 200050, Peoples R China.
   Hunan Univ, Coll Mat Sci & Engn, Changsha 4100082, Peoples R China.
RP Liu, XY (reprint author), City Univ Hong Kong, Dept Phys & Mat Sci, Tat Chee Ave, Kowloon, Hong Kong, Peoples R China.
EM xyliu@mail.sic.ac.cn; paul.chu@cityu.edu.hk
RI Chu, Paul/B-5923-2013; Liu, Xuanyong/J-2609-2018
OI Chu, Paul/0000-0002-5581-4883; 
CR Bosetti M, 2001, BIOMATERIALS, V22, P987, DOI 10.1016/S0142-9612(00)00264-7
   CANHAM LT, 1996, S NOV 28 29 1995 BOS, P189
   Chevalier J, 2006, BIOMATERIALS, V27, P535, DOI 10.1016/j.biomaterials.2005.07.034
   Dobson KD, 1997, LANGMUIR, V13, P3392, DOI 10.1021/la962024i
   Fang MM, 1997, J AM CHEM SOC, V119, P12184, DOI 10.1021/ja972569e
   Ferraris M, 2000, BIOMATERIALS, V21, P765, DOI 10.1016/S0142-9612(99)00209-4
   Gua Y.W., 2005, BIOMATERIALS, V26, P713
   Hirst RA, 2002, INFECT IMMUN, V70, P1017, DOI 10.1128/IAI.70.2.1017-1022.2002
   *ISO, 1995, 13356 ISODIS
   *ISO, 1995, 150SC 1 ISO TC
   Kim HW, 2003, BIOMATERIALS, V24, P3277, DOI 10.1016/S0142-9612(03)00162-5
   KOKUBO T, 1990, J BIOMED MATER RES, V24, P721, DOI 10.1002/jbm.820240607
   Liu SQ, 2002, BIOELECTROCHEMISTRY, V57, P149, DOI 10.1016/S1567-5394(02)00114-7
   Liu XY, 2005, BIOMATERIALS, V26, P6143, DOI 10.1016/j.biomaterials.2005.04.035
   Liu XY, 2003, SURF COAT TECH, V172, P270, DOI 10.1016/S0257-8972(03)00344-X
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Mendez-Vivar J, 2001, J NON-CRYST SOLIDS, V288, P200, DOI 10.1016/S0022-3093(01)00644-5
   Moritz T, 2001, SEP PURIF TECHNOL, V25, P501, DOI 10.1016/S1383-5866(01)00080-6
   Nakamoto K., 1986, INFRARED RAMAN SPECT, P124
   Pecharroman C, 1996, J APPL PHYS, V80, P3479, DOI 10.1063/1.363218
   Pettersson A, 2000, J COLLOID INTERF SCI, V228, P73, DOI 10.1006/jcis.2000.6939
   PHILLIPPI CM, 1971, J AM CERAM SOC, V54, P254, DOI 10.1111/j.1151-2916.1971.tb12283.x
   Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6
   Stanic V, 2002, BIOMATERIALS, V23, P3833, DOI 10.1016/S0142-9612(02)00119-9
   Svetina M, 2001, ACTA MATER, V49, P2169, DOI 10.1016/S1359-6454(01)00136-7
   Uchida M, 2002, J CERAM SOC JPN, V110, P710, DOI 10.2109/jcersj.110.710
   Uchida M, 2002, J BIOMED MATER RES, V60, P277, DOI 10.1002/jbm.10071
   Uchida M, 2002, BIOMATERIALS, V23, P313, DOI 10.1016/S0142-9612(01)00110-7
   Vayssieres L, 1998, J COLLOID INTERF SCI, V205, P205, DOI 10.1006/jcis.1998.5614
   Weng J, 1997, BIOMATERIALS, V18, P1027, DOI 10.1016/S0142-9612(97)00022-7
   Yang YZ, 2003, BIOMATERIALS, V24, P619, DOI 10.1016/S0142-9612(02)00376-9
   Zhang HZ, 1999, J PHYS CHEM B, V103, P4656, DOI 10.1021/jp984574q
   Zhang T, 2002, APPL PHYS LETT, V80, P3700, DOI 10.1063/1.1481235
   Zhu NN, 2004, ANAL CHIM ACTA, V510, P163, DOI 10.1016/j.aca.2004.01.017
NR 34
TC 66
Z9 72
U1 4
U2 30
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2006
VL 27
IS 21
BP 3904
EP 3911
DI 10.1016/j.biomaterials.2006.03.007
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 041PD
UT WOS:000237467200005
PM 16564082
DA 2018-10-19
ER

PT J
AU Qu, CY
   Qin, QH
   Kang, YL
AF Qu, CY
   Qin, QH
   Kang, YL
TI A hypothetical mechanism of bone remodeling and modeling under
   electromagnetic loads
SO BIOMATERIALS
LA English
DT Article
DE bone modeling and remodeling; electromagnetic field; biomaterial;
   biomechanics
ID ADAPTIVE ELASTICITY; TRANSVERSE LOADS; FATIGUE DAMAGE; MECHANOSTAT;
   PIEZOELECTRICITY; PARADIGM; REPAIR; FIELDS
AB A hypothetical regulation mechanism for bone modeling- and remodeling under electromagnetic field is proposed. In this hypothesis, the bone modeling and remodeling mechanism is described as follows: the circular loads that we bear during ordinary daily activities generate micro-damage in cortical bone and these micro-cracks are removed by osteoclasts. Then growth factors, which are in latent forms in osteocytes, are activated by osteoclasts and released into bone fluid. These growth factors stimulate osteoblasts to refill the cavities. An electromagnetic field can stimulate the multiplication of growth factors and accelerate the bone remodeling process indirectly. It can be seen that many features reported in adaptive bone modeling and remodeling are explained by the proposed hypothesis. Further, a computational model is established based on the hypothesis, which can simulate the bone modeling and remodeling process under multi-field loads. (c) 2006 Elsevier Ltd. All rights reserved.
C1 Australian Natl Univ, Dept Engn, Canberra, ACT, Australia.
   Tianjin Univ, Dept Mech, Tianjin 300072, Peoples R China.
RP Qin, QH (reprint author), Australian Natl Univ, Dept Engn, GPO Box 4, Canberra, ACT, Australia.
EM qinghua.qin@anu.edu.au
RI Qin, Qinghua/A-4845-2008
OI Qin, Qinghua/0000-0003-0948-784X
CR Albright J. A., 1987, SCI BASIS ORTHOPAEDI
   Asahina Izumi, 1997, Journal of Medical and Dental Sciences, V44, P63
   BEAUPRE GS, 1990, J ORTHOPAED RES, V8, P662, DOI 10.1002/jor.1100080507
   BEAUPRE GS, 1990, J ORTHOP RES, V8, P651, DOI 10.1002/jor.1100080506
   BESSETT CA, 1982, J BONE JOINT SURG AM, V64, P888
   COWIN SC, 1976, J ELASTICITY, V6, P313, DOI 10.1007/BF00041724
   COWIN SC, 1978, J ELASTICITY, V8, P285, DOI 10.1007/BF00130467
   FITZSIMMONS RJ, 1992, J CELL PHYSIOL, V150, P84, DOI 10.1002/jcp.1041500112
   Frost HM, 1998, AM J HUM BIOL, V10, P599, DOI 10.1002/(SICI)1520-6300(1998)10:5<599::AID-AJHB6>3.0.CO;2-9
   FROST HM, 1987, ANAT RECORD, V219, P1, DOI 10.1002/ar.1092190104
   Frost HM, 1996, ANAT RECORD, V244, P139, DOI 10.1002/(SICI)1097-0185(199602)244:2<139::AID-AR1>3.0.CO;2-X
   Frost HM, 2003, ANAT REC PART A, V275A, P1081, DOI 10.1002/ar.a.10119
   FUKADA E, 1957, J PHYS SOC JPN, V12, P1158, DOI 10.1143/JPSJ.12.1158
   Giordano N, 2001, CURR THER RES CLIN E, V62, P187, DOI 10.1016/S0011-393X(01)80030-8
   GJELSVIK A, 1973, J BIOMECH, V6, P187, DOI 10.1016/0021-9290(73)90087-0
   GJELSVIK A, 1973, J BIOMECH, V6, P69, DOI 10.1016/0021-9290(73)90039-0
   HART RT, 1989, BONE MECHANICS, P253
   Hazelwood SJ, 2001, J BIOMECH, V34, P299, DOI 10.1016/S0021-9290(00)00221-9
   HEGEDUS DH, 1976, J ELASTICITY, V6, P337, DOI 10.1007/BF00040896
   KELLY PJ, 1990, MICROVASC RES, V39, P364, DOI 10.1016/0026-2862(90)90049-W
   Lammens J, 1998, J BONE MINER RES, V13, P279, DOI 10.1359/jbmr.1998.13.2.279
   Lanyon LE, 1984, CALCIFIED TISSUE INT, V36, P56
   MARTIN B, 1992, J ORTHOP RES, V10, P818, DOI 10.1002/jor.1100100611
   MARTIN B, 1995, J ORTHOP RES, V13, P309, DOI 10.1002/jor.1100130303
   Martin R. B, 1998, SKELETAL TISSUE MECH
   MARTIN RB, 1985, YEARB PHYS ANTHROPOL, V28, P227
   MARTIN RB, 1982, J BIOMECH, V15, P37
   MCLEOD KJ, 1992, J BONE JOINT SURG AM, V74A, P920, DOI 10.2106/00004623-199274060-00014
   NAGAI M, 1994, J DENT RES, V73, P1601, DOI 10.1177/00220345940730100401
   NEILSEN HM, 1994, ACTA ORTHOP SCAND, V64, P106
   Qin QH, 2005, BIOMATERIALS, V26, P6798, DOI 10.1016/j.biomaterials.2005.03.042
   Qin QH, 2004, INT J SOLIDS STRUCT, V41, P2447, DOI 10.1016/j.ijsolstr.2003.12.026
   Qu C. Y., 2005, P 9 INT C INSP APPR, P373
   RUIMERMAN R, 2005, THESIS EINDHOVEN, P3
   Turner CH, 1998, BONE, V23, P399, DOI 10.1016/S8756-3282(98)00118-5
   Weinreb M, 1997, BONE, V20, P521, DOI 10.1016/S8756-3282(97)00033-1
   Wolff J., 1892, GESETZ TRANSFORMATIO
   Zhung H.M., 1997, BIOCHEM BIOPH RES CO, V237, P225
NR 38
TC 23
Z9 28
U1 2
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0142-9612
J9 BIOMATERIALS
JI Biomaterials
PD JUL
PY 2006
VL 27
IS 21
BP 4050
EP 4057
DI 10.1016/j.biomaterials.2006.03.015
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 041PD
UT WOS:000237467200022
PM 16574223
DA 2018-10-19
ER

PT J
AU Kalsi, JS
   Christopher, N
   Ralph, DJ
   Minhas, S
AF Kalsi, Jas S.
   Christopher, Nim
   Ralph, David J.
   Minhas, Sliks
TI Plaque incision and fascia lata grafting in the surgical management of
   Peyronie's disease
SO BJU INTERNATIONAL
LA English
DT Article
DE Peyronie's disease; surgery; grafts; plaque incision
ID FOLLOW-UP; PENILE DEFORMITY; NESBIT OPERATION; CURVATURE
AB OBJECTIVE To assess the outcome of using modified human fascia lata (Tutoplase (TM), Mentor Corp, Santa Barbara, CA, USA) in the surgical management of Peyronie's disease (PD), as the penile deformity associated with PD can be corrected by plaque incision and saphenous vein grafting (Lue procedure).
   PATIENTS AND METHODS In all, 14 patients (mean age 51 years, range 34-59) with PD had their penile deformity corrected by plaque incision and Tutoplast grafting. Three patients had a previous unsuccessful Nesbit operation. The mean (range) penile deformity before surgery was 67.2 (20-90)degrees and the mean follow-up was 31 (17-37) months.
   RESULTS Using set criteria, 13 patients were satisfied (excellent or satisfactory) with the results of surgery. The penis was completely straight in 11 of 14 patients. One patient developed de novo erectile dysfunction after surgery. In 10 patients there was no penile shortening, whereas four reported penile shortening of > 1 cm.
   CONCLUSION Fascia lata Tutoplast grafts provide a reliable and well tolerated biomaterial for penile reconstruction in PD. The outcome of using Tutoplast is similar to that from saphenous vein but without the morbidity associated with the donor site. However, there remains a significant risk of penile shortening and development of erectile dysfunction.
C1 UCL Hosp NHS Trust, Dept Androl & Genital Reconstrunct, London W1P 9LL, England.
   Inst Urol, London, England.
RP Minhas, S (reprint author), UCL Hosp NHS Trust, Dept Androl & Genital Reconstrunct, 2nd Floor,Maple House,149 Tottenham Court Rd, London W1P 9LL, England.
EM sminhas@btinternet.com
CR Andrews HO, 1999, INT J IMPOT RES, V11, P119, DOI 10.1038/sj.ijir.3900390
   AUSTONI E, 1994, J ANDROL, V15, pS57
   DAS S, 1980, J UROLOGY, V124, P818, DOI 10.1016/S0022-5347(17)55682-7
   DEVINE CJ, 1974, J UROLOGY, V111, P44, DOI 10.1016/S0022-5347(17)59886-9
   FitzGerald MP, 2000, BJU INT, V86, P826, DOI 10.1046/j.1464-410x.2000.00917.x
   GELBARD MK, 1991, J UROLOGY, V145, P772, DOI 10.1016/S0022-5347(17)38447-1
   Groutz A, 2001, UROLOGY, V58, P179, DOI 10.1016/S0090-4295(01)01177-3
   Kalsi J, 2005, BJU INT, V95, P1029, DOI 10.1111/j.1464-410X.2005.05459.x
   Kargi E, 2004, PLAST RECONSTR SURG, V113, P254, DOI 10.1097/01.PRS.0000095951.04305.38
   Knoll LD, 2001, UROLOGY, V57, P753, DOI 10.1016/S0090-4295(00)01079-7
   Levine LA, 2003, J UROLOGY, V170, P2359, DOI 10.1097/01.ju.0000091102.10849.95
   LOWE DH, 1982, UROLOGY, V19, P609, DOI 10.1016/0090-4295(82)90010-3
   Lue TF, 1998, J UROLOGY, V160, P2047, DOI 10.1016/S0022-5347(01)62239-0
   McBride AW, 2005, AM J OBSTET GYNECOL, V192, P1677, DOI 10.1016/j.ajog.2005.01.078
   Montorsi F, 2004, J UROLOGY, V171, P331
   PRYOR JP, 1979, J UROLOGY, V122, P622, DOI 10.1016/S0022-5347(17)56530-1
   RALPH DJ, 1995, J UROLOGY, V154, P1362, DOI 10.1016/S0022-5347(01)66862-9
   Sampaio JS, 2002, EUR UROL, V41, P551, DOI 10.1016/S0302-2838(02)00071-4
   Shioshvili TJ, 2005, EUR UROL, V48, P129, DOI 10.1016/j.eururo.2005.01.018
   Syed AH, 2003, UROLOGY, V61, P999, DOI 10.1016/S0090-4295(02)02549-9
   VALE JA, 1996, VASCULAR ANDROLOGY 1, P78
NR 21
TC 20
Z9 20
U1 0
U2 0
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1464-4096
J9 BJU INT
JI BJU Int.
PD JUL
PY 2006
VL 98
IS 1
BP 110
EP 114
DI 10.1111/j.1464-410X.2006.06251.x
PG 5
WC Urology & Nephrology
SC Urology & Nephrology
GA 062MJ
UT WOS:000238948900026
PM 16831154
OA Bronze
DA 2018-10-19
ER

PT J
AU Bunger, MH
   Foss, M
   Erlacher, K
   Li, H
   Zou, X
   Langdahl, BL
   Bunger, C
   Birkedal, H
   Besenbacher, F
   Pedersen, JS
AF Bunger, M. H.
   Foss, M.
   Erlacher, K.
   Li, H.
   Zou, X.
   Langdahl, B. L.
   Bunger, C.
   Birkedal, H.
   Besenbacher, F.
   Pedersen, J. S.
TI Bone nanostructure near titanium and porous tantalum implants studied by
   scanning small angle X-ray scattering
SO EUROPEAN CELLS & MATERIALS
LA English
DT Article
DE small angle X-ray scattering; biocompatibility; orthopaedic implants;
   bone ultrastructure; biomineralization
ID MINERAL CRYSTALS; MODEL; RECONSTRUCTION; BIOMATERIAL; INTERFACE;
   COLLAGEN; GROWTH
AB Bone sections including either titanium or porous tantalum implant devices used for interbody spinal fusion were investigated with position-resolved small angle X-ray scattering (sSAXS). The samples were obtained from six-month-old pigs that had undergone surgery three months prior to sacrifice. The aim of the study was to explore the possibility of using sSAXS to obtain information about thickness, orientation and shape/arrangement of the mineral crystals in bone near the implant surfaces. Detailed sSAXS scans were carried out in two different regions of bone adjacent to the implant in each of the implant samples. In the implant vicinity the mineral crystals tended to be aligned with the surface of the implants. The mean crystal thickness was between 2.1 and 3.0 nm. The mineral crystal thickness increased linearly with distance from the implant in both regions of the porous tantalum implant and in one of the regions in the titanium sample. In the second region of the titanium sample the thickest mineral crystals were found close to the implant surface. The observed differences in mineral thickness with distance from the implant surfaces might be explained by differences in mechanical load induced by the implant material and the geometrical design of the implant. The study shows that sSAXS is a powerful tool to characterize the nanostructure of bone near implant surfaces.
C1 Univ Aarhus, Interdisciplinary Nanosci Ctr INANO, DK-8000 Aarhus C, Denmark.
   Aarhus Univ Hosp, Ortopaed Res Lab, DK-8000 Aarhus, Denmark.
   Aarhus Univ, Dept Phys & Astron, DK-8000 Aarhus, Denmark.
   Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark.
RP Foss, M (reprint author), Univ Aarhus, Interdisciplinary Nanosci Ctr INANO, Bldg 1522,Ny Munkegade, DK-8000 Aarhus C, Denmark.
EM foss@inano.dk
RI Pedersen, Jan/A-8346-2008; Besenbacher, Flemming/A-9623-2010
OI Pedersen, Jan/0000-0002-7768-0206; Birkedal, Henrik/0000-0002-4201-2179
CR Albrektsson T., 2001, EUR SPINE J, V10, P96
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bobyn JD, 2004, J BONE JOINT SURG AM, V86A, P123, DOI 10.2106/00004623-200412002-00017
   Bobyn JD, 1999, J ARTHROPLASTY, V14, P347, DOI 10.1016/S0883-5403(99)90062-1
   Bobyn JD, 1999, ORTHOPEDICS, V22, P810
   Bunger MH, 2006, BONE, V39, P530, DOI 10.1016/j.bone.2006.03.013
   Cedola A, 2006, PHYS MED BIOL, V51, pN109, DOI 10.1088/0031-9155/51/6/N02
   FRATZL P, 1992, J BONE MINER RES, V7, P329
   FRATZL P, 1991, CALCIFIED TISSUE INT, V48, P407, DOI 10.1007/BF02556454
   Fratzl P, 1996, Connect Tissue Res, V34, P247, DOI 10.3109/03008209609005268
   FRATZL P, 1994, J STAT PHYS, V77, P125, DOI 10.1007/BF02186835
   GEFEN A, 2005, REV PHYS MEASUREMENT, V4, P37
   Landis W J, 1999, Gravit Space Biol Bull, V12, P15
   LANDIS WJ, 1993, J STRUCT BIOL, V110, P39, DOI 10.1006/jsbi.1993.1003
   LI H, 2004, DAN MED B, V51, P304
   Li HS, 2005, SPINE, V30, P890, DOI 10.1097/01.brs.0000159097.74426.ea
   LINDNER P, 2002, NEUTRONS XRAYS LIGHT
   MANN S, 2002, BIOMINERALIZATION PR
   Melsen F, 1993, Osteoporos Int, V3 Suppl 1, P98, DOI 10.1007/BF01621876
   Pedersen JS, 2004, J APPL CRYSTALLOGR, V37, P369, DOI 10.1107/S0021889804004170
   Poon WCK, 1997, ADV COLLOID INTERFAC, V73, P71, DOI 10.1016/S0001-8686(97)90003-8
   Rinnerthaler S, 1999, CALCIFIED TISSUE INT, V64, P422, DOI 10.1007/PL00005824
   Smit TH, 2002, EUR SPINE J, V11, P137, DOI 10.1007/s005860100346
   Waite JH, 2004, BIOCHEMISTRY-US, V43, P7653, DOI 10.1021/bi049380h
   Young M. F., 2003, Osteoporosis International, V14, P35
   Zizak I, 2003, J STRUCT BIOL, V141, P208, DOI 10.1016/S1047-8477(02)00635-4
   ZOU X, 2005, SPINE, V30, P392
   Zou Xuenong, 2004, Spine J, V4, P99, DOI 10.1016/S1529-9430(03)00407-8
NR 28
TC 19
Z9 20
U1 1
U2 6
PU SWISS SOCIETY FOR BIOMATERIALS, AO RESEARCH INSTITUTE
PI DAVOS
PA CLAVADELSTRASSE, DAVOS, SWITZERLAND
SN 1473-2262
J9 EUR CELLS MATER
JI Eur. Cells Mater.
PD JUL-DEC
PY 2006
VL 12
BP 81
EP 91
PG 11
WC Cell & Tissue Engineering; Engineering, Biomedical; Materials Science,
   Biomaterials; Orthopedics
SC Cell Biology; Engineering; Materials Science; Orthopedics
GA 140JP
UT WOS:000244501200016
PM 17136679
OA DOAJ Gold
DA 2018-10-19
ER

PT J
AU Alobaid, N
   Salacinski, HJ
   Sales, KM
   Ramesh, B
   Kannan, RY
   Hamilton, G
   Seifalian, AM
AF Alobaid, N.
   Salacinski, H. J.
   Sales, K. M.
   Ramesh, B.
   Kannan, R. Y.
   Hamilton, G.
   Seifalian, A. M.
TI Nanocomposite containing bioactive peptides promote endothelialisation
   by circulating progenitor cells: An in vitro evaluation
SO EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
LA English
DT Article
DE nanocomposite; tissue engineering; stem cells; endothelial progenitor
   cells; bypass graft; peptides; vascular; RGD; silsesquioxane
ID INFRAINGUINAL EPTFE GRAFTS; CORONARY-ARTERY-DISEASE; BYPASS GRAFTS;
   ANGIOGENESIS; MOBILIZATION; SCAFFOLDS; ISCHEMIA; INCREASE
AB Objective. The formation of an endothelial cell layer on the luminal surface of cardiovascular devices, especially bypass grafts, is an important attribute in order to improve their patency. Endothelial progenitor cells (EPCs) have a potential role in the endothelialisation of bypass grafts. We hypothesised that a novel approach to improve endothelialisation of bypass grafts by EPCs would be the creation on the graft lumen of a microenvironment that supports EPC adhesion and differentiation.
   Methods. A new generation of nanocomposite based on silsesquioxane in the form of polyhedral oligomeric silsesquioxane (POSS) nanocages which incorporate bioactive peptides (RGD) was made into sheets. Peripheral blood mononuclear cells (PBMCs) containing EPCs isolated from six consenting young, healthy, adult volunteers were then plated both on (1) sheets of the nanocomposite with the bioactive peptide, (2) sheets of the nanocomposite without the bioactive peptide, (3) culture dishes as control and then cultured in Presence of vascular endothelial growth factor (VEGF). Confirmation of endothelial and EPCs markers was carried out using fluorescence-activated cell sorter (FACS) analysis, reverse transcription polymerase chain reaction (RT-PCR) and immunostaining.
   Results. One to two percent of PBMCs expressed CD34 as determined by FACS analysis. Cells were demonstrated to express mRNA for the EPC markers CD34, platelet-endothelial cell adhesion molecule-1 (CD31), CD133 and vascular endothelial growth factor receptor-2(FlK-1/KDR). Endothelial cell-colony forming units were formed between day 5 and day 7 after plating. Colonies were confirmed to be endothelial like cells by immunostaining. There were significantly greater numbers of EPC colonies on the bioactive nanocomposites as compared to the nanocomposite alone and the uncoated dishes.
   Conclusion. We report a new nanocomposite based biomaterial that has been demonstrated, in vitro, to promote endothelialisation from PBMCs containing EPCs.
C1 UCL, Acad Div Surg & Intervent Sci, Biomat & Tissue Engn Ctr, London NW3 2PF, England.
   Royal Free Hampstead NHS Trust Hosp, Vasc Unit, London NW3 2QG, England.
   UCL, Dept Prot & Mol Biol, London NW3 2PF, England.
RP Seifalian, AM (reprint author), UCL, Acad Div Surg & Intervent Sci, Biomat & Tissue Engn Ctr, Rowland Hill St, London NW3 2PF, England.
EM a.seifalian@medsch.ucl.ac.uk
RI Seifalian, Alexander/I-6028-2013
OI Seifalian, Alexander/0000-0002-1180-3322
CR Adams V, 2004, ARTERIOSCL THROM VAS, V24, P684, DOI 10.1161/01.ATV.0000124104.23702.a0
   Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0
   Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964
   Bahlmann FH, 2004, BLOOD, V103, P921, DOI 10.1182/blood-2003-04-1284
   Campbell JH, 2001, ANN NY ACAD SCI, V947, P18
   Deutsch M, 1999, SURGERY, V126, P847, DOI 10.1067/msy.2099.99852
   Havemann K, 2003, ADV EXP MED BIOL, V522, P47
   Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287
   Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Kannan RY, 2005, ACCOUNTS CHEM RES, V38, P879, DOI 10.1021/ar050055b
   Kidane AG, 2004, BIOMACROMOLECULES, V5, P798, DOI 10.1021/bm0344553
   Kidane AG, 2003, MED BIOL ENG COMPUT, V41, P740, DOI 10.1007/BF02349983
   Lev EI, 2005, J VASC RES, V42, P408, DOI 10.1159/000087370
   Meinhart JG, 2001, ANN THORAC SURG, V71, pS327, DOI 10.1016/S0003-4975(01)02555-3
   Mooney D, 2001, NAT MED, V7, P996, DOI 10.1038/nm0901-996b
   Rafii S, 2002, GENE THER, V9, P631, DOI 10.1038/sj/gt/3301723
   Rashid ST, 2004, EUR J VASC ENDOVASC, V27, P608, DOI 10.1016/j.ejvs.2004.01.020
   Roberts N, 2005, J CELL MOL MED, V9, P583, DOI 10.1111/j.1582-4934.2005.tb00490.x
   ROHDE E, 2005, STEM CELLS      0901
   SALACINSKI HJ, 2005, Patent No. 2005000189
   Sales KM, 2005, TRENDS BIOTECHNOL, V23, P461, DOI 10.1016/j.tibtech.2005.06.006
   Seifalian AM, 2003, BIOMATERIALS, V24, P2549, DOI 10.1016/S0142-9612(02)00608-7
   Seifalian AM, 2002, ARTIF ORGANS, V26, P307, DOI 10.1046/j.1525-1594.2002.06841.x
   Silver JH, 1999, BIOMATERIALS, V20, P1533, DOI 10.1016/S0142-9612(98)00173-2
   Strehlow K, 2003, CIRCULATION, V107, P3059, DOI 10.1161/01.CIR.0000077911.81151.30
   TAI NR, 2000, BRIT J SURG, V87, P1480
   Takahashi T, 1999, NAT MED, V5, P434
   Tiwari A, 2003, EUR J VASC ENDOVASC, V25, P325, DOI 10.1053/ejvs.2002.1854
   Tiwari A, 2002, FASEB J, V16, DOI 10.1096/fj.01-0826com
   Vara DS, 2005, BIOMATERIALS, V26, P3987, DOI 10.1016/j.biomaterials.2004.10.015
   Vasa M, 2001, CIRCULATION, V103, P2885, DOI 10.1161/hc2401.092816
   Wijelath ES, 2004, J VASC SURG, V39, P655, DOI 10.1016/j.jvs.2003.10.042
   Wu X, 2004, AM J PHYSIOL-HEART C, V287, pH480, DOI 10.1152/ajpheart.01232.2003
   Zisch AH, 2004, CURR OPIN BIOTECH, V15, P424, DOI 10.1016/j.copbio.2004.08.005
NR 35
TC 52
Z9 55
U1 0
U2 10
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 1078-5884
J9 EUR J VASC ENDOVASC
JI Eur. J. Vasc. Endovasc. Surg.
PD JUL
PY 2006
VL 32
IS 1
BP 76
EP 83
DI 10.1016/j.ejvs.2005.11.034
PG 8
WC Surgery; Peripheral Vascular Disease
SC Surgery; Cardiovascular System & Cardiology
GA 060JF
UT WOS:000238797800014
PM 16466940
OA Bronze
DA 2018-10-19
ER

PT J
AU Ayyala, RS
   Duarte, JL
   Sahiner, N
AF Ayyala, Ramesh S.
   Duarte, Jessica Laursen
   Sahiner, Nurettin
TI Glaucoma drainage devices: state of the art
SO EXPERT REVIEW OF MEDICAL DEVICES
LA English
DT Review
DE biomaterial; fibrosis; glaucoma drainage devices
ID RANDOMIZED CLINICAL-TRIAL; MOLTENO IMPLANT-SURGERY; DOUBLE-PLATE
   MOLTENO; ADJUNCTIVE MITOMYCIN-C; 500-MM(2) BAERVELDT IMPLANT; AHMED
   GLAUCOMA; REFRACTORY GLAUCOMA; VALVE IMPLANT; SINGLE-PLATE; COMPLICATED
   GLAUCOMAS
AB Glaucoma drainage devices (GDDs) create an alternate aqueous pathway by channeling aqueous from the anterior chamber through a long tube to an equatorial plate, inserted under the conjunctiva, which promotes bleb formation. GDDs are being used more frequently in the treatment of glaucoma, both as the primary procedure of choice and following failure of trabeculectomy operations. This article outlines the current concepts involving different GDDs, surgical techniques and a review of the current literature. In addition, the importance of the biomaterial and its implications for the success of the operation are discussed.
C1 Tulane Univ, Med Ctr, Dept Ophthalmol, Glaucoma Serv, New Orleans, LA 70112 USA.
   Univ Delaware, Newark, DE USA.
RP Ayyala, RS (reprint author), Tulane Univ, Med Ctr, Dept Ophthalmol, Glaucoma Serv, 1430 Tulane Ave SL-69, New Orleans, LA 70112 USA.
EM rayyala@tulane.edu
OI Sahiner, Nurettin/0000-0003-0120-530X
CR AIRAKSINEN PJ, 1990, ACTA OPHTHALMOL, V68, P690
   Aung T, 1998, OPHTHALMOLOGY, V105, P2117, DOI 10.1016/S0161-6420(98)91136-8
   Ayyala RS, 1998, OPHTHALMOLOGY, V105, P1968, DOI 10.1016/S0161-6420(98)91049-1
   Ayyala RS, 2004, J GLAUCOMA, V13, P145, DOI 10.1097/00061198-200404000-00011
   Ayyala RS, 1998, OPHTHALMOLOGY, V105, P1550, DOI 10.1016/S0161-6420(98)98046-0
   Ayyala RS, 2002, OPHTHALMIC SURG LAS, V33, P94
   Ayyala RS, 2001, OPHTHALMIC SURG LAS, V32, P248
   Ayyala RS, 2000, ARCH OPHTHALMOL-CHIC, V118, P1081, DOI 10.1001/archopht.118.8.1081
   Ayyala RS, 1999, ARCH OPHTHALMOL-CHIC, V117, P233
   BEEBE WE, 1990, OPHTHALMOLOGY, V97, P1414
   BIGAR F, 1982, OPHTHALMOLOGY, V89, P596
   BLAKE DA, IN PRESS J GLAUCOMA
   BOCK RH, 1950, AM J OPHTHALMOL, V33, P929, DOI 10.1016/0002-9394(50)91610-2
   Britt MT, 1999, OPHTHALMOLOGY, V106, P2312, DOI 10.1016/S0161-6420(99)90532-8
   Broadway DC, 2001, BRIT J OPHTHALMOL, V85, P689, DOI 10.1136/bjo.85.6.689
   BROWN RD, 1983, T OPHTHAL SOC UK, V103, P297
   Cantor L, 1998, J GLAUCOMA, V7, P240
   Chung HA, 2004, J BIOMED MATER RES A, V70A, P179, DOI 10.1002/jbm.a.20117
   COLEMAN AL, 1995, AM J OPHTHALMOL, V120, P23, DOI 10.1016/S0002-9394(14)73755-9
   Dahan E, 2005, J GLAUCOMA, V14, P98, DOI 10.1097/01.ijg.0000151688.34904.b7
   DOWNES RN, 1988, EYE, V2, P250, DOI 10.1038/eye.1988.50
   EGBERT PR, 1989, OPHTHALMIC SURG LAS, V20, P53
   EPSTEIN E, 1959, Br J Ophthalmol, V43, P641, DOI 10.1136/bjo.43.11.641
   FELLENBAUM PS, 1994, OPHTHALMOLOGY, V101, P1178
   FLEISS JL, 1981, COMP PROPORTIONS SEV, P138
   FREEDMAN J, 1991, ARCH OPHTHALMOL-CHIC, V109, P1417, DOI 10.1001/archopht.1991.01080100097051
   FREEDMAN J, 1985, OPHTHALMIC SURG LAS, V16, P480
   FREEDMAN J, 1992, OPHTHALMIC SURG LAS, V23, P238
   Goldman VJ, 1997, PHYSICA E, V1, P15, DOI 10.1016/S1386-9477(98)00004-6
   HEUER DK, 1992, OPHTHALMOLOGY, V99, P1512
   Hill RA, 2000, AM J OPHTHALMOL, V129, P608, DOI 10.1016/S0002-9394(99)00465-1
   HINKLE DH, 2005, COMP POLYPROPYLENE P
   HODKIN MJ, 1995, AM J OPHTHALMOL, V120, P32, DOI 10.1016/S0002-9394(14)73756-0
   Hong CH, 2005, SURV OPHTHALMOL, V50, P48, DOI 10.1016/j.survophthal.2004.10.006
   Huang MC, 1999, AM J OPHTHALMOL, V127, P27, DOI 10.1016/S0002-9394(98)00394-8
   JacobLaBarre JT, 1996, INVEST OPHTH VIS SCI, V37, P1164
   Joos KM, 2001, OPHTHALMOLOGY, V108, P279, DOI 10.1016/S0161-6420(00)00521-2
   Kaci M, 2005, MACROMOL MATER ENG, V290, P802, DOI 10.1002/mame.200500096
   KAHOOK MY, 2006, BR J OPHTHALMOL, DOI DOI 10.1136/BJO.2006.091272
   Kee C, 2001, J GLAUCOMA, V10, P466, DOI 10.1097/00061198-200112000-00005
   KHOLODOVYCH V, 2004, POLYMER, V4, P7367
   Kirkness C M, 1987, Dev Ophthalmol, V14, P161
   Kook MS, 2000, OPHTHALMIC SURG LAS, V31, P100
   Krishna R, 2001, OPHTHALMOLOGY, V108, P621, DOI 10.1016/S0161-6420(00)00537-6
   KRUPIN T, 1976, AM J OPHTHALMOL, V81, P232, DOI 10.1016/0002-9394(76)90737-6
   KRUPIN T, 1994, OPHTHALMOLOGY, V101, P651
   Lai JSM, 2000, BRIT J OPHTHALMOL, V84, P718, DOI 10.1136/bjo.84.7.718
   LATINA MA, 1990, OPHTHALMIC SURG LAS, V21, P444
   Law SK, 2005, OPHTHALMOLOGY, V112, P1514, DOI 10.1016/j.ophtha.2005.04.012
   Lee D, 1997, OPHTHALMOLOGY, V104, P2126, DOI 10.1016/S0161-6420(97)30050-5
   Leen MM, 1996, ARCH OPHTHALMOL-CHIC, V114, P223
   LLOYD MA, 1994, OPHTHALMOLOGY, V101, P1456
   LLOYD MA, 1991, OPHTHALMOLOGY, V98, P1401
   LLOYD MAE, 1994, OPHTHALMOLOGY, V101, P640
   LOTUFO DG, 1991, OPHTHALMIC SURG LAS, V22, P650
   MCDERMOTT ML, 1993, AM J OPHTHALMOL, V115, P93, DOI 10.1016/S0002-9394(14)73530-5
   MERMOUD A, 1992, OPHTHALMOLOGICA, V205, P113, DOI 10.1159/000310324
   Mills RP, 1996, OPHTHALMOLOGY, V103, P299
   Minckler D S, 1987, Trans Am Ophthalmol Soc, V85, P368
   MINCKLER DS, 1988, OPHTHALMOLOGY, V95, P1181
   Minckler DS, 2006, COCHRANE DB SYST REV, V2
   Moghimi SM, 2002, BBA-MOL CELL RES, V1590, P131, DOI 10.1016/S0167-4889(02)00204-5
   Molteno A, 1988, GLAUCOMA, P192
   MOLTENO ACB, 1986, AUST NZ J OPHTHALMOL, V14, P343, DOI 10.1111/j.1442-9071.1986.tb00470.x
   Molteno ACB, 2001, OPHTHALMOLOGY, V108, P2193, DOI 10.1016/S0161-6420(01)00836-3
   Molteno ACB, 2003, OPHTHALMOLOGY, V110, P2198, DOI 10.1016/S0161-6420(03)00803-0
   MOLTENO ACB, 1976, S AFR MED J, V50, P1062
   MOLTENO ACB, 1976, S AFR MED J, V50, P881
   MOLTENO ACB, 1969, BR J OPHTHALMOL, V53, P609
   MOLTENO ACB, 1981, T OPHTHALMOL SOC NZ, V33, P29
   MULDOON WE, 1951, AMA ARCH OPHTHALMOL, V45, P666
   NAIRNE JEAH, 1988, BRIT J OPHTHALMOL, V72, P846
   Nguyen QH, 1998, ARCH OPHTHALMOL-CHIC, V116, P571, DOI 10.1001/archopht.116.5.571
   Nyska A, 2003, J GLAUCOMA, V12, P275, DOI 10.1097/00061198-200306000-00017
   Okano T., 1998, BIORELATED POLYM GEL, P1
   Osada Y, 1998, ADV MATER, V10, P11
   Peppas NA, 2000, EUR J PHARM BIOPHARM, V50, P27, DOI 10.1016/S0939-6411(00)00090-4
   PERKINS TW, 1995, OPHTHALMOLOGY, V102, P91
   Perkins TW, 1998, J GLAUCOMA, V7, P86
   PETITTI DB, 2000, ADV ISSUES META ANAL, P75
   PIANTADOSI S, 1997, OVERVIEWS META ANAL, P419
   Pompe W, 2003, MAT SCI ENG A-STRUCT, V362, P40, DOI 10.1016/S0921-5093(03)00580-X
   PRICE FW, 1989, OPHTHALMIC SURG LAS, V20, P781
   PRICE FW, 1995, OPHTHALMIC SURG LAS, V26, P130
   PUSKAS JE, BIOMACROMOLECULES, V5, P1141
   RAPUANO CJ, 1995, CORNEA, V14, P26
   ROLLETT M, 1906, REV GEN OPHTHALMOL, V25, P481
   Rosiak JM, 1999, NUCL INSTRUM METH B, V151, P56, DOI 10.1016/S0168-583X(99)00118-4
   Schocket S S, 1986, Trans Am Ophthalmol Soc, V84, P743
   SHERWOOD MB, 1993, OPHTHALMOLOGY, V100, P85
   Shintani Hideharu, 2005, Biocontrol Science, V10, P3
   Sidoti PA, 2001, OPHTHALMOLOGY, V108, P1050, DOI 10.1016/S0161-6420(01)00583-8
   SIEGNER SW, 1995, OPHTHALMOLOGY, V102, P1298, DOI 10.1016/S0161-6420(95)30871-8
   SMITH MF, 1995, ARCH OPHTHALMOL-CHIC, V113, P444, DOI 10.1001/archopht.1995.01100040060027
   SMITH MF, 1992, ARCH OPHTHALMOL-CHIC, V110, P1246, DOI 10.1001/archopht.1992.01080210064026
   SMITH SL, 1993, OPHTHALMOLOGY, V100, P914
   STEFANSSON J, 1925, AM J OPHTHALMOL, V8, P681
   Stewart RM, 2005, AM J OPHTHALMOL, V140, P340
   SUSANNA R, 1994, OPHTHALMIC SURG LAS, V25, P458
   SVEDBERGH B, 1975, ACTA OPHTHALMOL, V53, P839
   Svorcik V, 2001, RADIAT PHYS CHEM, V60, P89, DOI 10.1016/S0969-806X(00)00320-0
   Syed HM, 2004, J GLAUCOMA, V13, P38, DOI 10.1097/00061198-200402000-00008
   Tan WB, 2005, J BIOMED MATER RES A, V75A, P56, DOI 10.1002/jbm.a.30410
   Tang LP, 2005, EXPERT REV MED DEVIC, V2, P493, DOI 10.1586/17434440.2.4.493
   TANG LP, 1993, J EXP MED, V178, P2147, DOI 10.1084/jem.178.6.2147
   TENG CC, 1959, AM J OPHTHALMOL, V47, P16, DOI 10.1016/S0002-9394(14)78135-8
   Topouzis F, 1999, AM J OPHTHALMOL, V128, P198, DOI 10.1016/S0002-9394(99)00080-X
   TRAVERSO CE, 1989, INT OPHTHALMOL, V13, P159, DOI 10.1007/BF02028657
   TRONCOSO MU, 1949, AM J OPHTHALMOL, V32, P499, DOI 10.1016/0002-9394(49)90874-0
   Tsai JC, 2003, OPHTHALMOLOGY, V110, P1814, DOI 10.1016/S0161-6420(03)00574-8
   Vadgama P, 2005, ANN RP CH C, V101, P14, DOI 10.1039/b408906p
   VARMA R, 1995, AM J OPHTHALMOL, V119, P401, DOI 10.1016/S0002-9394(14)71224-3
   VERDONCK C, 1995, B SOC BELGE OPHTALMO, V225, P27
   Wamsley S, 2004, AM J OPHTHALMOL, V138, P1049, DOI 10.1016/j.ajo.2004.06.024
   Wang AF, 2006, COLLOID SURFACE B, V47, P57, DOI 10.1016/j.colsurfb.2005.11.016
   WARD WJ, 1987, AUST NZ J OPHTHALMOL, V15, P109, DOI 10.1111/j.1442-9071.1987.tb00054.x
   Wilcox MJ, 2000, J GLAUCOMA, V9, P74
   Wilson MR, 2000, AM J OPHTHALMOL, V130, P267, DOI 10.1016/S0002-9394(00)00473-6
   WILSON RP, 1992, OPHTHALMOLOGY, V99, P672
   Zahr AS, 2005, LANGMUIR, V21, P403, DOI 10.1021/la0478595
   ZORAB A, 1912, OPHTHALMOSCOPE, V10, P258
NR 121
TC 27
Z9 28
U1 0
U2 5
PU FUTURE DRUGS LTD
PI LONDON
PA UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB,
   ENGLAND
SN 1743-4440
J9 EXPERT REV MED DEVIC
JI Expert Rev. Med. Devices
PD JUL
PY 2006
VL 3
IS 4
BP 509
EP 521
DI 10.1586/17434440.3.4.509
PG 13
WC Engineering, Biomedical
SC Engineering
GA 106LL
UT WOS:000242101900016
PM 16866647
DA 2018-10-19
ER

PT J
AU Ekholm, M
   Helander, P
   Hietanen, J
   Lindqvist, C
   Salo, A
   Kellomaki, M
   Suuronen, R
AF Ekholm, M.
   Helander, P.
   Hietanen, J.
   Lindqvist, C.
   Salo, A.
   Kellomaki, M.
   Suuronen, R.
TI A histological and immunohistochemical study of tissue reactions to
   solid poly(ortho ester) in rabbits
SO INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY
LA English
DT Article
DE solid poly(ortho ester); bone substitute; foreign body reaction;
   tenascin; fibronectin
ID FIBRIN-COLLAGEN PASTE; DEMINERALIZED BONE; BIOERODIBLE POLYORTHOESTER;
   BIOABSORBABLE POLYMERS; CELLULAR FIBRONECTIN; RATS; FIXATION; INDUCTION;
   IMPLANTS; TENASCIN
AB In many cases only the temporary presence of a biomaterial is needed in tissue support, augmentation or replacement. In such cases biodegradable materials are better alternatives than biostable ones. At present, biodegradable polymers are widely used in the field of maxillofacial surgery as sutures, fracture fixation devices and as absorbable membranes. The most often used polymers are aliphatic polyesters, such as polyglycolic acid (PGA) and polylactic acid (PLA). Poly(ortho ester) is a surface eroding polymer, which has been under development since 1970, but is used mostly in drug delivery systems in semisolid form.
   The aim of this study was to evaluate the tissue reactions of solid poly(ortho ester) (POE), histologically and immunohistochemically. Resorption times and the effect of 2 different sterilization methods (gamma radiation and ethylene oxide) upon resorption were also evaluated. Material was implanted into the tibia and subcutaneously into the mandibular ramus area of 24 rabbits. Follow-up times were 1-10, 14 and 24 weeks.
   Histological studies showed that POE induces a moderate inflammation in soft tissue and in bone. At 24 week follow-up, inflammation was mild in soft tissue and moderate in bone. In immunohistochemical studies, no highly fluorescent layer of tenascin or fibronectin was found adjacent to the implant. Resorption of gamma-sterilized rods was faster than ethylene oxide-sterilized rods. The total resorption time was more than 24 weeks in both groups. Clinically the healing was uneventful and the implants the well tolerated by the living tissue. This encourages these authors to continue studies with this interesting new material to search for the ideal material for bone filling and fracture fixation.
C1 Univ Helsinki, Cent Hosp, Dept Oral & Maxillofacial Surg, FIN-00014 Helsinki, Finland.
   Univ Helsinki, Inst Dent, Dept Oral Pathol, FIN-00014 Helsinki, Finland.
   Univ Helsinki, Cent Hosp, HUSLAB, Oral Pathol Unit, FIN-00014 Helsinki, Finland.
   Univ Helsinki, Inst Dent, Dept Oral & Maxillofacial Surg, FIN-00014 Helsinki, Finland.
   Tampere Univ Technol, Inst Biomat, FIN-33101 Tampere, Finland.
   Univ Tampere, Inst Regenerat Med, REGEA, FIN-33101 Tampere, Finland.
   Univ Tampere, Sch Med, FIN-33101 Tampere, Finland.
   Tampere Univ Hosp, Tampere, Finland.
RP Ekholm, M (reprint author), Tuurinniitynkuja 4-6, Espoo 02200, Finland.
EM mekholm@vihdent.net
RI Kellomaki, Minna/G-6190-2010
OI Kellomaki, Minna/0000-0003-4321-1820
CR Babbush Charles A, 2003, Implant Dent, V12, P325, DOI 10.1097/01.ID.0000095466.18042.31
   BETZ P, 1993, INT J LEGAL MED, V105, P325, DOI 10.1007/BF01222116
   Bostman O, 2000, BIOMATERIALS, V21, P2615, DOI 10.1016/S0142-9612(00)00129-0
   BOSTMAN O, 1990, J BONE JOINT SURG BR, V72, P592
   CARNEMOLLA B, 1989, J CELL BIOL, V108, P1139, DOI 10.1083/jcb.108.3.1139
   Enislidis G, 2005, INT J ORAL MAX SURG, V34, P19, DOI 10.1016/j.ijom.2004.03.020
   GOLDNER JACQUES, 1938, AMER JOUR PATH, V14, P237
   HELLER J, 1992, MACROMOLECULES, V25, P3362, DOI 10.1021/ma00039a007
   Heller J, 2002, ADV DRUG DELIVER REV, V54, P1015, DOI 10.1016/S0169-409X(02)00055-8
   Kellomaki M, 1997, J MATER SCI LETT, V16, P1786, DOI 10.1023/A:1018548130539
   Kontio R, 1998, J MATER SCI-MATER M, V9, P603, DOI 10.1023/A:1008921811674
   Laine P, 2004, INT J ORAL MAX SURG, V33, P240, DOI 10.1016/j.ijom.2003.0510
   LUOMANEN M, 1991, J ORAL PATHOL MED, V20, P133, DOI 10.1111/j.1600-0714.1991.tb00907.x
   MACKIE EJ, 1988, J CELL BIOL, V107, P2757, DOI 10.1083/jcb.107.6.2757
   MERKLI A, 1994, PHARMACEUT RES, V11, P1485, DOI 10.1023/A:1018964511053
   PINHOLT EM, 1992, J ORAL MAXIL SURG, V50, P1300, DOI 10.1016/0278-2391(92)90231-N
   SCHENK R, 1965, ACTA ANAT, V60, P3
   Serino G, 2003, CLIN ORAL IMPLAN RES, V14, P651, DOI 10.1034/j.1600-0501.2003.00970.x
   SOLHEIM E, 1992, J BONE JOINT SURG AM, V74A, P705, DOI 10.2106/00004623-199274050-00009
   SOLHEIM E, 1992, J BONE JOINT SURG AM, V74A, P1456, DOI 10.2106/00004623-199274100-00004
   SOLHEIM E, 1992, J BIOMED MATER RES, V26, P791, DOI 10.1002/jbm.820260608
   SOLHEIM E, 1992, J NEUROSURG, V76, P275, DOI 10.3171/jns.1992.76.2.0275
   SOLHEIM E, 1995, J BIOMED MATER RES, V29, P141
   SUDMANN B, 1993, ACTA ORTHOP SCAND, V64, P336, DOI 10.3109/17453679308993639
   TAYLOR MS, 1994, J APPL BIOMATER, V5, P151, DOI 10.1002/jab.770050208
   VARTIO T, 1987, J CELL SCI, V88, P419
   VISTNES LM, 1976, SURGERY, V79, P690
NR 27
TC 9
Z9 9
U1 1
U2 6
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0901-5027
J9 INT J ORAL MAX SURG
JI Int. J. Oral Maxillofac. Surg.
PD JUL
PY 2006
VL 35
IS 7
BP 631
EP 635
DI 10.1016/j.ijom.2006.01.029
PG 5
WC Dentistry, Oral Surgery & Medicine; Surgery
SC Dentistry, Oral Surgery & Medicine; Surgery
GA 061BG
UT WOS:000238845600010
PM 16540288
DA 2018-10-19
ER

PT J
AU Hosseinkhani, H
   Hosseinkhani, M
   Kobayashi, H
AF Hosseinkhani, H
   Hosseinkhani, M
   Kobayashi, H
TI Design of tissue-engineered nanoscaffold through self-assembly of
   peptide amphiphile
SO JOURNAL OF BIOACTIVE AND COMPATIBLE POLYMERS
LA English
DT Article
DE extracellular matrix; peptide amphiphile; nanofibers; osteogenic
   differentiation; scaffold
ID MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; IN-VITRO; OSTEOBLAST
   ADHESION; BONE; SCAFFOLDS; POLYMER; CULTURE; MATRIX; GROWTH
AB In order to mimic in vivo topography of the native tissue created by extracellular matrix (ECM) components, which make up all soft tissues, the surface features of each biomaterial should be considered as a nano-dimensional structure. In this study, an artificial ECM was designed to mimic the nanostructured. topography created by ECM components in native tissue. The proliferation and differentiation of mesenchymal stem cells (MSCs) was investigated in a three dimensional (3-D) network of nanofibers formed by the self-assembly of peptide amphiphile (PA) molecules. PA was synthesized by standard solid phase chemistry that ends with the alkylation of the NH, terminus of the peptide. The sequence of arginine-glycine-aspartic acid (RGD) was included in peptide design as well. A 3-D network of nanofibers was formed by mixing MSC suspensions in a media with dilute aqueous solution of PA. The attachment, proliferation and osteogenic differentiation of MSCs were influenced by the self-assembled PA nanofibers as the cell scaffold and the values were significantly high compared with those in the static culture (2-D tissue culture plate).
C1 Natl Inst Mat Sci, ICYS, Tsukuba, Ibaraki 3050044, Japan.
   Kyoto Univ Hosp, Grad Sch Med, Dept Cardiovasc Med, Kyoto 6068507, Japan.
RP Hosseinkhani, H (reprint author), Natl Inst Mat Sci, ICYS, Nanobiomat Res Bldg,Namiki 1-1, Tsukuba, Ibaraki 3050044, Japan.
EM hossein.hosseinkhani@nims.go.jp
RI kobayashi, hisatoshi/H-2720-2011
OI kobayashi, hisatoshi/0000-0001-9487-0725
CR BELLOWS CG, 1990, DEV BIOL, V140, P132, DOI 10.1016/0012-1606(90)90060-V
   Boo JS, 2002, J CRANIOFAC SURG, V13, P231, DOI 10.1097/00001665-200203000-00009
   CAPPELLO J, 1994, PLASTICS MICROBES, P35
   Elias KL, 2002, BIOMATERIALS, V23, P3279, DOI 10.1016/S0142-9612(02)00087-X
   FERRARI FA, 1988, Patent No. 8803533
   FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x
   Freed LE, 1998, ADV DRUG DELIVER REV, V33, P15, DOI 10.1016/S0169-409X(98)00017-9
   FREED LE, 1993, J CELL BIOCHEM, V51, P257, DOI 10.1002/jcb.240510304
   Gittens SA, 2001, J DRUG TARGET, V9, P407, DOI 10.3109/10611860108998776
   Glowacki J, 1998, CELL TRANSPLANT, V7, P319, DOI 10.1016/S0963-6897(98)00003-7
   Goh KL, 2003, J THEOR BIOL, V223, P259, DOI 10.1016/S0022-5193(03)00083-3
   Goldstein AS, 2001, BIOMATERIALS, V22, P1279, DOI 10.1016/S0142-9612(00)00280-5
   Griffith M, 1999, SCIENCE, V286, P2169, DOI 10.1126/science.286.5447.2169
   Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187
   Hong YS, 2003, BIOMACROMOLECULES, V4, P1433, DOI 10.1021/bm0341374
   Hukins DWL, 2005, NAT MATER, V4, P881, DOI 10.1038/nmat1540
   Ingber DE, 1995, J BIOMECH, V28, P1471, DOI 10.1016/0021-9290(95)00095-X
   Ishaug SL, 1997, J BIOMED MATER RES, V36, P17
   Kim BS, 1999, EXP CELL RES, V251, P318, DOI 10.1006/excr.1999.4595
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   LENNON DP, 1995, EXP CELL RES, V219, P211, DOI 10.1006/excr.1995.1221
   Liu F, 2002, BONE, V31, P212, DOI 10.1016/S8756-3282(02)00806-2
   Livingston T, 2002, J BIOMED MATER RES, V62, P1, DOI 10.1002/jbm.10157
   Ma PX, 1999, J BIOMED MATER RES, V44, P217
   Ma T, 2000, BIOTECHNOL BIOENG, V70, P606, DOI 10.1002/1097-0290(20001220)70:6<606::AID-BIT2>3.0.CO;2-H
   Ma ZW, 2005, TISSUE ENG, V11, P101, DOI 10.1089/ten.2005.11.101
   MuellerKlieser W, 1997, AM J PHYSIOL-CELL PH, V273, pC1109
   Niklason LE, 1999, SCIENCE, V284, P489, DOI 10.1126/science.284.5413.489
   Noshi T, 2000, J BIOMED MATER RES, V52, P621
   Papas KK, 1999, BIOTECHNOL BIOENG, V66, P219
   Peretti GM, 2000, TISSUE ENG, V6, P567, DOI 10.1089/107632700750022206
   Peter SJ, 1998, J CELL BIOCHEM, V71, P55, DOI 10.1002/(SICI)1097-4644(19981001)71:1<55::AID-JCB6>3.0.CO;2-0
   Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449
   Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9
   RAO J, 1992, ANAL BIOCHEM, V207, P186, DOI 10.1016/0003-2697(92)90521-8
   ROSENBERG MD, 1963, SCIENCE, V139, P411, DOI 10.1126/science.139.3553.411
   RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619
   Schneider AI, 1999, IN VITRO CELL DEV-AN, V35, P515
   Shin H, 2004, J BIOMED MATER RES A, V69A, P535, DOI 10.1002/jbm.a.30027
   Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783
   Smith LA, 2004, COLLOID SURFACE B, V39, P125, DOI [10.1016/j.colsurfb.2003.12.004, 10.1016/j.colsurfb.2003.l2.004]
   Tabata Y, 2003, TISSUE ENG, V9, pS5, DOI 10.1089/10763270360696941
   Takahashi Y, 2003, TISSUE ENG, V9, P931, DOI 10.1089/107632703322495574
   Vandenburgh H, 1996, HUM GENE THER, V7, P2195, DOI 10.1089/hum.1996.7.17-2195
   Wang YC, 2003, TISSUE ENG, V9, P1205, DOI 10.1089/10763270360728116
   Webster TJ, 2001, TISSUE ENG, V7, P291, DOI 10.1089/10763270152044152
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   WILLIAMS JA, 1992, PATHOL BIOL, V40, P813
   Woerly S, 1996, BIOMATERIALS, V17, P301, DOI 10.1016/0142-9612(96)85568-2
   Xie YB, 2001, TISSUE ENG, V7, P585, DOI 10.1089/107632701753213200
   Yoshikawa T, 1998, J BIOMED MATER RES, V41, P568, DOI 10.1002/(SICI)1097-4636(19980915)41:4<568::AID-JBM8>3.3.CO;2-6
NR 51
TC 79
Z9 79
U1 2
U2 17
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0883-9115
J9 J BIOACT COMPAT POL
JI J. Bioact. Compat. Polym.
PD JUL
PY 2006
VL 21
IS 4
BP 277
EP 296
DI 10.1177/0883911506066934
PG 20
WC Biotechnology & Applied Microbiology; Materials Science, Biomaterials;
   Polymer Science
SC Biotechnology & Applied Microbiology; Materials Science; Polymer Science
GA 059UZ
UT WOS:000238759000001
DA 2018-10-19
ER

PT J
AU Kannan, RY
   Salacinski, HJ
   Vara, DS
   Odlyha, M
   Seifalian, AM
AF Kannan, Ruben Y.
   Salacinski, Henryk J.
   Vara, Dina S.
   Odlyha, Marianne
   Seifalian, Alexander M.
TI Review paper: Principles and applications of surface analytical
   techniques at the vascular interface
SO JOURNAL OF BIOMATERIALS APPLICATIONS
LA English
DT Review
DE polymer; vascular interface; electron spectroscopy; microcalorimetry;
   X-ray surface analytical techniques; ATR-Fourier transform infrared and
   Raman spectroscopy; electron probe; ion probe techniques
ID ION MASS-SPECTROMETRY; ENHANCED RAMAN-SCATTERING; ENDOTHELIAL-CELL
   GROWTH; ATOMIC-FORCE MICROSCOPY; AIR-WATER-INTERFACE; HUMAN
   SERUM-ALBUMIN; POLYMER SURFACES; IN-VITRO; SEGMENTED POLYURETHANE;
   BIOMATERIAL SURFACES
AB Surface properties have been found to be one of the key parameters which cause degradation and of thrombogenicity in all polymers used in biomedical devices, thus signifying the importance and the necessity for quantitative and accurate characterization of the polymer surface itself as used in the construction of the device. The characterization techniques employed generally involve thermal and spectroscopic measurements, in which class the electrochemical investigations and scanning probe microscopies can also be included. Current hypotheses on the correlations that exist between surface parameters and hemocompatibility and degradation of polymers are examined herein, but concentrating on the field of clinically utilized polymeric materials as used within medical devices themselves. Furthermore, this review provides a brief but complete synopsis of these techniques and other emerging ones, which have proven useful in the analysis of the surface properties of polymeric materials as used in the construction of cardiovascular devices. Statements and examples are given as to how specific information can be acquired from these differing methodologies and how it aids in the design and development of new polymers for usage in biomedical device construction.
C1 UCL, Acad Div Surg & Intervent Sci, BTEC, London, England.
   Univ London, Dept Chem Mat, Birkbeck Coll, London, England.
   Royal Free Hampstead NHS Trust Hosp, London, England.
RP Seifalian, AM (reprint author), UCL, Acad Div Surg & Intervent Sci, BTEC, Mortimer St, London, England.
EM a.seifalian@medsch.ucl.ac.uk
RI Seifalian, Alexander/I-6028-2013
OI Seifalian, Alexander/0000-0002-1180-3322
CR Amato I, 1997, SCIENCE, V276, P1982, DOI 10.1126/science.276.5321.1982
   Anderson JM, 1998, POLYM INT, V46, P163, DOI 10.1002/(SICI)1097-0126(199807)46:3<163::AID-PI972>3.0.CO;2-9
   Azioune A, 2004, LANGMUIR, V20, P3350, DOI 10.1021/la030407s
   Aziz CA, 1996, J BIOMED MATER RES, V32, P193, DOI 10.1002/(SICI)1097-4636(199610)32:2<193::AID-JBM7>3.0.CO;2-O
   BAIER RE, 1971, FED PROC, V30, P1523
   Barbucci R, 2003, BIOMATERIALS, V24, P915, DOI 10.1016/S0142-9612(02)00425-8
   Barbucci R, 2002, BIOMOL ENG, V19, P161, DOI 10.1016/S1389-0344(02)00022-9
   Belu AM, 2003, BIOMATERIALS, V24, P3635, DOI 10.1016/S0142-9612(03)00159-5
   Benesch J, 2001, J BIOMAT SCI-POLYM E, V12, P581, DOI 10.1163/156856201316883421
   Blandamer MJ, 2003, CHEM SOC REV, V32, P264, DOI 10.1039/b207308k
   BOLAND T, 1995, P NATL ACAD SCI USA, V92, P5297, DOI 10.1073/pnas.92.12.5297
   Burns NL, 1998, BIOMATERIALS, V19, P423, DOI 10.1016/S0142-9612(97)00225-1
   Chandy T, 2000, BIOMATERIALS, V21, P699, DOI 10.1016/S0142-9612(99)00231-8
   Chen Z, 1999, J BIOMAT SCI-POLYM E, V10, P901
   Chilkoti A, 1995, BIOPHYS J, V69, P2125, DOI 10.1016/S0006-3495(95)80083-4
   CHILKOTI A, 1995, ANAL CHEM, V67, P2883, DOI 10.1021/ac00113a024
   Chittur KK, 1998, BIOMATERIALS, V19, P357, DOI 10.1016/S0142-9612(97)00223-8
   Cook AD, 1997, BIOMATERIALS, V18, P1417, DOI 10.1016/S0142-9612(97)00075-6
   Dal Ponte DB, 2002, J ENDOVASC THER, V9, P333, DOI 10.1583/1545-1550(2002)009<0333:AAHAWA>2.0.CO;2
   Davenas J, 2002, BIOMOL ENG, V19, P263, DOI 10.1016/S1389-0344(02)00037-0
   Drude P, 1889, ANN PHYS CHEM, V272, P865
   Elzein T, 2004, J COLLOID INTERF SCI, V273, P381, DOI 10.1016/j.jcis.2004.02.001
   ERTEL SI, 1991, J BIOMAT SCI-POLYM E, V3, P163, DOI 10.1163/156856291X00269
   Ghanbari-Siahkali A, 2003, APPL SPECTROSC, V57, P1482, DOI 10.1366/000370203322640116
   Gillen G, 1998, RAPID COMMUN MASS SP, V12, P1303, DOI 10.1002/(SICI)1097-0231(19981015)12:19<1303::AID-RCM330>3.0.CO;2-7
   Goessl A, 2001, J BIOMAT SCI-POLYM E, V12, P721, DOI 10.1163/156856201750411620
   GRAHAM SW, 1981, J BIOMED MATER RES, V15, P465, DOI 10.1002/jbm.820150403
   GRANERO L, 1993, EUR J PHARM SCI, V1, P3, DOI 10.1016/0928-0987(93)90012-Y
   GRIEP MA, 1986, BIOCHEMISTRY-US, V25, P6688, DOI 10.1021/bi00369a054
   GROBE GL, 1987, J BIOMED MATER RES, V21, P211, DOI 10.1002/jbm.820210206
   Grundke K, 1996, PROG COLL POL SCI S, V101, P58
   GUIDOIN P, 1994, ASIAO J, V40, pM870
   GUIDOIN R, 1993, BIOMATERIALS, V14, P694, DOI 10.1016/0142-9612(93)90068-D
   Hanlon E.B., 2000, PHYS MED BIOL, V45, P1
   Harzallah B, 1998, INT J BIOL MACROMOL, V23, P73, DOI 10.1016/S0141-8130(98)00035-X
   HODGKIN JH, 1990, BIOMATERIALS, V11, P9, DOI 10.1016/0142-9612(90)90044-Q
   Houlne MP, 2002, ANAL CHEM, V74, P4311, DOI 10.1021/ac020325t
   Hu SW, 2002, ANAL CHEM, V74, P4117, DOI 10.1021/ac025700w
   ISHIHARA K, 1995, BIOMATERIALS, V16, P873, DOI 10.1016/0142-9612(95)94150-J
   Iwasaki Y, 2003, J BIOMED MATER RES A, V65A, P164, DOI 10.1002/jbm.a.10459
   Jansson E, 2001, BIOMATERIALS, V22, P1803, DOI 10.1016/S0142-9612(00)00359-8
   Jenney CR, 1999, J BIOMED MATER RES, V46, P11, DOI 10.1002/(SICI)1097-4636(199907)46:1<11::AID-JBM2>3.3.CO;2-P
   Ji J, 2001, BIOMATERIALS, V22, P3015, DOI 10.1016/S0142-9612(01)00048-5
   KAELBLE DH, 1970, J ADHESION, V2, P66, DOI 10.1080/0021846708544582
   Kannan RY, 2006, BIOMACROMOLECULES, V7, P215, DOI 10.1021/bm050590z
   Kannan RY, 2006, BIOMATERIALS, V27, P1971, DOI 10.1016/j.biomaterials.2005.10.006
   Kannan RY, 2005, J BIOMED MATER RES B, V74B, P570, DOI 10.1002/jbm.b.30247
   Kannan RY, 2005, ACCOUNTS CHEM RES, V38, P879, DOI 10.1021/ar050055b
   KANNAN RY, IN PRESS PLAST RECON
   Kellner R., 1998, ANAL CHEM
   KHATTAB MA, 1995, J DRUG TARGET, V3, P39, DOI 10.3109/10611869509015931
   Kingshott P, 1999, ANAL BIOCHEM, V273, P156, DOI 10.1006/abio.1999.4201
   Kinumi T, 2000, J MASS SPECTROM, V35, P417, DOI 10.1002/(SICI)1096-9888(200003)35:3<417::AID-JMS952>3.0.CO;2-#
   Kirby BJ, 2003, LAB CHIP, V3, P5, DOI 10.1039/b21062ln
   LEE G, 1989, SCIENCE, V244, P475, DOI 10.1126/science.2470146
   Lee GJ, 2002, TETRAHEDRON-ASYMMETR, V13, P9, DOI 10.1016/S0957-4166(02)00044-7
   Lee JH, 1998, J COLLOID INTERF SCI, V205, P323, DOI 10.1006/jcis.1998.5688
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Lee KY, 1997, IEEE ELECTR DEVICE L, V18, P4, DOI 10.1109/55.553058
   Lee LT, 1999, J PHYS CHEM B, V103, P7489, DOI 10.1021/jp991032f
   Lewis AL, 2000, BIOMATERIALS, V21, P1847, DOI 10.1016/S0142-9612(00)00055-7
   Lewis G, 2003, J BIOMED MATER RES B, V66B, P487, DOI 10.1002/jbm.b.10044
   Lhoest JB, 2001, J BIOMED MATER RES, V57, P432, DOI 10.1002/1097-4636(20011205)57:3<432::AID-JBM1186>3.0.CO;2-G
   Li YL, 2003, BIOTECHNOL BIOENG, V84, P305, DOI 10.1002/bit.10757
   LIM F, 1994, BIOMATERIALS, V15, P408, DOI 10.1016/0142-9612(94)90218-6
   LU JR, 1995, J PHYS CHEM-US, V99, P8233, DOI 10.1021/j100020a055
   Lyman DJ, 2001, J BIOMED MATER RES, V58, P221, DOI 10.1002/1097-4636(2001)58:3<221::AID-JBM1011>3.3.CO;2-M
   Magoshi T, 2002, BIOMACROMOLECULES, V3, P976, DOI 10.1021/bm0200377
   Mathur AB, 1997, J BIOMED MATER RES, V36, P246, DOI 10.1002/(SICI)1097-4636(199708)36:2<246::AID-JBM14>3.3.CO;2-9
   McAnally GD, 2003, APPL SPECTROSC, V57, P44, DOI 10.1366/000370203321165197
   Merrett K, 2002, J BIOMAT SCI-POLYM E, V13, P593, DOI 10.1163/156856202320269111
   MIRZADEH H, 1995, BIOMATERIALS, V16, P641, DOI 10.1016/0142-9612(95)93862-8
   Murray-Wijelath J, 2004, J BIOMED MATER RES B, V70B, P223, DOI 10.1002/jbm.b.30044
   Nitschke M, 2002, J BIOMED MATER RES, V59, P632, DOI 10.1002/jbm.1274.abs
   Notingher I, 2003, APPL SPECTROSC, V57, P1494, DOI 10.1366/000370203322640134
   OKOSHI T, 1993, J THORAC CARDIOV SUR, V105, P791
   Oleinikov VA, 1998, BIOORG KHIM+, V24, P412
   Olivieri MP, 1999, J BIOMED MATER RES, V46, P355, DOI 10.1002/(SICI)1097-4636(19990905)46:3<355::AID-JBM7>3.0.CO;2-O
   PASIC M, 1994, ANN THORAC SURG, V58, P677, DOI 10.1016/0003-4975(94)90726-9
   PEREZLUNA VH, 1994, J BIOMED MATER RES, V28, P1111, DOI 10.1002/jbm.820281002
   Pignataro B, 1997, BIOMATERIALS, V18, P1461, DOI 10.1016/S0142-9612(97)00090-2
   Polzonetti G, 2000, BIOMATERIALS, V21, P1531, DOI 10.1016/S0142-9612(00)00025-9
   Ramires PA, 2000, J BIOMED MATER RES, V51, P535, DOI 10.1002/1097-4636(20000905)51:3<535::AID-JBM31>3.0.CO;2-P
   RATNER BD, 1993, CLIN MATER, V13, P71, DOI 10.1016/0267-6605(93)90093-M
   Renke-Gluszko M, 2004, BIOMATERIALS, V25, P5191, DOI 10.1016/j.biomaterials.2003.12.021
   Riepe G, 1997, EUR J VASC ENDOVASC, V13, P540, DOI 10.1016/S1078-5884(97)80062-7
   Riviere J.C., 1990, SURFACE ANAL TECHNIQ
   RYU GH, 1995, J BIOMED MATER RES, V29, P403, DOI 10.1002/jbm.820290315
   Saito N, 1997, BIOMATERIALS, V18, P1195, DOI 10.1016/S0142-9612(97)00046-X
   Salacinski HJ, 2001, J BIOMATER APPL, V15, P241, DOI 10.1106/NA5T-J57A-JTDD-FD04
   Sanchez-Cortes S, 2002, BIOMACROMOLECULES, V3, P655, DOI 10.1021/bm015640o
   Sawyer P N, 1968, Ann N Y Acad Sci, V146, P49, DOI 10.1111/j.1749-6632.1968.tb20270.x
   SEEGER JM, 1995, J VASC SURG, V22, P327, DOI 10.1016/S0741-5214(95)70148-6
   Seifalian AM, 2003, BIOMATERIALS, V24, P2549, DOI 10.1016/S0142-9612(02)00608-7
   Seifalian AM, 2005, Patent, Patent No. [WO2005070998, 2005070998]
   SHIN YC, 1994, J BIOMAT SCI-POLYM E, V6, P281
   SIPEHIA R, 1993, BIOMAT ARTIF CELL IM, V21, P647, DOI 10.3109/10731199309117389
   Soldani G, 2002, J MICROSC-OXFORD, V206, P139, DOI 10.1046/j.1365-2818.2002.01021.x
   SUNNER J, 1995, ANAL CHEM, V67, P4335, DOI 10.1021/ac00119a021
   Tang YW, 2002, J BIOMAT SCI-POLYM E, V13, P463, DOI 10.1163/156856202320253965
   Tanyanyiwa J, 2002, ELECTROPHORESIS, V23, P3659, DOI 10.1002/1522-2683(200211)23:21<3659::AID-ELPS3659>3.0.CO;2-M
   TYLER BJ, 1992, J BIOMED MATER RES, V26, P273, DOI 10.1002/jbm.820260302
   UCHIDA N, 1993, J BIOMED MATER RES, V27, P1269, DOI 10.1002/jbm.820271007
   Vasilets VN, 1997, BIOMATERIALS, V18, P1139, DOI 10.1016/S0142-9612(97)00045-8
   von Smoluchowski M, 1917, Z PHYS CHEM-STOCH VE, V92, P129
   VONVON RA, 1996, ANAL BIOANAL CHEM, V355, P543
   Vyorykka J, 2003, APPL SPECTROSC, V57, P1123, DOI 10.1366/00037020360695982
   Weibel D, 2003, ANAL CHEM, V75, P1754, DOI 10.1021/ac026338o
   Werner C, 1999, INT J ARTIF ORGANS, V22, P160
   Wetzels GMR, 1999, BIOMATERIALS, V20, P1879, DOI 10.1016/S0142-9612(99)00067-8
   Wiggins MJ, 2001, J BIOMED MATER RES, V58, P302
   Wu ZY, 2002, ELECTROPHORESIS, V23, P782, DOI 10.1002/1522-2683(200203)23:5<782::AID-ELPS782>3.0.CO;2-K
   Wulf M, 1999, J COLLOID INTERF SCI, V210, P172, DOI 10.1006/jcis.1998.5942
   Xu GZ, 2004, ANAL CHEM, V76, P1213, DOI 10.1021/ac035422g
   Xu YD, 2003, ANAL CHEM, V75, P185, DOI 10.1021/ac025907p
   Zhang Z, 1997, BIOMATERIALS, V18, P113, DOI 10.1016/S0142-9612(96)00054-3
   Zheng JW, 2000, SPECTROSC SPECT ANAL, V20, P814
NR 117
TC 17
Z9 19
U1 4
U2 35
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0885-3282
J9 J BIOMATER APPL
JI J. Biomater. Appl.
PD JUL
PY 2006
VL 21
IS 1
BP 5
EP 32
DI 10.1177/0885328206065728
PG 28
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 056QU
UT WOS:000238541000001
PM 16684795
DA 2018-10-19
ER

PT J
AU Harris, LG
   Mead, L
   Muller-Oberlander, E
   Richards, RG
AF Harris, LG
   Mead, L
   Muller-Oberlander, E
   Richards, RG
TI Bacteria and cell cytocompatibility studies on coated medical grade
   titanium surfaces
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE staphylococci; fibroblasts; titanium; cytocompatibility; antimicrobial
ID STAPHYLOCOCCUS-AUREUS INFECTIONS; COAGULASE-NEGATIVE STAPHYLOCOCCI;
   IMPLANT-RELATED OSTEOMYELITIS; CHLORHEXIDINE DIACETATE; EXTERNAL
   FIXATION; POVIDONE-IODINE; BONE CEMENTS; ANTIBIOTICS; VANCOMYCIN;
   BIOMATERIAL
AB Acute and chronic osteomyelitis caused by staphylococci can be difficult to treat by conventional means and often has marked consequences for the patient. Current methods of treatment involve the use of systemic antibiotics, the local implantation of nondegradable drug carriers, and surgical debridement. A possible solution that could prevent initial bacterial adhesion could be to modify the implant surface with an antimicrobial coating while maintaining biocompatibility to host cells. This study describes the cytocompatibility evaluation of different coatings (poly(D,L-lactide) (PDLLA), politerefate (PTF), calcium phosphate/anodic plasma-chemical treatment (CaP/APC), polyurethane (PU), and polyvinylpyrollidone (PVP) on titanium surfaces with and without chlorhexidine diacetate (CHA) to Staphylococcus aureus, Staphylococcus epidermidis, and hTERT human fibroblasts. Surface characterization of the coatings showed no significant variation in the roughness or hydrophobicity of the coated surfaces, except the CaP/APC surface that was porous yet the smoothest, and PVP, PVP + CHA, and CaP/APC + CHA that were more hydrophilic in nature than the others. On the surfaces without CHA, both staphylococcal strains and spread fibroblasts were observed, but on the CHA impregnated surfaces few bacteria and no intact fibroblasts were seen. Flow cytometry found fewer bacteria in the media and on the surfaces containing CHA in comparison to the surfaces without CHA. The release kinetics varied from slow (over 200 h) to burst release: PDLLA > PTF > PU > CaP/APC = PVP. This study showed that PDLLA and PTF have the best potential as coatings on implants for drug delivery, as they were cytocompatible to hTERT fibroblasts, eluted CHA effectively, and passed mechanical testing. The actual release kinetics of PDLLA and PTF are important, as the amount of CHA present should remain above the minimal inhibitory concentration value for a limited time before disappearing completely. (c) 2006 Wiley Periodicals, Inc.
C1 AO Res Inst, CH-7270 Davos, Switzerland.
   Synthes Inc, CH-4436 Oberdorf, Switzerland.
RP Harris, LG (reprint author), Univ Wales Swansea, Sch Med, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.
EM llinos.harris@yahoo.co.uk
OI Richards, Robert/0000-0002-7778-2480; Harris, Llinos/0000-0002-0295-3038
CR BARTH E, 1989, BIOMATERIALS, V10, P325, DOI 10.1016/0142-9612(89)90073-2
   Baxter L. C., 2002, European Cells & Materials, V4, P1
   BRUMFITT W, 1985, LANCET, V1, P1442
   Calhoun JH, 1997, CLIN ORTHOP RELAT R, P206
   CHEUNG J, 1985, ANAESTH INTENS CARE, V13, P429
   DANCE DAB, 1987, J HOSP INFECT, V10, P10, DOI 10.1016/0195-6701(87)90027-2
   Darouiche RO, 1998, J BONE JOINT SURG AM, V80A, P1336, DOI 10.2106/00004623-199809000-00013
   Davies R, 2005, J BONE JOINT SURG BR, V87B, P716, DOI 10.1302/0301-620X.87B5.15623
   Duran L W, 2000, Med Device Technol, V11, P14
   *EUR ANT RES SURV, 2002, EUR ANT RES SURV SYS
   Flock JI, 1999, MOL MED TODAY, V5, P532, DOI 10.1016/S1357-4310(99)01597-X
   Forster H, 2004, J ORTHOPAED RES, V22, P671, DOI 10.1016/j.orthres.2003.10.003
   FRAUCHIGER VM, 2003, THESIS ETH ZURICH
   Gallardo-Moreno AM, 2001, FEMS MICROBIOL LETT, V203, P75, DOI 10.1016/S0378-1097(01)00345-7
   GARVIN KL, 1994, J BONE JOINT SURG AM, V76A, P1500, DOI 10.2106/00004623-199410000-00009
   GOGOLEWSKI S, 1993, J BIOMED MATER RES, V27, P1135, DOI 10.1002/jbm.820270904
   GOLDSCHMIDT P, 1977, J PERIODONTOL, V48, P212, DOI 10.1902/jop.1977.48.4.212
   Gollwitzer H, 2003, J ANTIMICROB CHEMOTH, V51, P585, DOI 10.1093/jac/dkg105
   HARRIS LG, 2002, EUR CELL MAT S, V6, P94
   HARRIS LG, 2005, AO DIALOGUE, V18, P23
   HOWARD EG, 1988, Patent No. 909
   Hoyle B D, 1991, Prog Drug Res, V37, P91
   Kendall RW, 1996, CLIN ORTHOP RELAT R, P273
   Khatod M, 2003, J TRAUMA, V55, P949, DOI 10.1097/01.TA.0000092685.80435.63
   KORKUSUZ F, 1993, J BONE JOINT SURG BR, V75, P111
   Leach W J, 1992, J R Coll Surg Edinb, V37, P265
   Lee- Smith J, 2001, J ORTHOPAEDIC NURSIN, V5, P37
   Levy S.B., 2002, J APPL MICROBIOL S, V92, P65
   Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806
   Lucke M, 2003, BONE, V32, P521, DOI 10.1016/S8756-3282(03)00050-4
   OHTOSHI T, 1986, CLIN ALLERGY, V16, P155, DOI 10.1111/j.1365-2222.1986.tb00759.x
   Piozzi A, 2004, J CHEMOTHERAPY, V16, P446, DOI 10.1179/joc.2004.16.5.446
   Price JS, 1996, J BIOMED MATER RES, V30, P281, DOI 10.1002/(SICI)1097-4636(199603)30:3<281::AID-JBM2>3.0.CO;2-M
   QUIRYNEN M, 1995, J CLIN PERIODONTOL, V22, P1, DOI 10.1111/j.1600-051X.1995.tb01765.x
   REVERDY ME, 1992, MED MICROBIOL LETT, V1, P56
   RICHARDS RG, 1995, J MICROSC-OXFORD, V177, P43, DOI 10.1111/j.1365-2818.1995.tb03532.x
   SANCHEZ IR, 1988, VET SURG, V17, P182, DOI 10.1111/j.1532-950X.1988.tb00995.x
   SANCHEZ IR, 1988, VET SURG, V17, P291, DOI 10.1111/j.1532-950X.1988.tb01019.x
   Sims M., 2000, J ORTHOP NURSING, V4, P59
   Stickler DJ, 2002, J APPL MICROBIOL, V92, p163S, DOI 10.1046/j.1365-2672.92.5s1.6.x
   Tunney MM, 2002, BIOMATERIALS, V23, P4601, DOI 10.1016/S0142-9612(02)00206-5
   van de Belt H, 2001, BIOMATERIALS, V22, P1607, DOI 10.1016/S0142-9612(00)00313-6
   Vaudaux P, 2001, J ANTIMICROB CHEMOTH, V47, P163, DOI 10.1093/jac/47.2.163
   Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7
   von Eiff C, 2001, POSTGRAD MED, V110, P63, DOI 10.3810/pgm.2001.10.1046
   WAHLIG H, 1980, ACTA ORTHOP SCAND, V51, P49, DOI 10.3109/17453678008990768
   WEBB JCJ, 2004, 14 ANN EUR ORTH RES
   *WHO, 1997, CENTR VEN CATH ARR G
   WILCOX MH, 1991, J ANTIMICROB CHEMOTH, V27, P577, DOI 10.1093/jac/27.5.577
   WILCOX MH, 1994, J ANTIMICROB CHEMOTH, V33, P431, DOI 10.1093/jac/33.3.431
NR 50
TC 65
Z9 67
U1 1
U2 19
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2006
VL 78A
IS 1
BP 50
EP 58
DI 10.1002/jbm.a.30611
PG 9
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 051JR
UT WOS:000238157900007
PM 16602121
DA 2018-10-19
ER

PT J
AU Williams, SK
   Kleinert, LB
   Hagen, KM
   Clapper, DL
AF Williams, SK
   Kleinert, LB
   Hagen, KM
   Clapper, DL
TI Covalent modification of porous implants using extracellular matrix
   proteins to accelerate neovascularization
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE laminin 1; extracellular matrix; ePTFE; angiogenesis; neovascularization
ID FIBROBLAST-GROWTH-FACTOR; POLYTETRAFLUOROETHYLENE GRAFTS;
   ADIPOSE-TISSUE; ANGIOGENESIS; POROSITY; CELLS; EPTFE; DIFFERENTIATION;
   COMPONENTS; ADHESION
AB Healing associated with many polymeric biomedical implants commonly involves the formation of an avascular fibrous capsule. The lack of either formation or persistence of blood vessels in formed fibrous capsules, as well as a lack of new blood vessels within porous polymeric implants, often results in poor performance of the implant. The current study evaluated the use of extracellular matrix protein modification of a commonly used biomedical implant material, expanded polytetrafluoroethylene (ePTFE), as a mechanism to increase the neovascularization both within these porous implants and in tissue that forms in the peri-implant area. Discs of ePTFE were covalently modified with different extracellular matrix proteins including collagen type IV, fibronectin, and laminin type I. Discs were implanted into the adipose tissue of adult rats, and following a 5-week implant phase, histologic analysis of peri-implant tissue angiogenesis and implant neovascularization was performed. Striking differences were observed in angiogenic and neovascularization responses to matrix-modified ePTFE when compared with control, untreated ePTFE. Fibronectin treatment resulted in an extensive inflammatory response but, relative to the degree of inflammation, limited evidence of tissue angiogenesis or polymer neovascularization. Collagen type IV treatment groups exhibited a significant increase in angiogenesis in the peri-implant tissue with minimal evidence of implant neovascularization. In contrast to all other implant modifications, laminin type 1-treated ePTFE samples stimulated an extensive peri-implant tissue angiogenic response and a coordinate neovascularization of the porous interstices of the biomaterial. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Arizona, Biomed Engn Program, Tucson, AZ 85721 USA.
RP Williams, SK (reprint author), Univ Arizona, Biomed Engn Program, Tucson, AZ 85721 USA.
EM skwill@u.arizona.edu
FU NHLBI NIH HHS [HL 063875]
CR AKERS DL, 1993, J VASC SURG, V18, P10, DOI 10.1067/mva.1993.41708
   Amos R.A., 1995, ENCY HDB BIOMATERI A, V1, P895
   Bando H, 2000, ADV EXP MED BIOL, V476, P267
   Berney T, 1999, CELL TRANSPLANT, V8, P577, DOI 10.1177/096368979900800602
   Black AF, 1998, FASEB J, V12, P1331
   Boswell CA, 1999, J BIOMED MATER RES, V48, P591, DOI 10.1002/(SICI)1097-4636(1999)48:5<591::AID-JBM1>3.0.CO;2-9
   Chaplain MAJ, 1996, INVAS METAST, V16, P222
   CHENG YF, 1989, J CELL PHYSIOL, V139, P275, DOI 10.1002/jcp.1041390209
   CLAPPER DL, 1994, T SOC BIOMATER, V17, P345
   Dike LE, 1999, IN VITRO CELL DEV-AN, V35, P441
   Grant D S, 1997, EXS, V79, P317
   Hoying JB, 1996, J CELL PHYSIOL, V168, P294, DOI 10.1002/(SICI)1097-4652(199608)168:2<294::AID-JCP8>3.0.CO;2-K
   Kanda S, 1999, EXP CELL RES, V248, P203, DOI 10.1006/excr.1999.4400
   KOHLER TR, 1992, SURGERY, V112, P901
   Ling SH, 1999, HYPERTENSION, V34, P1141, DOI 10.1161/01.HYP.34.5.1141
   Lugassy C, 1999, J CUTAN PATHOL, V26, P78, DOI 10.1111/j.1600-0560.1999.tb01806.x
   MADRI JA, 1983, J CELL BIOL, V97, P153, DOI 10.1083/jcb.97.1.153
   Rongish BJ, 1996, J MOL CELL CARDIOL, V28, P2203, DOI 10.1006/jmcc.1996.0212
   Salzmann DL, 1997, J BIOMED MATER RES, V34, P463, DOI 10.1002/(SICI)1097-4636(19970315)34:4<463::AID-JBM7>3.0.CO;2-I
   Senger DR, 1997, P NATL ACAD SCI USA, V94, P13612, DOI 10.1073/pnas.94.25.13612
   Williams SK, 1997, J BIOMED MATER RES, V35, P473
NR 21
TC 10
Z9 11
U1 0
U2 1
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2006
VL 78A
IS 1
BP 59
EP 65
DI 10.1002/jbm.a.30659
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 051JR
UT WOS:000238157900008
PM 16602088
DA 2018-10-19
ER

PT J
AU Mitchell, SB
   Sanders, JE
AF Mitchell, S. B.
   Sanders, J. E.
TI A unique device for controlled electrospinning
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE electrospirming; encapsulation; fibro-porous; tissue engineering;
   biomaterial; polymer
ID SURFACE MICROARCHITECTURAL DESIGN; ELECTRICALLY FORCED JETS; POLYMER
   MELTS; BIOMEDICAL APPLICATIONS; POLY(ETHYLENE OXIDE); VASCULAR
   PROSTHESIS; EXCIMER-LASER; FIBERS; NANOFIBERS; MEMBRANES
AB The purpose of this research was to develop a system for controlled electrospinning of fibro-porous scaffolds for tissue engineering applications and to use this system to assess mesh architecture sensitivity to manufacturing parameters. The intent was to achieve scaffolds with well-controlled fiber diameters and inter-fiber spacing. To accomplish these objectives, a custom, closed-loop controlled, electrospinning system was built. The system was unique in that it had a collection surface that was independent of the electrodes. The system allowed independent manipulation and analysis of a number of manufacturing parameters: distance between the electrodes, distance from the nozzle to the collection surface, applied voltage, temperature of the melt, collection surface dielectric strength, and collection surface area. Morphological analysis of fabricated meshes showed that all test parameters significantly affected fiber diameter and inter-fiber spacing. Further, contrary to what is generally accepted in the electrospinning literature, voltage and temperature (inversely related to viscosity) were not the most significant parameters. Features of the collection surface, including dielectric strength and surface area, were more significant. This dominance is, in part, a reflection of the unique electrospinning system used. The collection surface, which was not connected to either of the electrodes, substantially altered the electric field between the electrodes. Using the developed controlled electrospinning system, thermoplastic polyurethane meshes with fiber diameters ranging from 5 to 18 mu m with variability less than 1.8% were made; inter-fiber spacing ranged from 4 to 90 mu m with variability less than 20.2%. The system has potential use in biomedical applications where meshes with controlled fiber diameter and inter-fiber spacing are of interest. (c) 2006 Wiley Periodicals, Inc.
C1 Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
RP Sanders, JE (reprint author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.
EM isanders@u.washington.edu
CR Annis D, 1978, Trans Am Soc Artif Intern Organs, V24, P209
   Bognitzki M, 2001, ADV MATER, V13, P70, DOI 10.1002/1521-4095(200101)13:1<70::AID-ADMA70>3.3.CO;2-8
   Boland ED, 2001, J MACROMOL SCI PURE, V38, P1231, DOI 10.1081/MA-100108380
   BRAUKER JH, 1995, J BIOMED MATER RES, V29, P1517, DOI 10.1002/jbm.820291208
   Buchko CJ, 1999, POLYMER, V40, P7397, DOI 10.1016/S0032-3861(98)00866-0
   Buer A, 2001, TEXT RES J, V71, P323, DOI 10.1177/004051750107100408
   Deitzel JM, 2001, POLYMER, V42, P261, DOI 10.1016/S0032-3861(00)00250-0
   Deitzel JM, 2001, POLYMER, V42, P8163, DOI 10.1016/S0032-3861(01)00336-6
   Demir MM, 2002, POLYMER, V43, P3303, DOI 10.1016/S0032-3861(02)00136-2
   DOSHI J, 1995, J ELECTROSTAT, V35, P151, DOI 10.1016/0304-3886(95)00041-8
   Fong H, 1999, POLYMER, V40, P4585, DOI 10.1016/S0032-3861(99)00068-3
   Fridrikh SV, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.144502
   Gibson PW, 1999, AICHE J, V45, P190, DOI 10.1002/aic.690450116
   Hohman MM, 2001, PHYS FLUIDS, V13, P2201, DOI 10.1063/1.1383791
   Hohman MM, 2001, PHYS FLUIDS, V13, P2221, DOI 10.1063/1.1384013
   Huang L, 2001, J BIOMAT SCI-POLYM E, V12, P979, DOI 10.1163/156856201753252516
   Jin HJ, 2002, BIOMACROMOLECULES, V3, P1233, DOI 10.1021/bm025581u
   Kenawy ER, 2002, J CONTROL RELEASE, V81, P57, DOI 10.1016/S0168-3659(02)00041-X
   LARRONDO L, 1981, J POLYM SCI POL PHYS, V19, P909, DOI 10.1002/pol.1981.180190601
   LARRONDO L, 1981, J POLYM SCI POL PHYS, V19, P921, DOI 10.1002/pol.1981.180190602
   LARRONDO L, 1981, J POLYM SCI POL PHYS, V19, P933, DOI 10.1002/pol.1981.180190603
   Lee KH, 2003, POLYMER, V44, P1287, DOI 10.1016/S0032-3861(02)00820-0
   Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167
   Liu HQ, 2002, J POLYM SCI POL PHYS, V40, P2119, DOI 10.1002/polb.10261
   Lu QW, 2003, POLYMER, V44, P3309, DOI 10.1016/S0032-3861(03)00223-4
   Martin G.E., 1977, U.S. Patent, Patent No. [4,044,404, 4044404]
   Matsuda T, 1996, J BIOMED MATER RES, V31, P235, DOI 10.1002/(SICI)1097-4636(199606)31:2<235::AID-JBM10>3.0.CO;2-K
   Matthews JA, 2002, BIOMACROMOLECULES, V3, P232, DOI 10.1021/bm015533u
   MITCHELL SB, 2004, THESIS U WASHINGTON
   Mo XM, 2004, BIOMATERIALS, V25, P1883, DOI 10.1016/j.biomaterials.2003.08.042
   Nakayama Y, 2000, J BIOMED MATER RES, V51, P520, DOI 10.1002/1097-4636(20000905)51:3<520::AID-JBM29>3.0.CO;2-A
   Norris ID, 2000, SYNTHETIC MET, V114, P109, DOI 10.1016/S0379-6779(00)00217-4
   Russ J. C., 2000, PRACTICAL STEREOLOGY, P1
   Sanders JE, 2000, J BIOMED MATER RES, V52, P231, DOI 10.1002/1097-4636(200010)52:1<231::AID-JBM29>3.0.CO;2-E
   Shin YM, 2001, APPL PHYS LETT, V78, P1149, DOI 10.1063/1.1345798
   Shin YM, 2001, POLYMER, V42, P9955, DOI 10.1016/S0032-3861(01)00540-7
   Spivak AF, 2000, MECH RES COMMUN, V27, P37, DOI 10.1016/S0093-6413(00)00060-4
   Spivak AF, 1998, APPL PHYS LETT, V73, P3067, DOI 10.1063/1.122674
   SRINIVASAN G, 1995, POLYM INT, V36, P195, DOI 10.1002/pi.1995.210360210
   TAYLOR G, 1969, PROC R SOC LON SER-A, V313, P453, DOI 10.1098/rspa.1969.0205
   Theron A, 2001, NANOTECHNOLOGY, V12, P384, DOI 10.1088/0957-4484/12/3/329
   Theron SA, 2004, POLYMER, V45, P2017, DOI 10.1016/j.polymer.2004.01.024
   Underwood E. E., 1970, QUANTITATIVE STEREOL, P148
   Wilson G J, 1993, ASAIO J, V39, pM526
   Yarin AL, 2001, J APPL PHYS, V89, P3018, DOI 10.1063/1.1333035
   Yarin AL, 2001, J APPL PHYS, V90, P4836, DOI 10.1063/1.1408260
   Zong XH, 2002, POLYMER, V43, P4403, DOI 10.1016/S0032-3861(02)00275-6
NR 47
TC 42
Z9 43
U1 0
U2 26
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1549-3296
EI 1552-4965
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2006
VL 78A
IS 1
BP 110
EP 120
DI 10.1002/jbm.a.30673
PG 11
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 051JR
UT WOS:000238157900014
PM 16604530
DA 2018-10-19
ER

PT J
AU Homaeigohar, SSH
   Shokrgozar, MA
   Javadpour, J
   Khavandi, A
   Sadi, AY
AF Homaeigohar, SSH
   Shokrgozar, MA
   Javadpour, J
   Khavandi, A
   Sadi, AY
TI Effect of reinforcement particle size on in vitro behavior of
   beta-tricalcium phosphate-reinforced high-density polyethylene: A novel
   orthopedic composite
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biocompatibility; bone graft; calcium phosphate; composite; in vitro
   test
ID DEPENDENT ANIMAL-CELLS; CALCIUM; HYDROXYAPATITE; PROLIFERATION;
   CERAMICS; GROWTH; SUBSTITUTION; CARBONATE; IMPLANTS; ADHESION
AB beta-Tricalcium phosphate-reinforced high-density polyethylene (beta-TCP/HDPE) is a new biomaterial, which was made to simulate bone composition and study its capacity to act like bony tissues. This material was produced by replacing mineral component and collagen soft tissue of bone with beta-TCP and HDPE, respectively. The biocompatibility of composite samples with different volume fractions of TCP (20, 30, and 40 vol %) and two different particle sizes (80-100 and 120-140 mesh size) was examined in vitro using the osteoblast cell line G-292 by proliferation, alkaline phosphatase (ALP) production, and cell adhesion assays. Cell-material interaction on the surface of the composites was observed by scanning electron microscopy (SEM). The effect of beta-TCP particle size on behavior of the osteoblast cell line was compared between two groups of the composite samples containing smaller and larger reinforcement particle sizes as well as with those of a negative control. In general, results showed that the composite samples containing larger particles supported a higher rate of proliferation and ALP production by osteoblast cells after 3, 7, and 14 days incubation compared to the composite samples with smaller particle size and control. Furthermore, more cells were attached to the surface of composite samples containing larger particle size when compared to the smaller particle size composites (p < 0.05). This number was nearly equal with numbers adhered on negative control [tissue culture polystyrene (TPS)] and significantly higher in comparison with composite control [polyethylene (PE)] (p < 0.05). Adhered cells presented a normal morphology by SEM and many of the cells were seen to be undergoing cell division. These findings indicate that beta-TCP/HDPE composites are biocompatible, nontoxic, and in some cases, act to stimulate proliferation of the cells, ALP production, and cell adhesion when compared to the control counterparts. Furthermore, beta-TCP/HDPE samples with larger reinforcement particle size were shown to possess better biological properties. (c) 2006 Wiley Periodicals, Inc.
C1 Natl Cell Bank Iran, Pasteur Inst Iran, Tehran, Iran.
   Iran Univ Sci & Technol, Dept Mat Sci & Engn, Tehran, Iran.
RP Shokrgozar, MA (reprint author), Natl Cell Bank Iran, Pasteur Inst Iran, Tehran, Iran.
EM mashokrgozar@pasteur.ac.ir
RI khavandi, alireza/S-6562-2018; Homaeigohar, Shahin/E-1796-2015;
   shokrgozar, mohammad ali/L-4149-2017; Khavandi, Alireza/S-3732-2018
OI Homaeigohar, Shahin/0000-0003-2426-6690; shokrgozar, mohammad
   ali/0000-0001-5123-4155; 
CR Barralet J, 1998, J BIOMED MATER RES, V41, P79, DOI 10.1002/(SICI)1097-4636(199807)41:1<79::AID-JBM10>3.0.CO;2-C
   Bronzino J.D, 2000, BIOMEDICAL ENG HDB, V1
   Ehara A, 2003, BIOMATERIALS, V24, P831, DOI 10.1016/S0142-9612(02)00411-8
   Evans SL, 1998, BIOMATERIALS, V19, P1329, DOI 10.1016/S0142-9612(97)00217-2
   GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P298
   Hench LL, 1998, J AM CERAM SOC, V81, P1705
   Homaeigohar SS, 2006, J EUR CERAM SOC, V26, P273, DOI 10.1016/j.jeurceramsoc.2004.10.003
   Homaeigohar SSH, 2005, J BIOMED MATER RES A, V75A, P14, DOI 10.1002/jbm.a.30333
   Hulshoff JEG, 1998, J BIOMED MATER RES, V40, P464, DOI 10.1002/(SICI)1097-4636(19980605)40:3<464::AID-JBM18>3.0.CO;2-J
   KANATANI M, 1991, BIOCHEM BIOPH RES CO, V181, P1425, DOI 10.1016/0006-291X(91)92098-5
   KREIGER NS, 1992, AM J PHYSIOL, V262, P442
   Layman DL, 1998, J BIOMED MATER RES, V40, P282, DOI 10.1002/(SICI)1097-4636(199805)40:2<282::AID-JBM13>3.0.CO;2-O
   LOZA J, 1995, BONE, V16, P341
   Maxian SH, 1998, J BIOMED MATER RES, V40, P171, DOI 10.1002/(SICI)1097-4636(199805)40:2<171::AID-JBM1>3.0.CO;2-I
   Monchau F, 2002, BIOMOL ENG, V19, P143, DOI 10.1016/S1389-0344(02)00023-0
   Pioletti DP, 2000, BIOMATERIALS, V21, P1103, DOI 10.1016/S0142-9612(99)00250-1
   Ramachandra R. R., 1997, J MATER SCI-MATER M, V8, P511
   Ramakrishna S, 2001, COMPOS SCI TECHNOL, V61, P1189, DOI 10.1016/S0266-3538(00)00241-4
   RAVIGAVITAL N, 2000, J BIOMED MATER RES, V51, P660
   Suzuki T, 1999, J BIOSCI BIOENG, V87, P320, DOI 10.1016/S1389-1723(99)80039-5
   SUZUKI T, 1991, J FERMENT BIOENG, V72, P450, DOI 10.1016/0922-338X(91)90053-J
   Suzuki T, 1997, J BIOMED MATER RES, V34, P507, DOI 10.1002/(SICI)1097-4636(19970315)34:4<507::AID-JBM11>3.3.CO;2-P
   Suzuki T, 2000, J BIOSCI BIOENG, V89, P18, DOI 10.1016/S1389-1723(00)88045-7
   Wang M, 1998, BIOMATERIALS, V19, P2357, DOI 10.1016/S0142-9612(98)00154-9
   Yuan HP, 1998, J MATER SCI-MATER M, V9, P723, DOI 10.1023/A:1008950902047
NR 25
TC 10
Z9 11
U1 0
U2 1
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2006
VL 78A
IS 1
BP 129
EP 138
DI 10.1002/jbm.a.30691
PG 10
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 051JR
UT WOS:000238157900016
PM 16612817
DA 2018-10-19
ER

PT J
AU Van Tienhoven, EAE
   Korbee, D
   Schipper, L
   Verharen, HW
   De Jong, WH
AF Van Tienhoven, EAE
   Korbee, D
   Schipper, L
   Verharen, HW
   De Jong, WH
TI In vitro and in vivo (cyto)toxicity assays using PVC and LDPE as model
   materials
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
LA English
DT Article
DE biocompatibility; cytotoxicity; biomaterials; implantation; mice and
   rats
ID FOREIGN-BODY REACTION; CELL-LINE; BIOCOMPATIBILITY; CYTOTOXICITY;
   BIOMATERIAL; RESPONSES; IMPLANTS; FILMS; RATS; MICE
AB The choice for a biomaterial is partly based on the outcome of (cyto)toxicity assays. The rationales behind the selection of certain parameters, such as cell lines, controls, and animals, were evaluated using a positive and a negative control, and one experimental sample designed to induce intermediate toxicity. Extraction and direct contact assays were performed using human epidermal keratinocytes and mouse fibroblasts and mouse epithelial cells. Cell survival was measured with the tetrazolium salt (MTT) reduction assay. In addition, local implantation studies were performed in mice and rats. The positive control induced a high degree of toxicity in all in vitro tests performed, indicating that the toxicity observed in the direct contact assay was due to in situ extraction of toxic components. In the direct contact assay the negative control tested on the mouse fibroblasts resulted in a significant reduction of cell survival. No decrease in cell survival was found using the experimental sample. Subcutaneous implantation studies in mice showed that the positive control material induced a severe degeneration in mice. However, in rats just minimal alterations were noted. The experimental material induced moderate responses only in mice. Our results indicate that the direct contact assay provides limited additional information on the cytotoxicity of materials if certain limitations are not taken into account. For the in vivo implantation assay mice were superior to rats in detecting local toxic responses. (c) 2006 Wiley Periodicals, Inc.
C1 Natl Inst Publ Hlth & Environm, Ctr Biol Med & Med Technol, NL-3702 BA Bilthoven, Netherlands.
   Natl Inst Publ Hlth & Environm, Lab Toxicol Pathol & Genet, NL-3702 BA Bilthoven, Netherlands.
RP Van Tienhoven, EAE (reprint author), Natl Inst Publ Hlth & Environm, Ctr Biol Med & Med Technol, POB 1, NL-3702 BA Bilthoven, Netherlands.
EM esther.van.tienhoven@rivm.nl
CR Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81
   Bailey LO, 2004, J BIOMED MATER RES A, V69A, P305, DOI 10.1002/jbm.a.20134
   Bergsma JE, 1995, J MATER SCI-MATER M, V6, P715, DOI 10.1007/BF00134307
   Bonnema H, 2003, J BIOMED MATER RES A, V64A, P502, DOI 10.1002/jbm.a.10404
   BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761
   Butler K, 2001, Biomed Sci Instrum, V37, P19
   Cadee JA, 2000, J BIOMED MATER RES, V50, P397
   Camps J, 2003, J ENDODONT, V29, P583, DOI 10.1097/00004770-200309000-00010
   CIAPETTI G, 1993, BIOMATERIALS, V14, P359, DOI 10.1016/0142-9612(93)90055-7
   Draye JP, 1998, BIOMATERIALS, V19, P1677, DOI 10.1016/S0142-9612(98)00049-0
   Gambarini G, 2003, Aust Endod J, V29, P17
   Hanks CT, 1996, DENT MATER, V12, P186, DOI 10.1016/S0109-5641(96)80020-0
   *ISO, 1999, 109935 ENISO
   *ISO, 1994, 109936 ENISO
   *ISO, 2003, 109931 ENISO
   JUSTE S, 2005, J BIOMED MATER RES A, V15, P389
   Khouw IMSL, 2000, J BIOMED MATER RES, V52, P439, DOI 10.1002/1097-4636(20001205)52:3<439::AID-JBM1>3.0.CO;2-C
   Kidd KR, 2002, J BIOMED MATER RES, V59, P682, DOI 10.1002/jbm.10032
   Kirkpatrick CJ, 1998, P I MECH ENG H, V212, P75, DOI 10.1243/0954411981533845
   Kirkpatrick CJ, 2002, BIOMOL ENG, V19, P211, DOI 10.1016/S1389-0344(02)00019-9
   Lavik E, 2004, APPL MICROBIOL BIOT, V65, P1, DOI 10.1007/s00253-004-1580-z
   LIU BS, 2003, J BIOMED MATER RES, V15, P1163
   Liu YC, 2005, BIOMATERIALS, V26, P4737, DOI 10.1016/j.biomaterials.2005.01.003
   Macnair R, 1997, J MATER SCI-MATER M, V8, P105, DOI 10.1023/A:1018510900941
   Mendes SC, 2001, BIOMATERIALS, V22, P2057, DOI 10.1016/S0142-9612(00)00395-1
   Mitchell W, 2003, BIOMATERIALS, V24, P737, DOI 10.1016/S0142-9612(02)00405-2
   Newby CS, 2000, J INVEST DERMATOL, V115, P292, DOI 10.1046/j.1523-1747.2000.00056.x
   Park JC, 2002, YONSEI MED J, V43, P518, DOI 10.3349/ymj.2002.43.4.518
   PETERS K, 2004, 7 WORLD BIOM C SYDN
   Pizzoferrato Arturo, 1994, Clinical Materials, V15, P173, DOI 10.1016/0267-6605(94)90081-7
   Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027
   Rogero SO, 2003, ARTIF ORGANS, V27, P424, DOI 10.1046/j.1525-1594.2003.07249.x
   SALTHOUSE TN, 1984, J BIOMED MATER RES, V18, P395, DOI 10.1002/jbm.820180407
   VanKooten TG, 1997, J MATER SCI-MATER M, V8, P835
   Wang XD, 2004, J BIOMED MATER RES A, V68A, P411, DOI 10.1002/jbm.a.20065
   Williams David, 2003, Med Device Technol, V14, P10
NR 36
TC 28
Z9 29
U1 1
U2 8
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1549-3296
J9 J BIOMED MATER RES A
JI J. Biomed. Mater. Res. Part A
PD JUL
PY 2006
VL 78A
IS 1
BP 175
EP 182
DI 10.1002/jbm.a.30679
PG 8
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 051JR
UT WOS:000238157900021
PM 16628708
DA 2018-10-19
ER

PT J
AU Lambert, JM
AF Lambert, JM
TI The nature of platinum in silicones for biomedical and healthcare use
SO JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS
LA English
DT Review
DE silicone(s)/PDMS; implant design : implant retrieval;
   measurement/assessment : toxicity
ID NEUTRON-ACTIVATION ANALYSIS; GROUP ELEMENTS; HYDROSILYLATION CATALYST;
   PHOSPHINE) COMPLEXES; BREAST IMPLANTS; ICP-MS; LIGANDS; NANOPARTICLES;
   MECHANISM; VINYLMETALLICS
AB Silicone is an important biomaterial in many different biomedical and healthcare applications. Network formation in one type of silicone relies upon a chemical crosslinking reaction that typically employs a platinum catalyst. As a consequence, low concentrations of platinum may remain in certain medical devices designed for human use. The characteristics of platinum in silicone before, during, and after the crosslinking reaction have been well described in the literature. This review summarizes the relevant literature on the organometallic and analytical chemistry of platinum in silicone and thus provides a foundation for understanding the effects this platinum may have, if any, in the various biomedical and healthcare applications where it may be present. (c) 2006 Wiley Periodicals. Inc.
C1 NuSil Technol, Biotech Ctr, Richmond, VA 23219 USA.
RP Lambert, JM (reprint author), NuSil Technol, Biotech Ctr, 800 E Leigh St,Suite 53, Richmond, VA 23219 USA.
EM jiml@nusil.com
CR Aiken JD, 1999, J MOL CATAL A-CHEM, V145, P1, DOI 10.1016/S1381-1169(99)00098-9
   Alfassi Z.B., 2000, ENCY ANAL CHEM, P12497
   ANDERSON IE, 1995, VET MICROBIOL, V43, P1, DOI 10.1016/0378-1135(94)00083-9
   Arepalli Sambasiva R, 2002, J Long Term Eff Med Implants, V12, P299
   ARKLES B, 1983, CHEMTECH, V13, P542
   Balcerzak M, 1997, ANALYST, V122, pR67, DOI 10.1039/a608153c
   Bartlett KL, 2001, ORGANOMETALLICS, V20, P2669, DOI 10.1021/om010072e
   Baru JS, 2001, J AM COLL SURGEONS, V192, P79, DOI 10.1016/S1072-7515(00)00743-2
   BERKE H, 1978, J AM CHEM SOC, V100, P7224, DOI 10.1021/ja00491a018
   Bond A. M., 2003, BROADENING ELECTROCH
   Bondurant S, 2000, SAFETY SILICON BREAS
   Bradley J. S., 1994, CLUSTERS COLLOIDS TH, P459, DOI DOI 10.1002/9783527616077.CH6
   Brook M. A., 2000, SILICON ORGANIC ORGA
   Candlin J. P., 1968, REACTIONS TRANSITION
   Chai ZF, 2002, ANAL BIOANAL CHEM, V372, P407, DOI 10.1007/s00216-001-1218-2
   CHALK AJ, 1965, J AM CHEM SOC, V87, P16, DOI 10.1021/ja01079a004
   CHANDRA G, 1987, ORGANOMETALLICS, V6, P191, DOI 10.1021/om00144a036
   Chauhan BPS, 2005, J AM CHEM SOC, V127, P5790, DOI 10.1021/ja042824c
   Chauhan BPS, 2004, J AM CHEM SOC, V126, P8493, DOI 10.1021/ja049604j
   Chauhan BPS, 2003, J ORGANOMET CHEM, V686, P24, DOI 10.1016/S0022-328X(03)00612-0
   Chauhan BPS, 2003, J AM CHEM SOC, V125, P2876, DOI 10.1021/ja028957k
   Christian G. D., 2003, ANAL CHEM
   Clarson S. J., 2003, SYNTHESIS PROPERTIES
   Collman J. P., 1980, PRINCIPLES APPL ORGA
   COMPTON RA, 1997, J LONG-TERM EFF MED, V7, P1
   Cotton F. A., 1999, ADV INORGANIC CHEM
   Crabtree R. H., 2001, ORGANOMETALLIC CHEM
   CROSS RJ, 1995, NICKEL PALLADIUM PLA, P391
   Cundari TR, 2001, COMPUTATIONAL ORGANO
   DEJONGH LJ, 1994, PHYS CHEM METAL CLUS, V18
   DENICOLA RR, 1950, J UROLOGY, V63, P168, DOI 10.1016/S0022-5347(17)68748-2
   Ek KH, 2004, SCI TOTAL ENVIRON, V334, P21, DOI 10.1016/j.scitotenv.2004.04.027
   ELJAMMAL A, 1995, ANAL PROC, V32, P293, DOI 10.1039/ai9953200293
   FITCH JW, 1978, J ORGANOMET CHEM, V160, P477, DOI 10.1016/S0022-328X(00)89104-4
   Flassbeck D, 2003, ANAL BIOANAL CHEM, V375, P356, DOI 10.1007/s00216-002-1694-z
   Gelevert T, 2001, THER DRUG MONIT, V23, P169, DOI 10.1097/00007691-200104000-00013
   Giaveri G, 2001, ANAL CHEM, V73, P3488, DOI 10.1021/ac010084+
   Ginzburg S. I., 1975, ANAL CHEM PLATINUM M
   Glascock M.D., OVERVIEW NEUTRON ACT
   Hann S, 2003, ANAL BIOANAL CHEM, V376, P198, DOI 10.1007/s00216-003-1861-x
   Hartley F. R., 1973, CHEM PLATINUM PALLAD
   HARTLEY FR, 1991, CHEM PLATINUM GROUP
   HASCHKE EM, 1973, J ORGANOMET CHEM, V57, pC93, DOI 10.1016/S0022-328X(00)86597-3
   HILL SJ, 1999, INDUCTIVELLY COUPLED
   Hitchcock PB, 1997, J ORGANOMET CHEM, V528, P185, DOI 10.1016/S0022-328X(96)06676-4
   Hitchcock PB, 1997, J ORGANOMET CHEM, V534, P139, DOI 10.1016/S0022-328X(96)06925-2
   HITCHCOCK PB, 1991, ANGEW CHEM INT EDIT, V30, P438, DOI 10.1002/anie.199104381
   HOFFMANN R, 1981, SCIENCE, V211, P995, DOI 10.1126/science.211.4486.995
   Hoffmann R., 1982, FRONTIERS CHEM, P247
   HOLCOMBE JA, 2000, ENCY ANAL CHEM APPL, P9451
   Hou X., 2000, ENCY ANAL CHEM, P9468
   Huang JC, 2004, LANGMUIR, V20, P5145, DOI 10.1021/la036135a
   Jagadeesh MN, 2002, ORGANOMETALLICS, V21, P2076, DOI 10.1021/om0200196
   Jenkins R, 2000, ENCY ANAL CHEM, P13269
   Jones R. G., 2000, SILICON CONTAINING P
   Karstedt B., 1973, U. S. Patent, Patent No. [US3775452, 3775452, 3,775,452]
   Kawai J., 2000, ENCY ANAL CHEM, P13288
   Kebbekus BB, 2003, SAMPLE PREPARATION T, V162, P227
   Kellner R., 2004, ANAL CHEM MODERN APP
   Koningsberger D., 1988, XRAY ABSORPTION PRIN
   Lahey F., 1946, ANN SURG, V124, P1027
   Lambert JB, 1996, J AM CHEM SOC, V118, P7867, DOI 10.1021/ja9613670
   LAPPERT MF, 1995, J ORGANOMET CHEM, V492, pC11, DOI 10.1016/0022-328X(94)05359-J
   LEVENE GM, 1971, BRIT J DERMATOL, V85, P500
   LEVIER RR, 1993, PLAST RECONSTR SURG, V92, P163
   Lewis LN, 1996, J ORGANOMET CHEM, V521, P221, DOI 10.1016/0022-328X(96)06247-X
   LEWIS LN, 1995, ORGANOMETALLICS, V14, P2202, DOI 10.1021/om00005a021
   Lewis LN, 1997, PLATIN MET REV, V41, P66
   LINDGREN ES, 2000, ENCY ANAL CHEM APPL, P13315
   Lugowski SJ, 2000, J TRACE ELEM MED BIO, V14, P31, DOI 10.1016/S0946-672X(00)80021-8
   Lykissa ED, 1997, ANAL CHEM, V69, P4912, DOI 10.1021/ac970710w
   Maharaj SVM, 2004, ANAL BIOANAL CHEM, V380, P84, DOI 10.1007/s00216-004-2714-y
   Marciniec B., 2002, SILICON CHEM, P155
   MCMILLIN CR, 1994, RUBBER CHEM TECHNOL, V67, P417, DOI 10.5254/1.3538684
   Noll W., 1968, CHEM TECHNOLOGY SILI
   NYGREN O, 1990, ANAL CHEM, V62, P1637, DOI 10.1021/ac00214a020
   Ojima I., 1998, CHEM ORGANIC SILICON, P1687
   Petrucci F, 2004, MICROCHEM J, V76, P131, DOI 10.1016/j.microc.2003.11.005
   Philippot K, 2003, CR CHIM, V6, P1019, DOI 10.1016/j.crci.2003.07.010
   PREGOSIN PS, 1982, COORDIN CHEM REV, V44, P247, DOI 10.1016/S0010-8545(00)80523-8
   Ramirez E, 2004, J ORGANOMET CHEM, V689, P4601, DOI 10.1016/j.jorganchem.2004.09.006
   Ratner BD, 2004, BIOMATERIALS SCI INT
   Ravindra K, 2004, SCI TOTAL ENVIRON, V318, P1, DOI 10.1016/S0048-9697(03)00372-3
   Rietz B, 2002, TRACE ELEM ELECTROLY, V19, P38
   ROUESAC F, 2000, CHEM ANAL MODERN INS
   Roy AK, 2002, J AM CHEM SOC, V124, P9510, DOI 10.1021/ja0127335
   Schmeltzer JM, 2002, LANGMUIR, V18, P2971, DOI 10.1021/la0156560
   SCHMID G, 1992, CHEM REV, V92, P1709, DOI 10.1021/cr00016a002
   Schmid G., 2004, NANOPARTICLES THEORY
   Schmid G., 1994, CLUSTERS COLLOIDS TH
   Smith A., 1991, ANAL CHEM SILICONES
   SOMMER LH, 1947, J AM CHEM SOC, V69, P188, DOI 10.1021/ja01193a508
   SPEIER JL, 1957, J AM CHEM SOC, V79, P974, DOI 10.1021/ja01561a054
   Stein J, 1999, J AM CHEM SOC, V121, P3693, DOI 10.1021/ja9825377
   Steinberger HU, 2003, CAN J CHEM, V81, P1223, DOI 10.1139/V03-121
   Taylor H.E., 2001, INDUCTIVELY COUPLED
   Thomas D. R., 1993, SILOXANE POLYM, P567
   Vince V, 2004, J BIOMAT SCI-POLYM E, V15, P173, DOI 10.1163/156856204322793566
   WATANABE H, 1980, J ORGANOMET CHEM, V195, P363, DOI 10.1016/S0022-328X(00)93320-5
   Watterson JD, 2003, J ENDOUROL, V17, P269, DOI 10.1089/089277903322145431
   WEBB JL, 1991, Patent No. 5026890
   WHITE HS, 2000, ENCY ANAL CHEM APPL, P9841
   Wilkinson G, 1982, COMPREHENSIVE ORGANO, V6, P471
   Wynne K.J., 2004, ENCY BIOMATERIALS BI, P1348
   Yang Z, 2002, APPL SPECTROSC REV, V37, P57, DOI 10.1081/ASR-120004747
   Yoda R, 1998, J BIOMAT SCI-POLYM E, V9, P561, DOI 10.1163/156856298X00046
   YOUNG GB, 1995, NICKEL PALLADIUM PLA, P533
   Zimmermann S, 2003, ANAL CHIM ACTA, V498, P93, DOI 10.1016/j.aca.2003.08.061
   1974, Patent No. 3798252
NR 109
TC 14
Z9 14
U1 2
U2 25
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 1552-4973
J9 J BIOMED MATER RES B
JI J. Biomed. Mater. Res. Part B
PD JUL
PY 2006
VL 78B
IS 1
BP 167
EP 180
DI 10.1002/jbm.b.30471
PG 14
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 059MQ
UT WOS:000238737300023
PM 16470825
DA 2018-10-19
ER

PT J
AU Pluhar, GE
   Turner, AS
   Pierce, AR
   Toth, CA
   Wheeler, DL
AF Pluhar, G. E.
   Turner, A. S.
   Pierce, A. R.
   Toth, C. A.
   Wheeler, D. L.
TI A comparison of two biomaterial carriers for osteogenic protein-1
   (BMP-7) in an ovine critical defect model
SO JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME
LA English
DT Article
ID BONE MORPHOGENETIC PROTEIN; RETRIEVED HUMAN ALLOGRAFTS; FEMORAL
   NONUNION; SEGMENTAL BONE; FRACTURES; DELIVERY; MATRIX; RATS;
   CARBOXYMETHYLCELLULOSE; BIOAVAILABILITY
AB Critical size defects in ovine tibiae, stabilised with intramedullary interlocking nails, were used to assess whether the addition of carboxymethylcellulose to the standard osteogenic protein-1 (OP-1/BMP-7) implant would affect the implant's efficacy for bone regeneration. The biomaterial carriers were a 'putty' carrier of carboxymethylcellulose and bovine-derived type-I collagen (OPP) or the standard with collagen alone (OPC). These two treatments were also compared to "ungrafted" negative controls. Efficacy of regeneration was determined using radiological, biomechanical and histological evaluations after four months of healing. The defects, filled with OPP and OPC, demonstrated radiodense material spanning the defect after one month of healing, with radiographic evidence of recorticalisation and remodelling by two months. The OPP and OPC treatment groups had equivalent structural and material properties that were significantly greater than those in the ungrafted controls. The structural properties of the OPP- and OPC-treated limbs were equivalent to those of the contralateral untreated limb (p > 0.05), yet material properties were inferior (p < 0.05). Histopathology revealed no residual inflammatory response to the biomaterial carriers or OP-1. The OPP- and OPC-treated animals had 60% to 85% lamellar bone within the defect, and less than 25% of the regenerate was composed of fibrous tissue. The defects in the untreated control animals contained less than 40% lamellar bone and more than 60% was fibrous tissue, creating full cortical thickness defects. In our studies carboxymethylcellulose did not adversely affect the capacity of the standard OP-1 implant for regenerating bone.
C1 Univ Minnesota, Dept Vet Clin Sci, St Paul, MN 55108 USA.
RP Pluhar, GE (reprint author), Univ Minnesota, Dept Vet Clin Sci, 1352 Boyd Ave, St Paul, MN 55108 USA.
EM pluha006@umn.edu
CR ASPENBERG P, 1989, ACTA ORTHOP SCAND, V60, P473, DOI 10.3109/17453678909149323
   BERREY BH, 1990, J BONE JOINT SURG AM, V72A, P825, DOI 10.2106/00004623-199072060-00005
   BOS GD, 1983, J BONE JOINT SURG AM, V65, P89, DOI 10.2106/00004623-198365010-00012
   BOS GD, 1983, J BONE JOINT SURG AM, V65, P239, DOI 10.2106/00004623-198365020-00015
   BUCK BE, 1990, CLIN ORTHOP RELAT R, P249
   Chen XQ, 2002, J ORTHOPAED RES, V20, P142, DOI 10.1016/S0736-0266(01)00060-2
   Cook SD, 2002, J INVEST SURG, V15, P69, DOI 10.1080/08941930290085822
   Cook SD, 1999, ORTHOPEDICS, V22, P669
   Cook SD, 1998, J ORTHOP TRAUMA, V12, P407, DOI 10.1097/00005131-199808000-00007
   Cullinane DM, 2002, J ORTHOPAED RES, V20, P1240, DOI 10.1016/S0736-0266(02)00056-6
   den Boer FC, 1999, J ORTHOPAED RES, V17, P654, DOI 10.1002/jor.1100170506
   DUNCAN DB, 1955, BIOMETRICS, V11, P42
   Enneking WE, 2001, J BONE JOINT SURG AM, V83A, P971, DOI 10.2106/00004623-200107000-00001
   ENNEKING WF, 1991, J BONE JOINT SURG AM, V73A, P1123, DOI 10.2106/00004623-199173080-00002
   Friedlaender GE, 2001, J BONE JOINT SURG S1, V83, P151
   Geesink RGT, 1999, J BONE JOINT SURG BR, V81B, P710, DOI 10.1302/0301-620X.81B4.9311
   GOLDBERG VM, 1987, CLIN ORTHOP RELAT R, P7
   Gouin F, 1996, J BONE JOINT SURG BR, V78B, P38
   *HERC INC, 1999, HERC INC B
   Johnson EE, 1998, CLIN ORTHOP RELAT R, P105
   Johnson EE, 2000, CLIN ORTHOP RELAT R, P61
   Key JA, 1934, J BONE JOINT SURG, V16, P176
   KRUKOWSKI M, 1994, CLIN ORTHOP RELAT R, P266
   Lanyon LE., 1982, BONE CLIN ORTHOPAEDI, P273
   MANKIN HJ, 1983, CLIN ORTHOP RELAT R, P69
   MCBRIDE J, 1993, J INVEST SURG, V6, P369
   MCDONALD DJ, 1991, COMPLICATIONS LIMB S, P25
   Nemzek JA, 1996, CLIN ORTHOP RELAT R, P275
   Pecina M, 2001, INT ORTHOP, V25, P203, DOI 10.1007/s002640100262
   REDDI AH, 1976, J CELL BIOL, V69, P557, DOI 10.1083/jcb.69.3.557
   Salkeld SL, 2001, J BONE JOINT SURG AM, V83A, P803, DOI 10.2106/00004623-200106000-00001
   Santa-Comba A, 2001, J BIOMED MATER RES, V55, P396
   Scalia S, 2000, J PHARM PHARMACOL, V52, P383, DOI 10.1211/0022357001774129
   Suh DY, 2002, SPINE, V27, P353, DOI 10.1097/00007632-200202150-00006
   TACCHETTI C, 1992, EXP CELL RES, V200, P26, DOI 10.1016/S0014-4827(05)80067-9
   THOMPSON RC, 1993, J BONE JOINT SURG AM, V75A, P1663, DOI 10.2106/00004623-199311000-00011
   Ugwoke MI, 2000, INT J PHARM, V202, P125
   Wheeler DL, 2005, CLIN ORTHOP RELAT R, P36, DOI 10.1097/01.blo.0000165850.58583.50
   WHEELER DL, 2004, T ORTHOPAEDIC RES SO, P467
   WHEELER DL, 2004, T ORTHOPAEDIC RES SO, P466
   Woo BH, 2001, PHARMACEUT RES, V18, P1747, DOI 10.1023/A:1013382832091
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
   ZEHR RJ, 1991, COMPLICATIONS LIMB S, P3
NR 43
TC 28
Z9 34
U1 1
U2 14
PU BRITISH EDITORIAL SOC BONE JOINT SURGERY
PI LONDON
PA 22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND
SN 0301-620X
J9 J BONE JOINT SURG BR
JI J. Bone Joint Surg.-Br. Vol.
PD JUL
PY 2006
VL 88B
IS 7
BP 960
EP 966
DI 10.1302/0301-620X.88B7.17056
PG 7
WC Orthopedics; Surgery
SC Orthopedics; Surgery
GA 066KL
UT WOS:000239228200024
PM 16799005
OA Bronze
DA 2018-10-19
ER

PT J
AU Kneser, U
   Stangenberg, L
   Ohnolz, J
   Buettner, O
   Stern-Straeter, J
   Mobest, A
   Horch, RE
   Stark, GB
   Schaefer, DJ
AF Kneser, U.
   Stangenberg, L.
   Ohnolz, J.
   Buettner, O.
   Stern-Straeter, J.
   Moebest, A.
   Horch, R. E.
   Stark, G. B.
   Schaefer, D. J.
TI Evaluation of processed bovine cancellous bone matrix seeded with
   syngenic osteoblasts in a critical size calvarial defect rat model
SO JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LA English
DT Article
DE bone tissue engineering; osteoconduction; osteointegration; osteoblast
   transplantation; processed bovine cancellous bone matrix
ID MARROW STROMAL CELLS; MESENCHYMAL STEM-CELLS; IN-VITRO;
   MECHANICAL-PROPERTIES; VIVO; GROWTH; REPAIR; ANGIOGENESIS; GENE;
   SCAFFOLD
AB Introduction: Biologic bone substitutes may offer alternatives to bone grafting procedures. The aim of this study was to evaluate a preformed bone substitute based on processed bovine cancellous bone (PBCB) with or without osteogenic cells in a critical size calvarial defect rat model. Methods: Discs of PBCB (Tutobone (R)) were seeded with second passage fibrin gel-immobilized syngenic osteoblasts (group A, n = 40). Cell-free matrices (group B, n = 28) and untreated defects (group C; n=28) served as controls. Specimens were explanted between day 0 and 4 months after implantation and were subjected to histological and morphometric evaluation. Results: At I month, bone formation was limited to small peripheral areas. At 2 and 4 months, significant bone formation, matrix resorption as well as integration of the implants was evident in groups A and B. In group C no significant regeneration of the defects was observed. Morphometric analysis did not disclose differences in bone formation in matrices from groups A and B. Carboxyfluorescine-Diacetate-Succinimidylester (CFDA) labeling demonstrated low survival rates of transplanted cells. Discussion: Osteoblasts seeded into PBCB matrix display a differentiated phenotype following a 14 days cell culture period. Lack of initial vascularization may explain the absence of added osteogenicity in constructs from group A in comparison to group B. PBCB is well integrated and represents even without osteogenic cells a promising biomaterial for reconstruction of critical size calvarial bone defects.
C1 Univ Erlangen Nurnberg, Med Ctr, Dept Plast & Hand Surg, D-91054 Erlangen, Germany.
   Univ Freiburg, Med Ctr, Dept Plast & Hand Surg, D-7800 Freiburg, Germany.
   Univ Basel Hosp, Clin Reconstruct Surg, Dept Plast Reconstruct & Aesthet Surg, CH-4031 Basel, Switzerland.
RP Horch, RE (reprint author), Univ Erlangen Nurnberg, Med Ctr, Dept Plast & Hand Surg, Krankenhausstr 12, D-91054 Erlangen, Germany.
EM raymund.horch@chir.imed.uni-erlangen.de
OI Horch, Raymund E./0000-0002-6561-2353
CR Arnold U, 2003, J BIOMED MATER RES A, V67A, P260, DOI 10.1002/jbm.a.10577
   Behravesh E, 2003, J BIOMED MATER RES A, V65A, P260, DOI 10.1002/jbm.a.10461
   Bensaid W, 2003, BIOMATERIALS, V24, P2497, DOI 10.1016/S0142-9612(02)00618-X
   Breitbart AS, 1998, PLAST RECONSTR SURG, V101, P567, DOI 10.1097/00006534-199803000-00001
   Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x
   Cancedda Ranieri, 2003, Novartis Found Symp, V249, P133
   Cheng SL, 2001, CALCIFIED TISSUE INT, V68, P87, DOI 10.1007/BF02678146
   Cornu O, 2000, J ORTHOPAED RES, V18, P426, DOI 10.1002/jor.1100180314
   FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745
   Hofmann C, 2003, UNFALLCHIRURG, V106, P478, DOI 10.1007/s00113-003-0611-z
   Holy CE, 2003, J BIOMED MATER RES A, V65A, P447, DOI 10.1002/jbm.a.10453
   Ignatius AA, 2001, J BIOMED MATER RES, V58, P701, DOI 10.1002/jbm.10024
   Kadiyala S, 1997, CELL TRANSPLANT, V6, P125, DOI 10.1016/S0963-6897(96)00279-5
   Keith JD, 2004, INT J PERIODONT REST, V24, P11
   KHOURI RK, 1992, CLIN PLAST SURG, V19, P763
   Knaack D, 1998, J BIOMED MATER RES, V43, P399, DOI 10.1002/(SICI)1097-4636(199824)43:4<399::AID-JBM7>3.3.CO;2-A
   Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x
   Kokubo S, 2004, BIOMATERIALS, V25, P1795, DOI 10.1016/j.biomaterials.2003.08.030
   Kon E, 2000, J BIOMED MATER RES, V49, P328
   Lisignoli G, 2001, BIOMATERIALS, V22, P2095, DOI 10.1016/S0142-9612(00)00398-7
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   Mauney JR, 2005, BIOMATERIALS, V26, P3173, DOI 10.1016/j.biomaterials.2004.08.020
   McAuliffe John A, 2003, J Hand Ther, V16, P180
   Mueller-Stahl K, 2003, INT J ARTIF ORGANS, V26, P235
   Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0
   Ohgushi Hajime, 2003, Novartis Found Symp, V249, P118
   Peattie RA, 2004, BIOMATERIALS, V25, P2789, DOI 10.1016/j.biomaterials.2003.09.054
   Schaefer DJ, 2000, CHIRURG, V71, P1001, DOI 10.1007/s001040070002
   Schantz JT, 2003, TISSUE ENG, V9, pS127, DOI 10.1089/10763270360697030
   SCHMITZ JP, 1986, CLIN ORTHOP RELAT R, P299
   SCHMITZ JP, 1990, ACTA ANAT, V138, P185
   Shin H, 2003, BIOMATERIALS, V24, P4353, DOI 10.1016/S0142-9612(03)00339-9
   Stangenberg L, 2005, TISSUE ENG, V11, P855, DOI 10.1089/ten.2005.11.855
   Tabata Y, 2003, TISSUE ENG, V9, pS5, DOI 10.1089/10763270360696941
   Tanaka Y, 2003, PLAST RECONSTR SURG, V112, P1636, DOI 10.1097/01.PRS.0000086140.49022.AB
   Tholpady SS, 1999, LARYNGOSCOPE, V109, P1585, DOI 10.1097/00005537-199910000-00007
   Trentz OA, 2003, BIOMATERIALS, V24, P3417, DOI 10.1016/S0142-9612(03)00205-9
   Wenger A, 2004, TISSUE ENG, V10, P1536, DOI 10.1089/1076327042500283
   Younger E M, 1989, J Orthop Trauma, V3, P192, DOI 10.1097/00005131-198909000-00002
NR 40
TC 54
Z9 61
U1 1
U2 6
PU CAROL DAVILA UNIV PRESS
PI BUCHARESST
PA 8 EROILOR SANITARI BLVD, BUCHARESST 76241, ROMANIA
SN 1582-1838
J9 J CELL MOL MED
JI J. Cell. Mol. Med.
PD JUL-SEP
PY 2006
VL 10
IS 3
BP 695
EP 707
DI 10.2755/jcmm010.003.06
PG 13
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA 096RI
UT WOS:000241394100011
PM 16989729
OA Green Published
DA 2018-10-19
ER

PT J
AU Arndt, S
   Itthichaisri, C
   Maier, W
   Gellrich, NC
   Schipper, J
AF Arndt, Susan
   Itthichaisri, Chumpot
   Maier, Wolfgang
   Gellrich, Nils-C.
   Schipper, Joerg
TI Proliferation rate of human osteoblast-like cells on alloplastic
   biomaterials and their clinical application for the transnasal
   duraplasty procedure
SO JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LA English
DT Article
DE biocompatibility; biomaterials; human osteoblast-like cells;
   proliferation assay; duraplasty; vicryl-PDS fleece; absorbable implants
ID ENDOSCOPIC REPAIR; SKULL BASE; LONG-TERM; BONE; EXPERIENCE; FIBROBLASTS;
   SUBSTITUTES; PHOSPHATE; SURGERY; CULTURE
AB The possibility of transmission of slow virus infection (HIV) and Creutzfeld-Jakob disease by cadaveric dura implants makes it necessary to find synthetic, absorbable materials for the reconstruction of the dura mater. Various procedures with autologous or alloplastic material are described. Four commercially available biomaterials were choosen to study the proliferation rate and the biocompatibility of human osteoblast-like cells (HOB-like cells) on 2-dimensional material by biochemical analysis. With a proliferation assay, the viability and the proliferation capacity of osteoblast-like cells were evaluated. A clinical trial was added to study resorbable fleece as one of the previously tested biomaterial in a small patient group (8 patients) to close anterior cranial fossa dura defects. The results of the proliferation assay showed the highest proliferation rate of HOB-like cells on resorbable fleece. All patients in our clinical trial with anterior cranial fossa dura defects were successfully treated with resorbable fleece. There was no evidence for persisting cerebrospinal fluid rhinorrhea or foreign body reaction after the period of wound healing. The present study demonstrated an excellent biocompatibility of resorbable fleece. The vicryl fleece is an alternative alloplastic material for endonasal closure of defined substantial defects of the dura with cerebrospinal fluid.
C1 Univ Freiburg, Dept Otorhinolaryngol Head & Neck Surg, D-79106 Freiburg, Germany.
   Univ Freiburg, Dept Oral & Maxillofacial Surg, D-79106 Freiburg, Germany.
   Med Acad Hannover, Dept Oral & Maxillofacial Surg, Hannover, Germany.
RP Arndt, S (reprint author), Univ Freiburg, Dept Otorhinolaryngol Head & Neck Surg, Killianstr 5, D-79106 Freiburg, Germany.
EM arndt@hno.ukl.uni-freiburg.de
CR Bach AD, 2004, J CELL MOL MED, V8, P413, DOI 10.1111/j.1582-4934.2004.tb00466.x
   Barbolt TA, 2001, NEUROL RES, V23, P813, DOI 10.1179/016164101101199405
   BIBAS AG, 2001, BRIT J NEUROSURGERY, V14, P49
   Burns JA, 1996, LARYNGOSCOPE, V106, P1080, DOI 10.1097/00005537-199609000-00007
   Caroli E, 2004, SURG NEUROL, V61, P55, DOI 10.1016/S0090-3019(03)00524-X
   Dalby MJ, 2001, BIOMATERIALS, V22, P1739, DOI 10.1016/S0142-9612(00)00334-3
   Dandy WE, 1926, ARCH SURG-CHICAGO, V12, P949, DOI 10.1001/archsurg.1926.01130050003001
   Fini M, 2002, BIOMATERIALS, V23, P4523, DOI 10.1016/S0142-9612(02)00196-5
   Haisch A, 1996, HNO, V44, P624, DOI 10.1007/s001060050067
   Hao SP, 1996, LARYNGOSCOPE, V106, P501
   Hillmann G, 2002, BIOMATERIALS, V23, P1461, DOI 10.1016/S0142-9612(01)00270-8
   HIRSCH O, 1952, AMA ARCH OTOLARYNGOL, V56, P1
   Horch RE, 2005, J CELL MOL MED, V9, P592, DOI 10.1111/j.1582-4934.2005.tb00491.x
   Kneser U, 2006, J CELL MOL MED, V10, P7, DOI 10.1111/j.1582-4934.2006.tb00287.x
   Logeart-Avramoglou D, 2005, J CELL MOL MED, V9, P72, DOI 10.1111/j.1582-4934.2005.tb00338.x
   McFarland CD, 1999, J BIOMED MATER RES, V44, P1
   MOUNEY JR, 2004, TISSUE ENG, V10, P81
   Neovius EB, 2003, TISSUE ENG, V9, P365, DOI 10.1089/107632703764664837
   Ogata K, 2005, J BIOMED MATER RES A, V72A, P127, DOI 10.1002/jbm.a.30146
   Perka C, 2000, BIOMATERIALS, V21, P1145, DOI 10.1016/S0142-9612(99)00280-X
   PULEO D, 1999, PREFACE BIOMATERIALS, V20, P2201
   Schick B, 2001, ANN OTO RHINOL LARYN, V110, P142, DOI 10.1177/000348940111000209
   Seidl RO, 2000, HNO, V48, P753, DOI 10.1007/s001060050654
   Sittinger M, 1996, BIOMATERIALS, V17, P237, DOI 10.1016/0142-9612(96)85561-X
   Stammberger H, 1997, LARYNGO RHINO OTOL, V76, P595, DOI 10.1055/s-2007-997487
   Verheggen R, 1997, ACTA NEUROCHIR, V139, P1074, DOI 10.1007/BF01411563
   von Wild KRH, 1999, SURG NEUROL, V52, P418, DOI 10.1016/S0090-3019(99)00125-1
   Weber R, 1996, ARCH OTOLARYNGOL, V122, P732
   Wolf G, 2005, HNO, V53, P439, DOI 10.1007/s00106-004-11565-3
   YAHYA A, 2000, J BIOMED MATER RES, V51, P703
NR 30
TC 0
Z9 0
U1 0
U2 0
PU CAROL DAVILA UNIV PRESS
PI BUCHARESST
PA 8 EROILOR SANITARI BLVD, BUCHARESST 76241, ROMANIA
SN 1582-1838
J9 J CELL MOL MED
JI J. Cell. Mol. Med.
PD JUL-SEP
PY 2006
VL 10
IS 3
BP 749
EP 757
DI 10.2755/jcmm010.003.03
PG 9
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA 096RI
UT WOS:000241394100016
PM 16989734
OA Green Published
DA 2018-10-19
ER

PT J
AU Aryal, S
   Bahadur, KCR
   Bhattarai, N
   Kim, CK
   Kim, HY
AF Aryal, S
   Bahadur, KCR
   Bhattarai, N
   Kim, CK
   Kim, HY
TI Study of electrolyte induced aggregation of gold nanoparticles capped by
   amino acids
SO JOURNAL OF COLLOID AND INTERFACE SCIENCE
LA English
DT Article
DE amino acid; gold; nanoparticles; biomaterial; surface modification
ID METAL PARTICLES; REAL-TIME; COLLOIDS; SURFACE; SPECTROSCOPY; THIOLS
AB This work reports the electrolyte induced aggregation of gold nanoparticles directly conjugated to amino acid by chemical reduction in aqueous solution. The study was focused on three different classes of amino acids depending on the nature of a substituent, viz. L-cysteine. L-leucine, and L-asparagine. The band broadening and the red shift of surface plasmon band with increase in flocculation parameter showed the aggregation of gold nanoparticles with increase in electrolyte concentration and decrease in pH as monitored by UV-visible spectrophotometer. The H-1 NMR spectrum demonstrates that the sulfide bond of cysteine and alpha amino group of leucine and asparagine interact with nanoparticles surface. Furthermore. transmission electron microscope (TEM) and thermogravimetric analysis (TGA) were performed to characterize and to support the fate of stabilization of the gold nanoparticles by amino acid. (c) 2006 Elsevier Inc. All rights reserved.
C1 Chonbuk Natl Univ, Dept Text Engn, Chonju 561756, South Korea.
   Chonbuk Natl Univ, Dept Bionanosyst Engn, Chonju 561756, South Korea.
   Univ Washington, Dept Mat Sci & Engn, Seattle, WA 98195 USA.
RP Kim, HY (reprint author), Chonbuk Natl Univ, Dept Text Engn, Chonju 561756, South Korea.
EM khy@moak.chonbuk.ac.kr
RI Kim, Hak Yong/G-3826-2013
OI Kim, Hak Yong/0000-0002-4133-124X; KC, Remant/0000-0002-3554-7247
CR Badia A, 1996, LANGMUIR, V12, P1262, DOI 10.1021/la9510487
   Bellino MG, 2004, PHYS CHEM CHEM PHYS, V6, P424, DOI 10.1039/b312252b
   Chen SW, 1999, LANGMUIR, V15, P682, DOI 10.1021/la980817u
   DANIEL S, 1866, J INORG BIOCHEM, V2, P77
   DEMAY J, 1983, IMMUNOCYTOCHEMISTRY, P83
   Ghosh SK, 2004, J PHYS CHEM B, V108, P13963, DOI 10.1021/jp047021q
   HOFFMAN AJ, 1992, J PHYS CHEM-US, V96, P5546, DOI 10.1021/j100192a067
   Hostetler MJ, 1996, J AM CHEM SOC, V118, P4212, DOI 10.1021/ja960198g
   HRUSHIKESH J, 2004, J PHYS CHEM B, V108, P11535
   Johnson SR, 1998, LANGMUIR, V14, P6639, DOI 10.1021/la9711342
   KLARA W, 2000, HISTOCHEM CELL BIOL, V114, P489
   KREUTER J, 1992, MICROCAPSULES NANOPA
   Leff DV, 1996, LANGMUIR, V12, P4723, DOI 10.1021/la960445u
   Levy R, 2004, J AM CHEM SOC, V126, P10076, DOI 10.1021/ja0487269
   Mayya KS, 1997, LANGMUIR, V13, P3944, DOI 10.1021/la962140l
   Mie G, 1908, ANN PHYS-BERLIN, V25, P377
   Mulvaney P, 1996, LANGMUIR, V12, P788, DOI 10.1021/la9502711
   Nath N, 2002, ANAL CHEM, V74, P504, DOI 10.1021/ac015657x
   Patil V, 1999, LANGMUIR, V15, P8197, DOI 10.1021/la990170t
   PATRICK E, 2001, ANALYST, V126, P1645
   Qiu HJ, 2004, CHEM MATER, V16, P850, DOI 10.1021/cm034519g
   QUINTEN M, 1986, SURF SCI, V172, P557, DOI 10.1016/0039-6028(86)90501-7
   Riboh JC, 2003, J PHYS CHEM B, V107, P1772, DOI 10.1021/jp022130v
   ROBERT E, 1997, SCIENCE, V277, P1078
   Roger H., 1995, J AM CHEM SOC, V117, P12537
   SAIKAT M, 2001, LANGMUIR, V17, P6262
   Selvakannan PR, 2003, LANGMUIR, V19, P3545, DOI 10.1021/la026906v
   Templeton AC, 1998, J AM CHEM SOC, V120, P1906, DOI 10.1021/ja973863+
   Weisbecker CS, 1996, LANGMUIR, V12, P3763, DOI 10.1021/la950776r
NR 29
TC 62
Z9 62
U1 2
U2 18
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0021-9797
J9 J COLLOID INTERF SCI
JI J. Colloid Interface Sci.
PD JUL 1
PY 2006
VL 299
IS 1
BP 189
EP 195
DI 10.1016/j.jcis.2006.01.045
PG 7
WC Chemistry, Physical
SC Chemistry
GA 052IP
UT WOS:000238227700021
PM 16499918
DA 2018-10-19
ER

PT J
AU Tang, XJ
   Wu, QY
AF Tang, XJ
   Wu, QY
TI Mesenchymal stem cellular adhesion and cytotoxicity study of random
   biopolyester scaffolds for tissue engineering
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID BONE-MARROW; CELLS; COPOLYESTERS; SURFACES
AB Mesenchymal stem cells (MSCs) were isolated from the bone marrow of rabbits and inoculated respectively on 3D scaffolds of poly(3-Hydroxybutyrate-co-3-Hydroxyvalerate) (PHBV), poly(butylenes succinate) (PBS) and different blends (100/0, 80/20, 50/50, 20/80, 0/100) (Wt%) in vitro. It was found that the (50/50) blends possessed the best performance on adhesion and cytotoxicity of MSCs. The scanning electronic microscopy (SEM) results showed that the (50/50) blends had the appropriate roughness for MSCs to attach and grow, which may be used as a suitable biomaterial to create small caliber vascular grafts.
C1 Chinese Acad Med Sci, Dept Cardiac Surg, Cardiovasc Inst, Beijing 100037, Peoples R China.
   Chinese Acad Med Sci, Fu Wai Hosp, Beijing 100037, Peoples R China.
   PUMC, Beijing 100037, Peoples R China.
   First Hosp Tsinghua Univ, Dept Cardiovasc, Beijing 100016, Peoples R China.
RP Tang, XJ (reprint author), Chinese Acad Med Sci, Dept Cardiac Surg, Cardiovasc Inst, Beijing 100037, Peoples R China.
EM hkcytangxiujie@sina.com; wuqingyu@public.bta.net.cn
CR ARNALDO R, 2002, ARTIF ORGANS, V28, P381
   Awad HA, 2000, J BIOMED MATER RES, V51, P233, DOI 10.1002/(SICI)1097-4636(200008)51:2<233::AID-JBM12>3.0.CO;2-B
   BRUDER SP, 1998, CLIN ORTHOP RELAT R, V247, P335
   Bruinink A, 2001, BIOMATERIALS, V22, P3169, DOI 10.1016/S0142-9612(01)00069-2
   Dewez JL, 1998, BIOMATERIALS, V19, P1441, DOI 10.1016/S0142-9612(98)00055-6
   Eckert R, 1997, CELL BIOL INT, V21, P707, DOI 10.1006/cbir.1997.0215
   GAO M, 2004, J BEIJING U CHEM TEC, V31, P67
   Goldstein AS, 1999, TISSUE ENG, V5, P421, DOI 10.1089/ten.1999.5.421
   KIM OY, 1995, CAN J MICROBIOL, V41, P32, DOI 10.1139/m95-165
   KUNIOKA M, 1989, APPL MICROBIOL BIOT, V30, P569
   KUNIOKA M, 1989, MACROMOLECULES, V22, P694, DOI 10.1021/ma00192a031
   Lee JH, 1997, BIOMATERIALS, V18, P351, DOI 10.1016/S0142-9612(96)00128-7
   LIN CQ, 1993, FASEB J, V7, P737
   MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317
   PEVEC WC, 1992, J VASC SURG, V16, P60, DOI 10.1016/0741-5214(92)90418-8
   Qiu ZB, 2003, POLYMER, V44, P7519, DOI 10.1016/j.polymer.2003.09.029
   SALTZMAN WM, 1997, PRINCIPLES TISSUE EN, P225
   SZILAGYI DE, 1986, J VASC SURG, V3, P421
   VACANTI JP, 1988, J PEDIATR SURG, V23, P3, DOI 10.1016/S0022-3468(88)80529-3
   Yoshikawa T, 1996, J BIOMED MATER RES, V32, P481
NR 20
TC 8
Z9 12
U1 1
U2 10
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2006
VL 17
IS 7
BP 627
EP 632
DI 10.1007/s10856-006-9225-7
PG 6
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 053AR
UT WOS:000238276400006
PM 16770547
DA 2018-10-19
ER

PT J
AU Crompton, KE
   Tomas, D
   Finkelstein, DI
   Marr, M
   Forsythe, JS
   Horne, MK
AF Crompton, K. E.
   Tomas, D.
   Finkelstein, D. I.
   Marr, M.
   Forsythe, J. S.
   Horne, M. K.
TI Inflammatory response on injection of chitosan/GP to the brain
SO JOURNAL OF MATERIALS SCIENCE-MATERIALS IN MEDICINE
LA English
DT Article
ID NERVE-CELL AFFINITY; IN-VIVO; DEACETYLATED CHITIN; DERIVATIVES; GROWTH;
   BIOCOMPATIBILITY; REGENERATION; SURFACE; MATRIX; BLOOD
AB Chitosan is a well-known biomaterial that, with the addition of glycerophosphate salt (GP), gels at physiological temperatures and therefore is useful for tissue engineering purposes. This study examines the procedure of injecting chitosan/ GP to the brain in order to form a gel track. The gel system and surgical technique were successful in this endeavour; however, on examining the inflammatory response to the material it was found that the chitosan/GP was wholly engulfed by macrophages within 7 days. This was determined by staining for both the gel and the macrophages, an important technique for localising injected material. The chitosan/GP-containing macrophages formed a neat tract at the lesion site, but after 45 days no chitosan/GP was found. It was concluded that, although chitosan/GP is present after implantation, it is not available for direct scaffolding in the brain.
C1 Univ Melbourne, Howard Florey Inst Expt Physiol & Med, Parkville, Vic 3010, Australia.
   CRC Polymers, Notting Hill, Vic 3168, Australia.
   Monash Univ, Dept Mat Engn, Clayton, Vic 3168, Australia.
RP Crompton, KE (reprint author), Univ Melbourne, Howard Florey Inst Expt Physiol & Med, Parkville, Vic 3010, Australia.
EM m.horne@hfi.unimelb.edu.au
OI Finkelstein, David/0000-0002-8167-4917; Forsythe,
   John/0000-0003-2849-229X
CR Ai H, 2003, J NEUROSCI METH, V128, P1, DOI 10.1016/S0165-0270(03)00191-2
   Blau A, 2001, J NEUROSCI METH, V112, P65, DOI 10.1016/S0165-0270(01)00458-7
   Cheng MY, 2003, BIOMATERIALS, V24, P2871, DOI 10.1016/S0142-9612(03)00117-0
   Chenite A, 2001, CARBOHYD POLYM, V46, P39, DOI 10.1016/S0144-8617(00)00281-2
   Chenite A, 2000, BIOMATERIALS, V21, P2155, DOI 10.1016/S0142-9612(00)00116-2
   Chung TW, 2003, ARTIF ORGANS, V27, P155, DOI 10.1046/j.1525-1594.2003.07045.x
   Crompton KE, 2005, BIOPHYS CHEM, V117, P47, DOI 10.1016/j.bpc.2005.03.009
   Dhiman HK, 2004, BIOMATERIALS, V25, P5147, DOI 10.1016/j.biomaterials.2003.12.025
   DORNISH M, 1997, 7 INT C CHIT CHIT, P664
   Elcin AE, 1998, NEUROL RES, V20, P648
   Feng J, 2004, BIOCHEM BIOPH RES CO, V317, P414, DOI 10.1016/j.bbrc.2004.03.048
   Gingras M, 2003, BIOMATERIALS, V24, P1653, DOI 10.1016/S0142-9612(02)00572-0
   Gong HP, 2000, J BIOMED MATER RES, V52, P285
   Grinnell F, 1978, Int Rev Cytol, V53, P65
   Hidaka Y, 1999, J BIOMED MATER RES, V46, P418, DOI 10.1002/(SICI)1097-4636(19990905)46:3<418::AID-JBM15>3.0.CO;2-T
   HIRANO S, 1989, BIOMATERIALS, V10, P574, DOI 10.1016/0142-9612(89)90066-5
   Itoh S, 2003, BRAIN RES, V993, P111, DOI 10.1016/j.brainres.2003.09.003
   Jarry C, 2001, J BIOMED MATER RES, V58, P127, DOI 10.1002/1097-4636(2001)58:1<127::AID-JBM190>3.0.CO;2-G
   LEE KY, 1995, BIOMATERIALS, V16, P1211, DOI 10.1016/0142-9612(95)98126-Y
   LI RH, 1998, POLYM TISSUE ENG, P235
   Mao JS, 2004, BIOMATERIALS, V25, P3973, DOI 10.1016/j.biomaterials.2003.10.080
   Mingyu Cheng, 2004, J Biomater Appl, V19, P59, DOI 10.1177/0885328204043450
   Molinaro G, 2002, BIOMATERIALS, V23, P2717, DOI 10.1016/S0142-9612(02)00004-2
   MUZZARELLI R, 1988, BIOMATERIALS, V9, P247, DOI 10.1016/0142-9612(88)90092-0
   NISHIMURA K, 1986, J BIOMED MATER RES, V20, P1359, DOI 10.1002/jbm.820200910
   PELUSO G, 1994, BIOMATERIALS, V15, P1215, DOI 10.1016/0142-9612(94)90272-0
   Serizawa T, 2000, BIOMACROMOLECULES, V1, P306, DOI 10.1021/bm000006g
   Tomihata K, 1997, BIOMATERIALS, V18, P567, DOI 10.1016/S0142-9612(96)00167-6
   Vogt AK, 2003, BIOTECHNOL PROGR, V19, P1562, DOI 10.1021/bp034016f
   Wang YC, 2003, BIOMACROMOLECULES, V4, P224, DOI 10.1021/bm0256294
   Xie WM, 2002, CARBOHYD POLYM, V50, P35, DOI 10.1016/S0144-8617(01)00370-8
   YUAN Y, 2004, BIOMATERIALS
   ZIELINSKI BA, 1994, BIOMATERIALS, V15, P1049
NR 33
TC 34
Z9 38
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-4530
EI 1573-4838
J9 J MATER SCI-MATER M
JI J. Mater. Sci.-Mater. Med.
PD JUL
PY 2006
VL 17
IS 7
BP 633
EP 639
DI 10.1007/s10856-006-9226-6
PG 7
WC Engineering, Biomedical; Materials Science, Biomaterials
SC Engineering; Materials Science
GA 053AR
UT WOS:000238276400007
PM 16770548
DA 2018-10-19
ER

PT J
AU Polizu, S
   Savadogo, O
   Poulin, P
   Yahia, L
AF Polizu, Stefania
   Savadogo, Oumarou
   Poulin, Philippe
   Yahia, L'Hocine
TI Applications of carbon nanotubes-based biomaterials in biomedical
   nanotechnology
SO JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY
LA English
DT Review
DE carbon nanotubes; biomaterial; micro-devices; nanosensors;
   nanobiotechnology; biomedical; nanotechnology; nano-robots;
   biocompatibility; bioactivity
ID DIRECT ELECTRON-TRANSFER; CHEMICAL-VAPOR-DEPOSITION; FIELD-EFFECT
   TRANSISTORS; ATOMIC-FORCE MICROSCOPY; SIDEWALL FUNCTIONALIZATION;
   ELECTROCHEMICAL SENSORS; GLUCOSE-OXIDASE; PROTEIN IMMOBILIZATION;
   MECHANICAL-PROPERTIES; WATER-SOLUBILIZATION
AB One of the facets of nanotechnology applications is the immense opportunities they offer for new developments in medicine and health sciences. Carbon nanotubes (CNTs) have particularly attracted attention for designing new monitoring systems for environment and living cells as well as nanosensors. Carbon nanotubes-based biomaterials are also employed as support for active prosthesis or functional matrices in reparation of parts of the human body. These nanostructures are studied as molecular-level building blocks for the complex and miniaturized medical device, and substrate for stimulation of cellular growth. The CNTs are cylindrical shaped with caged molecules which can act as nanoscale containers for molecular species, well required for biomolecular recognition and drug delivery systems. Endowed with very large aspect ratios, an excellent electrical conductivity and inertness along with mechanical robustness, nanotubes found enormous applications in molecular electronics and bioelectronics. The ballistic electrical behaviour of SWNTs conjugated with functionalization promotes a large variety of biosensors for individual molecules. Actuative response of CNTs is considered very promising feature for nanodevices, micro-robots and artificial muscles. An description of CNTs based biomaterials is attempted in this review, in order to point out their enormous potential for biomedical nanotechnology and nanobiotechnology.
C1 Ecole Polytech, Montreal, PQ H3C 3A7, Canada.
   Ctr Rech Paul Pascal, Bordeaux, France.
RP Polizu, S (reprint author), Ecole Polytech, Montreal, PQ H3C 3A7, Canada.
CR Ajayan PM, 1999, P NATL ACAD SCI USA, V96, P14199, DOI 10.1073/pnas.96.25.14199
   AJAYAN PM, 1993, NATURE, V362, P522, DOI 10.1038/362522a0
   Ajayan PM, 2001, TOP APPL PHYS, V80, P391
   Ajayan PM, 1999, CHEM REV, V99, P1787, DOI 10.1021/cr970102g
   AJIKI H, 1993, J PHYS SOC JPN, V62, P1255, DOI 10.1143/JPSJ.62.1255
   Aoki N, 2005, J BIOMED NANOTECHNOL, V1, P402, DOI 10.1166/jbn.2005.048
   Ausman KD, 1999, NANOTECHNOLOGY, V10, P258, DOI 10.1088/0957-4484/10/3/306
   Avouris P, 1999, APPL SURF SCI, V141, P201, DOI 10.1016/S0169-4332(98)00506-6
   Awasthi K, 2005, J NANOSCI NANOTECHNO, V5, P1616, DOI 10.1166/jnn.2005.407
   Azamian BR, 2002, J AM CHEM SOC, V124, P12664, DOI 10.1021/ja0272989
   Azamian BR, 2002, CHEM COMMUN, P366, DOI 10.1039/b110690b
   BACKER SE, 2002, NANO LETT, V2, P1413
   Bahr JL, 2001, J AM CHEM SOC, V123, P6536, DOI 10.1021/ja010462s
   Bahr JL, 2002, J MATER CHEM, V12, P1952, DOI 10.1039/b201013p
   BAKER SE, 2003, MATER RES SOC S P, P737
   BAKER SE, 2003, MAT RES SOC P, V737
   Balavoine F, 1999, ANGEW CHEM INT EDIT, V38, P1912, DOI 10.1002/(SICI)1521-3773(19990712)38:13/14<1912::AID-ANIE1912>3.0.CO;2-2
   Ball P., 2002, NANOTECHNOLOGY, V13, P15
   Banerjee S, 2005, J NANOSCI NANOTECHNO, V5, P841, DOI 10.1166/jnn.2005.173
   Barisci JN, 2000, J ELECTROCHEM SOC, V147, P4580, DOI 10.1149/1.1394104
   Barisci JN, 2003, SMART MATER STRUCT, V12, P549, DOI 10.1088/0964-1726/12/4/306
   Barisci JN, 2000, J ELECTROANAL CHEM, V488, P92, DOI 10.1016/S0022-0728(00)00179-0
   Baughman RH, 1999, SCIENCE, V284, P1340, DOI 10.1126/science.284.5418.1340
   Baughman RH, 2000, SCIENCE, V290, P1310, DOI 10.1126/science.290.5495.1310
   Baughman RH, 1996, SYNTHETIC MET, V78, P339, DOI 10.1016/0379-6779(96)80158-5
   Baughman RH, 2002, SCIENCE, V297, P787, DOI 10.1126/science.1060928
   Bekyarova E, 2005, J BIOMED NANOTECHNOL, V1, P3, DOI 10.1166/jbn.2005.004
   Bendjemil B, 2004, APPL PHYS A-MATER, V78, P311, DOI 10.1007/s00339-003-2351-x
   Biro LP, 1999, MATER STRUCT, V6, P104
   Bogunia-Kubik K, 2002, BIOSYSTEMS, V65, P123, DOI 10.1016/S0303-2647(02)00010-2
   Bonard JM, 1997, ADV MATER, V9, P827, DOI 10.1002/adma.19970091014
   Boul PJ, 1999, CHEM PHYS LETT, V310, P367, DOI 10.1016/S0009-2614(99)00713-7
   Britto PJ, 1996, BIOELECTROCH BIOENER, V41, P121, DOI 10.1016/0302-4598(96)05078-7
   Cantalini C, 2003, SENSOR ACTUAT B-CHEM, V93, P333, DOI 10.1016/S0925-4005(03)00224-7
   Cavalcanti A., 2004, P IEEE INT C EL CIRC, P447
   Charlier JC, 2002, ACCOUNTS CHEM RES, V35, P1063, DOI 10.1021/ar010166k
   Chen J, 1998, SCIENCE, V282, P95, DOI 10.1126/science.282.5386.95
   Chen RJ, 2003, P NATL ACAD SCI USA, V100, P4984, DOI 10.1073/pnas.0837064100
   Chen RJ, 2001, J AM CHEM SOC, V123, P3838, DOI 10.1021/ja010172b
   Chen Y, 1998, J MATER RES, V13, P2423, DOI 10.1557/JMR.1998.0337
   CHENG Y, 2004, REV SCI INSTRUM, V75, P3266
   Cheung CL, 2000, P NATL ACAD SCI USA, V97, P3809, DOI 10.1073/pnas.050498597
   Collins PG, 2000, SCIENCE, V287, P1801, DOI 10.1126/science.287.5459.1801
   Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875
   Cui DX, 2004, NANOTECHNOLOGY, V15, P154, DOI 10.1088/0957-4484/15/1/030
   Cui DX, 2005, TOXICOL LETT, V155, P73, DOI 10.1016/j.toxlet.2004.08.015
   Cui XL, 2005, J BIOMED NANOTECHNOL, V1, P320, DOI 10.1166/jbn.2005.038
   Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711
   Dai HJ, 2002, SURF SCI, V500, P218, DOI 10.1016/S0039-6028(01)01558-8
   Dai HJ, 1999, J PHYS CHEM B, V103, P11246, DOI 10.1021/jp992328o
   Dai LM, 2002, PURE APPL CHEM, V74, P1753, DOI 10.1351/pac200274091753
   Dalton AB, 2003, NATURE, V423, P703, DOI 10.1038/423703a
   Davis JJ, 1998, INORG CHIM ACTA, V272, P261, DOI 10.1016/S0020-1693(97)05926-4
   Decossas S, 2003, SURF SCI, V543, P57, DOI 10.1016/S0039-6028(03)00919-1
   Delvaux M, 2003, BIOSENS BIOELECTRON, V18, P943, DOI 10.1016/S0956-5663(02)00209-9
   Dieckmann GR, 2003, J AM CHEM SOC, V125, P1770, DOI 10.1021/ja029084x
   DONG L, 2001, IEEE INT C ROB AUT, V1, P632
   DRESSELHAUS MS, 1995, CARBON, V33, P883, DOI 10.1016/0008-6223(95)00017-8
   DRESSLHAUS MS, 1998, PHYS CARBON NANOTUBE
   Dwyer C, 2002, NANOTECHNOLOGY, V13, P601, DOI 10.1088/0957-4484/13/5/311
   Eletskii A. V., 1997, Physics-Uspekhi, V40, P899, DOI 10.1070/PU1997v040n09ABEH000282
   Falvo MR, 1997, NATURE, V389, P582
   FALVO MR, 1999, MICROSC MICROANAL, V4, P504
   FRAY DJ, 2001, P 4 INT C MAT ENG RE, V1, P1
   Fraysse J, 2002, CARBON, V40, P1735, DOI 10.1016/S0008-6223(02)00041-6
   Freire RS, 2003, J BRAZIL CHEM SOC, V14, P230, DOI 10.1590/S0103-50532003000200008
   FREITAS R, 2001, PAHWAYS NOVARTIS J, P37
   Freitas RA, 2005, J COMPUT THEOR NANOS, V2, P1
   FREITAS RA, 2003, NANOMEDICINE BIOCO A, V2, P49
   FREITAS RA, 2003, NANOMEDECINE BIOCO A, V2, P7
   Frost MC, 2003, MICROCHEM J, V74, P277, DOI 10.1016/S0026-265X(03)00033-X
   Fukuda T, 2003, P IEEE, V91, P1803, DOI 10.1109/JPROC.2003.818334
   Gao HJ, 2003, NANO LETT, V3, P471, DOI 10.1021/nl025967a
   Gao M, 2003, ELECTROANAL, V15, P1089, DOI 10.1002/elan.200390131
   Garg A, 1998, CHEM PHYS LETT, V295, P273, DOI 10.1016/S0009-2614(98)00969-5
   Garibaldi S, 2006, NANOTECHNOLOGY, V17, P391, DOI 10.1088/0957-4484/17/2/008
   Gavalas VG, 1998, BIOSENS BIOELECTRON, V13, P1205, DOI 10.1016/S0956-5663(98)00066-9
   Ghosh S, 2003, SCIENCE, V299, P1042, DOI 10.1126/science.1079080
   Guiseppi-Elie A, 2002, NANOTECHNOLOGY, V13, P559, DOI 10.1088/0957-4484/13/5/303
   Haberzettl CA, 2002, NANOTECHNOLOGY, V13, pR9, DOI 10.1088/0957-4484/13/4/201
   HADDON RC, 1993, SCIENCE, V261, P1545, DOI 10.1126/science.261.5128.1545
   Hafner JH, 2001, PROG BIOPHYS MOL BIO, V77, P73, DOI 10.1016/S0079-6107(01)00011-6
   Hamon MA, 1999, ADV MATER, V11, P834, DOI 10.1002/(SICI)1521-4095(199907)11:10<834::AID-ADMA834>3.0.CO;2-R
   Hamon MA, 2001, CHEM PHYS LETT, V347, P8, DOI 10.1016/S0009-2614(01)01035-1
   Hamon MA, 2002, APPL PHYS A-MATER, V74, P333, DOI 10.1007/s003390201281
   HAMON MA, 1999, ADV MATER, P11
   Harutyunyan A R, 2002, EUR CELLS MATER, V3, P84
   He PG, 2004, CHEM COMMUN, P348, DOI 10.1039/b313030b
   Hertel T, 1998, J PHYS CHEM B, V102, P910, DOI 10.1021/jp9734686
   Hirsch A, 2002, ANGEW CHEM INT EDIT, V41, P1853, DOI 10.1002/1521-3773(20020603)41:11<1853::AID-ANIE1853>3.0.CO;2-N
   HIRSCH A, 1993, ANGEW CHEM INT EDIT, V32, P1138, DOI 10.1002/anie.199311381
   HIURA H, 1994, NATURE, V367, P148, DOI 10.1038/367148a0
   Holzinger M, 2001, ANGEW CHEM INT EDIT, V40, P4002, DOI 10.1002/1521-3773(20011105)40:21<4002::AID-ANIE4002>3.0.CO;2-8
   Huczko A, 2001, FULLERENE SCI TECHN, V9, P251, DOI 10.1081/FST-100102973
   IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0
   Iijima S, 2002, PHYSICA B, V323, P1, DOI 10.1016/S0921-4526(02)00869-4
   IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0
   Joselevich E, 2004, CHEMPHYSCHEM, V5, P619, DOI 10.1002/cphc.200301049
   Joshi KA, 2005, ELECTROANAL, V17, P54, DOI 10.1002/elan.200403118
   Journet C, 1999, SYNTHETIC MET, V103, P2488, DOI 10.1016/S0379-6779(98)01074-1
   Kam NWS, 2004, J AM CHEM SOC, V126, P6850, DOI 10.1021/ja0486059
   Kelley K, 2005, J NANOSCI NANOTECHNO, V5, P1041, DOI 10.1166/jnn.2005.155
   Kelly KF, 1999, CHEM PHYS LETT, V313, P445, DOI 10.1016/S0009-2614(99)00973-2
   Keusgen M, 2002, NATURWISSENSCHAFTEN, V89, P433, DOI 10.1007/s00114-002-0358-3
   Khabashesku VN, 2002, ACCOUNTS CHEM RES, V35, P1087, DOI 10.1021/ar020146y
   Kim OK, 2003, J AM CHEM SOC, V125, P4426, DOI 10.1021/ja029233b
   Kim P, 1999, SCIENCE, V286, P2148, DOI 10.1126/science.286.5447.2148
   KIURA K, 2005, J BIOMED NANOTECHNOL, V1, P139
   Kong J, 2000, SCIENCE, V287, P622, DOI 10.1126/science.287.5453.622
   Kouklin NA, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2112183
   KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0
   Kumar A, 2005, J BIOMED NANOTECHNOL, V1, P392, DOI 10.1166/jbn.2005.052
   Lam CW, 2004, TOXICOL SCI, V77, P126, DOI 10.1093/toxsci/kfg243
   Landi BJ, 2005, MAT SCI ENG B-SOLID, V116, P359, DOI 10.1016/j.mseb.2004.05.047
   LANGER L, 1994, J MATER RES, V9, P927, DOI 10.1557/JMR.1994.0927
   Lenihan JS, 2004, J NANOSCI NANOTECHNO, V4, P600, DOI 10.1166/jnn.2004.150
   Lin Y, 2006, J NANOSCI NANOTECHNO, V6, P868, DOI 10.1166/jnn.2006.130
   LIOPO AV, 2006, J NANOSCI NANOTECHNO, V6
   Liu GD, 2006, J NANOSCI NANOTECHNO, V6, P948, DOI 10.1166/jnn.2006.133
   Liu PF, 2002, SENSOR ACTUAT B-CHEM, V84, P194, DOI 10.1016/S0925-4005(02)00024-2
   LIU X, 2003, MOL NANOELECTRONIC M, P1
   Lourie O, 1998, PHYS REV LETT, V81, P1638, DOI 10.1103/PhysRevLett.81.1638
   LOVAT V, 2005, NANO LETT, P5
   Lu G, 2005, NANO LETT, V5, P897, DOI 10.1021/nl050354u
   MacDonald RA, 2005, J BIOMED MATER RES A, V74A, P489, DOI 10.1002/jbm.a.30386
   Madden JDW, 2004, IEEE J OCEANIC ENG, V29, P706, DOI 10.1109/JOE.2004.833135
   Mani RC, 2003, NANO LETT, V3, P671, DOI 10.1021/nl034125o
   Martinez MT, 2003, NANOTECHNOLOGY, V14, P691, DOI 10.1088/0957-4484/14/7/301
   Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175
   McEuen PL, 2000, PHYS WORLD, V13, P31
   McKenzie JL, 2004, BIOMATERIALS, V25, P1309, DOI 10.1016/j.biomaterials.2003.08.006
   MCKENZIE JL, 2002, AICH
   MENEZES AJ, 2001, MECH ENG MAGAZINE ON
   Mickelson ET, 1998, CHEM PHYS LETT, V296, P188, DOI 10.1016/S0009-2614(98)01026-4
   Mickelson ET, 1999, J PHYS CHEM B, V103, P4318, DOI 10.1021/jp9845524
   Minett A, 2002, CURR APPL PHYS, V2, P61, DOI 10.1016/S1567-1739(01)00100-6
   MINTMIRE JW, 1992, PHYS REV LETT, V68, P631, DOI 10.1103/PhysRevLett.68.631
   Minunni M, 2001, FRESEN J ANAL CHEM, V369, P589, DOI 10.1007/s002160100761
   Miyagawa H, 2005, J NANOSCI NANOTECHNO, V5, P1593, DOI 10.1166/jnn.2005.181
   Monteiro-Riviere NA, 2005, TOXICOL LETT, V155, P377, DOI 10.1016/j.toxlet.2004.11.004
   MOSER J, 2002, NNUN MAT PHYS PROCES, P72
   Murakami H, 2006, J NANOSCI NANOTECHNO, V6, P16, DOI 10.1166/jnn.2006.072
   Naguib NN, 2005, NANOTECHNOLOGY, V16, P567, DOI 10.1088/0957-4484/16/4/038
   Nakamura H, 2003, ANAL BIOANAL CHEM, V377, P446, DOI 10.1007/s00216-003-1947-5
   Nguyen CV, 2001, NANOTECHNOLOGY, V12, P363, DOI 10.1088/0957-4484/12/3/326
   Nguyen CV, 2002, NANO LETT, V2, P1079, DOI 10.1021/nl025689f
   Ni B, 2000, PHYS REV B, V61, P16343, DOI 10.1103/PhysRevB.61.R16343
   Niyogi S, 2002, ACCOUNTS CHEM RES, V35, P1105, DOI 10.1021/ar010155r
   O'Connell MJ, 2001, CHEM PHYS LETT, V342, P265, DOI 10.1016/S0009-2614(01)00490-0
   Obataya I, 2005, NANO LETT, V5, P27, DOI 10.1021/nl0485399
   Odom TW, 1998, NATURE, V391, P62
   Odom TW, 2000, J PHYS CHEM B, V104, P2794, DOI 10.1021/jp993592k
   Ong KG, 2002, IEEE SENS J, V2, P82, DOI 10.1109/JSEN.2002.1000247
   Ouyang M, 2002, ACCOUNTS CHEM RES, V35, P1018, DOI 10.1021/ar0101685
   Panhuis MIH, 2003, CHEM BIOL, V10, P897, DOI 10.1016/j.chembiol.2003.10.005
   Pantarotto D, 2003, CHEM BIOL, V10, P961, DOI 10.1016/j.chembiol.2003.09.011
   Pantarotto D, 2004, CHEM COMMUN, P16, DOI 10.1039/b311254c
   Pasco N, 2000, APPL MICROBIOL BIOT, V53, P613, DOI 10.1007/s002530051666
   Pastorin G, 2005, J BIOMED NANOTECHNOL, V1, P133, DOI 10.1166/jbn.2005.017
   Peng S, 2003, NANO LETT, V3, P513, DOI 10.1021/nl034064u
   Peng S, 2000, NANOTECHNOLOGY, V11, P57, DOI 10.1088/0957-4484/11/2/303
   PENG S, 2001, 3 INT WORKSH STRUCT, P1
   Perez B, 2005, J NANOSCI NANOTECHNO, V5, P1694, DOI 10.1166/jnn.2005.400
   Petit P, 2003, CR PHYS, V4, P967, DOI 10.1016/j.crhy.2003.10.021
   Pompeo F, 2002, NANO LETT, V2, P369, DOI 10.1021/nl015680y
   Popov VN, 2004, MAT SCI ENG R, V43, P61, DOI 10.1016/j.mser.2003.10.001
   Price RL, 2003, BIOMATERIALS, V24, P1877, DOI 10.1016/S0142-9612(02)00609-9
   Rao CNR, 2001, J MATER CHEM, V11, P2887, DOI 10.1039/b105058n
   Rao CNR, 2001, CHEMPHYSCHEM, V2, P78, DOI 10.1002/1439-7641(20010216)2:2<78::AID-CPHC78>3.0.CO;2-7
   Recknor JB, 2004, BIOMATERIALS, V25, P2753, DOI 10.1016/j.biomaterials.2003.11.045
   Requicha AAG, 2003, P IEEE, V91, P1922, DOI 10.1109/JPROC.2003.818333
   Richard C, 2003, SCIENCE, V300, P775, DOI 10.1126/science.1080848
   Rinzler AG, 1998, APPL PHYS A-MATER, V67, P29, DOI 10.1007/s003390050734
   RINZLER AG, 1995, SCIENCE, V269, P1550, DOI 10.1126/science.269.5230.1550
   ROBERTSON DH, 1992, PHYS REV B, V45, P12592, DOI 10.1103/PhysRevB.45.12592
   Rojas-Chapana JA, 2006, J NANOSCI NANOTECHNO, V6, P316, DOI 10.1166/jnn.2006.004
   Roth S, 2002, CURR APPL PHYS, V2, P311, DOI 10.1016/S1567-1739(02)00116-5
   Salvetat JP, 2006, J NANOSCI NANOTECHNO, V6, P1857, DOI 10.1166/jnn.2006.305
   Sayes CM, 2006, TOXICOL LETT, V161, P135, DOI 10.1016/j.toxlet.2005.08.011
   Schaffar BPH, 2002, ANAL BIOANAL CHEM, V372, P254, DOI 10.1007/s00216-001-1186-6
   Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948
   SEO JW, 2003, NEW J PHYS, V5
   SERVICE RF, 1998, SCIENCE, V281, P941
   Sharon M, 2005, J BIOMED NANOTECHNOL, V1, P365, DOI 10.1166/jbn.2005.034
   Shea HR, 1999, MICROELECTRON ENG, V46, P101, DOI 10.1016/S0167-9317(99)00025-8
   Sherigara BS, 2003, ELECTROANAL, V15, P753, DOI 10.1002/elan.200390094
   Shim M, 2002, NANO LETT, V2, P285, DOI 10.1021/nl015692j
   Sinha N, 2006, J NANOSCI NANOTECHNO, V6, P573, DOI 10.1166/jnn.2006.121
   Smalley RE, 1997, REV MOD PHYS, V69, P723, DOI 10.1103/RevModPhys.69.723
   Smela E., 2003, ADV MATER, V15, P6
   Sotiropoulou S, 2003, BIOSENS BIOELECTRON, V18, P211, DOI 10.1016/S0956-5663(02)00183-5
   SOTIROPOULU S, 2003, CARBON NANOTUBE ARRA, V375, P103
   Spinks G. M., 2001, ELECTROACTIVE POLYM, P223
   Srivastava A, 2004, NAT MATER, V3, P610, DOI 10.1038/nmat1192
   Srivastava D., 2003, Applied Mechanics Review, V56, P215, DOI 10.1115/1.1538625
   Star A, 2006, P NATL ACAD SCI USA, V103, P921, DOI 10.1073/pnas.0504146103
   Star A, 2003, MACROMOLECULES, V36, P553, DOI 10.1021/ma021417n
   Star A, 2002, ANGEW CHEM INT EDIT, V41, P2508, DOI 10.1002/1521-3773(20020715)41:14<2508::AID-ANIE2508>3.0.CO;2-A
   STAR A, 2003, NANO LETT, V3, P461
   Stevens JL, 2003, NANO LETT, V3, P331, DOI 10.1021/nl025944w
   STEVENS RMD, 2001, NANOTECHNOLOGY, V11, P1
   Stradiotto NR, 2003, J BRAZIL CHEM SOC, V14, P159, DOI 10.1590/S0103-50532003000200003
   Strano MS, 2003, SCIENCE, V301, P1519, DOI 10.1126/science.1087691
   Sun YP, 2002, ACCOUNTS CHEM RES, V35, P1096, DOI 10.1021/ar010160v
   Supronowicz P., 2001, 47 ANN M ORTH RES SO
   Tahhan M, 2003, SMART MATER STRUCT, V12, P626, DOI 10.1088/0964-1726/12/4/313
   Thien-Nga L, 2002, NANO LETT, V2, P1349, DOI 10.1021/nl025740f
   Treacy M. M. J., 1996, NATURE, V381, P6584
   Turner APF, 1999, CLIN CHEM, V45, P1596
   Unger E, 2002, CURR APPL PHYS, V2, P107, DOI 10.1016/S1567-1739(01)00072-4
   Varghese OK, 2001, SENSOR ACTUAT B-CHEM, V81, P32, DOI 10.1016/S0925-4005(01)00923-6
   VIGOLO A, 2000, SCIENCE, V290, P1331
   Vigolo B, 2002, APPL PHYS LETT, V81, P1210, DOI 10.1063/1.1497706
   Vivekchang SRC, 2003, P INDIAN AS-CHEM SCI, V115, P509
   Wang SG, 2003, BIOCHEM BIOPH RES CO, V311, P572, DOI 10.1016/j.bbrc.2003.10.031
   Wang SG, 2003, ELECTROCHEM COMMUN, V5, P800, DOI 10.1016/j.elecom.2003.07.007
   Wang SQ, 2003, NAT MATER, V2, P196, DOI 10.1038/nmat833
   Warheit DB, 2004, TOXICOL SCI, V77, P117, DOI 10.1093/toxsci/kfg228
   Watanabe H, 2001, APPL PHYS LETT, V79, P2462, DOI 10.1063/1.1408604
   Webster TJ, 2004, NANOTECHNOLOGY, V15, P48, DOI 10.1088/0957-4484/15/1/009
   Wei JQ, 2003, J MATER CHEM, V13, P1340, DOI 10.1039/b300484h
   Wildoer JWG, 1998, NATURE, V391, P59, DOI 10.1038/34139
   Williams KA, 2002, NATURE, V420, P761, DOI 10.1038/420761a
   Wilson NR, 2002, J PHYS CHEM B, V106, P13102, DOI 10.1021/jp026583b
   Wohlstadter JN, 2003, ADV MATER, V15, P1184, DOI 10.1002/adma.200304259
   Wong E W, 1997, SCIENCE, V277, P197
   Wong SS, 1998, NATURE, V394, P52
   Wong SS, 1998, J AM CHEM SOC, V120, P603, DOI 10.1021/ja9737735
   WU W, 2005, ANGEW CHEM, V117, P6516
   Xu Y, 2005, J BIOMED NANOTECHNOL, V1, P202, DOI 10.1166/jbn.2005.022
   Ye JS, 2003, ELECTROANAL, V15, P1693, DOI 10.1002/elan.200302752
   Yue GZ, 2002, APPL PHYS LETT, V81, P355, DOI 10.1063/1.1492305
   Yun YH, 2005, SMART MATER STRUCT, V14, P1526, DOI 10.1088/0964-1726/14/6/045
   YUNG M, 2003, SPIE P, V37, P5220
   Zhang NY, 2006, SMART MATER STRUCT, V15, P123, DOI 10.1088/0964-1726/15/1/040
   Zhang XJ, 2000, ELECTROANAL, V12, P1113, DOI 10.1002/1521-4109(200010)12:14<1113::AID-ELAN1113>3.0.CO;2-U
   Zhao JJ, 2002, NANOTECHNOLOGY, V13, P195, DOI 10.1088/0957-4484/13/2/312
   Zhao Q, 2002, ELECTROANAL, V14, P1609, DOI 10.1002/elan.200290000
   Zhao YD, 2002, ANAL SCI, V18, P939, DOI 10.2116/analsci.18.939
   Zhu HW, 2002, SCIENCE, V296, P884, DOI 10.1126/science.1066996
NR 240
TC 99
Z9 99
U1 5
U2 83
PU AMER SCIENTIFIC PUBLISHERS
PI VALENCIA
PA 26650 THE OLD RD, STE 208, VALENCIA, CA 91381-0751 USA
SN 1533-4880
J9 J NANOSCI NANOTECHNO
JI J. Nanosci. Nanotechnol.
PD JUL
PY 2006
VL 6
IS 7
BP 1883
EP 1904
DI 10.1166/jnn.2006.197
PG 22
WC Chemistry, Multidisciplinary; Nanoscience & Nanotechnology; Materials
   Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 070SA
UT WOS:000239542900002
PM 17025102
DA 2018-10-19
ER

PT J
AU Ju, BF
   Ju, Y
AF Ju, Bing-Feng
   Ju, Yang
TI Video enhanced depth-sensing indentation technique for characterizing
   mechanical behaviour of biomaterials
SO MEASUREMENT SCIENCE AND TECHNOLOGY
LA English
DT Article
DE biomaterial; microindentation; mechanical properties; adhesion
ID ATOMIC-FORCE MICROSCOPY; ELASTOMERIC MEMBRANES; EXTRACELLULAR-MATRIX;
   FRACTURE-MECHANICS; BLISTER TEST; MODULUS; DEFORMATION; ADHESIVE;
   STRENGTH; SURFACES
AB A video enhanced depth-sensing indentation with concomitant experimental technique was developed for the purpose of characterizing the mechanical behaviour of biomaterials. This indentation system possesses the capability of simultaneously measuring the applied force and resultant displacement of biomaterials. Its motion unit is a dc motor incorporated with a PZT actuator, which are activated individually. It can generate a long travelling distance of up to 12.0 mm with a resolution of 0.1 mu m or discrete motion of up to 120.0 mu m with micro-steps less than 10 nm. An up-to-date force transducer is driven by the motion unit, which has a maximum range of 5.0 mN with a resolution better than 0.1 mu N. Armed with a high magnification side-view system, it can offer extra lateral profile variation of samples during the compression procedure, which is essential for observing and analysing the gradual rupture. The technique was applied to characterize the elastic properties of thin biomembranes and large deformation of a single biomimetic microcapsule along with its adhesion on a flat surface. Experimental results verified the performance and application of the homemade indentation apparatus. This study presented that the quantitative characterization of mechanical behaviour for broad varieties of biomaterials is feasible.
C1 Tohoku Univ, Grad Sch Engn, Dept Nanomech, Aoba Ku, Sendai, Miyagi 9808579, Japan.
RP Ju, BF (reprint author), Tohoku Univ, Grad Sch Engn, Dept Nanomech, Aoba Ku, Aoba 6-6-01, Sendai, Miyagi 9808579, Japan.
EM mbfju@ism.mech.tohoku.ac.jp
CR Alenghat FJ, 2000, BIOCHEM BIOPH RES CO, V277, P93, DOI 10.1006/bbrc.2000.3636
   Begley MR, 2004, J MECH PHYS SOLIDS, V52, P2005, DOI 10.1016/j.jmps.2004.03.002
   BENNETT SJ, 1974, INT J FRACTURE, V10, P33, DOI 10.1007/BF00955077
   BONGRAND P, 1999, REP PROG PHYS, V62, P912
   Briscoe BJ, 1998, J PHYS D APPL PHYS, V31, P2395, DOI 10.1088/0022-3727/31/19/006
   BRISCOE BJ, 1991, P ROY SOC LOND A MAT, V433, P23, DOI 10.1098/rspa.1991.0033
   Chan V, 2004, BIOMATERIALS, V25, P4327, DOI 10.1016/j.biomaterials.2003.11.021
   Claes LE, 1999, J BIOMECH, V32, P255, DOI 10.1016/S0021-9290(98)00153-5
   Foo JJ, 2003, ANN BIOMED ENG, V31, P1279, DOI 10.1114/1.1616934
   Foris P.L., 1978, US Patent, Patent No. [4087376, 4,087,376]
   Fung YC, 1993, BIOMECHANICS MECH PR
   Henon S, 1999, BIOPHYS J, V76, P1145, DOI 10.1016/S0006-3495(99)77279-6
   HOCHMUTH RM, 1993, BIOPHYS J, V64, P1596, DOI 10.1016/S0006-3495(93)81530-3
   Jones WR, 1999, J BIOMECH, V32, P119, DOI 10.1016/S0021-9290(98)00166-3
   Kendall K, 1998, P ROY SOC A-MATH PHY, V454, P2529, DOI 10.1098/rspa.1998.0269
   Khoo HS, 2005, MEAS SCI TECHNOL, V16, P653, DOI 10.1088/0957-0233/16/3/005
   Leckband D, 2000, ANNU REV BIOPH BIOM, V29, P1, DOI 10.1146/annurev.biophys.29.1.1
   Lim YY, 2004, PHILOS MAG, V84, P2877, DOI 10.1080/14786430410001716782
   Lim YY, 2003, PHILOS MAG, V83, P3427, DOI 10.1080/14786430310001608701
   Liu KK, 2004, REV SCI INSTRUM, V75, P524, DOI 10.1063/1.1638894
   Liu KK, 2001, J PHYS D APPL PHYS, V34, pL91, DOI 10.1088/0022-3727/34/15/102
   Liu KK, 1998, J PHYS D APPL PHYS, V31, P294, DOI 10.1088/0022-3727/31/3/008
   Mackin TJ, 2004, POLYM COMPOSITE, V25, P442, DOI 10.1002/pc.20037
   Mathur AB, 2001, J BIOMECH, V34, P1545, DOI 10.1016/S0021-9290(01)00149-X
   Morrison B, 2000, J BIOMECH ENG-T ASME, V122, P224, DOI 10.1115/1.429650
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   Petsev DN, 1999, LANGMUIR, V15, P1096, DOI 10.1021/la981034b
   Putnam AJ, 2001, AM J PHYSIOL-CELL PH, V280, pC556
   Shao JY, 1999, BIOPHYS J, V77, P587, DOI 10.1016/S0006-3495(99)76915-8
   Taber L. A., 1995, APPL MECH REV, V490, P6, DOI DOI 10.1115/1.3005109
   Vinckier A, 1998, FEBS LETT, V430, P12, DOI 10.1016/S0014-5793(98)00592-4
   Wan K. T., 1995, INT J FRACTURE, V74, P181
   Wan KT, 1999, J ADHESION, V70, P209, DOI 10.1080/00218469908009556
   Zhang Z, 1999, J MICROENCAPSUL, V16, P117, DOI 10.1080/026520499289365
NR 34
TC 2
Z9 2
U1 0
U2 9
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-0233
EI 1361-6501
J9 MEAS SCI TECHNOL
JI Meas. Sci. Technol.
PD JUL
PY 2006
VL 17
IS 7
BP 1776
EP 1784
DI 10.1088/0957-0233/17/7/016
PG 9
WC Engineering, Multidisciplinary; Instruments & Instrumentation
SC Engineering; Instruments & Instrumentation
GA 058DT
UT WOS:000238645900018
DA 2018-10-19
ER

PT J
AU Li, WJ
   Jiang, YJ
   Tuan, RS
AF Li, Wan-Ju
   Jiang, Yi Jen
   Tuan, Rocky S.
TI Chondrocyte phenotype in engineered fibrous matrix is regulated by fiber
   size
SO TISSUE ENGINEERING
LA English
DT Article
ID POLYMER-DEMIXED NANOTOPOGRAPHY; MESENCHYMAL STEM-CELLS;
   ARTICULAR-CARTILAGE; EXTRACELLULAR-MATRIX; NANOPHASE CERAMICS; ENHANCED
   FUNCTIONS; IN-VITRO; BEHAVIOR; SCAFFOLDS; OSTEOBLASTS
AB A biomaterial scaffold acting as a functional substitute for the native extracellular matrix provides space for cell accommodation. In this study, we seeded chondrocytes, isolated from 4- to 6-month-old calves, in 2 types of poly(L-lactide) scaffolds, composed of micro- and nanofibers, and compared the effects on cellular activities. Scanning electron microscopy revealed a well-spread morphology for chondrocytes grown on microfibers. In contrast, chondrocytes on the nanofibers were found to have a rounded morphology and displayed a disorganized actin cytoskeletal structure compared to the organized cytoskeleton seen in well-spread chondrocytes culture on the microfibrous scaffold. Both scaffolds supported chondrocyte proliferation, with a higher rate seen in cultures in nanofibrous scaffold. Quantitative reverse transcription-polymerase chain reaction analysis showed that both cultures supported expression of collagen types I and II and aggrecan. Biochemical analysis showed a higher level of sulfated glycosaminoglycan in the nanofiber culture, confirmed by more intense alcian blue histologic staining. The nanofiber cultures also showed higher immunostaining for collagen types II and IX, aggrecan, and cartilage proteoglycan link protein. Based on these results, we conclude that chondrocytes respond differently to fibrous scaffolds of varying diameters, and that the scaffolds made of nanofibrous biomaterial promote efficient cell-based cartilage tissue engineering.
C1 NIAMSD, Cartilage Biol & Orthopaed Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.
RP Tuan, RS (reprint author), NIAMSD, Cartilage Biol & Orthopaed Branch, NIH, Dept Hlth & Human Serv, Bldg 50,Room 1503,MSC 8022, Bethesda, MD 20892 USA.
EM tuanr@mail.nih.gov
RI Li, Wan-Ju/A-7002-2008
OI Li, Wan-Ju/0000-0002-6579-8063
FU Intramural NIH HHS
CR ABBOTT J, 1966, J CELL BIOL, V28, P473, DOI 10.1083/jcb.28.3.473
   BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7
   Bhardwaj T, 2001, J BIOMED MATER RES, V57, P190, DOI 10.1002/1097-4636(200111)57:2<190::AID-JBM1158>3.0.CO;2-J
   Boudreau Nancy J., 1999, Biochemical Journal, V339, P481, DOI 10.1042/0264-6021:3390481
   Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425
   Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829
   Curtis A, 1997, BIOMATERIALS, V18, P1573, DOI 10.1016/S0142-9612(97)00144-0
   Dalby MJ, 2002, TISSUE ENG, V8, P1099, DOI 10.1089/107632702320934191
   Dalby MJ, 2002, BIOMATERIALS, V23, P2945, DOI 10.1016/S0142-9612(01)00424-0
   Durrant LA, 1999, J ANAT, V194, P343, DOI 10.1046/j.1469-7580.1999.19430343.x
   Elias KL, 2002, BIOMATERIALS, V23, P3279, DOI 10.1016/S0142-9612(02)00087-X
   ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Flemming RG, 1999, BIOMATERIALS, V20, P573, DOI 10.1016/S0142-9612(98)00209-9
   FREED LE, 1993, J BIOMED MATER RES, V27, P11, DOI 10.1002/jbm.820270104
   FREED LE, 1994, BIO-TECHNOL, V12, P689, DOI 10.1038/nbt0794-689
   Freed LE, 1998, EXP CELL RES, V240, P58, DOI 10.1006/excr.1998.4010
   Frenkel SR, 2004, ANN BIOMED ENG, V32, P26, DOI 10.1023/B:ABME.0000007788.41804.0d
   Hersel U, 2003, BIOMATERIALS, V24, P4385, DOI 10.1016/S0142-9612(03)00343-0
   HYNES RO, 1999, TRENDS CELL BIOL, V9, P33
   KLOMPMAKER J, 1991, BIOMATERIALS, V12, P810, DOI 10.1016/0142-9612(91)90066-J
   Kuboki Y, 2001, J BONE JOINT SURG AM, V83A, pS105
   Langelier E, 2000, J HISTOCHEM CYTOCHEM, V48, P1307, DOI 10.1177/002215540004801002
   LEE JH, 1994, BIOMATERIALS, V15, P705, DOI 10.1016/0142-9612(94)90169-4
   Lehnert D, 2004, J CELL SCI, V117, P41, DOI 10.1242/jcs.00836
   Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005
   Li WJ, 2003, J BIOMED MATER RES A, V67A, P1105, DOI 10.1002/jbm.a.10101
   Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006
   McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9
   MOONEY DJ, 1995, J CELL SCI, V108, P2311
   Rosso F, 2004, J CELL PHYSIOL, V199, P174, DOI 10.1002/jcp.10471
   Sanders JE, 2000, J BIOMED MATER RES, V52, P231, DOI 10.1002/1097-4636(200010)52:1<231::AID-JBM29>3.0.CO;2-E
   SINHA RK, 1994, CLIN ORTHOP RELAT R, P258
   Sinha RK, 1996, BONE, V18, P451, DOI 10.1016/8756-3282(96)00044-0
   Takahashi Y, 2004, J BIOMAT SCI-POLYM E, V15, P41, DOI 10.1163/156856204322752228
   Wang XB, 2004, OSTEOARTHR CARTILAGE, V12, P963, DOI 10.1016/j.joca.2004.08.008
   Webster TJ, 2000, BIOMATERIALS, V21, P1803, DOI 10.1016/S0142-9612(00)00075-2
   Webster TJ, 1999, BIOMATERIALS, V20, P1221, DOI 10.1016/S0142-9612(99)00020-4
   Xie YB, 2001, TISSUE ENG, V7, P585, DOI 10.1089/107632701753213200
   Yang SF, 2001, TISSUE ENG, V7, P679, DOI 10.1089/107632701753337645
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 41
TC 166
Z9 169
U1 2
U2 27
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JUL
PY 2006
VL 12
IS 7
BP 1775
EP 1785
DI 10.1089/ten.2006.12.1775
PG 11
WC Cell & Tissue Engineering
SC Cell Biology
GA 071BK
UT WOS:000239571800006
PM 16889508
DA 2018-10-19
ER

PT J
AU Fassina, L
   Visai, L
   Benazzo, F
   Benedetti, L
   Calligaro, A
   De Angelis, MGC
   Farina, A
   Maliardi, V
   Magenes, G
AF Fassina, Lorenzo
   Visai, Livia
   Benazzo, Francesco
   Benedetti, Laura
   Calligaro, Alberto
   De Angelis, Maria Gabriella Cusella
   Farina, Aurora
   Maliardi, Valentina
   Magenes, Giovanni
TI Effects of electromagnetic stimulation on calcified matrix production by
   SAOS-2 cells over a polyurethane porous scaffold
SO TISSUE ENGINEERING
LA English
DT Article
ID MARROW STROMAL CELLS; COMBINED MAGNETIC-FIELDS; OSTEOBLAST-LIKE CELLS;
   IN-VITRO; BONE-FORMATION; OSTEOGENIC DIFFERENTIATION;
   EXTRACELLULAR-MATRIX; OSTEOSARCOMA CELLS; GENE-EXPRESSION; DECORIN
AB There is increasing interest in designing new biomaterials that could potentially be used in the form of scaffolds as bone substitutes. In this study we used a hydrophobic crosslinked polyurethane in a typical tissue-engineering approach, that is, the seeding and in vitro culturing of cells using a porous scaffold. Using an electromagnetic bioreactor (magnetic field intensity, 2 mT; frequency, 75 Hz), we investigated the effect of the electromagnetic stimulation on SAOS-2 human osteoblast proliferation and calcified matrix production. Cell proliferation was twice as high; expression of decorin, osteocalcin, osteopontin, type I collagen, and type III collagen was greater (1.3, 12.2, 12.1, 10.0, and 10.5 times as great, respectively); and calcium deposition was 5 times as great as under static conditions without electromagnetic stimulation. RT-PCR analysis revealed the electromagnetically upregulated transcription specific for decorin, fibronectin, osteocalcin, osteopontin, transforming growth factor-beta, type I collagen, and type III collagen. The immunolocalization of the extracellular matrix constituents showed their colocalization in the cell-rich areas. The bioreactor and the polyurethane foam were designed to obtain cell colonization and calcified matrix deposition. This cultured biomaterial could be used, in clinical applications, as an osteoinductive implant for bone repair.
C1 Univ Pavia, Dipartimento Informat & Sistemist, I-27100 Pavia, Italy.
   Univ Pavia, Dipartimento Biochim, I-27100 Pavia, Italy.
   Univ Pavia, Dipartimento SMEC, IRCCS San Matteo, I-27100 Pavia, Italy.
   Univ Pavia, Dipartimento Med Sperimentale, I-27100 Pavia, Italy.
RP Fassina, L (reprint author), Univ Pavia, Dipartimento Informat & Sistemist, Via Ferrata,1, I-27100 Pavia, Italy.
EM lorenzo.fassina@unipv.it
RI Magenes, Giovanni/C-4202-2012; Fassina, Lorenzo/K-9283-2015
OI Magenes, Giovanni/0000-0002-7558-1490; Fassina,
   Lorenzo/0000-0002-5587-4632
CR Aaron RK, 1996, J ORTHOPAED RES, V14, P582, DOI 10.1002/jor.1100140412
   Aaron RK, 2004, CLIN ORTHOP RELAT R, P21, DOI 10.1097/01.blo.0000118699.26862.41
   Aaron RK, 2004, CLIN ORTHOP RELAT R, P30, DOI 10.1097/01.blo.0000118698.46535.83
   Akita S, 2004, TISSUE ENG, V10, P789, DOI 10.1089/1076327041348338
   Anderson HC, 2002, J BONE MINER METAB, V20, P73, DOI 10.1007/s007740200010
   ANDERSON HC, 1995, CLIN ORTHOP RELAT R, P129
   ANDERSON HC, 1992, BONE MINER, V16, P49, DOI 10.1016/0169-6009(92)90821-T
   Bancroft GN, 2002, P NATL ACAD SCI USA, V99, P12600, DOI 10.1073/pnas.202296599
   Banerjee AG, 2003, CANCER RES, V63, P7769
   Belanger MC, 2000, ARTIF ORGANS, V24, P879, DOI 10.1046/j.1525-1594.2000.06504.x
   BIANCO P, 1990, J HISTOCHEM CYTOCHEM, V38, P1549, DOI 10.1177/38.11.2212616
   Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283
   Bodamyali T, 1998, BIOCHEM BIOPH RES CO, V250, P458, DOI 10.1006/bbrc.1998.9243
   Botchwey EA, 2001, J BIOMED MATER RES, V55, P242
   CANE V, 1993, J ORTHOPAED RES, V11, P664, DOI 10.1002/jor.1100110508
   Chang WHS, 2004, BIOELECTROMAGNETICS, V25, P457, DOI 10.1002/bem.20016
   CHUNG CH, 1992, CALCIFIED TISSUE INT, V51, P305, DOI 10.1007/BF00334492
   CIOMBOR DM, 1993, J CELL BIOCHEM, V52, P37, DOI 10.1002/jcb.240520106
   Davies JE, 1996, ANAT REC, V245, P426
   De Mattei M, 1999, BIOELECTROMAGNETICS, V20, P177, DOI 10.1002/(SICI)1521-186X(1999)20:3<177::AID-BEM4>3.0.CO;2-#
   DERYNCK R, 1985, NATURE, V316, P701, DOI 10.1038/316701a0
   Devin JE, 1996, J BIOMAT SCI-POLYM E, V7, P661, DOI 10.1163/156856296X00435
   Diniz P, 2002, BIOELECTROMAGNETICS, V23, P398, DOI 10.1002/bem.10032
   El-Ghannam A, 1999, J ORTHOPAED RES, V17, P340, DOI 10.1002/jor.1100170307
   FARLEY JR, 1994, J BONE MINER RES, V9, P497
   Fassina L, 2005, TISSUE ENG, V11, P685, DOI 10.1089/ten.2005.11.685
   Fisher L W, 1995, Acta Orthop Scand Suppl, V266, P61
   FISHER LW, 1989, J BIOL CHEM, V264, P4571
   FITZSIMMONS RJ, 1994, CALCIFIED TISSUE INT, V55, P376, DOI 10.1007/BF00299318
   FITZSIMMONS RJ, 1995, J BONE MINER RES, V10, P812
   Fu SC, 2005, CLIN ORTHOP RELAT R, P226, DOI 10.1097/01.blo.0000145887.48534.6f
   Gomes ME, 2003, J BIOMED MATER RES A, V67A, P87, DOI 10.1002/jbm.a.10075
   Gorna K, 2003, J BIOMED MATER RES A, V67A, P813, DOI 10.1002/jbm.a.10148
   Gorna K, 2002, J BIOMED MATER RES, V60, P592, DOI 10.1002/jbm.10100
   Guerkov HH, 2001, CLIN ORTHOP RELAT R, P265
   Heermeier K, 1998, BIOELECTROMAGNETICS, V19, P222, DOI 10.1002/(SICI)1521-186X(1998)19:4<222::AID-BEM4>3.0.CO;2-3
   HSU SM, 1981, AM J CLIN PATHOL, V75, P816, DOI 10.1093/ajcp/75.6.816
   IshaugRiley SL, 1997, J BIOMED MATER RES, V36, P1, DOI 10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
   Iwata M, 2004, BLOOD, V103, P4496, DOI 10.1182/blood-2004-01-0256
   Liang XB, 2003, J AM SOC NEPHROL, V14, P1443, DOI 10.1097/01.ASN.000056860.64692.C0
   Lohmann CH, 2000, J ORTHOP RES, V18, P637, DOI 10.1002/jor.1100180417
   Lohmann CH, 2003, J ORTHOP RES, V21, P326, DOI 10.1016/S0736-0266(02)00137-7
   MAKELA JK, 1990, BIOCHIM BIOPHYS ACTA, V1049, P171, DOI 10.1016/0167-4781(90)90037-3
   Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115
   Matsunaga S, 1996, IN VIVO, V10, P351
   Mauney JR, 2004, TISSUE ENG, V10, P81, DOI 10.1089/107632704322791727
   Nishikawa M, 2004, CELL TRANSPLANT, V13, P367, DOI 10.3727/000000004783983819
   Otter MW, 1998, CLIN ORTHOP S, V355S, P90
   Overbergh L, 1999, CYTOKINE, V11, P305, DOI 10.1006/cyto.1998.0426
   OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304
   Pavalko FM, 2003, J CELL BIOCHEM, V88, P104, DOI 10.1002/jcb.10284
   QUARLES LD, 1992, J BONE MINER RES, V7, P683
   Rossi A, 1996, BIOCHEMISTRY-US, V35, P6048, DOI 10.1021/bi9518151
   Sert C, 2002, J BONE MINER METAB, V20, P345, DOI 10.1007/s007740200050
   TENENBAUM HC, 1989, CELL TISSUE RES, V257, P555, DOI 10.1007/BF00221466
   Torricelli P, 2003, J BIOMED MATER RES A, V64A, P182, DOI 10.1002/jbm.a.10372
   van den Dolder J, 2003, BIOMATERIALS, V24, P1745, DOI 10.1016/S0142-9612(02)00537-9
   VERT M, 1994, BIOMATERIALS, V15, P1209, DOI 10.1016/0142-9612(94)90271-2
   VOGEL KG, 1987, J BIOL CHEM, V262, P13607
   Yamada Y, 2003, J CLIN ENDOCR METAB, V88, P3372, DOI 10.1210/jc.2002-021449
   Yang YZ, 2003, J BIOMED MATER RES A, V67A, P344, DOI 10.1002/jbm.a.10578
   ZOU X, 2003, APMIS S, V109, P127
NR 62
TC 79
Z9 82
U1 0
U2 12
PU MARY ANN LIEBERT INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1076-3279
J9 TISSUE ENG
JI Tissue Eng.
PD JUL
PY 2006
VL 12
IS 7
BP 1985
EP 1999
DI 10.1089/ten.2006.12.1985
PG 15
WC Cell & Tissue Engineering
SC Cell Biology
GA 071BK
UT WOS:000239571800025
PM 16889527
DA 2018-10-19
ER

PT J
AU Wang, TW
   Wu, HC
   Huang, YC
   Sun, JS
   Lin, FH
AF Wang, Tzu-Wei
   Wu, Hsi-Chin
   Huang, Yi-Chau
   Sun, Jui-Sheng
   Lin, Feng-Huei
TI PREPARATION AND EVALUATION OF GAG-INCORPORATED SKIN SUBSTITUTE: AN IN
   VITRO STUDY
SO BIOMEDICAL ENGINEERING-APPLICATIONS BASIS COMMUNICATIONS
LA English
DT Article
DE biomaterial; skin substitute; tissue engineering
AB A bi-layered gelatin-C6S-HA membrane with different pore sizes was prepared by freeze-drying at different temperatures 20 and 196, respectively. Glycosaminoglycans (GAGs) were incorporated within the gelatin matrices to mimic the dermal composition and to create an appropriate environment for cell growth. The gelatin-C6S-HA membrane was cross-linked by 1-ethyl- 3(3-dimethylaminopropryl) carbodiimide (EDC) to resist rapidly biodegradation by matrix enzymes. In this study, the lower layer of the sponge was inoculated with dermal fibroblasts for dermis development and as the feeder layer for epidermal keratinocytes. The upper layer was seeded with keratinocytes for epidermalization. After cultured for a period of time in air-liquid interface, the upper layer was developed into an epidermis structure with stratified epidermal layers. The lower part was developed into dermis-like structure synthesized by dermal fibroblasts surrounding with its own secreted extracellular matrix. In brief, the bi-layered skin equivalent with biological dermal analog and epidermal analog would be a suitable tool for autologous skin equivalent tissue engineering.
C1 [Wang, Tzu-Wei; Wu, Hsi-Chin; Huang, Yi-Chau; Lin, Feng-Huei] Natl Taiwan Univ, Coll Med & Engn, Inst Biomed Engn, Taipei, Taiwan.
   [Sun, Jui-Sheng] Natl Yang Ming Univ, Inst Rehabil Sci & Technol, Taipei, Taiwan.
   [Sun, Jui-Sheng] Taipei City Hosp, Dept Orthoped Surg, Yang Ming Branch, Taipei, Taiwan.
RP Lin, FH (reprint author), Natl Taiwan Univ, Inst Biomed Engn, Taipei, Taiwan.
EM double@ha.mc.ntu.edu.tw
OI SUN, JUI-SHENG/0000-0001-5142-8777
CR BOYCE ST, 1988, SURGERY, V103, P421
   Choi YS, 1999, J BIOMED MATER RES, V48, P631, DOI 10.1002/(SICI)1097-4636(1999)48:5<631::AID-JBM6>3.0.CO;2-Y
   Park SN, 2002, BIOMATERIALS, V23, P1205, DOI 10.1016/S0142-9612(01)00235-6
   Pieper JS, 1999, BIOMATERIALS, V20, P847, DOI 10.1016/S0142-9612(98)00240-3
   Purdue Gary F., 1997, Journal of Burn Care and Rehabilitation, V18, P52, DOI 10.1097/00004630-199701000-00009
   RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8
   Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200
   Smola H, 1998, EXP CELL RES, V239, P399, DOI 10.1006/excr.1997.3910
NR 8
TC 1
Z9 1
U1 0
U2 0
PU WORLD SCIENTIFIC PUBL CO PTE LTD
PI SINGAPORE
PA 5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE
SN 1016-2372
EI 1793-7132
J9 BIOMED ENG-APP BAS C
JI Biomed. Eng.-Appl. Basis Commun.
PD JUN 25
PY 2006
VL 18
IS 3
BP 153
EP 157
DI 10.4015/S1016237206000257
PG 5
WC Engineering, Biomedical
SC Engineering
GA V98HV
UT WOS:000213391400008
OA Bronze
DA 2018-10-19
ER

EF